ID,Intake ID,Excretion ID,Subject group,Population,Country,Cohort,Intake Time definition,Intake Assessment method,Intake,Intake detail,Supplement intakes included?,Intake Arithmetic mean,Intake Geometric mean,Intake Median,Intake Unit,Intake Adjusted on,Biomarker Time definition,Biospecimen,Analytical method,Biomarker,Biomarker detail,Biomarker Arithmetic mean,Biomarker Geometric mean,Biomarker Median,Biomarker Unit,Biomarker Adjusted on,Correlation size,Correlation type,Correlation value,Correlation 95% CI lower,Correlation 95% CI upper,Correlation p-value,Significant?,Measurement adjustment,Deattenuated?,Covariates,Publication
3,25,1,All [by creatinine],Elderly subjects,Italy,InCHIANTI (Invecchiare in Chianti),baseline,Food Frequency Questionnaire (FFQ),Polyphenols,"",,,,436.6,mg/day,,,"Urine, 24-h",Folin-Ciocalteu,Polyphenols,"",,,151.0,mg/day,,928,Pearson,0.211,,,< 0.001,Yes,,,,Zamora-Ros 2011
4,25,23,All [by creatinine],Elderly subjects,Italy,InCHIANTI (Invecchiare in Chianti),baseline,Food Frequency Questionnaire (FFQ),Polyphenols,"",,,,436.6,mg/day,,,"Urine, 24-h",Folin-Ciocalteu,Polyphenols,"",,,156.6,mg/g,Creatinine,928,Pearson,0.014,,,= 0.692,No,,,,Zamora-Ros 2011
5,25,23,All [by creatinine],Elderly subjects,Italy,InCHIANTI (Invecchiare in Chianti),baseline,Food Frequency Questionnaire (FFQ),Polyphenols,"",,,,436.6,mg/day,,,"Urine, 24-h",Folin-Ciocalteu,Polyphenols,"",,,156.6,mg/g,Creatinine,928,Pearson,0.113,,,= 0.002,Yes,,,"Age, Sex, Physical activity, BMI, Energy, Renal function",Zamora-Ros 2011
6,25,1,All [by creatinine],Elderly subjects,Italy,InCHIANTI (Invecchiare in Chianti),baseline,Food Frequency Questionnaire (FFQ),Polyphenols,"",,,,436.6,mg/day,,,"Urine, 24-h",Folin-Ciocalteu,Polyphenols,"",,,151.0,mg/day,,928,Pearson,0.164,,,< 0.001,Yes,,,"Age, Sex, Physical activity, BMI, Energy, Renal function",Zamora-Ros 2011
7,34,118,Soy consumers,Cases and controls in a case-control study on uterine fibroids,United States,,,24-h Dietary recall (1-day),Genistein,"",,,30.6,,nmol/day,,,"Urine, overnight",GC-MS after enzymatic hydrolysis,Genistein,"",,,,nmol/mg,Creatinine,76,Pearson,0.43,,,< 0.001,Yes,,,,Atkinson 2002
8,35,119,Soy consumers,Cases and controls in a case-control study on uterine fibroids,United States,,,24-h Dietary recall (1-day),Daidzein,"",,,23.0,,nmol/day,,,"Urine, overnight",GC-MS after enzymatic hydrolysis,Daidzein,"",,,,nmol/mg,Creatinine,76,Pearson,0.49,,,< 0.001,Yes,,,,Atkinson 2002
9,35,122,Soy consumers,Cases and controls in a case-control study on uterine fibroids,United States,,,24-h Dietary recall (1-day),Daidzein,"",,,23.0,,nmol/day,,,"Urine, overnight",GC-MS after enzymatic hydrolysis,Isoflavones,Daidzein + Equol + O-Desmethylangolensin,,,,nmol/mg,Creatinine,76,Pearson,0.55,,,< 0.001,Yes,,,,Atkinson 2002
10,124,44,Soy consumers,Cases and controls in a case-control study on uterine fibroids,United States,,,24-h Dietary recall (1-day),Isoflavones,Genistein + Daidzein,,,,,nmol/day,,,"Urine, overnight",GC-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + O-Desmethylangolensin,,3.4,,nmol/mg,Creatinine,76,Pearson,0.53,,,< 0.001,Yes,,,,Atkinson 2002
11,42,120,Soy consumers,Cases and controls in a case-control study on uterine fibroids,United States,,,Food Frequency Questionnaire (FFQ),Genistein,"",,,24.7,,nmol/week,,,"Urine, overnight",GC-MS after enzymatic hydrolysis,Genistein,"",,,,nmol/mg,Creatinine,105,Pearson,0.31,,,< 0.01,Yes,,,,Atkinson 2002
12,43,121,Soy consumers,Cases and controls in a case-control study on uterine fibroids,United States,,,Food Frequency Questionnaire (FFQ),Daidzein,"",,,17.8,,nmol/week,,,"Urine, overnight",GC-MS after enzymatic hydrolysis,Daidzein,"",,,,nmol/mg,Creatinine,105,Pearson,0.24,,,= 0.01,Yes,,,,Atkinson 2002
13,43,123,Soy consumers,Cases and controls in a case-control study on uterine fibroids,United States,,,Food Frequency Questionnaire (FFQ),Daidzein,"",,,17.8,,nmol/week,,,"Urine, overnight",GC-MS after enzymatic hydrolysis,Isoflavones,Daidzein + Equol + O-Desmethylangolensin,,,,nmol/mg,Creatinine,105,Pearson,0.28,,,< 0.01,Yes,,,,Atkinson 2002
14,125,45,Soy consumers,Cases and controls in a case-control study on uterine fibroids,United States,,,Food Frequency Questionnaire (FFQ),Isoflavones,Genistein + Daidzein,,,,,nmol/week,,,"Urine, overnight",GC-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + O-Desmethylangolensin,,1.4,,nmol/mg,Creatinine,105,Pearson,0.29,,,< 0.01,Yes,,,,Atkinson 2002
855,908,916,Soy consumers (Soy intake: ≥ once a week),Cases and controls in a case-control study on uterine fibroids,United States,,,Food Frequency Questionnaire (FFQ),Genistein,"",,,81.3,,nmol/week,,,"Urine, overnight",GC-MS after enzymatic hydrolysis,Genistein,"",,,,nmol/mg,Creatinine,39,Pearson,0.06,,,= 0.74,No,,,,Atkinson 2002
856,909,918,Soy consumers (Soy intake: ≥ once a week),Cases and controls in a case-control study on uterine fibroids,United States,,,Food Frequency Questionnaire (FFQ),Daidzein,"",,,60.4,,nmol/week,,,"Urine, overnight",GC-MS after enzymatic hydrolysis,Daidzein,"",,,,nmol/mg,Creatinine,39,Pearson,0.03,,,= 0.88,No,,,,Atkinson 2002
857,909,920,Soy consumers (Soy intake: ≥ once a week),Cases and controls in a case-control study on uterine fibroids,United States,,,Food Frequency Questionnaire (FFQ),Daidzein,"",,,60.4,,nmol/week,,,"Urine, overnight",GC-MS after enzymatic hydrolysis,Isoflavones,Daidzein + Equol + O-Desmethylangolensin,,,,nmol/mg,Creatinine,39,Pearson,0.07,,,= 0.65,No,,,,Atkinson 2002
858,914,912,Soy consumers (Soy intake: ≥ once a week),Cases and controls in a case-control study on uterine fibroids,United States,,,Food Frequency Questionnaire (FFQ),Isoflavones,Genistein + Daidzein,,,,,nmol/week,,,"Urine, overnight",GC-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + O-Desmethylangolensin,,2.3,,nmol/mg,Creatinine,39,Pearson,0.07,,,= 0.66,No,,,,Atkinson 2002
859,910,917,Soy consumers (Soy intake: ≥ once or twice a month),Cases and controls in a case-control study on uterine fibroids,United States,,,Food Frequency Questionnaire (FFQ),Genistein,"",,,11.9,,nmol/week,,,"Urine, overnight",GC-MS after enzymatic hydrolysis,Genistein,"",,,,nmol/mg,Creatinine,66,Pearson,0.25,,,= 0.05,No,,,,Atkinson 2002
860,911,919,Soy consumers (Soy intake: ≥ once or twice a month),Cases and controls in a case-control study on uterine fibroids,United States,,,Food Frequency Questionnaire (FFQ),Daidzein,"",,,8.4,,nmol/week,,,"Urine, overnight",GC-MS after enzymatic hydrolysis,Daidzein,"",,,,nmol/mg,Creatinine,66,Pearson,0.12,,,= 0.35,No,,,,Atkinson 2002
861,911,921,Soy consumers (Soy intake: ≥ once or twice a month),Cases and controls in a case-control study on uterine fibroids,United States,,,Food Frequency Questionnaire (FFQ),Daidzein,"",,,8.4,,nmol/week,,,"Urine, overnight",GC-MS after enzymatic hydrolysis,Isoflavones,Daidzein + Equol + O-Desmethylangolensin,,,,nmol/mg,Creatinine,66,Pearson,0.13,,,= 0.3,No,,,,Atkinson 2002
862,915,913,Soy consumers (Soy intake: ≥ once or twice a month),Cases and controls in a case-control study on uterine fibroids,United States,,,Food Frequency Questionnaire (FFQ),Isoflavones,Genistein + Daidzein,,,,,nmol/week,,,"Urine, overnight",GC-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + O-Desmethylangolensin,,1.0,,nmol/mg,Creatinine,66,Pearson,0.16,,,= 0.2,No,,,,Atkinson 2002
15,51,46,All,Controls in a case-control study on prostate cancer inherited susceptibility and diet,United Kingdom,PCANDIET (Prostate Cancer and Diet),,Food Frequency Questionnaire (FFQ),Isoflavones,"",,,,1.0,mg/day,,,"Serum, non-fasting",GC-ID-MS after enzymatic hydrolysis,Equol,"",,,0.0,nmol/L,,198,Spearman,0.07,,,= 0.315,No,,,,Heald 2006
16,51,47,All,Controls in a case-control study on prostate cancer inherited susceptibility and diet,United Kingdom,PCANDIET (Prostate Cancer and Diet),,Food Frequency Questionnaire (FFQ),Isoflavones,"",,,,1.0,mg/day,,,"Serum, non-fasting",GC-ID-MS after enzymatic hydrolysis,Daidzein,"",,,18.0,nmol/L,,198,Spearman,0.24,,,= 0.001,Yes,,,,Heald 2006
17,51,49,All,Controls in a case-control study on prostate cancer inherited susceptibility and diet,United Kingdom,PCANDIET (Prostate Cancer and Diet),,Food Frequency Questionnaire (FFQ),Isoflavones,"",,,,1.0,mg/day,,,"Serum, non-fasting",GC-ID-MS after enzymatic hydrolysis,Isoflavones,Daidzein + Equol,,,18.66,nmol/L,,198,Spearman,0.24,,,= 0.001,Yes,,,,Heald 2006
18,51,48,All,Controls in a case-control study on prostate cancer inherited susceptibility and diet,United Kingdom,PCANDIET (Prostate Cancer and Diet),,Food Frequency Questionnaire (FFQ),Isoflavones,"",,,,1.0,mg/day,,,"Serum, non-fasting",GC-ID-MS after enzymatic hydrolysis,Genistein,"",,,33.79,nmol/L,,196,Spearman,0.26,,,< 0.001,Yes,,,,Heald 2006
19,51,50,All,Controls in a case-control study on prostate cancer inherited susceptibility and diet,United Kingdom,PCANDIET (Prostate Cancer and Diet),,Food Frequency Questionnaire (FFQ),Isoflavones,"",,,,1.0,mg/day,,,"Serum, non-fasting",GC-ID-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol,,,51.49,nmol/L,,196,Spearman,0.27,,,< 0.001,Yes,,,,Heald 2006
20,126,129,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Daidzein,"",,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Daidzein,"",,,,nmol/mg,Creatinine,24,Spearman,0.64,,,< 0.01,Yes,,,,Kim 2010
21,126,130,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Daidzein,"",,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Genistein,"",,,,nmol/mg,Creatinine,24,Spearman,0.62,,,< 0.001,Yes,,,,Kim 2010
22,126,131,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Daidzein,"",,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Glycitein,"",,,,nmol/mg,Creatinine,24,Spearman,0.59,,,< 0.01,Yes,,,,Kim 2010
23,126,132,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Daidzein,"",,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Equol,"",,,,nmol/mg,Creatinine,24,Spearman,0.21,,,>= 0.05,No,,,,Kim 2010
24,126,133,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Daidzein,"",,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,O-Desmethylangolensin,"",,,,nmol/mg,Creatinine,24,Spearman,0.43,,,< 0.05,Yes,,,,Kim 2010
25,126,134,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Daidzein,"",,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Dihydrodaidzein,"",,,,nmol/mg,Creatinine,24,Spearman,0.36,,,>= 0.05,No,,,,Kim 2010
26,126,135,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Daidzein,"",,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Dihydrogenistein,"",,,,nmol/mg,Creatinine,24,Spearman,0.17,,,>= 0.05,No,,,,Kim 2010
29,126,136,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Daidzein,"",,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin + Dihydrodaidzein + Dihydrogenistein,,,,nmol/mg,Creatinine,24,Spearman,0.74,,,< 0.001,Yes,,,,Kim 2010
30,126,140,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Daidzein,"",,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Glycitein,,,,nmol/mg,Creatinine,24,Spearman,0.71,,,< 0.001,Yes,,,,Kim 2010
31,127,129,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Genistein,"",,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Daidzein,"",,,,nmol/mg,Creatinine,24,Spearman,0.58,,,< 0.01,Yes,,,,Kim 2010
32,127,130,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Genistein,"",,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Genistein,"",,,,nmol/mg,Creatinine,24,Spearman,0.62,,,< 0.01,Yes,,,,Kim 2010
33,127,131,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Genistein,"",,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Glycitein,"",,,,nmol/mg,Creatinine,24,Spearman,0.55,,,< 0.01,Yes,,,,Kim 2010
34,127,132,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Genistein,"",,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Equol,"",,,,nmol/mg,Creatinine,24,Spearman,0.2,,,>= 0.05,No,,,,Kim 2010
35,127,133,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Genistein,"",,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,O-Desmethylangolensin,"",,,,nmol/mg,Creatinine,24,Spearman,0.39,,,>= 0.05,No,,,,Kim 2010
36,127,134,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Genistein,"",,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Dihydrodaidzein,"",,,,nmol/mg,Creatinine,24,Spearman,0.38,,,>= 0.05,No,,,,Kim 2010
37,127,135,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Genistein,"",,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Dihydrogenistein,"",,,,nmol/mg,Creatinine,24,Spearman,0.14,,,>= 0.05,No,,,,Kim 2010
40,127,136,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Genistein,"",,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin + Dihydrodaidzein + Dihydrogenistein,,,,nmol/mg,Creatinine,24,Spearman,0.68,,,< 0.001,Yes,,,,Kim 2010
41,127,140,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Genistein,"",,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Glycitein,,,,nmol/mg,Creatinine,24,Spearman,0.63,,,< 0.01,Yes,,,,Kim 2010
42,128,129,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Glycitein,"",,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Daidzein,"",,,,nmol/mg,Creatinine,24,Spearman,0.63,,,< 0.001,Yes,,,,Kim 2010
43,128,130,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Glycitein,"",,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Genistein,"",,,,nmol/mg,Creatinine,24,Spearman,0.69,,,< 0.001,Yes,,,,Kim 2010
44,128,131,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Glycitein,"",,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Glycitein,"",,,,nmol/mg,Creatinine,24,Spearman,0.57,,,< 0.01,Yes,,,,Kim 2010
45,128,132,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Glycitein,"",,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Equol,"",,,,nmol/mg,Creatinine,24,Spearman,0.21,,,>= 0.05,No,,,,Kim 2010
46,128,133,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Glycitein,"",,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,O-Desmethylangolensin,"",,,,nmol/mg,Creatinine,24,Spearman,0.3,,,>= 0.05,No,,,,Kim 2010
47,128,134,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Glycitein,"",,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Dihydrodaidzein,"",,,,nmol/mg,Creatinine,24,Spearman,0.17,,,>= 0.05,No,,,,Kim 2010
48,128,135,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Glycitein,"",,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Dihydrogenistein,"",,,,nmol/mg,Creatinine,24,Spearman,0.14,,,>= 0.05,No,,,,Kim 2010
51,128,136,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Glycitein,"",,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin + Dihydrodaidzein + Dihydrogenistein,,,,nmol/mg,Creatinine,24,Spearman,0.71,,,< 0.001,Yes,,,,Kim 2010
52,128,140,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Glycitein,"",,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Glycitein,,,,nmol/mg,Creatinine,24,Spearman,0.64,,,< 0.01,Yes,,,,Kim 2010
53,137,129,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Isoflavones,Genistein + Daidzein + Glycitein,,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Daidzein,"",,,,nmol/mg,Creatinine,24,Spearman,0.61,,,< 0.01,Yes,,,,Kim 2010
54,137,130,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Isoflavones,Genistein + Daidzein + Glycitein,,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Genistein,"",,,,nmol/mg,Creatinine,24,Spearman,0.64,,,< 0.01,Yes,,,,Kim 2010
55,137,131,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Isoflavones,Genistein + Daidzein + Glycitein,,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Glycitein,"",,,,nmol/mg,Creatinine,24,Spearman,0.59,,,< 0.01,Yes,,,,Kim 2010
56,137,132,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Isoflavones,Genistein + Daidzein + Glycitein,,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Equol,"",,,,nmol/mg,Creatinine,24,Spearman,0.22,,,>= 0.05,No,,,,Kim 2010
57,137,133,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Isoflavones,Genistein + Daidzein + Glycitein,,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,O-Desmethylangolensin,"",,,,nmol/mg,Creatinine,24,Spearman,0.41,,,< 0.05,Yes,,,,Kim 2010
58,137,134,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Isoflavones,Genistein + Daidzein + Glycitein,,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Dihydrodaidzein,"",,,,nmol/mg,Creatinine,24,Spearman,0.35,,,>= 0.05,No,,,,Kim 2010
59,137,135,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Isoflavones,Genistein + Daidzein + Glycitein,,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Dihydrogenistein,"",,,,nmol/mg,Creatinine,24,Spearman,0.19,,,>= 0.05,No,,,,Kim 2010
62,137,136,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Isoflavones,Genistein + Daidzein + Glycitein,,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin + Dihydrodaidzein + Dihydrogenistein,,,,nmol/mg,Creatinine,24,Spearman,0.72,,,< 0.001,Yes,,,,Kim 2010
63,137,140,All [by intake],Pubertal girls,"Korea, Republic of",,,Dietary record (3-day),Isoflavones,Genistein + Daidzein + Glycitein,,,,,mg/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Glycitein,,,,nmol/mg,Creatinine,24,Spearman,0.68,,,< 0.01,Yes,,,,Kim 2010
64,86,94,All,Female university students,Germany,,,Dietary record (7-day),Quercetin,"",,17.89,,17.25,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Quercetin,"",22.87,,20.26,nmol/L,,48,Spearman,0.3,,,< 0.05,Yes,,,,Radtke 2002
76,86,95,All,Female university students,Germany,,,Dietary record (7-day),Quercetin,"",,17.89,,17.25,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Kaempferol,"",10.65,,8.72,nmol/L,,48,Spearman,0.14,,,>= 0.05,No,,,,Radtke 2002
88,86,145,All,Female university students,Germany,,,Dietary record (7-day),Quercetin,"",,17.89,,17.25,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonols,Quercetin + Kaempferol,,,,nmol/L,,47,Spearman,0.26,,,>= 0.05,No,,,,Radtke 2002
100,86,96,All,Female university students,Germany,,,Dietary record (7-day),Quercetin,"",,17.89,,17.25,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Naringenin,"",8.15,,0.0,nmol/L,,45,Spearman,-0.05,,,>= 0.05,No,,,,Radtke 2002
112,86,97,All,Female university students,Germany,,,Dietary record (7-day),Quercetin,"",,17.89,,17.25,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Hesperetin,"",22.16,,5.75,nmol/L,,47,Spearman,0.02,,,>= 0.05,No,,,,Radtke 2002
124,86,146,All,Female university students,Germany,,,Dietary record (7-day),Quercetin,"",,17.89,,17.25,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavanones,Naringenin + Hesperetin,,,,nmol/L,,45,Spearman,0.01,,,>= 0.05,No,,,,Radtke 2002
65,87,94,All,Female university students,Germany,,,Dietary record (7-day),Kaempferol,"",,4.72,,3.16,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Quercetin,"",22.87,,20.26,nmol/L,,48,Spearman,0.4,,,< 0.01,Yes,,,,Radtke 2002
77,87,95,All,Female university students,Germany,,,Dietary record (7-day),Kaempferol,"",,4.72,,3.16,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Kaempferol,"",10.65,,8.72,nmol/L,,48,Spearman,0.46,,,< 0.01,Yes,,,,Radtke 2002
89,87,145,All,Female university students,Germany,,,Dietary record (7-day),Kaempferol,"",,4.72,,3.16,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonols,Quercetin + Kaempferol,,,,nmol/L,,47,Spearman,0.5,,,< 0.01,Yes,,,,Radtke 2002
101,87,96,All,Female university students,Germany,,,Dietary record (7-day),Kaempferol,"",,4.72,,3.16,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Naringenin,"",8.15,,0.0,nmol/L,,45,Spearman,-0.09,,,>= 0.05,No,,,,Radtke 2002
113,87,97,All,Female university students,Germany,,,Dietary record (7-day),Kaempferol,"",,4.72,,3.16,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Hesperetin,"",22.16,,5.75,nmol/L,,47,Spearman,0.04,,,>= 0.05,No,,,,Radtke 2002
125,87,146,All,Female university students,Germany,,,Dietary record (7-day),Kaempferol,"",,4.72,,3.16,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavanones,Naringenin + Hesperetin,,,,nmol/L,,45,Spearman,0.0,,,>= 0.05,No,,,,Radtke 2002
67,88,94,All,Female university students,Germany,,,Dietary record (7-day),Naringenin,"",,12.11,,5.45,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Quercetin,"",22.87,,20.26,nmol/L,,48,Spearman,0.08,,,>= 0.05,No,,,,Radtke 2002
79,88,95,All,Female university students,Germany,,,Dietary record (7-day),Naringenin,"",,12.11,,5.45,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Kaempferol,"",10.65,,8.72,nmol/L,,48,Spearman,-0.1,,,>= 0.05,No,,,,Radtke 2002
91,88,145,All,Female university students,Germany,,,Dietary record (7-day),Naringenin,"",,12.11,,5.45,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonols,Quercetin + Kaempferol,,,,nmol/L,,47,Spearman,0.02,,,>= 0.05,No,,,,Radtke 2002
103,88,96,All,Female university students,Germany,,,Dietary record (7-day),Naringenin,"",,12.11,,5.45,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Naringenin,"",8.15,,0.0,nmol/L,,45,Spearman,0.35,,,< 0.05,Yes,,,,Radtke 2002
115,88,97,All,Female university students,Germany,,,Dietary record (7-day),Naringenin,"",,12.11,,5.45,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Hesperetin,"",22.16,,5.75,nmol/L,,47,Spearman,0.5,,,< 0.01,Yes,,,,Radtke 2002
127,88,146,All,Female university students,Germany,,,Dietary record (7-day),Naringenin,"",,12.11,,5.45,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavanones,Naringenin + Hesperetin,,,,nmol/L,,45,Spearman,0.45,,,< 0.01,Yes,,,,Radtke 2002
68,89,94,All,Female university students,Germany,,,Dietary record (7-day),Hesperetin,"",,17.37,,13.06,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Quercetin,"",22.87,,20.26,nmol/L,,48,Spearman,-0.16,,,>= 0.05,No,,,,Radtke 2002
80,89,95,All,Female university students,Germany,,,Dietary record (7-day),Hesperetin,"",,17.37,,13.06,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Kaempferol,"",10.65,,8.72,nmol/L,,48,Spearman,-0.08,,,>= 0.05,No,,,,Radtke 2002
92,89,145,All,Female university students,Germany,,,Dietary record (7-day),Hesperetin,"",,17.37,,13.06,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonols,Quercetin + Kaempferol,,,,nmol/L,,47,Spearman,-0.15,,,>= 0.05,No,,,,Radtke 2002
104,89,96,All,Female university students,Germany,,,Dietary record (7-day),Hesperetin,"",,17.37,,13.06,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Naringenin,"",8.15,,0.0,nmol/L,,45,Spearman,0.3,,,< 0.05,Yes,,,,Radtke 2002
116,89,97,All,Female university students,Germany,,,Dietary record (7-day),Hesperetin,"",,17.37,,13.06,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Hesperetin,"",22.16,,5.75,nmol/L,,47,Spearman,0.32,,,< 0.05,Yes,,,,Radtke 2002
128,89,146,All,Female university students,Germany,,,Dietary record (7-day),Hesperetin,"",,17.37,,13.06,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavanones,Naringenin + Hesperetin,,,,nmol/L,,45,Spearman,0.3,,,< 0.05,Yes,,,,Radtke 2002
70,90,94,All,Female university students,Germany,,,Dietary record (1-day),Quercetin,"",,24.0,,16.53,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Quercetin,"",22.87,,20.26,nmol/L,,48,Spearman,0.42,,,< 0.01,Yes,,,,Radtke 2002
82,90,95,All,Female university students,Germany,,,Dietary record (1-day),Quercetin,"",,24.0,,16.53,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Kaempferol,"",10.65,,8.72,nmol/L,,48,Spearman,0.28,,,>= 0.05,No,,,,Radtke 2002
94,90,145,All,Female university students,Germany,,,Dietary record (1-day),Quercetin,"",,24.0,,16.53,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonols,Quercetin + Kaempferol,,,,nmol/L,,47,Spearman,0.45,,,< 0.01,Yes,,,,Radtke 2002
106,90,96,All,Female university students,Germany,,,Dietary record (1-day),Quercetin,"",,24.0,,16.53,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Naringenin,"",8.15,,0.0,nmol/L,,45,Spearman,-0.02,,,>= 0.05,No,,,,Radtke 2002
118,90,97,All,Female university students,Germany,,,Dietary record (1-day),Quercetin,"",,24.0,,16.53,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Hesperetin,"",22.16,,5.75,nmol/L,,47,Spearman,0.08,,,>= 0.05,No,,,,Radtke 2002
130,90,146,All,Female university students,Germany,,,Dietary record (1-day),Quercetin,"",,24.0,,16.53,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavanones,Naringenin + Hesperetin,,,,nmol/L,,45,Spearman,0.03,,,>= 0.05,No,,,,Radtke 2002
71,91,94,All,Female university students,Germany,,,Dietary record (1-day),Kaempferol,"",,5.27,,2.21,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Quercetin,"",22.87,,20.26,nmol/L,,48,Spearman,0.21,,,>= 0.05,No,,,,Radtke 2002
83,91,95,All,Female university students,Germany,,,Dietary record (1-day),Kaempferol,"",,5.27,,2.21,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Kaempferol,"",10.65,,8.72,nmol/L,,48,Spearman,0.5,,,< 0.01,Yes,,,,Radtke 2002
95,91,145,All,Female university students,Germany,,,Dietary record (1-day),Kaempferol,"",,5.27,,2.21,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonols,Quercetin + Kaempferol,,,,nmol/L,,47,Spearman,0.43,,,< 0.01,Yes,,,,Radtke 2002
107,91,96,All,Female university students,Germany,,,Dietary record (1-day),Kaempferol,"",,5.27,,2.21,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Naringenin,"",8.15,,0.0,nmol/L,,45,Spearman,-0.07,,,>= 0.05,No,,,,Radtke 2002
119,91,97,All,Female university students,Germany,,,Dietary record (1-day),Kaempferol,"",,5.27,,2.21,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Hesperetin,"",22.16,,5.75,nmol/L,,47,Spearman,0.07,,,>= 0.05,No,,,,Radtke 2002
131,91,146,All,Female university students,Germany,,,Dietary record (1-day),Kaempferol,"",,5.27,,2.21,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavanones,Naringenin + Hesperetin,,,,nmol/L,,45,Spearman,0.0,,,>= 0.05,No,,,,Radtke 2002
73,92,94,All,Female university students,Germany,,,Dietary record (1-day),Naringenin,"",,9.38,,0.43,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Quercetin,"",22.87,,20.26,nmol/L,,48,Spearman,0.07,,,>= 0.05,No,,,,Radtke 2002
85,92,95,All,Female university students,Germany,,,Dietary record (1-day),Naringenin,"",,9.38,,0.43,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Kaempferol,"",10.65,,8.72,nmol/L,,48,Spearman,-0.07,,,>= 0.05,No,,,,Radtke 2002
97,92,145,All,Female university students,Germany,,,Dietary record (1-day),Naringenin,"",,9.38,,0.43,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonols,Quercetin + Kaempferol,,,,nmol/L,,47,Spearman,0.02,,,>= 0.05,No,,,,Radtke 2002
109,92,96,All,Female university students,Germany,,,Dietary record (1-day),Naringenin,"",,9.38,,0.43,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Naringenin,"",8.15,,0.0,nmol/L,,45,Spearman,0.47,,,< 0.01,Yes,,,,Radtke 2002
121,92,97,All,Female university students,Germany,,,Dietary record (1-day),Naringenin,"",,9.38,,0.43,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Hesperetin,"",22.16,,5.75,nmol/L,,47,Spearman,0.65,,,< 0.01,Yes,,,,Radtke 2002
133,92,146,All,Female university students,Germany,,,Dietary record (1-day),Naringenin,"",,9.38,,0.43,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavanones,Naringenin + Hesperetin,,,,nmol/L,,45,Spearman,0.6,,,< 0.01,Yes,,,,Radtke 2002
74,93,94,All,Female university students,Germany,,,Dietary record (1-day),Hesperetin,"",,14.39,,2.43,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Quercetin,"",22.87,,20.26,nmol/L,,48,Spearman,-0.02,,,>= 0.05,No,,,,Radtke 2002
86,93,95,All,Female university students,Germany,,,Dietary record (1-day),Hesperetin,"",,14.39,,2.43,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Kaempferol,"",10.65,,8.72,nmol/L,,48,Spearman,-0.03,,,>= 0.05,No,,,,Radtke 2002
98,93,145,All,Female university students,Germany,,,Dietary record (1-day),Hesperetin,"",,14.39,,2.43,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonols,Quercetin + Kaempferol,,,,nmol/L,,47,Spearman,-0.01,,,>= 0.05,No,,,,Radtke 2002
110,93,96,All,Female university students,Germany,,,Dietary record (1-day),Hesperetin,"",,14.39,,2.43,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Naringenin,"",8.15,,0.0,nmol/L,,45,Spearman,0.43,,,< 0.01,Yes,,,,Radtke 2002
122,93,97,All,Female university students,Germany,,,Dietary record (1-day),Hesperetin,"",,14.39,,2.43,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Hesperetin,"",22.16,,5.75,nmol/L,,47,Spearman,0.64,,,< 0.01,Yes,,,,Radtke 2002
134,93,146,All,Female university students,Germany,,,Dietary record (1-day),Hesperetin,"",,14.39,,2.43,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavanones,Naringenin + Hesperetin,,,,nmol/L,,45,Spearman,0.59,,,< 0.01,Yes,,,,Radtke 2002
75,141,94,All,Female university students,Germany,,,Dietary record (1-day),Flavanones,Naringenin + Hesperetin,,,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Quercetin,"",22.87,,20.26,nmol/L,,48,Spearman,0.03,,,>= 0.05,No,,,,Radtke 2002
87,141,95,All,Female university students,Germany,,,Dietary record (1-day),Flavanones,Naringenin + Hesperetin,,,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Kaempferol,"",10.65,,8.72,nmol/L,,48,Spearman,-0.07,,,>= 0.05,No,,,,Radtke 2002
99,141,145,All,Female university students,Germany,,,Dietary record (1-day),Flavanones,Naringenin + Hesperetin,,,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonols,Quercetin + Kaempferol,,,,nmol/L,,47,Spearman,-0.01,,,>= 0.05,No,,,,Radtke 2002
111,141,96,All,Female university students,Germany,,,Dietary record (1-day),Flavanones,Naringenin + Hesperetin,,,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Naringenin,"",8.15,,0.0,nmol/L,,45,Spearman,0.44,,,< 0.01,Yes,,,,Radtke 2002
123,141,97,All,Female university students,Germany,,,Dietary record (1-day),Flavanones,Naringenin + Hesperetin,,,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Hesperetin,"",22.16,,5.75,nmol/L,,47,Spearman,0.63,,,< 0.01,Yes,,,,Radtke 2002
135,141,146,All,Female university students,Germany,,,Dietary record (1-day),Flavanones,Naringenin + Hesperetin,,,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavanones,Naringenin + Hesperetin,,,,nmol/L,,45,Spearman,0.57,,,< 0.01,Yes,,,,Radtke 2002
72,142,94,All,Female university students,Germany,,,Dietary record (1-day),Flavonols,Quercetin + Kaempferol,,,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Quercetin,"",22.87,,20.26,nmol/L,,48,Spearman,0.42,,,< 0.01,Yes,,,,Radtke 2002
84,142,95,All,Female university students,Germany,,,Dietary record (1-day),Flavonols,Quercetin + Kaempferol,,,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Kaempferol,"",10.65,,8.72,nmol/L,,48,Spearman,0.37,,,< 0.01,Yes,,,,Radtke 2002
96,142,145,All,Female university students,Germany,,,Dietary record (1-day),Flavonols,Quercetin + Kaempferol,,,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonols,Quercetin + Kaempferol,,,,nmol/L,,47,Spearman,0.49,,,< 0.01,Yes,,,,Radtke 2002
108,142,96,All,Female university students,Germany,,,Dietary record (1-day),Flavonols,Quercetin + Kaempferol,,,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Naringenin,"",8.15,,0.0,nmol/L,,45,Spearman,-0.06,,,>= 0.05,No,,,,Radtke 2002
120,142,97,All,Female university students,Germany,,,Dietary record (1-day),Flavonols,Quercetin + Kaempferol,,,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Hesperetin,"",22.16,,5.75,nmol/L,,47,Spearman,0.08,,,>= 0.05,No,,,,Radtke 2002
132,142,146,All,Female university students,Germany,,,Dietary record (1-day),Flavonols,Quercetin + Kaempferol,,,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavanones,Naringenin + Hesperetin,,,,nmol/L,,45,Spearman,0.01,,,>= 0.05,No,,,,Radtke 2002
69,143,94,All,Female university students,Germany,,,Dietary record (7-day),Flavanones,Naringenin + Hesperetin,,,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Quercetin,"",22.87,,20.26,nmol/L,,48,Spearman,0.02,,,>= 0.05,No,,,,Radtke 2002
81,143,95,All,Female university students,Germany,,,Dietary record (7-day),Flavanones,Naringenin + Hesperetin,,,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Kaempferol,"",10.65,,8.72,nmol/L,,48,Spearman,-0.12,,,>= 0.05,No,,,,Radtke 2002
93,143,145,All,Female university students,Germany,,,Dietary record (7-day),Flavanones,Naringenin + Hesperetin,,,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonols,Quercetin + Kaempferol,,,,nmol/L,,47,Spearman,-0.02,,,>= 0.05,No,,,,Radtke 2002
105,143,96,All,Female university students,Germany,,,Dietary record (7-day),Flavanones,Naringenin + Hesperetin,,,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Naringenin,"",8.15,,0.0,nmol/L,,45,Spearman,0.36,,,< 0.05,Yes,,,,Radtke 2002
117,143,97,All,Female university students,Germany,,,Dietary record (7-day),Flavanones,Naringenin + Hesperetin,,,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Hesperetin,"",22.16,,5.75,nmol/L,,47,Spearman,0.46,,,< 0.01,Yes,,,,Radtke 2002
129,143,146,All,Female university students,Germany,,,Dietary record (7-day),Flavanones,Naringenin + Hesperetin,,,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavanones,Naringenin + Hesperetin,,,,nmol/L,,45,Spearman,0.42,,,< 0.01,Yes,,,,Radtke 2002
66,144,94,All,Female university students,Germany,,,Dietary record (7-day),Flavonols,Quercetin + Kaempferol,,,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Quercetin,"",22.87,,20.26,nmol/L,,48,Spearman,0.36,,,< 0.05,Yes,,,,Radtke 2002
78,144,95,All,Female university students,Germany,,,Dietary record (7-day),Flavonols,Quercetin + Kaempferol,,,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Kaempferol,"",10.65,,8.72,nmol/L,,48,Spearman,0.27,,,>= 0.05,No,,,,Radtke 2002
90,144,145,All,Female university students,Germany,,,Dietary record (7-day),Flavonols,Quercetin + Kaempferol,,,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonols,Quercetin + Kaempferol,,,,nmol/L,,47,Spearman,0.37,,,< 0.01,Yes,,,,Radtke 2002
102,144,96,All,Female university students,Germany,,,Dietary record (7-day),Flavonols,Quercetin + Kaempferol,,,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Naringenin,"",8.15,,0.0,nmol/L,,45,Spearman,-0.07,,,>= 0.05,No,,,,Radtke 2002
114,144,97,All,Female university students,Germany,,,Dietary record (7-day),Flavonols,Quercetin + Kaempferol,,,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Hesperetin,"",22.16,,5.75,nmol/L,,47,Spearman,0.04,,,>= 0.05,No,,,,Radtke 2002
126,144,146,All,Female university students,Germany,,,Dietary record (7-day),Flavonols,Quercetin + Kaempferol,,,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavanones,Naringenin + Hesperetin,,,,nmol/L,,45,Spearman,0.01,,,>= 0.05,No,,,,Radtke 2002
137,104,109,All,Women at high risk for breast or ovarian cancer participant in a cancer risk assessment program,United States,,baseline,Food Frequency Questionnaire (FFQ),Genistein,"",,3.9,,0.013,mg/day,,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Genistein,"",136.4,,67.4,ng/mg,Creatinine,27,Spearman,0.54,,, ,Unspecified,,,,Tseng 2008
136,106,108,All,Women at high risk for breast or ovarian cancer participant in a cancer risk assessment program,United States,,baseline,Food Frequency Questionnaire (FFQ),Daidzein,"",,2.9,,0.015,mg/day,,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Daidzein,"",313.4,,110.3,ng/mg,Creatinine,27,Spearman,0.48,,, ,Unspecified,,,,Tseng 2008
138,105,108,All,Women at high risk for breast or ovarian cancer participant in a cancer risk assessment program,United States,,baseline,Food Frequency Questionnaire (FFQ),Daidzein,"",,2.1,,0.032,mg/day,,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Daidzein,"",313.4,,110.3,ng/mg,Creatinine,27,Spearman,0.38,,, ,Unspecified,,,,Tseng 2008
139,107,109,All,Women at high risk for breast or ovarian cancer participant in a cancer risk assessment program,United States,,baseline,Food Frequency Questionnaire (FFQ),Genistein,"",,2.2,,0.129,mg/day,,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Genistein,"",136.4,,67.4,ng/mg,Creatinine,27,Spearman,0.33,,, ,Unspecified,,,,Tseng 2008
397,426,578,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Apple,"",,,,47.0,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Phloretin,"",,,,umol/L,,119,Pearson,0.22,,,< 0.05,Yes,,,,Brantsaeter 2007
468,426,600,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Apple,"",,,,47.0,g/day,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,119,Pearson,0.16,,,>= 0.05,No,,,,Brantsaeter 2007
399,428,578,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Fruits,Apple,,,,250.0,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Phloretin,"",,,,umol/L,,119,Pearson,0.29,,,< 0.01,Yes,,,,Brantsaeter 2007
470,428,600,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Fruits,Apple,,,,250.0,g/day,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,119,Pearson,0.11,,,>= 0.05,No,,,,Brantsaeter 2007
403,430,580,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Fruit juices,"",,,,150.0,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Hesperetin,"",,,,umol/L,,119,Pearson,0.21,,,< 0.05,Yes,,,,Brantsaeter 2007
472,430,602,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Fruit juices,"",,,,150.0,g/day,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,119,Pearson,0.14,,,>= 0.05,No,,,,Brantsaeter 2007
405,432,582,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Flavanones,Naringenin + Hesperetin + Eriodictyol,,,,umol/L,,119,Pearson,0.39,,,< 0.01,Yes,,,,Brantsaeter 2007
407,432,580,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Hesperetin,"",,,,umol/L,,119,Pearson,0.41,,,< 0.01,Yes,,,,Brantsaeter 2007
474,432,602,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,g/day,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,119,Pearson,0.29,,,< 0.01,Yes,,,,Brantsaeter 2007
476,432,604,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,g/day,,,"Plasma, unspecified",HPLC,Zeaxanthin,"",,,,umol/L,,119,Pearson,0.28,,,< 0.01,Yes,,,,Brantsaeter 2007
409,434,578,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Fruits,Apple + Fruit juices,,,,420.0,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Phloretin,"",,,,umol/L,,119,Pearson,0.21,,,< 0.05,Yes,,,,Brantsaeter 2007
478,434,604,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Fruits,Apple + Fruit juices,,,,420.0,g/day,,,"Plasma, unspecified",HPLC,Zeaxanthin,"",,,,umol/L,,119,Pearson,0.21,,,< 0.05,Yes,,,,Brantsaeter 2007
480,436,606,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Tomato,"",,,,,g/day,,,"Plasma, unspecified",HPLC,Lycopene,"",,,,umol/L,,119,Pearson,0.25,,,< 0.01,Yes,,,,Brantsaeter 2007
482,438,600,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Carrot,"",,,,,g/day,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,119,Pearson,0.34,,,< 0.01,Yes,,,,Brantsaeter 2007
411,440,584,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Vegetables,Tomato + Carrot,,,,84.0,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Isorhamnetin,"",,,,umol/L,,119,Pearson,0.02,,,>= 0.05,No,,,,Brantsaeter 2007
484,440,608,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Vegetables,Tomato + Carrot,,,,84.0,g/day,,,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,umol/L,,119,Pearson,0.18,,,>= 0.05,No,,,,Brantsaeter 2007
413,442,586,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,28.0,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Enterolactone,"",,,,umol/L,,119,Pearson,0.21,,,< 0.05,Yes,,,,Brantsaeter 2007
486,442,610,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,28.0,g/day,,,"Plasma, unspecified",HPLC,Lutein,"",,,,umol/L,,119,Pearson,0.2,,,< 0.05,Yes,,,,Brantsaeter 2007
415,444,586,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Vegetables,Vegetables,,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Enterolactone,"",,,,umol/L,,119,Pearson,0.2,,,< 0.05,Yes,,,,Brantsaeter 2007
488,444,600,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Vegetables,Vegetables,,,,,g/day,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,119,Pearson,0.34,,,< 0.01,Yes,,,,Brantsaeter 2007
417,446,588,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Soy foods,"",,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein,,,,umol/L,,119,Pearson,0.24,,,< 0.01,Yes,,,,Brantsaeter 2007
419,448,590,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Vegetables,Tomato + Carrot + Vegetables,,,,170.0,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Quercetin,"",,,,umol/L,,119,Pearson,0.01,,,>= 0.05,No,,,,Brantsaeter 2007
421,448,594,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Vegetables,Tomato + Carrot + Vegetables,,,,170.0,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Flavonoids,Quercetin + Kaempferol + Naringenin + Hesperetin + Isorhamnetin + Apigenin + Phloretin + Eriodictyol + Tamarixetin,,,,umol/L,,119,Pearson,-0.14,,,>= 0.05,No,,,,Brantsaeter 2007
490,448,600,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Vegetables,Tomato + Carrot + Vegetables,,,,170.0,g/day,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,119,Pearson,0.18,,,>= 0.05,No,,,,Brantsaeter 2007
492,448,608,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Vegetables,Tomato + Carrot + Vegetables,,,,170.0,g/day,,,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,umol/L,,119,Pearson,0.21,,,< 0.05,Yes,,,,Brantsaeter 2007
423,452,578,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,630.0,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Phloretin,"",,,,umol/L,,119,Pearson,0.26,,,< 0.01,Yes,,,,Brantsaeter 2007
425,452,582,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,630.0,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Flavanones,Naringenin + Hesperetin + Eriodictyol,,,,umol/L,,119,Pearson,0.15,,,>= 0.05,No,,,,Brantsaeter 2007
427,452,596,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,630.0,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Flavonols,Isorhamnetin + Tamarixetin,,,,umol/L,,119,Pearson,0.1,,,>= 0.05,No,,,,Brantsaeter 2007
429,452,594,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,630.0,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Flavonoids,Quercetin + Kaempferol + Naringenin + Hesperetin + Isorhamnetin + Apigenin + Phloretin + Eriodictyol + Tamarixetin,,,,umol/L,,119,Pearson,0.16,,,>= 0.05,No,,,,Brantsaeter 2007
494,452,610,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,630.0,g/day,,,"Plasma, unspecified",HPLC,Lutein,"",,,,umol/L,,119,Pearson,0.23,,,< 0.05,Yes,,,,Brantsaeter 2007
496,452,602,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,630.0,g/day,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,119,Pearson,0.19,,,< 0.05,Yes,,,,Brantsaeter 2007
498,452,600,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,630.0,g/day,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,119,Pearson,0.1,,,>= 0.05,No,,,,Brantsaeter 2007
500,452,608,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,630.0,g/day,,,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,umol/L,,119,Pearson,0.14,,,>= 0.05,No,,,,Brantsaeter 2007
431,460,598,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Tea,"",,,,120.0,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Kaempferol,"",,,,umol/L,,119,Pearson,0.3,,,< 0.01,Yes,,,,Brantsaeter 2007
502,462,612,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Coffee,"",,,,20.0,g/day,,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,119,Pearson,0.32,,,< 0.01,Yes,,,,Brantsaeter 2007
433,464,578,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Apple,"",,,,65.0,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Phloretin,"",,,,umol/L,,119,Pearson,0.19,,,< 0.05,Yes,,,,Brantsaeter 2007
504,464,600,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Apple,"",,,,65.0,g/day,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,119,Pearson,0.2,,,< 0.05,Yes,,,,Brantsaeter 2007
435,466,578,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Fruits,Apple,,,,180.0,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Phloretin,"",,,,umol/L,,119,Pearson,0.41,,,< 0.01,Yes,,,,Brantsaeter 2007
506,466,600,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Fruits,Apple,,,,180.0,g/day,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,119,Pearson,0.24,,,< 0.01,Yes,,,,Brantsaeter 2007
437,468,580,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Fruit juices,"",,,,150.0,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Hesperetin,"",,,,umol/L,,119,Pearson,0.35,,,< 0.01,Yes,,,,Brantsaeter 2007
508,468,602,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Fruit juices,"",,,,150.0,g/day,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,119,Pearson,0.3,,,< 0.01,Yes,,,,Brantsaeter 2007
439,470,582,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Citrus fruits,"",,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Flavanones,Naringenin + Hesperetin + Eriodictyol,,,,umol/L,,119,Pearson,0.63,,,< 0.01,Yes,,,,Brantsaeter 2007
441,470,580,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Citrus fruits,"",,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Hesperetin,"",,,,umol/L,,119,Pearson,0.64,,,< 0.01,Yes,,,,Brantsaeter 2007
510,470,602,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Citrus fruits,"",,,,,g/day,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,119,Pearson,0.39,,,< 0.01,Yes,,,,Brantsaeter 2007
512,470,604,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Citrus fruits,"",,,,,g/day,,,"Plasma, unspecified",HPLC,Zeaxanthin,"",,,,umol/L,,119,Pearson,0.31,,,< 0.01,Yes,,,,Brantsaeter 2007
443,472,578,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Fruits,Apple + Fruit juices,,,,390.0,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Phloretin,"",,,,umol/L,,119,Pearson,0.37,,,< 0.01,Yes,,,,Brantsaeter 2007
514,472,604,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Fruits,Apple + Fruit juices,,,,390.0,g/day,,,"Plasma, unspecified",HPLC,Zeaxanthin,"",,,,umol/L,,119,Pearson,0.22,,,< 0.05,Yes,,,,Brantsaeter 2007
516,474,606,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Tomato,"",,,,,g/day,,,"Plasma, unspecified",HPLC,Lycopene,"",,,,umol/L,,119,Pearson,0.15,,,>= 0.05,No,,,,Brantsaeter 2007
518,476,600,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Carrot,"",,,,,g/day,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,119,Pearson,0.5,,,< 0.01,Yes,,,,Brantsaeter 2007
445,478,584,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Vegetables,Tomato + Carrot,,,,86.0,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Isorhamnetin,"",,,,umol/L,,119,Pearson,0.22,,,< 0.05,Yes,,,,Brantsaeter 2007
520,478,608,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Vegetables,Tomato + Carrot,,,,86.0,g/day,,,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,umol/L,,119,Pearson,0.23,,,< 0.05,Yes,,,,Brantsaeter 2007
447,480,586,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Vegetables,"",,,,25.0,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Enterolactone,"",,,,umol/L,,119,Pearson,0.33,,,< 0.01,Yes,,,,Brantsaeter 2007
522,480,610,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Vegetables,"",,,,25.0,g/day,,,"Plasma, unspecified",HPLC,Lutein,"",,,,umol/L,,119,Pearson,0.3,,,< 0.01,Yes,,,,Brantsaeter 2007
449,482,586,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Vegetables,Vegetables,,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Enterolactone,"",,,,umol/L,,119,Pearson,0.26,,,< 0.01,Yes,,,,Brantsaeter 2007
524,482,600,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Vegetables,Vegetables,,,,,g/day,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,119,Pearson,0.39,,,< 0.01,Yes,,,,Brantsaeter 2007
451,484,588,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Soy foods,"",,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein,,,,umol/L,,119,Pearson,0.2,,,< 0.05,Yes,,,,Brantsaeter 2007
453,486,590,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Vegetables,Tomato + Carrot + Vegetables,,,,150.0,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Quercetin,"",,,,umol/L,,119,Pearson,0.17,,,>= 0.05,No,,,,Brantsaeter 2007
455,486,594,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Vegetables,Tomato + Carrot + Vegetables,,,,150.0,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Flavonoids,Quercetin + Kaempferol + Naringenin + Hesperetin + Isorhamnetin + Apigenin + Phloretin + Eriodictyol + Tamarixetin,,,,umol/L,,119,Pearson,0.0,,,>= 0.05,No,,,,Brantsaeter 2007
526,486,600,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Vegetables,Tomato + Carrot + Vegetables,,,,150.0,g/day,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,119,Pearson,0.29,,,< 0.01,Yes,,,,Brantsaeter 2007
528,486,608,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Vegetables,Tomato + Carrot + Vegetables,,,,150.0,g/day,,,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,umol/L,,119,Pearson,0.32,,,< 0.01,Yes,,,,Brantsaeter 2007
457,490,578,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,540.0,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Phloretin,"",,,,umol/L,,119,Pearson,0.36,,,< 0.01,Yes,,,,Brantsaeter 2007
459,490,582,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,540.0,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Flavanones,Naringenin + Hesperetin + Eriodictyol,,,,umol/L,,119,Pearson,0.29,,,< 0.01,Yes,,,,Brantsaeter 2007
461,490,596,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,540.0,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Flavonols,Isorhamnetin + Tamarixetin,,,,umol/L,,119,Pearson,0.32,,,< 0.01,Yes,,,,Brantsaeter 2007
463,490,594,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,540.0,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Flavonoids,Quercetin + Kaempferol + Naringenin + Hesperetin + Isorhamnetin + Apigenin + Phloretin + Eriodictyol + Tamarixetin,,,,umol/L,,119,Pearson,0.31,,,< 0.01,Yes,,,,Brantsaeter 2007
530,490,610,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,540.0,g/day,,,"Plasma, unspecified",HPLC,Lutein,"",,,,umol/L,,119,Pearson,0.21,,,< 0.05,Yes,,,,Brantsaeter 2007
532,490,602,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,540.0,g/day,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,119,Pearson,0.38,,,< 0.01,Yes,,,,Brantsaeter 2007
534,490,600,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,540.0,g/day,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,119,Pearson,0.25,,,< 0.01,Yes,,,,Brantsaeter 2007
536,490,608,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,540.0,g/day,,,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,umol/L,,119,Pearson,0.24,,,< 0.01,Yes,,,,Brantsaeter 2007
465,498,598,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Tea,"",,,,93.0,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Kaempferol,"",,,,umol/L,,119,Pearson,0.46,,,< 0.01,Yes,,,,Brantsaeter 2007
538,500,612,All [by supplement],Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Coffee,"",,,,13.0,g/day,,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,119,Pearson,0.33,,,< 0.01,Yes,,,,Brantsaeter 2007
396,425,577,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Apple,"",,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Phloretin,"",,,,umol/L,,99,Pearson,0.25,,,< 0.05,Yes,,,,Brantsaeter 2007
398,427,577,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Fruits,Apple,,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Phloretin,"",,,,umol/L,,99,Pearson,0.33,,,< 0.01,Yes,,,,Brantsaeter 2007
402,429,579,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Fruit juices,"",,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Hesperetin,"",,,,umol/L,,99,Pearson,0.28,,,< 0.01,Yes,,,,Brantsaeter 2007
404,431,581,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Flavanones,Naringenin + Hesperetin + Eriodictyol,,,,umol/L,,99,Pearson,0.41,,,< 0.01,Yes,,,,Brantsaeter 2007
406,431,579,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Hesperetin,"",,,,umol/L,,99,Pearson,0.44,,,< 0.01,Yes,,,,Brantsaeter 2007
408,433,577,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Fruits,Apple + Fruit juices,,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Phloretin,"",,,,umol/L,,99,Pearson,0.24,,,< 0.05,Yes,,,,Brantsaeter 2007
410,439,583,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Vegetables,Tomato + Carrot,,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Isorhamnetin,"",,,,umol/L,,99,Pearson,0.04,,,>= 0.05,No,,,,Brantsaeter 2007
412,441,585,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Enterolactone,"",,,,umol/L,,99,Pearson,0.22,,,< 0.05,Yes,,,,Brantsaeter 2007
414,443,585,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Vegetables,Vegetables,,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Enterolactone,"",,,,umol/L,,99,Pearson,0.19,,,>= 0.05,No,,,,Brantsaeter 2007
416,445,587,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Soy foods,"",,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein,,,,umol/L,,99,Pearson,0.17,,,>= 0.05,No,,,,Brantsaeter 2007
418,447,589,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Vegetables,Tomato + Carrot + Vegetables,,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Quercetin,"",,,,umol/L,,99,Pearson,0.03,,,>= 0.05,No,,,,Brantsaeter 2007
420,447,593,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Vegetables,Tomato + Carrot + Vegetables,,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Flavonoids,Quercetin + Kaempferol + Naringenin + Hesperetin + Isorhamnetin + Apigenin + Phloretin + Eriodictyol + Tamarixetin,,,,umol/L,,99,Pearson,-0.15,,,>= 0.05,No,,,,Brantsaeter 2007
422,451,577,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Phloretin,"",,,,umol/L,,99,Pearson,0.3,,,< 0.01,Yes,,,,Brantsaeter 2007
424,451,581,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Flavanones,Naringenin + Hesperetin + Eriodictyol,,,,umol/L,,99,Pearson,0.18,,,>= 0.05,No,,,,Brantsaeter 2007
426,451,595,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Flavonols,Isorhamnetin + Tamarixetin,,,,umol/L,,99,Pearson,0.14,,,>= 0.05,No,,,,Brantsaeter 2007
428,451,593,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Flavonoids,Quercetin + Kaempferol + Naringenin + Hesperetin + Isorhamnetin + Apigenin + Phloretin + Eriodictyol + Tamarixetin,,,,umol/L,,99,Pearson,0.19,,,>= 0.05,No,,,,Brantsaeter 2007
430,459,597,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Tea,"",,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Kaempferol,"",,,,umol/L,,99,Pearson,0.41,,,< 0.01,Yes,,,,Brantsaeter 2007
432,463,577,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Apple,"",,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Phloretin,"",,,,umol/L,,99,Pearson,0.21,,,< 0.05,Yes,,,,Brantsaeter 2007
434,465,577,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Fruits,Apple,,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Phloretin,"",,,,umol/L,,99,Pearson,0.44,,,< 0.01,Yes,,,,Brantsaeter 2007
436,467,579,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Fruit juices,"",,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Hesperetin,"",,,,umol/L,,99,Pearson,0.38,,,< 0.01,Yes,,,,Brantsaeter 2007
438,469,581,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Citrus fruits,"",,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Flavanones,Naringenin + Hesperetin + Eriodictyol,,,,umol/L,,99,Pearson,0.66,,,< 0.01,Yes,,,,Brantsaeter 2007
440,469,579,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Citrus fruits,"",,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Hesperetin,"",,,,umol/L,,99,Pearson,0.66,,,< 0.01,Yes,,,,Brantsaeter 2007
442,471,577,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Fruits,Apple + Fruit juices,,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Phloretin,"",,,,umol/L,,99,Pearson,0.39,,,< 0.01,Yes,,,,Brantsaeter 2007
444,477,583,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Vegetables,Tomato + Carrot,,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Isorhamnetin,"",,,,umol/L,,99,Pearson,0.2,,,< 0.05,Yes,,,,Brantsaeter 2007
446,479,585,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Vegetables,"",,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Enterolactone,"",,,,umol/L,,99,Pearson,0.38,,,< 0.01,Yes,,,,Brantsaeter 2007
448,481,585,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Vegetables,Vegetables,,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Enterolactone,"",,,,umol/L,,99,Pearson,0.35,,,< 0.01,Yes,,,,Brantsaeter 2007
450,483,587,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Soy foods,"",,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein,,,,umol/L,,99,Pearson,0.17,,,>= 0.05,No,,,,Brantsaeter 2007
452,485,589,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Vegetables,Tomato + Carrot + Vegetables,,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Quercetin,"",,,,umol/L,,99,Pearson,0.15,,,>= 0.05,No,,,,Brantsaeter 2007
454,485,593,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Vegetables,Tomato + Carrot + Vegetables,,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Flavonoids,Quercetin + Kaempferol + Naringenin + Hesperetin + Isorhamnetin + Apigenin + Phloretin + Eriodictyol + Tamarixetin,,,,umol/L,,99,Pearson,-0.02,,,>= 0.05,No,,,,Brantsaeter 2007
456,489,577,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Phloretin,"",,,,umol/L,,99,Pearson,0.38,,,< 0.01,Yes,,,,Brantsaeter 2007
458,489,581,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Flavanones,Naringenin + Hesperetin + Eriodictyol,,,,umol/L,,99,Pearson,0.28,,,< 0.01,Yes,,,,Brantsaeter 2007
460,489,595,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Flavonols,Isorhamnetin + Tamarixetin,,,,umol/L,,99,Pearson,0.33,,,< 0.01,Yes,,,,Brantsaeter 2007
462,489,593,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Flavonoids,Quercetin + Kaempferol + Naringenin + Hesperetin + Isorhamnetin + Apigenin + Phloretin + Eriodictyol + Tamarixetin,,,,umol/L,,99,Pearson,0.31,,,< 0.01,Yes,,,,Brantsaeter 2007
464,497,597,Flavonoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Tea,"",,,,,g/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Kaempferol,"",,,,umol/L,,99,Pearson,0.5,,,< 0.01,Yes,,,,Brantsaeter 2007
467,613,599,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Apple,"",,,,,g/day,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,106,Pearson,0.16,,,>= 0.05,No,,,,Brantsaeter 2007
469,614,599,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Fruits,Apple,,,,,g/day,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,106,Pearson,0.11,,,>= 0.05,No,,,,Brantsaeter 2007
471,615,601,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Fruit juices,"",,,,,g/day,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,106,Pearson,0.12,,,>= 0.05,No,,,,Brantsaeter 2007
473,616,601,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,g/day,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,106,Pearson,0.23,,,< 0.05,Yes,,,,Brantsaeter 2007
475,616,603,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,g/day,,,"Plasma, unspecified",HPLC,Zeaxanthin,"",,,,umol/L,,106,Pearson,0.23,,,< 0.05,Yes,,,,Brantsaeter 2007
477,617,603,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Fruits,Apple + Fruit juices,,,,,g/day,,,"Plasma, unspecified",HPLC,Zeaxanthin,"",,,,umol/L,,106,Pearson,0.22,,,< 0.05,Yes,,,,Brantsaeter 2007
479,618,605,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Tomato,"",,,,,g/day,,,"Plasma, unspecified",HPLC,Lycopene,"",,,,umol/L,,106,Pearson,0.22,,,< 0.05,Yes,,,,Brantsaeter 2007
481,619,599,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Carrot,"",,,,,g/day,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,106,Pearson,0.33,,,< 0.01,Yes,,,,Brantsaeter 2007
483,620,607,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Vegetables,Tomato + Carrot,,,,,g/day,,,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,umol/L,,106,Pearson,0.18,,,>= 0.05,No,,,,Brantsaeter 2007
485,621,609,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,g/day,,,"Plasma, unspecified",HPLC,Lutein,"",,,,umol/L,,106,Pearson,0.24,,,< 0.05,Yes,,,,Brantsaeter 2007
487,622,599,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Vegetables,Vegetables,,,,,g/day,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,106,Pearson,0.37,,,< 0.01,Yes,,,,Brantsaeter 2007
489,624,599,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Vegetables,Tomato + Carrot + Vegetables,,,,,g/day,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,106,Pearson,0.2,,,< 0.05,Yes,,,,Brantsaeter 2007
491,624,607,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Vegetables,Tomato + Carrot + Vegetables,,,,,g/day,,,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,umol/L,,106,Pearson,0.2,,,< 0.05,Yes,,,,Brantsaeter 2007
493,625,609,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,,g/day,,,"Plasma, unspecified",HPLC,Lutein,"",,,,umol/L,,106,Pearson,0.21,,,< 0.05,Yes,,,,Brantsaeter 2007
495,625,601,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,,g/day,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,106,Pearson,0.2,,,< 0.05,Yes,,,,Brantsaeter 2007
497,625,599,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,,g/day,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,106,Pearson,0.11,,,>= 0.05,No,,,,Brantsaeter 2007
499,625,607,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,,g/day,,,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,umol/L,,106,Pearson,0.13,,,>= 0.05,No,,,,Brantsaeter 2007
501,627,611,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,g/day,,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,106,Pearson,0.31,,,< 0.01,Yes,,,,Brantsaeter 2007
503,628,599,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Apple,"",,,,,g/day,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,106,Pearson,0.2,,,< 0.05,Yes,,,,Brantsaeter 2007
505,629,599,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Fruits,Apple,,,,,g/day,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,106,Pearson,0.23,,,< 0.05,Yes,,,,Brantsaeter 2007
507,630,601,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Fruit juices,"",,,,,g/day,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,106,Pearson,0.3,,,< 0.01,Yes,,,,Brantsaeter 2007
509,631,601,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Citrus fruits,"",,,,,g/day,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,106,Pearson,0.39,,,< 0.01,Yes,,,,Brantsaeter 2007
511,631,603,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Citrus fruits,"",,,,,g/day,,,"Plasma, unspecified",HPLC,Zeaxanthin,"",,,,umol/L,,106,Pearson,0.32,,,< 0.01,Yes,,,,Brantsaeter 2007
513,632,603,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Fruits,Apple + Fruit juices,,,,,g/day,,,"Plasma, unspecified",HPLC,Zeaxanthin,"",,,,umol/L,,106,Pearson,0.22,,,< 0.05,Yes,,,,Brantsaeter 2007
515,633,605,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Tomato,"",,,,,g/day,,,"Plasma, unspecified",HPLC,Lycopene,"",,,,umol/L,,106,Pearson,0.11,,,>= 0.05,No,,,,Brantsaeter 2007
517,634,599,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Carrot,"",,,,,g/day,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,106,Pearson,0.48,,,< 0.01,Yes,,,,Brantsaeter 2007
519,635,607,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Vegetables,Tomato + Carrot,,,,,g/day,,,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,umol/L,,106,Pearson,0.24,,,< 0.05,Yes,,,,Brantsaeter 2007
521,636,609,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Vegetables,"",,,,,g/day,,,"Plasma, unspecified",HPLC,Lutein,"",,,,umol/L,,106,Pearson,0.25,,,< 0.05,Yes,,,,Brantsaeter 2007
523,637,599,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Vegetables,Vegetables,,,,,g/day,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,106,Pearson,0.39,,,< 0.01,Yes,,,,Brantsaeter 2007
525,639,599,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Vegetables,Tomato + Carrot + Vegetables,,,,,g/day,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,106,Pearson,0.3,,,< 0.01,Yes,,,,Brantsaeter 2007
527,639,607,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Vegetables,Tomato + Carrot + Vegetables,,,,,g/day,,,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,umol/L,,106,Pearson,0.29,,,< 0.01,Yes,,,,Brantsaeter 2007
529,640,609,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,,g/day,,,"Plasma, unspecified",HPLC,Lutein,"",,,,umol/L,,106,Pearson,0.18,,,>= 0.05,No,,,,Brantsaeter 2007
531,640,601,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,,g/day,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,106,Pearson,0.36,,,< 0.01,Yes,,,,Brantsaeter 2007
533,640,599,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,,g/day,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,106,Pearson,0.22,,,< 0.05,Yes,,,,Brantsaeter 2007
535,640,607,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Fruits + Vegetables,Apple + Tomato + Carrot + Vegetables + Fruit juices,,,,,g/day,,,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,umol/L,,106,Pearson,0.2,,,< 0.05,Yes,,,,Brantsaeter 2007
537,642,611,Carotenoid supplement nonusers,Participants in the validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Coffee,"",,,,,g/day,,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,106,Pearson,0.35,,,< 0.01,Yes,,,,Brantsaeter 2007
140,149,153,All,Controls in a case-control study on colorectal adenomas,United States,,,Food Frequency Questionnaire (FFQ),Benzo[a]pyrene,"",,,,6.4,ng/day,,,"Urine, overnight",HPLC,1-Hydroxypyrene glucuronide,"",,,0.1,ng/mL,,36,Spearman,0.17,,,>= 0.05,No,,,,Deziel 2011
539,643,153,All,Controls in a case-control study on colorectal adenomas,United States,,,Food Frequency Questionnaire (FFQ),Meat,"",,,,49.7,g/day,,,"Urine, overnight",HPLC,1-Hydroxypyrene glucuronide,"",,,0.1,ng/mL,,36,Spearman,0.02,,,>= 0.05,No,,,,Deziel 2011
141,150,153,All,Controls in a case-control study on colorectal adenomas,United States,,,Food Frequency Questionnaire (FFQ),Benzo[a]pyrene,"",,,,7.3,ng/day,,,"Urine, overnight",HPLC,1-Hydroxypyrene glucuronide,"",,,0.1,ng/mL,,36,Spearman,0.13,,,>= 0.05,No,,,,Deziel 2011
540,644,153,All,Controls in a case-control study on colorectal adenomas,United States,,,Food Frequency Questionnaire (FFQ),Meat,"",,,,33.8,g/day,,,"Urine, overnight",HPLC,1-Hydroxypyrene glucuronide,"",,,0.1,ng/mL,,36,Spearman,0.2,,,>= 0.05,No,,,,Deziel 2011
142,151,153,All,Controls in a case-control study on colorectal adenomas,United States,,,Dietary record (1-day),Benzo[a]pyrene,"",,,,1.4,ng/day,,,"Urine, overnight",HPLC,1-Hydroxypyrene glucuronide,"",,,0.1,ng/mL,,36,Spearman,0.27,,,>= 0.05,No,,,,Deziel 2011
541,645,153,All,Controls in a case-control study on colorectal adenomas,United States,,,Dietary record (1-day),Meat,"",,,,128.5,g/day,,,"Urine, overnight",HPLC,1-Hydroxypyrene glucuronide,"",,,0.1,ng/mL,,36,Spearman,0.33,,,< 0.05,Yes,,,,Deziel 2011
542,649,646,All,Women living in the Helsinki area,Finland,,,Dietary record (5-day),Fibre from Cereals,"",,10.02,,,g/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",94.0,,,nmol/L,,56,Pearson,0.463,,,< 0.001,Yes,,,"Age, BMI",Aubertin-Leheudre 2010
546,649,647,All,Women living in the Helsinki area,Finland,,,Dietary record (5-day),Fibre from Cereals,"",,10.02,,,g/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",90.0,,,nmol/L,,56,Pearson,0.411,,,< 0.01,Yes,,,"Age, BMI",Aubertin-Leheudre 2010
550,649,648,All,Women living in the Helsinki area,Finland,,,Dietary record (5-day),Fibre from Cereals,"",,10.02,,,g/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",185.0,,,nmol/L,,56,Pearson,0.423,,,< 0.01,Yes,,,"Age, BMI",Aubertin-Leheudre 2010
545,650,646,All,Women living in the Helsinki area,Finland,,,Dietary record (5-day),Dietary fibre,Fibre from Cereals + Fibre from Vegetables + Fibre from Fruits,,19.84,,,g/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",94.0,,,nmol/L,,56,Pearson,0.376,,,< 0.01,Yes,,,"Age, BMI",Aubertin-Leheudre 2010
549,650,647,All,Women living in the Helsinki area,Finland,,,Dietary record (5-day),Dietary fibre,Fibre from Cereals + Fibre from Vegetables + Fibre from Fruits,,19.84,,,g/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",90.0,,,nmol/L,,56,Pearson,0.28,,,< 0.05,Yes,,,"Age, BMI",Aubertin-Leheudre 2010
553,650,648,All,Women living in the Helsinki area,Finland,,,Dietary record (5-day),Dietary fibre,Fibre from Cereals + Fibre from Vegetables + Fibre from Fruits,,19.84,,,g/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",185.0,,,nmol/L,,56,Pearson,0.312,,,< 0.05,Yes,,,"Age, BMI",Aubertin-Leheudre 2010
543,651,646,All,Women living in the Helsinki area,Finland,,,Dietary record (5-day),Fibre from Vegetables,"",,,,,g/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",94.0,,,nmol/L,,56,Pearson,0.024,,,>= 0.05,No,,,"Age, BMI",Aubertin-Leheudre 2010
547,651,647,All,Women living in the Helsinki area,Finland,,,Dietary record (5-day),Fibre from Vegetables,"",,,,,g/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",90.0,,,nmol/L,,56,Pearson,-0.028,,,>= 0.05,No,,,"Age, BMI",Aubertin-Leheudre 2010
551,651,648,All,Women living in the Helsinki area,Finland,,,Dietary record (5-day),Fibre from Vegetables,"",,,,,g/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",185.0,,,nmol/L,,56,Pearson,0.011,,,>= 0.05,No,,,"Age, BMI",Aubertin-Leheudre 2010
544,652,646,All,Women living in the Helsinki area,Finland,,,Dietary record (5-day),Fibre from Fruits,"",,,,,g/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",94.0,,,nmol/L,,56,Pearson,0.117,,,>= 0.05,No,,,"Age, BMI",Aubertin-Leheudre 2010
548,652,647,All,Women living in the Helsinki area,Finland,,,Dietary record (5-day),Fibre from Fruits,"",,,,,g/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",90.0,,,nmol/L,,56,Pearson,-0.059,,,>= 0.05,No,,,"Age, BMI",Aubertin-Leheudre 2010
552,652,648,All,Women living in the Helsinki area,Finland,,,Dietary record (5-day),Fibre from Fruits,"",,,,,g/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",185.0,,,nmol/L,,56,Pearson,0.01,,,>= 0.05,No,,,"Age, BMI",Aubertin-Leheudre 2010
144,155,158,All,Participants in previous studies on phyto-oestrogen intake,United Kingdom,,,Duplicate diet (LC-MS after enzymatic hydrolysis),Isoflavones,Genistein + Daidzein,,11.03,,,mg/day,,,"Urine, 24-h",LC-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein,2.48,,,mg/day,,14,Spearman,0.97,,,< 0.001,Yes,,,,Ritchie 2004
145,163,164,All,Participants in previous studies on phyto-oestrogen intake,United Kingdom,,,Duplicate diet (LC-MS after enzymatic hydrolysis),Isoflavones,Genistein + Daidzein,,11.93,,,mg/day,,,"Plasma, non-fasting",LC-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein,121.86,,,ng/mL,,11,Spearman,0.92,,,< 0.001,Yes,,,,Ritchie 2004
146,178,179,All [Clinical trial],Participants in a clinical trial,Spain,,,Food Frequency Questionnaire (FFQ),Polyphenols,"",,,,,mg/day,,,"Urine, first morning spot",Folin-Ciocalteu,Polyphenols,"",,,,mg/g,Creatinine,12,Spearman,0.482,,,= 0.003,Yes,,,,Medina-Remon 2009
554,653,179,All [Clinical trial],Participants in a clinical trial,Spain,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,g/day,,,"Urine, first morning spot",Folin-Ciocalteu,Polyphenols,"",,,,mg/g,Creatinine,12,Spearman,0.332,,,= 0.048,Yes,,,,Medina-Remon 2009
555,654,179,All [Clinical trial],Participants in a clinical trial,Spain,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,g/day,,,"Urine, first morning spot",Folin-Ciocalteu,Polyphenols,"",,,,mg/g,Creatinine,12,Spearman,0.504,,,= 0.002,Yes,,,,Medina-Remon 2009
556,655,179,All [Clinical trial],Participants in a clinical trial,Spain,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Urine, first morning spot",Folin-Ciocalteu,Polyphenols,"",,,,mg/g,Creatinine,12,Spearman,0.501,,,= 0.002,Yes,,,,Medina-Remon 2009
557,656,179,All [Clinical trial],Participants in a clinical trial,Spain,,,Food Frequency Questionnaire (FFQ),Legume-family vegetables,"",,,,,g/day,,,"Urine, first morning spot",Folin-Ciocalteu,Polyphenols,"",,,,mg/g,Creatinine,12,Spearman,-0.106,,,= 0.539,No,,,,Medina-Remon 2009
558,657,179,All [Clinical trial],Participants in a clinical trial,Spain,,,Food Frequency Questionnaire (FFQ),Cereals,"",,,,,g/day,,,"Urine, first morning spot",Folin-Ciocalteu,Polyphenols,"",,,,mg/g,Creatinine,12,Spearman,-0.644,,,= 0.001,Yes,,,,Medina-Remon 2009
559,658,179,All [Clinical trial],Participants in a clinical trial,Spain,,,Food Frequency Questionnaire (FFQ),Beverages,"",,,,,g/day,,,"Urine, first morning spot",Folin-Ciocalteu,Polyphenols,"",,,,mg/g,Creatinine,12,Spearman,0.293,,,= 0.082,No,,,,Medina-Remon 2009
560,659,179,All [Clinical trial],Participants in a clinical trial,Spain,,,Food Frequency Questionnaire (FFQ),Oils,"",,,,,g/day,,,"Urine, first morning spot",Folin-Ciocalteu,Polyphenols,"",,,,mg/g,Creatinine,12,Spearman,-0.094,,,= 0.586,No,,,,Medina-Remon 2009
561,660,179,All [Clinical trial],Participants in a clinical trial,Spain,,,Food Frequency Questionnaire (FFQ),Nuts,"",,,,,g/day,,,"Urine, first morning spot",Folin-Ciocalteu,Polyphenols,"",,,,mg/g,Creatinine,12,Spearman,0.221,,,= 0.195,No,,,,Medina-Remon 2009
562,661,179,All [Clinical trial],Participants in a clinical trial,Spain,,,Food Frequency Questionnaire (FFQ),Chocolate,"",,,,,g/day,,,"Urine, first morning spot",Folin-Ciocalteu,Polyphenols,"",,,,mg/g,Creatinine,12,Spearman,0.103,,,= 0.551,No,,,,Medina-Remon 2009
147,187,186,All [Cross-sectional study],Participants in a cross-sectional study,Spain,PREDIMED (Prevención con Dieta Mediterránea),,Food Frequency Questionnaire (FFQ),Polyphenols,"",,,,,mg/day,,,"Urine, first morning spot",Folin-Ciocalteu,Polyphenols,"",,,,mg/g,Creatinine,60,Spearman,0.257,,,= 0.04,Yes,,,,Medina-Remon 2009
563,662,186,All [Cross-sectional study],Participants in a cross-sectional study,Spain,PREDIMED (Prevención con Dieta Mediterránea),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Urine, first morning spot",Folin-Ciocalteu,Polyphenols,"",,,,mg/g,Creatinine,60,Spearman,0.339,,,= 0.008,Yes,,,,Medina-Remon 2009
148,190,188,All,Cases and controls undergoing endoscopy in a case-control study on colorectal adenomas,Netherlands,POLIEP,,Food Frequency Questionnaire (FFQ),Lariciresinol,"",,,463.0,,ug/day,,,"Plasma, non-fasting",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",,1.4,,nmol/L,,637,Spearman,0.09,,,< 0.05,Yes,,,,Milder 2007
153,190,189,All,Cases and controls undergoing endoscopy in a case-control study on colorectal adenomas,Netherlands,POLIEP,,Food Frequency Questionnaire (FFQ),Lariciresinol,"",,,463.0,,ug/day,,,"Plasma, non-fasting",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",,11.3,,nmol/L,,637,Spearman,0.18,,,< 0.001,Yes,,,,Milder 2007
149,191,188,All,Cases and controls undergoing endoscopy in a case-control study on colorectal adenomas,Netherlands,POLIEP,,Food Frequency Questionnaire (FFQ),Pinoresinol,"",,,328.0,,ug/day,,,"Plasma, non-fasting",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",,1.4,,nmol/L,,637,Spearman,0.1,,,< 0.05,Yes,,,,Milder 2007
154,191,189,All,Cases and controls undergoing endoscopy in a case-control study on colorectal adenomas,Netherlands,POLIEP,,Food Frequency Questionnaire (FFQ),Pinoresinol,"",,,328.0,,ug/day,,,"Plasma, non-fasting",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",,11.3,,nmol/L,,637,Spearman,0.18,,,< 0.001,Yes,,,,Milder 2007
150,192,188,All,Cases and controls undergoing endoscopy in a case-control study on colorectal adenomas,Netherlands,POLIEP,,Food Frequency Questionnaire (FFQ),Secoisolariciresinol,"",,,180.0,,ug/day,,,"Plasma, non-fasting",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",,1.4,,nmol/L,,637,Spearman,0.02,,,>= 0.05,No,,,,Milder 2007
155,192,189,All,Cases and controls undergoing endoscopy in a case-control study on colorectal adenomas,Netherlands,POLIEP,,Food Frequency Questionnaire (FFQ),Secoisolariciresinol,"",,,180.0,,ug/day,,,"Plasma, non-fasting",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",,11.3,,nmol/L,,637,Spearman,0.1,,,< 0.01,Yes,,,,Milder 2007
151,193,188,All,Cases and controls undergoing endoscopy in a case-control study on colorectal adenomas,Netherlands,POLIEP,,Food Frequency Questionnaire (FFQ),Matairesinol,"",,,6.0,,ug/day,,,"Plasma, non-fasting",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",,1.4,,nmol/L,,637,Spearman,0.07,,,>= 0.05,No,,,,Milder 2007
156,193,189,All,Cases and controls undergoing endoscopy in a case-control study on colorectal adenomas,Netherlands,POLIEP,,Food Frequency Questionnaire (FFQ),Matairesinol,"",,,6.0,,ug/day,,,"Plasma, non-fasting",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",,11.3,,nmol/L,,637,Spearman,0.21,,,< 0.001,Yes,,,,Milder 2007
152,194,188,All,Cases and controls undergoing endoscopy in a case-control study on colorectal adenomas,Netherlands,POLIEP,,Food Frequency Questionnaire (FFQ),Lignans,Lariciresinol + Pinoresinol + Secoisolariciresinol + Matairesinol,,,989.0,,ug/day,,,"Plasma, non-fasting",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",,1.4,,nmol/L,,637,Spearman,0.09,,,< 0.05,Yes,,,,Milder 2007
157,194,189,All,Cases and controls undergoing endoscopy in a case-control study on colorectal adenomas,Netherlands,POLIEP,,Food Frequency Questionnaire (FFQ),Lignans,Lariciresinol + Pinoresinol + Secoisolariciresinol + Matairesinol,,,989.0,,ug/day,,,"Plasma, non-fasting",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",,11.3,,nmol/L,,637,Spearman,0.18,,,< 0.001,Yes,,,,Milder 2007
158,195,188,All,Cases and controls undergoing endoscopy in a case-control study on colorectal adenomas,Netherlands,POLIEP,,Food Frequency Questionnaire (FFQ),Lariciresinol,"",,,6.2,,ug/day/kg,Body weight,,"Plasma, non-fasting",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",,1.4,,nmol/L,,637,Spearman,0.12,,,< 0.01,Yes,,,,Milder 2007
163,195,189,All,Cases and controls undergoing endoscopy in a case-control study on colorectal adenomas,Netherlands,POLIEP,,Food Frequency Questionnaire (FFQ),Lariciresinol,"",,,6.2,,ug/day/kg,Body weight,,"Plasma, non-fasting",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",,11.3,,nmol/L,,637,Spearman,0.24,,,< 0.001,Yes,,,,Milder 2007
159,196,188,All,Cases and controls undergoing endoscopy in a case-control study on colorectal adenomas,Netherlands,POLIEP,,Food Frequency Questionnaire (FFQ),Pinoresinol,"",,,4.4,,ug/day/kg,Body weight,,"Plasma, non-fasting",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",,1.4,,nmol/L,,637,Spearman,0.13,,,< 0.001,Yes,,,,Milder 2007
164,196,189,All,Cases and controls undergoing endoscopy in a case-control study on colorectal adenomas,Netherlands,POLIEP,,Food Frequency Questionnaire (FFQ),Pinoresinol,"",,,4.4,,ug/day/kg,Body weight,,"Plasma, non-fasting",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",,11.3,,nmol/L,,637,Spearman,0.23,,,< 0.001,Yes,,,,Milder 2007
160,197,188,All,Cases and controls undergoing endoscopy in a case-control study on colorectal adenomas,Netherlands,POLIEP,,Food Frequency Questionnaire (FFQ),Secoisolariciresinol,"",,,2.4,,ug/day/kg,Body weight,,"Plasma, non-fasting",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",,1.4,,nmol/L,,637,Spearman,0.06,,,>= 0.05,No,,,,Milder 2007
165,197,189,All,Cases and controls undergoing endoscopy in a case-control study on colorectal adenomas,Netherlands,POLIEP,,Food Frequency Questionnaire (FFQ),Secoisolariciresinol,"",,,2.4,,ug/day/kg,Body weight,,"Plasma, non-fasting",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",,11.3,,nmol/L,,637,Spearman,0.18,,,< 0.001,Yes,,,,Milder 2007
161,198,188,All,Cases and controls undergoing endoscopy in a case-control study on colorectal adenomas,Netherlands,POLIEP,,Food Frequency Questionnaire (FFQ),Matairesinol,"",,,0.1,,ug/day/kg,Body weight,,"Plasma, non-fasting",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",,1.4,,nmol/L,,637,Spearman,0.09,,,< 0.05,Yes,,,,Milder 2007
166,198,189,All,Cases and controls undergoing endoscopy in a case-control study on colorectal adenomas,Netherlands,POLIEP,,Food Frequency Questionnaire (FFQ),Matairesinol,"",,,0.1,,ug/day/kg,Body weight,,"Plasma, non-fasting",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",,11.3,,nmol/L,,637,Spearman,0.23,,,< 0.001,Yes,,,,Milder 2007
162,199,188,All,Cases and controls undergoing endoscopy in a case-control study on colorectal adenomas,Netherlands,POLIEP,,Food Frequency Questionnaire (FFQ),Lignans,Lariciresinol + Pinoresinol + Secoisolariciresinol + Matairesinol,,,13.2,,ug/day/kg,Body weight,,"Plasma, non-fasting",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",,1.4,,nmol/L,,637,Spearman,0.12,,,< 0.01,Yes,,,,Milder 2007
167,199,189,All,Cases and controls undergoing endoscopy in a case-control study on colorectal adenomas,Netherlands,POLIEP,,Food Frequency Questionnaire (FFQ),Lignans,Lariciresinol + Pinoresinol + Secoisolariciresinol + Matairesinol,,,13.2,,ug/day/kg,Body weight,,"Plasma, non-fasting",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",,11.3,,nmol/L,,637,Spearman,0.24,,,< 0.001,Yes,,,,Milder 2007
169,8105,218,All [by study],Subjects in a non-Asian population,United States,CTS (California Teachers Study),,Food Frequency Questionnaire (FFQ),Genistein,"",,,,,mg/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Genistein,"",,,,missing unit,Creatinine,296,Pearson,0.45,,, ,Unspecified,"Energy by ?, Creatinine",Yes,,Horn-Ross 2006
171,8106,220,All [by study],Subjects in a non-Asian population,United States,CTS (California Teachers Study),,Food Frequency Questionnaire (FFQ),Daidzein,"",,,,,mg/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Isoflavones,Daidzein + Equol + O-Desmethylangolensin + Dihydrodaidzein,,,,missing unit,Creatinine,296,Pearson,0.55,,, ,Unspecified,"Energy by ?, Creatinine",Yes,,Horn-Ross 2006
173,8107,221,All [by study],Subjects in a non-Asian population,United States,CTS (California Teachers Study),,Food Frequency Questionnaire (FFQ),Isoflavones,Genistein + Daidzein + Biochanin A + Formononetin,,,,,mg/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin + Dihydrodaidzein,,,,missing unit,Creatinine,296,Pearson,0.5,,, ,Unspecified,"Energy by ?, Creatinine",Yes,,Horn-Ross 2006
175,8108,222,All [by study],Subjects in a non-Asian population,United States,CTS (California Teachers Study),,Food Frequency Questionnaire (FFQ),Lignans,Secoisolariciresinol + Matairesinol,,,,,ug/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Lignans,Enterodiol + Enterolactone,,,,missing unit,Creatinine,296,Pearson,0.16,,, ,Unspecified,"Energy by ?, Creatinine",Yes,,Horn-Ross 2006
168,8109,218,All [by study],Subjects in a non-Asian population,United States,CTS (California Teachers Study),,24-h Dietary recall (1-day),Genistein,"",,,,,mg/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Genistein,"",,,,missing unit,Creatinine,304,Pearson,0.41,,, ,Unspecified,"Energy by ?, Creatinine",Yes,,Horn-Ross 2006
170,8110,220,All [by study],Subjects in a non-Asian population,United States,CTS (California Teachers Study),,24-h Dietary recall (1-day),Daidzein,"",,,,,mg/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Isoflavones,Daidzein + Equol + O-Desmethylangolensin + Dihydrodaidzein,,,,missing unit,Creatinine,304,Pearson,0.46,,, ,Unspecified,"Energy by ?, Creatinine",Yes,,Horn-Ross 2006
172,8111,221,All [by study],Subjects in a non-Asian population,United States,CTS (California Teachers Study),,24-h Dietary recall (1-day),Isoflavones,Genistein + Daidzein + Biochanin A + Formononetin,,,,,mg/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin + Dihydrodaidzein,,,,missing unit,Creatinine,304,Pearson,0.43,,, ,Unspecified,"Energy by ?, Creatinine",Yes,,Horn-Ross 2006
174,8112,222,All [by study],Subjects in a non-Asian population,United States,CTS (California Teachers Study),,24-h Dietary recall (1-day),Lignans,Secoisolariciresinol + Matairesinol,,,,,ug/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Lignans,Enterodiol + Enterolactone,,,,missing unit,Creatinine,304,Pearson,0.21,,, ,Unspecified,"Energy by ?, Creatinine",Yes,,Horn-Ross 2006
176,233,255,All,University campus population,China,,,Food Frequency Questionnaire (FFQ),Flavonols,Quercetin + Kaempferol + Isorhamnetin,,35.75,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonols,Quercetin + Kaempferol + Isorhamnetin,201.93,,,nmol/L,,92,Pearson,0.64,,,= 0.013,Yes,,,,Zhang 2010
177,233,255,All,University campus population,China,,,Food Frequency Questionnaire (FFQ),Flavonols,Quercetin + Kaempferol + Isorhamnetin,,35.75,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonols,Quercetin + Kaempferol + Isorhamnetin,201.93,,,nmol/L,,92,Pearson,0.52,,,= 0.006,Yes,Energy by residual method,,,Zhang 2010
178,234,256,All,University campus population,China,,,Food Frequency Questionnaire (FFQ),Quercetin,"",,14.68,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Quercetin,"",72.32,,,nmol/L,,92,Pearson,0.46,,,= 0.001,Yes,,,,Zhang 2010
179,234,256,All,University campus population,China,,,Food Frequency Questionnaire (FFQ),Quercetin,"",,14.68,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Quercetin,"",72.32,,,nmol/L,,92,Pearson,0.32,,,= 0.001,Yes,Energy by residual method,,,Zhang 2010
180,235,257,All,University campus population,China,,,Food Frequency Questionnaire (FFQ),Kaempferol,"",,11.19,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Kaempferol,"",90.77,,,nmol/L,,92,Pearson,0.52,,,= 0.001,Yes,,,,Zhang 2010
181,235,257,All,University campus population,China,,,Food Frequency Questionnaire (FFQ),Kaempferol,"",,11.19,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Kaempferol,"",90.77,,,nmol/L,,92,Pearson,0.44,,,= 0.013,Yes,Energy by residual method,,,Zhang 2010
182,236,258,All,University campus population,China,,,Food Frequency Questionnaire (FFQ),Isorhamnetin,"",,9.89,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Isorhamnetin,"",38.84,,,nmol/L,,92,Pearson,0.37,,,= 0.026,Yes,,,,Zhang 2010
183,236,258,All,University campus population,China,,,Food Frequency Questionnaire (FFQ),Isorhamnetin,"",,9.89,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Isorhamnetin,"",38.84,,,nmol/L,,92,Pearson,0.34,,,= 0.028,Yes,Energy by residual method,,,Zhang 2010
184,237,259,All,University campus population,China,,,Food Frequency Questionnaire (FFQ),Flavones,Apigenin + Luteolin,,11.19,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavones,Apigenin + Luteolin,112.5,,,nmol/L,,92,Pearson,0.58,,,= 0.015,Yes,,,,Zhang 2010
185,237,259,All,University campus population,China,,,Food Frequency Questionnaire (FFQ),Flavones,Apigenin + Luteolin,,11.19,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavones,Apigenin + Luteolin,112.5,,,nmol/L,,92,Pearson,0.41,,,= 0.001,Yes,Energy by residual method,,,Zhang 2010
186,238,260,All,University campus population,China,,,Food Frequency Questionnaire (FFQ),Apigenin,"",,3.47,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Apigenin,"",11.87,,,nmol/L,,92,Pearson,0.52,,,= 0.002,Yes,,,,Zhang 2010
187,238,260,All,University campus population,China,,,Food Frequency Questionnaire (FFQ),Apigenin,"",,3.47,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Apigenin,"",11.87,,,nmol/L,,92,Pearson,0.36,,,= 0.001,Yes,Energy by residual method,,,Zhang 2010
188,239,261,All,University campus population,China,,,Food Frequency Questionnaire (FFQ),Luteolin,"",,7.72,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Luteolin,"",100.63,,,nmol/L,,92,Pearson,0.5,,,= 0.012,Yes,,,,Zhang 2010
189,239,261,All,University campus population,China,,,Food Frequency Questionnaire (FFQ),Luteolin,"",,7.72,,,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Luteolin,"",100.63,,,nmol/L,,92,Pearson,0.38,,,= 0.003,Yes,Energy by residual method,,,Zhang 2010
221,304,303,All [by intake],First consecutive participants entering a substudy of PREDIMED,Spain,PREDIMED (Prevención con Dieta Mediterránea),,Food Frequency Questionnaire (FFQ),Wine,"",,,,,ug/day,,,"Urine, first morning spot",LC-MS/MS,Resveratrol metabolites,trans-Resveratrol 3-O-glucuronide + cis-Resveratrol 3-O-glucuronide + cis-Resveratrol 4'-O-glucuronide + trans-Resveratrol 4'-O-sulfate + trans-Resveratrol 3-O-sulfate + cis-Resveratrol 4'-O-sulfate,,,,nmol/g,Creatinine,1000,Spearman,0.895,,,< 0.001,Yes,,,,Zamora-Ros 2009
222,305,303,All [by intake],First consecutive participants entering a substudy of PREDIMED,Spain,PREDIMED (Prevención con Dieta Mediterránea),,Food Frequency Questionnaire (FFQ),Resveratrols,Resveratrol 3-O-glucoside (cis + trans) + Resveratrol (cis + trans),,,,,ug/day,,,"Urine, first morning spot",LC-MS/MS,Resveratrol metabolites,trans-Resveratrol 3-O-glucuronide + cis-Resveratrol 3-O-glucuronide + cis-Resveratrol 4'-O-glucuronide + trans-Resveratrol 4'-O-sulfate + trans-Resveratrol 3-O-sulfate + cis-Resveratrol 4'-O-sulfate,,,,nmol/g,Creatinine,1000,Spearman,0.89,,,< 0.001,Yes,,,,Zamora-Ros 2009
223,314,327,All [by intake],Premenopausal women,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Soy milk,"",,,,,g/day,,,"Plasma, unspecified",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Daidzein,"",,,,nmol/L,,80,Spearman,0.72,,,< 0.001,Yes,,,,Verkasalo 2001
271,314,326,All [by intake],Premenopausal women,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Soy milk,"",,,,,g/day,,,"Plasma, unspecified",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Genistein,"",,,,nmol/L,,80,Spearman,0.72,,,< 0.001,Yes,,,,Verkasalo 2001
225,316,327,All [by intake],Premenopausal women,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Soy foods,"",,,,,g/day,,,"Plasma, unspecified",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Daidzein,"",,,,nmol/L,,80,Spearman,0.28,,,= 0.012,Yes,,,,Verkasalo 2001
273,316,326,All [by intake],Premenopausal women,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Soy foods,"",,,,,g/day,,,"Plasma, unspecified",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Genistein,"",,,,nmol/L,,80,Spearman,0.24,,,= 0.034,Yes,,,,Verkasalo 2001
227,318,327,All [by intake],Premenopausal women,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Soy foods,Soy milk + Soy foods,,,,,g/day,,,"Plasma, unspecified",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Daidzein,"",,,,nmol/L,,80,Spearman,0.74,,,< 0.001,Yes,,,,Verkasalo 2001
275,318,326,All [by intake],Premenopausal women,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Soy foods,Soy milk + Soy foods,,,,,g/day,,,"Plasma, unspecified",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Genistein,"",,,,nmol/L,,80,Spearman,0.73,,,< 0.001,Yes,,,,Verkasalo 2001
231,320,327,All [by intake],Premenopausal women,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Genistein,"",,,,,mg/day,,,"Plasma, unspecified",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Daidzein,"",,,,nmol/L,,80,Spearman,0.72,,,< 0.001,Yes,,,,Verkasalo 2001
279,320,326,All [by intake],Premenopausal women,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Genistein,"",,,,,mg/day,,,"Plasma, unspecified",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Genistein,"",,,,nmol/L,,80,Spearman,0.69,,,< 0.001,Yes,,,,Verkasalo 2001
229,322,327,All [by intake],Premenopausal women,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Daidzein,"",,,,,mg/day,,,"Plasma, unspecified",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Daidzein,"",,,,nmol/L,,80,Spearman,0.74,,,< 0.001,Yes,,,,Verkasalo 2001
277,322,326,All [by intake],Premenopausal women,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Daidzein,"",,,,,mg/day,,,"Plasma, unspecified",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Genistein,"",,,,nmol/L,,80,Spearman,0.71,,,< 0.001,Yes,,,,Verkasalo 2001
233,324,327,All [by intake],Premenopausal women,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Isoflavones,Genistein + Daidzein,,,,,mg/day,,,"Plasma, unspecified",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Daidzein,"",,,,nmol/L,,80,Spearman,0.56,,,< 0.001,Yes,,,,Verkasalo 2001
281,324,326,All [by intake],Premenopausal women,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Isoflavones,Genistein + Daidzein,,,,,mg/day,,,"Plasma, unspecified",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Genistein,"",,,,nmol/L,,80,Spearman,0.53,,,< 0.001,Yes,,,,Verkasalo 2001
224,315,327,All [by intake],Premenopausal women,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Soy milk,"",,,,,g/day,,,"Plasma, unspecified",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Daidzein,"",,,,nmol/L,,80,Spearman,0.74,,,< 0.001,Yes,,,,Verkasalo 2001
272,315,326,All [by intake],Premenopausal women,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Soy milk,"",,,,,g/day,,,"Plasma, unspecified",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Genistein,"",,,,nmol/L,,80,Spearman,0.77,,,< 0.001,Yes,,,,Verkasalo 2001
226,317,327,All [by intake],Premenopausal women,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Soy foods,"",,,,,g/day,,,"Plasma, unspecified",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Daidzein,"",,,,nmol/L,,80,Spearman,0.69,,,< 0.001,Yes,,,,Verkasalo 2001
274,317,326,All [by intake],Premenopausal women,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Soy foods,"",,,,,g/day,,,"Plasma, unspecified",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Genistein,"",,,,nmol/L,,80,Spearman,0.66,,,< 0.001,Yes,,,,Verkasalo 2001
228,319,327,All [by intake],Premenopausal women,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Soy foods,Soy milk + Soy foods,,,,,g/day,,,"Plasma, unspecified",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Daidzein,"",,,,nmol/L,,80,Spearman,0.78,,,< 0.001,Yes,,,,Verkasalo 2001
276,319,326,All [by intake],Premenopausal women,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Soy foods,Soy milk + Soy foods,,,,,g/day,,,"Plasma, unspecified",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Genistein,"",,,,nmol/L,,80,Spearman,0.78,,,< 0.001,Yes,,,,Verkasalo 2001
232,321,327,All [by intake],Premenopausal women,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Genistein,"",,,,,mg/day,,,"Plasma, unspecified",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Daidzein,"",,,,nmol/L,,80,Spearman,0.79,,,< 0.001,Yes,,,,Verkasalo 2001
280,321,326,All [by intake],Premenopausal women,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Genistein,"",,,,,mg/day,,,"Plasma, unspecified",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Genistein,"",,,,nmol/L,,80,Spearman,0.8,,,< 0.001,Yes,,,,Verkasalo 2001
230,323,327,All [by intake],Premenopausal women,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Daidzein,"",,,,,mg/day,,,"Plasma, unspecified",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Daidzein,"",,,,nmol/L,,80,Spearman,0.79,,,< 0.001,Yes,,,,Verkasalo 2001
278,323,326,All [by intake],Premenopausal women,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Daidzein,"",,,,,mg/day,,,"Plasma, unspecified",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Genistein,"",,,,nmol/L,,80,Spearman,0.8,,,< 0.001,Yes,,,,Verkasalo 2001
234,325,327,All [by intake],Premenopausal women,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Isoflavones,Genistein + Daidzein,,,,,mg/day,,,"Plasma, unspecified",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Daidzein,"",,,,nmol/L,,80,Spearman,0.79,,,< 0.001,Yes,,,,Verkasalo 2001
282,325,326,All [by intake],Premenopausal women,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Isoflavones,Genistein + Daidzein,,,,,mg/day,,,"Plasma, unspecified",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Genistein,"",,,,nmol/L,,80,Spearman,0.8,,,< 0.001,Yes,,,,Verkasalo 2001
283,390,391,All,University students,China,,,Dietary record (7-day),Quercetin,"",,13.58,,10.76,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Quercetin,"",80.23,,53.95,nmol/L,,92,Spearman,0.51,,,< 0.05,Yes,,,,Cao 2010
291,390,399,All,University students,China,,,Dietary record (7-day),Quercetin,"",,13.58,,10.76,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Kaempferol,"",57.86,,38.0,nmol/L,,92,Spearman,0.19,,,>= 0.05,No,,,,Cao 2010
299,390,400,All,University students,China,,,Dietary record (7-day),Quercetin,"",,13.58,,10.76,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Isorhamnetin,"",39.94,,20.09,nmol/L,,92,Spearman,0.31,,,>= 0.05,No,,,,Cao 2010
307,390,401,All,University students,China,,,Dietary record (7-day),Quercetin,"",,13.58,,10.76,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonols,Quercetin + Kaempferol + Isorhamnetin,178.03,,159.92,nmol/L,,92,Spearman,0.52,,,< 0.05,Yes,,,,Cao 2010
315,390,402,All,University students,China,,,Dietary record (7-day),Quercetin,"",,13.58,,10.76,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Apigenin,"",10.62,,6.07,nmol/L,,92,Spearman,0.57,,,>= 0.05,No,,,,Cao 2010
323,390,403,All,University students,China,,,Dietary record (7-day),Quercetin,"",,13.58,,10.76,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Luteolin,"",99.9,,77.46,nmol/L,,92,Spearman,0.56,,,>= 0.05,No,,,,Cao 2010
331,390,404,All,University students,China,,,Dietary record (7-day),Quercetin,"",,13.58,,10.76,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavones,Apigenin + Luteolin,108.08,,80.14,nmol/L,,92,Spearman,0.57,,,>= 0.05,No,,,,Cao 2010
339,390,405,All,University students,China,,,Dietary record (7-day),Quercetin,"",,13.58,,10.76,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonoids,Quercetin + Kaempferol + Isorhamnetin + Apigenin + Luteolin,286.11,,289.21,nmol/L,,92,Spearman,0.65,,,>= 0.05,No,,,,Cao 2010
284,392,391,All,University students,China,,,Dietary record (7-day),Kaempferol,"",,14.97,,10.94,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Quercetin,"",80.23,,53.95,nmol/L,,92,Spearman,0.11,,,>= 0.05,No,,,,Cao 2010
292,392,399,All,University students,China,,,Dietary record (7-day),Kaempferol,"",,14.97,,10.94,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Kaempferol,"",57.86,,38.0,nmol/L,,92,Spearman,0.44,,,< 0.05,Yes,,,,Cao 2010
300,392,400,All,University students,China,,,Dietary record (7-day),Kaempferol,"",,14.97,,10.94,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Isorhamnetin,"",39.94,,20.09,nmol/L,,92,Spearman,0.33,,,>= 0.05,No,,,,Cao 2010
308,392,401,All,University students,China,,,Dietary record (7-day),Kaempferol,"",,14.97,,10.94,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonols,Quercetin + Kaempferol + Isorhamnetin,178.03,,159.92,nmol/L,,92,Spearman,0.39,,,>= 0.05,No,,,,Cao 2010
316,392,402,All,University students,China,,,Dietary record (7-day),Kaempferol,"",,14.97,,10.94,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Apigenin,"",10.62,,6.07,nmol/L,,92,Spearman,0.28,,,>= 0.05,No,,,,Cao 2010
324,392,403,All,University students,China,,,Dietary record (7-day),Kaempferol,"",,14.97,,10.94,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Luteolin,"",99.9,,77.46,nmol/L,,92,Spearman,0.29,,,>= 0.05,No,,,,Cao 2010
332,392,404,All,University students,China,,,Dietary record (7-day),Kaempferol,"",,14.97,,10.94,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavones,Apigenin + Luteolin,108.08,,80.14,nmol/L,,92,Spearman,0.32,,,>= 0.05,No,,,,Cao 2010
340,392,405,All,University students,China,,,Dietary record (7-day),Kaempferol,"",,14.97,,10.94,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonoids,Quercetin + Kaempferol + Isorhamnetin + Apigenin + Luteolin,286.11,,289.21,nmol/L,,92,Spearman,0.43,,,>= 0.05,No,,,,Cao 2010
285,393,391,All,University students,China,,,Dietary record (7-day),Isorhamnetin,"",,12.31,,10.84,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Quercetin,"",80.23,,53.95,nmol/L,,92,Spearman,0.09,,,>= 0.05,No,,,,Cao 2010
293,393,399,All,University students,China,,,Dietary record (7-day),Isorhamnetin,"",,12.31,,10.84,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Kaempferol,"",57.86,,38.0,nmol/L,,92,Spearman,0.45,,,>= 0.05,No,,,,Cao 2010
301,393,400,All,University students,China,,,Dietary record (7-day),Isorhamnetin,"",,12.31,,10.84,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Isorhamnetin,"",39.94,,20.09,nmol/L,,92,Spearman,0.33,,,< 0.05,Yes,,,,Cao 2010
309,393,401,All,University students,China,,,Dietary record (7-day),Isorhamnetin,"",,12.31,,10.84,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonols,Quercetin + Kaempferol + Isorhamnetin,178.03,,159.92,nmol/L,,92,Spearman,0.39,,,< 0.05,Yes,,,,Cao 2010
317,393,402,All,University students,China,,,Dietary record (7-day),Isorhamnetin,"",,12.31,,10.84,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Apigenin,"",10.62,,6.07,nmol/L,,92,Spearman,0.28,,,>= 0.05,No,,,,Cao 2010
325,393,403,All,University students,China,,,Dietary record (7-day),Isorhamnetin,"",,12.31,,10.84,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Luteolin,"",99.9,,77.46,nmol/L,,92,Spearman,0.3,,,>= 0.05,No,,,,Cao 2010
333,393,404,All,University students,China,,,Dietary record (7-day),Isorhamnetin,"",,12.31,,10.84,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavones,Apigenin + Luteolin,108.08,,80.14,nmol/L,,92,Spearman,0.32,,,>= 0.05,No,,,,Cao 2010
341,393,405,All,University students,China,,,Dietary record (7-day),Isorhamnetin,"",,12.31,,10.84,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonoids,Quercetin + Kaempferol + Isorhamnetin + Apigenin + Luteolin,286.11,,289.21,nmol/L,,92,Spearman,0.41,,,>= 0.05,No,,,,Cao 2010
286,394,391,All,University students,China,,,Dietary record (7-day),Flavonols,Quercetin + Kaempferol + Isorhamnetin,,40.87,,38.66,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Quercetin,"",80.23,,53.95,nmol/L,,92,Spearman,0.27,,,>= 0.05,No,,,,Cao 2010
294,394,399,All,University students,China,,,Dietary record (7-day),Flavonols,Quercetin + Kaempferol + Isorhamnetin,,40.87,,38.66,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Kaempferol,"",57.86,,38.0,nmol/L,,92,Spearman,0.4,,,>= 0.05,No,,,,Cao 2010
302,394,400,All,University students,China,,,Dietary record (7-day),Flavonols,Quercetin + Kaempferol + Isorhamnetin,,40.87,,38.66,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Isorhamnetin,"",39.94,,20.09,nmol/L,,92,Spearman,0.35,,,>= 0.05,No,,,,Cao 2010
310,394,401,All,University students,China,,,Dietary record (7-day),Flavonols,Quercetin + Kaempferol + Isorhamnetin,,40.87,,38.66,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonols,Quercetin + Kaempferol + Isorhamnetin,178.03,,159.92,nmol/L,,92,Spearman,0.48,,,< 0.05,Yes,,,,Cao 2010
318,394,402,All,University students,China,,,Dietary record (7-day),Flavonols,Quercetin + Kaempferol + Isorhamnetin,,40.87,,38.66,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Apigenin,"",10.62,,6.07,nmol/L,,92,Spearman,0.41,,,>= 0.05,No,,,,Cao 2010
326,394,403,All,University students,China,,,Dietary record (7-day),Flavonols,Quercetin + Kaempferol + Isorhamnetin,,40.87,,38.66,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Luteolin,"",99.9,,77.46,nmol/L,,92,Spearman,0.46,,,>= 0.05,No,,,,Cao 2010
334,394,404,All,University students,China,,,Dietary record (7-day),Flavonols,Quercetin + Kaempferol + Isorhamnetin,,40.87,,38.66,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavones,Apigenin + Luteolin,108.08,,80.14,nmol/L,,92,Spearman,0.48,,,>= 0.05,No,,,,Cao 2010
342,394,405,All,University students,China,,,Dietary record (7-day),Flavonols,Quercetin + Kaempferol + Isorhamnetin,,40.87,,38.66,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonoids,Quercetin + Kaempferol + Isorhamnetin + Apigenin + Luteolin,286.11,,289.21,nmol/L,,92,Spearman,0.57,,,>= 0.05,No,,,,Cao 2010
287,395,391,All,University students,China,,,Dietary record (7-day),Apigenin,"",,4.23,,3.54,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Quercetin,"",80.23,,53.95,nmol/L,,92,Spearman,0.32,,,>= 0.05,No,,,,Cao 2010
295,395,399,All,University students,China,,,Dietary record (7-day),Apigenin,"",,4.23,,3.54,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Kaempferol,"",57.86,,38.0,nmol/L,,92,Spearman,0.41,,,>= 0.05,No,,,,Cao 2010
303,395,400,All,University students,China,,,Dietary record (7-day),Apigenin,"",,4.23,,3.54,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Isorhamnetin,"",39.94,,20.09,nmol/L,,92,Spearman,0.38,,,>= 0.05,No,,,,Cao 2010
311,395,401,All,University students,China,,,Dietary record (7-day),Apigenin,"",,4.23,,3.54,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonols,Quercetin + Kaempferol + Isorhamnetin,178.03,,159.92,nmol/L,,92,Spearman,0.49,,,>= 0.05,No,,,,Cao 2010
319,395,402,All,University students,China,,,Dietary record (7-day),Apigenin,"",,4.23,,3.54,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Apigenin,"",10.62,,6.07,nmol/L,,92,Spearman,0.42,,,< 0.05,Yes,,,,Cao 2010
327,395,403,All,University students,China,,,Dietary record (7-day),Apigenin,"",,4.23,,3.54,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Luteolin,"",99.9,,77.46,nmol/L,,92,Spearman,0.4,,,>= 0.05,No,,,,Cao 2010
335,395,404,All,University students,China,,,Dietary record (7-day),Apigenin,"",,4.23,,3.54,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavones,Apigenin + Luteolin,108.08,,80.14,nmol/L,,92,Spearman,0.41,,,>= 0.05,No,,,,Cao 2010
343,395,405,All,University students,China,,,Dietary record (7-day),Apigenin,"",,4.23,,3.54,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonoids,Quercetin + Kaempferol + Isorhamnetin + Apigenin + Luteolin,286.11,,289.21,nmol/L,,92,Spearman,0.55,,,< 0.05,Yes,,,,Cao 2010
288,396,391,All,University students,China,,,Dietary record (7-day),Luteolin,"",,8.08,,7.41,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Quercetin,"",80.23,,53.95,nmol/L,,92,Spearman,0.23,,,>= 0.05,No,,,,Cao 2010
296,396,399,All,University students,China,,,Dietary record (7-day),Luteolin,"",,8.08,,7.41,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Kaempferol,"",57.86,,38.0,nmol/L,,92,Spearman,0.47,,,>= 0.05,No,,,,Cao 2010
304,396,400,All,University students,China,,,Dietary record (7-day),Luteolin,"",,8.08,,7.41,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Isorhamnetin,"",39.94,,20.09,nmol/L,,92,Spearman,0.39,,,>= 0.05,No,,,,Cao 2010
312,396,401,All,University students,China,,,Dietary record (7-day),Luteolin,"",,8.08,,7.41,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonols,Quercetin + Kaempferol + Isorhamnetin,178.03,,159.92,nmol/L,,92,Spearman,0.48,,,>= 0.05,No,,,,Cao 2010
320,396,402,All,University students,China,,,Dietary record (7-day),Luteolin,"",,8.08,,7.41,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Apigenin,"",10.62,,6.07,nmol/L,,92,Spearman,0.37,,,>= 0.05,No,,,,Cao 2010
328,396,403,All,University students,China,,,Dietary record (7-day),Luteolin,"",,8.08,,7.41,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Luteolin,"",99.9,,77.46,nmol/L,,92,Spearman,0.44,,,< 0.05,Yes,,,,Cao 2010
336,396,404,All,University students,China,,,Dietary record (7-day),Luteolin,"",,8.08,,7.41,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavones,Apigenin + Luteolin,108.08,,80.14,nmol/L,,92,Spearman,0.46,,,>= 0.05,No,,,,Cao 2010
344,396,405,All,University students,China,,,Dietary record (7-day),Luteolin,"",,8.08,,7.41,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonoids,Quercetin + Kaempferol + Isorhamnetin + Apigenin + Luteolin,286.11,,289.21,nmol/L,,92,Spearman,0.56,,,< 0.05,Yes,,,,Cao 2010
289,397,391,All,University students,China,,,Dietary record (7-day),Flavones,Apigenin + Luteolin,,12.31,,11.03,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Quercetin,"",80.23,,53.95,nmol/L,,92,Spearman,0.27,,,>= 0.05,No,,,,Cao 2010
297,397,399,All,University students,China,,,Dietary record (7-day),Flavones,Apigenin + Luteolin,,12.31,,11.03,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Kaempferol,"",57.86,,38.0,nmol/L,,92,Spearman,0.46,,,>= 0.05,No,,,,Cao 2010
305,397,400,All,University students,China,,,Dietary record (7-day),Flavones,Apigenin + Luteolin,,12.31,,11.03,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Isorhamnetin,"",39.94,,20.09,nmol/L,,92,Spearman,0.39,,,>= 0.05,No,,,,Cao 2010
313,397,401,All,University students,China,,,Dietary record (7-day),Flavones,Apigenin + Luteolin,,12.31,,11.03,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonols,Quercetin + Kaempferol + Isorhamnetin,178.03,,159.92,nmol/L,,92,Spearman,0.5,,,>= 0.05,No,,,,Cao 2010
321,397,402,All,University students,China,,,Dietary record (7-day),Flavones,Apigenin + Luteolin,,12.31,,11.03,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Apigenin,"",10.62,,6.07,nmol/L,,92,Spearman,0.41,,,>= 0.05,No,,,,Cao 2010
329,397,403,All,University students,China,,,Dietary record (7-day),Flavones,Apigenin + Luteolin,,12.31,,11.03,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Luteolin,"",99.9,,77.46,nmol/L,,92,Spearman,0.44,,,>= 0.05,No,,,,Cao 2010
337,397,404,All,University students,China,,,Dietary record (7-day),Flavones,Apigenin + Luteolin,,12.31,,11.03,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavones,Apigenin + Luteolin,108.08,,80.14,nmol/L,,92,Spearman,0.46,,,< 0.05,Yes,,,,Cao 2010
345,397,405,All,University students,China,,,Dietary record (7-day),Flavones,Apigenin + Luteolin,,12.31,,11.03,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonoids,Quercetin + Kaempferol + Isorhamnetin + Apigenin + Luteolin,286.11,,289.21,nmol/L,,92,Spearman,0.57,,,>= 0.05,No,,,,Cao 2010
290,398,391,All,University students,China,,,Dietary record (7-day),Flavonoids,Quercetin + Kaempferol + Isorhamnetin + Apigenin + Luteolin,,53.19,,49.47,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Quercetin,"",80.23,,53.95,nmol/L,,92,Spearman,0.27,,,>= 0.05,No,,,,Cao 2010
298,398,399,All,University students,China,,,Dietary record (7-day),Flavonoids,Quercetin + Kaempferol + Isorhamnetin + Apigenin + Luteolin,,53.19,,49.47,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Kaempferol,"",57.86,,38.0,nmol/L,,92,Spearman,0.43,,,>= 0.05,No,,,,Cao 2010
306,398,400,All,University students,China,,,Dietary record (7-day),Flavonoids,Quercetin + Kaempferol + Isorhamnetin + Apigenin + Luteolin,,53.19,,49.47,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Isorhamnetin,"",39.94,,20.09,nmol/L,,92,Spearman,0.37,,,>= 0.05,No,,,,Cao 2010
314,398,401,All,University students,China,,,Dietary record (7-day),Flavonoids,Quercetin + Kaempferol + Isorhamnetin + Apigenin + Luteolin,,53.19,,49.47,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonols,Quercetin + Kaempferol + Isorhamnetin,178.03,,159.92,nmol/L,,92,Spearman,0.5,,,>= 0.05,No,,,,Cao 2010
322,398,402,All,University students,China,,,Dietary record (7-day),Flavonoids,Quercetin + Kaempferol + Isorhamnetin + Apigenin + Luteolin,,53.19,,49.47,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Apigenin,"",10.62,,6.07,nmol/L,,92,Spearman,0.4,,,>= 0.05,No,,,,Cao 2010
330,398,403,All,University students,China,,,Dietary record (7-day),Flavonoids,Quercetin + Kaempferol + Isorhamnetin + Apigenin + Luteolin,,53.19,,49.47,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Luteolin,"",99.9,,77.46,nmol/L,,92,Spearman,0.46,,,>= 0.05,No,,,,Cao 2010
338,398,404,All,University students,China,,,Dietary record (7-day),Flavonoids,Quercetin + Kaempferol + Isorhamnetin + Apigenin + Luteolin,,53.19,,49.47,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavones,Apigenin + Luteolin,108.08,,80.14,nmol/L,,92,Spearman,0.48,,,>= 0.05,No,,,,Cao 2010
346,398,405,All,University students,China,,,Dietary record (7-day),Flavonoids,Quercetin + Kaempferol + Isorhamnetin + Apigenin + Luteolin,,53.19,,49.47,mg/day,,,"Plasma, fasting",HPLC after enzymatic hydrolysis,Flavonoids,Quercetin + Kaempferol + Isorhamnetin + Apigenin + Luteolin,286.11,,289.21,nmol/L,,92,Spearman,0.58,,,< 0.05,Yes,,,,Cao 2010
571,667,673,Children,Children and adolescents,Germany,DONALD (Dortmund Nutritional and Anthropometric Longitudinally Designed study),,Weighed Dietary record (3-day),Proteins,"",,56.8,,,g/day,,,"Urine, 24-h",Kjeldahl method,Nitrogen,"",538.0,,,mmol/day,,120,Spearman,0.64,,,< 0.0001,Yes,,,,Krupp 2012
570,668,674,Children,Children and adolescents,Germany,DONALD (Dortmund Nutritional and Anthropometric Longitudinally Designed study),,Weighed Dietary record (3-day),Fruits + Vegetables,Fruits + Vegetables + Fruit juices + Vegetable juices,,,,411.0,g/day,,,"Urine, 24-h",Colorimetry,Hippuric acid,"",,,2.1,mmol/day,,120,Spearman,0.62,,,< 0.0001,Yes,,,,Krupp 2012
572,669,675,Children,Children and adolescents,Germany,DONALD (Dortmund Nutritional and Anthropometric Longitudinally Designed study),,Weighed Dietary record (3-day),Potassium,"",,2.41,,,g/day,,,"Urine, 24-h",Atomic absorption spectrometry (AAS),Potassium,"",47.7,,,mmol/day,,120,Spearman,0.65,,,< 0.0001,Yes,,,,Krupp 2012
574,670,676,Adolescents,Children and adolescents,Germany,DONALD (Dortmund Nutritional and Anthropometric Longitudinally Designed study),,Weighed Dietary record (3-day),Proteins,"",,66.4,,,g/day,,,"Urine, 24-h",Kjeldahl method,Nitrogen,"",628.0,,,mmol/day,,120,Spearman,0.62,,,< 0.0001,Yes,,,,Krupp 2012
573,671,677,Adolescents,Children and adolescents,Germany,DONALD (Dortmund Nutritional and Anthropometric Longitudinally Designed study),,Weighed Dietary record (3-day),Fruits + Vegetables,Fruits + Vegetables + Fruit juices + Vegetable juices,,,,430.0,g/day,,,"Urine, 24-h",Colorimetry,Hippuric acid,"",,,2.82,mmol/day,,120,Spearman,0.41,,,< 0.0001,Yes,,,,Krupp 2012
575,672,678,Adolescents,Children and adolescents,Germany,DONALD (Dortmund Nutritional and Anthropometric Longitudinally Designed study),,Weighed Dietary record (3-day),Potassium,"",,2.68,,,g/day,,,"Urine, 24-h",Atomic absorption spectrometry (AAS),Potassium,"",53.9,,,mmol/day,,120,Spearman,0.58,,,< 0.0001,Yes,,,,Krupp 2012
582,683,680,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Dietary fibre,Fibre from Cereals,,,19.0,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,8.4,,umol/L,,95,Spearman,0.4,0.22,0.55,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
592,683,682,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Dietary fibre,Fibre from Cereals,,,19.0,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,9.0,,umol/L,,95,Spearman,0.34,0.16,0.5,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
602,683,696,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Dietary fibre,Fibre from Cereals,,,19.0,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,95,Spearman,0.46,0.3,0.6,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
612,683,696,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Dietary fibre,Fibre from Cereals,,,19.0,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,95,Spearman,0.71,0.54,0.83,>= 0.05,No,"Energy by residual method, Creatinine",Yes,,Landberg 2012
622,683,679,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Dietary fibre,Fibre from Cereals,,,19.0,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,3.3,,umol/L,,95,Spearman,0.28,0.09,0.45,< 0.01,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
632,683,693,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Dietary fibre,Fibre from Cereals,,,19.0,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,12.0,,umol/L,,95,Spearman,0.39,0.22,0.55,< 0.001,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
642,683,681,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Dietary fibre,Fibre from Cereals,,,19.0,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,4.2,,umol/L,,95,Spearman,0.16,-0.04,0.34,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
652,683,694,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Dietary fibre,Fibre from Cereals,,,19.0,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,13.4,,umol/L,,95,Spearman,0.3,0.11,0.46,< 0.01,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
662,683,695,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Dietary fibre,Fibre from Cereals,,,19.0,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,95,Spearman,0.29,0.1,0.46,< 0.01,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
672,683,697,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Dietary fibre,Fibre from Cereals,,,19.0,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/L,,95,Spearman,0.45,0.28,0.59,< 0.001,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
584,684,680,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Fibre from Cereals,"",,,5.8,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,8.4,,umol/L,,95,Spearman,0.33,0.15,0.5,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
594,684,682,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Fibre from Cereals,"",,,5.8,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,9.0,,umol/L,,95,Spearman,0.3,0.12,0.47,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
604,684,696,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Fibre from Cereals,"",,,5.8,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,95,Spearman,0.4,0.22,0.55,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
614,684,696,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Fibre from Cereals,"",,,5.8,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,95,Spearman,0.61,0.38,0.77,>= 0.05,No,"Energy by residual method, Creatinine",Yes,,Landberg 2012
624,684,679,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Fibre from Cereals,"",,,5.8,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,3.3,,umol/L,,95,Spearman,0.33,0.14,0.49,< 0.001,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
634,684,693,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Fibre from Cereals,"",,,5.8,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,12.0,,umol/L,,95,Spearman,0.34,0.16,0.5,< 0.001,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
644,684,681,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Fibre from Cereals,"",,,5.8,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,4.2,,umol/L,,95,Spearman,0.21,0.01,0.38,< 0.05,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
654,684,694,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Fibre from Cereals,"",,,5.8,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,13.4,,umol/L,,95,Spearman,0.28,0.1,0.45,< 0.01,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
664,684,695,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Fibre from Cereals,"",,,5.8,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,95,Spearman,0.35,0.17,0.51,< 0.01,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
674,684,697,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Fibre from Cereals,"",,,5.8,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/L,,95,Spearman,0.4,0.23,0.56,< 0.001,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
576,685,680,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Whole grain cereals,"",,,15.9,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,8.4,,umol/L,,95,Spearman,0.37,0.19,0.53,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
586,685,682,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Whole grain cereals,"",,,15.9,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,9.0,,umol/L,,95,Spearman,0.25,0.06,0.43,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
596,685,696,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Whole grain cereals,"",,,15.9,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,95,Spearman,0.39,0.22,0.55,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
606,685,696,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Whole grain cereals,"",,,15.9,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,95,Spearman,0.6,0.37,0.76,>= 0.05,No,"Energy by residual method, Creatinine",Yes,,Landberg 2012
616,685,679,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Whole grain cereals,"",,,15.9,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,3.3,,umol/L,,95,Spearman,0.34,0.16,0.5,< 0.001,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
626,685,693,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Whole grain cereals,"",,,15.9,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,12.0,,umol/L,,95,Spearman,0.38,0.2,0.53,< 0.001,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
636,685,681,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Whole grain cereals,"",,,15.9,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,4.2,,umol/L,,95,Spearman,0.23,0.04,0.4,< 0.05,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
646,685,694,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Whole grain cereals,"",,,15.9,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,13.4,,umol/L,,95,Spearman,0.37,0.19,0.53,< 0.01,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
656,685,695,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Whole grain cereals,"",,,15.9,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,95,Spearman,0.25,0.06,0.42,< 0.01,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
666,685,697,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Whole grain cereals,"",,,15.9,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/L,,95,Spearman,0.41,0.23,0.56,< 0.001,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
578,686,680,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Bran,"",,,3.8,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,8.4,,umol/L,,95,Spearman,0.22,0.02,0.39,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
588,686,682,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Bran,"",,,3.8,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,9.0,,umol/L,,95,Spearman,0.29,0.1,0.46,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
598,686,696,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Bran,"",,,3.8,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,95,Spearman,0.32,0.13,0.48,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
608,686,696,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Bran,"",,,3.8,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,95,Spearman,0.48,0.22,0.68,>= 0.05,No,"Energy by residual method, Creatinine",Yes,,Landberg 2012
618,686,679,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Bran,"",,,3.8,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,3.3,,umol/L,,95,Spearman,0.26,0.07,0.43,< 0.01,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
628,686,693,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Bran,"",,,3.8,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,12.0,,umol/L,,95,Spearman,0.23,0.04,0.41,< 0.01,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
638,686,681,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Bran,"",,,3.8,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,4.2,,umol/L,,95,Spearman,0.2,0.01,0.38,< 0.05,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
648,686,694,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Bran,"",,,3.8,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,13.4,,umol/L,,95,Spearman,0.27,0.09,0.44,< 0.01,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
658,686,695,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Bran,"",,,3.8,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,95,Spearman,0.3,0.12,0.47,< 0.01,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
668,686,697,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Bran,"",,,3.8,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/L,,95,Spearman,0.33,0.14,0.49,< 0.01,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
580,687,680,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Germ,"",,,0.8,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,8.4,,umol/L,,95,Spearman,0.31,0.12,0.48,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
590,687,682,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Germ,"",,,0.8,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,9.0,,umol/L,,95,Spearman,0.17,-0.03,0.35,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
600,687,696,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Germ,"",,,0.8,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,95,Spearman,0.3,0.11,0.47,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
610,687,696,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Germ,"",,,0.8,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,95,Spearman,0.45,0.18,0.66,>= 0.05,No,"Energy by residual method, Creatinine",Yes,,Landberg 2012
620,687,679,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Germ,"",,,0.8,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,3.3,,umol/L,,95,Spearman,0.21,0.02,0.39,< 0.05,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
630,687,693,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Germ,"",,,0.8,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,12.0,,umol/L,,95,Spearman,0.3,0.11,0.47,< 0.01,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
640,687,681,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Germ,"",,,0.8,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,4.2,,umol/L,,95,Spearman,0.13,-0.07,0.32,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
650,687,694,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Germ,"",,,0.8,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,13.4,,umol/L,,95,Spearman,0.16,-0.03,0.34,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
660,687,695,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Germ,"",,,0.8,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,95,Spearman,0.22,0.03,0.4,< 0.05,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
670,687,697,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),baseline,Food Frequency Questionnaire (FFQ),Germ,"",,,0.8,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/L,,95,Spearman,0.3,0.11,0.46,< 0.01,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
583,688,680,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Dietary fibre,Fibre from Cereals,,,19.7,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,8.4,,umol/L,,95,Spearman,0.35,0.17,0.51,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
593,688,682,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Dietary fibre,Fibre from Cereals,,,19.7,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,9.0,,umol/L,,95,Spearman,0.4,0.22,0.55,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
603,688,696,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Dietary fibre,Fibre from Cereals,,,19.7,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,95,Spearman,0.47,0.3,0.61,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
613,688,696,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Dietary fibre,Fibre from Cereals,,,19.7,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,95,Spearman,0.72,0.56,0.83,>= 0.05,No,"Energy by residual method, Creatinine",Yes,,Landberg 2012
623,688,679,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Dietary fibre,Fibre from Cereals,,,19.7,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,3.3,,umol/L,,95,Spearman,0.29,0.1,0.45,< 0.01,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
633,688,693,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Dietary fibre,Fibre from Cereals,,,19.7,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,12.0,,umol/L,,95,Spearman,0.35,0.17,0.51,< 0.001,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
643,688,681,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Dietary fibre,Fibre from Cereals,,,19.7,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,4.2,,umol/L,,95,Spearman,0.29,0.1,0.45,< 0.001,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
653,688,694,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Dietary fibre,Fibre from Cereals,,,19.7,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,13.4,,umol/L,,95,Spearman,0.38,0.2,0.53,< 0.001,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
663,688,695,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Dietary fibre,Fibre from Cereals,,,19.7,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,95,Spearman,0.38,0.2,0.53,< 0.001,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
585,689,680,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Fibre from Cereals,"",,,6.4,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,8.4,,umol/L,,95,Spearman,0.25,0.06,0.43,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
595,689,682,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Fibre from Cereals,"",,,6.4,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,9.0,,umol/L,,95,Spearman,0.15,-0.05,0.33,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
605,689,696,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Fibre from Cereals,"",,,6.4,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,95,Spearman,0.25,0.06,0.42,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
615,689,696,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Fibre from Cereals,"",,,6.4,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,95,Spearman,0.38,0.1,0.6,>= 0.05,No,"Energy by residual method, Creatinine",Yes,,Landberg 2012
625,689,679,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Fibre from Cereals,"",,,6.4,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,3.3,,umol/L,,95,Spearman,0.28,0.09,0.45,< 0.01,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
635,689,693,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Fibre from Cereals,"",,,6.4,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,12.0,,umol/L,,95,Spearman,0.28,0.09,0.45,< 0.01,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
645,689,681,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Fibre from Cereals,"",,,6.4,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,4.2,,umol/L,,95,Spearman,0.16,-0.03,0.34,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
655,689,694,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Fibre from Cereals,"",,,6.4,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,13.4,,umol/L,,95,Spearman,0.16,-0.03,0.35,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
665,689,695,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Fibre from Cereals,"",,,6.4,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,95,Spearman,0.29,0.1,0.46,< 0.01,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
673,689,697,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Fibre from Cereals,"",,,6.4,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/L,,95,Spearman,0.47,0.31,0.61,< 0.001,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
675,689,697,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Fibre from Cereals,"",,,6.4,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/L,,95,Spearman,0.29,0.1,0.45,< 0.01,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
577,690,680,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Whole grain cereals,"",,,23.0,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,8.4,,umol/L,,95,Spearman,0.31,0.12,0.47,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
587,690,682,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Whole grain cereals,"",,,23.0,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,9.0,,umol/L,,95,Spearman,0.17,-0.03,0.35,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
597,690,696,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Whole grain cereals,"",,,23.0,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,95,Spearman,0.3,0.11,0.47,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
607,690,696,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Whole grain cereals,"",,,23.0,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,95,Spearman,0.45,0.18,0.66,>= 0.05,No,"Energy by residual method, Creatinine",Yes,,Landberg 2012
617,690,679,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Whole grain cereals,"",,,23.0,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,3.3,,umol/L,,95,Spearman,0.32,0.13,0.48,< 0.01,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
627,690,693,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Whole grain cereals,"",,,23.0,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,12.0,,umol/L,,95,Spearman,0.33,0.14,0.49,< 0.01,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
637,690,681,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Whole grain cereals,"",,,23.0,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,4.2,,umol/L,,95,Spearman,0.16,-0.04,0.34,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
647,690,694,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Whole grain cereals,"",,,23.0,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,13.4,,umol/L,,95,Spearman,0.31,0.13,0.48,< 0.01,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
657,690,695,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Whole grain cereals,"",,,23.0,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,95,Spearman,0.17,-0.03,0.35,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
667,690,697,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Whole grain cereals,"",,,23.0,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/L,,95,Spearman,0.32,0.13,0.48,< 0.01,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
579,691,680,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Bran,"",,,4.9,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,8.4,,umol/L,,95,Spearman,0.13,-0.07,0.31,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
589,691,682,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Bran,"",,,4.9,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,9.0,,umol/L,,95,Spearman,0.1,-0.09,0.29,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
599,691,696,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Bran,"",,,4.9,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,95,Spearman,0.15,-0.05,0.33,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
609,691,696,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Bran,"",,,4.9,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,95,Spearman,0.22,-0.07,0.48,>= 0.05,No,"Energy by residual method, Creatinine",Yes,,Landberg 2012
619,691,679,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Bran,"",,,4.9,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,3.3,,umol/L,,95,Spearman,0.16,-0.04,0.34,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
629,691,693,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Bran,"",,,4.9,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,12.0,,umol/L,,95,Spearman,0.15,-0.05,0.33,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
639,691,681,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Bran,"",,,4.9,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,4.2,,umol/L,,95,Spearman,0.14,-0.05,0.33,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
649,691,694,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Bran,"",,,4.9,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,13.4,,umol/L,,95,Spearman,0.12,-0.07,0.31,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
659,691,695,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Bran,"",,,4.9,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,95,Spearman,0.2,0.0,0.37,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
669,691,697,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Bran,"",,,4.9,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/L,,95,Spearman,0.17,-0.02,0.36,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
581,692,680,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Germ,"",,,1.3,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,8.4,,umol/L,,95,Spearman,0.22,0.03,0.4,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
591,692,682,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Germ,"",,,1.3,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,9.0,,umol/L,,95,Spearman,0.06,-0.13,0.25,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
601,692,696,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Germ,"",,,1.3,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,95,Spearman,0.18,-0.02,0.36,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
611,692,696,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Germ,"",,,1.3,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,95,Spearman,0.27,-0.02,0.52,>= 0.05,No,"Energy by residual method, Creatinine",Yes,,Landberg 2012
621,692,679,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Germ,"",,,1.3,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,3.3,,umol/L,,95,Spearman,0.2,0.01,0.38,< 0.05,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
631,692,693,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Germ,"",,,1.3,,g/day,,1 year,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,12.0,,umol/L,,95,Spearman,0.23,0.03,0.4,< 0.05,Yes,"Energy by residual method, Creatinine",No,,Landberg 2012
641,692,681,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Germ,"",,,1.3,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,4.2,,umol/L,,95,Spearman,0.06,-0.14,0.25,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
651,692,694,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Germ,"",,,1.3,,g/day,,2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,13.4,,umol/L,,95,Spearman,0.07,-0.13,0.26,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
661,692,695,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Germ,"",,,1.3,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,95,Spearman,0.17,-0.02,0.35,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
671,692,697,All,Women participant in the hormone stability study,United States,NHS (Nurses' Health Study),4 years,Food Frequency Questionnaire (FFQ),Germ,"",,,1.3,,g/day,,1 year; 2.8 years,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/L,,95,Spearman,0.19,-0.01,0.37,>= 0.05,No,"Energy by residual method, Creatinine",No,,Landberg 2012
676,698,702,All,Pregnant women from a private obstetric hospital and a university hospital,Japan,,,Diet History Questionnaire (DHQ),Folates,"",No,261.0,,,ug/day,,,"Serum, non-fasting",Chemiluminescence immunoassay (CLIA),Folates,"",6.57,,,ng/mL,,167,Pearson,0.251,,,= 0.001,Yes,,,Research settings,Shiraishi 2012
677,699,702,All,Pregnant women from a private obstetric hospital and a university hospital,Japan,,,Diet History Questionnaire (DHQ),Folates,"",No,142.0,,,ug/1000 kcal,Energy,,"Serum, non-fasting",Chemiluminescence immunoassay (CLIA),Folates,"",6.57,,,ng/mL,,167,Pearson,0.286,,,< 0.001,Yes,Energy by density method,,Research settings,Shiraishi 2012
678,700,703,All,Pregnant women from a private obstetric hospital and a university hospital,Japan,,,Diet History Questionnaire (DHQ),Vitamin B12,"",No,5.74,,,ug/day,,,"Serum, non-fasting",Chemiluminescence immunoassay (CLIA),Vitamin B12,"",268.0,,,pg/mL,,167,Pearson,0.174,,,= 0.025,Yes,,,Research settings,Shiraishi 2012
679,701,703,All,Pregnant women from a private obstetric hospital and a university hospital,Japan,,,Diet History Questionnaire (DHQ),Vitamin B12,"",No,3.1,,,ug/1000 kcal,Energy,,"Serum, non-fasting",Chemiluminescence immunoassay (CLIA),Vitamin B12,"",268.0,,,pg/mL,,167,Pearson,0.222,,,= 0.004,Yes,Energy by density method,,Research settings,Shiraishi 2012
680,2470,2474,Nauseous excluded,Pregnant women from a private obstetric hospital and a university hospital,Japan,,,Diet History Questionnaire (DHQ),Folates,"",No,,,,ug/day,,,"Serum, non-fasting",Chemiluminescence immunoassay (CLIA),Folates,"",,,,ng/mL,,121,Pearson,0.245,,,= 0.007,Yes,,,Research settings,Shiraishi 2012
681,2471,2474,Nauseous excluded,Pregnant women from a private obstetric hospital and a university hospital,Japan,,,Diet History Questionnaire (DHQ),Folates,"",No,,,,ug/1000 kcal,Energy,,"Serum, non-fasting",Chemiluminescence immunoassay (CLIA),Folates,"",,,,ng/mL,,121,Pearson,0.28,,,= 0.002,Yes,Energy by density method,,Research settings,Shiraishi 2012
682,2472,2475,Nauseous excluded,Pregnant women from a private obstetric hospital and a university hospital,Japan,,,Diet History Questionnaire (DHQ),Vitamin B12,"",No,,,,ug/day,,,"Serum, non-fasting",Chemiluminescence immunoassay (CLIA),Vitamin B12,"",,,,pg/mL,,121,Pearson,0.249,,,= 0.006,Yes,,,Research settings,Shiraishi 2012
683,2473,2475,Nauseous excluded,Pregnant women from a private obstetric hospital and a university hospital,Japan,,,Diet History Questionnaire (DHQ),Vitamin B12,"",No,,,,ug/1000 kcal,Energy,,"Serum, non-fasting",Chemiluminescence immunoassay (CLIA),Vitamin B12,"",,,,pg/mL,,121,Pearson,0.313,,,= 0.001,Yes,Energy by density method,,Research settings,Shiraishi 2012
684,708,712,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Genistein,"",,0.4,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Genistein,"",,3.3,,ng/mL,,2908,Pearson,0.45,,,< 0.001,Yes,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
685,708,713,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Genistein,"",,0.4,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Daidzein,"",,4.0,,ng/mL,,2908,Pearson,0.43,,,< 0.001,Yes,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
686,708,714,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Genistein,"",,0.4,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,O-Desmethylangolensin,"",,1.3,,ng/mL,,2908,Pearson,0.34,,,< 0.001,Yes,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
687,708,715,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Genistein,"",,0.4,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Equol,"",,2.1,,ng/mL,,2908,Pearson,0.14,,,< 0.001,Yes,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
688,708,717,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Genistein,"",,0.4,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Isoflavones,Daidzein + Equol + O-Desmethylangolensin,,,,ng/mL,,2908,Pearson,0.45,,,< 0.001,Yes,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
689,708,716,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Genistein,"",,0.4,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + O-Desmethylangolensin,,4.8,,ng/mL,,2908,Pearson,0.48,,,< 0.001,Yes,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
690,709,712,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Daidzein,"",,0.2,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Genistein,"",,3.3,,ng/mL,,2908,Pearson,0.45,,,< 0.001,Yes,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
691,709,713,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Daidzein,"",,0.2,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Daidzein,"",,4.0,,ng/mL,,2908,Pearson,0.44,,,< 0.001,Yes,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
692,709,714,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Daidzein,"",,0.2,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,O-Desmethylangolensin,"",,1.3,,ng/mL,,2908,Pearson,0.35,,,< 0.001,Yes,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
693,709,715,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Daidzein,"",,0.2,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Equol,"",,2.1,,ng/mL,,2908,Pearson,0.15,,,< 0.001,Yes,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
694,709,717,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Daidzein,"",,0.2,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Isoflavones,Daidzein + Equol + O-Desmethylangolensin,,,,ng/mL,,2908,Pearson,0.46,,,< 0.001,Yes,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
695,709,716,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Daidzein,"",,0.2,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + O-Desmethylangolensin,,4.8,,ng/mL,,2908,Pearson,0.48,,,< 0.001,Yes,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
696,710,712,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Glycitein,"",,0.1,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Genistein,"",,3.3,,ng/mL,,2908,Pearson,0.42,,,< 0.001,Yes,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
697,710,713,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Glycitein,"",,0.1,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Daidzein,"",,4.0,,ng/mL,,2908,Pearson,0.39,,,< 0.001,Yes,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
698,710,714,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Glycitein,"",,0.1,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,O-Desmethylangolensin,"",,1.3,,ng/mL,,2908,Pearson,0.29,,,< 0.001,Yes,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
699,710,715,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Glycitein,"",,0.1,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Equol,"",,2.1,,ng/mL,,2908,Pearson,0.1,,,>= 0.05,No,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
700,710,717,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Glycitein,"",,0.1,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Isoflavones,Daidzein + Equol + O-Desmethylangolensin,,,,ng/mL,,2908,Pearson,0.39,,,< 0.001,Yes,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
701,710,716,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Glycitein,"",,0.1,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + O-Desmethylangolensin,,4.8,,ng/mL,,2908,Pearson,0.42,,,< 0.001,Yes,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
714,711,712,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Isoflavones,Genistein + Daidzein + Glycitein + Biochanin A + Formononetin,,0.7,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Genistein,"",,3.3,,ng/mL,,2908,Pearson,0.45,,,< 0.001,Yes,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
715,711,713,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Isoflavones,Genistein + Daidzein + Glycitein + Biochanin A + Formononetin,,0.7,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Daidzein,"",,4.0,,ng/mL,,2908,Pearson,0.44,,,< 0.001,Yes,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
716,711,714,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Isoflavones,Genistein + Daidzein + Glycitein + Biochanin A + Formononetin,,0.7,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,O-Desmethylangolensin,"",,1.3,,ng/mL,,2908,Pearson,0.34,,,< 0.001,Yes,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
717,711,715,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Isoflavones,Genistein + Daidzein + Glycitein + Biochanin A + Formononetin,,0.7,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Equol,"",,2.1,,ng/mL,,2908,Pearson,0.14,,,< 0.001,Yes,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
718,711,717,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Isoflavones,Genistein + Daidzein + Glycitein + Biochanin A + Formononetin,,0.7,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Isoflavones,Daidzein + Equol + O-Desmethylangolensin,,,,ng/mL,,2908,Pearson,0.45,,,< 0.001,Yes,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
719,711,716,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Isoflavones,Genistein + Daidzein + Glycitein + Biochanin A + Formononetin,,0.7,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + O-Desmethylangolensin,,4.8,,ng/mL,,2908,Pearson,0.48,,,< 0.001,Yes,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
702,897,712,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Biochanin A,"",,,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Genistein,"",,3.3,,ng/mL,,2908,Pearson,-0.02,,,>= 0.05,No,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
703,897,713,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Biochanin A,"",,,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Daidzein,"",,4.0,,ng/mL,,2908,Pearson,-0.01,,,>= 0.05,No,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
704,897,714,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Biochanin A,"",,,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,O-Desmethylangolensin,"",,1.3,,ng/mL,,2908,Pearson,-0.01,,,>= 0.05,No,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
705,897,715,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Biochanin A,"",,,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Equol,"",,2.1,,ng/mL,,2908,Pearson,0.0,,,>= 0.05,No,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
706,897,717,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Biochanin A,"",,,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Isoflavones,Daidzein + Equol + O-Desmethylangolensin,,,,ng/mL,,2908,Pearson,-0.01,,,>= 0.05,No,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
707,897,716,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Biochanin A,"",,,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + O-Desmethylangolensin,,4.8,,ng/mL,,2908,Pearson,-0.02,,,>= 0.05,No,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
708,898,712,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Formononetin,"",,,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Genistein,"",,3.3,,ng/mL,,2908,Pearson,0.07,,,< 0.01,Yes,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
709,898,713,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Formononetin,"",,,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Daidzein,"",,4.0,,ng/mL,,2908,Pearson,0.06,,,< 0.001,Yes,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
710,898,714,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Formononetin,"",,,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,O-Desmethylangolensin,"",,1.3,,ng/mL,,2908,Pearson,-0.01,,,>= 0.05,No,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
711,898,715,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Formononetin,"",,,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Equol,"",,2.1,,ng/mL,,2908,Pearson,-0.01,,,>= 0.05,No,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
712,898,717,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Formononetin,"",,,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Isoflavones,Daidzein + Equol + O-Desmethylangolensin,,,,ng/mL,,2908,Pearson,0.03,,,>= 0.05,No,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
713,898,716,All,General adult population,United States,NHANES (National Health and Nutrition Examination Survey),,24-h Dietary recall (1-day),Formononetin,"",,,,,mg/1000 kcal,Energy,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + O-Desmethylangolensin,,4.8,,ng/mL,,2908,Pearson,0.05,,,< 0.05,Yes,Energy by density method,,"Age, Sex, BMI, Ethnicity, Income level, Alcohol consumption, Smoking status",Chun 2009
720,721,735,All,Premenopausal women participant in a prospective study,Canada,,,Food Frequency Questionnaire (FFQ),Phytoestrogens,Genistein + Daidzein + Equol + Enterodiol + Enterolactone + Secoisolariciresinol,,27.5,,15.0,mg/day,,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Phytoestrogens,Genistein + Daidzein + Equol + Enterodiol + Enterolactone + Secoisolariciresinol,38.0,,15.9,umol/day,,26,Spearman,0.54,,,= 0.005,Yes,,,,French 2007
722,722,730,All,Premenopausal women participant in a prospective study,Canada,,,Food Frequency Questionnaire (FFQ),Isoflavones,Genistein + Daidzein + Equol,,13.7,,2.1,mg/day,,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol,17.4,,4.1,umol/day,,26,Spearman,0.54,,,= 0.004,Yes,,,,French 2007
724,723,734,All,Premenopausal women participant in a prospective study,Canada,,,Food Frequency Questionnaire (FFQ),Lignans,Enterodiol + Enterolactone + Secoisolariciresinol,,13.8,,3.8,mg/day,,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Lignans,Enterodiol + Enterolactone + Secoisolariciresinol,20.6,,6.4,umol/day,,26,Spearman,0.4,,,= 0.045,Yes,,,,French 2007
721,724,735,All,Premenopausal women participant in a prospective study,Canada,,,Food Frequency Questionnaire (FFQ),Phytoestrogens,Genistein + Daidzein + Equol + Enterodiol + Enterolactone + Secoisolariciresinol,,19.6,,2.0,mg/day,,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Phytoestrogens,Genistein + Daidzein + Equol + Enterodiol + Enterolactone + Secoisolariciresinol,38.0,,15.9,umol/day,,26,Spearman,0.67,,,= 0.001,Yes,,,,French 2007
723,725,730,All,Premenopausal women participant in a prospective study,Canada,,,Food Frequency Questionnaire (FFQ),Isoflavones,Genistein + Daidzein + Equol,,10.8,,0.0,mg/day,,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol,17.4,,4.1,umol/day,,26,Spearman,0.64,,,< 0.001,Yes,,,,French 2007
725,726,734,All,Premenopausal women participant in a prospective study,Canada,,,Food Frequency Questionnaire (FFQ),Lignans,Enterodiol + Enterolactone + Secoisolariciresinol,,8.8,,0.7,mg/day,,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Lignans,Enterodiol + Enterolactone + Secoisolariciresinol,20.6,,6.4,umol/day,,26,Spearman,0.46,,,= 0.019,Yes,,,,French 2007
728,736,740,All,Postmenopausal women,United States,,baseline,Food Frequency Questionnaire (FFQ),Genistein,"",,,8.1,7.5,mg/week,,baseline; 1 week,"Plasma, fasting",LC-MS after enzymatic hydrolysis,Genistein,"",,12.2,10.9,nmol/L,,96,Pearson,0.43,,,< 0.001,Yes,,,,Frankenfeld 2003
730,738,741,All,Postmenopausal women,United States,,baseline,Food Frequency Questionnaire (FFQ),Daidzein,"",,,6.2,3.7,mg/week,,baseline; 1 week,"Plasma, fasting",LC-MS after enzymatic hydrolysis,Daidzein,"",,6.9,5.0,nmol/L,,96,Pearson,0.37,,,< 0.001,Yes,,,,Frankenfeld 2003
726,742,741,All,Postmenopausal women,United States,,baseline,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,,,,servings/day,,baseline; 1 week,"Plasma, fasting",LC-MS after enzymatic hydrolysis,Daidzein,"",,6.9,5.0,nmol/L,,96,Pearson,0.17,,,= 0.06,No,,,,Frankenfeld 2003
727,742,740,All,Postmenopausal women,United States,,baseline,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,,,,servings/day,,baseline; 1 week,"Plasma, fasting",LC-MS after enzymatic hydrolysis,Genistein,"",,12.2,10.9,nmol/L,,96,Pearson,0.28,,,= 0.01,Yes,,,,Frankenfeld 2003
729,737,740,All,Postmenopausal women,United States,,baseline,Food Frequency Questionnaire (FFQ),Genistein,"",,,2.5,0.0,mg/week,,baseline; 1 week,"Plasma, fasting",LC-MS after enzymatic hydrolysis,Genistein,"",,12.2,10.9,nmol/L,,96,Pearson,0.38,,,< 0.001,Yes,,,,Frankenfeld 2003
731,739,741,All,Postmenopausal women,United States,,baseline,Food Frequency Questionnaire (FFQ),Daidzein,"",,,2.2,0.0,mg/week,,baseline; 1 week,"Plasma, fasting",LC-MS after enzymatic hydrolysis,Daidzein,"",,6.9,5.0,nmol/L,,96,Pearson,0.35,,,< 0.001,Yes,,,,Frankenfeld 2003
732,743,745,All,General population,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Food Frequency Questionnaire (FFQ),Daidzein,"",,18.3,,15.3,mg/day,,,"Serum, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Daidzein,"",119.9,,77.4,nmol/L,,202,Spearman,0.31,0.18,0.44, ,Unspecified,,,,Yamamoto 2001
733,743,746,All,General population,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Food Frequency Questionnaire (FFQ),Daidzein,"",,18.3,,15.3,mg/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Daidzein,"",17.0,,12.5,umol/day,,93,Spearman,0.29,0.09,0.49, ,Unspecified,,,,Yamamoto 2001
736,743,745,All,General population,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Food Frequency Questionnaire (FFQ),Daidzein,"",,18.3,,15.3,mg/day,,,"Serum, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Daidzein,"",119.9,,77.4,nmol/L,,202,Spearman,0.26,0.13,0.39, ,Unspecified,Energy by residual method,,,Yamamoto 2001
737,743,746,All,General population,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Food Frequency Questionnaire (FFQ),Daidzein,"",,18.3,,15.3,mg/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Daidzein,"",17.0,,12.5,umol/day,,93,Spearman,0.4,0.21,0.6, ,Unspecified,"Energy by residual method, Creatinine by residual method",,,Yamamoto 2001
740,747,749,All,General population,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Food Frequency Questionnaire (FFQ),Genistein,"",,31.4,,25.5,mg/day,,,"Serum, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Genistein,"",475.3,,333.6,nmol/L,,202,Spearman,0.33,0.21,0.46, ,Unspecified,,,,Yamamoto 2001
741,747,750,All,General population,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Food Frequency Questionnaire (FFQ),Genistein,"",,31.4,,25.5,mg/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Genistein,"",14.2,,9.9,umol/day,,93,Spearman,0.2,-0.01,0.41, ,Unspecified,,,,Yamamoto 2001
744,747,749,All,General population,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Food Frequency Questionnaire (FFQ),Genistein,"",,31.4,,25.5,mg/day,,,"Serum, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Genistein,"",475.3,,333.6,nmol/L,,202,Spearman,0.22,0.08,0.35, ,Unspecified,Energy by residual method,,,Yamamoto 2001
745,747,750,All,General population,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Food Frequency Questionnaire (FFQ),Genistein,"",,31.4,,25.5,mg/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Genistein,"",14.2,,9.9,umol/day,,93,Spearman,0.3,0.08,0.51, ,Unspecified,"Energy by residual method, Creatinine by residual method",,,Yamamoto 2001
734,744,745,All,General population,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Daidzein,"",,14.5,,14.0,mg/day,,,"Serum, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Daidzein,"",119.9,,77.4,nmol/L,,202,Spearman,0.39,0.27,0.51, ,Unspecified,,,,Yamamoto 2001
735,744,746,All,General population,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Daidzein,"",,14.5,,14.0,mg/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Daidzein,"",17.0,,12.5,umol/day,,93,Spearman,0.43,0.25,0.6, ,Unspecified,,,,Yamamoto 2001
738,744,745,All,General population,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Daidzein,"",,14.5,,14.0,mg/day,,,"Serum, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Daidzein,"",119.9,,77.4,nmol/L,,202,Spearman,0.37,0.25,0.49, ,Unspecified,Energy by residual method,,,Yamamoto 2001
739,744,746,All,General population,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Daidzein,"",,14.5,,14.0,mg/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Daidzein,"",17.0,,12.5,umol/day,,93,Spearman,0.48,0.31,0.64, ,Unspecified,"Energy by residual method, Creatinine by residual method",,,Yamamoto 2001
742,748,749,All,General population,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Genistein,"",,23.4,,22.3,mg/day,,,"Serum, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Genistein,"",475.3,,333.6,nmol/L,,202,Spearman,0.42,0.3,0.53, ,Unspecified,,,,Yamamoto 2001
743,748,750,All,General population,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Genistein,"",,23.4,,22.3,mg/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Genistein,"",14.2,,9.9,umol/day,,93,Spearman,0.38,0.21,0.56, ,Unspecified,,,,Yamamoto 2001
746,748,749,All,General population,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Genistein,"",,23.4,,22.3,mg/day,,,"Serum, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Genistein,"",475.3,,333.6,nmol/L,,202,Spearman,0.33,0.21,0.45, ,Unspecified,Energy by residual method,,,Yamamoto 2001
747,748,750,All,General population,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Genistein,"",,23.4,,22.3,mg/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Genistein,"",14.2,,9.9,umol/day,,93,Spearman,0.36,0.18,0.55, ,Unspecified,"Energy by residual method, Creatinine by residual method",,,Yamamoto 2001
748,775,771,All,Participants in a substudy of PREDIMED,Spain,PREDIMED (Prevención con Dieta Mediterránea),,Food Frequency Questionnaire (FFQ),Polyphenols,"",,,,,g/day,,,"Urine, first morning spot",Folin-Ciocalteu,Polyphenols,"",,,,mg/g,Creatinine,147,Pearson,0.179,,,< 0.001,Yes,,,,Medina-Remon 2011
780,816,821,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Fruits,Apple + Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Flavonoids,Quercetin + Genistein + Daidzein + Kaempferol + Naringenin + Hesperetin + Isorhamnetin + Phloretin + Eriodictyol,,,,ug/day,,79,Spearman,0.31,0.16,0.45,< 0.01,Yes,,,,Krogholm 2010
781,816,822,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Fruits,Apple + Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Flavanones,Naringenin + Hesperetin + Eriodictyol,,,,ug/day,,79,Spearman,0.28,0.13,0.43,< 0.01,Yes,,,,Krogholm 2010
782,816,823,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Fruits,Apple + Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Hesperetin,"",,,,ug/day,,79,Spearman,0.29,0.14,0.43,< 0.01,Yes,,,,Krogholm 2010
783,816,824,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Fruits,Apple + Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Naringenin,"",,,,ug/day,,79,Spearman,0.23,0.08,0.37,< 0.01,Yes,,,,Krogholm 2010
784,816,825,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Fruits,Apple + Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Eriodictyol,"",,,,ug/day,,79,Spearman,0.25,0.1,0.39,< 0.01,Yes,,,,Krogholm 2010
785,816,826,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Fruits,Apple + Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Quercetin,"",,,,ug/day,,79,Spearman,0.18,0.03,0.33,< 0.05,Yes,,,,Krogholm 2010
786,816,827,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Fruits,Apple + Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Phloretin,"",,,,ug/day,,79,Spearman,0.22,0.07,0.36,< 0.01,Yes,,,,Krogholm 2010
787,816,828,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Fruits,Apple + Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Daidzein,"",,,,ug/day,,79,Spearman,0.11,-0.05,0.26,>= 0.05,No,,,,Krogholm 2010
788,816,829,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Fruits,Apple + Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Genistein,"",,,,ug/day,,79,Spearman,0.12,-0.04,0.27,>= 0.05,No,,,,Krogholm 2010
789,816,830,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Fruits,Apple + Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Kaempferol,"",,,,ug/day,,79,Spearman,0.18,0.03,0.33,< 0.05,Yes,,,,Krogholm 2010
790,816,833,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Fruits,Apple + Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Polyphenols,Naringenin + Hesperetin + Phloretin + Eriodictyol,,,,ug/day,,79,Spearman,0.29,0.14,0.43,< 0.01,Yes,,,,Krogholm 2010
791,817,821,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Citrus fruits,Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Flavonoids,Quercetin + Genistein + Daidzein + Kaempferol + Naringenin + Hesperetin + Isorhamnetin + Phloretin + Eriodictyol,,,,ug/day,,79,Spearman,0.23,0.08,0.37,< 0.01,Yes,,,,Krogholm 2010
792,817,822,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Citrus fruits,Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Flavanones,Naringenin + Hesperetin + Eriodictyol,,,,ug/day,,79,Spearman,0.24,0.09,0.38,< 0.01,Yes,,,,Krogholm 2010
793,817,823,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Citrus fruits,Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Hesperetin,"",,,,ug/day,,79,Spearman,0.27,0.12,0.41,< 0.01,Yes,,,,Krogholm 2010
794,817,824,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Citrus fruits,Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Naringenin,"",,,,ug/day,,79,Spearman,0.19,0.04,0.34,< 0.05,Yes,,,,Krogholm 2010
795,817,825,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Citrus fruits,Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Eriodictyol,"",,,,ug/day,,79,Spearman,0.08,-0.08,0.23,>= 0.05,No,,,,Krogholm 2010
796,817,826,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Citrus fruits,Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Quercetin,"",,,,ug/day,,79,Spearman,0.07,-0.09,0.24,>= 0.05,No,,,,Krogholm 2010
797,817,827,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Citrus fruits,Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Phloretin,"",,,,ug/day,,79,Spearman,0.09,-0.07,0.24,>= 0.05,No,,,,Krogholm 2010
798,817,828,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Citrus fruits,Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Daidzein,"",,,,ug/day,,79,Spearman,0.12,-0.04,0.27,>= 0.05,No,,,,Krogholm 2010
799,817,829,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Citrus fruits,Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Genistein,"",,,,ug/day,,79,Spearman,0.03,-0.13,0.19,>= 0.05,No,,,,Krogholm 2010
800,817,830,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Citrus fruits,Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Kaempferol,"",,,,ug/day,,79,Spearman,0.08,-0.08,0.23,>= 0.05,No,,,,Krogholm 2010
801,817,833,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Citrus fruits,Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Polyphenols,Naringenin + Hesperetin + Phloretin + Eriodictyol,,,,ug/day,,79,Spearman,0.24,0.09,0.38,< 0.01,Yes,,,,Krogholm 2010
802,818,821,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Vegetables,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Flavonoids,Quercetin + Genistein + Daidzein + Kaempferol + Naringenin + Hesperetin + Isorhamnetin + Phloretin + Eriodictyol,,,,ug/day,,79,Spearman,0.21,0.06,0.36,< 0.01,Yes,,,,Krogholm 2010
803,818,822,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Vegetables,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Flavanones,Naringenin + Hesperetin + Eriodictyol,,,,ug/day,,79,Spearman,0.23,0.08,0.37,< 0.01,Yes,,,,Krogholm 2010
804,818,823,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Vegetables,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Hesperetin,"",,,,ug/day,,79,Spearman,0.13,0.03,0.28,>= 0.05,No,,,,Krogholm 2010
805,818,824,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Vegetables,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Naringenin,"",,,,ug/day,,79,Spearman,0.25,0.1,0.39,< 0.01,Yes,,,,Krogholm 2010
806,818,825,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Vegetables,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Eriodictyol,"",,,,ug/day,,79,Spearman,0.19,0.04,0.34,< 0.05,Yes,,,,Krogholm 2010
807,818,826,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Vegetables,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Quercetin,"",,,,ug/day,,79,Spearman,0.15,0.0,0.3,>= 0.05,No,,,,Krogholm 2010
808,818,827,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Vegetables,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Phloretin,"",,,,ug/day,,79,Spearman,0.12,-0.04,0.27,>= 0.05,No,,,,Krogholm 2010
809,818,828,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Vegetables,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Daidzein,"",,,,ug/day,,79,Spearman,0.07,-0.09,0.22,>= 0.05,No,,,,Krogholm 2010
810,818,829,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Vegetables,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Genistein,"",,,,ug/day,,79,Spearman,0.12,-0.04,0.27,>= 0.05,No,,,,Krogholm 2010
811,818,830,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Vegetables,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Kaempferol,"",,,,ug/day,,79,Spearman,0.15,0.0,0.3,>= 0.05,No,,,,Krogholm 2010
812,818,833,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Vegetables,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Polyphenols,Naringenin + Hesperetin + Phloretin + Eriodictyol,,,,ug/day,,79,Spearman,0.22,0.07,0.36,< 0.05,Yes,,,,Krogholm 2010
813,819,821,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Fruits + Vegetables,Apple + Vegetables + Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Flavonoids,Quercetin + Genistein + Daidzein + Kaempferol + Naringenin + Hesperetin + Isorhamnetin + Phloretin + Eriodictyol,,,,ug/day,,79,Spearman,0.37,0.23,0.5,< 0.01,Yes,,,,Krogholm 2010
814,819,822,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Fruits + Vegetables,Apple + Vegetables + Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Flavanones,Naringenin + Hesperetin + Eriodictyol,,,,ug/day,,79,Spearman,0.36,0.22,0.49,< 0.01,Yes,,,,Krogholm 2010
815,819,823,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Fruits + Vegetables,Apple + Vegetables + Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Hesperetin,"",,,,ug/day,,79,Spearman,0.31,0.16,0.45,< 0.01,Yes,,,,Krogholm 2010
816,819,824,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Fruits + Vegetables,Apple + Vegetables + Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Naringenin,"",,,,ug/day,,79,Spearman,0.33,0.18,0.46,< 0.01,Yes,,,,Krogholm 2010
817,819,825,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Fruits + Vegetables,Apple + Vegetables + Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Eriodictyol,"",,,,ug/day,,79,Spearman,0.3,0.15,0.44,< 0.01,Yes,,,,Krogholm 2010
818,819,826,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Fruits + Vegetables,Apple + Vegetables + Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Quercetin,"",,,,ug/day,,79,Spearman,0.2,0.05,0.35,< 0.05,Yes,,,,Krogholm 2010
819,819,827,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Fruits + Vegetables,Apple + Vegetables + Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Phloretin,"",,,,ug/day,,79,Spearman,0.23,0.08,0.37,< 0.01,Yes,,,,Krogholm 2010
820,819,828,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Fruits + Vegetables,Apple + Vegetables + Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Daidzein,"",,,,ug/day,,79,Spearman,0.1,-0.06,0.25,>= 0.05,No,,,,Krogholm 2010
821,819,829,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Fruits + Vegetables,Apple + Vegetables + Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Genistein,"",,,,ug/day,,79,Spearman,0.14,-0.02,0.29,>= 0.05,No,,,,Krogholm 2010
822,819,830,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Fruits + Vegetables,Apple + Vegetables + Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Kaempferol,"",,,,ug/day,,79,Spearman,0.2,0.05,0.35,< 0.05,Yes,,,,Krogholm 2010
823,819,833,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Fruits + Vegetables,Apple + Vegetables + Orange,,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Polyphenols,Naringenin + Hesperetin + Phloretin + Eriodictyol,,,,ug/day,,79,Spearman,0.37,0.23,0.5,< 0.01,Yes,,,,Krogholm 2010
835,820,821,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Apple,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Flavonoids,Quercetin + Genistein + Daidzein + Kaempferol + Naringenin + Hesperetin + Isorhamnetin + Phloretin + Eriodictyol,,,,ug/day,,79,Spearman,0.24,0.09,0.38,< 0.01,Yes,,,,Krogholm 2010
836,820,822,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Apple,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Flavanones,Naringenin + Hesperetin + Eriodictyol,,,,ug/day,,79,Spearman,0.2,0.05,0.35,< 0.05,Yes,,,,Krogholm 2010
837,820,823,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Apple,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Hesperetin,"",,,,ug/day,,79,Spearman,0.19,0.04,0.34,< 0.05,Yes,,,,Krogholm 2010
838,820,824,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Apple,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Naringenin,"",,,,ug/day,,79,Spearman,0.19,0.04,0.34,< 0.05,Yes,,,,Krogholm 2010
839,820,825,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Apple,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Eriodictyol,"",,,,ug/day,,79,Spearman,0.16,0.0,0.31,< 0.05,Yes,,,,Krogholm 2010
840,820,826,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Apple,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Quercetin,"",,,,ug/day,,79,Spearman,0.17,0.01,0.32,< 0.05,Yes,,,,Krogholm 2010
841,820,827,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Apple,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Phloretin,"",,,,ug/day,,79,Spearman,0.22,0.07,0.36,< 0.01,Yes,,,,Krogholm 2010
842,820,828,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Apple,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Daidzein,"",,,,ug/day,,79,Spearman,0.03,-0.13,0.19,>= 0.05,No,,,,Krogholm 2010
843,820,829,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Apple,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Genistein,"",,,,ug/day,,79,Spearman,0.12,-0.04,0.27,>= 0.05,No,,,,Krogholm 2010
844,820,830,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Apple,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Kaempferol,"",,,,ug/day,,79,Spearman,0.16,0.0,0.31,< 0.05,Yes,,,,Krogholm 2010
845,820,833,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Apple,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Polyphenols,Naringenin + Hesperetin + Phloretin + Eriodictyol,,,,ug/day,,79,Spearman,0.22,0.07,0.36,< 0.01,Yes,,,,Krogholm 2010
824,832,821,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Orange,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Flavonoids,Quercetin + Genistein + Daidzein + Kaempferol + Naringenin + Hesperetin + Isorhamnetin + Phloretin + Eriodictyol,,,,ug/day,,79,Spearman,0.23,0.08,0.37,< 0.01,Yes,,,,Krogholm 2010
825,832,822,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Orange,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Flavanones,Naringenin + Hesperetin + Eriodictyol,,,,ug/day,,79,Spearman,0.26,0.11,0.4,< 0.01,Yes,,,,Krogholm 2010
826,832,823,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Orange,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Hesperetin,"",,,,ug/day,,79,Spearman,0.24,0.09,0.38,< 0.01,Yes,,,,Krogholm 2010
827,832,824,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Orange,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Naringenin,"",,,,ug/day,,79,Spearman,0.24,0.09,0.38,< 0.01,Yes,,,,Krogholm 2010
828,832,825,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Orange,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Eriodictyol,"",,,,ug/day,,79,Spearman,0.11,-0.05,0.26,>= 0.05,No,,,,Krogholm 2010
829,832,826,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Orange,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Quercetin,"",,,,ug/day,,79,Spearman,-0.06,-0.21,0.1,>= 0.05,No,,,,Krogholm 2010
830,832,827,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Orange,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Phloretin,"",,,,ug/day,,79,Spearman,-0.04,-0.2,0.12,>= 0.05,No,,,,Krogholm 2010
831,832,828,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Orange,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Daidzein,"",,,,ug/day,,79,Spearman,0.08,-0.08,0.23,>= 0.05,No,,,,Krogholm 2010
832,832,829,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Orange,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Genistein,"",,,,ug/day,,79,Spearman,-0.08,-0.23,0.08,>= 0.05,No,,,,Krogholm 2010
833,832,830,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Orange,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Kaempferol,"",,,,ug/day,,79,Spearman,-0.06,-0.21,0.1,>= 0.05,No,,,,Krogholm 2010
834,832,833,All,Employees at workplaces in Copenhagen area with or without a free-fruit program intervention,Denmark,,,24-h Dietary recall (1-day),Orange,"",,,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Polyphenols,Naringenin + Hesperetin + Phloretin + Eriodictyol,,,,ug/day,,79,Spearman,0.25,0.1,0.39,< 0.01,Yes,,,,Krogholm 2010
865,953,957,All,Adults in the Seattle metropolitan area participant in a feeding study,United States,,baseline,Food Frequency Questionnaire (FFQ),Genistein,"",,,11.9,11.1,mg/week,,,"Plasma, fasting",LC-MS after enzymatic hydrolysis,Genistein,"",,16.9,12.8,nmol/L,,77,Pearson,0.53,0.35,0.67, ,Unspecified,,,,Frankenfeld 2002
863,954,958,All,Adults in the Seattle metropolitan area participant in a feeding study,United States,,baseline,Food Frequency Questionnaire (FFQ),Daidzein,"",,,9.7,7.6,mg/week,,,"Plasma, fasting",LC-MS after enzymatic hydrolysis,Daidzein,"",,8.8,4.7,nmol/L,,77,Pearson,0.45,0.25,0.61, ,Unspecified,,,,Frankenfeld 2002
866,955,957,All,Adults in the Seattle metropolitan area participant in a feeding study,United States,,baseline,Food Frequency Questionnaire (FFQ),Genistein,"",,,6.5,3.0,mg/week,,,"Plasma, fasting",LC-MS after enzymatic hydrolysis,Genistein,"",,16.9,12.8,nmol/L,,62,Pearson,0.46,0.26,0.62, ,Unspecified,,,,Frankenfeld 2002
864,956,958,All,Adults in the Seattle metropolitan area participant in a feeding study,United States,,baseline,Food Frequency Questionnaire (FFQ),Daidzein,"",,,5.6,2.1,mg/week,,,"Plasma, fasting",LC-MS after enzymatic hydrolysis,Daidzein,"",,8.8,4.7,nmol/L,,62,Pearson,0.45,0.25,0.61, ,Unspecified,,,,Frankenfeld 2002
868,965,982,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Fruits,Fruits + Nuts + Melon + Citrus fruits + Fruit juices,,254.9,,,g/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",,,,missing unit,,123,Spearman,0.5,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
882,965,983,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Fruits,Fruits + Nuts + Melon + Citrus fruits + Fruit juices,,254.9,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,123,Spearman,0.44,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
896,965,984,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Fruits,Fruits + Nuts + Melon + Citrus fruits + Fruit juices,,254.9,,,g/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,missing unit,,123,Spearman,0.29,,,< 0.01,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
874,966,982,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Vegetables,Vegetables + Root vegetables + Onion + Leafy vegetables + Pickles + Dry vegetables,,204.9,,,g/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",,,,missing unit,,123,Spearman,0.48,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
888,966,983,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Vegetables,Vegetables + Root vegetables + Onion + Leafy vegetables + Pickles + Dry vegetables,,204.9,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,123,Spearman,0.41,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
902,966,984,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Vegetables,Vegetables + Root vegetables + Onion + Leafy vegetables + Pickles + Dry vegetables,,204.9,,,g/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,missing unit,,123,Spearman,0.27,,,< 0.05,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
869,969,982,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,g/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",,,,missing unit,,123,Spearman,0.53,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
883,969,983,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,123,Spearman,0.33,,,< 0.01,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
897,969,984,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,g/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,missing unit,,123,Spearman,0.29,,,< 0.01,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
870,970,982,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Melon,"",,,,,g/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",,,,missing unit,,123,Spearman,0.08,,,>= 0.05,No,,,"Age, Sex, BMI, Education",Mohammadifard 2011
884,970,983,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Melon,"",,,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,123,Spearman,0.06,,,>= 0.05,No,,,"Age, Sex, BMI, Education",Mohammadifard 2011
898,970,984,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Melon,"",,,,,g/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,missing unit,,123,Spearman,0.07,,,>= 0.05,No,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
871,972,982,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,g/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",,,,missing unit,,123,Spearman,0.42,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
885,972,983,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,123,Spearman,0.44,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
899,972,984,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,g/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,missing unit,,123,Spearman,0.26,,,< 0.05,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
872,973,982,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Nuts,"",,,,,g/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",,,,missing unit,,123,Spearman,0.19,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
886,973,983,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Nuts,"",,,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,123,Spearman,0.27,,,< 0.05,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
900,973,984,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Nuts,"",,,,,g/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,missing unit,,123,Spearman,0.24,,,< 0.05,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
873,974,982,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Fruit juices,"",,,,,g/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",,,,missing unit,,123,Spearman,0.35,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
887,974,983,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Fruit juices,"",,,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,123,Spearman,0.29,,,< 0.01,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
901,974,984,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Fruit juices,"",,,,,g/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,missing unit,,123,Spearman,0.17,,,>= 0.05,No,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
875,975,982,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Root vegetables,"",,,,,g/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",,,,missing unit,,123,Spearman,0.38,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
889,975,983,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Root vegetables,"",,,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,123,Spearman,0.42,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
903,975,984,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Root vegetables,"",,,,,g/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,missing unit,,123,Spearman,0.28,,,< 0.05,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
876,976,982,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Onion,"",,,,,g/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",,,,missing unit,,123,Spearman,0.39,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
890,976,983,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Onion,"",,,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,123,Spearman,0.41,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
904,976,984,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Onion,"",,,,,g/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,missing unit,,123,Spearman,0.21,,,< 0.05,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
877,977,982,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Leafy vegetables,"",,,,,g/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",,,,missing unit,,123,Spearman,0.37,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
891,977,983,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Leafy vegetables,"",,,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,123,Spearman,0.39,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
905,977,984,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Leafy vegetables,"",,,,,g/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,missing unit,,123,Spearman,0.25,,,< 0.05,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
878,978,982,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,g/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",,,,missing unit,,123,Spearman,0.48,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
892,978,983,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,123,Spearman,0.37,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
906,978,984,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,g/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,missing unit,,123,Spearman,0.28,,,< 0.05,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
879,979,982,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Pickles,"",,,,,g/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",,,,missing unit,,123,Spearman,0.08,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
893,979,983,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Pickles,"",,,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,123,Spearman,0.27,,,< 0.05,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
907,979,984,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Pickles,"",,,,,g/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,missing unit,,123,Spearman,0.16,,,>= 0.05,No,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
880,980,982,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Dry vegetables,"",,,,,g/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",,,,missing unit,,123,Spearman,0.19,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
894,980,983,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Dry vegetables,"",,,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,123,Spearman,0.24,,,< 0.05,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
908,980,984,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Dry vegetables,"",,,,,g/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,missing unit,,123,Spearman,0.15,,,>= 0.05,No,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
881,981,982,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Nuts + Melon + Root vegetables + Onion + Leafy vegetables + Pickles + Dry vegetables + Citrus fruits + Fruit juices,,,,,g/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",,,,missing unit,,123,Spearman,0.55,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
895,981,983,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Nuts + Melon + Root vegetables + Onion + Leafy vegetables + Pickles + Dry vegetables + Citrus fruits + Fruit juices,,,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,123,Spearman,0.47,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
909,981,984,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Nuts + Melon + Root vegetables + Onion + Leafy vegetables + Pickles + Dry vegetables + Citrus fruits + Fruit juices,,,,,g/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,missing unit,,123,Spearman,0.28,,,< 0.05,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
921,967,1003,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Fruits,Fruits + Nuts + Melon + Citrus fruits + Fruit juices,,270.2,,,g/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",,,,missing unit,,101,Spearman,0.49,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
941,967,1004,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Fruits,Fruits + Nuts + Melon + Citrus fruits + Fruit juices,,270.2,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,101,Spearman,0.42,,,< 0.001,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
955,967,1005,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Fruits,Fruits + Nuts + Melon + Citrus fruits + Fruit juices,,270.2,,,g/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,missing unit,,101,Spearman,0.32,,,< 0.001,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
927,968,1003,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Vegetables,Vegetables + Root vegetables + Onion + Leafy vegetables + Pickles + Dry vegetables,,183.3,,,g/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",,,,missing unit,,101,Spearman,0.48,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
947,968,1004,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Vegetables,Vegetables + Root vegetables + Onion + Leafy vegetables + Pickles + Dry vegetables,,183.3,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,101,Spearman,0.43,,,< 0.001,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
961,968,1005,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Vegetables,Vegetables + Root vegetables + Onion + Leafy vegetables + Pickles + Dry vegetables,,183.3,,,g/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,missing unit,,101,Spearman,0.31,,,< 0.01,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
922,985,1003,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,g/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",,,,missing unit,,101,Spearman,0.12,,,>= 0.05,No,,,"Age, Sex, BMI, Education",Mohammadifard 2011
942,985,1004,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,101,Spearman,0.04,,,>= 0.05,No,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
956,985,1005,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,g/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,missing unit,,101,Spearman,0.08,,,>= 0.05,No,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
923,986,1003,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Melon,"",,,,,g/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",,,,missing unit,,101,Spearman,0.37,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
943,986,1004,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Melon,"",,,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,101,Spearman,0.35,,,< 0.001,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
957,986,1005,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Melon,"",,,,,g/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,missing unit,,101,Spearman,0.35,,,< 0.001,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
924,987,1003,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,g/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",,,,missing unit,,101,Spearman,0.36,,,< 0.01,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
944,987,1004,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,101,Spearman,0.45,,,< 0.001,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
958,987,1005,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,g/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,missing unit,,101,Spearman,0.28,,,< 0.01,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
925,988,1003,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Nuts,"",,,,,g/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",,,,missing unit,,101,Spearman,0.17,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
945,988,1004,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Nuts,"",,,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,101,Spearman,0.31,,,< 0.01,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
959,988,1005,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Nuts,"",,,,,g/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,missing unit,,101,Spearman,0.22,,,< 0.05,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
926,989,1003,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Fruit juices,"",,,,,g/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",,,,missing unit,,101,Spearman,0.32,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
946,989,1004,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Fruit juices,"",,,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,101,Spearman,0.3,,,< 0.01,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
960,989,1005,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Fruit juices,"",,,,,g/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,missing unit,,101,Spearman,0.18,,,>= 0.05,No,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
928,990,1003,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Root vegetables,"",,,,,g/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",,,,missing unit,,101,Spearman,0.37,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
948,990,1004,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Root vegetables,"",,,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,101,Spearman,0.38,,,< 0.001,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
962,990,1005,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Root vegetables,"",,,,,g/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,missing unit,,101,Spearman,0.25,,,< 0.05,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
929,991,1003,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Onion,"",,,,,g/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",,,,missing unit,,101,Spearman,0.36,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
949,991,1004,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Onion,"",,,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,101,Spearman,0.35,,,< 0.001,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
963,991,1005,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Onion,"",,,,,g/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,missing unit,,101,Spearman,0.21,,,< 0.05,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
930,992,1003,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Leafy vegetables,"",,,,,g/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",,,,missing unit,,101,Spearman,0.37,,,>= 0.05,No,,,"Age, Sex, BMI, Education",Mohammadifard 2011
950,992,1004,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Leafy vegetables,"",,,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,101,Spearman,0.46,,,< 0.001,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
964,992,1005,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Leafy vegetables,"",,,,,g/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,missing unit,,101,Spearman,0.28,,,< 0.05,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
931,993,1003,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,g/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",,,,missing unit,,101,Spearman,0.49,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
951,993,1004,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,101,Spearman,0.38,,,< 0.001,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
965,993,1005,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,g/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,missing unit,,101,Spearman,0.32,,,< 0.01,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
932,994,1003,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Pickles,"",,,,,g/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",,,,missing unit,,101,Spearman,0.06,,,>= 0.05,No,,,"Age, Sex, BMI, Education",Mohammadifard 2011
952,994,1004,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Pickles,"",,,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,101,Spearman,0.28,,,< 0.05,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
966,994,1005,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Pickles,"",,,,,g/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,missing unit,,101,Spearman,0.05,,,>= 0.05,No,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
933,995,1003,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Dry vegetables,"",,,,,g/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",,,,missing unit,,101,Spearman,0.18,,,>= 0.05,No,,,"Age, Sex, BMI, Education",Mohammadifard 2011
953,995,1004,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Dry vegetables,"",,,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,101,Spearman,0.28,,,< 0.05,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
967,995,1005,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Dry vegetables,"",,,,,g/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,missing unit,,101,Spearman,0.24,,,< 0.05,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
934,996,1003,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Nuts + Melon + Root vegetables + Onion + Leafy vegetables + Pickles + Dry vegetables + Citrus fruits + Fruit juices,,,,,g/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",,,,missing unit,,101,Spearman,0.52,,,< 0.001,Yes,,,"Age, Sex, BMI, Education",Mohammadifard 2011
954,996,1004,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Nuts + Melon + Root vegetables + Onion + Leafy vegetables + Pickles + Dry vegetables + Citrus fruits + Fruit juices,,,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,101,Spearman,0.45,,,< 0.001,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
968,996,1005,All,Participants in a dietary validation study,"Iran, Islamic Republic of",IHHP (Isfahan Healthy Heart Program),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Nuts + Melon + Root vegetables + Onion + Leafy vegetables + Pickles + Dry vegetables + Citrus fruits + Fruit juices,,,,,g/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,missing unit,,101,Spearman,0.35,,,< 0.001,Yes,,,"Age, Sex, BMI, Education, Cholesterol, Triglycerides",Mohammadifard 2011
1012,1060,1067,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Dietary fibre,Fibre from Cereals,,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Heptadecylresorcinol (C17:0),"",,,,nmol/L,,51,Spearman,-0.01,,,>= 0.05,No,,,,Andersson 2011
1013,1060,1068,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Dietary fibre,Fibre from Cereals,,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Nonadecylresorcinol (C19:0),"",,,,nmol/L,,51,Spearman,0.11,,,>= 0.05,No,,,,Andersson 2011
1014,1060,1069,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Dietary fibre,Fibre from Cereals,,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Heneicosylresorcinol (C21:0),"",,,,nmol/L,,51,Spearman,0.23,,,>= 0.05,No,,,,Andersson 2011
1015,1060,1070,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Dietary fibre,Fibre from Cereals,,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Tricosylresorcinol (C23:0),"",,,,nmol/L,,51,Spearman,0.18,,,>= 0.05,No,,,,Andersson 2011
1016,1060,1071,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Dietary fibre,Fibre from Cereals,,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Pentacosylresorcinol (C25:0),"",,,,nmol/L,,51,Spearman,0.12,,,>= 0.05,No,,,,Andersson 2011
1017,1060,1072,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Dietary fibre,Fibre from Cereals,,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0) + 5-n-Heptadecylresorcinol (C17:0) / 5-n-Heneicosylresorcinol (C21:0),,,,nmol/L,,51,Spearman,0.16,,,>= 0.05,No,,,,Andersson 2011
1005,1061,1067,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Heptadecylresorcinol (C17:0),"",,,,nmol/L,,51,Spearman,0.29,,,< 0.05,Yes,,,,Andersson 2011
1006,1061,1068,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Nonadecylresorcinol (C19:0),"",,,,nmol/L,,51,Spearman,0.28,,,< 0.05,Yes,,,,Andersson 2011
1007,1061,1069,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Heneicosylresorcinol (C21:0),"",,,,nmol/L,,51,Spearman,0.32,,,< 0.05,Yes,,,,Andersson 2011
1008,1061,1070,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Tricosylresorcinol (C23:0),"",,,,nmol/L,,51,Spearman,0.35,,,< 0.01,Yes,,,,Andersson 2011
1009,1061,1071,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Pentacosylresorcinol (C25:0),"",,,,nmol/L,,51,Spearman,0.31,,,< 0.05,Yes,,,,Andersson 2011
1010,1061,1072,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0) + 5-n-Heptadecylresorcinol (C17:0) / 5-n-Heneicosylresorcinol (C21:0),,,,nmol/L,,51,Spearman,0.32,,,< 0.05,Yes,,,,Andersson 2011
969,1062,1067,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,70.0,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Heptadecylresorcinol (C17:0),"",,,,nmol/L,,51,Spearman,0.08,,,>= 0.05,No,,,,Andersson 2011
970,1062,1068,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,70.0,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Nonadecylresorcinol (C19:0),"",,,,nmol/L,,51,Spearman,0.15,,,>= 0.05,No,,,,Andersson 2011
971,1062,1069,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,70.0,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Heneicosylresorcinol (C21:0),"",,,,nmol/L,,51,Spearman,0.25,,,>= 0.05,No,,,,Andersson 2011
972,1062,1070,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,70.0,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Tricosylresorcinol (C23:0),"",,,,nmol/L,,51,Spearman,0.29,,,< 0.05,Yes,,,,Andersson 2011
973,1062,1071,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,70.0,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Pentacosylresorcinol (C25:0),"",,,,nmol/L,,51,Spearman,0.23,,,>= 0.05,No,,,,Andersson 2011
974,1062,1072,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,70.0,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0) + 5-n-Heptadecylresorcinol (C17:0) / 5-n-Heneicosylresorcinol (C21:0),,,,nmol/L,,51,Spearman,0.24,,,>= 0.05,No,,,,Andersson 2011
975,1062,1073,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,70.0,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Heptadecylresorcinol (C17:0) / 5-n-Heneicosylresorcinol (C21:0),"",,,,without unit,,51,Spearman,-0.16,,,>= 0.05,No,,,,Andersson 2011
977,1063,1067,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Heptadecylresorcinol (C17:0),"",,,,nmol/L,,51,Spearman,0.73,,,< 0.05,Yes,,,,Andersson 2011
978,1063,1068,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Nonadecylresorcinol (C19:0),"",,,,nmol/L,,51,Spearman,0.29,,,< 0.05,Yes,,,,Andersson 2011
979,1063,1069,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Heneicosylresorcinol (C21:0),"",,,,nmol/L,,51,Spearman,0.19,,,>= 0.05,No,,,,Andersson 2011
980,1063,1070,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Tricosylresorcinol (C23:0),"",,,,nmol/L,,51,Spearman,0.31,,,< 0.01,Yes,,,,Andersson 2011
981,1063,1071,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Pentacosylresorcinol (C25:0),"",,,,nmol/L,,51,Spearman,0.45,,,< 0.01,Yes,,,,Andersson 2011
982,1063,1072,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0) + 5-n-Heptadecylresorcinol (C17:0) / 5-n-Heneicosylresorcinol (C21:0),,,,nmol/L,,51,Spearman,0.28,,,< 0.05,Yes,,,,Andersson 2011
983,1063,1073,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Heptadecylresorcinol (C17:0) / 5-n-Heneicosylresorcinol (C21:0),"",,,,without unit,,51,Spearman,0.49,,,< 0.001,Yes,,,,Andersson 2011
984,1064,1067,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Heptadecylresorcinol (C17:0),"",,,,nmol/L,,51,Spearman,-0.22,,,>= 0.05,No,,,,Andersson 2011
985,1064,1068,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Nonadecylresorcinol (C19:0),"",,,,nmol/L,,51,Spearman,0.23,,,>= 0.05,No,,,,Andersson 2011
986,1064,1069,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Heneicosylresorcinol (C21:0),"",,,,nmol/L,,51,Spearman,0.47,,,< 0.001,Yes,,,,Andersson 2011
987,1064,1070,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Tricosylresorcinol (C23:0),"",,,,nmol/L,,51,Spearman,0.43,,,< 0.01,Yes,,,,Andersson 2011
988,1064,1071,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Pentacosylresorcinol (C25:0),"",,,,nmol/L,,51,Spearman,0.27,,,>= 0.05,No,,,,Andersson 2011
989,1064,1072,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0) + 5-n-Heptadecylresorcinol (C17:0) / 5-n-Heneicosylresorcinol (C21:0),,,,nmol/L,,51,Spearman,0.41,,,< 0.01,Yes,,,,Andersson 2011
990,1064,1073,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Heptadecylresorcinol (C17:0) / 5-n-Heneicosylresorcinol (C21:0),"",,,,without unit,,51,Spearman,-0.59,,,< 0.001,Yes,,,,Andersson 2011
991,1065,1067,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Heptadecylresorcinol (C17:0),"",,,,nmol/L,,51,Spearman,0.37,,,< 0.01,Yes,,,,Andersson 2011
992,1065,1068,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Nonadecylresorcinol (C19:0),"",,,,nmol/L,,51,Spearman,0.41,,,< 0.01,Yes,,,,Andersson 2011
993,1065,1069,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Heneicosylresorcinol (C21:0),"",,,,nmol/L,,51,Spearman,0.55,,,< 0.05,Yes,,,,Andersson 2011
994,1065,1070,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Tricosylresorcinol (C23:0),"",,,,nmol/L,,51,Spearman,0.61,,,< 0.05,Yes,,,,Andersson 2011
995,1065,1071,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Pentacosylresorcinol (C25:0),"",,,,nmol/L,,51,Spearman,0.56,,,< 0.05,Yes,,,,Andersson 2011
996,1065,1072,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0) + 5-n-Heptadecylresorcinol (C17:0) / 5-n-Heneicosylresorcinol (C21:0),,,,nmol/L,,51,Spearman,0.53,,,< 0.001,Yes,,,,Andersson 2011
997,1065,1073,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Heptadecylresorcinol (C17:0) / 5-n-Heneicosylresorcinol (C21:0),"",,,,without unit,,51,Spearman,-0.12,,,>= 0.05,No,,,,Andersson 2011
998,1066,1067,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain rye,"",,,,,percentParent,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Heptadecylresorcinol (C17:0),"",,,,nmol/L,,51,Spearman,0.5,,,< 0.001,Yes,,,,Andersson 2011
999,1066,1068,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain rye,"",,,,,percentParent,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Nonadecylresorcinol (C19:0),"",,,,nmol/L,,51,Spearman,0.01,,,>= 0.05,No,,,,Andersson 2011
1000,1066,1069,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain rye,"",,,,,percentParent,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Heneicosylresorcinol (C21:0),"",,,,nmol/L,,51,Spearman,-0.24,,,>= 0.05,No,,,,Andersson 2011
1001,1066,1070,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain rye,"",,,,,percentParent,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Tricosylresorcinol (C23:0),"",,,,nmol/L,,51,Spearman,0.16,,,>= 0.05,No,,,,Andersson 2011
1002,1066,1071,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain rye,"",,,,,percentParent,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Pentacosylresorcinol (C25:0),"",,,,nmol/L,,51,Spearman,0.05,,,>= 0.05,No,,,,Andersson 2011
1003,1066,1072,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain rye,"",,,,,percentParent,,baseline; 3 months,"Plasma, fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0) + 5-n-Heptadecylresorcinol (C17:0) / 5-n-Heneicosylresorcinol (C21:0),,,,nmol/L,,51,Spearman,-0.14,,,>= 0.05,No,,,,Andersson 2011
1004,1066,1073,All,Adults from the university campus area in Uppsala,Sweden,,baseline; 3 months,Weighed Dietary record (3-day),Whole grain rye,"",,,,,percentParent,,baseline; 3 months,"Plasma, fasting",GC-MS,5-n-Heptadecylresorcinol (C17:0) / 5-n-Heneicosylresorcinol (C21:0),"",,,,without unit,,51,Spearman,0.64,,,< 0.001,Yes,,,,Andersson 2011
1036,7728,7748,African Americans,African American and white adults from Los Angeles area,United States,,,24-h Dietary recall (1-day),Lutein/Zeaxanthin,"",Yes,,3090.0,,ug/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,0.22,,umol/L,,124,Pearson,0.23,,,< 0.001,Yes,,,"Age, Sex, Education, BMI, Cholesterol",Arab 2011
1037,7729,7749,African Americans,African American and white adults from Los Angeles area,United States,,,24-h Dietary recall (1-day),beta-Cryptoxanthin,"",Yes,,99.0,,ug/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,0.16,,umol/L,,124,Pearson,0.4,,,< 0.001,Yes,,,"Age, Sex, Education, BMI, Cholesterol",Arab 2011
1038,7730,7750,African Americans,African American and white adults from Los Angeles area,United States,,,24-h Dietary recall (1-day),Lycopene,"",Yes,,4723.0,,ug/day,,,"Plasma, fasting",HPLC,Lycopene,"",,0.61,,umol/L,,124,Pearson,0.15,,,>= 0.05,No,,,"Age, Sex, Education, BMI, Cholesterol",Arab 2011
1039,7731,7751,African Americans,African American and white adults from Los Angeles area,United States,,,24-h Dietary recall (1-day),alpha-Carotene,"",Yes,,286.0,,ug/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,0.04,,umol/L,,124,Pearson,0.18,,,< 0.001,Yes,,,"Age, Sex, Education, BMI, Cholesterol",Arab 2011
1040,7732,7752,African Americans,African American and white adults from Los Angeles area,United States,,,24-h Dietary recall (1-day),beta-Carotene,"",Yes,,1298.0,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,0.23,,umol/L,,124,Pearson,0.03,,,< 0.05,Yes,,,"Age, Sex, Education, BMI, Cholesterol",Arab 2011
1046,7733,7748,African Americans,African American and white adults from Los Angeles area,United States,,,Diet History Questionnaire (DHQ),Lutein/Zeaxanthin,"",Yes,,2114.0,,ug/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,0.22,,umol/L,,124,Pearson,0.21,,,= 0.004,Yes,,,"Age, Sex, Education, BMI, Cholesterol",Arab 2011
1047,7734,7749,African Americans,African American and white adults from Los Angeles area,United States,,,Diet History Questionnaire (DHQ),beta-Cryptoxanthin,"",Yes,,118.0,,ug/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,0.16,,umol/L,,124,Pearson,0.26,,,>= 0.05,No,,,"Age, Sex, Education, BMI, Cholesterol",Arab 2011
1048,7735,7750,African Americans,African American and white adults from Los Angeles area,United States,,,Diet History Questionnaire (DHQ),Lycopene,"",Yes,,5762.0,,ug/day,,,"Plasma, fasting",HPLC,Lycopene,"",,0.61,,umol/L,,124,Pearson,0.2,,,>= 0.05,No,,,"Age, Sex, Education, BMI, Cholesterol",Arab 2011
1049,7736,7751,African Americans,African American and white adults from Los Angeles area,United States,,,Diet History Questionnaire (DHQ),alpha-Carotene,"",Yes,,456.0,,ug/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,0.04,,umol/L,,124,Pearson,0.24,,,>= 0.05,No,,,"Age, Sex, Education, BMI, Cholesterol",Arab 2011
1050,7737,7752,African Americans,African American and white adults from Los Angeles area,United States,,,Diet History Questionnaire (DHQ),beta-Carotene,"",Yes,,2237.0,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,0.23,,umol/L,,124,Pearson,0.17,,,= 0.004,Yes,,,"Age, Sex, Education, BMI, Cholesterol",Arab 2011
1041,7738,7753,Whites,African American and white adults from Los Angeles area,United States,,,24-h Dietary recall (1-day),Lutein/Zeaxanthin,"",Yes,,3210.0,,ug/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,0.24,,umol/L,,126,Pearson,0.48,,,< 0.001,Yes,,,"Age, Sex, Education, BMI, Cholesterol",Arab 2011
1042,7739,7754,Whites,African American and white adults from Los Angeles area,United States,,,24-h Dietary recall (1-day),beta-Cryptoxanthin,"",Yes,,112.0,,ug/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,0.14,,umol/L,,126,Pearson,0.51,,,< 0.001,Yes,,,"Age, Sex, Education, BMI, Cholesterol",Arab 2011
1043,7740,7755,Whites,African American and white adults from Los Angeles area,United States,,,24-h Dietary recall (1-day),Lycopene,"",Yes,,6475.0,,ug/day,,,"Plasma, fasting",HPLC,Lycopene,"",,0.59,,umol/L,,126,Pearson,0.13,,,>= 0.05,No,,,"Age, Sex, Education, BMI, Cholesterol",Arab 2011
1044,7741,7756,Whites,African American and white adults from Los Angeles area,United States,,,24-h Dietary recall (1-day),alpha-Carotene,"",Yes,,987.0,,ug/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,0.07,,umol/L,,126,Pearson,0.27,,,< 0.001,Yes,,,"Age, Sex, Education, BMI, Cholesterol",Arab 2011
1045,7742,7757,Whites,African American and white adults from Los Angeles area,United States,,,24-h Dietary recall (1-day),beta-Carotene,"",Yes,,1926.0,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,0.31,,umol/L,,126,Pearson,0.38,,,< 0.05,Yes,,,"Age, Sex, Education, BMI, Cholesterol",Arab 2011
1051,7743,7753,Whites,African American and white adults from Los Angeles area,United States,,,Diet History Questionnaire (DHQ),Lutein/Zeaxanthin,"",Yes,,2186.0,,ug/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,0.24,,umol/L,,126,Pearson,0.47,,,= 0.004,Yes,,,"Age, Sex, Education, BMI, Cholesterol",Arab 2011
1052,7744,7754,Whites,African American and white adults from Los Angeles area,United States,,,Diet History Questionnaire (DHQ),beta-Cryptoxanthin,"",Yes,,115.0,,ug/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,0.14,,umol/L,,126,Pearson,0.33,,,>= 0.05,No,,,"Age, Sex, Education, BMI, Cholesterol",Arab 2011
1053,7745,7755,Whites,African American and white adults from Los Angeles area,United States,,,Diet History Questionnaire (DHQ),Lycopene,"",Yes,,5885.0,,ug/day,,,"Plasma, fasting",HPLC,Lycopene,"",,0.59,,umol/L,,126,Pearson,0.002,,,>= 0.05,No,,,"Age, Sex, Education, BMI, Cholesterol",Arab 2011
1054,7746,7756,Whites,African American and white adults from Los Angeles area,United States,,,Diet History Questionnaire (DHQ),alpha-Carotene,"",Yes,,546.0,,ug/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,0.07,,umol/L,,126,Pearson,0.28,,,>= 0.05,No,,,"Age, Sex, Education, BMI, Cholesterol",Arab 2011
1055,7747,7757,Whites,African American and white adults from Los Angeles area,United States,,,Diet History Questionnaire (DHQ),beta-Carotene,"",Yes,,3246.0,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,0.31,,umol/L,,126,Pearson,0.31,,,= 0.004,Yes,,,"Age, Sex, Education, BMI, Cholesterol",Arab 2011
1083,1146,1110,All,Elementary-school children,Japan,,Day 1,Weighed Dietary record (4-day),Thiamin,"",No,2.75,,,umol/day,,baseline,"Urine, 24-h",HPLC,Thiamin,"",0.766,,,umol/day,,108,Pearson,0.07,,,>= 0.05,No,,,,Tsuji 2011
1084,1147,1111,All,Elementary-school children,Japan,,Day 1,Weighed Dietary record (4-day),Riboflavin,"",No,3.6,,,umol/day,,baseline,"Urine, 24-h",HPLC,Riboflavin,"",0.29,,,umol/day,,108,Pearson,0.23,,,< 0.05,Yes,,,,Tsuji 2011
1085,1148,1112,All,Elementary-school children,Japan,,Day 1,Weighed Dietary record (4-day),Vitamin B6,"",No,6.0,,,umol/day,,baseline,"Urine, 24-h",HPLC,4-Pyridoxic acid,"",2.36,,,umol/day,,108,Pearson,0.17,,,>= 0.05,No,,,,Tsuji 2011
1086,1149,1113,All,Elementary-school children,Japan,,Day 1,Weighed Dietary record (4-day),Vitamin B12,"",No,4.64,,,nmol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",0.026,,,nmol/day,,108,Pearson,0.11,,,>= 0.05,No,,,,Tsuji 2011
1087,1150,1115,All,Elementary-school children,Japan,,Day 1,Weighed Dietary record (4-day),Niacin,"",No,101.4,,,umol/day,,baseline,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,65.6,,,umol/day,,108,Pearson,0.23,,,< 0.05,Yes,,,,Tsuji 2011
1088,1151,1115,All,Elementary-school children,Japan,,Day 1,Weighed Dietary record (4-day),Niacin (Niacin Equivalents),"",No,218.0,,,umol/day,,baseline,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,65.6,,,umol/day,,108,Pearson,0.25,,,< 0.01,Yes,,,,Tsuji 2011
1089,1152,1116,All,Elementary-school children,Japan,,Day 1,Weighed Dietary record (4-day),Pantothenic acid,"",No,28.7,,,umol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus plantarum),Pantothenic acid,"",11.6,,,umol/day,,108,Pearson,0.25,,,< 0.01,Yes,,,,Tsuji 2011
1090,1153,1117,All,Elementary-school children,Japan,,Day 1,Weighed Dietary record (4-day),Folates,"",No,532.0,,,nmol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus casei),Folates,"",16.8,,,nmol/day,,108,Pearson,0.24,,,< 0.05,Yes,,,,Tsuji 2011
1091,1154,1118,All,Elementary-school children,Japan,,Day 1,Weighed Dietary record (4-day),Vitamin C,"",No,445.0,,,umol/day,,baseline,"Urine, 24-h",HPLC,Ascorbic acid metabolites,"Ascorbic acid + L-Dehydroascorbic acid + 2,3-Diketogulonic acid",161.0,,,umol/day,,108,Pearson,0.18,,,>= 0.05,No,,,,Tsuji 2011
1074,1137,1110,All,Elementary-school children,Japan,,Day 2,Weighed Dietary record (4-day),Thiamin,"",No,2.6,,,umol/day,,baseline,"Urine, 24-h",HPLC,Thiamin,"",0.766,,,umol/day,,108,Pearson,0.22,,,< 0.05,Yes,,,,Tsuji 2011
1075,1138,1111,All,Elementary-school children,Japan,,Day 2,Weighed Dietary record (4-day),Riboflavin,"",No,3.59,,,umol/day,,baseline,"Urine, 24-h",HPLC,Riboflavin,"",0.29,,,umol/day,,108,Pearson,0.33,,,< 0.001,Yes,,,,Tsuji 2011
1076,1139,1112,All,Elementary-school children,Japan,,Day 2,Weighed Dietary record (4-day),Vitamin B6,"",No,5.97,,,umol/day,,baseline,"Urine, 24-h",HPLC,4-Pyridoxic acid,"",2.36,,,umol/day,,108,Pearson,0.36,,,< 0.001,Yes,,,,Tsuji 2011
1077,1140,1113,All,Elementary-school children,Japan,,Day 2,Weighed Dietary record (4-day),Vitamin B12,"",No,4.76,,,nmol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",0.026,,,nmol/day,,108,Pearson,-0.02,,,>= 0.05,No,,,,Tsuji 2011
1078,1141,1115,All,Elementary-school children,Japan,,Day 2,Weighed Dietary record (4-day),Niacin,"",No,105.3,,,umol/day,,baseline,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,65.6,,,umol/day,,108,Pearson,0.21,,,< 0.05,Yes,,,,Tsuji 2011
1079,1142,1115,All,Elementary-school children,Japan,,Day 2,Weighed Dietary record (4-day),Niacin (Niacin Equivalents),"",No,218.0,,,umol/day,,baseline,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,65.6,,,umol/day,,108,Pearson,0.16,,,>= 0.05,No,,,,Tsuji 2011
1080,1143,1116,All,Elementary-school children,Japan,,Day 2,Weighed Dietary record (4-day),Pantothenic acid,"",No,27.0,,,umol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus plantarum),Pantothenic acid,"",11.6,,,umol/day,,108,Pearson,0.31,,,< 0.001,Yes,,,,Tsuji 2011
1081,1144,1117,All,Elementary-school children,Japan,,Day 2,Weighed Dietary record (4-day),Folates,"",No,491.0,,,nmol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus casei),Folates,"",16.8,,,nmol/day,,108,Pearson,0.18,,,>= 0.05,No,,,,Tsuji 2011
1082,1145,1118,All,Elementary-school children,Japan,,Day 2,Weighed Dietary record (4-day),Vitamin C,"",No,403.0,,,umol/day,,baseline,"Urine, 24-h",HPLC,Ascorbic acid metabolites,"Ascorbic acid + L-Dehydroascorbic acid + 2,3-Diketogulonic acid",161.0,,,umol/day,,108,Pearson,0.26,,,< 0.01,Yes,,,,Tsuji 2011
1065,1128,1110,All,Elementary-school children,Japan,,Day 3,Weighed Dietary record (4-day),Thiamin,"",No,2.9,,,umol/day,,baseline,"Urine, 24-h",HPLC,Thiamin,"",0.766,,,umol/day,,108,Pearson,0.25,,,< 0.01,Yes,,,,Tsuji 2011
1066,1129,1111,All,Elementary-school children,Japan,,Day 3,Weighed Dietary record (4-day),Riboflavin,"",No,3.75,,,umol/day,,baseline,"Urine, 24-h",HPLC,Riboflavin,"",0.29,,,umol/day,,108,Pearson,0.36,,,< 0.001,Yes,,,,Tsuji 2011
1067,1130,1112,All,Elementary-school children,Japan,,Day 3,Weighed Dietary record (4-day),Vitamin B6,"",No,5.96,,,umol/day,,baseline,"Urine, 24-h",HPLC,4-Pyridoxic acid,"",2.36,,,umol/day,,108,Pearson,0.32,,,< 0.001,Yes,,,,Tsuji 2011
1068,1131,1113,All,Elementary-school children,Japan,,Day 3,Weighed Dietary record (4-day),Vitamin B12,"",No,4.85,,,nmol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",0.026,,,nmol/day,,108,Pearson,0.14,,,>= 0.05,No,,,,Tsuji 2011
1069,1132,1115,All,Elementary-school children,Japan,,Day 3,Weighed Dietary record (4-day),Niacin,"",No,101.7,,,umol/day,,baseline,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,65.6,,,umol/day,,108,Pearson,0.11,,,>= 0.05,No,,,,Tsuji 2011
1070,1133,1115,All,Elementary-school children,Japan,,Day 3,Weighed Dietary record (4-day),Niacin (Niacin Equivalents),"",No,218.0,,,umol/day,,baseline,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,65.6,,,umol/day,,108,Pearson,0.23,,,< 0.01,Yes,,,,Tsuji 2011
1071,1134,1116,All,Elementary-school children,Japan,,Day 3,Weighed Dietary record (4-day),Pantothenic acid,"",No,30.1,,,umol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus plantarum),Pantothenic acid,"",11.6,,,umol/day,,108,Pearson,0.2,,,< 0.05,Yes,,,,Tsuji 2011
1072,1135,1117,All,Elementary-school children,Japan,,Day 3,Weighed Dietary record (4-day),Folates,"",No,615.0,,,nmol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus casei),Folates,"",16.8,,,nmol/day,,108,Pearson,0.12,,,>= 0.05,No,,,,Tsuji 2011
1073,1136,1118,All,Elementary-school children,Japan,,Day 3,Weighed Dietary record (4-day),Vitamin C,"",No,448.0,,,umol/day,,baseline,"Urine, 24-h",HPLC,Ascorbic acid metabolites,"Ascorbic acid + L-Dehydroascorbic acid + 2,3-Diketogulonic acid",161.0,,,umol/day,,108,Pearson,0.23,,,< 0.05,Yes,,,,Tsuji 2011
1056,1119,1110,All,Elementary-school children,Japan,,Day 4,Weighed Dietary record (4-day),Thiamin,"",No,3.13,,,umol/day,,baseline,"Urine, 24-h",HPLC,Thiamin,"",0.766,,,umol/day,,108,Pearson,0.41,,,< 0.001,Yes,,,,Tsuji 2011
1057,1120,1111,All,Elementary-school children,Japan,,Day 4,Weighed Dietary record (4-day),Riboflavin,"",No,3.47,,,umol/day,,baseline,"Urine, 24-h",HPLC,Riboflavin,"",0.29,,,umol/day,,108,Pearson,0.36,,,< 0.001,Yes,,,,Tsuji 2011
1058,1121,1112,All,Elementary-school children,Japan,,Day 4,Weighed Dietary record (4-day),Vitamin B6,"",No,5.93,,,umol/day,,baseline,"Urine, 24-h",HPLC,4-Pyridoxic acid,"",2.36,,,umol/day,,108,Pearson,0.42,,,< 0.001,Yes,,,,Tsuji 2011
1059,1122,1113,All,Elementary-school children,Japan,,Day 4,Weighed Dietary record (4-day),Vitamin B12,"",No,3.15,,,nmol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",0.026,,,nmol/day,,108,Pearson,0.18,,,>= 0.05,No,,,,Tsuji 2011
1060,1123,1115,All,Elementary-school children,Japan,,Day 4,Weighed Dietary record (4-day),Niacin,"",No,97.0,,,umol/day,,baseline,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,65.6,,,umol/day,,108,Pearson,0.28,,,< 0.001,Yes,,,,Tsuji 2011
1061,1124,1115,All,Elementary-school children,Japan,,Day 4,Weighed Dietary record (4-day),Niacin (Niacin Equivalents),"",No,214.0,,,umol/day,,baseline,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,65.6,,,umol/day,,108,Pearson,0.28,,,< 0.01,Yes,,,,Tsuji 2011
1062,1125,1116,All,Elementary-school children,Japan,,Day 4,Weighed Dietary record (4-day),Pantothenic acid,"",No,27.6,,,umol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus plantarum),Pantothenic acid,"",11.6,,,umol/day,,108,Pearson,0.23,,,< 0.05,Yes,,,,Tsuji 2011
1063,1126,1117,All,Elementary-school children,Japan,,Day 4,Weighed Dietary record (4-day),Folates,"",No,575.0,,,nmol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus casei),Folates,"",16.8,,,nmol/day,,108,Pearson,0.27,,,< 0.01,Yes,,,,Tsuji 2011
1064,1127,1118,All,Elementary-school children,Japan,,Day 4,Weighed Dietary record (4-day),Vitamin C,"",No,477.0,,,umol/day,,baseline,"Urine, 24-h",HPLC,Ascorbic acid metabolites,"Ascorbic acid + L-Dehydroascorbic acid + 2,3-Diketogulonic acid",161.0,,,umol/day,,108,Pearson,0.35,,,< 0.001,Yes,,,,Tsuji 2011
1092,1155,1110,All,Elementary-school children,Japan,,,Weighed Dietary record (4-day),Thiamin,"",No,2.85,,,umol/day,,baseline,"Urine, 24-h",HPLC,Thiamin,"",0.766,,,umol/day,,108,Pearson,0.35,,,< 0.001,Yes,,,,Tsuji 2011
1093,1156,1111,All,Elementary-school children,Japan,,,Weighed Dietary record (4-day),Riboflavin,"",No,3.6,,,umol/day,,baseline,"Urine, 24-h",HPLC,Riboflavin,"",0.29,,,umol/day,,108,Pearson,0.42,,,< 0.001,Yes,,,,Tsuji 2011
1094,1157,1112,All,Elementary-school children,Japan,,,Weighed Dietary record (4-day),Vitamin B6,"",No,5.96,,,umol/day,,baseline,"Urine, 24-h",HPLC,4-Pyridoxic acid,"",2.36,,,umol/day,,108,Pearson,0.43,,,< 0.001,Yes,,,,Tsuji 2011
1095,1158,1113,All,Elementary-school children,Japan,,,Weighed Dietary record (4-day),Vitamin B12,"",No,4.35,,,nmol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",0.026,,,nmol/day,,108,Pearson,0.1,,,>= 0.05,No,,,,Tsuji 2011
1096,1159,1115,All,Elementary-school children,Japan,,,Weighed Dietary record (4-day),Niacin,"",No,101.4,,,umol/day,,baseline,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,65.6,,,umol/day,,108,Pearson,0.32,,,< 0.001,Yes,,,,Tsuji 2011
1097,1160,1115,All,Elementary-school children,Japan,,,Weighed Dietary record (4-day),Niacin (Niacin Equivalents),"",No,217.0,,,umol/day,,baseline,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,65.6,,,umol/day,,108,Pearson,0.32,,,< 0.001,Yes,,,,Tsuji 2011
1098,1161,1116,All,Elementary-school children,Japan,,,Weighed Dietary record (4-day),Pantothenic acid,"",No,28.3,,,umol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus plantarum),Pantothenic acid,"",11.6,,,umol/day,,108,Pearson,0.32,,,< 0.001,Yes,,,,Tsuji 2011
1099,1162,1117,All,Elementary-school children,Japan,,,Weighed Dietary record (4-day),Folates,"",No,553.0,,,nmol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus casei),Folates,"",16.8,,,nmol/day,,108,Pearson,0.27,,,< 0.01,Yes,,,,Tsuji 2011
1100,1163,1118,All,Elementary-school children,Japan,,,Weighed Dietary record (4-day),Vitamin C,"",No,443.0,,,umol/day,,baseline,"Urine, 24-h",HPLC,Ascorbic acid metabolites,"Ascorbic acid + L-Dehydroascorbic acid + 2,3-Diketogulonic acid",161.0,,,umol/day,,108,Pearson,0.39,,,< 0.001,Yes,,,,Tsuji 2011
1101,1164,1172,All,Adolescents from a public school of Piracicaba,Brazil,,,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,4150.6,,3433.1,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,missing unit,,80,Pearson,0.093,0.092,0.094, ,Unspecified,,,"BMI, Fat, Cholesterol, Fiber",Slater 2010
1102,1165,1172,All,Adolescents from a public school of Piracicaba,Brazil,,,Food Frequency Questionnaire (FFQ),Fruits,"",,284.0,,169.4,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,missing unit,,80,Pearson,0.217,0.216,0.218, ,Unspecified,,,"BMI, Fat, Cholesterol, Fiber",Slater 2010
1103,1166,1172,All,Adolescents from a public school of Piracicaba,Brazil,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,104.3,,79.2,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,missing unit,,80,Pearson,0.147,0.146,0.148, ,Unspecified,,,"BMI, Fat, Cholesterol, Fiber",Slater 2010
1104,1167,1172,All,Adolescents from a public school of Piracicaba,Brazil,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,306.8,,276.2,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,missing unit,,80,Pearson,0.235,0.234,0.236, ,Unspecified,,,"BMI, Fat, Cholesterol, Fiber",Slater 2010
1105,1168,1172,All,Adolescents from a public school of Piracicaba,Brazil,,,24-h Dietary recall (1-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,6910.8,,4396.6,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,missing unit,,80,Pearson,0.095,0.094,0.096, ,Unspecified,,,"BMI, Fat, Cholesterol, Fiber",Slater 2010
1106,1169,1172,All,Adolescents from a public school of Piracicaba,Brazil,,,24-h Dietary recall (1-day),Fruits,"",,97.7,,98.6,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,missing unit,,80,Pearson,0.13,0.129,0.131, ,Unspecified,,,"BMI, Fat, Cholesterol, Fiber",Slater 2010
1107,1170,1172,All,Adolescents from a public school of Piracicaba,Brazil,,,24-h Dietary recall (1-day),Vegetables,"",,66.8,,52.1,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,missing unit,,80,Pearson,0.072,0.071,0.073, ,Unspecified,,,"BMI, Fat, Cholesterol, Fiber",Slater 2010
1108,1171,1172,All,Adolescents from a public school of Piracicaba,Brazil,,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,94.4,,68.8,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,missing unit,,80,Pearson,0.137,0.136,0.138, ,Unspecified,,,"BMI, Fat, Cholesterol, Fiber",Slater 2010
1121,1190,1235,Males,Participants in a dietary validation study,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),baseline,Dietary record (7-day),alpha-Carotene,"",,1095.0,,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",0.07,,,mg/mL,,89,Spearman,0.22,0.02,0.43, ,Unspecified,,,,Kobayashi 2011
1122,1191,1236,Males,Participants in a dietary validation study,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),baseline,Dietary record (7-day),beta-Carotene,"",,3484.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.32,,,mg/mL,,89,Spearman,0.22,0.02,0.41, ,Unspecified,,,,Kobayashi 2011
1123,1192,1237,Males,Participants in a dietary validation study,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),baseline,Dietary record (7-day),Lycopene,"",,2835.0,,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",0.11,,,mg/mL,,89,Spearman,0.37,0.18,0.57, ,Unspecified,,,,Kobayashi 2011
1124,1199,1238,Males,Participants in a dietary validation study,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),baseline,Dietary record (7-day),Vitamin B6,"",,1.41,,,mg/day,,,"Plasma, fasting",HPLC,Pyridoxal 5'-phosphate,"",204.7,,,nmol/L,,90,Spearman,0.18,-0.03,0.39, ,Unspecified,,,,Kobayashi 2011
1125,1200,1239,Males,Participants in a dietary validation study,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),baseline,Dietary record (7-day),Vitamin B12,"",,12.1,,,ug/day,,,"Plasma, fasting",Chemiluminescence immunoassay (CLIA),Vitamin B12,"",479.3,,,pmol/L,,90,Spearman,-0.03,-0.24,0.18, ,Unspecified,,,,Kobayashi 2011
1126,1201,1240,Males,Participants in a dietary validation study,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),baseline,Dietary record (7-day),Folates,"",,325.4,,,ug/day,,,"Plasma, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",77.9,,,nmol/L,,90,Spearman,0.04,-0.17,0.25, ,Unspecified,,,,Kobayashi 2011
1120,1203,1234,Males,Participants in a dietary validation study,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),baseline,Dietary record (7-day),Vitamin C,"",,93.3,,,mg/day,,,"Plasma, fasting",Spectrophotometry,Ascorbic acid,"",1.17,,,mg/dL,,90,Spearman,-0.06,-0.27,0.14, ,Unspecified,,,,Kobayashi 2011
1110,1174,1235,Males,Participants in a dietary validation study,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),baseline,Dietary record (7-day),alpha-Carotene,"",,997.0,,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",0.07,,,mg/mL,,89,Spearman,0.1,-0.1,0.31, ,Unspecified,,,,Kobayashi 2011
1111,1175,1236,Males,Participants in a dietary validation study,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),baseline,Dietary record (7-day),beta-Carotene,"",,3413.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.32,,,mg/mL,,89,Spearman,0.24,0.04,0.44, ,Unspecified,,,,Kobayashi 2011
1112,1176,1237,Males,Participants in a dietary validation study,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),baseline,Dietary record (7-day),Lycopene,"",,3408.0,,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",0.11,,,mg/mL,,89,Spearman,0.3,0.09,0.5, ,Unspecified,,,,Kobayashi 2011
1113,1183,1238,Males,Participants in a dietary validation study,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),baseline,Dietary record (7-day),Vitamin B6,"",,1.65,,,mg/day,,,"Plasma, fasting",HPLC,Pyridoxal 5'-phosphate,"",204.7,,,nmol/L,,90,Spearman,0.1,-0.12,0.31, ,Unspecified,,,,Kobayashi 2011
1114,1184,1239,Males,Participants in a dietary validation study,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),baseline,Dietary record (7-day),Vitamin B12,"",,12.0,,,ug/day,,,"Plasma, fasting",Chemiluminescence immunoassay (CLIA),Vitamin B12,"",479.3,,,pmol/L,,90,Spearman,0.02,-0.19,0.24, ,Unspecified,,,,Kobayashi 2011
1115,1185,1240,Males,Participants in a dietary validation study,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),baseline,Dietary record (7-day),Folates,"",,396.5,,,ug/day,,,"Plasma, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",77.9,,,nmol/L,,90,Spearman,0.04,-0.17,0.26, ,Unspecified,,,,Kobayashi 2011
1109,1187,1234,Males,Participants in a dietary validation study,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),baseline,Dietary record (7-day),Vitamin C,"",,104.0,,,mg/day,,,"Plasma, fasting",Spectrophotometry,Ascorbic acid,"",1.17,,,mg/dL,,90,Spearman,-0.05,-0.27,0.18, ,Unspecified,,,,Kobayashi 2011
1128,1220,1242,Females,Participants in a dietary validation study,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),baseline,Dietary record (7-day),alpha-Carotene,"",,893.0,,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",0.1,,,mg/mL,,101,Spearman,0.19,-0.01,0.39, ,Unspecified,,,,Kobayashi 2011
1129,1221,1243,Females,Participants in a dietary validation study,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),baseline,Dietary record (7-day),beta-Carotene,"",,3443.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.57,,,mg/mL,,101,Spearman,0.17,-0.03,0.37, ,Unspecified,,,,Kobayashi 2011
1130,1222,1244,Females,Participants in a dietary validation study,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),baseline,Dietary record (7-day),Lycopene,"",,3126.0,,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",0.13,,,mg/mL,,101,Spearman,0.37,0.16,0.57, ,Unspecified,,,,Kobayashi 2011
1127,1233,1241,Females,Participants in a dietary validation study,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),baseline,Dietary record (7-day),Vitamin C,"",,105.7,,,mg/day,,,"Plasma, fasting",Spectrophotometry,Ascorbic acid,"",1.31,,,mg/dL,,101,Spearman,-0.02,-0.23,0.19, ,Unspecified,,,,Kobayashi 2011
1117,1205,1242,Females,Participants in a dietary validation study,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),baseline,Dietary record (7-day),alpha-Carotene,"",,826.0,,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",0.1,,,mg/mL,,101,Spearman,-0.01,-0.21,0.2, ,Unspecified,,,,Kobayashi 2011
1118,1206,1243,Females,Participants in a dietary validation study,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),baseline,Dietary record (7-day),beta-Carotene,"",,3309.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.57,,,mg/mL,,101,Spearman,0.21,0.01,0.41, ,Unspecified,,,,Kobayashi 2011
1119,1207,1244,Females,Participants in a dietary validation study,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),baseline,Dietary record (7-day),Lycopene,"",,3877.0,,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",0.13,,,mg/mL,,101,Spearman,0.35,0.15,0.56, ,Unspecified,,,,Kobayashi 2011
1116,1218,1241,Females,Participants in a dietary validation study,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),baseline,Dietary record (7-day),Vitamin C,"",,118.2,,,mg/day,,,"Plasma, fasting",Spectrophotometry,Ascorbic acid,"",1.31,,,mg/dL,,101,Spearman,-0.07,-0.28,0.14, ,Unspecified,,,,Kobayashi 2011
1131,1248,1260,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Rye bread,"",,,,62.5,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Heptadecylresorcinol (C17:0),"",,,,nmol/L,,360,Spearman,0.31,,,< 0.001,Yes,,No,,Landberg 2011
1140,1248,1261,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Rye bread,"",,,,62.5,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Nonadecylresorcinol (C19:0),"",,,,nmol/L,,360,Spearman,0.26,,,< 0.001,Yes,,No,,Landberg 2011
1149,1248,1262,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Rye bread,"",,,,62.5,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Heneicosylresorcinol (C21:0),"",,,,nmol/L,,360,Spearman,0.21,,,< 0.001,Yes,,No,,Landberg 2011
1158,1248,1263,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Rye bread,"",,,,62.5,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Tricosylresorcinol (C23:0),"",,,,nmol/L,,360,Spearman,0.25,,,< 0.001,Yes,,No,,Landberg 2011
1167,1248,1264,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Rye bread,"",,,,62.5,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Pentacosylresorcinol (C25:0),"",,,,nmol/L,,360,Spearman,0.26,,,< 0.001,Yes,,No,,Landberg 2011
1176,1248,1259,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Rye bread,"",,,,62.5,g/day,,,"Plasma, non-fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0),115.0,,78.0,nmol/L,,360,Spearman,0.25,,,< 0.001,Yes,,No,,Landberg 2011
1134,1249,1260,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Wheat bread,"",,,,31.4,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Heptadecylresorcinol (C17:0),"",,,,nmol/L,,360,Spearman,0.02,,,>= 0.05,No,,No,,Landberg 2011
1143,1249,1261,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Wheat bread,"",,,,31.4,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Nonadecylresorcinol (C19:0),"",,,,nmol/L,,360,Spearman,0.11,,,< 0.05,Yes,,No,,Landberg 2011
1152,1249,1262,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Wheat bread,"",,,,31.4,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Heneicosylresorcinol (C21:0),"",,,,nmol/L,,360,Spearman,0.16,,,< 0.01,Yes,,No,,Landberg 2011
1161,1249,1263,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Wheat bread,"",,,,31.4,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Tricosylresorcinol (C23:0),"",,,,nmol/L,,360,Spearman,0.11,,,< 0.05,Yes,,No,,Landberg 2011
1170,1249,1264,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Wheat bread,"",,,,31.4,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Pentacosylresorcinol (C25:0),"",,,,nmol/L,,360,Spearman,0.06,,,>= 0.05,No,,No,,Landberg 2011
1179,1249,1259,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Wheat bread,"",,,,31.4,g/day,,,"Plasma, non-fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0),115.0,,78.0,nmol/L,,360,Spearman,0.09,,,>= 0.05,No,,No,,Landberg 2011
1133,1250,1260,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Crisp bread,"",,,,1.0,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Heptadecylresorcinol (C17:0),"",,,,nmol/L,,360,Spearman,0.11,,,< 0.05,Yes,,No,,Landberg 2011
1142,1250,1261,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Crisp bread,"",,,,1.0,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Nonadecylresorcinol (C19:0),"",,,,nmol/L,,360,Spearman,0.09,,,>= 0.05,No,,No,,Landberg 2011
1151,1250,1262,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Crisp bread,"",,,,1.0,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Heneicosylresorcinol (C21:0),"",,,,nmol/L,,360,Spearman,0.08,,,>= 0.05,No,,No,,Landberg 2011
1160,1250,1263,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Crisp bread,"",,,,1.0,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Tricosylresorcinol (C23:0),"",,,,nmol/L,,360,Spearman,0.08,,,>= 0.05,No,,No,,Landberg 2011
1169,1250,1264,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Crisp bread,"",,,,1.0,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Pentacosylresorcinol (C25:0),"",,,,nmol/L,,360,Spearman,0.05,,,>= 0.05,No,,No,,Landberg 2011
1178,1250,1259,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Crisp bread,"",,,,1.0,g/day,,,"Plasma, non-fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0),115.0,,78.0,nmol/L,,360,Spearman,0.12,,,< 0.05,Yes,,No,,Landberg 2011
1132,1251,1260,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),White bread,"",,,,4.3,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Heptadecylresorcinol (C17:0),"",,,,nmol/L,,360,Spearman,-0.07,,,>= 0.05,No,,No,,Landberg 2011
1141,1251,1261,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),White bread,"",,,,4.3,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Nonadecylresorcinol (C19:0),"",,,,nmol/L,,360,Spearman,-0.06,,,>= 0.05,No,,No,,Landberg 2011
1150,1251,1262,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),White bread,"",,,,4.3,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Heneicosylresorcinol (C21:0),"",,,,nmol/L,,360,Spearman,-0.05,,,>= 0.05,No,,No,,Landberg 2011
1159,1251,1263,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),White bread,"",,,,4.3,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Tricosylresorcinol (C23:0),"",,,,nmol/L,,360,Spearman,-0.06,,,>= 0.05,No,,No,,Landberg 2011
1168,1251,1264,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),White bread,"",,,,4.3,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Pentacosylresorcinol (C25:0),"",,,,nmol/L,,360,Spearman,-0.07,,,>= 0.05,No,,No,,Landberg 2011
1177,1251,1259,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),White bread,"",,,,4.3,g/day,,,"Plasma, non-fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0),115.0,,78.0,nmol/L,,360,Spearman,-0.06,,,>= 0.05,No,,No,,Landberg 2011
1135,1254,1260,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Beer,"",,,,,mL/day,,,"Plasma, non-fasting",GC-MS,5-n-Heptadecylresorcinol (C17:0),"",,,,nmol/L,,360,Spearman,0.06,,,>= 0.05,No,,No,,Landberg 2011
1144,1254,1261,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Beer,"",,,,,mL/day,,,"Plasma, non-fasting",GC-MS,5-n-Nonadecylresorcinol (C19:0),"",,,,nmol/L,,360,Spearman,-0.06,,,>= 0.05,No,,No,,Landberg 2011
1153,1254,1262,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Beer,"",,,,,mL/day,,,"Plasma, non-fasting",GC-MS,5-n-Heneicosylresorcinol (C21:0),"",,,,nmol/L,,360,Spearman,-0.08,,,>= 0.05,No,,No,,Landberg 2011
1162,1254,1263,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Beer,"",,,,,mL/day,,,"Plasma, non-fasting",GC-MS,5-n-Tricosylresorcinol (C23:0),"",,,,nmol/L,,360,Spearman,-0.11,,,< 0.05,Yes,,No,,Landberg 2011
1171,1254,1264,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Beer,"",,,,,mL/day,,,"Plasma, non-fasting",GC-MS,5-n-Pentacosylresorcinol (C25:0),"",,,,nmol/L,,360,Spearman,0.04,,,>= 0.05,No,,No,,Landberg 2011
1180,1254,1259,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Beer,"",,,,,mL/day,,,"Plasma, non-fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0),115.0,,78.0,nmol/L,,360,Spearman,-0.09,,,>= 0.05,No,,No,,Landberg 2011
1136,1255,1260,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,15.0,,,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Heptadecylresorcinol (C17:0),"",,,,nmol/L,,360,Spearman,0.05,,,>= 0.05,No,,No,,Landberg 2011
1145,1255,1261,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,15.0,,,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Nonadecylresorcinol (C19:0),"",,,,nmol/L,,360,Spearman,0.02,,,>= 0.05,No,,No,,Landberg 2011
1154,1255,1262,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,15.0,,,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Heneicosylresorcinol (C21:0),"",,,,nmol/L,,360,Spearman,0.01,,,>= 0.05,No,,No,,Landberg 2011
1163,1255,1263,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,15.0,,,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Tricosylresorcinol (C23:0),"",,,,nmol/L,,360,Spearman,0.01,,,>= 0.05,No,,No,,Landberg 2011
1172,1255,1264,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,15.0,,,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Pentacosylresorcinol (C25:0),"",,,,nmol/L,,360,Spearman,-0.1,,,>= 0.05,No,,No,,Landberg 2011
1181,1255,1259,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,15.0,,,g/day,,,"Plasma, non-fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0),115.0,,78.0,nmol/L,,360,Spearman,0.02,,,>= 0.05,No,,No,,Landberg 2011
1137,1256,1260,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Dietary fibre,Fibre from Cereals + Fibre from Foods,,,,,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Heptadecylresorcinol (C17:0),"",,,,nmol/L,,360,Spearman,0.1,,,< 0.05,Yes,,No,,Landberg 2011
1146,1256,1261,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Dietary fibre,Fibre from Cereals + Fibre from Foods,,,,,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Nonadecylresorcinol (C19:0),"",,,,nmol/L,,360,Spearman,0.14,,,< 0.01,Yes,,No,,Landberg 2011
1155,1256,1262,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Dietary fibre,Fibre from Cereals + Fibre from Foods,,,,,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Heneicosylresorcinol (C21:0),"",,,,nmol/L,,360,Spearman,0.14,,,< 0.01,Yes,,No,,Landberg 2011
1164,1256,1263,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Dietary fibre,Fibre from Cereals + Fibre from Foods,,,,,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Tricosylresorcinol (C23:0),"",,,,nmol/L,,360,Spearman,0.13,,,< 0.01,Yes,,No,,Landberg 2011
1173,1256,1264,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Dietary fibre,Fibre from Cereals + Fibre from Foods,,,,,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Pentacosylresorcinol (C25:0),"",,,,nmol/L,,360,Spearman,0.11,,,>= 0.05,No,,No,,Landberg 2011
1182,1256,1259,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Dietary fibre,Fibre from Cereals + Fibre from Foods,,,,,g/day,,,"Plasma, non-fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0),115.0,,78.0,nmol/L,,360,Spearman,0.14,,,< 0.01,Yes,,No,,Landberg 2011
1138,1257,1260,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Fibre from Cereals,"",,,,,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Heptadecylresorcinol (C17:0),"",,,,nmol/L,,360,Spearman,0.17,,,< 0.01,Yes,,No,,Landberg 2011
1147,1257,1261,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Fibre from Cereals,"",,,,,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Nonadecylresorcinol (C19:0),"",,,,nmol/L,,360,Spearman,0.2,,,< 0.01,Yes,,No,,Landberg 2011
1156,1257,1262,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Fibre from Cereals,"",,,,,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Heneicosylresorcinol (C21:0),"",,,,nmol/L,,360,Spearman,0.2,,,< 0.001,Yes,,No,,Landberg 2011
1165,1257,1263,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Fibre from Cereals,"",,,,,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Tricosylresorcinol (C23:0),"",,,,nmol/L,,360,Spearman,0.19,,,< 0.001,Yes,,No,,Landberg 2011
1174,1257,1264,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Fibre from Cereals,"",,,,,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Pentacosylresorcinol (C25:0),"",,,,nmol/L,,360,Spearman,0.16,,,>= 0.05,No,,No,,Landberg 2011
1183,1257,1259,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Fibre from Cereals,"",,,,,g/day,,,"Plasma, non-fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0),115.0,,78.0,nmol/L,,360,Spearman,0.19,,,< 0.001,Yes,,No,,Landberg 2011
1139,1258,1260,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Fibre from Foods,"",,,,,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Heptadecylresorcinol (C17:0),"",,,,nmol/L,,360,Spearman,0.0,,,>= 0.05,No,,No,,Landberg 2011
1148,1258,1261,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Fibre from Foods,"",,,,,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Nonadecylresorcinol (C19:0),"",,,,nmol/L,,360,Spearman,0.04,,,>= 0.05,No,,No,,Landberg 2011
1157,1258,1262,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Fibre from Foods,"",,,,,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Heneicosylresorcinol (C21:0),"",,,,nmol/L,,360,Spearman,0.05,,,>= 0.05,No,,No,,Landberg 2011
1166,1258,1263,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Fibre from Foods,"",,,,,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Tricosylresorcinol (C23:0),"",,,,nmol/L,,360,Spearman,0.05,,,>= 0.05,No,,No,,Landberg 2011
1175,1258,1264,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Fibre from Foods,"",,,,,g/day,,,"Plasma, non-fasting",GC-MS,5-n-Pentacosylresorcinol (C25:0),"",,,,nmol/L,,360,Spearman,0.03,,,< 0.05,Yes,,No,,Landberg 2011
1184,1258,1259,All,Cases and controls post-menopausal women in a case-control study on endometrial cancer,Denmark,"DCH (Diet, Cancer and Health)",,Food Frequency Questionnaire (FFQ),Fibre from Foods,"",,,,,g/day,,,"Plasma, non-fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0),115.0,,78.0,nmol/L,,360,Spearman,0.05,,,>= 0.05,No,,No,,Landberg 2011
1193,1265,1281,All,Middle-aged subjects in Southern China,China,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,19.056,,,g/day,,,"Red blood cell membrane, unspecified",GC-FID,"Fatty acids, saturated (SFA)","",39.997,,,percentRoot,,125,Spearman,-0.15,,,>= 0.05,No,,,,Zhang 2010
1194,1266,1282,All,Middle-aged subjects in Southern China,China,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)","",,27.3,,,g/day,,,"Red blood cell membrane, unspecified",GC-FID,"Fatty acids, monounsaturated (MUFA)","",16.352,,,percentRoot,,125,Spearman,0.07,,,>= 0.05,No,,,,Zhang 2010
1195,1267,1283,All,Middle-aged subjects in Southern China,China,,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)","alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Fatty acids, n6-polyunsaturated (n6-PUFA)",,18.936,,,g/day,,,"Red blood cell membrane, unspecified",GC-FID,"Fatty acids, polyunsaturated (PUFA)","alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Fatty acids, n6-polyunsaturated (n6-PUFA)",40.217,,,percentRoot,,125,Spearman,-0.08,,,>= 0.05,No,,,,Zhang 2010
1196,1268,1284,All,Middle-aged subjects in Southern China,China,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)","",,17.715,,,g/day,,,"Red blood cell membrane, unspecified",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)","",28.666,,,percentRoot,,125,Spearman,0.1,,,>= 0.05,No,,,,Zhang 2010
1197,1269,1285,All,Middle-aged subjects in Southern China,China,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,1.393,,,g/day,,,"Red blood cell membrane, unspecified",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3),11.551,,,percentRoot,,125,Spearman,-0.04,,,>= 0.05,No,,,,Zhang 2010
1198,1270,1286,All,Middle-aged subjects in Southern China,China,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,1.352,,,g/day,,,"Red blood cell membrane, unspecified",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.114,,,percentRoot,,125,Spearman,0.19,,,< 0.05,Yes,,,,Zhang 2010
1199,1271,1287,All,Middle-aged subjects in Southern China,China,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,0.013,,,g/day,,,"Red blood cell membrane, unspecified",GC-FID,EPA (cis-20:5n-3),"",0.312,,,percentRoot,,125,Spearman,0.37,,,< 0.01,Yes,,,,Zhang 2010
1200,1272,1288,All,Middle-aged subjects in Southern China,China,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,0.024,,,g/day,,,"Red blood cell membrane, unspecified",GC-FID,DHA (cis-22:6n-3),"",9.714,,,percentRoot,,125,Spearman,0.16,,,>= 0.05,No,,,,Zhang 2010
1185,1273,1281,All,Middle-aged subjects in Southern China,China,,,Dietary record (3-day),"Fatty acids, saturated (SFA)","",,19.007,,,g/day,,,"Red blood cell membrane, unspecified",GC-FID,"Fatty acids, saturated (SFA)","",39.997,,,percentRoot,,125,Spearman,0.11,,,>= 0.05,No,,,,Zhang 2010
1186,1274,1282,All,Middle-aged subjects in Southern China,China,,,Dietary record (3-day),"Fatty acids, monounsaturated (MUFA)","",,27.968,,,g/day,,,"Red blood cell membrane, unspecified",GC-FID,"Fatty acids, monounsaturated (MUFA)","",16.352,,,percentRoot,,125,Spearman,0.09,,,>= 0.05,No,,,,Zhang 2010
1187,1275,1283,All,Middle-aged subjects in Southern China,China,,,Dietary record (3-day),"Fatty acids, polyunsaturated (PUFA)","alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Fatty acids, n6-polyunsaturated (n6-PUFA)",,20.811,,,g/day,,,"Red blood cell membrane, unspecified",GC-FID,"Fatty acids, polyunsaturated (PUFA)","alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Fatty acids, n6-polyunsaturated (n6-PUFA)",40.217,,,percentRoot,,125,Spearman,0.02,,,>= 0.05,No,,,,Zhang 2010
1188,1276,1284,All,Middle-aged subjects in Southern China,China,,,Dietary record (3-day),"Fatty acids, n6-polyunsaturated (n6-PUFA)","",,19.517,,,g/day,,,"Red blood cell membrane, unspecified",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)","",28.666,,,percentRoot,,125,Spearman,0.15,,,>= 0.05,No,,,,Zhang 2010
1189,1277,1285,All,Middle-aged subjects in Southern China,China,,,Dietary record (3-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,1.455,,,g/day,,,"Red blood cell membrane, unspecified",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3),11.551,,,percentRoot,,125,Spearman,-0.01,,,>= 0.05,No,,,,Zhang 2010
1190,1278,1286,All,Middle-aged subjects in Southern China,China,,,Dietary record (3-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,1.358,,,g/day,,,"Red blood cell membrane, unspecified",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.114,,,percentRoot,,125,Spearman,0.28,,,< 0.01,Yes,,,,Zhang 2010
1191,1279,1287,All,Middle-aged subjects in Southern China,China,,,Dietary record (3-day),EPA (cis-20:5n-3),"",,0.029,,,g/day,,,"Red blood cell membrane, unspecified",GC-FID,EPA (cis-20:5n-3),"",0.312,,,percentRoot,,125,Spearman,0.28,,,< 0.01,Yes,,,,Zhang 2010
1192,1280,1288,All,Middle-aged subjects in Southern China,China,,,Dietary record (3-day),DHA (cis-22:6n-3),"",,0.04,,,g/day,,,"Red blood cell membrane, unspecified",GC-FID,DHA (cis-22:6n-3),"",9.714,,,percentRoot,,125,Spearman,0.1,,,>= 0.05,No,,,,Zhang 2010
1201,1301,1304,All [by diagnosis],Depressed and non-depressed participants in mood disorders studies in New York City area,United States,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,234.2,,45.9,mg/day,,,"Plasma, fasting and non-fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",20.1,,18.6,mg/L,,61,Spearman,0.22,,,= 0.086,No,,,,Sublette 2011
1202,1302,1305,All [by diagnosis],Depressed and non-depressed participants in mood disorders studies in New York City area,United States,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,49.8,,17.0,mg/day,,,"Plasma, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",54.4,,51.4,mg/L,,61,Spearman,0.5,,,< 0.0001,Yes,,,,Sublette 2011
1203,1303,1306,All [by diagnosis],Depressed and non-depressed participants in mood disorders studies in New York City area,United States,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,26.4,,11.0,mg/day,,,"Plasma, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",20.1,,16.5,mg/L,,61,Spearman,0.38,,,= 0.002,Yes,,,,Sublette 2011
1204,1324,1313,All,University students,Japan,,Day 4,Weighed Dietary record (4-day),Thiamin,"",No,2.27,,,umol/day,,baseline,"Urine, 24-h",HPLC,Thiamin,"",0.425,,,umol/day,,148,Pearson,0.29,,,< 0.001,Yes,,,,Tsuji 2010
1205,1325,1314,All,University students,Japan,,Day 4,Weighed Dietary record (4-day),Riboflavin,"",No,3.32,,,umol/day,,baseline,"Urine, 24-h",HPLC,Riboflavin,"",0.382,,,umol/day,,148,Pearson,0.32,,,< 0.001,Yes,,,,Tsuji 2010
1206,1326,1315,All,University students,Japan,,Day 4,Weighed Dietary record (4-day),Vitamin B6,"",No,5.3,,,umol/day,,baseline,"Urine, 24-h",HPLC,4-Pyridoxic acid,"",3.68,,,umol/day,,148,Pearson,0.26,,,< 0.01,Yes,,,,Tsuji 2010
1207,1327,1316,All,University students,Japan,,Day 4,Weighed Dietary record (4-day),Vitamin B12,"",No,2.88,,,nmol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",0.028,,,nmol/day,,148,Pearson,0.05,,,>= 0.05,No,,,,Tsuji 2010
1208,1328,1318,All,University students,Japan,,Day 4,Weighed Dietary record (4-day),Niacin,"",No,90.8,,,umol/day,,baseline,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,84.5,,,umol/day,,148,Pearson,0.32,,,< 0.001,Yes,,,,Tsuji 2010
1209,1329,1318,All,University students,Japan,,Day 4,Weighed Dietary record (4-day),Niacin (Niacin Equivalents),"",No,184.0,,,umol/day,,baseline,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,84.5,,,umol/day,,148,Pearson,0.29,,,< 0.001,Yes,,,,Tsuji 2010
1210,1330,1319,All,University students,Japan,,Day 4,Weighed Dietary record (4-day),Pantothenic acid,"",No,23.6,,,umol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus plantarum),Pantothenic acid,"",16.5,,,umol/day,,148,Pearson,0.33,,,< 0.001,Yes,,,,Tsuji 2010
1211,1331,1320,All,University students,Japan,,Day 4,Weighed Dietary record (4-day),Folates,"",No,569.0,,,nmol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus casei),Folates,"",23.1,,,nmol/day,,148,Pearson,0.15,,,>= 0.05,No,,,,Tsuji 2010
1212,1332,1321,All,University students,Japan,,Day 4,Weighed Dietary record (4-day),Vitamin C,"",No,425.0,,,umol/day,,baseline,"Urine, 24-h",HPLC,Ascorbic acid metabolites,"Ascorbic acid + L-Dehydroascorbic acid + 2,3-Diketogulonic acid",139.0,,,umol/day,,148,Pearson,0.29,,,< 0.001,Yes,,,,Tsuji 2010
1213,1333,1313,All,University students,Japan,,Day 3,Weighed Dietary record (4-day),Thiamin,"",No,2.46,,,umol/day,,baseline,"Urine, 24-h",HPLC,Thiamin,"",0.425,,,umol/day,,148,Pearson,0.35,,,< 0.001,Yes,,,,Tsuji 2010
1214,1334,1314,All,University students,Japan,,Day 3,Weighed Dietary record (4-day),Riboflavin,"",No,3.47,,,umol/day,,baseline,"Urine, 24-h",HPLC,Riboflavin,"",0.382,,,umol/day,,148,Pearson,0.28,,,< 0.001,Yes,,,,Tsuji 2010
1215,1335,1315,All,University students,Japan,,Day 3,Weighed Dietary record (4-day),Vitamin B6,"",No,5.62,,,umol/day,,baseline,"Urine, 24-h",HPLC,4-Pyridoxic acid,"",3.68,,,umol/day,,148,Pearson,0.37,,,< 0.001,Yes,,,,Tsuji 2010
1216,1336,1316,All,University students,Japan,,Day 3,Weighed Dietary record (4-day),Vitamin B12,"",No,3.59,,,nmol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",0.028,,,nmol/day,,148,Pearson,0.01,,,>= 0.05,No,,,,Tsuji 2010
1217,1337,1318,All,University students,Japan,,Day 3,Weighed Dietary record (4-day),Niacin,"",No,96.5,,,umol/day,,baseline,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,84.5,,,umol/day,,148,Pearson,0.26,,,< 0.01,Yes,,,,Tsuji 2010
1218,1338,1318,All,University students,Japan,,Day 3,Weighed Dietary record (4-day),Niacin (Niacin Equivalents),"",No,191.0,,,umol/day,,baseline,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,84.5,,,umol/day,,148,Pearson,0.24,,,< 0.01,Yes,,,,Tsuji 2010
1219,1339,1319,All,University students,Japan,,Day 3,Weighed Dietary record (4-day),Pantothenic acid,"",No,23.9,,,umol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus plantarum),Pantothenic acid,"",16.5,,,umol/day,,148,Pearson,0.44,,,< 0.001,Yes,,,,Tsuji 2010
1220,1340,1320,All,University students,Japan,,Day 3,Weighed Dietary record (4-day),Folates,"",No,591.0,,,nmol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus casei),Folates,"",23.1,,,nmol/day,,148,Pearson,0.24,,,< 0.01,Yes,,,,Tsuji 2010
1221,1341,1321,All,University students,Japan,,Day 3,Weighed Dietary record (4-day),Vitamin C,"",No,476.0,,,umol/day,,baseline,"Urine, 24-h",HPLC,Ascorbic acid metabolites,"Ascorbic acid + L-Dehydroascorbic acid + 2,3-Diketogulonic acid",139.0,,,umol/day,,148,Pearson,0.34,,,< 0.001,Yes,,,,Tsuji 2010
1222,1342,1313,All,University students,Japan,,Day 2,Weighed Dietary record (4-day),Thiamin,"",No,2.46,,,umol/day,,baseline,"Urine, 24-h",HPLC,Thiamin,"",0.425,,,umol/day,,148,Pearson,0.27,,,< 0.001,Yes,,,,Tsuji 2010
1223,1343,1314,All,University students,Japan,,Day 2,Weighed Dietary record (4-day),Riboflavin,"",No,3.43,,,umol/day,,baseline,"Urine, 24-h",HPLC,Riboflavin,"",0.382,,,umol/day,,148,Pearson,0.31,,,< 0.001,Yes,,,,Tsuji 2010
1224,1344,1315,All,University students,Japan,,Day 2,Weighed Dietary record (4-day),Vitamin B6,"",No,5.83,,,umol/day,,baseline,"Urine, 24-h",HPLC,4-Pyridoxic acid,"",3.68,,,umol/day,,148,Pearson,0.21,,,< 0.01,Yes,,,,Tsuji 2010
1225,1345,1316,All,University students,Japan,,Day 2,Weighed Dietary record (4-day),Vitamin B12,"",No,3.49,,,nmol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",0.028,,,nmol/day,,148,Pearson,-0.06,,,>= 0.05,No,,,,Tsuji 2010
1226,1346,1318,All,University students,Japan,,Day 2,Weighed Dietary record (4-day),Niacin,"",No,98.8,,,umol/day,,baseline,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,84.5,,,umol/day,,148,Pearson,0.17,,,< 0.05,Yes,,,,Tsuji 2010
1227,1347,1318,All,University students,Japan,,Day 2,Weighed Dietary record (4-day),Niacin (Niacin Equivalents),"",No,196.0,,,umol/day,,baseline,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,84.5,,,umol/day,,148,Pearson,0.2,,,< 0.05,Yes,,,,Tsuji 2010
1228,1348,1319,All,University students,Japan,,Day 2,Weighed Dietary record (4-day),Pantothenic acid,"",No,24.3,,,umol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus plantarum),Pantothenic acid,"",16.5,,,umol/day,,148,Pearson,0.28,,,< 0.001,Yes,,,,Tsuji 2010
1229,1349,1320,All,University students,Japan,,Day 2,Weighed Dietary record (4-day),Folates,"",No,610.0,,,nmol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus casei),Folates,"",23.1,,,nmol/day,,148,Pearson,0.19,,,< 0.05,Yes,,,,Tsuji 2010
1230,1350,1321,All,University students,Japan,,Day 2,Weighed Dietary record (4-day),Vitamin C,"",No,546.0,,,umol/day,,baseline,"Urine, 24-h",HPLC,Ascorbic acid metabolites,"Ascorbic acid + L-Dehydroascorbic acid + 2,3-Diketogulonic acid",139.0,,,umol/day,,148,Pearson,0.16,,,>= 0.05,No,,,,Tsuji 2010
1231,1351,1313,All,University students,Japan,,Day 1,Weighed Dietary record (4-day),Thiamin,"",No,2.09,,,umol/day,,baseline,"Urine, 24-h",HPLC,Thiamin,"",0.425,,,umol/day,,148,Pearson,0.12,,,>= 0.05,No,,,,Tsuji 2010
1232,1352,1314,All,University students,Japan,,Day 1,Weighed Dietary record (4-day),Riboflavin,"",No,3.17,,,umol/day,,baseline,"Urine, 24-h",HPLC,Riboflavin,"",0.382,,,umol/day,,148,Pearson,0.11,,,>= 0.05,No,,,,Tsuji 2010
1233,1353,1315,All,University students,Japan,,Day 1,Weighed Dietary record (4-day),Vitamin B6,"",No,5.25,,,umol/day,,baseline,"Urine, 24-h",HPLC,4-Pyridoxic acid,"",3.68,,,umol/day,,148,Pearson,0.21,,,< 0.01,Yes,,,,Tsuji 2010
1234,1354,1316,All,University students,Japan,,Day 1,Weighed Dietary record (4-day),Vitamin B12,"",No,3.05,,,nmol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",0.028,,,nmol/day,,148,Pearson,0.1,,,>= 0.05,No,,,,Tsuji 2010
1235,1355,1318,All,University students,Japan,,Day 1,Weighed Dietary record (4-day),Niacin,"",No,93.4,,,umol/day,,baseline,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,84.5,,,umol/day,,148,Pearson,0.22,,,< 0.01,Yes,,,,Tsuji 2010
1236,1356,1318,All,University students,Japan,,Day 1,Weighed Dietary record (4-day),Niacin (Niacin Equivalents),"",No,184.0,,,umol/day,,baseline,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,84.5,,,umol/day,,148,Pearson,0.21,,,< 0.05,Yes,,,,Tsuji 2010
1237,1357,1319,All,University students,Japan,,Day 1,Weighed Dietary record (4-day),Pantothenic acid,"",No,22.7,,,umol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus plantarum),Pantothenic acid,"",16.5,,,umol/day,,148,Pearson,0.1,,,>= 0.05,No,,,,Tsuji 2010
1238,1358,1320,All,University students,Japan,,Day 1,Weighed Dietary record (4-day),Folates,"",No,569.0,,,nmol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus casei),Folates,"",23.1,,,nmol/day,,148,Pearson,0.07,,,>= 0.05,No,,,,Tsuji 2010
1239,1359,1321,All,University students,Japan,,Day 1,Weighed Dietary record (4-day),Vitamin C,"",No,388.0,,,umol/day,,baseline,"Urine, 24-h",HPLC,Ascorbic acid metabolites,"Ascorbic acid + L-Dehydroascorbic acid + 2,3-Diketogulonic acid",139.0,,,umol/day,,148,Pearson,0.22,,,< 0.01,Yes,,,,Tsuji 2010
1240,1360,1313,All,University students,Japan,,,Weighed Dietary record (4-day),Thiamin,"",No,2.32,,,umol/day,,baseline,"Urine, 24-h",HPLC,Thiamin,"",0.425,,,umol/day,,148,Pearson,0.39,,,< 0.001,Yes,,,,Tsuji 2010
1241,1361,1314,All,University students,Japan,,,Weighed Dietary record (4-day),Riboflavin,"",No,3.0,,,umol/day,,baseline,"Urine, 24-h",HPLC,Riboflavin,"",0.382,,,umol/day,,148,Pearson,0.39,,,< 0.001,Yes,,,,Tsuji 2010
1242,1362,1315,All,University students,Japan,,,Weighed Dietary record (4-day),Vitamin B6,"",No,5.5,,,umol/day,,baseline,"Urine, 24-h",HPLC,4-Pyridoxic acid,"",3.68,,,umol/day,,148,Pearson,0.39,,,< 0.001,Yes,,,,Tsuji 2010
1243,1363,1316,All,University students,Japan,,,Weighed Dietary record (4-day),Vitamin B12,"",No,3.23,,,nmol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",0.028,,,nmol/day,,148,Pearson,0.07,,,>= 0.05,No,,,,Tsuji 2010
1244,1364,1318,All,University students,Japan,,,Weighed Dietary record (4-day),Niacin,"",No,94.9,,,umol/day,,baseline,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,84.5,,,umol/day,,148,Pearson,0.33,,,< 0.001,Yes,,,,Tsuji 2010
1245,1365,1318,All,University students,Japan,,,Weighed Dietary record (4-day),Niacin (Niacin Equivalents),"",No,190.0,,,umol/day,,baseline,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,84.5,,,umol/day,,148,Pearson,0.32,,,< 0.001,Yes,,,,Tsuji 2010
1246,1366,1319,All,University students,Japan,,,Weighed Dietary record (4-day),Pantothenic acid,"",No,23.6,,,umol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus plantarum),Pantothenic acid,"",16.5,,,umol/day,,148,Pearson,0.41,,,< 0.001,Yes,,,,Tsuji 2010
1247,1367,1320,All,University students,Japan,,,Weighed Dietary record (4-day),Folates,"",No,588.0,,,nmol/day,,baseline,"Urine, 24-h",Microbioassay (Lactobacillus casei),Folates,"",23.1,,,nmol/day,,148,Pearson,0.24,,,< 0.01,Yes,,,,Tsuji 2010
1248,1368,1321,All,University students,Japan,,,Weighed Dietary record (4-day),Vitamin C,"",No,455.0,,,umol/day,,baseline,"Urine, 24-h",HPLC,Ascorbic acid metabolites,"Ascorbic acid + L-Dehydroascorbic acid + 2,3-Diketogulonic acid",139.0,,,umol/day,,148,Pearson,0.41,,,< 0.001,Yes,,,,Tsuji 2010
1249,1371,1370,Males,Asymptomatic subjects at high risk of coronary artery disease,Spain,PREDIMED (Prevención con Dieta Mediterránea),,Food Frequency Questionnaire (FFQ),Ethanol,Ethanol from Alcoholic beverages,,,,11.8,g/day,,,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Ethyl glucuronide,"",,,239.5,ng/mL,,350,Spearman,0.6,,,< 0.001,Yes,,,,Schroder 2009
1250,1372,1370,Males,Asymptomatic subjects at high risk of coronary artery disease,Spain,PREDIMED (Prevención con Dieta Mediterránea),,Food Frequency Questionnaire (FFQ),Ethanol from Alcoholic beverages,"",,,,10.0,g/day,,,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Ethyl glucuronide,"",,,239.5,ng/mL,,350,Spearman,0.585,,,< 0.001,Yes,,,,Schroder 2009
1251,1373,1370,Males,Asymptomatic subjects at high risk of coronary artery disease,Spain,PREDIMED (Prevención con Dieta Mediterránea),,Food Frequency Questionnaire (FFQ),Ethanol from Alcoholic beverages,"",,,,2.4,g/day,,,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Ethyl glucuronide,"",,,239.5,ng/mL,,350,Spearman,0.442,,,< 0.001,Yes,,,,Schroder 2009
1252,1376,1375,Females,Asymptomatic subjects at high risk of coronary artery disease,Spain,PREDIMED (Prevención con Dieta Mediterránea),,Food Frequency Questionnaire (FFQ),Ethanol,Ethanol from Alcoholic beverages,,,,0.0,g/day,,,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Ethyl glucuronide,"",,,55.0,ng/mL,,421,Spearman,0.348,,,< 0.001,Yes,,,,Schroder 2009
1253,1377,1375,Females,Asymptomatic subjects at high risk of coronary artery disease,Spain,PREDIMED (Prevención con Dieta Mediterránea),,Food Frequency Questionnaire (FFQ),Ethanol from Alcoholic beverages,"",,,,0.0,g/day,,,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Ethyl glucuronide,"",,,55.0,ng/mL,,421,Spearman,0.358,,,< 0.001,Yes,,,,Schroder 2009
1254,1378,1375,Females,Asymptomatic subjects at high risk of coronary artery disease,Spain,PREDIMED (Prevención con Dieta Mediterránea),,Food Frequency Questionnaire (FFQ),Ethanol from Alcoholic beverages,"",,,,0.0,g/day,,,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Ethyl glucuronide,"",,,55.0,ng/mL,,421,Spearman,0.3,,,< 0.001,Yes,,,,Schroder 2009
1255,1442,1450,Males,Participants in a dietary validation study,Sweden,VIP (Vasterbotten Intervention Project),,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Plasma, fasting",Competitive protein-binding assay (CPBA),Folates,"",,,,nmol/L,,96,Spearman,0.24,,,= 0.03,Yes,Energy by residual method,,,Johansson 2010
1259,1446,1452,Males,Participants in a dietary validation study,Sweden,VIP (Vasterbotten Intervention Project),,Food Frequency Questionnaire (FFQ),Vitamin B12,"",No,,,,ug/day,,,"Plasma, fasting",Competitive protein-binding assay (CPBA),Vitamin B12,"",,,,pmol/L,,96,Spearman,0.11,,,= 0.325,No,Energy by residual method,,,Johansson 2010
1256,1443,1450,Males,Participants in a dietary validation study,Sweden,VIP (Vasterbotten Intervention Project),,24-h Dietary recall (1-day),Folates,"",No,,,,ug/day,,,"Plasma, fasting",Competitive protein-binding assay (CPBA),Folates,"",,,,nmol/L,,96,Spearman,0.18,,,= 0.088,No,Energy by residual method,,,Johansson 2010
1260,1447,1452,Males,Participants in a dietary validation study,Sweden,VIP (Vasterbotten Intervention Project),,24-h Dietary recall (1-day),Vitamin B12,"",No,,,,ug/day,,,"Plasma, fasting",Competitive protein-binding assay (CPBA),Vitamin B12,"",,,,pmol/L,,96,Spearman,0.19,,,= 0.077,No,Energy by residual method,,,Johansson 2010
1257,1444,1451,Females,Participants in a dietary validation study,Sweden,VIP (Vasterbotten Intervention Project),,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Plasma, fasting",Competitive protein-binding assay (CPBA),Folates,"",,,,nmol/L,,99,Spearman,0.2,,,= 0.066,No,Energy by residual method,,,Johansson 2010
1261,1448,1453,Females,Participants in a dietary validation study,Sweden,VIP (Vasterbotten Intervention Project),,Food Frequency Questionnaire (FFQ),Vitamin B12,"",No,,,,ug/day,,,"Plasma, fasting",Competitive protein-binding assay (CPBA),Vitamin B12,"",,,,pmol/L,,99,Spearman,0.3,,,= 0.004,Yes,Energy by residual method,,,Johansson 2010
1258,1445,1451,Females,Participants in a dietary validation study,Sweden,VIP (Vasterbotten Intervention Project),,24-h Dietary recall (1-day),Folates,"",No,,,,ug/day,,,"Plasma, fasting",Competitive protein-binding assay (CPBA),Folates,"",,,,nmol/L,,99,Spearman,0.33,,,= 0.001,Yes,Energy by residual method,,,Johansson 2010
1262,1449,1453,Females,Participants in a dietary validation study,Sweden,VIP (Vasterbotten Intervention Project),,24-h Dietary recall (1-day),Vitamin B12,"",No,,,,ug/day,,,"Plasma, fasting",Competitive protein-binding assay (CPBA),Vitamin B12,"",,,,pmol/L,,99,Spearman,0.19,,,= 0.076,No,Energy by residual method,,,Johansson 2010
1263,1536,1537,FFQ 1,Controls in a case-control study on B vitamins and prostate cancer,Sweden,VIP (Vasterbotten Intervention Project),,Food Frequency Questionnaire (FFQ),Folates,"",Yes,,,,ug/day,,,"Plasma, fasting",Microbioassay (Lactobacillus casei),Folates,"",,,,nmol/L,,530,Spearman,0.28,,,< 0.001,Yes,Energy by residual method,,,Johansson 2010
1265,1540,1541,FFQ 1,Controls in a case-control study on B vitamins and prostate cancer,Sweden,VIP (Vasterbotten Intervention Project),,Food Frequency Questionnaire (FFQ),Vitamin B12,"",Yes,,,,ug/day,,,"Plasma, fasting",Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",,,,pmol/L,,530,Spearman,0.15,,,= 0.001,Yes,Energy by residual method,,,Johansson 2010
1267,1544,1545,FFQ 1,Controls in a case-control study on B vitamins and prostate cancer,Sweden,VIP (Vasterbotten Intervention Project),,Food Frequency Questionnaire (FFQ),Riboflavin,"",Yes,,,,mg/day,,,"Plasma, fasting",LC-MS,Riboflavin,"",,,,nmol/L,,530,Spearman,0.13,,,= 0.02,Yes,Energy by residual method,,,Johansson 2010
1269,1548,1549,FFQ 1,Controls in a case-control study on B vitamins and prostate cancer,Sweden,VIP (Vasterbotten Intervention Project),,Food Frequency Questionnaire (FFQ),Vitamin B6,"",Yes,,,,mg/day,,,"Plasma, fasting",LC-MS,Pyridoxal 5'-phosphate,"",,,,nmol/L,,530,Spearman,0.27,,,< 0.001,Yes,Energy by residual method,,,Johansson 2010
1264,1538,1539,FFQ 2,Controls in a case-control study on B vitamins and prostate cancer,Sweden,VIP (Vasterbotten Intervention Project),,Food Frequency Questionnaire (FFQ),Folates,"",Yes,,,,ug/day,,,"Plasma, fasting",Microbioassay (Lactobacillus casei),Folates,"",,,,nmol/L,,340,Spearman,0.31,,,< 0.001,Yes,Energy by residual method,,,Johansson 2010
1266,1542,1543,FFQ 2,Controls in a case-control study on B vitamins and prostate cancer,Sweden,VIP (Vasterbotten Intervention Project),,Food Frequency Questionnaire (FFQ),Vitamin B12,"",Yes,,,,ug/day,,,"Plasma, fasting",Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",,,,pmol/L,,340,Spearman,0.18,,,= 0.001,Yes,Energy by residual method,,,Johansson 2010
1268,1546,1547,FFQ 2,Controls in a case-control study on B vitamins and prostate cancer,Sweden,VIP (Vasterbotten Intervention Project),,Food Frequency Questionnaire (FFQ),Riboflavin,"",Yes,,,,mg/day,,,"Plasma, fasting",LC-MS,Riboflavin,"",,,,nmol/L,,340,Spearman,0.28,,,< 0.001,Yes,Energy by residual method,,,Johansson 2010
1270,1550,1551,FFQ 2,Controls in a case-control study on B vitamins and prostate cancer,Sweden,VIP (Vasterbotten Intervention Project),,Food Frequency Questionnaire (FFQ),Vitamin B6,"",Yes,,,,mg/day,,,"Plasma, fasting",LC-MS,Pyridoxal 5'-phosphate,"",,,,nmol/L,,340,Spearman,0.24,,,< 0.001,Yes,Energy by residual method,,,Johansson 2010
1271,1561,1563,All,Pregnant women in Ljubljana and surroundings,Slovenia,,pregnancy,Food Frequency Questionnaire (FFQ),Fish,Tuna + Cod + Gilt-head bream + Sea bass + Trout-family fish,,6.3,,6.0,portions/month,,pregnancy,Hair,Atomic absorption spectrometry (AAS),Mercury,"",377.0,,297.0,ng/g,,574,Spearman,0.35,0.28,0.42,< 0.05,Yes,,,,Miklavcic 2011
1272,1561,1562,All,Pregnant women in Ljubljana and surroundings,Slovenia,,pregnancy,Food Frequency Questionnaire (FFQ),Fish,Tuna + Cod + Gilt-head bream + Sea bass + Trout-family fish,,6.3,,6.0,portions/month,,delivery,Cord blood,Atomic absorption spectrometry (AAS),Mercury,"",2.0,,1.5,ng/g,,446,Spearman,0.43,0.36,0.51,< 0.05,Yes,,,,Miklavcic 2011
1273,1561,1564,All,Pregnant women in Ljubljana and surroundings,Slovenia,,pregnancy,Food Frequency Questionnaire (FFQ),Fish,Tuna + Cod + Gilt-head bream + Sea bass + Trout-family fish,,6.3,,6.0,portions/month,,delivery + 1 to 2 months,Breast milk,Atomic absorption spectrometry (AAS),Mercury,"",0.3,,0.2,ng/g,,284,Spearman,0.08,-0.04,0.2,>= 0.05,No,,,,Miklavcic 2011
1274,1561,1565,All,Pregnant women in Ljubljana and surroundings,Slovenia,,pregnancy,Food Frequency Questionnaire (FFQ),Fish,Tuna + Cod + Gilt-head bream + Sea bass + Trout-family fish,,6.3,,6.0,portions/month,,delivery,Cord blood,Atomic absorption spectrometry (AAS),Methylmercury,"",,,,ng/g,,446,Spearman,0.31,0.06,0.52,< 0.05,Yes,,,,Miklavcic 2011
1275,14401,1563,All,Pregnant women in Ljubljana and surroundings,Slovenia,,pregnancy,Food Frequency Questionnaire (FFQ),Mercury,"",,,,,missing unit,,pregnancy,Hair,Atomic absorption spectrometry (AAS),Mercury,"",377.0,,297.0,ng/g,,574,Spearman,0.41,0.32,0.5,< 0.05,Yes,,,,Miklavcic 2011
1276,14401,1562,All,Pregnant women in Ljubljana and surroundings,Slovenia,,pregnancy,Food Frequency Questionnaire (FFQ),Mercury,"",,,,,missing unit,,delivery,Cord blood,Atomic absorption spectrometry (AAS),Mercury,"",2.0,,1.5,ng/g,,446,Spearman,0.42,0.32,0.5,< 0.05,Yes,,,,Miklavcic 2011
1277,14401,1564,All,Pregnant women in Ljubljana and surroundings,Slovenia,,pregnancy,Food Frequency Questionnaire (FFQ),Mercury,"",,,,,missing unit,,delivery + 1 to 2 months,Breast milk,Atomic absorption spectrometry (AAS),Mercury,"",0.3,,0.2,ng/g,,284,Spearman,0.14,0.02,0.25,< 0.05,Yes,,,,Miklavcic 2011
1278,14401,1565,All,Pregnant women in Ljubljana and surroundings,Slovenia,,pregnancy,Food Frequency Questionnaire (FFQ),Mercury,"",,,,,missing unit,,delivery,Cord blood,Atomic absorption spectrometry (AAS),Methylmercury,"",,,,ng/g,,446,Spearman,0.42,0.16,0.63,< 0.05,Yes,,,,Miklavcic 2011
1285,1566,1573,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,80.0,,,g/day,,,"Serum, fasting",GC-HRMS,"2,3,4,7,8-PeCDF","",85.0,,,pg/g,Fat,125,Spearman,0.47,,, ,Unspecified,Age,,,Turunen 2010
1291,1566,1574,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,80.0,,,g/day,,,"Serum, fasting",GC-HRMS,OCDD,"",320.0,,,pg/g,Fat,125,Spearman,0.19,,, ,Unspecified,Age,,,Turunen 2010
1303,1566,1576,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,80.0,,,g/day,,,"Serum, fasting",GC-HRMS,PCB-126,"",190.0,,,pg/g,Fat,125,Spearman,0.5,,, ,Unspecified,Age,,,Turunen 2010
1309,1566,1577,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,80.0,,,g/day,,,"Serum, fasting",GC-HRMS,PCB-153,"",410.0,,,ng/g,Fat,125,Spearman,0.41,,, ,Unspecified,Age,,,Turunen 2010
1315,1566,1578,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,80.0,,,g/day,,,"Whole blood, fasting",GC-ID-MS,Methylmercury,"",5.2,,,ng/mL,,125,Spearman,0.43,,, ,Unspecified,Age,,,Turunen 2010
1363,1566,1579,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,80.0,,,g/day,,,"Serum, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),6.8,,,percentRoot,,125,Spearman,0.38,,, ,Unspecified,Age,,,Turunen 2010
1369,1566,1580,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,80.0,,,g/day,,,"Serum, fasting",GC-FID,EPA (cis-20:5n-3),"",2.2,,,percentRoot,,125,Spearman,0.36,,, ,Unspecified,Age,,,Turunen 2010
1375,1566,1581,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,80.0,,,g/day,,,"Serum, fasting",GC-FID,DHA (cis-22:6n-3),"",3.9,,,percentRoot,,125,Spearman,0.37,,, ,Unspecified,Age,,,Turunen 2010
1381,1566,1583,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,80.0,,,g/day,,,"Serum, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.9,,,percentRoot,,125,Spearman,0.0,,, ,Unspecified,Age,,,Turunen 2010
1387,1566,1584,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,80.0,,,g/day,,,"Serum, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),30.0,,,percentRoot,,125,Spearman,-0.05,,, ,Unspecified,Age,,,Turunen 2010
1286,1567,1573,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,1.3,,,g/day,,,"Serum, fasting",GC-HRMS,"2,3,4,7,8-PeCDF","",85.0,,,pg/g,Fat,125,Spearman,0.45,,, ,Unspecified,Age,,,Turunen 2010
1292,1567,1574,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,1.3,,,g/day,,,"Serum, fasting",GC-HRMS,OCDD,"",320.0,,,pg/g,Fat,125,Spearman,0.16,,, ,Unspecified,Age,,,Turunen 2010
1304,1567,1576,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,1.3,,,g/day,,,"Serum, fasting",GC-HRMS,PCB-126,"",190.0,,,pg/g,Fat,125,Spearman,0.48,,, ,Unspecified,Age,,,Turunen 2010
1310,1567,1577,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,1.3,,,g/day,,,"Serum, fasting",GC-HRMS,PCB-153,"",410.0,,,ng/g,Fat,125,Spearman,0.35,,, ,Unspecified,Age,,,Turunen 2010
1316,1567,1578,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,1.3,,,g/day,,,"Whole blood, fasting",GC-ID-MS,Methylmercury,"",5.2,,,ng/mL,,125,Spearman,0.36,,, ,Unspecified,Age,,,Turunen 2010
1364,1567,1579,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,1.3,,,g/day,,,"Serum, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),6.8,,,percentRoot,,125,Spearman,0.43,,, ,Unspecified,Age,,,Turunen 2010
1370,1567,1580,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,1.3,,,g/day,,,"Serum, fasting",GC-FID,EPA (cis-20:5n-3),"",2.2,,,percentRoot,,125,Spearman,0.42,,, ,Unspecified,Age,,,Turunen 2010
1376,1567,1581,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,1.3,,,g/day,,,"Serum, fasting",GC-FID,DHA (cis-22:6n-3),"",3.9,,,percentRoot,,125,Spearman,0.4,,, ,Unspecified,Age,,,Turunen 2010
1382,1567,1583,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,1.3,,,g/day,,,"Serum, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.9,,,percentRoot,,125,Spearman,-0.01,,, ,Unspecified,Age,,,Turunen 2010
1388,1567,1584,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,1.3,,,g/day,,,"Serum, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),30.0,,,percentRoot,,125,Spearman,-0.03,,, ,Unspecified,Age,,,Turunen 2010
1287,1568,1573,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,14.0,,,times/month,,,"Serum, fasting",GC-HRMS,"2,3,4,7,8-PeCDF","",85.0,,,pg/g,Fat,125,Spearman,0.42,,, ,Unspecified,Age,,,Turunen 2010
1293,1568,1574,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,14.0,,,times/month,,,"Serum, fasting",GC-HRMS,OCDD,"",320.0,,,pg/g,Fat,125,Spearman,0.08,,, ,Unspecified,Age,,,Turunen 2010
1305,1568,1576,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,14.0,,,times/month,,,"Serum, fasting",GC-HRMS,PCB-126,"",190.0,,,pg/g,Fat,125,Spearman,0.41,,, ,Unspecified,Age,,,Turunen 2010
1311,1568,1577,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,14.0,,,times/month,,,"Serum, fasting",GC-HRMS,PCB-153,"",410.0,,,ng/g,Fat,125,Spearman,0.4,,, ,Unspecified,Age,,,Turunen 2010
1317,1568,1578,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,14.0,,,times/month,,,"Whole blood, fasting",GC-ID-MS,Methylmercury,"",5.2,,,ng/mL,,125,Spearman,0.39,,, ,Unspecified,Age,,,Turunen 2010
1365,1568,1579,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,14.0,,,times/month,,,"Serum, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),6.8,,,percentRoot,,125,Spearman,0.35,,, ,Unspecified,Age,,,Turunen 2010
1371,1568,1580,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,14.0,,,times/month,,,"Serum, fasting",GC-FID,EPA (cis-20:5n-3),"",2.2,,,percentRoot,,125,Spearman,0.34,,, ,Unspecified,Age,,,Turunen 2010
1377,1568,1581,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,14.0,,,times/month,,,"Serum, fasting",GC-FID,DHA (cis-22:6n-3),"",3.9,,,percentRoot,,125,Spearman,0.35,,, ,Unspecified,Age,,,Turunen 2010
1383,1568,1583,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,14.0,,,times/month,,,"Serum, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.9,,,percentRoot,,125,Spearman,-0.06,,, ,Unspecified,Age,,,Turunen 2010
1389,1568,1584,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,14.0,,,times/month,,,"Serum, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),30.0,,,percentRoot,,125,Spearman,-0.04,,, ,Unspecified,Age,,,Turunen 2010
1288,1569,1573,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,Fatty fish + Lean fish,,14.0,,,times/month,,,"Serum, fasting",GC-HRMS,"2,3,4,7,8-PeCDF","",85.0,,,pg/g,Fat,125,Spearman,0.45,,, ,Unspecified,Age,,,Turunen 2010
1294,1569,1574,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,Fatty fish + Lean fish,,14.0,,,times/month,,,"Serum, fasting",GC-HRMS,OCDD,"",320.0,,,pg/g,Fat,125,Spearman,0.07,,, ,Unspecified,Age,,,Turunen 2010
1306,1569,1576,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,Fatty fish + Lean fish,,14.0,,,times/month,,,"Serum, fasting",GC-HRMS,PCB-126,"",190.0,,,pg/g,Fat,125,Spearman,0.44,,, ,Unspecified,Age,,,Turunen 2010
1312,1569,1577,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,Fatty fish + Lean fish,,14.0,,,times/month,,,"Serum, fasting",GC-HRMS,PCB-153,"",410.0,,,ng/g,Fat,125,Spearman,0.42,,, ,Unspecified,Age,,,Turunen 2010
1318,1569,1578,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,Fatty fish + Lean fish,,14.0,,,times/month,,,"Whole blood, fasting",GC-ID-MS,Methylmercury,"",5.2,,,ng/mL,,125,Spearman,0.4,,, ,Unspecified,Age,,,Turunen 2010
1366,1569,1579,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,Fatty fish + Lean fish,,14.0,,,times/month,,,"Serum, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),6.8,,,percentRoot,,125,Spearman,0.32,,, ,Unspecified,Age,,,Turunen 2010
1372,1569,1580,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,Fatty fish + Lean fish,,14.0,,,times/month,,,"Serum, fasting",GC-FID,EPA (cis-20:5n-3),"",2.2,,,percentRoot,,125,Spearman,0.33,,, ,Unspecified,Age,,,Turunen 2010
1378,1569,1581,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,Fatty fish + Lean fish,,14.0,,,times/month,,,"Serum, fasting",GC-FID,DHA (cis-22:6n-3),"",3.9,,,percentRoot,,125,Spearman,0.33,,, ,Unspecified,Age,,,Turunen 2010
1384,1569,1583,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,Fatty fish + Lean fish,,14.0,,,times/month,,,"Serum, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.9,,,percentRoot,,125,Spearman,-0.01,,, ,Unspecified,Age,,,Turunen 2010
1390,1569,1584,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,Fatty fish + Lean fish,,14.0,,,times/month,,,"Serum, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),30.0,,,percentRoot,,125,Spearman,-0.1,,, ,Unspecified,Age,,,Turunen 2010
1289,1570,1573,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fatty fish,"",,7.3,,,times/month,,,"Serum, fasting",GC-HRMS,"2,3,4,7,8-PeCDF","",85.0,,,pg/g,Fat,125,Spearman,0.42,,, ,Unspecified,Age,,,Turunen 2010
1295,1570,1574,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fatty fish,"",,7.3,,,times/month,,,"Serum, fasting",GC-HRMS,OCDD,"",320.0,,,pg/g,Fat,125,Spearman,0.08,,, ,Unspecified,Age,,,Turunen 2010
1307,1570,1576,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fatty fish,"",,7.3,,,times/month,,,"Serum, fasting",GC-HRMS,PCB-126,"",190.0,,,pg/g,Fat,125,Spearman,0.39,,, ,Unspecified,Age,,,Turunen 2010
1313,1570,1577,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fatty fish,"",,7.3,,,times/month,,,"Serum, fasting",GC-HRMS,PCB-153,"",410.0,,,ng/g,Fat,125,Spearman,0.33,,, ,Unspecified,Age,,,Turunen 2010
1319,1570,1578,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fatty fish,"",,7.3,,,times/month,,,"Whole blood, fasting",GC-ID-MS,Methylmercury,"",5.2,,,ng/mL,,125,Spearman,0.22,,, ,Unspecified,Age,,,Turunen 2010
1367,1570,1579,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fatty fish,"",,7.3,,,times/month,,,"Serum, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),6.8,,,percentRoot,,125,Spearman,0.36,,, ,Unspecified,Age,,,Turunen 2010
1373,1570,1580,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fatty fish,"",,7.3,,,times/month,,,"Serum, fasting",GC-FID,EPA (cis-20:5n-3),"",2.2,,,percentRoot,,125,Spearman,0.35,,, ,Unspecified,Age,,,Turunen 2010
1379,1570,1581,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fatty fish,"",,7.3,,,times/month,,,"Serum, fasting",GC-FID,DHA (cis-22:6n-3),"",3.9,,,percentRoot,,125,Spearman,0.36,,, ,Unspecified,Age,,,Turunen 2010
1385,1570,1583,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fatty fish,"",,7.3,,,times/month,,,"Serum, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.9,,,percentRoot,,125,Spearman,-0.09,,, ,Unspecified,Age,,,Turunen 2010
1391,1570,1584,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fatty fish,"",,7.3,,,times/month,,,"Serum, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),30.0,,,percentRoot,,125,Spearman,0.04,,, ,Unspecified,Age,,,Turunen 2010
1290,1571,1573,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Lean fish,"",,4.8,,,times/month,,,"Serum, fasting",GC-HRMS,"2,3,4,7,8-PeCDF","",85.0,,,pg/g,Fat,125,Spearman,0.13,,, ,Unspecified,Age,,,Turunen 2010
1296,1571,1574,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Lean fish,"",,4.8,,,times/month,,,"Serum, fasting",GC-HRMS,OCDD,"",320.0,,,pg/g,Fat,125,Spearman,0.03,,, ,Unspecified,Age,,,Turunen 2010
1308,1571,1576,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Lean fish,"",,4.8,,,times/month,,,"Serum, fasting",GC-HRMS,PCB-126,"",190.0,,,pg/g,Fat,125,Spearman,0.21,,, ,Unspecified,Age,,,Turunen 2010
1314,1571,1577,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Lean fish,"",,4.8,,,times/month,,,"Serum, fasting",GC-HRMS,PCB-153,"",410.0,,,ng/g,Fat,125,Spearman,0.19,,, ,Unspecified,Age,,,Turunen 2010
1320,1571,1578,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Lean fish,"",,4.8,,,times/month,,,"Whole blood, fasting",GC-ID-MS,Methylmercury,"",5.2,,,ng/mL,,125,Spearman,0.21,,, ,Unspecified,Age,,,Turunen 2010
1368,1571,1579,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Lean fish,"",,4.8,,,times/month,,,"Serum, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),6.8,,,percentRoot,,125,Spearman,0.09,,, ,Unspecified,Age,,,Turunen 2010
1374,1571,1580,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Lean fish,"",,4.8,,,times/month,,,"Serum, fasting",GC-FID,EPA (cis-20:5n-3),"",2.2,,,percentRoot,,125,Spearman,0.14,,, ,Unspecified,Age,,,Turunen 2010
1380,1571,1581,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Lean fish,"",,4.8,,,times/month,,,"Serum, fasting",GC-FID,DHA (cis-22:6n-3),"",3.9,,,percentRoot,,125,Spearman,0.1,,, ,Unspecified,Age,,,Turunen 2010
1386,1571,1583,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Lean fish,"",,4.8,,,times/month,,,"Serum, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.9,,,percentRoot,,125,Spearman,0.08,,, ,Unspecified,Age,,,Turunen 2010
1392,1571,1584,Males,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Lean fish,"",,4.8,,,times/month,,,"Serum, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),30.0,,,percentRoot,,125,Spearman,-0.19,,, ,Unspecified,Age,,,Turunen 2010
1327,1585,1592,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,61.0,,,g/day,,,"Serum, fasting",GC-HRMS,"2,3,4,7,8-PeCDF","",46.0,,,pg/g,Fat,139,Spearman,0.34,,, ,Unspecified,Age,,,Turunen 2010
1333,1585,1593,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,61.0,,,g/day,,,"Serum, fasting",GC-HRMS,OCDD,"",410.0,,,pg/g,Fat,139,Spearman,-0.11,,, ,Unspecified,Age,,,Turunen 2010
1345,1585,1595,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,61.0,,,g/day,,,"Serum, fasting",GC-HRMS,PCB-126,"",120.0,,,pg/g,Fat,139,Spearman,0.32,,, ,Unspecified,Age,,,Turunen 2010
1351,1585,1596,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,61.0,,,g/day,,,"Serum, fasting",GC-HRMS,PCB-153,"",200.0,,,ng/g,Fat,139,Spearman,0.31,,, ,Unspecified,Age,,,Turunen 2010
1357,1585,1597,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,61.0,,,g/day,,,"Whole blood, fasting",GC-ID-MS,Methylmercury,"",2.9,,,ng/mL,,139,Spearman,0.45,,, ,Unspecified,Age,,,Turunen 2010
1393,1585,1598,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,61.0,,,g/day,,,"Serum, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),6.8,,,percentRoot,,139,Spearman,0.31,,, ,Unspecified,Age,,,Turunen 2010
1399,1585,1599,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,61.0,,,g/day,,,"Serum, fasting",GC-FID,EPA (cis-20:5n-3),"",1.8,,,percentRoot,,139,Spearman,0.19,,, ,Unspecified,Age,,,Turunen 2010
1405,1585,1600,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,61.0,,,g/day,,,"Serum, fasting",GC-FID,DHA (cis-22:6n-3),"",4.4,,,percentRoot,,139,Spearman,0.29,,, ,Unspecified,Age,,,Turunen 2010
1411,1585,1602,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,61.0,,,g/day,,,"Serum, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.89,,,percentRoot,,139,Spearman,0.01,,, ,Unspecified,Age,,,Turunen 2010
1417,1585,1603,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,61.0,,,g/day,,,"Serum, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),31.0,,,percentRoot,,139,Spearman,0.02,,, ,Unspecified,Age,,,Turunen 2010
1328,1586,1592,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,0.97,,,g/day,,,"Serum, fasting",GC-HRMS,"2,3,4,7,8-PeCDF","",46.0,,,pg/g,Fat,139,Spearman,0.26,,, ,Unspecified,Age,,,Turunen 2010
1334,1586,1593,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,0.97,,,g/day,,,"Serum, fasting",GC-HRMS,OCDD,"",410.0,,,pg/g,Fat,139,Spearman,-0.09,,, ,Unspecified,Age,,,Turunen 2010
1346,1586,1595,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,0.97,,,g/day,,,"Serum, fasting",GC-HRMS,PCB-126,"",120.0,,,pg/g,Fat,139,Spearman,0.23,,, ,Unspecified,Age,,,Turunen 2010
1352,1586,1596,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,0.97,,,g/day,,,"Serum, fasting",GC-HRMS,PCB-153,"",200.0,,,ng/g,Fat,139,Spearman,0.23,,, ,Unspecified,Age,,,Turunen 2010
1358,1586,1597,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,0.97,,,g/day,,,"Whole blood, fasting",GC-ID-MS,Methylmercury,"",2.9,,,ng/mL,,139,Spearman,0.31,,, ,Unspecified,Age,,,Turunen 2010
1394,1586,1598,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,0.97,,,g/day,,,"Serum, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),6.8,,,percentRoot,,139,Spearman,0.32,,, ,Unspecified,Age,,,Turunen 2010
1400,1586,1599,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,0.97,,,g/day,,,"Serum, fasting",GC-FID,EPA (cis-20:5n-3),"",1.8,,,percentRoot,,139,Spearman,0.27,,, ,Unspecified,Age,,,Turunen 2010
1406,1586,1600,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,0.97,,,g/day,,,"Serum, fasting",GC-FID,DHA (cis-22:6n-3),"",4.4,,,percentRoot,,139,Spearman,0.27,,, ,Unspecified,Age,,,Turunen 2010
1412,1586,1602,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,0.97,,,g/day,,,"Serum, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.89,,,percentRoot,,139,Spearman,-0.01,,, ,Unspecified,Age,,,Turunen 2010
1418,1586,1603,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,0.97,,,g/day,,,"Serum, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),31.0,,,percentRoot,,139,Spearman,0.0,,, ,Unspecified,Age,,,Turunen 2010
1329,1587,1592,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,12.0,,,times/month,,,"Serum, fasting",GC-HRMS,"2,3,4,7,8-PeCDF","",46.0,,,pg/g,Fat,139,Spearman,0.44,,, ,Unspecified,Age,,,Turunen 2010
1335,1587,1593,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,12.0,,,times/month,,,"Serum, fasting",GC-HRMS,OCDD,"",410.0,,,pg/g,Fat,139,Spearman,0.08,,, ,Unspecified,Age,,,Turunen 2010
1347,1587,1595,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,12.0,,,times/month,,,"Serum, fasting",GC-HRMS,PCB-126,"",120.0,,,pg/g,Fat,139,Spearman,0.45,,, ,Unspecified,Age,,,Turunen 2010
1353,1587,1596,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,12.0,,,times/month,,,"Serum, fasting",GC-HRMS,PCB-153,"",200.0,,,ng/g,Fat,139,Spearman,0.4,,, ,Unspecified,Age,,,Turunen 2010
1359,1587,1597,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,12.0,,,times/month,,,"Whole blood, fasting",GC-ID-MS,Methylmercury,"",2.9,,,ng/mL,,139,Spearman,0.5,,, ,Unspecified,Age,,,Turunen 2010
1395,1587,1598,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,12.0,,,times/month,,,"Serum, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),6.8,,,percentRoot,,139,Spearman,0.34,,, ,Unspecified,Age,,,Turunen 2010
1401,1587,1599,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,12.0,,,times/month,,,"Serum, fasting",GC-FID,EPA (cis-20:5n-3),"",1.8,,,percentRoot,,139,Spearman,0.34,,, ,Unspecified,Age,,,Turunen 2010
1407,1587,1600,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,12.0,,,times/month,,,"Serum, fasting",GC-FID,DHA (cis-22:6n-3),"",4.4,,,percentRoot,,139,Spearman,0.27,,, ,Unspecified,Age,,,Turunen 2010
1413,1587,1602,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,12.0,,,times/month,,,"Serum, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.89,,,percentRoot,,139,Spearman,0.04,,, ,Unspecified,Age,,,Turunen 2010
1419,1587,1603,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,12.0,,,times/month,,,"Serum, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),31.0,,,percentRoot,,139,Spearman,-0.05,,, ,Unspecified,Age,,,Turunen 2010
1330,1588,1592,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,Fatty fish + Lean fish,,12.0,,,times/month,,,"Serum, fasting",GC-HRMS,"2,3,4,7,8-PeCDF","",46.0,,,pg/g,Fat,139,Spearman,0.32,,, ,Unspecified,Age,,,Turunen 2010
1336,1588,1593,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,Fatty fish + Lean fish,,12.0,,,times/month,,,"Serum, fasting",GC-HRMS,OCDD,"",410.0,,,pg/g,Fat,139,Spearman,0.02,,, ,Unspecified,Age,,,Turunen 2010
1348,1588,1595,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,Fatty fish + Lean fish,,12.0,,,times/month,,,"Serum, fasting",GC-HRMS,PCB-126,"",120.0,,,pg/g,Fat,139,Spearman,0.35,,, ,Unspecified,Age,,,Turunen 2010
1354,1588,1596,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,Fatty fish + Lean fish,,12.0,,,times/month,,,"Serum, fasting",GC-HRMS,PCB-153,"",200.0,,,ng/g,Fat,139,Spearman,0.27,,, ,Unspecified,Age,,,Turunen 2010
1360,1588,1597,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,Fatty fish + Lean fish,,12.0,,,times/month,,,"Whole blood, fasting",GC-ID-MS,Methylmercury,"",2.9,,,ng/mL,,139,Spearman,0.42,,, ,Unspecified,Age,,,Turunen 2010
1396,1588,1598,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,Fatty fish + Lean fish,,12.0,,,times/month,,,"Serum, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),6.8,,,percentRoot,,139,Spearman,0.2,,, ,Unspecified,Age,,,Turunen 2010
1402,1588,1599,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,Fatty fish + Lean fish,,12.0,,,times/month,,,"Serum, fasting",GC-FID,EPA (cis-20:5n-3),"",1.8,,,percentRoot,,139,Spearman,0.24,,, ,Unspecified,Age,,,Turunen 2010
1408,1588,1600,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,Fatty fish + Lean fish,,12.0,,,times/month,,,"Serum, fasting",GC-FID,DHA (cis-22:6n-3),"",4.4,,,percentRoot,,139,Spearman,0.16,,, ,Unspecified,Age,,,Turunen 2010
1414,1588,1602,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,Fatty fish + Lean fish,,12.0,,,times/month,,,"Serum, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.89,,,percentRoot,,139,Spearman,-0.02,,, ,Unspecified,Age,,,Turunen 2010
1420,1588,1603,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fish,Fatty fish + Lean fish,,12.0,,,times/month,,,"Serum, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),31.0,,,percentRoot,,139,Spearman,-0.03,,, ,Unspecified,Age,,,Turunen 2010
1331,1589,1592,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fatty fish,"",,5.9,,,times/month,,,"Serum, fasting",GC-HRMS,"2,3,4,7,8-PeCDF","",46.0,,,pg/g,Fat,139,Spearman,0.32,,, ,Unspecified,Age,,,Turunen 2010
1337,1589,1593,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fatty fish,"",,5.9,,,times/month,,,"Serum, fasting",GC-HRMS,OCDD,"",410.0,,,pg/g,Fat,139,Spearman,-0.14,,, ,Unspecified,Age,,,Turunen 2010
1349,1589,1595,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fatty fish,"",,5.9,,,times/month,,,"Serum, fasting",GC-HRMS,PCB-126,"",120.0,,,pg/g,Fat,139,Spearman,0.29,,, ,Unspecified,Age,,,Turunen 2010
1355,1589,1596,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fatty fish,"",,5.9,,,times/month,,,"Serum, fasting",GC-HRMS,PCB-153,"",200.0,,,ng/g,Fat,139,Spearman,0.23,,, ,Unspecified,Age,,,Turunen 2010
1361,1589,1597,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fatty fish,"",,5.9,,,times/month,,,"Whole blood, fasting",GC-ID-MS,Methylmercury,"",2.9,,,ng/mL,,139,Spearman,0.27,,, ,Unspecified,Age,,,Turunen 2010
1397,1589,1598,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fatty fish,"",,5.9,,,times/month,,,"Serum, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),6.8,,,percentRoot,,139,Spearman,0.25,,, ,Unspecified,Age,,,Turunen 2010
1403,1589,1599,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fatty fish,"",,5.9,,,times/month,,,"Serum, fasting",GC-FID,EPA (cis-20:5n-3),"",1.8,,,percentRoot,,139,Spearman,0.38,,, ,Unspecified,Age,,,Turunen 2010
1409,1589,1600,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fatty fish,"",,5.9,,,times/month,,,"Serum, fasting",GC-FID,DHA (cis-22:6n-3),"",4.4,,,percentRoot,,139,Spearman,0.18,,, ,Unspecified,Age,,,Turunen 2010
1415,1589,1602,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fatty fish,"",,5.9,,,times/month,,,"Serum, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.89,,,percentRoot,,139,Spearman,0.12,,, ,Unspecified,Age,,,Turunen 2010
1421,1589,1603,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Fatty fish,"",,5.9,,,times/month,,,"Serum, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),31.0,,,percentRoot,,139,Spearman,-0.08,,, ,Unspecified,Age,,,Turunen 2010
1332,1590,1592,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Lean fish,"",,5.0,,,times/month,,,"Serum, fasting",GC-HRMS,"2,3,4,7,8-PeCDF","",46.0,,,pg/g,Fat,139,Spearman,0.18,,, ,Unspecified,Age,,,Turunen 2010
1338,1590,1593,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Lean fish,"",,5.0,,,times/month,,,"Serum, fasting",GC-HRMS,OCDD,"",410.0,,,pg/g,Fat,139,Spearman,0.1,,, ,Unspecified,Age,,,Turunen 2010
1350,1590,1595,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Lean fish,"",,5.0,,,times/month,,,"Serum, fasting",GC-HRMS,PCB-126,"",120.0,,,pg/g,Fat,139,Spearman,0.21,,, ,Unspecified,Age,,,Turunen 2010
1356,1590,1596,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Lean fish,"",,5.0,,,times/month,,,"Serum, fasting",GC-HRMS,PCB-153,"",200.0,,,ng/g,Fat,139,Spearman,0.2,,, ,Unspecified,Age,,,Turunen 2010
1362,1590,1597,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Lean fish,"",,5.0,,,times/month,,,"Whole blood, fasting",GC-ID-MS,Methylmercury,"",2.9,,,ng/mL,,139,Spearman,0.29,,, ,Unspecified,Age,,,Turunen 2010
1398,1590,1598,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Lean fish,"",,5.0,,,times/month,,,"Serum, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),6.8,,,percentRoot,,139,Spearman,0.04,,, ,Unspecified,Age,,,Turunen 2010
1404,1590,1599,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Lean fish,"",,5.0,,,times/month,,,"Serum, fasting",GC-FID,EPA (cis-20:5n-3),"",1.8,,,percentRoot,,139,Spearman,0.07,,, ,Unspecified,Age,,,Turunen 2010
1410,1590,1600,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Lean fish,"",,5.0,,,times/month,,,"Serum, fasting",GC-FID,DHA (cis-22:6n-3),"",4.4,,,percentRoot,,139,Spearman,0.01,,, ,Unspecified,Age,,,Turunen 2010
1416,1590,1602,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Lean fish,"",,5.0,,,times/month,,,"Serum, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.89,,,percentRoot,,139,Spearman,-0.11,,, ,Unspecified,Age,,,Turunen 2010
1422,1590,1603,Females,Professional fishermen and their families,Finland,Fishermen Study,baseline,Food Frequency Questionnaire (FFQ),Lean fish,"",,5.0,,,times/month,,,"Serum, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),31.0,,,percentRoot,,139,Spearman,0.03,,, ,Unspecified,Age,,,Turunen 2010
1423,1604,1606,Males,Subjects with data on fish consumption,Finland,Health 2000,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,48.0,,,g/day,,,"Serum, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),3.9,,,percentRoot,,577,Spearman,0.35,,, ,Unspecified,Age,,,Turunen 2010
1425,1604,1607,Males,Subjects with data on fish consumption,Finland,Health 2000,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,48.0,,,g/day,,,"Serum, fasting",GC-FID,EPA (cis-20:5n-3),"",1.2,,,percentRoot,,577,Spearman,0.29,,, ,Unspecified,Age,,,Turunen 2010
1427,1604,1608,Males,Subjects with data on fish consumption,Finland,Health 2000,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,48.0,,,g/day,,,"Serum, fasting",GC-FID,DHA (cis-22:6n-3),"",2.2,,,percentRoot,,577,Spearman,0.37,,, ,Unspecified,Age,,,Turunen 2010
1429,1604,1610,Males,Subjects with data on fish consumption,Finland,Health 2000,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,48.0,,,g/day,,,"Serum, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.81,,,percentRoot,,577,Spearman,0.02,,, ,Unspecified,Age,,,Turunen 2010
1431,1604,1611,Males,Subjects with data on fish consumption,Finland,Health 2000,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,48.0,,,g/day,,,"Serum, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),32.0,,,percentRoot,,577,Spearman,0.03,,, ,Unspecified,Age,,,Turunen 2010
1424,1605,1606,Males,Subjects with data on fish consumption,Finland,Health 2000,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,0.85,,,g/day,,,"Serum, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),3.9,,,percentRoot,,577,Spearman,0.35,,, ,Unspecified,Age,,,Turunen 2010
1426,1605,1607,Males,Subjects with data on fish consumption,Finland,Health 2000,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,0.85,,,g/day,,,"Serum, fasting",GC-FID,EPA (cis-20:5n-3),"",1.2,,,percentRoot,,577,Spearman,0.29,,, ,Unspecified,Age,,,Turunen 2010
1428,1605,1608,Males,Subjects with data on fish consumption,Finland,Health 2000,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,0.85,,,g/day,,,"Serum, fasting",GC-FID,DHA (cis-22:6n-3),"",2.2,,,percentRoot,,577,Spearman,0.38,,, ,Unspecified,Age,,,Turunen 2010
1430,1605,1610,Males,Subjects with data on fish consumption,Finland,Health 2000,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,0.85,,,g/day,,,"Serum, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.81,,,percentRoot,,577,Spearman,0.02,,, ,Unspecified,Age,,,Turunen 2010
1432,1605,1611,Males,Subjects with data on fish consumption,Finland,Health 2000,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,0.85,,,g/day,,,"Serum, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),32.0,,,percentRoot,,577,Spearman,0.02,,, ,Unspecified,Age,,,Turunen 2010
1433,1612,1614,Females,Subjects with data on fish consumption,Finland,Health 2000,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,46.0,,,g/day,,,"Serum, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),4.0,,,percentRoot,,712,Spearman,0.27,,, ,Unspecified,Age,,,Turunen 2010
1435,1612,1615,Females,Subjects with data on fish consumption,Finland,Health 2000,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,46.0,,,g/day,,,"Serum, fasting",GC-FID,EPA (cis-20:5n-3),"",1.2,,,percentRoot,,712,Spearman,0.26,,, ,Unspecified,Age,,,Turunen 2010
1437,1612,1616,Females,Subjects with data on fish consumption,Finland,Health 2000,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,46.0,,,g/day,,,"Serum, fasting",GC-FID,DHA (cis-22:6n-3),"",2.2,,,percentRoot,,712,Spearman,0.26,,, ,Unspecified,Age,,,Turunen 2010
1439,1612,1618,Females,Subjects with data on fish consumption,Finland,Health 2000,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,46.0,,,g/day,,,"Serum, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.81,,,percentRoot,,712,Spearman,0.02,,, ,Unspecified,Age,,,Turunen 2010
1441,1612,1619,Females,Subjects with data on fish consumption,Finland,Health 2000,baseline,Food Frequency Questionnaire (FFQ),Fish,"",,46.0,,,g/day,,,"Serum, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),32.0,,,percentRoot,,712,Spearman,-0.06,,, ,Unspecified,Age,,,Turunen 2010
1434,1613,1614,Females,Subjects with data on fish consumption,Finland,Health 2000,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,0.81,,,g/day,,,"Serum, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),4.0,,,percentRoot,,712,Spearman,0.29,,, ,Unspecified,Age,,,Turunen 2010
1436,1613,1615,Females,Subjects with data on fish consumption,Finland,Health 2000,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,0.81,,,g/day,,,"Serum, fasting",GC-FID,EPA (cis-20:5n-3),"",1.2,,,percentRoot,,712,Spearman,0.27,,, ,Unspecified,Age,,,Turunen 2010
1438,1613,1616,Females,Subjects with data on fish consumption,Finland,Health 2000,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,0.81,,,g/day,,,"Serum, fasting",GC-FID,DHA (cis-22:6n-3),"",2.2,,,percentRoot,,712,Spearman,0.28,,, ,Unspecified,Age,,,Turunen 2010
1440,1613,1618,Females,Subjects with data on fish consumption,Finland,Health 2000,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,0.81,,,g/day,,,"Serum, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.81,,,percentRoot,,712,Spearman,0.01,,, ,Unspecified,Age,,,Turunen 2010
1442,1613,1619,Females,Subjects with data on fish consumption,Finland,Health 2000,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3) + Heneicosapentaenoic acid (HPA; cis-21:5n-3),,0.81,,,g/day,,,"Serum, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),32.0,,,percentRoot,,712,Spearman,-0.04,,, ,Unspecified,Age,,,Turunen 2010
1443,1620,1641,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Marine mammal meat,Beluga meat + Seal meat,,9.0,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,EPA (cis-20:5n-3),"",1.64,,,percentRoot,,627,Spearman,0.22,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1454,1620,1642,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Marine mammal meat,Beluga meat + Seal meat,,9.0,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,DPA (cis-22:5n-3),"",2.15,,,percentRoot,,627,Spearman,0.16,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1465,1620,1643,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Marine mammal meat,Beluga meat + Seal meat,,9.0,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,DHA (cis-22:6n-3),"",5.37,,,percentRoot,,627,Spearman,0.17,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1476,1620,1644,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Marine mammal meat,Beluga meat + Seal meat,,9.0,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.16,,,percentRoot,,627,Spearman,0.19,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1487,1620,1639,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Marine mammal meat,Beluga meat + Seal meat,,9.0,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.49,,,percentRoot,,627,Spearman,0.2,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1444,1621,1641,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Beluga meat,"",,3.5,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,EPA (cis-20:5n-3),"",1.64,,,percentRoot,,627,Spearman,-0.01,,,>= 0.05,No,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1455,1621,1642,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Beluga meat,"",,3.5,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,DPA (cis-22:5n-3),"",2.15,,,percentRoot,,627,Spearman,-0.003,,,>= 0.05,No,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1466,1621,1643,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Beluga meat,"",,3.5,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,DHA (cis-22:6n-3),"",5.37,,,percentRoot,,627,Spearman,-0.03,,,>= 0.05,No,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1477,1621,1644,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Beluga meat,"",,3.5,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.16,,,percentRoot,,627,Spearman,-0.02,,,>= 0.05,No,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1488,1621,1639,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Beluga meat,"",,3.5,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.49,,,percentRoot,,627,Spearman,-0.01,,,>= 0.05,No,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1445,1622,1641,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Seal meat,"",,5.4,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,EPA (cis-20:5n-3),"",1.64,,,percentRoot,,627,Spearman,0.31,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1456,1622,1642,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Seal meat,"",,5.4,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,DPA (cis-22:5n-3),"",2.15,,,percentRoot,,627,Spearman,0.23,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1467,1622,1643,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Seal meat,"",,5.4,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,DHA (cis-22:6n-3),"",5.37,,,percentRoot,,627,Spearman,0.26,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1478,1622,1644,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Seal meat,"",,5.4,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.16,,,percentRoot,,627,Spearman,0.28,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1489,1622,1639,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Seal meat,"",,5.4,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.49,,,percentRoot,,627,Spearman,0.29,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1446,1623,1641,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Marine mammal fats,Beluga misirak and blubber + Seal misirak and blubber,,4.3,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,EPA (cis-20:5n-3),"",1.64,,,percentRoot,,627,Spearman,0.44,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1457,1623,1642,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Marine mammal fats,Beluga misirak and blubber + Seal misirak and blubber,,4.3,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,DPA (cis-22:5n-3),"",2.15,,,percentRoot,,627,Spearman,0.38,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1468,1623,1643,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Marine mammal fats,Beluga misirak and blubber + Seal misirak and blubber,,4.3,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,DHA (cis-22:6n-3),"",5.37,,,percentRoot,,627,Spearman,0.36,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1479,1623,1644,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Marine mammal fats,Beluga misirak and blubber + Seal misirak and blubber,,4.3,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.16,,,percentRoot,,627,Spearman,0.41,,,< 0.0001,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1490,1623,1639,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Marine mammal fats,Beluga misirak and blubber + Seal misirak and blubber,,4.3,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.49,,,percentRoot,,627,Spearman,0.41,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1447,1624,1641,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Beluga misirak and blubber,"",,3.0,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,EPA (cis-20:5n-3),"",1.64,,,percentRoot,,627,Spearman,0.32,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1458,1624,1642,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Beluga misirak and blubber,"",,3.0,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,DPA (cis-22:5n-3),"",2.15,,,percentRoot,,627,Spearman,0.27,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1469,1624,1643,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Beluga misirak and blubber,"",,3.0,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,DHA (cis-22:6n-3),"",5.37,,,percentRoot,,627,Spearman,0.27,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1480,1624,1644,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Beluga misirak and blubber,"",,3.0,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.16,,,percentRoot,,627,Spearman,0.3,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1491,1624,1639,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Beluga misirak and blubber,"",,3.0,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.49,,,percentRoot,,627,Spearman,0.31,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1448,1625,1641,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Seal misirak and blubber,"",,1.3,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,EPA (cis-20:5n-3),"",1.64,,,percentRoot,,627,Spearman,0.29,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1459,1625,1642,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Seal misirak and blubber,"",,1.3,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,DPA (cis-22:5n-3),"",2.15,,,percentRoot,,627,Spearman,0.24,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1470,1625,1643,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Seal misirak and blubber,"",,1.3,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,DHA (cis-22:6n-3),"",5.37,,,percentRoot,,627,Spearman,0.25,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1481,1625,1644,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Seal misirak and blubber,"",,1.3,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.16,,,percentRoot,,627,Spearman,0.27,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1492,1625,1639,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Seal misirak and blubber,"",,1.3,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.49,,,percentRoot,,627,Spearman,0.27,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1449,1626,1641,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Seafood,Arctic char,,48.5,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,EPA (cis-20:5n-3),"",1.64,,,percentRoot,,627,Spearman,0.36,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1460,1626,1642,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Seafood,Arctic char,,48.5,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,DPA (cis-22:5n-3),"",2.15,,,percentRoot,,627,Spearman,0.24,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1471,1626,1643,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Seafood,Arctic char,,48.5,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,DHA (cis-22:6n-3),"",5.37,,,percentRoot,,627,Spearman,0.35,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1482,1626,1644,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Seafood,Arctic char,,48.5,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.16,,,percentRoot,,627,Spearman,0.35,,,< 0.0001,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1493,1626,1639,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Seafood,Arctic char,,48.5,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.49,,,percentRoot,,627,Spearman,0.36,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1450,1627,1641,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Arctic char,"",,26.9,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,EPA (cis-20:5n-3),"",1.64,,,percentRoot,,627,Spearman,0.32,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1461,1627,1642,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Arctic char,"",,26.9,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,DPA (cis-22:5n-3),"",2.15,,,percentRoot,,627,Spearman,0.24,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1472,1627,1643,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Arctic char,"",,26.9,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,DHA (cis-22:6n-3),"",5.37,,,percentRoot,,627,Spearman,0.3,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1483,1627,1644,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Arctic char,"",,26.9,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.16,,,percentRoot,,627,Spearman,0.31,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1494,1627,1639,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Arctic char,"",,26.9,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.49,,,percentRoot,,627,Spearman,0.32,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1451,1628,1641,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Game animals,"",,47.1,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,EPA (cis-20:5n-3),"",1.64,,,percentRoot,,627,Spearman,0.16,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1462,1628,1642,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Game animals,"",,47.1,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,DPA (cis-22:5n-3),"",2.15,,,percentRoot,,627,Spearman,0.19,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1473,1628,1643,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Game animals,"",,47.1,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,DHA (cis-22:6n-3),"",5.37,,,percentRoot,,627,Spearman,0.15,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1484,1628,1644,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Game animals,"",,47.1,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.16,,,percentRoot,,627,Spearman,0.17,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1495,1628,1639,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Game animals,"",,47.1,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.49,,,percentRoot,,627,Spearman,0.17,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1452,1629,1641,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Game bird eggs,"",,0.41,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,EPA (cis-20:5n-3),"",1.64,,,percentRoot,,627,Spearman,0.22,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1463,1629,1642,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Game bird eggs,"",,0.41,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,DPA (cis-22:5n-3),"",2.15,,,percentRoot,,627,Spearman,0.13,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1474,1629,1643,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Game bird eggs,"",,0.41,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,DHA (cis-22:6n-3),"",5.37,,,percentRoot,,627,Spearman,0.23,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1485,1629,1644,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Game bird eggs,"",,0.41,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.16,,,percentRoot,,627,Spearman,0.22,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1496,1629,1639,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Game bird eggs,"",,0.41,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.49,,,percentRoot,,627,Spearman,0.21,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1453,1630,1641,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Country foods,Beluga meat + Seal meat + Beluga misirak and blubber + Seal misirak and blubber + Arctic char + Game animals + Game bird eggs,,152.0,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,EPA (cis-20:5n-3),"",1.64,,,percentRoot,,627,Spearman,0.3,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1464,1630,1642,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Country foods,Beluga meat + Seal meat + Beluga misirak and blubber + Seal misirak and blubber + Arctic char + Game animals + Game bird eggs,,152.0,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,DPA (cis-22:5n-3),"",2.15,,,percentRoot,,627,Spearman,0.21,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1475,1630,1643,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Country foods,Beluga meat + Seal meat + Beluga misirak and blubber + Seal misirak and blubber + Arctic char + Game animals + Game bird eggs,,152.0,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,DHA (cis-22:6n-3),"",5.37,,,percentRoot,,627,Spearman,0.28,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1486,1630,1644,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Country foods,Beluga meat + Seal meat + Beluga misirak and blubber + Seal misirak and blubber + Arctic char + Game animals + Game bird eggs,,152.0,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.16,,,percentRoot,,627,Spearman,0.29,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1497,1630,1639,All,Nunavik Inuit adults,Canada,Nunavik Inuit Health Survey,,Food Frequency Questionnaire (FFQ),Country foods,Beluga meat + Seal meat + Beluga misirak and blubber + Seal misirak and blubber + Arctic char + Game animals + Game bird eggs,,152.0,,,g/day,,,"Red blood cell membrane, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.49,,,percentRoot,,627,Spearman,0.29,,,< 0.05,Yes,,,"Age, Sex, Occupational status, Marital status, Education, Income, Smoking, Obesity, Hypercholesterolemia, Diabetes, Energy intake, Alcohol consumption",Lucas 2010
1520,1645,1712,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin C,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,Ascorbic acid,"",,,,missing unit,,19,Pearson,0.15,,,>= 0.05,No,,,,Bowman 2011
1586,1645,1712,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin C,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,Ascorbic acid,"",,,,missing unit,,19,Pearson,0.15,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1652,1645,1712,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin C,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,Ascorbic acid,"",,,,missing unit,,19,Pearson,0.09,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1521,1646,1713,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,missing unit,,19,Pearson,0.15,,,>= 0.05,No,,,,Bowman 2011
1587,1646,1713,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,missing unit,,19,Pearson,0.15,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1653,1646,1713,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,missing unit,,19,Pearson,0.21,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1522,1647,1714,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,gamma-Tocopherol,"",,,,missing unit,,19,Pearson,-0.2,,,>= 0.05,No,,,,Bowman 2011
1588,1647,1714,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,gamma-Tocopherol,"",,,,missing unit,,19,Pearson,-0.2,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1654,1647,1714,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,gamma-Tocopherol,"",,,,missing unit,,19,Pearson,-0.37,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1523,1648,1715,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,missing unit,,19,Pearson,-0.19,,,>= 0.05,No,,,,Bowman 2011
1589,1648,1715,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,missing unit,,19,Pearson,-0.19,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1655,1648,1715,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,missing unit,,19,Pearson,-0.35,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1524,1649,1716,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,19,Pearson,-0.11,,,>= 0.05,No,,,,Bowman 2011
1590,1649,1716,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,19,Pearson,-0.11,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1656,1649,1716,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,19,Pearson,-0.15,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1525,1650,1717,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,missing unit,,19,Pearson,0.43,,,>= 0.05,No,,,,Bowman 2011
1591,1650,1717,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,missing unit,,19,Pearson,0.43,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1657,1650,1717,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,missing unit,,19,Pearson,0.44,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1526,1651,1718,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,19,Pearson,0.45,,,>= 0.05,No,,,,Bowman 2011
1592,1651,1718,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,19,Pearson,0.35,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1658,1651,1718,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,19,Pearson,0.22,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1527,1652,1719,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,Lycopene,"",,,,missing unit,,19,Pearson,-0.01,,,>= 0.05,No,,,,Bowman 2011
1593,1652,1719,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,Lycopene,"",,,,missing unit,,19,Pearson,0.01,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1659,1652,1719,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,Lycopene,"",,,,missing unit,,19,Pearson,0.06,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1528,1653,1720,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin B6,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Radioimmunoassay (RIA),Pyridoxal 5'-phosphate,"",,,,missing unit,,19,Pearson,0.05,,,>= 0.05,No,,,,Bowman 2011
1594,1653,1720,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin B6,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Radioimmunoassay (RIA),Pyridoxal 5'-phosphate,"",,,,missing unit,,19,Pearson,0.09,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1660,1653,1720,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin B6,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Radioimmunoassay (RIA),Pyridoxal 5'-phosphate,"",,,,missing unit,,19,Pearson,0.12,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1529,1654,1721,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Folates,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Radioimmunoassay (RIA),Folates,"",,,,missing unit,,19,Pearson,-0.25,,,>= 0.05,No,,,,Bowman 2011
1595,1654,1721,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Folates,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Radioimmunoassay (RIA),Folates,"",,,,missing unit,,19,Pearson,0.04,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1661,1654,1721,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Folates,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Radioimmunoassay (RIA),Folates,"",,,,missing unit,,19,Pearson,0.04,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1530,1655,1722,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin B12,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Radioimmunoassay (RIA),Vitamin B12,"",,,,missing unit,,19,Pearson,0.1,,,>= 0.05,No,,,,Bowman 2011
1596,1655,1722,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin B12,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Radioimmunoassay (RIA),Vitamin B12,"",,,,missing unit,,19,Pearson,-0.25,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1662,1655,1722,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin B12,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Radioimmunoassay (RIA),Vitamin B12,"",,,,missing unit,,19,Pearson,-0.07,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1531,1656,1723,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin D,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,25-Hydroxycholecalciferol,"",,,,missing unit,,19,Pearson,0.15,,,>= 0.05,No,,,,Bowman 2011
1597,1656,1723,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin D,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,25-Hydroxycholecalciferol,"",,,,missing unit,,19,Pearson,0.1,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1663,1656,1723,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin D,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,25-Hydroxycholecalciferol,"",,,,missing unit,,19,Pearson,0.18,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1533,1657,1724,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,missing unit,,19,Pearson,-0.06,,,>= 0.05,No,,,,Bowman 2011
1599,1657,1724,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,missing unit,,19,Pearson,-0.06,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1665,1657,1724,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,missing unit,,19,Pearson,-0.07,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1534,1658,1725,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)","",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)","",,,,missing unit,,19,Pearson,-0.1,,,>= 0.05,No,,,,Bowman 2011
1600,1658,1725,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)","",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)","",,,,missing unit,,19,Pearson,-0.1,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1666,1658,1725,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)","",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)","",,,,missing unit,,19,Pearson,0.05,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1535,1659,1726,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,missing unit,,19,Pearson,-0.04,,,>= 0.05,No,,,,Bowman 2011
1601,1659,1726,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,missing unit,,19,Pearson,-0.04,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1667,1659,1726,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,missing unit,,19,Pearson,0.01,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1536,1660,1727,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,missing unit,,19,Pearson,-0.05,,,>= 0.05,No,,,,Bowman 2011
1602,1660,1727,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,missing unit,,19,Pearson,-0.05,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1668,1660,1727,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,missing unit,,19,Pearson,-0.16,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1537,1661,1728,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",,,,missing unit,,19,Pearson,-0.05,,,>= 0.05,No,,,,Bowman 2011
1603,1661,1728,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",,,,missing unit,,19,Pearson,-0.05,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1669,1661,1728,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",,,,missing unit,,19,Pearson,-0.01,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1538,1662,1729,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,missing unit,,19,Pearson,0.23,,,>= 0.05,No,,,,Bowman 2011
1604,1662,1729,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,missing unit,,19,Pearson,0.23,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1670,1662,1729,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,missing unit,,19,Pearson,0.23,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1539,1663,1730,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",,,,missing unit,,19,Pearson,0.22,,,>= 0.05,No,,,,Bowman 2011
1605,1663,1730,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",,,,missing unit,,19,Pearson,0.22,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1671,1663,1730,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",,,,missing unit,,19,Pearson,0.38,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1540,1664,1731,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",,,,missing unit,,19,Pearson,0.04,,,>= 0.05,No,,,,Bowman 2011
1606,1664,1731,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",,,,missing unit,,19,Pearson,0.04,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1672,1664,1731,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",,,,missing unit,,19,Pearson,0.06,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1532,1667,1733,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Selenium,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Atomic emission spectrometry (AES),Selenium,"",,,,missing unit,,19,Pearson,-0.41,,,>= 0.05,No,,,,Bowman 2011
1598,1667,1733,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Selenium,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Atomic emission spectrometry (AES),Selenium,"",,,,missing unit,,19,Pearson,-0.41,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1664,1667,1733,Mild cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Selenium,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Atomic emission spectrometry (AES),Selenium,"",,,,missing unit,,19,Pearson,-0.5,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1542,1668,1734,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin C,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,Ascorbic acid,"",,,,missing unit,,19,Pearson,0.52,,,< 0.05,Yes,,,,Bowman 2011
1608,1668,1734,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin C,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,Ascorbic acid,"",,,,missing unit,,19,Pearson,0.52,,,< 0.05,Yes,Energy by residual method,,,Bowman 2011
1674,1668,1734,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin C,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,Ascorbic acid,"",,,,missing unit,,19,Pearson,0.51,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1543,1669,1735,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,missing unit,,19,Pearson,0.1,,,>= 0.05,No,,,,Bowman 2011
1609,1669,1735,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,missing unit,,19,Pearson,0.1,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1675,1669,1735,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,missing unit,,19,Pearson,-0.04,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1544,1670,1736,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,gamma-Tocopherol,"",,,,missing unit,,19,Pearson,-0.02,,,>= 0.05,No,,,,Bowman 2011
1610,1670,1736,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,gamma-Tocopherol,"",,,,missing unit,,19,Pearson,-0.02,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1676,1670,1736,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,gamma-Tocopherol,"",,,,missing unit,,19,Pearson,-0.04,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1545,1671,1737,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,missing unit,,19,Pearson,0.72,,,< 0.01,Yes,,,,Bowman 2011
1611,1671,1737,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,missing unit,,19,Pearson,0.72,,,< 0.01,Yes,Energy by residual method,,,Bowman 2011
1677,1671,1737,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,missing unit,,19,Pearson,0.76,,,< 0.01,Yes,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1546,1672,1738,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,19,Pearson,0.72,,,< 0.01,Yes,,,,Bowman 2011
1612,1672,1738,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,19,Pearson,0.72,,,< 0.01,Yes,Energy by residual method,,,Bowman 2011
1678,1672,1738,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,19,Pearson,0.64,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1547,1673,1739,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,missing unit,,19,Pearson,0.65,,,< 0.01,Yes,,,,Bowman 2011
1613,1673,1739,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,missing unit,,19,Pearson,0.65,,,< 0.01,Yes,Energy by residual method,,,Bowman 2011
1679,1673,1739,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,missing unit,,19,Pearson,0.73,,,< 0.01,Yes,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1548,1674,1740,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,19,Pearson,0.48,,,< 0.05,Yes,,,,Bowman 2011
1614,1674,1740,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,19,Pearson,0.49,,,< 0.05,Yes,Energy by residual method,,,Bowman 2011
1680,1674,1740,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,19,Pearson,0.71,,,< 0.01,Yes,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1549,1675,1741,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,Lycopene,"",,,,missing unit,,19,Pearson,0.23,,,>= 0.05,No,,,,Bowman 2011
1615,1675,1741,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,Lycopene,"",,,,missing unit,,19,Pearson,0.23,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1681,1675,1741,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,Lycopene,"",,,,missing unit,,19,Pearson,0.06,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1550,1676,1742,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin B6,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Radioimmunoassay (RIA),Pyridoxal 5'-phosphate,"",,,,missing unit,,19,Pearson,-0.28,,,>= 0.05,No,,,,Bowman 2011
1616,1676,1742,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin B6,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Radioimmunoassay (RIA),Pyridoxal 5'-phosphate,"",,,,missing unit,,19,Pearson,-0.2,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1682,1676,1742,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin B6,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Radioimmunoassay (RIA),Pyridoxal 5'-phosphate,"",,,,missing unit,,19,Pearson,-0.18,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1551,1677,1743,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Folates,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Radioimmunoassay (RIA),Folates,"",,,,missing unit,,19,Pearson,0.39,,,>= 0.05,No,,,,Bowman 2011
1617,1677,1743,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Folates,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Radioimmunoassay (RIA),Folates,"",,,,missing unit,,19,Pearson,-0.28,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1683,1677,1743,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Folates,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Radioimmunoassay (RIA),Folates,"",,,,missing unit,,19,Pearson,-0.29,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1552,1678,1744,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin B12,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Radioimmunoassay (RIA),Vitamin B12,"",,,,missing unit,,19,Pearson,0.28,,,>= 0.05,No,,,,Bowman 2011
1618,1678,1744,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin B12,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Radioimmunoassay (RIA),Vitamin B12,"",,,,missing unit,,19,Pearson,0.39,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1684,1678,1744,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin B12,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Radioimmunoassay (RIA),Vitamin B12,"",,,,missing unit,,19,Pearson,0.42,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1553,1679,1745,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin D,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,25-Hydroxycholecalciferol,"",,,,missing unit,,19,Pearson,0.52,,,< 0.05,Yes,,,,Bowman 2011
1619,1679,1745,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin D,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,25-Hydroxycholecalciferol,"",,,,missing unit,,19,Pearson,0.28,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1685,1679,1745,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin D,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,25-Hydroxycholecalciferol,"",,,,missing unit,,19,Pearson,0.13,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1555,1680,1746,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,missing unit,,19,Pearson,0.3,,,>= 0.05,No,,,,Bowman 2011
1621,1680,1746,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,missing unit,,19,Pearson,0.3,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1687,1680,1746,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,missing unit,,19,Pearson,-0.09,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1556,1681,1747,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)","",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)","",,,,missing unit,,19,Pearson,-0.15,,,>= 0.05,No,,,,Bowman 2011
1622,1681,1747,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)","",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)","",,,,missing unit,,19,Pearson,-0.14,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1688,1681,1747,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)","",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)","",,,,missing unit,,19,Pearson,0.03,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1557,1682,1748,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,missing unit,,19,Pearson,-0.32,,,>= 0.05,No,,,,Bowman 2011
1623,1682,1748,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,missing unit,,19,Pearson,-0.32,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1689,1682,1748,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,missing unit,,19,Pearson,-0.42,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1558,1683,1749,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,missing unit,,19,Pearson,0.23,,,>= 0.05,No,,,,Bowman 2011
1624,1683,1749,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,missing unit,,19,Pearson,0.23,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1690,1683,1749,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,missing unit,,19,Pearson,-0.14,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1559,1684,1750,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",,,,missing unit,,19,Pearson,0.1,,,>= 0.05,No,,,,Bowman 2011
1625,1684,1750,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",,,,missing unit,,19,Pearson,0.1,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1691,1684,1750,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",,,,missing unit,,19,Pearson,0.14,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1560,1685,1751,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,missing unit,,19,Pearson,0.03,,,>= 0.05,No,,,,Bowman 2011
1626,1685,1751,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,missing unit,,19,Pearson,0.03,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1692,1685,1751,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,missing unit,,19,Pearson,-0.12,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1561,1686,1752,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",,,,missing unit,,19,Pearson,0.43,,,>= 0.05,No,,,,Bowman 2011
1627,1686,1752,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",,,,missing unit,,19,Pearson,0.43,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1693,1686,1752,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",,,,missing unit,,19,Pearson,0.41,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1562,1687,1753,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",,,,missing unit,,19,Pearson,0.65,,,< 0.01,Yes,,,,Bowman 2011
1628,1687,1753,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",,,,missing unit,,19,Pearson,0.65,,,< 0.01,Yes,Energy by residual method,,,Bowman 2011
1694,1687,1753,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",,,,missing unit,,19,Pearson,0.66,,,< 0.01,Yes,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1554,1689,1755,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Selenium,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Atomic emission spectrometry (AES),Selenium,"",,,,missing unit,,19,Pearson,-0.13,,,>= 0.05,No,,,,Bowman 2011
1620,1689,1755,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Selenium,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Atomic emission spectrometry (AES),Selenium,"",,,,missing unit,,19,Pearson,-0.13,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1686,1689,1755,No cognitive impairment,Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Selenium,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Atomic emission spectrometry (AES),Selenium,"",,,,missing unit,,19,Pearson,-0.14,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1498,1690,1756,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin C,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,Ascorbic acid,"",,,,missing unit,,38,Pearson,0.32,,,>= 0.05,No,,,,Bowman 2011
1564,1690,1756,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin C,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,Ascorbic acid,"",,,,missing unit,,38,Pearson,0.32,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1630,1690,1756,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin C,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,Ascorbic acid,"",,,,missing unit,,38,Pearson,0.3,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1499,1691,1757,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,missing unit,,38,Pearson,0.17,,,>= 0.05,No,,,,Bowman 2011
1565,1691,1757,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,missing unit,,38,Pearson,0.17,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1631,1691,1757,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,missing unit,,38,Pearson,0.11,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1500,1692,1758,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,gamma-Tocopherol,"",,,,missing unit,,38,Pearson,-0.21,,,>= 0.05,No,,,,Bowman 2011
1566,1692,1758,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,gamma-Tocopherol,"",,,,missing unit,,38,Pearson,-0.16,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1632,1692,1758,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,gamma-Tocopherol,"",,,,missing unit,,38,Pearson,-0.15,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1501,1693,1759,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,missing unit,,38,Pearson,0.48,,,< 0.01,Yes,,,,Bowman 2011
1567,1693,1759,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,missing unit,,38,Pearson,0.47,,,< 0.01,Yes,Energy by residual method,,,Bowman 2011
1633,1693,1759,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,missing unit,,38,Pearson,0.37,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1502,1694,1760,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,38,Pearson,0.41,,,< 0.01,Yes,,,,Bowman 2011
1568,1694,1760,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,38,Pearson,0.41,,,< 0.01,Yes,Energy by residual method,,,Bowman 2011
1634,1694,1760,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,38,Pearson,0.35,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1503,1695,1761,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,missing unit,,38,Pearson,0.49,,,< 0.01,Yes,,,,Bowman 2011
1569,1695,1761,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,missing unit,,38,Pearson,0.49,,,< 0.01,Yes,Energy by residual method,,,Bowman 2011
1635,1695,1761,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,missing unit,,38,Pearson,0.49,,,< 0.01,Yes,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1504,1696,1762,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,38,Pearson,0.43,,,< 0.01,Yes,,,,Bowman 2011
1570,1696,1762,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,38,Pearson,0.43,,,< 0.01,Yes,Energy by residual method,,,Bowman 2011
1636,1696,1762,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,38,Pearson,0.34,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1505,1697,1763,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,Lycopene,"",,,,missing unit,,38,Pearson,0.12,,,>= 0.05,No,,,,Bowman 2011
1571,1697,1763,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,Lycopene,"",,,,missing unit,,38,Pearson,0.12,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1637,1697,1763,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,Lycopene,"",,,,missing unit,,38,Pearson,0.08,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1506,1698,1764,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin B6,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Radioimmunoassay (RIA),Pyridoxal 5'-phosphate,"",,,,missing unit,,38,Pearson,-0.08,,,>= 0.05,No,,,,Bowman 2011
1572,1698,1764,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin B6,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Radioimmunoassay (RIA),Pyridoxal 5'-phosphate,"",,,,missing unit,,38,Pearson,0.01,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1638,1698,1764,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin B6,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Radioimmunoassay (RIA),Pyridoxal 5'-phosphate,"",,,,missing unit,,38,Pearson,0.01,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1507,1699,1765,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Folates,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Radioimmunoassay (RIA),Folates,"",,,,missing unit,,38,Pearson,0.04,,,>= 0.05,No,,,,Bowman 2011
1573,1699,1765,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Folates,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Radioimmunoassay (RIA),Folates,"",,,,missing unit,,38,Pearson,-0.08,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1639,1699,1765,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Folates,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Radioimmunoassay (RIA),Folates,"",,,,missing unit,,38,Pearson,-0.1,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1508,1700,1766,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin B12,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Radioimmunoassay (RIA),Vitamin B12,"",,,,missing unit,,38,Pearson,0.19,,,>= 0.05,No,,,,Bowman 2011
1574,1700,1766,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin B12,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Radioimmunoassay (RIA),Vitamin B12,"",,,,missing unit,,38,Pearson,0.04,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1640,1700,1766,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin B12,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Radioimmunoassay (RIA),Vitamin B12,"",,,,missing unit,,38,Pearson,0.14,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1509,1701,1767,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin D,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,25-Hydroxycholecalciferol,"",,,,missing unit,,38,Pearson,0.32,,,>= 0.05,No,,,,Bowman 2011
1575,1701,1767,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin D,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,25-Hydroxycholecalciferol,"",,,,missing unit,,38,Pearson,0.19,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1641,1701,1767,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Vitamin D,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",HPLC,25-Hydroxycholecalciferol,"",,,,missing unit,,38,Pearson,0.16,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1511,1702,1768,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,missing unit,,38,Pearson,0.1,,,>= 0.05,No,,,,Bowman 2011
1577,1702,1768,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,missing unit,,38,Pearson,0.1,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1643,1702,1768,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,missing unit,,38,Pearson,0.0,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1512,1703,1769,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)","",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)","",,,,missing unit,,38,Pearson,-0.15,,,>= 0.05,No,,,,Bowman 2011
1578,1703,1769,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)","",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)","",,,,missing unit,,38,Pearson,-0.15,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1644,1703,1769,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)","",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)","",,,,missing unit,,38,Pearson,-0.07,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1513,1704,1770,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,missing unit,,38,Pearson,-0.13,,,>= 0.05,No,,,,Bowman 2011
1579,1704,1770,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,missing unit,,38,Pearson,-0.13,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1645,1704,1770,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,missing unit,,38,Pearson,-0.11,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1514,1705,1771,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,missing unit,,38,Pearson,0.09,,,>= 0.05,No,,,,Bowman 2011
1580,1705,1771,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,missing unit,,38,Pearson,0.07,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1646,1705,1771,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,missing unit,,38,Pearson,-0.07,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1515,1706,1772,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",,,,missing unit,,38,Pearson,0.01,,,>= 0.05,No,,,,Bowman 2011
1581,1706,1772,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",,,,missing unit,,38,Pearson,-0.01,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1647,1706,1772,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",,,,missing unit,,38,Pearson,0.03,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1516,1707,1773,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,missing unit,,38,Pearson,0.15,,,>= 0.05,No,,,,Bowman 2011
1582,1707,1773,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,missing unit,,38,Pearson,0.15,,,>= 0.05,No,Energy by residual method,,,Bowman 2011
1648,1707,1773,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,missing unit,,38,Pearson,0.14,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1517,1708,1774,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",,,,missing unit,,38,Pearson,0.39,,,< 0.05,Yes,,,,Bowman 2011
1583,1708,1774,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",,,,missing unit,,38,Pearson,0.39,,,< 0.05,Yes,Energy by residual method,,,Bowman 2011
1649,1708,1774,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",,,,missing unit,,38,Pearson,0.39,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1518,1709,1775,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",,,,missing unit,,38,Pearson,0.39,,,< 0.05,Yes,,,,Bowman 2011
1584,1709,1775,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",,,,missing unit,,38,Pearson,0.39,,,< 0.05,Yes,Energy by residual method,,,Bowman 2011
1650,1709,1775,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",,,,missing unit,,38,Pearson,0.38,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1510,1711,1777,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Selenium,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Atomic emission spectrometry (AES),Selenium,"",,,,missing unit,,38,Pearson,-0.33,,,< 0.05,Yes,,,,Bowman 2011
1576,1711,1777,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Selenium,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Atomic emission spectrometry (AES),Selenium,"",,,,missing unit,,38,Pearson,-0.33,,,< 0.05,Yes,Energy by residual method,,,Bowman 2011
1642,1711,1777,All [by diagnosis],Elderly subjects with and without mild cognitive impairment,United States,,baseline,Food Frequency Questionnaire (FFQ),Selenium,"",,,,,missing unit,,baseline; 1 month,"Plasma, fasting",Atomic emission spectrometry (AES),Selenium,"",,,,missing unit,,38,Pearson,-0.32,,,>= 0.05,No,Energy by residual method,,"Age, Sex, ApoE genotype, Cholesterol",Bowman 2011
1696,1787,1778,All,Elderly women,Japan,,Day 4,Weighed Dietary record (4-day),Thiamin,"",No,2.51,,,umol/day,,Day 4,"Urine, 24-h",HPLC,Thiamin,"",0.459,,,umol/day,,35,Pearson,0.47,,,< 0.01,Yes,,,,Tsuji 2010
1697,1788,1779,All,Elderly women,Japan,,Day 4,Weighed Dietary record (4-day),Riboflavin,"",No,3.47,,,umol/day,,Day 4,"Urine, 24-h",HPLC,Riboflavin,"",0.852,,,umol/day,,35,Pearson,0.49,,,< 0.01,Yes,,,,Tsuji 2010
1698,1789,1780,All,Elderly women,Japan,,Day 4,Weighed Dietary record (4-day),Vitamin B6,"",No,7.06,,,umol/day,,Day 4,"Urine, 24-h",HPLC,4-Pyridoxic acid,"",4.45,,,umol/day,,35,Pearson,0.37,,,< 0.05,Yes,,,,Tsuji 2010
1699,1790,1781,All,Elderly women,Japan,,Day 4,Weighed Dietary record (4-day),Vitamin B12,"",No,5.81,,,nmol/day,,Day 4,"Urine, 24-h",Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",0.034,,,nmol/day,,35,Pearson,0.15,,,>= 0.05,No,,,,Tsuji 2010
1700,1791,1783,All,Elderly women,Japan,,Day 4,Weighed Dietary record (4-day),Niacin,"",No,113.0,,,umol/day,,Day 4,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,89.7,,,umol/day,,35,Pearson,0.35,,,< 0.05,Yes,,,,Tsuji 2010
1701,1792,1783,All,Elderly women,Japan,,Day 4,Weighed Dietary record (4-day),Niacin (Niacin Equivalents),"",No,213.0,,,umol/day,,Day 4,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,89.7,,,umol/day,,35,Pearson,0.37,,,< 0.05,Yes,,,,Tsuji 2010
1702,1793,1784,All,Elderly women,Japan,,Day 4,Weighed Dietary record (4-day),Pantothenic acid,"",No,26.1,,,umol/day,,Day 4,"Urine, 24-h",Microbioassay (Lactobacillus plantarum),Pantothenic acid,"",15.1,,,umol/day,,35,Pearson,0.59,,,< 0.001,Yes,,,,Tsuji 2010
1703,1794,1785,All,Elderly women,Japan,,Day 4,Weighed Dietary record (4-day),Folates,"",No,792.0,,,nmol/day,,Day 4,"Urine, 24-h",Microbioassay (Lactobacillus casei),Folates,"",36.6,,,nmol/day,,35,Pearson,0.55,,,< 0.001,Yes,,,,Tsuji 2010
1704,1795,1786,All,Elderly women,Japan,,Day 4,Weighed Dietary record (4-day),Vitamin C,"",No,627.0,,,umol/day,,Day 4,"Urine, 24-h",HPLC,Ascorbic acid metabolites,"Ascorbic acid + L-Dehydroascorbic acid + 2,3-Diketogulonic acid",214.0,,,umol/day,,35,Pearson,0.46,,,< 0.01,Yes,,,,Tsuji 2010
1705,1796,1778,All,Elderly women,Japan,,Day 3,Weighed Dietary record (4-day),Thiamin,"",No,2.5,,,umol/day,,Day 4,"Urine, 24-h",HPLC,Thiamin,"",0.459,,,umol/day,,35,Pearson,0.54,,,< 0.001,Yes,,,,Tsuji 2010
1706,1797,1779,All,Elderly women,Japan,,Day 3,Weighed Dietary record (4-day),Riboflavin,"",No,3.6,,,umol/day,,Day 4,"Urine, 24-h",HPLC,Riboflavin,"",0.852,,,umol/day,,35,Pearson,0.46,,,< 0.01,Yes,,,,Tsuji 2010
1707,1798,1780,All,Elderly women,Japan,,Day 3,Weighed Dietary record (4-day),Vitamin B6,"",No,7.04,,,umol/day,,Day 4,"Urine, 24-h",HPLC,4-Pyridoxic acid,"",4.45,,,umol/day,,35,Pearson,0.13,,,>= 0.05,No,,,,Tsuji 2010
1708,1799,1781,All,Elderly women,Japan,,Day 3,Weighed Dietary record (4-day),Vitamin B12,"",No,5.89,,,nmol/day,,Day 4,"Urine, 24-h",Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",0.034,,,nmol/day,,35,Pearson,-0.07,,,>= 0.05,No,,,,Tsuji 2010
1709,1800,1783,All,Elderly women,Japan,,Day 3,Weighed Dietary record (4-day),Niacin,"",No,127.0,,,umol/day,,Day 4,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,89.7,,,umol/day,,35,Pearson,0.38,,,< 0.05,Yes,,,,Tsuji 2010
1710,1801,1783,All,Elderly women,Japan,,Day 3,Weighed Dietary record (4-day),Niacin (Niacin Equivalents),"",No,232.0,,,umol/day,,Day 4,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,89.7,,,umol/day,,35,Pearson,0.45,,,< 0.01,Yes,,,,Tsuji 2010
1711,1802,1784,All,Elderly women,Japan,,Day 3,Weighed Dietary record (4-day),Pantothenic acid,"",No,25.5,,,umol/day,,Day 4,"Urine, 24-h",Microbioassay (Lactobacillus plantarum),Pantothenic acid,"",15.1,,,umol/day,,35,Pearson,0.49,,,< 0.01,Yes,,,,Tsuji 2010
1712,1803,1785,All,Elderly women,Japan,,Day 3,Weighed Dietary record (4-day),Folates,"",No,845.0,,,nmol/day,,Day 4,"Urine, 24-h",Microbioassay (Lactobacillus casei),Folates,"",36.6,,,nmol/day,,35,Pearson,0.24,,,>= 0.05,No,,,,Tsuji 2010
1713,1804,1786,All,Elderly women,Japan,,Day 3,Weighed Dietary record (4-day),Vitamin C,"",No,620.0,,,umol/day,,Day 4,"Urine, 24-h",HPLC,Ascorbic acid metabolites,"Ascorbic acid + L-Dehydroascorbic acid + 2,3-Diketogulonic acid",214.0,,,umol/day,,35,Pearson,0.43,,,< 0.01,Yes,,,,Tsuji 2010
1723,1805,1778,All,Elderly women,Japan,,Day 2,Weighed Dietary record (4-day),Thiamin,"",No,2.62,,,umol/day,,Day 4,"Urine, 24-h",HPLC,Thiamin,"",0.459,,,umol/day,,35,Pearson,0.28,,,>= 0.05,No,,,,Tsuji 2010
1724,1806,1779,All,Elderly women,Japan,,Day 2,Weighed Dietary record (4-day),Riboflavin,"",No,3.69,,,umol/day,,Day 4,"Urine, 24-h",HPLC,Riboflavin,"",0.852,,,umol/day,,35,Pearson,0.52,,,< 0.001,Yes,,,,Tsuji 2010
1725,1807,1780,All,Elderly women,Japan,,Day 2,Weighed Dietary record (4-day),Vitamin B6,"",No,7.57,,,umol/day,,Day 4,"Urine, 24-h",HPLC,4-Pyridoxic acid,"",4.45,,,umol/day,,35,Pearson,0.34,,,< 0.05,Yes,,,,Tsuji 2010
1726,1808,1781,All,Elderly women,Japan,,Day 2,Weighed Dietary record (4-day),Vitamin B12,"",No,4.95,,,nmol/day,,Day 4,"Urine, 24-h",Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",0.034,,,nmol/day,,35,Pearson,0.12,,,>= 0.05,No,,,,Tsuji 2010
1727,1809,1783,All,Elderly women,Japan,,Day 2,Weighed Dietary record (4-day),Niacin,"",No,129.0,,,umol/day,,Day 4,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,89.7,,,umol/day,,35,Pearson,0.39,,,< 0.05,Yes,,,,Tsuji 2010
1728,1810,1783,All,Elderly women,Japan,,Day 2,Weighed Dietary record (4-day),Niacin (Niacin Equivalents),"",No,239.0,,,umol/day,,Day 4,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,89.7,,,umol/day,,35,Pearson,0.39,,,< 0.05,Yes,,,,Tsuji 2010
1729,1811,1784,All,Elderly women,Japan,,Day 2,Weighed Dietary record (4-day),Pantothenic acid,"",No,25.6,,,umol/day,,Day 4,"Urine, 24-h",Microbioassay (Lactobacillus plantarum),Pantothenic acid,"",15.1,,,umol/day,,35,Pearson,0.46,,,< 0.01,Yes,,,,Tsuji 2010
1730,1812,1785,All,Elderly women,Japan,,Day 2,Weighed Dietary record (4-day),Folates,"",No,854.0,,,nmol/day,,Day 4,"Urine, 24-h",Microbioassay (Lactobacillus casei),Folates,"",36.6,,,nmol/day,,35,Pearson,0.48,,,>= 0.05,No,,,,Tsuji 2010
1731,1813,1786,All,Elderly women,Japan,,Day 2,Weighed Dietary record (4-day),Vitamin C,"",No,722.0,,,umol/day,,Day 4,"Urine, 24-h",HPLC,Ascorbic acid metabolites,"Ascorbic acid + L-Dehydroascorbic acid + 2,3-Diketogulonic acid",214.0,,,umol/day,,35,Pearson,0.39,,,>= 0.05,No,,,,Tsuji 2010
1732,1814,1778,All,Elderly women,Japan,,Day 1,Weighed Dietary record (4-day),Thiamin,"",No,2.37,,,umol/day,,Day 4,"Urine, 24-h",HPLC,Thiamin,"",0.459,,,umol/day,,35,Pearson,0.42,,,< 0.05,Yes,,,,Tsuji 2010
1733,1815,1779,All,Elderly women,Japan,,Day 1,Weighed Dietary record (4-day),Riboflavin,"",No,3.54,,,umol/day,,Day 4,"Urine, 24-h",HPLC,Riboflavin,"",0.852,,,umol/day,,35,Pearson,0.34,,,< 0.05,Yes,,,,Tsuji 2010
1734,1816,1780,All,Elderly women,Japan,,Day 1,Weighed Dietary record (4-day),Vitamin B6,"",No,7.45,,,umol/day,,Day 4,"Urine, 24-h",HPLC,4-Pyridoxic acid,"",4.45,,,umol/day,,35,Pearson,0.16,,,>= 0.05,No,,,,Tsuji 2010
1735,1817,1781,All,Elderly women,Japan,,Day 1,Weighed Dietary record (4-day),Vitamin B12,"",No,6.75,,,nmol/day,,Day 4,"Urine, 24-h",Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",0.034,,,nmol/day,,35,Pearson,-0.03,,,>= 0.05,No,,,,Tsuji 2010
1736,1818,1783,All,Elderly women,Japan,,Day 1,Weighed Dietary record (4-day),Niacin,"",No,121.0,,,umol/day,,Day 4,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,89.7,,,umol/day,,35,Pearson,0.32,,,>= 0.05,No,,,,Tsuji 2010
1737,1819,1783,All,Elderly women,Japan,,Day 1,Weighed Dietary record (4-day),Niacin (Niacin Equivalents),"",No,223.0,,,umol/day,,Day 4,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,89.7,,,umol/day,,35,Pearson,0.26,,,>= 0.05,No,,,,Tsuji 2010
1738,1820,1784,All,Elderly women,Japan,,Day 1,Weighed Dietary record (4-day),Pantothenic acid,"",No,24.5,,,umol/day,,Day 4,"Urine, 24-h",Microbioassay (Lactobacillus plantarum),Pantothenic acid,"",15.1,,,umol/day,,35,Pearson,0.3,,,>= 0.05,No,,,,Tsuji 2010
1739,1821,1785,All,Elderly women,Japan,,Day 1,Weighed Dietary record (4-day),Folates,"",No,818.0,,,nmol/day,,Day 4,"Urine, 24-h",Microbioassay (Lactobacillus casei),Folates,"",36.6,,,nmol/day,,35,Pearson,0.28,,,>= 0.05,No,,,,Tsuji 2010
1740,1822,1786,All,Elderly women,Japan,,Day 1,Weighed Dietary record (4-day),Vitamin C,"",No,642.0,,,umol/day,,Day 4,"Urine, 24-h",HPLC,Ascorbic acid metabolites,"Ascorbic acid + L-Dehydroascorbic acid + 2,3-Diketogulonic acid",214.0,,,umol/day,,35,Pearson,0.53,,,< 0.001,Yes,,,,Tsuji 2010
1741,1823,1778,All,Elderly women,Japan,,Day 4,Weighed Dietary record (4-day),Thiamin,"",No,2.5,,,umol/day,,Day 4,"Urine, 24-h",HPLC,Thiamin,"",0.459,,,umol/day,,35,Pearson,0.59,,,< 0.001,Yes,,,,Tsuji 2010
1742,1824,1779,All,Elderly women,Japan,,Day 4,Weighed Dietary record (4-day),Riboflavin,"",No,3.57,,,umol/day,,Day 4,"Urine, 24-h",HPLC,Riboflavin,"",0.852,,,umol/day,,35,Pearson,0.55,,,< 0.001,Yes,,,,Tsuji 2010
1743,1825,1780,All,Elderly women,Japan,,Day 4,Weighed Dietary record (4-day),Vitamin B6,"",No,7.58,,,umol/day,,Day 4,"Urine, 24-h",HPLC,4-Pyridoxic acid,"",4.45,,,umol/day,,35,Pearson,0.33,,,>= 0.05,No,,,,Tsuji 2010
1744,1826,1781,All,Elderly women,Japan,,Day 4,Weighed Dietary record (4-day),Vitamin B12,"",No,5.85,,,nmol/day,,Day 4,"Urine, 24-h",Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",0.034,,,nmol/day,,35,Pearson,-0.03,,,>= 0.05,No,,,,Tsuji 2010
1745,1827,1783,All,Elderly women,Japan,,Day 4,Weighed Dietary record (4-day),Niacin,"",No,122.0,,,umol/day,,Day 4,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,89.7,,,umol/day,,35,Pearson,0.52,,,< 0.001,Yes,,,,Tsuji 2010
1746,1828,1783,All,Elderly women,Japan,,Day 4,Weighed Dietary record (4-day),Niacin (Niacin Equivalents),"",No,227.0,,,umol/day,,Day 4,"Urine, 24-h",HPLC,Nicotinamide metabolites,Nicotinamide + N-Methyl-2-pyridone-5-carboxamide + N-Methyl-4-pyridone-3-carboxamide + N-Methylnicotinamide,89.7,,,umol/day,,35,Pearson,0.49,,,< 0.01,Yes,,,,Tsuji 2010
1747,1829,1784,All,Elderly women,Japan,,Day 4,Weighed Dietary record (4-day),Pantothenic acid,"",No,25.4,,,umol/day,,Day 4,"Urine, 24-h",Microbioassay (Lactobacillus plantarum),Pantothenic acid,"",15.1,,,umol/day,,35,Pearson,0.56,,,< 0.001,Yes,,,,Tsuji 2010
1748,1830,1785,All,Elderly women,Japan,,Day 4,Weighed Dietary record (4-day),Folates,"",No,828.0,,,nmol/day,,Day 4,"Urine, 24-h",Microbioassay (Lactobacillus casei),Folates,"",36.6,,,nmol/day,,35,Pearson,0.43,,,< 0.01,Yes,,,,Tsuji 2010
1749,1831,1786,All,Elderly women,Japan,,Day 4,Weighed Dietary record (4-day),Vitamin C,"",No,653.0,,,umol/day,,Day 4,"Urine, 24-h",HPLC,Ascorbic acid metabolites,"Ascorbic acid + L-Dehydroascorbic acid + 2,3-Diketogulonic acid",214.0,,,umol/day,,35,Pearson,0.53,,,< 0.001,Yes,,,,Tsuji 2010
1750,1888,1895,All,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,ug/dL,,255,Pearson,0.32,,,< 0.001,Yes,,,,Signorello 2010
1757,1888,1895,All,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,ug/dL,,255,Pearson,0.35,,,< 0.001,Yes,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption",Signorello 2010
1751,1889,1896,All,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,ug/dL,,255,Pearson,0.25,,,< 0.001,Yes,,,,Signorello 2010
1758,1889,1896,All,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,ug/dL,,255,Pearson,0.28,,,< 0.001,Yes,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption",Signorello 2010
1752,1890,1897,All,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,ug/dL,,255,Pearson,0.37,,,< 0.001,Yes,,,,Signorello 2010
1759,1890,1897,All,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,ug/dL,,255,Pearson,0.35,,,< 0.001,Yes,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption",Signorello 2010
1753,1891,1898,All,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,Lutein/Zeaxanthin,"",,,,ug/dL,,255,Pearson,0.35,,,< 0.001,Yes,,,,Signorello 2010
1760,1891,1898,All,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,Lutein/Zeaxanthin,"",,,,ug/dL,,255,Pearson,0.28,,,< 0.001,Yes,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption",Signorello 2010
1754,1892,1899,All,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,ug/dL,,255,Pearson,0.18,,,< 0.01,Yes,,,,Signorello 2010
1761,1892,1899,All,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,ug/dL,,255,Pearson,0.15,,,< 0.05,Yes,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption",Signorello 2010
1755,1893,1900,All,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),Folate (Dietary Folate Equivalents),"",No,,,,ug/day,,,"Serum, non-fasting",Microbioassay (Lactobacillus casei),Folates,"",,,,ng/mL,,255,Pearson,0.19,,,< 0.01,Yes,,,,Signorello 2010
1762,1893,1900,All,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),Folate (Dietary Folate Equivalents),"",No,,,,ug/day,,,"Serum, non-fasting",Microbioassay (Lactobacillus casei),Folates,"",,,,ng/mL,,255,Pearson,0.26,,,< 0.001,Yes,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption",Signorello 2010
1756,1894,1901,All,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",No,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",,,,mg/dL,,255,Pearson,-0.05,,,>= 0.05,No,,,,Signorello 2010
1763,1894,1901,All,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",No,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",,,,mg/dL,,255,Pearson,0.09,,,>= 0.05,No,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption",Signorello 2010
1771,1916,1923,Whites,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,ug/dL,,130,Pearson,0.23,,,< 0.05,Yes,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption",Signorello 2010
1772,1917,1924,Whites,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,ug/dL,,130,Pearson,0.23,,,< 0.05,Yes,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption",Signorello 2010
1773,1918,1925,Whites,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,ug/dL,,130,Pearson,0.29,,,< 0.01,Yes,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption",Signorello 2010
1774,1919,1926,Whites,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,Lutein/Zeaxanthin,"",,,,ug/dL,,130,Pearson,0.32,,,< 0.001,Yes,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption",Signorello 2010
1775,1920,1927,Whites,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,ug/dL,,130,Pearson,0.31,,,< 0.01,Yes,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption",Signorello 2010
1776,1921,1928,Whites,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),Folate (Dietary Folate Equivalents),"",No,,,,ug/day,,,"Serum, non-fasting",Microbioassay (Lactobacillus casei),Folates,"",,,,ng/mL,,130,Pearson,0.32,,,< 0.001,Yes,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption",Signorello 2010
1777,1922,1929,Whites,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",No,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",,,,mg/dL,,130,Pearson,0.09,,,>= 0.05,No,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption",Signorello 2010
1764,1902,1909,African Americans,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,ug/dL,,125,Pearson,0.44,,,< 0.001,Yes,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption",Signorello 2010
1765,1903,1910,African Americans,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,ug/dL,,125,Pearson,0.35,,,< 0.001,Yes,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption",Signorello 2010
1766,1904,1911,African Americans,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,ug/dL,,125,Pearson,0.41,,,< 0.001,Yes,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption",Signorello 2010
1767,1905,1912,African Americans,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,Lutein/Zeaxanthin,"",,,,ug/dL,,125,Pearson,0.23,,,< 0.05,Yes,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption",Signorello 2010
1768,1906,1913,African Americans,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,ug/dL,,125,Pearson,0.06,,,>= 0.05,No,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption",Signorello 2010
1769,1907,1914,African Americans,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),Folate (Dietary Folate Equivalents),"",No,,,,ug/day,,,"Serum, non-fasting",Microbioassay (Lactobacillus casei),Folates,"",,,,ng/mL,,125,Pearson,0.16,,,>= 0.05,No,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption",Signorello 2010
1770,1908,1915,African Americans,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",No,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",,,,mg/dL,,125,Pearson,0.09,,,>= 0.05,No,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption",Signorello 2010
1785,1944,1951,Females,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,ug/dL,,127,Pearson,0.47,,,< 0.001,Yes,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption, Use of hormone replacement therapy",Signorello 2010
1786,1945,1952,Females,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,ug/dL,,127,Pearson,0.41,,,< 0.001,Yes,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption, Use of hormone replacement therapy",Signorello 2010
1787,1946,1953,Females,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,ug/dL,,127,Pearson,0.37,,,< 0.001,Yes,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption, Use of hormone replacement therapy",Signorello 2010
1788,1947,1954,Females,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,Lutein/Zeaxanthin,"",,,,ug/dL,,127,Pearson,0.35,,,< 0.001,Yes,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption, Use of hormone replacement therapy",Signorello 2010
1789,1948,1955,Females,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,ug/dL,,127,Pearson,0.11,,,>= 0.05,No,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption, Use of hormone replacement therapy",Signorello 2010
1790,1949,1956,Females,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),Folate (Dietary Folate Equivalents),"",No,,,,ug/day,,,"Serum, non-fasting",Microbioassay (Lactobacillus casei),Folates,"",,,,ng/mL,,127,Pearson,0.22,,,< 0.05,Yes,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption, Use of hormone replacement therapy",Signorello 2010
1791,1950,1957,Females,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",No,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",,,,mg/dL,,127,Pearson,0.26,,,< 0.01,Yes,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption, Use of hormone replacement therapy",Signorello 2010
1778,1930,1937,Males,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,ug/dL,,62,Pearson,0.23,,,< 0.05,Yes,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption",Signorello 2010
1779,1931,1938,Males,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,ug/dL,,62,Pearson,0.17,,,>= 0.05,No,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption",Signorello 2010
1780,1932,1939,Males,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,ug/dL,,62,Pearson,0.34,,,< 0.001,Yes,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption",Signorello 2010
1781,1933,1940,Males,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,Lutein/Zeaxanthin,"",,,,ug/dL,,62,Pearson,0.26,,,< 0.01,Yes,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption",Signorello 2010
1782,1934,1941,Males,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",No,,,,ug/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,ug/dL,,62,Pearson,0.23,,,< 0.05,Yes,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption",Signorello 2010
1783,1935,1942,Males,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),Folate (Dietary Folate Equivalents),"",No,,,,ug/day,,,"Serum, non-fasting",Microbioassay (Lactobacillus casei),Folates,"",,,,ng/mL,,62,Pearson,0.28,,,< 0.01,Yes,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption",Signorello 2010
1784,1936,1943,Males,African American and non-Hispanic whites,United States,SCCS (Southern Community Cohort Study),,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",No,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",,,,mg/dL,,62,Pearson,-0.04,,,>= 0.05,No,,,"Age, Sex, Ethnicity, Energy, BMI, Use of vitamin supplements, Physical activity, Education, Cholesterol, Triglycerides, Use of cholesterol-lowering medication, Alcohol consumption",Signorello 2010
1792,1961,1995,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,146.0,,100.0,mg/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,DHA (cis-22:6n-3),"",7.47,,,percentRoot,,105,Spearman,0.309,,,< 0.05,Yes,,,,Friesen 2010
1793,1961,1993,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,146.0,,100.0,mg/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,EPA (cis-20:5n-3),"",0.69,,,percentRoot,,105,Spearman,0.433,,,< 0.05,Yes,,,,Friesen 2010
1794,1961,1990,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,146.0,,100.0,mg/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",5.48,,,percentRoot,,105,Spearman,-0.447,,,< 0.05,Yes,,,,Friesen 2010
1795,1961,1991,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,146.0,,100.0,mg/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,Osbond acid (cis-22:5n-6),"",0.81,,,percentRoot,,105,Spearman,-0.472,,,< 0.05,Yes,,,,Friesen 2010
1796,1961,1989,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,146.0,,100.0,mg/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",16.5,,,percentRoot,,105,Spearman,-0.167,,,>= 0.05,No,,,,Friesen 2010
1797,1961,1986,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,146.0,,100.0,mg/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",4.72,,,percentRoot,,105,Spearman,-0.098,,,>= 0.05,No,,,,Friesen 2010
1798,1961,1992,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,146.0,,100.0,mg/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.26,,,percentRoot,,105,Spearman,0.012,,,>= 0.05,No,,,,Friesen 2010
1799,1961,1978,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,146.0,,100.0,mg/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,DHA (cis-22:6n-3),"",2.11,,,percentRoot,,105,Spearman,0.369,,,< 0.05,Yes,,,,Friesen 2010
1800,1961,1976,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,146.0,,100.0,mg/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,EPA (cis-20:5n-3),"",0.32,,,percentRoot,,105,Spearman,0.302,,,< 0.05,Yes,,,,Friesen 2010
1801,1961,1973,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,146.0,,100.0,mg/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.27,,,percentRoot,,105,Spearman,-0.204,,,< 0.05,Yes,,,,Friesen 2010
1802,1961,1974,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,146.0,,100.0,mg/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,Osbond acid (cis-22:5n-6),"",0.21,,,percentRoot,,105,Spearman,-0.103,,,>= 0.05,No,,,,Friesen 2010
1803,1961,1972,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,146.0,,100.0,mg/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",5.33,,,percentRoot,,105,Spearman,-0.075,,,>= 0.05,No,,,,Friesen 2010
1804,1961,1969,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,146.0,,100.0,mg/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",20.7,,,percentRoot,,105,Spearman,0.036,,,>= 0.05,No,,,,Friesen 2010
1805,1961,1975,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,146.0,,100.0,mg/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.39,,,percentRoot,,105,Spearman,0.038,,,>= 0.05,No,,,,Friesen 2010
1822,1962,1995,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,81.1,,60.0,mg/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,DHA (cis-22:6n-3),"",7.47,,,percentRoot,,105,Spearman,0.257,,,< 0.05,Yes,,,,Friesen 2010
1823,1962,1993,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,81.1,,60.0,mg/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,EPA (cis-20:5n-3),"",0.69,,,percentRoot,,105,Spearman,0.391,,,< 0.05,Yes,,,,Friesen 2010
1824,1962,1990,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,81.1,,60.0,mg/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",5.48,,,percentRoot,,105,Spearman,-0.421,,,< 0.05,Yes,,,,Friesen 2010
1825,1962,1991,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,81.1,,60.0,mg/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,Osbond acid (cis-22:5n-6),"",0.81,,,percentRoot,,105,Spearman,-0.46,,,< 0.05,Yes,,,,Friesen 2010
1826,1962,1989,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,81.1,,60.0,mg/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",16.5,,,percentRoot,,105,Spearman,-0.172,,,>= 0.05,No,,,,Friesen 2010
1827,1962,1986,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,81.1,,60.0,mg/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",4.72,,,percentRoot,,105,Spearman,-0.102,,,>= 0.05,No,,,,Friesen 2010
1828,1962,1992,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,81.1,,60.0,mg/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.26,,,percentRoot,,105,Spearman,0.002,,,>= 0.05,No,,,,Friesen 2010
1829,1962,1978,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,81.1,,60.0,mg/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,DHA (cis-22:6n-3),"",2.11,,,percentRoot,,105,Spearman,0.305,,,< 0.05,Yes,,,,Friesen 2010
1830,1962,1976,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,81.1,,60.0,mg/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,EPA (cis-20:5n-3),"",0.32,,,percentRoot,,105,Spearman,0.228,,,< 0.05,Yes,,,,Friesen 2010
1831,1962,1973,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,81.1,,60.0,mg/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.27,,,percentRoot,,105,Spearman,-0.211,,,< 0.05,Yes,,,,Friesen 2010
1832,1962,1974,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,81.1,,60.0,mg/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,Osbond acid (cis-22:5n-6),"",0.21,,,percentRoot,,105,Spearman,-0.126,,,>= 0.05,No,,,,Friesen 2010
1833,1962,1972,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,81.1,,60.0,mg/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",5.33,,,percentRoot,,105,Spearman,-0.118,,,>= 0.05,No,,,,Friesen 2010
1834,1962,1969,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,81.1,,60.0,mg/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",20.7,,,percentRoot,,105,Spearman,0.069,,,>= 0.05,No,,,,Friesen 2010
1835,1962,1975,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,81.1,,60.0,mg/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.39,,,percentRoot,,105,Spearman,0.062,,,>= 0.05,No,,,,Friesen 2010
1864,1963,1995,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,1.69,,1.37,g/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,DHA (cis-22:6n-3),"",7.47,,,percentRoot,,105,Spearman,-0.261,,,< 0.05,Yes,,,,Friesen 2010
1865,1963,1993,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,1.69,,1.37,g/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,EPA (cis-20:5n-3),"",0.69,,,percentRoot,,105,Spearman,-0.25,,,< 0.05,Yes,,,,Friesen 2010
1866,1963,1990,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,1.69,,1.37,g/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",5.48,,,percentRoot,,105,Spearman,0.115,,,>= 0.05,No,,,,Friesen 2010
1867,1963,1991,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,1.69,,1.37,g/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,Osbond acid (cis-22:5n-6),"",0.81,,,percentRoot,,105,Spearman,0.146,,,>= 0.05,No,,,,Friesen 2010
1868,1963,1989,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,1.69,,1.37,g/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",16.5,,,percentRoot,,105,Spearman,-0.09,,,>= 0.05,No,,,,Friesen 2010
1869,1963,1986,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,1.69,,1.37,g/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",4.72,,,percentRoot,,105,Spearman,-0.057,,,>= 0.05,No,,,,Friesen 2010
1870,1963,1992,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,1.69,,1.37,g/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.26,,,percentRoot,,105,Spearman,0.081,,,>= 0.05,No,,,,Friesen 2010
1871,1963,1978,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,1.69,,1.37,g/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,DHA (cis-22:6n-3),"",2.11,,,percentRoot,,105,Spearman,-0.091,,,>= 0.05,No,,,,Friesen 2010
1872,1963,1976,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,1.69,,1.37,g/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,EPA (cis-20:5n-3),"",0.32,,,percentRoot,,105,Spearman,-0.132,,,>= 0.05,No,,,,Friesen 2010
1873,1963,1973,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,1.69,,1.37,g/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.27,,,percentRoot,,105,Spearman,0.071,,,>= 0.05,No,,,,Friesen 2010
1874,1963,1974,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,1.69,,1.37,g/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,Osbond acid (cis-22:5n-6),"",0.21,,,percentRoot,,105,Spearman,0.012,,,>= 0.05,No,,,,Friesen 2010
1875,1963,1972,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,1.69,,1.37,g/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",5.33,,,percentRoot,,105,Spearman,0.065,,,>= 0.05,No,,,,Friesen 2010
1876,1963,1969,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,1.69,,1.37,g/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",20.7,,,percentRoot,,105,Spearman,0.012,,,>= 0.05,No,,,,Friesen 2010
1877,1963,1975,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,1.69,,1.37,g/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.39,,,percentRoot,,105,Spearman,0.136,,,>= 0.05,No,,,,Friesen 2010
1836,1964,1995,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,120.0,,108.0,mg/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,DHA (cis-22:6n-3),"",7.47,,,percentRoot,,105,Spearman,-0.085,,,>= 0.05,No,,,,Friesen 2010
1837,1964,1993,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,120.0,,108.0,mg/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,EPA (cis-20:5n-3),"",0.69,,,percentRoot,,105,Spearman,0.074,,,>= 0.05,No,,,,Friesen 2010
1838,1964,1990,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,120.0,,108.0,mg/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",5.48,,,percentRoot,,105,Spearman,-0.186,,,>= 0.05,No,,,,Friesen 2010
1839,1964,1991,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,120.0,,108.0,mg/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,Osbond acid (cis-22:5n-6),"",0.81,,,percentRoot,,105,Spearman,-0.195,,,>= 0.05,No,,,,Friesen 2010
1840,1964,1989,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,120.0,,108.0,mg/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",16.5,,,percentRoot,,105,Spearman,-0.128,,,>= 0.05,No,,,,Friesen 2010
1841,1964,1986,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,120.0,,108.0,mg/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",4.72,,,percentRoot,,105,Spearman,0.014,,,>= 0.05,No,,,,Friesen 2010
1842,1964,1992,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,120.0,,108.0,mg/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.26,,,percentRoot,,105,Spearman,0.035,,,>= 0.05,No,,,,Friesen 2010
1843,1964,1978,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,120.0,,108.0,mg/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,DHA (cis-22:6n-3),"",2.11,,,percentRoot,,105,Spearman,0.014,,,>= 0.05,No,,,,Friesen 2010
1844,1964,1976,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,120.0,,108.0,mg/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,EPA (cis-20:5n-3),"",0.32,,,percentRoot,,105,Spearman,-0.037,,,>= 0.05,No,,,,Friesen 2010
1845,1964,1973,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,120.0,,108.0,mg/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.27,,,percentRoot,,105,Spearman,-0.152,,,>= 0.05,No,,,,Friesen 2010
1846,1964,1974,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,120.0,,108.0,mg/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,Osbond acid (cis-22:5n-6),"",0.21,,,percentRoot,,105,Spearman,-0.153,,,>= 0.05,No,,,,Friesen 2010
1847,1964,1972,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,120.0,,108.0,mg/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",5.33,,,percentRoot,,105,Spearman,-0.05,,,>= 0.05,No,,,,Friesen 2010
1848,1964,1969,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,120.0,,108.0,mg/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",20.7,,,percentRoot,,105,Spearman,0.141,,,>= 0.05,No,,,,Friesen 2010
1849,1964,1975,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,120.0,,108.0,mg/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.39,,,percentRoot,,105,Spearman,0.009,,,>= 0.05,No,,,,Friesen 2010
1850,1965,1995,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,12.2,,10.8,g/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,DHA (cis-22:6n-3),"",7.47,,,percentRoot,,105,Spearman,-0.264,,,< 0.05,Yes,,,,Friesen 2010
1851,1965,1993,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,12.2,,10.8,g/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,EPA (cis-20:5n-3),"",0.69,,,percentRoot,,105,Spearman,-0.228,,,< 0.05,Yes,,,,Friesen 2010
1852,1965,1990,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,12.2,,10.8,g/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",5.48,,,percentRoot,,105,Spearman,0.04,,,>= 0.05,No,,,,Friesen 2010
1853,1965,1991,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,12.2,,10.8,g/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,Osbond acid (cis-22:5n-6),"",0.81,,,percentRoot,,105,Spearman,0.021,,,>= 0.05,No,,,,Friesen 2010
1854,1965,1989,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,12.2,,10.8,g/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",16.5,,,percentRoot,,105,Spearman,-0.152,,,>= 0.05,No,,,,Friesen 2010
1855,1965,1986,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,12.2,,10.8,g/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",4.72,,,percentRoot,,105,Spearman,-0.013,,,>= 0.05,No,,,,Friesen 2010
1856,1965,1992,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,12.2,,10.8,g/day,,,"Red blood cell membrane (Ethanolamine phosphoglyceride), fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.26,,,percentRoot,,105,Spearman,-0.01,,,>= 0.05,No,,,,Friesen 2010
1857,1965,1978,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,12.2,,10.8,g/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,DHA (cis-22:6n-3),"",2.11,,,percentRoot,,105,Spearman,0.002,,,>= 0.05,No,,,,Friesen 2010
1858,1965,1976,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,12.2,,10.8,g/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,EPA (cis-20:5n-3),"",0.32,,,percentRoot,,105,Spearman,-0.112,,,>= 0.05,No,,,,Friesen 2010
1859,1965,1973,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,12.2,,10.8,g/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.27,,,percentRoot,,105,Spearman,0.053,,,>= 0.05,No,,,,Friesen 2010
1860,1965,1974,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,12.2,,10.8,g/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,Osbond acid (cis-22:5n-6),"",0.21,,,percentRoot,,105,Spearman,-0.008,,,>= 0.05,No,,,,Friesen 2010
1861,1965,1972,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,12.2,,10.8,g/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",5.33,,,percentRoot,,105,Spearman,0.053,,,>= 0.05,No,,,,Friesen 2010
1862,1965,1969,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,12.2,,10.8,g/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",20.7,,,percentRoot,,105,Spearman,0.05,,,>= 0.05,No,,,,Friesen 2010
1863,1965,1975,All,Near-term pregnant women,Canada,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,12.2,,10.8,g/day,,,"Red blood cell membrane (Phosphatidylcholine), fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.39,,,percentRoot,,105,Spearman,0.058,,,>= 0.05,No,,,,Friesen 2010
1878,2060,2066,All [by gender],"Ethnically diverse population with participants born in Australia, Greece, Italy or the UK",Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,ug/day,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,2744,Pearson,0.35,0.31,0.38, ,Unspecified,,No,,Hodge 2009
1879,2061,2067,All [by gender],"Ethnically diverse population with participants born in Australia, Greece, Italy or the UK",Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,ug/day,,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,2876,Pearson,0.23,0.19,0.26, ,Unspecified,,No,,Hodge 2009
1880,2062,2068,All [by gender],"Ethnically diverse population with participants born in Australia, Greece, Italy or the UK",Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,ug/day,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,2975,Pearson,0.4,0.36,0.43, ,Unspecified,,No,,Hodge 2009
1881,2063,2069,All [by gender],"Ethnically diverse population with participants born in Australia, Greece, Italy or the UK",Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,ug/day,,,"Plasma, unspecified",HPLC,Lycopene,"",,,,umol/L,,2679,Pearson,0.21,0.18,0.25, ,Unspecified,,No,,Hodge 2009
1882,2064,2070,All [by gender],"Ethnically diverse population with participants born in Australia, Greece, Italy or the UK",Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,,,ug/day,,,"Plasma, unspecified",HPLC,Lutein/Zeaxanthin,"",,,,umol/L,,2990,Pearson,0.21,0.18,0.25, ,Unspecified,,No,,Hodge 2009
1883,2065,2071,All [by gender],"Ethnically diverse population with participants born in Australia, Greece, Italy or the UK",Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Retinol,"",,,,,ug/day,,,"Plasma, unspecified",HPLC,Retinol,"",,,,umol/L,,3084,Pearson,0.027,-0.01,0.06, ,Unspecified,,No,,Hodge 2009
1884,2072,2078,All [by gender],"Ethnically diverse population with participants born in Australia, Greece, Italy or the UK",Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,ug/MJ,Energy,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/mol,Cholesterol,2744,Pearson,0.4,0.37,0.43, ,Unspecified,"Energy by density method, Cholesterol",No,,Hodge 2009
2625,2072,2078,All [by gender],"Ethnically diverse population with participants born in Australia, Greece, Italy or the UK",Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,ug/MJ,Energy,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/mol,Cholesterol,2744,Pearson,0.78,0.68,0.85, ,Unspecified,,Yes,,Hodge 2009
1885,2073,2079,All [by gender],"Ethnically diverse population with participants born in Australia, Greece, Italy or the UK",Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,ug/MJ,Energy,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/mol,Cholesterol,2876,Pearson,0.28,0.24,0.31, ,Unspecified,"Energy by density method, Cholesterol",No,,Hodge 2009
2626,2073,2079,All [by gender],"Ethnically diverse population with participants born in Australia, Greece, Italy or the UK",Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,ug/MJ,Energy,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/mol,Cholesterol,2876,Pearson,0.57,0.43,0.69, ,Unspecified,,Yes,,Hodge 2009
1886,2074,2080,All [by gender],"Ethnically diverse population with participants born in Australia, Greece, Italy or the UK",Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,ug/MJ,Energy,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/mol,Cholesterol,2975,Pearson,0.46,0.43,0.49, ,Unspecified,"Energy by density method, Cholesterol",No,,Hodge 2009
2627,2074,2080,All [by gender],"Ethnically diverse population with participants born in Australia, Greece, Italy or the UK",Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,ug/MJ,Energy,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/mol,Cholesterol,2975,Pearson,1.0,,, ,Unspecified,,Yes,,Hodge 2009
1887,2075,2081,All [by gender],"Ethnically diverse population with participants born in Australia, Greece, Italy or the UK",Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,ug/MJ,Energy,,"Plasma, unspecified",HPLC,Lycopene,"",,,,umol/mol,Cholesterol,2679,Pearson,0.28,0.24,0.31, ,Unspecified,"Energy by density method, Cholesterol",No,,Hodge 2009
2628,2075,2081,All [by gender],"Ethnically diverse population with participants born in Australia, Greece, Italy or the UK",Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,ug/MJ,Energy,,"Plasma, unspecified",HPLC,Lycopene,"",,,,umol/mol,Cholesterol,2679,Pearson,1.0,,, ,Unspecified,,Yes,,Hodge 2009
1888,2076,2082,All [by gender],"Ethnically diverse population with participants born in Australia, Greece, Italy or the UK",Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,,,ug/MJ,Energy,,"Plasma, unspecified",HPLC,Lutein/Zeaxanthin,"",,,,umol/mol,Cholesterol,2990,Pearson,0.29,0.26,0.32, ,Unspecified,"Energy by density method, Cholesterol",No,,Hodge 2009
2629,2076,2082,All [by gender],"Ethnically diverse population with participants born in Australia, Greece, Italy or the UK",Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,,,ug/MJ,Energy,,"Plasma, unspecified",HPLC,Lutein/Zeaxanthin,"",,,,umol/mol,Cholesterol,2990,Pearson,0.73,0.49,0.87, ,Unspecified,,Yes,,Hodge 2009
1889,2077,2083,All [by gender],"Ethnically diverse population with participants born in Australia, Greece, Italy or the UK",Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Retinol,"",,,,,ug/MJ,Energy,,"Plasma, unspecified",HPLC,Retinol,"",,,,umol/mol,Cholesterol,3084,Pearson,0.037,0.02,0.08, ,Unspecified,"Energy by density method, Cholesterol",No,,Hodge 2009
2630,2077,2083,All [by gender],"Ethnically diverse population with participants born in Australia, Greece, Italy or the UK",Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Retinol,"",,,,,ug/MJ,Energy,,"Plasma, unspecified",HPLC,Retinol,"",,,,umol/mol,Cholesterol,3084,Pearson,0.08,0.002,0.16, ,Unspecified,,Yes,,Hodge 2009
1893,2090,2084,All,Women,Australia,,,Food Frequency Questionnaire (FFQ),Sodium,"",No,3008.0,,,mg/day,,,"Urine, 24-h",Method missing,Sodium,"",127.0,,,mmol/day,,62,Pearson,0.352,,,< 0.01,Yes,,,,Lassale 2009
1894,2091,2085,All,Women,Australia,,,Food Frequency Questionnaire (FFQ),Potassium,"",No,4129.0,,,mg/day,,,"Urine, 24-h",Method missing,Potassium,"",852.0,,,mmol/day,,62,Pearson,0.245,,,> 0.05,No,,,,Lassale 2009
1895,2092,2086,All,Women,Australia,,,Food Frequency Questionnaire (FFQ),Proteins,"",No,86.7,,,g/day,,,"Urine, 24-h",Method missing,Urea,"",375.5,,,mmol/day,,62,Pearson,0.536,,,< 0.01,Yes,,,,Lassale 2009
1890,2087,2084,All,Women,Australia,,,Weighed Dietary record (4-day),Sodium,"",No,2482.0,,,mg/day,,,"Urine, 24-h",Method missing,Sodium,"",127.0,,,mmol/day,,62,Pearson,0.486,,,< 0.01,Yes,,,,Lassale 2009
1891,2088,2085,All,Women,Australia,,,Weighed Dietary record (4-day),Potassium,"",No,3513.0,,,mg/day,,,"Urine, 24-h",Method missing,Potassium,"",852.0,,,mmol/day,,62,Pearson,0.601,,,< 0.01,Yes,,,,Lassale 2009
1892,2089,2086,All,Women,Australia,,,Weighed Dietary record (4-day),Proteins,"",No,90.7,,,g/day,,,"Urine, 24-h",Method missing,Urea,"",375.5,,,mmol/day,,62,Pearson,0.694,,,< 0.01,Yes,,,,Lassale 2009
1896,2093,2109,Whites,Whites and African Americans in North Carolina,United States,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,3625.0,ug/day,,,"Plasma, semi-fasting",HPLC,beta-Carotene,"",,,0.19,umol/L,,81,Pearson,0.33,,,< 0.01,Yes,,No,"Age, Sex, Education, BMI, Cholesterol",Satia 2009
1897,2094,2110,Whites,Whites and African Americans in North Carolina,United States,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,617.0,ug/day,,,"Plasma, semi-fasting",HPLC,alpha-Carotene,"",,,0.051,umol/L,,81,Pearson,0.31,,,< 0.01,Yes,,No,"Age, Sex, Education, BMI, Cholesterol",Satia 2009
1898,2095,2111,Whites,Whites and African Americans in North Carolina,United States,,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,194.0,ug/day,,,"Plasma, semi-fasting",HPLC,beta-Cryptoxanthin,"",,,0.091,umol/L,,81,Pearson,0.28,,,< 0.01,Yes,,No,"Age, Sex, Education, BMI, Cholesterol",Satia 2009
1899,2096,2112,Whites,Whites and African Americans in North Carolina,United States,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,,3034.0,ug/day,,,"Plasma, semi-fasting",HPLC,Lutein/Zeaxanthin,"",,,0.128,umol/L,,81,Pearson,0.24,,,< 0.05,Yes,,No,"Age, Sex, Education, BMI, Cholesterol",Satia 2009
1900,2097,2113,Whites,Whites and African Americans in North Carolina,United States,,,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,4343.0,ug/day,,,"Plasma, semi-fasting",HPLC,Lycopene,"",,,0.392,umol/L,,81,Pearson,0.12,,,>= 0.05,No,,No,"Age, Sex, Education, BMI, Cholesterol",Satia 2009
1901,2098,2114,Whites,Whites and African Americans in North Carolina,United States,,,Food Frequency Questionnaire (FFQ),Retinol,"",,,,,missing unit,,,"Plasma, semi-fasting",HPLC,Retinol,"",,,,missing unit,,81,Pearson,0.12,,,>= 0.05,No,,No,"Age, Sex, Education, BMI, Cholesterol",Satia 2009
1902,2099,2115,Whites,Whites and African Americans in North Carolina,United States,,,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",,,,12.8,mg/day,,,"Plasma, semi-fasting",HPLC,alpha-Tocopherol,"",,,9.7,umol/L,,81,Pearson,0.15,,,>= 0.05,No,,No,"Age, Sex, Education, BMI, Cholesterol",Satia 2009
1903,2100,2116,Whites,Whites and African Americans in North Carolina,United States,,,Food Frequency Questionnaire (FFQ),Vitamin C,"",,,,145.0,mg/day,,,"Plasma, semi-fasting",HPLC,Ascorbic acid,"",,,9.06,umol/L,,81,Pearson,0.15,,,>= 0.05,No,,No,"Age, Sex, Education, BMI",Satia 2009
1912,2101,2109,Whites,Whites and African Americans in North Carolina,United States,,,24-h Dietary recall (1-day),beta-Carotene,"",,,,2937.0,ug/day,,,"Plasma, semi-fasting",HPLC,beta-Carotene,"",,,0.19,umol/L,,81,Pearson,0.24,,,< 0.05,Yes,,No,"Age, Sex, Education, BMI, Cholesterol",Satia 2009
1913,2102,2110,Whites,Whites and African Americans in North Carolina,United States,,,24-h Dietary recall (1-day),alpha-Carotene,"",,,,305.0,ug/day,,,"Plasma, semi-fasting",HPLC,alpha-Carotene,"",,,0.051,umol/L,,81,Pearson,0.19,,,>= 0.05,No,,No,"Age, Sex, Education, BMI, Cholesterol",Satia 2009
1914,2103,2111,Whites,Whites and African Americans in North Carolina,United States,,,24-h Dietary recall (1-day),beta-Cryptoxanthin,"",,,,164.0,ug/day,,,"Plasma, semi-fasting",HPLC,beta-Cryptoxanthin,"",,,0.091,umol/L,,81,Pearson,0.14,,,>= 0.05,No,,No,"Age, Sex, Education, BMI, Cholesterol",Satia 2009
1915,2104,2112,Whites,Whites and African Americans in North Carolina,United States,,,24-h Dietary recall (1-day),Lutein/Zeaxanthin,"",,,,2411.0,ug/day,,,"Plasma, semi-fasting",HPLC,Lutein/Zeaxanthin,"",,,0.128,umol/L,,81,Pearson,0.31,,,< 0.01,Yes,,No,"Age, Sex, Education, BMI, Cholesterol",Satia 2009
1916,2105,2113,Whites,Whites and African Americans in North Carolina,United States,,,24-h Dietary recall (1-day),Lycopene,"",,,,4890.0,ug/day,,,"Plasma, semi-fasting",HPLC,Lycopene,"",,,0.392,umol/L,,81,Pearson,0.08,,,>= 0.05,No,,No,"Age, Sex, Education, BMI, Cholesterol",Satia 2009
1917,2106,2114,Whites,Whites and African Americans in North Carolina,United States,,,24-h Dietary recall (1-day),Retinol,"",,,,,missing unit,,,"Plasma, semi-fasting",HPLC,Retinol,"",,,,missing unit,,81,Pearson,0.14,,,>= 0.05,No,,No,"Age, Sex, Education, BMI, Cholesterol",Satia 2009
1918,2107,2115,Whites,Whites and African Americans in North Carolina,United States,,,24-h Dietary recall (1-day),alpha-Tocopherol,"",,,,9.7,mg/day,,,"Plasma, semi-fasting",HPLC,alpha-Tocopherol,"",,,9.7,umol/L,,81,Pearson,0.19,,,>= 0.05,No,,No,"Age, Sex, Education, BMI, Cholesterol",Satia 2009
1919,2108,2116,Whites,Whites and African Americans in North Carolina,United States,,,24-h Dietary recall (1-day),Vitamin C,"",,,,105.0,mg/day,,,"Plasma, semi-fasting",HPLC,Ascorbic acid,"",,,9.06,umol/L,,81,Pearson,0.2,,,>= 0.05,No,,No,"Age, Sex, Education, BMI",Satia 2009
1904,2117,2133,African Americans,Whites and African Americans in North Carolina,United States,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,2865.0,ug/day,,,"Plasma, semi-fasting",HPLC,beta-Carotene,"",,,0.133,umol/L,,83,Pearson,0.27,,,< 0.05,Yes,,No,"Age, Sex, Education, BMI, Cholesterol",Satia 2009
1905,2118,2134,African Americans,Whites and African Americans in North Carolina,United States,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,242.0,ug/day,,,"Plasma, semi-fasting",HPLC,alpha-Carotene,"",,,0.031,umol/L,,83,Pearson,0.31,,,< 0.01,Yes,,No,"Age, Sex, Education, BMI, Cholesterol",Satia 2009
1906,2119,2135,African Americans,Whites and African Americans in North Carolina,United States,,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,125.0,ug/day,,,"Plasma, semi-fasting",HPLC,beta-Cryptoxanthin,"",,,0.094,umol/L,,83,Pearson,0.33,,,< 0.01,Yes,,No,"Age, Sex, Education, BMI, Cholesterol",Satia 2009
1907,2120,2136,African Americans,Whites and African Americans in North Carolina,United States,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,,1936.0,ug/day,,,"Plasma, semi-fasting",HPLC,Lutein/Zeaxanthin,"",,,0.114,umol/L,,83,Pearson,0.32,,,< 0.01,Yes,,No,"Age, Sex, Education, BMI, Cholesterol",Satia 2009
1908,2121,2137,African Americans,Whites and African Americans in North Carolina,United States,,,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,3970.0,ug/day,,,"Plasma, semi-fasting",HPLC,Lycopene,"",,,0.402,umol/L,,83,Pearson,0.11,,,>= 0.05,No,,No,"Age, Sex, Education, BMI, Cholesterol",Satia 2009
1909,2122,2138,African Americans,Whites and African Americans in North Carolina,United States,,,Food Frequency Questionnaire (FFQ),Retinol,"",,,,,missing unit,,,"Plasma, semi-fasting",HPLC,Retinol,"",,,,missing unit,,83,Pearson,0.23,,,< 0.05,Yes,,No,"Age, Sex, Education, BMI, Cholesterol",Satia 2009
1910,2123,2139,African Americans,Whites and African Americans in North Carolina,United States,,,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",,,,7.6,mg/day,,,"Plasma, semi-fasting",HPLC,alpha-Tocopherol,"",,,7.4,umol/L,,83,Pearson,0.12,,,>= 0.05,No,,No,"Age, Sex, Education, BMI, Cholesterol",Satia 2009
1911,2124,2140,African Americans,Whites and African Americans in North Carolina,United States,,,Food Frequency Questionnaire (FFQ),Vitamin C,"",,,,110.0,mg/day,,,"Plasma, semi-fasting",HPLC,Ascorbic acid,"",,,8.19,umol/L,,83,Pearson,0.1,,,>= 0.05,No,,No,"Age, Sex, Education, BMI",Satia 2009
1928,2125,2133,African Americans,Whites and African Americans in North Carolina,United States,,,24-h Dietary recall (1-day),beta-Carotene,"",,,,2151.0,ug/day,,,"Plasma, semi-fasting",HPLC,beta-Carotene,"",,,0.133,umol/L,,83,Pearson,0.24,,,< 0.05,Yes,,No,"Age, Sex, Education, BMI, Cholesterol",Satia 2009
1929,2126,2134,African Americans,Whites and African Americans in North Carolina,United States,,,24-h Dietary recall (1-day),alpha-Carotene,"",,,,175.0,ug/day,,,"Plasma, semi-fasting",HPLC,alpha-Carotene,"",,,0.031,umol/L,,83,Pearson,0.13,,,>= 0.05,No,,No,"Age, Sex, Education, BMI, Cholesterol",Satia 2009
1930,2127,2135,African Americans,Whites and African Americans in North Carolina,United States,,,24-h Dietary recall (1-day),beta-Cryptoxanthin,"",,,,140.0,ug/day,,,"Plasma, semi-fasting",HPLC,beta-Cryptoxanthin,"",,,0.094,umol/L,,83,Pearson,0.43,,,< 0.0001,Yes,,No,"Age, Sex, Education, BMI, Cholesterol",Satia 2009
1931,2128,2136,African Americans,Whites and African Americans in North Carolina,United States,,,24-h Dietary recall (1-day),Lutein/Zeaxanthin,"",,,,1631.0,ug/day,,,"Plasma, semi-fasting",HPLC,Lutein/Zeaxanthin,"",,,0.114,umol/L,,83,Pearson,0.48,,,< 0.0001,Yes,,No,"Age, Sex, Education, BMI, Cholesterol",Satia 2009
1932,2129,2137,African Americans,Whites and African Americans in North Carolina,United States,,,24-h Dietary recall (1-day),Lycopene,"",,,,3241.0,ug/day,,,"Plasma, semi-fasting",HPLC,Lycopene,"",,,0.402,umol/L,,83,Pearson,0.28,,,< 0.01,Yes,,No,"Age, Sex, Education, BMI, Cholesterol",Satia 2009
1933,2130,2138,African Americans,Whites and African Americans in North Carolina,United States,,,24-h Dietary recall (1-day),Retinol,"",,,,,missing unit,,,"Plasma, semi-fasting",HPLC,Retinol,"",,,,missing unit,,83,Pearson,0.12,,,>= 0.05,No,,No,"Age, Sex, Education, BMI, Cholesterol",Satia 2009
1934,2131,2139,African Americans,Whites and African Americans in North Carolina,United States,,,24-h Dietary recall (1-day),alpha-Tocopherol,"",,,,6.9,mg/day,,,"Plasma, semi-fasting",HPLC,alpha-Tocopherol,"",,,7.4,umol/L,,83,Pearson,0.14,,,>= 0.05,No,,No,"Age, Sex, Education, BMI, Cholesterol",Satia 2009
1935,2132,2140,African Americans,Whites and African Americans in North Carolina,United States,,,24-h Dietary recall (1-day),Vitamin C,"",,,,90.0,mg/day,,,"Plasma, semi-fasting",HPLC,Ascorbic acid,"",,,8.19,umol/L,,83,Pearson,0.17,,,>= 0.05,No,,No,"Age, Sex, Education, BMI",Satia 2009
1936,2141,2156,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),alpha-Carotene,"",,235.2,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,alpha-Carotene,"",0.117,,,umol/L,,116,Spearman,-0.01,,,= 0.919,No,Energy by density method ?,,,Okuda 2009
1948,2141,2156,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),alpha-Carotene,"",,235.2,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,alpha-Carotene,"",0.117,,,umol/L,,116,Spearman,-0.003,,,= 0.979,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
1937,2142,2157,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),beta-Carotene,"",,1445.1,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",0.434,,,umol/L,,116,Spearman,0.228,,,= 0.014,Yes,Energy by density method ?,,,Okuda 2009
1949,2142,2157,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),beta-Carotene,"",,1445.1,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",0.434,,,umol/L,,116,Spearman,0.242,,,= 0.011,Yes,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
1938,2143,2158,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),beta-Cryptoxanthin,"",,112.9,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.174,,,umol/L,,116,Spearman,0.199,,,= 0.032,Yes,Energy by density method ?,,,Okuda 2009
1950,2143,2158,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),beta-Cryptoxanthin,"",,112.9,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.174,,,umol/L,,116,Spearman,0.178,,,= 0.061,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
1940,2144,2161,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",,3.8,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,alpha-Tocopherol,"",17.941,,,umol/L,,116,Spearman,0.046,,,= 0.624,No,Energy by density method ?,,,Okuda 2009
1952,2144,2161,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",,3.8,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,alpha-Tocopherol,"",17.941,,,umol/L,,116,Spearman,-0.022,,,= 0.817,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
1941,2145,2162,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),gamma-Tocopherol,"",,7.7,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,gamma-Tocopherol,"",1.473,,,umol/L,,115,Spearman,0.071,,,= 0.451,No,Energy by density method ?,,,Okuda 2009
1953,2145,2162,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),gamma-Tocopherol,"",,7.7,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,gamma-Tocopherol,"",1.473,,,umol/L,,115,Spearman,0.033,,,= 0.732,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2062,2146,2163,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),EPA (cis-20:5n-3),"",,107.2,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",0.71,,,percentRoot,,106,Spearman,0.148,,,= 0.129,No,Energy by density method ?,,,Okuda 2009
2066,2146,2163,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),EPA (cis-20:5n-3),"",,107.2,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",0.71,,,percentRoot,,106,Spearman,0.144,,,= 0.144,No,Energy by density method ?,,BMI,Okuda 2009
2063,2147,2164,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),DPA (cis-22:5n-3),"",,36.0,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DPA (cis-22:5n-3),"",2.22,,,percentRoot,,106,Spearman,0.108,,,= 0.271,No,Energy by density method ?,,,Okuda 2009
2067,2147,2164,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),DPA (cis-22:5n-3),"",,36.0,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DPA (cis-22:5n-3),"",2.22,,,percentRoot,,106,Spearman,0.106,,,= 0.28,No,Energy by density method ?,,BMI,Okuda 2009
2064,2148,2165,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),DHA (cis-22:6n-3),"",,187.6,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",6.82,,,percentRoot,,106,Spearman,0.224,,,= 0.021,Yes,Energy by density method ?,,,Okuda 2009
2068,2148,2165,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),DHA (cis-22:6n-3),"",,187.6,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",6.82,,,percentRoot,,106,Spearman,0.225,,,= 0.021,Yes,Energy by density method ?,,BMI,Okuda 2009
2065,2149,2166,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,143.6,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.76,,,percentRoot,,106,Spearman,0.23,,,= 0.018,Yes,Energy by density method ?,,,Okuda 2009
2069,2149,2166,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,143.6,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.76,,,percentRoot,,106,Spearman,0.229,,,= 0.019,Yes,Energy by density method ?,,BMI,Okuda 2009
1990,2150,2156,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Green-yellow vegetables,"",,29.6,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,alpha-Carotene,"",0.117,,,umol/L,,116,Spearman,0.105,,,= 0.271,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
1991,2150,2157,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Green-yellow vegetables,"",,29.6,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",0.434,,,umol/L,,116,Spearman,0.308,,,= 0.001,Yes,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
1992,2150,2158,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Green-yellow vegetables,"",,29.6,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.174,,,umol/L,,116,Spearman,0.061,,,= 0.522,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
1993,2150,2159,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Green-yellow vegetables,"",,29.6,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Lycopene,"",0.187,,,umol/L,,116,Spearman,0.1,,,= 0.295,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
1994,2150,2160,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Green-yellow vegetables,"",,29.6,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",0.498,,,umol/L,,116,Spearman,0.03,,,= 0.751,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
1995,2150,2254,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Green-yellow vegetables,"",,29.6,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,umol/L,,116,Spearman,0.251,,,= 0.008,Yes,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
1996,2151,2156,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Vegetables,"",,42.0,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,alpha-Carotene,"",0.117,,,umol/L,,116,Spearman,0.03,,,= 0.753,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
1997,2151,2157,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Vegetables,"",,42.0,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",0.434,,,umol/L,,116,Spearman,0.219,,,= 0.021,Yes,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
1998,2151,2158,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Vegetables,"",,42.0,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.174,,,umol/L,,116,Spearman,-0.035,,,= 0.711,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
1999,2151,2159,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Vegetables,"",,42.0,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Lycopene,"",0.187,,,umol/L,,116,Spearman,0.008,,,= 0.934,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2000,2151,2160,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Vegetables,"",,42.0,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",0.498,,,umol/L,,116,Spearman,0.07,,,= 0.461,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2001,2151,2254,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Vegetables,"",,42.0,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,umol/L,,116,Spearman,0.136,,,= 0.153,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2002,2152,2156,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fruits,"",,17.7,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,alpha-Carotene,"",0.117,,,umol/L,,116,Spearman,0.213,,,= 0.024,Yes,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2003,2152,2157,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fruits,"",,17.7,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",0.434,,,umol/L,,116,Spearman,0.024,,,= 0.802,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2004,2152,2158,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fruits,"",,17.7,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.174,,,umol/L,,116,Spearman,0.309,,,= 0.001,Yes,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2005,2152,2159,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fruits,"",,17.7,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Lycopene,"",0.187,,,umol/L,,116,Spearman,0.205,,,= 0.03,Yes,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2006,2152,2160,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fruits,"",,17.7,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",0.498,,,umol/L,,116,Spearman,0.153,,,= 0.108,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2007,2152,2254,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fruits,"",,17.7,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,umol/L,,116,Spearman,0.163,,,= 0.087,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2094,2153,2163,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fatty fish,"",,10.0,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",0.71,,,percentRoot,,106,Spearman,0.099,,,= 0.317,No,Energy by density method ?,,BMI,Okuda 2009
2095,2153,2164,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fatty fish,"",,10.0,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DPA (cis-22:5n-3),"",2.22,,,percentRoot,,106,Spearman,0.119,,,= 0.227,No,Energy by density method ?,,BMI,Okuda 2009
2096,2153,2165,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fatty fish,"",,10.0,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",6.82,,,percentRoot,,106,Spearman,0.212,,,= 0.03,Yes,Energy by density method ?,,BMI,Okuda 2009
2097,2153,2166,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fatty fish,"",,10.0,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.76,,,percentRoot,,106,Spearman,0.202,,,= 0.039,Yes,Energy by density method ?,,BMI,Okuda 2009
2098,2154,2163,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fish,Fatty fish,,20.4,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",0.71,,,percentRoot,,106,Spearman,0.107,,,= 0.278,No,Energy by density method ?,,BMI,Okuda 2009
2099,2154,2164,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fish,Fatty fish,,20.4,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DPA (cis-22:5n-3),"",2.22,,,percentRoot,,106,Spearman,0.036,,,= 0.718,No,Energy by density method ?,,BMI,Okuda 2009
2100,2154,2165,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fish,Fatty fish,,20.4,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",6.82,,,percentRoot,,106,Spearman,0.189,,,= 0.054,No,Energy by density method ?,,BMI,Okuda 2009
2101,2154,2166,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fish,Fatty fish,,20.4,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.76,,,percentRoot,,106,Spearman,0.157,,,= 0.109,No,Energy by density method ?,,BMI,Okuda 2009
2102,2155,2163,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Seafood,Fatty fish,,25.1,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",0.71,,,percentRoot,,106,Spearman,0.139,,,= 0.158,No,Energy by density method ?,,BMI,Okuda 2009
2103,2155,2164,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Seafood,Fatty fish,,25.1,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DPA (cis-22:5n-3),"",2.22,,,percentRoot,,106,Spearman,0.006,,,= 0.948,No,Energy by density method ?,,BMI,Okuda 2009
2104,2155,2165,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Seafood,Fatty fish,,25.1,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",6.82,,,percentRoot,,106,Spearman,0.192,,,= 0.05,Yes,Energy by density method ?,,BMI,Okuda 2009
2105,2155,2166,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Seafood,Fatty fish,,25.1,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.76,,,percentRoot,,106,Spearman,0.156,,,= 0.111,No,Energy by density method ?,,BMI,Okuda 2009
1939,2245,2246,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,umol/L,,116,Spearman,0.184,,,= 0.048,Yes,Energy by density method ?,,,Okuda 2009
1951,2245,2246,Children - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,umol/L,,116,Spearman,0.207,,,= 0.029,Yes,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
1954,2167,2182,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),alpha-Carotene,"",,264.2,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,alpha-Carotene,"",0.108,,,umol/L,,100,Spearman,0.094,,,= 0.354,No,Energy by density method ?,,,Okuda 2009
1960,2167,2182,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),alpha-Carotene,"",,264.2,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,alpha-Carotene,"",0.108,,,umol/L,,100,Spearman,0.073,,,= 0.481,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
1955,2168,2183,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),beta-Carotene,"",,1706.9,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",0.374,,,umol/L,,100,Spearman,0.15,,,= 0.137,No,Energy by density method ?,,,Okuda 2009
1961,2168,2183,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),beta-Carotene,"",,1706.9,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",0.374,,,umol/L,,100,Spearman,0.17,,,= 0.1,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
1956,2169,2184,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),beta-Cryptoxanthin,"",,147.0,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.215,,,umol/L,,100,Spearman,0.262,,,= 0.008,Yes,Energy by density method ?,,,Okuda 2009
1962,2169,2184,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),beta-Cryptoxanthin,"",,147.0,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.215,,,umol/L,,100,Spearman,0.281,,,= 0.006,Yes,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
1958,2170,2187,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",,4.3,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,alpha-Tocopherol,"",16.157,,,umol/L,,100,Spearman,0.066,,,= 0.513,No,Energy by density method ?,,,Okuda 2009
1964,2170,2187,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",,4.3,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,alpha-Tocopherol,"",16.157,,,umol/L,,100,Spearman,0.139,,,= 0.181,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
1959,2171,2188,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),gamma-Tocopherol,"",,8.5,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,gamma-Tocopherol,"",1.458,,,umol/L,,99,Spearman,0.002,,,= 0.986,No,Energy by density method ?,,,Okuda 2009
1965,2171,2188,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),gamma-Tocopherol,"",,8.5,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,gamma-Tocopherol,"",1.458,,,umol/L,,99,Spearman,0.011,,,= 0.916,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2070,2172,2189,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),EPA (cis-20:5n-3),"",,110.4,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",0.71,,,percentRoot,,85,Spearman,0.135,,,= 0.218,No,Energy by density method ?,,,Okuda 2009
2074,2172,2189,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),EPA (cis-20:5n-3),"",,110.4,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",0.71,,,percentRoot,,85,Spearman,0.123,,,= 0.266,No,Energy by density method ?,,BMI,Okuda 2009
2071,2173,2190,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),DPA (cis-22:5n-3),"",,37.6,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DPA (cis-22:5n-3),"",2.14,,,percentRoot,,85,Spearman,0.214,,,= 0.049,Yes,Energy by density method ?,,,Okuda 2009
2075,2173,2190,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),DPA (cis-22:5n-3),"",,37.6,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DPA (cis-22:5n-3),"",2.14,,,percentRoot,,85,Spearman,0.18,,,= 0.102,No,Energy by density method ?,,BMI,Okuda 2009
2072,2174,2191,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),DHA (cis-22:6n-3),"",,196.8,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",6.86,,,percentRoot,,85,Spearman,-0.001,,,= 0.99,No,Energy by density method ?,,,Okuda 2009
2076,2174,2191,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),DHA (cis-22:6n-3),"",,196.8,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",6.86,,,percentRoot,,85,Spearman,-0.011,,,= 0.923,No,Energy by density method ?,,BMI,Okuda 2009
2073,2175,2192,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,148.5,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.73,,,percentRoot,,85,Spearman,0.131,,,= 0.232,No,Energy by density method ?,,,Okuda 2009
2077,2175,2192,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,148.5,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.73,,,percentRoot,,85,Spearman,0.112,,,= 0.31,No,Energy by density method ?,,BMI,Okuda 2009
2008,2176,2182,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Green-yellow vegetables,"",,35.8,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,alpha-Carotene,"",0.108,,,umol/L,,100,Spearman,0.042,,,= 0.682,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2009,2176,2183,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Green-yellow vegetables,"",,35.8,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",0.374,,,umol/L,,100,Spearman,0.25,,,= 0.014,Yes,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2010,2176,2184,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Green-yellow vegetables,"",,35.8,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.215,,,umol/L,,100,Spearman,0.056,,,= 0.585,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2011,2176,2185,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Green-yellow vegetables,"",,35.8,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Lycopene,"",0.177,,,umol/L,,100,Spearman,0.068,,,= 0.513,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2012,2176,2186,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Green-yellow vegetables,"",,35.8,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",0.492,,,umol/L,,100,Spearman,0.177,,,= 0.084,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2013,2176,2256,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Green-yellow vegetables,"",,35.8,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,umol/L,,100,Spearman,0.198,,,= 0.053,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2014,2177,2182,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Vegetables,"",,53.9,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,alpha-Carotene,"",0.108,,,umol/L,,100,Spearman,0.097,,,= 0.348,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2015,2177,2183,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Vegetables,"",,53.9,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",0.374,,,umol/L,,100,Spearman,0.185,,,= 0.071,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2016,2177,2184,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Vegetables,"",,53.9,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.215,,,umol/L,,100,Spearman,-0.057,,,= 0.582,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2017,2177,2185,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Vegetables,"",,53.9,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Lycopene,"",0.177,,,umol/L,,100,Spearman,0.083,,,= 0.423,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2018,2177,2186,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Vegetables,"",,53.9,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",0.492,,,umol/L,,100,Spearman,0.155,,,= 0.132,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2019,2177,2256,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Vegetables,"",,53.9,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,umol/L,,100,Spearman,0.118,,,= 0.251,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2020,2178,2182,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fruits,"",,19.7,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,alpha-Carotene,"",0.108,,,umol/L,,100,Spearman,0.218,,,= 0.033,Yes,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2021,2178,2183,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fruits,"",,19.7,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",0.374,,,umol/L,,100,Spearman,-0.046,,,= 0.659,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2022,2178,2184,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fruits,"",,19.7,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.215,,,umol/L,,100,Spearman,0.26,,,= 0.011,Yes,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2023,2178,2185,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fruits,"",,19.7,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Lycopene,"",0.177,,,umol/L,,100,Spearman,-0.049,,,= 0.636,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2024,2178,2186,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fruits,"",,19.7,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",0.492,,,umol/L,,100,Spearman,0.182,,,= 0.076,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2025,2178,2256,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fruits,"",,19.7,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,umol/L,,100,Spearman,0.119,,,= 0.248,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2106,2179,2189,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fatty fish,"",,10.1,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",0.71,,,percentRoot,,85,Spearman,0.146,,,= 0.186,No,Energy by density method ?,,BMI,Okuda 2009
2107,2179,2190,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fatty fish,"",,10.1,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DPA (cis-22:5n-3),"",2.14,,,percentRoot,,85,Spearman,0.185,,,= 0.092,No,Energy by density method ?,,BMI,Okuda 2009
2108,2179,2191,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fatty fish,"",,10.1,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",6.86,,,percentRoot,,85,Spearman,-0.043,,,= 0.695,No,Energy by density method ?,,BMI,Okuda 2009
2109,2179,2192,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fatty fish,"",,10.1,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.73,,,percentRoot,,85,Spearman,0.097,,,= 0.379,No,Energy by density method ?,,BMI,Okuda 2009
2110,2180,2189,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fish,Fatty fish,,20.3,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",0.71,,,percentRoot,,85,Spearman,0.128,,,= 0.246,No,Energy by density method ?,,BMI,Okuda 2009
2111,2180,2190,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fish,Fatty fish,,20.3,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DPA (cis-22:5n-3),"",2.14,,,percentRoot,,85,Spearman,0.168,,,= 0.126,No,Energy by density method ?,,BMI,Okuda 2009
2112,2180,2191,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fish,Fatty fish,,20.3,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",6.86,,,percentRoot,,85,Spearman,-0.073,,,= 0.508,No,Energy by density method ?,,BMI,Okuda 2009
2113,2180,2192,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fish,Fatty fish,,20.3,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.73,,,percentRoot,,85,Spearman,0.07,,,= 0.526,No,Energy by density method ?,,BMI,Okuda 2009
2114,2181,2189,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Seafood,Fatty fish,,25.8,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",0.71,,,percentRoot,,85,Spearman,0.097,,,= 0.381,No,Energy by density method ?,,BMI,Okuda 2009
2115,2181,2190,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Seafood,Fatty fish,,25.8,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DPA (cis-22:5n-3),"",2.14,,,percentRoot,,85,Spearman,0.194,,,= 0.077,Yes,Energy by density method ?,,BMI,Okuda 2009
2116,2181,2191,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Seafood,Fatty fish,,25.8,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",6.86,,,percentRoot,,85,Spearman,-0.047,,,= 0.67,No,Energy by density method ?,,BMI,Okuda 2009
2117,2181,2192,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Seafood,Fatty fish,,25.8,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.73,,,percentRoot,,85,Spearman,0.107,,,= 0.331,No,Energy by density method ?,,BMI,Okuda 2009
1957,2247,2248,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,umol/L,,100,Spearman,0.111,,,= 0.272,No,Energy by density method ?,,,Okuda 2009
1963,2247,2248,Children - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,umol/L,,100,Spearman,0.11,,,= 0.29,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
1966,2193,2208,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),alpha-Carotene,"",,134.7,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,alpha-Carotene,"",0.093,,,umol/L,,98,Spearman,0.213,,,= 0.035,Yes,Energy by density method ?,,,Okuda 2009
1972,2193,2208,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),alpha-Carotene,"",,134.7,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,alpha-Carotene,"",0.093,,,umol/L,,98,Spearman,0.197,,,= 0.057,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
1967,2194,2209,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),beta-Carotene,"",,1140.3,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",0.307,,,umol/L,,98,Spearman,0.234,,,= 0.02,Yes,Energy by density method ?,,,Okuda 2009
1973,2194,2209,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),beta-Carotene,"",,1140.3,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",0.307,,,umol/L,,98,Spearman,0.25,,,= 0.015,Yes,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
1968,2195,2210,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),beta-Cryptoxanthin,"",,92.2,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.152,,,umol/L,,98,Spearman,0.22,,,= 0.03,Yes,Energy by density method ?,,,Okuda 2009
1974,2195,2210,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),beta-Cryptoxanthin,"",,92.2,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.152,,,umol/L,,98,Spearman,0.276,,,= 0.007,Yes,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
1970,2196,2213,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",,4.1,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,alpha-Tocopherol,"",17.096,,,umol/L,,98,Spearman,0.009,,,= 0.927,No,Energy by density method ?,,,Okuda 2009
1976,2196,2213,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",,4.1,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,alpha-Tocopherol,"",17.096,,,umol/L,,98,Spearman,-0.011,,,= 0.919,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
1971,2197,2214,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),gamma-Tocopherol,"",,7.4,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,gamma-Tocopherol,"",1.351,,,umol/L,,98,Spearman,-0.068,,,= 0.508,No,Energy by density method ?,,,Okuda 2009
1977,2197,2214,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),gamma-Tocopherol,"",,7.4,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,gamma-Tocopherol,"",1.351,,,umol/L,,98,Spearman,-0.035,,,= 0.739,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2078,2198,2215,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),EPA (cis-20:5n-3),"",,113.9,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",0.71,,,percentRoot,,91,Spearman,0.35,,,= 0.001,Yes,Energy by density method ?,,,Okuda 2009
2082,2198,2215,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),EPA (cis-20:5n-3),"",,113.9,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",0.71,,,percentRoot,,91,Spearman,0.368,,,= 0.000,Yes,Energy by density method ?,,BMI,Okuda 2009
2079,2199,2216,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),DPA (cis-22:5n-3),"",,37.2,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DPA (cis-22:5n-3),"",2.24,,,percentRoot,,91,Spearman,0.103,,,= 0.334,No,Energy by density method ?,,,Okuda 2009
2083,2199,2216,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),DPA (cis-22:5n-3),"",,37.2,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DPA (cis-22:5n-3),"",2.24,,,percentRoot,,91,Spearman,0.098,,,= 0.359,No,Energy by density method ?,,BMI,Okuda 2009
2080,2200,2217,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),DHA (cis-22:6n-3),"",,206.4,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",6.52,,,percentRoot,,91,Spearman,0.215,,,= 0.04,Yes,Energy by density method ?,,,Okuda 2009
2084,2200,2217,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),DHA (cis-22:6n-3),"",,206.4,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",6.52,,,percentRoot,,91,Spearman,0.215,,,= 0.042,Yes,Energy by density method ?,,BMI,Okuda 2009
2081,2201,2218,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,152.7,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.49,,,percentRoot,,91,Spearman,0.222,,,= 0.034,Yes,Energy by density method ?,,,Okuda 2009
2085,2201,2218,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,152.7,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.49,,,percentRoot,,91,Spearman,0.222,,,= 0.035,Yes,Energy by density method ?,,BMI,Okuda 2009
2026,2202,2208,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Green-yellow vegetables,"",,32.4,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,alpha-Carotene,"",0.093,,,umol/L,,98,Spearman,0.266,,,= 0.01,Yes,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2027,2202,2209,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Green-yellow vegetables,"",,32.4,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",0.307,,,umol/L,,98,Spearman,0.205,,,= 0.047,Yes,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2028,2202,2210,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Green-yellow vegetables,"",,32.4,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.152,,,umol/L,,98,Spearman,0.15,,,= 0.148,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2029,2202,2211,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Green-yellow vegetables,"",,32.4,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Lycopene,"",0.159,,,umol/L,,98,Spearman,0.166,,,= 0.111,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2030,2202,2212,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Green-yellow vegetables,"",,32.4,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",0.413,,,umol/L,,98,Spearman,0.048,,,= 0.648,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2031,2202,2258,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Green-yellow vegetables,"",,32.4,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,umol/L,,98,Spearman,0.199,,,= 0.055,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2032,2203,2208,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Vegetables,"",,61.0,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,alpha-Carotene,"",0.093,,,umol/L,,98,Spearman,0.301,,,= 0.003,Yes,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2033,2203,2209,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Vegetables,"",,61.0,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",0.307,,,umol/L,,98,Spearman,0.108,,,= 0.3,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2034,2203,2210,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Vegetables,"",,61.0,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.152,,,umol/L,,98,Spearman,0.191,,,= 0.066,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2035,2203,2211,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Vegetables,"",,61.0,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Lycopene,"",0.159,,,umol/L,,98,Spearman,0.183,,,= 0.077,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2036,2203,2212,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Vegetables,"",,61.0,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",0.413,,,umol/L,,98,Spearman,0.244,,,= 0.018,Yes,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2037,2203,2258,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Vegetables,"",,61.0,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,umol/L,,98,Spearman,0.223,,,= 0.031,Yes,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2038,2204,2208,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fruits,"",,13.1,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,alpha-Carotene,"",0.093,,,umol/L,,98,Spearman,0.147,,,= 0.158,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2039,2204,2209,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fruits,"",,13.1,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",0.307,,,umol/L,,98,Spearman,0.109,,,= 0.298,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2040,2204,2210,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fruits,"",,13.1,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.152,,,umol/L,,98,Spearman,0.341,,,= 0.001,Yes,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2041,2204,2211,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fruits,"",,13.1,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Lycopene,"",0.159,,,umol/L,,98,Spearman,0.158,,,= 0.128,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2042,2204,2212,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fruits,"",,13.1,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",0.413,,,umol/L,,98,Spearman,0.165,,,= 0.111,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2043,2204,2258,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fruits,"",,13.1,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,umol/L,,98,Spearman,0.159,,,= 0.126,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2118,2205,2215,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fatty fish,"",,13.4,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",0.71,,,percentRoot,,91,Spearman,0.289,,,= 0.006,Yes,Energy by density method ?,,BMI,Okuda 2009
2119,2205,2216,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fatty fish,"",,13.4,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DPA (cis-22:5n-3),"",2.24,,,percentRoot,,91,Spearman,0.096,,,= 0.369,No,Energy by density method ?,,BMI,Okuda 2009
2120,2205,2217,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fatty fish,"",,13.4,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",6.52,,,percentRoot,,91,Spearman,0.168,,,= 0.114,No,Energy by density method ?,,BMI,Okuda 2009
2121,2205,2218,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fatty fish,"",,13.4,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.49,,,percentRoot,,91,Spearman,0.19,,,= 0.073,No,Energy by density method ?,,BMI,Okuda 2009
2122,2206,2215,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fish,Fatty fish,,27.0,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",0.71,,,percentRoot,,91,Spearman,0.363,,,< 0.001,Yes,Energy by density method ?,,BMI,Okuda 2009
2123,2206,2216,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fish,Fatty fish,,27.0,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DPA (cis-22:5n-3),"",2.24,,,percentRoot,,91,Spearman,0.111,,,= 0.298,No,Energy by density method ?,,BMI,Okuda 2009
2124,2206,2217,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fish,Fatty fish,,27.0,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",6.52,,,percentRoot,,91,Spearman,0.188,,,= 0.077,No,Energy by density method ?,,BMI,Okuda 2009
2125,2206,2218,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fish,Fatty fish,,27.0,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.49,,,percentRoot,,91,Spearman,0.213,,,= 0.044,Yes,Energy by density method ?,,BMI,Okuda 2009
2126,2207,2215,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Seafood,Fatty fish,,33.7,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",0.71,,,percentRoot,,91,Spearman,0.385,,,< 0.001,Yes,Energy by density method ?,,BMI,Okuda 2009
2127,2207,2216,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Seafood,Fatty fish,,33.7,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DPA (cis-22:5n-3),"",2.24,,,percentRoot,,91,Spearman,0.115,,,= 0.281,No,Energy by density method ?,,BMI,Okuda 2009
2128,2207,2217,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Seafood,Fatty fish,,33.7,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",6.52,,,percentRoot,,91,Spearman,0.208,,,= 0.049,Yes,Energy by density method ?,,BMI,Okuda 2009
2129,2207,2218,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Seafood,Fatty fish,,33.7,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.49,,,percentRoot,,91,Spearman,0.239,,,= 0.023,Yes,Energy by density method ?,,BMI,Okuda 2009
1969,2249,2250,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,umol/L,,98,Spearman,0.257,,,= 0.011,Yes,Energy by density method ?,,,Okuda 2009
1975,2249,2250,Adolescents - Males,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,umol/L,,98,Spearman,0.263,,,= 0.01,Yes,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
1978,2219,2234,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),alpha-Carotene,"",,160.4,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,alpha-Carotene,"",0.11,,,umol/L,,84,Spearman,0.134,,,= 0.226,No,Energy by density method ?,,,Okuda 2009
1984,2219,2234,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),alpha-Carotene,"",,160.4,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,alpha-Carotene,"",0.11,,,umol/L,,84,Spearman,0.118,,,= 0.296,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
1979,2220,2235,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),beta-Carotene,"",,1239.9,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",0.333,,,umol/L,,84,Spearman,0.333,,,= 0.002,Yes,Energy by density method ?,,,Okuda 2009
1985,2220,2235,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),beta-Carotene,"",,1239.9,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",0.333,,,umol/L,,84,Spearman,0.302,,,= 0.007,Yes,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
1980,2221,2236,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),beta-Cryptoxanthin,"",,120.0,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.177,,,umol/L,,84,Spearman,0.303,,,= 0.005,Yes,Energy by density method ?,,,Okuda 2009
1986,2221,2236,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),beta-Cryptoxanthin,"",,120.0,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.177,,,umol/L,,84,Spearman,0.233,,,= 0.038,Yes,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
1982,2222,2239,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",,4.4,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,alpha-Tocopherol,"",17.066,,,umol/L,,84,Spearman,-0.145,,,= 0.188,No,Energy by density method ?,,,Okuda 2009
1988,2222,2239,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",,4.4,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,alpha-Tocopherol,"",17.066,,,umol/L,,84,Spearman,-0.105,,,= 0.354,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
1983,2223,2240,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),gamma-Tocopherol,"",,7.9,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,gamma-Tocopherol,"",1.469,,,umol/L,,84,Spearman,-0.107,,,= 0.334,No,Energy by density method ?,,,Okuda 2009
1989,2223,2240,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),gamma-Tocopherol,"",,7.9,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,gamma-Tocopherol,"",1.469,,,umol/L,,84,Spearman,-0.055,,,= 0.631,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2086,2224,2241,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),EPA (cis-20:5n-3),"",,110.5,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",0.72,,,percentRoot,,75,Spearman,0.249,,,= 0.031,Yes,Energy by density method ?,,,Okuda 2009
2090,2224,2241,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),EPA (cis-20:5n-3),"",,110.5,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",0.72,,,percentRoot,,75,Spearman,0.246,,,= 0.035,Yes,Energy by density method ?,,BMI,Okuda 2009
2087,2225,2242,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),DPA (cis-22:5n-3),"",,35.8,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DPA (cis-22:5n-3),"",2.2,,,percentRoot,,75,Spearman,0.301,,,= 0.009,Yes,Energy by density method ?,,,Okuda 2009
2091,2225,2242,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),DPA (cis-22:5n-3),"",,35.8,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DPA (cis-22:5n-3),"",2.2,,,percentRoot,,75,Spearman,0.303,,,= 0.009,Yes,Energy by density method ?,,BMI,Okuda 2009
2088,2226,2243,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),DHA (cis-22:6n-3),"",,202.7,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",6.55,,,percentRoot,,75,Spearman,0.43,,,< 0.001,Yes,Energy by density method ?,,,Okuda 2009
2092,2226,2243,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),DHA (cis-22:6n-3),"",,202.7,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",6.55,,,percentRoot,,75,Spearman,0.435,,,< 0.001,Yes,Energy by density method ?,,BMI,Okuda 2009
2089,2227,2244,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,147.2,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.49,,,percentRoot,,75,Spearman,0.473,,,< 0.001,Yes,Energy by density method ?,,,Okuda 2009
2093,2227,2244,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,147.2,,,mg/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.49,,,percentRoot,,75,Spearman,0.477,,,< 0.001,Yes,Energy by density method ?,,BMI,Okuda 2009
2044,2228,2234,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Green-yellow vegetables,"",,35.8,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,alpha-Carotene,"",0.11,,,umol/L,,84,Spearman,0.254,,,= 0.023,Yes,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2045,2228,2235,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Green-yellow vegetables,"",,35.8,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",0.333,,,umol/L,,84,Spearman,0.332,,,= 0.003,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2046,2228,2236,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Green-yellow vegetables,"",,35.8,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.177,,,umol/L,,84,Spearman,0.076,,,= 0.503,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2047,2228,2237,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Green-yellow vegetables,"",,35.8,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Lycopene,"",0.169,,,umol/L,,84,Spearman,0.042,,,= 0.712,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2048,2228,2238,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Green-yellow vegetables,"",,35.8,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",0.395,,,umol/L,,84,Spearman,0.182,,,= 0.107,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2049,2228,2260,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Green-yellow vegetables,"",,35.8,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,umol/L,,84,Spearman,0.309,,,= 0.005,Yes,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2050,2229,2234,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Vegetables,"",,67.2,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,alpha-Carotene,"",0.11,,,umol/L,,84,Spearman,0.058,,,= 0.61,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2051,2229,2235,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Vegetables,"",,67.2,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",0.333,,,umol/L,,84,Spearman,-0.013,,,= 0.91,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2052,2229,2236,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Vegetables,"",,67.2,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.177,,,umol/L,,84,Spearman,0.121,,,= 0.286,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2053,2229,2237,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Vegetables,"",,67.2,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Lycopene,"",0.169,,,umol/L,,84,Spearman,-0.259,,,= 0.02,Yes,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2054,2229,2238,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Vegetables,"",,67.2,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",0.395,,,umol/L,,84,Spearman,0.056,,,= 0.619,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2055,2229,2260,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Vegetables,"",,67.2,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,umol/L,,84,Spearman,0.035,,,= 0.757,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2056,2230,2234,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fruits,"",,17.7,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,alpha-Carotene,"",0.11,,,umol/L,,84,Spearman,0.139,,,= 0.219,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2057,2230,2235,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fruits,"",,17.7,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",0.333,,,umol/L,,84,Spearman,0.069,,,= 0.543,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2058,2230,2236,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fruits,"",,17.7,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.177,,,umol/L,,84,Spearman,0.235,,,= 0.036,Yes,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2059,2230,2237,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fruits,"",,17.7,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Lycopene,"",0.169,,,umol/L,,84,Spearman,-0.007,,,= 0.954,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2060,2230,2238,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fruits,"",,17.7,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",0.395,,,umol/L,,84,Spearman,-0.097,,,= 0.394,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2061,2230,2260,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fruits,"",,17.7,,,g/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,umol/L,,84,Spearman,0.11,,,= 0.33,No,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2130,2231,2241,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fatty fish,"",,13.8,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",0.72,,,percentRoot,,75,Spearman,0.209,,,= 0.074,No,Energy by density method ?,,BMI,Okuda 2009
2131,2231,2242,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fatty fish,"",,13.8,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DPA (cis-22:5n-3),"",2.2,,,percentRoot,,75,Spearman,0.247,,,= 0.034,Yes,Energy by density method ?,,BMI,Okuda 2009
2132,2231,2243,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fatty fish,"",,13.8,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",6.55,,,percentRoot,,75,Spearman,0.415,,,< 0.001,Yes,Energy by density method ?,,BMI,Okuda 2009
2133,2231,2244,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fatty fish,"",,13.8,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.49,,,percentRoot,,75,Spearman,0.412,,,< 0.001,Yes,Energy by density method ?,,BMI,Okuda 2009
2134,2232,2241,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fish,Fatty fish,,26.2,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",0.72,,,percentRoot,,75,Spearman,0.19,,,= 0.105,No,Energy by density method ?,,BMI,Okuda 2009
2135,2232,2242,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fish,Fatty fish,,26.2,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DPA (cis-22:5n-3),"",2.2,,,percentRoot,,75,Spearman,0.315,,,= 0.006,Yes,Energy by density method ?,,BMI,Okuda 2009
2136,2232,2243,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fish,Fatty fish,,26.2,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",6.55,,,percentRoot,,75,Spearman,0.446,,,< 0.001,Yes,Energy by density method ?,,BMI,Okuda 2009
2137,2232,2244,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Fish,Fatty fish,,26.2,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.49,,,percentRoot,,75,Spearman,0.456,,,< 0.001,Yes,Energy by density method ?,,BMI,Okuda 2009
2138,2233,2241,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Seafood,Fatty fish,,32.6,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",0.72,,,percentRoot,,75,Spearman,0.207,,,= 0.077,No,Energy by density method ?,,BMI,Okuda 2009
2139,2233,2242,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Seafood,Fatty fish,,32.6,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DPA (cis-22:5n-3),"",2.2,,,percentRoot,,75,Spearman,0.248,,,= 0.033,Yes,Energy by density method ?,,BMI,Okuda 2009
2140,2233,2243,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Seafood,Fatty fish,,32.6,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",6.55,,,percentRoot,,75,Spearman,0.414,,,< 0.001,Yes,Energy by density method ?,,BMI,Okuda 2009
2141,2233,2244,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Seafood,Fatty fish,,32.6,,,g/1000 kcal,Energy,,"Red blood cell membrane, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),9.49,,,percentRoot,,75,Spearman,0.42,,,< 0.001,Yes,Energy by density method ?,,BMI,Okuda 2009
1981,2251,2252,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,umol/L,,84,Spearman,0.339,,,= 0.002,Yes,Energy by density method ?,,,Okuda 2009
1987,2251,2252,Adolescents - Females,Students in Shunan City,Japan,Shunan Child Cohort Study,,Diet History Questionnaire (DHQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,,mg/1000 kcal,Energy,,"Serum, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,umol/L,,84,Spearman,0.306,,,= 0.006,Yes,Energy by density method ?,,"BMI, Cholesterol, Smoking, Fasting blood sampling",Okuda 2009
2142,2297,2304,HIKCUPS,Overweight and normal weight children from the Hunter region,Australia,HIKCUPS (Hunter Illawarra Kids Challenge Using Parent Support),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,6633.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",0.34,,,umol/L,,55,Pearson,0.17,,,>= 0.05,No,,,,Burrows 2009
2147,2297,2304,HIKCUPS,Overweight and normal weight children from the Hunter region,Australia,HIKCUPS (Hunter Illawarra Kids Challenge Using Parent Support),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,6633.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",0.34,,,umol/L,,55,Pearson,0.56,,,< 0.001,Yes,,,BMI,Burrows 2009
2143,2298,2305,HIKCUPS,Overweight and normal weight children from the Hunter region,Australia,HIKCUPS (Hunter Illawarra Kids Challenge Using Parent Support),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,1672.0,,,ug/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",0.07,,,umol/L,,55,Pearson,0.25,,,< 0.001,Yes,,,,Burrows 2009
2148,2298,2305,HIKCUPS,Overweight and normal weight children from the Hunter region,Australia,HIKCUPS (Hunter Illawarra Kids Challenge Using Parent Support),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,1672.0,,,ug/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",0.07,,,umol/L,,55,Pearson,0.51,,,< 0.001,Yes,,,BMI,Burrows 2009
2144,2299,2306,HIKCUPS,Overweight and normal weight children from the Hunter region,Australia,HIKCUPS (Hunter Illawarra Kids Challenge Using Parent Support),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",No,467.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",0.15,,,umol/L,,55,Pearson,0.07,,,>= 0.05,No,,,,Burrows 2009
2149,2299,2306,HIKCUPS,Overweight and normal weight children from the Hunter region,Australia,HIKCUPS (Hunter Illawarra Kids Challenge Using Parent Support),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",No,467.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",0.15,,,umol/L,,55,Pearson,0.32,,,< 0.001,Yes,,,BMI,Burrows 2009
2145,2300,2307,HIKCUPS,Overweight and normal weight children from the Hunter region,Australia,HIKCUPS (Hunter Illawarra Kids Challenge Using Parent Support),,Food Frequency Questionnaire (FFQ),Lycopene,"",No,4711.0,,,ug/day,,,"Plasma, fasting",HPLC,Lycopene,"",0.5,,,umol/L,,55,Pearson,-0.09,,,>= 0.05,No,,,,Burrows 2009
2150,2300,2307,HIKCUPS,Overweight and normal weight children from the Hunter region,Australia,HIKCUPS (Hunter Illawarra Kids Challenge Using Parent Support),,Food Frequency Questionnaire (FFQ),Lycopene,"",No,4711.0,,,ug/day,,,"Plasma, fasting",HPLC,Lycopene,"",0.5,,,umol/L,,55,Pearson,0.42,,,< 0.001,Yes,,,BMI,Burrows 2009
2146,2301,2308,HIKCUPS,Overweight and normal weight children from the Hunter region,Australia,HIKCUPS (Hunter Illawarra Kids Challenge Using Parent Support),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,2446.0,,,ug/day,,,"Plasma, fasting",HPLC,Lutein,"",0.33,,,umol/L,,55,Pearson,0.14,,,>= 0.05,No,,,,Burrows 2009
2151,2301,2308,HIKCUPS,Overweight and normal weight children from the Hunter region,Australia,HIKCUPS (Hunter Illawarra Kids Challenge Using Parent Support),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,2446.0,,,ug/day,,,"Plasma, fasting",HPLC,Lutein,"",0.33,,,umol/L,,55,Pearson,0.16,,,>= 0.05,No,,,BMI,Burrows 2009
2152,2302,2304,HIKCUPS,Overweight and normal weight children from the Hunter region,Australia,HIKCUPS (Hunter Illawarra Kids Challenge Using Parent Support),,Food Frequency Questionnaire (FFQ),Fruits,"",,2.3,,,servings/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",0.34,,,umol/L,,55,Pearson,0.51,,,< 0.001,Yes,,,BMI,Burrows 2009
2153,2302,2305,HIKCUPS,Overweight and normal weight children from the Hunter region,Australia,HIKCUPS (Hunter Illawarra Kids Challenge Using Parent Support),,Food Frequency Questionnaire (FFQ),Fruits,"",,2.3,,,servings/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",0.07,,,umol/L,,55,Pearson,0.42,,,< 0.001,Yes,,,BMI,Burrows 2009
2154,2302,2306,HIKCUPS,Overweight and normal weight children from the Hunter region,Australia,HIKCUPS (Hunter Illawarra Kids Challenge Using Parent Support),,Food Frequency Questionnaire (FFQ),Fruits,"",,2.3,,,servings/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",0.15,,,umol/L,,55,Pearson,0.36,,,< 0.001,Yes,,,BMI,Burrows 2009
2155,2302,2307,HIKCUPS,Overweight and normal weight children from the Hunter region,Australia,HIKCUPS (Hunter Illawarra Kids Challenge Using Parent Support),,Food Frequency Questionnaire (FFQ),Fruits,"",,2.3,,,servings/day,,,"Plasma, fasting",HPLC,Lycopene,"",0.5,,,umol/L,,55,Pearson,0.42,,,< 0.001,Yes,,,BMI,Burrows 2009
2156,2302,2308,HIKCUPS,Overweight and normal weight children from the Hunter region,Australia,HIKCUPS (Hunter Illawarra Kids Challenge Using Parent Support),,Food Frequency Questionnaire (FFQ),Fruits,"",,2.3,,,servings/day,,,"Plasma, fasting",HPLC,Lutein,"",0.33,,,umol/L,,55,Pearson,0.1,,,>= 0.05,No,,,BMI,Burrows 2009
2157,2303,2304,HIKCUPS,Overweight and normal weight children from the Hunter region,Australia,HIKCUPS (Hunter Illawarra Kids Challenge Using Parent Support),,Food Frequency Questionnaire (FFQ),Vegetables,"",,5.2,,,servings/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",0.34,,,umol/L,,55,Pearson,0.54,,,< 0.001,Yes,,,BMI,Burrows 2009
2158,2303,2305,HIKCUPS,Overweight and normal weight children from the Hunter region,Australia,HIKCUPS (Hunter Illawarra Kids Challenge Using Parent Support),,Food Frequency Questionnaire (FFQ),Vegetables,"",,5.2,,,servings/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",0.07,,,umol/L,,55,Pearson,0.46,,,< 0.001,Yes,,,BMI,Burrows 2009
2159,2303,2306,HIKCUPS,Overweight and normal weight children from the Hunter region,Australia,HIKCUPS (Hunter Illawarra Kids Challenge Using Parent Support),,Food Frequency Questionnaire (FFQ),Vegetables,"",,5.2,,,servings/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",0.15,,,umol/L,,55,Pearson,0.34,,,< 0.001,Yes,,,BMI,Burrows 2009
2160,2303,2307,HIKCUPS,Overweight and normal weight children from the Hunter region,Australia,HIKCUPS (Hunter Illawarra Kids Challenge Using Parent Support),,Food Frequency Questionnaire (FFQ),Vegetables,"",,5.2,,,servings/day,,,"Plasma, fasting",HPLC,Lycopene,"",0.5,,,umol/L,,55,Pearson,0.41,,,< 0.001,Yes,,,BMI,Burrows 2009
2161,2303,2308,HIKCUPS,Overweight and normal weight children from the Hunter region,Australia,HIKCUPS (Hunter Illawarra Kids Challenge Using Parent Support),,Food Frequency Questionnaire (FFQ),Vegetables,"",,5.2,,,servings/day,,,"Plasma, fasting",HPLC,Lutein,"",0.33,,,umol/L,,55,Pearson,0.17,,,>= 0.05,No,,,BMI,Burrows 2009
2350,2262,2269,Normal weight,Overweight and normal weight children from the Hunter region,Australia,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,1652.0,,,ug/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",0.12,,,umol/L,,38,Pearson,0.37,,,< 0.05,Yes,,,BMI ?,Burrows 2009
2351,2286,2293,Obese,Overweight and normal weight children from the Hunter region,Australia,HIKCUPS (Hunter Illawarra Kids Challenge Using Parent Support),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,1687.0,,,ug/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",0.05,,,umol/L,,35,Pearson,0.34,,,< 0.05,Yes,,,BMI ?,Burrows 2009
2192,2375,2363,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),baseline,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,,,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,,,umol/L,,402,Pearson,0.32,,,< 0.05,Yes,,No,,Talegawkar 2008
2198,2375,2363,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),baseline,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,,,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,,,umol/L,,402,Pearson,0.35,,,< 0.05,Yes,,No,"Age, Sex, Energy, BMI, Cholesterol, Smoking status, Month of FFQ administration",Talegawkar 2008
2193,2376,2364,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),baseline,Food Frequency Questionnaire (FFQ),beta-Carotene,"",Yes,,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,402,Pearson,0.22,,,< 0.05,Yes,,No,,Talegawkar 2008
2199,2376,2364,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),baseline,Food Frequency Questionnaire (FFQ),beta-Carotene,"",Yes,,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,402,Pearson,0.26,,,< 0.05,Yes,,No,"Age, Sex, Energy, BMI, Cholesterol, Smoking status, Month of FFQ administration",Talegawkar 2008
2194,2377,2364,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),baseline,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,238,Pearson,0.12,,,< 0.05,Yes,,No,,Talegawkar 2008
2200,2377,2364,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),baseline,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,238,Pearson,0.17,,,< 0.05,Yes,,No,"Age, Sex, Energy, BMI, Cholesterol, Smoking status, Month of FFQ administration",Talegawkar 2008
2195,2378,2366,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),baseline,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",No,,,,ug/day,,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,402,Pearson,0.29,,,< 0.05,Yes,,No,,Talegawkar 2008
2201,2378,2366,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),baseline,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",No,,,,ug/day,,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,402,Pearson,0.34,,,< 0.05,Yes,,No,"Age, Sex, Energy, BMI, Cholesterol, Smoking status, Month of FFQ administration",Talegawkar 2008
2196,2379,2367,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),baseline,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,,,,ug/day,,,"Serum, fasting",HPLC,Lutein/Zeaxanthin,"",,,,umol/L,,402,Pearson,0.13,,,< 0.05,Yes,,No,,Talegawkar 2008
2202,2379,2367,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),baseline,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,,,,ug/day,,,"Serum, fasting",HPLC,Lutein/Zeaxanthin,"",,,,umol/L,,402,Pearson,0.15,,,< 0.05,Yes,,No,"Age, Sex, Energy, BMI, Cholesterol, Smoking status, Month of FFQ administration",Talegawkar 2008
2197,2380,2368,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),baseline,Food Frequency Questionnaire (FFQ),Lycopene,"",No,,,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",,,,umol/L,,402,Pearson,0.24,,,< 0.05,Yes,,No,,Talegawkar 2008
2203,2380,2368,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),baseline,Food Frequency Questionnaire (FFQ),Lycopene,"",No,,,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",,,,umol/L,,402,Pearson,0.19,,,< 0.05,Yes,,No,"Age, Sex, Energy, BMI, Cholesterol, Smoking status, Month of FFQ administration",Talegawkar 2008
2204,2381,2363,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),4 months and 1 week,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,,,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,,,umol/L,,402,Pearson,0.18,,,< 0.05,Yes,,No,,Talegawkar 2008
2210,2381,2363,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),4 months and 1 week,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,,,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,,,umol/L,,400,Pearson,0.21,,,< 0.05,Yes,,No,"Age, Sex, Energy, BMI, Cholesterol, Smoking status, Month of FFQ administration",Talegawkar 2008
2205,2382,2364,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),4 months and 1 week,Food Frequency Questionnaire (FFQ),beta-Carotene,"",Yes,,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,402,Pearson,0.28,,,< 0.05,Yes,,No,,Talegawkar 2008
2211,2382,2364,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),4 months and 1 week,Food Frequency Questionnaire (FFQ),beta-Carotene,"",Yes,,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,400,Pearson,0.28,,,< 0.05,Yes,,No,"Age, Sex, Energy, BMI, Cholesterol, Smoking status, Month of FFQ administration",Talegawkar 2008
2206,2383,2364,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),4 months and 1 week,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,238,Pearson,0.21,,,< 0.05,Yes,,No,,Talegawkar 2008
2212,2383,2364,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),4 months and 1 week,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,238,Pearson,0.2,,,< 0.05,Yes,,No,"Age, Sex, Energy, BMI, Cholesterol, Smoking status, Month of FFQ administration",Talegawkar 2008
2207,2384,2366,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),4 months and 1 week,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",No,,,,ug/day,,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,402,Pearson,0.25,,,< 0.05,Yes,,No,,Talegawkar 2008
2213,2384,2366,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),4 months and 1 week,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",No,,,,ug/day,,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,400,Pearson,0.26,,,< 0.05,Yes,,No,"Age, Sex, Energy, BMI, Cholesterol, Smoking status, Month of FFQ administration",Talegawkar 2008
2208,2385,2367,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),4 months and 1 week,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,,,,ug/day,,,"Serum, fasting",HPLC,Lutein/Zeaxanthin,"",,,,umol/L,,402,Pearson,0.2,,,< 0.05,Yes,,No,,Talegawkar 2008
2214,2385,2367,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),4 months and 1 week,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,,,,ug/day,,,"Serum, fasting",HPLC,Lutein/Zeaxanthin,"",,,,umol/L,,400,Pearson,0.17,,,< 0.05,Yes,,No,"Age, Sex, Energy, BMI, Cholesterol, Smoking status, Month of FFQ administration",Talegawkar 2008
2209,2386,2368,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),4 months and 1 week,Food Frequency Questionnaire (FFQ),Lycopene,"",No,,,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",,,,umol/L,,402,Pearson,0.14,,,< 0.05,Yes,,No,,Talegawkar 2008
2215,2386,2368,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),4 months and 1 week,Food Frequency Questionnaire (FFQ),Lycopene,"",No,,,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",,,,umol/L,,400,Pearson,0.14,,,< 0.05,Yes,,No,"Age, Sex, Energy, BMI, Cholesterol, Smoking status, Month of FFQ administration",Talegawkar 2008
2180,2369,2363,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),,24-h Dietary recall (1-day),alpha-Carotene,"",No,,,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,,,umol/L,,402,Pearson,0.41,,,>= 0.05,No,,Yes,,Talegawkar 2008
2186,2369,2363,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),,24-h Dietary recall (1-day),alpha-Carotene,"",No,,,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,,,umol/L,,401,Pearson,0.37,,,>= 0.05,No,,Yes,"Age, Sex, Energy, BMI, Cholesterol, Smoking status",Talegawkar 2008
2181,2370,2364,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),,24-h Dietary recall (1-day),beta-Carotene,"",Yes,,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,402,Pearson,0.35,,,>= 0.05,No,,Yes,,Talegawkar 2008
2187,2370,2364,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),,24-h Dietary recall (1-day),beta-Carotene,"",Yes,,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,401,Pearson,0.35,,,>= 0.05,No,,Yes,"Age, Sex, Energy, BMI, Cholesterol, Smoking status",Talegawkar 2008
2182,2371,2364,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),,24-h Dietary recall (1-day),beta-Carotene,"",No,,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,238,Pearson,0.32,,,>= 0.05,No,,Yes,,Talegawkar 2008
2188,2371,2364,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),,24-h Dietary recall (1-day),beta-Carotene,"",No,,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,238,Pearson,0.25,,,>= 0.05,No,,Yes,"Age, Sex, Energy, BMI, Cholesterol, Smoking status",Talegawkar 2008
2183,2372,2366,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),,24-h Dietary recall (1-day),beta-Cryptoxanthin,"",No,,,,ug/day,,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,402,Pearson,0.44,,,>= 0.05,No,,Yes,,Talegawkar 2008
2189,2372,2366,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),,24-h Dietary recall (1-day),beta-Cryptoxanthin,"",No,,,,ug/day,,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,401,Pearson,0.42,,,>= 0.05,No,,Yes,"Age, Sex, Energy, BMI, Cholesterol, Smoking status",Talegawkar 2008
2184,2373,2367,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),,24-h Dietary recall (1-day),Lutein/Zeaxanthin,"",No,,,,ug/day,,,"Serum, fasting",HPLC,Lutein/Zeaxanthin,"",,,,umol/L,,402,Pearson,0.39,,,>= 0.05,No,,Yes,,Talegawkar 2008
2190,2373,2367,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),,24-h Dietary recall (1-day),Lutein/Zeaxanthin,"",No,,,,ug/day,,,"Serum, fasting",HPLC,Lutein/Zeaxanthin,"",,,,umol/L,,401,Pearson,0.33,,,>= 0.05,No,,Yes,"Age, Sex, Energy, BMI, Cholesterol, Smoking status",Talegawkar 2008
2185,2374,2368,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),,24-h Dietary recall (1-day),Lycopene,"",No,,,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",,,,umol/L,,402,Pearson,0.4,,,>= 0.05,No,,Yes,,Talegawkar 2008
2191,2374,2368,All [by gender],African American participants in the Diet and Physical Activity Sub-Study (DPASS),United States,JHS (Jackson Heart Study),,24-h Dietary recall (1-day),Lycopene,"",No,,,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",,,,umol/L,,401,Pearson,0.37,,,>= 0.05,No,,Yes,"Age, Sex, Energy, BMI, Cholesterol, Smoking status",Talegawkar 2008
2243,2391,2394,Sub-study I,Participants in a dietary validation study,Norway,,,Weighed Dietary record (7-day),Fruits,"",,,,248.0,g/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,98.0,nmol/L,,147,Pearson,0.1,-0.06,0.26,>= 0.05,No,,,BMI,Carlsen 2011
2244,2391,2395,Sub-study I,Participants in a dietary validation study,Norway,,,Weighed Dietary record (7-day),Fruits,"",,,,248.0,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,414.0,nmol/L,,147,Pearson,-0.02,-0.18,0.14,>= 0.05,No,,,BMI,Carlsen 2011
2245,2391,2396,Sub-study I,Participants in a dietary validation study,Norway,,,Weighed Dietary record (7-day),Fruits,"",,,,248.0,g/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,141.0,nmol/L,,147,Pearson,0.38,0.23,0.51,< 0.001,Yes,,,BMI,Carlsen 2011
2246,2391,2397,Sub-study I,Participants in a dietary validation study,Norway,,,Weighed Dietary record (7-day),Fruits,"",,,,248.0,g/day,,,"Plasma, fasting",HPLC,Lutein,"",,,156.0,nmol/L,,147,Pearson,0.1,-0.06,0.26,>= 0.05,No,,,BMI,Carlsen 2011
2247,2391,2398,Sub-study I,Participants in a dietary validation study,Norway,,,Weighed Dietary record (7-day),Fruits,"",,,,248.0,g/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,567.0,nmol/L,,147,Pearson,-0.04,-0.2,0.12,>= 0.05,No,,,BMI,Carlsen 2011
2248,2391,2399,Sub-study I,Participants in a dietary validation study,Norway,,,Weighed Dietary record (7-day),Fruits,"",,,,248.0,g/day,,,"Plasma, fasting",HPLC,Zeaxanthin,"",,,39.0,nmol/L,,147,Pearson,0.08,-0.08,0.24,>= 0.05,No,,,BMI,Carlsen 2011
2249,2391,2400,Sub-study I,Participants in a dietary validation study,Norway,,,Weighed Dietary record (7-day),Fruits,"",,,,248.0,g/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,1529.0,nmol/L,,147,Pearson,0.03,-0.13,0.19,>= 0.05,No,,,BMI,Carlsen 2011
2250,2391,2401,Sub-study I,Participants in a dietary validation study,Norway,,,Weighed Dietary record (7-day),Fruits,"",,,,248.0,g/day,,,"Plasma, fasting",HPLC,Carotenes,alpha-Carotene + beta-Carotene,,,,nmol/L,,147,Pearson,0.0,-0.16,0.16,>= 0.05,No,,,BMI,Carlsen 2011
2251,2391,2402,Sub-study I,Participants in a dietary validation study,Norway,,,Weighed Dietary record (7-day),Fruits,"",,,,248.0,g/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,nmol/L,,147,Pearson,0.1,-0.06,0.26,>= 0.05,No,,,BMI,Carlsen 2011
2252,2392,2394,Sub-study I,Participants in a dietary validation study,Norway,,,Weighed Dietary record (7-day),Vegetables,"",,,,161.0,g/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,98.0,nmol/L,,147,Pearson,0.27,0.11,0.41,< 0.001,Yes,,,BMI,Carlsen 2011
2253,2392,2395,Sub-study I,Participants in a dietary validation study,Norway,,,Weighed Dietary record (7-day),Vegetables,"",,,,161.0,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,414.0,nmol/L,,147,Pearson,0.27,0.11,0.41,< 0.001,Yes,,,BMI,Carlsen 2011
2254,2392,2396,Sub-study I,Participants in a dietary validation study,Norway,,,Weighed Dietary record (7-day),Vegetables,"",,,,161.0,g/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,141.0,nmol/L,,147,Pearson,-0.03,-0.19,0.13,>= 0.05,No,,,BMI,Carlsen 2011
2255,2392,2397,Sub-study I,Participants in a dietary validation study,Norway,,,Weighed Dietary record (7-day),Vegetables,"",,,,161.0,g/day,,,"Plasma, fasting",HPLC,Lutein,"",,,156.0,nmol/L,,147,Pearson,0.14,-0.02,0.29,>= 0.05,No,,,BMI,Carlsen 2011
2256,2392,2398,Sub-study I,Participants in a dietary validation study,Norway,,,Weighed Dietary record (7-day),Vegetables,"",,,,161.0,g/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,567.0,nmol/L,,147,Pearson,0.03,-0.13,0.19,>= 0.05,No,,,BMI,Carlsen 2011
2257,2392,2399,Sub-study I,Participants in a dietary validation study,Norway,,,Weighed Dietary record (7-day),Vegetables,"",,,,161.0,g/day,,,"Plasma, fasting",HPLC,Zeaxanthin,"",,,39.0,nmol/L,,147,Pearson,0.01,-0.15,0.17,>= 0.05,No,,,BMI,Carlsen 2011
2258,2392,2400,Sub-study I,Participants in a dietary validation study,Norway,,,Weighed Dietary record (7-day),Vegetables,"",,,,161.0,g/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,1529.0,nmol/L,,147,Pearson,0.14,-0.02,0.29,>= 0.05,No,,,BMI,Carlsen 2011
2259,2392,2401,Sub-study I,Participants in a dietary validation study,Norway,,,Weighed Dietary record (7-day),Vegetables,"",,,,161.0,g/day,,,"Plasma, fasting",HPLC,Carotenes,alpha-Carotene + beta-Carotene,,,,nmol/L,,147,Pearson,0.28,0.12,0.42,< 0.001,Yes,,,BMI,Carlsen 2011
2260,2392,2402,Sub-study I,Participants in a dietary validation study,Norway,,,Weighed Dietary record (7-day),Vegetables,"",,,,161.0,g/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,nmol/L,,147,Pearson,0.2,0.04,0.35,< 0.05,Yes,,,BMI,Carlsen 2011
2261,2393,2394,Sub-study I,Participants in a dietary validation study,Norway,,,Weighed Dietary record (7-day),Fruits + Vegetables,Fruits + Vegetables,,,,418.0,g/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,98.0,nmol/L,,147,Pearson,0.2,0.04,0.35,< 0.05,Yes,,,BMI,Carlsen 2011
2262,2393,2395,Sub-study I,Participants in a dietary validation study,Norway,,,Weighed Dietary record (7-day),Fruits + Vegetables,Fruits + Vegetables,,,,418.0,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,414.0,nmol/L,,147,Pearson,0.09,-0.07,0.25,>= 0.05,No,,,BMI,Carlsen 2011
2263,2393,2396,Sub-study I,Participants in a dietary validation study,Norway,,,Weighed Dietary record (7-day),Fruits + Vegetables,Fruits + Vegetables,,,,418.0,g/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,141.0,nmol/L,,147,Pearson,0.33,0.18,0.47,< 0.001,Yes,,,BMI,Carlsen 2011
2264,2393,2397,Sub-study I,Participants in a dietary validation study,Norway,,,Weighed Dietary record (7-day),Fruits + Vegetables,Fruits + Vegetables,,,,418.0,g/day,,,"Plasma, fasting",HPLC,Lutein,"",,,156.0,nmol/L,,147,Pearson,0.15,-0.01,0.3,>= 0.05,No,,,BMI,Carlsen 2011
2265,2393,2398,Sub-study I,Participants in a dietary validation study,Norway,,,Weighed Dietary record (7-day),Fruits + Vegetables,Fruits + Vegetables,,,,418.0,g/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,567.0,nmol/L,,147,Pearson,-0.03,-0.19,0.13,>= 0.05,No,,,BMI,Carlsen 2011
2266,2393,2399,Sub-study I,Participants in a dietary validation study,Norway,,,Weighed Dietary record (7-day),Fruits + Vegetables,Fruits + Vegetables,,,,418.0,g/day,,,"Plasma, fasting",HPLC,Zeaxanthin,"",,,39.0,nmol/L,,147,Pearson,0.08,-0.08,0.24,>= 0.05,No,,,BMI,Carlsen 2011
2267,2393,2400,Sub-study I,Participants in a dietary validation study,Norway,,,Weighed Dietary record (7-day),Fruits + Vegetables,Fruits + Vegetables,,,,418.0,g/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,1529.0,nmol/L,,147,Pearson,0.1,-0.06,0.26,>= 0.05,No,,,BMI,Carlsen 2011
2268,2393,2401,Sub-study I,Participants in a dietary validation study,Norway,,,Weighed Dietary record (7-day),Fruits + Vegetables,Fruits + Vegetables,,,,418.0,g/day,,,"Plasma, fasting",HPLC,Carotenes,alpha-Carotene + beta-Carotene,,,,nmol/L,,147,Pearson,0.12,-0.04,0.28,>= 0.05,No,,,BMI,Carlsen 2011
2269,2393,2402,Sub-study I,Participants in a dietary validation study,Norway,,,Weighed Dietary record (7-day),Fruits + Vegetables,Fruits + Vegetables,,,,418.0,g/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,nmol/L,,147,Pearson,0.19,0.03,0.34,< 0.05,Yes,,,BMI,Carlsen 2011
2216,2387,2394,Sub-study I,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,220.0,g/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,98.0,nmol/L,,147,Pearson,0.15,-0.01,0.3,>= 0.05,No,,,BMI,Carlsen 2011
2217,2387,2395,Sub-study I,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,220.0,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,414.0,nmol/L,,147,Pearson,0.08,-0.08,0.24,>= 0.05,No,,,BMI,Carlsen 2011
2218,2387,2396,Sub-study I,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,220.0,g/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,141.0,nmol/L,,147,Pearson,0.37,0.22,0.5,< 0.001,Yes,,,BMI,Carlsen 2011
2219,2387,2397,Sub-study I,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,220.0,g/day,,,"Plasma, fasting",HPLC,Lutein,"",,,156.0,nmol/L,,147,Pearson,0.1,-0.06,0.26,>= 0.05,No,,,BMI,Carlsen 2011
2220,2387,2398,Sub-study I,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,220.0,g/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,567.0,nmol/L,,147,Pearson,0.04,-0.12,0.2,>= 0.05,No,,,BMI,Carlsen 2011
2221,2387,2399,Sub-study I,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,220.0,g/day,,,"Plasma, fasting",HPLC,Zeaxanthin,"",,,39.0,nmol/L,,147,Pearson,0.11,-0.05,0.27,>= 0.05,No,,,BMI,Carlsen 2011
2222,2387,2400,Sub-study I,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,220.0,g/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,1529.0,nmol/L,,147,Pearson,0.12,-0.04,0.28,>= 0.05,No,,,BMI,Carlsen 2011
2223,2387,2401,Sub-study I,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,220.0,g/day,,,"Plasma, fasting",HPLC,Carotenes,alpha-Carotene + beta-Carotene,,,,nmol/L,,147,Pearson,0.09,-0.07,0.25,>= 0.05,No,,,BMI,Carlsen 2011
2224,2387,2402,Sub-study I,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,220.0,g/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,nmol/L,,147,Pearson,0.18,0.02,0.33,< 0.05,Yes,,,BMI,Carlsen 2011
2225,2388,2394,Sub-study I,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,243.0,g/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,98.0,nmol/L,,147,Pearson,0.28,0.12,0.42,< 0.001,Yes,,,BMI,Carlsen 2011
2226,2388,2395,Sub-study I,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,243.0,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,414.0,nmol/L,,147,Pearson,0.34,0.19,0.48,< 0.001,Yes,,,BMI,Carlsen 2011
2227,2388,2396,Sub-study I,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,243.0,g/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,141.0,nmol/L,,147,Pearson,0.11,-0.05,0.27,>= 0.05,No,,,BMI,Carlsen 2011
2228,2388,2397,Sub-study I,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,243.0,g/day,,,"Plasma, fasting",HPLC,Lutein,"",,,156.0,nmol/L,,147,Pearson,0.14,-0.02,0.29,>= 0.05,No,,,BMI,Carlsen 2011
2229,2388,2398,Sub-study I,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,243.0,g/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,567.0,nmol/L,,147,Pearson,0.15,-0.01,0.3,>= 0.05,No,,,BMI,Carlsen 2011
2230,2388,2399,Sub-study I,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,243.0,g/day,,,"Plasma, fasting",HPLC,Zeaxanthin,"",,,39.0,nmol/L,,147,Pearson,0.09,-0.07,0.25,>= 0.05,No,,,BMI,Carlsen 2011
2231,2388,2400,Sub-study I,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,243.0,g/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,1529.0,nmol/L,,147,Pearson,0.27,0.11,0.41,< 0.001,Yes,,,BMI,Carlsen 2011
2232,2388,2401,Sub-study I,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,243.0,g/day,,,"Plasma, fasting",HPLC,Carotenes,alpha-Carotene + beta-Carotene,,,,nmol/L,,147,Pearson,0.34,0.19,0.48,< 0.001,Yes,,,BMI,Carlsen 2011
2233,2388,2402,Sub-study I,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,243.0,g/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,nmol/L,,147,Pearson,0.29,0.13,0.43,< 0.001,Yes,,,BMI,Carlsen 2011
2234,2389,2394,Sub-study I,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,513.0,g/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,98.0,nmol/L,,147,Pearson,0.3,0.15,0.44,< 0.001,Yes,,,BMI,Carlsen 2011
2235,2389,2395,Sub-study I,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,513.0,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,414.0,nmol/L,,147,Pearson,0.26,0.1,0.4,< 0.01,Yes,,,BMI,Carlsen 2011
2236,2389,2396,Sub-study I,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,513.0,g/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,141.0,nmol/L,,147,Pearson,0.37,0.22,0.5,< 0.001,Yes,,,BMI,Carlsen 2011
2237,2389,2397,Sub-study I,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,513.0,g/day,,,"Plasma, fasting",HPLC,Lutein,"",,,156.0,nmol/L,,147,Pearson,0.18,0.02,0.33,>= 0.05,No,,,BMI,Carlsen 2011
2238,2389,2398,Sub-study I,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,513.0,g/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,567.0,nmol/L,,147,Pearson,0.12,-0.42,0.28,>= 0.05,No,,,BMI,Carlsen 2011
2239,2389,2399,Sub-study I,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,513.0,g/day,,,"Plasma, fasting",HPLC,Zeaxanthin,"",,,39.0,nmol/L,,147,Pearson,0.18,0.02,0.33,>= 0.05,No,,,BMI,Carlsen 2011
2240,2389,2400,Sub-study I,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,513.0,g/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,1529.0,nmol/L,,147,Pearson,0.28,0.12,0.42,< 0.001,Yes,,,BMI,Carlsen 2011
2241,2389,2401,Sub-study I,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,513.0,g/day,,,"Plasma, fasting",HPLC,Carotenes,alpha-Carotene + beta-Carotene,,,,nmol/L,,147,Pearson,0.28,0.12,0.42,< 0.001,Yes,,,BMI,Carlsen 2011
2242,2389,2402,Sub-study I,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,513.0,g/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,nmol/L,,147,Pearson,0.34,0.19,0.48,< 0.001,Yes,,,BMI,Carlsen 2011
2270,2403,2406,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,235.0,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Apigenin,"",,,0.9,ug/day,,85,Pearson,0.23,0.02,0.42,< 0.05,Yes,,,,Carlsen 2011
2271,2403,2407,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,235.0,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Eriodictyol,"",,,31.7,ug/day,,85,Pearson,0.27,0.06,0.46,< 0.05,Yes,,,,Carlsen 2011
2272,2403,2408,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,235.0,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Hesperetin,"",,,98.0,ug/day,,85,Pearson,0.53,0.36,0.67,< 0.001,Yes,,,,Carlsen 2011
2273,2403,2409,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,235.0,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",,,7.9,ug/day,,85,Pearson,0.19,-0.02,0.39,>= 0.05,No,,,,Carlsen 2011
2274,2403,2410,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,235.0,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Naringenin,"",,,221.4,ug/day,,85,Pearson,0.49,0.31,0.64,< 0.001,Yes,,,,Carlsen 2011
2275,2403,2411,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,235.0,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Phloretin,"",,,62.7,ug/day,,85,Pearson,0.11,-0.11,0.32,>= 0.05,No,,,,Carlsen 2011
2276,2403,2412,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,235.0,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Quercetin,"",,,61.2,ug/day,,85,Pearson,0.03,-0.18,0.24,>= 0.05,No,,,,Carlsen 2011
2277,2403,2413,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,235.0,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Tamarixetin/Isorhamnetin,"",,,20.5,ug/day,,85,Pearson,0.46,0.27,0.61,< 0.001,Yes,,,,Carlsen 2011
2278,2403,2414,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,235.0,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Flavonoids,Quercetin + Kaempferol + Naringenin + Hesperetin + Apigenin + Phloretin + Eriodictyol + Tamarixetin/Isorhamnetin,,,650.5,ug/day,,85,Pearson,0.45,0.26,0.61,< 0.001,Yes,,,,Carlsen 2011
2279,2403,2415,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,235.0,g/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,112.0,nmol/L,,85,Pearson,0.45,0.26,0.61,< 0.001,Yes,,,BMI,Carlsen 2011
2280,2403,2416,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,235.0,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,501.0,nmol/L,,85,Pearson,0.31,0.1,0.49,< 0.001,Yes,,,BMI,Carlsen 2011
2281,2403,2417,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,235.0,g/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,140.0,nmol/L,,85,Pearson,0.49,0.31,0.64,< 0.001,Yes,,,BMI,Carlsen 2011
2282,2403,2418,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,235.0,g/day,,,"Plasma, fasting",HPLC,Lutein,"",,,163.0,nmol/L,,85,Pearson,0.31,0.1,0.49,< 0.01,Yes,,,BMI,Carlsen 2011
2283,2403,2419,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,235.0,g/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,623.0,nmol/L,,85,Pearson,0.12,-0.1,0.32,>= 0.05,No,,,BMI,Carlsen 2011
2284,2403,2420,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,235.0,g/day,,,"Plasma, fasting",HPLC,Zeaxanthin,"",,,39.0,nmol/L,,85,Pearson,0.33,0.13,0.51,< 0.05,Yes,,,BMI,Carlsen 2011
2285,2403,2421,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,235.0,g/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,1612.0,nmol/L,,85,Pearson,0.43,0.24,0.59,< 0.001,Yes,,,BMI,Carlsen 2011
2286,2404,2406,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,222.0,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Apigenin,"",,,0.9,ug/day,,85,Pearson,0.26,0.05,0.45,< 0.05,Yes,,,,Carlsen 2011
2287,2404,2407,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,222.0,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Eriodictyol,"",,,31.7,ug/day,,85,Pearson,0.05,-0.16,0.26,>= 0.05,No,,,,Carlsen 2011
2288,2404,2408,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,222.0,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Hesperetin,"",,,98.0,ug/day,,85,Pearson,0.15,-0.07,0.35,>= 0.05,No,,,,Carlsen 2011
2289,2404,2409,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,222.0,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",,,7.9,ug/day,,85,Pearson,0.07,-0.15,0.28,>= 0.05,No,,,,Carlsen 2011
2290,2404,2410,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,222.0,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Naringenin,"",,,221.4,ug/day,,85,Pearson,0.12,-0.1,0.32,>= 0.05,No,,,,Carlsen 2011
2291,2404,2411,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,222.0,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Phloretin,"",,,62.7,ug/day,,85,Pearson,0.01,-0.2,0.22,>= 0.05,No,,,,Carlsen 2011
2292,2404,2412,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,222.0,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Quercetin,"",,,61.2,ug/day,,85,Pearson,-0.02,-0.23,0.19,>= 0.05,No,,,,Carlsen 2011
2293,2404,2413,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,222.0,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Tamarixetin/Isorhamnetin,"",,,20.5,ug/day,,85,Pearson,0.26,0.05,0.45,< 0.05,Yes,,,,Carlsen 2011
2294,2404,2414,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,222.0,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Flavonoids,Quercetin + Kaempferol + Naringenin + Hesperetin + Apigenin + Phloretin + Eriodictyol + Tamarixetin/Isorhamnetin,,,650.5,ug/day,,85,Pearson,0.11,-0.11,0.32,>= 0.05,No,,,,Carlsen 2011
2295,2404,2415,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,222.0,g/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,112.0,nmol/L,,85,Pearson,0.37,0.17,0.54,< 0.001,Yes,,,BMI,Carlsen 2011
2296,2404,2416,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,222.0,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,501.0,nmol/L,,85,Pearson,0.29,0.08,0.47,< 0.01,Yes,,,BMI,Carlsen 2011
2297,2404,2417,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,222.0,g/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,140.0,nmol/L,,85,Pearson,0.14,-0.07,0.34,>= 0.05,No,,,BMI,Carlsen 2011
2298,2404,2418,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,222.0,g/day,,,"Plasma, fasting",HPLC,Lutein,"",,,163.0,nmol/L,,85,Pearson,0.24,0.03,0.43,< 0.05,Yes,,,BMI,Carlsen 2011
2299,2404,2419,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,222.0,g/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,623.0,nmol/L,,85,Pearson,0.17,-0.04,0.37,>= 0.05,No,,,BMI,Carlsen 2011
2300,2404,2420,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,222.0,g/day,,,"Plasma, fasting",HPLC,Zeaxanthin,"",,,39.0,nmol/L,,85,Pearson,0.05,-0.16,0.26,>= 0.05,No,,,BMI,Carlsen 2011
2301,2404,2421,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,222.0,g/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,1612.0,nmol/L,,85,Pearson,0.34,0.14,0.52,< 0.01,Yes,,,BMI,Carlsen 2011
2302,2405,2406,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,489.0,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Apigenin,"",,,0.9,ug/day,,85,Pearson,0.3,0.09,0.48,< 0.01,Yes,,,,Carlsen 2011
2303,2405,2407,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,489.0,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Eriodictyol,"",,,31.7,ug/day,,85,Pearson,0.24,0.03,0.43,< 0.05,Yes,,,,Carlsen 2011
2304,2405,2408,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,489.0,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Hesperetin,"",,,98.0,ug/day,,85,Pearson,0.44,0.25,0.6,< 0.001,Yes,,,,Carlsen 2011
2305,2405,2409,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,489.0,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",,,7.9,ug/day,,85,Pearson,0.19,-0.02,0.39,>= 0.05,No,,,,Carlsen 2011
2306,2405,2410,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,489.0,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Naringenin,"",,,221.4,ug/day,,85,Pearson,0.4,0.2,0.56,< 0.001,Yes,,,,Carlsen 2011
2307,2405,2411,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,489.0,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Phloretin,"",,,62.7,ug/day,,85,Pearson,0.11,-0.11,0.32,>= 0.05,No,,,,Carlsen 2011
2308,2405,2412,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,489.0,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Quercetin,"",,,61.2,ug/day,,85,Pearson,0.01,-0.2,0.22,>= 0.05,No,,,,Carlsen 2011
2309,2405,2413,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,489.0,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Tamarixetin/Isorhamnetin,"",,,20.5,ug/day,,85,Pearson,0.47,0.29,0.62,< 0.001,Yes,,,,Carlsen 2011
2310,2405,2414,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,489.0,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Flavonoids,Quercetin + Kaempferol + Naringenin + Hesperetin + Apigenin + Phloretin + Eriodictyol + Tamarixetin/Isorhamnetin,,,650.5,ug/day,,85,Pearson,0.39,0.19,0.56,< 0.001,Yes,,,,Carlsen 2011
2311,2405,2415,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,489.0,g/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,112.0,nmol/L,,85,Pearson,0.53,0.36,0.67,< 0.001,Yes,,,BMI,Carlsen 2011
2312,2405,2416,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,489.0,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,501.0,nmol/L,,85,Pearson,0.37,0.17,0.54,< 0.001,Yes,,,BMI,Carlsen 2011
2313,2405,2417,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,489.0,g/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,140.0,nmol/L,,85,Pearson,0.41,0.22,0.57,< 0.001,Yes,,,BMI,Carlsen 2011
2314,2405,2418,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,489.0,g/day,,,"Plasma, fasting",HPLC,Lutein,"",,,163.0,nmol/L,,85,Pearson,0.31,0.1,0.49,< 0.01,Yes,,,BMI,Carlsen 2011
2315,2405,2419,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,489.0,g/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,623.0,nmol/L,,85,Pearson,0.16,-0.06,0.36,>= 0.05,No,,,BMI,Carlsen 2011
2316,2405,2420,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,489.0,g/day,,,"Plasma, fasting",HPLC,Zeaxanthin,"",,,39.0,nmol/L,,85,Pearson,0.25,0.04,0.44,< 0.05,Yes,,,BMI,Carlsen 2011
2317,2405,2421,Sub-study II,Participants in a dietary validation study,Norway,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,489.0,g/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,1612.0,nmol/L,,85,Pearson,0.46,0.27,0.61,< 0.001,Yes,,,BMI,Carlsen 2011
2318,2422,2454,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,Food Frequency Questionnaire (FFQ),Myristic acid (14:0),"",,,4.7,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,Myristic acid (14:0),"",,0.61,,percentRoot,,88,Spearman,0.23,,,< 0.05,Yes,,,,Wennberg 2009
2320,2424,2456,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,Food Frequency Questionnaire (FFQ),Pentadecylic acid (15:0),"",,,0.3,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,Pentadecylic acid (15:0),"",,0.21,,percentRoot,,88,Spearman,0.31,,,< 0.005,Yes,,,,Wennberg 2009
2322,2426,2458,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,,21.0,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,Palmitic acid (16:0),"",,28.0,,percentRoot,,88,Spearman,-0.02,,,>= 0.05,No,,,,Wennberg 2009
2324,2428,2460,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,Food Frequency Questionnaire (FFQ),Margaric acid (17:0),"",,,0.17,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,Margaric acid (17:0),"",,0.4,,percentRoot,,88,Spearman,0.3,,,< 0.005,Yes,,,,Wennberg 2009
2326,2430,2462,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,9.5,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,14.0,,percentRoot,,88,Spearman,-0.08,,,>= 0.05,No,,,,Wennberg 2009
2328,2432,2464,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,1.1,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,0.31,,percentRoot,,88,Spearman,-0.3,,,< 0.005,Yes,,,,Wennberg 2009
2330,2434,2466,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,0.09,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,EPA (cis-20:5n-3),"",,1.4,,percentRoot,,88,Spearman,0.42,,,< 0.005,Yes,,,,Wennberg 2009
2332,2436,2468,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,0.21,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,DHA (cis-22:6n-3),"",,5.3,,percentRoot,,88,Spearman,0.48,,,< 0.005,Yes,,,,Wennberg 2009
2334,2438,2454,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,24-h Dietary recall (1-day),Myristic acid (14:0),"",,,4.7,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,Myristic acid (14:0),"",,0.61,,percentRoot,,88,Spearman,0.29,,,< 0.005,Yes,,,,Wennberg 2009
2336,2440,2456,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,24-h Dietary recall (1-day),Pentadecylic acid (15:0),"",,,0.36,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,Pentadecylic acid (15:0),"",,0.21,,percentRoot,,88,Spearman,0.31,,,< 0.005,Yes,,,,Wennberg 2009
2338,2442,2458,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,24-h Dietary recall (1-day),Palmitic acid (16:0),"",,,21.0,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,Palmitic acid (16:0),"",,28.0,,percentRoot,,88,Spearman,0.24,,,< 0.05,Yes,,,,Wennberg 2009
2340,2444,2460,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,24-h Dietary recall (1-day),Margaric acid (17:0),"",,,0.21,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,Margaric acid (17:0),"",,0.4,,percentRoot,,88,Spearman,0.06,,,>= 0.05,No,,,,Wennberg 2009
2342,2446,2462,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,24-h Dietary recall (1-day),Linoleic acid (LA; cis-18:2n-6),"",,,12.0,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,14.0,,percentRoot,,88,Spearman,0.11,,,>= 0.05,No,,,,Wennberg 2009
2344,2448,2464,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,24-h Dietary recall (1-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,1.7,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,0.31,,percentRoot,,88,Spearman,-0.09,,,>= 0.05,No,,,,Wennberg 2009
2346,2450,2466,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,24-h Dietary recall (1-day),EPA (cis-20:5n-3),"",,,0.1,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,EPA (cis-20:5n-3),"",,1.4,,percentRoot,,88,Spearman,0.39,,,< 0.005,Yes,,,,Wennberg 2009
2348,2452,2468,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,24-h Dietary recall (1-day),DHA (cis-22:6n-3),"",,,0.25,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,DHA (cis-22:6n-3),"",,5.3,,percentRoot,,88,Spearman,0.38,,,< 0.005,Yes,,,,Wennberg 2009
2319,2423,2455,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,Food Frequency Questionnaire (FFQ),Myristic acid (14:0),"",,,4.8,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,Myristic acid (14:0),"",,0.63,,percentRoot,,92,Spearman,0.18,,,>= 0.05,No,,,,Wennberg 2009
2321,2425,2457,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,Food Frequency Questionnaire (FFQ),Pentadecylic acid (15:0),"",,,0.3,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,Pentadecylic acid (15:0),"",,0.22,,percentRoot,,92,Spearman,0.34,,,< 0.005,Yes,,,,Wennberg 2009
2323,2427,2459,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,,21.0,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,Palmitic acid (16:0),"",,28.0,,percentRoot,,92,Spearman,0.04,,,>= 0.05,No,,,,Wennberg 2009
2325,2429,2461,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,Food Frequency Questionnaire (FFQ),Margaric acid (17:0),"",,,0.18,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,Margaric acid (17:0),"",,0.4,,percentRoot,,92,Spearman,0.25,,,< 0.05,Yes,,,,Wennberg 2009
2327,2431,2463,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,9.6,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,15.0,,percentRoot,,92,Spearman,0.09,,,>= 0.05,No,,,,Wennberg 2009
2329,2433,2465,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,1.2,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,0.33,,percentRoot,,92,Spearman,-0.12,,,>= 0.05,No,,,,Wennberg 2009
2331,2435,2467,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,0.11,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,EPA (cis-20:5n-3),"",,1.4,,percentRoot,,92,Spearman,0.46,,,< 0.005,Yes,,,,Wennberg 2009
2333,2437,2469,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,0.24,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,DHA (cis-22:6n-3),"",,5.7,,percentRoot,,92,Spearman,0.51,,,< 0.005,Yes,,,,Wennberg 2009
2335,2439,2455,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,24-h Dietary recall (1-day),Myristic acid (14:0),"",,,4.7,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,Myristic acid (14:0),"",,0.63,,percentRoot,,92,Spearman,0.29,,,< 0.005,Yes,,,,Wennberg 2009
2337,2441,2457,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,24-h Dietary recall (1-day),Pentadecylic acid (15:0),"",,,0.36,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,Pentadecylic acid (15:0),"",,0.22,,percentRoot,,92,Spearman,0.43,,,< 0.005,Yes,,,,Wennberg 2009
2339,2443,2459,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,24-h Dietary recall (1-day),Palmitic acid (16:0),"",,,21.0,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,Palmitic acid (16:0),"",,28.0,,percentRoot,,92,Spearman,0.06,,,>= 0.05,No,,,,Wennberg 2009
2341,2445,2461,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,24-h Dietary recall (1-day),Margaric acid (17:0),"",,,0.21,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,Margaric acid (17:0),"",,0.4,,percentRoot,,92,Spearman,0.32,,,< 0.005,Yes,,,,Wennberg 2009
2343,2447,2463,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,24-h Dietary recall (1-day),Linoleic acid (LA; cis-18:2n-6),"",,,12.0,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,15.0,,percentRoot,,92,Spearman,0.13,,,>= 0.05,No,,,,Wennberg 2009
2345,2449,2465,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,24-h Dietary recall (1-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,1.8,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,0.33,,percentRoot,,92,Spearman,-0.08,,,>= 0.05,No,,,,Wennberg 2009
2347,2451,2467,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,24-h Dietary recall (1-day),EPA (cis-20:5n-3),"",,,0.09,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,EPA (cis-20:5n-3),"",,1.4,,percentRoot,,92,Spearman,0.4,,,< 0.005,Yes,,,,Wennberg 2009
2349,2453,2469,Adults in Northern Sweden,Adults in Northern Sweden,Sweden,VIP (Vasterbotten Intervention Project),,24-h Dietary recall (1-day),DHA (cis-22:6n-3),"",,,0.22,,percentRoot,,,"Red blood cell membrane, fasting",GC-FID,DHA (cis-22:6n-3),"",,5.7,,percentRoot,,92,Spearman,0.42,,,< 0.005,Yes,,,,Wennberg 2009
2353,2516,2521,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Fats,"",,29.74,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin + Dihydrodaidzein + Dihydrogenistein,,15.25,17.13,nmol/mg,Creatinine,2165,Spearman,0.01,-0.03,0.05,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2359,2516,2522,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Fats,"",,29.74,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Daidzein,"",,4.99,5.57,nmol/mg,Creatinine,2165,Spearman,0.02,-0.02,0.06,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2365,2516,2523,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Fats,"",,29.74,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Genistein,"",,2.07,2.41,nmol/mg,Creatinine,2165,Spearman,0.0,-0.05,0.04,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2371,2516,2524,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Fats,"",,29.74,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Glycitein,"",,0.81,0.94,nmol/mg,Creatinine,2165,Spearman,0.0,-0.04,0.04,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2377,2516,2525,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Fats,"",,29.74,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,O-Desmethylangolensin,"",,0.82,1.52,nmol/mg,Creatinine,2165,Spearman,0.0,-0.04,0.04,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2383,2516,2526,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Fats,"",,29.74,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Dihydrodaidzein,"",,0.58,0.81,nmol/mg,Creatinine,2165,Spearman,0.01,-0.03,0.06,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2389,2516,2527,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Fats,"",,29.74,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Dihydrogenistein,"",,0.18,0.19,nmol/mg,Creatinine,2165,Spearman,-0.01,-0.05,0.04,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2395,2516,2528,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Fats,"",,29.74,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Equol,"",,0.06,0.11,nmol/mg,Creatinine,2165,Spearman,0.01,-0.03,0.06,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2401,2516,2529,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Fats,"",,29.74,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",,0.26,0.3,nmol/mg,Creatinine,2165,Spearman,0.03,-0.02,0.07,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2407,2516,2530,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Fats,"",,29.74,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",,0.34,1.18,nmol/mg,Creatinine,2165,Spearman,0.07,0.02,0.11,< 0.05,Yes,,,"Age, BMI, Exercise, Energy",Wu 2012
2356,2518,2521,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Soy foods,"",,144.32,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin + Dihydrodaidzein + Dihydrogenistein,,15.25,17.13,nmol/mg,Creatinine,2165,Spearman,0.21,0.17,0.25,< 0.05,Yes,,,"Age, BMI, Exercise, Energy",Wu 2012
2362,2518,2522,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Soy foods,"",,144.32,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Daidzein,"",,4.99,5.57,nmol/mg,Creatinine,2165,Spearman,0.22,0.18,0.26,< 0.05,Yes,,,"Age, BMI, Exercise, Energy",Wu 2012
2368,2518,2523,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Soy foods,"",,144.32,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Genistein,"",,2.07,2.41,nmol/mg,Creatinine,2165,Spearman,0.2,0.16,0.24,< 0.05,Yes,,,"Age, BMI, Exercise, Energy",Wu 2012
2374,2518,2524,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Soy foods,"",,144.32,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Glycitein,"",,0.81,0.94,nmol/mg,Creatinine,2165,Spearman,0.2,0.16,0.24,< 0.05,Yes,,,"Age, BMI, Exercise, Energy",Wu 2012
2380,2518,2525,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Soy foods,"",,144.32,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,O-Desmethylangolensin,"",,0.82,1.52,nmol/mg,Creatinine,2165,Spearman,0.11,0.07,0.15,< 0.05,Yes,,,"Age, BMI, Exercise, Energy",Wu 2012
2386,2518,2526,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Soy foods,"",,144.32,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Dihydrodaidzein,"",,0.58,0.81,nmol/mg,Creatinine,2165,Spearman,0.1,0.06,0.14,< 0.05,Yes,,,"Age, BMI, Exercise, Energy",Wu 2012
2392,2518,2527,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Soy foods,"",,144.32,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Dihydrogenistein,"",,0.18,0.19,nmol/mg,Creatinine,2165,Spearman,0.09,0.05,0.14,< 0.05,Yes,,,"Age, BMI, Exercise, Energy",Wu 2012
2398,2518,2528,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Soy foods,"",,144.32,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Equol,"",,0.06,0.11,nmol/mg,Creatinine,2165,Spearman,0.04,0.0,0.08,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2404,2518,2529,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Soy foods,"",,144.32,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",,0.26,0.3,nmol/mg,Creatinine,2165,Spearman,0.01,-0.04,0.06,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2410,2518,2530,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Soy foods,"",,144.32,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",,0.34,1.18,nmol/mg,Creatinine,2165,Spearman,0.01,-0.04,0.06,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2352,2519,2521,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Proteins from Soy foods,"",,9.1,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin + Dihydrodaidzein + Dihydrogenistein,,15.25,17.13,nmol/mg,Creatinine,2165,Spearman,0.03,-0.01,0.07,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2358,2519,2522,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Proteins from Soy foods,"",,9.1,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Daidzein,"",,4.99,5.57,nmol/mg,Creatinine,2165,Spearman,0.03,-0.01,0.07,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2364,2519,2523,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Proteins from Soy foods,"",,9.1,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Genistein,"",,2.07,2.41,nmol/mg,Creatinine,2165,Spearman,0.01,-0.03,0.05,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2370,2519,2524,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Proteins from Soy foods,"",,9.1,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Glycitein,"",,0.81,0.94,nmol/mg,Creatinine,2165,Spearman,0.03,-0.01,0.07,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2376,2519,2525,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Proteins from Soy foods,"",,9.1,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,O-Desmethylangolensin,"",,0.82,1.52,nmol/mg,Creatinine,2165,Spearman,0.01,-0.03,0.05,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2382,2519,2526,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Proteins from Soy foods,"",,9.1,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Dihydrodaidzein,"",,0.58,0.81,nmol/mg,Creatinine,2165,Spearman,0.01,-0.03,0.05,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2388,2519,2527,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Proteins from Soy foods,"",,9.1,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Dihydrogenistein,"",,0.18,0.19,nmol/mg,Creatinine,2165,Spearman,0.0,-0.04,0.04,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2394,2519,2528,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Proteins from Soy foods,"",,9.1,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Equol,"",,0.06,0.11,nmol/mg,Creatinine,2165,Spearman,0.01,-0.03,0.06,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2400,2519,2529,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Proteins from Soy foods,"",,9.1,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",,0.26,0.3,nmol/mg,Creatinine,2165,Spearman,0.0,-0.05,0.05,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2406,2519,2530,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Proteins from Soy foods,"",,9.1,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",,0.34,1.18,nmol/mg,Creatinine,2165,Spearman,0.04,-0.01,0.09,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2357,2520,2521,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Isoflavones,"",,31.29,,,mg/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin + Dihydrodaidzein + Dihydrogenistein,,15.25,17.13,nmol/mg,Creatinine,2165,Spearman,0.2,0.16,0.24,< 0.05,Yes,,,"Age, BMI, Exercise, Energy",Wu 2012
2363,2520,2522,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Isoflavones,"",,31.29,,,mg/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Daidzein,"",,4.99,5.57,nmol/mg,Creatinine,2165,Spearman,0.2,0.16,0.24,< 0.05,Yes,,,"Age, BMI, Exercise, Energy",Wu 2012
2369,2520,2523,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Isoflavones,"",,31.29,,,mg/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Genistein,"",,2.07,2.41,nmol/mg,Creatinine,2165,Spearman,0.18,0.14,0.22,< 0.05,Yes,,,"Age, BMI, Exercise, Energy",Wu 2012
2375,2520,2524,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Isoflavones,"",,31.29,,,mg/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Glycitein,"",,0.81,0.94,nmol/mg,Creatinine,2165,Spearman,0.18,0.14,0.22,< 0.05,Yes,,,"Age, BMI, Exercise, Energy",Wu 2012
2381,2520,2525,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Isoflavones,"",,31.29,,,mg/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,O-Desmethylangolensin,"",,0.82,1.52,nmol/mg,Creatinine,2165,Spearman,0.11,0.07,0.15,< 0.05,Yes,,,"Age, BMI, Exercise, Energy",Wu 2012
2387,2520,2526,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Isoflavones,"",,31.29,,,mg/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Dihydrodaidzein,"",,0.58,0.81,nmol/mg,Creatinine,2165,Spearman,0.11,0.07,0.15,< 0.05,Yes,,,"Age, BMI, Exercise, Energy",Wu 2012
2393,2520,2527,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Isoflavones,"",,31.29,,,mg/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Dihydrogenistein,"",,0.18,0.19,nmol/mg,Creatinine,2165,Spearman,0.1,0.06,0.14,< 0.05,Yes,,,"Age, BMI, Exercise, Energy",Wu 2012
2399,2520,2528,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Isoflavones,"",,31.29,,,mg/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Equol,"",,0.06,0.11,nmol/mg,Creatinine,2165,Spearman,0.05,0.01,0.1,< 0.05,Yes,,,"Age, BMI, Exercise, Energy",Wu 2012
2405,2520,2529,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Isoflavones,"",,31.29,,,mg/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",,0.26,0.3,nmol/mg,Creatinine,2165,Spearman,0.01,-0.03,0.06,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2411,2520,2530,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Isoflavones,"",,31.29,,,mg/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",,0.34,1.18,nmol/mg,Creatinine,2165,Spearman,0.02,-0.03,0.07,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2355,2531,2521,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin + Dihydrodaidzein + Dihydrogenistein,,15.25,17.13,nmol/mg,Creatinine,2165,Spearman,-0.07,-0.11,-0.03,< 0.05,Yes,,,"Age, BMI, Exercise, Energy",Wu 2012
2361,2531,2522,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Daidzein,"",,4.99,5.57,nmol/mg,Creatinine,2165,Spearman,-0.06,-0.11,-0.02,< 0.05,Yes,,,"Age, BMI, Exercise, Energy",Wu 2012
2367,2531,2523,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Genistein,"",,2.07,2.41,nmol/mg,Creatinine,2165,Spearman,-0.06,-0.11,-0.02,< 0.05,Yes,,,"Age, BMI, Exercise, Energy",Wu 2012
2373,2531,2524,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Glycitein,"",,0.81,0.94,nmol/mg,Creatinine,2165,Spearman,-0.06,-0.1,-0.02,< 0.05,Yes,,,"Age, BMI, Exercise, Energy",Wu 2012
2379,2531,2525,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,O-Desmethylangolensin,"",,0.82,1.52,nmol/mg,Creatinine,2165,Spearman,-0.05,-0.09,-0.01,< 0.05,Yes,,,"Age, BMI, Exercise, Energy",Wu 2012
2385,2531,2526,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Dihydrodaidzein,"",,0.58,0.81,nmol/mg,Creatinine,2165,Spearman,-0.03,-0.07,0.01,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2391,2531,2527,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Dihydrogenistein,"",,0.18,0.19,nmol/mg,Creatinine,2165,Spearman,-0.04,-0.08,0.01,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2397,2531,2528,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Equol,"",,0.06,0.11,nmol/mg,Creatinine,2165,Spearman,-0.02,-0.07,0.02,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2403,2531,2529,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",,0.26,0.3,nmol/mg,Creatinine,2165,Spearman,0.04,-0.01,0.08,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2409,2531,2530,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",,0.34,1.18,nmol/mg,Creatinine,2165,Spearman,0.03,-0.02,0.08,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2354,2532,2521,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin + Dihydrodaidzein + Dihydrogenistein,,15.25,17.13,nmol/mg,Creatinine,2165,Spearman,-0.03,-0.08,0.01,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2360,2532,2522,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Daidzein,"",,4.99,5.57,nmol/mg,Creatinine,2165,Spearman,-0.03,-0.07,0.01,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2366,2532,2523,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Genistein,"",,2.07,2.41,nmol/mg,Creatinine,2165,Spearman,-0.05,-0.09,-0.01,< 0.05,Yes,,,"Age, BMI, Exercise, Energy",Wu 2012
2372,2532,2524,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Glycitein,"",,0.81,0.94,nmol/mg,Creatinine,2165,Spearman,-0.04,-0.08,0.0,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2378,2532,2525,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,O-Desmethylangolensin,"",,0.82,1.52,nmol/mg,Creatinine,2165,Spearman,0.0,-0.04,0.04,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2384,2532,2526,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Dihydrodaidzein,"",,0.58,0.81,nmol/mg,Creatinine,2165,Spearman,-0.04,-0.08,0.0,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2390,2532,2527,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Dihydrogenistein,"",,0.18,0.19,nmol/mg,Creatinine,2165,Spearman,-0.04,-0.08,0.01,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2396,2532,2528,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Equol,"",,0.06,0.11,nmol/mg,Creatinine,2165,Spearman,-0.03,-0.07,0.01,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2402,2532,2529,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",,0.26,0.3,nmol/mg,Creatinine,2165,Spearman,0.01,-0.03,0.06,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2408,2532,2530,All,Midle-aged and elderly women,China,SWHS (Shanghai Women's Health Study),,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,g/day,,,"Urine, spot",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",,0.34,1.18,nmol/mg,Creatinine,2165,Spearman,-0.01,-0.06,0.03,>= 0.05,No,,,"Age, BMI, Exercise, Energy",Wu 2012
2412,2533,2550,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,367.2,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,98.6,,nmol/L,,25,Pearson,0.569,,,< 0.01,Yes,,,"Age, Percentage body fat",Chung 2009
2430,2533,2567,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,367.2,,ug/day,,,"Adipose tissue, abdomen",HPLC,alpha-Carotene,"",,280.5,,pmol/mg,Specimen dry weight,25,Pearson,0.236,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2448,2533,2586,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,367.2,,ug/day,,,"Adipose tissue, buttocks",HPLC,alpha-Carotene,"",,166.7,,pmol/mg,Specimen dry weight,25,Pearson,0.516,,,< 0.05,Yes,,,"Age, Percentage body fat",Chung 2009
2466,2533,2604,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,367.2,,ug/day,,,"Adipose tissue, thigh",HPLC,alpha-Carotene,"",,127.3,,pmol/mg,Specimen dry weight,25,Pearson,0.037,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2413,2534,2551,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Carotenes,beta-Carotene + 13-cis-beta-Carotene + 9-cis-beta-Carotene,,,2960.7,,ug/day,,,"Serum, fasting",HPLC,Carotenes,beta-Carotene + 13-cis-beta-Carotene + 9-cis-beta-Carotene,,568.8,,nmol/L,,25,Pearson,0.536,,,< 0.01,Yes,,,"Age, Percentage body fat",Chung 2009
2431,2534,2568,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Carotenes,beta-Carotene + 13-cis-beta-Carotene + 9-cis-beta-Carotene,,,2960.7,,ug/day,,,"Adipose tissue, abdomen",HPLC,Carotenes,beta-Carotene + 13-cis-beta-Carotene + 9-cis-beta-Carotene,,1472.0,,pmol/mg,Specimen dry weight,25,Pearson,0.426,,,< 0.05,Yes,,,"Age, Percentage body fat",Chung 2009
2449,2534,2587,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Carotenes,beta-Carotene + 13-cis-beta-Carotene + 9-cis-beta-Carotene,,,2960.7,,ug/day,,,"Adipose tissue, buttocks",HPLC,Carotenes,beta-Carotene + 13-cis-beta-Carotene + 9-cis-beta-Carotene,,1129.5,,pmol/mg,Specimen dry weight,25,Pearson,0.187,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2467,2534,2605,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Carotenes,beta-Carotene + 13-cis-beta-Carotene + 9-cis-beta-Carotene,,,2960.7,,ug/day,,,"Adipose tissue, thigh",HPLC,Carotenes,beta-Carotene + 13-cis-beta-Carotene + 9-cis-beta-Carotene,,836.4,,pmol/mg,Specimen dry weight,25,Pearson,0.032,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2414,2535,2552,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,528.3,,nmol/L,,25,Pearson,0.537,,,< 0.01,Yes,,,"Age, Percentage body fat",Chung 2009
2432,2535,2569,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,ug/day,,,"Adipose tissue, abdomen",HPLC,beta-Carotene,"",,939.2,,pmol/mg,Specimen dry weight,25,Pearson,0.443,,,< 0.05,Yes,,,"Age, Percentage body fat",Chung 2009
2450,2535,2588,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,ug/day,,,"Adipose tissue, buttocks",HPLC,beta-Carotene,"",,709.2,,pmol/mg,Specimen dry weight,25,Pearson,0.318,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2468,2535,2606,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,ug/day,,,"Adipose tissue, thigh",HPLC,beta-Carotene,"",,557.0,,pmol/mg,Specimen dry weight,25,Pearson,0.083,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2415,2536,2553,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),13-cis-beta-Carotene,"",,,,,ug/day,,,"Serum, fasting",HPLC,13-cis-beta-Carotene,"",,22.8,,nmol/L,,25,Pearson,0.435,,,< 0.05,Yes,,,"Age, Percentage body fat",Chung 2009
2433,2536,2570,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),13-cis-beta-Carotene,"",,,,,ug/day,,,"Adipose tissue, abdomen",HPLC,13-cis-beta-Carotene,"",,294.6,,pmol/mg,Specimen dry weight,25,Pearson,0.399,,,< 0.1,No,,,"Age, Percentage body fat",Chung 2009
2451,2536,2589,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),13-cis-beta-Carotene,"",,,,,ug/day,,,"Adipose tissue, buttocks",HPLC,13-cis-beta-Carotene,"",,285.0,,pmol/mg,Specimen dry weight,25,Pearson,0.124,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2469,2536,2607,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),13-cis-beta-Carotene,"",,,,,ug/day,,,"Adipose tissue, thigh",HPLC,13-cis-beta-Carotene,"",,164.9,,pmol/mg,Specimen dry weight,25,Pearson,-0.099,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2416,2537,2554,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),9-cis-beta-Carotene,"",,,,,ug/day,,,"Serum, fasting",HPLC,9-cis-beta-Carotene,"",,17.7,,nmol/L,,25,Pearson,0.563,,,< 0.01,Yes,,,"Age, Percentage body fat",Chung 2009
2434,2537,2571,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),9-cis-beta-Carotene,"",,,,,ug/day,,,"Adipose tissue, abdomen",HPLC,9-cis-beta-Carotene,"",,238.2,,pmol/mg,Specimen dry weight,25,Pearson,0.346,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2452,2537,2590,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),9-cis-beta-Carotene,"",,,,,ug/day,,,"Adipose tissue, buttocks",HPLC,9-cis-beta-Carotene,"",,152.9,,pmol/mg,Specimen dry weight,25,Pearson,0.116,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2470,2537,2608,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),9-cis-beta-Carotene,"",,,,,ug/day,,,"Adipose tissue, thigh",HPLC,9-cis-beta-Carotene,"",,121.1,,pmol/mg,Specimen dry weight,25,Pearson,-0.066,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2417,2538,2555,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Carotenes,13-cis-beta-Carotene + 9-cis-beta-Carotene,,,,,ug/day,,,"Serum, fasting",HPLC,Carotenes,13-cis-beta-Carotene + 9-cis-beta-Carotene,,40.5,,nmol/L,,25,Pearson,0.506,,,< 0.05,Yes,,,"Age, Percentage body fat",Chung 2009
2435,2538,2572,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Carotenes,13-cis-beta-Carotene + 9-cis-beta-Carotene,,,,,ug/day,,,"Adipose tissue, abdomen",HPLC,Carotenes,13-cis-beta-Carotene + 9-cis-beta-Carotene,,532.7,,pmol/mg,Specimen dry weight,25,Pearson,0.383,,,< 0.1,No,,,"Age, Percentage body fat",Chung 2009
2453,2538,2591,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Carotenes,13-cis-beta-Carotene + 9-cis-beta-Carotene,,,,,ug/day,,,"Adipose tissue, buttocks",HPLC,Carotenes,13-cis-beta-Carotene + 9-cis-beta-Carotene,,437.9,,pmol/mg,Specimen dry weight,25,Pearson,0.1,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2471,2538,2609,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Carotenes,13-cis-beta-Carotene + 9-cis-beta-Carotene,,,,,ug/day,,,"Adipose tissue, thigh",HPLC,Carotenes,13-cis-beta-Carotene + 9-cis-beta-Carotene,,279.4,,pmol/mg,Specimen dry weight,25,Pearson,-0.06,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2418,2539,2556,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,135.5,,ug/day,,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",,422.4,,nmol/L,,25,Pearson,0.423,,,< 0.05,Yes,,,"Age, Percentage body fat",Chung 2009
2436,2539,2573,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,135.5,,ug/day,,,"Adipose tissue, abdomen",HPLC,beta-Cryptoxanthin,"",,418.6,,pmol/mg,Specimen dry weight,25,Pearson,0.47,,,< 0.05,Yes,,,"Age, Percentage body fat",Chung 2009
2454,2539,2592,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,135.5,,ug/day,,,"Adipose tissue, buttocks",HPLC,beta-Cryptoxanthin,"",,399.2,,pmol/mg,Specimen dry weight,25,Pearson,0.051,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2472,2539,2610,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,135.5,,ug/day,,,"Adipose tissue, thigh",HPLC,beta-Cryptoxanthin,"",,256.3,,pmol/mg,Specimen dry weight,25,Pearson,0.425,,,< 0.05,Yes,,,"Age, Percentage body fat",Chung 2009
2419,2540,2557,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lycopenes,Lycopene + 15-cis-Lycopene + 13-cis-Lycopene + 9-cis-Lycopene + 5-cis-Lycopene,,,2105.4,,ug/day,,,"Serum, fasting",HPLC,Lycopenes,Lycopene + 15-cis-Lycopene + 13-cis-Lycopene + 9-cis-Lycopene + 5-cis-Lycopene,,405.8,,nmol/L,,25,Pearson,0.078,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2437,2540,2574,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lycopenes,Lycopene + 15-cis-Lycopene + 13-cis-Lycopene + 9-cis-Lycopene + 5-cis-Lycopene,,,2105.4,,ug/day,,,"Adipose tissue, abdomen",HPLC,Lycopenes,Lycopene + 15-cis-Lycopene + 13-cis-Lycopene + 9-cis-Lycopene + 5-cis-Lycopene,,3329.6,,pmol/mg,Specimen dry weight,25,Pearson,0.408,,,< 0.1,No,,,"Age, Percentage body fat",Chung 2009
2455,2540,2593,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lycopenes,Lycopene + 15-cis-Lycopene + 13-cis-Lycopene + 9-cis-Lycopene + 5-cis-Lycopene,,,2105.4,,ug/day,,,"Adipose tissue, buttocks",HPLC,Lycopenes,Lycopene + 15-cis-Lycopene + 13-cis-Lycopene + 9-cis-Lycopene + 5-cis-Lycopene,,2472.0,,pmol/mg,Specimen dry weight,25,Pearson,0.244,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2473,2540,2611,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lycopenes,Lycopene + 15-cis-Lycopene + 13-cis-Lycopene + 9-cis-Lycopene + 5-cis-Lycopene,,,2105.4,,ug/day,,,"Adipose tissue, thigh",HPLC,Lycopenes,Lycopene + 15-cis-Lycopene + 13-cis-Lycopene + 9-cis-Lycopene + 5-cis-Lycopene,,2055.8,,pmol/mg,Specimen dry weight,25,Pearson,0.064,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2420,2541,2558,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",,142.8,,nmol/L,,25,Pearson,0.052,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2438,2541,2575,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,ug/day,,,"Adipose tissue, abdomen",HPLC,Lycopene,"",,891.6,,pmol/mg,Specimen dry weight,25,Pearson,0.244,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2456,2541,2594,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,ug/day,,,"Adipose tissue, buttocks",HPLC,Lycopene,"",,705.1,,pmol/mg,Specimen dry weight,25,Pearson,0.166,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2474,2541,2612,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,ug/day,,,"Adipose tissue, thigh",HPLC,Lycopene,"",,614.2,,pmol/mg,Specimen dry weight,25,Pearson,-0.009,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2421,2542,2559,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),15-cis-Lycopene,"",,,,,ug/day,,,"Serum, fasting",HPLC,15-cis-Lycopene,"",,8.3,,nmol/L,,25,Pearson,0.138,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2439,2542,2576,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),15-cis-Lycopene,"",,,,,ug/day,,,"Adipose tissue, abdomen",HPLC,15-cis-Lycopene,"",,929.8,,pmol/mg,Specimen dry weight,25,Pearson,0.621,,,< 0.01,Yes,,,"Age, Percentage body fat",Chung 2009
2457,2542,2595,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),15-cis-Lycopene,"",,,,,ug/day,,,"Adipose tissue, buttocks",HPLC,15-cis-Lycopene,"",,578.9,,pmol/mg,Specimen dry weight,25,Pearson,0.255,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2475,2542,2613,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),15-cis-Lycopene,"",,,,,ug/day,,,"Adipose tissue, thigh",HPLC,15-cis-Lycopene,"",,449.4,,pmol/mg,Specimen dry weight,25,Pearson,0.234,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2422,2543,2560,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),13-cis-Lycopene,"",,,,,ug/day,,,"Serum, fasting",HPLC,13-cis-Lycopene,"",,70.5,,nmol/L,,25,Pearson,0.14,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2440,2543,2577,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),13-cis-Lycopene,"",,,,,ug/day,,,"Adipose tissue, abdomen",HPLC,13-cis-Lycopene,"",,127.5,,pmol/mg,Specimen dry weight,25,Pearson,0.406,,,< 0.1,No,,,"Age, Percentage body fat",Chung 2009
2458,2543,2596,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),13-cis-Lycopene,"",,,,,ug/day,,,"Adipose tissue, buttocks",HPLC,13-cis-Lycopene,"",,106.2,,pmol/mg,Specimen dry weight,25,Pearson,-0.033,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2476,2543,2614,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),13-cis-Lycopene,"",,,,,ug/day,,,"Adipose tissue, thigh",HPLC,13-cis-Lycopene,"",,85.0,,pmol/mg,Specimen dry weight,25,Pearson,0.456,,,< 0.05,Yes,,,"Age, Percentage body fat",Chung 2009
2423,2544,2561,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),9-cis-Lycopene,"",,,,,ug/day,,,"Serum, fasting",HPLC,9-cis-Lycopene,"",,50.7,,nmol/L,,25,Pearson,0.037,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2441,2544,2578,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),9-cis-Lycopene,"",,,,,ug/day,,,"Adipose tissue, abdomen",HPLC,9-cis-Lycopene,"",,443.3,,pmol/mg,Specimen dry weight,25,Pearson,0.456,,,< 0.05,Yes,,,"Age, Percentage body fat",Chung 2009
2459,2544,2597,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),9-cis-Lycopene,"",,,,,ug/day,,,"Adipose tissue, buttocks",HPLC,9-cis-Lycopene,"",,325.5,,pmol/mg,Specimen dry weight,25,Pearson,0.314,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2477,2544,2615,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),9-cis-Lycopene,"",,,,,ug/day,,,"Adipose tissue, thigh",HPLC,9-cis-Lycopene,"",,294.3,,pmol/mg,Specimen dry weight,25,Pearson,0.021,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2424,2545,2562,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),5-cis-Lycopene,"",,,,,ug/day,,,"Serum, fasting",HPLC,5-cis-Lycopene,"",,133.0,,nmol/L,,25,Pearson,0.067,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2442,2545,2579,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),5-cis-Lycopene,"",,,,,ug/day,,,"Adipose tissue, abdomen",HPLC,5-cis-Lycopene,"",,1056.5,,pmol/mg,Specimen dry weight,25,Pearson,0.296,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2460,2545,2598,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),5-cis-Lycopene,"",,,,,ug/day,,,"Adipose tissue, buttocks",HPLC,5-cis-Lycopene,"",,848.5,,pmol/mg,Specimen dry weight,25,Pearson,0.21,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2478,2545,2616,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),5-cis-Lycopene,"",,,,,ug/day,,,"Adipose tissue, thigh",HPLC,5-cis-Lycopene,"",,672.3,,pmol/mg,Specimen dry weight,25,Pearson,0.001,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2425,2546,2563,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lycopenes,15-cis-Lycopene + 13-cis-Lycopene + 9-cis-Lycopene + 5-cis-Lycopene,,,,,ug/day,,,"Serum, fasting",HPLC,Lycopenes,15-cis-Lycopene + 13-cis-Lycopene + 9-cis-Lycopene + 5-cis-Lycopene,,262.5,,nmol/L,,25,Pearson,0.093,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2443,2546,2580,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lycopenes,15-cis-Lycopene + 13-cis-Lycopene + 9-cis-Lycopene + 5-cis-Lycopene,,,,,ug/day,,,"Adipose tissue, abdomen",HPLC,Lycopenes,15-cis-Lycopene + 13-cis-Lycopene + 9-cis-Lycopene + 5-cis-Lycopene,,2504.6,,pmol/mg,Specimen dry weight,25,Pearson,0.501,,,< 0.05,Yes,,,"Age, Percentage body fat",Chung 2009
2461,2546,2599,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lycopenes,15-cis-Lycopene + 13-cis-Lycopene + 9-cis-Lycopene + 5-cis-Lycopene,,,,,ug/day,,,"Adipose tissue, buttocks",HPLC,Lycopenes,15-cis-Lycopene + 13-cis-Lycopene + 9-cis-Lycopene + 5-cis-Lycopene,,1768.1,,pmol/mg,Specimen dry weight,25,Pearson,0.291,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2479,2546,2617,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lycopenes,15-cis-Lycopene + 13-cis-Lycopene + 9-cis-Lycopene + 5-cis-Lycopene,,,,,ug/day,,,"Adipose tissue, thigh",HPLC,Lycopenes,15-cis-Lycopene + 13-cis-Lycopene + 9-cis-Lycopene + 5-cis-Lycopene,,1440.3,,pmol/mg,Specimen dry weight,25,Pearson,0.104,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2426,2547,2564,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,2534.6,,ug/day,,,"Serum, fasting",HPLC,Carotenoids,Zeaxanthin + Lutein,,231.9,,nmol/L,,25,Pearson,-0.044,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2427,2547,2565,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,2534.6,,ug/day,,,"Serum, fasting",HPLC,Lutein,"",,197.6,,nmol/L,,25,Pearson,0.007,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2428,2547,2566,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,2534.6,,ug/day,,,"Serum, fasting",HPLC,Zeaxanthin,"",,34.4,,nmol/L,,25,Pearson,-0.388,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2444,2547,2581,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,2534.6,,ug/day,,,"Adipose tissue, abdomen",HPLC,Carotenoids,Zeaxanthin + Lutein,,456.3,,pmol/mg,Specimen dry weight,25,Pearson,-0.306,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2445,2547,2582,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,2534.6,,ug/day,,,"Adipose tissue, abdomen",HPLC,Lutein,"",,295.8,,pmol/mg,Specimen dry weight,25,Pearson,-0.038,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2446,2547,2583,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,2534.6,,ug/day,,,"Adipose tissue, abdomen",HPLC,Zeaxanthin,"",,183.4,,pmol/mg,Specimen dry weight,25,Pearson,-0.409,,,< 0.1,No,,,"Age, Percentage body fat",Chung 2009
2462,2547,2600,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,2534.6,,ug/day,,,"Adipose tissue, buttocks",HPLC,Carotenoids,Zeaxanthin + Lutein,,277.0,,pmol/mg,Specimen dry weight,25,Pearson,-0.284,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2463,2547,2601,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,2534.6,,ug/day,,,"Adipose tissue, buttocks",HPLC,Lutein,"",,170.8,,pmol/mg,Specimen dry weight,25,Pearson,-0.135,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2464,2547,2602,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,2534.6,,ug/day,,,"Adipose tissue, buttocks",HPLC,Zeaxanthin,"",,127.5,,pmol/mg,Specimen dry weight,25,Pearson,-0.361,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2480,2547,2618,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,2534.6,,ug/day,,,"Adipose tissue, thigh",HPLC,Carotenoids,Zeaxanthin + Lutein,,268.5,,pmol/mg,Specimen dry weight,25,Pearson,-0.003,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2481,2547,2619,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,2534.6,,ug/day,,,"Adipose tissue, thigh",HPLC,Lutein,"",,181.3,,pmol/mg,Specimen dry weight,25,Pearson,0.105,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2482,2547,2620,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,2534.6,,ug/day,,,"Adipose tissue, thigh",HPLC,Zeaxanthin,"",,101.0,,pmol/mg,Specimen dry weight,25,Pearson,-0.272,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2429,2622,2623,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + 13-cis-beta-Carotene + 9-cis-beta-Carotene + 15-cis-Lycopene + 13-cis-Lycopene + 9-cis-Lycopene + 5-cis-Lycopene + Lutein/Zeaxanthin,,,,,ug/day,,,"Serum, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene + 13-cis-beta-Carotene + 9-cis-beta-Carotene + 15-cis-Lycopene + 13-cis-Lycopene + 9-cis-Lycopene + 5-cis-Lycopene,,,,nmol/L,,25,Pearson,0.514,,,< 0.05,Yes,,,"Age, Percentage body fat",Chung 2009
2447,2622,2585,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + 13-cis-beta-Carotene + 9-cis-beta-Carotene + 15-cis-Lycopene + 13-cis-Lycopene + 9-cis-Lycopene + 5-cis-Lycopene + Lutein/Zeaxanthin,,,,,ug/day,,,"Adipose tissue, abdomen",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene + 13-cis-beta-Carotene + 9-cis-beta-Carotene + 15-cis-Lycopene + 13-cis-Lycopene + 9-cis-Lycopene + 5-cis-Lycopene,,5938.7,,pmol/mg,Specimen dry weight,25,Pearson,0.521,,,< 0.05,Yes,,,"Age, Percentage body fat",Chung 2009
2465,2622,2603,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + 13-cis-beta-Carotene + 9-cis-beta-Carotene + 15-cis-Lycopene + 13-cis-Lycopene + 9-cis-Lycopene + 5-cis-Lycopene + Lutein/Zeaxanthin,,,,,ug/day,,,"Adipose tissue, buttocks",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene + 13-cis-beta-Carotene + 9-cis-beta-Carotene + 15-cis-Lycopene + 13-cis-Lycopene + 9-cis-Lycopene + 5-cis-Lycopene,,4426.7,,pmol/mg,Specimen dry weight,25,Pearson,0.292,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2483,2622,2621,All,General adult population in Boston,United States,,,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + 13-cis-beta-Carotene + 9-cis-beta-Carotene + 15-cis-Lycopene + 13-cis-Lycopene + 9-cis-Lycopene + 5-cis-Lycopene + Lutein/Zeaxanthin,,,,,ug/day,,,"Adipose tissue, thigh",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene + 13-cis-beta-Carotene + 9-cis-beta-Carotene + 15-cis-Lycopene + 13-cis-Lycopene + 9-cis-Lycopene + 5-cis-Lycopene,,3507.0,,pmol/mg,Specimen dry weight,25,Pearson,-0.037,,,>= 0.05,No,,,"Age, Percentage body fat",Chung 2009
2488,2624,2652,All [by supplement],Female students at the University of Manitoba,Canada,,,Food Choice Map (FCM),Folate (Dietary Folate Equivalents),"",Yes,,,505.4,ug/day,,,"Serum, fasting",Competitive protein-binding assay (CPBA),Folates,"",,,,ng/mL,,95,Pearson,0.43,,,< 0.01,Yes,Energy ?,,,Shuaibi 2008
2490,2625,2653,All [by supplement],Female students at the University of Manitoba,Canada,,,Food Choice Map (FCM),Vitamin B12,"",Yes,,,4.2,ug/day,,,"Serum, fasting",Competitive protein-binding assay (CPBA),Vitamin B12,"",,,,pg/mL,,95,Pearson,0.4,,,< 0.01,Yes,Energy ?,,,Shuaibi 2008
2489,2630,2652,All [by supplement],Female students at the University of Manitoba,Canada,,,Dietary record (3-day),Folate (Dietary Folate Equivalents),"",Yes,,,458.9,ug/day,,,"Serum, fasting",Competitive protein-binding assay (CPBA),Folates,"",,,,ng/mL,,95,Pearson,0.39,,,< 0.01,Yes,Energy ?,,,Shuaibi 2008
2491,2631,2653,All [by supplement],Female students at the University of Manitoba,Canada,,,Dietary record (3-day),Vitamin B12,"",Yes,,,3.6,ug/day,,,"Serum, fasting",Competitive protein-binding assay (CPBA),Vitamin B12,"",,,,pg/mL,,95,Pearson,0.44,,,< 0.01,Yes,Energy ?,,,Shuaibi 2008
2484,2626,2648,Supplement nonusers,Female students at the University of Manitoba,Canada,,,Food Choice Map (FCM),Folate (Dietary Folate Equivalents),"",No,,,447.9,ug/day,,,"Serum, fasting",Competitive protein-binding assay (CPBA),Folates,"",,,13.6,ng/mL,,70,Pearson,0.26,,,< 0.05,Yes,Energy ?,,,Shuaibi 2008
2486,2627,2649,Supplement nonusers,Female students at the University of Manitoba,Canada,,,Food Choice Map (FCM),Vitamin B12,"",No,,,3.5,ug/day,,,"Serum, fasting",Competitive protein-binding assay (CPBA),Vitamin B12,"",,,541.3,pg/mL,,70,Pearson,0.15,,,= 0.23,No,Energy ?,,,Shuaibi 2008
2485,2632,2648,Supplement nonusers,Female students at the University of Manitoba,Canada,,,Dietary record (3-day),Folate (Dietary Folate Equivalents),"",No,,,414.8,ug/day,,,"Serum, fasting",Competitive protein-binding assay (CPBA),Folates,"",,,13.6,ng/mL,,70,Pearson,0.2,,,= 0.11,No,Energy ?,,,Shuaibi 2008
2487,2633,2649,Supplement nonusers,Female students at the University of Manitoba,Canada,,,Dietary record (3-day),Vitamin B12,"",No,,,2.8,ug/day,,,"Serum, fasting",Competitive protein-binding assay (CPBA),Vitamin B12,"",,,541.3,pg/mL,,70,Pearson,0.25,,,< 0.05,Yes,Energy ?,,,Shuaibi 2008
2517,2654,2679,All [by ethnicity],Multi-ethnic population,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Fish,"",,1.0,,,times/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,835,Pearson,0.38,,,< 0.05,Yes,,,,Chung 2008
2518,2655,2679,All [by ethnicity],Multi-ethnic population,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Shellfish,"",,0.3,,,times/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,835,Pearson,-0.02,,,>= 0.05,No,,,,Chung 2008
2519,2656,2679,All [by ethnicity],Multi-ethnic population,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Seafood,"",,0.4,,,times/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,835,Pearson,-0.01,,,>= 0.05,No,,,,Chung 2008
2520,2657,2679,All [by ethnicity],Multi-ethnic population,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Fish,"",,0.2,,,times/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,835,Pearson,0.05,,,>= 0.05,No,,,,Chung 2008
2516,2684,2679,All [by ethnicity],Multi-ethnic population,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Seafood,Fish + Seafood + Shellfish,,,,,times/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,835,Pearson,0.27,,,< 0.05,Yes,,,,Chung 2008
2493,2659,2680,Whites,Multi-ethnic population,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Fish,"",,1.0,,,times/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,397,Pearson,0.46,,,< 0.05,Yes,,,,Chung 2008
2494,2660,2680,Whites,Multi-ethnic population,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Shellfish,"",,0.3,,,times/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,397,Pearson,0.05,,,>= 0.05,No,,,,Chung 2008
2495,2661,2680,Whites,Multi-ethnic population,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Seafood,"",,0.3,,,times/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,397,Pearson,0.01,,,>= 0.05,No,,,,Chung 2008
2496,2662,2680,Whites,Multi-ethnic population,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Fish,"",,0.1,,,times/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,397,Pearson,0.03,,,>= 0.05,No,,,,Chung 2008
2492,2685,2680,Whites,Multi-ethnic population,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Seafood,Fish + Seafood + Shellfish,,,,,times/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,397,Pearson,0.4,,,< 0.05,Yes,,,,Chung 2008
2511,2674,2683,Hispanics,Multi-ethnic population,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Fish,"",,0.6,,,times/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,200,Pearson,0.39,,,< 0.05,Yes,,,,Chung 2008
2512,2675,2683,Hispanics,Multi-ethnic population,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Shellfish,"",,0.2,,,times/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,200,Pearson,0.01,,,>= 0.05,No,,,,Chung 2008
2513,2676,2683,Hispanics,Multi-ethnic population,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Seafood,"",,0.3,,,times/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,200,Pearson,-0.04,,,>= 0.05,No,,,,Chung 2008
2514,2677,2683,Hispanics,Multi-ethnic population,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Fish,"",,0.2,,,times/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,200,Pearson,-0.05,,,>= 0.05,No,,,,Chung 2008
2510,2688,2683,Hispanics,Multi-ethnic population,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Seafood,Fish + Seafood + Shellfish,,,,,times/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,200,Pearson,0.2,,,< 0.05,Yes,,,,Chung 2008
2505,2669,2682,African Americans,Multi-ethnic population,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Fish,"",,1.2,,,times/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,168,Pearson,0.24,,,< 0.05,Yes,,,,Chung 2008
2506,2670,2682,African Americans,Multi-ethnic population,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Shellfish,"",,0.4,,,times/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,168,Pearson,-0.12,,,>= 0.05,No,,,,Chung 2008
2507,2671,2682,African Americans,Multi-ethnic population,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Seafood,"",,0.9,,,times/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,168,Pearson,0.02,,,>= 0.05,No,,,,Chung 2008
2508,2672,2682,African Americans,Multi-ethnic population,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Fish,"",,0.2,,,times/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,168,Pearson,0.2,,,>= 0.05,No,,,,Chung 2008
2504,2687,2682,African Americans,Multi-ethnic population,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Seafood,Fish + Seafood + Shellfish,,,,,times/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,168,Pearson,0.24,,,< 0.05,Yes,,,,Chung 2008
2499,2664,2681,Chinese Americans,Multi-ethnic population,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Fish,"",,1.6,,,times/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,70,Pearson,0.4,,,< 0.05,Yes,,,,Chung 2008
2500,2665,2681,Chinese Americans,Multi-ethnic population,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Shellfish,"",,0.5,,,times/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,70,Pearson,0.0,,,>= 0.05,No,,,,Chung 2008
2501,2666,2681,Chinese Americans,Multi-ethnic population,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Seafood,"",,0.4,,,times/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,70,Pearson,0.0,,,>= 0.05,No,,,,Chung 2008
2502,2667,2681,Chinese Americans,Multi-ethnic population,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Fish,"",,0.5,,,times/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,70,Pearson,0.12,,,>= 0.05,No,,,,Chung 2008
2498,2686,2681,Chinese Americans,Multi-ethnic population,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Seafood,Fish + Seafood + Shellfish,,,,,times/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,70,Pearson,0.13,,,>= 0.05,No,,,,Chung 2008
2522,2694,2699,All,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,104.0,,,mg/day,,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",0.8,,,percentRoot,,273,Pearson,0.37,,, ,Unspecified,,,"Age, Energy",Arsenault 2009
2523,2695,2701,All,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,206.0,,,mg/day,,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",3.09,,,percentRoot,,273,Pearson,0.48,,, ,Unspecified,,,"Age, Energy",Arsenault 2009
2544,2696,2748,All,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Fatty fish,Tuna + Fatty fish,,,,0.94,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,273,Spearman,0.3,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2545,2697,2748,All,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Seafood,Lean fish + Shellfish,,,,0.47,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,273,Spearman,0.2,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2546,2698,2748,All,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Seafood,Tuna + Fatty fish + Lean fish + Shellfish,,,,1.47,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,273,Spearman,0.36,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2524,2742,2748,All,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,,mg/day,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,273,Pearson,0.48,,, ,Unspecified,,,"Age, Energy",Arsenault 2009
2540,2754,2748,All,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Fatty fish,"",,,,,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,273,Spearman,0.36,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2541,2755,2748,All,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Tuna,"",,,,,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,273,Spearman,0.13,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2542,2756,2748,All,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Lean fish,"",,,,,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,273,Spearman,0.21,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2543,2757,2748,All,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Shellfish,"",,,,,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,273,Spearman,0.08,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2525,2702,2707,High cognitive function,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,108.0,,,mg/day,,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",0.79,,,percentRoot,,186,Pearson,0.4,,, ,Unspecified,,,"Age, Energy",Arsenault 2009
2526,2703,2709,High cognitive function,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,209.0,,,mg/day,,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",3.06,,,percentRoot,,186,Pearson,0.48,,, ,Unspecified,,,,Arsenault 2009
2551,2704,2749,High cognitive function,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Fatty fish,Tuna + Fatty fish,,,,0.94,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,186,Spearman,0.29,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2552,2705,2749,High cognitive function,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Seafood,Lean fish + Shellfish,,,,0.47,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,186,Spearman,0.15,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2553,2706,2749,High cognitive function,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Seafood,Tuna + Fatty fish + Lean fish + Shellfish,,,,1.47,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,186,Spearman,0.31,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2527,2743,2749,High cognitive function,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,,mg/day,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,186,Pearson,0.48,,, ,Unspecified,,,,Arsenault 2009
2547,2758,2749,High cognitive function,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Fatty fish,"",,,,,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,186,Spearman,0.4,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2548,2759,2749,High cognitive function,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Tuna,"",,,,,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,186,Spearman,0.08,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2549,2760,2749,High cognitive function,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Lean fish,"",,,,,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,186,Spearman,0.17,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2550,2761,2749,High cognitive function,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Shellfish,"",,,,,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,186,Spearman,0.02,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2528,2710,2715,Low cognitive function,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,95.2,,,mg/day,,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",0.79,,,percentRoot,,87,Pearson,0.29,,, ,Unspecified,,,"Age, Energy",Arsenault 2009
2529,2711,2717,Low cognitive function,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,199.0,,,mg/day,,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",3.06,,,percentRoot,,87,Pearson,0.51,,, ,Unspecified,,,"Age, Energy",Arsenault 2009
2558,2712,2750,Low cognitive function,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Fatty fish,Tuna + Fatty fish,,,,1.0,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,87,Spearman,0.33,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2559,2713,2750,Low cognitive function,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Seafood,Lean fish + Shellfish,,,,0.47,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,87,Spearman,0.32,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2560,2714,2750,Low cognitive function,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Seafood,Tuna + Fatty fish + Lean fish + Shellfish,,,,1.47,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,87,Spearman,0.47,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2530,2744,2750,Low cognitive function,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,,mg/day,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,87,Pearson,0.47,,, ,Unspecified,,,"Age, Energy",Arsenault 2009
2554,2762,2750,Low cognitive function,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Fatty fish,"",,,,,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,87,Spearman,0.29,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2555,2763,2750,Low cognitive function,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Tuna,"",,,,,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,87,Spearman,0.25,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2556,2764,2750,Low cognitive function,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Lean fish,"",,,,,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,87,Spearman,0.32,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2557,2765,2750,Low cognitive function,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Shellfish,"",,,,,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,87,Spearman,0.19,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2531,2718,2723,No cognitive impairment,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,105.0,,,mg/day,,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",0.85,,,percentRoot,,129,Pearson,0.38,,, ,Unspecified,,,"Age, Energy",Arsenault 2009
2532,2719,2725,No cognitive impairment,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,211.0,,,mg/day,,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",3.03,,,percentRoot,,129,Pearson,0.49,,, ,Unspecified,,,"Age, Energy",Arsenault 2009
2565,2720,2751,No cognitive impairment,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Fatty fish,Tuna + Fatty fish,,,,0.94,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,129,Spearman,0.34,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2566,2721,2751,No cognitive impairment,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Seafood,Lean fish + Shellfish,,,,0.47,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,129,Spearman,0.15,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2567,2722,2751,No cognitive impairment,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Seafood,Tuna + Fatty fish + Lean fish + Shellfish,,,,1.47,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,129,Spearman,0.35,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2533,2745,2751,No cognitive impairment,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,,mg/day,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,129,Pearson,0.49,,, ,Unspecified,,,"Age, Energy",Arsenault 2009
2561,2766,2751,No cognitive impairment,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Fatty fish,"",,,,,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,129,Spearman,0.39,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2562,2767,2751,No cognitive impairment,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Tuna,"",,,,,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,129,Spearman,0.13,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2563,2768,2751,No cognitive impairment,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Lean fish,"",,,,,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,129,Spearman,0.21,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2564,2769,2751,No cognitive impairment,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Shellfish,"",,,,,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,129,Spearman,-0.04,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2534,2726,2731,Mild cognitive impairment,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,101.0,,,mg/day,,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",0.75,,,percentRoot,,82,Pearson,0.35,,, ,Unspecified,,,"Age, Energy",Arsenault 2009
2535,2727,2733,Mild cognitive impairment,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,200.0,,,mg/day,,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",3.15,,,percentRoot,,82,Pearson,0.48,,, ,Unspecified,,,"Age, Energy",Arsenault 2009
2572,2728,2752,Mild cognitive impairment,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Fatty fish,Tuna + Fatty fish,,,,1.0,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,82,Spearman,0.3,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2573,2729,2752,Mild cognitive impairment,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Seafood,Lean fish + Shellfish,,,,0.47,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,82,Spearman,0.17,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2574,2730,2752,Mild cognitive impairment,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Seafood,Tuna + Fatty fish + Lean fish + Shellfish,,,,1.47,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,82,Spearman,0.32,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2536,2746,2752,Mild cognitive impairment,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,,mg/day,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,82,Pearson,0.45,,, ,Unspecified,,,"Age, Energy",Arsenault 2009
2568,2770,2752,Mild cognitive impairment,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Fatty fish,"",,,,,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,82,Spearman,0.37,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2569,2771,2752,Mild cognitive impairment,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Tuna,"",,,,,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,82,Spearman,0.1,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2570,2772,2752,Mild cognitive impairment,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Lean fish,"",,,,,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,82,Spearman,0.18,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2571,2773,2752,Mild cognitive impairment,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Shellfish,"",,,,,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,82,Spearman,0.09,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2537,2734,2739,Dementia,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,107.0,,,mg/day,,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",0.76,,,percentRoot,,62,Pearson,0.43,,, ,Unspecified,,,"Age, Energy",Arsenault 2009
2538,2735,2741,Dementia,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,203.0,,,mg/day,,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",3.15,,,percentRoot,,62,Pearson,0.5,,, ,Unspecified,,,"Age, Energy",Arsenault 2009
2579,2736,2753,Dementia,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Fatty fish,Tuna + Fatty fish,,,,0.94,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,62,Spearman,0.24,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2580,2737,2753,Dementia,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Seafood,Lean fish + Shellfish,,,,0.47,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,62,Spearman,0.36,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2581,2738,2753,Dementia,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Seafood,Tuna + Fatty fish + Lean fish + Shellfish,,,,1.94,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,62,Spearman,0.47,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2539,2747,2753,Dementia,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,,mg/day,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,62,Pearson,0.52,,, ,Unspecified,,,"Age, Energy",Arsenault 2009
2575,2774,2753,Dementia,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Fatty fish,"",,,,,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,62,Spearman,0.29,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2576,2775,2753,Dementia,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Tuna,"",,,,,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,62,Spearman,0.21,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2577,2776,2753,Dementia,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Lean fish,"",,,,,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,62,Spearman,0.3,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2578,2777,2753,Dementia,Elderly subjects with mild-to-moderate cognitive impairment or dementia,United States,"NAME (Nutrition, Aging, and Memory in Elders)",,Food Frequency Questionnaire (FFQ),Shellfish,"",,,,,servings/week,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,62,Spearman,0.27,,, ,Unspecified,,,"Age, Energy, Use of fish-oil supplements",Arsenault 2009
2582,2778,2779,All [by blood adducts],Women participant in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Acrylamide,"",,19.3,,,ug/day,,,Hemoglobin,LC-MS/MS,Acrylamide-hemoglobin adduct,"",,,43.9,pmol/g,,296,Pearson,0.19,0.08,0.3,< 0.001,Yes,,No,Laboratory batch,Wilson 2009
2583,2778,2780,All [by blood adducts],Women participant in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Acrylamide,"",,19.3,,,ug/day,,,Hemoglobin,LC-MS/MS,Glycidamide-hemoglobin adduct,"",,,49.4,pmol/g,,296,Pearson,0.24,0.13,0.35,< 0.0001,Yes,,No,Laboratory batch,Wilson 2009
2584,2778,2781,All [by blood adducts],Women participant in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Acrylamide,"",,19.3,,,ug/day,,,Hemoglobin,LC-MS/MS,Acrylamide-Hb metabolites,Glycidamide-hemoglobin adduct + Acrylamide-hemoglobin adduct,,,94.3,pmol/g,,296,Pearson,0.24,0.12,0.34,< 0.0001,Yes,,No,Laboratory batch,Wilson 2009
2585,2778,2779,All [by blood adducts],Women participant in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Acrylamide,"",,19.3,,,ug/day,,,Hemoglobin,LC-MS/MS,Acrylamide-hemoglobin adduct,"",,,43.9,pmol/g,,296,Pearson,0.26,0.14,0.36,< 0.0001,Yes,,No,"Laboratory batch, Energy",Wilson 2009
2586,2778,2780,All [by blood adducts],Women participant in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Acrylamide,"",,19.3,,,ug/day,,,Hemoglobin,LC-MS/MS,Glycidamide-hemoglobin adduct,"",,,49.4,pmol/g,,296,Pearson,0.31,0.2,0.41,< 0.0001,Yes,,No,"Laboratory batch, Energy",Wilson 2009
2587,2778,2781,All [by blood adducts],Women participant in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Acrylamide,"",,19.3,,,ug/day,,,Hemoglobin,LC-MS/MS,Acrylamide-Hb metabolites,Glycidamide-hemoglobin adduct + Acrylamide-hemoglobin adduct,,,94.3,pmol/g,,296,Pearson,0.31,0.2,0.41,< 0.0001,Yes,,No,"Laboratory batch, Energy",Wilson 2009
2588,2778,2779,All [by blood adducts],Women participant in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Acrylamide,"",,19.3,,,ug/day,,,Hemoglobin,LC-MS/MS,Acrylamide-hemoglobin adduct,"",,,43.9,pmol/g,,296,Pearson,0.26,0.14,0.36,< 0.0001,Yes,,No,"Laboratory batch, Energy, Age",Wilson 2009
2589,2778,2780,All [by blood adducts],Women participant in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Acrylamide,"",,19.3,,,ug/day,,,Hemoglobin,LC-MS/MS,Glycidamide-hemoglobin adduct,"",,,49.4,pmol/g,,296,Pearson,0.31,0.2,0.41,< 0.0001,Yes,,No,"Laboratory batch, Energy, Age",Wilson 2009
2590,2778,2781,All [by blood adducts],Women participant in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Acrylamide,"",,19.3,,,ug/day,,,Hemoglobin,LC-MS/MS,Acrylamide-Hb metabolites,Glycidamide-hemoglobin adduct + Acrylamide-hemoglobin adduct,,,94.3,pmol/g,,296,Pearson,0.31,0.2,0.41,< 0.0001,Yes,,No,"Laboratory batch, Energy, Age",Wilson 2009
2591,2778,2779,All [by blood adducts],Women participant in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Acrylamide,"",,19.3,,,ug/day,,,Hemoglobin,LC-MS/MS,Acrylamide-hemoglobin adduct,"",,,43.9,pmol/g,,296,Pearson,0.27,0.16,0.38,< 0.0001,Yes,,No,"Laboratory batch, Energy, Age, BMI, Alcohol",Wilson 2009
2592,2778,2780,All [by blood adducts],Women participant in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Acrylamide,"",,19.3,,,ug/day,,,Hemoglobin,LC-MS/MS,Glycidamide-hemoglobin adduct,"",,,49.4,pmol/g,,296,Pearson,0.33,0.22,0.43,< 0.0001,Yes,,No,"Laboratory batch, Energy, Age, BMI, Alcohol",Wilson 2009
2593,2778,2781,All [by blood adducts],Women participant in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Acrylamide,"",,19.3,,,ug/day,,,Hemoglobin,LC-MS/MS,Acrylamide-Hb metabolites,Glycidamide-hemoglobin adduct + Acrylamide-hemoglobin adduct,,,94.3,pmol/g,,296,Pearson,0.32,0.21,0.42,< 0.0001,Yes,,No,"Laboratory batch, Energy, Age, BMI, Alcohol",Wilson 2009
2594,2778,2779,All [by blood adducts],Women participant in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Acrylamide,"",,19.3,,,ug/day,,,Hemoglobin,LC-MS/MS,Acrylamide-hemoglobin adduct,"",,,43.9,pmol/g,,296,Pearson,0.29,0.17,0.4,< 0.0001,Yes,,Yes,"Laboratory batch, Energy, Age, BMI, Alcohol",Wilson 2009
2595,2778,2780,All [by blood adducts],Women participant in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Acrylamide,"",,19.3,,,ug/day,,,Hemoglobin,LC-MS/MS,Glycidamide-hemoglobin adduct,"",,,49.4,pmol/g,,296,Pearson,0.35,0.24,0.46,< 0.0001,Yes,,Yes,"Laboratory batch, Energy, Age, BMI, Alcohol",Wilson 2009
2596,2778,2781,All [by blood adducts],Women participant in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Acrylamide,"",,19.3,,,ug/day,,,Hemoglobin,LC-MS/MS,Acrylamide-Hb metabolites,Glycidamide-hemoglobin adduct + Acrylamide-hemoglobin adduct,,,94.3,pmol/g,,296,Pearson,0.34,0.23,0.45,< 0.0001,Yes,,Yes,"Laboratory batch, Energy, Age, BMI, Alcohol",Wilson 2009
2601,2804,2824,Soy users (recall),Participants in a dietary calibration study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Proteins from Soy foods,"",Yes,9.25,,,g/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Daidzein,"",,5601.0,,pmol/mg,Creatinine,58,Pearson,0.72,0.43,0.96, ,Unspecified,,Yes,,Jaceldo-Siegl 2008
2602,2804,2827,Soy users (recall),Participants in a dietary calibration study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Proteins from Soy foods,"",Yes,9.25,,,g/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Genistein,"",,1703.0,,pmol/mg,Creatinine,58,Pearson,0.67,0.43,0.91, ,Unspecified,,Yes,,Jaceldo-Siegl 2008
2603,2804,2833,Soy users (recall),Participants in a dietary calibration study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Proteins from Soy foods,"",Yes,9.25,,,g/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Equol,"",,,,pmol/12h,,58,Spearman,-0.06,-0.31,0.21, ,Unspecified,,Yes,,Jaceldo-Siegl 2008
2604,2804,2830,Soy users (recall),Participants in a dietary calibration study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Proteins from Soy foods,"",Yes,9.25,,,g/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol,,7644.0,,pmol/mg,Creatinine,58,Pearson,0.72,0.47,0.98, ,Unspecified,,Yes,,Jaceldo-Siegl 2008
2597,2798,2812,All [by intake from recall],Participants in a dietary calibration study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Proteins from Soy foods,"",Yes,5.41,,,g/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Daidzein,"",,2782.0,,pmol/mg,Creatinine,100,Pearson,0.75,0.54,0.92, ,Unspecified,,Yes,,Jaceldo-Siegl 2008
2598,2798,2815,All [by intake from recall],Participants in a dietary calibration study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Proteins from Soy foods,"",Yes,5.41,,,g/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Genistein,"",,802.0,,pmol/mg,Creatinine,100,Pearson,0.71,0.5,0.85, ,Unspecified,,Yes,,Jaceldo-Siegl 2008
2599,2798,2821,All [by intake from recall],Participants in a dietary calibration study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Proteins from Soy foods,"",Yes,5.41,,,g/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Equol,"",,,,pmol/12h,,100,Spearman,0.03,-0.18,0.18, ,Unspecified,,Yes,,Jaceldo-Siegl 2008
2600,2798,2818,All [by intake from recall],Participants in a dietary calibration study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Proteins from Soy foods,"",Yes,5.41,,,g/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol,,3732.0,,pmol/mg,Creatinine,100,Pearson,0.75,0.55,0.93, ,Unspecified,,Yes,,Jaceldo-Siegl 2008
2605,2799,8071,All [by intake from questionnaire],Participants in a dietary calibration study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Proteins from Soy foods,"",Yes,6.5,,,g/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Daidzein,"",,,,pmol/mg,Creatinine,91,Pearson,0.56,0.41,0.68, ,Unspecified,,Yes,,Jaceldo-Siegl 2008
2606,2799,8072,All [by intake from questionnaire],Participants in a dietary calibration study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Proteins from Soy foods,"",Yes,6.5,,,g/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Genistein,"",,,,pmol/mg,Creatinine,91,Pearson,0.55,0.41,0.66, ,Unspecified,,Yes,,Jaceldo-Siegl 2008
2607,2799,8074,All [by intake from questionnaire],Participants in a dietary calibration study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Proteins from Soy foods,"",Yes,6.5,,,g/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Equol,"",,,,pmol/12h,,91,Spearman,0.12,-0.09,0.3, ,Unspecified,,Yes,,Jaceldo-Siegl 2008
2608,2799,8073,All [by intake from questionnaire],Participants in a dietary calibration study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Proteins from Soy foods,"",Yes,6.5,,,g/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol,,,,pmol/mg,Creatinine,91,Pearson,0.57,0.41,0.68, ,Unspecified,,Yes,,Jaceldo-Siegl 2008
2609,2805,8075,Soy users (questionnaire),Participants in a dietary calibration study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Proteins from Soy foods,"",Yes,8.42,,,g/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Daidzein,"",,,,pmol/mg,Creatinine,70,Pearson,0.5,0.32,0.65, ,Unspecified,,Yes,,Jaceldo-Siegl 2008
2610,2805,8076,Soy users (questionnaire),Participants in a dietary calibration study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Proteins from Soy foods,"",Yes,8.42,,,g/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Genistein,"",,,,pmol/mg,Creatinine,70,Pearson,0.48,0.29,0.61, ,Unspecified,,Yes,,Jaceldo-Siegl 2008
2611,2805,8078,Soy users (questionnaire),Participants in a dietary calibration study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Proteins from Soy foods,"",Yes,8.42,,,g/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Equol,"",,,,pmol/12h,,70,Spearman,0.11,-0.13,0.32, ,Unspecified,,Yes,,Jaceldo-Siegl 2008
2612,2805,8077,Soy users (questionnaire),Participants in a dietary calibration study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Proteins from Soy foods,"",Yes,8.42,,,g/day,,,"Urine, overnight",LC-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol,,,,pmol/mg,Creatinine,70,Pearson,0.5,0.32,0.64, ,Unspecified,,Yes,,Jaceldo-Siegl 2008
2613,2834,2835,All,Volunteers from Cambridgeshire,United Kingdom,,,Dietary record (7-day),Thiamin,Thiamin from Foods,,2.22,,,mg/day,,day 1; day 2; day 3; day 4; day 5; ... ; day 30,"Urine, 24-h",HPLC,Thiamin,"",526.5,,,ug/day,,13,Spearman,0.72,,,= 0.006,Yes,,,,Tasevska 2008
2614,2836,2835,All,Volunteers from Cambridgeshire,United Kingdom,,,Dietary record (7-day),Thiamin from Foods,"",,8.5,,,percentRoot,,day 1; day 2; day 3; day 4; day 5; ... ; day 30,"Urine, 24-h",HPLC,Thiamin,"",526.5,,,ug/day,,13,Spearman,-0.105,,,>= 0.05,No,,,,Tasevska 2008
2615,2837,2835,All,Volunteers from Cambridgeshire,United Kingdom,,,Dietary record (7-day),Thiamin from Foods,"",,8.2,,,percentRoot,,day 1; day 2; day 3; day 4; day 5; ... ; day 30,"Urine, 24-h",HPLC,Thiamin,"",526.5,,,ug/day,,13,Spearman,-0.094,,,>= 0.05,No,,,,Tasevska 2008
2616,2838,2835,All,Volunteers from Cambridgeshire,United Kingdom,,,Dietary record (7-day),Thiamin from Foods,"",,6.1,,,percentRoot,,day 1; day 2; day 3; day 4; day 5; ... ; day 30,"Urine, 24-h",HPLC,Thiamin,"",526.5,,,ug/day,,13,Spearman,-0.418,,,>= 0.05,No,,,,Tasevska 2008
2617,2839,2835,All,Volunteers from Cambridgeshire,United Kingdom,,,Dietary record (7-day),Thiamin from Foods,"",,18.2,,,percentRoot,,day 1; day 2; day 3; day 4; day 5; ... ; day 30,"Urine, 24-h",HPLC,Thiamin,"",526.5,,,ug/day,,13,Spearman,0.011,,,>= 0.05,No,,,,Tasevska 2008
2618,2840,2835,All,Volunteers from Cambridgeshire,United Kingdom,,,Dietary record (7-day),Thiamin from Foods,"",,12.5,,,percentRoot,,day 1; day 2; day 3; day 4; day 5; ... ; day 30,"Urine, 24-h",HPLC,Thiamin,"",526.5,,,ug/day,,13,Spearman,0.578,,,= 0.039,Yes,,,,Tasevska 2008
2619,2841,2835,All,Volunteers from Cambridgeshire,United Kingdom,,,Dietary record (7-day),Thiamin from Foods,"",,9.0,,,percentRoot,,day 1; day 2; day 3; day 4; day 5; ... ; day 30,"Urine, 24-h",HPLC,Thiamin,"",526.5,,,ug/day,,13,Spearman,0.57,,,= 0.042,Yes,,,,Tasevska 2008
2620,2842,2835,All,Volunteers from Cambridgeshire,United Kingdom,,,Dietary record (7-day),Thiamin from Foods,"",,8.1,,,percentRoot,,day 1; day 2; day 3; day 4; day 5; ... ; day 30,"Urine, 24-h",HPLC,Thiamin,"",526.5,,,ug/day,,13,Spearman,0.554,,,= 0.049,Yes,,,,Tasevska 2008
2621,2843,2835,All,Volunteers from Cambridgeshire,United Kingdom,,,Dietary record (7-day),Thiamin from Foods,"",,6.3,,,percentRoot,,day 1; day 2; day 3; day 4; day 5; ... ; day 30,"Urine, 24-h",HPLC,Thiamin,"",526.5,,,ug/day,,13,Spearman,-0.525,,,>= 0.05,No,,,,Tasevska 2008
2622,2844,2835,All,Volunteers from Cambridgeshire,United Kingdom,,,Dietary record (7-day),Thiamin from Foods,"",,1.5,,,percentRoot,,day 1; day 2; day 3; day 4; day 5; ... ; day 30,"Urine, 24-h",HPLC,Thiamin,"",526.5,,,ug/day,,13,Spearman,-0.023,,,>= 0.05,No,,,,Tasevska 2008
2623,2845,2835,All,Volunteers from Cambridgeshire,United Kingdom,,,Dietary record (7-day),Thiamin from Foods,"",,1.3,,,percentRoot,,day 1; day 2; day 3; day 4; day 5; ... ; day 30,"Urine, 24-h",HPLC,Thiamin,"",526.5,,,ug/day,,13,Spearman,0.218,,,>= 0.05,No,,,,Tasevska 2008
2624,2846,2835,All,Volunteers from Cambridgeshire,United Kingdom,,,Dietary record (7-day),Thiamin from Foods,"",,3.4,,,percentRoot,,day 1; day 2; day 3; day 4; day 5; ... ; day 30,"Urine, 24-h",HPLC,Thiamin,"",526.5,,,ug/day,,13,Spearman,0.161,,,>= 0.05,No,,,,Tasevska 2008
2631,2895,2847,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Lauric acid (12:0),"",,0.67,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Lauric acid (12:0),"",0.02,,,percentRoot,,306,Spearman,0.14,,,>= 0.05,No,,,,Sun 2007
2655,2895,2847,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Lauric acid (12:0),"",,0.67,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Lauric acid (12:0),"",0.02,,,percentRoot,,306,Spearman,0.16,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2678,2895,2871,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Lauric acid (12:0),"",,0.67,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,Lauric acid (12:0),"",0.002,,,percentRoot,,306,Spearman,0.12,,,>= 0.05,No,,,,Sun 2007
2701,2895,2871,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Lauric acid (12:0),"",,0.67,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,Lauric acid (12:0),"",0.002,,,percentRoot,,306,Spearman,0.13,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2632,2896,2848,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Myristic acid (14:0),"",,3.98,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Myristic acid (14:0),"",0.58,,,percentRoot,,306,Spearman,0.2,,,>= 0.05,No,,,,Sun 2007
2656,2896,2848,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Myristic acid (14:0),"",,3.98,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Myristic acid (14:0),"",0.58,,,percentRoot,,306,Spearman,0.2,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2679,2896,2872,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Myristic acid (14:0),"",,3.98,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,Myristic acid (14:0),"",0.19,,,percentRoot,,306,Spearman,0.17,,,>= 0.05,No,,,,Sun 2007
2702,2896,2872,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Myristic acid (14:0),"",,3.98,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,Myristic acid (14:0),"",0.19,,,percentRoot,,306,Spearman,0.16,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2633,2897,2849,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,21.6,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Palmitic acid (16:0),"",19.31,,,percentRoot,,306,Spearman,0.15,,,>= 0.05,No,,,,Sun 2007
2657,2897,2849,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,21.6,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Palmitic acid (16:0),"",19.31,,,percentRoot,,306,Spearman,0.12,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2680,2897,2873,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,21.6,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,Palmitic acid (16:0),"",18.65,,,percentRoot,,306,Spearman,0.08,,,>= 0.05,No,,,,Sun 2007
2703,2897,2873,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,21.6,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,Palmitic acid (16:0),"",18.65,,,percentRoot,,306,Spearman,0.03,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2634,2898,2850,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Stearic acid (18:0),"",,7.88,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Stearic acid (18:0),"",7.29,,,percentRoot,,306,Spearman,0.05,,,>= 0.05,No,,,,Sun 2007
2658,2898,2850,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Stearic acid (18:0),"",,7.88,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Stearic acid (18:0),"",7.29,,,percentRoot,,306,Spearman,0.06,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2681,2898,2874,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Stearic acid (18:0),"",,7.88,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,Stearic acid (18:0),"",13.14,,,percentRoot,,306,Spearman,-0.03,,,>= 0.05,No,,,,Sun 2007
2704,2898,2874,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Stearic acid (18:0),"",,7.88,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,Stearic acid (18:0),"",13.14,,,percentRoot,,306,Spearman,0.01,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2635,2899,2851,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Lauric acid (12:0),,33.74,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Lauric acid (12:0),28.71,,,percentRoot,,306,Spearman,0.2,,,>= 0.05,No,,,,Sun 2007
2659,2899,2851,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Lauric acid (12:0),,33.74,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Lauric acid (12:0),28.71,,,percentRoot,,306,Spearman,0.16,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2682,2899,2875,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Lauric acid (12:0),,33.74,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Lauric acid (12:0),34.37,,,percentRoot,,306,Spearman,0.15,,,>= 0.05,No,,,,Sun 2007
2705,2899,2875,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Lauric acid (12:0),,33.74,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Lauric acid (12:0),34.37,,,percentRoot,,306,Spearman,0.12,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2636,2900,2852,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Palmitoleic acid (cis-16:1n-7),"",,1.94,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Palmitoleic acid (cis-16:1n-7),"",1.94,,,percentRoot,,306,Spearman,0.16,,,>= 0.05,No,,,,Sun 2007
2660,2900,2852,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Palmitoleic acid (cis-16:1n-7),"",,1.94,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Palmitoleic acid (cis-16:1n-7),"",1.94,,,percentRoot,,306,Spearman,0.16,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2683,2900,2876,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Palmitoleic acid (cis-16:1n-7),"",,1.94,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,Palmitoleic acid (cis-16:1n-7),"",0.49,,,percentRoot,,306,Spearman,0.15,,,>= 0.05,No,,,,Sun 2007
2706,2900,2876,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Palmitoleic acid (cis-16:1n-7),"",,1.94,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,Palmitoleic acid (cis-16:1n-7),"",0.49,,,percentRoot,,306,Spearman,0.1,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2637,2901,2853,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,29.21,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Oleic acid (cis-18:1n-9),"",18.6,,,percentRoot,,306,Spearman,0.1,,,>= 0.05,No,,,,Sun 2007
2661,2901,2853,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,29.21,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Oleic acid (cis-18:1n-9),"",18.6,,,percentRoot,,306,Spearman,0.12,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2684,2901,2877,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,29.21,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,Oleic acid (cis-18:1n-9),"",13.26,,,percentRoot,,306,Spearman,0.12,,,>= 0.05,No,,,,Sun 2007
2707,2901,2877,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,29.21,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,Oleic acid (cis-18:1n-9),"",13.26,,,percentRoot,,306,Spearman,0.14,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2639,2903,2855,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + 8-Eicosenoic acid (cis-20:1n-12) + Oleic acid (cis-18:1n-9),,38.33,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + 8-Eicosenoic acid (cis-20:1n-12) + Oleic acid (cis-18:1n-9),22.86,,,percentRoot,,306,Spearman,0.04,,,>= 0.05,No,,,,Sun 2007
2662,2903,2855,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + 8-Eicosenoic acid (cis-20:1n-12) + Oleic acid (cis-18:1n-9),,38.33,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + 8-Eicosenoic acid (cis-20:1n-12) + Oleic acid (cis-18:1n-9),22.86,,,percentRoot,,306,Spearman,0.04,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2685,2903,2879,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + 8-Eicosenoic acid (cis-20:1n-12) + Oleic acid (cis-18:1n-9),,38.33,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + 8-Eicosenoic acid (cis-20:1n-12) + Oleic acid (cis-18:1n-9),18.64,,,percentRoot,,306,Spearman,0.06,,,>= 0.05,No,,,,Sun 2007
2708,2903,2879,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + 8-Eicosenoic acid (cis-20:1n-12) + Oleic acid (cis-18:1n-9),,38.33,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + 8-Eicosenoic acid (cis-20:1n-12) + Oleic acid (cis-18:1n-9),18.64,,,percentRoot,,306,Spearman,0.05,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2640,2904,2856,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,1.66,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.5,,,percentRoot,,306,Spearman,0.23,,,>= 0.05,No,,,,Sun 2007
2663,2904,2856,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,1.66,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.5,,,percentRoot,,306,Spearman,0.23,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2686,2904,2880,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,1.66,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.18,,,percentRoot,,306,Spearman,0.17,,,>= 0.05,No,,,,Sun 2007
2709,2904,2880,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,1.66,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.18,,,percentRoot,,306,Spearman,0.18,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2641,2905,2857,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,0.12,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",0.49,,,percentRoot,,130,Spearman,0.27,,,< 0.01,Yes,,,,Sun 2007
2664,2905,2857,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,0.12,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",0.49,,,percentRoot,,130,Spearman,0.21,,,< 0.01,Yes,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2687,2905,2881,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,0.12,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",1.15,,,percentRoot,,132,Spearman,0.23,,,< 0.01,Yes,,,,Sun 2007
2710,2905,2881,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,0.12,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",1.15,,,percentRoot,,132,Spearman,0.38,,,< 0.01,Yes,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2642,2906,2858,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),DPA (cis-22:5n-3),"",No,0.04,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,DPA (cis-22:5n-3),"",0.44,,,percentRoot,,306,Spearman,0.01,,,>= 0.05,No,,,,Sun 2007
2665,2906,2858,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),DPA (cis-22:5n-3),"",No,0.04,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,DPA (cis-22:5n-3),"",0.44,,,percentRoot,,306,Spearman,-0.03,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2688,2906,2882,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),DPA (cis-22:5n-3),"",No,0.04,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,DPA (cis-22:5n-3),"",1.85,,,percentRoot,,306,Spearman,0.02,,,>= 0.05,No,,,,Sun 2007
2711,2906,2882,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),DPA (cis-22:5n-3),"",No,0.04,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,DPA (cis-22:5n-3),"",1.85,,,percentRoot,,306,Spearman,0.01,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2643,2907,2859,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,0.29,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",1.56,,,percentRoot,,306,Spearman,0.47,,,< 0.01,Yes,,,,Sun 2007
2666,2907,2859,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,0.29,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",1.56,,,percentRoot,,306,Spearman,0.48,,,< 0.01,Yes,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2689,2907,2883,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,0.29,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",3.71,,,percentRoot,,306,Spearman,0.54,,,< 0.01,Yes,,,,Sun 2007
2712,2907,2883,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,0.29,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",3.71,,,percentRoot,,306,Spearman,0.56,,,< 0.01,Yes,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2644,2908,2860,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,2.11,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),2.94,,,percentRoot,,130,Spearman,0.31,,,< 0.05,Yes,,,,Sun 2007
2667,2908,2860,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,2.11,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),2.94,,,percentRoot,,130,Spearman,0.3,,,< 0.05,Yes,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2690,2908,2884,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,2.11,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),7.06,,,percentRoot,,132,Spearman,0.42,,,< 0.05,Yes,,,,Sun 2007
2713,2908,2884,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,2.11,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),7.06,,,percentRoot,,132,Spearman,0.41,,,< 0.05,Yes,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2645,2909,2861,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,16.54,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",30.58,,,percentRoot,,306,Spearman,0.24,,,>= 0.05,No,,,,Sun 2007
2668,2909,2861,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,16.54,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",30.58,,,percentRoot,,306,Spearman,0.25,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2691,2909,2885,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,16.54,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",13.66,,,percentRoot,,306,Spearman,0.19,,,>= 0.05,No,,,,Sun 2007
2714,2909,2885,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,16.54,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",13.66,,,percentRoot,,306,Spearman,0.24,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2646,2910,2862,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,0.23,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",7.8,,,percentRoot,,306,Spearman,0.003,,,>= 0.05,No,,,,Sun 2007
2669,2910,2862,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,0.23,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",7.8,,,percentRoot,,306,Spearman,-0.01,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2692,2910,2886,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,0.23,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",14.63,,,percentRoot,,306,Spearman,-0.06,,,>= 0.05,No,,,,Sun 2007
2715,2910,2886,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,0.23,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",14.63,,,percentRoot,,306,Spearman,-0.04,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2647,2911,2863,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,16.79,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),41.16,,,percentRoot,,306,Spearman,0.21,,,>= 0.05,No,,,,Sun 2007
2670,2911,2863,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,16.79,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),41.16,,,percentRoot,,306,Spearman,0.21,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2693,2911,2887,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,16.79,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),33.91,,,percentRoot,,306,Spearman,0.16,,,>= 0.05,No,,,,Sun 2007
2716,2911,2887,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,16.79,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),33.91,,,percentRoot,,306,Spearman,0.19,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2648,2912,2864,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,19.03,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),44.87,,,percentRoot,,306,Spearman,0.24,,,>= 0.05,No,,,,Sun 2007
2671,2912,2864,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,19.03,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),44.87,,,percentRoot,,306,Spearman,0.23,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2694,2912,2888,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,19.03,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),43.48,,,percentRoot,,306,Spearman,0.16,,,>= 0.05,No,,,,Sun 2007
2717,2912,2888,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,19.03,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),43.48,,,percentRoot,,306,Spearman,0.13,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2649,2913,2865,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Palmitelaidic acid (trans-16:1n-7),"",,0.26,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Palmitelaidic acid (trans-16:1n-7),"",0.15,,,percentRoot,,306,Spearman,0.26,,,>= 0.05,No,,,,Sun 2007
2672,2913,2865,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Palmitelaidic acid (trans-16:1n-7),"",,0.26,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Palmitelaidic acid (trans-16:1n-7),"",0.15,,,percentRoot,,306,Spearman,0.27,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2695,2913,2889,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Palmitelaidic acid (trans-16:1n-7),"",,0.26,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,Palmitelaidic acid (trans-16:1n-7),"",0.14,,,percentRoot,,306,Spearman,0.23,,,>= 0.05,No,,,,Sun 2007
2718,2913,2889,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Palmitelaidic acid (trans-16:1n-7),"",,0.26,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,Palmitelaidic acid (trans-16:1n-7),"",0.14,,,percentRoot,,306,Spearman,0.25,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2650,2914,2866,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),trans-Octadecenoic acids (trans-18:1),"",,3.71,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,trans-Octadecenoic acids (trans-18:1),"",1.1,,,percentRoot,,306,Spearman,0.27,,,< 0.001,Yes,,,,Sun 2007
2673,2914,2866,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),trans-Octadecenoic acids (trans-18:1),"",,3.71,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,trans-Octadecenoic acids (trans-18:1),"",1.1,,,percentRoot,,306,Spearman,0.29,,,< 0.001,Yes,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2696,2914,2890,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),trans-Octadecenoic acids (trans-18:1),"",,3.71,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,trans-Octadecenoic acids (trans-18:1),"",1.16,,,percentRoot,,306,Spearman,0.39,,,< 0.001,Yes,,,,Sun 2007
2719,2914,2890,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),trans-Octadecenoic acids (trans-18:1),"",,3.71,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,trans-Octadecenoic acids (trans-18:1),"",1.16,,,percentRoot,,306,Spearman,0.42,,,< 0.001,Yes,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2651,2915,2867,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Linoelaidic acid (trans-18:2n-6),"",,0.25,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Linoelaidic acid (trans-18:2n-6),"",0.26,,,percentRoot,,306,Spearman,0.26,,,>= 0.05,No,,,,Sun 2007
2674,2915,2867,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Linoelaidic acid (trans-18:2n-6),"",,0.25,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Linoelaidic acid (trans-18:2n-6),"",0.26,,,percentRoot,,306,Spearman,0.25,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2697,2915,2891,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Linoelaidic acid (trans-18:2n-6),"",,0.25,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,Linoelaidic acid (trans-18:2n-6),"",0.12,,,percentRoot,,306,Spearman,0.24,,,>= 0.05,No,,,,Sun 2007
2720,2915,2891,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Linoelaidic acid (trans-18:2n-6),"",,0.25,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,Linoelaidic acid (trans-18:2n-6),"",0.12,,,percentRoot,,306,Spearman,0.26,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2652,2916,2868,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),cis-9-Linoelaidic acid (9cis-18:2n-6),"",,0.45,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,cis-9-Linoelaidic acid (9cis-18:2n-6),"",0.28,,,percentRoot,,306,Spearman,0.17,,,>= 0.05,No,,,,Sun 2007
2675,2916,2868,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),cis-9-Linoelaidic acid (9cis-18:2n-6),"",,0.45,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,cis-9-Linoelaidic acid (9cis-18:2n-6),"",0.28,,,percentRoot,,306,Spearman,0.15,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2698,2916,2892,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),cis-9-Linoelaidic acid (9cis-18:2n-6),"",,0.45,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,cis-9-Linoelaidic acid (9cis-18:2n-6),"",0.14,,,percentRoot,,306,Spearman,0.2,,,>= 0.05,No,,,,Sun 2007
2721,2916,2892,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),cis-9-Linoelaidic acid (9cis-18:2n-6),"",,0.45,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,cis-9-Linoelaidic acid (9cis-18:2n-6),"",0.14,,,percentRoot,,306,Spearman,0.19,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2653,2917,2869,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6),,0.69,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6),0.72,,,percentRoot,,306,Spearman,0.21,,,>= 0.05,No,,,,Sun 2007
2676,2917,2869,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6),,0.69,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6),0.72,,,percentRoot,,306,Spearman,0.19,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2699,2917,2893,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6),,0.69,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6),0.36,,,percentRoot,,306,Spearman,0.25,,,>= 0.05,No,,,,Sun 2007
2722,2917,2893,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6),,0.69,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6),0.36,,,percentRoot,,306,Spearman,0.23,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2654,2918,2870,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + trans-Octadecenoic acids (trans-18:1),,4.67,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + trans-Octadecenoic acids (trans-18:1),1.98,,,percentRoot,,306,Spearman,0.29,,,< 0.01,Yes,,,,Sun 2007
2677,2918,2870,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + trans-Octadecenoic acids (trans-18:1),,4.67,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + trans-Octadecenoic acids (trans-18:1),1.98,,,percentRoot,,306,Spearman,0.3,,,< 0.01,Yes,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2700,2918,2894,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + trans-Octadecenoic acids (trans-18:1),,4.67,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + trans-Octadecenoic acids (trans-18:1),1.65,,,percentRoot,,306,Spearman,0.41,,,< 0.01,Yes,,,,Sun 2007
2723,2918,2894,All,Controls in a coronary heart disease substudy,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + trans-Octadecenoic acids (trans-18:1),,4.67,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + trans-Octadecenoic acids (trans-18:1),1.65,,,percentRoot,,306,Spearman,0.43,,,< 0.01,Yes,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
2724,2985,2991,All,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",,,,umol/L,,545,Pearson,0.21,,,< 0.0001,Yes,"Energy by residual method, Cholesterol",,,Vioque 2007
2742,2985,2991,All,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",,,,umol/L,,545,Pearson,0.19,,,< 0.0001,Yes,"Energy by residual method, Cholesterol",,"Sex, Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2725,2986,2992,All,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",,,,umol/L,,545,Pearson,0.19,,,< 0.0001,Yes,"Energy by residual method, Cholesterol",,,Vioque 2007
2743,2986,2992,All,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",,,,umol/L,,545,Pearson,0.17,,,< 0.0001,Yes,"Energy by residual method, Cholesterol",,"Sex, Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2726,2987,2993,All,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",,,,umol/L,,545,Pearson,0.1,,,< 0.05,Yes,"Energy by residual method, Cholesterol",,,Vioque 2007
2744,2987,2993,All,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",,,,umol/L,,545,Pearson,0.12,,,< 0.01,Yes,"Energy by residual method, Cholesterol",,"Sex, Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2727,2988,2994,All,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",,,,umol/L,,545,Pearson,0.18,,,< 0.0001,Yes,"Energy by residual method, Cholesterol",,,Vioque 2007
2745,2988,2994,All,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",,,,umol/L,,545,Pearson,0.17,,,< 0.0001,Yes,"Energy by residual method, Cholesterol",,"Sex, Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2728,2989,2995,All,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,545,Pearson,0.2,,,< 0.0001,Yes,"Energy by residual method, Cholesterol",,,Vioque 2007
2746,2989,2995,All,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,545,Pearson,0.19,,,< 0.0001,Yes,"Energy by residual method, Cholesterol",,"Sex, Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2729,2990,2996,All,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Vitamin C,"",,,,,mg/day,,,"Plasma, fasting and non-fasting",Fluorometry,Vitamin C,"",,,,umol/L,,545,Pearson,0.36,,,< 0.0001,Yes,Energy by residual method,,,Vioque 2007
2747,2990,2996,All,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Vitamin C,"",,,,,mg/day,,,"Plasma, fasting and non-fasting",Fluorometry,Vitamin C,"",,,,umol/L,,545,Pearson,0.29,,,< 0.0001,Yes,Energy by residual method,,"Sex, Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2730,2919,2925,Males,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,720.3,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",0.061,,,umol/L,,252,Pearson,0.21,,,< 0.01,Yes,"Energy by residual method, Cholesterol",,,Vioque 2007
2748,2919,2925,Males,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,720.3,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",0.061,,,umol/L,,252,Pearson,0.18,,,< 0.01,Yes,"Energy by residual method, Cholesterol",,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2731,2920,2926,Males,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,4000.1,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",0.196,,,umol/L,,252,Pearson,0.14,,,< 0.05,Yes,"Energy by residual method, Cholesterol",,,Vioque 2007
2749,2920,2926,Males,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,4000.1,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",0.196,,,umol/L,,252,Pearson,0.11,,,< 0.05,Yes,"Energy by residual method, Cholesterol",,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2732,2921,2927,Males,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,4283.0,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",0.139,,,umol/L,,252,Pearson,0.07,,,>= 0.05,No,"Energy by residual method, Cholesterol",,,Vioque 2007
2750,2921,2927,Males,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,4283.0,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",0.139,,,umol/L,,252,Pearson,0.07,,,>= 0.05,No,"Energy by residual method, Cholesterol",,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2733,2922,2928,Males,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Lycopene,"",,4009.4,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",0.474,,,umol/L,,252,Pearson,0.21,,,< 0.001,Yes,"Energy by residual method, Cholesterol",,,Vioque 2007
2751,2922,2928,Males,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Lycopene,"",,4009.4,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",0.474,,,umol/L,,252,Pearson,0.2,,,< 0.01,Yes,"Energy by residual method, Cholesterol",,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2734,2923,2929,Males,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,276.1,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.107,,,umol/L,,252,Pearson,0.23,,,< 0.001,Yes,"Energy by residual method, Cholesterol",,,Vioque 2007
2752,2923,2929,Males,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,276.1,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.107,,,umol/L,,252,Pearson,0.21,,,< 0.01,Yes,"Energy by residual method, Cholesterol",,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2735,2924,2930,Males,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Vitamin C,"",,125.4,,,mg/day,,,"Plasma, fasting and non-fasting",Fluorometry,Vitamin C,"",38.3,,,umol/L,,252,Pearson,0.36,,,< 0.0001,Yes,Energy by residual method,,,Vioque 2007
2753,2924,2930,Males,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Vitamin C,"",,125.4,,,mg/day,,,"Plasma, fasting and non-fasting",Fluorometry,Vitamin C,"",38.3,,,umol/L,,252,Pearson,0.31,,,< 0.0001,Yes,Energy by residual method,,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2736,2931,2937,Females,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,832.2,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",0.096,,,umol/L,,293,Pearson,0.17,,,< 0.01,Yes,"Energy by residual method, Cholesterol",,,Vioque 2007
2754,2931,2937,Females,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,832.2,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",0.096,,,umol/L,,293,Pearson,0.18,,,< 0.01,Yes,"Energy by residual method, Cholesterol",,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2737,2932,2938,Females,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,4358.2,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",0.304,,,umol/L,,293,Pearson,0.2,,,< 0.001,Yes,"Energy by residual method, Cholesterol",,,Vioque 2007
2755,2932,2938,Females,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,4358.2,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",0.304,,,umol/L,,293,Pearson,0.21,,,< 0.0001,Yes,"Energy by residual method, Cholesterol",,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2738,2933,2939,Females,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,4600.1,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",0.153,,,umol/L,,293,Pearson,0.13,,,< 0.05,Yes,"Energy by residual method, Cholesterol",,,Vioque 2007
2756,2933,2939,Females,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,4600.1,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",0.153,,,umol/L,,293,Pearson,0.15,,,< 0.05,Yes,"Energy by residual method, Cholesterol",,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2739,2934,2940,Females,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Lycopene,"",,4042.8,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",0.703,,,umol/L,,293,Pearson,0.14,,,< 0.05,Yes,"Energy by residual method, Cholesterol",,,Vioque 2007
2757,2934,2940,Females,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Lycopene,"",,4042.8,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",0.703,,,umol/L,,293,Pearson,0.15,,,< 0.05,Yes,"Energy by residual method, Cholesterol",,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2740,2935,2941,Females,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,313.6,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.136,,,umol/L,,293,Pearson,0.16,,,< 0.01,Yes,"Energy by residual method, Cholesterol",,,Vioque 2007
2758,2935,2941,Females,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,313.6,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.136,,,umol/L,,293,Pearson,0.18,,,< 0.05,Yes,"Energy by residual method, Cholesterol",,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2741,2936,2942,Females,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Vitamin C,"",,136.2,,,mg/day,,,"Plasma, fasting and non-fasting",Fluorometry,Vitamin C,"",51.0,,,umol/L,,293,Pearson,0.27,,,< 0.0001,Yes,Energy by residual method,,,Vioque 2007
2759,2936,2942,Females,Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Vitamin C,"",,136.2,,,mg/day,,,"Plasma, fasting and non-fasting",Fluorometry,Vitamin C,"",51.0,,,umol/L,,293,Pearson,0.26,,,< 0.0001,Yes,Energy by residual method,,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2760,2943,2951,Normal weight (BMI: <25kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,765.9,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",0.14,,,umol/L,,85,Pearson,0.41,,,< 0.001,Yes,"Energy by residual method, Cholesterol",,,Vioque 2007
2778,2943,2951,Normal weight (BMI: <25kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,765.9,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",0.14,,,umol/L,,85,Pearson,0.34,,,< 0.01,Yes,"Energy by residual method, Cholesterol",,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2761,2944,2952,Normal weight (BMI: <25kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,3931.4,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",0.393,,,umol/L,,85,Pearson,0.35,,,< 0.05,Yes,"Energy by residual method, Cholesterol",,,Vioque 2007
2779,2944,2952,Normal weight (BMI: <25kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,3931.4,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",0.393,,,umol/L,,85,Pearson,0.31,,,< 0.01,Yes,"Energy by residual method, Cholesterol",,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2762,2945,2953,Normal weight (BMI: <25kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,3971.9,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",0.163,,,umol/L,,85,Pearson,0.1,,,>= 0.05,No,"Energy by residual method, Cholesterol",,,Vioque 2007
2780,2945,2953,Normal weight (BMI: <25kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,3971.9,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",0.163,,,umol/L,,85,Pearson,0.11,,,>= 0.05,No,"Energy by residual method, Cholesterol",,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2763,2946,2954,Normal weight (BMI: <25kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Lycopene,"",,4209.3,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",0.926,,,umol/L,,85,Pearson,0.23,,,< 0.05,Yes,"Energy by residual method, Cholesterol",,,Vioque 2007
2781,2946,2954,Normal weight (BMI: <25kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Lycopene,"",,4209.3,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",0.926,,,umol/L,,85,Pearson,0.23,,,< 0.05,Yes,"Energy by residual method, Cholesterol",,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2764,2947,2955,Normal weight (BMI: <25kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,269.2,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.13,,,umol/L,,85,Pearson,0.26,,,< 0.05,Yes,"Energy by residual method, Cholesterol",,,Vioque 2007
2782,2947,2955,Normal weight (BMI: <25kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,269.2,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.13,,,umol/L,,85,Pearson,0.2,,,< 0.05,Yes,"Energy by residual method, Cholesterol",,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2765,2948,2956,Normal weight (BMI: <25kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Vitamin C,"",,124.1,,,mg/day,,,"Plasma, fasting and non-fasting",Fluorometry,Vitamin C,"",42.5,,,umol/L,,85,Pearson,0.41,,,< 0.001,Yes,Energy by residual method,,,Vioque 2007
2783,2948,2956,Normal weight (BMI: <25kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Vitamin C,"",,124.1,,,mg/day,,,"Plasma, fasting and non-fasting",Fluorometry,Vitamin C,"",42.5,,,umol/L,,85,Pearson,0.38,,,< 0.01,Yes,Energy by residual method,,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2766,2957,2965,Overweight (BMI: 25 to 30 kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,794.3,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",0.077,,,umol/L,,261,Pearson,0.24,,,< 0.001,Yes,"Energy by residual method, Cholesterol",,,Vioque 2007
2784,2957,2965,Overweight (BMI: 25 to 30 kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,794.3,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",0.077,,,umol/L,,261,Pearson,0.21,,,< 0.01,Yes,"Energy by residual method, Cholesterol",,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2767,2958,2966,Overweight (BMI: 25 to 30 kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,4297.0,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",0.249,,,umol/L,,261,Pearson,0.15,,,< 0.05,Yes,"Energy by residual method, Cholesterol",,,Vioque 2007
2785,2958,2966,Overweight (BMI: 25 to 30 kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,4297.0,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",0.249,,,umol/L,,261,Pearson,0.11,,,>= 0.05,No,"Energy by residual method, Cholesterol",,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2768,2959,2967,Overweight (BMI: 25 to 30 kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,4565.6,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",0.157,,,umol/L,,261,Pearson,0.2,,,< 0.01,Yes,"Energy by residual method, Cholesterol",,,Vioque 2007
2786,2959,2967,Overweight (BMI: 25 to 30 kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,4565.6,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",0.157,,,umol/L,,261,Pearson,0.2,,,< 0.01,Yes,"Energy by residual method, Cholesterol",,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2769,2960,2968,Overweight (BMI: 25 to 30 kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Lycopene,"",,4227.6,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",0.608,,,umol/L,,261,Pearson,0.15,,,< 0.05,Yes,"Energy by residual method, Cholesterol",,,Vioque 2007
2787,2960,2968,Overweight (BMI: 25 to 30 kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Lycopene,"",,4227.6,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",0.608,,,umol/L,,261,Pearson,0.15,,,< 0.05,Yes,"Energy by residual method, Cholesterol",,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2770,2961,2969,Overweight (BMI: 25 to 30 kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,311.0,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.135,,,umol/L,,261,Pearson,0.2,,,< 0.01,Yes,"Energy by residual method, Cholesterol",,,Vioque 2007
2788,2961,2969,Overweight (BMI: 25 to 30 kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,311.0,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.135,,,umol/L,,261,Pearson,0.19,,,< 0.01,Yes,"Energy by residual method, Cholesterol",,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2771,2962,2970,Overweight (BMI: 25 to 30 kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Vitamin C,"",,139.1,,,mg/day,,,"Plasma, fasting and non-fasting",Fluorometry,Vitamin C,"",45.8,,,umol/L,,261,Pearson,0.35,,,< 0.0001,Yes,Energy by residual method,,,Vioque 2007
2789,2962,2970,Overweight (BMI: 25 to 30 kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Vitamin C,"",,139.1,,,mg/day,,,"Plasma, fasting and non-fasting",Fluorometry,Vitamin C,"",45.8,,,umol/L,,261,Pearson,0.26,,,< 0.0001,Yes,Energy by residual method,,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2772,2971,2979,Obese (BMI: >30kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,768.4,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",0.059,,,umol/L,,199,Pearson,0.1,,,>= 0.05,No,"Energy by residual method, Cholesterol",,,Vioque 2007
2790,2971,2979,Obese (BMI: >30kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,768.4,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",0.059,,,umol/L,,199,Pearson,0.11,,,>= 0.05,No,"Energy by residual method, Cholesterol",,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2773,2972,2980,Obese (BMI: >30kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,4167.3,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",0.201,,,umol/L,,199,Pearson,0.2,,,< 0.01,Yes,"Energy by residual method, Cholesterol",,,Vioque 2007
2791,2972,2980,Obese (BMI: >30kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,4167.3,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",0.201,,,umol/L,,199,Pearson,0.19,,,< 0.01,Yes,"Energy by residual method, Cholesterol",,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2774,2973,2981,Obese (BMI: >30kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,4512.0,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",0.126,,,umol/L,,199,Pearson,-0.04,,,>= 0.05,No,"Energy by residual method, Cholesterol",,,Vioque 2007
2792,2973,2981,Obese (BMI: >30kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,4512.0,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",0.126,,,umol/L,,199,Pearson,-0.02,,,>= 0.05,No,"Energy by residual method, Cholesterol",,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2775,2974,2982,Obese (BMI: >30kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Lycopene,"",,3687.0,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",0.444,,,umol/L,,199,Pearson,0.21,,,< 0.01,Yes,"Energy by residual method, Cholesterol",,,Vioque 2007
2793,2974,2982,Obese (BMI: >30kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Lycopene,"",,3687.0,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",0.444,,,umol/L,,199,Pearson,0.2,,,< 0.01,Yes,"Energy by residual method, Cholesterol",,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2776,2975,2983,Obese (BMI: >30kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,288.6,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.103,,,umol/L,,199,Pearson,0.17,,,< 0.05,Yes,"Energy by residual method, Cholesterol",,,Vioque 2007
2794,2975,2983,Obese (BMI: >30kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,288.6,,,ug/day,,,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",0.103,,,umol/L,,199,Pearson,0.18,,,< 0.05,Yes,"Energy by residual method, Cholesterol",,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2777,2976,2984,Obese (BMI: >30kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Vitamin C,"",,123.9,,,mg/day,,,"Plasma, fasting and non-fasting",Fluorometry,Vitamin C,"",45.4,,,umol/L,,199,Pearson,0.33,,,< 0.0001,Yes,Energy by residual method,,,Vioque 2007
2795,2976,2984,Obese (BMI: >30kg/m2),Elderly subjects in the province of Alicante,Spain,EUREYE (European Eye),,Food Frequency Questionnaire (FFQ),Vitamin C,"",,123.9,,,mg/day,,,"Plasma, fasting and non-fasting",Fluorometry,Vitamin C,"",45.4,,,umol/L,,199,Pearson,0.26,,,< 0.0001,Yes,Energy by residual method,,"Age, Smoking status, BMI, Alcohol intake, Supplement intake, Fasting status",Vioque 2007
2796,3005,3013,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fats,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,36.43,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",33.3,,,percentRoot,,276,Spearman,0.15,,,< 0.01,Yes,,,,Astorg 2008
2797,3005,3014,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fats,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,36.43,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",0.57,,,percentRoot,,276,Spearman,-0.22,,,< 0.001,Yes,,,,Astorg 2008
2798,3005,3015,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fats,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,36.43,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.51,,,percentRoot,,276,Spearman,-0.06,,,>= 0.05,No,,,,Astorg 2008
2799,3005,3016,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fats,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,36.43,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Eicosadienoic acid (cis-20:2n-6),"",0.23,,,percentRoot,,276,Spearman,-0.06,,,>= 0.05,No,,,,Astorg 2008
2800,3005,3017,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fats,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,36.43,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Mead acid (cis-20:3n-9),"",0.14,,,percentRoot,,276,Spearman,-0.13,,,< 0.05,Yes,,,,Astorg 2008
2801,3005,3018,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fats,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,36.43,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",1.54,,,percentRoot,,276,Spearman,-0.09,,,>= 0.05,No,,,,Astorg 2008
2802,3005,3019,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fats,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,36.43,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",7.9,,,percentRoot,,276,Spearman,-0.01,,,>= 0.05,No,,,,Astorg 2008
2803,3005,3020,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fats,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,36.43,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",1.36,,,percentRoot,,276,Spearman,-0.07,,,>= 0.05,No,,,,Astorg 2008
2804,3005,3021,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fats,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,36.43,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.21,,,percentRoot,,276,Spearman,-0.1,,,>= 0.05,No,,,,Astorg 2008
2805,3005,3022,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fats,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,36.43,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.54,,,percentRoot,,276,Spearman,-0.08,,,>= 0.05,No,,,,Astorg 2008
2806,3005,3023,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fats,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,36.43,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",2.49,,,percentRoot,,276,Spearman,-0.06,,,>= 0.05,No,,,,Astorg 2008
2807,3006,3013,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Linoleic acid (LA; cis-18:2n-6),"",,4.7,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",33.3,,,percentRoot,,276,Spearman,0.22,,,< 0.001,Yes,,,,Astorg 2008
2808,3006,3014,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Linoleic acid (LA; cis-18:2n-6),"",,4.7,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",0.57,,,percentRoot,,276,Spearman,-0.09,,,>= 0.05,No,,,,Astorg 2008
2809,3006,3015,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Linoleic acid (LA; cis-18:2n-6),"",,4.7,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.51,,,percentRoot,,276,Spearman,-0.05,,,>= 0.05,No,,,,Astorg 2008
2810,3006,3016,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Linoleic acid (LA; cis-18:2n-6),"",,4.7,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Eicosadienoic acid (cis-20:2n-6),"",0.23,,,percentRoot,,276,Spearman,0.07,,,>= 0.05,No,,,,Astorg 2008
2811,3006,3017,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Linoleic acid (LA; cis-18:2n-6),"",,4.7,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Mead acid (cis-20:3n-9),"",0.14,,,percentRoot,,276,Spearman,-0.29,,,< 0.001,Yes,,,,Astorg 2008
2812,3006,3018,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Linoleic acid (LA; cis-18:2n-6),"",,4.7,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",1.54,,,percentRoot,,276,Spearman,-0.12,,,< 0.05,Yes,,,,Astorg 2008
2813,3006,3019,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Linoleic acid (LA; cis-18:2n-6),"",,4.7,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",7.9,,,percentRoot,,276,Spearman,0.004,,,>= 0.05,No,,,,Astorg 2008
2814,3006,3020,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Linoleic acid (LA; cis-18:2n-6),"",,4.7,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",1.36,,,percentRoot,,276,Spearman,-0.08,,,>= 0.05,No,,,,Astorg 2008
2815,3006,3021,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Linoleic acid (LA; cis-18:2n-6),"",,4.7,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.21,,,percentRoot,,276,Spearman,-0.07,,,>= 0.05,No,,,,Astorg 2008
2816,3006,3022,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Linoleic acid (LA; cis-18:2n-6),"",,4.7,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.54,,,percentRoot,,276,Spearman,-0.12,,,< 0.05,Yes,,,,Astorg 2008
2817,3006,3023,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Linoleic acid (LA; cis-18:2n-6),"",,4.7,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",2.49,,,percentRoot,,276,Spearman,-0.01,,,>= 0.05,No,,,,Astorg 2008
2818,3007,3013,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,0.37,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",33.3,,,percentRoot,,276,Spearman,0.17,,,< 0.01,Yes,,,,Astorg 2008
2819,3007,3014,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,0.37,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",0.57,,,percentRoot,,276,Spearman,-0.13,,,< 0.05,Yes,,,,Astorg 2008
2820,3007,3015,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,0.37,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.51,,,percentRoot,,276,Spearman,0.06,,,>= 0.05,No,,,,Astorg 2008
2821,3007,3016,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,0.37,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Eicosadienoic acid (cis-20:2n-6),"",0.23,,,percentRoot,,276,Spearman,-0.07,,,>= 0.05,No,,,,Astorg 2008
2822,3007,3017,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,0.37,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Mead acid (cis-20:3n-9),"",0.14,,,percentRoot,,276,Spearman,-0.12,,,< 0.05,Yes,,,,Astorg 2008
2823,3007,3018,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,0.37,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",1.54,,,percentRoot,,276,Spearman,-0.06,,,>= 0.05,No,,,,Astorg 2008
2824,3007,3019,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,0.37,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",7.9,,,percentRoot,,276,Spearman,-0.005,,,>= 0.05,No,,,,Astorg 2008
2825,3007,3020,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,0.37,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",1.36,,,percentRoot,,276,Spearman,0.02,,,>= 0.05,No,,,,Astorg 2008
2826,3007,3021,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,0.37,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.21,,,percentRoot,,276,Spearman,-0.11,,,>= 0.05,No,,,,Astorg 2008
2827,3007,3022,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,0.37,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.54,,,percentRoot,,276,Spearman,0.06,,,>= 0.05,No,,,,Astorg 2008
2828,3007,3023,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,0.37,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",2.49,,,percentRoot,,276,Spearman,0.04,,,>= 0.05,No,,,,Astorg 2008
2829,3008,3013,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.08,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",33.3,,,percentRoot,,276,Spearman,-0.02,,,>= 0.05,No,,,,Astorg 2008
2830,3008,3014,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.08,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",0.57,,,percentRoot,,276,Spearman,0.06,,,>= 0.05,No,,,,Astorg 2008
2831,3008,3015,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.08,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.51,,,percentRoot,,276,Spearman,-0.15,,,< 0.05,Yes,,,,Astorg 2008
2832,3008,3016,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.08,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Eicosadienoic acid (cis-20:2n-6),"",0.23,,,percentRoot,,276,Spearman,-0.14,,,< 0.05,Yes,,,,Astorg 2008
2833,3008,3017,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.08,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Mead acid (cis-20:3n-9),"",0.14,,,percentRoot,,276,Spearman,-0.02,,,>= 0.05,No,,,,Astorg 2008
2834,3008,3018,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.08,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",1.54,,,percentRoot,,276,Spearman,-0.19,,,< 0.01,Yes,,,,Astorg 2008
2835,3008,3019,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.08,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",7.9,,,percentRoot,,276,Spearman,0.16,,,< 0.01,Yes,,,,Astorg 2008
2836,3008,3020,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.08,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",1.36,,,percentRoot,,276,Spearman,0.19,,,< 0.01,Yes,,,,Astorg 2008
2837,3008,3021,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.08,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.21,,,percentRoot,,276,Spearman,-0.03,,,>= 0.05,No,,,,Astorg 2008
2838,3008,3022,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.08,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.54,,,percentRoot,,276,Spearman,0.01,,,>= 0.05,No,,,,Astorg 2008
2839,3008,3023,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.08,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",2.49,,,percentRoot,,276,Spearman,0.13,,,< 0.05,Yes,,,,Astorg 2008
2840,3009,3013,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),EPA (cis-20:5n-3),"",,0.06,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",33.3,,,percentRoot,,276,Spearman,-0.007,,,>= 0.05,No,,,,Astorg 2008
2841,3009,3014,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),EPA (cis-20:5n-3),"",,0.06,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",0.57,,,percentRoot,,276,Spearman,0.001,,,>= 0.05,No,,,,Astorg 2008
2842,3009,3015,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),EPA (cis-20:5n-3),"",,0.06,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.51,,,percentRoot,,276,Spearman,-0.07,,,>= 0.05,No,,,,Astorg 2008
2843,3009,3016,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),EPA (cis-20:5n-3),"",,0.06,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Eicosadienoic acid (cis-20:2n-6),"",0.23,,,percentRoot,,276,Spearman,-0.11,,,>= 0.05,No,,,,Astorg 2008
2844,3009,3017,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),EPA (cis-20:5n-3),"",,0.06,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Mead acid (cis-20:3n-9),"",0.14,,,percentRoot,,276,Spearman,-0.06,,,>= 0.05,No,,,,Astorg 2008
2845,3009,3018,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),EPA (cis-20:5n-3),"",,0.06,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",1.54,,,percentRoot,,276,Spearman,-0.16,,,< 0.01,Yes,,,,Astorg 2008
2846,3009,3019,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),EPA (cis-20:5n-3),"",,0.06,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",7.9,,,percentRoot,,276,Spearman,-0.003,,,>= 0.05,No,,,,Astorg 2008
2847,3009,3020,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),EPA (cis-20:5n-3),"",,0.06,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",1.36,,,percentRoot,,276,Spearman,0.24,,,< 0.001,Yes,,,,Astorg 2008
2848,3009,3021,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),EPA (cis-20:5n-3),"",,0.06,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.21,,,percentRoot,,276,Spearman,-0.16,,,< 0.01,Yes,,,,Astorg 2008
2849,3009,3022,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),EPA (cis-20:5n-3),"",,0.06,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.54,,,percentRoot,,276,Spearman,0.07,,,>= 0.05,No,,,,Astorg 2008
2850,3009,3023,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),EPA (cis-20:5n-3),"",,0.06,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",2.49,,,percentRoot,,276,Spearman,0.23,,,< 0.01,Yes,,,,Astorg 2008
2851,3010,3013,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DPA (cis-22:5n-3),"",,0.03,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",33.3,,,percentRoot,,276,Spearman,-0.01,,,>= 0.05,No,,,,Astorg 2008
2852,3010,3014,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DPA (cis-22:5n-3),"",,0.03,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",0.57,,,percentRoot,,276,Spearman,-0.02,,,>= 0.05,No,,,,Astorg 2008
2853,3010,3015,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DPA (cis-22:5n-3),"",,0.03,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.51,,,percentRoot,,276,Spearman,-0.14,,,< 0.05,Yes,,,,Astorg 2008
2854,3010,3016,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DPA (cis-22:5n-3),"",,0.03,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Eicosadienoic acid (cis-20:2n-6),"",0.23,,,percentRoot,,276,Spearman,-0.18,,,< 0.01,Yes,,,,Astorg 2008
2855,3010,3017,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DPA (cis-22:5n-3),"",,0.03,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Mead acid (cis-20:3n-9),"",0.14,,,percentRoot,,276,Spearman,-0.05,,,>= 0.05,No,,,,Astorg 2008
2856,3010,3018,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DPA (cis-22:5n-3),"",,0.03,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",1.54,,,percentRoot,,276,Spearman,-0.23,,,< 0.001,Yes,,,,Astorg 2008
2857,3010,3019,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DPA (cis-22:5n-3),"",,0.03,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",7.9,,,percentRoot,,276,Spearman,0.13,,,< 0.05,Yes,,,,Astorg 2008
2858,3010,3020,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DPA (cis-22:5n-3),"",,0.03,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",1.36,,,percentRoot,,276,Spearman,0.27,,,< 0.001,Yes,,,,Astorg 2008
2859,3010,3021,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DPA (cis-22:5n-3),"",,0.03,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.21,,,percentRoot,,276,Spearman,-0.12,,,< 0.05,Yes,,,,Astorg 2008
2860,3010,3022,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DPA (cis-22:5n-3),"",,0.03,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.54,,,percentRoot,,276,Spearman,0.08,,,>= 0.05,No,,,,Astorg 2008
2861,3010,3023,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DPA (cis-22:5n-3),"",,0.03,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",2.49,,,percentRoot,,276,Spearman,0.19,,,< 0.01,Yes,,,,Astorg 2008
2862,3011,3013,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DHA (cis-22:6n-3),"",,0.11,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",33.3,,,percentRoot,,276,Spearman,0.02,,,>= 0.05,No,,,,Astorg 2008
2863,3011,3014,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DHA (cis-22:6n-3),"",,0.11,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",0.57,,,percentRoot,,276,Spearman,-0.02,,,>= 0.05,No,,,,Astorg 2008
2864,3011,3015,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DHA (cis-22:6n-3),"",,0.11,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.51,,,percentRoot,,276,Spearman,-0.03,,,>= 0.05,No,,,,Astorg 2008
2865,3011,3016,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DHA (cis-22:6n-3),"",,0.11,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Eicosadienoic acid (cis-20:2n-6),"",0.23,,,percentRoot,,276,Spearman,-0.13,,,< 0.05,Yes,,,,Astorg 2008
2866,3011,3017,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DHA (cis-22:6n-3),"",,0.11,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Mead acid (cis-20:3n-9),"",0.14,,,percentRoot,,276,Spearman,-0.08,,,>= 0.05,No,,,,Astorg 2008
2867,3011,3018,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DHA (cis-22:6n-3),"",,0.11,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",1.54,,,percentRoot,,276,Spearman,-0.16,,,< 0.01,Yes,,,,Astorg 2008
2868,3011,3019,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DHA (cis-22:6n-3),"",,0.11,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",7.9,,,percentRoot,,276,Spearman,0.01,,,>= 0.05,No,,,,Astorg 2008
2869,3011,3020,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DHA (cis-22:6n-3),"",,0.11,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",1.36,,,percentRoot,,276,Spearman,0.25,,,< 0.001,Yes,,,,Astorg 2008
2870,3011,3021,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DHA (cis-22:6n-3),"",,0.11,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.21,,,percentRoot,,276,Spearman,-0.2,,,< 0.001,Yes,,,,Astorg 2008
2871,3011,3022,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DHA (cis-22:6n-3),"",,0.11,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.54,,,percentRoot,,276,Spearman,0.08,,,>= 0.05,No,,,,Astorg 2008
2872,3011,3023,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DHA (cis-22:6n-3),"",,0.11,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",2.49,,,percentRoot,,276,Spearman,0.25,,,< 0.001,Yes,,,,Astorg 2008
2873,3012,3013,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.2,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",33.3,,,percentRoot,,276,Spearman,0.008,,,>= 0.05,No,,,,Astorg 2008
2874,3012,3014,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.2,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",0.57,,,percentRoot,,276,Spearman,-0.01,,,>= 0.05,No,,,,Astorg 2008
2875,3012,3015,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.2,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.51,,,percentRoot,,276,Spearman,-0.06,,,>= 0.05,No,,,,Astorg 2008
2876,3012,3016,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.2,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Eicosadienoic acid (cis-20:2n-6),"",0.23,,,percentRoot,,276,Spearman,-0.13,,,< 0.05,Yes,,,,Astorg 2008
2877,3012,3017,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.2,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Mead acid (cis-20:3n-9),"",0.14,,,percentRoot,,276,Spearman,-0.07,,,>= 0.05,No,,,,Astorg 2008
2878,3012,3018,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.2,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",1.54,,,percentRoot,,276,Spearman,-0.18,,,< 0.01,Yes,,,,Astorg 2008
2879,3012,3019,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.2,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",7.9,,,percentRoot,,276,Spearman,0.02,,,>= 0.05,No,,,,Astorg 2008
2880,3012,3020,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.2,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",1.36,,,percentRoot,,276,Spearman,0.25,,,< 0.001,Yes,,,,Astorg 2008
2881,3012,3021,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.2,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.21,,,percentRoot,,276,Spearman,-0.19,,,< 0.01,Yes,,,,Astorg 2008
2882,3012,3022,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.2,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.54,,,percentRoot,,276,Spearman,0.08,,,>= 0.05,No,,,,Astorg 2008
2883,3012,3023,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.2,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",2.49,,,percentRoot,,276,Spearman,0.25,,,< 0.001,Yes,,,,Astorg 2008
2975,3051,3020,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Lean fish,"",,23.0,,,g/day,,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",1.36,,,percentRoot,,276,Spearman,0.1,,,>= 0.05,No,,,,Astorg 2008
2976,3051,3022,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Lean fish,"",,23.0,,,g/day,,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.54,,,percentRoot,,276,Spearman,-0.02,,,>= 0.05,No,,,,Astorg 2008
2977,3051,3023,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Lean fish,"",,23.0,,,g/day,,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",2.49,,,percentRoot,,276,Spearman,0.08,,,>= 0.05,No,,,,Astorg 2008
2978,3052,3020,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fatty fish,"",,16.5,,,g/day,,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",1.36,,,percentRoot,,276,Spearman,0.23,,,< 0.001,Yes,,,,Astorg 2008
2979,3052,3022,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fatty fish,"",,16.5,,,g/day,,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.54,,,percentRoot,,276,Spearman,0.06,,,>= 0.05,No,,,,Astorg 2008
2980,3052,3023,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fatty fish,"",,16.5,,,g/day,,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",2.49,,,percentRoot,,276,Spearman,0.21,,,< 0.001,Yes,,,,Astorg 2008
2972,3053,3020,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fish,Fatty fish + Lean fish,,,,,g/day,,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",1.36,,,percentRoot,,276,Spearman,0.22,,,< 0.001,Yes,,,,Astorg 2008
2973,3053,3022,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fish,Fatty fish + Lean fish,,,,,g/day,,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.54,,,percentRoot,,276,Spearman,0.02,,,>= 0.05,No,,,,Astorg 2008
2974,3053,3023,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fish,Fatty fish + Lean fish,,,,,g/day,,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",2.49,,,percentRoot,,276,Spearman,0.18,,,< 0.01,Yes,,,,Astorg 2008
2981,3054,3020,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Shellfish,"",,12.8,,,g/day,,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",1.36,,,percentRoot,,276,Spearman,0.09,,,>= 0.05,No,,,,Astorg 2008
2982,3054,3022,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Shellfish,"",,12.8,,,g/day,,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.54,,,percentRoot,,276,Spearman,0.04,,,>= 0.05,No,,,,Astorg 2008
2983,3054,3023,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Shellfish,"",,12.8,,,g/day,,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",2.49,,,percentRoot,,276,Spearman,0.1,,,>= 0.05,No,,,,Astorg 2008
2984,3055,3020,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Seafood,Fatty fish + Lean fish + Shellfish,,52.3,,,g/day,,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",1.36,,,percentRoot,,276,Spearman,0.2,,,< 0.001,Yes,,,,Astorg 2008
2985,3055,3022,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Seafood,Fatty fish + Lean fish + Shellfish,,52.3,,,g/day,,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.54,,,percentRoot,,276,Spearman,0.03,,,>= 0.05,No,,,,Astorg 2008
2986,3055,3023,Males,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Seafood,Fatty fish + Lean fish + Shellfish,,52.3,,,g/day,,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",2.49,,,percentRoot,,276,Spearman,0.18,,,< 0.01,Yes,,,,Astorg 2008
2884,3032,3040,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fats,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,38.49,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",35.26,,,percentRoot,,257,Spearman,0.12,,,< 0.05,Yes,,,,Astorg 2008
2885,3032,3041,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fats,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,38.49,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",0.47,,,percentRoot,,257,Spearman,-0.04,,,>= 0.05,No,,,,Astorg 2008
2886,3032,3042,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fats,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,38.49,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.51,,,percentRoot,,257,Spearman,-0.007,,,>= 0.05,No,,,,Astorg 2008
2887,3032,3043,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fats,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,38.49,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Eicosadienoic acid (cis-20:2n-6),"",0.22,,,percentRoot,,257,Spearman,0.006,,,>= 0.05,No,,,,Astorg 2008
2888,3032,3044,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fats,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,38.49,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Mead acid (cis-20:3n-9),"",0.13,,,percentRoot,,257,Spearman,-0.08,,,>= 0.05,No,,,,Astorg 2008
2889,3032,3045,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fats,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,38.49,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",1.51,,,percentRoot,,257,Spearman,-0.14,,,< 0.05,Yes,,,,Astorg 2008
2890,3032,3046,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fats,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,38.49,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",8.05,,,percentRoot,,257,Spearman,0.05,,,>= 0.05,No,,,,Astorg 2008
2891,3032,3047,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fats,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,38.49,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",1.29,,,percentRoot,,257,Spearman,0.03,,,>= 0.05,No,,,,Astorg 2008
2892,3032,3048,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fats,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,38.49,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.2,,,percentRoot,,257,Spearman,0.01,,,>= 0.05,No,,,,Astorg 2008
2893,3032,3049,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fats,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,38.49,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.54,,,percentRoot,,257,Spearman,0.005,,,>= 0.05,No,,,,Astorg 2008
2894,3032,3050,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fats,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,38.49,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",2.65,,,percentRoot,,257,Spearman,-0.01,,,>= 0.05,No,,,,Astorg 2008
2895,3033,3040,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Linoleic acid (LA; cis-18:2n-6),"",,4.96,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",35.26,,,percentRoot,,257,Spearman,0.19,,,< 0.01,Yes,,,,Astorg 2008
2896,3033,3041,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Linoleic acid (LA; cis-18:2n-6),"",,4.96,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",0.47,,,percentRoot,,257,Spearman,0.05,,,>= 0.05,No,,,,Astorg 2008
2897,3033,3042,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Linoleic acid (LA; cis-18:2n-6),"",,4.96,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.51,,,percentRoot,,257,Spearman,-0.07,,,>= 0.05,No,,,,Astorg 2008
2898,3033,3043,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Linoleic acid (LA; cis-18:2n-6),"",,4.96,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Eicosadienoic acid (cis-20:2n-6),"",0.22,,,percentRoot,,257,Spearman,0.14,,,< 0.05,Yes,,,,Astorg 2008
2899,3033,3044,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Linoleic acid (LA; cis-18:2n-6),"",,4.96,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Mead acid (cis-20:3n-9),"",0.13,,,percentRoot,,257,Spearman,-0.2,,,< 0.01,Yes,,,,Astorg 2008
2900,3033,3045,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Linoleic acid (LA; cis-18:2n-6),"",,4.96,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",1.51,,,percentRoot,,257,Spearman,-0.06,,,>= 0.05,No,,,,Astorg 2008
2901,3033,3046,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Linoleic acid (LA; cis-18:2n-6),"",,4.96,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",8.05,,,percentRoot,,257,Spearman,0.04,,,>= 0.05,No,,,,Astorg 2008
2902,3033,3047,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Linoleic acid (LA; cis-18:2n-6),"",,4.96,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",1.29,,,percentRoot,,257,Spearman,-0.11,,,>= 0.05,No,,,,Astorg 2008
2903,3033,3048,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Linoleic acid (LA; cis-18:2n-6),"",,4.96,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.2,,,percentRoot,,257,Spearman,0.01,,,>= 0.05,No,,,,Astorg 2008
2904,3033,3049,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Linoleic acid (LA; cis-18:2n-6),"",,4.96,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.54,,,percentRoot,,257,Spearman,-0.08,,,>= 0.05,No,,,,Astorg 2008
2905,3033,3050,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Linoleic acid (LA; cis-18:2n-6),"",,4.96,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",2.65,,,percentRoot,,257,Spearman,-0.07,,,>= 0.05,No,,,,Astorg 2008
2906,3034,3040,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,0.4,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",35.26,,,percentRoot,,257,Spearman,0.02,,,>= 0.05,No,,,,Astorg 2008
2907,3034,3041,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,0.4,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",0.47,,,percentRoot,,257,Spearman,-0.03,,,>= 0.05,No,,,,Astorg 2008
2908,3034,3042,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,0.4,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.51,,,percentRoot,,257,Spearman,0.05,,,>= 0.05,No,,,,Astorg 2008
2909,3034,3043,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,0.4,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Eicosadienoic acid (cis-20:2n-6),"",0.22,,,percentRoot,,257,Spearman,0.01,,,>= 0.05,No,,,,Astorg 2008
2910,3034,3044,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,0.4,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Mead acid (cis-20:3n-9),"",0.13,,,percentRoot,,257,Spearman,-0.05,,,>= 0.05,No,,,,Astorg 2008
2911,3034,3045,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,0.4,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",1.51,,,percentRoot,,257,Spearman,-0.05,,,>= 0.05,No,,,,Astorg 2008
2912,3034,3046,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,0.4,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",8.05,,,percentRoot,,257,Spearman,-0.03,,,>= 0.05,No,,,,Astorg 2008
2913,3034,3047,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,0.4,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",1.29,,,percentRoot,,257,Spearman,0.09,,,>= 0.05,No,,,,Astorg 2008
2914,3034,3048,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,0.4,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.2,,,percentRoot,,257,Spearman,-0.08,,,>= 0.05,No,,,,Astorg 2008
2915,3034,3049,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,0.4,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.54,,,percentRoot,,257,Spearman,0.03,,,>= 0.05,No,,,,Astorg 2008
2916,3034,3050,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,0.4,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",2.65,,,percentRoot,,257,Spearman,0.05,,,>= 0.05,No,,,,Astorg 2008
2917,3035,3040,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.08,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",35.26,,,percentRoot,,257,Spearman,-0.09,,,>= 0.05,No,,,,Astorg 2008
2918,3035,3041,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.08,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",0.47,,,percentRoot,,257,Spearman,-0.01,,,>= 0.05,No,,,,Astorg 2008
2919,3035,3042,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.08,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.51,,,percentRoot,,257,Spearman,-0.06,,,>= 0.05,No,,,,Astorg 2008
2920,3035,3043,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.08,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Eicosadienoic acid (cis-20:2n-6),"",0.22,,,percentRoot,,257,Spearman,0.06,,,>= 0.05,No,,,,Astorg 2008
2921,3035,3044,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.08,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Mead acid (cis-20:3n-9),"",0.13,,,percentRoot,,257,Spearman,0.03,,,>= 0.05,No,,,,Astorg 2008
2922,3035,3045,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.08,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",1.51,,,percentRoot,,257,Spearman,-0.05,,,>= 0.05,No,,,,Astorg 2008
2923,3035,3046,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.08,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",8.05,,,percentRoot,,257,Spearman,0.17,,,< 0.01,Yes,,,,Astorg 2008
2924,3035,3047,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.08,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",1.29,,,percentRoot,,257,Spearman,0.12,,,< 0.05,Yes,,,,Astorg 2008
2925,3035,3048,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.08,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.2,,,percentRoot,,257,Spearman,0.04,,,>= 0.05,No,,,,Astorg 2008
2926,3035,3049,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.08,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.54,,,percentRoot,,257,Spearman,0.07,,,>= 0.05,No,,,,Astorg 2008
2927,3035,3050,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.08,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",2.65,,,percentRoot,,257,Spearman,0.14,,,< 0.05,Yes,,,,Astorg 2008
2928,3036,3040,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),EPA (cis-20:5n-3),"",,0.06,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",35.26,,,percentRoot,,257,Spearman,-0.14,,,< 0.05,Yes,,,,Astorg 2008
2929,3036,3041,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),EPA (cis-20:5n-3),"",,0.06,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",0.47,,,percentRoot,,257,Spearman,-0.05,,,>= 0.05,No,,,,Astorg 2008
2930,3036,3042,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),EPA (cis-20:5n-3),"",,0.06,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.51,,,percentRoot,,257,Spearman,0.02,,,>= 0.05,No,,,,Astorg 2008
2931,3036,3043,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),EPA (cis-20:5n-3),"",,0.06,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Eicosadienoic acid (cis-20:2n-6),"",0.22,,,percentRoot,,257,Spearman,0.03,,,>= 0.05,No,,,,Astorg 2008
2932,3036,3044,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),EPA (cis-20:5n-3),"",,0.06,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Mead acid (cis-20:3n-9),"",0.13,,,percentRoot,,257,Spearman,-0.004,,,>= 0.05,No,,,,Astorg 2008
2933,3036,3045,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),EPA (cis-20:5n-3),"",,0.06,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",1.51,,,percentRoot,,257,Spearman,-0.12,,,< 0.05,Yes,,,,Astorg 2008
2934,3036,3046,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),EPA (cis-20:5n-3),"",,0.06,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",8.05,,,percentRoot,,257,Spearman,0.04,,,>= 0.05,No,,,,Astorg 2008
2935,3036,3047,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),EPA (cis-20:5n-3),"",,0.06,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",1.29,,,percentRoot,,257,Spearman,0.27,,,< 0.001,Yes,,,,Astorg 2008
2936,3036,3048,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),EPA (cis-20:5n-3),"",,0.06,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.2,,,percentRoot,,257,Spearman,-0.09,,,>= 0.05,No,,,,Astorg 2008
2937,3036,3049,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),EPA (cis-20:5n-3),"",,0.06,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.54,,,percentRoot,,257,Spearman,0.06,,,>= 0.05,No,,,,Astorg 2008
2938,3036,3050,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),EPA (cis-20:5n-3),"",,0.06,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",2.65,,,percentRoot,,257,Spearman,0.29,,,< 0.001,Yes,,,,Astorg 2008
2939,3037,3040,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DPA (cis-22:5n-3),"",,0.03,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",35.26,,,percentRoot,,257,Spearman,-0.15,,,< 0.05,Yes,,,,Astorg 2008
2940,3037,3041,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DPA (cis-22:5n-3),"",,0.03,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",0.47,,,percentRoot,,257,Spearman,-0.04,,,>= 0.05,No,,,,Astorg 2008
2941,3037,3042,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DPA (cis-22:5n-3),"",,0.03,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.51,,,percentRoot,,257,Spearman,-0.03,,,>= 0.05,No,,,,Astorg 2008
2942,3037,3043,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DPA (cis-22:5n-3),"",,0.03,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Eicosadienoic acid (cis-20:2n-6),"",0.22,,,percentRoot,,257,Spearman,0.06,,,>= 0.05,No,,,,Astorg 2008
2943,3037,3044,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DPA (cis-22:5n-3),"",,0.03,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Mead acid (cis-20:3n-9),"",0.13,,,percentRoot,,257,Spearman,0.03,,,>= 0.05,No,,,,Astorg 2008
2944,3037,3045,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DPA (cis-22:5n-3),"",,0.03,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",1.51,,,percentRoot,,257,Spearman,-0.09,,,>= 0.05,No,,,,Astorg 2008
2945,3037,3046,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DPA (cis-22:5n-3),"",,0.03,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",8.05,,,percentRoot,,257,Spearman,0.11,,,>= 0.05,No,,,,Astorg 2008
2946,3037,3047,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DPA (cis-22:5n-3),"",,0.03,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",1.29,,,percentRoot,,257,Spearman,0.19,,,< 0.01,Yes,,,,Astorg 2008
2947,3037,3048,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DPA (cis-22:5n-3),"",,0.03,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.2,,,percentRoot,,257,Spearman,-0.06,,,>= 0.05,No,,,,Astorg 2008
2948,3037,3049,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DPA (cis-22:5n-3),"",,0.03,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.54,,,percentRoot,,257,Spearman,0.07,,,>= 0.05,No,,,,Astorg 2008
2949,3037,3050,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DPA (cis-22:5n-3),"",,0.03,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",2.65,,,percentRoot,,257,Spearman,0.24,,,< 0.001,Yes,,,,Astorg 2008
2950,3038,3040,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DHA (cis-22:6n-3),"",,0.12,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",35.26,,,percentRoot,,257,Spearman,-0.12,,,< 0.05,Yes,,,,Astorg 2008
2951,3038,3041,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DHA (cis-22:6n-3),"",,0.12,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",0.47,,,percentRoot,,257,Spearman,-0.06,,,>= 0.05,No,,,,Astorg 2008
2952,3038,3042,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DHA (cis-22:6n-3),"",,0.12,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.51,,,percentRoot,,257,Spearman,0.0,,,>= 0.05,No,,,,Astorg 2008
2953,3038,3043,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DHA (cis-22:6n-3),"",,0.12,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Eicosadienoic acid (cis-20:2n-6),"",0.22,,,percentRoot,,257,Spearman,0.06,,,>= 0.05,No,,,,Astorg 2008
2954,3038,3044,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DHA (cis-22:6n-3),"",,0.12,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Mead acid (cis-20:3n-9),"",0.13,,,percentRoot,,257,Spearman,-0.01,,,>= 0.05,No,,,,Astorg 2008
2955,3038,3045,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DHA (cis-22:6n-3),"",,0.12,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",1.51,,,percentRoot,,257,Spearman,-0.12,,,< 0.05,Yes,,,,Astorg 2008
2956,3038,3046,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DHA (cis-22:6n-3),"",,0.12,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",8.05,,,percentRoot,,257,Spearman,0.03,,,>= 0.05,No,,,,Astorg 2008
2957,3038,3047,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DHA (cis-22:6n-3),"",,0.12,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",1.29,,,percentRoot,,257,Spearman,0.23,,,< 0.001,Yes,,,,Astorg 2008
2958,3038,3048,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DHA (cis-22:6n-3),"",,0.12,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.2,,,percentRoot,,257,Spearman,-0.08,,,>= 0.05,No,,,,Astorg 2008
2959,3038,3049,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DHA (cis-22:6n-3),"",,0.12,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.54,,,percentRoot,,257,Spearman,0.04,,,>= 0.05,No,,,,Astorg 2008
2960,3038,3050,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),DHA (cis-22:6n-3),"",,0.12,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",2.65,,,percentRoot,,257,Spearman,0.27,,,< 0.001,Yes,,,,Astorg 2008
2961,3039,3040,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.2,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",35.26,,,percentRoot,,257,Spearman,-0.13,,,< 0.05,Yes,,,,Astorg 2008
2962,3039,3041,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.2,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",0.47,,,percentRoot,,257,Spearman,-0.06,,,>= 0.05,No,,,,Astorg 2008
2963,3039,3042,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.2,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.51,,,percentRoot,,257,Spearman,0.002,,,>= 0.05,No,,,,Astorg 2008
2964,3039,3043,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.2,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Eicosadienoic acid (cis-20:2n-6),"",0.22,,,percentRoot,,257,Spearman,0.05,,,>= 0.05,No,,,,Astorg 2008
2965,3039,3044,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.2,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Mead acid (cis-20:3n-9),"",0.13,,,percentRoot,,257,Spearman,-0.008,,,>= 0.05,No,,,,Astorg 2008
2966,3039,3045,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.2,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",1.51,,,percentRoot,,257,Spearman,-0.12,,,< 0.05,Yes,,,,Astorg 2008
2967,3039,3046,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.2,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",8.05,,,percentRoot,,257,Spearman,0.05,,,>= 0.05,No,,,,Astorg 2008
2968,3039,3047,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.2,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",1.29,,,percentRoot,,257,Spearman,0.25,,,< 0.001,Yes,,,,Astorg 2008
2969,3039,3048,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.2,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.2,,,percentRoot,,257,Spearman,-0.08,,,>= 0.05,No,,,,Astorg 2008
2970,3039,3049,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.2,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.54,,,percentRoot,,257,Spearman,0.06,,,>= 0.05,No,,,,Astorg 2008
2971,3039,3050,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.2,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",2.65,,,percentRoot,,257,Spearman,0.29,,,< 0.001,Yes,,,,Astorg 2008
2990,3056,3047,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Lean fish,"",,19.1,,,g/day,,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",1.29,,,percentRoot,,257,Spearman,0.12,,,< 0.05,Yes,,,,Astorg 2008
2991,3056,3049,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Lean fish,"",,19.1,,,g/day,,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.54,,,percentRoot,,257,Spearman,0.01,,,>= 0.05,No,,,,Astorg 2008
2992,3056,3050,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Lean fish,"",,19.1,,,g/day,,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",2.65,,,percentRoot,,257,Spearman,0.14,,,< 0.05,Yes,,,,Astorg 2008
2993,3057,3047,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fatty fish,"",,13.2,,,g/day,,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",1.29,,,percentRoot,,257,Spearman,0.29,,,< 0.001,Yes,,,,Astorg 2008
2994,3057,3049,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fatty fish,"",,13.2,,,g/day,,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.54,,,percentRoot,,257,Spearman,0.08,,,>= 0.05,No,,,,Astorg 2008
2995,3057,3050,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fatty fish,"",,13.2,,,g/day,,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",2.65,,,percentRoot,,257,Spearman,0.28,,,< 0.001,Yes,,,,Astorg 2008
2987,3058,3047,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fish,Fatty fish + Lean fish,,,,,g/day,,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",1.29,,,percentRoot,,257,Spearman,0.23,,,< 0.001,Yes,,,,Astorg 2008
2988,3058,3049,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fish,Fatty fish + Lean fish,,,,,g/day,,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.54,,,percentRoot,,257,Spearman,0.05,,,>= 0.05,No,,,,Astorg 2008
2989,3058,3050,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fish,Fatty fish + Lean fish,,,,,g/day,,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",2.65,,,percentRoot,,257,Spearman,0.26,,,< 0.001,Yes,,,,Astorg 2008
2996,3059,3047,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Shellfish,"",,8.6,,,g/day,,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",1.29,,,percentRoot,,257,Spearman,0.12,,,< 0.05,Yes,,,,Astorg 2008
2997,3059,3049,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Shellfish,"",,8.6,,,g/day,,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.54,,,percentRoot,,257,Spearman,0.0,,,>= 0.05,No,,,,Astorg 2008
2998,3059,3050,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Shellfish,"",,8.6,,,g/day,,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",2.65,,,percentRoot,,257,Spearman,0.09,,,>= 0.05,No,,,,Astorg 2008
2999,3060,3047,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Seafood,Fatty fish + Lean fish + Shellfish,,41.0,,,g/day,,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",1.29,,,percentRoot,,257,Spearman,0.25,,,< 0.001,Yes,,,,Astorg 2008
3000,3060,3049,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Seafood,Fatty fish + Lean fish + Shellfish,,41.0,,,g/day,,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.54,,,percentRoot,,257,Spearman,0.04,,,>= 0.05,No,,,,Astorg 2008
3001,3060,3050,Females,Middle-aged participants in a nested case-control study,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Seafood,Fatty fish + Lean fish + Shellfish,,41.0,,,g/day,,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",2.65,,,percentRoot,,257,Spearman,0.27,,,< 0.001,Yes,,,,Astorg 2008
3006,3108,3115,Non-vegans,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Milk,"",,,,,g/day,,,"Plasma, non-fasting",GC-MS after acid hydrolysis,Phytanic acid,"",,,,umol/L,,50,Spearman,0.31,,,>= 0.05,No,,,,Allen 2008
3019,3108,3113,Non-vegans,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Milk,"",,,,,g/day,,,"Plasma, non-fasting",GC-FID,Pentadecylic acid (15:0),"",,,,mmol/L,,50,Spearman,0.17,,,>= 0.05,No,,,,Allen 2008
3032,3108,3114,Non-vegans,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Milk,"",,,,,g/day,,,"Plasma, non-fasting",GC-FID,Margaric acid (17:0),"",,,,mmol/L,,50,Spearman,0.16,,,>= 0.05,No,,,,Allen 2008
3007,3109,3115,Non-vegans,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Cheese,"",,,,,g/day,,,"Plasma, non-fasting",GC-MS after acid hydrolysis,Phytanic acid,"",,,,umol/L,,50,Spearman,0.44,,,< 0.001,Yes,,,,Allen 2008
3020,3109,3113,Non-vegans,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Cheese,"",,,,,g/day,,,"Plasma, non-fasting",GC-FID,Pentadecylic acid (15:0),"",,,,mmol/L,,50,Spearman,0.22,,,>= 0.05,No,,,,Allen 2008
3033,3109,3114,Non-vegans,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Cheese,"",,,,,g/day,,,"Plasma, non-fasting",GC-FID,Margaric acid (17:0),"",,,,mmol/L,,50,Spearman,0.07,,,>= 0.05,No,,,,Allen 2008
3008,3110,3115,Non-vegans,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Yoghurt,"",,,,,g/day,,,"Plasma, non-fasting",GC-MS after acid hydrolysis,Phytanic acid,"",,,,umol/L,,50,Spearman,-0.1,,,>= 0.05,No,,,,Allen 2008
3021,3110,3113,Non-vegans,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Yoghurt,"",,,,,g/day,,,"Plasma, non-fasting",GC-FID,Pentadecylic acid (15:0),"",,,,mmol/L,,50,Spearman,0.01,,,>= 0.05,No,,,,Allen 2008
3034,3110,3114,Non-vegans,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Yoghurt,"",,,,,g/day,,,"Plasma, non-fasting",GC-FID,Margaric acid (17:0),"",,,,mmol/L,,50,Spearman,-0.08,,,>= 0.05,No,,,,Allen 2008
3009,3111,3115,Non-vegans,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Butter,"",,,,,g/day,,,"Plasma, non-fasting",GC-MS after acid hydrolysis,Phytanic acid,"",,,,umol/L,,50,Spearman,0.22,,,>= 0.05,No,,,,Allen 2008
3022,3111,3113,Non-vegans,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Butter,"",,,,,g/day,,,"Plasma, non-fasting",GC-FID,Pentadecylic acid (15:0),"",,,,mmol/L,,50,Spearman,0.47,,,< 0.001,Yes,,,,Allen 2008
3035,3111,3114,Non-vegans,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Butter,"",,,,,g/day,,,"Plasma, non-fasting",GC-FID,Margaric acid (17:0),"",,,,mmol/L,,50,Spearman,0.4,,,< 0.01,Yes,,,,Allen 2008
3013,3112,3115,Non-vegans,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentEnergy,Energy,,"Plasma, non-fasting",GC-MS after acid hydrolysis,Phytanic acid,"",,,,umol/L,,50,Spearman,0.68,,,< 0.0001,Yes,,,,Allen 2008
3026,3112,3113,Non-vegans,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentEnergy,Energy,,"Plasma, non-fasting",GC-FID,Pentadecylic acid (15:0),"",,,,mmol/L,,50,Spearman,0.48,,,< 0.001,Yes,,,,Allen 2008
3039,3112,3114,Non-vegans,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentEnergy,Energy,,"Plasma, non-fasting",GC-FID,Margaric acid (17:0),"",,,,mmol/L,,50,Spearman,0.06,,,>= 0.05,No,,,,Allen 2008
3003,3064,3081,Meat eaters,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Meat,Ruminant meat,,88.0,,,g/day,,,"Plasma, non-fasting",GC-MS after acid hydrolysis,Phytanic acid,"",,5.77,,umol/L,,25,Spearman,0.12,,,>= 0.05,No,,,,Allen 2008
3016,3064,3079,Meat eaters,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Meat,Ruminant meat,,88.0,,,g/day,,,"Plasma, non-fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,mmol/L,,25,Spearman,0.23,,,>= 0.05,No,,,,Allen 2008
3029,3064,3080,Meat eaters,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Meat,Ruminant meat,,88.0,,,g/day,,,"Plasma, non-fasting",GC-FID,Margaric acid (17:0),"",0.49,,,mmol/L,,25,Spearman,0.06,,,>= 0.05,No,,,,Allen 2008
3004,3065,3081,Meat eaters,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Ruminant meat,"",,30.0,,,g/day,,,"Plasma, non-fasting",GC-MS after acid hydrolysis,Phytanic acid,"",,5.77,,umol/L,,25,Spearman,0.21,,,>= 0.05,No,,,,Allen 2008
3017,3065,3079,Meat eaters,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Ruminant meat,"",,30.0,,,g/day,,,"Plasma, non-fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,mmol/L,,25,Spearman,0.42,,,< 0.05,Yes,,,,Allen 2008
3030,3065,3080,Meat eaters,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Ruminant meat,"",,30.0,,,g/day,,,"Plasma, non-fasting",GC-FID,Margaric acid (17:0),"",0.49,,,mmol/L,,25,Spearman,0.1,,,>= 0.05,No,,,,Allen 2008
3005,3066,3081,Meat eaters,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Seafood,Fatty fish,,48.0,,,g/day,,,"Plasma, non-fasting",GC-MS after acid hydrolysis,Phytanic acid,"",,5.77,,umol/L,,25,Spearman,-0.25,,,>= 0.05,No,,,,Allen 2008
3018,3066,3079,Meat eaters,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Seafood,Fatty fish,,48.0,,,g/day,,,"Plasma, non-fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,mmol/L,,25,Spearman,-0.3,,,>= 0.05,No,,,,Allen 2008
3031,3066,3080,Meat eaters,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Seafood,Fatty fish,,48.0,,,g/day,,,"Plasma, non-fasting",GC-FID,Margaric acid (17:0),"",0.49,,,mmol/L,,25,Spearman,0.37,,,>= 0.05,No,,,,Allen 2008
3010,3072,3081,Meat eaters,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fats from Meat,"",,3.6,,,percentEnergy,Energy,,"Plasma, non-fasting",GC-MS after acid hydrolysis,Phytanic acid,"",,5.77,,umol/L,,25,Spearman,0.07,,,>= 0.05,No,,,,Allen 2008
3023,3072,3079,Meat eaters,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fats from Meat,"",,3.6,,,percentEnergy,Energy,,"Plasma, non-fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,mmol/L,,25,Spearman,0.08,,,>= 0.05,No,,,,Allen 2008
3036,3072,3080,Meat eaters,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fats from Meat,"",,3.6,,,percentEnergy,Energy,,"Plasma, non-fasting",GC-FID,Margaric acid (17:0),"",0.49,,,mmol/L,,25,Spearman,-0.01,,,>= 0.05,No,,,,Allen 2008
3011,3073,3081,Meat eaters,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fats from Ruminant meat,"",,1.0,,,percentEnergy,Energy,,"Plasma, non-fasting",GC-MS after acid hydrolysis,Phytanic acid,"",,5.77,,umol/L,,25,Spearman,0.2,,,>= 0.05,No,,,,Allen 2008
3024,3073,3079,Meat eaters,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fats from Ruminant meat,"",,1.0,,,percentEnergy,Energy,,"Plasma, non-fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,mmol/L,,25,Spearman,0.37,,,>= 0.05,No,,,,Allen 2008
3037,3073,3080,Meat eaters,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fats from Ruminant meat,"",,1.0,,,percentEnergy,Energy,,"Plasma, non-fasting",GC-FID,Margaric acid (17:0),"",0.49,,,mmol/L,,25,Spearman,0.14,,,>= 0.05,No,,,,Allen 2008
3012,3074,3081,Meat eaters,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fats from Fish,"",,2.2,,,percentEnergy,Energy,,"Plasma, non-fasting",GC-MS after acid hydrolysis,Phytanic acid,"",,5.77,,umol/L,,25,Spearman,-0.19,,,>= 0.05,No,,,,Allen 2008
3025,3074,3079,Meat eaters,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fats from Fish,"",,2.2,,,percentEnergy,Energy,,"Plasma, non-fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,mmol/L,,25,Spearman,-0.21,,,>= 0.05,No,,,,Allen 2008
3038,3074,3080,Meat eaters,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fats from Fish,"",,2.2,,,percentEnergy,Energy,,"Plasma, non-fasting",GC-FID,Margaric acid (17:0),"",0.49,,,mmol/L,,25,Spearman,0.33,,,>= 0.05,No,,,,Allen 2008
3002,3106,3081,Meat eaters,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Dairy foods + Ruminant meat,"",,,,,g/day,,,"Plasma, non-fasting",GC-MS after acid hydrolysis,Phytanic acid,"",,5.77,,umol/L,,25,Spearman,0.34,,,>= 0.05,No,,,,Allen 2008
3015,3106,3079,Meat eaters,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Dairy foods + Ruminant meat,"",,,,,g/day,,,"Plasma, non-fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,mmol/L,,25,Spearman,0.5,,,< 0.01,Yes,,,,Allen 2008
3028,3106,3080,Meat eaters,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Dairy foods + Ruminant meat,"",,,,,g/day,,,"Plasma, non-fasting",GC-FID,Margaric acid (17:0),"",0.49,,,mmol/L,,25,Spearman,0.35,,,>= 0.05,No,,,,Allen 2008
3014,3107,3081,Meat eaters,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fats from Dairy foods + Ruminant meat,Fats from Meat + Fats from Dairy foods,,,,,percentEnergy,Energy,,"Plasma, non-fasting",GC-MS after acid hydrolysis,Phytanic acid,"",,5.77,,umol/L,,25,Spearman,0.65,,,< 0.001,Yes,,,,Allen 2008
3027,3107,3079,Meat eaters,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fats from Dairy foods + Ruminant meat,Fats from Meat + Fats from Dairy foods,,,,,percentEnergy,Energy,,"Plasma, non-fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,mmol/L,,25,Spearman,0.61,,,< 0.001,Yes,,,,Allen 2008
3040,3107,3080,Meat eaters,Women with different diets,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fats from Dairy foods + Ruminant meat,Fats from Meat + Fats from Dairy foods,,,,,percentEnergy,Energy,,"Plasma, non-fasting",GC-FID,Margaric acid (17:0),"",0.49,,,mmol/L,,25,Spearman,0.16,,,>= 0.05,No,,,,Allen 2008
3041,3121,3116,All,Women of reproductive age participant in a case-control study on congenital heart defects,Netherlands,,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,177.0,ug/day,,,"Serum, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",,,13.5,nmol/L,,53,Pearson,0.2,,, ,Unspecified,,,,Verkleij-Hagoort 2007
3042,3121,3117,All,Women of reproductive age participant in a case-control study on congenital heart defects,Netherlands,,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,177.0,ug/day,,,"Red blood cell, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",,,596.0,nmol/L,,53,Pearson,0.28,,, ,Unspecified,,,,Verkleij-Hagoort 2007
3043,3122,3118,All,Women of reproductive age participant in a case-control study on congenital heart defects,Netherlands,,,Food Frequency Questionnaire (FFQ),Vitamin B12,"",No,,,3.9,ug/day,,,"Serum, fasting",Chemiluminescence immunoassay (CLIA),Vitamin B12,"",,,245.0,pmol/L,,53,Pearson,0.21,,, ,Unspecified,,,,Verkleij-Hagoort 2007
3044,3124,3116,All,Women of reproductive age participant in a case-control study on congenital heart defects,Netherlands,,,24-h Dietary recall (1-day),Folates,"",No,,,169.0,ug/day,,,"Serum, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",,,13.5,nmol/L,,53,Pearson,0.22,,, ,Unspecified,,,,Verkleij-Hagoort 2007
3045,3124,3117,All,Women of reproductive age participant in a case-control study on congenital heart defects,Netherlands,,,24-h Dietary recall (1-day),Folates,"",No,,,169.0,ug/day,,,"Red blood cell, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",,,596.0,nmol/L,,53,Pearson,0.49,,, ,Unspecified,,,,Verkleij-Hagoort 2007
3046,3125,3118,All,Women of reproductive age participant in a case-control study on congenital heart defects,Netherlands,,,24-h Dietary recall (1-day),Vitamin B12,"",No,,,3.4,ug/day,,,"Serum, fasting",Chemiluminescence immunoassay (CLIA),Vitamin B12,"",,,245.0,pmol/L,,53,Pearson,0.05,,, ,Unspecified,,,,Verkleij-Hagoort 2007
3048,3133,3151,All [by gender],Adults in California,United States,,baseline,Food Frequency Questionnaire (FFQ),Folates,"",Yes,556.0,,,ug/day,,baseline,"Red blood cell, fasting",LC-MS/MS,Folates,"",1178.0,,,nmol/L,,337,Pearson,0.283,,,< 0.0001,Yes,,,,Owens 2007
3047,3145,3151,All [by gender],Adults in California,United States,,baseline,Dietary Folate Equivalent (DFE) screener,Folates,"",Yes,524.0,,,ug/day,,baseline,"Red blood cell, fasting",LC-MS/MS,Folates,"",1178.0,,,nmol/L,,337,Pearson,0.335,,,< 0.0001,Yes,,,,Owens 2007
3049,3148,3151,All [by gender],Adults in California,United States,,baseline,Dietary Folate Equivalent (DFE) screener,Folate (Dietary Folate Equivalents),"",Yes,788.0,,,ug/day,,baseline,"Red blood cell, fasting",LC-MS/MS,Folates,"",1178.0,,,nmol/L,,337,Pearson,0.338,,,< 0.0001,Yes,,,,Owens 2007
3065,3167,3152,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,30.33,,27.22,g/day,,,"Plasma, non-fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),605.56,,569.12,ug/mL,,43,Spearman,-0.04,,,>= 0.05,No,Energy by residual method,,,McNaughton 2007
3066,3168,3153,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,15.22,,13.35,g/day,,,"Plasma, non-fasting",GC-FID,Palmitic acid (16:0),"",362.96,,346.07,ug/mL,,43,Spearman,-0.09,,,>= 0.05,No,Energy by residual method,,,McNaughton 2007
3067,3169,3154,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Food Frequency Questionnaire (FFQ),Stearic acid (18:0),"",,7.31,,6.62,g/day,,,"Plasma, non-fasting",GC-FID,Stearic acid (18:0),"",201.35,,196.28,ug/mL,,43,Spearman,-0.02,,,>= 0.05,No,Energy by residual method,,,McNaughton 2007
3068,3170,3155,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,25.4,,22.5,g/day,,,"Plasma, non-fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),177.52,,162.82,ug/mL,,43,Spearman,-0.1,,,>= 0.05,No,Energy by residual method,,,McNaughton 2007
3069,3171,3156,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,23.39,,21.01,g/day,,,"Plasma, non-fasting",GC-FID,Oleic acid (cis-18:1n-9),"",134.56,,126.97,ug/mL,,43,Spearman,-0.06,,,>= 0.05,No,Energy by residual method,,,McNaughton 2007
3070,3172,3157,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans","",,0.11,,0.01,g/day,,,"Plasma, non-fasting",GC-FID,"Fatty acids, trans","",13.65,,13.58,ug/mL,,43,Spearman,0.19,,,>= 0.05,No,Energy by residual method,,,McNaughton 2007
3071,3173,3158,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,8.47,,7.84,g/day,,,"Plasma, non-fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),506.06,,489.37,ug/mL,,43,Spearman,0.16,,,>= 0.05,No,Energy by residual method,,,McNaughton 2007
3072,3174,3159,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.12,,1.01,g/day,,,"Plasma, non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),79.92,,78.13,ug/mL,,43,Spearman,0.21,,,>= 0.05,No,Energy by residual method,,,McNaughton 2007
3073,3175,3160,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.26,,0.2,g/day,,,"Plasma, non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),77.25,,73.95,ug/mL,,43,Spearman,0.38,,,< 0.05,Yes,Energy by residual method,,,McNaughton 2007
3074,3176,3161,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,8.37,,7.69,g/day,,,"Plasma, non-fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",286.47,,271.4,ug/mL,,43,Spearman,0.34,,,< 0.05,Yes,Energy by residual method,,,McNaughton 2007
3075,3177,3162,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,0.08,,0.08,g/day,,,"Plasma, non-fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",144.85,,137.62,ug/mL,,43,Spearman,0.13,,,>= 0.05,No,Energy by residual method,,,McNaughton 2007
3076,3178,3163,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,0.86,,0.76,g/day,,,"Plasma, non-fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",1.66,,1.33,ug/mL,,43,Spearman,0.0,,,>= 0.05,No,Energy by residual method,,,McNaughton 2007
3077,3179,3164,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,0.09,,0.07,g/day,,,"Plasma, non-fasting",GC-FID,EPA (cis-20:5n-3),"",11.46,,9.39,ug/mL,,43,Spearman,0.21,,,>= 0.05,No,Energy by residual method,,,McNaughton 2007
3078,3180,3165,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Food Frequency Questionnaire (FFQ),DPA (cis-22:5n-3),"",,0.04,,0.03,g/day,,,"Plasma, non-fasting",GC-FID,DPA (cis-22:5n-3),"",15.13,,14.63,ug/mL,,43,Spearman,-0.05,,,>= 0.05,No,Energy by residual method,,,McNaughton 2007
3079,3181,3166,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,0.12,,0.09,g/day,,,"Plasma, non-fasting",GC-FID,DHA (cis-22:6n-3),"",50.67,,48.85,ug/mL,,43,Spearman,0.32,,,< 0.05,Yes,Energy by residual method,,,McNaughton 2007
3050,3182,3152,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Weighed Dietary record (2-day),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,29.43,,29.56,g/day,,,"Plasma, non-fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),605.56,,569.12,ug/mL,,43,Spearman,-0.09,,,>= 0.05,No,Energy by residual method,,,McNaughton 2007
3051,3183,3153,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Weighed Dietary record (2-day),Palmitic acid (16:0),"",,14.66,,14.36,g/day,,,"Plasma, non-fasting",GC-FID,Palmitic acid (16:0),"",362.96,,346.07,ug/mL,,43,Spearman,-0.1,,,>= 0.05,No,Energy by residual method,,,McNaughton 2007
3052,3184,3154,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Weighed Dietary record (2-day),Stearic acid (18:0),"",,6.95,,7.02,g/day,,,"Plasma, non-fasting",GC-FID,Stearic acid (18:0),"",201.35,,196.28,ug/mL,,43,Spearman,0.02,,,>= 0.05,No,Energy by residual method,,,McNaughton 2007
3053,3185,3155,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Weighed Dietary record (2-day),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,23.4,,23.65,g/day,,,"Plasma, non-fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),177.52,,162.82,ug/mL,,43,Spearman,-0.13,,,>= 0.05,No,Energy by residual method,,,McNaughton 2007
3054,3186,3156,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Weighed Dietary record (2-day),Oleic acid (cis-18:1n-9),"",,21.66,,22.1,g/day,,,"Plasma, non-fasting",GC-FID,Oleic acid (cis-18:1n-9),"",134.56,,126.97,ug/mL,,43,Spearman,-0.11,,,>= 0.05,No,Energy by residual method,,,McNaughton 2007
3055,3187,3157,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Weighed Dietary record (2-day),"Fatty acids, trans","",,0.01,,0.01,g/day,,,"Plasma, non-fasting",GC-FID,"Fatty acids, trans","",13.65,,13.58,ug/mL,,43,Spearman,0.16,,,>= 0.05,No,Energy by residual method,,,McNaughton 2007
3056,3188,3158,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Weighed Dietary record (2-day),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,9.38,,8.86,g/day,,,"Plasma, non-fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),506.06,,489.37,ug/mL,,43,Spearman,-0.11,,,>= 0.05,No,Energy by residual method,,,McNaughton 2007
3057,3189,3159,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Weighed Dietary record (2-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.02,,0.98,g/day,,,"Plasma, non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),79.92,,78.13,ug/mL,,43,Spearman,0.33,,,< 0.05,Yes,Energy by residual method,,,McNaughton 2007
3058,3190,3160,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Weighed Dietary record (2-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.22,,0.16,g/day,,,"Plasma, non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),77.25,,73.95,ug/mL,,43,Spearman,0.44,,,< 0.05,Yes,Energy by residual method,,,McNaughton 2007
3059,3191,3161,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Weighed Dietary record (2-day),Linoleic acid (LA; cis-18:2n-6),"",,9.28,,8.72,g/day,,,"Plasma, non-fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",286.47,,271.4,ug/mL,,43,Spearman,-0.01,,,>= 0.05,No,Energy by residual method,,,McNaughton 2007
3060,3192,3162,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Weighed Dietary record (2-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.09,,0.08,g/day,,,"Plasma, non-fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",144.85,,137.62,ug/mL,,43,Spearman,0.35,,,< 0.05,Yes,Energy by residual method,,,McNaughton 2007
3061,3193,3163,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Weighed Dietary record (2-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,0.8,,0.8,g/day,,,"Plasma, non-fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",1.66,,1.33,ug/mL,,43,Spearman,0.09,,,>= 0.05,No,Energy by residual method,,,McNaughton 2007
3062,3194,3164,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Weighed Dietary record (2-day),EPA (cis-20:5n-3),"",,0.08,,0.05,g/day,,,"Plasma, non-fasting",GC-FID,EPA (cis-20:5n-3),"",11.46,,9.39,ug/mL,,43,Spearman,0.22,,,>= 0.05,No,Energy by residual method,,,McNaughton 2007
3063,3195,3165,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Weighed Dietary record (2-day),DPA (cis-22:5n-3),"",,0.04,,0.03,g/day,,,"Plasma, non-fasting",GC-FID,DPA (cis-22:5n-3),"",15.13,,14.63,ug/mL,,43,Spearman,0.25,,,>= 0.05,No,Energy by residual method,,,McNaughton 2007
3064,3196,3166,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Weighed Dietary record (2-day),DHA (cis-22:6n-3),"",,0.11,,0.08,g/day,,,"Plasma, non-fasting",GC-FID,DHA (cis-22:6n-3),"",50.67,,48.85,ug/mL,,43,Spearman,0.43,,,< 0.05,Yes,Energy by residual method,,,McNaughton 2007
3089,3220,3201,All,Elderly participants in three folate supplementation studies,Netherlands,,,Food Frequency Questionnaire (FFQ),Folates,"",No,196.0,,,ug/day,,,"Serum, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",12.8,,,nmol/L,,1281,Spearman,0.14,,,< 0.01,Yes,,,,van de Rest 2007
3090,3220,3202,All,Elderly participants in three folate supplementation studies,Netherlands,,,Food Frequency Questionnaire (FFQ),Folates,"",No,196.0,,,ug/day,,,"Red blood cell, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",661.3,,,nmol/L,,1281,Spearman,0.05,,,>= 0.05,No,,,,van de Rest 2007
8623,3220,3200,All,Elderly participants in three folate supplementation studies,Netherlands,,,Food Frequency Questionnaire (FFQ),Folates,"",No,196.0,,,ug/day,,,"Plasma, fasting",HPLC,Homocysteine,"",12.6,,,umol/L,,1281,Spearman,0.02,,,>= 0.05,No,,,,van de Rest 2007
3080,3221,3206,FACIT-Study,Elderly participants in three folate supplementation studies,Netherlands,FACIT (Folic Acid and Carotid Intima-media Thickness),,Food Frequency Questionnaire (FFQ),Folates,"",No,207.0,,,ug/day,,,"Serum, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",12.5,,,nmol/L,,819,Spearman,0.16,,,< 0.01,Yes,,,,van de Rest 2007
3081,3221,3207,FACIT-Study,Elderly participants in three folate supplementation studies,Netherlands,FACIT (Folic Acid and Carotid Intima-media Thickness),,Food Frequency Questionnaire (FFQ),Folates,"",No,207.0,,,ug/day,,,"Red blood cell, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",623.2,,,nmol/L,,819,Spearman,0.11,,,< 0.01,Yes,,,,van de Rest 2007
8614,3221,3205,FACIT-Study,Elderly participants in three folate supplementation studies,Netherlands,FACIT (Folic Acid and Carotid Intima-media Thickness),,Food Frequency Questionnaire (FFQ),Folates,"",No,207.0,,,ug/day,,,"Plasma, fasting",HPLC,Homocysteine,"",13.3,,,umol/L,,819,Spearman,-0.05,,,>= 0.05,No,,,,van de Rest 2007
3086,3223,3216,Dolfin-Study,Elderly participants in three folate supplementation studies,Netherlands,Dolfin Study,,Food Frequency Questionnaire (FFQ),Folates,"",No,174.0,,,ug/day,,,"Serum, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",12.9,,,nmol/L,,305,Spearman,0.14,,,< 0.05,Yes,,,,van de Rest 2007
3087,3223,3217,Dolfin-Study,Elderly participants in three folate supplementation studies,Netherlands,Dolfin Study,,Food Frequency Questionnaire (FFQ),Folates,"",No,174.0,,,ug/day,,,"Red blood cell, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",731.4,,,nmol/L,,305,Spearman,0.07,,,>= 0.05,No,,,,van de Rest 2007
8620,3223,3215,Dolfin-Study,Elderly participants in three folate supplementation studies,Netherlands,Dolfin Study,,Food Frequency Questionnaire (FFQ),Folates,"",No,174.0,,,ug/day,,,"Plasma, fasting",HPLC,Homocysteine,"",11.6,,,umol/L,,305,Spearman,-0.1,,,>= 0.05,No,,,,van de Rest 2007
3083,3222,3211,CHEF-Study,Elderly participants in three folate supplementation studies,Netherlands,CHEF Study,,Food Frequency Questionnaire (FFQ),Folates,"",No,186.0,,,ug/day,,,"Serum, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",14.3,,,nmol/L,,157,Spearman,0.17,,,< 0.05,Yes,,,,van de Rest 2007
3084,3222,3212,CHEF-Study,Elderly participants in three folate supplementation studies,Netherlands,CHEF Study,,Food Frequency Questionnaire (FFQ),Folates,"",No,186.0,,,ug/day,,,"Red blood cell, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",727.4,,,nmol/L,,157,Spearman,0.02,,,>= 0.05,No,,,,van de Rest 2007
8617,3222,3210,CHEF-Study,Elderly participants in three folate supplementation studies,Netherlands,CHEF Study,,Food Frequency Questionnaire (FFQ),Folates,"",No,186.0,,,ug/day,,,"Plasma, fasting",HPLC,Homocysteine,"",10.9,,,umol/L,,157,Spearman,0.08,,,>= 0.05,No,,,,van de Rest 2007
3092,3257,3225,FACIT-Study - Males,Elderly participants in three folate supplementation studies,Netherlands,FACIT (Folic Acid and Carotid Intima-media Thickness),,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Serum, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",,,,nmol/L,,590,Spearman,0.2,,,< 0.01,Yes,,,,van de Rest 2007
3093,3257,3226,FACIT-Study - Males,Elderly participants in three folate supplementation studies,Netherlands,FACIT (Folic Acid and Carotid Intima-media Thickness),,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Red blood cell, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",,,,nmol/L,,590,Spearman,0.1,,,< 0.05,Yes,,,,van de Rest 2007
8615,3257,3227,FACIT-Study - Males,Elderly participants in three folate supplementation studies,Netherlands,FACIT (Folic Acid and Carotid Intima-media Thickness),,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Plasma, fasting",HPLC,Homocysteine,"",,,,umol/L,,590,Spearman,-0.08,,,< 0.05,Yes,,,,van de Rest 2007
3104,3261,3237,FACIT-Study - Females,Elderly participants in three folate supplementation studies,Netherlands,FACIT (Folic Acid and Carotid Intima-media Thickness),,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Serum, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",,,,nmol/L,,229,Spearman,0.12,,,>= 0.05,No,,,,van de Rest 2007
3105,3261,3238,FACIT-Study - Females,Elderly participants in three folate supplementation studies,Netherlands,FACIT (Folic Acid and Carotid Intima-media Thickness),,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Red blood cell, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",,,,nmol/L,,229,Spearman,0.1,,,>= 0.05,No,,,,van de Rest 2007
8616,3261,3239,FACIT-Study - Females,Elderly participants in three folate supplementation studies,Netherlands,FACIT (Folic Acid and Carotid Intima-media Thickness),,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Plasma, fasting",HPLC,Homocysteine,"",,,,umol/L,,229,Spearman,-0.02,,,>= 0.05,No,,,,van de Rest 2007
3098,3259,3231,Dolfin-Study - Males,Elderly participants in three folate supplementation studies,Netherlands,Dolfin Study,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Serum, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",,,,nmol/L,,180,Spearman,0.26,,,< 0.01,Yes,,,,van de Rest 2007
3099,3259,3232,Dolfin-Study - Males,Elderly participants in three folate supplementation studies,Netherlands,Dolfin Study,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Red blood cell, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",,,,nmol/L,,180,Spearman,0.14,,,>= 0.05,No,,,,van de Rest 2007
8621,3259,3233,Dolfin-Study - Males,Elderly participants in three folate supplementation studies,Netherlands,Dolfin Study,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Plasma, fasting",HPLC,Homocysteine,"",,,,umol/L,,180,Spearman,-0.26,,,< 0.01,Yes,,,,van de Rest 2007
3110,3263,3243,Dolfin-Study - Females,Elderly participants in three folate supplementation studies,Netherlands,Dolfin Study,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Serum, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",,,,nmol/L,,125,Spearman,0.02,,,>= 0.05,No,,,,van de Rest 2007
3111,3263,3244,Dolfin-Study - Females,Elderly participants in three folate supplementation studies,Netherlands,Dolfin Study,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Red blood cell, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",,,,nmol/L,,125,Spearman,-0.05,,,>= 0.05,No,,,,van de Rest 2007
8622,3263,3245,Dolfin-Study - Females,Elderly participants in three folate supplementation studies,Netherlands,Dolfin Study,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Plasma, fasting",HPLC,Homocysteine,"",,,,umol/L,,125,Spearman,0.03,,,>= 0.05,No,,,,van de Rest 2007
3095,3258,3228,CHEF-Study - Males,Elderly participants in three folate supplementation studies,Netherlands,CHEF Study,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Serum, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",,,,nmol/L,,91,Spearman,-0.01,,,>= 0.05,No,,,,van de Rest 2007
3096,3258,3229,CHEF-Study - Males,Elderly participants in three folate supplementation studies,Netherlands,CHEF Study,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Red blood cell, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",,,,nmol/L,,91,Spearman,-0.09,,,>= 0.05,No,,,,van de Rest 2007
8618,3258,3230,CHEF-Study - Males,Elderly participants in three folate supplementation studies,Netherlands,CHEF Study,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Plasma, fasting",HPLC,Homocysteine,"",,,,umol/L,,91,Spearman,0.19,,,>= 0.05,No,,,,van de Rest 2007
3107,3262,3240,CHEF-Study - Females,Elderly participants in three folate supplementation studies,Netherlands,CHEF Study,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Serum, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",,,,nmol/L,,66,Spearman,0.4,,,< 0.01,Yes,,,,van de Rest 2007
3108,3262,3241,CHEF-Study - Females,Elderly participants in three folate supplementation studies,Netherlands,CHEF Study,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Red blood cell, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",,,,nmol/L,,66,Spearman,0.08,,,>= 0.05,No,,,,van de Rest 2007
8619,3262,3242,CHEF-Study - Females,Elderly participants in three folate supplementation studies,Netherlands,CHEF Study,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Plasma, fasting",HPLC,Homocysteine,"",,,,umol/L,,66,Spearman,-0.19,,,>= 0.05,No,,,,van de Rest 2007
3101,3260,3234,Males,Elderly participants in three folate supplementation studies,Netherlands,,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Serum, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",,,,nmol/L,,858,Spearman,0.19,,,< 0.01,Yes,,,,van de Rest 2007
3102,3260,3235,Males,Elderly participants in three folate supplementation studies,Netherlands,,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Red blood cell, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",,,,nmol/L,,858,Spearman,0.07,,,>= 0.05,No,,,,van de Rest 2007
8624,3260,3236,Males,Elderly participants in three folate supplementation studies,Netherlands,,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Plasma, fasting",HPLC,Homocysteine,"",,,,umol/L,,858,Spearman,-0.04,,,>= 0.05,No,,,,van de Rest 2007
3113,3264,3246,Females,Elderly participants in three folate supplementation studies,Netherlands,,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Serum, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",,,,nmol/L,,423,Spearman,0.11,,,< 0.05,Yes,,,,van de Rest 2007
3114,3264,3247,Females,Elderly participants in three folate supplementation studies,Netherlands,,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Red blood cell, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",,,,nmol/L,,423,Spearman,0.0,,,>= 0.05,No,,,,van de Rest 2007
8625,3264,3248,Females,Elderly participants in three folate supplementation studies,Netherlands,,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Plasma, fasting",HPLC,Homocysteine,"",,,,umol/L,,423,Spearman,0.04,,,>= 0.05,No,,,,van de Rest 2007
3116,3288,3289,All [by gender],High school students,Taiwan,,,Dietary record (3-day),Vitamin B6,"",No,,,,mg/day,,,"Plasma, fasting",HPLC,Pyridoxal 5'-phosphate,"",,,,nmol/L,,127,Pearson,0.821,,,< 0.001,Yes,,,,Chang 2007
3117,3288,3290,All [by gender],High school students,Taiwan,,,Dietary record (3-day),Vitamin B6,"",No,,,,mg/day,,,"Urine, 24-h",HPLC,4-Pyridoxic acid,"",,,,umol/day,,127,Pearson,0.723,,,< 0.001,Yes,,,,Chang 2007
3119,3294,3292,All,Subjects from the Nestlé Research Centre,Switzerland,,,Food Frequency Questionnaire (FFQ),Whole grain cereals,Whole grain wheat,,29.0,,,g/day,,,"Plasma, fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0),55.8,,,nmol/L,,29,Pearson,0.54,,,< 0.01,Yes,Energy ?,,"Age ?, Sex ?, BMI ?",Ross 2009
3122,3297,3292,All,Subjects from the Nestlé Research Centre,Switzerland,,,Food Frequency Questionnaire (FFQ),Alkylresorcinols,"",,,,,mg/day,,,"Plasma, fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0),55.8,,,nmol/L,,29,Pearson,0.56,,,< 0.01,Yes,Energy ?,,"Age ?, Sex ?, BMI ?",Ross 2009
3125,3300,3292,All,Subjects from the Nestlé Research Centre,Switzerland,,,Food Frequency Questionnaire (FFQ),Whole grain wheat,"",,,,,g/day,,,"Plasma, fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0),55.8,,,nmol/L,,29,Pearson,0.37,,,< 0.05,Yes,Energy ?,,"Age ?, Sex ?, BMI ?",Ross 2009
3128,3303,3292,All,Subjects from the Nestlé Research Centre,Switzerland,,,Food Frequency Questionnaire (FFQ),Fibre from Cereals,"",,,,,g/day,,,"Plasma, fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0),55.8,,,nmol/L,,29,Pearson,0.6,,,< 0.01,Yes,Energy ?,,"Age ?, Sex ?, BMI ?",Ross 2009
3120,3295,3292,All,Subjects from the Nestlé Research Centre,Switzerland,,,Food Frequency Questionnaire (FFQ),Whole grain cereals,Whole grain wheat,,21.0,,,g/day,,,"Plasma, fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0),55.8,,,nmol/L,,29,Pearson,0.59,,,< 0.01,Yes,Energy ?,,"Age ?, Sex ?, BMI ?",Ross 2009
3123,3298,3292,All,Subjects from the Nestlé Research Centre,Switzerland,,,Food Frequency Questionnaire (FFQ),Alkylresorcinols,"",,,,,mg/day,,,"Plasma, fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0),55.8,,,nmol/L,,29,Pearson,0.52,,,< 0.01,Yes,Energy ?,,"Age ?, Sex ?, BMI ?",Ross 2009
3126,3301,3292,All,Subjects from the Nestlé Research Centre,Switzerland,,,Food Frequency Questionnaire (FFQ),Whole grain wheat,"",,,,,g/day,,,"Plasma, fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0),55.8,,,nmol/L,,29,Pearson,0.43,,,< 0.05,Yes,Energy ?,,"Age ?, Sex ?, BMI ?",Ross 2009
3129,3304,3292,All,Subjects from the Nestlé Research Centre,Switzerland,,,Food Frequency Questionnaire (FFQ),Fibre from Cereals,"",,,,,g/day,,,"Plasma, fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0),55.8,,,nmol/L,,29,Pearson,0.44,,,< 0.05,Yes,Energy ?,,"Age ?, Sex ?, BMI ?",Ross 2009
3118,3293,3292,All,Subjects from the Nestlé Research Centre,Switzerland,,,Weighed Dietary record (3-day),Whole grain cereals,Whole grain wheat,,26.0,,,g/day,,,"Plasma, fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0),55.8,,,nmol/L,,29,Pearson,0.57,,,< 0.01,Yes,Energy ?,,"Age ?, Sex ?, BMI ?",Ross 2009
3121,3296,3292,All,Subjects from the Nestlé Research Centre,Switzerland,,,Weighed Dietary record (3-day),Alkylresorcinols,"",,,,,mg/day,,,"Plasma, fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0),55.8,,,nmol/L,,29,Pearson,0.37,,,< 0.05,Yes,Energy ?,,"Age ?, Sex ?, BMI ?",Ross 2009
3124,3299,3292,All,Subjects from the Nestlé Research Centre,Switzerland,,,Weighed Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,,"Plasma, fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0),55.8,,,nmol/L,,29,Pearson,0.47,,,< 0.05,Yes,Energy ?,,"Age ?, Sex ?, BMI ?",Ross 2009
3127,3302,3292,All,Subjects from the Nestlé Research Centre,Switzerland,,,Weighed Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,,"Plasma, fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0),55.8,,,nmol/L,,29,Pearson,0.13,,,>= 0.05,No,Energy ?,,"Age ?, Sex ?, BMI ?",Ross 2009
3130,3305,3315,All,Volunteers from the Perth metropolitan area,Australia,,,Food Frequency Questionnaire (FFQ),Fish,Fish + Fatty fish + Lean fish,,,215.0,,g/week,,,"Red blood cell membrane, fasting",GC-FID,EPA (cis-20:5n-3),"",1.42,1.33,,percentRoot,,88,Spearman,0.31,,,< 0.05,Yes,,,,Mina 2007
3142,3305,3317,All,Volunteers from the Perth metropolitan area,Australia,,,Food Frequency Questionnaire (FFQ),Fish,Fish + Fatty fish + Lean fish,,,215.0,,g/week,,,"Red blood cell membrane, fasting",GC-FID,DHA (cis-22:6n-3),"",5.28,5.17,,percentRoot,,88,Spearman,0.28,,,< 0.05,Yes,,,,Mina 2007
3131,3306,3315,All,Volunteers from the Perth metropolitan area,Australia,,,Food Frequency Questionnaire (FFQ),Fish,"",,,104.0,,g/week,,,"Red blood cell membrane, fasting",GC-FID,EPA (cis-20:5n-3),"",1.42,1.33,,percentRoot,,80,Spearman,0.25,,,< 0.05,Yes,,,,Mina 2007
3143,3306,3317,All,Volunteers from the Perth metropolitan area,Australia,,,Food Frequency Questionnaire (FFQ),Fish,"",,,104.0,,g/week,,,"Red blood cell membrane, fasting",GC-FID,DHA (cis-22:6n-3),"",5.28,5.17,,percentRoot,,80,Spearman,0.18,,,>= 0.05,No,,,,Mina 2007
3132,3307,3315,All,Volunteers from the Perth metropolitan area,Australia,,,Food Frequency Questionnaire (FFQ),Fish,"",,,21.0,,g/week,,,"Red blood cell membrane, fasting",GC-FID,EPA (cis-20:5n-3),"",1.42,1.33,,percentRoot,,62,Spearman,0.04,,,>= 0.05,No,,,,Mina 2007
3144,3307,3317,All,Volunteers from the Perth metropolitan area,Australia,,,Food Frequency Questionnaire (FFQ),Fish,"",,,21.0,,g/week,,,"Red blood cell membrane, fasting",GC-FID,DHA (cis-22:6n-3),"",5.28,5.17,,percentRoot,,62,Spearman,0.11,,,>= 0.05,No,,,,Mina 2007
3133,3308,3315,All,Volunteers from the Perth metropolitan area,Australia,,,Food Frequency Questionnaire (FFQ),Fatty fish,"",,,32.0,,g/week,,,"Red blood cell membrane, fasting",GC-FID,EPA (cis-20:5n-3),"",1.42,1.33,,percentRoot,,70,Spearman,0.47,,,< 0.05,Yes,,,,Mina 2007
3145,3308,3317,All,Volunteers from the Perth metropolitan area,Australia,,,Food Frequency Questionnaire (FFQ),Fatty fish,"",,,32.0,,g/week,,,"Red blood cell membrane, fasting",GC-FID,DHA (cis-22:6n-3),"",5.28,5.17,,percentRoot,,70,Spearman,0.33,,,< 0.05,Yes,,,,Mina 2007
3134,3309,3315,All,Volunteers from the Perth metropolitan area,Australia,,,Food Frequency Questionnaire (FFQ),Lean fish,"",,,101.0,,g/week,,,"Red blood cell membrane, fasting",GC-FID,EPA (cis-20:5n-3),"",1.42,1.33,,percentRoot,,83,Spearman,0.01,,,>= 0.05,No,,,,Mina 2007
3146,3309,3317,All,Volunteers from the Perth metropolitan area,Australia,,,Food Frequency Questionnaire (FFQ),Lean fish,"",,,101.0,,g/week,,,"Red blood cell membrane, fasting",GC-FID,DHA (cis-22:6n-3),"",5.28,5.17,,percentRoot,,83,Spearman,0.09,,,>= 0.05,No,,,,Mina 2007
3140,3310,3315,All,Volunteers from the Perth metropolitan area,Australia,,,Food Frequency Questionnaire (FFQ),Seafood,Seafood,,,51.0,,g/week,,,"Red blood cell membrane, fasting",GC-FID,EPA (cis-20:5n-3),"",1.42,1.33,,percentRoot,,86,Spearman,0.16,,,>= 0.05,No,,,,Mina 2007
3152,3310,3317,All,Volunteers from the Perth metropolitan area,Australia,,,Food Frequency Questionnaire (FFQ),Seafood,Seafood,,,51.0,,g/week,,,"Red blood cell membrane, fasting",GC-FID,DHA (cis-22:6n-3),"",5.28,5.17,,percentRoot,,86,Spearman,0.3,,,< 0.05,Yes,,,,Mina 2007
3137,3311,3315,All,Volunteers from the Perth metropolitan area,Australia,,,Food Frequency Questionnaire (FFQ),Seafood,"",,,25.0,,g/week,,,"Red blood cell membrane, fasting",GC-FID,EPA (cis-20:5n-3),"",1.42,1.33,,percentRoot,,78,Spearman,0.1,,,>= 0.05,No,,,,Mina 2007
3149,3311,3317,All,Volunteers from the Perth metropolitan area,Australia,,,Food Frequency Questionnaire (FFQ),Seafood,"",,,25.0,,g/week,,,"Red blood cell membrane, fasting",GC-FID,DHA (cis-22:6n-3),"",5.28,5.17,,percentRoot,,78,Spearman,0.19,,,>= 0.05,No,,,,Mina 2007
3138,3312,3315,All,Volunteers from the Perth metropolitan area,Australia,,,Food Frequency Questionnaire (FFQ),Seafood,"",,,1.8,,g/week,,,"Red blood cell membrane, fasting",GC-FID,EPA (cis-20:5n-3),"",1.42,1.33,,percentRoot,,36,Spearman,0.29,,,< 0.05,Yes,,,,Mina 2007
3150,3312,3317,All,Volunteers from the Perth metropolitan area,Australia,,,Food Frequency Questionnaire (FFQ),Seafood,"",,,1.8,,g/week,,,"Red blood cell membrane, fasting",GC-FID,DHA (cis-22:6n-3),"",5.28,5.17,,percentRoot,,36,Spearman,0.31,,,< 0.05,Yes,,,,Mina 2007
3139,3313,3315,All,Volunteers from the Perth metropolitan area,Australia,,,Food Frequency Questionnaire (FFQ),Seafood,"",,,6.3,,g/week,,,"Red blood cell membrane, fasting",GC-FID,EPA (cis-20:5n-3),"",1.42,1.33,,percentRoot,,54,Spearman,-0.05,,,>= 0.05,No,,,,Mina 2007
3151,3313,3317,All,Volunteers from the Perth metropolitan area,Australia,,,Food Frequency Questionnaire (FFQ),Seafood,"",,,6.3,,g/week,,,"Red blood cell membrane, fasting",GC-FID,DHA (cis-22:6n-3),"",5.28,5.17,,percentRoot,,54,Spearman,0.11,,,>= 0.05,No,,,,Mina 2007
3136,3314,3315,All,Volunteers from the Perth metropolitan area,Australia,,,Food Frequency Questionnaire (FFQ),Shellfish,"",,,15.0,,g/week,,,"Red blood cell membrane, fasting",GC-FID,EPA (cis-20:5n-3),"",1.42,1.33,,percentRoot,,67,Spearman,0.3,,,< 0.05,Yes,,,,Mina 2007
3148,3314,3317,All,Volunteers from the Perth metropolitan area,Australia,,,Food Frequency Questionnaire (FFQ),Shellfish,"",,,15.0,,g/week,,,"Red blood cell membrane, fasting",GC-FID,DHA (cis-22:6n-3),"",5.28,5.17,,percentRoot,,67,Spearman,0.22,,,< 0.05,Yes,,,,Mina 2007
3141,3328,3315,All,Volunteers from the Perth metropolitan area,Australia,,,Food Frequency Questionnaire (FFQ),Seafood,Fish + Fatty fish + Lean fish + Shellfish,,,,,g/week,,,"Red blood cell membrane, fasting",GC-FID,EPA (cis-20:5n-3),"",1.42,1.33,,percentRoot,,67,Spearman,0.33,,,< 0.05,Yes,,,,Mina 2007
3153,3328,3317,All,Volunteers from the Perth metropolitan area,Australia,,,Food Frequency Questionnaire (FFQ),Seafood,Fish + Fatty fish + Lean fish + Shellfish,,,,,g/week,,,"Red blood cell membrane, fasting",GC-FID,DHA (cis-22:6n-3),"",5.28,5.17,,percentRoot,,67,Spearman,0.28,,,< 0.05,Yes,,,,Mina 2007
3154,3419,3433,All [by gender],Participants in a case-cohort study,Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0),,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0),,,,percentRoot,,4439,Pearson,0.1,0.07,0.13, ,Unspecified,,No,,Hodge 2007
3168,3419,3433,All [by gender],Participants in a case-cohort study,Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0),,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0),,,,percentRoot,,4439,Pearson,0.16,0.11,0.2, ,Unspecified,,Yes,,Hodge 2007
3155,3420,3434,All [by gender],Participants in a case-cohort study,Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9),,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9),,,,percentRoot,,4439,Pearson,0.26,0.24,0.29, ,Unspecified,,No,,Hodge 2007
3169,3420,3434,All [by gender],Participants in a case-cohort study,Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9),,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9),,,,percentRoot,,4439,Pearson,0.46,0.38,0.53, ,Unspecified,,Yes,,Hodge 2007
3156,3421,3435,All [by gender],Participants in a case-cohort study,Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,percentRoot,,4439,Pearson,0.26,0.24,0.29, ,Unspecified,,No,,Hodge 2007
3170,3421,3435,All [by gender],Participants in a case-cohort study,Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,percentRoot,,4439,Pearson,0.39,0.33,0.44, ,Unspecified,,Yes,,Hodge 2007
3157,3422,3436,All [by gender],Participants in a case-cohort study,Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, trans","",,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, trans","",,,,percentRoot,,4439,Spearman,-0.22,-0.25,-0.19, ,Unspecified,,No,,Hodge 2007
3158,3423,3437,All [by gender],Participants in a case-cohort study,Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,percentRoot,,4439,Pearson,0.25,0.22,0.28, ,Unspecified,,No,,Hodge 2007
3172,3423,3437,All [by gender],Participants in a case-cohort study,Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,percentRoot,,4439,Pearson,0.38,0.32,0.44, ,Unspecified,,Yes,,Hodge 2007
3159,3424,3438,All [by gender],Participants in a case-cohort study,Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,4439,Pearson,0.31,0.28,0.33, ,Unspecified,,No,,Hodge 2007
3173,3424,3438,All [by gender],Participants in a case-cohort study,Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,4439,Pearson,0.57,0.47,0.65, ,Unspecified,,Yes,,Hodge 2007
3160,3425,3439,All [by gender],Participants in a case-cohort study,Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,4439,Pearson,0.09,0.06,0.12, ,Unspecified,,No,,Hodge 2007
3174,3425,3439,All [by gender],Participants in a case-cohort study,Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,4439,Pearson,0.17,0.11,0.23, ,Unspecified,,Yes,,Hodge 2007
3161,3426,3440,All [by gender],Participants in a case-cohort study,Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Palmitoleic acid (cis-16:1n-7),"",,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Palmitoleic acid (cis-16:1n-7),"",,,,percentRoot,,4439,Pearson,0.06,0.03,0.09, ,Unspecified,,No,,Hodge 2007
3175,3426,3440,All [by gender],Participants in a case-cohort study,Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Palmitoleic acid (cis-16:1n-7),"",,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Palmitoleic acid (cis-16:1n-7),"",,,,percentRoot,,4439,Pearson,0.2,0.08,0.32, ,Unspecified,,Yes,,Hodge 2007
3162,3427,3441,All [by gender],Participants in a case-cohort study,Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,4439,Pearson,0.22,0.2,0.25, ,Unspecified,,No,,Hodge 2007
3176,3427,3441,All [by gender],Participants in a case-cohort study,Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,4439,Pearson,0.45,0.35,0.53, ,Unspecified,,Yes,,Hodge 2007
3163,3428,3442,All [by gender],Participants in a case-cohort study,Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,4439,Pearson,0.2,0.17,0.23, ,Unspecified,,No,,Hodge 2007
3177,3428,3442,All [by gender],Participants in a case-cohort study,Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,4439,Pearson,0.58,0.38,0.73, ,Unspecified,,Yes,,Hodge 2007
3165,3429,3444,All [by gender],Participants in a case-cohort study,Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,percentRoot,,4439,Spearman,0.03,-0.004,0.06, ,Unspecified,,No,,Hodge 2007
3179,3429,3444,All [by gender],Participants in a case-cohort study,Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,percentRoot,,4439,Spearman,0.06,0.0,0.12, ,Unspecified,,Yes,,Hodge 2007
3164,3430,3443,All [by gender],Participants in a case-cohort study,Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",,,,percentRoot,,4439,Pearson,0.07,0.04,0.1, ,Unspecified,,No,,Hodge 2007
3178,3430,3443,All [by gender],Participants in a case-cohort study,Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",,,,percentRoot,,4439,Pearson,0.24,0.11,0.35, ,Unspecified,,Yes,,Hodge 2007
3166,3431,3445,All [by gender],Participants in a case-cohort study,Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,4439,Spearman,0.18,0.15,0.21, ,Unspecified,,No,,Hodge 2007
3180,3431,3445,All [by gender],Participants in a case-cohort study,Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,4439,Spearman,0.4,0.3,0.49, ,Unspecified,,Yes,,Hodge 2007
3167,3432,3446,All [by gender],Participants in a case-cohort study,Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,4439,Spearman,0.4,0.37,0.42, ,Unspecified,,No,,Hodge 2007
3181,3432,3446,All [by gender],Participants in a case-cohort study,Australia,MCCS (Melbourne Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,4439,Spearman,0.78,0.61,0.88, ,Unspecified,,Yes,,Hodge 2007
3182,3456,3449,All [by diet],Postmenopausal and premenopausal women living in the Helsinki area,Finland,,,Dietary record (5-day),Fibre from Cereals,"",,10.0,,,g/day,,,"Plasma, fasting",GC-MS,5-n-Heptadecylresorcinol (C17:0),"",10.5,,,nmol/L,,56,Pearson,0.387,,,= 0.004,Yes,,,"BMI, Age",Aubertin-Leheudre 2008
3183,3456,3450,All [by diet],Postmenopausal and premenopausal women living in the Helsinki area,Finland,,,Dietary record (5-day),Fibre from Cereals,"",,10.0,,,g/day,,,"Plasma, fasting",GC-MS,5-n-Nonadecylresorcinol (C19:0),"",19.3,,,nmol/L,,56,Pearson,0.35,,,= 0.01,Yes,,,"BMI, Age",Aubertin-Leheudre 2008
3184,3456,3451,All [by diet],Postmenopausal and premenopausal women living in the Helsinki area,Finland,,,Dietary record (5-day),Fibre from Cereals,"",,10.0,,,g/day,,,"Plasma, fasting",GC-MS,5-n-Heneicosylresorcinol (C21:0),"",17.3,,,nmol/L,,56,Pearson,0.428,,,= 0.001,Yes,,,"BMI, Age",Aubertin-Leheudre 2008
3185,3456,3452,All [by diet],Postmenopausal and premenopausal women living in the Helsinki area,Finland,,,Dietary record (5-day),Fibre from Cereals,"",,10.0,,,g/day,,,"Plasma, fasting",GC-MS,5-n-Tricosylresorcinol (C23:0),"",11.3,,,nmol/L,,56,Pearson,0.409,,,= 0.002,Yes,,,"BMI, Age",Aubertin-Leheudre 2008
3186,3456,3453,All [by diet],Postmenopausal and premenopausal women living in the Helsinki area,Finland,,,Dietary record (5-day),Fibre from Cereals,"",,10.0,,,g/day,,,"Plasma, fasting",GC-MS,5-n-Pentacosylresorcinol (C25:0),"",7.1,,,nmol/L,,56,Pearson,0.283,,,= 0.04,Yes,,,"BMI, Age",Aubertin-Leheudre 2008
3187,3456,3455,All [by diet],Postmenopausal and premenopausal women living in the Helsinki area,Finland,,,Dietary record (5-day),Fibre from Cereals,"",,10.0,,,g/day,,,"Plasma, fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0) + 5-n-Heptadecylresorcinol (C17:0) / 5-n-Heneicosylresorcinol (C21:0),65.5,,,nmol/L,,56,Pearson,0.406,,,= 0.003,Yes,,,"BMI, Age",Aubertin-Leheudre 2008
3188,3456,3447,All [by diet],Postmenopausal and premenopausal women living in the Helsinki area,Finland,,,Dietary record (5-day),Fibre from Cereals,"",,10.0,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",26.8,,,umol/day,,56,Pearson,0.359,,,= 0.008,Yes,,,"BMI, Age",Aubertin-Leheudre 2008
3189,3456,3448,All [by diet],Postmenopausal and premenopausal women living in the Helsinki area,Finland,,,Dietary record (5-day),Fibre from Cereals,"",,10.0,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",40.2,,,umol/day,,56,Pearson,0.402,,,= 0.003,Yes,,,"BMI, Age",Aubertin-Leheudre 2008
3190,3460,3447,All [by diet],Postmenopausal and premenopausal women living in the Helsinki area,Finland,,,Dietary record (5-day),Dietary fibre,Fibre from Cereals + Fibre from Vegetables + Fibre from Berries + Fibre from Legumes,,19.8,,,g/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",26.8,,,umol/day,,56,Pearson,0.3,,,= 0.025,Yes,,,"BMI, Age",Aubertin-Leheudre 2008
3191,3470,3469,Vegetarians,Postmenopausal and premenopausal women living in the Helsinki area,Finland,,,Dietary record (5-day),Fibre from Cereals,"",,11.0,,,g/day,,,"Plasma, fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0) + 5-n-Heptadecylresorcinol (C17:0) / 5-n-Heneicosylresorcinol (C21:0),60.9,,,nmol/L,,20,Pearson,0.548,,,= 0.018,Yes,,,"BMI, Age",Aubertin-Leheudre 2008
3192,3484,3483,Omnivores,Postmenopausal and premenopausal women living in the Helsinki area,Finland,,,Dietary record (5-day),Fibre from Cereals,"",,9.5,,,g/day,,,"Plasma, fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0) + 5-n-Heptadecylresorcinol (C17:0) / 5-n-Heneicosylresorcinol (C21:0),67.3,,,nmol/L,,36,Pearson,0.372,,,= 0.033,Yes,,,"BMI, Age",Aubertin-Leheudre 2008
3193,3534,3552,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fruits + Vegetables,Legume-family vegetables + Root vegetables + Leafy vegetables + Bulb and stem vegetables + Flower vegetables + Mushrooms + Pome fruits + Citrus fruits + Tropical fruits + Fruiting vegetables + Fruit juices,,,,,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,3521,Spearman,0.25,,,< 0.001,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3208,3534,3553,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fruits + Vegetables,Legume-family vegetables + Root vegetables + Leafy vegetables + Bulb and stem vegetables + Flower vegetables + Mushrooms + Pome fruits + Citrus fruits + Tropical fruits + Fruiting vegetables + Fruit juices,,,,,g/day,,,"Serum, fasting",Fluorometry,Vitamin C,"",,,,umol/L,,3521,Spearman,0.34,,,< 0.001,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3223,3534,3554,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fruits + Vegetables,Legume-family vegetables + Root vegetables + Leafy vegetables + Bulb and stem vegetables + Flower vegetables + Mushrooms + Pome fruits + Citrus fruits + Tropical fruits + Fruiting vegetables + Fruit juices,,,,,g/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,3521,Spearman,0.06,,,< 0.01,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3194,3535,3552,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Vegetables,Legume-family vegetables + Root vegetables + Leafy vegetables + Bulb and stem vegetables + Flower vegetables + Mushrooms + Fruiting vegetables,,,,,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,3521,Spearman,0.24,,,< 0.001,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3209,3535,3553,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Vegetables,Legume-family vegetables + Root vegetables + Leafy vegetables + Bulb and stem vegetables + Flower vegetables + Mushrooms + Fruiting vegetables,,,,,g/day,,,"Serum, fasting",Fluorometry,Vitamin C,"",,,,umol/L,,3521,Spearman,0.16,,,< 0.001,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3224,3535,3554,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Vegetables,Legume-family vegetables + Root vegetables + Leafy vegetables + Bulb and stem vegetables + Flower vegetables + Mushrooms + Fruiting vegetables,,,,,g/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,3521,Spearman,0.05,,,< 0.01,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3195,3536,3552,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fruiting vegetables,"",,,,,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,3521,Spearman,0.1,,,< 0.001,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3210,3536,3553,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fruiting vegetables,"",,,,,g/day,,,"Serum, fasting",Fluorometry,Vitamin C,"",,,,umol/L,,3521,Spearman,0.11,,,< 0.001,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3225,3536,3554,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fruiting vegetables,"",,,,,g/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,3521,Spearman,0.03,,,>= 0.05,No,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3196,3537,3552,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Root vegetables,"",,,,,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,3521,Spearman,0.22,,,< 0.001,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3211,3537,3553,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Root vegetables,"",,,,,g/day,,,"Serum, fasting",Fluorometry,Vitamin C,"",,,,umol/L,,3521,Spearman,0.12,,,< 0.001,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3226,3537,3554,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Root vegetables,"",,,,,g/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,3521,Spearman,0.04,,,>= 0.05,No,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3197,3538,3552,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Leafy vegetables,"",,,,,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,3521,Spearman,0.13,,,< 0.001,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3212,3538,3553,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Leafy vegetables,"",,,,,g/day,,,"Serum, fasting",Fluorometry,Vitamin C,"",,,,umol/L,,3521,Spearman,0.1,,,< 0.001,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3227,3538,3554,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Leafy vegetables,"",,,,,g/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,3521,Spearman,0.09,,,< 0.001,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3198,3539,3552,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Legume-family vegetables,"",,,,,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,3521,Spearman,0.09,,,< 0.001,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3213,3539,3553,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Legume-family vegetables,"",,,,,g/day,,,"Serum, fasting",Fluorometry,Vitamin C,"",,,,umol/L,,3521,Spearman,0.04,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3228,3539,3554,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Legume-family vegetables,"",,,,,g/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,3521,Spearman,-0.001,,,>= 0.05,No,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3199,3540,3552,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Bulb and stem vegetables,"",,,,,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,3521,Spearman,0.14,,,< 0.001,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3214,3540,3553,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Bulb and stem vegetables,"",,,,,g/day,,,"Serum, fasting",Fluorometry,Vitamin C,"",,,,umol/L,,3521,Spearman,0.07,,,< 0.001,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3229,3540,3554,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Bulb and stem vegetables,"",,,,,g/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,3521,Spearman,0.04,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3200,3541,3552,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Flower vegetables,"",,,,,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,3521,Spearman,0.11,,,< 0.001,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3215,3541,3553,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Flower vegetables,"",,,,,g/day,,,"Serum, fasting",Fluorometry,Vitamin C,"",,,,umol/L,,3521,Spearman,0.08,,,< 0.001,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3230,3541,3554,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Flower vegetables,"",,,,,g/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,3521,Spearman,0.01,,,>= 0.05,No,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3201,3542,3552,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Mushrooms,"",,,,,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,3521,Spearman,-0.03,,,>= 0.05,No,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3216,3542,3553,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Mushrooms,"",,,,,g/day,,,"Serum, fasting",Fluorometry,Vitamin C,"",,,,umol/L,,3521,Spearman,0.03,,,>= 0.05,No,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3231,3542,3554,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Mushrooms,"",,,,,g/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,3521,Spearman,0.02,,,>= 0.05,No,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3202,3543,3552,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fruits,Pome fruits + Citrus fruits + Tropical fruits + Fruit juices,,,,,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,3521,Spearman,0.18,,,< 0.001,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3217,3543,3553,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fruits,Pome fruits + Citrus fruits + Tropical fruits + Fruit juices,,,,,g/day,,,"Serum, fasting",Fluorometry,Vitamin C,"",,,,umol/L,,3521,Spearman,0.34,,,< 0.001,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3232,3543,3554,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fruits,Pome fruits + Citrus fruits + Tropical fruits + Fruit juices,,,,,g/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,3521,Spearman,0.04,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3203,3544,3552,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fruits,Pome fruits + Citrus fruits + Tropical fruits,,,,,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,3521,Spearman,0.19,,,< 0.001,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3218,3544,3553,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fruits,Pome fruits + Citrus fruits + Tropical fruits,,,,,g/day,,,"Serum, fasting",Fluorometry,Vitamin C,"",,,,umol/L,,3521,Spearman,0.29,,,< 0.001,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3233,3544,3554,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fruits,Pome fruits + Citrus fruits + Tropical fruits,,,,,g/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,3521,Spearman,0.04,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3204,3545,3552,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Pome fruits,"",,,,,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,3521,Spearman,0.15,,,< 0.001,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3219,3545,3553,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Pome fruits,"",,,,,g/day,,,"Serum, fasting",Fluorometry,Vitamin C,"",,,,umol/L,,3521,Spearman,0.19,,,< 0.001,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3234,3545,3554,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Pome fruits,"",,,,,g/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,3521,Spearman,0.03,,,>= 0.05,No,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3205,3548,3552,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Citrus fruits,"",,,,,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,3521,Spearman,0.16,,,< 0.001,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3220,3548,3553,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Citrus fruits,"",,,,,g/day,,,"Serum, fasting",Fluorometry,Vitamin C,"",,,,umol/L,,3521,Spearman,0.28,,,< 0.001,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3235,3548,3554,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Citrus fruits,"",,,,,g/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,3521,Spearman,0.04,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3206,3549,3552,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Tropical fruits,"",,,,,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,3521,Spearman,0.11,,,< 0.001,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3221,3549,3553,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Tropical fruits,"",,,,,g/day,,,"Serum, fasting",Fluorometry,Vitamin C,"",,,,umol/L,,3521,Spearman,0.17,,,< 0.001,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3236,3549,3554,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Tropical fruits,"",,,,,g/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,3521,Spearman,0.02,,,>= 0.05,No,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3207,3551,3552,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fruit juices,"",,,,,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,3521,Spearman,0.04,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3222,3551,3553,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fruit juices,"",,,,,g/day,,,"Serum, fasting",Fluorometry,Vitamin C,"",,,,umol/L,,3521,Spearman,0.19,,,< 0.001,Yes,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3237,3551,3554,All [by gender],Adults,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Fruit juices,"",,,,,g/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,3521,Spearman,0.02,,,>= 0.05,No,"Energy by residual method, Cholesterol, Triglycerides",,,Dauchet 2008
3256,3566,3581,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,263.0,g/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,missing unit,,125,Spearman,0.26,,,< 0.05,Yes,,,,Toft 2008
3257,3566,3582,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,263.0,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,125,Spearman,0.28,,,< 0.05,Yes,,,,Toft 2008
3258,3566,3583,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,263.0,g/day,,,"Plasma, fasting",HPLC,Lutein,"",,,,missing unit,,125,Spearman,0.16,,,>= 0.05,No,,,,Toft 2008
3259,3566,3584,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,263.0,g/day,,,"Plasma, fasting",HPLC,Zeaxanthin,"",,,,missing unit,,125,Spearman,0.13,,,>= 0.05,No,,,,Toft 2008
3260,3566,3585,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,263.0,g/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,125,Spearman,0.27,,,< 0.05,Yes,,,,Toft 2008
3261,3566,3586,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,263.0,g/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,missing unit,,125,Spearman,0.06,,,>= 0.05,No,,,,Toft 2008
3262,3566,3587,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,263.0,g/day,,,"Plasma, fasting",HPLC,Phytofluene,"",,,,missing unit,,125,Spearman,0.11,,,>= 0.05,No,,,,Toft 2008
3263,3566,3588,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,263.0,g/day,,,"Plasma, fasting",HPLC,Phytoene,"",,,,missing unit,,125,Spearman,0.17,,,< 0.05,Yes,,,,Toft 2008
3264,3566,3589,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,263.0,g/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene + Phytoene + Phytofluene,,,,missing unit,,125,Spearman,0.27,,,< 0.05,Yes,,,,Toft 2008
3310,3566,3581,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,263.0,g/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,missing unit,,125,Spearman,0.29,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3311,3566,3582,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,263.0,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,125,Spearman,0.28,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3312,3566,3583,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,263.0,g/day,,,"Plasma, fasting",HPLC,Lutein,"",,,,missing unit,,125,Spearman,0.2,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3313,3566,3584,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,263.0,g/day,,,"Plasma, fasting",HPLC,Zeaxanthin,"",,,,missing unit,,125,Spearman,0.15,,,>= 0.05,No,Energy by residual method,,,Toft 2008
3314,3566,3585,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,263.0,g/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,125,Spearman,0.24,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3315,3566,3586,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,263.0,g/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,missing unit,,125,Spearman,0.09,,,>= 0.05,No,Energy by residual method,,,Toft 2008
3316,3566,3587,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,263.0,g/day,,,"Plasma, fasting",HPLC,Phytofluene,"",,,,missing unit,,125,Spearman,0.14,,,>= 0.05,No,Energy by residual method,,,Toft 2008
3317,3566,3588,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,263.0,g/day,,,"Plasma, fasting",HPLC,Phytoene,"",,,,missing unit,,125,Spearman,0.2,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3318,3566,3589,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,263.0,g/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene + Phytoene + Phytofluene,,,,missing unit,,125,Spearman,0.29,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3238,3567,3581,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,133.0,g/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,missing unit,,125,Spearman,0.39,,,< 0.05,Yes,,,,Toft 2008
3239,3567,3582,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,133.0,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,125,Spearman,0.28,,,< 0.05,Yes,,,,Toft 2008
3240,3567,3583,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,133.0,g/day,,,"Plasma, fasting",HPLC,Lutein,"",,,,missing unit,,125,Spearman,0.36,,,< 0.05,Yes,,,,Toft 2008
3241,3567,3584,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,133.0,g/day,,,"Plasma, fasting",HPLC,Zeaxanthin,"",,,,missing unit,,125,Spearman,0.2,,,< 0.05,Yes,,,,Toft 2008
3242,3567,3585,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,133.0,g/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,125,Spearman,0.37,,,< 0.05,Yes,,,,Toft 2008
3243,3567,3586,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,133.0,g/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,missing unit,,125,Spearman,-0.04,,,>= 0.05,No,,,,Toft 2008
3244,3567,3587,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,133.0,g/day,,,"Plasma, fasting",HPLC,Phytofluene,"",,,,missing unit,,125,Spearman,0.17,,,< 0.05,Yes,,,,Toft 2008
3245,3567,3588,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,133.0,g/day,,,"Plasma, fasting",HPLC,Phytoene,"",,,,missing unit,,125,Spearman,0.23,,,< 0.05,Yes,,,,Toft 2008
3246,3567,3589,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,133.0,g/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene + Phytoene + Phytofluene,,,,missing unit,,125,Spearman,0.31,,,< 0.05,Yes,,,,Toft 2008
3292,3567,3581,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,133.0,g/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,missing unit,,125,Spearman,0.4,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3293,3567,3582,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,133.0,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,125,Spearman,0.28,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3294,3567,3583,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,133.0,g/day,,,"Plasma, fasting",HPLC,Lutein,"",,,,missing unit,,125,Spearman,0.37,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3295,3567,3584,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,133.0,g/day,,,"Plasma, fasting",HPLC,Zeaxanthin,"",,,,missing unit,,125,Spearman,0.21,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3296,3567,3585,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,133.0,g/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,125,Spearman,0.37,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3297,3567,3586,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,133.0,g/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,missing unit,,125,Spearman,-0.03,,,>= 0.05,No,Energy by residual method,,,Toft 2008
3298,3567,3587,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,133.0,g/day,,,"Plasma, fasting",HPLC,Phytofluene,"",,,,missing unit,,125,Spearman,0.18,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3299,3567,3588,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,133.0,g/day,,,"Plasma, fasting",HPLC,Phytoene,"",,,,missing unit,,125,Spearman,0.24,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3300,3567,3589,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,133.0,g/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene + Phytoene + Phytofluene,,,,missing unit,,125,Spearman,0.32,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3274,3599,3581,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,missing unit,,125,Spearman,0.44,,,< 0.05,Yes,,,,Toft 2008
3275,3599,3582,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,125,Spearman,0.38,,,< 0.05,Yes,,,,Toft 2008
3276,3599,3583,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,Lutein,"",,,,missing unit,,125,Spearman,0.34,,,< 0.05,Yes,,,,Toft 2008
3277,3599,3584,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,Zeaxanthin,"",,,,missing unit,,125,Spearman,0.22,,,< 0.05,Yes,,,,Toft 2008
3278,3599,3585,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,125,Spearman,0.4,,,< 0.05,Yes,,,,Toft 2008
3279,3599,3586,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,missing unit,,125,Spearman,0.002,,,>= 0.05,No,,,,Toft 2008
3280,3599,3587,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,Phytofluene,"",,,,missing unit,,125,Spearman,0.19,,,< 0.05,Yes,,,,Toft 2008
3281,3599,3588,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,Phytoene,"",,,,missing unit,,125,Spearman,0.27,,,< 0.05,Yes,,,,Toft 2008
3282,3599,3589,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene + Phytoene + Phytofluene,,,,missing unit,,125,Spearman,0.39,,,< 0.05,Yes,,,,Toft 2008
3328,3599,3581,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,missing unit,,125,Spearman,0.47,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3329,3599,3582,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,125,Spearman,0.39,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3330,3599,3583,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,Lutein,"",,,,missing unit,,125,Spearman,0.38,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3331,3599,3584,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,Zeaxanthin,"",,,,missing unit,,125,Spearman,0.24,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3332,3599,3585,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,125,Spearman,0.39,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3333,3599,3586,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,missing unit,,125,Spearman,0.03,,,>= 0.05,No,Energy by residual method,,,Toft 2008
3334,3599,3587,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,Phytofluene,"",,,,missing unit,,125,Spearman,0.22,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3335,3599,3588,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,Phytoene,"",,,,missing unit,,125,Spearman,0.3,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3336,3599,3589,Males,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene + Phytoene + Phytofluene,,,,missing unit,,125,Spearman,0.42,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3265,3578,3590,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,259.0,g/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,missing unit,,139,Spearman,0.33,,,< 0.05,Yes,,,,Toft 2008
3266,3578,3591,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,259.0,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,139,Spearman,0.22,,,< 0.05,Yes,,,,Toft 2008
3267,3578,3592,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,259.0,g/day,,,"Plasma, fasting",HPLC,Lutein,"",,,,missing unit,,139,Spearman,0.23,,,< 0.05,Yes,,,,Toft 2008
3268,3578,3593,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,259.0,g/day,,,"Plasma, fasting",HPLC,Zeaxanthin,"",,,,missing unit,,139,Spearman,0.19,,,< 0.05,Yes,,,,Toft 2008
3269,3578,3594,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,259.0,g/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,139,Spearman,0.16,,,>= 0.05,No,,,,Toft 2008
3270,3578,3595,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,259.0,g/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,missing unit,,139,Spearman,-0.03,,,>= 0.05,No,,,,Toft 2008
3271,3578,3596,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,259.0,g/day,,,"Plasma, fasting",HPLC,Phytofluene,"",,,,missing unit,,139,Spearman,0.19,,,< 0.05,Yes,,,,Toft 2008
3272,3578,3597,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,259.0,g/day,,,"Plasma, fasting",HPLC,Phytoene,"",,,,missing unit,,139,Spearman,0.17,,,< 0.05,Yes,,,,Toft 2008
3273,3578,3598,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,259.0,g/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene + Phytoene + Phytofluene,,,,missing unit,,139,Spearman,0.26,,,< 0.05,Yes,,,,Toft 2008
3319,3578,3590,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,259.0,g/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,missing unit,,139,Spearman,0.26,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3320,3578,3591,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,259.0,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,139,Spearman,0.16,,,>= 0.05,No,Energy by residual method,,,Toft 2008
3321,3578,3592,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,259.0,g/day,,,"Plasma, fasting",HPLC,Lutein,"",,,,missing unit,,139,Spearman,0.19,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3322,3578,3593,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,259.0,g/day,,,"Plasma, fasting",HPLC,Zeaxanthin,"",,,,missing unit,,139,Spearman,0.17,,,>= 0.05,No,Energy by residual method,,,Toft 2008
3323,3578,3594,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,259.0,g/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,139,Spearman,0.11,,,>= 0.05,No,Energy by residual method,,,Toft 2008
3324,3578,3595,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,259.0,g/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,missing unit,,139,Spearman,-0.03,,,>= 0.05,No,Energy by residual method,,,Toft 2008
3325,3578,3596,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,259.0,g/day,,,"Plasma, fasting",HPLC,Phytofluene,"",,,,missing unit,,139,Spearman,0.17,,,>= 0.05,No,Energy by residual method,,,Toft 2008
3326,3578,3597,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,259.0,g/day,,,"Plasma, fasting",HPLC,Phytoene,"",,,,missing unit,,139,Spearman,0.19,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3327,3578,3598,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,259.0,g/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene + Phytoene + Phytofluene,,,,missing unit,,139,Spearman,0.22,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3247,3579,3590,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,318.0,g/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,missing unit,,139,Spearman,0.37,,,< 0.05,Yes,,,,Toft 2008
3248,3579,3591,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,318.0,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,139,Spearman,0.24,,,< 0.05,Yes,,,,Toft 2008
3249,3579,3592,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,318.0,g/day,,,"Plasma, fasting",HPLC,Lutein,"",,,,missing unit,,139,Spearman,0.2,,,< 0.05,Yes,,,,Toft 2008
3250,3579,3593,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,318.0,g/day,,,"Plasma, fasting",HPLC,Zeaxanthin,"",,,,missing unit,,139,Spearman,0.19,,,< 0.05,Yes,,,,Toft 2008
3251,3579,3594,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,318.0,g/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,139,Spearman,0.3,,,< 0.05,Yes,,,,Toft 2008
3252,3579,3595,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,318.0,g/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,missing unit,,139,Spearman,-0.06,,,>= 0.05,No,,,,Toft 2008
3253,3579,3596,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,318.0,g/day,,,"Plasma, fasting",HPLC,Phytofluene,"",,,,missing unit,,139,Spearman,0.25,,,< 0.05,Yes,,,,Toft 2008
3254,3579,3597,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,318.0,g/day,,,"Plasma, fasting",HPLC,Phytoene,"",,,,missing unit,,139,Spearman,0.13,,,>= 0.05,No,,,,Toft 2008
3255,3579,3598,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,318.0,g/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene + Phytoene + Phytofluene,,,,missing unit,,139,Spearman,0.29,,,< 0.05,Yes,,,,Toft 2008
3301,3579,3590,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,318.0,g/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,missing unit,,139,Spearman,0.33,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3302,3579,3591,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,318.0,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,139,Spearman,0.2,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3303,3579,3592,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,318.0,g/day,,,"Plasma, fasting",HPLC,Lutein,"",,,,missing unit,,139,Spearman,0.18,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3304,3579,3593,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,318.0,g/day,,,"Plasma, fasting",HPLC,Zeaxanthin,"",,,,missing unit,,139,Spearman,0.18,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3305,3579,3594,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,318.0,g/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,139,Spearman,0.25,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3306,3579,3595,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,318.0,g/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,missing unit,,139,Spearman,-0.08,,,>= 0.05,No,Energy by residual method,,,Toft 2008
3307,3579,3596,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,318.0,g/day,,,"Plasma, fasting",HPLC,Phytofluene,"",,,,missing unit,,139,Spearman,0.22,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3308,3579,3597,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,318.0,g/day,,,"Plasma, fasting",HPLC,Phytoene,"",,,,missing unit,,139,Spearman,0.15,,,>= 0.05,No,Energy by residual method,,,Toft 2008
3309,3579,3598,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,318.0,g/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene + Phytoene + Phytofluene,,,,missing unit,,139,Spearman,0.26,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3283,3600,3590,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,missing unit,,139,Spearman,0.41,,,< 0.05,Yes,,,,Toft 2008
3284,3600,3591,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,139,Spearman,0.29,,,< 0.05,Yes,,,,Toft 2008
3285,3600,3592,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,Lutein,"",,,,missing unit,,139,Spearman,0.25,,,< 0.05,Yes,,,,Toft 2008
3286,3600,3593,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,Zeaxanthin,"",,,,missing unit,,139,Spearman,0.23,,,< 0.05,Yes,,,,Toft 2008
3287,3600,3594,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,139,Spearman,0.29,,,< 0.05,Yes,,,,Toft 2008
3288,3600,3595,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,missing unit,,139,Spearman,-0.03,,,>= 0.05,No,,,,Toft 2008
3289,3600,3596,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,Phytofluene,"",,,,missing unit,,139,Spearman,0.27,,,< 0.05,Yes,,,,Toft 2008
3290,3600,3597,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,Phytoene,"",,,,missing unit,,139,Spearman,0.16,,,< 0.05,Yes,,,,Toft 2008
3291,3600,3598,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene + Phytoene + Phytofluene,,,,missing unit,,139,Spearman,0.33,,,< 0.05,Yes,,,,Toft 2008
3337,3600,3590,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,missing unit,,139,Spearman,0.38,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3338,3600,3591,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,139,Spearman,0.24,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3339,3600,3592,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,Lutein,"",,,,missing unit,,139,Spearman,0.23,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3340,3600,3593,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,Zeaxanthin,"",,,,missing unit,,139,Spearman,0.24,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3341,3600,3594,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,139,Spearman,0.26,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3342,3600,3595,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,missing unit,,139,Spearman,-0.04,,,>= 0.05,No,Energy by residual method,,,Toft 2008
3343,3600,3596,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,Phytofluene,"",,,,missing unit,,139,Spearman,0.26,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3344,3600,3597,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,Phytoene,"",,,,missing unit,,139,Spearman,0.22,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3345,3600,3598,Females,Participants in a dietary validation study,Denmark,Inter99 Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene + Phytoene + Phytofluene,,,,missing unit,,139,Spearman,0.32,,,< 0.05,Yes,Energy by residual method,,,Toft 2008
3346,3610,3601,All [by gender],Yup'ik Eskimos in southwest Alaska,United States,CANHR (Center for Alaska Native Health Research),,24-h Dietary recall (1-day) + Dietary record (3-day),EPA (cis-20:5n-3),"",,,,,missing unit,,,"Red blood cell membrane, unspecified",Mass spectrometry (MS),15N/14N,"",8.5,,,‰ (delta unit),,221,Pearson,0.47,,,< 0.001,Yes,,,,O'Brien 2009
3347,3610,3602,All [by gender],Yup'ik Eskimos in southwest Alaska,United States,CANHR (Center for Alaska Native Health Research),,24-h Dietary recall (1-day) + Dietary record (3-day),EPA (cis-20:5n-3),"",,,,,missing unit,,,"Red blood cell membrane, unspecified",GC-FID,EPA (cis-20:5n-3),"",2.0,,,percentRoot,,221,Pearson,0.64,,,< 0.001,Yes,,,,O'Brien 2009
3348,3611,3601,All [by gender],Yup'ik Eskimos in southwest Alaska,United States,CANHR (Center for Alaska Native Health Research),,24-h Dietary recall (1-day) + Dietary record (3-day),DHA (cis-22:6n-3),"",,,,,missing unit,,,"Red blood cell membrane, unspecified",Mass spectrometry (MS),15N/14N,"",8.5,,,‰ (delta unit),,221,Pearson,0.46,,,< 0.001,Yes,,,,O'Brien 2009
3349,3611,3603,All [by gender],Yup'ik Eskimos in southwest Alaska,United States,CANHR (Center for Alaska Native Health Research),,24-h Dietary recall (1-day) + Dietary record (3-day),DHA (cis-22:6n-3),"",,,,,missing unit,,,"Red blood cell membrane, unspecified",GC-FID,DHA (cis-22:6n-3),"",6.0,,,percentRoot,,221,Pearson,0.54,,,< 0.001,Yes,,,,O'Brien 2009
3350,3624,3628,All,Volunteers from the Tucson community,United States,,,Food Frequency Questionnaire (FFQ),Cabbage-family vegetables,Cooked cabbage-family vegetables + Raw cabbage-family vegetables,,84.0,,,g/day,,13 days,"Urine, 24-h",HPLC,Dithiocarbamates,"",11.0,,,umol/L,,106,Spearman,0.26,,,= 0.01,Yes,,,,Thomson 2007
3351,3625,3628,All,Volunteers from the Tucson community,United States,,,Food Frequency Questionnaire (FFQ),Cooked cabbage-family vegetables,"",,47.0,,,g/day,,13 days,"Urine, 24-h",HPLC,Dithiocarbamates,"",11.0,,,umol/L,,106,Spearman,0.23,,,= 0.02,Yes,,,,Thomson 2007
3352,3626,3628,All,Volunteers from the Tucson community,United States,,,Food Frequency Questionnaire (FFQ),Raw cabbage-family vegetables,"",,30.0,,,g/day,,13 days,"Urine, 24-h",HPLC,Dithiocarbamates,"",11.0,,,umol/L,,106,Spearman,0.27,,,= 0.01,Yes,,,,Thomson 2007
3353,3627,3628,All,Volunteers from the Tucson community,United States,,,Food Frequency Questionnaire (FFQ),Cabbage-family vegetables,Cooked cabbage-family vegetables + Raw cabbage-family vegetables,,48.0,,,g/day,,13 days,"Urine, 24-h",HPLC,Dithiocarbamates,"",11.0,,,umol/L,,106,Spearman,0.19,,,= 0.06,No,,,,Thomson 2007
3412,3630,3639,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,24.6,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Myristic acid (14:0),"",3.6,,,percentRoot,,197,Pearson,0.37,,,< 0.01,Yes,,,,Biong 2006
3413,3630,3640,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,24.6,,,g/day,,,"Adipose tissue, buttocks",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.55,,,percentRoot,,197,Pearson,0.26,,,< 0.01,Yes,,,,Biong 2006
3414,3630,3641,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,24.6,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.39,,,percentRoot,,197,Pearson,0.39,,,< 0.01,Yes,,,,Biong 2006
3415,3630,3642,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,24.6,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.27,,,percentRoot,,197,Pearson,0.27,,,< 0.01,Yes,,,,Biong 2006
3416,3630,3643,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,24.6,,,g/day,,,"Adipose tissue, buttocks",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.36,,,percentRoot,,197,Pearson,0.18,,,< 0.05,Yes,,,,Biong 2006
3417,3630,3644,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,24.6,,,g/day,,,"Serum (non-esterified fatty acids), fasting",GC-FID,Myristic acid (14:0),"",2.1,,,percentRoot,,205,Pearson,0.16,,,< 0.05,Yes,,,,Biong 2006
3418,3630,3645,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,24.6,,,g/day,,,"Serum (non-esterified fatty acids), fasting",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.13,,,percentRoot,,205,Spearman,0.17,,,< 0.01,Yes,,,,Biong 2006
3419,3630,3646,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,24.6,,,g/day,,,"Serum (non-esterified fatty acids), fasting",GC-FID,Pentadecylic acid (15:0),"",0.37,,,percentRoot,,205,Pearson,0.14,,,< 0.05,Yes,,,,Biong 2006
3420,3630,3648,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,24.6,,,g/day,,,"Serum (non-esterified fatty acids), fasting",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.24,,,percentRoot,,205,Pearson,0.14,,,< 0.05,Yes,,,,Biong 2006
3421,3630,3649,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,24.6,,,g/day,,,"Serum (triglycerides), fasting",GC-FID,Myristic acid (14:0),"",1.87,,,percentRoot,,205,Pearson,0.09,,,>= 0.05,No,,,,Biong 2006
3422,3630,3650,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,24.6,,,g/day,,,"Serum (triglycerides), fasting",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.09,,,percentRoot,,205,Spearman,0.19,,,< 0.01,Yes,,,,Biong 2006
3423,3630,3651,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,24.6,,,g/day,,,"Serum (triglycerides), fasting",GC-FID,Pentadecylic acid (15:0),"",0.34,,,percentRoot,,205,Pearson,0.4,,,< 0.01,Yes,,,,Biong 2006
3424,3630,3652,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,24.6,,,g/day,,,"Serum (triglycerides), fasting",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.27,,,percentRoot,,205,Pearson,0.2,,,< 0.01,Yes,,,,Biong 2006
3425,3630,3653,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,24.6,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,Myristic acid (14:0),"",0.81,,,percentRoot,,202,Pearson,0.08,,,>= 0.05,No,,,,Biong 2006
3426,3630,3654,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,24.6,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.02,,,percentRoot,,202,Spearman,0.16,,,< 0.05,Yes,,,,Biong 2006
3427,3630,3655,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,24.6,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,Pentadecylic acid (15:0),"",0.23,,,percentRoot,,202,Spearman,0.27,,,< 0.01,Yes,,,,Biong 2006
3428,3630,3656,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,24.6,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.23,,,percentRoot,,202,Spearman,0.14,,,< 0.05,Yes,,,,Biong 2006
3429,3630,3657,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,24.6,,,g/day,,,"Serum (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",0.48,,,percentRoot,,190,Spearman,0.0,,,>= 0.05,No,,,,Biong 2006
3430,3630,3658,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,24.6,,,g/day,,,"Serum (phospholipids), fasting",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.29,,,percentRoot,,190,Spearman,0.15,,,< 0.05,Yes,,,,Biong 2006
3431,3630,3659,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,24.6,,,g/day,,,"Serum (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",0.84,,,percentRoot,,190,Spearman,0.05,,,>= 0.05,No,,,,Biong 2006
3432,3630,3660,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,24.6,,,g/day,,,"Serum (phospholipids), fasting",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.17,,,percentRoot,,190,Spearman,0.0,,,>= 0.05,No,,,,Biong 2006
3433,3632,3639,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Cheese,"",,37.0,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Myristic acid (14:0),"",3.6,,,percentRoot,,197,Pearson,0.21,,,< 0.01,Yes,,,,Biong 2006
3434,3632,3640,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Cheese,"",,37.0,,,g/day,,,"Adipose tissue, buttocks",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.55,,,percentRoot,,197,Pearson,0.2,,,< 0.01,Yes,,,,Biong 2006
3435,3632,3641,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Cheese,"",,37.0,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.39,,,percentRoot,,197,Pearson,0.3,,,< 0.01,Yes,,,,Biong 2006
3436,3632,3642,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Cheese,"",,37.0,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.27,,,percentRoot,,197,Pearson,0.17,,,< 0.05,Yes,,,,Biong 2006
3437,3632,3643,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Cheese,"",,37.0,,,g/day,,,"Adipose tissue, buttocks",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.36,,,percentRoot,,197,Pearson,0.16,,,< 0.05,Yes,,,,Biong 2006
3438,3632,3644,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Cheese,"",,37.0,,,g/day,,,"Serum (non-esterified fatty acids), fasting",GC-FID,Myristic acid (14:0),"",2.1,,,percentRoot,,205,Pearson,0.12,,,>= 0.05,No,,,,Biong 2006
3439,3632,3645,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Cheese,"",,37.0,,,g/day,,,"Serum (non-esterified fatty acids), fasting",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.13,,,percentRoot,,205,Spearman,0.29,,,< 0.01,Yes,,,,Biong 2006
3440,3632,3646,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Cheese,"",,37.0,,,g/day,,,"Serum (non-esterified fatty acids), fasting",GC-FID,Pentadecylic acid (15:0),"",0.37,,,percentRoot,,205,Pearson,0.11,,,>= 0.05,No,,,,Biong 2006
3441,3632,3648,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Cheese,"",,37.0,,,g/day,,,"Serum (non-esterified fatty acids), fasting",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.24,,,percentRoot,,205,Pearson,0.17,,,>= 0.05,No,,,,Biong 2006
3442,3632,3649,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Cheese,"",,37.0,,,g/day,,,"Serum (triglycerides), fasting",GC-FID,Myristic acid (14:0),"",1.87,,,percentRoot,,205,Pearson,0.09,,,>= 0.05,No,,,,Biong 2006
3443,3632,3650,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Cheese,"",,37.0,,,g/day,,,"Serum (triglycerides), fasting",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.09,,,percentRoot,,205,Spearman,0.15,,,< 0.05,Yes,,,,Biong 2006
3444,3632,3651,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Cheese,"",,37.0,,,g/day,,,"Serum (triglycerides), fasting",GC-FID,Pentadecylic acid (15:0),"",0.34,,,percentRoot,,205,Pearson,0.27,,,< 0.01,Yes,,,,Biong 2006
3445,3632,3652,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Cheese,"",,37.0,,,g/day,,,"Serum (triglycerides), fasting",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.27,,,percentRoot,,205,Pearson,0.15,,,< 0.05,Yes,,,,Biong 2006
3446,3632,3653,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Cheese,"",,37.0,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,Myristic acid (14:0),"",0.81,,,percentRoot,,202,Pearson,0.05,,,>= 0.05,No,,,,Biong 2006
3447,3632,3654,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Cheese,"",,37.0,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.02,,,percentRoot,,202,Spearman,0.12,,,>= 0.05,No,,,,Biong 2006
3448,3632,3655,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Cheese,"",,37.0,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,Pentadecylic acid (15:0),"",0.23,,,percentRoot,,202,Spearman,0.17,,,< 0.05,Yes,,,,Biong 2006
3449,3632,3656,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Cheese,"",,37.0,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.23,,,percentRoot,,202,Spearman,0.07,,,>= 0.05,No,,,,Biong 2006
3450,3632,3657,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Cheese,"",,37.0,,,g/day,,,"Serum (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",0.48,,,percentRoot,,190,Spearman,0.06,,,>= 0.05,No,,,,Biong 2006
3451,3632,3658,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Cheese,"",,37.0,,,g/day,,,"Serum (phospholipids), fasting",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.29,,,percentRoot,,190,Spearman,0.13,,,>= 0.05,No,,,,Biong 2006
3452,3632,3659,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Cheese,"",,37.0,,,g/day,,,"Serum (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",0.84,,,percentRoot,,190,Spearman,0.17,,,< 0.05,Yes,,,,Biong 2006
3453,3632,3660,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Cheese,"",,37.0,,,g/day,,,"Serum (phospholipids), fasting",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.17,,,percentRoot,,190,Spearman,0.06,,,>= 0.05,No,,,,Biong 2006
3475,3633,3639,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Butter,"",,,,1.4,g/day,,,"Adipose tissue, buttocks",GC-FID,Myristic acid (14:0),"",3.6,,,percentRoot,,197,Spearman,0.23,,,< 0.01,Yes,,,,Biong 2006
3476,3633,3640,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Butter,"",,,,1.4,g/day,,,"Adipose tissue, buttocks",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.55,,,percentRoot,,197,Spearman,0.18,,,< 0.01,Yes,,,,Biong 2006
3477,3633,3641,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Butter,"",,,,1.4,g/day,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.39,,,percentRoot,,197,Spearman,0.21,,,< 0.01,Yes,,,,Biong 2006
3478,3633,3642,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Butter,"",,,,1.4,g/day,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.27,,,percentRoot,,197,Spearman,0.12,,,>= 0.05,No,,,,Biong 2006
3479,3633,3643,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Butter,"",,,,1.4,g/day,,,"Adipose tissue, buttocks",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.36,,,percentRoot,,197,Spearman,0.14,,,>= 0.05,No,,,,Biong 2006
3480,3633,3644,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Butter,"",,,,1.4,g/day,,,"Serum (non-esterified fatty acids), fasting",GC-FID,Myristic acid (14:0),"",2.1,,,percentRoot,,205,Spearman,0.13,,,>= 0.05,No,,,,Biong 2006
3481,3633,3645,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Butter,"",,,,1.4,g/day,,,"Serum (non-esterified fatty acids), fasting",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.13,,,percentRoot,,205,Spearman,0.11,,,>= 0.05,No,,,,Biong 2006
3482,3633,3646,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Butter,"",,,,1.4,g/day,,,"Serum (non-esterified fatty acids), fasting",GC-FID,Pentadecylic acid (15:0),"",0.37,,,percentRoot,,205,Spearman,0.07,,,>= 0.05,No,,,,Biong 2006
3483,3633,3648,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Butter,"",,,,1.4,g/day,,,"Serum (non-esterified fatty acids), fasting",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.24,,,percentRoot,,205,Spearman,0.11,,,>= 0.05,No,,,,Biong 2006
3484,3633,3649,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Butter,"",,,,1.4,g/day,,,"Serum (triglycerides), fasting",GC-FID,Myristic acid (14:0),"",1.87,,,percentRoot,,205,Spearman,-0.01,,,>= 0.05,No,,,,Biong 2006
3485,3633,3650,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Butter,"",,,,1.4,g/day,,,"Serum (triglycerides), fasting",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.09,,,percentRoot,,205,Spearman,0.03,,,>= 0.05,No,,,,Biong 2006
3486,3633,3651,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Butter,"",,,,1.4,g/day,,,"Serum (triglycerides), fasting",GC-FID,Pentadecylic acid (15:0),"",0.34,,,percentRoot,,205,Spearman,0.21,,,< 0.01,Yes,,,,Biong 2006
3487,3633,3652,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Butter,"",,,,1.4,g/day,,,"Serum (triglycerides), fasting",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.27,,,percentRoot,,205,Spearman,0.12,,,>= 0.05,No,,,,Biong 2006
3488,3633,3653,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Butter,"",,,,1.4,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,Myristic acid (14:0),"",0.81,,,percentRoot,,202,Spearman,-0.92,,,>= 0.05,No,,,,Biong 2006
3489,3633,3654,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Butter,"",,,,1.4,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.02,,,percentRoot,,202,Spearman,0.05,,,>= 0.05,No,,,,Biong 2006
3490,3633,3655,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Butter,"",,,,1.4,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,Pentadecylic acid (15:0),"",0.23,,,percentRoot,,202,Spearman,0.14,,,< 0.05,Yes,,,,Biong 2006
3491,3633,3656,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Butter,"",,,,1.4,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.23,,,percentRoot,,202,Spearman,0.19,,,< 0.01,Yes,,,,Biong 2006
3492,3633,3657,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Butter,"",,,,1.4,g/day,,,"Serum (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",0.48,,,percentRoot,,190,Spearman,0.05,,,>= 0.05,No,,,,Biong 2006
3493,3633,3658,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Butter,"",,,,1.4,g/day,,,"Serum (phospholipids), fasting",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.29,,,percentRoot,,190,Spearman,0.12,,,>= 0.05,No,,,,Biong 2006
3494,3633,3659,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Butter,"",,,,1.4,g/day,,,"Serum (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",0.84,,,percentRoot,,190,Spearman,0.0,,,>= 0.05,No,,,,Biong 2006
3495,3633,3660,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Butter,"",,,,1.4,g/day,,,"Serum (phospholipids), fasting",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.17,,,percentRoot,,190,Spearman,0.12,,,>= 0.05,No,,,,Biong 2006
3454,3634,3639,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Milk,"",,,,0.8,g/day,,,"Adipose tissue, buttocks",GC-FID,Myristic acid (14:0),"",3.6,,,percentRoot,,197,Pearson,0.2,,,< 0.01,Yes,,,,Biong 2006
3455,3634,3640,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Milk,"",,,,0.8,g/day,,,"Adipose tissue, buttocks",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.55,,,percentRoot,,197,Pearson,0.06,,,>= 0.05,No,,,,Biong 2006
3456,3634,3641,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Milk,"",,,,0.8,g/day,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.39,,,percentRoot,,197,Pearson,0.21,,,< 0.01,Yes,,,,Biong 2006
3457,3634,3642,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Milk,"",,,,0.8,g/day,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.27,,,percentRoot,,197,Pearson,0.27,,,< 0.01,Yes,,,,Biong 2006
3458,3634,3643,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Milk,"",,,,0.8,g/day,,,"Adipose tissue, buttocks",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.36,,,percentRoot,,197,Pearson,0.07,,,>= 0.05,No,,,,Biong 2006
3459,3634,3644,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Milk,"",,,,0.8,g/day,,,"Serum (non-esterified fatty acids), fasting",GC-FID,Myristic acid (14:0),"",2.1,,,percentRoot,,205,Pearson,0.08,,,>= 0.05,No,,,,Biong 2006
3460,3634,3645,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Milk,"",,,,0.8,g/day,,,"Serum (non-esterified fatty acids), fasting",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.13,,,percentRoot,,205,Spearman,0.03,,,>= 0.05,No,,,,Biong 2006
3461,3634,3646,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Milk,"",,,,0.8,g/day,,,"Serum (non-esterified fatty acids), fasting",GC-FID,Pentadecylic acid (15:0),"",0.37,,,percentRoot,,205,Pearson,0.03,,,>= 0.05,No,,,,Biong 2006
3462,3634,3648,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Milk,"",,,,0.8,g/day,,,"Serum (non-esterified fatty acids), fasting",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.24,,,percentRoot,,205,Pearson,0.1,,,>= 0.05,No,,,,Biong 2006
3463,3634,3649,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Milk,"",,,,0.8,g/day,,,"Serum (triglycerides), fasting",GC-FID,Myristic acid (14:0),"",1.87,,,percentRoot,,205,Pearson,0.06,,,>= 0.05,No,,,,Biong 2006
3464,3634,3650,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Milk,"",,,,0.8,g/day,,,"Serum (triglycerides), fasting",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.09,,,percentRoot,,205,Spearman,0.1,,,>= 0.05,No,,,,Biong 2006
3465,3634,3651,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Milk,"",,,,0.8,g/day,,,"Serum (triglycerides), fasting",GC-FID,Pentadecylic acid (15:0),"",0.34,,,percentRoot,,205,Pearson,0.26,,,< 0.01,Yes,,,,Biong 2006
3466,3634,3652,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Milk,"",,,,0.8,g/day,,,"Serum (triglycerides), fasting",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.27,,,percentRoot,,205,Pearson,0.12,,,>= 0.05,No,,,,Biong 2006
3467,3634,3653,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Milk,"",,,,0.8,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,Myristic acid (14:0),"",0.81,,,percentRoot,,202,Pearson,0.09,,,>= 0.05,No,,,,Biong 2006
3468,3634,3654,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Milk,"",,,,0.8,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.02,,,percentRoot,,202,Spearman,0.05,,,>= 0.05,No,,,,Biong 2006
3469,3634,3655,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Milk,"",,,,0.8,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,Pentadecylic acid (15:0),"",0.23,,,percentRoot,,202,Spearman,0.17,,,< 0.05,Yes,,,,Biong 2006
3470,3634,3656,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Milk,"",,,,0.8,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.23,,,percentRoot,,202,Spearman,0.07,,,>= 0.05,No,,,,Biong 2006
3471,3634,3657,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Milk,"",,,,0.8,g/day,,,"Serum (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",0.48,,,percentRoot,,190,Spearman,0.05,,,>= 0.05,No,,,,Biong 2006
3472,3634,3658,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Milk,"",,,,0.8,g/day,,,"Serum (phospholipids), fasting",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.29,,,percentRoot,,190,Spearman,0.16,,,< 0.05,Yes,,,,Biong 2006
3473,3634,3659,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Milk,"",,,,0.8,g/day,,,"Serum (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",0.84,,,percentRoot,,190,Spearman,0.05,,,>= 0.05,No,,,,Biong 2006
3474,3634,3660,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Milk,"",,,,0.8,g/day,,,"Serum (phospholipids), fasting",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.17,,,percentRoot,,190,Spearman,0.04,,,>= 0.05,No,,,,Biong 2006
3354,3635,3639,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Myristic acid (14:0),"",,4.0,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Myristic acid (14:0),"",3.6,,,percentRoot,,197,Pearson,0.6,,,< 0.01,Yes,,,,Biong 2006
3358,3635,3644,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Myristic acid (14:0),"",,4.0,,,g/day,,,"Serum (non-esterified fatty acids), fasting",GC-FID,Myristic acid (14:0),"",2.1,,,percentRoot,,205,Pearson,0.18,,,< 0.01,Yes,,,,Biong 2006
3361,3635,3649,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Myristic acid (14:0),"",,4.0,,,g/day,,,"Serum (triglycerides), fasting",GC-FID,Myristic acid (14:0),"",1.87,,,percentRoot,,205,Pearson,0.18,,,< 0.01,Yes,,,,Biong 2006
3364,3635,3653,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Myristic acid (14:0),"",,4.0,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,Myristic acid (14:0),"",0.81,,,percentRoot,,202,Pearson,0.24,,,< 0.01,Yes,,,,Biong 2006
3367,3635,3657,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Myristic acid (14:0),"",,4.0,,,g/day,,,"Serum (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",0.48,,,percentRoot,,190,Spearman,0.11,,,>= 0.05,No,,,,Biong 2006
3355,3636,3640,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),cis-Tetradecenoic acids (cis-14:1),"",,0.26,,,g/day,,,"Adipose tissue, buttocks",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.55,,,percentRoot,,197,Pearson,0.47,,,< 0.01,Yes,,,,Biong 2006
3359,3636,3645,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),cis-Tetradecenoic acids (cis-14:1),"",,0.26,,,g/day,,,"Serum (non-esterified fatty acids), fasting",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.13,,,percentRoot,,205,Spearman,0.34,,,< 0.01,Yes,,,,Biong 2006
3362,3636,3650,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),cis-Tetradecenoic acids (cis-14:1),"",,0.26,,,g/day,,,"Serum (triglycerides), fasting",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.09,,,percentRoot,,205,Spearman,0.28,,,< 0.01,Yes,,,,Biong 2006
3365,3636,3654,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),cis-Tetradecenoic acids (cis-14:1),"",,0.26,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.02,,,percentRoot,,202,Spearman,0.15,,,< 0.05,Yes,,,,Biong 2006
3368,3636,3658,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),cis-Tetradecenoic acids (cis-14:1),"",,0.26,,,g/day,,,"Serum (phospholipids), fasting",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.29,,,percentRoot,,190,Spearman,0.26,,,< 0.01,Yes,,,,Biong 2006
3356,3637,3641,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Pentadecylic acid (15:0),"",,0.5,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.39,,,percentRoot,,197,Pearson,0.55,,,< 0.01,Yes,,,,Biong 2006
3360,3637,3646,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Pentadecylic acid (15:0),"",,0.5,,,g/day,,,"Serum (non-esterified fatty acids), fasting",GC-FID,Pentadecylic acid (15:0),"",0.37,,,percentRoot,,205,Pearson,0.08,,,>= 0.05,No,,,,Biong 2006
3363,3637,3651,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Pentadecylic acid (15:0),"",,0.5,,,g/day,,,"Serum (triglycerides), fasting",GC-FID,Pentadecylic acid (15:0),"",0.34,,,percentRoot,,205,Pearson,0.45,,,< 0.01,Yes,,,,Biong 2006
3366,3637,3655,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Pentadecylic acid (15:0),"",,0.5,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,Pentadecylic acid (15:0),"",0.23,,,percentRoot,,202,Spearman,0.42,,,< 0.01,Yes,,,,Biong 2006
3369,3637,3659,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Pentadecylic acid (15:0),"",,0.5,,,g/day,,,"Serum (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",0.84,,,percentRoot,,190,Spearman,0.09,,,>= 0.05,No,,,,Biong 2006
3357,3638,3642,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Margaric acid (17:0),"",,0.25,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.27,,,percentRoot,,197,Pearson,0.35,,,< 0.01,Yes,,,,Biong 2006
3370,3661,3639,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Myristic acid (14:0),"",3.6,,,percentRoot,,197,Pearson,0.5,,,< 0.01,Yes,,,,Biong 2006
3371,3661,3640,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.55,,,percentRoot,,197,Pearson,0.41,,,< 0.01,Yes,,,,Biong 2006
3372,3661,3641,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.39,,,percentRoot,,197,Pearson,0.55,,,< 0.01,Yes,,,,Biong 2006
3373,3661,3642,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.27,,,percentRoot,,197,Pearson,0.3,,,< 0.01,Yes,,,,Biong 2006
3374,3661,3643,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.36,,,percentRoot,,197,Pearson,0.33,,,< 0.01,Yes,,,,Biong 2006
3375,3661,3644,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (non-esterified fatty acids), fasting",GC-FID,Myristic acid (14:0),"",2.1,,,percentRoot,,205,Pearson,0.18,,,< 0.01,Yes,,,,Biong 2006
3376,3661,3645,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (non-esterified fatty acids), fasting",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.13,,,percentRoot,,205,Spearman,0.31,,,< 0.01,Yes,,,,Biong 2006
3377,3661,3646,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (non-esterified fatty acids), fasting",GC-FID,Pentadecylic acid (15:0),"",0.37,,,percentRoot,,205,Pearson,0.08,,,>= 0.05,No,,,,Biong 2006
3378,3661,3648,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (non-esterified fatty acids), fasting",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.24,,,percentRoot,,205,Pearson,0.3,,,< 0.01,Yes,,,,Biong 2006
3379,3661,3649,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (triglycerides), fasting",GC-FID,Myristic acid (14:0),"",1.87,,,percentRoot,,205,Pearson,0.18,,,< 0.01,Yes,,,,Biong 2006
3380,3661,3650,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (triglycerides), fasting",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.09,,,percentRoot,,205,Spearman,0.27,,,< 0.01,Yes,,,,Biong 2006
3381,3661,3651,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (triglycerides), fasting",GC-FID,Pentadecylic acid (15:0),"",0.34,,,percentRoot,,205,Pearson,0.45,,,< 0.01,Yes,,,,Biong 2006
3382,3661,3652,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (triglycerides), fasting",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.27,,,percentRoot,,205,Pearson,0.35,,,< 0.01,Yes,,,,Biong 2006
3383,3661,3653,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,Myristic acid (14:0),"",0.81,,,percentRoot,,202,Pearson,0.21,,,< 0.01,Yes,,,,Biong 2006
3384,3661,3654,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.02,,,percentRoot,,202,Spearman,0.19,,,< 0.01,Yes,,,,Biong 2006
3385,3661,3655,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,Pentadecylic acid (15:0),"",0.23,,,percentRoot,,202,Spearman,0.42,,,< 0.01,Yes,,,,Biong 2006
3386,3661,3656,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.23,,,percentRoot,,202,Spearman,0.23,,,< 0.05,Yes,,,,Biong 2006
3387,3661,3657,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",0.48,,,percentRoot,,190,Spearman,0.05,,,>= 0.05,No,,,,Biong 2006
3388,3661,3658,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.29,,,percentRoot,,190,Spearman,0.22,,,< 0.01,Yes,,,,Biong 2006
3389,3661,3659,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",0.84,,,percentRoot,,190,Spearman,0.1,,,>= 0.05,No,,,,Biong 2006
3390,3661,3660,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.17,,,percentRoot,,190,Spearman,0.05,,,>= 0.05,No,,,,Biong 2006
3391,3662,3639,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Cheese,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Myristic acid (14:0),"",3.6,,,percentRoot,,197,Pearson,0.24,,,< 0.01,Yes,,,,Biong 2006
3392,3662,3640,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Cheese,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.55,,,percentRoot,,197,Pearson,0.23,,,< 0.01,Yes,,,,Biong 2006
3393,3662,3641,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Cheese,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.39,,,percentRoot,,197,Pearson,0.26,,,< 0.01,Yes,,,,Biong 2006
3394,3662,3642,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Cheese,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.27,,,percentRoot,,197,Pearson,0.1,,,>= 0.05,No,,,,Biong 2006
3395,3662,3643,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Cheese,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.36,,,percentRoot,,197,Pearson,0.2,,,< 0.01,Yes,,,,Biong 2006
3396,3662,3644,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Cheese,"",,,,,percentRoot,,,"Serum (non-esterified fatty acids), fasting",GC-FID,Myristic acid (14:0),"",2.1,,,percentRoot,,205,Pearson,0.08,,,>= 0.05,No,,,,Biong 2006
3397,3662,3645,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Cheese,"",,,,,percentRoot,,,"Serum (non-esterified fatty acids), fasting",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.13,,,percentRoot,,205,Spearman,0.33,,,< 0.01,Yes,,,,Biong 2006
3398,3662,3646,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Cheese,"",,,,,percentRoot,,,"Serum (non-esterified fatty acids), fasting",GC-FID,Pentadecylic acid (15:0),"",0.37,,,percentRoot,,205,Pearson,-0.01,,,>= 0.05,No,,,,Biong 2006
3399,3662,3648,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Cheese,"",,,,,percentRoot,,,"Serum (non-esterified fatty acids), fasting",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.24,,,percentRoot,,205,Pearson,0.22,,,>= 0.05,No,,,,Biong 2006
3400,3662,3649,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Cheese,"",,,,,percentRoot,,,"Serum (triglycerides), fasting",GC-FID,Myristic acid (14:0),"",1.87,,,percentRoot,,205,Pearson,0.08,,,>= 0.05,No,,,,Biong 2006
3401,3662,3650,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Cheese,"",,,,,percentRoot,,,"Serum (triglycerides), fasting",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.09,,,percentRoot,,205,Spearman,0.12,,,>= 0.05,No,,,,Biong 2006
3402,3662,3651,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Cheese,"",,,,,percentRoot,,,"Serum (triglycerides), fasting",GC-FID,Pentadecylic acid (15:0),"",0.34,,,percentRoot,,205,Pearson,0.19,,,< 0.01,Yes,,,,Biong 2006
3403,3662,3652,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Cheese,"",,,,,percentRoot,,,"Serum (triglycerides), fasting",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.27,,,percentRoot,,205,Pearson,0.23,,,< 0.01,Yes,,,,Biong 2006
3404,3662,3653,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Cheese,"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,Myristic acid (14:0),"",0.81,,,percentRoot,,202,Pearson,0.12,,,>= 0.05,No,,,,Biong 2006
3405,3662,3654,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Cheese,"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.02,,,percentRoot,,202,Spearman,0.09,,,>= 0.05,No,,,,Biong 2006
3406,3662,3655,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Cheese,"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,Pentadecylic acid (15:0),"",0.23,,,percentRoot,,202,Spearman,0.28,,,< 0.01,Yes,,,,Biong 2006
3407,3662,3656,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Cheese,"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.23,,,percentRoot,,202,Spearman,0.1,,,>= 0.05,No,,,,Biong 2006
3408,3662,3657,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Cheese,"",,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",0.48,,,percentRoot,,190,Spearman,0.04,,,>= 0.05,No,,,,Biong 2006
3409,3662,3658,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Cheese,"",,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,cis-Tetradecenoic acids (cis-14:1),"",0.29,,,percentRoot,,190,Spearman,0.12,,,>= 0.05,No,,,,Biong 2006
3410,3662,3659,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Cheese,"",,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",0.84,,,percentRoot,,190,Spearman,0.12,,,>= 0.05,No,,,,Biong 2006
3411,3662,3660,All,Cases and controls in a case-control study on myocardial infarction,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Cheese,"",,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,cis-Heptadecenoic acids (cis-17:1),"",0.17,,,percentRoot,,190,Spearman,0.1,,,>= 0.05,No,,,,Biong 2006
3496,3663,3667,All,Staff and students from the University of Wollongong,Australia,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,259.0,,212.0,mg/day,,,"Red blood cell membrane, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),6.57,,,percentRoot,,53,Spearman,0.5,,,< 0.001,Yes,,,,Sullivan 2006
3500,3663,3671,All,Staff and students from the University of Wollongong,Australia,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,259.0,,212.0,mg/day,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),3.35,,,percentRoot,,53,Spearman,0.54,,,< 0.001,Yes,,,,Sullivan 2006
3497,3664,3668,All,Staff and students from the University of Wollongong,Australia,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,73.0,,58.0,mg/day,,,"Red blood cell membrane, fasting",GC-FID,EPA (cis-20:5n-3),"",0.43,,,percentRoot,,53,Spearman,0.4,,,< 0.01,Yes,,,,Sullivan 2006
3501,3664,3672,All,Staff and students from the University of Wollongong,Australia,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,73.0,,58.0,mg/day,,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",0.84,,,percentRoot,,53,Spearman,0.54,,,< 0.001,Yes,,,,Sullivan 2006
3498,3665,3669,All,Staff and students from the University of Wollongong,Australia,,,Food Frequency Questionnaire (FFQ),DPA (cis-22:5n-3),"",,52.0,,48.0,mg/day,,,"Red blood cell membrane, fasting",GC-FID,DPA (cis-22:5n-3),"",2.08,,,percentRoot,,53,Spearman,0.05,,,>= 0.05,No,,,,Sullivan 2006
3502,3665,3673,All,Staff and students from the University of Wollongong,Australia,,,Food Frequency Questionnaire (FFQ),DPA (cis-22:5n-3),"",,52.0,,48.0,mg/day,,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.48,,,percentRoot,,53,Spearman,0.09,,,>= 0.05,No,,,,Sullivan 2006
3499,3666,3670,All,Staff and students from the University of Wollongong,Australia,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,134.0,,108.0,mg/day,,,"Red blood cell membrane, fasting",GC-FID,DHA (cis-22:6n-3),"",4.06,,,percentRoot,,53,Spearman,0.39,,,< 0.01,Yes,,,,Sullivan 2006
3503,3666,3674,All,Staff and students from the University of Wollongong,Australia,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,134.0,,108.0,mg/day,,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",2.02,,,percentRoot,,53,Spearman,0.48,,,< 0.001,Yes,,,,Sullivan 2006
3504,3693,3724,All [by supplement],Pregnant women participant in the dietary validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Iodine,"",Yes,,,140.0,ug/day,,,"Urine, 24-h",Mass spectrometry (MS),Iodine,"",,,,ug/day,,84,Spearman,0.42,0.26,0.56,< 0.01,Yes,,,,Brantsaeter 2009
3507,3702,3724,All [by supplement],Pregnant women participant in the dietary validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Iodine,"",Yes,,,130.0,ug/day,,,"Urine, 24-h",Mass spectrometry (MS),Iodine,"",,,,ug/day,,84,Spearman,0.52,0.38,0.64,< 0.01,Yes,,,,Brantsaeter 2009
3505,8092,3675,Iodine supplement nonusers,Pregnant women participant in the dietary validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Milk,Milk,,,,,g/day,,,"Urine, 24-h",Mass spectrometry (MS),Iodine,"",146.0,,118.0,ug/day,,84,Spearman,0.32,0.11,0.5,< 0.01,Yes,,,,Brantsaeter 2009
3506,8094,3675,Iodine supplement nonusers,Pregnant women participant in the dietary validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Dairy foods,Cheese + Yoghurt + Butter + Milk,,,,,g/day,,,"Urine, 24-h",Mass spectrometry (MS),Iodine,"",146.0,,118.0,ug/day,,84,Spearman,0.34,0.14,0.52,< 0.01,Yes,,,,Brantsaeter 2009
3508,8093,3675,Iodine supplement nonusers,Pregnant women participant in the dietary validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Milk,Milk,,,,,g/day,,,"Urine, 24-h",Mass spectrometry (MS),Iodine,"",146.0,,118.0,ug/day,,84,Spearman,0.41,0.21,0.57,< 0.01,Yes,,,,Brantsaeter 2009
3509,8095,3675,Iodine supplement nonusers,Pregnant women participant in the dietary validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Dairy foods,Cheese + Yoghurt + Butter + Milk,,,,,g/day,,,"Urine, 24-h",Mass spectrometry (MS),Iodine,"",146.0,,118.0,ug/day,,84,Spearman,0.48,0.3,0.63,< 0.01,Yes,,,,Brantsaeter 2009
3510,3805,3789,All [by intake from Mediterranean Diet Index (MDI)],Adults from Catalonia,Spain,ENCAT (Evaluations of Nutritional Status in Catalonia),,24-h Dietary recall (1-day),Mediterranean diet (MDI),"",,,,,% diet adherence,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,326,Pearson,0.141,,,= 0.044,Yes,,,"Energy, Age, Sex",Bach-Faig 2006
3512,3805,3791,All [by intake from Mediterranean Diet Index (MDI)],Adults from Catalonia,Spain,ENCAT (Evaluations of Nutritional Status in Catalonia),,24-h Dietary recall (1-day),Mediterranean diet (MDI),"",,,,,% diet adherence,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,326,Pearson,0.09,,,= 0.225,No,,,"Energy, Age, Sex",Bach-Faig 2006
3514,3805,3793,All [by intake from Mediterranean Diet Index (MDI)],Adults from Catalonia,Spain,ENCAT (Evaluations of Nutritional Status in Catalonia),,24-h Dietary recall (1-day),Mediterranean diet (MDI),"",,,,,% diet adherence,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,326,Pearson,0.035,,,= 0.644,No,"Cholesterol, Triglycerides",,"Energy, Age, Sex",Bach-Faig 2006
3516,3805,3795,All [by intake from Mediterranean Diet Index (MDI)],Adults from Catalonia,Spain,ENCAT (Evaluations of Nutritional Status in Catalonia),,24-h Dietary recall (1-day),Mediterranean diet (MDI),"",,,,,% diet adherence,,,"Serum, fasting",HPLC,Retinol,"",,,,umol/L,,326,Pearson,0.025,,,= 0.124,No,,,"Energy, Age, Sex",Bach-Faig 2006
3518,3805,3797,All [by intake from Mediterranean Diet Index (MDI)],Adults from Catalonia,Spain,ENCAT (Evaluations of Nutritional Status in Catalonia),,24-h Dietary recall (1-day),Mediterranean diet (MDI),"",,,,,% diet adherence,,,"Serum, fasting",HPLC,Retinol,"",,,,umol/L,,326,Pearson,-0.038,,,= 0.66,No,"Cholesterol, Triglycerides",,"Energy, Age, Sex",Bach-Faig 2006
3520,3805,3799,All [by intake from Mediterranean Diet Index (MDI)],Adults from Catalonia,Spain,ENCAT (Evaluations of Nutritional Status in Catalonia),,24-h Dietary recall (1-day),Mediterranean diet (MDI),"",,,,,% diet adherence,,,"Serum, fasting",Colorimetry,Vitamin C,"",,,,mg/L,,326,Pearson,0.095,,,= 0.047,Yes,,,"Energy, Age, Sex",Bach-Faig 2006
3522,3805,3801,All [by intake from Mediterranean Diet Index (MDI)],Adults from Catalonia,Spain,ENCAT (Evaluations of Nutritional Status in Catalonia),,24-h Dietary recall (1-day),Mediterranean diet (MDI),"",,,,,% diet adherence,,,"Serum, fasting",Radioimmunoassay (RIA),Vitamin B12,"",,,,pg/mL,,326,Pearson,0.05,,,= 0.722,No,,,"Energy, Age, Sex",Bach-Faig 2006
3524,3805,3803,All [by intake from Mediterranean Diet Index (MDI)],Adults from Catalonia,Spain,ENCAT (Evaluations of Nutritional Status in Catalonia),,24-h Dietary recall (1-day),Mediterranean diet (MDI),"",,,,,% diet adherence,,,"Serum, fasting",Radioimmunoassay (RIA),Folates,"",,,,ng/mL,,326,Pearson,0.18,,,= 0.001,Yes,,,"Energy, Age, Sex",Bach-Faig 2006
3511,3806,3790,All [by intake from Mediterranean Diet Score (MDS)],Adults from Catalonia,Spain,ENCAT (Evaluations of Nutritional Status in Catalonia),,24-h Dietary recall (1-day),Mediterranean diet (MDS),"",,,,,% diet adherence,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,326,Pearson,0.153,,,= 0.006,Yes,,,"Energy, Age",Bach-Faig 2006
3513,3806,3792,All [by intake from Mediterranean Diet Score (MDS)],Adults from Catalonia,Spain,ENCAT (Evaluations of Nutritional Status in Catalonia),,24-h Dietary recall (1-day),Mediterranean diet (MDS),"",,,,,% diet adherence,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,326,Pearson,0.055,,,= 0.327,No,,,"Energy, Age",Bach-Faig 2006
3515,3806,3794,All [by intake from Mediterranean Diet Score (MDS)],Adults from Catalonia,Spain,ENCAT (Evaluations of Nutritional Status in Catalonia),,24-h Dietary recall (1-day),Mediterranean diet (MDS),"",,,,,% diet adherence,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,326,Pearson,0.115,,,= 0.039,Yes,"Cholesterol, Triglycerides",,"Energy, Age",Bach-Faig 2006
3517,3806,3796,All [by intake from Mediterranean Diet Score (MDS)],Adults from Catalonia,Spain,ENCAT (Evaluations of Nutritional Status in Catalonia),,24-h Dietary recall (1-day),Mediterranean diet (MDS),"",,,,,% diet adherence,,,"Serum, fasting",HPLC,Retinol,"",,,,umol/L,,326,Pearson,0.073,,,= 0.188,No,,,"Energy, Age",Bach-Faig 2006
3519,3806,3798,All [by intake from Mediterranean Diet Score (MDS)],Adults from Catalonia,Spain,ENCAT (Evaluations of Nutritional Status in Catalonia),,24-h Dietary recall (1-day),Mediterranean diet (MDS),"",,,,,% diet adherence,,,"Serum, fasting",HPLC,Retinol,"",,,,umol/L,,326,Pearson,0.108,,,= 0.052,No,"Cholesterol, Triglycerides",,"Energy, Age",Bach-Faig 2006
3521,3806,3800,All [by intake from Mediterranean Diet Score (MDS)],Adults from Catalonia,Spain,ENCAT (Evaluations of Nutritional Status in Catalonia),,24-h Dietary recall (1-day),Mediterranean diet (MDS),"",,,,,% diet adherence,,,"Serum, fasting",Colorimetry,Vitamin C,"",,,,mg/L,,326,Pearson,0.152,,,= 0.006,Yes,,,"Energy, Age",Bach-Faig 2006
3523,3806,3802,All [by intake from Mediterranean Diet Score (MDS)],Adults from Catalonia,Spain,ENCAT (Evaluations of Nutritional Status in Catalonia),,24-h Dietary recall (1-day),Mediterranean diet (MDS),"",,,,,% diet adherence,,,"Serum, fasting",Radioimmunoassay (RIA),Vitamin B12,"",,,,pg/mL,,326,Pearson,-0.025,,,= 0.648,No,,,"Energy, Age",Bach-Faig 2006
3525,3806,3804,All [by intake from Mediterranean Diet Score (MDS)],Adults from Catalonia,Spain,ENCAT (Evaluations of Nutritional Status in Catalonia),,24-h Dietary recall (1-day),Mediterranean diet (MDS),"",,,,,% diet adherence,,,"Serum, fasting",Radioimmunoassay (RIA),Folates,"",,,,ng/mL,,326,Pearson,0.164,,,= 0.003,Yes,,,"Energy, Age",Bach-Faig 2006
3526,3813,3810,Males,Adults living in mainland Britain,United Kingdom,NDNS (National Diet and Nutrition Survey),,Weighed Dietary record (7-day),Phylloquinone,"",,,,,ug/day,,,"Plasma, non-fasting",HPLC,Phylloquinone,"",1.8,1.13,1.08,nmol/L,,530,Pearson,0.26,,,< 0.001,Yes,,,,Thane 2006
3528,3813,3810,Males,Adults living in mainland Britain,United Kingdom,NDNS (National Diet and Nutrition Survey),,Weighed Dietary record (7-day),Phylloquinone,"",,,,,ug/day,,,"Plasma, non-fasting",HPLC,Phylloquinone,"",1.8,1.13,1.08,nmol/L,,530,Pearson,0.24,,,< 0.001,Yes,,,Age,Thane 2006
3530,3815,3810,Males,Adults living in mainland Britain,United Kingdom,NDNS (National Diet and Nutrition Survey),,Weighed Dietary record (7-day),Phylloquinone,"",,,,,ug/day,,,"Plasma, non-fasting",HPLC,Phylloquinone,"",1.8,1.13,1.08,nmol/L,,270,Pearson,0.3,,,< 0.001,Yes,,,Age ?,Thane 2006
3527,3814,3812,Females,Adults living in mainland Britain,United Kingdom,NDNS (National Diet and Nutrition Survey),,Weighed Dietary record (7-day),Phylloquinone,"",,,,,ug/day,,,"Plasma, non-fasting",HPLC,Phylloquinone,"",1.5,0.81,0.83,nmol/L,,624,Pearson,0.32,,,< 0.001,Yes,,,,Thane 2006
3529,3814,3812,Females,Adults living in mainland Britain,United Kingdom,NDNS (National Diet and Nutrition Survey),,Weighed Dietary record (7-day),Phylloquinone,"",,,,,ug/day,,,"Plasma, non-fasting",HPLC,Phylloquinone,"",1.5,0.81,0.83,nmol/L,,624,Pearson,0.27,,,< 0.001,Yes,,,Age,Thane 2006
3531,3816,3812,Females,Adults living in mainland Britain,United Kingdom,NDNS (National Diet and Nutrition Survey),,Weighed Dietary record (7-day),Phylloquinone,"",,,,,ug/day,,,"Plasma, non-fasting",HPLC,Phylloquinone,"",1.5,0.81,0.83,nmol/L,,306,Pearson,0.13,,,= 0.02,Yes,,,Age ?,Thane 2006
3534,3820,3837,All,Volunteers from the Human Nutrition Unit volunteer databank at the Institute of Food Research in Norwich,United Kingdom,,,Food Frequency Questionnaire (FFQ),Quercetin,"",,29.0,,,mg/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Quercetin,"",60.1,,,ug/day,,49,Unspecified,0.827,0.712,0.899,< 0.0001,Yes,,,,Ranka 2008
3535,3821,3838,All,Volunteers from the Human Nutrition Unit volunteer databank at the Institute of Food Research in Norwich,United Kingdom,,,Food Frequency Questionnaire (FFQ),Naringenin,"",,56.0,,,mg/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Naringenin,"",0.56,,,mg/day,,49,Unspecified,0.251,-0.032,0.497,< 0.05,Yes,,,,Ranka 2008
3538,3853,3839,Males,Adults,United States,,,Diet History Questionnaire (DHQ),alpha-Carotene,"",No,,425.0,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,0.07,,umol/L,,44,Spearman,0.56,,,< 0.001,Yes,,,,Dixon 2006
3549,3853,3839,Males,Adults,United States,,,Diet History Questionnaire (DHQ),alpha-Carotene,"",No,,425.0,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,0.07,,umol/L,,44,Spearman,0.56,,,< 0.001,Yes,,,Energy,Dixon 2006
3560,3853,3839,Males,Adults,United States,,,Diet History Questionnaire (DHQ),alpha-Carotene,"",No,,425.0,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,0.07,,umol/L,,44,Spearman,0.52,,,< 0.001,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3539,3854,3840,Males,Adults,United States,,,Diet History Questionnaire (DHQ),beta-Carotene,"",No,,2452.0,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,0.21,,umol/L,,44,Spearman,0.27,,,>= 0.05,No,,,,Dixon 2006
3550,3854,3840,Males,Adults,United States,,,Diet History Questionnaire (DHQ),beta-Carotene,"",No,,2452.0,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,0.21,,umol/L,,44,Spearman,0.25,,,>= 0.05,No,,,Energy,Dixon 2006
3561,3854,3840,Males,Adults,United States,,,Diet History Questionnaire (DHQ),beta-Carotene,"",No,,2452.0,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,0.21,,umol/L,,44,Spearman,0.16,,,>= 0.05,No,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3540,3855,3841,Males,Adults,United States,,,Diet History Questionnaire (DHQ),beta-Cryptoxanthin,"",No,,129.0,,ug/day,,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",,0.09,,umol/L,,44,Spearman,0.62,,,< 0.001,Yes,,,,Dixon 2006
3551,3855,3841,Males,Adults,United States,,,Diet History Questionnaire (DHQ),beta-Cryptoxanthin,"",No,,129.0,,ug/day,,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",,0.09,,umol/L,,44,Spearman,0.62,,,< 0.001,Yes,,,Energy,Dixon 2006
3562,3855,3841,Males,Adults,United States,,,Diet History Questionnaire (DHQ),beta-Cryptoxanthin,"",No,,129.0,,ug/day,,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",,0.09,,umol/L,,44,Spearman,0.62,,,< 0.001,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3541,3856,3893,Males,Adults,United States,,,Diet History Questionnaire (DHQ),Lutein/Zeaxanthin,"",No,,2068.0,,ug/day,,,"Serum, fasting",HPLC,Lutein,"",,,,umol/L,,44,Spearman,0.17,,,>= 0.05,No,,,,Dixon 2006
3552,3856,3893,Males,Adults,United States,,,Diet History Questionnaire (DHQ),Lutein/Zeaxanthin,"",No,,2068.0,,ug/day,,,"Serum, fasting",HPLC,Lutein,"",,,,umol/L,,44,Spearman,0.24,,,>= 0.05,No,,,Energy,Dixon 2006
3563,3856,3893,Males,Adults,United States,,,Diet History Questionnaire (DHQ),Lutein/Zeaxanthin,"",No,,2068.0,,ug/day,,,"Serum, fasting",HPLC,Lutein,"",,,,umol/L,,44,Spearman,0.35,,,< 0.01,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3542,3857,3843,Males,Adults,United States,,,Diet History Questionnaire (DHQ),Lycopene,"",No,,6762.0,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",,0.67,,umol/L,,44,Spearman,0.42,,,< 0.01,Yes,,,,Dixon 2006
3553,3857,3843,Males,Adults,United States,,,Diet History Questionnaire (DHQ),Lycopene,"",No,,6762.0,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",,0.67,,umol/L,,44,Spearman,0.42,,,< 0.01,Yes,,,Energy,Dixon 2006
3564,3857,3843,Males,Adults,United States,,,Diet History Questionnaire (DHQ),Lycopene,"",No,,6762.0,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",,0.67,,umol/L,,44,Spearman,0.43,,,< 0.01,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3543,3859,3839,Males,Adults,United States,,,Diet History Questionnaire (DHQ),Vitamin A (beta-Carotene Equivalents),"",Yes,,3077.0,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,0.07,,umol/L,,44,Spearman,0.42,,,< 0.01,Yes,,,,Dixon 2006
3544,3859,3840,Males,Adults,United States,,,Diet History Questionnaire (DHQ),Vitamin A (beta-Carotene Equivalents),"",Yes,,3077.0,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,0.21,,umol/L,,44,Spearman,0.3,,,>= 0.05,No,,,,Dixon 2006
3554,3859,3839,Males,Adults,United States,,,Diet History Questionnaire (DHQ),Vitamin A (beta-Carotene Equivalents),"",Yes,,3077.0,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,0.07,,umol/L,,44,Spearman,0.41,,,< 0.01,Yes,,,Energy,Dixon 2006
3555,3859,3840,Males,Adults,United States,,,Diet History Questionnaire (DHQ),Vitamin A (beta-Carotene Equivalents),"",Yes,,3077.0,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,0.21,,umol/L,,44,Spearman,0.28,,,>= 0.05,No,,,Energy,Dixon 2006
3565,3859,3839,Males,Adults,United States,,,Diet History Questionnaire (DHQ),Vitamin A (beta-Carotene Equivalents),"",Yes,,3077.0,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,0.07,,umol/L,,44,Spearman,0.37,,,< 0.05,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3566,3859,3840,Males,Adults,United States,,,Diet History Questionnaire (DHQ),Vitamin A (beta-Carotene Equivalents),"",Yes,,3077.0,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,0.21,,umol/L,,44,Spearman,0.21,,,>= 0.05,No,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3545,3860,3844,Males,Adults,United States,,,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",No,,7.7,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,25.1,,umol/L,,44,Spearman,0.11,,,>= 0.05,No,,,,Dixon 2006
3556,3860,3844,Males,Adults,United States,,,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",No,,7.7,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,25.1,,umol/L,,44,Spearman,0.24,,,>= 0.05,No,,,Energy,Dixon 2006
3567,3860,3844,Males,Adults,United States,,,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",No,,7.7,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,25.1,,umol/L,,44,Spearman,0.48,,,< 0.01,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3546,3861,3845,Males,Adults,United States,,,Diet History Questionnaire (DHQ),gamma-Tocopherol,"",No,,13.8,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",,3.7,,umol/L,,44,Spearman,-0.13,,,>= 0.05,No,,,,Dixon 2006
3557,3861,3845,Males,Adults,United States,,,Diet History Questionnaire (DHQ),gamma-Tocopherol,"",No,,13.8,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",,3.7,,umol/L,,44,Spearman,0.02,,,>= 0.05,No,,,Energy,Dixon 2006
3568,3861,3845,Males,Adults,United States,,,Diet History Questionnaire (DHQ),gamma-Tocopherol,"",No,,13.8,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",,3.7,,umol/L,,44,Spearman,0.09,,,>= 0.05,No,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3547,3862,3844,Males,Adults,United States,,,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",Yes,,20.0,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,25.1,,umol/L,,44,Spearman,0.64,,,< 0.001,Yes,,,,Dixon 2006
3548,3862,3845,Males,Adults,United States,,,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",Yes,,20.0,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",,3.7,,umol/L,,44,Spearman,-0.65,,,< 0.001,Yes,,,,Dixon 2006
3558,3862,3844,Males,Adults,United States,,,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",Yes,,20.0,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,25.1,,umol/L,,44,Spearman,0.68,,,< 0.001,Yes,,,Energy,Dixon 2006
3559,3862,3845,Males,Adults,United States,,,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",Yes,,20.0,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",,3.7,,umol/L,,44,Spearman,-0.65,,,< 0.001,Yes,,,Energy,Dixon 2006
3569,3862,3844,Males,Adults,United States,,,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",Yes,,20.0,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,25.1,,umol/L,,44,Spearman,0.72,,,< 0.001,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3570,3862,3845,Males,Adults,United States,,,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",Yes,,20.0,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",,3.7,,umol/L,,44,Spearman,-0.69,,,< 0.001,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3571,3863,3839,Males,Adults,United States,,,24-h Dietary recall (1-day),alpha-Carotene,"",No,,209.0,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,0.07,,umol/L,,44,Spearman,0.45,,,< 0.01,Yes,,,,Dixon 2006
3582,3863,3839,Males,Adults,United States,,,24-h Dietary recall (1-day),alpha-Carotene,"",No,,209.0,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,0.07,,umol/L,,44,Spearman,0.45,,,< 0.01,Yes,,,Energy,Dixon 2006
3593,3863,3839,Males,Adults,United States,,,24-h Dietary recall (1-day),alpha-Carotene,"",No,,209.0,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,0.07,,umol/L,,44,Spearman,0.49,,,< 0.01,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3572,3864,3840,Males,Adults,United States,,,24-h Dietary recall (1-day),beta-Carotene,"",No,,2049.0,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,0.21,,umol/L,,44,Spearman,0.4,,,< 0.001,Yes,,,,Dixon 2006
3583,3864,3840,Males,Adults,United States,,,24-h Dietary recall (1-day),beta-Carotene,"",No,,2049.0,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,0.21,,umol/L,,44,Spearman,0.39,,,< 0.05,Yes,,,Energy,Dixon 2006
3594,3864,3840,Males,Adults,United States,,,24-h Dietary recall (1-day),beta-Carotene,"",No,,2049.0,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,0.21,,umol/L,,44,Spearman,0.4,,,< 0.05,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3573,3865,3841,Males,Adults,United States,,,24-h Dietary recall (1-day),beta-Cryptoxanthin,"",No,,95.0,,ug/day,,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",,0.09,,umol/L,,44,Spearman,0.5,,,< 0.001,Yes,,,,Dixon 2006
3584,3865,3841,Males,Adults,United States,,,24-h Dietary recall (1-day),beta-Cryptoxanthin,"",No,,95.0,,ug/day,,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",,0.09,,umol/L,,44,Spearman,0.53,,,< 0.001,Yes,,,Energy,Dixon 2006
3595,3865,3841,Males,Adults,United States,,,24-h Dietary recall (1-day),beta-Cryptoxanthin,"",No,,95.0,,ug/day,,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",,0.09,,umol/L,,44,Spearman,0.44,,,< 0.01,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3574,3866,3893,Males,Adults,United States,,,24-h Dietary recall (1-day),Lutein/Zeaxanthin,"",No,,1616.0,,ug/day,,,"Serum, fasting",HPLC,Lutein,"",,,,umol/L,,44,Spearman,0.08,,,>= 0.05,No,,,,Dixon 2006
3585,3866,3893,Males,Adults,United States,,,24-h Dietary recall (1-day),Lutein/Zeaxanthin,"",No,,1616.0,,ug/day,,,"Serum, fasting",HPLC,Lutein,"",,,,umol/L,,44,Spearman,0.14,,,>= 0.05,No,,,Energy,Dixon 2006
3596,3866,3893,Males,Adults,United States,,,24-h Dietary recall (1-day),Lutein/Zeaxanthin,"",No,,1616.0,,ug/day,,,"Serum, fasting",HPLC,Lutein,"",,,,umol/L,,44,Spearman,0.15,,,>= 0.05,No,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3575,3867,3843,Males,Adults,United States,,,24-h Dietary recall (1-day),Lycopene,"",No,,7658.0,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",,0.67,,umol/L,,44,Spearman,0.47,,,< 0.01,Yes,,,,Dixon 2006
3586,3867,3843,Males,Adults,United States,,,24-h Dietary recall (1-day),Lycopene,"",No,,7658.0,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",,0.67,,umol/L,,44,Spearman,0.5,,,< 0.001,Yes,,,Energy,Dixon 2006
3597,3867,3843,Males,Adults,United States,,,24-h Dietary recall (1-day),Lycopene,"",No,,7658.0,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",,0.67,,umol/L,,44,Spearman,0.45,,,< 0.01,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3576,3869,3839,Males,Adults,United States,,,24-h Dietary recall (1-day),Vitamin A (beta-Carotene Equivalents),"",Yes,,2569.0,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,0.07,,umol/L,,44,Spearman,0.47,,,< 0.01,Yes,,,,Dixon 2006
3577,3869,3840,Males,Adults,United States,,,24-h Dietary recall (1-day),Vitamin A (beta-Carotene Equivalents),"",Yes,,2569.0,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,0.21,,umol/L,,44,Spearman,0.47,,,< 0.01,Yes,,,,Dixon 2006
3587,3869,3839,Males,Adults,United States,,,24-h Dietary recall (1-day),Vitamin A (beta-Carotene Equivalents),"",Yes,,2569.0,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,0.07,,umol/L,,44,Spearman,0.46,,,< 0.01,Yes,,,Energy,Dixon 2006
3588,3869,3840,Males,Adults,United States,,,24-h Dietary recall (1-day),Vitamin A (beta-Carotene Equivalents),"",Yes,,2569.0,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,0.21,,umol/L,,44,Spearman,0.46,,,< 0.01,Yes,,,Energy,Dixon 2006
3598,3869,3839,Males,Adults,United States,,,24-h Dietary recall (1-day),Vitamin A (beta-Carotene Equivalents),"",Yes,,2569.0,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,0.07,,umol/L,,44,Spearman,0.48,,,< 0.01,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3599,3869,3840,Males,Adults,United States,,,24-h Dietary recall (1-day),Vitamin A (beta-Carotene Equivalents),"",Yes,,2569.0,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,0.21,,umol/L,,44,Spearman,0.46,,,< 0.01,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3578,3870,3844,Males,Adults,United States,,,24-h Dietary recall (1-day),alpha-Tocopherol,"",No,,8.9,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,25.1,,umol/L,,44,Spearman,0.11,,,>= 0.05,No,,,,Dixon 2006
3589,3870,3844,Males,Adults,United States,,,24-h Dietary recall (1-day),alpha-Tocopherol,"",No,,8.9,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,25.1,,umol/L,,44,Spearman,0.36,,,< 0.05,Yes,,,Energy,Dixon 2006
3600,3870,3844,Males,Adults,United States,,,24-h Dietary recall (1-day),alpha-Tocopherol,"",No,,8.9,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,25.1,,umol/L,,44,Spearman,0.43,,,< 0.01,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3579,3871,3845,Males,Adults,United States,,,24-h Dietary recall (1-day),gamma-Tocopherol,"",No,,18.9,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",,3.7,,umol/L,,44,Spearman,-0.12,,,>= 0.05,No,,,,Dixon 2006
3590,3871,3845,Males,Adults,United States,,,24-h Dietary recall (1-day),gamma-Tocopherol,"",No,,18.9,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",,3.7,,umol/L,,44,Spearman,0.13,,,>= 0.05,No,,,Energy,Dixon 2006
3601,3871,3845,Males,Adults,United States,,,24-h Dietary recall (1-day),gamma-Tocopherol,"",No,,18.9,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",,3.7,,umol/L,,44,Spearman,0.14,,,>= 0.05,No,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3580,3872,3844,Males,Adults,United States,,,24-h Dietary recall (1-day),alpha-Tocopherol,"",Yes,,27.0,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,25.1,,umol/L,,44,Spearman,0.6,,,< 0.001,Yes,,,,Dixon 2006
3581,3872,3845,Males,Adults,United States,,,24-h Dietary recall (1-day),alpha-Tocopherol,"",Yes,,27.0,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",,3.7,,umol/L,,44,Spearman,-0.61,,,< 0.001,Yes,,,,Dixon 2006
3591,3872,3844,Males,Adults,United States,,,24-h Dietary recall (1-day),alpha-Tocopherol,"",Yes,,27.0,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,25.1,,umol/L,,44,Spearman,0.69,,,< 0.001,Yes,,,Energy,Dixon 2006
3592,3872,3845,Males,Adults,United States,,,24-h Dietary recall (1-day),alpha-Tocopherol,"",Yes,,27.0,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",,3.7,,umol/L,,44,Spearman,-0.57,,,< 0.001,Yes,,,Energy,Dixon 2006
3602,3872,3844,Males,Adults,United States,,,24-h Dietary recall (1-day),alpha-Tocopherol,"",Yes,,27.0,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,25.1,,umol/L,,44,Spearman,0.66,,,< 0.001,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3603,3872,3845,Males,Adults,United States,,,24-h Dietary recall (1-day),alpha-Tocopherol,"",Yes,,27.0,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",,3.7,,umol/L,,44,Spearman,-0.71,,,< 0.001,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3604,3873,3846,Females,Adults,United States,,,Diet History Questionnaire (DHQ),alpha-Carotene,"",No,,526.0,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,0.1,,umol/L,,86,Spearman,0.39,,,< 0.001,Yes,,,,Dixon 2006
3615,3873,3846,Females,Adults,United States,,,Diet History Questionnaire (DHQ),alpha-Carotene,"",No,,526.0,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,0.1,,umol/L,,86,Spearman,0.39,,,< 0.001,Yes,,,Energy,Dixon 2006
3626,3873,3846,Females,Adults,United States,,,Diet History Questionnaire (DHQ),alpha-Carotene,"",No,,526.0,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,0.1,,umol/L,,86,Spearman,0.44,,,< 0.001,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3605,3874,3847,Females,Adults,United States,,,Diet History Questionnaire (DHQ),beta-Carotene,"",No,,2683.0,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,0.26,,umol/L,,86,Spearman,0.24,,,< 0.05,Yes,,,,Dixon 2006
3616,3874,3847,Females,Adults,United States,,,Diet History Questionnaire (DHQ),beta-Carotene,"",No,,2683.0,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,0.26,,umol/L,,86,Spearman,0.24,,,< 0.05,Yes,,,Energy,Dixon 2006
3627,3874,3847,Females,Adults,United States,,,Diet History Questionnaire (DHQ),beta-Carotene,"",No,,2683.0,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,0.26,,umol/L,,86,Spearman,0.31,,,< 0.01,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3606,3875,3848,Females,Adults,United States,,,Diet History Questionnaire (DHQ),beta-Cryptoxanthin,"",No,,130.0,,ug/day,,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",,0.09,,umol/L,,86,Spearman,0.38,,,< 0.001,Yes,,,,Dixon 2006
3617,3875,3848,Females,Adults,United States,,,Diet History Questionnaire (DHQ),beta-Cryptoxanthin,"",No,,130.0,,ug/day,,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",,0.09,,umol/L,,86,Spearman,0.37,,,< 0.001,Yes,,,Energy,Dixon 2006
3628,3875,3848,Females,Adults,United States,,,Diet History Questionnaire (DHQ),beta-Cryptoxanthin,"",No,,130.0,,ug/day,,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",,0.09,,umol/L,,86,Spearman,0.44,,,< 0.001,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3607,3876,3894,Females,Adults,United States,,,Diet History Questionnaire (DHQ),Lutein/Zeaxanthin,"",No,,2119.0,,ug/day,,,"Serum, fasting",HPLC,Lutein,"",,,,umol/L,,86,Spearman,0.15,,,>= 0.05,No,,,,Dixon 2006
3618,3876,3894,Females,Adults,United States,,,Diet History Questionnaire (DHQ),Lutein/Zeaxanthin,"",No,,2119.0,,ug/day,,,"Serum, fasting",HPLC,Lutein,"",,,,umol/L,,86,Spearman,0.16,,,>= 0.05,No,,,Energy,Dixon 2006
3629,3876,3894,Females,Adults,United States,,,Diet History Questionnaire (DHQ),Lutein/Zeaxanthin,"",No,,2119.0,,ug/day,,,"Serum, fasting",HPLC,Lutein,"",,,,umol/L,,86,Spearman,0.16,,,>= 0.05,No,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3608,3877,3850,Females,Adults,United States,,,Diet History Questionnaire (DHQ),Lycopene,"",No,,5612.0,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",,0.61,,umol/L,,86,Spearman,0.22,,,< 0.05,Yes,,,,Dixon 2006
3619,3877,3850,Females,Adults,United States,,,Diet History Questionnaire (DHQ),Lycopene,"",No,,5612.0,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",,0.61,,umol/L,,86,Spearman,0.23,,,< 0.05,Yes,,,Energy,Dixon 2006
3630,3877,3850,Females,Adults,United States,,,Diet History Questionnaire (DHQ),Lycopene,"",No,,5612.0,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",,0.61,,umol/L,,86,Spearman,0.21,,,>= 0.05,No,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3609,3879,3846,Females,Adults,United States,,,Diet History Questionnaire (DHQ),Vitamin A (beta-Carotene Equivalents),"",Yes,,3482.0,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,0.1,,umol/L,,86,Spearman,0.39,,,< 0.001,Yes,,,,Dixon 2006
3610,3879,3847,Females,Adults,United States,,,Diet History Questionnaire (DHQ),Vitamin A (beta-Carotene Equivalents),"",Yes,,3482.0,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,0.26,,umol/L,,86,Spearman,0.28,,,< 0.01,Yes,,,,Dixon 2006
3620,3879,3846,Females,Adults,United States,,,Diet History Questionnaire (DHQ),Vitamin A (beta-Carotene Equivalents),"",Yes,,3482.0,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,0.1,,umol/L,,86,Spearman,0.39,,,< 0.001,Yes,,,Energy,Dixon 2006
3621,3879,3847,Females,Adults,United States,,,Diet History Questionnaire (DHQ),Vitamin A (beta-Carotene Equivalents),"",Yes,,3482.0,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,0.26,,umol/L,,86,Spearman,0.28,,,< 0.01,Yes,,,Energy,Dixon 2006
3631,3879,3846,Females,Adults,United States,,,Diet History Questionnaire (DHQ),Vitamin A (beta-Carotene Equivalents),"",Yes,,3482.0,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,0.1,,umol/L,,86,Spearman,0.45,,,< 0.001,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3632,3879,3847,Females,Adults,United States,,,Diet History Questionnaire (DHQ),Vitamin A (beta-Carotene Equivalents),"",Yes,,3482.0,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,0.26,,umol/L,,86,Spearman,0.34,,,< 0.01,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3611,3880,3851,Females,Adults,United States,,,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",No,,6.7,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,28.0,,umol/L,,86,Spearman,0.12,,,>= 0.05,No,,,,Dixon 2006
3622,3880,3851,Females,Adults,United States,,,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",No,,6.7,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,28.0,,umol/L,,86,Spearman,0.15,,,>= 0.05,No,,,Energy,Dixon 2006
3633,3880,3851,Females,Adults,United States,,,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",No,,6.7,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,28.0,,umol/L,,86,Spearman,0.19,,,>= 0.05,No,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3612,3881,3852,Females,Adults,United States,,,Diet History Questionnaire (DHQ),gamma-Tocopherol,"",No,,11.2,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",,3.2,,umol/L,,86,Spearman,0.21,,,< 0.05,Yes,,,,Dixon 2006
3623,3881,3852,Females,Adults,United States,,,Diet History Questionnaire (DHQ),gamma-Tocopherol,"",No,,11.2,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",,3.2,,umol/L,,86,Spearman,0.26,,,< 0.05,Yes,,,Energy,Dixon 2006
3634,3881,3852,Females,Adults,United States,,,Diet History Questionnaire (DHQ),gamma-Tocopherol,"",No,,11.2,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",,3.2,,umol/L,,86,Spearman,0.18,,,>= 0.05,No,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3613,3882,3851,Females,Adults,United States,,,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",Yes,,27.0,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,28.0,,umol/L,,86,Spearman,0.68,,,< 0.001,Yes,,,,Dixon 2006
3614,3882,3852,Females,Adults,United States,,,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",Yes,,27.0,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",,3.2,,umol/L,,86,Spearman,-0.47,,,< 0.001,Yes,,,,Dixon 2006
3624,3882,3851,Females,Adults,United States,,,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",Yes,,27.0,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,28.0,,umol/L,,86,Spearman,0.68,,,< 0.001,Yes,,,Energy,Dixon 2006
3625,3882,3852,Females,Adults,United States,,,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",Yes,,27.0,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",,3.2,,umol/L,,86,Spearman,-0.49,,,< 0.001,Yes,,,Energy,Dixon 2006
3635,3882,3851,Females,Adults,United States,,,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",Yes,,27.0,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,28.0,,umol/L,,86,Spearman,0.72,,,< 0.001,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3636,3882,3852,Females,Adults,United States,,,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",Yes,,27.0,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",,3.2,,umol/L,,86,Spearman,-0.59,,,< 0.001,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3637,3883,3846,Females,Adults,United States,,,24-h Dietary recall (1-day),alpha-Carotene,"",No,,332.0,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,0.1,,umol/L,,86,Spearman,0.27,,,< 0.05,Yes,,,,Dixon 2006
3648,3883,3846,Females,Adults,United States,,,24-h Dietary recall (1-day),alpha-Carotene,"",No,,332.0,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,0.1,,umol/L,,86,Spearman,0.27,,,< 0.05,Yes,,,Energy,Dixon 2006
3659,3883,3846,Females,Adults,United States,,,24-h Dietary recall (1-day),alpha-Carotene,"",No,,332.0,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,0.1,,umol/L,,86,Spearman,0.29,,,< 0.01,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3638,3884,3847,Females,Adults,United States,,,24-h Dietary recall (1-day),beta-Carotene,"",No,,1956.0,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,0.26,,umol/L,,86,Spearman,0.32,,,< 0.01,Yes,,,,Dixon 2006
3649,3884,3847,Females,Adults,United States,,,24-h Dietary recall (1-day),beta-Carotene,"",No,,1956.0,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,0.26,,umol/L,,86,Spearman,0.33,,,< 0.01,Yes,,,Energy,Dixon 2006
3660,3884,3847,Females,Adults,United States,,,24-h Dietary recall (1-day),beta-Carotene,"",No,,1956.0,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,0.26,,umol/L,,86,Spearman,0.32,,,< 0.01,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3639,3885,3848,Females,Adults,United States,,,24-h Dietary recall (1-day),beta-Cryptoxanthin,"",No,,58.0,,ug/day,,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",,0.09,,umol/L,,86,Spearman,0.51,,,< 0.001,Yes,,,,Dixon 2006
3650,3885,3848,Females,Adults,United States,,,24-h Dietary recall (1-day),beta-Cryptoxanthin,"",No,,58.0,,ug/day,,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",,0.09,,umol/L,,86,Spearman,0.5,,,< 0.001,Yes,,,Energy,Dixon 2006
3661,3885,3848,Females,Adults,United States,,,24-h Dietary recall (1-day),beta-Cryptoxanthin,"",No,,58.0,,ug/day,,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",,0.09,,umol/L,,86,Spearman,0.43,,,< 0.001,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3640,3886,3894,Females,Adults,United States,,,24-h Dietary recall (1-day),Lutein/Zeaxanthin,"",No,,1410.0,,ug/day,,,"Serum, fasting",HPLC,Lutein,"",,,,umol/L,,86,Spearman,0.49,,,< 0.001,Yes,,,,Dixon 2006
3651,3886,3894,Females,Adults,United States,,,24-h Dietary recall (1-day),Lutein/Zeaxanthin,"",No,,1410.0,,ug/day,,,"Serum, fasting",HPLC,Lutein,"",,,,umol/L,,86,Spearman,0.51,,,< 0.001,Yes,,,Energy,Dixon 2006
3662,3886,3894,Females,Adults,United States,,,24-h Dietary recall (1-day),Lutein/Zeaxanthin,"",No,,1410.0,,ug/day,,,"Serum, fasting",HPLC,Lutein,"",,,,umol/L,,86,Spearman,0.48,,,< 0.001,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3641,3887,3850,Females,Adults,United States,,,24-h Dietary recall (1-day),Lycopene,"",No,,3505.0,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",,0.61,,umol/L,,86,Spearman,0.23,,,< 0.05,Yes,,,,Dixon 2006
3652,3887,3850,Females,Adults,United States,,,24-h Dietary recall (1-day),Lycopene,"",No,,3505.0,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",,0.61,,umol/L,,86,Spearman,0.23,,,< 0.05,Yes,,,Energy,Dixon 2006
3663,3887,3850,Females,Adults,United States,,,24-h Dietary recall (1-day),Lycopene,"",No,,3505.0,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",,0.61,,umol/L,,86,Spearman,0.23,,,< 0.05,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3642,3889,3846,Females,Adults,United States,,,24-h Dietary recall (1-day),Vitamin A (beta-Carotene Equivalents),"",Yes,,2444.0,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,0.1,,umol/L,,86,Spearman,0.42,,,< 0.001,Yes,,,,Dixon 2006
3643,3889,3847,Females,Adults,United States,,,24-h Dietary recall (1-day),Vitamin A (beta-Carotene Equivalents),"",Yes,,2444.0,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,0.26,,umol/L,,86,Spearman,0.34,,,< 0.01,Yes,,,,Dixon 2006
3653,3889,3846,Females,Adults,United States,,,24-h Dietary recall (1-day),Vitamin A (beta-Carotene Equivalents),"",Yes,,2444.0,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,0.1,,umol/L,,86,Spearman,0.42,,,< 0.001,Yes,,,Energy,Dixon 2006
3654,3889,3847,Females,Adults,United States,,,24-h Dietary recall (1-day),Vitamin A (beta-Carotene Equivalents),"",Yes,,2444.0,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,0.26,,umol/L,,86,Spearman,0.35,,,< 0.001,Yes,,,Energy,Dixon 2006
3664,3889,3846,Females,Adults,United States,,,24-h Dietary recall (1-day),Vitamin A (beta-Carotene Equivalents),"",Yes,,2444.0,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",,0.1,,umol/L,,86,Spearman,0.41,,,< 0.001,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3665,3889,3847,Females,Adults,United States,,,24-h Dietary recall (1-day),Vitamin A (beta-Carotene Equivalents),"",Yes,,2444.0,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,0.26,,umol/L,,86,Spearman,0.33,,,< 0.01,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3644,3890,3851,Females,Adults,United States,,,24-h Dietary recall (1-day),alpha-Tocopherol,"",No,,6.3,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,28.0,,umol/L,,86,Spearman,-0.05,,,>= 0.05,No,,,,Dixon 2006
3655,3890,3851,Females,Adults,United States,,,24-h Dietary recall (1-day),alpha-Tocopherol,"",No,,6.3,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,28.0,,umol/L,,86,Spearman,0.03,,,>= 0.05,No,,,Energy,Dixon 2006
3666,3890,3851,Females,Adults,United States,,,24-h Dietary recall (1-day),alpha-Tocopherol,"",No,,6.3,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,28.0,,umol/L,,86,Spearman,0.04,,,>= 0.05,No,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3645,3891,3852,Females,Adults,United States,,,24-h Dietary recall (1-day),gamma-Tocopherol,"",No,,13.7,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",,3.2,,umol/L,,86,Spearman,-0.08,,,>= 0.05,No,,,,Dixon 2006
3656,3891,3852,Females,Adults,United States,,,24-h Dietary recall (1-day),gamma-Tocopherol,"",No,,13.7,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",,3.2,,umol/L,,86,Spearman,0.2,,,>= 0.05,No,,,Energy,Dixon 2006
3667,3891,3852,Females,Adults,United States,,,24-h Dietary recall (1-day),gamma-Tocopherol,"",No,,13.7,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",,3.2,,umol/L,,86,Spearman,0.14,,,>= 0.05,No,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3646,3892,3851,Females,Adults,United States,,,24-h Dietary recall (1-day),alpha-Tocopherol,"",Yes,,33.0,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,28.0,,umol/L,,86,Spearman,0.61,,,< 0.001,Yes,,,,Dixon 2006
3647,3892,3852,Females,Adults,United States,,,24-h Dietary recall (1-day),alpha-Tocopherol,"",Yes,,33.0,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",,3.2,,umol/L,,86,Spearman,-0.56,,,< 0.001,Yes,,,,Dixon 2006
3657,3892,3851,Females,Adults,United States,,,24-h Dietary recall (1-day),alpha-Tocopherol,"",Yes,,33.0,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,28.0,,umol/L,,86,Spearman,0.63,,,< 0.001,Yes,,,Energy,Dixon 2006
3658,3892,3852,Females,Adults,United States,,,24-h Dietary recall (1-day),alpha-Tocopherol,"",Yes,,33.0,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",,3.2,,umol/L,,86,Spearman,-0.56,,,< 0.001,Yes,,,Energy,Dixon 2006
3668,3892,3851,Females,Adults,United States,,,24-h Dietary recall (1-day),alpha-Tocopherol,"",Yes,,33.0,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,28.0,,umol/L,,86,Spearman,0.74,,,< 0.001,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3669,3892,3852,Females,Adults,United States,,,24-h Dietary recall (1-day),alpha-Tocopherol,"",Yes,,33.0,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",,3.2,,umol/L,,86,Spearman,-0.61,,,< 0.001,Yes,,,"Energy, BMI, Smoking status, Cholesterol, Triglycerides",Dixon 2006
3670,3896,3930,All,Pregnant women participant in a dietary validation study,Denmark,DNBC (Danish National Birth Cohort),,Food Frequency Questionnaire (FFQ),Proteins,"",No,91.0,,,g/day,,,"Urine, 24-h",Elemental analysis,Nitrogen,"",72.0,,,g/day,,87,Spearman,0.17,,,>= 0.05,No,,,,Mikkelsen 2006
3671,3899,3931,All,Pregnant women participant in a dietary validation study,Denmark,DNBC (Danish National Birth Cohort),,Food Frequency Questionnaire (FFQ),Retinol,"",Yes,1258.0,,,ug/day,,,"Plasma, fasting",HPLC,Retinol,"",0.42,,,ug/mL,,87,Spearman,-0.03,,,>= 0.05,No,,,,Mikkelsen 2006
3672,3902,3932,All,Pregnant women participant in a dietary validation study,Denmark,DNBC (Danish National Birth Cohort),,Food Frequency Questionnaire (FFQ),Folate (Dietary Folate Equivalents),"",Yes,816.0,,,ug/day,,,"Red blood cell, fasting",Time-resolved fluoroimmunoassay (TR-FIA),Folates,"",708.0,,,nmol/L,,87,Spearman,0.55,,,< 0.0001,Yes,,,,Mikkelsen 2006
3673,3903,3933,All,Pregnant women participant in a dietary validation study,Denmark,DNBC (Danish National Birth Cohort),,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)","",No,0.54,,,g/day,,,"Red blood cell, fasting",GC-FID,EPA (cis-20:5n-3),"",0.51,,,percentRoot,,87,Spearman,0.37,,,< 0.001,Yes,,,,Mikkelsen 2006
3674,3905,3930,All,Pregnant women participant in a dietary validation study,Denmark,DNBC (Danish National Birth Cohort),,Food Frequency Questionnaire (FFQ),Proteins,"",No,87.0,,,g/10 MJ,Energy,,"Urine, 24-h",Elemental analysis,Nitrogen,"",72.0,,,g/day,,87,Spearman,0.2,,,>= 0.05,No,Energy by density method,,,Mikkelsen 2006
3675,3908,3931,All,Pregnant women participant in a dietary validation study,Denmark,DNBC (Danish National Birth Cohort),,Food Frequency Questionnaire (FFQ),Retinol,"",Yes,1190.0,,,ug/10 MJ,Energy,,"Plasma, fasting",HPLC,Retinol,"",0.42,,,ug/mL,,87,Spearman,-0.04,,,>= 0.05,No,Energy by density method,,,Mikkelsen 2006
3676,3911,3932,All,Pregnant women participant in a dietary validation study,Denmark,DNBC (Danish National Birth Cohort),,Food Frequency Questionnaire (FFQ),Folate (Dietary Folate Equivalents),"",Yes,803.0,,,ug/10 MJ,Energy,,"Red blood cell, fasting",Time-resolved fluoroimmunoassay (TR-FIA),Folates,"",708.0,,,nmol/L,,87,Spearman,0.58,,,< 0.0001,Yes,Energy by density method,,,Mikkelsen 2006
3677,3912,3933,All,Pregnant women participant in a dietary validation study,Denmark,DNBC (Danish National Birth Cohort),,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)","",No,0.5,,,g/10 MJ,Energy,,"Red blood cell, fasting",GC-FID,EPA (cis-20:5n-3),"",0.51,,,percentRoot,,87,Spearman,0.36,,,< 0.001,Yes,Energy by density method,,,Mikkelsen 2006
3678,3914,3930,All,Pregnant women participant in a dietary validation study,Denmark,DNBC (Danish National Birth Cohort),,Weighed Dietary record (7-day),Proteins,"",No,91.0,,,g/day,,,"Urine, 24-h",Elemental analysis,Nitrogen,"",72.0,,,g/day,,87,Spearman,0.64,,,< 0.0001,Yes,,,,Mikkelsen 2006
3679,3917,3931,All,Pregnant women participant in a dietary validation study,Denmark,DNBC (Danish National Birth Cohort),,Weighed Dietary record (7-day),Retinol,"",Yes,1143.0,,,ug/day,,,"Plasma, fasting",HPLC,Retinol,"",0.42,,,ug/mL,,87,Spearman,-0.008,,,>= 0.05,No,,,,Mikkelsen 2006
3680,3920,3932,All,Pregnant women participant in a dietary validation study,Denmark,DNBC (Danish National Birth Cohort),,Weighed Dietary record (7-day),Folate (Dietary Folate Equivalents),"",Yes,840.0,,,ug/day,,,"Red blood cell, fasting",Time-resolved fluoroimmunoassay (TR-FIA),Folates,"",708.0,,,nmol/L,,87,Spearman,0.52,,,< 0.0001,Yes,,,,Mikkelsen 2006
3681,3921,3933,All,Pregnant women participant in a dietary validation study,Denmark,DNBC (Danish National Birth Cohort),,Weighed Dietary record (7-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)","",No,0.43,,,g/day,,,"Red blood cell, fasting",GC-FID,EPA (cis-20:5n-3),"",0.51,,,percentRoot,,87,Spearman,0.62,,,< 0.0001,Yes,,,,Mikkelsen 2006
3682,3922,3930,All,Pregnant women participant in a dietary validation study,Denmark,DNBC (Danish National Birth Cohort),,Weighed Dietary record (7-day),Proteins,"",No,80.0,,,g/10 MJ,Energy,,"Urine, 24-h",Elemental analysis,Nitrogen,"",72.0,,,g/day,,87,Spearman,0.4,,,< 0.0001,Yes,Energy by density method,,,Mikkelsen 2006
3683,3925,3931,All,Pregnant women participant in a dietary validation study,Denmark,DNBC (Danish National Birth Cohort),,Weighed Dietary record (7-day),Retinol,"",Yes,1050.0,,,ug/10 MJ,Energy,,"Plasma, fasting",HPLC,Retinol,"",0.42,,,ug/mL,,87,Spearman,0.04,,,>= 0.05,No,Energy by density method,,,Mikkelsen 2006
3684,3928,3932,All,Pregnant women participant in a dietary validation study,Denmark,DNBC (Danish National Birth Cohort),,Weighed Dietary record (7-day),Folate (Dietary Folate Equivalents),"",Yes,799.0,,,ug/10 MJ,Energy,,"Red blood cell, fasting",Time-resolved fluoroimmunoassay (TR-FIA),Folates,"",708.0,,,nmol/L,,87,Spearman,0.54,,,< 0.0001,Yes,Energy by density method,,,Mikkelsen 2006
3685,3929,3933,All,Pregnant women participant in a dietary validation study,Denmark,DNBC (Danish National Birth Cohort),,Weighed Dietary record (7-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)","",No,0.37,,,g/10 MJ,Energy,,"Red blood cell, fasting",GC-FID,EPA (cis-20:5n-3),"",0.51,,,percentRoot,,87,Spearman,0.6,,,< 0.0001,Yes,Energy by density method,,,Mikkelsen 2006
3697,3934,3958,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Apple,"",,58.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",11.4,,,umol/day,,53,Spearman,0.12,,,= 0.39,No,,,,Mennen 2006
3745,3934,3959,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Apple,"",,58.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",5.4,,,umol/day,,53,Spearman,0.36,,,= 0.009,Yes,,,,Mennen 2006
3767,3934,3960,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Apple,"",,58.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Gallic acid,"",1.6,,,umol/day,,53,Spearman,0.08,,,= 0.55,No,,,,Mennen 2006
3789,3934,3961,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Apple,"",,58.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,4-O-Methylgallic acid,"",6.1,,,umol/day,,53,Spearman,0.07,,,= 0.6,No,,,,Mennen 2006
3813,3934,3962,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Apple,"",,58.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Quercetin,"",0.7,,,umol/day,,53,Spearman,0.25,,,= 0.07,No,,,,Mennen 2006
3823,3934,3963,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Apple,"",,58.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Isorhamnetin,"",0.5,,,umol/day,,53,Spearman,0.31,,,= 0.02,Yes,,,,Mennen 2006
3833,3934,3964,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Apple,"",,58.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.8,,,umol/day,,53,Spearman,0.45,,,= 0.0007,Yes,,,,Mennen 2006
3873,3934,3969,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Apple,"",,58.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Phloretin,"",0.73,,,umol/day,,53,Spearman,0.35,,,= 0.01,Yes,,,,Mennen 2006
3914,3934,3974,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Apple,"",,58.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",6.2,,,umol/L,,53,Spearman,-0.06,,,= 0.66,No,,,,Mennen 2006
3936,3934,3975,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Apple,"",,58.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",2.7,,,umol/L,,53,Spearman,0.19,,,= 0.18,No,,,,Mennen 2006
3954,3934,3976,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Apple,"",,58.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Gallic acid,"",1.1,,,umol/L,,53,Spearman,0.003,,,= 0.98,No,,,,Mennen 2006
3966,3934,3977,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Apple,"",,58.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,4-O-Methylgallic acid,"",4.4,,,umol/L,,53,Spearman,-0.04,,,= 0.79,No,,,,Mennen 2006
3978,3934,3978,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Apple,"",,58.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Quercetin,"",0.4,,,umol/L,,53,Spearman,-0.03,,,= 0.86,No,,,,Mennen 2006
3988,3934,3979,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Apple,"",,58.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Isorhamnetin,"",0.3,,,umol/L,,53,Spearman,-0.02,,,= 0.89,No,,,,Mennen 2006
3998,3934,3980,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Apple,"",,58.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.4,,,umol/L,,53,Spearman,0.14,,,= 0.33,No,,,,Mennen 2006
4038,3934,3985,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Apple,"",,58.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Phloretin,"",0.42,,,umol/L,,53,Spearman,0.6,,,< 0.0001,Yes,,,,Mennen 2006
3686,3935,3957,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Peach,"",,34.1,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,5-Caffeoylquinic acid,"",4.2,,,umol/day,,53,Spearman,-0.02,,,= 0.87,No,,,,Mennen 2006
3698,3935,3958,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Peach,"",,34.1,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",11.4,,,umol/day,,53,Spearman,0.005,,,= 0.97,No,,,,Mennen 2006
3746,3935,3959,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Peach,"",,34.1,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",5.4,,,umol/day,,53,Spearman,0.02,,,= 0.91,No,,,,Mennen 2006
3768,3935,3960,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Peach,"",,34.1,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Gallic acid,"",1.6,,,umol/day,,53,Spearman,-0.15,,,= 0.28,No,,,,Mennen 2006
3790,3935,3961,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Peach,"",,34.1,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,4-O-Methylgallic acid,"",6.1,,,umol/day,,53,Spearman,-0.14,,,= 0.33,No,,,,Mennen 2006
3814,3935,3962,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Peach,"",,34.1,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Quercetin,"",0.7,,,umol/day,,53,Spearman,-0.09,,,= 0.5,No,,,,Mennen 2006
3824,3935,3963,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Peach,"",,34.1,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Isorhamnetin,"",0.5,,,umol/day,,53,Spearman,-0.09,,,= 0.5,No,,,,Mennen 2006
3834,3935,3964,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Peach,"",,34.1,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.8,,,umol/day,,53,Spearman,0.01,,,= 0.92,No,,,,Mennen 2006
3874,3935,3969,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Peach,"",,34.1,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Phloretin,"",0.73,,,umol/day,,53,Spearman,-0.05,,,= 0.74,No,,,,Mennen 2006
3885,3935,3965,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Peach,"",,34.1,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",23.9,,,umol/day,,53,Spearman,0.24,,,= 0.08,No,,,,Mennen 2006
3894,3935,3966,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Peach,"",,34.1,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",2.0,,,umol/day,,53,Spearman,0.009,,,= 0.95,No,,,,Mennen 2006
3903,3935,3973,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Peach,"",,34.1,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,5-Caffeoylquinic acid,"",6.6,,,umol/L,,53,Spearman,-0.09,,,= 0.51,No,,,,Mennen 2006
3915,3935,3974,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Peach,"",,34.1,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",6.2,,,umol/L,,53,Spearman,0.09,,,= 0.5,No,,,,Mennen 2006
3937,3935,3975,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Peach,"",,34.1,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",2.7,,,umol/L,,53,Spearman,-0.2,,,= 0.15,No,,,,Mennen 2006
3955,3935,3976,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Peach,"",,34.1,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Gallic acid,"",1.1,,,umol/L,,53,Spearman,-0.06,,,= 0.66,No,,,,Mennen 2006
3967,3935,3977,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Peach,"",,34.1,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,4-O-Methylgallic acid,"",4.4,,,umol/L,,53,Spearman,-0.05,,,= 0.7,No,,,,Mennen 2006
3979,3935,3978,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Peach,"",,34.1,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Quercetin,"",0.4,,,umol/L,,53,Spearman,0.06,,,= 0.65,No,,,,Mennen 2006
3989,3935,3979,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Peach,"",,34.1,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Isorhamnetin,"",0.3,,,umol/L,,53,Spearman,0.04,,,= 0.78,No,,,,Mennen 2006
3999,3935,3980,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Peach,"",,34.1,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.4,,,umol/L,,53,Spearman,0.12,,,= 0.39,No,,,,Mennen 2006
4039,3935,3985,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Peach,"",,34.1,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Phloretin,"",0.42,,,umol/L,,53,Spearman,-0.007,,,= 0.96,No,,,,Mennen 2006
4050,3935,3981,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Peach,"",,34.1,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",10.7,,,umol/L,,53,Spearman,0.24,,,= 0.08,No,,,,Mennen 2006
4059,3935,3982,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Peach,"",,34.1,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",0.8,,,umol/L,,53,Spearman,-0.04,,,= 0.77,No,,,,Mennen 2006
3687,3936,3957,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Berries,"",,47.5,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,5-Caffeoylquinic acid,"",4.2,,,umol/day,,53,Spearman,0.08,,,= 0.55,No,,,,Mennen 2006
3699,3936,3958,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Berries,"",,47.5,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",11.4,,,umol/day,,53,Spearman,-0.03,,,= 0.81,No,,,,Mennen 2006
3747,3936,3959,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Berries,"",,47.5,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",5.4,,,umol/day,,53,Spearman,-0.13,,,= 0.35,No,,,,Mennen 2006
3769,3936,3960,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Berries,"",,47.5,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Gallic acid,"",1.6,,,umol/day,,53,Spearman,0.06,,,= 0.7,No,,,,Mennen 2006
3791,3936,3961,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Berries,"",,47.5,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,4-O-Methylgallic acid,"",6.1,,,umol/day,,53,Spearman,-0.08,,,= 0.57,No,,,,Mennen 2006
3815,3936,3962,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Berries,"",,47.5,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Quercetin,"",0.7,,,umol/day,,53,Spearman,-0.07,,,= 0.63,No,,,,Mennen 2006
3825,3936,3963,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Berries,"",,47.5,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Isorhamnetin,"",0.5,,,umol/day,,53,Spearman,-0.002,,,= 0.99,No,,,,Mennen 2006
3835,3936,3964,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Berries,"",,47.5,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.8,,,umol/day,,53,Spearman,0.19,,,= 0.17,No,,,,Mennen 2006
3875,3936,3969,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Berries,"",,47.5,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Phloretin,"",0.73,,,umol/day,,53,Spearman,0.04,,,= 0.78,No,,,,Mennen 2006
3886,3936,3965,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Berries,"",,47.5,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",23.9,,,umol/day,,53,Spearman,-0.11,,,= 0.44,No,,,,Mennen 2006
3895,3936,3966,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Berries,"",,47.5,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",2.0,,,umol/day,,53,Spearman,-0.22,,,= 0.12,No,,,,Mennen 2006
3904,3936,3973,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Berries,"",,47.5,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,5-Caffeoylquinic acid,"",6.6,,,umol/L,,53,Spearman,-0.1,,,= 0.47,No,,,,Mennen 2006
3916,3936,3974,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Berries,"",,47.5,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",6.2,,,umol/L,,53,Spearman,0.05,,,= 0.73,No,,,,Mennen 2006
3938,3936,3975,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Berries,"",,47.5,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",2.7,,,umol/L,,53,Spearman,-0.34,,,= 0.01,Yes,,,,Mennen 2006
3956,3936,3976,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Berries,"",,47.5,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Gallic acid,"",1.1,,,umol/L,,53,Spearman,-0.002,,,= 0.98,No,,,,Mennen 2006
3968,3936,3977,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Berries,"",,47.5,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,4-O-Methylgallic acid,"",4.4,,,umol/L,,53,Spearman,0.02,,,= 0.9,No,,,,Mennen 2006
3980,3936,3978,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Berries,"",,47.5,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Quercetin,"",0.4,,,umol/L,,53,Spearman,-0.15,,,= 0.29,No,,,,Mennen 2006
3990,3936,3979,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Berries,"",,47.5,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Isorhamnetin,"",0.3,,,umol/L,,53,Spearman,0.03,,,= 0.85,No,,,,Mennen 2006
4000,3936,3980,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Berries,"",,47.5,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.4,,,umol/L,,53,Spearman,0.28,,,= 0.04,No,,,,Mennen 2006
4040,3936,3985,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Berries,"",,47.5,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Phloretin,"",0.42,,,umol/L,,53,Spearman,-0.01,,,= 0.92,No,,,,Mennen 2006
4051,3936,3981,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Berries,"",,47.5,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",10.7,,,umol/L,,53,Spearman,-0.03,,,= 0.86,No,,,,Mennen 2006
4060,3936,3982,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Berries,"",,47.5,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",0.8,,,umol/L,,53,Spearman,-0.19,,,= 0.17,No,,,,Mennen 2006
3700,3937,3958,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Grapefruit,"",,18.9,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",11.4,,,umol/day,,53,Spearman,-0.06,,,= 0.7,No,,,,Mennen 2006
3748,3937,3959,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Grapefruit,"",,18.9,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",5.4,,,umol/day,,53,Spearman,0.06,,,= 0.68,No,,,,Mennen 2006
3836,3937,3964,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Grapefruit,"",,18.9,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.8,,,umol/day,,53,Spearman,-0.11,,,= 0.43,No,,,,Mennen 2006
3855,3937,3967,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Grapefruit,"",,18.9,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Hesperetin,"",3.0,,,umol/day,,53,Spearman,0.18,,,= 0.21,No,,,,Mennen 2006
3864,3937,3968,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Grapefruit,"",,18.9,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Naringenin,"",9.9,,,umol/day,,53,Spearman,0.2,,,= 0.15,No,,,,Mennen 2006
3876,3937,3969,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Grapefruit,"",,18.9,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Phloretin,"",0.73,,,umol/day,,53,Spearman,0.14,,,= 0.33,No,,,,Mennen 2006
3917,3937,3974,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Grapefruit,"",,18.9,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",6.2,,,umol/L,,53,Spearman,0.12,,,= 0.4,No,,,,Mennen 2006
3939,3937,3975,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Grapefruit,"",,18.9,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",2.7,,,umol/L,,53,Spearman,-0.07,,,= 0.63,No,,,,Mennen 2006
4001,3937,3980,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Grapefruit,"",,18.9,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.4,,,umol/L,,53,Spearman,0.05,,,= 0.73,No,,,,Mennen 2006
4020,3937,3983,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Grapefruit,"",,18.9,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Hesperetin,"",1.8,,,umol/L,,53,Spearman,0.11,,,= 0.45,No,,,,Mennen 2006
4029,3937,3984,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Grapefruit,"",,18.9,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Naringenin,"",5.6,,,umol/L,,53,Spearman,0.31,,,= 0.02,Yes,,,,Mennen 2006
4041,3937,3985,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Grapefruit,"",,18.9,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Phloretin,"",0.42,,,umol/L,,53,Spearman,0.06,,,= 0.68,No,,,,Mennen 2006
3701,3938,3958,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Grapefruit juice,"",,17.5,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",11.4,,,umol/day,,53,Spearman,0.13,,,= 0.36,No,,,,Mennen 2006
3749,3938,3959,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Grapefruit juice,"",,17.5,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",5.4,,,umol/day,,53,Spearman,0.06,,,= 0.65,No,,,,Mennen 2006
3837,3938,3964,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Grapefruit juice,"",,17.5,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.8,,,umol/day,,53,Spearman,0.04,,,= 0.8,No,,,,Mennen 2006
3856,3938,3967,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Grapefruit juice,"",,17.5,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Hesperetin,"",3.0,,,umol/day,,53,Spearman,-0.06,,,= 0.68,No,,,,Mennen 2006
3865,3938,3968,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Grapefruit juice,"",,17.5,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Naringenin,"",9.9,,,umol/day,,53,Spearman,0.18,,,= 0.21,No,,,,Mennen 2006
3877,3938,3969,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Grapefruit juice,"",,17.5,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Phloretin,"",0.73,,,umol/day,,53,Spearman,0.04,,,= 0.8,No,,,,Mennen 2006
3918,3938,3974,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Grapefruit juice,"",,17.5,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",6.2,,,umol/L,,53,Spearman,0.13,,,= 0.34,No,,,,Mennen 2006
3940,3938,3975,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Grapefruit juice,"",,17.5,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",2.7,,,umol/L,,53,Spearman,-0.08,,,= 0.59,No,,,,Mennen 2006
4002,3938,3980,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Grapefruit juice,"",,17.5,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.4,,,umol/L,,53,Spearman,0.16,,,= 0.25,No,,,,Mennen 2006
4021,3938,3983,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Grapefruit juice,"",,17.5,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Hesperetin,"",1.8,,,umol/L,,53,Spearman,-0.11,,,= 0.41,No,,,,Mennen 2006
4030,3938,3984,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Grapefruit juice,"",,17.5,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Naringenin,"",5.6,,,umol/L,,53,Spearman,0.36,,,= 0.008,Yes,,,,Mennen 2006
4042,3938,3985,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Grapefruit juice,"",,17.5,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Phloretin,"",0.42,,,umol/L,,53,Spearman,0.14,,,= 0.33,No,,,,Mennen 2006
3702,3939,3958,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Orange,"",,10.8,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",11.4,,,umol/day,,53,Spearman,-0.15,,,= 0.27,No,,,,Mennen 2006
3750,3939,3959,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Orange,"",,10.8,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",5.4,,,umol/day,,53,Spearman,-0.11,,,= 0.43,No,,,,Mennen 2006
3838,3939,3964,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Orange,"",,10.8,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.8,,,umol/day,,53,Spearman,-0.11,,,= 0.43,No,,,,Mennen 2006
3857,3939,3967,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Orange,"",,10.8,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Hesperetin,"",3.0,,,umol/day,,53,Spearman,0.35,,,= 0.01,Yes,,,,Mennen 2006
3866,3939,3968,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Orange,"",,10.8,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Naringenin,"",9.9,,,umol/day,,53,Spearman,0.08,,,= 0.57,No,,,,Mennen 2006
3878,3939,3969,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Orange,"",,10.8,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Phloretin,"",0.73,,,umol/day,,53,Spearman,-0.03,,,= 0.85,No,,,,Mennen 2006
3919,3939,3974,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Orange,"",,10.8,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",6.2,,,umol/L,,53,Spearman,0.37,,,= 0.007,Yes,,,,Mennen 2006
3941,3939,3975,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Orange,"",,10.8,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",2.7,,,umol/L,,53,Spearman,0.2,,,= 0.15,No,,,,Mennen 2006
4003,3939,3980,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Orange,"",,10.8,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.4,,,umol/L,,53,Spearman,-0.12,,,= 0.38,No,,,,Mennen 2006
4022,3939,3983,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Orange,"",,10.8,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Hesperetin,"",1.8,,,umol/L,,53,Spearman,0.4,,,= 0.003,Yes,,,,Mennen 2006
4031,3939,3984,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Orange,"",,10.8,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Naringenin,"",5.6,,,umol/L,,53,Spearman,0.26,,,= 0.06,No,,,,Mennen 2006
4043,3939,3985,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Orange,"",,10.8,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Phloretin,"",0.42,,,umol/L,,53,Spearman,-0.05,,,= 0.72,No,,,,Mennen 2006
3703,3940,3958,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Orange juice,"",,37.1,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",11.4,,,umol/day,,53,Spearman,-0.08,,,= 0.55,No,,,,Mennen 2006
3751,3940,3959,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Orange juice,"",,37.1,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",5.4,,,umol/day,,53,Spearman,0.04,,,= 0.77,No,,,,Mennen 2006
3839,3940,3964,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Orange juice,"",,37.1,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.8,,,umol/day,,53,Spearman,-0.12,,,= 0.4,No,,,,Mennen 2006
3858,3940,3967,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Orange juice,"",,37.1,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Hesperetin,"",3.0,,,umol/day,,53,Spearman,0.18,,,= 0.21,No,,,,Mennen 2006
3867,3940,3968,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Orange juice,"",,37.1,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Naringenin,"",9.9,,,umol/day,,53,Spearman,0.18,,,= 0.2,No,,,,Mennen 2006
3879,3940,3969,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Orange juice,"",,37.1,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Phloretin,"",0.73,,,umol/day,,53,Spearman,0.09,,,= 0.53,No,,,,Mennen 2006
3920,3940,3974,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Orange juice,"",,37.1,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",6.2,,,umol/L,,53,Spearman,-0.18,,,= 0.19,No,,,,Mennen 2006
3942,3940,3975,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Orange juice,"",,37.1,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",2.7,,,umol/L,,53,Spearman,-0.06,,,= 0.66,No,,,,Mennen 2006
4004,3940,3980,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Orange juice,"",,37.1,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.4,,,umol/L,,53,Spearman,-0.04,,,= 0.79,No,,,,Mennen 2006
4023,3940,3983,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Orange juice,"",,37.1,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Hesperetin,"",1.8,,,umol/L,,53,Spearman,0.46,,,= 0.0006,Yes,,,,Mennen 2006
4032,3940,3984,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Orange juice,"",,37.1,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Naringenin,"",5.6,,,umol/L,,53,Spearman,0.21,,,= 0.13,No,,,,Mennen 2006
4044,3940,3985,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Orange juice,"",,37.1,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Phloretin,"",0.42,,,umol/L,,53,Spearman,-0.06,,,= 0.66,No,,,,Mennen 2006
3704,3941,3958,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Citrus fruits,Orange + Grapefruit,,31.5,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",11.4,,,umol/day,,53,Spearman,-0.11,,,= 0.42,No,,,,Mennen 2006
3752,3941,3959,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Citrus fruits,Orange + Grapefruit,,31.5,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",5.4,,,umol/day,,53,Spearman,-0.09,,,= 0.51,No,,,,Mennen 2006
3840,3941,3964,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Citrus fruits,Orange + Grapefruit,,31.5,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.8,,,umol/day,,53,Spearman,-0.17,,,= 0.21,No,,,,Mennen 2006
3859,3941,3967,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Citrus fruits,Orange + Grapefruit,,31.5,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Hesperetin,"",3.0,,,umol/day,,53,Spearman,0.45,,,= 0.0007,Yes,,,,Mennen 2006
3868,3941,3968,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Citrus fruits,Orange + Grapefruit,,31.5,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Naringenin,"",9.9,,,umol/day,,53,Spearman,0.28,,,= 0.04,Yes,,,,Mennen 2006
3880,3941,3969,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Citrus fruits,Orange + Grapefruit,,31.5,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Phloretin,"",0.73,,,umol/day,,53,Spearman,0.09,,,= 0.54,No,,,,Mennen 2006
3921,3941,3974,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Citrus fruits,Orange + Grapefruit,,31.5,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",6.2,,,umol/L,,53,Spearman,0.27,,,= 0.05,Yes,,,,Mennen 2006
3943,3941,3975,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Citrus fruits,Orange + Grapefruit,,31.5,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",2.7,,,umol/L,,53,Spearman,0.08,,,= 0.59,No,,,,Mennen 2006
4005,3941,3980,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Citrus fruits,Orange + Grapefruit,,31.5,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.4,,,umol/L,,53,Spearman,-0.07,,,= 0.61,No,,,,Mennen 2006
4024,3941,3983,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Citrus fruits,Orange + Grapefruit,,31.5,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Hesperetin,"",1.8,,,umol/L,,53,Spearman,0.42,,,= 0.002,Yes,,,,Mennen 2006
4033,3941,3984,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Citrus fruits,Orange + Grapefruit,,31.5,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Naringenin,"",5.6,,,umol/L,,53,Spearman,0.48,,,= 0.0003,Yes,,,,Mennen 2006
4045,3941,3985,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Citrus fruits,Orange + Grapefruit,,31.5,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Phloretin,"",0.42,,,umol/L,,53,Spearman,0.01,,,= 0.95,No,,,,Mennen 2006
3705,3942,3958,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Citrus fruits,Orange + Grapefruit + Grapefruit juice + Orange juice,,92.0,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",11.4,,,umol/day,,53,Spearman,-0.06,,,= 0.69,No,,,,Mennen 2006
3753,3942,3959,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Citrus fruits,Orange + Grapefruit + Grapefruit juice + Orange juice,,92.0,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",5.4,,,umol/day,,53,Spearman,0.04,,,= 0.78,No,,,,Mennen 2006
3841,3942,3964,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Citrus fruits,Orange + Grapefruit + Grapefruit juice + Orange juice,,92.0,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.8,,,umol/day,,53,Spearman,-0.19,,,= 0.18,No,,,,Mennen 2006
3860,3942,3967,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Citrus fruits,Orange + Grapefruit + Grapefruit juice + Orange juice,,92.0,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Hesperetin,"",3.0,,,umol/day,,53,Spearman,0.46,,,= 0.0006,Yes,,,,Mennen 2006
3869,3942,3968,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Citrus fruits,Orange + Grapefruit + Grapefruit juice + Orange juice,,92.0,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Naringenin,"",9.9,,,umol/day,,53,Spearman,0.37,,,= 0.007,Yes,,,,Mennen 2006
3881,3942,3969,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Citrus fruits,Orange + Grapefruit + Grapefruit juice + Orange juice,,92.0,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Phloretin,"",0.73,,,umol/day,,53,Spearman,0.11,,,= 0.46,No,,,,Mennen 2006
3922,3942,3974,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Citrus fruits,Orange + Grapefruit + Grapefruit juice + Orange juice,,92.0,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",6.2,,,umol/L,,53,Spearman,0.04,,,= 0.75,No,,,,Mennen 2006
3944,3942,3975,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Citrus fruits,Orange + Grapefruit + Grapefruit juice + Orange juice,,92.0,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",2.7,,,umol/L,,53,Spearman,0.02,,,= 0.9,No,,,,Mennen 2006
4006,3942,3980,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Citrus fruits,Orange + Grapefruit + Grapefruit juice + Orange juice,,92.0,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.4,,,umol/L,,53,Spearman,-0.07,,,= 0.64,No,,,,Mennen 2006
4025,3942,3983,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Citrus fruits,Orange + Grapefruit + Grapefruit juice + Orange juice,,92.0,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Hesperetin,"",1.8,,,umol/L,,53,Spearman,0.52,,,< 0.0001,Yes,,,,Mennen 2006
4034,3942,3984,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Citrus fruits,Orange + Grapefruit + Grapefruit juice + Orange juice,,92.0,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Naringenin,"",5.6,,,umol/L,,53,Spearman,0.56,,,< 0.0001,Yes,,,,Mennen 2006
4046,3942,3985,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Citrus fruits,Orange + Grapefruit + Grapefruit juice + Orange juice,,92.0,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Phloretin,"",0.42,,,umol/L,,53,Spearman,-0.02,,,= 0.92,No,,,,Mennen 2006
3688,3943,3957,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice,,267.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,5-Caffeoylquinic acid,"",4.2,,,umol/day,,53,Spearman,-0.07,,,= 0.48,No,,,,Mennen 2006
3706,3943,3958,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice,,267.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",11.4,,,umol/day,,53,Spearman,-0.15,,,= 0.28,No,,,,Mennen 2006
3754,3943,3959,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice,,267.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",5.4,,,umol/day,,53,Spearman,-0.06,,,= 0.68,No,,,,Mennen 2006
3776,3943,3960,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice,,267.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Gallic acid,"",1.6,,,umol/day,,53,Spearman,0.06,,,= 0.67,No,,,,Mennen 2006
3792,3943,3961,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice,,267.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,4-O-Methylgallic acid,"",6.1,,,umol/day,,53,Spearman,0.02,,,= 0.9,No,,,,Mennen 2006
3816,3943,3962,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice,,267.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Quercetin,"",0.7,,,umol/day,,53,Spearman,-0.02,,,= 0.87,No,,,,Mennen 2006
3826,3943,3963,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice,,267.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Isorhamnetin,"",0.5,,,umol/day,,53,Spearman,0.16,,,= 0.26,No,,,,Mennen 2006
3842,3943,3964,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice,,267.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.8,,,umol/day,,53,Spearman,0.27,,,= 0.05,Yes,,,,Mennen 2006
3861,3943,3967,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice,,267.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Hesperetin,"",3.0,,,umol/day,,53,Spearman,0.23,,,= 0.1,No,,,,Mennen 2006
3870,3943,3968,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice,,267.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Naringenin,"",9.9,,,umol/day,,53,Spearman,0.19,,,= 0.18,No,,,,Mennen 2006
3882,3943,3969,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice,,267.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Phloretin,"",0.73,,,umol/day,,53,Spearman,0.21,,,= 0.14,No,,,,Mennen 2006
3887,3943,3965,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice,,267.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",23.9,,,umol/day,,53,Spearman,0.07,,,= 0.6,No,,,,Mennen 2006
3896,3943,3966,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice,,267.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",2.0,,,umol/day,,53,Spearman,-0.1,,,= 0.47,No,,,,Mennen 2006
3905,3943,3973,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice,,267.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,5-Caffeoylquinic acid,"",6.6,,,umol/L,,53,Spearman,-0.1,,,= 0.48,No,,,,Mennen 2006
3923,3943,3974,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice,,267.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",6.2,,,umol/L,,53,Spearman,0.04,,,= 0.79,No,,,,Mennen 2006
3945,3943,3975,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice,,267.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",2.7,,,umol/L,,53,Spearman,-0.26,,,= 0.06,No,,,,Mennen 2006
3957,3943,3976,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice,,267.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Gallic acid,"",1.1,,,umol/L,,53,Spearman,-0.007,,,= 0.96,No,,,,Mennen 2006
3969,3943,3977,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice,,267.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,4-O-Methylgallic acid,"",4.4,,,umol/L,,53,Spearman,0.05,,,= 0.72,No,,,,Mennen 2006
3981,3943,3978,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice,,267.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Quercetin,"",0.4,,,umol/L,,53,Spearman,-0.21,,,= 0.14,No,,,,Mennen 2006
3991,3943,3979,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice,,267.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Isorhamnetin,"",0.3,,,umol/L,,53,Spearman,0.1,,,= 0.47,No,,,,Mennen 2006
4007,3943,3980,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice,,267.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.4,,,umol/L,,53,Spearman,0.3,,,= 0.03,Yes,,,,Mennen 2006
4026,3943,3983,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice,,267.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Hesperetin,"",1.8,,,umol/L,,53,Spearman,0.22,,,= 0.11,No,,,,Mennen 2006
4035,3943,3984,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice,,267.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Naringenin,"",5.6,,,umol/L,,53,Spearman,0.28,,,= 0.04,Yes,,,,Mennen 2006
4047,3943,3985,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice,,267.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Phloretin,"",0.42,,,umol/L,,53,Spearman,0.28,,,= 0.04,Yes,,,,Mennen 2006
4052,3943,3981,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice,,267.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",10.7,,,umol/L,,53,Spearman,0.13,,,= 0.34,No,,,,Mennen 2006
4061,3943,3982,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice,,267.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",0.8,,,umol/L,,53,Spearman,-0.07,,,= 0.61,No,,,,Mennen 2006
3689,3944,3957,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruit juices,"",,64.3,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,5-Caffeoylquinic acid,"",4.2,,,umol/day,,53,Spearman,-0.02,,,= 0.87,No,,,,Mennen 2006
3707,3944,3958,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruit juices,"",,64.3,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",11.4,,,umol/day,,53,Spearman,-0.01,,,= 0.93,No,,,,Mennen 2006
3755,3944,3959,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruit juices,"",,64.3,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",5.4,,,umol/day,,53,Spearman,0.1,,,= 0.47,No,,,,Mennen 2006
3777,3944,3960,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruit juices,"",,64.3,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Gallic acid,"",1.6,,,umol/day,,53,Spearman,0.18,,,= 0.19,No,,,,Mennen 2006
3793,3944,3961,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruit juices,"",,64.3,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,4-O-Methylgallic acid,"",6.1,,,umol/day,,53,Spearman,0.16,,,= 0.24,No,,,,Mennen 2006
3817,3944,3962,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruit juices,"",,64.3,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Quercetin,"",0.7,,,umol/day,,53,Spearman,0.1,,,= 0.49,No,,,,Mennen 2006
3827,3944,3963,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruit juices,"",,64.3,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Isorhamnetin,"",0.5,,,umol/day,,53,Spearman,0.14,,,= 0.32,No,,,,Mennen 2006
3843,3944,3964,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruit juices,"",,64.3,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.8,,,umol/day,,53,Spearman,-0.12,,,= 0.37,No,,,,Mennen 2006
3862,3944,3967,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruit juices,"",,64.3,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Hesperetin,"",3.0,,,umol/day,,53,Spearman,0.28,,,= 0.04,Yes,,,,Mennen 2006
3871,3944,3968,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruit juices,"",,64.3,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Naringenin,"",9.9,,,umol/day,,53,Spearman,0.37,,,= 0.007,Yes,,,,Mennen 2006
3883,3944,3969,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruit juices,"",,64.3,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Phloretin,"",0.73,,,umol/day,,53,Spearman,0.16,,,= 0.25,No,,,,Mennen 2006
3888,3944,3965,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruit juices,"",,64.3,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",23.9,,,umol/day,,53,Spearman,0.11,,,= 0.41,No,,,,Mennen 2006
3897,3944,3966,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruit juices,"",,64.3,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",2.0,,,umol/day,,53,Spearman,0.05,,,= 0.72,No,,,,Mennen 2006
3906,3944,3973,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruit juices,"",,64.3,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,5-Caffeoylquinic acid,"",6.6,,,umol/L,,53,Spearman,-0.25,,,= 0.07,No,,,,Mennen 2006
3924,3944,3974,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruit juices,"",,64.3,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",6.2,,,umol/L,,53,Spearman,-0.14,,,= 0.31,No,,,,Mennen 2006
3946,3944,3975,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruit juices,"",,64.3,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",2.7,,,umol/L,,53,Spearman,-0.13,,,= 0.34,No,,,,Mennen 2006
3958,3944,3976,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruit juices,"",,64.3,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Gallic acid,"",1.1,,,umol/L,,53,Spearman,0.33,,,= 0.02,Yes,,,,Mennen 2006
3970,3944,3977,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruit juices,"",,64.3,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,4-O-Methylgallic acid,"",4.4,,,umol/L,,53,Spearman,0.37,,,= 0.006,Yes,,,,Mennen 2006
3982,3944,3978,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruit juices,"",,64.3,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Quercetin,"",0.4,,,umol/L,,53,Spearman,0.07,,,= 0.62,No,,,,Mennen 2006
3992,3944,3979,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruit juices,"",,64.3,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Isorhamnetin,"",0.3,,,umol/L,,53,Spearman,0.3,,,= 0.03,Yes,,,,Mennen 2006
4008,3944,3980,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruit juices,"",,64.3,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.4,,,umol/L,,53,Spearman,0.007,,,= 0.96,No,,,,Mennen 2006
4027,3944,3983,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruit juices,"",,64.3,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Hesperetin,"",1.8,,,umol/L,,53,Spearman,0.39,,,= 0.004,Yes,,,,Mennen 2006
4036,3944,3984,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruit juices,"",,64.3,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Naringenin,"",5.6,,,umol/L,,53,Spearman,0.44,,,= 0.001,Yes,,,,Mennen 2006
4048,3944,3985,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruit juices,"",,64.3,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Phloretin,"",0.42,,,umol/L,,53,Spearman,0.09,,,= 0.51,No,,,,Mennen 2006
4053,3944,3981,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruit juices,"",,64.3,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",10.7,,,umol/L,,53,Spearman,0.09,,,= 0.53,No,,,,Mennen 2006
4062,3944,3982,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruit juices,"",,64.3,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",0.8,,,umol/L,,53,Spearman,0.04,,,= 0.77,No,,,,Mennen 2006
3690,3945,3957,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice + Fruit juices,,336.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,5-Caffeoylquinic acid,"",4.2,,,umol/day,,53,Spearman,-0.11,,,= 0.43,No,,,,Mennen 2006
3708,3945,3958,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice + Fruit juices,,336.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",11.4,,,umol/day,,53,Spearman,-0.17,,,= 0.23,No,,,,Mennen 2006
3756,3945,3959,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice + Fruit juices,,336.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",5.4,,,umol/day,,53,Spearman,-0.07,,,= 0.61,No,,,,Mennen 2006
3778,3945,3960,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice + Fruit juices,,336.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Gallic acid,"",1.6,,,umol/day,,53,Spearman,0.1,,,= 0.49,No,,,,Mennen 2006
3794,3945,3961,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice + Fruit juices,,336.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,4-O-Methylgallic acid,"",6.1,,,umol/day,,53,Spearman,0.02,,,= 0.87,No,,,,Mennen 2006
3818,3945,3962,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice + Fruit juices,,336.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Quercetin,"",0.7,,,umol/day,,53,Spearman,0.01,,,= 0.94,No,,,,Mennen 2006
3828,3945,3963,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice + Fruit juices,,336.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Isorhamnetin,"",0.5,,,umol/day,,53,Spearman,0.19,,,= 0.17,No,,,,Mennen 2006
3844,3945,3964,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice + Fruit juices,,336.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.8,,,umol/day,,53,Spearman,0.21,,,= 0.13,No,,,,Mennen 2006
3863,3945,3967,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice + Fruit juices,,336.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Hesperetin,"",3.0,,,umol/day,,53,Spearman,0.25,,,= 0.07,No,,,,Mennen 2006
3872,3945,3968,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice + Fruit juices,,336.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Naringenin,"",9.9,,,umol/day,,53,Spearman,0.35,,,= 0.01,Yes,,,,Mennen 2006
3884,3945,3969,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice + Fruit juices,,336.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Phloretin,"",0.73,,,umol/day,,53,Spearman,0.3,,,= 0.03,No,,,,Mennen 2006
3889,3945,3965,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice + Fruit juices,,336.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",23.9,,,umol/day,,53,Spearman,0.09,,,= 0.52,No,,,,Mennen 2006
3898,3945,3966,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice + Fruit juices,,336.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",2.0,,,umol/day,,53,Spearman,-0.02,,,= 0.86,No,,,,Mennen 2006
3907,3945,3973,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice + Fruit juices,,336.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,5-Caffeoylquinic acid,"",6.6,,,umol/L,,53,Spearman,-0.16,,,= 0.26,No,,,,Mennen 2006
3925,3945,3974,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice + Fruit juices,,336.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",6.2,,,umol/L,,53,Spearman,-0.006,,,= 0.97,No,,,,Mennen 2006
3947,3945,3975,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice + Fruit juices,,336.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",2.7,,,umol/L,,53,Spearman,-0.32,,,= 0.02,Yes,,,,Mennen 2006
3959,3945,3976,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice + Fruit juices,,336.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Gallic acid,"",1.1,,,umol/L,,53,Spearman,0.16,,,= 0.26,No,,,,Mennen 2006
3971,3945,3977,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice + Fruit juices,,336.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,4-O-Methylgallic acid,"",4.4,,,umol/L,,53,Spearman,0.22,,,= 0.12,No,,,,Mennen 2006
3983,3945,3978,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice + Fruit juices,,336.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Quercetin,"",0.4,,,umol/L,,53,Spearman,-0.13,,,= 0.35,No,,,,Mennen 2006
3993,3945,3979,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice + Fruit juices,,336.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Isorhamnetin,"",0.3,,,umol/L,,53,Spearman,0.21,,,= 0.12,No,,,,Mennen 2006
4009,3945,3980,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice + Fruit juices,,336.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.4,,,umol/L,,53,Spearman,0.29,,,= 0.04,Yes,,,,Mennen 2006
4028,3945,3983,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice + Fruit juices,,336.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Hesperetin,"",1.8,,,umol/L,,53,Spearman,0.32,,,= 0.02,No,,,,Mennen 2006
4037,3945,3984,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice + Fruit juices,,336.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Naringenin,"",5.6,,,umol/L,,53,Spearman,0.44,,,= 0.001,Yes,,,,Mennen 2006
4049,3945,3985,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice + Fruit juices,,336.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Phloretin,"",0.42,,,umol/L,,53,Spearman,0.31,,,= 0.03,Yes,,,,Mennen 2006
4054,3945,3981,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice + Fruit juices,,336.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",10.7,,,umol/L,,53,Spearman,0.13,,,= 0.37,No,,,,Mennen 2006
4063,3945,3982,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Fruits,Apple + Orange + Berries + Peach + Grapefruit + Grapefruit juice + Orange juice + Fruit juices,,336.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",0.8,,,umol/L,,53,Spearman,-0.007,,,= 0.96,No,,,,Mennen 2006
3691,3946,3957,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Vegetables,"",,277.0,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,5-Caffeoylquinic acid,"",4.2,,,umol/day,,53,Spearman,-0.14,,,= 0.32,No,,,,Mennen 2006
3709,3946,3958,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Vegetables,"",,277.0,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",11.4,,,umol/day,,53,Spearman,-0.05,,,= 0.71,No,,,,Mennen 2006
3757,3946,3959,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Vegetables,"",,277.0,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",5.4,,,umol/day,,53,Spearman,-0.1,,,= 0.47,No,,,,Mennen 2006
3779,3946,3960,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Vegetables,"",,277.0,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Gallic acid,"",1.6,,,umol/day,,53,Spearman,-0.26,,,= 0.06,No,,,,Mennen 2006
3795,3946,3961,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Vegetables,"",,277.0,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,4-O-Methylgallic acid,"",6.1,,,umol/day,,53,Spearman,-0.23,,,= 0.1,No,,,,Mennen 2006
3819,3946,3962,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Vegetables,"",,277.0,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Quercetin,"",0.7,,,umol/day,,53,Spearman,0.02,,,= 0.89,No,,,,Mennen 2006
3829,3946,3963,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Vegetables,"",,277.0,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Isorhamnetin,"",0.5,,,umol/day,,53,Spearman,-0.03,,,= 0.85,No,,,,Mennen 2006
3845,3946,3964,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Vegetables,"",,277.0,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.8,,,umol/day,,53,Spearman,0.17,,,= 0.22,No,,,,Mennen 2006
3890,3946,3965,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Vegetables,"",,277.0,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",23.9,,,umol/day,,53,Spearman,0.31,,,= 0.02,Yes,,,,Mennen 2006
3899,3946,3966,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Vegetables,"",,277.0,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",2.0,,,umol/day,,53,Spearman,-0.04,,,= 0.79,No,,,,Mennen 2006
3908,3946,3973,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Vegetables,"",,277.0,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,5-Caffeoylquinic acid,"",6.6,,,umol/L,,53,Spearman,0.11,,,= 0.45,No,,,,Mennen 2006
3926,3946,3974,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Vegetables,"",,277.0,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",6.2,,,umol/L,,53,Spearman,-0.19,,,= 0.17,No,,,,Mennen 2006
3948,3946,3975,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Vegetables,"",,277.0,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",2.7,,,umol/L,,53,Spearman,-0.12,,,= 0.38,No,,,,Mennen 2006
3960,3946,3976,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Vegetables,"",,277.0,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Gallic acid,"",1.1,,,umol/L,,53,Spearman,-0.27,,,= 0.05,Yes,,,,Mennen 2006
3972,3946,3977,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Vegetables,"",,277.0,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,4-O-Methylgallic acid,"",4.4,,,umol/L,,53,Spearman,-0.23,,,= 0.1,No,,,,Mennen 2006
3984,3946,3978,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Vegetables,"",,277.0,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Quercetin,"",0.4,,,umol/L,,53,Spearman,0.04,,,= 0.77,No,,,,Mennen 2006
3994,3946,3979,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Vegetables,"",,277.0,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Isorhamnetin,"",0.3,,,umol/L,,53,Spearman,-0.12,,,= 0.41,No,,,,Mennen 2006
4010,3946,3980,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Vegetables,"",,277.0,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.4,,,umol/L,,53,Spearman,0.12,,,= 0.38,No,,,,Mennen 2006
4055,3946,3981,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Vegetables,"",,277.0,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",10.7,,,umol/L,,53,Spearman,-0.09,,,= 0.53,No,,,,Mennen 2006
4064,3946,3982,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Vegetables,"",,277.0,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",0.8,,,umol/L,,53,Spearman,-0.17,,,= 0.22,No,,,,Mennen 2006
3710,3947,3958,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Onion,"",,6.3,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",11.4,,,umol/day,,53,Spearman,-0.13,,,= 0.36,No,,,,Mennen 2006
3758,3947,3959,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Onion,"",,6.3,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",5.4,,,umol/day,,53,Spearman,0.05,,,= 0.74,No,,,,Mennen 2006
3780,3947,3960,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Onion,"",,6.3,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Gallic acid,"",1.6,,,umol/day,,53,Spearman,-0.1,,,= 0.47,No,,,,Mennen 2006
3796,3947,3961,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Onion,"",,6.3,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,4-O-Methylgallic acid,"",6.1,,,umol/day,,53,Spearman,-0.21,,,= 0.13,No,,,,Mennen 2006
3820,3947,3962,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Onion,"",,6.3,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Quercetin,"",0.7,,,umol/day,,53,Spearman,0.05,,,= 0.72,No,,,,Mennen 2006
3830,3947,3963,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Onion,"",,6.3,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Isorhamnetin,"",0.5,,,umol/day,,53,Spearman,-0.05,,,= 0.73,No,,,,Mennen 2006
3846,3947,3964,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Onion,"",,6.3,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.8,,,umol/day,,53,Spearman,-0.06,,,= 0.7,No,,,,Mennen 2006
3927,3947,3974,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Onion,"",,6.3,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",6.2,,,umol/L,,53,Spearman,-0.14,,,= 0.32,No,,,,Mennen 2006
3949,3947,3975,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Onion,"",,6.3,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",2.7,,,umol/L,,53,Spearman,-0.06,,,= 0.65,No,,,,Mennen 2006
3961,3947,3976,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Onion,"",,6.3,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Gallic acid,"",1.1,,,umol/L,,53,Spearman,0.02,,,= 0.86,No,,,,Mennen 2006
3973,3947,3977,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Onion,"",,6.3,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,4-O-Methylgallic acid,"",4.4,,,umol/L,,53,Spearman,0.01,,,= 0.92,No,,,,Mennen 2006
3985,3947,3978,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Onion,"",,6.3,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Quercetin,"",0.4,,,umol/L,,53,Spearman,0.15,,,= 0.3,No,,,,Mennen 2006
3995,3947,3979,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Onion,"",,6.3,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Isorhamnetin,"",0.3,,,umol/L,,53,Spearman,-0.03,,,= 0.81,No,,,,Mennen 2006
4011,3947,3980,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Onion,"",,6.3,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.4,,,umol/L,,53,Spearman,0.13,,,= 0.34,No,,,,Mennen 2006
3711,3949,3958,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Dark bread,"",,18.8,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",11.4,,,umol/day,,53,Spearman,-0.2,,,= 0.16,No,,,,Mennen 2006
3847,3949,3964,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Dark bread,"",,18.8,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.8,,,umol/day,,53,Spearman,-0.009,,,= 0.95,No,,,,Mennen 2006
3891,3949,3965,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Dark bread,"",,18.8,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",23.9,,,umol/day,,53,Spearman,0.18,,,= 0.19,No,,,,Mennen 2006
3900,3949,3966,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Dark bread,"",,18.8,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",2.0,,,umol/day,,53,Spearman,0.24,,,= 0.08,No,,,,Mennen 2006
3928,3949,3974,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Dark bread,"",,18.8,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",6.2,,,umol/L,,53,Spearman,-0.09,,,= 0.51,No,,,,Mennen 2006
4012,3949,3980,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Dark bread,"",,18.8,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.4,,,umol/L,,53,Spearman,0.03,,,= 0.81,No,,,,Mennen 2006
4056,3949,3981,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Dark bread,"",,18.8,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",10.7,,,umol/L,,53,Spearman,0.05,,,= 0.74,No,,,,Mennen 2006
4065,3949,3982,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Dark bread,"",,18.8,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",0.8,,,umol/L,,53,Spearman,0.18,,,= 0.2,No,,,,Mennen 2006
3712,3950,3958,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Cereals,"",,33.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",11.4,,,umol/day,,53,Spearman,-0.08,,,= 0.56,No,,,,Mennen 2006
3848,3950,3964,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Cereals,"",,33.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.8,,,umol/day,,53,Spearman,-0.07,,,= 0.63,No,,,,Mennen 2006
3892,3950,3965,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Cereals,"",,33.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",23.9,,,umol/day,,53,Spearman,-0.002,,,= 0.99,No,,,,Mennen 2006
3901,3950,3966,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Cereals,"",,33.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",2.0,,,umol/day,,53,Spearman,0.06,,,= 0.69,No,,,,Mennen 2006
3929,3950,3974,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Cereals,"",,33.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",6.2,,,umol/L,,53,Spearman,0.15,,,= 0.28,No,,,,Mennen 2006
4013,3950,3980,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Cereals,"",,33.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.4,,,umol/L,,53,Spearman,0.05,,,= 0.74,No,,,,Mennen 2006
4057,3950,3981,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Cereals,"",,33.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",10.7,,,umol/L,,53,Spearman,-0.004,,,= 0.98,No,,,,Mennen 2006
4066,3950,3982,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Cereals,"",,33.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",0.8,,,umol/L,,53,Spearman,0.1,,,= 0.48,No,,,,Mennen 2006
3692,3951,3957,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Potato,"",,56.4,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,5-Caffeoylquinic acid,"",4.2,,,umol/day,,53,Spearman,0.1,,,= 0.46,No,,,,Mennen 2006
3713,3951,3958,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Potato,"",,56.4,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",11.4,,,umol/day,,53,Spearman,0.02,,,= 0.9,No,,,,Mennen 2006
3849,3951,3964,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Potato,"",,56.4,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.8,,,umol/day,,53,Spearman,0.03,,,= 0.84,No,,,,Mennen 2006
3893,3951,3965,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Potato,"",,56.4,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",23.9,,,umol/day,,53,Spearman,0.06,,,= 0.67,No,,,,Mennen 2006
3902,3951,3966,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Potato,"",,56.4,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",2.0,,,umol/day,,53,Spearman,-0.06,,,= 0.65,No,,,,Mennen 2006
3909,3951,3973,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Potato,"",,56.4,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,5-Caffeoylquinic acid,"",6.6,,,umol/L,,53,Spearman,0.1,,,= 0.49,No,,,,Mennen 2006
3930,3951,3974,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Potato,"",,56.4,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",6.2,,,umol/L,,53,Spearman,0.01,,,= 0.92,No,,,,Mennen 2006
4014,3951,3980,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Potato,"",,56.4,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.4,,,umol/L,,53,Spearman,-0.02,,,= 0.89,No,,,,Mennen 2006
4058,3951,3981,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Potato,"",,56.4,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Enterolactone,"",10.7,,,umol/L,,53,Spearman,0.23,,,= 0.1,No,,,,Mennen 2006
4067,3951,3982,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Potato,"",,56.4,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",0.8,,,umol/L,,53,Spearman,0.01,,,= 0.94,No,,,,Mennen 2006
3714,3952,3958,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Chocolate,"",,11.4,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",11.4,,,umol/day,,53,Spearman,-0.04,,,= 0.79,No,,,,Mennen 2006
3762,3952,3959,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Chocolate,"",,11.4,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",5.4,,,umol/day,,53,Spearman,0.17,,,= 0.22,No,,,,Mennen 2006
3784,3952,3960,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Chocolate,"",,11.4,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Gallic acid,"",1.6,,,umol/day,,53,Spearman,-0.09,,,= 0.5,No,,,,Mennen 2006
3797,3952,3961,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Chocolate,"",,11.4,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,4-O-Methylgallic acid,"",6.1,,,umol/day,,53,Spearman,-0.07,,,= 0.64,No,,,,Mennen 2006
3850,3952,3964,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Chocolate,"",,11.4,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.8,,,umol/day,,53,Spearman,0.05,,,= 0.73,No,,,,Mennen 2006
3931,3952,3974,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Chocolate,"",,11.4,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",6.2,,,umol/L,,53,Spearman,0.21,,,= 0.13,No,,,,Mennen 2006
3950,3952,3975,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Chocolate,"",,11.4,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",2.7,,,umol/L,,53,Spearman,-0.03,,,= 0.85,No,,,,Mennen 2006
3962,3952,3976,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Chocolate,"",,11.4,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Gallic acid,"",1.1,,,umol/L,,53,Spearman,0.02,,,= 0.84,No,,,,Mennen 2006
3974,3952,3977,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Chocolate,"",,11.4,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,4-O-Methylgallic acid,"",4.4,,,umol/L,,53,Spearman,0.08,,,= 0.55,No,,,,Mennen 2006
4015,3952,3980,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Chocolate,"",,11.4,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.4,,,umol/L,,53,Spearman,0.1,,,= 0.49,No,,,,Mennen 2006
4068,3952,3982,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Chocolate,"",,11.4,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Enterodiol,"",0.8,,,umol/L,,53,Spearman,-0.11,,,= 0.45,No,,,,Mennen 2006
3693,3953,3957,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Coffee,"",,250.0,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,5-Caffeoylquinic acid,"",4.2,,,umol/day,,53,Spearman,0.24,,,= 0.09,No,,,,Mennen 2006
3715,3953,3958,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Coffee,"",,250.0,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",11.4,,,umol/day,,53,Spearman,0.24,,,= 0.08,No,,,,Mennen 2006
3851,3953,3964,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Coffee,"",,250.0,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.8,,,umol/day,,53,Spearman,0.02,,,= 0.9,No,,,,Mennen 2006
3910,3953,3973,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Coffee,"",,250.0,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,5-Caffeoylquinic acid,"",6.6,,,umol/L,,53,Spearman,0.63,,,< 0.0001,Yes,,,,Mennen 2006
3932,3953,3974,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Coffee,"",,250.0,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",6.2,,,umol/L,,53,Spearman,0.29,,,= 0.03,Yes,,,,Mennen 2006
4016,3953,3980,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Coffee,"",,250.0,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.4,,,umol/L,,53,Spearman,-0.21,,,= 0.13,No,,,,Mennen 2006
3694,3954,3957,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Black tea,"",,259.9,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,5-Caffeoylquinic acid,"",4.2,,,umol/day,,53,Spearman,-0.13,,,= 0.37,No,,,,Mennen 2006
3716,3954,3958,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Black tea,"",,259.9,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",11.4,,,umol/day,,53,Spearman,-0.22,,,= 0.11,No,,,,Mennen 2006
3764,3954,3959,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Black tea,"",,259.9,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",5.4,,,umol/day,,53,Spearman,-0.14,,,= 0.32,No,,,,Mennen 2006
3786,3954,3960,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Black tea,"",,259.9,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Gallic acid,"",1.6,,,umol/day,,53,Spearman,0.06,,,= 0.69,No,,,,Mennen 2006
3798,3954,3961,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Black tea,"",,259.9,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,4-O-Methylgallic acid,"",6.1,,,umol/day,,53,Spearman,-0.006,,,= 0.97,No,,,,Mennen 2006
3821,3954,3962,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Black tea,"",,259.9,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Quercetin,"",0.7,,,umol/day,,53,Spearman,-0.1,,,= 0.48,No,,,,Mennen 2006
3831,3954,3963,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Black tea,"",,259.9,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Isorhamnetin,"",0.5,,,umol/day,,53,Spearman,-0.006,,,= 0.97,No,,,,Mennen 2006
3852,3954,3964,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Black tea,"",,259.9,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.8,,,umol/day,,53,Spearman,-0.03,,,= 0.85,No,,,,Mennen 2006
3911,3954,3973,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Black tea,"",,259.9,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,5-Caffeoylquinic acid,"",6.6,,,umol/L,,53,Spearman,-0.31,,,= 0.03,Yes,,,,Mennen 2006
3933,3954,3974,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Black tea,"",,259.9,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",6.2,,,umol/L,,53,Spearman,-0.2,,,= 0.16,No,,,,Mennen 2006
3951,3954,3975,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Black tea,"",,259.9,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",2.7,,,umol/L,,53,Spearman,-0.44,,,= 0.001,Yes,,,,Mennen 2006
3963,3954,3976,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Black tea,"",,259.9,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Gallic acid,"",1.1,,,umol/L,,53,Spearman,0.45,,,= 0.0008,Yes,,,,Mennen 2006
3975,3954,3977,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Black tea,"",,259.9,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,4-O-Methylgallic acid,"",4.4,,,umol/L,,53,Spearman,0.54,,,< 0.0001,Yes,,,,Mennen 2006
3986,3954,3978,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Black tea,"",,259.9,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Quercetin,"",0.4,,,umol/L,,53,Spearman,0.18,,,= 0.2,No,,,,Mennen 2006
3996,3954,3979,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Black tea,"",,259.9,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Isorhamnetin,"",0.3,,,umol/L,,53,Spearman,0.18,,,= 0.21,No,,,,Mennen 2006
4017,3954,3980,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Black tea,"",,259.9,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.4,,,umol/L,,53,Spearman,0.27,,,= 0.05,Yes,,,,Mennen 2006
3695,3955,3957,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Herbal tea,"",,25.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,5-Caffeoylquinic acid,"",4.2,,,umol/day,,53,Spearman,-0.13,,,= 0.36,No,,,,Mennen 2006
3717,3955,3958,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Herbal tea,"",,25.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",11.4,,,umol/day,,53,Spearman,0.02,,,= 0.89,No,,,,Mennen 2006
3765,3955,3959,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Herbal tea,"",,25.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",5.4,,,umol/day,,53,Spearman,0.21,,,= 0.14,No,,,,Mennen 2006
3787,3955,3960,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Herbal tea,"",,25.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Gallic acid,"",1.6,,,umol/day,,53,Spearman,-0.02,,,= 0.89,No,,,,Mennen 2006
3799,3955,3961,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Herbal tea,"",,25.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,4-O-Methylgallic acid,"",6.1,,,umol/day,,53,Spearman,-0.27,,,= 0.05,No,,,,Mennen 2006
3822,3955,3962,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Herbal tea,"",,25.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Quercetin,"",0.7,,,umol/day,,53,Spearman,0.1,,,= 0.49,No,,,,Mennen 2006
3832,3955,3963,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Herbal tea,"",,25.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Isorhamnetin,"",0.5,,,umol/day,,53,Spearman,0.04,,,= 0.79,No,,,,Mennen 2006
3853,3955,3964,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Herbal tea,"",,25.7,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.8,,,umol/day,,53,Spearman,0.15,,,= 0.27,No,,,,Mennen 2006
3912,3955,3973,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Herbal tea,"",,25.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,5-Caffeoylquinic acid,"",6.6,,,umol/L,,53,Spearman,-0.11,,,= 0.44,No,,,,Mennen 2006
3934,3955,3974,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Herbal tea,"",,25.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",6.2,,,umol/L,,53,Spearman,0.01,,,= 0.93,No,,,,Mennen 2006
3952,3955,3975,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Herbal tea,"",,25.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",2.7,,,umol/L,,53,Spearman,0.14,,,= 0.33,No,,,,Mennen 2006
3964,3955,3976,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Herbal tea,"",,25.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Gallic acid,"",1.1,,,umol/L,,53,Spearman,0.09,,,= 0.54,No,,,,Mennen 2006
3976,3955,3977,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Herbal tea,"",,25.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,4-O-Methylgallic acid,"",4.4,,,umol/L,,53,Spearman,0.14,,,= 0.33,No,,,,Mennen 2006
3987,3955,3978,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Herbal tea,"",,25.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Quercetin,"",0.4,,,umol/L,,53,Spearman,0.12,,,= 0.38,No,,,,Mennen 2006
3997,3955,3979,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Herbal tea,"",,25.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Isorhamnetin,"",0.3,,,umol/L,,53,Spearman,0.25,,,= 0.07,No,,,,Mennen 2006
4018,3955,3980,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Herbal tea,"",,25.7,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.4,,,umol/L,,53,Spearman,-0.005,,,= 0.97,No,,,,Mennen 2006
3696,3956,3957,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Wine,"",,104.2,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,5-Caffeoylquinic acid,"",4.2,,,umol/day,,53,Spearman,0.25,,,= 0.07,No,,,,Mennen 2006
3718,3956,3958,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Wine,"",,104.2,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",11.4,,,umol/day,,53,Spearman,0.38,,,= 0.005,Yes,,,,Mennen 2006
3766,3956,3959,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Wine,"",,104.2,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",5.4,,,umol/day,,53,Spearman,0.18,,,= 0.19,No,,,,Mennen 2006
3788,3956,3960,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Wine,"",,104.2,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Gallic acid,"",1.6,,,umol/day,,53,Spearman,0.7,,,< 0.0001,Yes,,,,Mennen 2006
3800,3956,3961,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Wine,"",,104.2,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,4-O-Methylgallic acid,"",6.1,,,umol/day,,53,Spearman,0.52,,,< 0.0001,Yes,,,,Mennen 2006
3854,3956,3964,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Wine,"",,104.2,,,g/day,,,"Urine, 24-h",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.8,,,umol/day,,53,Spearman,0.11,,,= 0.42,No,,,,Mennen 2006
3913,3956,3973,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Wine,"",,104.2,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,5-Caffeoylquinic acid,"",6.6,,,umol/L,,53,Spearman,-0.01,,,= 0.93,No,,,,Mennen 2006
3935,3956,3974,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Wine,"",,104.2,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Caffeic acid,"",6.2,,,umol/L,,53,Spearman,-0.06,,,= 0.69,No,,,,Mennen 2006
3953,3956,3975,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Wine,"",,104.2,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,m-Coumaric acid,"",2.7,,,umol/L,,53,Spearman,0.16,,,= 0.26,No,,,,Mennen 2006
3965,3956,3976,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Wine,"",,104.2,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Gallic acid,"",1.1,,,umol/L,,53,Spearman,0.45,,,= 0.0007,Yes,,,,Mennen 2006
3977,3956,3977,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Wine,"",,104.2,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,4-O-Methylgallic acid,"",4.4,,,umol/L,,53,Spearman,0.37,,,= 0.006,Yes,,,,Mennen 2006
4019,3956,3980,All [by intake],Adults living in the Parisian area,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (2-day),Wine,"",,104.2,,,g/day,,,"Urine, first morning spot",LC-MS/MS after enzymatic hydrolysis,Kaempferol,"",0.4,,,umol/L,,53,Spearman,0.12,,,= 0.39,No,,,,Mennen 2006
4069,3989,3991,All,Pregnant women participant in the dietary validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Acrylamide,"",,,,0.48,ug/day/kg,Body weight,,"Urine, 24-h",LC-MS,Acrylamide metabolites,N-Acetyl-S-(3-amino-3-oxopropyl)cysteine + N-Acetyl-S-(3-amino-2-hydroxy-3-oxopropyl)cysteine,,,0.16,ug/day,,116,Spearman,0.26,,,= 0.005,Yes,,,,Brantsaeter 2008
4071,3992,3991,All,Pregnant women participant in the dietary validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Food Frequency Questionnaire (FFQ),Acrylamide,"",,,,,ug/day,,,"Urine, 24-h",LC-MS,Acrylamide metabolites,N-Acetyl-S-(3-amino-3-oxopropyl)cysteine + N-Acetyl-S-(3-amino-2-hydroxy-3-oxopropyl)cysteine,,,0.16,ug/day,,116,Spearman,0.19,,,= 0.047,Yes,,,,Brantsaeter 2008
4070,3990,3991,All,Pregnant women participant in the dietary validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Acrylamide,"",,,,0.41,ug/day/kg,Body weight,,"Urine, 24-h",LC-MS,Acrylamide metabolites,N-Acetyl-S-(3-amino-3-oxopropyl)cysteine + N-Acetyl-S-(3-amino-2-hydroxy-3-oxopropyl)cysteine,,,0.16,ug/day,,116,Spearman,0.34,,,< 0.001,Yes,,,,Brantsaeter 2008
4072,3993,3991,All,Pregnant women participant in the dietary validation study of the MoBa cohort,Norway,MoBa (Norwegian Mother and Child Cohort),,Weighed Dietary record (4-day),Acrylamide,"",,,,,ug/day,,,"Urine, 24-h",LC-MS,Acrylamide metabolites,N-Acetyl-S-(3-amino-3-oxopropyl)cysteine + N-Acetyl-S-(3-amino-2-hydroxy-3-oxopropyl)cysteine,,,0.16,ug/day,,116,Spearman,0.29,,,= 0.002,Yes,,,,Brantsaeter 2008
4073,4015,4008,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Tomato + Carrot + Root vegetables + Leafy vegetables + Citrus fruits + Cabbage-family vegetables,,,,,missing unit,,,"Plasma, unspecified",HPLC,Lutein,"",,,,umol/L,,2969,Spearman,0.38,,,< 0.05,Yes,,,,Al-Delaimy 2005
4093,4015,4009,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Tomato + Carrot + Root vegetables + Leafy vegetables + Citrus fruits + Cabbage-family vegetables,,,,,missing unit,,,"Plasma, unspecified",HPLC,Zeaxanthin,"",,,,umol/L,,2969,Spearman,0.36,,,< 0.05,Yes,,,,Al-Delaimy 2005
4113,4015,4010,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Tomato + Carrot + Root vegetables + Leafy vegetables + Citrus fruits + Cabbage-family vegetables,,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,2969,Spearman,0.46,,,< 0.05,Yes,,,,Al-Delaimy 2005
4133,4015,4011,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Tomato + Carrot + Root vegetables + Leafy vegetables + Citrus fruits + Cabbage-family vegetables,,,,,missing unit,,,"Plasma, unspecified",HPLC,Lycopene,"",,,,umol/L,,2969,Spearman,0.24,,,< 0.05,Yes,,,,Al-Delaimy 2005
4153,4015,4012,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Tomato + Carrot + Root vegetables + Leafy vegetables + Citrus fruits + Cabbage-family vegetables,,,,,missing unit,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,2969,Spearman,0.09,,,< 0.05,Yes,,,,Al-Delaimy 2005
4173,4015,4013,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Tomato + Carrot + Root vegetables + Leafy vegetables + Citrus fruits + Cabbage-family vegetables,,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,2969,Spearman,0.17,,,< 0.05,Yes,,,,Al-Delaimy 2005
4193,4015,4014,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Tomato + Carrot + Root vegetables + Leafy vegetables + Citrus fruits + Cabbage-family vegetables,,,,,missing unit,,,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,umol/L,,2969,Spearman,0.38,,,< 0.05,Yes,,,,Al-Delaimy 2005
4075,4016,4008,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vegetables,Tomato + Carrot + Root vegetables + Leafy vegetables + Cabbage-family vegetables,,,,,missing unit,,,"Plasma, unspecified",HPLC,Lutein,"",,,,umol/L,,2969,Spearman,0.3,,,< 0.05,Yes,,,,Al-Delaimy 2005
4095,4016,4009,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vegetables,Tomato + Carrot + Root vegetables + Leafy vegetables + Cabbage-family vegetables,,,,,missing unit,,,"Plasma, unspecified",HPLC,Zeaxanthin,"",,,,umol/L,,2969,Spearman,0.26,,,< 0.05,Yes,,,,Al-Delaimy 2005
4115,4016,4010,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vegetables,Tomato + Carrot + Root vegetables + Leafy vegetables + Cabbage-family vegetables,,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,2969,Spearman,0.26,,,< 0.05,Yes,,,,Al-Delaimy 2005
4135,4016,4011,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vegetables,Tomato + Carrot + Root vegetables + Leafy vegetables + Cabbage-family vegetables,,,,,missing unit,,,"Plasma, unspecified",HPLC,Lycopene,"",,,,umol/L,,2969,Spearman,0.19,,,< 0.05,Yes,,,,Al-Delaimy 2005
4155,4016,4012,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vegetables,Tomato + Carrot + Root vegetables + Leafy vegetables + Cabbage-family vegetables,,,,,missing unit,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,2969,Spearman,0.16,,,< 0.05,Yes,,,,Al-Delaimy 2005
4175,4016,4013,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vegetables,Tomato + Carrot + Root vegetables + Leafy vegetables + Cabbage-family vegetables,,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,2969,Spearman,0.21,,,< 0.05,Yes,,,,Al-Delaimy 2005
4195,4016,4014,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vegetables,Tomato + Carrot + Root vegetables + Leafy vegetables + Cabbage-family vegetables,,,,,missing unit,,,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,umol/L,,2969,Spearman,0.31,,,< 0.05,Yes,,,,Al-Delaimy 2005
4077,4017,4008,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Leafy vegetables,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Lutein,"",,,,umol/L,,2969,Spearman,0.24,,,< 0.05,Yes,,,,Al-Delaimy 2005
4097,4017,4009,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Leafy vegetables,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Zeaxanthin,"",,,,umol/L,,2969,Spearman,0.27,,,< 0.05,Yes,,,,Al-Delaimy 2005
4117,4017,4010,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Leafy vegetables,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,2969,Spearman,0.25,,,< 0.05,Yes,,,,Al-Delaimy 2005
4137,4017,4011,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Leafy vegetables,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Lycopene,"",,,,umol/L,,2969,Spearman,0.06,,,< 0.05,Yes,,,,Al-Delaimy 2005
4157,4017,4012,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Leafy vegetables,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,2969,Spearman,0.06,,,< 0.05,Yes,,,,Al-Delaimy 2005
4177,4017,4013,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Leafy vegetables,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,2969,Spearman,0.12,,,< 0.05,Yes,,,,Al-Delaimy 2005
4197,4017,4014,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Leafy vegetables,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,umol/L,,2969,Spearman,0.2,,,< 0.05,Yes,,,,Al-Delaimy 2005
4099,4018,4009,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Root vegetables,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Zeaxanthin,"",,,,umol/L,,2969,Spearman,-0.08,,,< 0.05,Yes,,,,Al-Delaimy 2005
4119,4018,4010,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Root vegetables,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,2969,Spearman,-0.07,,,< 0.05,Yes,,,,Al-Delaimy 2005
4139,4018,4011,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Root vegetables,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Lycopene,"",,,,umol/L,,2969,Spearman,-0.06,,,< 0.05,Yes,,,,Al-Delaimy 2005
4159,4018,4012,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Root vegetables,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,2969,Spearman,0.39,,,< 0.05,Yes,,,,Al-Delaimy 2005
4179,4018,4013,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Root vegetables,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,2969,Spearman,0.18,,,< 0.05,Yes,,,,Al-Delaimy 2005
4199,4018,4014,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Root vegetables,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,umol/L,,2969,Spearman,0.05,,,< 0.05,Yes,,,,Al-Delaimy 2005
4101,4019,4009,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Cabbage-family vegetables,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Zeaxanthin,"",,,,umol/L,,2969,Spearman,-0.06,,,< 0.05,Yes,,,,Al-Delaimy 2005
4121,4019,4010,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Cabbage-family vegetables,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,2969,Spearman,-0.07,,,< 0.05,Yes,,,,Al-Delaimy 2005
4161,4019,4012,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Cabbage-family vegetables,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,2969,Spearman,0.18,,,< 0.05,Yes,,,,Al-Delaimy 2005
4181,4019,4013,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Cabbage-family vegetables,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,2969,Spearman,0.09,,,< 0.05,Yes,,,,Al-Delaimy 2005
4083,4020,4008,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Tomato,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Lutein,"",,,,umol/L,,2298,Spearman,0.36,,,< 0.05,Yes,,,,Al-Delaimy 2005
4103,4020,4009,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Tomato,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Zeaxanthin,"",,,,umol/L,,2298,Spearman,0.25,,,< 0.05,Yes,,,,Al-Delaimy 2005
4123,4020,4010,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Tomato,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,2298,Spearman,0.25,,,< 0.05,Yes,,,,Al-Delaimy 2005
4143,4020,4011,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Tomato,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Lycopene,"",,,,umol/L,,2298,Spearman,0.38,,,< 0.05,Yes,,,,Al-Delaimy 2005
4163,4020,4012,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Tomato,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,2298,Spearman,0.08,,,< 0.05,Yes,,,,Al-Delaimy 2005
4183,4020,4013,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Tomato,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,2298,Spearman,0.19,,,< 0.05,Yes,,,,Al-Delaimy 2005
4203,4020,4014,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Tomato,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,umol/L,,2298,Spearman,0.39,,,< 0.05,Yes,,,,Al-Delaimy 2005
4105,4021,4009,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Carrot,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Zeaxanthin,"",,,,umol/L,,2969,Spearman,-0.05,,,< 0.05,Yes,,,,Al-Delaimy 2005
4165,4021,4012,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Carrot,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,2969,Spearman,0.38,,,< 0.05,Yes,,,,Al-Delaimy 2005
4185,4021,4013,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Carrot,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,2969,Spearman,0.18,,,< 0.05,Yes,,,,Al-Delaimy 2005
4205,4021,4014,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Carrot,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,umol/L,,2969,Spearman,0.08,,,< 0.05,Yes,,,,Al-Delaimy 2005
4087,4022,4008,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,Fruits + Citrus fruits,,,,,missing unit,,,"Plasma, unspecified",HPLC,Lutein,"",,,,umol/L,,2969,Spearman,0.37,,,< 0.05,Yes,,,,Al-Delaimy 2005
4107,4022,4009,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,Fruits + Citrus fruits,,,,,missing unit,,,"Plasma, unspecified",HPLC,Zeaxanthin,"",,,,umol/L,,2969,Spearman,0.37,,,< 0.05,Yes,,,,Al-Delaimy 2005
4127,4022,4010,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,Fruits + Citrus fruits,,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,2969,Spearman,0.52,,,< 0.05,Yes,,,,Al-Delaimy 2005
4147,4022,4011,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,Fruits + Citrus fruits,,,,,missing unit,,,"Plasma, unspecified",HPLC,Lycopene,"",,,,umol/L,,2969,Spearman,0.22,,,< 0.05,Yes,,,,Al-Delaimy 2005
4187,4022,4013,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,Fruits + Citrus fruits,,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,2969,Spearman,0.11,,,< 0.05,Yes,,,,Al-Delaimy 2005
4207,4022,4014,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,Fruits + Citrus fruits,,,,,missing unit,,,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,umol/L,,2969,Spearman,0.36,,,< 0.05,Yes,,,,Al-Delaimy 2005
4089,4023,4008,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Lutein,"",,,,umol/L,,2390,Spearman,0.42,,,< 0.05,Yes,,,,Al-Delaimy 2005
4109,4023,4009,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Zeaxanthin,"",,,,umol/L,,2390,Spearman,0.32,,,< 0.05,Yes,,,,Al-Delaimy 2005
4129,4023,4010,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,2390,Spearman,0.4,,,< 0.05,Yes,,,,Al-Delaimy 2005
4149,4023,4011,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Lycopene,"",,,,umol/L,,2390,Spearman,0.32,,,< 0.05,Yes,,,,Al-Delaimy 2005
4169,4023,4012,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,2390,Spearman,0.18,,,< 0.05,Yes,,,,Al-Delaimy 2005
4189,4023,4013,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,2390,Spearman,0.24,,,< 0.05,Yes,,,,Al-Delaimy 2005
4209,4023,4014,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,umol/L,,2390,Spearman,0.43,,,< 0.05,Yes,,,,Al-Delaimy 2005
4091,4024,4008,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Lutein,"",,,,umol/L,,2390,Spearman,0.16,,,< 0.05,Yes,,,,Al-Delaimy 2005
4111,4024,4009,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Zeaxanthin,"",,,,umol/L,,2390,Spearman,0.14,,,< 0.05,Yes,,,,Al-Delaimy 2005
4131,4024,4010,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,2390,Spearman,0.41,,,< 0.05,Yes,,,,Al-Delaimy 2005
4151,4024,4011,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Lycopene,"",,,,umol/L,,2390,Spearman,0.1,,,< 0.05,Yes,,,,Al-Delaimy 2005
4171,4024,4012,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,2390,Spearman,0.06,,,< 0.05,Yes,,,,Al-Delaimy 2005
4191,4024,4013,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,2390,Spearman,0.09,,,< 0.05,Yes,,,,Al-Delaimy 2005
4211,4024,4014,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,umol/L,,2390,Spearman,0.2,,,< 0.05,Yes,,,,Al-Delaimy 2005
4074,4025,4008,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Fruits + Vegetables,Fruits + Tomato + Carrot + Root vegetables + Leafy vegetables + Citrus fruits + Cabbage-family vegetables,,,,,missing unit,,,"Plasma, unspecified",HPLC,Lutein,"",,,,umol/L,,2974,Spearman,0.31,,,< 0.05,Yes,,,,Al-Delaimy 2005
4094,4025,4009,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Fruits + Vegetables,Fruits + Tomato + Carrot + Root vegetables + Leafy vegetables + Citrus fruits + Cabbage-family vegetables,,,,,missing unit,,,"Plasma, unspecified",HPLC,Zeaxanthin,"",,,,umol/L,,2974,Spearman,0.32,,,< 0.05,Yes,,,,Al-Delaimy 2005
4114,4025,4010,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Fruits + Vegetables,Fruits + Tomato + Carrot + Root vegetables + Leafy vegetables + Citrus fruits + Cabbage-family vegetables,,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,2974,Spearman,0.39,,,< 0.05,Yes,,,,Al-Delaimy 2005
4134,4025,4011,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Fruits + Vegetables,Fruits + Tomato + Carrot + Root vegetables + Leafy vegetables + Citrus fruits + Cabbage-family vegetables,,,,,missing unit,,,"Plasma, unspecified",HPLC,Lycopene,"",,,,umol/L,,2974,Spearman,0.14,,,< 0.05,Yes,,,,Al-Delaimy 2005
4154,4025,4012,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Fruits + Vegetables,Fruits + Tomato + Carrot + Root vegetables + Leafy vegetables + Citrus fruits + Cabbage-family vegetables,,,,,missing unit,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,2974,Spearman,0.1,,,< 0.05,Yes,,,,Al-Delaimy 2005
4174,4025,4013,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Fruits + Vegetables,Fruits + Tomato + Carrot + Root vegetables + Leafy vegetables + Citrus fruits + Cabbage-family vegetables,,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,2974,Spearman,0.15,,,< 0.05,Yes,,,,Al-Delaimy 2005
4194,4025,4014,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Fruits + Vegetables,Fruits + Tomato + Carrot + Root vegetables + Leafy vegetables + Citrus fruits + Cabbage-family vegetables,,,,,missing unit,,,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,umol/L,,2974,Spearman,0.3,,,< 0.05,Yes,,,,Al-Delaimy 2005
4076,4026,4008,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Vegetables,Tomato + Carrot + Root vegetables + Leafy vegetables + Cabbage-family vegetables,,,,,missing unit,,,"Plasma, unspecified",HPLC,Lutein,"",,,,umol/L,,2974,Spearman,0.23,,,< 0.05,Yes,,,,Al-Delaimy 2005
4096,4026,4009,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Vegetables,Tomato + Carrot + Root vegetables + Leafy vegetables + Cabbage-family vegetables,,,,,missing unit,,,"Plasma, unspecified",HPLC,Zeaxanthin,"",,,,umol/L,,2974,Spearman,0.22,,,< 0.05,Yes,,,,Al-Delaimy 2005
4116,4026,4010,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Vegetables,Tomato + Carrot + Root vegetables + Leafy vegetables + Cabbage-family vegetables,,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,2974,Spearman,0.19,,,< 0.05,Yes,,,,Al-Delaimy 2005
4136,4026,4011,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Vegetables,Tomato + Carrot + Root vegetables + Leafy vegetables + Cabbage-family vegetables,,,,,missing unit,,,"Plasma, unspecified",HPLC,Lycopene,"",,,,umol/L,,2974,Spearman,0.12,,,< 0.05,Yes,,,,Al-Delaimy 2005
4156,4026,4012,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Vegetables,Tomato + Carrot + Root vegetables + Leafy vegetables + Cabbage-family vegetables,,,,,missing unit,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,2974,Spearman,0.13,,,< 0.05,Yes,,,,Al-Delaimy 2005
4176,4026,4013,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Vegetables,Tomato + Carrot + Root vegetables + Leafy vegetables + Cabbage-family vegetables,,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,2974,Spearman,0.16,,,< 0.05,Yes,,,,Al-Delaimy 2005
4196,4026,4014,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Vegetables,Tomato + Carrot + Root vegetables + Leafy vegetables + Cabbage-family vegetables,,,,,missing unit,,,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,umol/L,,2974,Spearman,0.21,,,< 0.05,Yes,,,,Al-Delaimy 2005
4078,4027,4008,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Leafy vegetables,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Lutein,"",,,,umol/L,,2974,Spearman,0.14,,,< 0.05,Yes,,,,Al-Delaimy 2005
4098,4027,4009,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Leafy vegetables,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Zeaxanthin,"",,,,umol/L,,2974,Spearman,0.16,,,< 0.05,Yes,,,,Al-Delaimy 2005
4118,4027,4010,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Leafy vegetables,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,2974,Spearman,0.14,,,< 0.05,Yes,,,,Al-Delaimy 2005
4178,4027,4013,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Leafy vegetables,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,2974,Spearman,0.07,,,< 0.05,Yes,,,,Al-Delaimy 2005
4198,4027,4014,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Leafy vegetables,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,umol/L,,2974,Spearman,0.11,,,< 0.05,Yes,,,,Al-Delaimy 2005
4100,4028,4009,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Root vegetables,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Zeaxanthin,"",,,,umol/L,,2974,Spearman,-0.04,,,< 0.05,Yes,,,,Al-Delaimy 2005
4160,4028,4012,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Root vegetables,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,2974,Spearman,0.2,,,< 0.05,Yes,,,,Al-Delaimy 2005
4180,4028,4013,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Root vegetables,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,2974,Spearman,0.09,,,< 0.05,Yes,,,,Al-Delaimy 2005
4122,4029,4010,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Cabbage-family vegetables,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,2974,Spearman,-0.05,,,< 0.05,Yes,,,,Al-Delaimy 2005
4162,4029,4012,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Cabbage-family vegetables,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,2974,Spearman,0.1,,,< 0.05,Yes,,,,Al-Delaimy 2005
4182,4029,4013,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Cabbage-family vegetables,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,2974,Spearman,0.05,,,< 0.05,Yes,,,,Al-Delaimy 2005
4084,4030,4008,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Tomato,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Lutein,"",,,,umol/L,,2974,Spearman,0.18,,,< 0.05,Yes,,,,Al-Delaimy 2005
4104,4030,4009,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Tomato,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Zeaxanthin,"",,,,umol/L,,2974,Spearman,0.14,,,< 0.05,Yes,,,,Al-Delaimy 2005
4124,4030,4010,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Tomato,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,2974,Spearman,0.1,,,< 0.05,Yes,,,,Al-Delaimy 2005
4144,4030,4011,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Tomato,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Lycopene,"",,,,umol/L,,2974,Spearman,0.25,,,< 0.05,Yes,,,,Al-Delaimy 2005
4164,4030,4012,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Tomato,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,2974,Spearman,0.06,,,< 0.05,Yes,,,,Al-Delaimy 2005
4184,4030,4013,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Tomato,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,2974,Spearman,0.12,,,< 0.05,Yes,,,,Al-Delaimy 2005
4204,4030,4014,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Tomato,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,umol/L,,2974,Spearman,0.22,,,< 0.05,Yes,,,,Al-Delaimy 2005
4166,4031,4012,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Carrot,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,2974,Spearman,0.19,,,< 0.05,Yes,,,,Al-Delaimy 2005
4186,4031,4013,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Carrot,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,2974,Spearman,0.08,,,< 0.05,Yes,,,,Al-Delaimy 2005
4206,4031,4014,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Carrot,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,umol/L,,2974,Spearman,0.04,,,< 0.05,Yes,,,,Al-Delaimy 2005
4088,4032,4008,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Fruits,Fruits + Citrus fruits,,,,,missing unit,,,"Plasma, unspecified",HPLC,Lutein,"",,,,umol/L,,2974,Spearman,0.25,,,< 0.05,Yes,,,,Al-Delaimy 2005
4108,4032,4009,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Fruits,Fruits + Citrus fruits,,,,,missing unit,,,"Plasma, unspecified",HPLC,Zeaxanthin,"",,,,umol/L,,2974,Spearman,0.26,,,< 0.05,Yes,,,,Al-Delaimy 2005
4128,4032,4010,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Fruits,Fruits + Citrus fruits,,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,2974,Spearman,0.39,,,< 0.05,Yes,,,,Al-Delaimy 2005
4148,4032,4011,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Fruits,Fruits + Citrus fruits,,,,,missing unit,,,"Plasma, unspecified",HPLC,Lycopene,"",,,,umol/L,,2974,Spearman,0.1,,,< 0.05,Yes,,,,Al-Delaimy 2005
4168,4032,4012,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Fruits,Fruits + Citrus fruits,,,,,missing unit,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,2974,Spearman,0.06,,,< 0.05,Yes,,,,Al-Delaimy 2005
4188,4032,4013,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Fruits,Fruits + Citrus fruits,,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,2974,Spearman,0.11,,,< 0.05,Yes,,,,Al-Delaimy 2005
4208,4032,4014,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Fruits,Fruits + Citrus fruits,,,,,missing unit,,,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,umol/L,,2974,Spearman,0.25,,,< 0.05,Yes,,,,Al-Delaimy 2005
4090,4033,4008,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Fruits,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Lutein,"",,,,umol/L,,2974,Spearman,0.21,,,< 0.05,Yes,,,,Al-Delaimy 2005
4110,4033,4009,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Fruits,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Zeaxanthin,"",,,,umol/L,,2974,Spearman,0.21,,,< 0.05,Yes,,,,Al-Delaimy 2005
4130,4033,4010,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Fruits,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,2974,Spearman,0.27,,,< 0.05,Yes,,,,Al-Delaimy 2005
4150,4033,4011,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Fruits,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Lycopene,"",,,,umol/L,,2974,Spearman,0.09,,,< 0.05,Yes,,,,Al-Delaimy 2005
4170,4033,4012,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Fruits,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,alpha-Carotene,"",,,,umol/L,,2974,Spearman,0.08,,,< 0.05,Yes,,,,Al-Delaimy 2005
4190,4033,4013,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Fruits,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,2974,Spearman,0.12,,,< 0.05,Yes,,,,Al-Delaimy 2005
4210,4033,4014,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Fruits,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,umol/L,,2974,Spearman,0.21,,,< 0.05,Yes,,,,Al-Delaimy 2005
4092,4034,4008,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Citrus fruits,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Lutein,"",,,,umol/L,,2974,Spearman,0.09,,,< 0.05,Yes,,,,Al-Delaimy 2005
4112,4034,4009,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Citrus fruits,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Zeaxanthin,"",,,,umol/L,,2974,Spearman,0.1,,,< 0.05,Yes,,,,Al-Delaimy 2005
4132,4034,4010,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Citrus fruits,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,2974,Spearman,0.26,,,< 0.05,Yes,,,,Al-Delaimy 2005
4212,4034,4014,All [by gender],Participants in the EPIC calibration study from nine European countries,France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Citrus fruits,"",,,,,missing unit,,,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,umol/L,,2974,Spearman,0.09,,,< 0.05,Yes,,,,Al-Delaimy 2005
4227,4095,4119,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),Proteins,"",,,,,g/day,,,"Urine, 24-h",Spectrophotometry,Nitrogen,"",,,,g/day,,131,Pearson,0.27,,, ,Unspecified,,,,Malekshah 2006
4232,4095,4121,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),Proteins,"",,,,,g/day,,,"Urine, 24-h",Spectrophotometry,Nitrogen,"",,,,g/day,,131,Pearson,0.29,,, ,Unspecified,,,,Malekshah 2006
4223,4096,4071,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),Vitamin C,"",,,,,mg/day,,,"Serum, unspecified",Fluorometry,Vitamin C,"",19.21,,,umol/L,,103,Pearson,0.27,,, ,Unspecified,,,,Malekshah 2006
4228,4096,4115,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),Vitamin C,"",,,,,mg/day,,,"Serum, unspecified",Fluorometry,Vitamin C,"",,,,umol/L,,103,Pearson,0.33,,, ,Unspecified,,,,Malekshah 2006
4224,4097,4122,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),Vitamin A (Retinol Equivalents),"",,,,,ug/day,,,"Serum, unspecified",HPLC,Retinol,"",,,,umol/L,,131,Pearson,0.17,,, ,Unspecified,,,,Malekshah 2006
4229,4097,4116,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),Vitamin A (Retinol Equivalents),"",,,,,ug/day,,,"Serum, unspecified",HPLC,Retinol,"",,,,umol/L,,131,Pearson,0.26,,, ,Unspecified,,,,Malekshah 2006
4226,4098,4123,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),Vitamin E,"",,,,,mg/day,,,"Serum, unspecified",HPLC,alpha-Tocopherol,"",,,,umol/L,,131,Pearson,0.19,,, ,Unspecified,,,,Malekshah 2006
4231,4098,4118,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),Vitamin E,"",,,,,mg/day,,,"Serum, unspecified",HPLC,alpha-Tocopherol,"",,,,umol/L,,131,Pearson,-0.01,,, ,Unspecified,,,,Malekshah 2006
4225,4099,4076,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,ug/day,,,"Serum, unspecified",HPLC,beta-Carotene,"",0.164,,,umol/L,,121,Pearson,0.19,,, ,Unspecified,,,,Malekshah 2006
4230,4099,4117,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,ug/day,,,"Serum, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,121,Pearson,0.27,,, ,Unspecified,,,,Malekshah 2006
4237,4100,4121,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),Proteins,"",,,,,g/day,,,"Urine, 24-h",Spectrophotometry,Nitrogen,"",,,,g/day,,131,Pearson,0.27,,, ,Unspecified,,,,Malekshah 2006
4233,4101,4115,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),Vitamin C,"",,,,,mg/day,,,"Serum, unspecified",Fluorometry,Vitamin C,"",,,,umol/L,,103,Pearson,0.25,,, ,Unspecified,,,,Malekshah 2006
4234,4102,4116,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),Vitamin A (Retinol Equivalents),"",,,,,ug/day,,,"Serum, unspecified",HPLC,Retinol,"",,,,umol/L,,131,Pearson,0.29,,, ,Unspecified,,,,Malekshah 2006
4236,4103,4118,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),Vitamin E,"",,,,,mg/day,,,"Serum, unspecified",HPLC,alpha-Tocopherol,"",,,,umol/L,,131,Pearson,0.03,,, ,Unspecified,,,,Malekshah 2006
4235,4104,4117,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,ug/day,,,"Serum, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,121,Pearson,0.31,,, ,Unspecified,,,,Malekshah 2006
4242,4105,4120,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),Proteins,"",,,,,g/day,,,"Urine, 24-h",Spectrophotometry,Nitrogen,"",,,,g/day,,131,Pearson,0.12,,, ,Unspecified,,,,Malekshah 2006
4247,4105,4121,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),Proteins,"",,,,,g/day,,,"Urine, 24-h",Spectrophotometry,Nitrogen,"",,,,g/day,,131,Pearson,0.23,,, ,Unspecified,,,,Malekshah 2006
4238,4106,4078,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),Vitamin C,"",,,,,mg/day,,,"Serum, unspecified",Fluorometry,Vitamin C,"",25.68,,,umol/L,,103,Pearson,0.48,,, ,Unspecified,,,,Malekshah 2006
4243,4106,4115,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),Vitamin C,"",,,,,mg/day,,,"Serum, unspecified",Fluorometry,Vitamin C,"",,,,umol/L,,103,Pearson,0.34,,, ,Unspecified,,,,Malekshah 2006
4239,4107,4124,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),Vitamin A (Retinol Equivalents),"",,,,,ug/day,,,"Serum, unspecified",HPLC,Retinol,"",,,,umol/L,,131,Pearson,0.25,,, ,Unspecified,,,,Malekshah 2006
4244,4107,4116,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),Vitamin A (Retinol Equivalents),"",,,,,ug/day,,,"Serum, unspecified",HPLC,Retinol,"",,,,umol/L,,131,Pearson,0.27,,, ,Unspecified,,,,Malekshah 2006
4241,4108,4125,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),Vitamin E,"",,,,,mg/day,,,"Serum, unspecified",HPLC,alpha-Tocopherol,"",,,,umol/L,,131,Pearson,0.16,,, ,Unspecified,,,,Malekshah 2006
4246,4108,4118,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),Vitamin E,"",,,,,mg/day,,,"Serum, unspecified",HPLC,alpha-Tocopherol,"",,,,umol/L,,131,Pearson,0.12,,, ,Unspecified,,,,Malekshah 2006
4240,4109,4083,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,ug/day,,,"Serum, unspecified",HPLC,beta-Carotene,"",0.198,,,umol/L,,121,Pearson,0.43,,, ,Unspecified,,,,Malekshah 2006
4245,4109,4117,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,ug/day,,,"Serum, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,121,Pearson,0.44,,, ,Unspecified,,,,Malekshah 2006
4252,4110,4121,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),Proteins,"",,,,,g/day,,,"Urine, 24-h",Spectrophotometry,Nitrogen,"",,,,g/day,,131,Pearson,0.35,,, ,Unspecified,,,,Malekshah 2006
4248,4111,4115,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),Vitamin C,"",,,,,mg/day,,,"Serum, unspecified",Fluorometry,Vitamin C,"",,,,umol/L,,103,Pearson,0.25,,, ,Unspecified,,,,Malekshah 2006
4249,4112,4116,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),Vitamin A (Retinol Equivalents),"",,,,,ug/day,,,"Serum, unspecified",HPLC,Retinol,"",,,,umol/L,,131,Pearson,0.27,,, ,Unspecified,,,,Malekshah 2006
4251,4113,4118,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),Vitamin E,"",,,,,mg/day,,,"Serum, unspecified",HPLC,alpha-Tocopherol,"",,,,umol/L,,131,Pearson,0.07,,, ,Unspecified,,,,Malekshah 2006
4250,4114,4117,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,ug/day,,,"Serum, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,121,Pearson,0.35,,, ,Unspecified,,,,Malekshah 2006
4222,4090,4121,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),Proteins,"",,,,,g/day,,,"Urine, 24-h",Spectrophotometry,Nitrogen,"",,,,g/day,,131,Pearson,0.37,,, ,Unspecified,,,,Malekshah 2006
4218,4091,4115,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),Vitamin C,"",,,,,mg/day,,,"Serum, unspecified",Fluorometry,Vitamin C,"",,,,umol/L,,103,Pearson,0.35,,, ,Unspecified,,,,Malekshah 2006
4219,4092,4116,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),Vitamin A (Retinol Equivalents),"",,,,,ug/day,,,"Serum, unspecified",HPLC,Retinol,"",,,,umol/L,,131,Pearson,0.32,,, ,Unspecified,,,,Malekshah 2006
4221,4093,4118,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),Vitamin E,"",,,,,mg/day,,,"Serum, unspecified",HPLC,alpha-Tocopherol,"",,,,umol/L,,131,Pearson,0.06,,, ,Unspecified,,,,Malekshah 2006
4220,4094,4117,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,ug/day,,,"Serum, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,121,Pearson,0.37,,, ,Unspecified,,,,Malekshah 2006
4217,4085,4121,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,24-h Dietary recall (2-day),Proteins,"",,,,,g/day,,,"Urine, 24-h",Spectrophotometry,Nitrogen,"",,,,g/day,,131,Pearson,0.38,,, ,Unspecified,,,,Malekshah 2006
4213,4086,4115,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,24-h Dietary recall (2-day),Vitamin C,"",,,,,mg/day,,,"Serum, unspecified",Fluorometry,Vitamin C,"",,,,umol/L,,103,Pearson,0.37,,, ,Unspecified,,,,Malekshah 2006
4214,4087,4116,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,24-h Dietary recall (2-day),Vitamin A (Retinol Equivalents),"",,,,,ug/day,,,"Serum, unspecified",HPLC,Retinol,"",,,,umol/L,,131,Pearson,0.26,,, ,Unspecified,,,,Malekshah 2006
4216,4088,4118,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,24-h Dietary recall (2-day),Vitamin E,"",,,,,mg/day,,,"Serum, unspecified",HPLC,alpha-Tocopherol,"",,,,umol/L,,131,Pearson,0.1,,, ,Unspecified,,,,Malekshah 2006
4215,4089,4117,All [by gender],Subjects from Golestan Province,"Iran, Islamic Republic of",GCS (Golestan Cohort Study),,24-h Dietary recall (2-day),beta-Carotene,"",,,,,ug/day,,,"Serum, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,121,Pearson,0.35,,, ,Unspecified,,,,Malekshah 2006
4254,4289,4305,All [by diet],Men in Melbourne area participant in a study on diet and thrombotic risk factors,Australia,,,Food Frequency Questionnaire (FFQ),Stearic acid (18:0),"",,,,,g/day,,,"Plasma, fasting",GC-FID,Stearic acid (18:0),"",,,,mg/100 mL,,126,Unspecified,0.312,,,< 0.01,Yes,,,,Mann 2006
4255,4290,4307,All [by diet],Men in Melbourne area participant in a study on diet and thrombotic risk factors,Australia,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0),,,,,g/day,,,"Plasma, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Arachidic acid (20:0),,,,mg/100 mL,,126,Unspecified,0.194,,,< 0.05,Yes,,,,Mann 2006
4256,4291,4321,All [by diet],Men in Melbourne area participant in a study on diet and thrombotic risk factors,Australia,,,Food Frequency Questionnaire (FFQ),cis-Octadecenoic acids (cis-18:1),"",,,,,g/day,,,"Plasma, fasting",GC-FID,cis-Octadecenoic acids (cis-18:1),Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7),,,,mg/100 mL,,126,Unspecified,0.188,,,< 0.05,Yes,,,,Mann 2006
4258,4295,4313,All [by diet],Men in Melbourne area participant in a study on diet and thrombotic risk factors,Australia,,,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,,,,g/day,,,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",,,,mg/100 mL,,126,Unspecified,0.275,,,< 0.01,Yes,,,,Mann 2006
4259,4296,4314,All [by diet],Men in Melbourne area participant in a study on diet and thrombotic risk factors,Australia,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,g/day,,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",,,,mg/100 mL,,126,Unspecified,0.394,,,< 0.01,Yes,,,,Mann 2006
4260,4297,4315,All [by diet],Men in Melbourne area participant in a study on diet and thrombotic risk factors,Australia,,,Food Frequency Questionnaire (FFQ),DPA (cis-22:5n-3),"",,,,,g/day,,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",,,,mg/100 mL,,126,Unspecified,0.344,,,< 0.01,Yes,,,,Mann 2006
4261,4298,4316,All [by diet],Men in Melbourne area participant in a study on diet and thrombotic risk factors,Australia,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,g/day,,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",,,,mg/100 mL,,126,Unspecified,0.409,,,< 0.01,Yes,,,,Mann 2006
4263,4302,4320,All [by diet],Men in Melbourne area participant in a study on diet and thrombotic risk factors,Australia,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,,g/day,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,mg/100 mL,,126,Unspecified,0.474,,,< 0.01,Yes,,,,Mann 2006
4264,4409,4415,All [by diet],Volunteers from the Dunedin area,New Zealand,,,Dietary record (4-day),"Fatty acids, saturated (SFA)","",,,,,g/day,,,"Plasma, fasting",GC-FID,Myristic acid (14:0),"",,,,percentRoot,,129,Pearson,0.34,,,< 0.001,Yes,,,,Skeaff 2006
4270,4409,4416,All [by diet],Volunteers from the Dunedin area,New Zealand,,,Dietary record (4-day),"Fatty acids, saturated (SFA)","",,,,,g/day,,,"Plasma, fasting",GC-FID,Pentadecylic acid (15:0),"",,,,percentRoot,,129,Pearson,0.42,,,< 0.001,Yes,,,,Skeaff 2006
4276,4409,4417,All [by diet],Volunteers from the Dunedin area,New Zealand,,,Dietary record (4-day),"Fatty acids, saturated (SFA)","",,,,,g/day,,,"Plasma, fasting",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,129,Pearson,-0.06,,,< 0.476,No,,,,Skeaff 2006
4265,4410,4415,All [by diet],Volunteers from the Dunedin area,New Zealand,,,Dietary record (4-day),"Fatty acids, saturated (SFA)","",,,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Myristic acid (14:0),"",,,,percentRoot,,129,Pearson,0.45,,,< 0.001,Yes,,,,Skeaff 2006
4271,4410,4416,All [by diet],Volunteers from the Dunedin area,New Zealand,,,Dietary record (4-day),"Fatty acids, saturated (SFA)","",,,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Pentadecylic acid (15:0),"",,,,percentRoot,,129,Pearson,0.55,,,< 0.001,Yes,,,,Skeaff 2006
4277,4410,4417,All [by diet],Volunteers from the Dunedin area,New Zealand,,,Dietary record (4-day),"Fatty acids, saturated (SFA)","",,,,,percentEnergy,Energy,,"Plasma, fasting",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,129,Pearson,-0.03,,,< 0.718,No,,,,Skeaff 2006
4266,4411,4415,All [by diet],Volunteers from the Dunedin area,New Zealand,,,Dietary record (4-day),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Plasma, fasting",GC-FID,Myristic acid (14:0),"",,,,percentRoot,,129,Pearson,0.56,,,< 0.001,Yes,,,,Skeaff 2006
4272,4411,4416,All [by diet],Volunteers from the Dunedin area,New Zealand,,,Dietary record (4-day),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Plasma, fasting",GC-FID,Pentadecylic acid (15:0),"",,,,percentRoot,,129,Pearson,0.59,,,< 0.001,Yes,,,,Skeaff 2006
4278,4411,4417,All [by diet],Volunteers from the Dunedin area,New Zealand,,,Dietary record (4-day),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Plasma, fasting",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,129,Pearson,0.15,,,< 0.1,No,,,,Skeaff 2006
4282,4424,4418,All,Type I diabetic patients,Spain,,,Food Frequency Questionnaire (FFQ),Lutein,"",,1268.0,,,ug/day,,,"Serum, fasting",HPLC,Lutein,"",0.21,,,umol/L,,40,Spearman,0.4,,,< 0.05,Yes,,,,Granado-Lorencio 2006
4283,4425,4419,All,Type I diabetic patients,Spain,,,Food Frequency Questionnaire (FFQ),Zeaxanthin,"",,110.0,,,ug/day,,,"Serum, fasting",HPLC,Zeaxanthin,"",0.07,,,umol/L,,40,Spearman,0.49,,,< 0.001,Yes,,,,Granado-Lorencio 2006
4284,4426,4420,All,Type I diabetic patients,Spain,,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,515.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",0.42,,,umol/L,,40,Spearman,0.74,,,< 0.001,Yes,,,,Granado-Lorencio 2006
4285,4427,4421,All,Type I diabetic patients,Spain,,,Food Frequency Questionnaire (FFQ),Lycopene,"",,3292.0,,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",0.56,,,umol/L,,40,Spearman,0.2,,,>= 0.05,No,,,,Granado-Lorencio 2006
4286,4428,4422,All,Type I diabetic patients,Spain,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,367.0,,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",0.08,,,umol/L,,40,Spearman,0.41,,,< 0.001,Yes,,,,Granado-Lorencio 2006
4287,4429,4423,All,Type I diabetic patients,Spain,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,1942.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.39,,,umol/L,,40,Spearman,0.42,,,< 0.001,Yes,,,,Granado-Lorencio 2006
4288,4430,4418,All,Type I diabetic patients,Spain,,,Dietary record (3-day),Lutein,"",,717.0,,,ug/day,,,"Serum, fasting",HPLC,Lutein,"",0.21,,,umol/L,,40,Spearman,0.24,,,>= 0.05,No,,,,Granado-Lorencio 2006
4289,4431,4419,All,Type I diabetic patients,Spain,,,Dietary record (3-day),Zeaxanthin,"",,97.0,,,ug/day,,,"Serum, fasting",HPLC,Zeaxanthin,"",0.07,,,umol/L,,40,Spearman,0.18,,,>= 0.05,No,,,,Granado-Lorencio 2006
4290,4432,4420,All,Type I diabetic patients,Spain,,,Dietary record (3-day),beta-Cryptoxanthin,"",,664.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",0.42,,,umol/L,,40,Spearman,0.61,,,< 0.001,Yes,,,,Granado-Lorencio 2006
4291,4433,4421,All,Type I diabetic patients,Spain,,,Dietary record (3-day),Lycopene,"",,2785.0,,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",0.56,,,umol/L,,40,Spearman,0.2,,,>= 0.05,No,,,,Granado-Lorencio 2006
4292,4434,4422,All,Type I diabetic patients,Spain,,,Dietary record (3-day),alpha-Carotene,"",,192.0,,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",0.08,,,umol/L,,40,Spearman,0.08,,,>= 0.05,No,,,,Granado-Lorencio 2006
4293,4435,4423,All,Type I diabetic patients,Spain,,,Dietary record (3-day),beta-Carotene,"",,1031.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.39,,,umol/L,,40,Spearman,0.08,,,>= 0.05,No,,,,Granado-Lorencio 2006
4298,4437,4438,All,Breast cancer survivors from the non-intervention group of the WHEL study,United States,WHEL (Women's Healthy Eating and Living),,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Yes,24.88,,,mg/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,2.4,,,mmol/L,,1013,Pearson,0.35,,, ,Unspecified,,,,Natarajan 2006
4299,4437,4443,All,Breast cancer survivors from the non-intervention group of the WHEL study,United States,WHEL (Women's Healthy Eating and Living),,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Yes,24.88,,,mg/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,2.34,,,mmol/L,,1013,Pearson,0.28,,, ,Unspecified,,,,Natarajan 2006
4300,4442,4438,All,Breast cancer survivors from the non-intervention group of the WHEL study,United States,WHEL (Women's Healthy Eating and Living),,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Yes,25.31,,,mg/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,2.4,,,mmol/L,,1013,Pearson,0.29,,, ,Unspecified,,,,Natarajan 2006
4301,4442,4443,All,Breast cancer survivors from the non-intervention group of the WHEL study,United States,WHEL (Women's Healthy Eating and Living),,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Yes,25.31,,,mg/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,2.34,,,mmol/L,,1013,Pearson,0.31,,, ,Unspecified,,,,Natarajan 2006
4294,4436,4438,All,Breast cancer survivors from the non-intervention group of the WHEL study,United States,WHEL (Women's Healthy Eating and Living),,24-h Dietary recall (1-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Yes,20.21,,,mg/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,2.4,,,mmol/L,,1013,Pearson,0.45,,, ,Unspecified,,,,Natarajan 2006
4295,4436,4443,All,Breast cancer survivors from the non-intervention group of the WHEL study,United States,WHEL (Women's Healthy Eating and Living),,24-h Dietary recall (1-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Yes,20.21,,,mg/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,2.34,,,mmol/L,,1013,Pearson,0.37,,, ,Unspecified,,,,Natarajan 2006
4296,4441,4438,All,Breast cancer survivors from the non-intervention group of the WHEL study,United States,WHEL (Women's Healthy Eating and Living),,24-h Dietary recall (1-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Yes,18.78,,,mg/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,2.4,,,mmol/L,,1013,Pearson,0.36,,, ,Unspecified,,,,Natarajan 2006
4297,4441,4443,All,Breast cancer survivors from the non-intervention group of the WHEL study,United States,WHEL (Women's Healthy Eating and Living),,24-h Dietary recall (1-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Yes,18.78,,,mg/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,2.34,,,mmol/L,,1013,Pearson,0.4,,, ,Unspecified,,,,Natarajan 2006
4302,4452,4446,Males,Controls in nested case-control studies on fatty acids and cancer risks,Japan,JACC Study (Japan Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Fish,"",,,,,missing unit,,,"Plasma, non-fasting",GC-FID,EPA (cis-20:5n-3),"",,2.82,,percentRoot,,621,Spearman,0.16,,,< 0.001,Yes,,,Age,Wakai 2005
4305,4452,4447,Males,Controls in nested case-control studies on fatty acids and cancer risks,Japan,JACC Study (Japan Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Fish,"",,,,,missing unit,,,"Plasma, non-fasting",GC-FID,DPA (cis-22:5n-3),"",,0.85,,percentRoot,,621,Spearman,0.14,,,< 0.001,Yes,,,Age,Wakai 2005
4308,4452,4448,Males,Controls in nested case-control studies on fatty acids and cancer risks,Japan,JACC Study (Japan Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Fish,"",,,,,missing unit,,,"Plasma, non-fasting",GC-FID,DHA (cis-22:6n-3),"",,5.07,,percentRoot,,621,Spearman,0.16,,,< 0.001,Yes,,,Age,Wakai 2005
4303,4453,4446,Males,Controls in nested case-control studies on fatty acids and cancer risks,Japan,JACC Study (Japan Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Fish,"",,,,,missing unit,,,"Plasma, non-fasting",GC-FID,EPA (cis-20:5n-3),"",,2.82,,percentRoot,,436,Spearman,0.04,,,>= 0.1,No,,,Age,Wakai 2005
4306,4453,4447,Males,Controls in nested case-control studies on fatty acids and cancer risks,Japan,JACC Study (Japan Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Fish,"",,,,,missing unit,,,"Plasma, non-fasting",GC-FID,DPA (cis-22:5n-3),"",,0.85,,percentRoot,,436,Spearman,0.04,,,>= 0.1,No,,,Age,Wakai 2005
4309,4453,4448,Males,Controls in nested case-control studies on fatty acids and cancer risks,Japan,JACC Study (Japan Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Fish,"",,,,,missing unit,,,"Plasma, non-fasting",GC-FID,DHA (cis-22:6n-3),"",,5.07,,percentRoot,,436,Spearman,0.08,,,>= 0.1,No,,,Age,Wakai 2005
4304,4454,4446,Males,Controls in nested case-control studies on fatty acids and cancer risks,Japan,JACC Study (Japan Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Fish,"",,,,,missing unit,,,"Plasma, non-fasting",GC-FID,EPA (cis-20:5n-3),"",,2.82,,percentRoot,,595,Spearman,0.16,,,< 0.001,Yes,,,Age,Wakai 2005
4307,4454,4447,Males,Controls in nested case-control studies on fatty acids and cancer risks,Japan,JACC Study (Japan Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Fish,"",,,,,missing unit,,,"Plasma, non-fasting",GC-FID,DPA (cis-22:5n-3),"",,0.85,,percentRoot,,595,Spearman,0.11,,,< 0.01,Yes,,,Age,Wakai 2005
4310,4454,4448,Males,Controls in nested case-control studies on fatty acids and cancer risks,Japan,JACC Study (Japan Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Fish,"",,,,,missing unit,,,"Plasma, non-fasting",GC-FID,DHA (cis-22:6n-3),"",,5.07,,percentRoot,,595,Spearman,0.18,,,< 0.001,Yes,,,Age,Wakai 2005
4311,4455,4449,Females,Controls in nested case-control studies on fatty acids and cancer risks,Japan,JACC Study (Japan Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Fish,"",,,,,missing unit,,,"Plasma, non-fasting",GC-FID,EPA (cis-20:5n-3),"",,2.47,,percentRoot,,612,Spearman,0.12,,,< 0.01,Yes,,,Age,Wakai 2005
4314,4455,4450,Females,Controls in nested case-control studies on fatty acids and cancer risks,Japan,JACC Study (Japan Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Fish,"",,,,,missing unit,,,"Plasma, non-fasting",GC-FID,DPA (cis-22:5n-3),"",,0.8,,percentRoot,,612,Spearman,0.05,,,>= 0.1,No,,,Age,Wakai 2005
4317,4455,4451,Females,Controls in nested case-control studies on fatty acids and cancer risks,Japan,JACC Study (Japan Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Fish,"",,,,,missing unit,,,"Plasma, non-fasting",GC-FID,DHA (cis-22:6n-3),"",,4.93,,percentRoot,,612,Spearman,0.05,,,>= 0.1,No,,,Age,Wakai 2005
4312,4456,4449,Females,Controls in nested case-control studies on fatty acids and cancer risks,Japan,JACC Study (Japan Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Fish,"",,,,,missing unit,,,"Plasma, non-fasting",GC-FID,EPA (cis-20:5n-3),"",,2.47,,percentRoot,,444,Spearman,-0.01,,,>= 0.1,No,,,Age,Wakai 2005
4315,4456,4450,Females,Controls in nested case-control studies on fatty acids and cancer risks,Japan,JACC Study (Japan Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Fish,"",,,,,missing unit,,,"Plasma, non-fasting",GC-FID,DPA (cis-22:5n-3),"",,0.8,,percentRoot,,444,Spearman,0.05,,,>= 0.1,No,,,Age,Wakai 2005
4318,4456,4451,Females,Controls in nested case-control studies on fatty acids and cancer risks,Japan,JACC Study (Japan Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Fish,"",,,,,missing unit,,,"Plasma, non-fasting",GC-FID,DHA (cis-22:6n-3),"",,4.93,,percentRoot,,444,Spearman,0.03,,,>= 0.1,No,,,Age,Wakai 2005
4313,4457,4449,Females,Controls in nested case-control studies on fatty acids and cancer risks,Japan,JACC Study (Japan Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Fish,"",,,,,missing unit,,,"Plasma, non-fasting",GC-FID,EPA (cis-20:5n-3),"",,2.47,,percentRoot,,564,Spearman,0.08,,,< 0.1,No,,,Age,Wakai 2005
4316,4457,4450,Females,Controls in nested case-control studies on fatty acids and cancer risks,Japan,JACC Study (Japan Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Fish,"",,,,,missing unit,,,"Plasma, non-fasting",GC-FID,DPA (cis-22:5n-3),"",,0.8,,percentRoot,,564,Spearman,0.11,,,< 0.01,Yes,,,Age,Wakai 2005
4319,4457,4451,Females,Controls in nested case-control studies on fatty acids and cancer risks,Japan,JACC Study (Japan Collaborative Cohort Study),,Food Frequency Questionnaire (FFQ),Fish,"",,,,,missing unit,,,"Plasma, non-fasting",GC-FID,DHA (cis-22:6n-3),"",,4.93,,percentRoot,,564,Spearman,0.06,,,>= 0.1,No,,,Age,Wakai 2005
4320,4460,4499,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Pentadecylic acid (15:0),"",,0.29,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,196,Spearman,0.2,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4345,4460,4538,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Pentadecylic acid (15:0),"",,0.29,,,percentRoot,,,"Plasma, fasting",GC-FID,Pentadecylic acid (15:0),"",0.17,,,percentRoot,,196,Spearman,0.26,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4370,4460,4577,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Pentadecylic acid (15:0),"",,0.29,,,percentRoot,,,"Whole blood, fasting",GC-FID,Pentadecylic acid (15:0),"",0.14,,,percentRoot,,196,Spearman,0.23,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4321,4461,4500,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,25.73,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitic acid (16:0),"",20.53,,,percentRoot,,196,Spearman,0.1,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4346,4461,4539,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,25.73,,,percentRoot,,,"Plasma, fasting",GC-FID,Palmitic acid (16:0),"",22.78,,,percentRoot,,196,Spearman,0.14,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4371,4461,4578,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,25.73,,,percentRoot,,,"Whole blood, fasting",GC-FID,Palmitic acid (16:0),"",21.92,,,percentRoot,,196,Spearman,0.14,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4322,4462,4501,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Margaric acid (17:0),"",,0.31,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.2,,,percentRoot,,196,Spearman,0.07,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4347,4462,4540,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Margaric acid (17:0),"",,0.31,,,percentRoot,,,"Plasma, fasting",GC-FID,Margaric acid (17:0),"",0.28,,,percentRoot,,196,Spearman,0.09,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4372,4462,4579,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Margaric acid (17:0),"",,0.31,,,percentRoot,,,"Whole blood, fasting",GC-FID,Margaric acid (17:0),"",0.28,,,percentRoot,,196,Spearman,0.09,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4323,4463,4502,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Stearic acid (18:0),"",,7.45,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Stearic acid (18:0),"",2.65,,,percentRoot,,196,Spearman,0.05,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4348,4463,4541,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Stearic acid (18:0),"",,7.45,,,percentRoot,,,"Plasma, fasting",GC-FID,Stearic acid (18:0),"",6.76,,,percentRoot,,196,Spearman,0.01,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4373,4463,4580,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Stearic acid (18:0),"",,7.45,,,percentRoot,,,"Whole blood, fasting",GC-FID,Stearic acid (18:0),"",9.42,,,percentRoot,,196,Spearman,0.03,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4324,4466,4505,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0),,37.9,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0),25.0,,,percentRoot,,196,Spearman,0.04,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4349,4466,4544,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0),,37.9,,,percentRoot,,,"Plasma, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0),31.85,,,percentRoot,,196,Spearman,0.11,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4374,4466,4583,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0),,37.9,,,percentRoot,,,"Whole blood, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0),34.07,,,percentRoot,,196,Spearman,0.14,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4325,4469,4508,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,32.35,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Oleic acid (cis-18:1n-9),"",42.82,,,percentRoot,,196,Spearman,0.15,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4350,4469,4547,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,32.35,,,percentRoot,,,"Plasma, fasting",GC-FID,Oleic acid (cis-18:1n-9),"",20.74,,,percentRoot,,196,Spearman,0.21,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4375,4469,4586,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,32.35,,,percentRoot,,,"Whole blood, fasting",GC-FID,Oleic acid (cis-18:1n-9),"",18.23,,,percentRoot,,196,Spearman,0.19,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4326,4472,4511,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + 11-Eicosenoic acid (cis-20:1n-9),,35.57,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + 11-Eicosenoic acid (cis-20:1n-9),52.49,,,percentRoot,,196,Spearman,0.06,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4351,4472,4550,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + 11-Eicosenoic acid (cis-20:1n-9),,35.57,,,percentRoot,,,"Plasma, fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + 11-Eicosenoic acid (cis-20:1n-9),25.91,,,percentRoot,,196,Spearman,0.14,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4376,4472,4589,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + 11-Eicosenoic acid (cis-20:1n-9),,35.57,,,percentRoot,,,"Whole blood, fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + 11-Eicosenoic acid (cis-20:1n-9),23.32,,,percentRoot,,196,Spearman,0.12,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4327,4473,4512,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,1.71,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.62,,,percentRoot,,196,Spearman,0.51,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4352,4473,4551,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,1.71,,,percentRoot,,,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.49,,,percentRoot,,196,Spearman,0.39,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4377,4473,4590,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,1.71,,,percentRoot,,,"Whole blood, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.37,,,percentRoot,,196,Spearman,0.38,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4328,4475,4514,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,0.14,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",0.02,,,percentRoot,,91,Spearman,-0.08,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4353,4475,4553,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,0.14,,,percentRoot,,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",0.34,,,percentRoot,,63,Spearman,0.28,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4378,4475,4592,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,0.14,,,percentRoot,,,"Whole blood, fasting",GC-FID,EPA (cis-20:5n-3),"",0.81,,,percentRoot,,62,Spearman,0.22,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4329,4477,4516,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,0.21,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DHA (cis-22:6n-3),"",0.14,,,percentRoot,,196,Spearman,0.26,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4354,4477,4555,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,0.21,,,percentRoot,,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",1.49,,,percentRoot,,196,Spearman,0.31,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4379,4477,4594,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,0.21,,,percentRoot,,,"Whole blood, fasting",GC-FID,DHA (cis-22:6n-3),"",2.39,,,percentRoot,,196,Spearman,0.23,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4330,4478,4517,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3),,2.13,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3),0.95,,,percentRoot,,91,Spearman,0.39,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4355,4478,4556,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3),,2.13,,,percentRoot,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3),2.62,,,percentRoot,,63,Spearman,0.23,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4380,4478,4595,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3),,2.13,,,percentRoot,,,"Whole blood, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3),4.54,,,percentRoot,,62,Spearman,0.23,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4331,4479,4518,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,18.87,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",15.71,,,percentRoot,,196,Spearman,0.52,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4356,4479,4557,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,18.87,,,percentRoot,,,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",28.09,,,percentRoot,,196,Spearman,0.41,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4381,4479,4596,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,18.87,,,percentRoot,,,"Whole blood, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",22.38,,,percentRoot,,196,Spearman,0.43,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4332,4480,4519,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),gamma-Linolenic acid (GLA; cis-18:3n-6),"",,0.03,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",0.05,,,percentRoot,,196,Spearman,-0.08,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4357,4480,4558,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),gamma-Linolenic acid (GLA; cis-18:3n-6),"",,0.03,,,percentRoot,,,"Plasma, fasting",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",0.39,,,percentRoot,,196,Spearman,0.05,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4382,4480,4597,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),gamma-Linolenic acid (GLA; cis-18:3n-6),"",,0.03,,,percentRoot,,,"Whole blood, fasting",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",0.28,,,percentRoot,,196,Spearman,0.0,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4333,4481,4520,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",,0.04,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",0.33,,,percentRoot,,196,Spearman,0.02,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4358,4481,4559,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",,0.04,,,percentRoot,,,"Plasma, fasting",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",1.68,,,percentRoot,,196,Spearman,-0.14,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4383,4481,4598,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",,0.04,,,percentRoot,,,"Whole blood, fasting",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",1.75,,,percentRoot,,196,Spearman,-0.16,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4334,4482,4521,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,0.24,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",0.48,,,percentRoot,,196,Spearman,0.11,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4359,4482,4560,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,0.24,,,percentRoot,,,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",6.02,,,percentRoot,,196,Spearman,0.12,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4384,4482,4599,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,0.24,,,percentRoot,,,"Whole blood, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",9.08,,,percentRoot,,196,Spearman,0.05,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4335,4484,4523,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,19.25,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),17.04,,,percentRoot,,196,Spearman,0.51,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4360,4484,4562,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,19.25,,,percentRoot,,,"Plasma, fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),36.74,,,percentRoot,,196,Spearman,0.38,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4385,4484,4601,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,19.25,,,percentRoot,,,"Whole blood, fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),35.1,,,percentRoot,,196,Spearman,0.4,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4336,4485,4524,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Rumenic acid (9cis,11trans-18:2n-7)","",,0.3,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Rumenic acid (9cis,11trans-18:2n-7)","",0.54,,,percentRoot,,196,Spearman,0.25,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4361,4485,4563,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Rumenic acid (9cis,11trans-18:2n-7)","",,0.3,,,percentRoot,,,"Plasma, fasting",GC-FID,"Rumenic acid (9cis,11trans-18:2n-7)","",0.19,,,percentRoot,,196,Spearman,0.26,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4386,4485,4602,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Rumenic acid (9cis,11trans-18:2n-7)","",,0.3,,,percentRoot,,,"Whole blood, fasting",GC-FID,"Rumenic acid (9cis,11trans-18:2n-7)","",0.16,,,percentRoot,,196,Spearman,0.28,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4337,4486,4525,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)","alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + Eicosatrienoic acid (ETE; cis-20:3n-3) + gamma-Linolenic acid (GLA; cis-18:3n-6) + Rumenic acid (9cis,11trans-18:2n-7)",,21.38,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)","alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + Eicosatrienoic acid (ETE; cis-20:3n-3) + gamma-Linolenic acid (GLA; cis-18:3n-6) + Rumenic acid (9cis,11trans-18:2n-7)",17.33,,,percentRoot,,91,Spearman,0.51,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4362,4486,4564,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)","alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + Eicosatrienoic acid (ETE; cis-20:3n-3) + gamma-Linolenic acid (GLA; cis-18:3n-6) + Rumenic acid (9cis,11trans-18:2n-7)",,21.38,,,percentRoot,,,"Plasma, fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)","alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + Eicosatrienoic acid (ETE; cis-20:3n-3) + gamma-Linolenic acid (GLA; cis-18:3n-6) + Rumenic acid (9cis,11trans-18:2n-7)",38.39,,,percentRoot,,63,Spearman,0.39,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4387,4486,4603,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)","alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + Eicosatrienoic acid (ETE; cis-20:3n-3) + gamma-Linolenic acid (GLA; cis-18:3n-6) + Rumenic acid (9cis,11trans-18:2n-7)",,21.38,,,percentRoot,,,"Whole blood, fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)","alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + Eicosatrienoic acid (ETE; cis-20:3n-3) + gamma-Linolenic acid (GLA; cis-18:3n-6) + Rumenic acid (9cis,11trans-18:2n-7)",39.87,,,percentRoot,,62,Spearman,0.4,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4338,4487,4526,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Palmitelaidic acid (trans-16:1n-7),"",,0.17,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitelaidic acid (trans-16:1n-7),"",0.16,,,percentRoot,,196,Spearman,0.27,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4363,4487,4565,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Palmitelaidic acid (trans-16:1n-7),"",,0.17,,,percentRoot,,,"Plasma, fasting",GC-FID,Palmitelaidic acid (trans-16:1n-7),"",0.13,,,percentRoot,,196,Spearman,0.2,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4388,4487,4604,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Palmitelaidic acid (trans-16:1n-7),"",,0.17,,,percentRoot,,,"Whole blood, fasting",GC-FID,Palmitelaidic acid (trans-16:1n-7),"",0.12,,,percentRoot,,196,Spearman,0.23,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4339,4491,4530,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),trans-Octadecenoic acids (trans-18:1),Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9),,2.18,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecenoic acids (trans-18:1),Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9),1.41,,,percentRoot,,196,Spearman,0.24,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4364,4491,4569,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),trans-Octadecenoic acids (trans-18:1),Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9),,2.18,,,percentRoot,,,"Plasma, fasting",GC-FID,trans-Octadecenoic acids (trans-18:1),Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9),0.7,,,percentRoot,,196,Spearman,0.08,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4389,4491,4608,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),trans-Octadecenoic acids (trans-18:1),Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9),,2.18,,,percentRoot,,,"Whole blood, fasting",GC-FID,trans-Octadecenoic acids (trans-18:1),Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9),0.75,,,percentRoot,,196,Spearman,0.1,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4340,4492,4531,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Linoelaidic acid (trans-18:2n-6),"",,0.19,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoelaidic acid (trans-18:2n-6),"",0.26,,,percentRoot,,196,Spearman,0.27,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4365,4492,4570,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Linoelaidic acid (trans-18:2n-6),"",,0.19,,,percentRoot,,,"Plasma, fasting",GC-FID,Linoelaidic acid (trans-18:2n-6),"",0.15,,,percentRoot,,196,Spearman,0.1,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4390,4492,4609,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Linoelaidic acid (trans-18:2n-6),"",,0.19,,,percentRoot,,,"Whole blood, fasting",GC-FID,Linoelaidic acid (trans-18:2n-6),"",0.12,,,percentRoot,,196,Spearman,0.07,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4341,4493,4532,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),cis-9-Linoelaidic acid (9cis-18:2n-6),"",,0.47,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,cis-9-Linoelaidic acid (9cis-18:2n-6),"",0.55,,,percentRoot,,196,Spearman,0.41,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4366,4493,4571,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),cis-9-Linoelaidic acid (9cis-18:2n-6),"",,0.47,,,percentRoot,,,"Plasma, fasting",GC-FID,cis-9-Linoelaidic acid (9cis-18:2n-6),"",0.26,,,percentRoot,,196,Spearman,0.29,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4391,4493,4610,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),cis-9-Linoelaidic acid (9cis-18:2n-6),"",,0.47,,,percentRoot,,,"Whole blood, fasting",GC-FID,cis-9-Linoelaidic acid (9cis-18:2n-6),"",0.21,,,percentRoot,,196,Spearman,0.31,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4342,4494,4533,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),cis-12-Linoelaidic acid (12cis-18:2n-6),"",,0.52,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,cis-12-Linoelaidic acid (12cis-18:2n-6),"",0.29,,,percentRoot,,196,Spearman,0.42,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4367,4494,4572,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),cis-12-Linoelaidic acid (12cis-18:2n-6),"",,0.52,,,percentRoot,,,"Plasma, fasting",GC-FID,cis-12-Linoelaidic acid (12cis-18:2n-6),"",0.22,,,percentRoot,,196,Spearman,0.28,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4392,4494,4611,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),cis-12-Linoelaidic acid (12cis-18:2n-6),"",,0.52,,,percentRoot,,,"Whole blood, fasting",GC-FID,cis-12-Linoelaidic acid (12cis-18:2n-6),"",0.2,,,percentRoot,,196,Spearman,0.27,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4343,4495,4534,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6),,1.18,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6),1.1,,,percentRoot,,196,Spearman,0.4,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4368,4495,4573,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6),,1.18,,,percentRoot,,,"Plasma, fasting",GC-FID,trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6),0.63,,,percentRoot,,196,Spearman,0.24,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4393,4495,4612,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6),,1.18,,,percentRoot,,,"Whole blood, fasting",GC-FID,trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6),0.53,,,percentRoot,,196,Spearman,0.26,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4344,4496,4535,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6),,3.57,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6),2.69,,,percentRoot,,196,Spearman,0.31,,,< 0.05,Yes,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4369,4496,4574,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6),,3.57,,,percentRoot,,,"Plasma, fasting",GC-FID,"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6),1.47,,,percentRoot,,196,Spearman,0.11,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4394,4496,4613,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6),,3.57,,,percentRoot,,,"Whole blood, fasting",GC-FID,"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6),1.4,,,percentRoot,,196,Spearman,0.14,,,>= 0.05,No,Energy by residual method ?,,"Age, Sex, BMI",Baylin 2005
4403,4620,4623,All,Men from Oerland military flight station,Norway,,baseline,Food Frequency Questionnaire (FFQ),Fruits,"",,0.9,,0.7,times/day,,,"Serum, fasting",HPLC,Lutein,"",0.174,,0.168,umol/L,,86,Pearson,0.17,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4412,4620,4624,All,Men from Oerland military flight station,Norway,,baseline,Food Frequency Questionnaire (FFQ),Fruits,"",,0.9,,0.7,times/day,,,"Serum, fasting",HPLC,Zeaxanthin,"",0.039,,0.038,umol/L,,86,Pearson,0.11,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4421,4620,4625,All,Men from Oerland military flight station,Norway,,baseline,Food Frequency Questionnaire (FFQ),Fruits,"",,0.9,,0.7,times/day,,,"Serum, fasting",HPLC,Lycopene,"",0.746,,0.685,umol/L,,86,Pearson,0.1,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4430,4620,4626,All,Men from Oerland military flight station,Norway,,baseline,Food Frequency Questionnaire (FFQ),Fruits,"",,0.9,,0.7,times/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",0.088,,0.068,umol/L,,86,Pearson,0.13,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4439,4620,4627,All,Men from Oerland military flight station,Norway,,baseline,Food Frequency Questionnaire (FFQ),Fruits,"",,0.9,,0.7,times/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.449,,0.379,umol/L,,86,Pearson,0.14,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4402,4621,4623,All,Men from Oerland military flight station,Norway,,baseline,Food Frequency Questionnaire (FFQ),Vegetables,"",,0.8,,0.6,times/day,,,"Serum, fasting",HPLC,Lutein,"",0.174,,0.168,umol/L,,86,Pearson,0.1,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4411,4621,4624,All,Men from Oerland military flight station,Norway,,baseline,Food Frequency Questionnaire (FFQ),Vegetables,"",,0.8,,0.6,times/day,,,"Serum, fasting",HPLC,Zeaxanthin,"",0.039,,0.038,umol/L,,86,Pearson,0.08,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4420,4621,4625,All,Men from Oerland military flight station,Norway,,baseline,Food Frequency Questionnaire (FFQ),Vegetables,"",,0.8,,0.6,times/day,,,"Serum, fasting",HPLC,Lycopene,"",0.746,,0.685,umol/L,,86,Pearson,0.1,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4429,4621,4626,All,Men from Oerland military flight station,Norway,,baseline,Food Frequency Questionnaire (FFQ),Vegetables,"",,0.8,,0.6,times/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",0.088,,0.068,umol/L,,86,Pearson,0.35,,,< 0.01,Yes,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4438,4621,4627,All,Men from Oerland military flight station,Norway,,baseline,Food Frequency Questionnaire (FFQ),Vegetables,"",,0.8,,0.6,times/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.449,,0.379,umol/L,,86,Pearson,0.07,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4401,4622,4623,All,Men from Oerland military flight station,Norway,,baseline,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,times/day,,,"Serum, fasting",HPLC,Lutein,"",0.174,,0.168,umol/L,,86,Pearson,0.16,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4410,4622,4624,All,Men from Oerland military flight station,Norway,,baseline,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,times/day,,,"Serum, fasting",HPLC,Zeaxanthin,"",0.039,,0.038,umol/L,,86,Pearson,0.15,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4419,4622,4625,All,Men from Oerland military flight station,Norway,,baseline,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,times/day,,,"Serum, fasting",HPLC,Lycopene,"",0.746,,0.685,umol/L,,86,Pearson,0.12,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4428,4622,4626,All,Men from Oerland military flight station,Norway,,baseline,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,times/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",0.088,,0.068,umol/L,,86,Pearson,0.26,,,< 0.05,Yes,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4437,4622,4627,All,Men from Oerland military flight station,Norway,,baseline,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,times/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.449,,0.379,umol/L,,86,Pearson,0.12,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4400,4617,4623,All,Men from Oerland military flight station,Norway,,7 weeks,Food Frequency Questionnaire (FFQ),Fruits,"",,128.0,,100.0,g/day,,,"Serum, fasting",HPLC,Lutein,"",0.174,,0.168,umol/L,,100,Pearson,0.11,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4409,4617,4624,All,Men from Oerland military flight station,Norway,,7 weeks,Food Frequency Questionnaire (FFQ),Fruits,"",,128.0,,100.0,g/day,,,"Serum, fasting",HPLC,Zeaxanthin,"",0.039,,0.038,umol/L,,100,Pearson,0.16,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4418,4617,4625,All,Men from Oerland military flight station,Norway,,7 weeks,Food Frequency Questionnaire (FFQ),Fruits,"",,128.0,,100.0,g/day,,,"Serum, fasting",HPLC,Lycopene,"",0.746,,0.685,umol/L,,100,Pearson,0.1,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4427,4617,4626,All,Men from Oerland military flight station,Norway,,7 weeks,Food Frequency Questionnaire (FFQ),Fruits,"",,128.0,,100.0,g/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",0.088,,0.068,umol/L,,100,Pearson,0.03,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4436,4617,4627,All,Men from Oerland military flight station,Norway,,7 weeks,Food Frequency Questionnaire (FFQ),Fruits,"",,128.0,,100.0,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.449,,0.379,umol/L,,100,Pearson,-0.01,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4399,4618,4623,All,Men from Oerland military flight station,Norway,,7 weeks,Food Frequency Questionnaire (FFQ),Vegetables,"",,115.0,,94.0,g/day,,,"Serum, fasting",HPLC,Lutein,"",0.174,,0.168,umol/L,,100,Pearson,0.13,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4408,4618,4624,All,Men from Oerland military flight station,Norway,,7 weeks,Food Frequency Questionnaire (FFQ),Vegetables,"",,115.0,,94.0,g/day,,,"Serum, fasting",HPLC,Zeaxanthin,"",0.039,,0.038,umol/L,,100,Pearson,0.1,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4417,4618,4625,All,Men from Oerland military flight station,Norway,,7 weeks,Food Frequency Questionnaire (FFQ),Vegetables,"",,115.0,,94.0,g/day,,,"Serum, fasting",HPLC,Lycopene,"",0.746,,0.685,umol/L,,100,Pearson,0.18,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4426,4618,4626,All,Men from Oerland military flight station,Norway,,7 weeks,Food Frequency Questionnaire (FFQ),Vegetables,"",,115.0,,94.0,g/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",0.088,,0.068,umol/L,,100,Pearson,0.39,,,< 0.001,Yes,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4435,4618,4627,All,Men from Oerland military flight station,Norway,,7 weeks,Food Frequency Questionnaire (FFQ),Vegetables,"",,115.0,,94.0,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.449,,0.379,umol/L,,100,Pearson,0.09,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4398,4619,4623,All,Men from Oerland military flight station,Norway,,7 weeks,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Serum, fasting",HPLC,Lutein,"",0.174,,0.168,umol/L,,100,Pearson,0.16,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4407,4619,4624,All,Men from Oerland military flight station,Norway,,7 weeks,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Serum, fasting",HPLC,Zeaxanthin,"",0.039,,0.038,umol/L,,100,Pearson,0.17,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4416,4619,4625,All,Men from Oerland military flight station,Norway,,7 weeks,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Serum, fasting",HPLC,Lycopene,"",0.746,,0.685,umol/L,,100,Pearson,0.15,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4425,4619,4626,All,Men from Oerland military flight station,Norway,,7 weeks,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",0.088,,0.068,umol/L,,100,Pearson,0.25,,,< 0.05,Yes,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4434,4619,4627,All,Men from Oerland military flight station,Norway,,7 weeks,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.449,,0.379,umol/L,,100,Pearson,0.07,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4397,4614,4623,All,Men from Oerland military flight station,Norway,,,Weighed Dietary record (3-day),Fruits,"",,109.0,,78.0,g/day,,,"Serum, fasting",HPLC,Lutein,"",0.174,,0.168,umol/L,,100,Pearson,0.13,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4406,4614,4624,All,Men from Oerland military flight station,Norway,,,Weighed Dietary record (3-day),Fruits,"",,109.0,,78.0,g/day,,,"Serum, fasting",HPLC,Zeaxanthin,"",0.039,,0.038,umol/L,,100,Pearson,0.03,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4415,4614,4625,All,Men from Oerland military flight station,Norway,,,Weighed Dietary record (3-day),Fruits,"",,109.0,,78.0,g/day,,,"Serum, fasting",HPLC,Lycopene,"",0.746,,0.685,umol/L,,100,Pearson,-0.12,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4424,4614,4626,All,Men from Oerland military flight station,Norway,,,Weighed Dietary record (3-day),Fruits,"",,109.0,,78.0,g/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",0.088,,0.068,umol/L,,100,Pearson,0.16,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4433,4614,4627,All,Men from Oerland military flight station,Norway,,,Weighed Dietary record (3-day),Fruits,"",,109.0,,78.0,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.449,,0.379,umol/L,,100,Pearson,0.13,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4396,4615,4623,All,Men from Oerland military flight station,Norway,,,Weighed Dietary record (3-day),Vegetables,"",,108.0,,102.0,g/day,,,"Serum, fasting",HPLC,Lutein,"",0.174,,0.168,umol/L,,100,Pearson,0.21,,,< 0.05,Yes,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4405,4615,4624,All,Men from Oerland military flight station,Norway,,,Weighed Dietary record (3-day),Vegetables,"",,108.0,,102.0,g/day,,,"Serum, fasting",HPLC,Zeaxanthin,"",0.039,,0.038,umol/L,,100,Pearson,0.15,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4414,4615,4625,All,Men from Oerland military flight station,Norway,,,Weighed Dietary record (3-day),Vegetables,"",,108.0,,102.0,g/day,,,"Serum, fasting",HPLC,Lycopene,"",0.746,,0.685,umol/L,,100,Pearson,-0.05,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4423,4615,4626,All,Men from Oerland military flight station,Norway,,,Weighed Dietary record (3-day),Vegetables,"",,108.0,,102.0,g/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",0.088,,0.068,umol/L,,100,Pearson,0.52,,,< 0.001,Yes,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4432,4615,4627,All,Men from Oerland military flight station,Norway,,,Weighed Dietary record (3-day),Vegetables,"",,108.0,,102.0,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.449,,0.379,umol/L,,100,Pearson,0.26,,,< 0.05,Yes,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4395,4616,4623,All,Men from Oerland military flight station,Norway,,,Weighed Dietary record (3-day),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Serum, fasting",HPLC,Lutein,"",0.174,,0.168,umol/L,,100,Pearson,0.22,,,< 0.05,Yes,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4404,4616,4624,All,Men from Oerland military flight station,Norway,,,Weighed Dietary record (3-day),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Serum, fasting",HPLC,Zeaxanthin,"",0.039,,0.038,umol/L,,100,Pearson,0.16,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4413,4616,4625,All,Men from Oerland military flight station,Norway,,,Weighed Dietary record (3-day),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Serum, fasting",HPLC,Lycopene,"",0.746,,0.685,umol/L,,100,Pearson,-0.12,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4422,4616,4626,All,Men from Oerland military flight station,Norway,,,Weighed Dietary record (3-day),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",0.088,,0.068,umol/L,,100,Pearson,0.37,,,< 0.001,Yes,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4431,4616,4627,All,Men from Oerland military flight station,Norway,,,Weighed Dietary record (3-day),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.449,,0.379,umol/L,,100,Pearson,0.18,,,>= 0.05,No,,,"Cholesterol, Triglycerides, Age, BMI",Andersen 2005
4440,4630,4646,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,10.2,,,percentRoot,,,"Adipose tissue, unspecified",GC-FID,Pentadecylic acid (15:0),"",0.32,,,percentRoot,,107,Pearson,0.09,-0.1,0.28,>= 0.05,No,,,,Brevik 2005
4446,4630,4647,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,10.2,,,percentRoot,,,"Adipose tissue, unspecified",GC-FID,Margaric acid (17:0),"",0.34,,,percentRoot,,107,Pearson,-0.11,-0.29,0.09,>= 0.05,No,,,,Brevik 2005
4452,4630,4648,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,10.2,,,percentRoot,,,"Serum, fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,110,Pearson,0.09,-0.1,0.27,>= 0.05,No,,,,Brevik 2005
4458,4630,4649,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,10.2,,,percentRoot,,,"Serum, fasting",GC-FID,Margaric acid (17:0),"",0.37,,,percentRoot,,110,Pearson,-0.23,-0.4,-0.04,< 0.05,Yes,,,,Brevik 2005
4441,4633,4646,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Cheese,"",,9.8,,,percentRoot,,,"Adipose tissue, unspecified",GC-FID,Pentadecylic acid (15:0),"",0.32,,,percentRoot,,107,Pearson,0.25,0.06,0.42,< 0.01,Yes,,,,Brevik 2005
4447,4633,4647,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Cheese,"",,9.8,,,percentRoot,,,"Adipose tissue, unspecified",GC-FID,Margaric acid (17:0),"",0.34,,,percentRoot,,107,Pearson,0.16,-0.03,0.34,>= 0.05,No,,,,Brevik 2005
4453,4633,4648,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Cheese,"",,9.8,,,percentRoot,,,"Serum, fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,110,Pearson,0.27,0.09,0.44,< 0.01,Yes,,,,Brevik 2005
4459,4633,4649,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Cheese,"",,9.8,,,percentRoot,,,"Serum, fasting",GC-FID,Margaric acid (17:0),"",0.37,,,percentRoot,,110,Pearson,0.09,-0.1,0.27,>= 0.05,No,,,,Brevik 2005
4442,4636,4646,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,Fats from Cheese + Fats from Butter + Fats from Dairy foods,,22.6,,,percentRoot,,,"Adipose tissue, unspecified",GC-FID,Pentadecylic acid (15:0),"",0.32,,,percentRoot,,107,Pearson,0.28,0.1,0.45,< 0.01,Yes,,,,Brevik 2005
4448,4636,4647,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,Fats from Cheese + Fats from Butter + Fats from Dairy foods,,22.6,,,percentRoot,,,"Adipose tissue, unspecified",GC-FID,Margaric acid (17:0),"",0.34,,,percentRoot,,107,Pearson,0.03,-0.16,0.22,>= 0.05,No,,,,Brevik 2005
4454,4636,4648,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,Fats from Cheese + Fats from Butter + Fats from Dairy foods,,22.6,,,percentRoot,,,"Serum, fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,110,Pearson,0.28,0.1,0.45,< 0.01,Yes,,,,Brevik 2005
4460,4636,4649,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,Fats from Cheese + Fats from Butter + Fats from Dairy foods,,22.6,,,percentRoot,,,"Serum, fasting",GC-FID,Margaric acid (17:0),"",0.37,,,percentRoot,,110,Pearson,-0.1,-0.28,0.09,>= 0.05,No,,,,Brevik 2005
4443,4639,4646,All,Men from Oerland military flight station,Norway,,,Weighed Dietary record (3-day),Fats from Dairy foods,"",,9.5,,,percentRoot,,,"Adipose tissue, unspecified",GC-FID,Pentadecylic acid (15:0),"",0.32,,,percentRoot,,107,Pearson,0.16,-0.03,0.34,>= 0.05,No,,,,Brevik 2005
4449,4639,4647,All,Men from Oerland military flight station,Norway,,,Weighed Dietary record (3-day),Fats from Dairy foods,"",,9.5,,,percentRoot,,,"Adipose tissue, unspecified",GC-FID,Margaric acid (17:0),"",0.34,,,percentRoot,,107,Pearson,-0.07,-0.25,0.13,>= 0.05,No,,,,Brevik 2005
4455,4639,4648,All,Men from Oerland military flight station,Norway,,,Weighed Dietary record (3-day),Fats from Dairy foods,"",,9.5,,,percentRoot,,,"Serum, fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,110,Pearson,0.17,-0.02,0.35,>= 0.05,No,,,,Brevik 2005
4461,4639,4649,All,Men from Oerland military flight station,Norway,,,Weighed Dietary record (3-day),Fats from Dairy foods,"",,9.5,,,percentRoot,,,"Serum, fasting",GC-FID,Margaric acid (17:0),"",0.37,,,percentRoot,,110,Pearson,-0.26,-0.42,-0.07,< 0.01,Yes,,,,Brevik 2005
4444,4642,4646,All,Men from Oerland military flight station,Norway,,,Weighed Dietary record (3-day),Fats from Cheese,"",,8.8,,,percentRoot,,,"Adipose tissue, unspecified",GC-FID,Pentadecylic acid (15:0),"",0.32,,,percentRoot,,107,Pearson,0.39,0.22,0.54,< 0.01,Yes,,,,Brevik 2005
4450,4642,4647,All,Men from Oerland military flight station,Norway,,,Weighed Dietary record (3-day),Fats from Cheese,"",,8.8,,,percentRoot,,,"Adipose tissue, unspecified",GC-FID,Margaric acid (17:0),"",0.34,,,percentRoot,,107,Pearson,0.06,-0.14,0.24,>= 0.05,No,,,,Brevik 2005
4456,4642,4648,All,Men from Oerland military flight station,Norway,,,Weighed Dietary record (3-day),Fats from Cheese,"",,8.8,,,percentRoot,,,"Serum, fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,110,Pearson,0.37,0.19,0.52,< 0.01,Yes,,,,Brevik 2005
4462,4642,4649,All,Men from Oerland military flight station,Norway,,,Weighed Dietary record (3-day),Fats from Cheese,"",,8.8,,,percentRoot,,,"Serum, fasting",GC-FID,Margaric acid (17:0),"",0.37,,,percentRoot,,110,Pearson,0.22,0.04,0.39,< 0.05,Yes,,,,Brevik 2005
4445,4645,4646,All,Men from Oerland military flight station,Norway,,,Weighed Dietary record (3-day),Fats from Dairy foods,Fats from Cheese + Fats from Butter + Fats from Dairy foods,,21.2,,,percentRoot,,,"Adipose tissue, unspecified",GC-FID,Pentadecylic acid (15:0),"",0.32,,,percentRoot,,107,Pearson,0.52,0.37,0.65,< 0.01,Yes,,,,Brevik 2005
4451,4645,4647,All,Men from Oerland military flight station,Norway,,,Weighed Dietary record (3-day),Fats from Dairy foods,Fats from Cheese + Fats from Butter + Fats from Dairy foods,,21.2,,,percentRoot,,,"Adipose tissue, unspecified",GC-FID,Margaric acid (17:0),"",0.34,,,percentRoot,,107,Pearson,0.07,-0.12,0.26,>= 0.05,No,,,,Brevik 2005
4457,4645,4648,All,Men from Oerland military flight station,Norway,,,Weighed Dietary record (3-day),Fats from Dairy foods,Fats from Cheese + Fats from Butter + Fats from Dairy foods,,21.2,,,percentRoot,,,"Serum, fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,110,Pearson,0.43,0.26,0.57,< 0.01,Yes,,,,Brevik 2005
4463,4645,4649,All,Men from Oerland military flight station,Norway,,,Weighed Dietary record (3-day),Fats from Dairy foods,Fats from Cheese + Fats from Butter + Fats from Dairy foods,,21.2,,,percentRoot,,,"Serum, fasting",GC-FID,Margaric acid (17:0),"",0.37,,,percentRoot,,110,Pearson,0.05,-0.14,0.23,>= 0.05,No,,,,Brevik 2005
4464,4670,4650,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,4234.0,,,ug/day,,,"Serum, non-fasting",HPLC,alpha-Carotene,"",0.11,,,umol/L,,28,Spearman,0.36,,,>= 0.05,No,,,,McNaughton 2005
4465,4671,4651,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,10002.0,,,ug/day,,,"Serum, non-fasting",HPLC,beta-Carotene,"",0.62,,,umol/L,,28,Spearman,0.22,,,>= 0.05,No,,,,McNaughton 2005
4466,4672,4651,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",Yes,12198.0,,,ug/day,,,"Serum, non-fasting",HPLC,beta-Carotene,"",0.62,,,umol/L,,28,Spearman,0.12,,,>= 0.05,No,,,,McNaughton 2005
4467,4673,4652,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",No,626.0,,,ug/day,,,"Serum, non-fasting",HPLC,beta-Cryptoxanthin,"",0.25,,,umol/L,,28,Spearman,-0.002,,,>= 0.05,No,,,,McNaughton 2005
4468,4674,4653,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,1631.0,,,ug/day,,,"Serum, non-fasting",HPLC,Lutein/Zeaxanthin,"",0.36,,,umol/L,,28,Spearman,0.03,,,>= 0.05,No,,,,McNaughton 2005
4469,4675,4654,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Food Frequency Questionnaire (FFQ),Lycopene,"",No,3813.0,,,ug/day,,,"Serum, non-fasting",HPLC,Lycopene,"",0.17,,,umol/L,,28,Spearman,0.19,,,>= 0.05,No,,,,McNaughton 2005
4470,4676,4655,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,No,20306.0,,,ug/day,,,"Serum, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,1.51,,,umol/L,,28,Spearman,0.28,,,>= 0.05,No,,,,McNaughton 2005
4471,4677,4655,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Yes,22502.0,,,ug/day,,,"Serum, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,1.51,,,umol/L,,28,Spearman,0.18,,,>= 0.05,No,,,,McNaughton 2005
4472,4678,4656,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",No,12.8,,,mg/day,,,"Serum, non-fasting",HPLC,alpha-Tocopherol,"",34.8,,,umol/L,,28,Spearman,0.05,,,>= 0.05,No,,,,McNaughton 2005
4473,4679,4656,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",Yes,51.44,,,mg/day,,,"Serum, non-fasting",HPLC,alpha-Tocopherol,"",34.8,,,umol/L,,28,Spearman,0.31,,,>= 0.05,No,,,,McNaughton 2005
4474,4659,4650,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Weighed Dietary record (2-day),alpha-Carotene,"",No,1601.0,,,ug/day,,,"Serum, non-fasting",HPLC,alpha-Carotene,"",0.11,,,umol/L,,28,Spearman,0.19,,,>= 0.05,No,,,,McNaughton 2005
4475,4660,4651,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Weighed Dietary record (2-day),beta-Carotene,"",No,4067.0,,,ug/day,,,"Serum, non-fasting",HPLC,beta-Carotene,"",0.62,,,umol/L,,28,Spearman,0.26,,,>= 0.05,No,,,,McNaughton 2005
4476,4662,4652,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Weighed Dietary record (2-day),beta-Cryptoxanthin,"",No,213.0,,,ug/day,,,"Serum, non-fasting",HPLC,beta-Cryptoxanthin,"",0.25,,,umol/L,,28,Spearman,0.42,,,< 0.05,Yes,,,,McNaughton 2005
4477,4663,4653,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Weighed Dietary record (2-day),Lutein/Zeaxanthin,"",No,523.0,,,ug/day,,,"Serum, non-fasting",HPLC,Lutein/Zeaxanthin,"",0.36,,,umol/L,,28,Spearman,0.35,,,>= 0.05,No,,,,McNaughton 2005
4478,4664,4654,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Weighed Dietary record (2-day),Lycopene,"",No,2336.0,,,ug/day,,,"Serum, non-fasting",HPLC,Lycopene,"",0.17,,,umol/L,,28,Spearman,0.07,,,>= 0.05,No,,,,McNaughton 2005
4479,4665,4655,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Weighed Dietary record (2-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,No,8741.0,,,ug/day,,,"Serum, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,1.51,,,umol/L,,28,Spearman,0.33,,,>= 0.05,No,,,,McNaughton 2005
4480,4667,4656,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Weighed Dietary record (2-day),Vitamin E (alpha-Tocopherol Equivalents),"",No,7.82,,,mg/day,,,"Serum, non-fasting",HPLC,alpha-Tocopherol,"",34.8,,,umol/L,,28,Spearman,-0.11,,,>= 0.05,No,,,,McNaughton 2005
4481,4668,4656,All,Participants in a dietary validation study,Australia,Nambour Skin Cancer Study,,Weighed Dietary record (2-day),Vitamin E (alpha-Tocopherol Equivalents),"",Yes,37.69,,,mg/day,,,"Serum, non-fasting",HPLC,alpha-Tocopherol,"",34.8,,,umol/L,,28,Spearman,-0.02,,,>= 0.05,No,,,,McNaughton 2005
4504,4680,4692,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vegetables,"",,113.0,,,g/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",0.081,,,umol/L,,284,Spearman,0.21,,, ,Yes,,,,Jansen 2004
4505,4680,4693,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vegetables,"",,113.0,,,g/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",0.24,,,umol/L,,284,Spearman,0.19,,, ,Yes,,,,Jansen 2004
4506,4680,4694,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vegetables,"",,113.0,,,g/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",0.167,,,umol/L,,284,Spearman,0.13,,, ,Yes,,,,Jansen 2004
4507,4680,4695,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vegetables,"",,113.0,,,g/day,,,"Plasma, non-fasting",HPLC,Lutein,"",0.251,,,umol/L,,284,Spearman,0.27,,, ,Yes,,,,Jansen 2004
4508,4680,4696,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vegetables,"",,113.0,,,g/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",0.62,,,umol/L,,284,Spearman,0.04,,, ,No,,,,Jansen 2004
4509,4680,4697,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vegetables,"",,113.0,,,g/day,,,"Plasma, non-fasting",HPLC,Zeaxanthin,"",0.066,,,umol/L,,284,Spearman,0.16,,, ,Yes,,,,Jansen 2004
4510,4680,4699,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vegetables,"",,113.0,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene + Canthaxanthin,1.435,,,umol/L,,284,Spearman,0.19,,, ,Yes,,,,Jansen 2004
4511,4680,4700,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vegetables,"",,113.0,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lutein + beta-Carotene,,,,umol/L,,284,Spearman,0.28,,, ,Yes,,,,Jansen 2004
4512,4680,4701,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vegetables,"",,113.0,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenes,alpha-Carotene + beta-Carotene,,,,umol/L,,284,Spearman,0.2,,, ,Yes,,,,Jansen 2004
4513,4680,4702,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vegetables,"",,113.0,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,umol/L,,284,Spearman,0.21,,, ,Yes,,,,Jansen 2004
4514,4680,4703,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vegetables,"",,113.0,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,Zeaxanthin + Lutein,,,,umol/L,,284,Spearman,0.26,,, ,Yes,,,,Jansen 2004
4526,4681,4692,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,"",,153.0,,,g/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",0.081,,,umol/L,,284,Spearman,0.28,,, ,Yes,,,,Jansen 2004
4527,4681,4693,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,"",,153.0,,,g/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",0.24,,,umol/L,,284,Spearman,0.25,,, ,Yes,,,,Jansen 2004
4528,4681,4694,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,"",,153.0,,,g/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",0.167,,,umol/L,,284,Spearman,0.37,,, ,Yes,,,,Jansen 2004
4529,4681,4695,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,"",,153.0,,,g/day,,,"Plasma, non-fasting",HPLC,Lutein,"",0.251,,,umol/L,,284,Spearman,0.16,,, ,Yes,,,,Jansen 2004
4530,4681,4696,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,"",,153.0,,,g/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",0.62,,,umol/L,,284,Spearman,-0.07,,, ,No,,,,Jansen 2004
4531,4681,4697,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,"",,153.0,,,g/day,,,"Plasma, non-fasting",HPLC,Zeaxanthin,"",0.066,,,umol/L,,284,Spearman,0.08,,, ,No,,,,Jansen 2004
4532,4681,4699,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,"",,153.0,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene + Canthaxanthin,1.435,,,umol/L,,284,Spearman,0.15,,, ,Yes,,,,Jansen 2004
4533,4681,4700,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,"",,153.0,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lutein + beta-Carotene,,,,umol/L,,284,Spearman,0.29,,, ,Yes,,,,Jansen 2004
4534,4681,4701,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,"",,153.0,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenes,alpha-Carotene + beta-Carotene,,,,umol/L,,284,Spearman,0.27,,, ,Yes,,,,Jansen 2004
4535,4681,4702,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,"",,153.0,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,umol/L,,284,Spearman,0.34,,, ,Yes,,,,Jansen 2004
4536,4681,4703,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,"",,153.0,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,Zeaxanthin + Lutein,,,,umol/L,,284,Spearman,0.14,,, ,Yes,,,,Jansen 2004
4548,4684,4692,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruit juices + Vegetable juices,Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",0.081,,,umol/L,,284,Spearman,0.12,,, ,Yes,,,,Jansen 2004
4549,4684,4693,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruit juices + Vegetable juices,Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",0.24,,,umol/L,,284,Spearman,0.09,,, ,No,,,,Jansen 2004
4550,4684,4694,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruit juices + Vegetable juices,Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",0.167,,,umol/L,,284,Spearman,0.29,,, ,Yes,,,,Jansen 2004
4551,4684,4695,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruit juices + Vegetable juices,Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Lutein,"",0.251,,,umol/L,,284,Spearman,0.07,,, ,No,,,,Jansen 2004
4552,4684,4696,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruit juices + Vegetable juices,Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",0.62,,,umol/L,,284,Spearman,0.04,,, ,No,,,,Jansen 2004
4553,4684,4697,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruit juices + Vegetable juices,Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Zeaxanthin,"",0.066,,,umol/L,,284,Spearman,0.21,,, ,Yes,,,,Jansen 2004
4554,4684,4699,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruit juices + Vegetable juices,Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene + Canthaxanthin,1.435,,,umol/L,,284,Spearman,0.16,,, ,Yes,,,,Jansen 2004
4555,4684,4700,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruit juices + Vegetable juices,Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lutein + beta-Carotene,,,,umol/L,,284,Spearman,0.2,,, ,Yes,,,,Jansen 2004
4556,4684,4701,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruit juices + Vegetable juices,Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenes,alpha-Carotene + beta-Carotene,,,,umol/L,,284,Spearman,0.11,,, ,No,,,,Jansen 2004
4557,4684,4702,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruit juices + Vegetable juices,Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,umol/L,,284,Spearman,0.2,,, ,Yes,,,,Jansen 2004
4558,4684,4703,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruit juices + Vegetable juices,Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,Zeaxanthin + Lutein,,,,umol/L,,284,Spearman,0.1,,, ,No,,,,Jansen 2004
4482,4685,4692,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",0.081,,,umol/L,,284,Spearman,0.29,,, ,Yes,,,,Jansen 2004
4483,4685,4693,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",0.24,,,umol/L,,284,Spearman,0.24,,, ,Yes,,,,Jansen 2004
4484,4685,4694,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",0.167,,,umol/L,,284,Spearman,0.41,,, ,Yes,,,,Jansen 2004
4485,4685,4695,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Lutein,"",0.251,,,umol/L,,284,Spearman,0.19,,, ,Yes,,,,Jansen 2004
4486,4685,4696,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",0.62,,,umol/L,,284,Spearman,-0.02,,, ,No,,,,Jansen 2004
4487,4685,4697,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Zeaxanthin,"",0.066,,,umol/L,,284,Spearman,0.18,,, ,Yes,,,,Jansen 2004
4488,4685,4699,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene + Canthaxanthin,1.435,,,umol/L,,284,Spearman,0.21,,, ,Yes,,,,Jansen 2004
4489,4685,4700,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lutein + beta-Carotene,,,,umol/L,,284,Spearman,0.35,,, ,Yes,,,,Jansen 2004
4490,4685,4701,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenes,alpha-Carotene + beta-Carotene,,,,umol/L,,284,Spearman,0.27,,, ,Yes,,,,Jansen 2004
4491,4685,4702,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,umol/L,,284,Spearman,0.35,,, ,Yes,,,,Jansen 2004
4492,4685,4703,Males,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,Zeaxanthin + Lutein,,,,umol/L,,284,Spearman,0.2,,, ,Yes,,,,Jansen 2004
4515,4686,4704,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vegetables,"",,127.0,,,g/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",0.12,,,umol/L,,287,Spearman,0.17,,, ,Yes,,,,Jansen 2004
4516,4686,4705,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vegetables,"",,127.0,,,g/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",0.302,,,umol/L,,287,Spearman,0.15,,, ,Yes,,,,Jansen 2004
4517,4686,4706,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vegetables,"",,127.0,,,g/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",0.225,,,umol/L,,287,Spearman,0.0,,, ,No,,,,Jansen 2004
4518,4686,4707,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vegetables,"",,127.0,,,g/day,,,"Plasma, non-fasting",HPLC,Lutein,"",0.304,,,umol/L,,287,Spearman,0.19,,, ,Yes,,,,Jansen 2004
4519,4686,4708,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vegetables,"",,127.0,,,g/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",0.658,,,umol/L,,287,Spearman,0.02,,, ,No,,,,Jansen 2004
4520,4686,4709,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vegetables,"",,127.0,,,g/day,,,"Plasma, non-fasting",HPLC,Zeaxanthin,"",0.085,,,umol/L,,287,Spearman,0.1,,, ,No,,,,Jansen 2004
4521,4686,4711,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vegetables,"",,127.0,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene + Canthaxanthin,1.704,,,umol/L,,287,Spearman,0.15,,, ,Yes,,,,Jansen 2004
4522,4686,4712,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vegetables,"",,127.0,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lutein + beta-Carotene,,,,umol/L,,287,Spearman,0.16,,, ,Yes,,,,Jansen 2004
4523,4686,4713,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vegetables,"",,127.0,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenes,alpha-Carotene + beta-Carotene,,,,umol/L,,287,Spearman,0.17,,, ,Yes,,,,Jansen 2004
4524,4686,4714,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vegetables,"",,127.0,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,umol/L,,287,Spearman,0.12,,, ,Yes,,,,Jansen 2004
4525,4686,4715,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vegetables,"",,127.0,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,Zeaxanthin + Lutein,,,,umol/L,,287,Spearman,0.18,,, ,Yes,,,,Jansen 2004
4537,4687,4704,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,"",,186.0,,,g/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",0.12,,,umol/L,,287,Spearman,0.28,,, ,Yes,,,,Jansen 2004
4538,4687,4705,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,"",,186.0,,,g/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",0.302,,,umol/L,,287,Spearman,0.18,,, ,Yes,,,,Jansen 2004
4539,4687,4706,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,"",,186.0,,,g/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",0.225,,,umol/L,,287,Spearman,0.37,,, ,Yes,,,,Jansen 2004
4540,4687,4707,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,"",,186.0,,,g/day,,,"Plasma, non-fasting",HPLC,Lutein,"",0.304,,,umol/L,,287,Spearman,0.18,,, ,Yes,,,,Jansen 2004
4541,4687,4708,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,"",,186.0,,,g/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",0.658,,,umol/L,,287,Spearman,-0.11,,, ,No,,,,Jansen 2004
4542,4687,4709,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,"",,186.0,,,g/day,,,"Plasma, non-fasting",HPLC,Zeaxanthin,"",0.085,,,umol/L,,287,Spearman,0.16,,, ,Yes,,,,Jansen 2004
4543,4687,4711,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,"",,186.0,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene + Canthaxanthin,1.704,,,umol/L,,287,Spearman,0.18,,, ,Yes,,,,Jansen 2004
4544,4687,4712,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,"",,186.0,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lutein + beta-Carotene,,,,umol/L,,287,Spearman,0.31,,, ,Yes,,,,Jansen 2004
4545,4687,4713,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,"",,186.0,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenes,alpha-Carotene + beta-Carotene,,,,umol/L,,287,Spearman,0.23,,, ,Yes,,,,Jansen 2004
4546,4687,4714,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,"",,186.0,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,umol/L,,287,Spearman,0.31,,, ,Yes,,,,Jansen 2004
4547,4687,4715,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits,"",,186.0,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,Zeaxanthin + Lutein,,,,umol/L,,287,Spearman,0.19,,, ,Yes,,,,Jansen 2004
4559,4690,4704,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruit juices + Vegetable juices,Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",0.12,,,umol/L,,287,Spearman,0.07,,, ,No,,,,Jansen 2004
4560,4690,4705,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruit juices + Vegetable juices,Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",0.302,,,umol/L,,287,Spearman,-0.02,,, ,No,,,,Jansen 2004
4561,4690,4706,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruit juices + Vegetable juices,Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",0.225,,,umol/L,,287,Spearman,0.21,,, ,Yes,,,,Jansen 2004
4562,4690,4707,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruit juices + Vegetable juices,Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Lutein,"",0.304,,,umol/L,,287,Spearman,0.03,,, ,No,,,,Jansen 2004
4563,4690,4708,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruit juices + Vegetable juices,Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",0.658,,,umol/L,,287,Spearman,-0.04,,, ,No,,,,Jansen 2004
4564,4690,4709,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruit juices + Vegetable juices,Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Zeaxanthin,"",0.085,,,umol/L,,287,Spearman,0.23,,, ,Yes,,,,Jansen 2004
4565,4690,4711,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruit juices + Vegetable juices,Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene + Canthaxanthin,1.704,,,umol/L,,287,Spearman,0.04,,, ,No,,,,Jansen 2004
4566,4690,4712,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruit juices + Vegetable juices,Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lutein + beta-Carotene,,,,umol/L,,287,Spearman,0.1,,, ,No,,,,Jansen 2004
4567,4690,4713,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruit juices + Vegetable juices,Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenes,alpha-Carotene + beta-Carotene,,,,umol/L,,287,Spearman,0.0,,, ,No,,,,Jansen 2004
4568,4690,4714,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruit juices + Vegetable juices,Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,umol/L,,287,Spearman,0.09,,, ,No,,,,Jansen 2004
4569,4690,4715,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruit juices + Vegetable juices,Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,Zeaxanthin + Lutein,,,,umol/L,,287,Spearman,0.08,,, ,No,,,,Jansen 2004
4493,4691,4704,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",0.12,,,umol/L,,287,Spearman,0.28,,, ,Yes,,,,Jansen 2004
4494,4691,4705,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",0.302,,,umol/L,,287,Spearman,0.17,,, ,Yes,,,,Jansen 2004
4495,4691,4706,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",0.225,,,umol/L,,287,Spearman,0.35,,, ,Yes,,,,Jansen 2004
4496,4691,4707,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Lutein,"",0.304,,,umol/L,,287,Spearman,0.2,,, ,Yes,,,,Jansen 2004
4497,4691,4708,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",0.658,,,umol/L,,287,Spearman,-0.09,,, ,No,,,,Jansen 2004
4498,4691,4709,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Zeaxanthin,"",0.085,,,umol/L,,287,Spearman,0.23,,, ,Yes,,,,Jansen 2004
4499,4691,4711,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene + Canthaxanthin,1.704,,,umol/L,,287,Spearman,0.18,,, ,Yes,,,,Jansen 2004
4500,4691,4712,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lutein + beta-Carotene,,,,umol/L,,287,Spearman,0.31,,, ,Yes,,,,Jansen 2004
4501,4691,4713,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenes,alpha-Carotene + beta-Carotene,,,,umol/L,,287,Spearman,0.21,,, ,Yes,,,,Jansen 2004
4502,4691,4714,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,umol/L,,287,Spearman,0.29,,, ,Yes,,,,Jansen 2004
4503,4691,4715,Females,Adults,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Fruit juices + Vegetable juices,,,,,g/day,,,"Plasma, non-fasting",HPLC,Carotenoids,Zeaxanthin + Lutein,,,,umol/L,,287,Spearman,0.22,,, ,Yes,,,,Jansen 2004
4570,4716,4733,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,missing unit,,,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",,,71.0,mmol/L,,192,Pearson,0.34,,,< 0.001,Yes,,,,Meyerhardt 2005
4579,4716,4733,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,missing unit,,,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",,,71.0,mmol/L,,192,Pearson,0.38,,,< 0.001,Yes,Energy by residual method,,,Meyerhardt 2005
4588,4716,4733,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,missing unit,,,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",,,71.0,mmol/L,,192,Pearson,0.36,,,< 0.001,Yes,Energy by residual method,,"Age, Sex, BMI, Cholesterol, Smoking status, Weight change in last 4-6 weeks",Meyerhardt 2005
4571,4717,4734,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,missing unit,,,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",,,277.0,mmol/L,,192,Pearson,0.3,,,< 0.001,Yes,,,,Meyerhardt 2005
4580,4717,4734,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,missing unit,,,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",,,277.0,mmol/L,,192,Pearson,0.35,,,< 0.001,Yes,Energy by residual method,,,Meyerhardt 2005
4589,4717,4734,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,missing unit,,,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",,,277.0,mmol/L,,192,Pearson,0.33,,,< 0.001,Yes,Energy by residual method,,"Age, Sex, BMI, Cholesterol, Smoking status, Weight change in last 4-6 weeks",Meyerhardt 2005
4572,4718,4735,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),Carotenes,alpha-Carotene + beta-Carotene,,,,,missing unit,,,"Plasma, fasting and non-fasting",HPLC,Carotenes,alpha-Carotene + beta-Carotene,,,,mmol/L,,192,Pearson,0.28,,,< 0.001,Yes,,,,Meyerhardt 2005
4581,4718,4735,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),Carotenes,alpha-Carotene + beta-Carotene,,,,,missing unit,,,"Plasma, fasting and non-fasting",HPLC,Carotenes,alpha-Carotene + beta-Carotene,,,,mmol/L,,192,Pearson,0.34,,,< 0.001,Yes,Energy by residual method,,,Meyerhardt 2005
4590,4718,4735,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),Carotenes,alpha-Carotene + beta-Carotene,,,,,missing unit,,,"Plasma, fasting and non-fasting",HPLC,Carotenes,alpha-Carotene + beta-Carotene,,,,mmol/L,,192,Pearson,0.33,,,< 0.001,Yes,Energy by residual method,,"Age, Sex, BMI, Cholesterol, Smoking status, Weight change in last 4-6 weeks",Meyerhardt 2005
4573,4719,4736,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,missing unit,,,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,192,Pearson,0.39,,,< 0.001,Yes,,,,Meyerhardt 2005
4582,4719,4736,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,missing unit,,,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,192,Pearson,0.43,,,< 0.001,Yes,Energy by residual method,,,Meyerhardt 2005
4591,4719,4736,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,missing unit,,,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,192,Pearson,0.44,,,< 0.001,Yes,Energy by residual method,,"Age, Sex, BMI, Cholesterol, Smoking status, Weight change in last 4-6 weeks",Meyerhardt 2005
4574,4720,4737,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,,,missing unit,,,"Plasma, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",,,,missing unit,,192,Pearson,0.39,,,< 0.001,Yes,,,,Meyerhardt 2005
4583,4720,4737,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,,,missing unit,,,"Plasma, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",,,,missing unit,,192,Pearson,0.43,,,< 0.001,Yes,Energy by residual method,,,Meyerhardt 2005
4592,4720,4737,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,,,missing unit,,,"Plasma, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",,,,missing unit,,192,Pearson,0.39,,,< 0.001,Yes,Energy by residual method,,"Age, Sex, BMI, Cholesterol, Smoking status, Weight change in last 4-6 weeks",Meyerhardt 2005
4575,4721,4738,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,missing unit,,,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",,,,missing unit,,192,Pearson,0.3,,,< 0.001,Yes,,,,Meyerhardt 2005
4584,4721,4738,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,missing unit,,,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",,,,missing unit,,192,Pearson,0.34,,,< 0.001,Yes,Energy by residual method,,,Meyerhardt 2005
4593,4721,4738,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,missing unit,,,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",,,,missing unit,,192,Pearson,0.34,,,< 0.001,Yes,Energy by residual method,,"Age, Sex, BMI, Cholesterol, Smoking status, Weight change in last 4-6 weeks",Meyerhardt 2005
4576,4722,4739,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",,,,,missing unit,,,"Plasma, fasting and non-fasting",HPLC,alpha-Tocopherol,"",,,32.0,umol/L,,192,Pearson,0.32,,,< 0.001,Yes,,,,Meyerhardt 2005
4585,4722,4739,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",,,,,missing unit,,,"Plasma, fasting and non-fasting",HPLC,alpha-Tocopherol,"",,,32.0,umol/L,,192,Pearson,0.33,,,< 0.001,Yes,Energy by residual method,,,Meyerhardt 2005
4594,4722,4739,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",,,,,missing unit,,,"Plasma, fasting and non-fasting",HPLC,alpha-Tocopherol,"",,,32.0,umol/L,,192,Pearson,0.33,,,< 0.001,Yes,Energy by residual method,,"Age, Sex, BMI, Cholesterol, Smoking status, Weight change in last 4-6 weeks",Meyerhardt 2005
4577,4723,4739,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),Vitamin E,"",,,,,missing unit,,,"Plasma, fasting and non-fasting",HPLC,alpha-Tocopherol,"",,,32.0,umol/L,,192,Pearson,0.33,,,< 0.001,Yes,,,,Meyerhardt 2005
4578,4723,4740,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),Vitamin E,"",,,,,missing unit,,,"Plasma, fasting and non-fasting",HPLC,gamma-Tocopherol,"",,,,missing unit,,192,Pearson,-0.38,,,< 0.001,Yes,,,,Meyerhardt 2005
4586,4723,4739,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),Vitamin E,"",,,,,missing unit,,,"Plasma, fasting and non-fasting",HPLC,alpha-Tocopherol,"",,,32.0,umol/L,,192,Pearson,0.34,,,< 0.001,Yes,Energy by residual method,,,Meyerhardt 2005
4587,4723,4740,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),Vitamin E,"",,,,,missing unit,,,"Plasma, fasting and non-fasting",HPLC,gamma-Tocopherol,"",,,,missing unit,,192,Pearson,-0.4,,,< 0.001,Yes,Energy by residual method,,,Meyerhardt 2005
4595,4723,4739,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),Vitamin E,"",,,,,missing unit,,,"Plasma, fasting and non-fasting",HPLC,alpha-Tocopherol,"",,,32.0,umol/L,,192,Pearson,0.34,,,< 0.001,Yes,Energy by residual method,,"Age, Sex, BMI, Cholesterol, Smoking status, Weight change in last 4-6 weeks",Meyerhardt 2005
4596,4723,4740,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),Vitamin E,"",,,,,missing unit,,,"Plasma, fasting and non-fasting",HPLC,gamma-Tocopherol,"",,,,missing unit,,192,Pearson,-0.4,,,< 0.001,Yes,Energy by residual method,,"Age, Sex, BMI, Cholesterol, Smoking status, Weight change in last 4-6 weeks",Meyerhardt 2005
4597,4724,4741,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6),,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, trans",Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6),,,2.5,percentRoot,,192,Pearson,0.55,,,< 0.0001,Yes,Energy by residual method,,,Meyerhardt 2005
4598,4724,4742,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6),,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,trans-Octadecenoic acids (trans-18:1),Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9),,,,percentRoot,,192,Pearson,0.55,,,< 0.0001,Yes,Energy by residual method,,,Meyerhardt 2005
4600,4724,4743,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6),,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6),,,,percentRoot,,192,Pearson,0.54,,,< 0.0001,Yes,Energy by residual method,,,Meyerhardt 2005
4608,4724,4741,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6),,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, trans",Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6),,,2.5,percentRoot,,192,Pearson,0.55,,,< 0.0001,Yes,Energy by residual method,,"Age, Sex, BMI, Weight change in last 4-6 weeks",Meyerhardt 2005
4609,4724,4742,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6),,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,trans-Octadecenoic acids (trans-18:1),Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9),,,,percentRoot,,192,Pearson,0.55,,,< 0.0001,Yes,Energy by residual method,,"Age, Sex, BMI, Weight change in last 4-6 weeks",Meyerhardt 2005
4611,4724,4743,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6),,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6),,,,percentRoot,,192,Pearson,0.55,,,< 0.0001,Yes,Energy by residual method,,"Age, Sex, BMI, Weight change in last 4-6 weeks",Meyerhardt 2005
4599,4725,4742,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),trans-Octadecenoic acids (trans-18:1),Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9),,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,trans-Octadecenoic acids (trans-18:1),Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9),,,,percentRoot,,192,Pearson,0.54,,,< 0.0001,Yes,Energy by residual method,,,Meyerhardt 2005
4610,4725,4742,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),trans-Octadecenoic acids (trans-18:1),Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9),,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,trans-Octadecenoic acids (trans-18:1),Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9),,,,percentRoot,,192,Pearson,0.54,,,< 0.0001,Yes,Energy by residual method,,"Age, Sex, BMI, Weight change in last 4-6 weeks",Meyerhardt 2005
4601,4726,4743,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6),,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6),,,,percentRoot,,192,Pearson,0.55,,,< 0.0001,Yes,Energy by residual method,,,Meyerhardt 2005
4612,4726,4743,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6),,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6),,,,percentRoot,,192,Pearson,0.56,,,< 0.0001,Yes,Energy by residual method,,"Age, Sex, BMI, Weight change in last 4-6 weeks",Meyerhardt 2005
4602,4727,4744,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)","alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + 13Z,16Z,19Z-Docosatrienoic acid (cis-22:3n-3)",,,2.1,percentRoot,,192,Pearson,0.49,,,< 0.0001,Yes,Energy by residual method,,,Meyerhardt 2005
4613,4727,4744,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)","alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + 13Z,16Z,19Z-Docosatrienoic acid (cis-22:3n-3)",,,2.1,percentRoot,,192,Pearson,0.48,,,< 0.0001,Yes,Energy by residual method,,"Age, Sex, BMI, Weight change in last 4-6 weeks",Meyerhardt 2005
4603,4728,4745,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),cis-Docosapentaenoic acids (cis-22:5),"",,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,cis-Docosapentaenoic acids (cis-22:5),"",,,,percentRoot,,192,Pearson,0.23,,,= 0.001,Yes,Energy by residual method,,,Meyerhardt 2005
4614,4728,4745,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),cis-Docosapentaenoic acids (cis-22:5),"",,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,cis-Docosapentaenoic acids (cis-22:5),"",,,,percentRoot,,192,Pearson,0.26,,,= 0.0006,Yes,Energy by residual method,,"Age, Sex, BMI, Weight change in last 4-6 weeks",Meyerhardt 2005
4604,4729,4746,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,192,Pearson,0.27,,,= 0.0002,Yes,Energy by residual method,,,Meyerhardt 2005
4615,4729,4746,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,192,Pearson,0.29,,,< 0.0001,Yes,Energy by residual method,,"Age, Sex, BMI, Weight change in last 4-6 weeks",Meyerhardt 2005
4605,4730,4747,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,192,Pearson,0.43,,,< 0.0001,Yes,Energy by residual method,,,Meyerhardt 2005
4616,4730,4747,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,192,Pearson,0.42,,,< 0.0001,Yes,Energy by residual method,,"Age, Sex, BMI, Weight change in last 4-6 weeks",Meyerhardt 2005
4606,4731,4748,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,192,Pearson,0.21,,,< 0.003,Yes,Energy by residual method,,,Meyerhardt 2005
4617,4731,4748,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,192,Pearson,0.22,,,< 0.003,Yes,Energy by residual method,,"Age, Sex, BMI, Weight change in last 4-6 weeks",Meyerhardt 2005
4607,4732,4748,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,192,Pearson,0.21,,,< 0.003,Yes,Energy by residual method,,,Meyerhardt 2005
4618,4732,4748,All,Cancer patients receiving cytotoxic chemotherapy in Boston,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,192,Pearson,0.22,,,< 0.002,Yes,Energy by residual method,,"Age, Sex, BMI, Weight change in last 4-6 weeks",Meyerhardt 2005
4622,4755,4749,All,Controls in a case-control study on diet and breast cancer,United Kingdom,,,Food Frequency Questionnaire (FFQ),Genistein,"",,286.5,,,ug/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Genistein,"",18.3,,,nmol/L,,58,Spearman,0.21,,,= 0.12,No,,,,Bhakta 2005
4623,4756,4750,All,Controls in a case-control study on diet and breast cancer,United Kingdom,,,Food Frequency Questionnaire (FFQ),Daidzein,"",,229.1,,,ug/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Daidzein,"",7.8,,,nmol/L,,58,Spearman,0.32,,,= 0.02,Yes,,,,Bhakta 2005
4624,4757,4751,All,Controls in a case-control study on diet and breast cancer,United Kingdom,,,Food Frequency Questionnaire (FFQ),Lignans,Secoisolariciresinol + Matairesinol,,224.4,,,ug/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",13.7,,,nmol/L,,58,Spearman,0.1,,,= 0.43,No,,,,Bhakta 2005
4619,4752,4749,All,Controls in a case-control study on diet and breast cancer,United Kingdom,,,24-h Dietary recall (1-day),Genistein,"",,245.0,,,ug/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Genistein,"",18.3,,,nmol/L,,58,Spearman,0.43,,,< 0.001,Yes,,,,Bhakta 2005
4620,4753,4750,All,Controls in a case-control study on diet and breast cancer,United Kingdom,,,24-h Dietary recall (1-day),Daidzein,"",,159.5,,,ug/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Daidzein,"",7.8,,,nmol/L,,58,Spearman,0.4,,,= 0.002,Yes,,,,Bhakta 2005
4621,4754,4751,All,Controls in a case-control study on diet and breast cancer,United Kingdom,,,24-h Dietary recall (1-day),Lignans,Secoisolariciresinol + Matairesinol,,140.7,,,ug/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",13.7,,,nmol/L,,58,Spearman,0.08,,,= 0.5,No,,,,Bhakta 2005
4633,4784,4758,All,Participants in a dietary validation study,Israel,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,1505.0,,,mg/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",2.3,,,umol/L,,161,Pearson,0.35,,,= 0.001,Yes,"Energy by residual method, Sex",No,Cholesterol,Shai 2005
4647,4784,4758,All,Participants in a dietary validation study,Israel,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,1505.0,,,mg/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",2.3,,,umol/L,,161,Pearson,0.38,,,>= 0.05,No,"Energy by residual method, Sex",Yes,Cholesterol,Shai 2005
4634,4785,4759,All,Participants in a dietary validation study,Israel,,,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,12.0,,,mg/day,,,"Serum, fasting",Spectrophotometry,alpha-Tocopherol,"",480.65,,,umol/L,,161,Pearson,0.18,,,< 0.05,Yes,"Energy by residual method, Sex",No,Cholesterol,Shai 2005
4648,4785,4759,All,Participants in a dietary validation study,Israel,,,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,12.0,,,mg/day,,,"Serum, fasting",Spectrophotometry,alpha-Tocopherol,"",480.65,,,umol/L,,161,Pearson,0.19,,,>= 0.05,No,"Energy by residual method, Sex",Yes,Cholesterol,Shai 2005
4635,4786,4760,All,Participants in a dietary validation study,Israel,,,Food Frequency Questionnaire (FFQ),Folates,"",No,430.0,,,ug/day,,,"Serum, fasting",Enzyme immunoassay (EIA),Folates,"",24.25,,,nmol/L,,161,Pearson,0.41,,,= 0.001,Yes,"Energy by residual method, Sex",No,,Shai 2005
4649,4786,4760,All,Participants in a dietary validation study,Israel,,,Food Frequency Questionnaire (FFQ),Folates,"",No,430.0,,,ug/day,,,"Serum, fasting",Enzyme immunoassay (EIA),Folates,"",24.25,,,nmol/L,,161,Pearson,0.47,,,>= 0.05,No,"Energy by residual method, Sex",Yes,,Shai 2005
4636,4787,4758,All,Participants in a dietary validation study,Israel,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",Yes,1672.0,,,mg/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",2.3,,,umol/L,,161,Pearson,0.38,,,= 0.001,Yes,"Energy by residual method, Sex",No,Cholesterol,Shai 2005
4650,4787,4758,All,Participants in a dietary validation study,Israel,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",Yes,1672.0,,,mg/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",2.3,,,umol/L,,161,Pearson,0.42,,,>= 0.05,No,"Energy by residual method, Sex",Yes,Cholesterol,Shai 2005
4637,4788,4759,All,Participants in a dietary validation study,Israel,,,Food Frequency Questionnaire (FFQ),Vitamin E,"",Yes,95.0,,,mg/day,,,"Serum, fasting",Spectrophotometry,alpha-Tocopherol,"",480.65,,,umol/L,,161,Pearson,0.18,,,< 0.05,Yes,"Energy by residual method, Sex",No,Cholesterol,Shai 2005
4651,4788,4759,All,Participants in a dietary validation study,Israel,,,Food Frequency Questionnaire (FFQ),Vitamin E,"",Yes,95.0,,,mg/day,,,"Serum, fasting",Spectrophotometry,alpha-Tocopherol,"",480.65,,,umol/L,,161,Pearson,0.19,,,>= 0.05,No,"Energy by residual method, Sex",Yes,Cholesterol,Shai 2005
4638,4789,4760,All,Participants in a dietary validation study,Israel,,,Food Frequency Questionnaire (FFQ),Folates,"",Yes,529.0,,,ug/day,,,"Serum, fasting",Enzyme immunoassay (EIA),Folates,"",24.25,,,nmol/L,,161,Pearson,0.41,,,= 0.001,Yes,"Energy by residual method, Sex",No,,Shai 2005
4652,4789,4760,All,Participants in a dietary validation study,Israel,,,Food Frequency Questionnaire (FFQ),Folates,"",Yes,529.0,,,ug/day,,,"Serum, fasting",Enzyme immunoassay (EIA),Folates,"",24.25,,,nmol/L,,161,Pearson,0.47,,,>= 0.05,No,"Energy by residual method, Sex",Yes,,Shai 2005
4632,4793,4761,All,Participants in a dietary validation study,Israel,,,Food Frequency Questionnaire (FFQ),Proteins,"",No,93.0,,,g/day,,,"Urine, 24-h",Spectrophotometry,Nitrogen,"",,,,g/day,,161,Pearson,0.33,,,= 0.001,Yes,"Energy by residual method, Sex",No,,Shai 2005
4646,4793,4761,All,Participants in a dietary validation study,Israel,,,Food Frequency Questionnaire (FFQ),Proteins,"",No,93.0,,,g/day,,,"Urine, 24-h",Spectrophotometry,Nitrogen,"",,,,g/day,,161,Pearson,0.34,,,>= 0.05,No,"Energy by residual method, Sex",Yes,,Shai 2005
4626,4777,4758,All,Participants in a dietary validation study,Israel,,,24-h Dietary recall (1-day),beta-Carotene,"",No,825.0,,,mg/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",2.3,,,umol/L,,161,Pearson,0.38,,,= 0.001,Yes,"Energy by residual method, Sex",No,Cholesterol,Shai 2005
4640,4777,4758,All,Participants in a dietary validation study,Israel,,,24-h Dietary recall (1-day),beta-Carotene,"",No,825.0,,,mg/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",2.3,,,umol/L,,161,Pearson,0.41,,,>= 0.05,No,"Energy by residual method, Sex",Yes,Cholesterol,Shai 2005
4627,4778,4759,All,Participants in a dietary validation study,Israel,,,24-h Dietary recall (1-day),Vitamin E,"",No,9.0,,,mg/day,,,"Serum, fasting",Spectrophotometry,alpha-Tocopherol,"",480.65,,,umol/L,,161,Pearson,0.26,,,= 0.001,Yes,"Energy by residual method, Sex",No,Cholesterol,Shai 2005
4641,4778,4759,All,Participants in a dietary validation study,Israel,,,24-h Dietary recall (1-day),Vitamin E,"",No,9.0,,,mg/day,,,"Serum, fasting",Spectrophotometry,alpha-Tocopherol,"",480.65,,,umol/L,,161,Pearson,0.27,,,>= 0.05,No,"Energy by residual method, Sex",Yes,Cholesterol,Shai 2005
4628,4779,4760,All,Participants in a dietary validation study,Israel,,,24-h Dietary recall (1-day),Folates,"",No,291.0,,,ug/day,,,"Serum, fasting",Enzyme immunoassay (EIA),Folates,"",24.25,,,nmol/L,,161,Pearson,0.35,,,= 0.001,Yes,"Energy by residual method, Sex",No,,Shai 2005
4642,4779,4760,All,Participants in a dietary validation study,Israel,,,24-h Dietary recall (1-day),Folates,"",No,291.0,,,ug/day,,,"Serum, fasting",Enzyme immunoassay (EIA),Folates,"",24.25,,,nmol/L,,161,Pearson,0.4,,,>= 0.05,No,"Energy by residual method, Sex",Yes,,Shai 2005
4629,4780,4758,All,Participants in a dietary validation study,Israel,,,24-h Dietary recall (1-day),beta-Carotene,"",Yes,992.0,,,mg/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",2.3,,,umol/L,,161,Pearson,0.36,,,= 0.001,Yes,"Energy by residual method, Sex",No,Cholesterol,Shai 2005
4643,4780,4758,All,Participants in a dietary validation study,Israel,,,24-h Dietary recall (1-day),beta-Carotene,"",Yes,992.0,,,mg/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",2.3,,,umol/L,,161,Pearson,0.39,,,>= 0.05,No,"Energy by residual method, Sex",Yes,Cholesterol,Shai 2005
4630,4781,4759,All,Participants in a dietary validation study,Israel,,,24-h Dietary recall (1-day),Vitamin E,"",Yes,91.0,,,mg/day,,,"Serum, fasting",Spectrophotometry,alpha-Tocopherol,"",480.65,,,umol/L,,161,Pearson,0.32,,,= 0.001,Yes,"Energy by residual method, Sex",No,Cholesterol,Shai 2005
4644,4781,4759,All,Participants in a dietary validation study,Israel,,,24-h Dietary recall (1-day),Vitamin E,"",Yes,91.0,,,mg/day,,,"Serum, fasting",Spectrophotometry,alpha-Tocopherol,"",480.65,,,umol/L,,161,Pearson,0.33,,,>= 0.05,No,"Energy by residual method, Sex",Yes,Cholesterol,Shai 2005
4631,4782,4760,All,Participants in a dietary validation study,Israel,,,24-h Dietary recall (1-day),Folates,"",Yes,390.0,,,ug/day,,,"Serum, fasting",Enzyme immunoassay (EIA),Folates,"",24.25,,,nmol/L,,161,Pearson,0.36,,,= 0.001,Yes,"Energy by residual method, Sex",No,,Shai 2005
4645,4782,4760,All,Participants in a dietary validation study,Israel,,,24-h Dietary recall (1-day),Folates,"",Yes,390.0,,,ug/day,,,"Serum, fasting",Enzyme immunoassay (EIA),Folates,"",24.25,,,nmol/L,,161,Pearson,0.41,,,>= 0.05,No,"Energy by residual method, Sex",Yes,,Shai 2005
4625,4792,4761,All,Participants in a dietary validation study,Israel,,,24-h Dietary recall (1-day),Proteins,"",No,83.0,,,g/day,,,"Urine, 24-h",Spectrophotometry,Nitrogen,"",,,,g/day,,161,Pearson,0.29,,,= 0.001,Yes,"Energy by residual method, Sex",No,,Shai 2005
4639,4792,4761,All,Participants in a dietary validation study,Israel,,,24-h Dietary recall (1-day),Proteins,"",No,83.0,,,g/day,,,"Urine, 24-h",Spectrophotometry,Nitrogen,"",,,,g/day,,161,Pearson,0.3,,,>= 0.05,No,"Energy by residual method, Sex",Yes,,Shai 2005
4653,4794,4812,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Daidzein,"",,,193.8,205.5,ug/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin,,,,ug/mmol,Creatinine,331,Pearson,0.26,,,< 0.001,Yes,,,,Grace 2004
4654,4794,4797,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Daidzein,"",,,193.8,205.5,ug/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Daidzein,"",,16.0,17.2,ug/mmol,Creatinine,331,Pearson,0.26,,,< 0.001,Yes,,,,Grace 2004
4655,4794,4798,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Daidzein,"",,,193.8,205.5,ug/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Genistein,"",,8.6,7.9,ug/mmol,Creatinine,331,Pearson,0.29,,,< 0.001,Yes,,,,Grace 2004
4656,4794,4799,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Daidzein,"",,,193.8,205.5,ug/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Glycitein,"",,2.9,2.5,ug/mmol,Creatinine,331,Pearson,0.21,,,< 0.001,Yes,,,,Grace 2004
4657,4794,4800,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Daidzein,"",,,193.8,205.5,ug/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,O-Desmethylangolensin,"",,0.8,0.2,ug/mmol,Creatinine,331,Pearson,0.17,,,< 0.01,Yes,,,,Grace 2004
4658,4794,4801,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Daidzein,"",,,193.8,205.5,ug/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Equol,"",,0.5,0.1,ug/mmol,Creatinine,331,Pearson,0.09,,,>= 0.05,No,,,,Grace 2004
4659,4794,4813,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Daidzein,"",,,193.8,205.5,ug/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Lignans,Enterodiol + Enterolactone,,,,ug/mmol,Creatinine,331,Pearson,0.05,,,>= 0.05,No,,,,Grace 2004
4660,4794,4802,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Daidzein,"",,,193.8,205.5,ug/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Enterodiol,"",,7.8,7.8,ug/mmol,Creatinine,331,Pearson,0.14,,,< 0.05,Yes,,,,Grace 2004
4661,4794,4803,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Daidzein,"",,,193.8,205.5,ug/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Enterolactone,"",,78.5,93.5,ug/mmol,Creatinine,331,Pearson,0.06,,,>= 0.05,No,,,,Grace 2004
4662,4794,4814,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Daidzein,"",,,193.8,205.5,ug/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin,,,,ng/mL,,284,Pearson,0.29,,,< 0.001,Yes,,,,Grace 2004
4663,4794,4804,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Daidzein,"",,,193.8,205.5,ug/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Daidzein,"",,2.0,2.2,ng/mL,,284,Pearson,0.25,,,< 0.001,Yes,,,,Grace 2004
4664,4794,4805,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Daidzein,"",,,193.8,205.5,ug/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Genistein,"",,4.1,3.5,ng/mL,,284,Pearson,0.29,,,< 0.001,Yes,,,,Grace 2004
4665,4794,4806,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Daidzein,"",,,193.8,205.5,ug/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Glycitein,"",,0.1,0.1,ng/mL,,284,Pearson,0.12,,,< 0.05,Yes,,,,Grace 2004
4666,4794,4807,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Daidzein,"",,,193.8,205.5,ug/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,O-Desmethylangolensin,"",,0.1,0.0,ng/mL,,284,Pearson,0.21,,,= 0.001,Yes,,,,Grace 2004
4667,4794,4808,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Daidzein,"",,,193.8,205.5,ug/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Equol,"",,0.2,0.1,ng/mL,,284,Pearson,0.14,,,< 0.05,Yes,,,,Grace 2004
4668,4794,4815,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Daidzein,"",,,193.8,205.5,ug/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Lignans,Enterodiol + Enterolactone,,,,ng/mL,,284,Pearson,0.05,,,>= 0.05,No,,,,Grace 2004
4669,4794,4809,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Daidzein,"",,,193.8,205.5,ug/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Enterodiol,"",,0.4,0.3,ng/mL,,284,Pearson,0.07,,,>= 0.05,No,,,,Grace 2004
4670,4794,4810,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Daidzein,"",,,193.8,205.5,ug/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Enterolactone,"",,3.8,4.5,ng/mL,,284,Pearson,0.03,,,>= 0.05,No,,,,Grace 2004
4671,4795,4812,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Genistein,"",,,243.4,247.2,ug/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin,,,,ug/mmol,Creatinine,331,Pearson,0.26,,,< 0.001,Yes,,,,Grace 2004
4672,4795,4797,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Genistein,"",,,243.4,247.2,ug/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Daidzein,"",,16.0,17.2,ug/mmol,Creatinine,331,Pearson,0.27,,,< 0.001,Yes,,,,Grace 2004
4673,4795,4798,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Genistein,"",,,243.4,247.2,ug/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Genistein,"",,8.6,7.9,ug/mmol,Creatinine,331,Pearson,0.29,,,< 0.001,Yes,,,,Grace 2004
4674,4795,4799,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Genistein,"",,,243.4,247.2,ug/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Glycitein,"",,2.9,2.5,ug/mmol,Creatinine,331,Pearson,0.21,,,< 0.001,Yes,,,,Grace 2004
4675,4795,4800,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Genistein,"",,,243.4,247.2,ug/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,O-Desmethylangolensin,"",,0.8,0.2,ug/mmol,Creatinine,331,Pearson,0.19,,,< 0.001,Yes,,,,Grace 2004
4676,4795,4801,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Genistein,"",,,243.4,247.2,ug/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Equol,"",,0.5,0.1,ug/mmol,Creatinine,331,Pearson,0.1,,,>= 0.05,No,,,,Grace 2004
4677,4795,4813,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Genistein,"",,,243.4,247.2,ug/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Lignans,Enterodiol + Enterolactone,,,,ug/mmol,Creatinine,331,Pearson,0.06,,,>= 0.05,No,,,,Grace 2004
4678,4795,4802,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Genistein,"",,,243.4,247.2,ug/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Enterodiol,"",,7.8,7.8,ug/mmol,Creatinine,331,Pearson,0.14,,,< 0.05,Yes,,,,Grace 2004
4679,4795,4803,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Genistein,"",,,243.4,247.2,ug/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Enterolactone,"",,78.5,93.5,ug/mmol,Creatinine,331,Pearson,0.07,,,>= 0.05,No,,,,Grace 2004
4680,4795,4814,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Genistein,"",,,243.4,247.2,ug/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin,,,,ng/mL,,284,Pearson,0.31,,,< 0.001,Yes,,,,Grace 2004
4681,4795,4804,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Genistein,"",,,243.4,247.2,ug/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Daidzein,"",,2.0,2.2,ng/mL,,284,Pearson,0.27,,,< 0.001,Yes,,,,Grace 2004
4682,4795,4805,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Genistein,"",,,243.4,247.2,ug/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Genistein,"",,4.1,3.5,ng/mL,,284,Pearson,0.32,,,< 0.001,Yes,,,,Grace 2004
4683,4795,4806,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Genistein,"",,,243.4,247.2,ug/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Glycitein,"",,0.1,0.1,ng/mL,,284,Pearson,0.12,,,< 0.05,Yes,,,,Grace 2004
4684,4795,4807,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Genistein,"",,,243.4,247.2,ug/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,O-Desmethylangolensin,"",,0.1,0.0,ng/mL,,284,Pearson,0.23,,,< 0.001,Yes,,,,Grace 2004
4685,4795,4808,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Genistein,"",,,243.4,247.2,ug/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Equol,"",,0.2,0.1,ng/mL,,284,Pearson,0.15,,,< 0.05,Yes,,,,Grace 2004
4686,4795,4815,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Genistein,"",,,243.4,247.2,ug/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Lignans,Enterodiol + Enterolactone,,,,ng/mL,,284,Pearson,0.06,,,>= 0.05,No,,,,Grace 2004
4687,4795,4809,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Genistein,"",,,243.4,247.2,ug/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Enterodiol,"",,0.4,0.3,ng/mL,,284,Pearson,0.07,,,>= 0.05,No,,,,Grace 2004
4688,4795,4810,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Genistein,"",,,243.4,247.2,ug/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Enterolactone,"",,3.8,4.5,ng/mL,,284,Pearson,0.04,,,>= 0.05,No,,,,Grace 2004
4707,4796,4812,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Dietary fibre,"",,,13.3,13.7,g/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin,,,,ug/mmol,Creatinine,331,Pearson,0.0,,,>= 0.05,No,,,,Grace 2004
4708,4796,4797,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Dietary fibre,"",,,13.3,13.7,g/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Daidzein,"",,16.0,17.2,ug/mmol,Creatinine,331,Pearson,0.03,,,>= 0.05,No,,,,Grace 2004
4709,4796,4798,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Dietary fibre,"",,,13.3,13.7,g/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Genistein,"",,8.6,7.9,ug/mmol,Creatinine,331,Pearson,-0.01,,,>= 0.05,No,,,,Grace 2004
4710,4796,4799,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Dietary fibre,"",,,13.3,13.7,g/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Glycitein,"",,2.9,2.5,ug/mmol,Creatinine,331,Pearson,-0.06,,,>= 0.05,No,,,,Grace 2004
4711,4796,4800,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Dietary fibre,"",,,13.3,13.7,g/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,O-Desmethylangolensin,"",,0.8,0.2,ug/mmol,Creatinine,331,Pearson,-0.04,,,>= 0.05,No,,,,Grace 2004
4712,4796,4801,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Dietary fibre,"",,,13.3,13.7,g/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Equol,"",,0.5,0.1,ug/mmol,Creatinine,331,Pearson,-0.04,,,>= 0.05,No,,,,Grace 2004
4713,4796,4813,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Dietary fibre,"",,,13.3,13.7,g/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Lignans,Enterodiol + Enterolactone,,,,ug/mmol,Creatinine,331,Pearson,0.17,,,< 0.01,Yes,,,,Grace 2004
4714,4796,4802,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Dietary fibre,"",,,13.3,13.7,g/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Enterodiol,"",,7.8,7.8,ug/mmol,Creatinine,331,Pearson,0.13,,,< 0.05,Yes,,,,Grace 2004
4715,4796,4803,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Dietary fibre,"",,,13.3,13.7,g/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Enterolactone,"",,78.5,93.5,ug/mmol,Creatinine,331,Pearson,0.29,,,< 0.001,Yes,,,,Grace 2004
4716,4796,4814,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Dietary fibre,"",,,13.3,13.7,g/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin,,,,ng/mL,,284,Pearson,0.05,,,>= 0.05,No,,,,Grace 2004
4717,4796,4804,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Dietary fibre,"",,,13.3,13.7,g/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Daidzein,"",,2.0,2.2,ng/mL,,284,Pearson,0.07,,,>= 0.05,No,,,,Grace 2004
4718,4796,4805,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Dietary fibre,"",,,13.3,13.7,g/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Genistein,"",,4.1,3.5,ng/mL,,284,Pearson,0.05,,,>= 0.05,No,,,,Grace 2004
4719,4796,4806,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Dietary fibre,"",,,13.3,13.7,g/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Glycitein,"",,0.1,0.1,ng/mL,,284,Pearson,-0.07,,,>= 0.05,No,,,,Grace 2004
4720,4796,4807,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Dietary fibre,"",,,13.3,13.7,g/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,O-Desmethylangolensin,"",,0.1,0.0,ng/mL,,284,Pearson,0.0,,,>= 0.05,No,,,,Grace 2004
4721,4796,4808,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Dietary fibre,"",,,13.3,13.7,g/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Equol,"",,0.2,0.1,ng/mL,,284,Pearson,0.04,,,>= 0.05,No,,,,Grace 2004
4722,4796,4815,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Dietary fibre,"",,,13.3,13.7,g/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Lignans,Enterodiol + Enterolactone,,,,ng/mL,,284,Pearson,0.23,,,< 0.001,Yes,,,,Grace 2004
4723,4796,4809,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Dietary fibre,"",,,13.3,13.7,g/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Enterodiol,"",,0.4,0.3,ng/mL,,284,Pearson,0.03,,,>= 0.05,No,,,,Grace 2004
4724,4796,4810,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Dietary fibre,"",,,13.3,13.7,g/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Enterolactone,"",,3.8,4.5,ng/mL,,284,Pearson,0.22,,,< 0.001,Yes,,,,Grace 2004
4689,4811,4812,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Isoflavones,Genistein + Daidzein,,,,,ug/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin,,,,ug/mmol,Creatinine,331,Pearson,0.27,,,< 0.001,Yes,,,,Grace 2004
4690,4811,4797,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Isoflavones,Genistein + Daidzein,,,,,ug/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Daidzein,"",,16.0,17.2,ug/mmol,Creatinine,331,Pearson,0.27,,,< 0.001,Yes,,,,Grace 2004
4691,4811,4798,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Isoflavones,Genistein + Daidzein,,,,,ug/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Genistein,"",,8.6,7.9,ug/mmol,Creatinine,331,Pearson,0.3,,,< 0.001,Yes,,,,Grace 2004
4692,4811,4799,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Isoflavones,Genistein + Daidzein,,,,,ug/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Glycitein,"",,2.9,2.5,ug/mmol,Creatinine,331,Pearson,0.21,,,< 0.001,Yes,,,,Grace 2004
4693,4811,4800,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Isoflavones,Genistein + Daidzein,,,,,ug/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,O-Desmethylangolensin,"",,0.8,0.2,ug/mmol,Creatinine,331,Pearson,0.2,,,< 0.001,Yes,,,,Grace 2004
4694,4811,4801,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Isoflavones,Genistein + Daidzein,,,,,ug/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Equol,"",,0.5,0.1,ug/mmol,Creatinine,331,Pearson,0.1,,,>= 0.05,No,,,,Grace 2004
4695,4811,4813,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Isoflavones,Genistein + Daidzein,,,,,ug/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Lignans,Enterodiol + Enterolactone,,,,ug/mmol,Creatinine,331,Pearson,0.06,,,>= 0.05,No,,,,Grace 2004
4696,4811,4802,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Isoflavones,Genistein + Daidzein,,,,,ug/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Enterodiol,"",,7.8,7.8,ug/mmol,Creatinine,331,Pearson,0.13,,,< 0.05,Yes,,,,Grace 2004
4697,4811,4803,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Isoflavones,Genistein + Daidzein,,,,,ug/day,,,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Enterolactone,"",,78.5,93.5,ug/mmol,Creatinine,331,Pearson,0.07,,,>= 0.05,No,,,,Grace 2004
4698,4811,4814,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Isoflavones,Genistein + Daidzein,,,,,ug/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin,,,,ng/mL,,284,Pearson,0.31,,,< 0.001,Yes,,,,Grace 2004
4699,4811,4804,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Isoflavones,Genistein + Daidzein,,,,,ug/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Daidzein,"",,2.0,2.2,ng/mL,,284,Pearson,0.27,,,< 0.001,Yes,,,,Grace 2004
4700,4811,4805,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Isoflavones,Genistein + Daidzein,,,,,ug/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Genistein,"",,4.1,3.5,ng/mL,,284,Pearson,0.32,,,< 0.001,Yes,,,,Grace 2004
4701,4811,4806,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Isoflavones,Genistein + Daidzein,,,,,ug/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Glycitein,"",,0.1,0.1,ng/mL,,284,Pearson,0.12,,,< 0.05,Yes,,,,Grace 2004
4702,4811,4807,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Isoflavones,Genistein + Daidzein,,,,,ug/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,O-Desmethylangolensin,"",,0.1,0.0,ng/mL,,284,Pearson,0.24,,,< 0.001,Yes,,,,Grace 2004
4703,4811,4808,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Isoflavones,Genistein + Daidzein,,,,,ug/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Equol,"",,0.2,0.1,ng/mL,,284,Pearson,0.15,,,< 0.01,Yes,,,,Grace 2004
4704,4811,4815,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Isoflavones,Genistein + Daidzein,,,,,ug/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Lignans,Enterodiol + Enterolactone,,,,ng/mL,,284,Pearson,0.06,,,>= 0.05,No,,,,Grace 2004
4705,4811,4809,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Isoflavones,Genistein + Daidzein,,,,,ug/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Enterodiol,"",,0.4,0.3,ng/mL,,284,Pearson,0.07,,,>= 0.05,No,,,,Grace 2004
4706,4811,4810,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Isoflavones,Genistein + Daidzein,,,,,ug/day,,,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Enterolactone,"",,3.8,4.5,ng/mL,,284,Pearson,0.04,,,>= 0.05,No,,,,Grace 2004
4725,8146,8150,All,Mothers in Maastricht with or without an increased fruit and vegetable diet intervention,Netherlands,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Vitamin C,"",,,,umol/L,,156,Spearman,0.26,,,< 0.01,Yes,,,BMI,Bogers 2004
4729,8146,8151,All,Mothers in Maastricht with or without an increased fruit and vegetable diet intervention,Netherlands,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,umol/L,,157,Spearman,0.24,,,< 0.01,Yes,,,BMI,Bogers 2004
4733,8146,8152,All,Mothers in Maastricht with or without an increased fruit and vegetable diet intervention,Netherlands,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,servings/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,umol/L,,157,Spearman,0.37,,,< 0.01,Yes,,,BMI,Bogers 2004
4737,8146,8153,All,Mothers in Maastricht with or without an increased fruit and vegetable diet intervention,Netherlands,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,umol/L,,157,Spearman,0.17,,,< 0.05,Yes,,,BMI,Bogers 2004
4741,8146,8154,All,Mothers in Maastricht with or without an increased fruit and vegetable diet intervention,Netherlands,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,umol/L,,157,Spearman,0.26,,,< 0.01,Yes,,,BMI,Bogers 2004
4745,8146,8155,All,Mothers in Maastricht with or without an increased fruit and vegetable diet intervention,Netherlands,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,157,Spearman,0.16,,,>= 0.05,No,,,BMI,Bogers 2004
4749,8146,8156,All,Mothers in Maastricht with or without an increased fruit and vegetable diet intervention,Netherlands,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,umol/L,,157,Spearman,0.04,,,>= 0.05,No,,,BMI,Bogers 2004
4726,8147,8150,All,Mothers in Maastricht with or without an increased fruit and vegetable diet intervention,Netherlands,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Vitamin C,"",,,,umol/L,,156,Spearman,0.37,,,< 0.01,Yes,,,BMI,Bogers 2004
4730,8147,8151,All,Mothers in Maastricht with or without an increased fruit and vegetable diet intervention,Netherlands,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,umol/L,,157,Spearman,0.39,,,< 0.01,Yes,,,BMI,Bogers 2004
4734,8147,8152,All,Mothers in Maastricht with or without an increased fruit and vegetable diet intervention,Netherlands,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,servings/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,umol/L,,157,Spearman,0.23,,,< 0.01,Yes,,,BMI,Bogers 2004
4738,8147,8153,All,Mothers in Maastricht with or without an increased fruit and vegetable diet intervention,Netherlands,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,umol/L,,157,Spearman,0.23,,,< 0.01,Yes,,,BMI,Bogers 2004
4742,8147,8154,All,Mothers in Maastricht with or without an increased fruit and vegetable diet intervention,Netherlands,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,umol/L,,157,Spearman,0.13,,,>= 0.05,No,,,BMI,Bogers 2004
4746,8147,8155,All,Mothers in Maastricht with or without an increased fruit and vegetable diet intervention,Netherlands,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,157,Spearman,0.42,,,< 0.01,Yes,,,BMI,Bogers 2004
4750,8147,8156,All,Mothers in Maastricht with or without an increased fruit and vegetable diet intervention,Netherlands,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,umol/L,,157,Spearman,0.0,,,>= 0.05,No,,,BMI,Bogers 2004
4727,8148,8150,All,Mothers in Maastricht with or without an increased fruit and vegetable diet intervention,Netherlands,,,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Vitamin C,"",,,,umol/L,,156,Spearman,0.32,,,< 0.01,Yes,,,BMI,Bogers 2004
4731,8148,8151,All,Mothers in Maastricht with or without an increased fruit and vegetable diet intervention,Netherlands,,,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,umol/L,,157,Spearman,0.27,,,< 0.01,Yes,,,BMI,Bogers 2004
4735,8148,8152,All,Mothers in Maastricht with or without an increased fruit and vegetable diet intervention,Netherlands,,,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,servings/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,umol/L,,157,Spearman,0.06,,,>= 0.05,No,,,BMI,Bogers 2004
4739,8148,8153,All,Mothers in Maastricht with or without an increased fruit and vegetable diet intervention,Netherlands,,,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,umol/L,,157,Spearman,0.04,,,>= 0.05,No,,,BMI,Bogers 2004
4743,8148,8154,All,Mothers in Maastricht with or without an increased fruit and vegetable diet intervention,Netherlands,,,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,umol/L,,157,Spearman,0.03,,,>= 0.05,No,,,BMI,Bogers 2004
4747,8148,8155,All,Mothers in Maastricht with or without an increased fruit and vegetable diet intervention,Netherlands,,,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,157,Spearman,0.57,,,< 0.01,Yes,,,BMI,Bogers 2004
4751,8148,8156,All,Mothers in Maastricht with or without an increased fruit and vegetable diet intervention,Netherlands,,,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,umol/L,,157,Spearman,-0.07,,,>= 0.05,No,,,BMI,Bogers 2004
4728,8149,8150,All,Mothers in Maastricht with or without an increased fruit and vegetable diet intervention,Netherlands,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Citrus fruits,,,,,servings/day,,,"Plasma, fasting",HPLC,Vitamin C,"",,,,umol/L,,156,Spearman,0.37,,,< 0.01,Yes,,,BMI,Bogers 2004
4732,8149,8151,All,Mothers in Maastricht with or without an increased fruit and vegetable diet intervention,Netherlands,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Citrus fruits,,,,,servings/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,umol/L,,157,Spearman,0.37,,,< 0.01,Yes,,,BMI,Bogers 2004
4736,8149,8152,All,Mothers in Maastricht with or without an increased fruit and vegetable diet intervention,Netherlands,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Citrus fruits,,,,,servings/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,umol/L,,157,Spearman,0.36,,,< 0.01,Yes,,,BMI,Bogers 2004
4740,8149,8153,All,Mothers in Maastricht with or without an increased fruit and vegetable diet intervention,Netherlands,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Citrus fruits,,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,umol/L,,157,Spearman,0.23,,,< 0.01,Yes,,,BMI,Bogers 2004
4744,8149,8154,All,Mothers in Maastricht with or without an increased fruit and vegetable diet intervention,Netherlands,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Citrus fruits,,,,,servings/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,umol/L,,157,Spearman,0.23,,,< 0.01,Yes,,,BMI,Bogers 2004
4748,8149,8155,All,Mothers in Maastricht with or without an increased fruit and vegetable diet intervention,Netherlands,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Citrus fruits,,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,157,Spearman,0.31,,,< 0.01,Yes,,,BMI,Bogers 2004
4752,8149,8156,All,Mothers in Maastricht with or without an increased fruit and vegetable diet intervention,Netherlands,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables + Citrus fruits,,,,,servings/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,umol/L,,157,Spearman,0.02,,,>= 0.05,No,,,BMI,Bogers 2004
4781,4851,4868,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),Fatty acids,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6) + Palmitic acid (16:0) + Stearic acid (18:0) + cis-Octadecenoic acids (cis-18:1) + Myristic acid (14:0) + cis-Hexadecenoic acids (cis-16:1),,49264.0,,,mg/day,,,"Plasma, fasting",GC-FID,Fatty acids,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6) + Palmitic acid (16:0) + Stearic acid (18:0) + cis-Octadecenoic acids (cis-18:1) + Myristic acid (14:0) + cis-Hexadecenoic acids (cis-16:1),10.4,,,mmol/L,,15,Pearson,0.423,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4782,4852,4869,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0),,13888.0,,,mg/day,,,"Plasma, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0),3.21,,,mmol/L,,15,Pearson,0.009,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4783,4853,4870,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),Myristic acid (14:0),"",,1072.0,,,mg/day,,,"Plasma, fasting",GC-FID,Myristic acid (14:0),"",0.09,,,mmol/L,,15,Pearson,-0.057,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4784,4854,4871,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),Palmitic acid (16:0),"",,9291.0,,,mg/day,,,"Plasma, fasting",GC-FID,Palmitic acid (16:0),"",2.36,,,mmol/L,,15,Pearson,0.079,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4785,4855,4872,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),Stearic acid (18:0),"",,3524.0,,,mg/day,,,"Plasma, fasting",GC-FID,Stearic acid (18:0),"",0.77,,,mmol/L,,15,Pearson,-0.06,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4786,4856,4873,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),"Fatty acids, monounsaturated (MUFA)",cis-Octadecenoic acids (cis-18:1) + cis-Hexadecenoic acids (cis-16:1),,19218.0,,,mg/day,,,"Plasma, fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",cis-Octadecenoic acids (cis-18:1) + cis-Hexadecenoic acids (cis-16:1),2.41,,,mmol/L,,15,Pearson,0.438,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4787,4857,4874,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),cis-Hexadecenoic acids (cis-16:1),"",,1029.0,,,mg/day,,,"Plasma, fasting",GC-FID,cis-Hexadecenoic acids (cis-16:1),"",0.25,,,mmol/L,,15,Pearson,-0.141,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4788,4858,4875,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),cis-Octadecenoic acids (cis-18:1),"",,18189.0,,,mg/day,,,"Plasma, fasting",GC-FID,cis-Octadecenoic acids (cis-18:1),"",2.17,,,mmol/L,,15,Pearson,0.483,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4789,4859,4876,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,13057.0,,,mg/day,,,"Plasma, fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),4.0,,,mmol/L,,15,Pearson,0.482,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4790,4860,4877,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,12869.0,,,mg/day,,,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",3.25,,,mmol/L,,15,Pearson,0.491,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4791,4861,4878,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),Arachidonic acid (AA; cis-20:4n-6),"",,162.0,,,mg/day,,,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",0.59,,,mmol/L,,15,Pearson,0.165,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4792,4862,4879,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,3101.0,,,mg/day,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),0.78,,,mmol/L,,15,Pearson,0.541,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4793,4863,4880,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,2010.0,,,mg/day,,,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.1,,,mmol/L,,15,Pearson,0.345,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4794,4864,4881,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1092.0,,,mg/day,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),0.68,,,mmol/L,,15,Pearson,0.57,,,< 0.05,Yes,,,"Age, BMI",Kuriki 2003
4795,4865,4882,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),EPA (cis-20:5n-3),"",No,359.0,,,mg/day,,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",0.2,,,mmol/L,,15,Pearson,0.566,,,< 0.05,Yes,,,"Age, BMI",Kuriki 2003
4796,4866,4883,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),DPA (cis-22:5n-3),"",No,106.0,,,mg/day,,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.06,,,mmol/L,,15,Pearson,0.525,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4797,4867,4884,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),DHA (cis-22:6n-3),"",No,626.0,,,mg/day,,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",0.42,,,mmol/L,,15,Pearson,0.574,,,< 0.05,Yes,,,"Age, BMI",Kuriki 2003
4816,4920,4936,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0),,28.25,,,percentRoot,,,"Plasma, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0),30.94,,,percentRoot,,15,Pearson,-0.382,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4817,4921,4937,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),Myristic acid (14:0),"",,2.16,,,percentRoot,,,"Plasma, fasting",GC-FID,Myristic acid (14:0),"",0.84,,,percentRoot,,15,Pearson,0.002,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4818,4922,4938,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),Palmitic acid (16:0),"",,18.93,,,percentRoot,,,"Plasma, fasting",GC-FID,Palmitic acid (16:0),"",22.67,,,percentRoot,,15,Pearson,-0.468,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4819,4923,4939,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),Stearic acid (18:0),"",,7.16,,,percentRoot,,,"Plasma, fasting",GC-FID,Stearic acid (18:0),"",7.43,,,percentRoot,,15,Pearson,-0.242,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4820,4924,4940,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),"Fatty acids, monounsaturated (MUFA)",cis-Octadecenoic acids (cis-18:1) + cis-Hexadecenoic acids (cis-16:1),,38.99,,,percentRoot,,,"Plasma, fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",cis-Octadecenoic acids (cis-18:1) + cis-Hexadecenoic acids (cis-16:1),22.95,,,percentRoot,,15,Pearson,0.333,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4821,4925,4941,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),cis-Hexadecenoic acids (cis-16:1),"",,2.1,,,percentRoot,,,"Plasma, fasting",GC-FID,cis-Hexadecenoic acids (cis-16:1),"",2.35,,,percentRoot,,15,Pearson,-0.227,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4822,4926,4942,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),cis-Octadecenoic acids (cis-18:1),"",,36.88,,,percentRoot,,,"Plasma, fasting",GC-FID,cis-Octadecenoic acids (cis-18:1),"",20.61,,,percentRoot,,15,Pearson,0.43,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4823,4927,4943,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,26.52,,,percentRoot,,,"Plasma, fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),38.6,,,percentRoot,,15,Pearson,-0.339,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4824,4928,4944,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,26.13,,,percentRoot,,,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",31.31,,,percentRoot,,15,Pearson,-0.286,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4825,4929,4945,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.33,,,percentRoot,,,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",5.77,,,percentRoot,,15,Pearson,0.265,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4826,4930,4946,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,6.24,,,percentRoot,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),7.5,,,percentRoot,,15,Pearson,0.787,,,< 0.01,Yes,,,"Age, BMI",Kuriki 2003
4827,4931,4947,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,4.03,,,percentRoot,,,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.93,,,percentRoot,,15,Pearson,0.429,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4828,4932,4948,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,2.22,,,percentRoot,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),6.58,,,percentRoot,,15,Pearson,0.78,,,< 0.01,Yes,,,"Age, BMI",Kuriki 2003
4829,4933,4949,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),EPA (cis-20:5n-3),"",No,0.73,,,percentRoot,,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",1.91,,,percentRoot,,15,Pearson,0.658,,,< 0.05,Yes,,,"Age, BMI",Kuriki 2003
4830,4934,4950,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),DPA (cis-22:5n-3),"",No,0.21,,,percentRoot,,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.62,,,percentRoot,,15,Pearson,0.75,,,< 0.01,Yes,,,"Age, BMI",Kuriki 2003
4831,4935,4951,Males,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),DHA (cis-22:6n-3),"",No,1.28,,,percentRoot,,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",4.05,,,percentRoot,,15,Pearson,0.857,,,< 0.001,Yes,,,"Age, BMI",Kuriki 2003
4798,4885,4902,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),Fatty acids,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6) + Palmitic acid (16:0) + Stearic acid (18:0) + cis-Octadecenoic acids (cis-18:1) + Myristic acid (14:0) + cis-Hexadecenoic acids (cis-16:1),,46163.0,,,mg/day,,,"Plasma, fasting",GC-FID,Fatty acids,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6) + Palmitic acid (16:0) + Stearic acid (18:0) + cis-Octadecenoic acids (cis-18:1) + Myristic acid (14:0) + cis-Hexadecenoic acids (cis-16:1),10.71,,,mmol/L,,79,Pearson,-0.002,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4799,4886,4903,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0),,14391.0,,,mg/day,,,"Plasma, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0),3.42,,,mmol/L,,79,Pearson,0.021,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4800,4887,4904,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),Myristic acid (14:0),"",,1317.0,,,mg/day,,,"Plasma, fasting",GC-FID,Myristic acid (14:0),"",0.09,,,mmol/L,,79,Pearson,0.173,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4801,4888,4905,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),Palmitic acid (16:0),"",,9361.0,,,mg/day,,,"Plasma, fasting",GC-FID,Palmitic acid (16:0),"",2.5,,,mmol/L,,79,Pearson,0.003,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4802,4889,4906,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),Stearic acid (18:0),"",,3714.0,,,mg/day,,,"Plasma, fasting",GC-FID,Stearic acid (18:0),"",0.83,,,mmol/L,,79,Pearson,0.08,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4803,4890,4907,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),"Fatty acids, monounsaturated (MUFA)",cis-Octadecenoic acids (cis-18:1) + cis-Hexadecenoic acids (cis-16:1),,18305.0,,,mg/day,,,"Plasma, fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",cis-Octadecenoic acids (cis-18:1) + cis-Hexadecenoic acids (cis-16:1),2.25,,,mmol/L,,79,Pearson,0.097,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4804,4891,4908,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),cis-Hexadecenoic acids (cis-16:1),"",,1039.0,,,mg/day,,,"Plasma, fasting",GC-FID,cis-Hexadecenoic acids (cis-16:1),"",0.24,,,mmol/L,,79,Pearson,0.111,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4805,4892,4909,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),cis-Octadecenoic acids (cis-18:1),"",,17265.0,,,mg/day,,,"Plasma, fasting",GC-FID,cis-Octadecenoic acids (cis-18:1),"",2.01,,,mmol/L,,79,Pearson,0.099,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4806,4893,4910,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,10907.0,,,mg/day,,,"Plasma, fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),4.15,,,mmol/L,,79,Pearson,-0.054,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4807,4894,4911,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,10734.0,,,mg/day,,,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",3.36,,,mmol/L,,79,Pearson,0.006,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4808,4895,4912,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),Arachidonic acid (AA; cis-20:4n-6),"",,147.0,,,mg/day,,,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",0.66,,,mmol/L,,79,Pearson,0.03,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4809,4896,4913,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,2560.0,,,mg/day,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),0.89,,,mmol/L,,79,Pearson,0.207,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4810,4897,4914,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,1589.0,,,mg/day,,,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.08,,,mmol/L,,79,Pearson,0.192,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4811,4898,4915,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,971.0,,,mg/day,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),0.81,,,mmol/L,,79,Pearson,0.464,,,< 0.001,Yes,,,"Age, BMI",Kuriki 2003
4812,4899,4916,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),EPA (cis-20:5n-3),"",No,314.0,,,mg/day,,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",0.26,,,mmol/L,,79,Pearson,0.602,,,< 0.001,Yes,,,"Age, BMI",Kuriki 2003
4813,4900,4917,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),DPA (cis-22:5n-3),"",No,85.0,,,mg/day,,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.06,,,mmol/L,,79,Pearson,0.254,,,< 0.05,Yes,,,"Age, BMI",Kuriki 2003
4814,4901,4918,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),DHA (cis-22:6n-3),"",No,571.0,,,mg/day,,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",0.49,,,mmol/L,,79,Pearson,0.303,,,< 0.01,Yes,,,"Age, BMI",Kuriki 2003
4832,4952,4968,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0),,31.08,,,percentRoot,,,"Plasma, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0),31.75,,,percentRoot,,79,Pearson,0.129,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4833,4953,4969,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),Myristic acid (14:0),"",,2.83,,,percentRoot,,,"Plasma, fasting",GC-FID,Myristic acid (14:0),"",0.83,,,percentRoot,,79,Pearson,0.177,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4834,4954,4970,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),Palmitic acid (16:0),"",,20.25,,,percentRoot,,,"Plasma, fasting",GC-FID,Palmitic acid (16:0),"",23.16,,,percentRoot,,79,Pearson,0.098,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4835,4955,4971,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),Stearic acid (18:0),"",,8.0,,,percentRoot,,,"Plasma, fasting",GC-FID,Stearic acid (18:0),"",7.76,,,percentRoot,,79,Pearson,0.141,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4836,4956,4972,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),"Fatty acids, monounsaturated (MUFA)",cis-Octadecenoic acids (cis-18:1) + cis-Hexadecenoic acids (cis-16:1),,39.46,,,percentRoot,,,"Plasma, fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",cis-Octadecenoic acids (cis-18:1) + cis-Hexadecenoic acids (cis-16:1),20.82,,,percentRoot,,79,Pearson,0.305,,,< 0.01,Yes,,,"Age, BMI",Kuriki 2003
4837,4957,4973,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),cis-Hexadecenoic acids (cis-16:1),"",,2.24,,,percentRoot,,,"Plasma, fasting",GC-FID,cis-Hexadecenoic acids (cis-16:1),"",2.21,,,percentRoot,,79,Pearson,0.256,,,< 0.05,Yes,,,"Age, BMI",Kuriki 2003
4838,4958,4974,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),cis-Octadecenoic acids (cis-18:1),"",,37.23,,,percentRoot,,,"Plasma, fasting",GC-FID,cis-Octadecenoic acids (cis-18:1),"",18.62,,,percentRoot,,79,Pearson,0.3,,,< 0.01,Yes,,,"Age, BMI",Kuriki 2003
4839,4959,4975,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,23.83,,,percentRoot,,,"Plasma, fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),39.09,,,percentRoot,,79,Pearson,0.165,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4840,4960,4976,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,23.45,,,percentRoot,,,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",31.67,,,percentRoot,,79,Pearson,0.159,,,>= 0.05,No,,,"Age, BMI",Kuriki 2003
4841,4961,4977,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.33,,,percentRoot,,,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",6.24,,,percentRoot,,79,Pearson,0.354,,,< 0.01,Yes,,,"Age, BMI",Kuriki 2003
4842,4962,4978,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,5.62,,,percentRoot,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),8.34,,,percentRoot,,79,Pearson,0.474,,,< 0.001,Yes,,,"Age, BMI",Kuriki 2003
4843,4963,4979,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,3.48,,,percentRoot,,,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.76,,,percentRoot,,79,Pearson,0.243,,,< 0.05,Yes,,,"Age, BMI",Kuriki 2003
4844,4964,4980,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,2.15,,,percentRoot,,,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),7.59,,,percentRoot,,79,Pearson,0.68,,,< 0.001,Yes,,,"Age, BMI",Kuriki 2003
4845,4965,4981,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),EPA (cis-20:5n-3),"",No,0.69,,,percentRoot,,,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",2.4,,,percentRoot,,79,Pearson,0.692,,,< 0.001,Yes,,,"Age, BMI",Kuriki 2003
4846,4966,4982,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),DPA (cis-22:5n-3),"",No,0.19,,,percentRoot,,,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",0.58,,,percentRoot,,79,Pearson,0.486,,,< 0.001,Yes,,,"Age, BMI",Kuriki 2003
4847,4967,4983,Females,Middle-aged dietitians,Japan,,,Weighed Dietary record (7-day),DHA (cis-22:6n-3),"",No,1.26,,,percentRoot,,,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",4.6,,,percentRoot,,79,Pearson,0.587,,,< 0.001,Yes,,,"Age, BMI",Kuriki 2003
4848,4984,4986,All [Group 1],Anglo-Celtic adults living in Melbourne,Australia,,,Food Frequency Questionnaire (FFQ),Tea,"",,2.49,,,metriccup/day,,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,4-O-Methylgallic acid,"",,42.1,,ug/mmol,Creatinine,111,Spearman,0.5,,,< 0.001,Yes,,,,Hodgson 2004
4850,4985,4987,All [Group 1],Anglo-Celtic adults living in Melbourne,Australia,,,Food Frequency Questionnaire (FFQ),Coffee,"",,1.56,,,metriccup/day,,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Isoferulic acid,"",,11.1,,ug/mmol,Creatinine,111,Spearman,0.26,,,= 0.008,Yes,,,,Hodgson 2004
4849,4988,4990,All [Group 2],Western Australian adults participant in two studies,Australia,,,24-h Dietary recall (1-day) + Dietary record (1-day),Tea,"",,1.99,,,metriccup/day,,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,4-O-Methylgallic acid,"",,38.9,,ug/mmol,Creatinine,344,Spearman,0.57,,,< 0.001,Yes,,,,Hodgson 2004
4851,4989,4991,All [Group 2],Western Australian adults participant in two studies,Australia,,,24-h Dietary recall (1-day) + Dietary record (1-day),Coffee,"",,1.28,,,metriccup/day,,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Isoferulic acid,"",,7.8,,ug/mmol,Creatinine,344,Spearman,0.18,,,< 0.001,Yes,,,,Hodgson 2004
4865,4996,5244,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",Yes,48.7,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",33.83,,,umol/L,,29,Pearson,0.61,,,< 0.05,Yes,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4866,5000,5244,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",No,5.8,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",33.83,,,umol/L,,29,Pearson,0.34,,,>= 0.05,No,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4867,5004,5248,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",No,14.2,,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",5.39,,,umol/L,,29,Pearson,0.16,,,>= 0.05,No,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4868,5008,5252,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin E,"",Yes,50.3,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,39.1,,,umol/L,,29,Pearson,0.56,,,< 0.05,Yes,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4869,5012,5252,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,7.4,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,39.1,,,umol/L,,29,Pearson,-0.25,,,>= 0.05,No,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4870,5016,5256,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin C,"",Yes,180.7,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",26.18,,,umol/L,,29,Pearson,0.39,,,>= 0.05,No,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4871,5020,5256,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin C,"",No,115.5,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",26.18,,,umol/L,,29,Pearson,0.18,,,>= 0.05,No,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4872,5024,5260,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",Yes,3971.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.48,,,umol/L,,29,Pearson,0.14,,,>= 0.05,No,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4873,5028,5260,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,3419.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.48,,,umol/L,,29,Pearson,0.31,,,>= 0.05,No,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4874,5032,5264,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,559.0,,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",0.05,,,umol/L,,29,Pearson,0.78,,,< 0.05,Yes,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4875,5036,5268,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",No,48.7,,,ug/day,,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",0.15,,,umol/L,,29,Pearson,0.36,,,>= 0.05,No,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4876,5040,5272,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,5010.0,,,ug/day,,,"Serum, fasting",HPLC,Lutein/Zeaxanthin,"",0.39,,,umol/L,,29,Pearson,-0.27,,,>= 0.05,No,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4877,5044,5276,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Lycopene,"",No,7250.0,,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",0.4,,,umol/L,,29,Pearson,-0.1,,,>= 0.05,No,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4852,5056,5244,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",Yes,48.4,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",33.83,,,umol/L,,29,Pearson,0.53,,,< 0.05,Yes,"Lipids, Energy by residual method",,,Tangney 2004
4853,5060,5244,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",No,6.1,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",33.83,,,umol/L,,29,Pearson,0.1,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4854,5064,5248,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",No,14.4,,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",5.39,,,umol/L,,29,Pearson,0.17,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4855,5068,5252,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin E,"",Yes,62.1,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,39.1,,,umol/L,,29,Pearson,0.49,,,< 0.05,Yes,"Lipids, Energy by residual method",,,Tangney 2004
4856,5072,5252,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,7.4,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,39.1,,,umol/L,,29,Pearson,0.19,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4857,5076,5256,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin C,"",Yes,176.7,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",26.18,,,umol/L,,29,Pearson,0.39,,,< 0.05,Yes,"Lipids, Energy by residual method",,,Tangney 2004
4858,5080,5256,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin C,"",No,111.3,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",26.18,,,umol/L,,29,Pearson,0.3,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4859,5084,5260,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",Yes,4111.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.48,,,umol/L,,29,Pearson,-0.05,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4860,5088,5260,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,3508.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.48,,,umol/L,,29,Pearson,0.07,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4861,5092,5264,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,569.0,,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",0.05,,,umol/L,,29,Pearson,0.81,,,< 0.05,Yes,"Lipids, Energy by residual method",,,Tangney 2004
4862,5096,5268,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",No,46.6,,,ug/day,,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",0.15,,,umol/L,,29,Pearson,0.5,,,< 0.05,Yes,"Lipids, Energy by residual method",,,Tangney 2004
4863,5100,5272,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,5143.0,,,ug/day,,,"Serum, fasting",HPLC,Lutein/Zeaxanthin,"",0.39,,,umol/L,,29,Pearson,-0.13,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4864,5104,5276,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Lycopene,"",No,7475.0,,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",0.4,,,umol/L,,29,Pearson,-0.1,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4965,5116,5244,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),alpha-Tocopherol,"",Yes,17.9,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",33.83,,,umol/L,,29,Pearson,0.61,,,< 0.05,Yes,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4966,5120,5244,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),alpha-Tocopherol,"",No,7.3,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",33.83,,,umol/L,,29,Pearson,0.31,,,>= 0.05,No,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4967,5124,5248,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),gamma-Tocopherol,"",No,9.4,,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",5.39,,,umol/L,,29,Pearson,-0.27,,,>= 0.05,No,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4968,5128,5252,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin E,"",Yes,18.9,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,39.1,,,umol/L,,29,Pearson,0.57,,,< 0.05,Yes,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4969,5132,5252,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin E,"",No,5.6,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,39.1,,,umol/L,,29,Pearson,0.29,,,>= 0.05,No,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4970,5136,5256,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin C,"",Yes,81.5,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",26.18,,,umol/L,,29,Pearson,0.04,,,>= 0.05,No,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4971,5140,5256,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin C,"",No,60.7,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",26.18,,,umol/L,,29,Pearson,0.33,,,>= 0.05,No,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4972,5144,5260,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),beta-Carotene,"",Yes,4639.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.48,,,umol/L,,29,Pearson,0.24,,,>= 0.05,No,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4973,5148,5260,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),beta-Carotene,"",No,4477.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.48,,,umol/L,,29,Pearson,0.23,,,>= 0.05,No,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4956,5160,5244,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),alpha-Tocopherol,"",Yes,20.3,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",33.83,,,umol/L,,29,Pearson,0.26,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4957,5164,5244,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),alpha-Tocopherol,"",No,4.7,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",33.83,,,umol/L,,29,Pearson,0.27,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4958,5168,5248,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),gamma-Tocopherol,"",No,9.7,,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",5.39,,,umol/L,,29,Pearson,0.26,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4959,5172,5252,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin E,"",Yes,21.4,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,39.1,,,umol/L,,29,Pearson,0.25,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4960,5176,5252,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin E,"",No,5.7,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,39.1,,,umol/L,,29,Pearson,0.27,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4961,5180,5256,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin C,"",Yes,86.5,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",26.18,,,umol/L,,29,Pearson,0.17,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4962,5184,5256,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin C,"",No,63.2,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",26.18,,,umol/L,,29,Pearson,0.47,,,< 0.05,Yes,"Lipids, Energy by residual method",,,Tangney 2004
4963,5188,5260,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),beta-Carotene,"",Yes,4944.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.48,,,umol/L,,29,Pearson,0.26,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4964,5192,5260,Blacks,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),beta-Carotene,"",No,4752.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.48,,,umol/L,,29,Pearson,0.27,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4878,5057,5245,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",Yes,171.0,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",37.92,,,umol/L,,30,Pearson,0.46,,,< 0.05,Yes,"Lipids, Energy by residual method",,,Tangney 2004
4891,5057,5245,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",Yes,171.0,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",37.92,,,umol/L,,30,Pearson,0.55,,,< 0.05,Yes,"Lipids, Energy by residual method",,"Age, Race, BMI, Education",Tangney 2004
4879,5061,5245,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",No,6.2,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",37.92,,,umol/L,,30,Pearson,0.11,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4892,5061,5245,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",No,6.2,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",37.92,,,umol/L,,30,Pearson,0.38,,,>= 0.05,No,"Lipids, Energy by residual method",,"Age, Race, BMI, Education",Tangney 2004
4880,5065,5249,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",No,12.9,,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",4.5,,,umol/L,,30,Pearson,0.3,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4893,5065,5249,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",No,12.9,,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",4.5,,,umol/L,,30,Pearson,0.3,,,>= 0.05,No,"Lipids, Energy by residual method",,"Age, Race, BMI, Education",Tangney 2004
4881,5069,5253,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin E,"",Yes,155.2,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,42.38,,,umol/L,,30,Pearson,0.42,,,< 0.05,Yes,"Lipids, Energy by residual method",,,Tangney 2004
4894,5069,5253,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin E,"",Yes,155.2,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,42.38,,,umol/L,,30,Pearson,0.46,,,< 0.05,Yes,"Lipids, Energy by residual method",,"Age, Race, BMI, Education",Tangney 2004
4882,5073,5253,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,7.6,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,42.38,,,umol/L,,30,Pearson,0.13,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4895,5073,5253,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,7.6,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,42.38,,,umol/L,,30,Pearson,0.39,,,>= 0.05,No,"Lipids, Energy by residual method",,"Age, Race, BMI, Education",Tangney 2004
4883,5077,5257,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin C,"",Yes,351.5,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",34.81,,,umol/L,,30,Pearson,0.29,,,< 0.05,Yes,"Lipids, Energy by residual method",,,Tangney 2004
4896,5077,5257,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin C,"",Yes,351.5,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",34.81,,,umol/L,,30,Pearson,0.47,,,>= 0.05,No,"Lipids, Energy by residual method",,"Age, Race, BMI, Education",Tangney 2004
4884,5081,5257,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin C,"",No,124.5,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",34.81,,,umol/L,,30,Pearson,0.16,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4897,5081,5257,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin C,"",No,124.5,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",34.81,,,umol/L,,30,Pearson,0.14,,,>= 0.05,No,"Lipids, Energy by residual method",,"Age, Race, BMI, Education",Tangney 2004
4885,5085,5261,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",Yes,4596.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.42,,,umol/L,,30,Pearson,0.44,,,< 0.05,Yes,"Lipids, Energy by residual method",,,Tangney 2004
4898,5085,5261,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",Yes,4596.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.42,,,umol/L,,30,Pearson,0.52,,,< 0.05,Yes,"Lipids, Energy by residual method",,"Age, Race, BMI, Education",Tangney 2004
4886,5089,5261,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,3148.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.42,,,umol/L,,30,Pearson,0.05,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4899,5089,5261,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,3148.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.42,,,umol/L,,30,Pearson,0.15,,,>= 0.05,No,"Lipids, Energy by residual method",,"Age, Race, BMI, Education",Tangney 2004
4887,5093,5265,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,661.0,,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",0.09,,,umol/L,,30,Pearson,0.04,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4900,5093,5265,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,661.0,,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",0.09,,,umol/L,,30,Pearson,0.17,,,>= 0.05,No,"Lipids, Energy by residual method",,"Age, Race, BMI, Education",Tangney 2004
4888,5097,5269,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",No,88.5,,,ug/day,,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",0.18,,,umol/L,,30,Pearson,0.46,,,< 0.05,Yes,"Lipids, Energy by residual method",,,Tangney 2004
4901,5097,5269,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",No,88.5,,,ug/day,,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",0.18,,,umol/L,,30,Pearson,0.47,,,< 0.05,Yes,"Lipids, Energy by residual method",,"Age, Race, BMI, Education",Tangney 2004
4889,5101,5273,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,2841.0,,,ug/day,,,"Serum, fasting",HPLC,Lutein/Zeaxanthin,"",0.32,,,umol/L,,30,Pearson,0.31,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4902,5101,5273,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,2841.0,,,ug/day,,,"Serum, fasting",HPLC,Lutein/Zeaxanthin,"",0.32,,,umol/L,,30,Pearson,0.16,,,>= 0.05,No,"Lipids, Energy by residual method",,"Age, Race, BMI, Education",Tangney 2004
4890,5105,5277,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Lycopene,"",No,9558.0,,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",0.36,,,umol/L,,30,Pearson,0.32,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4903,5105,5277,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Lycopene,"",No,9558.0,,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",0.36,,,umol/L,,30,Pearson,0.1,,,>= 0.05,No,"Lipids, Energy by residual method",,"Age, Race, BMI, Education",Tangney 2004
4983,5117,5245,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),alpha-Tocopherol,"",Yes,73.0,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",37.92,,,umol/L,,30,Pearson,0.56,,,< 0.05,Yes,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4984,5121,5245,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),alpha-Tocopherol,"",No,8.7,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",37.92,,,umol/L,,30,Pearson,0.41,,,>= 0.05,No,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4985,5125,5249,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),gamma-Tocopherol,"",No,12.4,,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",4.5,,,umol/L,,30,Pearson,0.28,,,>= 0.05,No,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4986,5129,5253,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin E,"",Yes,74.4,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,42.38,,,umol/L,,30,Pearson,0.47,,,< 0.05,Yes,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4987,5133,5253,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin E,"",No,8.2,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,42.38,,,umol/L,,30,Pearson,0.4,,,>= 0.05,No,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4988,5137,5257,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin C,"",Yes,304.8,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",34.81,,,umol/L,,30,Pearson,0.48,,,< 0.05,Yes,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4989,5141,5257,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin C,"",No,12.4,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",34.81,,,umol/L,,30,Pearson,0.3,,,>= 0.05,No,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4990,5145,5261,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),beta-Carotene,"",Yes,4877.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.42,,,umol/L,,30,Pearson,0.09,,,>= 0.05,No,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4991,5149,5261,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),beta-Carotene,"",No,4747.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.42,,,umol/L,,30,Pearson,0.09,,,>= 0.05,No,Lipids,,"Age, Race, BMI, Education",Tangney 2004
4974,5161,5245,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),alpha-Tocopherol,"",Yes,66.1,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",37.92,,,umol/L,,30,Pearson,0.42,,,< 0.05,Yes,"Lipids, Energy by residual method",,,Tangney 2004
4975,5165,5245,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),alpha-Tocopherol,"",No,5.8,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",37.92,,,umol/L,,30,Pearson,-0.1,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4976,5169,5249,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),gamma-Tocopherol,"",No,10.5,,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",4.5,,,umol/L,,30,Pearson,-0.006,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4977,5173,5253,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin E,"",Yes,67.3,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,42.38,,,umol/L,,30,Pearson,0.87,,,< 0.05,Yes,"Lipids, Energy by residual method",,,Tangney 2004
4978,5177,5253,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin E,"",No,6.9,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,42.38,,,umol/L,,30,Pearson,-0.2,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4979,5181,5257,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin C,"",Yes,290.2,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",34.81,,,umol/L,,30,Pearson,0.29,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4980,5185,5257,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin C,"",No,102.8,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",34.81,,,umol/L,,30,Pearson,0.15,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4981,5189,5261,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),beta-Carotene,"",Yes,4399.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.42,,,umol/L,,30,Pearson,0.002,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4982,5193,5261,Whites,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),beta-Carotene,"",No,4275.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.42,,,umol/L,,30,Pearson,-0.06,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4917,4998,5246,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",Yes,75.5,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",34.95,,,umol/L,,34,Pearson,0.44,,,< 0.05,Yes,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
4943,4998,5246,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",Yes,75.5,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",34.95,,,umol/L,,34,Pearson,0.73,,,< 0.05,Yes,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
4918,5002,5246,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",No,7.4,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",34.95,,,umol/L,,34,Pearson,0.19,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
4944,5002,5246,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",No,7.4,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",34.95,,,umol/L,,34,Pearson,0.07,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
4919,5006,5250,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",No,13.0,,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",5.6,,,umol/L,,34,Pearson,0.3,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
4945,5006,5250,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",No,13.0,,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",5.6,,,umol/L,,34,Pearson,-0.02,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
4920,5010,5254,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin E,"",Yes,74.0,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,40.54,,,umol/L,,34,Pearson,0.69,,,< 0.05,Yes,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
4946,5010,5254,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin E,"",Yes,74.0,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,40.54,,,umol/L,,34,Pearson,0.93,,,< 0.05,Yes,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
4921,5014,5254,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,5.9,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,40.54,,,umol/L,,34,Pearson,0.72,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
4947,5014,5254,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,5.9,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,40.54,,,umol/L,,34,Pearson,-0.14,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
4922,5018,5258,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin C,"",Yes,225.4,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",31.51,,,umol/L,,34,Pearson,0.12,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
4948,5018,5258,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin C,"",Yes,225.4,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",31.51,,,umol/L,,34,Pearson,0.82,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
4923,5022,5258,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin C,"",No,130.1,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",31.51,,,umol/L,,34,Pearson,0.5,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
4949,5022,5258,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin C,"",No,130.1,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",31.51,,,umol/L,,34,Pearson,-0.37,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
4924,5026,5262,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",Yes,4012.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.4,,,umol/L,,34,Pearson,-0.5,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
4950,5026,5262,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",Yes,4012.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.4,,,umol/L,,34,Pearson,-0.36,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
4925,5030,5262,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,3760.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.4,,,umol/L,,34,Pearson,0.88,,,< 0.05,Yes,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
4951,5030,5262,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,3760.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.4,,,umol/L,,34,Pearson,0.09,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
4926,5034,5266,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,640.0,,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",0.07,,,umol/L,,34,Pearson,0.5,,,< 0.05,Yes,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
4952,5034,5266,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,640.0,,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",0.07,,,umol/L,,34,Pearson,0.54,,,< 0.05,Yes,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
4927,5038,5270,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",No,83.3,,,ug/day,,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",0.16,,,umol/L,,34,Pearson,0.3,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
4953,5038,5270,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",No,83.3,,,ug/day,,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",0.16,,,umol/L,,34,Pearson,0.36,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
4928,5042,5274,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,3194.0,,,ug/day,,,"Serum, fasting",HPLC,Lutein/Zeaxanthin,"",0.36,,,umol/L,,34,Pearson,-0.36,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
4954,5042,5274,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,3194.0,,,ug/day,,,"Serum, fasting",HPLC,Lutein/Zeaxanthin,"",0.36,,,umol/L,,34,Pearson,0.12,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
4929,5046,5278,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Lycopene,"",No,8158.0,,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",0.33,,,umol/L,,34,Pearson,-0.07,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
4955,5046,5278,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Lycopene,"",No,8158.0,,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",0.33,,,umol/L,,34,Pearson,0.06,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
4904,5058,5246,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",Yes,86.1,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",34.95,,,umol/L,,34,Pearson,0.4,,,< 0.05,Yes,"Lipids, Energy by residual method",,,Tangney 2004
4905,5062,5246,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",No,7.6,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",34.95,,,umol/L,,34,Pearson,0.03,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4906,5066,5250,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",No,13.5,,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",5.6,,,umol/L,,34,Pearson,0.33,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4907,5070,5254,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin E,"",Yes,85.5,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,40.54,,,umol/L,,34,Pearson,0.35,,,< 0.05,Yes,"Lipids, Energy by residual method",,,Tangney 2004
4908,5074,5254,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,6.0,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,40.54,,,umol/L,,34,Pearson,0.1,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4909,5078,5258,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin C,"",Yes,231.9,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",31.51,,,umol/L,,34,Pearson,0.31,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4910,5082,5258,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin C,"",No,131.5,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",31.51,,,umol/L,,34,Pearson,0.21,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4911,5086,5262,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",Yes,4012.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.4,,,umol/L,,34,Pearson,0.22,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4912,5090,5262,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,3629.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.4,,,umol/L,,34,Pearson,0.1,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4913,5094,5266,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,699.0,,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",0.07,,,umol/L,,34,Pearson,0.47,,,< 0.05,Yes,"Lipids, Energy by residual method",,,Tangney 2004
4914,5098,5270,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",No,99.6,,,ug/day,,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",0.16,,,umol/L,,34,Pearson,0.44,,,< 0.05,Yes,"Lipids, Energy by residual method",,,Tangney 2004
4915,5102,5274,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,4127.0,,,ug/day,,,"Serum, fasting",HPLC,Lutein/Zeaxanthin,"",0.36,,,umol/L,,34,Pearson,0.03,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4916,5106,5278,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Lycopene,"",No,10054.0,,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",0.33,,,umol/L,,34,Pearson,-0.02,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
5001,5118,5246,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),alpha-Tocopherol,"",Yes,41.2,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",34.95,,,umol/L,,34,Pearson,0.28,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
5002,5122,5246,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),alpha-Tocopherol,"",No,5.4,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",34.95,,,umol/L,,34,Pearson,0.37,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
5003,5126,5250,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),gamma-Tocopherol,"",No,10.9,,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",5.6,,,umol/L,,34,Pearson,-0.04,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
5004,5130,5254,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin E,"",Yes,40.3,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,40.54,,,umol/L,,34,Pearson,0.2,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
5005,5134,5254,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin E,"",No,6.6,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,40.54,,,umol/L,,34,Pearson,0.39,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
5006,5138,5258,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin C,"",Yes,173.6,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",31.51,,,umol/L,,34,Pearson,0.37,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
5007,5142,5258,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin C,"",No,82.6,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",31.51,,,umol/L,,34,Pearson,0.37,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
5008,5146,5262,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),beta-Carotene,"",Yes,4650.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.4,,,umol/L,,34,Pearson,0.004,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
5009,5150,5262,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),beta-Carotene,"",No,4452.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.4,,,umol/L,,34,Pearson,-0.005,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
4992,5162,5246,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),alpha-Tocopherol,"",Yes,41.2,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",34.95,,,umol/L,,34,Pearson,0.28,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4993,5166,5246,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),alpha-Tocopherol,"",No,5.3,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",34.95,,,umol/L,,34,Pearson,0.04,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4994,5170,5250,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),gamma-Tocopherol,"",No,10.9,,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",5.6,,,umol/L,,34,Pearson,0.05,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4995,5174,5254,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin E,"",Yes,42.3,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,40.54,,,umol/L,,34,Pearson,0.24,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4996,5178,5254,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin E,"",No,6.5,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,40.54,,,umol/L,,34,Pearson,0.03,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4997,5182,5258,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin C,"",Yes,183.2,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",31.51,,,umol/L,,34,Pearson,0.28,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4998,5186,5258,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin C,"",No,84.7,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",31.51,,,umol/L,,34,Pearson,0.3,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4999,5190,5262,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),beta-Carotene,"",Yes,4932.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.4,,,umol/L,,34,Pearson,0.24,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
5000,5194,5262,Females,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),beta-Carotene,"",No,4715.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.4,,,umol/L,,34,Pearson,0.23,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4930,5059,5247,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",Yes,147.6,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",37.27,,,umol/L,,25,Pearson,0.71,,,< 0.05,Yes,"Lipids, Energy by residual method",,,Tangney 2004
4931,5063,5247,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",No,7.5,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",37.27,,,umol/L,,25,Pearson,0.06,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4932,5067,5251,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",No,13.5,,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",4.06,,,umol/L,,25,Pearson,-0.04,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4933,5071,5255,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin E,"",Yes,144.7,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,41.12,,,umol/L,,25,Pearson,0.67,,,< 0.05,Yes,"Lipids, Energy by residual method",,,Tangney 2004
4934,5075,5255,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,5.7,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,41.12,,,umol/L,,25,Pearson,-0.01,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4935,5079,5259,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin C,"",Yes,311.4,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",28.79,,,umol/L,,25,Pearson,0.56,,,< 0.05,Yes,"Lipids, Energy by residual method",,,Tangney 2004
4936,5083,5259,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Vitamin C,"",No,101.9,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",28.79,,,umol/L,,25,Pearson,0.08,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4937,5087,5263,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",Yes,4724.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.51,,,umol/L,,25,Pearson,0.37,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4938,5091,5263,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,2875.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.51,,,umol/L,,25,Pearson,0.1,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4939,5095,5267,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,534.0,,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",0.07,,,umol/L,,25,Pearson,0.54,,,< 0.05,Yes,"Lipids, Energy by residual method",,,Tangney 2004
4940,5099,5271,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",No,83.4,,,ug/day,,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",0.18,,,umol/L,,25,Pearson,0.46,,,< 0.05,Yes,"Lipids, Energy by residual method",,,Tangney 2004
4941,5103,5275,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,3675.0,,,ug/day,,,"Serum, fasting",HPLC,Lutein/Zeaxanthin,"",0.35,,,umol/L,,25,Pearson,0.13,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
4942,5107,5279,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,Food Frequency Questionnaire (FFQ),Lycopene,"",No,10306.0,,,ug/day,,,"Serum, fasting",HPLC,Lycopene,"",0.44,,,umol/L,,25,Pearson,0.09,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
5019,5119,5247,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),alpha-Tocopherol,"",Yes,51.2,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",37.27,,,umol/L,,25,Pearson,0.61,,,< 0.05,Yes,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
5020,5123,5247,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),alpha-Tocopherol,"",No,6.1,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",37.27,,,umol/L,,25,Pearson,-0.24,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
5021,5127,5251,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),gamma-Tocopherol,"",No,10.7,,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",4.06,,,umol/L,,25,Pearson,-0.44,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
5022,5131,5255,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin E,"",Yes,52.3,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,41.12,,,umol/L,,25,Pearson,0.61,,,< 0.05,Yes,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
5023,5135,5255,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin E,"",No,7.3,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,41.12,,,umol/L,,25,Pearson,-0.19,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
5024,5139,5259,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin C,"",Yes,221.4,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",28.79,,,umol/L,,25,Pearson,0.01,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
5025,5143,5259,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin C,"",No,90.2,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",28.79,,,umol/L,,25,Pearson,0.17,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
5026,5147,5263,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),beta-Carotene,"",Yes,4738.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.51,,,umol/L,,25,Pearson,0.23,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
5027,5151,5263,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),beta-Carotene,"",No,4662.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.51,,,umol/L,,25,Pearson,0.23,,,>= 0.05,No,Lipids,,"Age, Sex, BMI, Education",Tangney 2004
5010,5163,5247,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),alpha-Tocopherol,"",Yes,40.3,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",37.27,,,umol/L,,25,Pearson,0.7,,,< 0.05,Yes,"Lipids, Energy by residual method",,,Tangney 2004
5011,5167,5247,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),alpha-Tocopherol,"",No,5.0,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",37.27,,,umol/L,,25,Pearson,-0.1,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
5012,5171,5251,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),gamma-Tocopherol,"",No,9.3,,,mg/day,,,"Serum, fasting",HPLC,gamma-Tocopherol,"",4.06,,,umol/L,,25,Pearson,-0.23,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
5013,5175,5255,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin E,"",Yes,41.4,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,41.12,,,umol/L,,25,Pearson,0.68,,,< 0.05,Yes,"Lipids, Energy by residual method",,,Tangney 2004
5014,5179,5255,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin E,"",No,6.1,,,mg/day,,,"Serum, fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,41.12,,,umol/L,,25,Pearson,-0.07,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
5015,5183,5259,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin C,"",Yes,199.5,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",28.79,,,umol/L,,25,Pearson,0.43,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
5016,5187,5259,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),Vitamin C,"",No,79.4,,,mg/day,,,"Serum, fasting",Colorimetry,Vitamin C,"",28.79,,,umol/L,,25,Pearson,0.39,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
5017,5191,5263,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),beta-Carotene,"",Yes,4311.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.51,,,umol/L,,25,Pearson,0.1,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
5018,5195,5263,Males,Elderly black and white participants in a dietary validation study,United States,CHAP (Chicago Health and Aging Project),,24-h Dietary recall (1-day),beta-Carotene,"",No,4240.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",0.51,,,umol/L,,25,Pearson,0.1,,,>= 0.05,No,"Lipids, Energy by residual method",,,Tangney 2004
5028,5331,5312,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,28.4,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Lauric acid (12:0),25.8,,,percentRoot,,49,Pearson,0.21,,,>= 0.05,No,,No,,Knutsen 2003
5029,5332,5313,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)","",,36.4,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),44.7,,,percentRoot,,49,Pearson,0.07,,,>= 0.05,No,,No,,Knutsen 2003
5032,5333,5314,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + Linoleic acid (LA; cis-18:2n-6),,27.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6) + cis-Docosapentaenoic acids (cis-22:5),22.7,,,percentRoot,,49,Pearson,0.62,,,< 0.001,Yes,,No,,Knutsen 2003
5030,5334,5322,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,24.6,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",20.1,,,percentRoot,,49,Pearson,0.61,,,< 0.001,Yes,,No,,Knutsen 2003
5031,5335,5323,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,2.1,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",1.06,,,percentRoot,,49,Pearson,0.29,,,< 0.05,Yes,,No,,Knutsen 2003
5037,5298,5312,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Lauric acid (12:0),,31.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Lauric acid (12:0),25.8,,,percentRoot,,49,Pearson,0.41,,,>= 0.05,No,,No,,Knutsen 2003
5052,5298,5312,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Lauric acid (12:0),,31.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Lauric acid (12:0),25.8,,,percentRoot,,49,Pearson,0.46,,,< 0.001,Yes,,Yes,,Knutsen 2003
5042,5299,5313,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,37.0,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),44.7,,,percentRoot,,49,Pearson,0.23,,,>= 0.05,No,,No,,Knutsen 2003
5057,5299,5313,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,37.0,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),44.7,,,percentRoot,,49,Pearson,0.29,,,< 0.05,Yes,,Yes,,Knutsen 2003
5047,5300,5314,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6) + cis-Docosapentaenoic acids (cis-22:5),,24.0,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6) + cis-Docosapentaenoic acids (cis-22:5),22.7,,,percentRoot,,49,Pearson,0.67,,,>= 0.05,No,,No,,Knutsen 2003
5062,5300,5314,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6) + cis-Docosapentaenoic acids (cis-22:5),,24.0,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6) + cis-Docosapentaenoic acids (cis-22:5),22.7,,,percentRoot,,49,Pearson,0.78,,,< 0.001,Yes,,Yes,,Knutsen 2003
5033,5301,5315,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Lauric acid (12:0),"",,1.5,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Lauric acid (12:0),"",0.2,,,percentRoot,,49,Pearson,0.29,,,>= 0.05,No,,No,,Knutsen 2003
5048,5301,5315,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Lauric acid (12:0),"",,1.5,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Lauric acid (12:0),"",0.2,,,percentRoot,,49,Pearson,0.34,,,< 0.05,Yes,,Yes,,Knutsen 2003
5034,5302,5316,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Myristic acid (14:0),"",,2.6,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Myristic acid (14:0),"",1.8,,,percentRoot,,49,Pearson,0.43,,,>= 0.05,No,,No,,Knutsen 2003
5049,5302,5316,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Myristic acid (14:0),"",,2.6,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Myristic acid (14:0),"",1.8,,,percentRoot,,49,Pearson,0.51,,,< 0.001,Yes,,Yes,,Knutsen 2003
5035,5303,5317,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Palmitic acid (16:0),"",,16.5,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitic acid (16:0),"",19.3,,,percentRoot,,49,Pearson,0.43,,,>= 0.05,No,,No,,Knutsen 2003
5050,5303,5317,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Palmitic acid (16:0),"",,16.5,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitic acid (16:0),"",19.3,,,percentRoot,,49,Pearson,0.48,,,< 0.001,Yes,,Yes,,Knutsen 2003
5036,5304,5318,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Stearic acid (18:0),"",,7.5,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Stearic acid (18:0),"",3.8,,,percentRoot,,49,Pearson,0.12,,,>= 0.05,No,,No,,Knutsen 2003
5051,5304,5318,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Stearic acid (18:0),"",,7.5,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Stearic acid (18:0),"",3.8,,,percentRoot,,49,Pearson,0.13,,,>= 0.05,No,,Yes,,Knutsen 2003
5038,5305,5319,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Myristoleic acid (cis-14:1n-5),"",,0.0,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Myristoleic acid (cis-14:1n-5),"",0.2,,,percentRoot,,49,Pearson,0.44,,,>= 0.05,No,,No,,Knutsen 2003
5053,5305,5319,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Myristoleic acid (cis-14:1n-5),"",,0.0,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Myristoleic acid (cis-14:1n-5),"",0.2,,,percentRoot,,49,Pearson,0.68,,,< 0.001,Yes,,Yes,,Knutsen 2003
5039,5306,5320,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Palmitoleic acid (cis-16:1n-7),"",,1.3,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitoleic acid (cis-16:1n-7),"",4.4,,,percentRoot,,49,Pearson,0.39,,,>= 0.05,No,,No,,Knutsen 2003
5054,5306,5320,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Palmitoleic acid (cis-16:1n-7),"",,1.3,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitoleic acid (cis-16:1n-7),"",4.4,,,percentRoot,,49,Pearson,0.45,,,< 0.001,Yes,,Yes,,Knutsen 2003
5040,5307,5321,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Oleic acid (cis-18:1n-9),"",,35.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Oleic acid (cis-18:1n-9),"",38.3,,,percentRoot,,49,Pearson,0.32,,,>= 0.05,No,,No,,Knutsen 2003
5055,5307,5321,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Oleic acid (cis-18:1n-9),"",,35.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Oleic acid (cis-18:1n-9),"",38.3,,,percentRoot,,49,Pearson,0.42,,,< 0.01,Yes,,Yes,,Knutsen 2003
5043,5308,5322,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Linoleic acid (LA; cis-18:2n-6),"",,21.9,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",20.1,,,percentRoot,,49,Pearson,0.66,,,>= 0.05,No,,No,,Knutsen 2003
5058,5308,5322,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Linoleic acid (LA; cis-18:2n-6),"",,21.9,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",20.1,,,percentRoot,,49,Pearson,0.77,,,< 0.001,Yes,,Yes,,Knutsen 2003
5044,5309,5323,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,1.9,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",1.06,,,percentRoot,,49,Pearson,0.51,,,>= 0.05,No,,No,,Knutsen 2003
5059,5309,5323,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,1.9,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",1.06,,,percentRoot,,49,Pearson,0.68,,,< 0.001,Yes,,Yes,,Knutsen 2003
5045,5310,5324,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),EPA (cis-20:5n-3),"",,0.1,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",0.0,,,percentRoot,,49,Pearson,0.19,,,>= 0.05,No,,No,,Knutsen 2003
5060,5310,5324,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),EPA (cis-20:5n-3),"",,0.1,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",0.0,,,percentRoot,,49,Pearson,0.23,,,>= 0.05,No,,Yes,,Knutsen 2003
5046,5311,5325,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),cis-Docosapentaenoic acids (cis-22:5),"",,0.03,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,cis-Docosapentaenoic acids (cis-22:5),"",0.16,,,percentRoot,,49,Pearson,0.32,,,>= 0.05,No,,No,,Knutsen 2003
5061,5311,5325,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),cis-Docosapentaenoic acids (cis-22:5),"",,0.03,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,cis-Docosapentaenoic acids (cis-22:5),"",0.16,,,percentRoot,,49,Pearson,0.54,,,< 0.001,Yes,,Yes,,Knutsen 2003
5041,5388,5389,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),cis-Eicosenoic acids (cis-20:1),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,cis-Eicosenoic acids (cis-20:1),"",,,,percentRoot,,49,Pearson,0.23,,,>= 0.05,No,,No,,Knutsen 2003
5056,5388,5389,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),cis-Eicosenoic acids (cis-20:1),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,cis-Eicosenoic acids (cis-20:1),"",,,,percentRoot,,49,Pearson,0.34,,,< 0.05,Yes,,Yes,,Knutsen 2003
5063,5383,5364,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,28.0,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Lauric acid (12:0),22.9,,,percentRoot,,72,Pearson,0.31,,,< 0.01,Yes,,No,,Knutsen 2003
5064,5384,5365,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)","",,38.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Myristoleic acid (cis-14:1n-5),47.2,,,percentRoot,,72,Pearson,0.31,,,< 0.01,Yes,,No,,Knutsen 2003
5067,5385,5366,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + Linoleic acid (LA; cis-18:2n-6),,26.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6) + cis-Docosapentaenoic acids (cis-22:5),23.4,,,percentRoot,,72,Pearson,0.53,,,< 0.001,Yes,,No,,Knutsen 2003
5065,5386,5374,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,24.0,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",20.5,,,percentRoot,,72,Pearson,0.52,,,< 0.001,Yes,,No,,Knutsen 2003
5066,5387,5375,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,1.9,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",1.1,,,percentRoot,,72,Pearson,0.49,,,< 0.001,Yes,,No,,Knutsen 2003
5072,5350,5364,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Lauric acid (12:0),,32.8,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Lauric acid (12:0),22.9,,,percentRoot,,72,Pearson,0.48,,,>= 0.05,No,,No,,Knutsen 2003
5101,5350,5364,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Lauric acid (12:0),,32.8,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Lauric acid (12:0),22.9,,,percentRoot,,72,Pearson,0.56,,,< 0.001,Yes,,Yes,,Knutsen 2003
5076,5351,5365,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Myristoleic acid (cis-14:1n-5),,36.9,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Myristoleic acid (cis-14:1n-5),47.2,,,percentRoot,,72,Pearson,0.03,,,>= 0.05,No,,No,,Knutsen 2003
5105,5351,5365,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Myristoleic acid (cis-14:1n-5),,36.9,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Myristoleic acid (cis-14:1n-5),47.2,,,percentRoot,,72,Pearson,0.04,,,>= 0.05,No,,Yes,,Knutsen 2003
5081,5352,5366,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6) + cis-Docosapentaenoic acids (cis-22:5),,23.0,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6) + cis-Docosapentaenoic acids (cis-22:5),23.4,,,percentRoot,,72,Pearson,0.57,,,>= 0.05,No,,No,,Knutsen 2003
5110,5352,5366,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6) + cis-Docosapentaenoic acids (cis-22:5),,23.0,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6) + cis-Docosapentaenoic acids (cis-22:5),23.4,,,percentRoot,,72,Pearson,0.7,,,< 0.001,Yes,,Yes,,Knutsen 2003
5068,5353,5367,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Lauric acid (12:0),"",,1.8,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Lauric acid (12:0),"",0.2,,,percentRoot,,72,Pearson,0.06,,,>= 0.05,No,,No,,Knutsen 2003
5097,5353,5367,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Lauric acid (12:0),"",,1.8,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Lauric acid (12:0),"",0.2,,,percentRoot,,72,Pearson,0.08,,,>= 0.05,No,,Yes,,Knutsen 2003
5069,5354,5368,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Myristic acid (14:0),"",,3.1,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Myristic acid (14:0),"",1.7,,,percentRoot,,72,Pearson,0.37,,,>= 0.05,No,,No,,Knutsen 2003
5098,5354,5368,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Myristic acid (14:0),"",,3.1,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Myristic acid (14:0),"",1.7,,,percentRoot,,72,Pearson,0.43,,,< 0.001,Yes,,Yes,,Knutsen 2003
5070,5355,5369,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Palmitic acid (16:0),"",,16.7,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitic acid (16:0),"",17.0,,,percentRoot,,72,Pearson,0.5,,,>= 0.05,No,,No,,Knutsen 2003
5099,5355,5369,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Palmitic acid (16:0),"",,16.7,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitic acid (16:0),"",17.0,,,percentRoot,,72,Pearson,0.57,,,< 0.001,Yes,,Yes,,Knutsen 2003
5071,5356,5370,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Stearic acid (18:0),"",,8.0,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Stearic acid (18:0),"",3.0,,,percentRoot,,72,Pearson,0.16,,,>= 0.05,No,,No,,Knutsen 2003
5100,5356,5370,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Stearic acid (18:0),"",,8.0,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Stearic acid (18:0),"",3.0,,,percentRoot,,72,Pearson,0.19,,,>= 0.05,No,,Yes,,Knutsen 2003
5073,5357,5371,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Myristoleic acid (cis-14:1n-5),"",,0.0,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Myristoleic acid (cis-14:1n-5),"",0.2,,,percentRoot,,72,Pearson,0.08,,,>= 0.05,No,,No,,Knutsen 2003
5102,5357,5371,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Myristoleic acid (cis-14:1n-5),"",,0.0,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Myristoleic acid (cis-14:1n-5),"",0.2,,,percentRoot,,72,Pearson,0.27,,,< 0.05,Yes,,Yes,,Knutsen 2003
5074,5358,5372,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Palmitoleic acid (cis-16:1n-7),"",,0.3,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitoleic acid (cis-16:1n-7),"",4.4,,,percentRoot,,72,Pearson,0.4,,,>= 0.05,No,,No,,Knutsen 2003
5103,5358,5372,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Palmitoleic acid (cis-16:1n-7),"",,0.3,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitoleic acid (cis-16:1n-7),"",4.4,,,percentRoot,,72,Pearson,0.48,,,< 0.001,Yes,,Yes,,Knutsen 2003
5075,5359,5373,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Oleic acid (cis-18:1n-9),"",,35.0,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Oleic acid (cis-18:1n-9),"",39.7,,,percentRoot,,72,Pearson,0.1,,,>= 0.05,No,,No,,Knutsen 2003
5104,5359,5373,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Oleic acid (cis-18:1n-9),"",,35.0,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Oleic acid (cis-18:1n-9),"",39.7,,,percentRoot,,72,Pearson,0.13,,,>= 0.05,No,,Yes,,Knutsen 2003
5077,5360,5374,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Linoleic acid (LA; cis-18:2n-6),"",,20.7,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",20.5,,,percentRoot,,72,Pearson,0.58,,,>= 0.05,No,,No,,Knutsen 2003
5106,5360,5374,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Linoleic acid (LA; cis-18:2n-6),"",,20.7,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",20.5,,,percentRoot,,72,Pearson,0.71,,,< 0.001,Yes,,Yes,,Knutsen 2003
5078,5361,5375,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,2.0,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",1.1,,,percentRoot,,72,Pearson,0.41,,,>= 0.05,No,,No,,Knutsen 2003
5107,5361,5375,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,2.0,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",1.1,,,percentRoot,,72,Pearson,0.62,,,< 0.001,Yes,,Yes,,Knutsen 2003
5079,5362,5376,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),EPA (cis-20:5n-3),"",,0.0,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",0.1,,,percentRoot,,72,Pearson,-0.04,,,>= 0.05,No,,No,,Knutsen 2003
5108,5362,5376,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),EPA (cis-20:5n-3),"",,0.0,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",0.1,,,percentRoot,,72,Pearson,-0.05,,,>= 0.05,No,,Yes,,Knutsen 2003
5080,5363,5377,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),cis-Docosapentaenoic acids (cis-22:5),"",,0.02,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,cis-Docosapentaenoic acids (cis-22:5),"",0.18,,,percentRoot,,72,Pearson,0.05,,,>= 0.05,No,,No,,Knutsen 2003
5109,5363,5377,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),cis-Docosapentaenoic acids (cis-22:5),"",,0.02,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,cis-Docosapentaenoic acids (cis-22:5),"",0.18,,,percentRoot,,72,Pearson,0.06,,,>= 0.05,No,,Yes,,Knutsen 2003
5112,5394,5392,All,Secondary school students from Harris Academy in Dundee,United Kingdom,,,Food Frequency Questionnaire (FFQ),Potassium,"",,93.8,,,mmol/day,,,"Urine, 24-h",Ion selective electrode (ISE),Potassium,"",43.4,,,mmol/day,,27,Spearman,-0.04,,,>= 0.05,No,,,,Lietz 2002
5114,5397,5395,All,Secondary school students from Harris Academy in Dundee,United Kingdom,,,Food Frequency Questionnaire (FFQ),Nitrogen,"",,1066.0,,,mmol/day,,,"Urine, 24-h",Spectrophotometry,Nitrogen,"",481.6,,,mmol/day,,27,Spearman,-0.2,,,>= 0.05,No,,,,Lietz 2002
5111,5393,5392,All,Secondary school students from Harris Academy in Dundee,United Kingdom,,,Weighed Dietary record (7-day),Potassium,"",,60.1,,,mmol/day,,,"Urine, 24-h",Ion selective electrode (ISE),Potassium,"",43.4,,,mmol/day,,27,Spearman,0.78,,,< 0.001,Yes,,,,Lietz 2002
5113,5396,5395,All,Secondary school students from Harris Academy in Dundee,United Kingdom,,,Weighed Dietary record (7-day),Nitrogen,"",,712.1,,,mmol/day,,,"Urine, 24-h",Spectrophotometry,Nitrogen,"",481.6,,,mmol/day,,27,Spearman,0.45,,,< 0.05,Yes,,,,Lietz 2002
5115,5428,5435,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,ug/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,umol/L,,159,Spearman,0.13,,,= 0.1,No,"Cholesterol, Energy by residual method",,"Age, Sex, BMI",Irwig 2002
5116,5429,5436,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,umol/L,,159,Spearman,0.1,,,= 0.22,No,"Cholesterol, Energy by residual method",,"Age, Sex, BMI",Irwig 2002
5117,5430,5437,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,ug/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,159,Spearman,0.38,,,< 0.0001,Yes,"Cholesterol, Energy by residual method",,"Age, Sex, BMI",Irwig 2002
5118,5431,5438,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,ug/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,umol/L,,159,Spearman,0.14,,,= 0.09,No,"Cholesterol, Energy by residual method",,"Age, Sex, BMI",Irwig 2002
5119,5432,5439,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,,,,ug/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,umol/L,,159,Spearman,0.17,,,= 0.04,Yes,"Cholesterol, Energy by residual method",,"Age, Sex, BMI",Irwig 2002
5120,5433,5440,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",,,,,mg/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,159,Spearman,0.05,,,= 0.5,No,"Cholesterol, Energy by residual method",,"Age, Sex, BMI",Irwig 2002
5121,5434,5441,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",,,,,mg/day,,,"Plasma, fasting",HPLC,gamma-Tocopherol,"",,,,umol/L,,159,Spearman,0.33,,,< 0.0001,Yes,"Cholesterol, Energy by residual method",,"Age, Sex, BMI",Irwig 2002
5122,5442,5435,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Pineapple,"",,,,,servings/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,umol/L,,159,Spearman,0.1,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5133,5442,5436,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Pineapple,"",,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,umol/L,,159,Spearman,0.17,,,< 0.05,Yes,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5144,5442,5437,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Pineapple,"",,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,159,Spearman,0.24,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5155,5442,5438,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Pineapple,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,umol/L,,159,Spearman,0.08,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5166,5442,5439,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Pineapple,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,umol/L,,159,Spearman,0.05,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5123,5443,5435,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Papaya,"",,,,,servings/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,umol/L,,159,Spearman,0.19,,,< 0.05,Yes,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5134,5443,5436,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Papaya,"",,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,umol/L,,159,Spearman,0.25,,,< 0.01,Yes,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5145,5443,5437,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Papaya,"",,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,159,Spearman,0.41,,,< 0.001,Yes,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5156,5443,5438,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Papaya,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,umol/L,,159,Spearman,0.01,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5167,5443,5439,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Papaya,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,umol/L,,159,Spearman,0.17,,,< 0.05,Yes,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5124,5444,5435,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Banana,"",,,,,servings/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,umol/L,,159,Spearman,0.2,,,< 0.05,Yes,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5135,5444,5436,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Banana,"",,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,umol/L,,159,Spearman,0.12,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5146,5444,5437,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Banana,"",,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,159,Spearman,0.23,,,< 0.01,Yes,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5157,5444,5438,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Banana,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,umol/L,,159,Spearman,0.02,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5168,5444,5439,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Banana,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,umol/L,,159,Spearman,0.09,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5125,5445,5435,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Melon,"",,,,,servings/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,umol/L,,159,Spearman,-0.23,,,< 0.01,Yes,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5136,5445,5436,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Melon,"",,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,umol/L,,159,Spearman,0.03,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5147,5445,5437,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Melon,"",,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,159,Spearman,0.02,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5158,5445,5438,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Melon,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,umol/L,,159,Spearman,-0.14,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5169,5445,5439,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Melon,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,umol/L,,159,Spearman,0.0,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5126,5446,5435,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Tropical fruits,Pineapple + Papaya + Banana,,,,,servings/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,umol/L,,159,Spearman,0.23,,,< 0.01,Yes,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5137,5446,5436,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Tropical fruits,Pineapple + Papaya + Banana,,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,umol/L,,159,Spearman,0.25,,,< 0.01,Yes,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5148,5446,5437,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Tropical fruits,Pineapple + Papaya + Banana,,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,159,Spearman,0.4,,,< 0.001,Yes,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5159,5446,5438,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Tropical fruits,Pineapple + Papaya + Banana,,,,,servings/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,umol/L,,159,Spearman,0.05,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5170,5446,5439,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Tropical fruits,Pineapple + Papaya + Banana,,,,,servings/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,umol/L,,159,Spearman,0.16,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5127,5447,5435,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Cucumber,"",,,,,servings/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,umol/L,,159,Spearman,0.15,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5138,5447,5436,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Cucumber,"",,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,umol/L,,159,Spearman,0.16,,,< 0.05,Yes,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5149,5447,5437,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Cucumber,"",,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,159,Spearman,0.24,,,< 0.01,Yes,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5160,5447,5438,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Cucumber,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,umol/L,,159,Spearman,0.12,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5171,5447,5439,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Cucumber,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,umol/L,,159,Spearman,0.1,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5128,5448,5435,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Tomato,"",,,,,servings/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,umol/L,,159,Spearman,0.09,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5139,5448,5436,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Tomato,"",,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,umol/L,,159,Spearman,0.22,,,< 0.01,Yes,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5150,5448,5437,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Tomato,"",,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,159,Spearman,0.2,,,< 0.05,Yes,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5161,5448,5438,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Tomato,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,umol/L,,159,Spearman,0.1,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5172,5448,5439,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Tomato,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,umol/L,,159,Spearman,0.07,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5129,5449,5435,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Lettuce,"",,,,,servings/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,umol/L,,159,Spearman,-0.1,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5140,5449,5436,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Lettuce,"",,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,umol/L,,159,Spearman,0.06,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5151,5449,5437,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Lettuce,"",,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,159,Spearman,0.16,,,< 0.05,Yes,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5162,5449,5438,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Lettuce,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,umol/L,,159,Spearman,0.01,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5173,5449,5439,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Lettuce,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,umol/L,,159,Spearman,0.13,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5130,5450,5435,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Banana,"",,,,,servings/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,umol/L,,159,Spearman,0.18,,,< 0.05,Yes,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5141,5450,5436,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Banana,"",,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,umol/L,,159,Spearman,-0.07,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5152,5450,5437,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Banana,"",,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,159,Spearman,0.02,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5163,5450,5438,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Banana,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,umol/L,,159,Spearman,0.04,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5174,5450,5439,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Banana,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,umol/L,,159,Spearman,-0.14,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5131,5451,5435,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Broccoli,"",,,,,servings/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,umol/L,,159,Spearman,0.02,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5142,5451,5436,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Broccoli,"",,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,umol/L,,159,Spearman,0.16,,,< 0.05,Yes,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5153,5451,5437,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Broccoli,"",,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,159,Spearman,0.16,,,< 0.05,Yes,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5164,5451,5438,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Broccoli,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,umol/L,,159,Spearman,0.08,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5175,5451,5439,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Broccoli,"",,,,,servings/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,umol/L,,159,Spearman,0.06,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5132,5452,5435,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Vegetables,Tomato + Cucumber + Lettuce,,,,,servings/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,umol/L,,159,Spearman,0.12,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5143,5452,5436,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Vegetables,Tomato + Cucumber + Lettuce,,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,umol/L,,159,Spearman,0.24,,,< 0.01,Yes,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5154,5452,5437,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Vegetables,Tomato + Cucumber + Lettuce,,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,umol/L,,159,Spearman,0.24,,,< 0.01,Yes,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5165,5452,5438,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Vegetables,Tomato + Cucumber + Lettuce,,,,,servings/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,umol/L,,159,Spearman,0.08,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5176,5452,5439,All [by gender],Adolescents,Costa Rica,,,Food Frequency Questionnaire (FFQ),Vegetables,Tomato + Cucumber + Lettuce,,,,,servings/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,umol/L,,159,Spearman,0.11,,,>= 0.05,No,Cholesterol,,"Age, Sex, BMI, Energy",Irwig 2002
5292,5494,5453,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),26.21,,,percentRoot,,503,Spearman,0.17,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5293,5494,5454,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Lauric acid (12:0),"",0.02,,,percentRoot,,496,Spearman,0.01,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5294,5494,5455,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Myristic acid (14:0),"",1.02,,,percentRoot,,503,Spearman,0.05,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5295,5494,5456,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.19,,,percentRoot,,503,Spearman,0.15,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5296,5494,5457,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitic acid (16:0),"",21.6,,,percentRoot,,503,Spearman,0.15,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5297,5494,5458,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.21,,,percentRoot,,503,Spearman,0.17,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5298,5494,5459,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Stearic acid (18:0),"",2.98,,,percentRoot,,503,Spearman,0.13,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5299,5494,5460,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Arachidic acid (20:0),"",0.19,,,percentRoot,,406,Spearman,-0.06,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5300,5494,5461,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Behenic acid (22:0),"",0.03,,,percentRoot,,340,Spearman,0.0,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5301,5494,5462,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Lignoceric acid (24:0),"",0.01,,,percentRoot,,502,Spearman,-0.01,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5302,5494,5463,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + 8-Eicosenoic acid (cis-20:1n-12) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + 11-Eicosenoic acid (cis-20:1n-9),54.08,,,percentRoot,,503,Spearman,0.14,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5303,5494,5464,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Myristoleic acid (cis-14:1n-5),"",0.14,,,percentRoot,,503,Spearman,0.0,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5304,5494,5465,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitoleic acid (cis-16:1n-7),"",6.22,,,percentRoot,,503,Spearman,-0.02,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5305,5494,5466,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Oleic acid (cis-18:1n-9),"",44.3,,,percentRoot,,503,Spearman,0.25,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5306,5494,5467,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Asclepic acid (cis-18:1n-7),"",2.45,,,percentRoot,,503,Spearman,-0.08,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5307,5494,5468,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,8-Eicosenoic acid (cis-20:1n-12),"",0.11,,,percentRoot,,503,Spearman,0.1,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5308,5494,5469,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,11-Eicosenoic acid (cis-20:1n-9),"",0.52,,,percentRoot,,503,Spearman,0.12,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5309,5494,5470,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),15.29,,,percentRoot,,503,Spearman,-0.29,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5310,5494,5471,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",13.37,,,percentRoot,,503,Spearman,-0.29,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5311,5494,5472,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",0.14,,,percentRoot,,405,Spearman,-0.1,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5312,5494,5473,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Eicosadienoic acid (cis-20:2n-6),"",0.22,,,percentRoot,,503,Spearman,-0.19,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5313,5494,5474,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",0.29,,,percentRoot,,473,Spearman,-0.15,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5314,5494,5475,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",0.44,,,percentRoot,,503,Spearman,-0.09,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5315,5494,5476,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.22,,,percentRoot,,503,Spearman,-0.06,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5316,5494,5477,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3),0.99,,,percentRoot,,503,Spearman,-0.16,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5317,5494,5478,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.55,,,percentRoot,,503,Spearman,-0.19,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5318,5494,5479,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Eicosatrienoic acid (ETE; cis-20:3n-3),"",0.02,,,percentRoot,,503,Spearman,-0.04,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5319,5494,5480,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",0.04,,,percentRoot,,503,Spearman,-0.05,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5320,5494,5481,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DPA (cis-22:5n-3),"",0.21,,,percentRoot,,503,Spearman,-0.02,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5321,5494,5482,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DHA (cis-22:6n-3),"",0.17,,,percentRoot,,503,Spearman,-0.04,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5322,5494,5483,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"11cis-Rumenic acid (9cis,11cis-18:2n-7)","",0.67,,,percentRoot,,503,Spearman,0.05,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5323,5494,5484,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),3.12,,,percentRoot,,503,Spearman,-0.18,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5324,5494,5485,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,trans-9-Tetradecenoic acid (trans-14:1n-5),"",0.02,,,percentRoot,,503,Spearman,0.04,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5325,5494,5486,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitelaidic acid (trans-16:1n-7),"",0.08,,,percentRoot,,503,Spearman,0.05,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5326,5494,5487,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Petroselaidic acid (trans-18:1n-12),"",0.54,,,percentRoot,,503,Spearman,-0.11,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5327,5494,5488,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Elaidic acid (trans-18:1n-9),"",0.63,,,percentRoot,,503,Spearman,-0.1,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5328,5494,5489,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Vaccenic acid (trans-18:1n-7),"",0.54,,,percentRoot,,503,Spearman,0.0,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5329,5494,5490,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecenoic acids (trans-18:1),Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9),2.24,,,percentRoot,,503,Spearman,-0.13,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5330,5494,5491,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoelaidic acid (trans-18:2n-6),"",0.34,,,percentRoot,,503,Spearman,-0.25,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5331,5494,5492,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,cis-9-Linoelaidic acid (9cis-18:2n-6),"",0.61,,,percentRoot,,503,Spearman,-0.3,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5332,5494,5493,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),,36.43,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,cis-12-Linoelaidic acid (12cis-18:2n-6),"",0.36,,,percentRoot,,503,Spearman,-0.31,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5177,5495,5454,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Lauric acid (12:0),"",,0.66,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Lauric acid (12:0),"",0.02,,,percentRoot,,496,Spearman,0.03,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5178,5496,5455,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Myristic acid (14:0),"",,3.12,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Myristic acid (14:0),"",1.02,,,percentRoot,,503,Spearman,0.15,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5179,5497,5456,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Pentadecylic acid (15:0),"",,0.02,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.19,,,percentRoot,,503,Spearman,0.04,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5180,5498,5457,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,27.01,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitic acid (16:0),"",21.6,,,percentRoot,,503,Spearman,0.13,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5181,5499,5458,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Margaric acid (17:0),"",,0.04,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.21,,,percentRoot,,503,Spearman,-0.02,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5182,5500,5459,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Stearic acid (18:0),"",,5.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Stearic acid (18:0),"",2.98,,,percentRoot,,503,Spearman,0.17,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5183,5501,5460,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Arachidic acid (20:0),"",,0.01,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Arachidic acid (20:0),"",0.19,,,percentRoot,,406,Spearman,-0.12,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5184,5502,5461,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Behenic acid (22:0),"",,0.03,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Behenic acid (22:0),"",0.03,,,percentRoot,,340,Spearman,-0.12,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5185,5503,5462,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Lignoceric acid (24:0),"",,0.02,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Lignoceric acid (24:0),"",0.01,,,percentRoot,,502,Spearman,0.01,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5333,5504,5453,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),26.21,,,percentRoot,,503,Spearman,-0.01,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5334,5504,5454,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Lauric acid (12:0),"",0.02,,,percentRoot,,496,Spearman,0.04,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5335,5504,5455,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Myristic acid (14:0),"",1.02,,,percentRoot,,503,Spearman,0.01,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5336,5504,5456,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.19,,,percentRoot,,503,Spearman,0.07,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5337,5504,5457,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitic acid (16:0),"",21.6,,,percentRoot,,503,Spearman,-0.06,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5338,5504,5458,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.21,,,percentRoot,,503,Spearman,0.16,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5339,5504,5459,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Stearic acid (18:0),"",2.98,,,percentRoot,,503,Spearman,0.15,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5340,5504,5460,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Arachidic acid (20:0),"",0.19,,,percentRoot,,406,Spearman,0.07,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5341,5504,5461,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Behenic acid (22:0),"",0.03,,,percentRoot,,340,Spearman,-0.01,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5342,5504,5462,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Lignoceric acid (24:0),"",0.01,,,percentRoot,,502,Spearman,-0.01,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5343,5504,5463,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + 8-Eicosenoic acid (cis-20:1n-12) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + 11-Eicosenoic acid (cis-20:1n-9),54.08,,,percentRoot,,503,Spearman,-0.08,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5344,5504,5464,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Myristoleic acid (cis-14:1n-5),"",0.14,,,percentRoot,,503,Spearman,-0.05,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5345,5504,5465,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitoleic acid (cis-16:1n-7),"",6.22,,,percentRoot,,503,Spearman,-0.19,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5346,5504,5466,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Oleic acid (cis-18:1n-9),"",44.3,,,percentRoot,,503,Spearman,0.05,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5347,5504,5467,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Asclepic acid (cis-18:1n-7),"",2.45,,,percentRoot,,503,Spearman,-0.17,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5348,5504,5468,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,8-Eicosenoic acid (cis-20:1n-12),"",0.11,,,percentRoot,,503,Spearman,0.07,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5349,5504,5469,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,11-Eicosenoic acid (cis-20:1n-9),"",0.52,,,percentRoot,,503,Spearman,0.04,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5350,5504,5470,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),15.29,,,percentRoot,,503,Spearman,0.08,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5351,5504,5471,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",13.37,,,percentRoot,,503,Spearman,0.08,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5352,5504,5472,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",0.14,,,percentRoot,,405,Spearman,-0.05,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5353,5504,5473,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Eicosadienoic acid (cis-20:2n-6),"",0.22,,,percentRoot,,503,Spearman,0.04,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5354,5504,5474,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",0.29,,,percentRoot,,473,Spearman,-0.03,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5355,5504,5475,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",0.44,,,percentRoot,,503,Spearman,-0.03,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5356,5504,5476,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.22,,,percentRoot,,503,Spearman,-0.03,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5357,5504,5477,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3),0.99,,,percentRoot,,503,Spearman,0.07,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5358,5504,5478,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.55,,,percentRoot,,503,Spearman,0.08,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5359,5504,5479,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Eicosatrienoic acid (ETE; cis-20:3n-3),"",0.02,,,percentRoot,,503,Spearman,0.03,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5360,5504,5480,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",0.04,,,percentRoot,,503,Spearman,-0.04,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5361,5504,5481,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DPA (cis-22:5n-3),"",0.21,,,percentRoot,,503,Spearman,0.0,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5362,5504,5482,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DHA (cis-22:6n-3),"",0.17,,,percentRoot,,503,Spearman,-0.03,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5363,5504,5483,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"11cis-Rumenic acid (9cis,11cis-18:2n-7)","",0.67,,,percentRoot,,503,Spearman,0.06,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5364,5504,5484,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),3.12,,,percentRoot,,503,Spearman,0.06,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5365,5504,5485,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,trans-9-Tetradecenoic acid (trans-14:1n-5),"",0.02,,,percentRoot,,503,Spearman,0.07,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5366,5504,5486,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitelaidic acid (trans-16:1n-7),"",0.08,,,percentRoot,,503,Spearman,0.13,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5367,5504,5487,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Petroselaidic acid (trans-18:1n-12),"",0.54,,,percentRoot,,503,Spearman,0.07,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5368,5504,5488,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Elaidic acid (trans-18:1n-9),"",0.63,,,percentRoot,,503,Spearman,0.08,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5369,5504,5489,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Vaccenic acid (trans-18:1n-7),"",0.54,,,percentRoot,,503,Spearman,0.14,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5370,5504,5490,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecenoic acids (trans-18:1),Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9),2.24,,,percentRoot,,503,Spearman,0.08,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5371,5504,5491,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoelaidic acid (trans-18:2n-6),"",0.34,,,percentRoot,,503,Spearman,0.01,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5372,5504,5492,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,cis-9-Linoelaidic acid (9cis-18:2n-6),"",0.61,,,percentRoot,,503,Spearman,-0.04,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5373,5504,5493,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + cis-Eicosenoic acids (cis-20:1),,42.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,cis-12-Linoelaidic acid (12cis-18:2n-6),"",0.36,,,percentRoot,,503,Spearman,-0.08,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5186,5505,5464,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Myristoleic acid (cis-14:1n-5),"",,0.01,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Myristoleic acid (cis-14:1n-5),"",0.14,,,percentRoot,,503,Spearman,0.04,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5187,5506,5465,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Palmitoleic acid (cis-16:1n-7),"",,1.83,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitoleic acid (cis-16:1n-7),"",6.22,,,percentRoot,,503,Spearman,-0.06,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5188,5507,5466,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,39.61,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Oleic acid (cis-18:1n-9),"",44.3,,,percentRoot,,503,Spearman,0.05,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5189,5508,5467,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Asclepic acid (cis-18:1n-7),"",,0.51,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Asclepic acid (cis-18:1n-7),"",2.45,,,percentRoot,,503,Spearman,-0.02,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5190,5509,5468,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),cis-Eicosenoic acids (cis-20:1),"",,0.24,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,8-Eicosenoic acid (cis-20:1n-12),"",0.11,,,percentRoot,,503,Spearman,0.05,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5191,5509,5469,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),cis-Eicosenoic acids (cis-20:1),"",,0.24,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,11-Eicosenoic acid (cis-20:1n-9),"",0.52,,,percentRoot,,503,Spearman,0.04,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5374,5511,5453,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),26.21,,,percentRoot,,503,Spearman,-0.17,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5375,5511,5454,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Lauric acid (12:0),"",0.02,,,percentRoot,,496,Spearman,0.04,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5376,5511,5455,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Myristic acid (14:0),"",1.02,,,percentRoot,,503,Spearman,0.0,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5377,5511,5456,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.19,,,percentRoot,,503,Spearman,0.03,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5378,5511,5457,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitic acid (16:0),"",21.6,,,percentRoot,,503,Spearman,-0.26,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5379,5511,5458,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.21,,,percentRoot,,503,Spearman,0.15,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5380,5511,5459,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Stearic acid (18:0),"",2.98,,,percentRoot,,503,Spearman,0.13,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5381,5511,5460,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Arachidic acid (20:0),"",0.19,,,percentRoot,,406,Spearman,0.27,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5382,5511,5461,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Behenic acid (22:0),"",0.03,,,percentRoot,,340,Spearman,-0.1,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5383,5511,5462,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Lignoceric acid (24:0),"",0.01,,,percentRoot,,502,Spearman,0.08,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5384,5511,5463,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + 8-Eicosenoic acid (cis-20:1n-12) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + 11-Eicosenoic acid (cis-20:1n-9),54.08,,,percentRoot,,503,Spearman,-0.44,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5385,5511,5464,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Myristoleic acid (cis-14:1n-5),"",0.14,,,percentRoot,,503,Spearman,-0.1,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5386,5511,5465,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitoleic acid (cis-16:1n-7),"",6.22,,,percentRoot,,503,Spearman,-0.33,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5387,5511,5466,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Oleic acid (cis-18:1n-9),"",44.3,,,percentRoot,,503,Spearman,-0.39,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5388,5511,5467,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Asclepic acid (cis-18:1n-7),"",2.45,,,percentRoot,,503,Spearman,-0.22,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5389,5511,5468,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,8-Eicosenoic acid (cis-20:1n-12),"",0.11,,,percentRoot,,503,Spearman,0.08,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5390,5511,5469,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,11-Eicosenoic acid (cis-20:1n-9),"",0.52,,,percentRoot,,503,Spearman,-0.17,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5391,5511,5470,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),15.29,,,percentRoot,,503,Spearman,0.58,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5392,5511,5471,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",13.37,,,percentRoot,,503,Spearman,0.58,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5393,5511,5472,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",0.14,,,percentRoot,,405,Spearman,0.13,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5394,5511,5473,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Eicosadienoic acid (cis-20:2n-6),"",0.22,,,percentRoot,,503,Spearman,0.33,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5395,5511,5474,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",0.29,,,percentRoot,,473,Spearman,0.19,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5396,5511,5475,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",0.44,,,percentRoot,,503,Spearman,0.05,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5397,5511,5476,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.22,,,percentRoot,,503,Spearman,0.03,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5398,5511,5477,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3),0.99,,,percentRoot,,503,Spearman,0.38,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5399,5511,5478,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.55,,,percentRoot,,503,Spearman,0.44,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5400,5511,5479,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Eicosatrienoic acid (ETE; cis-20:3n-3),"",0.02,,,percentRoot,,503,Spearman,0.13,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5401,5511,5480,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",0.04,,,percentRoot,,503,Spearman,0.02,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5402,5511,5481,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DPA (cis-22:5n-3),"",0.21,,,percentRoot,,503,Spearman,0.02,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5403,5511,5482,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DHA (cis-22:6n-3),"",0.17,,,percentRoot,,503,Spearman,0.02,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5404,5511,5483,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"11cis-Rumenic acid (9cis,11cis-18:2n-7)","",0.67,,,percentRoot,,503,Spearman,0.13,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5405,5511,5484,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),3.12,,,percentRoot,,503,Spearman,0.42,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5406,5511,5485,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,trans-9-Tetradecenoic acid (trans-14:1n-5),"",0.02,,,percentRoot,,503,Spearman,0.13,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5407,5511,5486,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitelaidic acid (trans-16:1n-7),"",0.08,,,percentRoot,,503,Spearman,0.24,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5408,5511,5487,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Petroselaidic acid (trans-18:1n-12),"",0.54,,,percentRoot,,503,Spearman,0.27,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5409,5511,5488,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Elaidic acid (trans-18:1n-9),"",0.63,,,percentRoot,,503,Spearman,0.31,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5410,5511,5489,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Vaccenic acid (trans-18:1n-7),"",0.54,,,percentRoot,,503,Spearman,0.35,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5411,5511,5490,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecenoic acids (trans-18:1),Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9),2.24,,,percentRoot,,503,Spearman,0.37,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5412,5511,5491,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoelaidic acid (trans-18:2n-6),"",0.34,,,percentRoot,,503,Spearman,0.38,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5413,5511,5492,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,cis-9-Linoelaidic acid (9cis-18:2n-6),"",0.61,,,percentRoot,,503,Spearman,0.42,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5414,5511,5493,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,17.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,cis-12-Linoelaidic acid (12cis-18:2n-6),"",0.36,,,percentRoot,,503,Spearman,0.37,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5192,5512,5471,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,17.06,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",13.37,,,percentRoot,,503,Spearman,0.58,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5193,5513,5472,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),gamma-Linolenic acid (GLA; cis-18:3n-6),"",,0.19,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",0.14,,,percentRoot,,405,Spearman,0.24,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5194,5515,5474,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",,0.02,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",0.29,,,percentRoot,,473,Spearman,-0.16,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5195,5516,5475,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,0.19,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",0.44,,,percentRoot,,503,Spearman,0.04,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5415,5518,5453,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),26.21,,,percentRoot,,503,Spearman,-0.05,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5416,5518,5454,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Lauric acid (12:0),"",0.02,,,percentRoot,,496,Spearman,0.08,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5417,5518,5455,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Myristic acid (14:0),"",1.02,,,percentRoot,,503,Spearman,0.05,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5418,5518,5456,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.19,,,percentRoot,,503,Spearman,0.05,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5419,5518,5457,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitic acid (16:0),"",21.6,,,percentRoot,,503,Spearman,-0.13,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5420,5518,5458,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.21,,,percentRoot,,503,Spearman,0.15,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5421,5518,5459,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Stearic acid (18:0),"",2.98,,,percentRoot,,503,Spearman,0.16,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5422,5518,5460,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Arachidic acid (20:0),"",0.19,,,percentRoot,,406,Spearman,0.26,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5423,5518,5461,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Behenic acid (22:0),"",0.03,,,percentRoot,,340,Spearman,-0.09,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5424,5518,5462,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Lignoceric acid (24:0),"",0.01,,,percentRoot,,502,Spearman,0.09,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5425,5518,5463,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + 8-Eicosenoic acid (cis-20:1n-12) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + 11-Eicosenoic acid (cis-20:1n-9),54.08,,,percentRoot,,503,Spearman,-0.31,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5426,5518,5464,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Myristoleic acid (cis-14:1n-5),"",0.14,,,percentRoot,,503,Spearman,-0.04,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5427,5518,5465,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitoleic acid (cis-16:1n-7),"",6.22,,,percentRoot,,503,Spearman,-0.23,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5428,5518,5466,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Oleic acid (cis-18:1n-9),"",44.3,,,percentRoot,,503,Spearman,-0.27,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5429,5518,5467,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Asclepic acid (cis-18:1n-7),"",2.45,,,percentRoot,,503,Spearman,-0.17,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5430,5518,5468,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,8-Eicosenoic acid (cis-20:1n-12),"",0.11,,,percentRoot,,503,Spearman,0.07,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5431,5518,5469,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,11-Eicosenoic acid (cis-20:1n-9),"",0.52,,,percentRoot,,503,Spearman,-0.1,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5432,5518,5470,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),15.29,,,percentRoot,,503,Spearman,0.36,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5433,5518,5471,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",13.37,,,percentRoot,,503,Spearman,0.36,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5434,5518,5472,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",0.14,,,percentRoot,,405,Spearman,0.13,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5435,5518,5473,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Eicosadienoic acid (cis-20:2n-6),"",0.22,,,percentRoot,,503,Spearman,0.2,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5436,5518,5474,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",0.29,,,percentRoot,,473,Spearman,0.07,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5437,5518,5475,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",0.44,,,percentRoot,,503,Spearman,-0.04,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5438,5518,5476,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.22,,,percentRoot,,503,Spearman,-0.07,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5439,5518,5477,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3),0.99,,,percentRoot,,503,Spearman,0.31,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5440,5518,5478,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.55,,,percentRoot,,503,Spearman,0.34,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5441,5518,5479,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Eicosatrienoic acid (ETE; cis-20:3n-3),"",0.02,,,percentRoot,,503,Spearman,0.15,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5442,5518,5480,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",0.04,,,percentRoot,,503,Spearman,0.13,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5443,5518,5481,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DPA (cis-22:5n-3),"",0.21,,,percentRoot,,503,Spearman,0.02,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5444,5518,5482,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DHA (cis-22:6n-3),"",0.17,,,percentRoot,,503,Spearman,0.05,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5445,5518,5483,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"11cis-Rumenic acid (9cis,11cis-18:2n-7)","",0.67,,,percentRoot,,503,Spearman,0.12,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5446,5518,5484,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),3.12,,,percentRoot,,503,Spearman,0.34,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5447,5518,5485,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,trans-9-Tetradecenoic acid (trans-14:1n-5),"",0.02,,,percentRoot,,503,Spearman,0.11,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5448,5518,5486,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitelaidic acid (trans-16:1n-7),"",0.08,,,percentRoot,,503,Spearman,0.23,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5449,5518,5487,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Petroselaidic acid (trans-18:1n-12),"",0.54,,,percentRoot,,503,Spearman,0.17,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5450,5518,5488,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Elaidic acid (trans-18:1n-9),"",0.63,,,percentRoot,,503,Spearman,0.26,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5451,5518,5489,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Vaccenic acid (trans-18:1n-7),"",0.54,,,percentRoot,,503,Spearman,0.27,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5452,5518,5490,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecenoic acids (trans-18:1),Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9),2.24,,,percentRoot,,503,Spearman,0.28,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5453,5518,5491,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoelaidic acid (trans-18:2n-6),"",0.34,,,percentRoot,,503,Spearman,0.31,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5454,5518,5492,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,cis-9-Linoelaidic acid (9cis-18:2n-6),"",0.61,,,percentRoot,,503,Spearman,0.36,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5455,5518,5493,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,1.53,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,cis-12-Linoelaidic acid (12cis-18:2n-6),"",0.36,,,percentRoot,,503,Spearman,0.34,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5196,5519,5478,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,1.3,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.55,,,percentRoot,,503,Spearman,0.34,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5197,5521,5480,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,0.06,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",0.04,,,percentRoot,,503,Spearman,0.15,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5198,5522,5481,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),DPA (cis-22:5n-3),"",,0.02,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DPA (cis-22:5n-3),"",0.21,,,percentRoot,,503,Spearman,0.03,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5199,5523,5482,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,0.18,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DHA (cis-22:6n-3),"",0.17,,,percentRoot,,503,Spearman,0.18,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5200,5524,5483,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"11cis-Rumenic acid (9cis,11cis-18:2n-7)","",,0.03,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"11cis-Rumenic acid (9cis,11cis-18:2n-7)","",0.67,,,percentRoot,,503,Spearman,0.1,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5456,5525,5453,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),26.21,,,percentRoot,,503,Spearman,-0.12,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5457,5525,5454,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Lauric acid (12:0),"",0.02,,,percentRoot,,496,Spearman,0.05,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5458,5525,5455,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Myristic acid (14:0),"",1.02,,,percentRoot,,503,Spearman,-0.08,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5459,5525,5456,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.19,,,percentRoot,,503,Spearman,-0.09,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5460,5525,5457,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitic acid (16:0),"",21.6,,,percentRoot,,503,Spearman,-0.18,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5461,5525,5458,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.21,,,percentRoot,,503,Spearman,0.06,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5462,5525,5459,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Stearic acid (18:0),"",2.98,,,percentRoot,,503,Spearman,0.09,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5463,5525,5460,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Arachidic acid (20:0),"",0.19,,,percentRoot,,406,Spearman,0.26,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5464,5525,5461,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Behenic acid (22:0),"",0.03,,,percentRoot,,340,Spearman,-0.11,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5465,5525,5462,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Lignoceric acid (24:0),"",0.01,,,percentRoot,,502,Spearman,0.06,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5466,5525,5463,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + 8-Eicosenoic acid (cis-20:1n-12) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + 11-Eicosenoic acid (cis-20:1n-9),54.08,,,percentRoot,,503,Spearman,-0.32,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5467,5525,5464,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Myristoleic acid (cis-14:1n-5),"",0.14,,,percentRoot,,503,Spearman,-0.1,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5468,5525,5465,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitoleic acid (cis-16:1n-7),"",6.22,,,percentRoot,,503,Spearman,-0.22,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5469,5525,5466,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Oleic acid (cis-18:1n-9),"",44.3,,,percentRoot,,503,Spearman,-0.28,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5470,5525,5467,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Asclepic acid (cis-18:1n-7),"",2.45,,,percentRoot,,503,Spearman,-0.09,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5471,5525,5468,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,8-Eicosenoic acid (cis-20:1n-12),"",0.11,,,percentRoot,,503,Spearman,0.04,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5472,5525,5469,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,11-Eicosenoic acid (cis-20:1n-9),"",0.52,,,percentRoot,,503,Spearman,-0.08,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5473,5525,5470,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),15.29,,,percentRoot,,503,Spearman,0.35,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5474,5525,5471,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",13.37,,,percentRoot,,503,Spearman,0.34,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5475,5525,5472,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",0.14,,,percentRoot,,405,Spearman,0.26,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5476,5525,5473,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Eicosadienoic acid (cis-20:2n-6),"",0.22,,,percentRoot,,503,Spearman,0.21,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5477,5525,5474,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",0.29,,,percentRoot,,473,Spearman,0.1,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5478,5525,5475,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",0.44,,,percentRoot,,503,Spearman,0.0,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5479,5525,5476,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.22,,,percentRoot,,503,Spearman,0.05,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5480,5525,5477,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3),0.99,,,percentRoot,,503,Spearman,0.22,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5481,5525,5478,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.55,,,percentRoot,,503,Spearman,0.28,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5482,5525,5479,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Eicosatrienoic acid (ETE; cis-20:3n-3),"",0.02,,,percentRoot,,503,Spearman,0.05,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5483,5525,5480,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",0.04,,,percentRoot,,503,Spearman,-0.02,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5484,5525,5481,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DPA (cis-22:5n-3),"",0.21,,,percentRoot,,503,Spearman,0.0,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5485,5525,5482,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DHA (cis-22:6n-3),"",0.17,,,percentRoot,,503,Spearman,0.01,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5486,5525,5483,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"11cis-Rumenic acid (9cis,11cis-18:2n-7)","",0.67,,,percentRoot,,503,Spearman,0.13,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5487,5525,5484,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),3.12,,,percentRoot,,503,Spearman,0.54,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5488,5525,5485,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,trans-9-Tetradecenoic acid (trans-14:1n-5),"",0.02,,,percentRoot,,503,Spearman,0.09,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5489,5525,5486,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitelaidic acid (trans-16:1n-7),"",0.08,,,percentRoot,,503,Spearman,0.16,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5490,5525,5487,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Petroselaidic acid (trans-18:1n-12),"",0.54,,,percentRoot,,503,Spearman,0.32,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5491,5525,5488,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Elaidic acid (trans-18:1n-9),"",0.63,,,percentRoot,,503,Spearman,0.4,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5492,5525,5489,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Vaccenic acid (trans-18:1n-7),"",0.54,,,percentRoot,,503,Spearman,0.36,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5493,5525,5490,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecenoic acids (trans-18:1),Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9),2.24,,,percentRoot,,503,Spearman,0.45,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5494,5525,5491,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoelaidic acid (trans-18:2n-6),"",0.34,,,percentRoot,,503,Spearman,0.52,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5495,5525,5492,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,cis-9-Linoelaidic acid (9cis-18:2n-6),"",0.61,,,percentRoot,,503,Spearman,0.58,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5496,5525,5493,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),,4.76,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,cis-12-Linoelaidic acid (12cis-18:2n-6),"",0.36,,,percentRoot,,503,Spearman,0.58,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5201,5526,5485,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),trans-9-Tetradecenoic acid (trans-14:1n-5),"",,0.01,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,trans-9-Tetradecenoic acid (trans-14:1n-5),"",0.02,,,percentRoot,,503,Spearman,0.09,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5202,5527,5486,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Palmitelaidic acid (trans-16:1n-7),"",,0.16,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitelaidic acid (trans-16:1n-7),"",0.08,,,percentRoot,,503,Spearman,0.12,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5203,5528,5487,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Petroselaidic acid (trans-18:1n-12),"",,0.5,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Petroselaidic acid (trans-18:1n-12),"",0.54,,,percentRoot,,503,Spearman,0.3,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5204,5529,5488,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Elaidic acid (trans-18:1n-9),"",,0.57,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Elaidic acid (trans-18:1n-9),"",0.63,,,percentRoot,,503,Spearman,0.43,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5205,5530,5489,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Vaccenic acid (trans-18:1n-7),"",,0.35,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Vaccenic acid (trans-18:1n-7),"",0.54,,,percentRoot,,503,Spearman,0.36,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5206,5531,5490,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),trans-Octadecenoic acids (trans-18:1),Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9),,2.94,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecenoic acids (trans-18:1),Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9),2.24,,,percentRoot,,503,Spearman,0.43,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5207,5532,5491,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Linoelaidic acid (trans-18:2n-6),"",,0.32,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoelaidic acid (trans-18:2n-6),"",0.34,,,percentRoot,,503,Spearman,0.53,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5208,5533,5492,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),cis-9-Linoelaidic acid (9cis-18:2n-6),"",,0.71,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,cis-9-Linoelaidic acid (9cis-18:2n-6),"",0.61,,,percentRoot,,503,Spearman,0.58,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5209,5534,5493,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),cis-12-Linoelaidic acid (12cis-18:2n-6),"",,0.66,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,cis-12-Linoelaidic acid (12cis-18:2n-6),"",0.36,,,percentRoot,,503,Spearman,0.61,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5210,5572,5453,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),26.21,,,percentRoot,,496,Spearman,0.18,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5211,5572,5454,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Lauric acid (12:0),"",0.02,,,percentRoot,,496,Spearman,0.02,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5212,5572,5455,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Myristic acid (14:0),"",1.02,,,percentRoot,,496,Spearman,0.07,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5213,5572,5456,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.19,,,percentRoot,,496,Spearman,0.11,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5214,5572,5457,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Palmitic acid (16:0),"",21.6,,,percentRoot,,496,Spearman,0.15,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5215,5572,5458,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.21,,,percentRoot,,496,Spearman,0.17,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5216,5572,5459,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Stearic acid (18:0),"",2.98,,,percentRoot,,496,Spearman,0.15,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5217,5572,5460,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Arachidic acid (20:0),"",0.19,,,percentRoot,,406,Spearman,-0.02,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5218,5572,5461,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Behenic acid (22:0),"",0.03,,,percentRoot,,340,Spearman,-0.04,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5219,5572,5462,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Lignoceric acid (24:0),"",0.01,,,percentRoot,,496,Spearman,0.02,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5220,5572,5463,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + 8-Eicosenoic acid (cis-20:1n-12) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + 11-Eicosenoic acid (cis-20:1n-9),54.08,,,percentRoot,,496,Spearman,0.11,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5221,5572,5464,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Myristoleic acid (cis-14:1n-5),"",0.14,,,percentRoot,,496,Spearman,0.0,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5222,5572,5465,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Palmitoleic acid (cis-16:1n-7),"",6.22,,,percentRoot,,496,Spearman,-0.03,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5223,5572,5466,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Oleic acid (cis-18:1n-9),"",44.3,,,percentRoot,,496,Spearman,0.2,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5224,5572,5467,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Asclepic acid (cis-18:1n-7),"",2.45,,,percentRoot,,496,Spearman,-0.05,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5225,5572,5468,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,8-Eicosenoic acid (cis-20:1n-12),"",0.11,,,percentRoot,,496,Spearman,0.1,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5226,5572,5469,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,11-Eicosenoic acid (cis-20:1n-9),"",0.52,,,percentRoot,,496,Spearman,0.15,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5227,5572,5470,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),15.29,,,percentRoot,,496,Spearman,-0.24,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5228,5572,5471,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",13.37,,,percentRoot,,496,Spearman,-0.24,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5229,5572,5472,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",0.14,,,percentRoot,,405,Spearman,-0.09,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5230,5572,5473,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Eicosadienoic acid (cis-20:2n-6),"",0.22,,,percentRoot,,496,Spearman,-0.11,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5231,5572,5474,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",0.29,,,percentRoot,,473,Spearman,-0.07,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5232,5572,5475,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",0.44,,,percentRoot,,496,Spearman,-0.03,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5233,5572,5476,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.22,,,percentRoot,,496,Spearman,-0.02,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5234,5572,5477,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3),0.99,,,percentRoot,,496,Spearman,-0.13,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5235,5572,5478,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.55,,,percentRoot,,496,Spearman,-0.19,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5236,5572,5479,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Eicosatrienoic acid (ETE; cis-20:3n-3),"",0.02,,,percentRoot,,496,Spearman,-0.01,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5237,5572,5480,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",0.04,,,percentRoot,,496,Spearman,0.03,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5238,5572,5481,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,DPA (cis-22:5n-3),"",0.21,,,percentRoot,,496,Spearman,-0.01,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5239,5572,5482,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,DHA (cis-22:6n-3),"",0.17,,,percentRoot,,496,Spearman,0.0,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5240,5572,5483,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,"11cis-Rumenic acid (9cis,11cis-18:2n-7)","",0.67,,,percentRoot,,496,Spearman,-0.02,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5241,5572,5484,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),3.12,,,percentRoot,,496,Spearman,-0.17,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5242,5572,5485,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,trans-9-Tetradecenoic acid (trans-14:1n-5),"",0.02,,,percentRoot,,496,Spearman,0.07,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5243,5572,5486,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Palmitelaidic acid (trans-16:1n-7),"",0.08,,,percentRoot,,496,Spearman,0.04,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5244,5572,5487,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Petroselaidic acid (trans-18:1n-12),"",0.54,,,percentRoot,,496,Spearman,-0.14,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5245,5572,5488,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Elaidic acid (trans-18:1n-9),"",0.63,,,percentRoot,,496,Spearman,-0.11,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5246,5572,5489,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Vaccenic acid (trans-18:1n-7),"",0.54,,,percentRoot,,496,Spearman,-0.04,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5247,5572,5490,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecenoic acids (trans-18:1),Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9),2.24,,,percentRoot,,496,Spearman,-0.15,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5248,5572,5491,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Linoelaidic acid (trans-18:2n-6),"",0.34,,,percentRoot,,496,Spearman,-0.23,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5249,5572,5492,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,cis-9-Linoelaidic acid (9cis-18:2n-6),"",0.61,,,percentRoot,,496,Spearman,-0.24,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5250,5572,5493,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Animal,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,cis-12-Linoelaidic acid (12cis-18:2n-6),"",0.36,,,percentRoot,,496,Spearman,-0.22,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5251,5573,5453,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),26.21,,,percentRoot,,503,Spearman,-0.13,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5252,5573,5454,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Lauric acid (12:0),"",0.02,,,percentRoot,,496,Spearman,0.05,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5253,5573,5455,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Myristic acid (14:0),"",1.02,,,percentRoot,,503,Spearman,-0.03,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5254,5573,5456,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.19,,,percentRoot,,503,Spearman,0.01,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5255,5573,5457,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Palmitic acid (16:0),"",21.6,,,percentRoot,,503,Spearman,-0.19,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5256,5573,5458,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.21,,,percentRoot,,503,Spearman,0.08,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5257,5573,5459,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Stearic acid (18:0),"",2.98,,,percentRoot,,503,Spearman,0.07,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5258,5573,5460,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Arachidic acid (20:0),"",0.19,,,percentRoot,,406,Spearman,0.17,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5259,5573,5461,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Behenic acid (22:0),"",0.03,,,percentRoot,,340,Spearman,0.0,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5260,5573,5462,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Lignoceric acid (24:0),"",0.01,,,percentRoot,,502,Spearman,0.05,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5261,5573,5463,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + 8-Eicosenoic acid (cis-20:1n-12) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Myristoleic acid (cis-14:1n-5) + 11-Eicosenoic acid (cis-20:1n-9),54.08,,,percentRoot,,503,Spearman,-0.29,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5262,5573,5464,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Myristoleic acid (cis-14:1n-5),"",0.14,,,percentRoot,,503,Spearman,-0.09,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5263,5573,5465,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Palmitoleic acid (cis-16:1n-7),"",6.22,,,percentRoot,,503,Spearman,-0.24,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5264,5573,5466,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Oleic acid (cis-18:1n-9),"",44.3,,,percentRoot,,503,Spearman,-0.22,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5265,5573,5467,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Asclepic acid (cis-18:1n-7),"",2.45,,,percentRoot,,503,Spearman,-0.19,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5266,5573,5468,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,8-Eicosenoic acid (cis-20:1n-12),"",0.11,,,percentRoot,,503,Spearman,0.03,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5267,5573,5469,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,11-Eicosenoic acid (cis-20:1n-9),"",0.52,,,percentRoot,,503,Spearman,-0.15,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5268,5573,5470,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),15.29,,,percentRoot,,503,Spearman,0.36,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5269,5573,5471,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",13.37,,,percentRoot,,503,Spearman,0.36,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5270,5573,5472,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",0.14,,,percentRoot,,405,Spearman,0.05,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5271,5573,5473,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Eicosadienoic acid (cis-20:2n-6),"",0.22,,,percentRoot,,503,Spearman,0.16,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5272,5573,5474,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",0.29,,,percentRoot,,473,Spearman,0.06,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5273,5573,5475,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",0.44,,,percentRoot,,503,Spearman,-0.01,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5274,5573,5476,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.22,,,percentRoot,,503,Spearman,-0.01,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5275,5573,5477,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3),0.99,,,percentRoot,,503,Spearman,0.24,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5276,5573,5478,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.55,,,percentRoot,,503,Spearman,0.3,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5277,5573,5479,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Eicosatrienoic acid (ETE; cis-20:3n-3),"",0.02,,,percentRoot,,503,Spearman,0.04,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5278,5573,5480,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",0.04,,,percentRoot,,503,Spearman,-0.06,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5279,5573,5481,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,DPA (cis-22:5n-3),"",0.21,,,percentRoot,,503,Spearman,-0.01,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5280,5573,5482,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,DHA (cis-22:6n-3),"",0.17,,,percentRoot,,503,Spearman,-0.02,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5281,5573,5483,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,"11cis-Rumenic acid (9cis,11cis-18:2n-7)","",0.67,,,percentRoot,,503,Spearman,0.1,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5282,5573,5484,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9) + trans-9-Tetradecenoic acid (trans-14:1n-5) + cis-12-Linoelaidic acid (12cis-18:2n-6),3.12,,,percentRoot,,503,Spearman,0.34,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5283,5573,5485,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,trans-9-Tetradecenoic acid (trans-14:1n-5),"",0.02,,,percentRoot,,503,Spearman,0.07,,,>= 0.001,No,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5284,5573,5486,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Palmitelaidic acid (trans-16:1n-7),"",0.08,,,percentRoot,,503,Spearman,0.17,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5285,5573,5487,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Petroselaidic acid (trans-18:1n-12),"",0.54,,,percentRoot,,503,Spearman,0.28,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5286,5573,5488,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Elaidic acid (trans-18:1n-9),"",0.63,,,percentRoot,,503,Spearman,0.28,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5287,5573,5489,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Vaccenic acid (trans-18:1n-7),"",0.54,,,percentRoot,,503,Spearman,0.3,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5288,5573,5490,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecenoic acids (trans-18:1),Vaccenic acid (trans-18:1n-7) + Petroselaidic acid (trans-18:1n-12) + Elaidic acid (trans-18:1n-9),2.24,,,percentRoot,,503,Spearman,0.33,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5289,5573,5491,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Linoelaidic acid (trans-18:2n-6),"",0.34,,,percentRoot,,503,Spearman,0.31,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5290,5573,5492,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,cis-9-Linoelaidic acid (9cis-18:2n-6),"",0.61,,,percentRoot,,503,Spearman,0.28,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5291,5573,5493,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Fats from Vegetable,"",,,,,g/day,,,"Adipose tissue, buttocks",GC-FID,cis-12-Linoelaidic acid (12cis-18:2n-6),"",0.36,,,percentRoot,,503,Spearman,0.21,,,< 0.001,Yes,,,"Age, Sex, BMI, Smoking status",Baylin 2002
5497,5580,5577,Males,Elderly subjects,United Kingdom,NDNS (National Diet and Nutrition Survey),,Weighed Dietary record (4-day),Phylloquinone,"",,,,,missing unit,,,"Plasma, fasting",HPLC,Phylloquinone,"",0.5,0.34,,nmol/L,,385,Pearson,0.18,,,< 0.001,Yes,,,,Thane 2002
5498,5581,5579,Females,Elderly subjects,United Kingdom,NDNS (National Diet and Nutrition Survey),,Weighed Dietary record (4-day),Phylloquinone,"",,,,,missing unit,,,"Plasma, fasting",HPLC,Phylloquinone,"",0.56,0.37,,nmol/L,,493,Pearson,0.3,,,< 0.001,Yes,,,,Thane 2002
5501,5606,5605,All [by gender],Finnish men and women,Finland,,,24-h Dietary recall (1-day),Cereals,"",,,,,g/day,,,"Serum, unspecified",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,,,nmol/L,,1784,Spearman,0.1,,, ,Unspecified,,,,Kilkkinen 2003
5503,5607,5605,All [by gender],Finnish men and women,Finland,,,24-h Dietary recall (1-day),Fruits,"",,,,,g/day,,,"Serum, unspecified",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,,,nmol/L,,1784,Spearman,0.13,,, ,Unspecified,,,,Kilkkinen 2003
5502,5608,5605,All [by gender],Finnish men and women,Finland,,,24-h Dietary recall (1-day),Vegetables,"",,,,,g/day,,,"Serum, unspecified",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,,,nmol/L,,1784,Spearman,0.06,,, ,Unspecified,,,,Kilkkinen 2003
5499,5590,5603,Males,Finnish men and women,Finland,,,24-h Dietary recall (1-day),Lignans,Secoisolariciresinol + Matairesinol,,173.0,,,ug/day,,,"Serum, unspecified",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",17.8,,,nmol/L,,926,Spearman,0.19,,, ,Unspecified,,,,Kilkkinen 2003
5500,5593,5604,Females,Finnish men and women,Finland,,,24-h Dietary recall (1-day),Lignans,Secoisolariciresinol + Matairesinol,,151.0,,,ug/day,,,"Serum, unspecified",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",20.7,,,nmol/L,,858,Spearman,0.16,,, ,Unspecified,,,,Kilkkinen 2003
5504,5629,5647,All,Pregnant women participant in a study on PUFAs and foetal neurodevelopment,Mexico,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,1.518,,,mg/day,,,"Red blood cell membrane, unspecified",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",1.851,,,percentRoot,,35,Pearson,0.32,,,< 0.05,Yes,,,,Parra 2002
5505,5631,5648,All,Pregnant women participant in a study on PUFAs and foetal neurodevelopment,Mexico,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,0.052,,,mg/day,,,"Red blood cell membrane, unspecified",GC-FID,EPA (cis-20:5n-3),"",1.304,,,percentRoot,,35,Pearson,0.36,,,< 0.05,Yes,,,,Parra 2002
5506,5632,5651,All,Pregnant women participant in a study on PUFAs and foetal neurodevelopment,Mexico,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,0.14,,,mg/day,,,"Red blood cell membrane, unspecified",GC-FID,DHA (cis-22:6n-3),"",6.059,,,percentRoot,,35,Pearson,0.35,,,< 0.05,Yes,,,,Parra 2002
5507,5653,5658,All [middle SES],Urban women of middle socioeconomic status from Tijuana,Mexico,,,Weighed Dietary record (5-day),Folates,"",,210.0,,,ug/day,,,"Serum, fasting",Method missing,Folates,"",9.1,,7.1,ng/mL,,34,Pearson,0.4,,,= 0.02,Yes,,,,Bacardi-Gascon 2003
5510,5660,5664,All,Female university students from Pavia,Italy,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,1107.0,,,ug/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",0.33,,,umol/L,,87,Pearson,0.76,0.66,0.84,< 0.0001,Yes,,,,Cena 2008
5511,5662,5664,All,Female university students from Pavia,Italy,,,Food Frequency Questionnaire (FFQ),Fruits,"",,1.17,,,servings/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",0.33,,,umol/L,,87,Pearson,0.54,,,< 0.01,Yes,,,,Cena 2008
5512,5663,5664,All,Female university students from Pavia,Italy,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,1.2,,,servings/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",0.33,,,umol/L,,87,Pearson,0.61,,,< 0.001,Yes,,,,Cena 2008
5513,5668,5685,All,Adults in London area,United Kingdom,,,Food Frequency Questionnaire (FFQ),Folates,"",Yes,366.0,,,ug/day,,,"Serum, fasting",Ion capture assay,Folates,"",,,,missing unit,,36,Pearson,0.47,,,< 0.01,Yes,,,Sex,Pufulete 2002
5514,5668,5686,All,Adults in London area,United Kingdom,,,Food Frequency Questionnaire (FFQ),Folates,"",Yes,366.0,,,ug/day,,,"Red blood cell, fasting",Ion capture assay,Folates,"",,,,missing unit,,36,Pearson,0.25,,,>= 0.05,No,,,Sex,Pufulete 2002
5525,5665,5685,All,Adults in London area,United Kingdom,,,Weighed Dietary record (7-day),Folates,"",Yes,316.0,,,ug/day,,,"Serum, fasting",Ion capture assay,Folates,"",,,,missing unit,,36,Pearson,0.39,,,< 0.05,Yes,,,Sex,Pufulete 2002
5526,5665,5686,All,Adults in London area,United Kingdom,,,Weighed Dietary record (7-day),Folates,"",Yes,316.0,,,ug/day,,,"Red blood cell, fasting",Ion capture assay,Folates,"",,,,missing unit,,36,Pearson,0.38,,,< 0.05,Yes,,,Sex,Pufulete 2002
5537,5665,5685,All,Adults in London area,United Kingdom,,,Weighed Dietary record (7-day),Folates,"",Yes,316.0,,,ug/day,,,"Serum, fasting",Ion capture assay,Folates,"",,,,missing unit,,36,Pearson,0.46,,,< 0.01,Yes,Energy by residual method,,Sex,Pufulete 2002
5538,5665,5686,All,Adults in London area,United Kingdom,,,Weighed Dietary record (7-day),Folates,"",Yes,316.0,,,ug/day,,,"Red blood cell, fasting",Ion capture assay,Folates,"",,,,missing unit,,36,Pearson,0.27,,,>= 0.05,No,Energy by residual method,,Sex,Pufulete 2002
5517,5669,5687,Males,Adults in London area,United Kingdom,,,Food Frequency Questionnaire (FFQ),Folates,"",Yes,368.0,,,ug/day,,,"Serum, fasting",Ion capture assay,Folates,"",,,,missing unit,,16,Pearson,0.55,,,< 0.05,Yes,,,,Pufulete 2002
5518,5669,5688,Males,Adults in London area,United Kingdom,,,Food Frequency Questionnaire (FFQ),Folates,"",Yes,368.0,,,ug/day,,,"Red blood cell, fasting",Ion capture assay,Folates,"",,,,missing unit,,16,Pearson,0.36,,,>= 0.05,No,,,,Pufulete 2002
5529,5666,5687,Males,Adults in London area,United Kingdom,,,Weighed Dietary record (7-day),Folates,"",Yes,371.0,,,ug/day,,,"Serum, fasting",Ion capture assay,Folates,"",,,,missing unit,,16,Pearson,0.52,,,< 0.05,Yes,,,,Pufulete 2002
5530,5666,5688,Males,Adults in London area,United Kingdom,,,Weighed Dietary record (7-day),Folates,"",Yes,371.0,,,ug/day,,,"Red blood cell, fasting",Ion capture assay,Folates,"",,,,missing unit,,16,Pearson,0.52,,,< 0.05,Yes,,,,Pufulete 2002
5541,5666,5687,Males,Adults in London area,United Kingdom,,,Weighed Dietary record (7-day),Folates,"",Yes,371.0,,,ug/day,,,"Serum, fasting",Ion capture assay,Folates,"",,,,missing unit,,16,Pearson,0.64,,,< 0.01,Yes,Energy by residual method,,,Pufulete 2002
5542,5666,5688,Males,Adults in London area,United Kingdom,,,Weighed Dietary record (7-day),Folates,"",Yes,371.0,,,ug/day,,,"Red blood cell, fasting",Ion capture assay,Folates,"",,,,missing unit,,16,Pearson,0.41,,,>= 0.05,No,Energy by residual method,,,Pufulete 2002
5521,5670,5689,Females,Adults in London area,United Kingdom,,,Food Frequency Questionnaire (FFQ),Folates,"",Yes,366.0,,,ug/day,,,"Serum, fasting",Ion capture assay,Folates,"",,,,missing unit,,20,Pearson,0.36,,,>= 0.05,No,,,,Pufulete 2002
5522,5670,5690,Females,Adults in London area,United Kingdom,,,Food Frequency Questionnaire (FFQ),Folates,"",Yes,366.0,,,ug/day,,,"Red blood cell, fasting",Ion capture assay,Folates,"",,,,missing unit,,20,Pearson,0.08,,,>= 0.05,No,,,,Pufulete 2002
5533,5667,5689,Females,Adults in London area,United Kingdom,,,Weighed Dietary record (7-day),Folates,"",Yes,272.0,,,ug/day,,,"Serum, fasting",Ion capture assay,Folates,"",,,,missing unit,,20,Pearson,0.23,,,>= 0.05,No,,,,Pufulete 2002
5534,5667,5690,Females,Adults in London area,United Kingdom,,,Weighed Dietary record (7-day),Folates,"",Yes,272.0,,,ug/day,,,"Red blood cell, fasting",Ion capture assay,Folates,"",,,,missing unit,,20,Pearson,0.14,,,>= 0.05,No,,,,Pufulete 2002
5545,5667,5689,Females,Adults in London area,United Kingdom,,,Weighed Dietary record (7-day),Folates,"",Yes,272.0,,,ug/day,,,"Serum, fasting",Ion capture assay,Folates,"",,,,missing unit,,20,Pearson,0.26,,,>= 0.05,No,Energy by residual method,,,Pufulete 2002
5546,5667,5690,Females,Adults in London area,United Kingdom,,,Weighed Dietary record (7-day),Folates,"",Yes,272.0,,,ug/day,,,"Red blood cell, fasting",Ion capture assay,Folates,"",,,,missing unit,,20,Pearson,0.13,,,>= 0.05,No,Energy by residual method,,,Pufulete 2002
5515,5680,9903,Supplement nonusers,Adults in London area,United Kingdom,,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Serum, fasting",Ion capture assay,Folates,"",,,,missing unit,,32,Pearson,0.42,,,< 0.05,Yes,,,Sex,Pufulete 2002
5516,5680,9904,Supplement nonusers,Adults in London area,United Kingdom,,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Red blood cell, fasting",Ion capture assay,Folates,"",,,,missing unit,,32,Pearson,0.2,,,>= 0.05,No,,,Sex,Pufulete 2002
5527,5679,9903,Supplement nonusers,Adults in London area,United Kingdom,,,Weighed Dietary record (7-day),Folates,"",No,,,,ug/day,,,"Serum, fasting",Ion capture assay,Folates,"",,,,missing unit,,32,Pearson,0.27,,,>= 0.05,No,,,Sex,Pufulete 2002
5528,5679,9904,Supplement nonusers,Adults in London area,United Kingdom,,,Weighed Dietary record (7-day),Folates,"",No,,,,ug/day,,,"Red blood cell, fasting",Ion capture assay,Folates,"",,,,missing unit,,32,Pearson,0.11,,,>= 0.05,No,,,Sex,Pufulete 2002
5539,5679,9903,Supplement nonusers,Adults in London area,United Kingdom,,,Weighed Dietary record (7-day),Folates,"",No,,,,ug/day,,,"Serum, fasting",Ion capture assay,Folates,"",,,,missing unit,,32,Pearson,0.38,,,< 0.05,Yes,Energy by residual method,,Sex,Pufulete 2002
5540,5679,9904,Supplement nonusers,Adults in London area,United Kingdom,,,Weighed Dietary record (7-day),Folates,"",No,,,,ug/day,,,"Red blood cell, fasting",Ion capture assay,Folates,"",,,,missing unit,,32,Pearson,0.17,,,>= 0.05,No,Energy by residual method,,Sex,Pufulete 2002
5519,5682,9905,Males - Supplement nonusers,Adults in London area,United Kingdom,,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Serum, fasting",Ion capture assay,Folates,"",,,,missing unit,,13,Pearson,0.44,,,>= 0.05,No,,,,Pufulete 2002
5520,5682,9906,Males - Supplement nonusers,Adults in London area,United Kingdom,,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Red blood cell, fasting",Ion capture assay,Folates,"",,,,missing unit,,13,Pearson,0.34,,,>= 0.05,No,,,,Pufulete 2002
5531,5681,9905,Males - Supplement nonusers,Adults in London area,United Kingdom,,,Weighed Dietary record (7-day),Folates,"",No,,,,ug/day,,,"Serum, fasting",Ion capture assay,Folates,"",,,,missing unit,,13,Pearson,0.34,,,>= 0.05,No,,,,Pufulete 2002
5532,5681,9906,Males - Supplement nonusers,Adults in London area,United Kingdom,,,Weighed Dietary record (7-day),Folates,"",No,,,,ug/day,,,"Red blood cell, fasting",Ion capture assay,Folates,"",,,,missing unit,,13,Pearson,0.06,,,>= 0.05,No,,,,Pufulete 2002
5543,5681,9905,Males - Supplement nonusers,Adults in London area,United Kingdom,,,Weighed Dietary record (7-day),Folates,"",No,,,,ug/day,,,"Serum, fasting",Ion capture assay,Folates,"",,,,missing unit,,13,Pearson,0.44,,,>= 0.05,No,Energy by residual method,,,Pufulete 2002
5544,5681,9906,Males - Supplement nonusers,Adults in London area,United Kingdom,,,Weighed Dietary record (7-day),Folates,"",No,,,,ug/day,,,"Red blood cell, fasting",Ion capture assay,Folates,"",,,,missing unit,,13,Pearson,0.39,,,>= 0.05,No,Energy by residual method,,,Pufulete 2002
5523,5684,9907,Females - Supplement nonusers,Adults in London area,United Kingdom,,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Serum, fasting",Ion capture assay,Folates,"",,,,missing unit,,19,Pearson,0.39,,,>= 0.05,No,,,,Pufulete 2002
5524,5684,9908,Females - Supplement nonusers,Adults in London area,United Kingdom,,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Red blood cell, fasting",Ion capture assay,Folates,"",,,,missing unit,,19,Pearson,0.08,,,>= 0.05,No,,,,Pufulete 2002
5535,5683,9907,Females - Supplement nonusers,Adults in London area,United Kingdom,,,Weighed Dietary record (7-day),Folates,"",No,,,,ug/day,,,"Serum, fasting",Ion capture assay,Folates,"",,,,missing unit,,19,Pearson,0.27,,,>= 0.05,No,,,,Pufulete 2002
5536,5683,9908,Females - Supplement nonusers,Adults in London area,United Kingdom,,,Weighed Dietary record (7-day),Folates,"",No,,,,ug/day,,,"Red blood cell, fasting",Ion capture assay,Folates,"",,,,missing unit,,19,Pearson,0.15,,,>= 0.05,No,,,,Pufulete 2002
5547,5683,9907,Females - Supplement nonusers,Adults in London area,United Kingdom,,,Weighed Dietary record (7-day),Folates,"",No,,,,ug/day,,,"Serum, fasting",Ion capture assay,Folates,"",,,,missing unit,,19,Pearson,0.37,,,>= 0.05,No,Energy by residual method,,,Pufulete 2002
5548,5683,9908,Females - Supplement nonusers,Adults in London area,United Kingdom,,,Weighed Dietary record (7-day),Folates,"",No,,,,ug/day,,,"Red blood cell, fasting",Ion capture assay,Folates,"",,,,missing unit,,19,Pearson,0.15,,,>= 0.05,No,Energy by residual method,,,Pufulete 2002
5552,5693,5695,All,Women from the university community,United States,,,Food Frequency Questionnaire (FFQ),Folates,"",Yes,458.5,,,ug/day,,,"Plasma, semi-fasting",Chemiluminescence immunoassay (CLIA),Folates,"",28.6,,,nmol/L,,28,Spearman,-0.261,,,> 0.06,No,,,,Yen 2003
8613,5693,20491,All,Women from the university community,United States,,,Food Frequency Questionnaire (FFQ),Folates,"",Yes,458.5,,,ug/day,,,"Plasma, semi-fasting",HPLC,Homocysteine,"",5.6,,,umol/L,,28,Spearman,0.203,,,> 0.06,No,,,,Yen 2003
5550,5691,5695,All,Women from the university community,United States,,,24-h Dietary recall (1-day),Folates,"",Yes,411.4,,,ug/day,,,"Plasma, semi-fasting",Chemiluminescence immunoassay (CLIA),Folates,"",28.6,,,nmol/L,,28,Spearman,0.354,,,= 0.06,No,,,,Yen 2003
8612,5691,20491,All,Women from the university community,United States,,,24-h Dietary recall (1-day),Folates,"",Yes,411.4,,,ug/day,,,"Plasma, semi-fasting",HPLC,Homocysteine,"",5.6,,,umol/L,,28,Spearman,-0.443,,,< 0.02,Yes,,,,Yen 2003
5553,5730,5708,All,Female university students,Germany,,,Food Frequency Questionnaire (FFQ),"Rumenic acid (9cis,11trans-18:2n-7)","",,,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,"Rumenic acid (9cis,11trans-18:2n-7)","",0.27,,0.26,percentRoot,,52,Pearson,0.09,,,>= 0.05,No,,,,Fremann 2002
5554,5730,5719,All,Female university students,Germany,,,Food Frequency Questionnaire (FFQ),"Rumenic acid (9cis,11trans-18:2n-7)","",,,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,"Rumenic acid (9cis,11trans-18:2n-7)","",0.54,,0.55,percentRoot,,52,Pearson,0.124,,,>= 0.05,No,,,,Fremann 2002
5555,5700,5708,All,Female university students,Germany,,,Dietary record (7-day),"Rumenic acid (9cis,11trans-18:2n-7)","",,0.44,,0.43,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,"Rumenic acid (9cis,11trans-18:2n-7)","",0.27,,0.26,percentRoot,,52,Pearson,0.285,,,< 0.05,Yes,,,,Fremann 2002
5556,5700,5719,All,Female university students,Germany,,,Dietary record (7-day),"Rumenic acid (9cis,11trans-18:2n-7)","",,0.44,,0.43,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,"Rumenic acid (9cis,11trans-18:2n-7)","",0.54,,0.55,percentRoot,,52,Pearson,0.272,,,>= 0.05,No,,,,Fremann 2002
8610,9948,5708,All,Female university students,Germany,,Day 7,Dietary record (7-day),"Rumenic acid (9cis,11trans-18:2n-7)","",,315.0,,314.0,mg/day,,,"Plasma (phospholipids), fasting",GC-FID,"Rumenic acid (9cis,11trans-18:2n-7)","",0.27,,0.26,percentRoot,,52,Pearson,0.28,,,< 0.05,Yes,,,,Fremann 2002
8611,9949,5719,All,Female university students,Germany,,Day 7,Dietary record (7-day),"Rumenic acid (9cis,11trans-18:2n-7)","",,0.44,,0.44,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,"Rumenic acid (9cis,11trans-18:2n-7)","",0.54,,0.55,percentRoot,,52,Pearson,0.409,,,< 0.01,Yes,,,,Fremann 2002
5561,5733,5738,Males,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,447.0,,,ug/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",135.0,,,nmol/L,,344,Spearman,0.24,,,< 0.001,Yes,"Cholesterol, Energy by residual method",,"Age, BMI, Smoking status",El-Sohemy 2002
5566,5733,5743,Males,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,447.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,alpha-Carotene,"",0.2,,,ug/g,,344,Spearman,0.04,,,>= 0.05,No,"Cholesterol, Energy by residual method",,"Age, BMI, Smoking status",El-Sohemy 2002
5562,5734,5739,Males,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,3407.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",484.0,,,nmol/L,,344,Spearman,0.22,,,< 0.001,Yes,"Cholesterol, Energy by residual method",,"Age, BMI, Smoking status",El-Sohemy 2002
5567,5734,5743,Males,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,3407.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,alpha-Carotene,"",0.2,,,ug/g,,344,Spearman,0.07,,,>= 0.05,No,"Cholesterol, Energy by residual method",,"Age, BMI, Smoking status",El-Sohemy 2002
5563,5735,5740,Males,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,383.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",181.0,,,nmol/L,,344,Spearman,0.44,,,< 0.001,Yes,"Cholesterol, Energy by residual method",,"Age, BMI, Smoking status",El-Sohemy 2002
5568,5735,5743,Males,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,383.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,alpha-Carotene,"",0.2,,,ug/g,,344,Spearman,0.23,,,< 0.001,Yes,"Cholesterol, Energy by residual method",,"Age, BMI, Smoking status",El-Sohemy 2002
5564,5736,5741,Males,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Lycopene,"",,5451.0,,,ug/day,,,"Plasma, fasting",HPLC,Lycopene,"",501.0,,,nmol/L,,344,Spearman,0.35,,,< 0.001,Yes,"Cholesterol, Energy by residual method",,"Age, BMI, Smoking status",El-Sohemy 2002
5569,5736,5743,Males,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Lycopene,"",,5451.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,alpha-Carotene,"",0.2,,,ug/g,,344,Spearman,0.26,,,< 0.001,Yes,"Cholesterol, Energy by residual method",,"Age, BMI, Smoking status",El-Sohemy 2002
5565,5737,5742,Males,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,2412.0,,,ug/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",316.0,,,nmol/L,,344,Spearman,0.2,,,< 0.01,Yes,"Cholesterol, Energy by residual method",,"Age, BMI, Smoking status",El-Sohemy 2002
5570,5737,5743,Males,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,2412.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,alpha-Carotene,"",0.2,,,ug/g,,344,Spearman,0.06,,,>= 0.05,No,"Cholesterol, Energy by residual method",,"Age, BMI, Smoking status",El-Sohemy 2002
5571,5748,5753,Females,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,727.0,,,ug/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",180.0,,,nmol/L,,115,Spearman,0.26,,,< 0.01,Yes,"Cholesterol, Energy by residual method",,"Age, BMI, Smoking status",El-Sohemy 2002
5581,5748,5758,Females,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,727.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,alpha-Carotene,"",0.23,,,ug/g,,115,Spearman,0.25,,,< 0.01,Yes,"Cholesterol, Energy by residual method",,"Age, BMI, Smoking status",El-Sohemy 2002
5572,5749,5754,Females,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,4668.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",821.0,,,nmol/L,,115,Spearman,0.13,,,>= 0.05,No,"Cholesterol, Energy by residual method",,"Age, BMI, Smoking status",El-Sohemy 2002
5582,5749,5758,Females,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,4668.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,alpha-Carotene,"",0.23,,,ug/g,,115,Spearman,0.29,,,< 0.01,Yes,"Cholesterol, Energy by residual method",,"Age, BMI, Smoking status",El-Sohemy 2002
5573,5750,5755,Females,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,552.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",275.0,,,nmol/L,,115,Spearman,0.55,,,< 0.001,Yes,"Cholesterol, Energy by residual method",,"Age, BMI, Smoking status",El-Sohemy 2002
5583,5750,5758,Females,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,552.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,alpha-Carotene,"",0.23,,,ug/g,,115,Spearman,0.44,,,< 0.001,Yes,"Cholesterol, Energy by residual method",,"Age, BMI, Smoking status",El-Sohemy 2002
5574,5751,5756,Females,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Lycopene,"",,5772.0,,,ug/day,,,"Plasma, fasting",HPLC,Lycopene,"",585.0,,,nmol/L,,115,Spearman,0.19,,,< 0.05,Yes,"Cholesterol, Energy by residual method",,"Age, BMI, Smoking status",El-Sohemy 2002
5584,5751,5758,Females,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Lycopene,"",,5772.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,alpha-Carotene,"",0.23,,,ug/g,,115,Spearman,0.14,,,>= 0.05,No,"Cholesterol, Energy by residual method",,"Age, BMI, Smoking status",El-Sohemy 2002
5575,5752,5757,Females,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,2893.0,,,ug/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",328.0,,,nmol/L,,115,Spearman,0.22,,,< 0.05,Yes,"Cholesterol, Energy by residual method",,"Age, BMI, Smoking status",El-Sohemy 2002
5585,5752,5758,Females,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,2893.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,alpha-Carotene,"",0.23,,,ug/g,,115,Spearman,0.17,,,>= 0.05,No,"Cholesterol, Energy by residual method",,"Age, BMI, Smoking status",El-Sohemy 2002
5621,5801,5881,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Myristic acid (14:0),"",,1.9,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Myristic acid (14:0),"",,,,percentRoot,,120,Pearson,0.0,,,>= 0.05,No,Energy by residual method,,"Age, Sex, County of residence",Kabagambe 2001
5622,5802,5882,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,20.0,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,120,Pearson,0.06,,,>= 0.05,No,Energy by residual method,,"Age, Sex, County of residence",Kabagambe 2001
5623,5803,5883,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Stearic acid (18:0),"",,6.0,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Stearic acid (18:0),"",,,,percentRoot,,120,Pearson,0.05,,,>= 0.05,No,Energy by residual method,,"Age, Sex, County of residence",Kabagambe 2001
5624,5804,5884,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Palmitoleic acid (cis-16:1n-7),"",,1.3,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Palmitoleic acid (cis-16:1n-7),"",,,,percentRoot,,120,Pearson,-0.06,,,>= 0.05,No,Energy by residual method,,"Age, Sex, County of residence",Kabagambe 2001
5625,5805,5885,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,30.0,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,120,Pearson,0.07,,,>= 0.05,No,Energy by residual method,,"Age, Sex, County of residence",Kabagambe 2001
5626,5806,5886,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,13.0,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,120,Pearson,0.51,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, County of residence",Kabagambe 2001
5627,5807,5887,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),cis-Linolenic acids (cis-18:3),"",,1.2,,,g/day,,,"Adipose tissue, buttocks",GC-FID,cis-Linolenic acids (cis-18:3),"",,,,percentRoot,,120,Pearson,0.27,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, County of residence",Kabagambe 2001
5607,5808,5867,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",,9.0,,,ug/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,missing unit,,120,Pearson,0.03,,,>= 0.05,No,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5614,5808,5874,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",,9.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,alpha-Tocopherol,"",,,,missing unit,,120,Pearson,0.15,,,>= 0.05,No,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5608,5809,5868,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",,15.0,,,ug/day,,,"Plasma, fasting",HPLC,gamma-Tocopherol,"",,,,missing unit,,120,Pearson,0.28,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5615,5809,5875,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",,15.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,gamma-Tocopherol,"",,,,missing unit,,120,Pearson,0.15,,,>= 0.05,No,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5609,5810,5869,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,640.0,,,ug/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,missing unit,,120,Pearson,0.32,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5616,5810,5876,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,640.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,alpha-Carotene,"",,,,missing unit,,120,Pearson,0.08,,,>= 0.05,No,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5610,5811,5870,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,4239.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,120,Pearson,0.33,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5617,5811,5877,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,4239.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,beta-Carotene,"",,,,missing unit,,120,Pearson,0.21,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5611,5812,5871,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,610.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,120,Pearson,0.53,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5618,5812,5878,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,610.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,120,Pearson,0.29,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5612,5813,5872,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Lycopene,"",,5180.0,,,ug/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,missing unit,,120,Pearson,0.24,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5619,5813,5879,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Lycopene,"",,5180.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,Lycopene,"",,,,missing unit,,120,Pearson,0.3,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5613,5814,5873,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,2922.0,,,ug/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,missing unit,,120,Pearson,0.28,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5620,5814,5880,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,2922.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,Lutein/Zeaxanthin,"",,,,missing unit,,120,Pearson,0.09,,,>= 0.05,No,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5642,5827,5881,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Myristic acid (14:0),"",,1.9,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Myristic acid (14:0),"",,,,percentRoot,,120,Pearson,0.04,,,>= 0.05,No,Energy by residual method,,"Age, Sex, County of residence",Kabagambe 2001
5643,5828,5882,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,21.0,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,120,Pearson,0.06,,,>= 0.05,No,Energy by residual method,,"Age, Sex, County of residence",Kabagambe 2001
5644,5829,5883,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Stearic acid (18:0),"",,6.3,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Stearic acid (18:0),"",,,,percentRoot,,120,Pearson,0.15,,,>= 0.05,No,Energy by residual method,,"Age, Sex, County of residence",Kabagambe 2001
5645,5830,5884,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Palmitoleic acid (cis-16:1n-7),"",,1.3,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Palmitoleic acid (cis-16:1n-7),"",,,,percentRoot,,120,Pearson,-0.02,,,>= 0.05,No,Energy by residual method,,"Age, Sex, County of residence",Kabagambe 2001
5646,5831,5885,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,32.0,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,120,Pearson,0.03,,,>= 0.05,No,Energy by residual method,,"Age, Sex, County of residence",Kabagambe 2001
5647,5832,5886,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,13.0,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,120,Pearson,0.55,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, County of residence",Kabagambe 2001
5648,5833,5887,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),cis-Linolenic acids (cis-18:3),"",,1.3,,,g/day,,,"Adipose tissue, buttocks",GC-FID,cis-Linolenic acids (cis-18:3),"",,,,percentRoot,,120,Pearson,0.23,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, County of residence",Kabagambe 2001
5628,5834,5867,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",,9.5,,,ug/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,missing unit,,120,Pearson,0.04,,,>= 0.05,No,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5635,5834,5874,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",,9.5,,,ug/day,,,"Adipose tissue, buttocks",HPLC,alpha-Tocopherol,"",,,,missing unit,,120,Pearson,0.09,,,>= 0.05,No,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5629,5835,5868,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",,15.0,,,ug/day,,,"Plasma, fasting",HPLC,gamma-Tocopherol,"",,,,missing unit,,120,Pearson,0.3,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5636,5835,5875,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",,15.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,gamma-Tocopherol,"",,,,missing unit,,120,Pearson,0.25,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5630,5836,5869,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,459.0,,,ug/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,missing unit,,120,Pearson,0.28,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5637,5836,5876,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,459.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,alpha-Carotene,"",,,,missing unit,,120,Pearson,-0.06,,,>= 0.05,No,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5631,5837,5870,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,3604.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,120,Pearson,0.36,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5638,5837,5877,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,3604.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,beta-Carotene,"",,,,missing unit,,120,Pearson,0.11,,,>= 0.05,No,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5632,5838,5871,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,457.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,120,Pearson,0.55,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5639,5838,5878,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,457.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,120,Pearson,0.33,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5633,5839,5872,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Lycopene,"",,5249.0,,,ug/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,missing unit,,120,Pearson,0.18,,,>= 0.05,No,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5640,5839,5879,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Lycopene,"",,5249.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,Lycopene,"",,,,missing unit,,120,Pearson,0.17,,,>= 0.05,No,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5634,5840,5873,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,2423.0,,,ug/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,missing unit,,120,Pearson,0.26,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5641,5840,5880,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,2423.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,Lutein/Zeaxanthin,"",,,,missing unit,,120,Pearson,0.2,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5663,5853,5881,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Myristic acid (14:0),"",,1.9,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Myristic acid (14:0),"",,,,percentRoot,,120,Pearson,0.02,,,>= 0.05,No,Energy by residual method,,"Age, Sex, County of residence",Kabagambe 2001
5664,5854,5882,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,20.0,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,120,Pearson,0.07,,,>= 0.05,No,Energy by residual method,,"Age, Sex, County of residence",Kabagambe 2001
5665,5855,5883,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Stearic acid (18:0),"",,6.1,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Stearic acid (18:0),"",,,,percentRoot,,120,Pearson,0.1,,,>= 0.05,No,Energy by residual method,,"Age, Sex, County of residence",Kabagambe 2001
5666,5856,5884,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Palmitoleic acid (cis-16:1n-7),"",,1.3,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Palmitoleic acid (cis-16:1n-7),"",,,,percentRoot,,120,Pearson,-0.06,,,>= 0.05,No,Energy by residual method,,"Age, Sex, County of residence",Kabagambe 2001
5667,5857,5885,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,31.0,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,120,Pearson,0.07,,,>= 0.05,No,Energy by residual method,,"Age, Sex, County of residence",Kabagambe 2001
5668,5858,5886,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,13.0,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,120,Pearson,0.59,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, County of residence",Kabagambe 2001
5669,5859,5887,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),cis-Linolenic acids (cis-18:3),"",,1.2,,,g/day,,,"Adipose tissue, buttocks",GC-FID,cis-Linolenic acids (cis-18:3),"",,,,percentRoot,,120,Pearson,0.27,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, County of residence",Kabagambe 2001
5649,5860,5867,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",,9.3,,,ug/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,missing unit,,120,Pearson,0.06,,,>= 0.05,No,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5656,5860,5874,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",,9.3,,,ug/day,,,"Adipose tissue, buttocks",HPLC,alpha-Tocopherol,"",,,,missing unit,,120,Pearson,0.13,,,>= 0.05,No,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5650,5861,5868,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",,15.0,,,ug/day,,,"Plasma, fasting",HPLC,gamma-Tocopherol,"",,,,missing unit,,120,Pearson,0.32,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5657,5861,5875,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",,15.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,gamma-Tocopherol,"",,,,missing unit,,120,Pearson,0.22,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5651,5862,5869,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,550.0,,,ug/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,missing unit,,120,Pearson,0.36,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5658,5862,5876,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,550.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,alpha-Carotene,"",,,,missing unit,,120,Pearson,0.01,,,>= 0.05,No,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5652,5863,5870,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,3921.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,120,Pearson,0.38,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5659,5863,5877,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,3921.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,beta-Carotene,"",,,,missing unit,,120,Pearson,0.16,,,>= 0.05,No,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5653,5864,5871,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,533.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,120,Pearson,0.58,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5660,5864,5878,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,533.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,120,Pearson,0.33,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5654,5865,5872,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Lycopene,"",,5215.0,,,ug/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,missing unit,,120,Pearson,0.26,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5661,5865,5879,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Lycopene,"",,5215.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,Lycopene,"",,,,missing unit,,120,Pearson,0.27,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5655,5866,5873,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,2672.0,,,ug/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,missing unit,,120,Pearson,0.27,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5662,5866,5880,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,2672.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,Lutein/Zeaxanthin,"",,,,missing unit,,120,Pearson,0.15,,,>= 0.05,No,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5600,5775,5881,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,24-h Dietary recall (1-day),Myristic acid (14:0),"",,1.4,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Myristic acid (14:0),"",,,,percentRoot,,120,Pearson,0.01,,,>= 0.05,No,Energy by residual method,,"Age, Sex, County of residence",Kabagambe 2001
5601,5776,5882,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,24-h Dietary recall (1-day),Palmitic acid (16:0),"",,11.0,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,120,Pearson,0.0,,,>= 0.05,No,Energy by residual method,,"Age, Sex, County of residence",Kabagambe 2001
5602,5777,5883,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,24-h Dietary recall (1-day),Stearic acid (18:0),"",,3.9,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Stearic acid (18:0),"",,,,percentRoot,,120,Pearson,0.28,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, County of residence",Kabagambe 2001
5603,5778,5884,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,24-h Dietary recall (1-day),Palmitoleic acid (cis-16:1n-7),"",,0.95,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Palmitoleic acid (cis-16:1n-7),"",,,,percentRoot,,120,Pearson,-0.08,,,>= 0.05,No,Energy by residual method,,"Age, Sex, County of residence",Kabagambe 2001
5604,5779,5885,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,24-h Dietary recall (1-day),Oleic acid (cis-18:1n-9),"",,17.0,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,120,Pearson,0.25,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, County of residence",Kabagambe 2001
5605,5780,5886,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,24-h Dietary recall (1-day),Linoleic acid (LA; cis-18:2n-6),"",,7.5,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,120,Pearson,0.37,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, County of residence",Kabagambe 2001
5606,5781,5887,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,24-h Dietary recall (1-day),cis-Linolenic acids (cis-18:3),"",,0.88,,,g/day,,,"Adipose tissue, buttocks",GC-FID,cis-Linolenic acids (cis-18:3),"",,,,percentRoot,,120,Pearson,0.31,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, County of residence",Kabagambe 2001
5586,5782,5867,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,24-h Dietary recall (1-day),alpha-Tocopherol,"",,3.0,,,ug/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,missing unit,,120,Pearson,0.18,,,>= 0.05,No,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5593,5782,5874,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,24-h Dietary recall (1-day),alpha-Tocopherol,"",,3.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,alpha-Tocopherol,"",,,,missing unit,,120,Pearson,0.15,,,>= 0.05,No,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5587,5783,5868,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,24-h Dietary recall (1-day),gamma-Tocopherol,"",,3.0,,,ug/day,,,"Plasma, fasting",HPLC,gamma-Tocopherol,"",,,,missing unit,,120,Pearson,0.24,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5594,5783,5875,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,24-h Dietary recall (1-day),gamma-Tocopherol,"",,3.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,gamma-Tocopherol,"",,,,missing unit,,120,Pearson,0.1,,,>= 0.05,No,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5588,5784,5869,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,24-h Dietary recall (1-day),alpha-Carotene,"",,118.0,,,ug/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,missing unit,,120,Pearson,0.25,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5595,5784,5876,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,24-h Dietary recall (1-day),alpha-Carotene,"",,118.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,alpha-Carotene,"",,,,missing unit,,120,Pearson,0.12,,,>= 0.05,No,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5589,5785,5870,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,24-h Dietary recall (1-day),beta-Carotene,"",,596.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,120,Pearson,0.26,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5596,5785,5877,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,24-h Dietary recall (1-day),beta-Carotene,"",,596.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,beta-Carotene,"",,,,missing unit,,120,Pearson,0.32,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5590,5786,5871,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,24-h Dietary recall (1-day),beta-Cryptoxanthin,"",,262.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,120,Pearson,0.25,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5597,5786,5878,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,24-h Dietary recall (1-day),beta-Cryptoxanthin,"",,262.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,120,Pearson,0.12,,,>= 0.05,No,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5591,5787,5872,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,24-h Dietary recall (1-day),Lycopene,"",,916.0,,,ug/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,missing unit,,120,Pearson,0.3,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5598,5787,5879,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,24-h Dietary recall (1-day),Lycopene,"",,916.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,Lycopene,"",,,,missing unit,,120,Pearson,0.28,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5592,5788,5873,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,24-h Dietary recall (1-day),Lutein/Zeaxanthin,"",,599.0,,,ug/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,missing unit,,120,Pearson,0.32,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5599,5788,5880,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,24-h Dietary recall (1-day),Lutein/Zeaxanthin,"",,599.0,,,ug/day,,,"Adipose tissue, buttocks",HPLC,Lutein/Zeaxanthin,"",,,,missing unit,,120,Pearson,0.25,,,< 0.05,Yes,Energy by residual method,,"Age, Sex, BMI, Smoking status, County of residence",Kabagambe 2001
5670,5888,5893,All,Adults with various levels of alcohol intake,Finland,,baseline,Food Frequency Questionnaire (FFQ),Ethanol,"",,13.3,,,g/day,,,"Serum, fasting",Colorimetry,Aspartate aminotransferase (ASAT),"",22.0,,,U/L,,34,Pearson,0.48,,,< 0.001,Yes,,,,Poikolainen 2002
5671,5888,5894,All,Adults with various levels of alcohol intake,Finland,,baseline,Food Frequency Questionnaire (FFQ),Ethanol,"",,13.3,,,g/day,,,"Serum, fasting",Colorimetry,Alanine aminotransferase (ALAT),"",28.3,,,U/L,,34,Pearson,0.41,,,< 0.001,Yes,,,,Poikolainen 2002
5672,5888,5895,All,Adults with various levels of alcohol intake,Finland,,baseline,Food Frequency Questionnaire (FFQ),Ethanol,"",,13.3,,,g/day,,,"Serum, fasting",Colorimetry,gamma-Glutamyltransferase (GGT),"",28.9,,,U/L,,34,Pearson,0.62,,,< 0.001,Yes,,,,Poikolainen 2002
5673,5888,5896,All,Adults with various levels of alcohol intake,Finland,,baseline,Food Frequency Questionnaire (FFQ),Ethanol,"",,13.3,,,g/day,,,"Serum, fasting",Turbidimetric immunoassay (TIA),Carbohydrate-deficient transferrin (CDT),"",4.2,,,% transferrin,,34,Pearson,-0.16,,,>= 0.001,No,,,,Poikolainen 2002
5674,5889,5893,All,Adults with various levels of alcohol intake,Finland,,2 months,Food Frequency Questionnaire (FFQ),Ethanol,"",,14.5,,,g/day,,,"Serum, fasting",Colorimetry,Aspartate aminotransferase (ASAT),"",22.0,,,U/L,,34,Pearson,0.61,,,< 0.001,Yes,,,,Poikolainen 2002
5675,5889,5894,All,Adults with various levels of alcohol intake,Finland,,2 months,Food Frequency Questionnaire (FFQ),Ethanol,"",,14.5,,,g/day,,,"Serum, fasting",Colorimetry,Alanine aminotransferase (ALAT),"",28.3,,,U/L,,34,Pearson,0.53,,,< 0.001,Yes,,,,Poikolainen 2002
5676,5889,5895,All,Adults with various levels of alcohol intake,Finland,,2 months,Food Frequency Questionnaire (FFQ),Ethanol,"",,14.5,,,g/day,,,"Serum, fasting",Colorimetry,gamma-Glutamyltransferase (GGT),"",28.9,,,U/L,,34,Pearson,0.67,,,< 0.001,Yes,,,,Poikolainen 2002
5677,5889,5896,All,Adults with various levels of alcohol intake,Finland,,2 months,Food Frequency Questionnaire (FFQ),Ethanol,"",,14.5,,,g/day,,,"Serum, fasting",Turbidimetric immunoassay (TIA),Carbohydrate-deficient transferrin (CDT),"",4.2,,,% transferrin,,34,Pearson,-0.12,,,>= 0.001,No,,,,Poikolainen 2002
5678,5890,5893,All,Adults with various levels of alcohol intake,Finland,,baseline,Food Frequency Questionnaire (FFQ),Ethanol,"",,30.9,,,g/day,,,"Serum, fasting",Colorimetry,Aspartate aminotransferase (ASAT),"",22.0,,,U/L,,34,Pearson,0.5,,,< 0.001,Yes,,,,Poikolainen 2002
5679,5890,5894,All,Adults with various levels of alcohol intake,Finland,,baseline,Food Frequency Questionnaire (FFQ),Ethanol,"",,30.9,,,g/day,,,"Serum, fasting",Colorimetry,Alanine aminotransferase (ALAT),"",28.3,,,U/L,,34,Pearson,0.33,,,< 0.001,Yes,,,,Poikolainen 2002
5680,5890,5895,All,Adults with various levels of alcohol intake,Finland,,baseline,Food Frequency Questionnaire (FFQ),Ethanol,"",,30.9,,,g/day,,,"Serum, fasting",Colorimetry,gamma-Glutamyltransferase (GGT),"",28.9,,,U/L,,34,Pearson,0.57,,,< 0.001,Yes,,,,Poikolainen 2002
5681,5890,5896,All,Adults with various levels of alcohol intake,Finland,,baseline,Food Frequency Questionnaire (FFQ),Ethanol,"",,30.9,,,g/day,,,"Serum, fasting",Turbidimetric immunoassay (TIA),Carbohydrate-deficient transferrin (CDT),"",4.2,,,% transferrin,,34,Pearson,-0.12,,,>= 0.001,No,,,,Poikolainen 2002
5682,5891,5893,All,Adults with various levels of alcohol intake,Finland,,2 months,Food Frequency Questionnaire (FFQ),Ethanol,"",,33.9,,,g/day,,,"Serum, fasting",Colorimetry,Aspartate aminotransferase (ASAT),"",22.0,,,U/L,,34,Pearson,0.56,,,< 0.001,Yes,,,,Poikolainen 2002
5683,5891,5894,All,Adults with various levels of alcohol intake,Finland,,2 months,Food Frequency Questionnaire (FFQ),Ethanol,"",,33.9,,,g/day,,,"Serum, fasting",Colorimetry,Alanine aminotransferase (ALAT),"",28.3,,,U/L,,34,Pearson,0.48,,,< 0.001,Yes,,,,Poikolainen 2002
5684,5891,5895,All,Adults with various levels of alcohol intake,Finland,,2 months,Food Frequency Questionnaire (FFQ),Ethanol,"",,33.9,,,g/day,,,"Serum, fasting",Colorimetry,gamma-Glutamyltransferase (GGT),"",28.9,,,U/L,,34,Pearson,0.65,,,< 0.001,Yes,,,,Poikolainen 2002
5685,5891,5896,All,Adults with various levels of alcohol intake,Finland,,2 months,Food Frequency Questionnaire (FFQ),Ethanol,"",,33.9,,,g/day,,,"Serum, fasting",Turbidimetric immunoassay (TIA),Carbohydrate-deficient transferrin (CDT),"",4.2,,,% transferrin,,34,Pearson,-0.16,,,>= 0.001,No,,,,Poikolainen 2002
5686,5892,5893,All,Adults with various levels of alcohol intake,Finland,,,Dietary record (31-day),Ethanol,"",,16.2,,,g/day,,,"Serum, fasting",Colorimetry,Aspartate aminotransferase (ASAT),"",22.0,,,U/L,,34,Pearson,0.52,,,< 0.001,Yes,,,,Poikolainen 2002
5687,5892,5894,All,Adults with various levels of alcohol intake,Finland,,,Dietary record (31-day),Ethanol,"",,16.2,,,g/day,,,"Serum, fasting",Colorimetry,Alanine aminotransferase (ALAT),"",28.3,,,U/L,,34,Pearson,0.42,,,< 0.001,Yes,,,,Poikolainen 2002
5688,5892,5895,All,Adults with various levels of alcohol intake,Finland,,,Dietary record (31-day),Ethanol,"",,16.2,,,g/day,,,"Serum, fasting",Colorimetry,gamma-Glutamyltransferase (GGT),"",28.9,,,U/L,,34,Pearson,0.55,,,< 0.001,Yes,,,,Poikolainen 2002
5689,5892,5896,All,Adults with various levels of alcohol intake,Finland,,,Dietary record (31-day),Ethanol,"",,16.2,,,g/day,,,"Serum, fasting",Turbidimetric immunoassay (TIA),Carbohydrate-deficient transferrin (CDT),"",4.2,,,% transferrin,,34,Pearson,-0.13,,,>= 0.001,No,,,,Poikolainen 2002
5690,5897,5908,All,Women,United States,NYUWHS (New York University Women's Health Study),baseline,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,missing unit,,baseline,"Serum, non-fasting",HPLC,beta-Carotene,"",,,,missing unit,,302,Spearman,0.28,,,< 0.01,Yes,,,BMI,van Kappel 2001
5698,5897,5909,All,Women,United States,NYUWHS (New York University Women's Health Study),baseline,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,missing unit,,baseline,"Serum, non-fasting",HPLC,alpha-Carotene,"",,,,missing unit,,302,Spearman,0.28,,,< 0.01,Yes,,,BMI,van Kappel 2001
5706,5897,5910,All,Women,United States,NYUWHS (New York University Women's Health Study),baseline,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,missing unit,,baseline,"Serum, non-fasting",HPLC,Lutein,"",,,,missing unit,,302,Spearman,0.21,,,< 0.01,Yes,,,BMI,van Kappel 2001
5713,5897,5912,All,Women,United States,NYUWHS (New York University Women's Health Study),baseline,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,missing unit,,baseline,"Serum, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,302,Spearman,0.39,,,< 0.01,Yes,,,BMI,van Kappel 2001
5691,5898,5908,All,Women,United States,NYUWHS (New York University Women's Health Study),baseline,Food Frequency Questionnaire (FFQ),Fruit juices,"",,,,,missing unit,,baseline,"Serum, non-fasting",HPLC,beta-Carotene,"",,,,missing unit,,302,Spearman,-0.15,,,< 0.01,Yes,,,BMI,van Kappel 2001
5714,5898,5912,All,Women,United States,NYUWHS (New York University Women's Health Study),baseline,Food Frequency Questionnaire (FFQ),Fruit juices,"",,,,,missing unit,,baseline,"Serum, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,302,Spearman,0.13,,,< 0.05,Yes,,,BMI,van Kappel 2001
5692,5899,5908,All,Women,United States,NYUWHS (New York University Women's Health Study),baseline,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,missing unit,,baseline,"Serum, non-fasting",HPLC,beta-Carotene,"",,,,missing unit,,302,Spearman,0.19,,,< 0.01,Yes,,,BMI,van Kappel 2001
5699,5899,5909,All,Women,United States,NYUWHS (New York University Women's Health Study),baseline,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,missing unit,,baseline,"Serum, non-fasting",HPLC,alpha-Carotene,"",,,,missing unit,,302,Spearman,0.24,,,< 0.01,Yes,,,BMI,van Kappel 2001
5707,5899,5910,All,Women,United States,NYUWHS (New York University Women's Health Study),baseline,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,missing unit,,baseline,"Serum, non-fasting",HPLC,Lutein,"",,,,missing unit,,302,Spearman,0.22,,,< 0.01,Yes,,,BMI,van Kappel 2001
5715,5899,5912,All,Women,United States,NYUWHS (New York University Women's Health Study),baseline,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,missing unit,,baseline,"Serum, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,302,Spearman,0.24,,,< 0.01,Yes,,,BMI,van Kappel 2001
5693,5900,5908,All,Women,United States,NYUWHS (New York University Women's Health Study),baseline,Food Frequency Questionnaire (FFQ),Cereals,"",,,,,missing unit,,baseline,"Serum, non-fasting",HPLC,beta-Carotene,"",,,,missing unit,,302,Spearman,0.16,,,< 0.01,Yes,,,BMI,van Kappel 2001
5700,5900,5909,All,Women,United States,NYUWHS (New York University Women's Health Study),baseline,Food Frequency Questionnaire (FFQ),Cereals,"",,,,,missing unit,,baseline,"Serum, non-fasting",HPLC,alpha-Carotene,"",,,,missing unit,,302,Spearman,0.15,,,< 0.01,Yes,,,BMI,van Kappel 2001
5711,5900,5911,All,Women,United States,NYUWHS (New York University Women's Health Study),baseline,Food Frequency Questionnaire (FFQ),Cereals,"",,,,,missing unit,,baseline,"Serum, non-fasting",HPLC,Zeaxanthin,"",,,,missing unit,,302,Spearman,0.15,,,< 0.01,Yes,,,BMI,van Kappel 2001
5716,5900,5912,All,Women,United States,NYUWHS (New York University Women's Health Study),baseline,Food Frequency Questionnaire (FFQ),Cereals,"",,,,,missing unit,,baseline,"Serum, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,302,Spearman,0.15,,,< 0.01,Yes,,,BMI,van Kappel 2001
5694,5901,5908,All,Women,United States,NYUWHS (New York University Women's Health Study),baseline,Food Frequency Questionnaire (FFQ),Fish,"",,,,,missing unit,,baseline,"Serum, non-fasting",HPLC,beta-Carotene,"",,,,missing unit,,302,Spearman,0.2,,,< 0.01,Yes,,,BMI,van Kappel 2001
5701,5901,5909,All,Women,United States,NYUWHS (New York University Women's Health Study),baseline,Food Frequency Questionnaire (FFQ),Fish,"",,,,,missing unit,,baseline,"Serum, non-fasting",HPLC,alpha-Carotene,"",,,,missing unit,,302,Spearman,0.23,,,< 0.01,Yes,,,BMI,van Kappel 2001
5708,5901,5910,All,Women,United States,NYUWHS (New York University Women's Health Study),baseline,Food Frequency Questionnaire (FFQ),Fish,"",,,,,missing unit,,baseline,"Serum, non-fasting",HPLC,Lutein,"",,,,missing unit,,302,Spearman,0.12,,,< 0.05,Yes,,,BMI,van Kappel 2001
5717,5901,5912,All,Women,United States,NYUWHS (New York University Women's Health Study),baseline,Food Frequency Questionnaire (FFQ),Fish,"",,,,,missing unit,,baseline,"Serum, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,302,Spearman,0.12,,,< 0.05,Yes,,,BMI,van Kappel 2001
5709,5902,5910,All,Women,United States,NYUWHS (New York University Women's Health Study),baseline,Food Frequency Questionnaire (FFQ),Poultry,"",,,,,missing unit,,baseline,"Serum, non-fasting",HPLC,Lutein,"",,,,missing unit,,302,Spearman,0.16,,,< 0.01,Yes,,,BMI,van Kappel 2001
5702,5903,5909,All,Women,United States,NYUWHS (New York University Women's Health Study),baseline,Food Frequency Questionnaire (FFQ),Dairy foods,"",,,,,missing unit,,baseline,"Serum, non-fasting",HPLC,alpha-Carotene,"",,,,missing unit,,302,Spearman,0.12,,,< 0.05,Yes,,,BMI,van Kappel 2001
5718,5903,5912,All,Women,United States,NYUWHS (New York University Women's Health Study),baseline,Food Frequency Questionnaire (FFQ),Dairy foods,"",,,,,missing unit,,baseline,"Serum, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,302,Spearman,0.22,,,< 0.01,Yes,,,BMI,van Kappel 2001
5695,5904,5908,All,Women,United States,NYUWHS (New York University Women's Health Study),baseline,Food Frequency Questionnaire (FFQ),Meat,"",,,,,missing unit,,baseline,"Serum, non-fasting",HPLC,beta-Carotene,"",,,,missing unit,,302,Spearman,-0.14,,,< 0.05,Yes,,,BMI,van Kappel 2001
5703,5904,5909,All,Women,United States,NYUWHS (New York University Women's Health Study),baseline,Food Frequency Questionnaire (FFQ),Meat,"",,,,,missing unit,,baseline,"Serum, non-fasting",HPLC,alpha-Carotene,"",,,,missing unit,,302,Spearman,-0.13,,,< 0.05,Yes,,,BMI,van Kappel 2001
5696,5905,5908,All,Women,United States,NYUWHS (New York University Women's Health Study),baseline,Food Frequency Questionnaire (FFQ),Meat,"",,,,,missing unit,,baseline,"Serum, non-fasting",HPLC,beta-Carotene,"",,,,missing unit,,302,Spearman,-0.21,,,< 0.01,Yes,,,BMI,van Kappel 2001
5704,5905,5909,All,Women,United States,NYUWHS (New York University Women's Health Study),baseline,Food Frequency Questionnaire (FFQ),Meat,"",,,,,missing unit,,baseline,"Serum, non-fasting",HPLC,alpha-Carotene,"",,,,missing unit,,302,Spearman,-0.14,,,< 0.05,Yes,,,BMI,van Kappel 2001
5710,5905,5910,All,Women,United States,NYUWHS (New York University Women's Health Study),baseline,Food Frequency Questionnaire (FFQ),Meat,"",,,,,missing unit,,baseline,"Serum, non-fasting",HPLC,Lutein,"",,,,missing unit,,302,Spearman,-0.16,,,< 0.01,Yes,,,BMI,van Kappel 2001
5719,5905,5912,All,Women,United States,NYUWHS (New York University Women's Health Study),baseline,Food Frequency Questionnaire (FFQ),Meat,"",,,,,missing unit,,baseline,"Serum, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,missing unit,,302,Spearman,-0.17,,,< 0.01,Yes,,,BMI,van Kappel 2001
5712,5907,5911,All,Women,United States,NYUWHS (New York University Women's Health Study),baseline,Food Frequency Questionnaire (FFQ),Tomato,"",,,,,missing unit,,baseline,"Serum, non-fasting",HPLC,Zeaxanthin,"",,,,missing unit,,302,Spearman,-0.14,,,< 0.05,Yes,,,BMI,van Kappel 2001
5720,5999,6002,All [by intake],Adults from Gipuzkoa,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,,g/day,,,"Serum (fatty acids), fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,nmol/L,,102,Unspecified,0.63,,,< 0.001,Yes,Energy by residual method ?,,"Age, BMI, Vegetable intake",Amiano 2001
5723,5999,6005,All [by intake],Adults from Gipuzkoa,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,,g/day,,,"Serum (LDL fraction phospholipids), fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,102,Unspecified,0.54,,,< 0.001,Yes,Energy by residual method ?,,"Age, BMI, Vegetable intake",Amiano 2001
5726,5999,6008,All [by intake],Adults from Gipuzkoa,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,,g/day,,,"Serum (LDL fraction cholesteryl esters), fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,102,Unspecified,0.56,,,< 0.001,Yes,Energy by residual method ?,,"Age, BMI, Vegetable intake",Amiano 2001
5721,6000,6003,All [by intake],Adults from Gipuzkoa,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),EPA (cis-20:5n-3),"",,,,,g/day,,,"Serum (fatty acids), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,nmol/L,,102,Unspecified,0.52,,,< 0.001,Yes,Energy by residual method ?,,"Age, BMI, Vegetable intake",Amiano 2001
5724,6000,6006,All [by intake],Adults from Gipuzkoa,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),EPA (cis-20:5n-3),"",,,,,g/day,,,"Serum (LDL fraction phospholipids), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,102,Unspecified,0.38,,,< 0.005,Yes,Energy by residual method ?,,"Age, BMI, Vegetable intake",Amiano 2001
5727,6000,6009,All [by intake],Adults from Gipuzkoa,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),EPA (cis-20:5n-3),"",,,,,g/day,,,"Serum (LDL fraction cholesteryl esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,102,Unspecified,0.55,,,< 0.001,Yes,Energy by residual method ?,,"Age, BMI, Vegetable intake",Amiano 2001
5722,6001,6004,All [by intake],Adults from Gipuzkoa,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),DHA (cis-22:6n-3),"",,,,,g/day,,,"Serum (fatty acids), fasting",GC-FID,DHA (cis-22:6n-3),"",,,,nmol/L,,102,Unspecified,0.62,,,< 0.001,Yes,Energy by residual method ?,,"Age, BMI, Vegetable intake",Amiano 2001
5725,6001,6007,All [by intake],Adults from Gipuzkoa,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),DHA (cis-22:6n-3),"",,,,,g/day,,,"Serum (LDL fraction phospholipids), fasting",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,102,Unspecified,0.52,,,< 0.001,Yes,Energy by residual method ?,,"Age, BMI, Vegetable intake",Amiano 2001
5728,6001,6010,All [by intake],Adults from Gipuzkoa,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),DHA (cis-22:6n-3),"",,,,,g/day,,,"Serum (LDL fraction cholesteryl esters), fasting",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,102,Unspecified,0.5,,,< 0.001,Yes,Energy by residual method ?,,"Age, BMI, Vegetable intake",Amiano 2001
5729,6011,6012,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",Colorimetry,Vitamin C,"",1.0,,1.0,mg/dL,,116,Spearman,0.59,,,< 0.0001,Yes,,,,Block 2001
5730,6011,6012,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",Colorimetry,Vitamin C,"",1.0,,1.0,mg/dL,,116,Spearman,0.59,,,< 0.0001,Yes,,,Age,Block 2001
5731,6011,6012,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",Colorimetry,Vitamin C,"",1.0,,1.0,mg/dL,,116,Spearman,0.58,,,< 0.0001,Yes,,,Education,Block 2001
5732,6011,6012,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",Colorimetry,Vitamin C,"",1.0,,1.0,mg/dL,,116,Spearman,0.61,,,< 0.0001,Yes,,,Body weight,Block 2001
5733,6011,6012,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",Colorimetry,Vitamin C,"",1.0,,1.0,mg/dL,,116,Spearman,0.62,,,< 0.0001,Yes,,,Energy,Block 2001
5734,6011,6012,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",Colorimetry,Vitamin C,"",1.0,,1.0,mg/dL,,116,Spearman,0.6,,,< 0.0001,Yes,,,Fat intake,Block 2001
5735,6011,6012,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",Colorimetry,Vitamin C,"",1.0,,1.0,mg/dL,,116,Spearman,0.64,,,< 0.0001,Yes,,,"Age, Energy",Block 2001
5736,6011,6013,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,Carotenoids,"",80.6,,72.6,ug/dL,,116,Spearman,0.34,,,< 0.001,Yes,,,,Block 2001
5737,6011,6013,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,Carotenoids,"",80.6,,72.6,ug/dL,,116,Spearman,0.37,,,< 0.001,Yes,,,Age,Block 2001
5738,6011,6013,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,Carotenoids,"",80.6,,72.6,ug/dL,,116,Spearman,0.33,,,< 0.001,Yes,,,Education,Block 2001
5739,6011,6013,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,Carotenoids,"",80.6,,72.6,ug/dL,,116,Spearman,0.35,,,< 0.001,Yes,,,Body weight,Block 2001
5740,6011,6013,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,Carotenoids,"",80.6,,72.6,ug/dL,,116,Spearman,0.34,,,< 0.001,Yes,,,Energy,Block 2001
5741,6011,6013,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,Carotenoids,"",80.6,,72.6,ug/dL,,116,Spearman,0.34,,,< 0.001,Yes,,,Fat intake,Block 2001
5742,6011,6013,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,Carotenoids,"",80.6,,72.6,ug/dL,,116,Spearman,0.37,,,< 0.001,Yes,,,"Age, Energy",Block 2001
5743,6011,6013,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,Carotenoids,"",80.6,,72.6,ug/dL,,116,Spearman,0.4,,,< 0.0001,Yes,Lipids,,,Block 2001
5744,6011,6013,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,Carotenoids,"",80.6,,72.6,ug/dL,,116,Spearman,0.43,,,< 0.0001,Yes,Lipids,,Age,Block 2001
5745,6011,6013,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,Carotenoids,"",80.6,,72.6,ug/dL,,116,Spearman,0.4,,,< 0.0001,Yes,Lipids,,Education,Block 2001
5746,6011,6013,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,Carotenoids,"",80.6,,72.6,ug/dL,,116,Spearman,0.42,,,< 0.0001,Yes,Lipids,,Body weight,Block 2001
5747,6011,6013,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,Carotenoids,"",80.6,,72.6,ug/dL,,116,Spearman,0.41,,,< 0.0001,Yes,Lipids,,Energy,Block 2001
5748,6011,6013,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,Carotenoids,"",80.6,,72.6,ug/dL,,116,Spearman,0.4,,,< 0.0001,Yes,Lipids,,Fat intake,Block 2001
5749,6011,6013,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,Carotenoids,"",80.6,,72.6,ug/dL,,116,Spearman,0.44,,,< 0.0001,Yes,Lipids,,"Age, Energy",Block 2001
5750,6011,6014,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",13.5,,10.4,ug/dL,,116,Spearman,0.35,,,< 0.001,Yes,,,,Block 2001
5751,6011,6014,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",13.5,,10.4,ug/dL,,116,Spearman,0.34,,,< 0.001,Yes,,,Age,Block 2001
5752,6011,6014,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",13.5,,10.4,ug/dL,,116,Spearman,0.35,,,< 0.001,Yes,,,Education,Block 2001
5753,6011,6014,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",13.5,,10.4,ug/dL,,116,Spearman,0.36,,,< 0.001,Yes,,,Body weight,Block 2001
5754,6011,6014,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",13.5,,10.4,ug/dL,,116,Spearman,0.36,,,< 0.001,Yes,,,Energy,Block 2001
5755,6011,6014,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",13.5,,10.4,ug/dL,,116,Spearman,0.34,,,< 0.001,Yes,,,Fat intake,Block 2001
5756,6011,6014,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",13.5,,10.4,ug/dL,,116,Spearman,0.36,,,< 0.001,Yes,,,"Age, Energy",Block 2001
5757,6011,6014,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",13.5,,10.4,ug/dL,,116,Spearman,0.38,,,< 0.0001,Yes,Lipids,,,Block 2001
5758,6011,6014,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",13.5,,10.4,ug/dL,,116,Spearman,0.36,,,< 0.0001,Yes,Lipids,,Age,Block 2001
5759,6011,6014,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",13.5,,10.4,ug/dL,,116,Spearman,0.38,,,< 0.0001,Yes,Lipids,,Education,Block 2001
5760,6011,6014,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",13.5,,10.4,ug/dL,,116,Spearman,0.38,,,< 0.0001,Yes,Lipids,,Body weight,Block 2001
5761,6011,6014,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",13.5,,10.4,ug/dL,,116,Spearman,0.39,,,< 0.0001,Yes,Lipids,,Energy,Block 2001
5762,6011,6014,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",13.5,,10.4,ug/dL,,116,Spearman,0.37,,,< 0.0001,Yes,Lipids,,Fat intake,Block 2001
5763,6011,6014,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",13.5,,10.4,ug/dL,,116,Spearman,0.38,,,< 0.0001,Yes,Lipids,,"Age, Energy",Block 2001
5764,6011,6015,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",11.2,,9.5,ug/dL,,116,Spearman,0.43,,,< 0.0001,Yes,,,,Block 2001
5765,6011,6015,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",11.2,,9.5,ug/dL,,116,Spearman,0.43,,,< 0.0001,Yes,,,Age,Block 2001
5766,6011,6015,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",11.2,,9.5,ug/dL,,116,Spearman,0.41,,,< 0.0001,Yes,,,Education,Block 2001
5767,6011,6015,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",11.2,,9.5,ug/dL,,116,Spearman,0.43,,,< 0.0001,Yes,,,Body weight,Block 2001
5768,6011,6015,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",11.2,,9.5,ug/dL,,116,Spearman,0.44,,,< 0.0001,Yes,,,Energy,Block 2001
5769,6011,6015,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",11.2,,9.5,ug/dL,,116,Spearman,0.42,,,< 0.0001,Yes,,,Fat intake,Block 2001
5770,6011,6015,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",11.2,,9.5,ug/dL,,116,Spearman,0.46,,,< 0.0001,Yes,,,"Age, Energy",Block 2001
5771,6011,6015,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",11.2,,9.5,ug/dL,,116,Spearman,0.46,,,< 0.0001,Yes,Lipids,,,Block 2001
5772,6011,6015,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",11.2,,9.5,ug/dL,,116,Spearman,0.47,,,< 0.0001,Yes,Lipids,,Age,Block 2001
5773,6011,6015,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",11.2,,9.5,ug/dL,,116,Spearman,0.45,,,< 0.0001,Yes,Lipids,,Education,Block 2001
5774,6011,6015,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",11.2,,9.5,ug/dL,,116,Spearman,0.47,,,< 0.0001,Yes,Lipids,,Body weight,Block 2001
5775,6011,6015,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",11.2,,9.5,ug/dL,,116,Spearman,0.49,,,< 0.0001,Yes,Lipids,,Energy,Block 2001
5776,6011,6015,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",11.2,,9.5,ug/dL,,116,Spearman,0.46,,,< 0.0001,Yes,Lipids,,Fat intake,Block 2001
5777,6011,6015,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",11.2,,9.5,ug/dL,,116,Spearman,0.5,,,< 0.0001,Yes,Lipids,,"Age, Energy",Block 2001
5778,6011,6016,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",0.96,,0.95,ug/dL,,116,Spearman,0.06,,,> 0.1,No,,,,Block 2001
5779,6011,6016,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",0.96,,0.95,ug/dL,,116,Spearman,0.03,,,> 0.1,No,,,Age,Block 2001
5780,6011,6016,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",0.96,,0.95,ug/dL,,116,Spearman,0.07,,,> 0.1,No,,,Education,Block 2001
5781,6011,6016,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",0.96,,0.95,ug/dL,,116,Spearman,0.06,,,> 0.1,No,,,Body weight,Block 2001
5782,6011,6016,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",0.96,,0.95,ug/dL,,116,Spearman,0.06,,,> 0.1,No,,,Energy,Block 2001
5783,6011,6016,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",0.96,,0.95,ug/dL,,116,Spearman,0.05,,,> 0.1,No,,,Fat intake,Block 2001
5784,6011,6016,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",0.96,,0.95,ug/dL,,116,Spearman,0.03,,,> 0.1,No,,,"Age, Energy",Block 2001
5785,6011,6016,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",0.96,,0.95,ug/dL,,116,Spearman,0.26,,,< 0.05,Yes,Lipids,,,Block 2001
5786,6011,6016,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",0.96,,0.95,ug/dL,,116,Spearman,0.22,,,< 0.05,Yes,Lipids,,Age,Block 2001
5787,6011,6016,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",0.96,,0.95,ug/dL,,116,Spearman,0.27,,,< 0.05,Yes,Lipids,,Education,Block 2001
5788,6011,6016,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",0.96,,0.95,ug/dL,,116,Spearman,0.26,,,< 0.05,Yes,Lipids,,Body weight,Block 2001
5789,6011,6016,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",0.96,,0.95,ug/dL,,116,Spearman,0.28,,,< 0.05,Yes,Lipids,,Energy,Block 2001
5790,6011,6016,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",0.96,,0.95,ug/dL,,116,Spearman,0.25,,,< 0.05,Yes,Lipids,,Fat intake,Block 2001
5791,6011,6016,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",0.96,,0.95,ug/dL,,116,Spearman,0.24,,,< 0.05,Yes,Lipids,,"Age, Energy",Block 2001
5792,6011,6017,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,gamma-Tocopherol,"",0.24,,0.23,ug/dL,,116,Spearman,-0.25,,,< 0.01,Yes,,,,Block 2001
5793,6011,6017,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,gamma-Tocopherol,"",0.24,,0.23,ug/dL,,116,Spearman,-0.26,,,< 0.01,Yes,,,Age,Block 2001
5794,6011,6017,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,gamma-Tocopherol,"",0.24,,0.23,ug/dL,,116,Spearman,-0.24,,,< 0.01,Yes,,,Education,Block 2001
5795,6011,6017,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,gamma-Tocopherol,"",0.24,,0.23,ug/dL,,116,Spearman,-0.25,,,< 0.01,Yes,,,Body weight,Block 2001
5796,6011,6017,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,gamma-Tocopherol,"",0.24,,0.23,ug/dL,,116,Spearman,-0.26,,,< 0.01,Yes,,,Energy,Block 2001
5797,6011,6017,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,gamma-Tocopherol,"",0.24,,0.23,ug/dL,,116,Spearman,-0.24,,,< 0.01,Yes,,,Fat intake,Block 2001
5798,6011,6017,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,gamma-Tocopherol,"",0.24,,0.23,ug/dL,,116,Spearman,-0.28,,,< 0.01,Yes,,,"Age, Energy",Block 2001
5799,6011,6017,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,gamma-Tocopherol,"",0.24,,0.23,ug/dL,,116,Spearman,-0.2,,,< 0.05,Yes,Lipids,,,Block 2001
5800,6011,6017,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,gamma-Tocopherol,"",0.24,,0.23,ug/dL,,116,Spearman,-0.21,,,< 0.05,Yes,Lipids,,Age,Block 2001
5801,6011,6017,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,gamma-Tocopherol,"",0.24,,0.23,ug/dL,,116,Spearman,-0.18,,,< 0.05,Yes,Lipids,,Education,Block 2001
5802,6011,6017,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,gamma-Tocopherol,"",0.24,,0.23,ug/dL,,116,Spearman,-0.2,,,< 0.05,Yes,Lipids,,Body weight,Block 2001
5803,6011,6017,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,gamma-Tocopherol,"",0.24,,0.23,ug/dL,,116,Spearman,-0.2,,,< 0.05,Yes,Lipids,,Energy,Block 2001
5804,6011,6017,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,gamma-Tocopherol,"",0.24,,0.23,ug/dL,,116,Spearman,-0.19,,,< 0.05,Yes,Lipids,,Fat intake,Block 2001
5805,6011,6017,All,Residents of Washington County and surrounding areas,United States,CLUE,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,2.9,,2.6,times/day,,,"Plasma, non-fasting",HPLC,gamma-Tocopherol,"",0.24,,0.23,ug/dL,,116,Spearman,-0.22,,,< 0.05,Yes,Lipids,,"Age, Energy",Block 2001
5818,6018,6067,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin A (Carotenoids),"",Yes,6361.8,,,ug/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",175.1,,,ug/dL,,97,Pearson,0.38,,,< 0.001,Yes,Energy by residual method,No,,Knutsen 2001
5819,6018,6067,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin A (Carotenoids),"",Yes,6361.8,,,ug/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",175.1,,,ug/dL,,97,Pearson,0.386,,,< 0.001,Yes,"Energy by residual method, Cholesterol by residual method",No,,Knutsen 2001
5824,6018,6067,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin A (Carotenoids),"",Yes,6361.8,,,ug/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",175.1,,,ug/dL,,97,Pearson,0.459,,, ,Unspecified,Energy by residual method,Yes,,Knutsen 2001
5825,6018,6067,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin A (Carotenoids),"",Yes,6361.8,,,ug/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",175.1,,,ug/dL,,97,Pearson,0.466,,, ,Unspecified,"Energy by residual method, Cholesterol by residual method",Yes,,Knutsen 2001
5820,6019,6068,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin E (alpha-Tocopherol Equivalents),"",Yes,36.3,,,mg/day,,,"Serum, fasting",Fluorometry,alpha-Tocopherol,"",15.0,,,ug/mL,,97,Pearson,0.512,,,< 0.001,Yes,Energy by residual method,No,,Knutsen 2001
5821,6019,6068,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin E (alpha-Tocopherol Equivalents),"",Yes,36.3,,,mg/day,,,"Serum, fasting",Fluorometry,alpha-Tocopherol,"",15.0,,,ug/mL,,97,Pearson,0.521,,,< 0.001,Yes,"Energy by residual method, Cholesterol by residual method",No,,Knutsen 2001
5826,6019,6068,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin E (alpha-Tocopherol Equivalents),"",Yes,36.3,,,mg/day,,,"Serum, fasting",Fluorometry,alpha-Tocopherol,"",15.0,,,ug/mL,,97,Pearson,0.598,,, ,Unspecified,Energy by residual method,Yes,,Knutsen 2001
5827,6019,6068,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin E (alpha-Tocopherol Equivalents),"",Yes,36.3,,,mg/day,,,"Serum, fasting",Fluorometry,alpha-Tocopherol,"",15.0,,,ug/mL,,97,Pearson,0.612,,, ,Unspecified,"Energy by residual method, Cholesterol by residual method",Yes,,Knutsen 2001
5822,6020,6069,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin C,"",Yes,354.4,,,mg/day,,,"Leukocytes, fasting",HPLC,Ascorbic acid,"",25.1,,,ug/10^8 cells,,97,Pearson,0.191,,,= 0.062,No,Energy by residual method,No,,Knutsen 2001
5828,6020,6069,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin C,"",Yes,354.4,,,mg/day,,,"Leukocytes, fasting",HPLC,Ascorbic acid,"",25.1,,,ug/10^8 cells,,97,Pearson,0.219,,, ,Unspecified,Energy by residual method,Yes,,Knutsen 2001
5823,6021,6066,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Folates,"",Yes,407.3,,,ug/day,,,"Red blood cell, fasting",Radioimmunoassay (RIA),Folates,"",315.5,,,ng/mL,,97,Pearson,0.486,,,< 0.001,Yes,Energy by residual method,No,,Knutsen 2001
5829,6021,6066,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Folates,"",Yes,407.3,,,ug/day,,,"Red blood cell, fasting",Radioimmunoassay (RIA),Folates,"",315.5,,,ng/mL,,97,Pearson,0.537,,, ,Unspecified,Energy by residual method,Yes,,Knutsen 2001
5806,6030,6067,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin A (Carotenoids),"",No,5963.4,,,ug/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",175.1,,,ug/dL,,97,Pearson,0.351,,,= 0.001,Yes,Energy by residual method,No,,Knutsen 2001
5807,6030,6067,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin A (Carotenoids),"",No,5963.4,,,ug/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",175.1,,,ug/dL,,97,Pearson,0.363,,,= 0.001,Yes,"Energy by residual method, Cholesterol by residual method",No,,Knutsen 2001
5812,6030,6067,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin A (Carotenoids),"",No,5963.4,,,ug/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",175.1,,,ug/dL,,97,Pearson,0.432,,, ,Unspecified,Energy by residual method,Yes,,Knutsen 2001
5813,6030,6067,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin A (Carotenoids),"",No,5963.4,,,ug/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",175.1,,,ug/dL,,97,Pearson,0.448,,, ,Unspecified,"Energy by residual method, Cholesterol by residual method",Yes,,Knutsen 2001
5808,6031,6068,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin E (alpha-Tocopherol Equivalents),"",No,9.1,,,mg/day,,,"Serum, fasting",Fluorometry,alpha-Tocopherol,"",15.0,,,ug/mL,,97,Pearson,0.271,,,= 0.047,Yes,Energy by residual method,No,,Knutsen 2001
5809,6031,6068,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin E (alpha-Tocopherol Equivalents),"",No,9.1,,,mg/day,,,"Serum, fasting",Fluorometry,alpha-Tocopherol,"",15.0,,,ug/mL,,97,Pearson,0.352,,,= 0.009,Yes,"Energy by residual method, Cholesterol by residual method",No,,Knutsen 2001
5814,6031,6068,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin E (alpha-Tocopherol Equivalents),"",No,9.1,,,mg/day,,,"Serum, fasting",Fluorometry,alpha-Tocopherol,"",15.0,,,ug/mL,,97,Pearson,0.33,,, ,Unspecified,Energy by residual method,Yes,,Knutsen 2001
5815,6031,6068,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin E (alpha-Tocopherol Equivalents),"",No,9.1,,,mg/day,,,"Serum, fasting",Fluorometry,alpha-Tocopherol,"",15.0,,,ug/mL,,97,Pearson,0.428,,, ,Unspecified,"Energy by residual method, Cholesterol by residual method",Yes,,Knutsen 2001
5810,6032,6069,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin C,"",No,136.8,,,mg/day,,,"Leukocytes, fasting",HPLC,Ascorbic acid,"",25.1,,,ug/10^8 cells,,97,Pearson,0.162,,,= 0.273,No,Energy by residual method,No,,Knutsen 2001
5816,6032,6069,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin C,"",No,136.8,,,mg/day,,,"Leukocytes, fasting",HPLC,Ascorbic acid,"",25.1,,,ug/10^8 cells,,97,Pearson,0.195,,, ,Unspecified,Energy by residual method,Yes,,Knutsen 2001
5811,6033,6066,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Folates,"",No,306.6,,,ug/day,,,"Red blood cell, fasting",Radioimmunoassay (RIA),Folates,"",315.5,,,ng/mL,,97,Pearson,0.478,,,< 0.001,Yes,Energy by residual method,No,,Knutsen 2001
5817,6033,6066,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Folates,"",No,306.6,,,ug/day,,,"Red blood cell, fasting",Radioimmunoassay (RIA),Folates,"",315.5,,,ng/mL,,97,Pearson,0.527,,, ,Unspecified,Energy by residual method,Yes,,Knutsen 2001
5836,6090,6067,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Vitamin A (Carotenoids),"",Yes,,,,ug/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",175.1,,,ug/dL,,97,Pearson,0.34,,,= 0.007,Yes,Energy by residual method,No,,Knutsen 2001
5837,6090,6067,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Vitamin A (Carotenoids),"",Yes,,,,ug/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",175.1,,,ug/dL,,97,Pearson,0.31,,,= 0.015,Yes,"Energy by residual method, Cholesterol by residual method",No,,Knutsen 2001
5838,6091,6068,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",Yes,,,,mg/day,,,"Serum, fasting",Fluorometry,alpha-Tocopherol,"",15.0,,,ug/mL,,97,Pearson,0.279,,,= 0.041,Yes,Energy by residual method,No,,Knutsen 2001
5839,6091,6068,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",Yes,,,,mg/day,,,"Serum, fasting",Fluorometry,alpha-Tocopherol,"",15.0,,,ug/mL,,97,Pearson,0.373,,,< 0.001,Yes,"Energy by residual method, Cholesterol by residual method",No,,Knutsen 2001
5840,6092,6069,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Vitamin C,"",Yes,,,,mg/day,,,"Leukocytes, fasting",HPLC,Ascorbic acid,"",25.1,,,ug/10^8 cells,,97,Pearson,0.195,,,= 0.226,No,Energy by residual method,No,,Knutsen 2001
5841,6093,6066,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Folates,"",Yes,,,,ug/day,,,"Red blood cell, fasting",Radioimmunoassay (RIA),Folates,"",315.5,,,ng/mL,,97,Pearson,0.237,,,= 0.052,No,Energy by residual method,No,,Knutsen 2001
5830,6094,6067,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Vitamin A (Carotenoids),"",No,,,,ug/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",175.1,,,ug/dL,,97,Pearson,0.393,,,= 0.002,Yes,Energy by residual method,No,,Knutsen 2001
5831,6094,6067,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Vitamin A (Carotenoids),"",No,,,,ug/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",175.1,,,ug/dL,,97,Pearson,0.362,,,= 0.004,Yes,"Energy by residual method, Cholesterol by residual method",No,,Knutsen 2001
5832,6095,6068,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",No,,,,mg/day,,,"Serum, fasting",Fluorometry,alpha-Tocopherol,"",15.0,,,ug/mL,,97,Pearson,0.089,,,= 0.528,No,Energy by residual method,No,,Knutsen 2001
5833,6095,6068,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",No,,,,mg/day,,,"Serum, fasting",Fluorometry,alpha-Tocopherol,"",15.0,,,ug/mL,,97,Pearson,0.09,,,= 0.522,No,"Energy by residual method, Cholesterol by residual method",No,,Knutsen 2001
5834,6096,6069,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Vitamin C,"",No,,,,mg/day,,,"Leukocytes, fasting",HPLC,Ascorbic acid,"",25.1,,,ug/10^8 cells,,97,Pearson,-0.02,,,= 0.98,No,Energy by residual method,No,,Knutsen 2001
5835,6097,6066,Non-Hispanic Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Red blood cell, fasting",Radioimmunoassay (RIA),Folates,"",315.5,,,ng/mL,,97,Pearson,0.11,,,= 0.915,No,Energy by residual method,No,,Knutsen 2001
5854,6042,6079,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin A (Carotenoids),"",Yes,6161.9,,,ug/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",164.2,,,ug/dL,,96,Pearson,0.38,,,< 0.001,Yes,Energy by residual method,No,,Knutsen 2001
5855,6042,6079,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin A (Carotenoids),"",Yes,6161.9,,,ug/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",164.2,,,ug/dL,,96,Pearson,0.43,,,< 0.001,Yes,"Energy by residual method, Cholesterol by residual method",No,,Knutsen 2001
5860,6042,6079,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin A (Carotenoids),"",Yes,6161.9,,,ug/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",164.2,,,ug/dL,,96,Pearson,0.485,,, ,Unspecified,Energy by residual method,Yes,,Knutsen 2001
5861,6042,6079,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin A (Carotenoids),"",Yes,6161.9,,,ug/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",164.2,,,ug/dL,,96,Pearson,0.552,,, ,Unspecified,"Energy by residual method, Cholesterol by residual method",Yes,,Knutsen 2001
5856,6043,6080,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin E (alpha-Tocopherol Equivalents),"",Yes,60.0,,,mg/day,,,"Serum, fasting",Fluorometry,alpha-Tocopherol,"",16.3,,,ug/mL,,96,Pearson,0.412,,,< 0.001,Yes,Energy by residual method,No,,Knutsen 2001
5857,6043,6080,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin E (alpha-Tocopherol Equivalents),"",Yes,60.0,,,mg/day,,,"Serum, fasting",Fluorometry,alpha-Tocopherol,"",16.3,,,ug/mL,,96,Pearson,0.471,,,< 0.001,Yes,"Energy by residual method, Cholesterol by residual method",No,,Knutsen 2001
5862,6043,6080,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin E (alpha-Tocopherol Equivalents),"",Yes,60.0,,,mg/day,,,"Serum, fasting",Fluorometry,alpha-Tocopherol,"",16.3,,,ug/mL,,96,Pearson,0.441,,, ,Unspecified,Energy by residual method,Yes,,Knutsen 2001
5863,6043,6080,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin E (alpha-Tocopherol Equivalents),"",Yes,60.0,,,mg/day,,,"Serum, fasting",Fluorometry,alpha-Tocopherol,"",16.3,,,ug/mL,,96,Pearson,0.504,,, ,Unspecified,"Energy by residual method, Cholesterol by residual method",Yes,,Knutsen 2001
5858,6044,6081,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin C,"",Yes,335.1,,,mg/day,,,"Leukocytes, fasting",HPLC,Ascorbic acid,"",28.8,,,ug/10^8 cells,,96,Pearson,0.168,,,= 0.092,No,Energy by residual method,No,,Knutsen 2001
5864,6044,6081,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin C,"",Yes,335.1,,,mg/day,,,"Leukocytes, fasting",HPLC,Ascorbic acid,"",28.8,,,ug/10^8 cells,,96,Pearson,0.171,,, ,Unspecified,Energy by residual method,Yes,,Knutsen 2001
5859,6045,6078,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Folates,"",Yes,485.0,,,ug/day,,,"Red blood cell, fasting",Radioimmunoassay (RIA),Folates,"",452.6,,,ng/mL,,96,Pearson,0.502,,,< 0.001,Yes,Energy by residual method,No,,Knutsen 2001
5865,6045,6078,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Folates,"",Yes,485.0,,,ug/day,,,"Red blood cell, fasting",Radioimmunoassay (RIA),Folates,"",452.6,,,ng/mL,,96,Pearson,0.551,,, ,Unspecified,Energy by residual method,Yes,,Knutsen 2001
5842,6054,6079,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin A (Carotenoids),"",No,5142.3,,,ug/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",164.2,,,ug/dL,,96,Pearson,0.351,,,= 0.004,Yes,Energy by residual method,No,,Knutsen 2001
5843,6054,6079,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin A (Carotenoids),"",No,5142.3,,,ug/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",164.2,,,ug/dL,,96,Pearson,0.427,,,< 0.001,Yes,"Energy by residual method, Cholesterol by residual method",No,,Knutsen 2001
5848,6054,6079,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin A (Carotenoids),"",No,5142.3,,,ug/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",164.2,,,ug/dL,,96,Pearson,0.448,,, ,Unspecified,Energy by residual method,Yes,,Knutsen 2001
5849,6054,6079,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin A (Carotenoids),"",No,5142.3,,,ug/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",164.2,,,ug/dL,,96,Pearson,0.549,,, ,Unspecified,"Energy by residual method, Cholesterol by residual method",Yes,,Knutsen 2001
5844,6055,6080,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin E (alpha-Tocopherol Equivalents),"",No,10.3,,,mg/day,,,"Serum, fasting",Fluorometry,alpha-Tocopherol,"",16.3,,,ug/mL,,96,Pearson,-0.342,,,= 0.029,Yes,Energy by residual method,No,,Knutsen 2001
5845,6055,6080,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin E (alpha-Tocopherol Equivalents),"",No,10.3,,,mg/day,,,"Serum, fasting",Fluorometry,alpha-Tocopherol,"",16.3,,,ug/mL,,96,Pearson,-0.141,,,= 0.376,No,"Energy by residual method, Cholesterol by residual method",No,,Knutsen 2001
5850,6055,6080,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin E (alpha-Tocopherol Equivalents),"",No,10.3,,,mg/day,,,"Serum, fasting",Fluorometry,alpha-Tocopherol,"",16.3,,,ug/mL,,96,Pearson,-0.409,,, ,Unspecified,Energy by residual method,Yes,,Knutsen 2001
5851,6055,6080,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin E (alpha-Tocopherol Equivalents),"",No,10.3,,,mg/day,,,"Serum, fasting",Fluorometry,alpha-Tocopherol,"",16.3,,,ug/mL,,96,Pearson,-0.175,,, ,Unspecified,"Energy by residual method, Cholesterol by residual method",Yes,,Knutsen 2001
5846,6056,6081,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin C,"",No,150.9,,,mg/day,,,"Leukocytes, fasting",HPLC,Ascorbic acid,"",28.8,,,ug/10^8 cells,,96,Pearson,0.106,,,= 0.491,No,Energy by residual method,No,,Knutsen 2001
5852,6056,6081,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Vitamin C,"",No,150.9,,,mg/day,,,"Leukocytes, fasting",HPLC,Ascorbic acid,"",28.8,,,ug/10^8 cells,,96,Pearson,0.12,,, ,Unspecified,Energy by residual method,Yes,,Knutsen 2001
5847,6057,6078,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Folates,"",No,372.7,,,ug/day,,,"Red blood cell, fasting",Radioimmunoassay (RIA),Folates,"",452.6,,,ng/mL,,96,Pearson,0.384,,,= 0.005,Yes,Energy by residual method,No,,Knutsen 2001
5853,6057,6078,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Folates,"",No,372.7,,,ug/day,,,"Red blood cell, fasting",Radioimmunoassay (RIA),Folates,"",452.6,,,ng/mL,,96,Pearson,0.418,,, ,Unspecified,Energy by residual method,Yes,,Knutsen 2001
5872,6098,6079,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Vitamin A (Carotenoids),"",Yes,,,,ug/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",164.2,,,ug/dL,,96,Pearson,0.284,,,= 0.026,Yes,Energy by residual method,No,,Knutsen 2001
5873,6098,6079,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Vitamin A (Carotenoids),"",Yes,,,,ug/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",164.2,,,ug/dL,,96,Pearson,0.294,,,= 0.022,Yes,"Energy by residual method, Cholesterol by residual method",No,,Knutsen 2001
5874,6099,6080,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",Yes,,,,mg/day,,,"Serum, fasting",Fluorometry,alpha-Tocopherol,"",16.3,,,ug/mL,,96,Pearson,0.397,,,= 0.002,Yes,Energy by residual method,No,,Knutsen 2001
5875,6099,6080,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",Yes,,,,mg/day,,,"Serum, fasting",Fluorometry,alpha-Tocopherol,"",16.3,,,ug/mL,,96,Pearson,0.555,,,< 0.001,Yes,"Energy by residual method, Cholesterol by residual method",No,,Knutsen 2001
5876,6100,6081,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Vitamin C,"",Yes,,,,mg/day,,,"Leukocytes, fasting",HPLC,Ascorbic acid,"",28.8,,,ug/10^8 cells,,96,Pearson,0.027,,,= 0.872,No,Energy by residual method,No,,Knutsen 2001
5877,6101,6078,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Folates,"",Yes,,,,ug/day,,,"Red blood cell, fasting",Radioimmunoassay (RIA),Folates,"",452.6,,,ng/mL,,96,Pearson,0.318,,,= 0.013,Yes,Energy by residual method,No,,Knutsen 2001
5866,6102,6079,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Vitamin A (Carotenoids),"",No,,,,ug/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",164.2,,,ug/dL,,96,Pearson,0.291,,,= 0.023,Yes,Energy by residual method,No,,Knutsen 2001
5867,6102,6079,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Vitamin A (Carotenoids),"",No,,,,ug/day,,,"Serum, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",164.2,,,ug/dL,,96,Pearson,0.329,,,= 0.009,Yes,"Energy by residual method, Cholesterol by residual method",No,,Knutsen 2001
5868,6103,6080,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",No,,,,mg/day,,,"Serum, fasting",Fluorometry,alpha-Tocopherol,"",16.3,,,ug/mL,,96,Pearson,-0.202,,,= 0.145,No,Energy by residual method,No,,Knutsen 2001
5869,6103,6080,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",No,,,,mg/day,,,"Serum, fasting",Fluorometry,alpha-Tocopherol,"",16.3,,,ug/mL,,96,Pearson,0.101,,,= 0.48,No,"Energy by residual method, Cholesterol by residual method",No,,Knutsen 2001
5870,6104,6081,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Vitamin C,"",No,,,,mg/day,,,"Leukocytes, fasting",HPLC,Ascorbic acid,"",28.8,,,ug/10^8 cells,,96,Pearson,-0.014,,,= 0.933,No,Energy by residual method,No,,Knutsen 2001
5871,6105,6078,Non-Hispanic Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Red blood cell, fasting",Radioimmunoassay (RIA),Folates,"",452.6,,,ng/mL,,96,Pearson,0.279,,,= 0.032,Yes,Energy by residual method,No,,Knutsen 2001
5898,6168,6300,Males,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,33.0,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,115,Spearman,-0.01,,,>= 0.05,No,,,"Age, Employment grade",Brunner 2001
5899,6170,6301,Males,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,18.0,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,115,Spearman,0.33,,,< 0.01,Yes,,,"Age, Employment grade",Brunner 2001
5903,6172,6305,Males,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),Vitamin E,"",,5.8,,,mg/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,mmol/L,,356,Spearman,-0.07,,,>= 0.05,No,,,"Age, Employment grade",Brunner 2001
5902,6174,6304,Males,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),Vitamin A (Carotenoids),"",,2713.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,mmol/L,,356,Spearman,0.22,,,< 0.0001,Yes,,,"Age, Employment grade",Brunner 2001
5900,6175,6302,Males,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,115,Spearman,0.37,,,< 0.001,Yes,,,"Age, Employment grade",Brunner 2001
5901,6176,6303,Males,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,115,Spearman,0.45,,,< 0.0001,Yes,,,"Age, Employment grade",Brunner 2001
5982,6207,6300,Males,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,33.0,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,115,Spearman,0.25,,,< 0.05,Yes,Energy by residual method,,"Age, Employment grade",Brunner 2001
5983,6209,6301,Males,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,18.0,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,115,Spearman,0.4,,,= 0.0001,Yes,Energy by residual method,,"Age, Employment grade",Brunner 2001
5987,6211,6305,Males,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),Vitamin E,"",,5.8,,,mg/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,mmol/L,,356,Spearman,-0.07,,,>= 0.05,No,Energy by residual method,,"Age, Employment grade",Brunner 2001
5986,6213,6304,Males,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),Vitamin A (Carotenoids),"",,2713.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,mmol/L,,356,Spearman,0.25,,,< 0.0001,Yes,Energy by residual method,,"Age, Employment grade",Brunner 2001
5984,6214,6302,Males,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,115,Spearman,0.38,,,< 0.0001,Yes,Energy by residual method,,"Age, Employment grade",Brunner 2001
5985,6215,6303,Males,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,115,Spearman,0.5,,,< 0.0001,Yes,Energy by residual method,,"Age, Employment grade",Brunner 2001
5914,6264,6300,Males,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,115,Spearman,0.16,,,>= 0.05,No,,,"Age, Employment grade",Brunner 2001
5915,6265,6301,Males,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,115,Spearman,0.43,,,< 0.0001,Yes,,,"Age, Employment grade",Brunner 2001
5916,6268,6302,Males,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,115,Spearman,0.38,,,< 0.0001,Yes,,,"Age, Employment grade",Brunner 2001
5917,6269,6303,Males,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,115,Spearman,0.54,,,< 0.0001,Yes,,,"Age, Employment grade",Brunner 2001
5994,6288,6300,Males,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,115,Spearman,0.17,,,>= 0.05,No,Energy by residual method,,"Age, Employment grade",Brunner 2001
5995,6289,6301,Males,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,115,Spearman,0.43,,,< 0.0001,Yes,Energy by residual method,,"Age, Employment grade",Brunner 2001
5996,6292,6302,Males,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,115,Spearman,0.38,,,< 0.0001,Yes,Energy by residual method,,"Age, Employment grade",Brunner 2001
5997,6293,6303,Males,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,115,Spearman,0.53,,,< 0.0001,Yes,Energy by residual method,,"Age, Employment grade",Brunner 2001
5878,6108,6300,Males,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),"Fatty acids, saturated (SFA)","",,38.0,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,115,Spearman,-0.04,,,>= 0.05,No,,,"Age, Employment grade",Brunner 2001
5879,6110,6301,Males,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,18.0,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,115,Spearman,0.36,,,< 0.001,Yes,,,"Age, Employment grade",Brunner 2001
5883,6112,6305,Males,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),Vitamin E,"",,6.5,,,mg/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,mmol/L,,356,Spearman,-0.01,,,>= 0.05,No,,,"Age, Employment grade",Brunner 2001
5882,6114,6304,Males,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),Vitamin A (Carotenoids),"",,2181.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,mmol/L,,356,Spearman,0.23,,,< 0.0001,Yes,,,"Age, Employment grade",Brunner 2001
5880,6115,6302,Males,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,115,Spearman,0.46,,,< 0.0001,Yes,,,"Age, Employment grade",Brunner 2001
5881,6116,6303,Males,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),EPA (cis-20:5n-3),"",,,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,115,Spearman,0.25,,,< 0.05,Yes,,,"Age, Employment grade",Brunner 2001
5962,6148,6300,Males,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),"Fatty acids, saturated (SFA)","",,38.0,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,115,Spearman,0.23,,,< 0.05,Yes,Energy by residual method,,"Age, Employment grade",Brunner 2001
5963,6150,6301,Males,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,18.0,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,115,Spearman,0.46,,,= 0.0001,Yes,Energy by residual method,,"Age, Employment grade",Brunner 2001
5967,6152,6305,Males,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),Vitamin E,"",,6.5,,,mg/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,mmol/L,,356,Spearman,-0.02,,,>= 0.05,No,Energy by residual method,,"Age, Employment grade",Brunner 2001
5966,6154,6304,Males,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),Vitamin A (Carotenoids),"",,2180.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,mmol/L,,356,Spearman,0.23,,,< 0.0001,Yes,Energy by residual method,,"Age, Employment grade",Brunner 2001
5964,6155,6302,Males,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,115,Spearman,0.45,,,< 0.0001,Yes,Energy by residual method,,"Age, Employment grade",Brunner 2001
5965,6156,6303,Males,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),EPA (cis-20:5n-3),"",,,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,115,Spearman,0.24,,,< 0.05,Yes,Energy by residual method,,"Age, Employment grade",Brunner 2001
5890,6226,6300,Males,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,115,Spearman,0.23,,,< 0.05,Yes,,,"Age, Employment grade",Brunner 2001
5891,6227,6301,Males,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,115,Spearman,0.37,,,< 0.001,Yes,,,"Age, Employment grade",Brunner 2001
5892,6228,6302,Males,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,115,Spearman,0.39,,,< 0.0001,Yes,,,"Age, Employment grade",Brunner 2001
5893,6229,6303,Males,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),EPA (cis-20:5n-3),"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,115,Spearman,0.28,,,< 0.01,Yes,,,"Age, Employment grade",Brunner 2001
5974,6252,6300,Males,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,115,Spearman,0.26,,,< 0.05,Yes,Energy by residual method,,"Age, Employment grade",Brunner 2001
5975,6253,6301,Males,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,115,Spearman,0.41,,,< 0.0001,Yes,Energy by residual method,,"Age, Employment grade",Brunner 2001
5976,6256,6302,Males,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,115,Spearman,0.41,,,< 0.0001,Yes,Energy by residual method,,"Age, Employment grade",Brunner 2001
5977,6257,6303,Males,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),EPA (cis-20:5n-3),"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,115,Spearman,0.19,,,>= 0.05,No,Energy by residual method,,"Age, Employment grade",Brunner 2001
5904,6178,6306,Females,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,28.0,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,71,Spearman,0.05,,,>= 0.05,No,,,"Age, Employment grade",Brunner 2001
5905,6180,6307,Females,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,15.0,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,71,Spearman,0.45,,,< 0.001,Yes,,,"Age, Employment grade",Brunner 2001
5909,6182,6308,Females,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),Vitamin E,"",,6.2,,,mg/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,mmol/L,,309,Spearman,-0.07,,,>= 0.05,No,,,"Age, Employment grade",Brunner 2001
5908,6184,6309,Females,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),Vitamin A (Carotenoids),"",,3100.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,mmol/L,,309,Spearman,0.2,,,< 0.001,Yes,,,"Age, Employment grade",Brunner 2001
5906,6185,6310,Females,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,71,Spearman,0.51,,,< 0.0001,Yes,,,"Age, Employment grade",Brunner 2001
5907,6186,6311,Females,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,71,Spearman,0.13,,,>= 0.05,No,,,"Age, Employment grade",Brunner 2001
5988,6217,6306,Females,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,28.0,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,71,Spearman,0.23,,,>= 0.05,No,Energy by residual method,,"Age, Employment grade",Brunner 2001
5989,6219,6307,Females,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,15.0,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,71,Spearman,0.33,,,< 0.01,Yes,Energy by residual method,,"Age, Employment grade",Brunner 2001
5993,6221,6308,Females,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),Vitamin E,"",,6.2,,,mg/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,mmol/L,,309,Spearman,-0.07,,,>= 0.05,No,Energy by residual method,,"Age, Employment grade",Brunner 2001
5992,6223,6309,Females,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),Vitamin A (Carotenoids),"",,3100.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,mmol/L,,309,Spearman,0.26,,,< 0.0001,Yes,Energy by residual method,,"Age, Employment grade",Brunner 2001
5990,6224,6310,Females,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,71,Spearman,0.46,,,< 0.001,Yes,Energy by residual method,,"Age, Employment grade",Brunner 2001
5991,6225,6311,Females,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,71,Spearman,0.18,,,>= 0.05,No,Energy by residual method,,"Age, Employment grade",Brunner 2001
5918,6270,6306,Females,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,71,Spearman,0.26,,,< 0.05,Yes,,,"Age, Employment grade",Brunner 2001
5919,6271,6307,Females,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,71,Spearman,0.5,,,< 0.0001,Yes,,,"Age, Employment grade",Brunner 2001
5920,6274,6310,Females,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,71,Spearman,0.57,,,< 0.0001,Yes,,,"Age, Employment grade",Brunner 2001
5921,6275,6311,Females,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,71,Spearman,0.23,,,>= 0.05,No,,,"Age, Employment grade",Brunner 2001
5998,6294,6306,Females,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,71,Spearman,0.26,,,< 0.05,Yes,Energy by residual method,,"Age, Employment grade",Brunner 2001
5999,6295,6307,Females,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,71,Spearman,0.41,,,< 0.001,Yes,Energy by residual method,,"Age, Employment grade",Brunner 2001
6000,6298,6310,Females,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,71,Spearman,0.53,,,< 0.0001,Yes,Energy by residual method,,"Age, Employment grade",Brunner 2001
6001,6299,6311,Females,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,71,Spearman,0.23,,,>= 0.05,No,Energy by residual method,,"Age, Employment grade",Brunner 2001
5884,6118,6306,Females,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),"Fatty acids, saturated (SFA)","",,30.0,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,71,Spearman,0.08,,,>= 0.05,No,,,"Age, Employment grade",Brunner 2001
5885,6120,6307,Females,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,14.0,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,71,Spearman,0.56,,,< 0.0001,Yes,,,"Age, Employment grade",Brunner 2001
5889,6122,6308,Females,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),Vitamin E,"",,6.0,,,mg/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,mmol/L,,309,Spearman,-0.04,,,>= 0.05,No,,,"Age, Employment grade",Brunner 2001
5888,6124,6309,Females,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),Vitamin A (Carotenoids),"",,2221.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,mmol/L,,309,Spearman,0.16,,,< 0.01,Yes,,,"Age, Employment grade",Brunner 2001
5886,6125,6310,Females,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,71,Spearman,0.67,,,< 0.0001,Yes,,,"Age, Employment grade",Brunner 2001
5887,6126,6311,Females,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),EPA (cis-20:5n-3),"",,,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,71,Spearman,0.38,,,< 0.01,Yes,,,"Age, Employment grade",Brunner 2001
5968,6158,6306,Females,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),"Fatty acids, saturated (SFA)","",,30.0,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,71,Spearman,0.25,,,>= 0.05,No,Energy by residual method,,"Age, Employment grade",Brunner 2001
5969,6160,6307,Females,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,14.0,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,71,Spearman,0.48,,,< 0.0001,Yes,Energy by residual method,,"Age, Employment grade",Brunner 2001
5973,6162,6308,Females,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),Vitamin E,"",,6.0,,,mg/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,mmol/L,,309,Spearman,-0.03,,,>= 0.05,No,Energy by residual method,,"Age, Employment grade",Brunner 2001
5972,6164,6309,Females,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),Vitamin A (Carotenoids),"",,2221.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,mmol/L,,309,Spearman,0.18,,,< 0.01,Yes,Energy by residual method,,"Age, Employment grade",Brunner 2001
5970,6165,6310,Females,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,71,Spearman,0.6,,,< 0.0001,Yes,Energy by residual method,,"Age, Employment grade",Brunner 2001
5971,6166,6311,Females,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),EPA (cis-20:5n-3),"",,,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,71,Spearman,0.42,,,< 0.001,Yes,Energy by residual method,,"Age, Employment grade",Brunner 2001
5894,6234,6306,Females,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,71,Spearman,0.15,,,>= 0.05,No,,,"Age, Employment grade",Brunner 2001
5895,6235,6307,Females,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,71,Spearman,0.49,,,< 0.0001,Yes,,,"Age, Employment grade",Brunner 2001
5896,6238,6310,Females,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,71,Spearman,0.61,,,< 0.0001,Yes,,,"Age, Employment grade",Brunner 2001
5897,6239,6311,Females,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),EPA (cis-20:5n-3),"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,71,Spearman,0.36,,,< 0.01,Yes,,,"Age, Employment grade",Brunner 2001
5978,6258,6306,Females,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,71,Spearman,0.16,,,>= 0.05,No,Energy by residual method,,"Age, Employment grade",Brunner 2001
5979,6259,6307,Females,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,71,Spearman,0.51,,,< 0.0001,Yes,Energy by residual method,,"Age, Employment grade",Brunner 2001
5980,6262,6310,Females,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,71,Spearman,0.62,,,< 0.0001,Yes,Energy by residual method,,"Age, Employment grade",Brunner 2001
5981,6263,6311,Females,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),EPA (cis-20:5n-3),"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,71,Spearman,0.38,,,< 0.01,Yes,Energy by residual method,,"Age, Employment grade",Brunner 2001
5942,6188,6312,Males - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,39.0,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,78,Spearman,0.14,,,>= 0.05,No,,,"Age, Employment grade",Brunner 2001
5943,6190,6313,Males - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,22.0,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,78,Spearman,0.31,,,< 0.05,Yes,,,"Age, Employment grade",Brunner 2001
5947,6192,6314,Males - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),Vitamin E,"",,6.8,,,mg/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,mmol/L,,216,Spearman,-0.11,,,>= 0.05,No,,,"Age, Employment grade",Brunner 2001
5946,6194,6315,Males - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),Vitamin A (Carotenoids),"",,3012.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,mmol/L,,216,Spearman,0.24,,,< 0.001,Yes,,,"Age, Employment grade",Brunner 2001
5944,6195,6316,Males - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,78,Spearman,0.4,,,< 0.01,Yes,,,"Age, Employment grade",Brunner 2001
5945,6196,6317,Males - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,78,Spearman,0.45,,,< 0.001,Yes,,,"Age, Employment grade",Brunner 2001
5954,6276,6312,Males - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,78,Spearman,0.24,,,>= 0.05,No,,,"Age, Employment grade",Brunner 2001
5955,6277,6313,Males - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,78,Spearman,0.55,,,< 0.0001,Yes,,,"Age, Employment grade",Brunner 2001
5956,6280,6316,Males - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,78,Spearman,0.47,,,< 0.0001,Yes,,,"Age, Employment grade",Brunner 2001
5957,6281,6317,Males - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,78,Spearman,0.56,,,< 0.0001,Yes,,,"Age, Employment grade",Brunner 2001
5922,6128,6312,Males - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),"Fatty acids, saturated (SFA)","",,43.0,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,92,Spearman,0.11,,,>= 0.05,No,,,"Age, Employment grade",Brunner 2001
5923,6130,6313,Males - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,20.0,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,92,Spearman,0.31,,,< 0.01,Yes,,,"Age, Employment grade",Brunner 2001
5927,6132,6314,Males - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),Vitamin E,"",,7.4,,,mg/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,mmol/L,,249,Spearman,0.02,,,>= 0.05,No,,,"Age, Employment grade",Brunner 2001
5926,6134,6315,Males - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),Vitamin A (Carotenoids),"",,2279.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,mmol/L,,249,Spearman,0.28,,,< 0.0001,Yes,,,"Age, Employment grade",Brunner 2001
5924,6135,6316,Males - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,92,Spearman,0.35,,,< 0.01,Yes,,,"Age, Employment grade",Brunner 2001
5925,6136,6317,Males - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),EPA (cis-20:5n-3),"",,,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,92,Spearman,0.31,,,< 0.01,Yes,,,"Age, Employment grade",Brunner 2001
5934,6240,6312,Males - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,92,Spearman,0.07,,,>= 0.05,No,,,"Age, Employment grade",Brunner 2001
5935,6241,6313,Males - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,92,Spearman,0.32,,,< 0.01,Yes,,,"Age, Employment grade",Brunner 2001
5936,6244,6316,Males - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,92,Spearman,0.35,,,< 0.01,Yes,,,"Age, Employment grade",Brunner 2001
5937,6245,6317,Males - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),EPA (cis-20:5n-3),"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,92,Spearman,0.34,,,< 0.01,Yes,,,"Age, Employment grade",Brunner 2001
5948,6198,6318,Females - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,32.0,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,50,Spearman,0.04,,,>= 0.05,No,,,"Age, Employment grade",Brunner 2001
5949,6200,6319,Females - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,17.0,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,50,Spearman,0.64,,,< 0.0001,Yes,,,"Age, Employment grade",Brunner 2001
5953,6202,6320,Females - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),Vitamin E,"",,6.8,,,mg/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,mmol/L,,220,Spearman,-0.07,,,>= 0.05,No,,,"Age, Employment grade",Brunner 2001
5952,6204,6321,Females - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),Vitamin A (Carotenoids),"",,3361.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,mmol/L,,220,Spearman,0.23,,,< 0.001,Yes,,,"Age, Employment grade",Brunner 2001
5950,6205,6322,Females - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,50,Spearman,0.63,,,< 0.0001,Yes,,,"Age, Employment grade",Brunner 2001
5951,6206,6323,Females - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,50,Spearman,0.14,,,>= 0.05,No,,,"Age, Employment grade",Brunner 2001
5958,6282,6318,Females - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,50,Spearman,0.29,,,>= 0.05,No,,,"Age, Employment grade",Brunner 2001
5959,6283,6319,Females - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,50,Spearman,0.51,,,< 0.001,Yes,,,"Age, Employment grade",Brunner 2001
5960,6286,6322,Females - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,50,Spearman,0.56,,,< 0.0001,Yes,,,"Age, Employment grade",Brunner 2001
5961,6287,6323,Females - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,50,Spearman,0.25,,,>= 0.05,No,,,"Age, Employment grade",Brunner 2001
5928,6138,6318,Females - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),"Fatty acids, saturated (SFA)","",,35.0,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,42,Spearman,0.03,,,>= 0.05,No,,,"Age, Employment grade",Brunner 2001
5929,6140,6319,Females - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,16.0,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,42,Spearman,0.77,,,< 0.0001,Yes,,,"Age, Employment grade",Brunner 2001
5933,6142,6320,Females - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),Vitamin E,"",,6.8,,,mg/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,mmol/L,,211,Spearman,-0.1,,,>= 0.05,No,,,"Age, Employment grade",Brunner 2001
5932,6144,6321,Females - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),Vitamin A (Carotenoids),"",,2405.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,mmol/L,,211,Spearman,0.14,,,< 0.05,Yes,,,"Age, Employment grade",Brunner 2001
5930,6145,6322,Females - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,42,Spearman,0.84,,,< 0.0001,Yes,,,"Age, Employment grade",Brunner 2001
5931,6146,6323,Females - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),EPA (cis-20:5n-3),"",,,,,g/day,,,"Serum (cholesteryl esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,42,Spearman,0.37,,,< 0.05,Yes,,,"Age, Employment grade",Brunner 2001
5938,6246,6318,Females - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,42,Spearman,0.1,,,>= 0.05,No,,,"Age, Employment grade",Brunner 2001
5939,6247,6319,Females - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,42,Spearman,0.56,,,< 0.001,Yes,,,"Age, Employment grade",Brunner 2001
5940,6250,6322,Females - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,42,Spearman,0.8,,,< 0.0001,Yes,,,"Age, Employment grade",Brunner 2001
5941,6251,6323,Females - Low energy reporters excluded,London-based civil servants,United Kingdom,Whitehall Study,,Dietary record (7-day),EPA (cis-20:5n-3),"",,,,,percentRoot,,,"Serum (cholesteryl esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,42,Spearman,0.37,,,< 0.05,Yes,,,"Age, Employment grade",Brunner 2001
6010,6402,6377,All,Obese patients in a clinic from Murcia,Spain,,,Dietary record (7-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,1.59,,,percentRoot,,,"Adipose tissue, intraabdominal (omental)",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.59,,,percentRoot,,24,Pearson,0.43,,,< 0.05,Yes,,,,Garaulet 2001
6003,6405,6330,All,Obese patients in a clinic from Murcia,Spain,,,Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,17.2,,,percentRoot,,,"Adipose tissue, periumbilical (subcutaneous)",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",15.12,,,percentRoot,,76,Pearson,0.44,,,< 0.001,Yes,,,,Garaulet 2001
6007,6405,6355,All,Obese patients in a clinic from Murcia,Spain,,,Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,17.2,,,percentRoot,,,"Adipose tissue, intraabdominal (perivisceral)",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",14.82,,,percentRoot,,57,Pearson,0.51,,,< 0.001,Yes,,,,Garaulet 2001
6011,6405,6380,All,Obese patients in a clinic from Murcia,Spain,,,Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,17.2,,,percentRoot,,,"Adipose tissue, intraabdominal (omental)",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",15.87,,,percentRoot,,24,Pearson,0.55,,,< 0.05,Yes,,,,Garaulet 2001
6004,6408,6339,All,Obese patients in a clinic from Murcia,Spain,,,Dietary record (7-day),Oleic acid (cis-18:1n-9),"",,52.48,,,percentRoot,,,"Adipose tissue, periumbilical (subcutaneous)",GC-FID,Oleic acid (cis-18:1n-9),"",48.1,,,percentRoot,,76,Pearson,0.27,,,< 0.05,Yes,,,,Garaulet 2001
6008,6408,6364,All,Obese patients in a clinic from Murcia,Spain,,,Dietary record (7-day),Oleic acid (cis-18:1n-9),"",,52.48,,,percentRoot,,,"Adipose tissue, intraabdominal (perivisceral)",GC-FID,Oleic acid (cis-18:1n-9),"",44.64,,,percentRoot,,57,Pearson,0.43,,,< 0.01,Yes,,,,Garaulet 2001
6005,6413,6347,All,Obese patients in a clinic from Murcia,Spain,,,Dietary record (7-day),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,17.11,,,percentRoot,,,"Adipose tissue, periumbilical (subcutaneous)",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),16.38,,,percentRoot,,76,Pearson,0.44,,,< 0.001,Yes,,,,Garaulet 2001
6009,6413,6372,All,Obese patients in a clinic from Murcia,Spain,,,Dietary record (7-day),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,17.11,,,percentRoot,,,"Adipose tissue, intraabdominal (perivisceral)",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),16.52,,,percentRoot,,57,Pearson,0.5,,,< 0.001,Yes,,,,Garaulet 2001
6013,6413,6397,All,Obese patients in a clinic from Murcia,Spain,,,Dietary record (7-day),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,17.11,,,percentRoot,,,"Adipose tissue, intraabdominal (omental)",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),17.17,,,percentRoot,,24,Pearson,0.46,,,< 0.05,Yes,,,,Garaulet 2001
6024,6496,6516,All,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Proteins,"",,,,,g/day,,,"Urine, 24-h",Kjeldahl method,Nitrogen,"",,,,g/day,,134,Spearman,0.67,,, ,Unspecified,,,,McKeown 2001
6025,6497,6517,All,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Potassium,"",,,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",,,,mmol/day,,134,Spearman,0.55,,, ,Unspecified,,,,McKeown 2001
6026,6498,6518,All,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Sodium,"",,,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",,,,mmol/day,,134,Spearman,0.48,,, ,Unspecified,,,,McKeown 2001
6027,6499,6519,All,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Vitamin C,"",Yes,,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",,,,umol/L,,118,Spearman,0.54,,, ,Unspecified,,,,McKeown 2001
6039,6500,6516,All,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Proteins,"",,,,,g/day,,,"Urine, 24-h",Kjeldahl method,Nitrogen,"",,,,g/day,,134,Spearman,0.57,,, ,Unspecified,,,,McKeown 2001
6040,6501,6517,All,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Potassium,"",,,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",,,,mmol/day,,134,Spearman,0.51,,, ,Unspecified,,,,McKeown 2001
6041,6502,6518,All,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Sodium,"",,,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",,,,mmol/day,,134,Spearman,0.48,,, ,Unspecified,,,,McKeown 2001
6042,6503,6519,All,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Vitamin C,"",Yes,,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",,,,umol/L,,118,Spearman,0.44,,, ,Unspecified,,,,McKeown 2001
6054,6504,6516,All,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Proteins,"",,,,,g/day,,,"Urine, 24-h",Kjeldahl method,Nitrogen,"",,,,g/day,,134,Spearman,0.66,,, ,Unspecified,,,,McKeown 2001
6055,6505,6517,All,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Potassium,"",,,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",,,,mmol/day,,134,Spearman,0.58,,, ,Unspecified,,,,McKeown 2001
6056,6506,6518,All,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Sodium,"",,,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",,,,mmol/day,,134,Spearman,0.48,,, ,Unspecified,,,,McKeown 2001
6057,6507,6519,All,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Vitamin C,"",Yes,,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",,,,umol/L,,118,Spearman,0.53,,, ,Unspecified,,,,McKeown 2001
6069,6508,6516,All,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Proteins,"",,,,,g/day,,,"Urine, 24-h",Kjeldahl method,Nitrogen,"",,,,g/day,,134,Spearman,0.29,,, ,Unspecified,,,,McKeown 2001
6070,6509,6517,All,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Potassium,"",,,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",,,,mmol/day,,134,Spearman,0.32,,, ,Unspecified,,,,McKeown 2001
6071,6510,6518,All,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Sodium,"",,,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",,,,mmol/day,,134,Spearman,0.2,,, ,Unspecified,,,,McKeown 2001
6072,6511,6519,All,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin C,"",Yes,,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",,,,umol/L,,118,Spearman,0.42,,, ,Unspecified,,,,McKeown 2001
6084,6512,6516,All,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Proteins,"",,,,,g/day,,,"Urine, 24-h",Kjeldahl method,Nitrogen,"",,,,g/day,,134,Spearman,0.21,,, ,Unspecified,,,,McKeown 2001
6085,6513,6517,All,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Potassium,"",,,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",,,,mmol/day,,134,Spearman,0.34,,, ,Unspecified,,,,McKeown 2001
6086,6514,6518,All,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Sodium,"",,,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",,,,mmol/day,,134,Spearman,0.18,,, ,Unspecified,,,,McKeown 2001
6087,6515,6519,All,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin C,"",Yes,,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",,,,umol/L,,118,Spearman,0.39,,, ,Unspecified,,,,McKeown 2001
6014,6416,6485,Males,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Proteins,"",,82.0,,,g/day,,,"Urine, 24-h",Kjeldahl method,Nitrogen,"",12.8,,,g/day,,57,Spearman,0.48,,, ,Unspecified,,,,McKeown 2001
6015,6417,6486,Males,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Potassium,"",,3.41,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",82.0,,,mmol/day,,57,Spearman,0.61,,, ,Unspecified,,,,McKeown 2001
6016,6418,6487,Males,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Sodium,"",,3.37,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",173.0,,,mmol/day,,57,Spearman,0.27,,, ,Unspecified,,,,McKeown 2001
6017,6420,6489,Males,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Vitamin C,"",Yes,81.0,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",58.0,,,umol/L,,48,Spearman,0.42,,, ,Unspecified,,,,McKeown 2001
6029,6430,6485,Males,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Proteins,"",,82.0,,,g/day,,,"Urine, 24-h",Kjeldahl method,Nitrogen,"",12.8,,,g/day,,57,Spearman,0.42,,, ,Unspecified,,,,McKeown 2001
6030,6431,6486,Males,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Potassium,"",,3.46,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",82.0,,,mmol/day,,57,Spearman,0.55,,, ,Unspecified,,,,McKeown 2001
6031,6432,6487,Males,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Sodium,"",,3.14,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",173.0,,,mmol/day,,57,Spearman,0.43,,, ,Unspecified,,,,McKeown 2001
6032,6434,6489,Males,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Vitamin C,"",Yes,74.0,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",58.0,,,umol/L,,48,Spearman,0.35,,, ,Unspecified,,,,McKeown 2001
6044,6444,6485,Males,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Proteins,"",,82.0,,,g/day,,,"Urine, 24-h",Kjeldahl method,Nitrogen,"",12.8,,,g/day,,57,Spearman,0.51,,, ,Unspecified,,,,McKeown 2001
6045,6445,6486,Males,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Potassium,"",,3.43,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",82.0,,,mmol/day,,57,Spearman,0.61,,, ,Unspecified,,,,McKeown 2001
6046,6446,6487,Males,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Sodium,"",,3.26,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",173.0,,,mmol/day,,57,Spearman,0.39,,, ,Unspecified,,,,McKeown 2001
6047,6448,6489,Males,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Vitamin C,"",Yes,77.0,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",58.0,,,umol/L,,48,Spearman,0.41,,, ,Unspecified,,,,McKeown 2001
6059,6458,6485,Males,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Proteins,"",,89.0,,,g/day,,,"Urine, 24-h",Kjeldahl method,Nitrogen,"",12.8,,,g/day,,57,Spearman,0.13,,, ,Unspecified,,,,McKeown 2001
6060,6459,6486,Males,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Potassium,"",,3.98,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",82.0,,,mmol/day,,57,Spearman,0.24,,, ,Unspecified,,,,McKeown 2001
6061,6460,6487,Males,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Sodium,"",,3.07,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",173.0,,,mmol/day,,57,Spearman,0.04,,, ,Unspecified,,,,McKeown 2001
6062,6462,6489,Males,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin C,"",Yes,118.0,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",58.0,,,umol/L,,48,Spearman,0.32,,, ,Unspecified,,,,McKeown 2001
6074,6472,6485,Males,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Proteins,"",,88.0,,,g/day,,,"Urine, 24-h",Kjeldahl method,Nitrogen,"",12.8,,,g/day,,57,Spearman,0.12,,, ,Unspecified,,,,McKeown 2001
6075,6473,6486,Males,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Potassium,"",,3.94,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",82.0,,,mmol/day,,57,Spearman,0.26,,, ,Unspecified,,,,McKeown 2001
6076,6474,6487,Males,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Sodium,"",,2.92,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",173.0,,,mmol/day,,57,Spearman,0.04,,, ,Unspecified,,,,McKeown 2001
6077,6476,6489,Males,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin C,"",Yes,111.0,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",58.0,,,umol/L,,48,Spearman,0.34,,, ,Unspecified,,,,McKeown 2001
6019,6423,6491,Females,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Proteins,"",,65.0,,,g/day,,,"Urine, 24-h",Kjeldahl method,Nitrogen,"",9.9,,,g/day,,77,Spearman,0.51,,, ,Unspecified,,,,McKeown 2001
6020,6424,6492,Females,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Potassium,"",,3.01,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",69.0,,,mmol/day,,77,Spearman,0.41,,, ,Unspecified,,,,McKeown 2001
6021,6425,6493,Females,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Sodium,"",,2.42,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",131.0,,,mmol/day,,77,Spearman,0.23,,, ,Unspecified,,,,McKeown 2001
6022,6427,6494,Females,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Vitamin C,"",Yes,100.0,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",65.2,,,umol/L,,70,Spearman,0.56,,, ,Unspecified,,,,McKeown 2001
6034,6437,6491,Females,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Proteins,"",,66.0,,,g/day,,,"Urine, 24-h",Kjeldahl method,Nitrogen,"",9.9,,,g/day,,77,Spearman,0.37,,, ,Unspecified,,,,McKeown 2001
6035,6438,6492,Females,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Potassium,"",,3.09,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",69.0,,,mmol/day,,77,Spearman,0.42,,, ,Unspecified,,,,McKeown 2001
6036,6439,6493,Females,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Sodium,"",,2.47,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",131.0,,,mmol/day,,77,Spearman,0.11,,, ,Unspecified,,,,McKeown 2001
6037,6441,6494,Females,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Vitamin C,"",Yes,90.0,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",65.2,,,umol/L,,70,Spearman,0.48,,, ,Unspecified,,,,McKeown 2001
6049,6451,6491,Females,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Proteins,"",,66.0,,,g/day,,,"Urine, 24-h",Kjeldahl method,Nitrogen,"",9.9,,,g/day,,77,Spearman,0.48,,, ,Unspecified,,,,McKeown 2001
6050,6452,6492,Females,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Potassium,"",,3.05,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",69.0,,,mmol/day,,77,Spearman,0.48,,, ,Unspecified,,,,McKeown 2001
6051,6453,6493,Females,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Sodium,"",,2.45,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",131.0,,,mmol/day,,77,Spearman,0.17,,, ,Unspecified,,,,McKeown 2001
6052,6455,6494,Females,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Vitamin C,"",Yes,95.0,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",65.2,,,umol/L,,70,Spearman,0.56,,, ,Unspecified,,,,McKeown 2001
6064,6465,6491,Females,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Proteins,"",,80.0,,,g/day,,,"Urine, 24-h",Kjeldahl method,Nitrogen,"",9.9,,,g/day,,77,Spearman,0.2,,, ,Unspecified,,,,McKeown 2001
6065,6466,6492,Females,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Potassium,"",,3.75,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",69.0,,,mmol/day,,77,Spearman,0.28,,, ,Unspecified,,,,McKeown 2001
6066,6467,6493,Females,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Sodium,"",,2.63,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",131.0,,,mmol/day,,77,Spearman,0.08,,, ,Unspecified,,,,McKeown 2001
6067,6469,6494,Females,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin C,"",Yes,136.0,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",65.2,,,umol/L,,70,Spearman,0.41,,, ,Unspecified,,,,McKeown 2001
6079,6479,6491,Females,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Proteins,"",,78.0,,,g/day,,,"Urine, 24-h",Kjeldahl method,Nitrogen,"",9.9,,,g/day,,77,Spearman,0.1,,, ,Unspecified,,,,McKeown 2001
6080,6480,6492,Females,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Potassium,"",,3.71,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",69.0,,,mmol/day,,77,Spearman,0.29,,, ,Unspecified,,,,McKeown 2001
6081,6481,6493,Females,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Sodium,"",,2.75,,,g/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",131.0,,,mmol/day,,77,Spearman,0.13,,, ,Unspecified,,,,McKeown 2001
6082,6483,6494,Females,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin C,"",Yes,132.0,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",65.2,,,umol/L,,70,Spearman,0.39,,, ,Unspecified,,,,McKeown 2001
6018,7767,6490,Supplement nonusers - Males,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Vitamin C,"",No,,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",55.0,,,umol/L,,39,Spearman,0.41,,, ,Unspecified,,,,McKeown 2001
6033,7768,6490,Supplement nonusers - Males,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Vitamin C,"",No,,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",55.0,,,umol/L,,39,Spearman,0.35,,, ,Unspecified,,,,McKeown 2001
6048,7769,6490,Supplement nonusers - Males,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Vitamin C,"",No,,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",55.0,,,umol/L,,39,Spearman,0.41,,, ,Unspecified,,,,McKeown 2001
6063,7770,6490,Supplement nonusers - Males,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin C,"",No,,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",55.0,,,umol/L,,39,Spearman,0.33,,, ,Unspecified,,,,McKeown 2001
6078,7771,6490,Supplement nonusers - Males,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin C,"",No,,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",55.0,,,umol/L,,39,Spearman,0.43,,, ,Unspecified,,,,McKeown 2001
6023,7772,6495,Supplement nonusers - Females,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Vitamin C,"",No,,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",60.4,,,umol/L,,50,Spearman,0.54,,, ,Unspecified,,,,McKeown 2001
6038,7773,6495,Supplement nonusers - Females,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Vitamin C,"",No,,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",60.4,,,umol/L,,50,Spearman,0.42,,, ,Unspecified,,,,McKeown 2001
6053,7774,6495,Supplement nonusers - Females,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Vitamin C,"",No,,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",60.4,,,umol/L,,50,Spearman,0.53,,, ,Unspecified,,,,McKeown 2001
6068,7775,6495,Supplement nonusers - Females,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin C,"",No,,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",60.4,,,umol/L,,50,Spearman,0.46,,, ,Unspecified,,,,McKeown 2001
6083,7776,6495,Supplement nonusers - Females,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin C,"",No,,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",60.4,,,umol/L,,50,Spearman,0.45,,, ,Unspecified,,,,McKeown 2001
6028,7777,6520,Supplement nonusers,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Vitamin C,"",No,,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",,,,umol/L,,89,Spearman,0.52,,, ,Unspecified,,,,McKeown 2001
6043,7778,6520,Supplement nonusers,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Vitamin C,"",No,,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",,,,umol/L,,89,Spearman,0.4,,, ,Unspecified,,,,McKeown 2001
6058,7779,6520,Supplement nonusers,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Dietary record (7-day),Vitamin C,"",No,,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",,,,umol/L,,89,Spearman,0.49,,, ,Unspecified,,,,McKeown 2001
6073,7780,6520,Supplement nonusers,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin C,"",No,,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",,,,umol/L,,89,Spearman,0.44,,, ,Unspecified,,,,McKeown 2001
6088,7781,6520,Supplement nonusers,Middle-aged participants in a dietary validation study,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin C,"",No,,,,mg/day,,,"Plasma, fasting",Fluorometry,Vitamin C,"",,,,umol/L,,89,Spearman,0.45,,, ,Unspecified,,,,McKeown 2001
6089,6525,6535,All [by intake from questionnaire],Male twin pairs with one living in Sweden and the other living in Finland,Finland,Finnish Twin Cohort,baseline,Food Frequency Questionnaire (FFQ),Ethanol,"",,14.8,,,g/day,,3 to 4 weeks,"Serum, fasting",Turbidimetric immunoassay (TIA),Carbohydrate-deficient transferrin (CDT),"",,,,% transferrin,,152,Spearman,0.46,,,= 0.053,Unspecified,,,,Carlsson 2003
6090,6525,6540,All [by intake from questionnaire],Male twin pairs with one living in Sweden and the other living in Finland,Finland,Finnish Twin Cohort,baseline,Food Frequency Questionnaire (FFQ),Ethanol,"",,14.8,,,g/day,,3 to 4 weeks,"Serum, fasting",Colorimetry,gamma-Glutamyltransferase (GGT),"",,,,U/L,,152,Spearman,0.32,,,= 0.076,Unspecified,,,,Carlsson 2003
6092,6530,8096,All [by intake from interview],Male twin pairs with one living in Sweden and the other living in Finland,Finland,Finnish Twin Cohort,3 to 4 weeks,Diet History Questionnaire (DHQ),Ethanol,"",,,,,g/day,,3 to 4 weeks,"Serum, fasting",Turbidimetric immunoassay (TIA),Carbohydrate-deficient transferrin (CDT),"",,,,% transferrin,,152,Spearman,0.44,,,= 0.049,Unspecified,,,,Carlsson 2003
6093,6530,8097,All [by intake from interview],Male twin pairs with one living in Sweden and the other living in Finland,Finland,Finnish Twin Cohort,3 to 4 weeks,Diet History Questionnaire (DHQ),Ethanol,"",,,,,g/day,,3 to 4 weeks,"Serum, fasting",Colorimetry,gamma-Glutamyltransferase (GGT),"",,,,U/L,,152,Spearman,0.3,,,= 0.041,Unspecified,,,,Carlsson 2003
6095,6585,6586,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",Yes,,,,mg/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,482,Spearman,0.16,0.07,0.25, ,Unspecified,"Triglycerides, Energy by residual method",,"Age, Sex, BMI, Smoking status",El-Sohemy 2001
6096,6585,6587,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",Yes,,,,mg/day,,,"Adipose tissue, buttocks",HPLC,alpha-Tocopherol,"",,,,ug/g,,482,Spearman,0.15,0.06,0.24, ,Unspecified,Energy by residual method,,"Age, Sex, BMI, Smoking status",El-Sohemy 2001
6097,6585,6589,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",Yes,,,,mg/day,,,"Plasma, fasting",HPLC,gamma-Tocopherol,"",,,,umol/L,,482,Spearman,0.24,0.15,0.32, ,Unspecified,"Triglycerides, Energy by residual method",,"Age, Sex, BMI, Smoking status",El-Sohemy 2001
6098,6585,6590,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",Yes,,,,mg/day,,,"Adipose tissue, buttocks",HPLC,gamma-Tocopherol,"",,,,ug/g,,482,Spearman,0.25,0.16,0.33, ,Unspecified,Energy by residual method,,"Age, Sex, BMI, Smoking status",El-Sohemy 2001
6103,6588,6586,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",Yes,,,,mg/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,482,Spearman,-0.03,-0.12,0.06, ,Unspecified,"Triglycerides, Energy by residual method",,"Age, Sex, BMI, Smoking status",El-Sohemy 2001
6104,6588,6587,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",Yes,,,,mg/day,,,"Adipose tissue, buttocks",HPLC,alpha-Tocopherol,"",,,,ug/g,,482,Spearman,0.08,-0.01,0.17, ,Unspecified,Energy by residual method,,"Age, Sex, BMI, Smoking status",El-Sohemy 2001
6105,6588,6589,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",Yes,,,,mg/day,,,"Plasma, fasting",HPLC,gamma-Tocopherol,"",,,,umol/L,,482,Spearman,0.42,0.34,0.49, ,Unspecified,"Triglycerides, Energy by residual method",,"Age, Sex, BMI, Smoking status",El-Sohemy 2001
6106,6588,6590,All,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",Yes,,,,mg/day,,,"Adipose tissue, buttocks",HPLC,gamma-Tocopherol,"",,,,ug/g,,482,Spearman,0.37,0.29,0.45, ,Unspecified,Energy by residual method,,"Age, Sex, BMI, Smoking status",El-Sohemy 2001
6099,6591,6592,Supplement nonusers,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",No,,,,mg/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,458,Spearman,0.09,0.0,0.19, ,Unspecified,"Triglycerides, Energy by residual method",,"Age, Sex, BMI, Smoking status",El-Sohemy 2001
6100,6591,6593,Supplement nonusers,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",No,,,,mg/day,,,"Adipose tissue, buttocks",HPLC,alpha-Tocopherol,"",,,,ug/g,,458,Spearman,0.1,0.01,0.19, ,Unspecified,Energy by residual method,,"Age, Sex, BMI, Smoking status",El-Sohemy 2001
6101,6591,6595,Supplement nonusers,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",No,,,,mg/day,,,"Plasma, fasting",HPLC,gamma-Tocopherol,"",,,,umol/L,,458,Spearman,0.27,0.19,0.36, ,Unspecified,"Triglycerides, Energy by residual method",,"Age, Sex, BMI, Smoking status",El-Sohemy 2001
6102,6591,6596,Supplement nonusers,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",No,,,,mg/day,,,"Adipose tissue, buttocks",HPLC,gamma-Tocopherol,"",,,,ug/g,,458,Spearman,0.25,0.16,0.34, ,Unspecified,Energy by residual method,,"Age, Sex, BMI, Smoking status",El-Sohemy 2001
6107,6594,6592,Supplement nonusers,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",No,,,,mg/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,458,Spearman,-0.06,-0.15,0.04, ,Unspecified,"Triglycerides, Energy by residual method",,"Age, Sex, BMI, Smoking status",El-Sohemy 2001
6108,6594,6593,Supplement nonusers,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",No,,,,mg/day,,,"Adipose tissue, buttocks",HPLC,alpha-Tocopherol,"",,,,ug/g,,458,Spearman,0.04,-0.05,0.13, ,Unspecified,Energy by residual method,,"Age, Sex, BMI, Smoking status",El-Sohemy 2001
6109,6594,6595,Supplement nonusers,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",No,,,,mg/day,,,"Plasma, fasting",HPLC,gamma-Tocopherol,"",,,,umol/L,,458,Spearman,0.43,0.35,0.5, ,Unspecified,"Triglycerides, Energy by residual method",,"Age, Sex, BMI, Smoking status",El-Sohemy 2001
6110,6594,6596,Supplement nonusers,Controls in a case-control study on diet and heart disease,Costa Rica,,,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",No,,,,mg/day,,,"Adipose tissue, buttocks",HPLC,gamma-Tocopherol,"",,,,ug/g,,458,Spearman,0.37,0.28,0.44, ,Unspecified,Energy by residual method,,"Age, Sex, BMI, Smoking status",El-Sohemy 2001
6111,6598,6626,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,16.1,,,g/day,,winter; summer,"Serum, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),47.6,,,percentRoot,,87,Pearson,-0.02,,,>= 0.05,No,,No,,Kobayashi 2001
6139,6598,6626,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,16.1,,,g/day,,winter; summer,"Serum, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),47.6,,,percentRoot,,87,Pearson,-0.03,,,>= 0.05,No,,Yes,,Kobayashi 2001
6112,6599,6627,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Palmitic acid (16:0),"",,9.9,,,g/day,,winter; summer,"Serum, fasting",GC-FID,Palmitic acid (16:0),"",28.7,,,percentRoot,,87,Pearson,-0.18,,,>= 0.05,No,,No,,Kobayashi 2001
6140,6599,6627,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Palmitic acid (16:0),"",,9.9,,,g/day,,winter; summer,"Serum, fasting",GC-FID,Palmitic acid (16:0),"",28.7,,,percentRoot,,87,Pearson,-0.2,,,>= 0.05,No,,Yes,,Kobayashi 2001
6113,6600,6628,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Stearic acid (18:0),"",,3.6,,,g/day,,winter; summer,"Serum, fasting",GC-FID,Stearic acid (18:0),"",15.1,,,percentRoot,,87,Pearson,0.14,,,>= 0.05,No,,No,,Kobayashi 2001
6141,6600,6628,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Stearic acid (18:0),"",,3.6,,,g/day,,winter; summer,"Serum, fasting",GC-FID,Stearic acid (18:0),"",15.1,,,percentRoot,,87,Pearson,0.15,,,>= 0.05,No,,Yes,,Kobayashi 2001
6114,6601,6629,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,19.6,,,g/day,,winter; summer,"Serum, fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),13.6,,,percentRoot,,87,Pearson,-0.02,,,>= 0.05,No,,No,,Kobayashi 2001
6142,6601,6629,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,19.6,,,g/day,,winter; summer,"Serum, fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),13.6,,,percentRoot,,87,Pearson,-0.02,,,>= 0.05,No,,Yes,,Kobayashi 2001
6115,6602,6630,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Oleic acid (cis-18:1n-9),"",,17.0,,,g/day,,winter; summer,"Serum, fasting",GC-FID,Oleic acid (cis-18:1n-9),"",8.8,,,percentRoot,,87,Pearson,-0.03,,,>= 0.05,No,,No,,Kobayashi 2001
6143,6602,6630,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Oleic acid (cis-18:1n-9),"",,17.0,,,g/day,,winter; summer,"Serum, fasting",GC-FID,Oleic acid (cis-18:1n-9),"",8.8,,,percentRoot,,87,Pearson,-0.04,,,>= 0.05,No,,Yes,,Kobayashi 2001
6116,6603,6631,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,15.8,,,g/day,,winter; summer,"Serum, fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),38.9,,,percentRoot,,87,Pearson,0.09,,,>= 0.05,No,,No,,Kobayashi 2001
6144,6603,6631,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,15.8,,,g/day,,winter; summer,"Serum, fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),38.9,,,percentRoot,,87,Pearson,0.1,,,>= 0.05,No,,Yes,,Kobayashi 2001
6117,6604,6632,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,3.5,,,g/day,,winter; summer,"Serum, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),12.4,,,percentRoot,,87,Pearson,0.39,,,< 0.001,Yes,,No,,Kobayashi 2001
6145,6604,6632,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,3.5,,,g/day,,winter; summer,"Serum, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),12.4,,,percentRoot,,87,Pearson,0.45,,,< 0.001,Yes,,Yes,,Kobayashi 2001
6118,6605,6633,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,1.8,,,g/day,,winter; summer,"Serum, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.2,,,percentRoot,,87,Pearson,-0.02,,,>= 0.05,No,,No,,Kobayashi 2001
6146,6605,6633,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,1.8,,,g/day,,winter; summer,"Serum, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.2,,,percentRoot,,87,Pearson,-0.02,,,>= 0.05,No,,Yes,,Kobayashi 2001
6119,6606,6634,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),EPA (cis-20:5n-3),"",No,0.6,,,g/day,,winter; summer,"Serum, fasting",GC-FID,EPA (cis-20:5n-3),"",3.7,,,percentRoot,,87,Pearson,0.66,,,< 0.001,Yes,,No,,Kobayashi 2001
6147,6606,6634,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),EPA (cis-20:5n-3),"",No,0.6,,,g/day,,winter; summer,"Serum, fasting",GC-FID,EPA (cis-20:5n-3),"",3.7,,,percentRoot,,87,Pearson,0.77,,,< 0.001,Yes,,Yes,,Kobayashi 2001
6120,6607,6635,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),DPA (cis-22:5n-3),"",No,0.1,,,g/day,,winter; summer,"Serum, fasting",GC-FID,DPA (cis-22:5n-3),"",1.2,,,percentRoot,,87,Pearson,0.38,,,< 0.001,Yes,,No,,Kobayashi 2001
6148,6607,6635,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),DPA (cis-22:5n-3),"",No,0.1,,,g/day,,winter; summer,"Serum, fasting",GC-FID,DPA (cis-22:5n-3),"",1.2,,,percentRoot,,87,Pearson,0.46,,,< 0.001,Yes,,Yes,,Kobayashi 2001
6121,6608,6636,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),DHA (cis-22:6n-3),"",No,0.9,,,g/day,,winter; summer,"Serum, fasting",GC-FID,DHA (cis-22:6n-3),"",7.3,,,percentRoot,,87,Pearson,0.36,,,< 0.001,Yes,,No,,Kobayashi 2001
6149,6608,6636,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),DHA (cis-22:6n-3),"",No,0.9,,,g/day,,winter; summer,"Serum, fasting",GC-FID,DHA (cis-22:6n-3),"",7.3,,,percentRoot,,87,Pearson,0.43,,,< 0.001,Yes,,Yes,,Kobayashi 2001
6122,6609,6637,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,12.2,,,g/day,,winter; summer,"Serum, fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),26.5,,,percentRoot,,87,Pearson,0.25,,,< 0.05,Yes,,No,,Kobayashi 2001
6150,6609,6637,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,12.2,,,g/day,,winter; summer,"Serum, fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),26.5,,,percentRoot,,87,Pearson,0.28,,,< 0.01,Yes,,Yes,,Kobayashi 2001
6123,6610,6638,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,12.2,,,g/day,,winter; summer,"Serum, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",17.3,,,percentRoot,,87,Pearson,0.2,,,>= 0.05,No,,No,,Kobayashi 2001
6151,6610,6638,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,12.2,,,g/day,,winter; summer,"Serum, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",17.3,,,percentRoot,,87,Pearson,0.23,,,< 0.05,Yes,,Yes,,Kobayashi 2001
6124,6611,6639,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.2,,,g/day,,winter; summer,"Serum, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",6.4,,,percentRoot,,87,Pearson,-0.22,,,< 0.05,Yes,,No,,Kobayashi 2001
6152,6611,6639,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.2,,,g/day,,winter; summer,"Serum, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",6.4,,,percentRoot,,87,Pearson,-0.27,,,< 0.05,Yes,,Yes,,Kobayashi 2001
6125,6612,6626,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,30.8,,,percentRoot,,winter; summer,"Serum, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),47.6,,,percentRoot,,87,Pearson,-0.08,,,>= 0.05,No,,No,,Kobayashi 2001
6153,6612,6626,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,30.8,,,percentRoot,,winter; summer,"Serum, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),47.6,,,percentRoot,,87,Pearson,-0.09,,,>= 0.05,No,,Yes,,Kobayashi 2001
6167,6612,6640,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,30.8,,,percentRoot,,winter,"Serum, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),47.3,,47.1,percentRoot,,87,Pearson,-0.11,,,>= 0.05,No,,,,Kobayashi 2001
6181,6612,6654,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,30.8,,,percentRoot,,summer,"Serum, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),47.8,,47.3,percentRoot,,87,Pearson,-0.02,,,>= 0.05,No,,,,Kobayashi 2001
6126,6613,6627,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Palmitic acid (16:0),"",,19.1,,,percentRoot,,winter; summer,"Serum, fasting",GC-FID,Palmitic acid (16:0),"",28.7,,,percentRoot,,87,Pearson,-0.01,,,>= 0.05,No,,No,,Kobayashi 2001
6154,6613,6627,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Palmitic acid (16:0),"",,19.1,,,percentRoot,,winter; summer,"Serum, fasting",GC-FID,Palmitic acid (16:0),"",28.7,,,percentRoot,,87,Pearson,-0.01,,,>= 0.05,No,,Yes,,Kobayashi 2001
6168,6613,6641,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Palmitic acid (16:0),"",,19.1,,,percentRoot,,winter,"Serum, fasting",GC-FID,Palmitic acid (16:0),"",28.5,,28.7,percentRoot,,87,Pearson,-0.05,,,>= 0.05,No,,,,Kobayashi 2001
6182,6613,6655,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Palmitic acid (16:0),"",,19.1,,,percentRoot,,summer,"Serum, fasting",GC-FID,Palmitic acid (16:0),"",28.9,,29.0,percentRoot,,87,Pearson,0.04,,,>= 0.05,No,,,,Kobayashi 2001
6127,6614,6628,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Stearic acid (18:0),"",,7.0,,,percentRoot,,winter; summer,"Serum, fasting",GC-FID,Stearic acid (18:0),"",15.1,,,percentRoot,,87,Pearson,-0.02,,,>= 0.05,No,,No,,Kobayashi 2001
6155,6614,6628,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Stearic acid (18:0),"",,7.0,,,percentRoot,,winter; summer,"Serum, fasting",GC-FID,Stearic acid (18:0),"",15.1,,,percentRoot,,87,Pearson,-0.03,,,>= 0.05,No,,Yes,,Kobayashi 2001
6169,6614,6642,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Stearic acid (18:0),"",,7.0,,,percentRoot,,winter,"Serum, fasting",GC-FID,Stearic acid (18:0),"",15.0,,15.0,percentRoot,,87,Pearson,-0.01,,,>= 0.05,No,,,,Kobayashi 2001
6183,6614,6656,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Stearic acid (18:0),"",,7.0,,,percentRoot,,summer,"Serum, fasting",GC-FID,Stearic acid (18:0),"",15.2,,15.0,percentRoot,,87,Pearson,-0.02,,,>= 0.05,No,,,,Kobayashi 2001
6128,6615,6629,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,37.7,,,percentRoot,,winter; summer,"Serum, fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),13.6,,,percentRoot,,87,Pearson,0.39,,,< 0.001,Yes,,No,,Kobayashi 2001
6156,6615,6629,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,37.7,,,percentRoot,,winter; summer,"Serum, fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),13.6,,,percentRoot,,87,Pearson,0.52,,,< 0.001,Yes,,Yes,,Kobayashi 2001
6170,6615,6643,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,37.7,,,percentRoot,,winter,"Serum, fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),13.7,,13.4,percentRoot,,87,Pearson,0.45,,,< 0.001,Yes,,,,Kobayashi 2001
6184,6615,6657,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,37.7,,,percentRoot,,summer,"Serum, fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),13.5,,13.3,percentRoot,,87,Pearson,0.2,,,>= 0.05,No,,,,Kobayashi 2001
6129,6616,6630,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Oleic acid (cis-18:1n-9),"",,32.7,,,percentRoot,,winter; summer,"Serum, fasting",GC-FID,Oleic acid (cis-18:1n-9),"",8.8,,,percentRoot,,87,Pearson,0.35,,,< 0.001,Yes,,No,,Kobayashi 2001
6157,6616,6630,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Oleic acid (cis-18:1n-9),"",,32.7,,,percentRoot,,winter; summer,"Serum, fasting",GC-FID,Oleic acid (cis-18:1n-9),"",8.8,,,percentRoot,,87,Pearson,0.42,,,< 0.001,Yes,,Yes,,Kobayashi 2001
6171,6616,6644,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Oleic acid (cis-18:1n-9),"",,32.7,,,percentRoot,,winter,"Serum, fasting",GC-FID,Oleic acid (cis-18:1n-9),"",8.8,,8.8,percentRoot,,87,Pearson,0.41,,,< 0.001,Yes,,,,Kobayashi 2001
6185,6616,6658,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Oleic acid (cis-18:1n-9),"",,32.7,,,percentRoot,,summer,"Serum, fasting",GC-FID,Oleic acid (cis-18:1n-9),"",8.8,,8.5,percentRoot,,87,Pearson,0.17,,,>= 0.05,No,,,,Kobayashi 2001
6130,6617,6631,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,30.6,,,percentRoot,,winter; summer,"Serum, fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),38.9,,,percentRoot,,87,Pearson,0.09,,,>= 0.05,No,,No,,Kobayashi 2001
6158,6617,6631,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,30.6,,,percentRoot,,winter; summer,"Serum, fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),38.9,,,percentRoot,,87,Pearson,0.1,,,>= 0.05,No,,Yes,,Kobayashi 2001
6172,6617,6645,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,30.6,,,percentRoot,,winter,"Serum, fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),39.0,,38.9,percentRoot,,87,Pearson,0.09,,,>= 0.05,No,,,,Kobayashi 2001
6186,6617,6659,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,30.6,,,percentRoot,,summer,"Serum, fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),38.7,,39.2,percentRoot,,87,Pearson,0.06,,,>= 0.05,No,,,,Kobayashi 2001
6131,6618,6632,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,6.8,,,percentRoot,,winter; summer,"Serum, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),12.4,,,percentRoot,,87,Pearson,0.66,,,< 0.001,Yes,,No,,Kobayashi 2001
6159,6618,6632,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,6.8,,,percentRoot,,winter; summer,"Serum, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),12.4,,,percentRoot,,87,Pearson,0.76,,,< 0.001,Yes,,Yes,,Kobayashi 2001
6173,6618,6646,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,6.8,,,percentRoot,,winter,"Serum, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),2.1,,2.0,percentRoot,,87,Pearson,0.61,,,< 0.001,Yes,,,,Kobayashi 2001
6187,6618,6660,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,6.8,,,percentRoot,,summer,"Serum, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),2.1,,2.1,percentRoot,,87,Pearson,0.6,,,< 0.001,Yes,,,,Kobayashi 2001
6132,6619,6633,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,3.6,,,percentRoot,,winter; summer,"Serum, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.2,,,percentRoot,,87,Pearson,0.07,,,>= 0.05,No,,No,,Kobayashi 2001
6160,6619,6633,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,3.6,,,percentRoot,,winter; summer,"Serum, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.2,,,percentRoot,,87,Pearson,0.09,,,>= 0.05,No,,Yes,,Kobayashi 2001
6174,6619,6647,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,3.6,,,percentRoot,,winter,"Serum, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.2,,0.2,percentRoot,,87,Pearson,0.05,,,>= 0.05,No,,,,Kobayashi 2001
6188,6619,6661,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,3.6,,,percentRoot,,summer,"Serum, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.2,,0.2,percentRoot,,87,Pearson,0.05,,,>= 0.05,No,,,,Kobayashi 2001
6133,6620,6634,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),EPA (cis-20:5n-3),"",No,1.1,,,percentRoot,,winter; summer,"Serum, fasting",GC-FID,EPA (cis-20:5n-3),"",3.7,,,percentRoot,,87,Pearson,0.75,,,< 0.001,Yes,,No,,Kobayashi 2001
6161,6620,6634,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),EPA (cis-20:5n-3),"",No,1.1,,,percentRoot,,winter; summer,"Serum, fasting",GC-FID,EPA (cis-20:5n-3),"",3.7,,,percentRoot,,87,Pearson,0.89,,,< 0.001,Yes,,Yes,,Kobayashi 2001
6175,6620,6648,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),EPA (cis-20:5n-3),"",No,1.1,,,percentRoot,,winter,"Serum, fasting",GC-FID,EPA (cis-20:5n-3),"",3.7,,3.5,percentRoot,,87,Pearson,0.7,,,< 0.001,Yes,,,,Kobayashi 2001
6189,6620,6662,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),EPA (cis-20:5n-3),"",No,1.1,,,percentRoot,,summer,"Serum, fasting",GC-FID,EPA (cis-20:5n-3),"",3.7,,3.2,percentRoot,,87,Pearson,0.63,,,< 0.001,Yes,,,,Kobayashi 2001
6134,6621,6635,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),DPA (cis-22:5n-3),"",No,0.3,,,percentRoot,,winter; summer,"Serum, fasting",GC-FID,DPA (cis-22:5n-3),"",1.2,,,percentRoot,,87,Pearson,0.49,,,< 0.001,Yes,,No,,Kobayashi 2001
6162,6621,6635,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),DPA (cis-22:5n-3),"",No,0.3,,,percentRoot,,winter; summer,"Serum, fasting",GC-FID,DPA (cis-22:5n-3),"",1.2,,,percentRoot,,87,Pearson,0.54,,,< 0.001,Yes,,Yes,,Kobayashi 2001
6176,6621,6649,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),DPA (cis-22:5n-3),"",No,0.3,,,percentRoot,,winter,"Serum, fasting",GC-FID,DPA (cis-22:5n-3),"",1.2,,1.2,percentRoot,,87,Pearson,0.45,,,< 0.001,Yes,,,,Kobayashi 2001
6190,6621,6663,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),DPA (cis-22:5n-3),"",No,0.3,,,percentRoot,,summer,"Serum, fasting",GC-FID,DPA (cis-22:5n-3),"",1.2,,1.2,percentRoot,,87,Pearson,0.46,,,< 0.001,Yes,,,,Kobayashi 2001
6135,6622,6636,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),DHA (cis-22:6n-3),"",No,1.7,,,percentRoot,,winter; summer,"Serum, fasting",GC-FID,DHA (cis-22:6n-3),"",7.3,,,percentRoot,,87,Pearson,0.5,,,< 0.001,Yes,,No,,Kobayashi 2001
6163,6622,6636,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),DHA (cis-22:6n-3),"",No,1.7,,,percentRoot,,winter; summer,"Serum, fasting",GC-FID,DHA (cis-22:6n-3),"",7.3,,,percentRoot,,87,Pearson,0.61,,,< 0.001,Yes,,Yes,,Kobayashi 2001
6177,6622,6650,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),DHA (cis-22:6n-3),"",No,1.7,,,percentRoot,,winter,"Serum, fasting",GC-FID,DHA (cis-22:6n-3),"",7.2,,6.9,percentRoot,,87,Pearson,0.44,,,< 0.001,Yes,,,,Kobayashi 2001
6191,6622,6664,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),DHA (cis-22:6n-3),"",No,1.7,,,percentRoot,,summer,"Serum, fasting",GC-FID,DHA (cis-22:6n-3),"",7.4,,7.2,percentRoot,,87,Pearson,0.46,,,< 0.001,Yes,,,,Kobayashi 2001
6136,6623,6637,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,23.6,,,percentRoot,,winter; summer,"Serum, fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),26.5,,,percentRoot,,87,Pearson,0.05,,,>= 0.05,No,,No,,Kobayashi 2001
6164,6623,6637,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,23.6,,,percentRoot,,winter; summer,"Serum, fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),26.5,,,percentRoot,,87,Pearson,0.05,,,>= 0.05,No,,Yes,,Kobayashi 2001
6178,6623,6651,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,23.6,,,percentRoot,,winter,"Serum, fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),2.4,,2.2,percentRoot,,87,Pearson,0.05,,,>= 0.05,No,,,,Kobayashi 2001
6192,6623,6665,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,23.6,,,percentRoot,,summer,"Serum, fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),2.3,,2.1,percentRoot,,87,Pearson,0.03,,,>= 0.05,No,,,,Kobayashi 2001
6137,6624,6638,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,23.5,,,percentRoot,,winter; summer,"Serum, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",17.3,,,percentRoot,,87,Pearson,-0.03,,,>= 0.05,No,,No,,Kobayashi 2001
6165,6624,6638,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,23.5,,,percentRoot,,winter; summer,"Serum, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",17.3,,,percentRoot,,87,Pearson,-0.03,,,>= 0.05,No,,Yes,,Kobayashi 2001
6179,6624,6652,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,23.5,,,percentRoot,,winter,"Serum, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",17.7,,17.8,percentRoot,,87,Pearson,0.01,,,>= 0.05,No,,,,Kobayashi 2001
6193,6624,6666,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,23.5,,,percentRoot,,summer,"Serum, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",16.9,,17.0,percentRoot,,87,Pearson,-0.06,,,>= 0.05,No,,,,Kobayashi 2001
6138,6625,6639,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.4,,,percentRoot,,winter; summer,"Serum, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",6.4,,,percentRoot,,87,Pearson,-0.25,,,< 0.05,Yes,,No,,Kobayashi 2001
6166,6625,6639,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.4,,,percentRoot,,winter; summer,"Serum, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",6.4,,,percentRoot,,87,Pearson,-0.37,,,< 0.001,Yes,,Yes,,Kobayashi 2001
6180,6625,6653,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.4,,,percentRoot,,winter,"Serum, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",6.4,,6.3,percentRoot,,87,Pearson,-0.24,,,< 0.05,Yes,,,,Kobayashi 2001
6194,6625,6667,All,Middle-aged men,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),,Dietary record (7-day),Arachidonic acid (AA; cis-20:4n-6),"",,0.4,,,percentRoot,,summer,"Serum, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",6.4,,6.1,percentRoot,,87,Pearson,-0.19,,,>= 0.05,No,,,,Kobayashi 2001
6195,6669,6668,All,Adults in Seattle area,United States,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,,,,servings/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,177,Pearson,0.16,,,< 0.05,Yes,,,"Age, Sex, BMI",Horner 2002
6196,6670,6668,All,Adults in Seattle area,United States,,,Food Frequency Questionnaire (FFQ),Fruits,"",,,,,servings/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,177,Pearson,0.11,,,>= 0.05,No,,,"Age, Sex, BMI",Horner 2002
6197,6671,6668,All,Adults in Seattle area,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,servings/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,177,Pearson,0.15,,,< 0.05,Yes,,,"Age, Sex, BMI",Horner 2002
6198,6672,6668,All,Adults in Seattle area,United States,,,Food Frequency Questionnaire (FFQ),Dietary fibre,Water-soluble fibre + Insoluble fibre,,,,,g/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,177,Pearson,0.13,,,>= 0.05,No,,,"Age, Sex, BMI",Horner 2002
6199,6673,6668,All,Adults in Seattle area,United States,,,Food Frequency Questionnaire (FFQ),Water-soluble fibre,"",,,,,g/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,177,Pearson,0.1,,,>= 0.05,No,,,"Age, Sex, BMI",Horner 2002
6200,6674,6668,All,Adults in Seattle area,United States,,,Food Frequency Questionnaire (FFQ),Insoluble fibre,"",,,,,g/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,177,Pearson,0.15,,,< 0.05,Yes,,,"Age, Sex, BMI",Horner 2002
6201,6675,6668,All,Adults in Seattle area,United States,,,Food Frequency Questionnaire (FFQ),Coffee + Tea,"",,,,,servings/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,177,Pearson,0.13,,,>= 0.05,No,,,"Age, Sex, BMI",Horner 2002
6202,6676,6668,All,Adults in Seattle area,United States,,,Food Frequency Questionnaire (FFQ),Ethanol,"",,,,,g/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,177,Pearson,0.2,,,< 0.01,Yes,,,"Age, Sex, BMI",Horner 2002
6203,6677,6668,All,Adults in Seattle area,United States,,,Food Frequency Questionnaire (FFQ),Wine,"",,,,,servings/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,177,Pearson,0.05,,,>= 0.05,No,,,"Age, Sex, BMI",Horner 2002
6204,6678,6668,All,Adults in Seattle area,United States,,,Food Frequency Questionnaire (FFQ),Beer,"",,,,,servings/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,177,Pearson,0.08,,,>= 0.05,No,,,"Age, Sex, BMI",Horner 2002
6205,6679,6668,All,Adults in Seattle area,United States,,,Food Frequency Questionnaire (FFQ),Liquor,"",,,,,servings/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,177,Pearson,0.08,,,>= 0.05,No,,,"Age, Sex, BMI",Horner 2002
6206,6680,6668,All,Adults in Seattle area,United States,,,Dietary record (3-day),Vegetables,"",,,,,servings/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,193,Pearson,0.17,,,< 0.05,Yes,,,"Age, Sex, BMI",Horner 2002
6207,6681,6668,All,Adults in Seattle area,United States,,,Dietary record (3-day),Fruits,"",,,,,servings/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,193,Pearson,0.08,,,>= 0.05,No,,,"Age, Sex, BMI",Horner 2002
6208,6682,6668,All,Adults in Seattle area,United States,,,Dietary record (3-day),Fruits + Vegetables,Fruits + Vegetables,,,,,servings/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,193,Pearson,0.2,,,< 0.01,Yes,,,"Age, Sex, BMI",Horner 2002
6209,6683,6668,All,Adults in Seattle area,United States,,,Dietary record (3-day),Dietary fibre,Water-soluble fibre + Insoluble fibre,,,,,g/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,193,Pearson,0.36,,,< 0.0001,Yes,,,"Age, Sex, BMI",Horner 2002
6210,6684,6668,All,Adults in Seattle area,United States,,,Dietary record (3-day),Water-soluble fibre,"",,,,,g/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,193,Pearson,0.35,,,< 0.0001,Yes,,,"Age, Sex, BMI",Horner 2002
6211,6685,6668,All,Adults in Seattle area,United States,,,Dietary record (3-day),Insoluble fibre,"",,,,,g/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,193,Pearson,0.34,,,< 0.0001,Yes,,,"Age, Sex, BMI",Horner 2002
6213,6687,6668,All,Adults in Seattle area,United States,,,Dietary record (3-day),Ethanol,"",,,,,g/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,193,Pearson,0.24,,,< 0.001,Yes,,,"Age, Sex, BMI",Horner 2002
6217,6691,6668,All,Adults in Seattle area,United States,,,Dietary record (3-day),Mushrooms,"",,,,,servings/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,193,Pearson,0.07,,,>= 0.05,No,,,"Age, Sex, BMI, Percentage of energy as fat",Horner 2002
6218,6692,6668,All,Adults in Seattle area,United States,,,Dietary record (3-day),Leafy vegetables,"",,,,,servings/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,193,Pearson,0.15,,,< 0.05,Yes,,,"Age, Sex, BMI, Percentage of energy as fat",Horner 2002
6219,6693,6668,All,Adults in Seattle area,United States,,,Dietary record (3-day),Lettuce,"",,,,,servings/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,193,Pearson,-0.07,,,>= 0.05,No,,,"Age, Sex, BMI, Percentage of energy as fat",Horner 2002
6220,6694,6668,All,Adults in Seattle area,United States,,,Dietary record (3-day),Cabbage-family vegetables,"",,,,,servings/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,193,Pearson,0.02,,,>= 0.05,No,,,"Age, Sex, BMI, Percentage of energy as fat",Horner 2002
6221,6695,6668,All,Adults in Seattle area,United States,,,Dietary record (3-day),Gourds,"",,,,,servings/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,193,Pearson,0.07,,,>= 0.05,No,,,"Age, Sex, BMI, Percentage of energy as fat",Horner 2002
6222,6696,6668,All,Adults in Seattle area,United States,,,Dietary record (3-day),Berries,"",,,,,servings/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,193,Pearson,0.05,,,>= 0.05,No,,,"Age, Sex, BMI, Percentage of energy as fat",Horner 2002
6223,6697,6668,All,Adults in Seattle area,United States,,,Dietary record (3-day),Walnut,"",,,,,servings/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,193,Pearson,0.15,,,< 0.05,Yes,,,"Age, Sex, BMI, Percentage of energy as fat",Horner 2002
6224,6698,6668,All,Adults in Seattle area,United States,,,Dietary record (3-day),Avocado,"",,,,,servings/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,193,Pearson,0.13,,,>= 0.05,No,,,"Age, Sex, BMI, Percentage of energy as fat",Horner 2002
6225,6699,6668,All,Adults in Seattle area,United States,,,Dietary record (3-day),Legume-family vegetables,"",,,,,servings/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,193,Pearson,0.2,,,< 0.01,Yes,,,"Age, Sex, BMI, Percentage of energy as fat",Horner 2002
6226,6700,6668,All,Adults in Seattle area,United States,,,Dietary record (3-day),Onion-family vegetables,"",,,,,servings/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,193,Pearson,0.05,,,>= 0.05,No,,,"Age, Sex, BMI, Percentage of energy as fat",Horner 2002
6227,6701,6668,All,Adults in Seattle area,United States,,,Dietary record (3-day),Banana,"",,,,,servings/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,193,Pearson,0.05,,,>= 0.05,No,,,"Age, Sex, BMI, Percentage of energy as fat",Horner 2002
6228,6702,6668,All,Adults in Seattle area,United States,,,Dietary record (3-day),Olive,"",,,,,servings/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,193,Pearson,0.07,,,>= 0.05,No,,,"Age, Sex, BMI, Percentage of energy as fat",Horner 2002
6229,6703,6668,All,Adults in Seattle area,United States,,,Dietary record (3-day),Sesame,"",,,,,servings/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,193,Pearson,0.2,,,< 0.01,Yes,,,"Age, Sex, BMI, Percentage of energy as fat",Horner 2002
6230,6704,6668,All,Adults in Seattle area,United States,,,Dietary record (3-day),Fruits,"",,,,,servings/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,193,Pearson,0.04,,,>= 0.05,No,,,"Age, Sex, BMI, Percentage of energy as fat",Horner 2002
6231,6705,6668,All,Adults in Seattle area,United States,,,Dietary record (3-day),Citrus fruits,"",,,,,servings/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,193,Pearson,0.08,,,>= 0.05,No,,,"Age, Sex, BMI, Percentage of energy as fat",Horner 2002
6232,6706,6668,All,Adults in Seattle area,United States,,,Dietary record (3-day),Potato-family vegetables,"",,,,,servings/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,193,Pearson,0.13,,,>= 0.05,No,,,"Age, Sex, BMI, Percentage of energy as fat",Horner 2002
6233,6707,6668,All,Adults in Seattle area,United States,,,Dietary record (3-day),Carrot-family vegetables,"",,,,,servings/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,193,Pearson,0.05,,,>= 0.05,No,,,"Age, Sex, BMI, Percentage of energy as fat",Horner 2002
6234,6708,6668,All,Adults in Seattle area,United States,,,Dietary record (3-day),Grape,"",,,,,servings/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Enterolactone,"",,13.97,,nmol/L,,193,Pearson,0.2,,,< 0.01,Yes,,,"Age, Sex, BMI, Percentage of energy as fat",Horner 2002
6235,6712,6715,All [by gender],Participants in a dietary validation study,Germany,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Ethanol,"",,,1.18,,g/day/kg,Body weight,,"Urine, 24-h",Chromatography,5-Hydroxytryptophol (5-HTOL) / 5-Hydroxyindole-3-acetic acid (5-HIAA),"",,16.0,,nmol/umol,,102,Pearson,0.92,,,< 0.0001,Yes,,,,Kroke 2001
6254,6727,6742,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,Fats from Dairy foods,,29.6,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Myristic acid (14:0),"",3.6,,,percentRoot,,114,Pearson,0.64,,,< 0.001,Yes,,,,Wolk 2001
6255,6727,6743,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,Fats from Dairy foods,,29.6,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Pentadecylic acid (15:0),"",0.36,,,percentRoot,,114,Pearson,0.71,,,< 0.001,Yes,,,,Wolk 2001
6256,6727,6744,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,Fats from Dairy foods,,29.6,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Margaric acid (17:0),"",0.25,,,percentRoot,,114,Pearson,0.16,,,>= 0.05,No,,,,Wolk 2001
6257,6727,6745,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,Fats from Dairy foods,,29.6,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Myristic acid (14:0),"",1.04,,,percentRoot,,104,Pearson,0.3,,,< 0.01,Yes,,,,Wolk 2001
6258,6727,6746,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,Fats from Dairy foods,,29.6,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,104,Pearson,0.47,,,< 0.001,Yes,,,,Wolk 2001
6259,6727,6747,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,Fats from Dairy foods,,29.6,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Margaric acid (17:0),"",0.1,,,percentRoot,,104,Pearson,0.4,,,< 0.01,Yes,,,,Wolk 2001
6260,6727,6748,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,Fats from Dairy foods,,29.6,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",0.47,,,percentRoot,,104,Pearson,0.3,,,< 0.01,Yes,,,,Wolk 2001
6261,6727,6749,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,Fats from Dairy foods,,29.6,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,104,Pearson,0.53,,,< 0.001,Yes,,,,Wolk 2001
6262,6727,6750,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,Fats from Dairy foods,,29.6,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Margaric acid (17:0),"",0.44,,,percentRoot,,104,Pearson,0.36,,,< 0.001,Yes,,,,Wolk 2001
6894,6727,7454,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,Fats from Dairy foods,,29.6,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,114,Pearson,0.54,,,< 0.001,Yes,,,,Wolk 2001
6895,6727,7455,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,Fats from Dairy foods,,29.6,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,104,Pearson,0.52,,,< 0.001,Yes,,,,Wolk 2001
6896,6727,7456,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,Fats from Dairy foods,,29.6,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,104,Pearson,0.49,,,< 0.001,Yes,,,,Wolk 2001
6272,6729,6742,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Myristic acid (14:0),"",,4.6,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Myristic acid (14:0),"",3.6,,,percentRoot,,114,Pearson,0.65,,,< 0.001,Yes,,,,Wolk 2001
6273,6729,6743,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Myristic acid (14:0),"",,4.6,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Pentadecylic acid (15:0),"",0.36,,,percentRoot,,114,Pearson,0.7,,,< 0.001,Yes,,,,Wolk 2001
6274,6729,6744,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Myristic acid (14:0),"",,4.6,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Margaric acid (17:0),"",0.25,,,percentRoot,,114,Pearson,0.18,,,>= 0.05,No,,,,Wolk 2001
6275,6729,6745,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Myristic acid (14:0),"",,4.6,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Myristic acid (14:0),"",1.04,,,percentRoot,,104,Pearson,0.33,,,< 0.001,Yes,,,,Wolk 2001
6276,6729,6746,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Myristic acid (14:0),"",,4.6,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,104,Pearson,0.5,,,< 0.001,Yes,,,,Wolk 2001
6277,6729,6747,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Myristic acid (14:0),"",,4.6,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Margaric acid (17:0),"",0.1,,,percentRoot,,104,Pearson,0.38,,,< 0.001,Yes,,,,Wolk 2001
6278,6729,6748,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Myristic acid (14:0),"",,4.6,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",0.47,,,percentRoot,,104,Pearson,0.33,,,< 0.001,Yes,,,,Wolk 2001
6279,6729,6749,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Myristic acid (14:0),"",,4.6,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,104,Pearson,0.57,,,< 0.001,Yes,,,,Wolk 2001
6280,6729,6750,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Myristic acid (14:0),"",,4.6,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Margaric acid (17:0),"",0.44,,,percentRoot,,104,Pearson,0.36,,,< 0.001,Yes,,,,Wolk 2001
6900,6729,7454,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Myristic acid (14:0),"",,4.6,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,114,Pearson,0.55,,,< 0.001,Yes,,,,Wolk 2001
6901,6729,7455,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Myristic acid (14:0),"",,4.6,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,104,Pearson,0.51,,,< 0.001,Yes,,,,Wolk 2001
6902,6729,7456,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Myristic acid (14:0),"",,4.6,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,104,Pearson,0.51,,,< 0.001,Yes,,,,Wolk 2001
6281,6730,6742,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Pentadecylic acid (15:0),"",,0.23,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Myristic acid (14:0),"",3.6,,,percentRoot,,114,Pearson,0.46,,,< 0.001,Yes,,,,Wolk 2001
6282,6730,6743,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Pentadecylic acid (15:0),"",,0.23,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Pentadecylic acid (15:0),"",0.36,,,percentRoot,,114,Pearson,0.58,,,< 0.001,Yes,,,,Wolk 2001
6283,6730,6744,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Pentadecylic acid (15:0),"",,0.23,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Margaric acid (17:0),"",0.25,,,percentRoot,,114,Pearson,0.22,,,< 0.05,Yes,,,,Wolk 2001
6284,6730,6745,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Pentadecylic acid (15:0),"",,0.23,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Myristic acid (14:0),"",1.04,,,percentRoot,,104,Pearson,0.33,,,< 0.001,Yes,,,,Wolk 2001
6285,6730,6746,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Pentadecylic acid (15:0),"",,0.23,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,104,Pearson,0.3,,,< 0.01,Yes,,,,Wolk 2001
6286,6730,6747,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Pentadecylic acid (15:0),"",,0.23,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Margaric acid (17:0),"",0.1,,,percentRoot,,104,Pearson,0.24,,,< 0.05,Yes,,,,Wolk 2001
6287,6730,6748,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Pentadecylic acid (15:0),"",,0.23,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",0.47,,,percentRoot,,104,Pearson,0.3,,,< 0.01,Yes,,,,Wolk 2001
6288,6730,6749,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Pentadecylic acid (15:0),"",,0.23,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,104,Pearson,0.4,,,< 0.001,Yes,,,,Wolk 2001
6289,6730,6750,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Pentadecylic acid (15:0),"",,0.23,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Margaric acid (17:0),"",0.44,,,percentRoot,,104,Pearson,0.18,,,>= 0.05,No,,,,Wolk 2001
6903,6730,7454,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Pentadecylic acid (15:0),"",,0.23,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,114,Pearson,0.5,,,< 0.001,Yes,,,,Wolk 2001
6904,6730,7455,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Pentadecylic acid (15:0),"",,0.23,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,104,Pearson,0.22,,,< 0.05,Yes,,,,Wolk 2001
6905,6730,7456,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Pentadecylic acid (15:0),"",,0.23,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,104,Pearson,0.31,,,< 0.01,Yes,,,,Wolk 2001
6290,6731,6742,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Margaric acid (17:0),"",,0.16,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Myristic acid (14:0),"",3.6,,,percentRoot,,114,Pearson,0.37,,,< 0.001,Yes,,,,Wolk 2001
6291,6731,6743,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Margaric acid (17:0),"",,0.16,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Pentadecylic acid (15:0),"",0.36,,,percentRoot,,114,Pearson,0.51,,,< 0.001,Yes,,,,Wolk 2001
6292,6731,6744,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Margaric acid (17:0),"",,0.16,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Margaric acid (17:0),"",0.25,,,percentRoot,,114,Pearson,0.24,,,< 0.05,Yes,,,,Wolk 2001
6293,6731,6745,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Margaric acid (17:0),"",,0.16,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Myristic acid (14:0),"",1.04,,,percentRoot,,104,Pearson,0.25,,,< 0.05,Yes,,,,Wolk 2001
6294,6731,6746,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Margaric acid (17:0),"",,0.16,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,104,Pearson,0.22,,,< 0.05,Yes,,,,Wolk 2001
6295,6731,6747,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Margaric acid (17:0),"",,0.16,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Margaric acid (17:0),"",0.1,,,percentRoot,,104,Pearson,0.26,,,< 0.01,Yes,,,,Wolk 2001
6296,6731,6748,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Margaric acid (17:0),"",,0.16,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",0.47,,,percentRoot,,104,Pearson,0.25,,,< 0.05,Yes,,,,Wolk 2001
6297,6731,6749,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Margaric acid (17:0),"",,0.16,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,104,Pearson,0.36,,,< 0.001,Yes,,,,Wolk 2001
6298,6731,6750,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Margaric acid (17:0),"",,0.16,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Margaric acid (17:0),"",0.44,,,percentRoot,,104,Pearson,0.17,,,>= 0.05,No,,,,Wolk 2001
6906,6731,7454,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Margaric acid (17:0),"",,0.16,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,114,Pearson,0.47,,,< 0.001,Yes,,,,Wolk 2001
6907,6731,7455,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Margaric acid (17:0),"",,0.16,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,104,Pearson,0.19,,,>= 0.05,No,,,,Wolk 2001
6908,6731,7456,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Margaric acid (17:0),"",,0.16,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,104,Pearson,0.28,,,< 0.01,Yes,,,,Wolk 2001
6236,6751,6742,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Myristic acid (14:0),"",3.6,,,percentRoot,,114,Pearson,0.48,,,< 0.001,Yes,,,,Wolk 2001
6237,6751,6743,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Pentadecylic acid (15:0),"",0.36,,,percentRoot,,114,Pearson,0.58,,,< 0.001,Yes,,,,Wolk 2001
6238,6751,6744,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Margaric acid (17:0),"",0.25,,,percentRoot,,114,Pearson,0.2,,,< 0.05,Yes,,,,Wolk 2001
6239,6751,6745,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Myristic acid (14:0),"",1.04,,,percentRoot,,104,Pearson,0.35,,,< 0.001,Yes,,,,Wolk 2001
6240,6751,6746,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,104,Pearson,0.32,,,< 0.001,Yes,,,,Wolk 2001
6241,6751,6747,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Margaric acid (17:0),"",0.1,,,percentRoot,,104,Pearson,0.22,,,< 0.05,Yes,,,,Wolk 2001
6242,6751,6748,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",0.47,,,percentRoot,,104,Pearson,0.31,,,< 0.01,Yes,,,,Wolk 2001
6243,6751,6749,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,104,Pearson,0.4,,,< 0.001,Yes,,,,Wolk 2001
6244,6751,6750,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Margaric acid (17:0),"",0.44,,,percentRoot,,104,Pearson,0.17,,,>= 0.05,No,,,,Wolk 2001
6888,6751,7454,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,114,Pearson,0.49,,,< 0.001,Yes,,,,Wolk 2001
6889,6751,7455,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,104,Pearson,0.22,,,< 0.05,Yes,,,,Wolk 2001
6890,6751,7456,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,104,Pearson,0.3,,,< 0.01,Yes,,,,Wolk 2001
6245,6752,6742,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Myristic acid (14:0),"",3.6,,,percentRoot,,114,Pearson,0.3,,,< 0.01,Yes,,,,Wolk 2001
6246,6752,6743,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Pentadecylic acid (15:0),"",0.36,,,percentRoot,,114,Pearson,0.27,,,< 0.01,Yes,,,,Wolk 2001
6247,6752,6744,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Margaric acid (17:0),"",0.25,,,percentRoot,,114,Pearson,-0.02,,,>= 0.05,No,,,,Wolk 2001
6248,6752,6745,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Myristic acid (14:0),"",1.04,,,percentRoot,,104,Pearson,0.01,,,>= 0.05,No,,,,Wolk 2001
6249,6752,6746,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,104,Pearson,0.26,,,< 0.01,Yes,,,,Wolk 2001
6250,6752,6747,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Margaric acid (17:0),"",0.1,,,percentRoot,,104,Pearson,0.26,,,< 0.01,Yes,,,,Wolk 2001
6251,6752,6748,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",0.47,,,percentRoot,,104,Pearson,0.03,,,>= 0.05,No,,,,Wolk 2001
6252,6752,6749,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,104,Pearson,0.26,,,< 0.01,Yes,,,,Wolk 2001
6253,6752,6750,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Margaric acid (17:0),"",0.44,,,percentRoot,,104,Pearson,0.29,,,< 0.01,Yes,,,,Wolk 2001
6891,6752,7454,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,114,Pearson,0.16,,,>= 0.05,No,,,,Wolk 2001
6892,6752,7455,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,104,Pearson,0.4,,,< 0.001,Yes,,,,Wolk 2001
6893,6752,7456,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,104,Pearson,0.32,,,< 0.001,Yes,,,,Wolk 2001
6263,6753,6742,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Myristic acid (14:0),"",3.6,,,percentRoot,,114,Pearson,0.56,,,< 0.001,Yes,,,,Wolk 2001
6264,6753,6743,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Pentadecylic acid (15:0),"",0.36,,,percentRoot,,114,Pearson,0.66,,,< 0.001,Yes,,,,Wolk 2001
6265,6753,6744,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Margaric acid (17:0),"",0.25,,,percentRoot,,114,Pearson,0.19,,,< 0.05,Yes,,,,Wolk 2001
6266,6753,6745,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Myristic acid (14:0),"",1.04,,,percentRoot,,104,Pearson,0.24,,,< 0.05,Yes,,,,Wolk 2001
6267,6753,6746,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,104,Pearson,0.41,,,< 0.001,Yes,,,,Wolk 2001
6268,6753,6747,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Margaric acid (17:0),"",0.1,,,percentRoot,,104,Pearson,0.42,,,< 0.001,Yes,,,,Wolk 2001
6269,6753,6748,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",0.47,,,percentRoot,,104,Pearson,0.26,,,< 0.01,Yes,,,,Wolk 2001
6270,6753,6749,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,104,Pearson,0.51,,,< 0.001,Yes,,,,Wolk 2001
6271,6753,6750,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Margaric acid (17:0),"",0.44,,,percentRoot,,104,Pearson,0.36,,,< 0.001,Yes,,,,Wolk 2001
6897,6753,7454,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,114,Pearson,0.53,,,< 0.001,Yes,,,,Wolk 2001
6898,6753,7455,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,104,Pearson,0.48,,,< 0.001,Yes,,,,Wolk 2001
6899,6753,7456,All,Men in central Sweden participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,104,Pearson,0.48,,,< 0.001,Yes,,,,Wolk 2001
6317,6737,6742,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,Fats from Dairy foods,,29.9,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Myristic acid (14:0),"",3.6,,,percentRoot,,114,Pearson,0.64,,,< 0.001,Yes,,,,Wolk 2001
6318,6737,6743,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,Fats from Dairy foods,,29.9,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Pentadecylic acid (15:0),"",0.36,,,percentRoot,,114,Pearson,0.74,,,< 0.001,Yes,,,,Wolk 2001
6319,6737,6744,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,Fats from Dairy foods,,29.9,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Margaric acid (17:0),"",0.25,,,percentRoot,,114,Pearson,0.23,,,< 0.05,Yes,,,,Wolk 2001
6320,6737,6745,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,Fats from Dairy foods,,29.9,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Myristic acid (14:0),"",1.04,,,percentRoot,,104,Pearson,0.34,,,< 0.001,Yes,,,,Wolk 2001
6321,6737,6746,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,Fats from Dairy foods,,29.9,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,104,Pearson,0.45,,,< 0.001,Yes,,,,Wolk 2001
6322,6737,6747,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,Fats from Dairy foods,,29.9,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Margaric acid (17:0),"",0.1,,,percentRoot,,104,Pearson,0.47,,,< 0.001,Yes,,,,Wolk 2001
6323,6737,6748,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,Fats from Dairy foods,,29.9,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",0.47,,,percentRoot,,104,Pearson,0.3,,,< 0.01,Yes,,,,Wolk 2001
6324,6737,6749,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,Fats from Dairy foods,,29.9,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,104,Pearson,0.5,,,< 0.001,Yes,,,,Wolk 2001
6325,6737,6750,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,Fats from Dairy foods,,29.9,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Margaric acid (17:0),"",0.44,,,percentRoot,,104,Pearson,0.39,,,< 0.001,Yes,,,,Wolk 2001
6915,6737,7454,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,Fats from Dairy foods,,29.9,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,114,Pearson,0.6,,,< 0.001,Yes,,,,Wolk 2001
6916,6737,7455,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,Fats from Dairy foods,,29.9,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,104,Pearson,0.56,,,< 0.001,Yes,,,,Wolk 2001
6917,6737,7456,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,Fats from Dairy foods,,29.9,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,104,Pearson,0.5,,,< 0.001,Yes,,,,Wolk 2001
6335,6739,6742,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Myristic acid (14:0),"",,4.6,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Myristic acid (14:0),"",3.6,,,percentRoot,,114,Pearson,0.66,,,< 0.001,Yes,,,,Wolk 2001
6336,6739,6743,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Myristic acid (14:0),"",,4.6,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Pentadecylic acid (15:0),"",0.36,,,percentRoot,,114,Pearson,0.74,,,< 0.001,Yes,,,,Wolk 2001
6337,6739,6744,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Myristic acid (14:0),"",,4.6,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Margaric acid (17:0),"",0.25,,,percentRoot,,114,Pearson,0.19,,,< 0.05,Yes,,,,Wolk 2001
6338,6739,6745,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Myristic acid (14:0),"",,4.6,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Myristic acid (14:0),"",1.04,,,percentRoot,,104,Pearson,0.35,,,< 0.001,Yes,,,,Wolk 2001
6339,6739,6746,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Myristic acid (14:0),"",,4.6,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,104,Pearson,0.48,,,< 0.001,Yes,,,,Wolk 2001
6340,6739,6747,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Myristic acid (14:0),"",,4.6,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Margaric acid (17:0),"",0.1,,,percentRoot,,104,Pearson,0.42,,,< 0.001,Yes,,,,Wolk 2001
6341,6739,6748,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Myristic acid (14:0),"",,4.6,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",0.47,,,percentRoot,,104,Pearson,0.27,,,< 0.01,Yes,,,,Wolk 2001
6342,6739,6749,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Myristic acid (14:0),"",,4.6,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,104,Pearson,0.47,,,< 0.001,Yes,,,,Wolk 2001
6343,6739,6750,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Myristic acid (14:0),"",,4.6,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Margaric acid (17:0),"",0.44,,,percentRoot,,104,Pearson,0.35,,,< 0.001,Yes,,,,Wolk 2001
6921,6739,7454,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Myristic acid (14:0),"",,4.6,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,114,Pearson,0.58,,,< 0.001,Yes,,,,Wolk 2001
6922,6739,7455,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Myristic acid (14:0),"",,4.6,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,104,Pearson,0.55,,,< 0.001,Yes,,,,Wolk 2001
6923,6739,7456,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Myristic acid (14:0),"",,4.6,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,104,Pearson,0.45,,,< 0.001,Yes,,,,Wolk 2001
6344,6740,6742,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Pentadecylic acid (15:0),"",,0.23,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Myristic acid (14:0),"",3.6,,,percentRoot,,114,Pearson,0.56,,,< 0.001,Yes,,,,Wolk 2001
6345,6740,6743,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Pentadecylic acid (15:0),"",,0.23,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Pentadecylic acid (15:0),"",0.36,,,percentRoot,,114,Pearson,0.67,,,< 0.001,Yes,,,,Wolk 2001
6346,6740,6744,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Pentadecylic acid (15:0),"",,0.23,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Margaric acid (17:0),"",0.25,,,percentRoot,,114,Pearson,0.22,,,< 0.01,Yes,,,,Wolk 2001
6347,6740,6745,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Pentadecylic acid (15:0),"",,0.23,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Myristic acid (14:0),"",1.04,,,percentRoot,,104,Pearson,0.36,,,< 0.001,Yes,,,,Wolk 2001
6348,6740,6746,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Pentadecylic acid (15:0),"",,0.23,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,104,Pearson,0.38,,,< 0.001,Yes,,,,Wolk 2001
6349,6740,6747,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Pentadecylic acid (15:0),"",,0.23,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Margaric acid (17:0),"",0.1,,,percentRoot,,104,Pearson,0.38,,,< 0.001,Yes,,,,Wolk 2001
6350,6740,6748,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Pentadecylic acid (15:0),"",,0.23,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",0.47,,,percentRoot,,104,Pearson,0.34,,,< 0.001,Yes,,,,Wolk 2001
6351,6740,6749,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Pentadecylic acid (15:0),"",,0.23,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,104,Pearson,0.44,,,< 0.001,Yes,,,,Wolk 2001
6352,6740,6750,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Pentadecylic acid (15:0),"",,0.23,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Margaric acid (17:0),"",0.44,,,percentRoot,,104,Pearson,0.25,,,< 0.05,Yes,,,,Wolk 2001
6924,6740,7454,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Pentadecylic acid (15:0),"",,0.23,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,114,Pearson,0.55,,,< 0.001,Yes,,,,Wolk 2001
6925,6740,7455,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Pentadecylic acid (15:0),"",,0.23,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,104,Pearson,0.41,,,< 0.001,Yes,,,,Wolk 2001
6926,6740,7456,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Pentadecylic acid (15:0),"",,0.23,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,104,Pearson,0.37,,,< 0.001,Yes,,,,Wolk 2001
6353,6741,6742,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Margaric acid (17:0),"",,0.17,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Myristic acid (14:0),"",3.6,,,percentRoot,,114,Pearson,0.47,,,< 0.001,Yes,,,,Wolk 2001
6354,6741,6743,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Margaric acid (17:0),"",,0.17,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Pentadecylic acid (15:0),"",0.36,,,percentRoot,,114,Pearson,0.6,,,< 0.001,Yes,,,,Wolk 2001
6355,6741,6744,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Margaric acid (17:0),"",,0.17,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Margaric acid (17:0),"",0.25,,,percentRoot,,114,Pearson,0.2,,,< 0.05,Yes,,,,Wolk 2001
6356,6741,6745,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Margaric acid (17:0),"",,0.17,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Myristic acid (14:0),"",1.04,,,percentRoot,,104,Pearson,0.29,,,< 0.01,Yes,,,,Wolk 2001
6357,6741,6746,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Margaric acid (17:0),"",,0.17,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,104,Pearson,0.3,,,< 0.01,Yes,,,,Wolk 2001
6358,6741,6747,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Margaric acid (17:0),"",,0.17,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Margaric acid (17:0),"",0.1,,,percentRoot,,104,Pearson,0.41,,,< 0.001,Yes,,,,Wolk 2001
6359,6741,6748,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Margaric acid (17:0),"",,0.17,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",0.47,,,percentRoot,,104,Pearson,0.27,,,< 0.01,Yes,,,,Wolk 2001
6360,6741,6749,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Margaric acid (17:0),"",,0.17,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,104,Pearson,0.36,,,< 0.001,Yes,,,,Wolk 2001
6361,6741,6750,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Margaric acid (17:0),"",,0.17,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Margaric acid (17:0),"",0.44,,,percentRoot,,104,Pearson,0.2,,,< 0.05,Yes,,,,Wolk 2001
6927,6741,7454,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Margaric acid (17:0),"",,0.17,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,114,Pearson,0.49,,,< 0.001,Yes,,,,Wolk 2001
6928,6741,7455,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Margaric acid (17:0),"",,0.17,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,104,Pearson,0.36,,,< 0.001,Yes,,,,Wolk 2001
6929,6741,7456,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Margaric acid (17:0),"",,0.17,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,104,Pearson,0.31,,,< 0.01,Yes,,,,Wolk 2001
6299,6754,6742,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Myristic acid (14:0),"",3.6,,,percentRoot,,114,Pearson,0.58,,,< 0.001,Yes,,,,Wolk 2001
6300,6754,6743,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Pentadecylic acid (15:0),"",0.36,,,percentRoot,,114,Pearson,0.69,,,< 0.001,Yes,,,,Wolk 2001
6301,6754,6744,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Margaric acid (17:0),"",0.25,,,percentRoot,,114,Pearson,0.22,,,< 0.05,Yes,,,,Wolk 2001
6302,6754,6745,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Myristic acid (14:0),"",1.04,,,percentRoot,,104,Pearson,0.39,,,< 0.001,Yes,,,,Wolk 2001
6303,6754,6746,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,104,Pearson,0.4,,,< 0.001,Yes,,,,Wolk 2001
6304,6754,6747,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Margaric acid (17:0),"",0.1,,,percentRoot,,104,Pearson,0.36,,,< 0.001,Yes,,,,Wolk 2001
6305,6754,6748,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",0.47,,,percentRoot,,104,Pearson,0.36,,,< 0.001,Yes,,,,Wolk 2001
6306,6754,6749,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,104,Pearson,0.46,,,< 0.001,Yes,,,,Wolk 2001
6307,6754,6750,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Margaric acid (17:0),"",0.44,,,percentRoot,,104,Pearson,0.26,,,< 0.01,Yes,,,,Wolk 2001
6909,6754,7454,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,114,Pearson,0.56,,,< 0.001,Yes,,,,Wolk 2001
6910,6754,7455,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,104,Pearson,0.42,,,< 0.001,Yes,,,,Wolk 2001
6911,6754,7456,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,104,Pearson,0.39,,,< 0.001,Yes,,,,Wolk 2001
6308,6755,6742,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Myristic acid (14:0),"",3.6,,,percentRoot,,114,Pearson,0.25,,,< 0.01,Yes,,,,Wolk 2001
6309,6755,6743,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Pentadecylic acid (15:0),"",0.36,,,percentRoot,,114,Pearson,0.27,,,< 0.01,Yes,,,,Wolk 2001
6310,6755,6744,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Margaric acid (17:0),"",0.25,,,percentRoot,,114,Pearson,0.07,,,>= 0.05,No,,,,Wolk 2001
6311,6755,6745,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Myristic acid (14:0),"",1.04,,,percentRoot,,104,Pearson,0.03,,,>= 0.05,No,,,,Wolk 2001
6312,6755,6746,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,104,Pearson,0.17,,,>= 0.05,No,,,,Wolk 2001
6313,6755,6747,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Margaric acid (17:0),"",0.1,,,percentRoot,,104,Pearson,0.25,,,< 0.05,Yes,,,,Wolk 2001
6314,6755,6748,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",0.47,,,percentRoot,,104,Pearson,-0.01,,,>= 0.05,No,,,,Wolk 2001
6315,6755,6749,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,104,Pearson,0.18,,,>= 0.05,No,,,,Wolk 2001
6316,6755,6750,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Margaric acid (17:0),"",0.44,,,percentRoot,,104,Pearson,0.26,,,< 0.01,Yes,,,,Wolk 2001
6912,6755,7454,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,114,Pearson,0.21,,,< 0.05,Yes,,,,Wolk 2001
6913,6755,7455,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,104,Pearson,0.3,,,< 0.01,Yes,,,,Wolk 2001
6914,6755,7456,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,104,Pearson,0.26,,,< 0.01,Yes,,,,Wolk 2001
6326,6756,6742,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Myristic acid (14:0),"",3.6,,,percentRoot,,114,Pearson,0.6,,,< 0.001,Yes,,,,Wolk 2001
6327,6756,6743,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Pentadecylic acid (15:0),"",0.36,,,percentRoot,,114,Pearson,0.72,,,< 0.001,Yes,,,,Wolk 2001
6328,6756,6744,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Margaric acid (17:0),"",0.25,,,percentRoot,,114,Pearson,0.23,,,< 0.05,Yes,,,,Wolk 2001
6329,6756,6745,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Myristic acid (14:0),"",1.04,,,percentRoot,,104,Pearson,0.3,,,< 0.01,Yes,,,,Wolk 2001
6330,6756,6746,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,104,Pearson,0.4,,,< 0.001,Yes,,,,Wolk 2001
6331,6756,6747,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,Margaric acid (17:0),"",0.1,,,percentRoot,,104,Pearson,0.54,,,< 0.001,Yes,,,,Wolk 2001
6332,6756,6748,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",0.47,,,percentRoot,,104,Pearson,0.25,,,< 0.01,Yes,,,,Wolk 2001
6333,6756,6749,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,104,Pearson,0.46,,,< 0.001,Yes,,,,Wolk 2001
6334,6756,6750,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,Margaric acid (17:0),"",0.44,,,percentRoot,,104,Pearson,0.37,,,< 0.001,Yes,,,,Wolk 2001
6918,6756,7454,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Adipose tissue (triglycerides), buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,114,Pearson,0.58,,,< 0.001,Yes,,,,Wolk 2001
6919,6756,7455,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Serum (cholesterol esters), fasting",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,104,Pearson,0.55,,,< 0.001,Yes,,,,Wolk 2001
6920,6756,7456,All,Men in central Sweden participant in a dietary validation study,Sweden,,,24-h Dietary recall (1-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Serum (phospholipids), fasting",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),,,,percentRoot,,104,Pearson,0.47,,,< 0.001,Yes,,,,Wolk 2001
6362,6771,6765,All,Participants in a dietary validation study,Denmark,DanThyr (Danish Investigation of Iodine Intake and Thyroid Diseases),,Food Frequency Questionnaire (FFQ),Iodine,"",Yes,,,159.0,ug/day,,,"Urine, 24-h",HPLC,Iodine,"",,,118.0,ug/day,,121,Spearman,0.66,,,< 0.001,Yes,,,,Rasmussen 2001
6363,6769,6763,Copenhagen,Participants in a dietary validation study,Denmark,DanThyr (Danish Investigation of Iodine Intake and Thyroid Diseases),,Food Frequency Questionnaire (FFQ),Iodine,"",Yes,,,213.0,ug/day,,,"Urine, 24-h",HPLC,Iodine,"",,,177.0,ug/day,,40,Spearman,0.69,,,< 0.001,Yes,,,,Rasmussen 2001
6364,6770,6764,Aalborg,Participants in a dietary validation study,Denmark,DanThyr (Danish Investigation of Iodine Intake and Thyroid Diseases),,Food Frequency Questionnaire (FFQ),Iodine,"",Yes,,,155.0,ug/day,,,"Urine, 24-h",HPLC,Iodine,"",,,98.0,ug/day,,81,Spearman,0.64,,,< 0.001,Yes,,,,Rasmussen 2001
6365,6777,6774,Supplement nonusers,Participants in a dietary validation study,Denmark,DanThyr (Danish Investigation of Iodine Intake and Thyroid Diseases),,Food Frequency Questionnaire (FFQ),Iodine,"",No,,,106.0,ug/day,,,"Urine, 24-h",HPLC,Iodine,"",,,91.0,ug/day,,73,Spearman,0.42,,,< 0.001,Yes,,,,Rasmussen 2001
6366,6778,6804,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,- 12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,3.6,,,servings/day,,baseline,"Serum, unspecified",HPLC,Lycopene,"",18.0,,,ug/dL,,782,Unspecified,-0.02,,,>= 0.05,No,,,,Resnicow 2000
6371,6778,6805,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,- 12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,3.6,,,servings/day,,baseline,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",22.4,,,ug/dL,,782,Unspecified,0.14,,,< 0.01,Yes,,,,Resnicow 2000
6376,6778,6806,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,- 12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,3.6,,,servings/day,,baseline,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",9.4,,,ug/dL,,782,Unspecified,0.15,,,< 0.01,Yes,,,,Resnicow 2000
6381,6778,6807,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,- 12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,3.6,,,servings/day,,baseline,"Serum, unspecified",HPLC,alpha-Carotene,"",4.1,,,ug/dL,,782,Unspecified,0.23,,,< 0.01,Yes,,,,Resnicow 2000
6386,6778,6808,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,- 12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,3.6,,,servings/day,,baseline,"Serum, unspecified",HPLC,beta-Carotene,"",23.6,,,ug/dL,,782,Unspecified,0.18,,,< 0.01,Yes,,,,Resnicow 2000
6391,6778,6809,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,- 12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,3.6,,,servings/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,782,Unspecified,0.19,,,< 0.01,Yes,,,,Resnicow 2000
6396,6778,6810,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,- 12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,3.6,,,servings/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,782,Unspecified,0.22,,,< 0.01,Yes,,,,Resnicow 2000
6506,6778,6804,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,- 12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,3.6,,,servings/day,,baseline,"Serum, unspecified",HPLC,Lycopene,"",18.0,,,ug/dL,,68,Unspecified,0.17,,,>= 0.05,No,,,,Resnicow 2000
6514,6778,6805,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,- 12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,3.6,,,servings/day,,baseline,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",22.4,,,ug/dL,,68,Unspecified,0.28,,,< 0.05,Yes,,,,Resnicow 2000
6522,6778,6806,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,- 12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,3.6,,,servings/day,,baseline,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",9.4,,,ug/dL,,68,Unspecified,0.27,,,< 0.05,Yes,,,,Resnicow 2000
6530,6778,6807,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,- 12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,3.6,,,servings/day,,baseline,"Serum, unspecified",HPLC,alpha-Carotene,"",4.1,,,ug/dL,,68,Unspecified,0.29,,,< 0.05,Yes,,,,Resnicow 2000
6538,6778,6808,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,- 12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,3.6,,,servings/day,,baseline,"Serum, unspecified",HPLC,beta-Carotene,"",23.6,,,ug/dL,,68,Unspecified,0.31,,,< 0.05,Yes,,,,Resnicow 2000
6546,6778,6809,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,- 12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,3.6,,,servings/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,68,Unspecified,0.35,,,< 0.01,Yes,,,,Resnicow 2000
6554,6778,6810,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,- 12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,3.6,,,servings/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,68,Unspecified,0.34,,,< 0.01,Yes,,,,Resnicow 2000
6367,6779,6804,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,- 12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,3.5,,,servings/day,,baseline,"Serum, unspecified",HPLC,Lycopene,"",18.0,,,ug/dL,,775,Unspecified,0.04,,,>= 0.05,No,,,,Resnicow 2000
6372,6779,6805,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,- 12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,3.5,,,servings/day,,baseline,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",22.4,,,ug/dL,,775,Unspecified,0.16,,,< 0.01,Yes,,,,Resnicow 2000
6377,6779,6806,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,- 12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,3.5,,,servings/day,,baseline,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",9.4,,,ug/dL,,775,Unspecified,0.25,,,< 0.01,Yes,,,,Resnicow 2000
6382,6779,6807,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,- 12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,3.5,,,servings/day,,baseline,"Serum, unspecified",HPLC,alpha-Carotene,"",4.1,,,ug/dL,,775,Unspecified,0.28,,,< 0.01,Yes,,,,Resnicow 2000
6387,6779,6808,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,- 12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,3.5,,,servings/day,,baseline,"Serum, unspecified",HPLC,beta-Carotene,"",23.6,,,ug/dL,,775,Unspecified,0.24,,,< 0.01,Yes,,,,Resnicow 2000
6392,6779,6809,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,- 12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,3.5,,,servings/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,775,Unspecified,0.27,,,< 0.01,Yes,,,,Resnicow 2000
6397,6779,6810,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,- 12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,3.5,,,servings/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,775,Unspecified,0.29,,,< 0.01,Yes,,,,Resnicow 2000
6507,6779,6804,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,- 12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,3.5,,,servings/day,,baseline,"Serum, unspecified",HPLC,Lycopene,"",18.0,,,ug/dL,,68,Unspecified,-0.08,,,>= 0.05,No,,,,Resnicow 2000
6515,6779,6805,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,- 12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,3.5,,,servings/day,,baseline,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",22.4,,,ug/dL,,68,Unspecified,0.03,,,>= 0.05,No,,,,Resnicow 2000
6523,6779,6806,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,- 12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,3.5,,,servings/day,,baseline,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",9.4,,,ug/dL,,68,Unspecified,0.19,,,>= 0.05,No,,,,Resnicow 2000
6531,6779,6807,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,- 12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,3.5,,,servings/day,,baseline,"Serum, unspecified",HPLC,alpha-Carotene,"",4.1,,,ug/dL,,68,Unspecified,0.24,,,>= 0.05,No,,,,Resnicow 2000
6539,6779,6808,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,- 12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,3.5,,,servings/day,,baseline,"Serum, unspecified",HPLC,beta-Carotene,"",23.6,,,ug/dL,,68,Unspecified,0.14,,,>= 0.05,No,,,,Resnicow 2000
6547,6779,6809,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,- 12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,3.5,,,servings/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,68,Unspecified,0.16,,,>= 0.05,No,,,,Resnicow 2000
6555,6779,6810,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,- 12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,3.5,,,servings/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,68,Unspecified,0.19,,,>= 0.05,No,,,,Resnicow 2000
6401,6780,6804,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Lycopene,"",Yes,2065.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lycopene,"",18.0,,,ug/dL,,802,Unspecified,0.06,,,>= 0.05,No,,,,Resnicow 2000
6509,6780,6804,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Lycopene,"",Yes,2065.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lycopene,"",18.0,,,ug/dL,,68,Unspecified,0.05,,,>= 0.05,No,,,,Resnicow 2000
6402,6781,6805,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",Yes,2628.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",22.4,,,ug/dL,,802,Unspecified,0.21,,,< 0.01,Yes,,,,Resnicow 2000
6517,6781,6805,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",Yes,2628.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",22.4,,,ug/dL,,68,Unspecified,0.27,,,< 0.05,Yes,,,,Resnicow 2000
6403,6782,6806,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",Yes,100.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",9.4,,,ug/dL,,802,Unspecified,0.35,,,< 0.01,Yes,,,,Resnicow 2000
6525,6782,6806,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",Yes,100.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",9.4,,,ug/dL,,68,Unspecified,0.5,,,< 0.01,Yes,,,,Resnicow 2000
6404,6783,6807,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",Yes,532.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,alpha-Carotene,"",4.1,,,ug/dL,,802,Unspecified,0.4,,,< 0.01,Yes,,,,Resnicow 2000
6533,6783,6807,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",Yes,532.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,alpha-Carotene,"",4.1,,,ug/dL,,68,Unspecified,0.49,,,< 0.01,Yes,,,,Resnicow 2000
6405,6784,6808,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),beta-Carotene,"",Yes,3650.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Carotene,"",23.6,,,ug/dL,,802,Unspecified,0.39,,,< 0.01,Yes,,,,Resnicow 2000
6541,6784,6808,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),beta-Carotene,"",Yes,3650.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Carotene,"",23.6,,,ug/dL,,68,Unspecified,0.44,,,< 0.01,Yes,,,,Resnicow 2000
6406,6785,6809,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,802,Unspecified,0.33,,,< 0.01,Yes,,,,Resnicow 2000
6549,6785,6809,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,68,Unspecified,0.52,,,< 0.01,Yes,,,,Resnicow 2000
6407,6786,6810,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,802,Unspecified,0.37,,,< 0.01,Yes,,,,Resnicow 2000
6557,6786,6810,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,68,Unspecified,0.5,,,< 0.05,Yes,,,,Resnicow 2000
6368,6787,6804,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,4.3,,,servings/day,,baseline,"Serum, unspecified",HPLC,Lycopene,"",18.0,,,ug/dL,,775,Unspecified,0.02,,,>= 0.05,No,,,,Resnicow 2000
6373,6787,6805,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,4.3,,,servings/day,,baseline,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",22.4,,,ug/dL,,775,Unspecified,0.21,,,< 0.01,Yes,,,,Resnicow 2000
6378,6787,6806,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,4.3,,,servings/day,,baseline,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",9.4,,,ug/dL,,775,Unspecified,0.26,,,< 0.01,Yes,,,,Resnicow 2000
6383,6787,6807,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,4.3,,,servings/day,,baseline,"Serum, unspecified",HPLC,alpha-Carotene,"",4.1,,,ug/dL,,775,Unspecified,0.34,,,< 0.01,Yes,,,,Resnicow 2000
6388,6787,6808,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,4.3,,,servings/day,,baseline,"Serum, unspecified",HPLC,beta-Carotene,"",23.6,,,ug/dL,,775,Unspecified,0.31,,,< 0.01,Yes,,,,Resnicow 2000
6393,6787,6809,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,4.3,,,servings/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,775,Unspecified,0.32,,,< 0.01,Yes,,,,Resnicow 2000
6398,6787,6810,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,4.3,,,servings/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,775,Unspecified,0.35,,,< 0.01,Yes,,,,Resnicow 2000
6508,6787,6804,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,4.3,,,servings/day,,baseline,"Serum, unspecified",HPLC,Lycopene,"",18.0,,,ug/dL,,68,Unspecified,0.24,,,>= 0.05,No,,,,Resnicow 2000
6516,6787,6805,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,4.3,,,servings/day,,baseline,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",22.4,,,ug/dL,,68,Unspecified,0.3,,,< 0.05,Yes,,,,Resnicow 2000
6524,6787,6806,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,4.3,,,servings/day,,baseline,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",9.4,,,ug/dL,,68,Unspecified,0.43,,,< 0.01,Yes,,,,Resnicow 2000
6532,6787,6807,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,4.3,,,servings/day,,baseline,"Serum, unspecified",HPLC,alpha-Carotene,"",4.1,,,ug/dL,,68,Unspecified,0.52,,,< 0.01,Yes,,,,Resnicow 2000
6540,6787,6808,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,4.3,,,servings/day,,baseline,"Serum, unspecified",HPLC,beta-Carotene,"",23.6,,,ug/dL,,68,Unspecified,0.46,,,< 0.01,Yes,,,,Resnicow 2000
6548,6787,6809,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,4.3,,,servings/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,68,Unspecified,0.53,,,< 0.01,Yes,,,,Resnicow 2000
6556,6787,6810,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,4.3,,,servings/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,68,Unspecified,0.53,,,< 0.01,Yes,,,,Resnicow 2000
6436,6788,6804,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Lycopene,"",Yes,2787.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lycopene,"",18.0,,,ug/dL,,285,Unspecified,0.11,,,>= 0.05,No,,,,Resnicow 2000
6511,6788,6804,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Lycopene,"",Yes,2787.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lycopene,"",18.0,,,ug/dL,,68,Unspecified,0.19,,,>= 0.05,No,,,,Resnicow 2000
6437,6789,6805,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Lutein/Zeaxanthin,"",Yes,3270.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",22.4,,,ug/dL,,285,Unspecified,0.19,,,< 0.01,Yes,,,,Resnicow 2000
6519,6789,6805,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Lutein/Zeaxanthin,"",Yes,3270.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",22.4,,,ug/dL,,68,Unspecified,0.15,,,>= 0.05,No,,,,Resnicow 2000
6438,6790,6806,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),beta-Cryptoxanthin,"",Yes,97.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",9.4,,,ug/dL,,285,Unspecified,0.34,,,< 0.01,Yes,,,,Resnicow 2000
6527,6790,6806,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),beta-Cryptoxanthin,"",Yes,97.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",9.4,,,ug/dL,,68,Unspecified,0.39,,,< 0.01,Yes,,,,Resnicow 2000
6439,6791,6807,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),alpha-Carotene,"",Yes,401.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,alpha-Carotene,"",4.1,,,ug/dL,,285,Unspecified,0.29,,,< 0.01,Yes,,,,Resnicow 2000
6535,6791,6807,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),alpha-Carotene,"",Yes,401.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,alpha-Carotene,"",4.1,,,ug/dL,,68,Unspecified,0.39,,,< 0.01,Yes,,,,Resnicow 2000
6440,6792,6808,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),beta-Carotene,"",Yes,2867.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Carotene,"",23.6,,,ug/dL,,285,Unspecified,0.25,,,< 0.01,Yes,,,,Resnicow 2000
6543,6792,6808,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),beta-Carotene,"",Yes,2867.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Carotene,"",23.6,,,ug/dL,,68,Unspecified,0.26,,,< 0.05,Yes,,,,Resnicow 2000
6441,6793,6809,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,285,Unspecified,0.31,,,< 0.01,Yes,,,,Resnicow 2000
6551,6793,6809,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,68,Unspecified,0.42,,,< 0.01,Yes,,,,Resnicow 2000
6442,6794,6810,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,285,Unspecified,0.39,,,< 0.01,Yes,,,,Resnicow 2000
6559,6794,6810,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,68,Unspecified,0.36,,,< 0.01,Yes,,,,Resnicow 2000
6369,6795,6804,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,3.1,,,servings/day,,baseline,"Serum, unspecified",HPLC,Lycopene,"",18.0,,,ug/dL,,285,Unspecified,0.03,,,>= 0.05,No,,,,Resnicow 2000
6374,6795,6805,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,3.1,,,servings/day,,baseline,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",22.4,,,ug/dL,,285,Unspecified,0.31,,,< 0.01,Yes,,,,Resnicow 2000
6379,6795,6806,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,3.1,,,servings/day,,baseline,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",9.4,,,ug/dL,,285,Unspecified,0.29,,,< 0.01,Yes,,,,Resnicow 2000
6384,6795,6807,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,3.1,,,servings/day,,baseline,"Serum, unspecified",HPLC,alpha-Carotene,"",4.1,,,ug/dL,,285,Unspecified,0.33,,,< 0.01,Yes,,,,Resnicow 2000
6389,6795,6808,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,3.1,,,servings/day,,baseline,"Serum, unspecified",HPLC,beta-Carotene,"",23.6,,,ug/dL,,285,Unspecified,0.28,,,< 0.01,Yes,,,,Resnicow 2000
6394,6795,6809,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,3.1,,,servings/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,285,Unspecified,0.34,,,< 0.01,Yes,,,,Resnicow 2000
6399,6795,6810,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,3.1,,,servings/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,285,Unspecified,0.37,,,< 0.01,Yes,,,,Resnicow 2000
6510,6795,6804,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,3.1,,,servings/day,,baseline,"Serum, unspecified",HPLC,Lycopene,"",18.0,,,ug/dL,,68,Unspecified,-0.15,,,>= 0.05,No,,,,Resnicow 2000
6518,6795,6805,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,3.1,,,servings/day,,baseline,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",22.4,,,ug/dL,,68,Unspecified,0.32,,,< 0.01,Yes,,,,Resnicow 2000
6526,6795,6806,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,3.1,,,servings/day,,baseline,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",9.4,,,ug/dL,,68,Unspecified,0.22,,,>= 0.05,No,,,,Resnicow 2000
6534,6795,6807,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,3.1,,,servings/day,,baseline,"Serum, unspecified",HPLC,alpha-Carotene,"",4.1,,,ug/dL,,68,Unspecified,0.42,,,< 0.01,Yes,,,,Resnicow 2000
6542,6795,6808,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,3.1,,,servings/day,,baseline,"Serum, unspecified",HPLC,beta-Carotene,"",23.6,,,ug/dL,,68,Unspecified,0.31,,,< 0.05,Yes,,,,Resnicow 2000
6550,6795,6809,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,3.1,,,servings/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,68,Unspecified,0.32,,,< 0.01,Yes,,,,Resnicow 2000
6558,6795,6810,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,3.1,,,servings/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,68,Unspecified,0.39,,,< 0.01,Yes,,,,Resnicow 2000
6471,6796,6804,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Lycopene,"",Yes,2200.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lycopene,"",18.0,,,ug/dL,,74,Unspecified,0.08,,,>= 0.05,No,,,,Resnicow 2000
6513,6796,6804,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Lycopene,"",Yes,2200.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lycopene,"",18.0,,,ug/dL,,68,Unspecified,0.08,,,>= 0.05,No,,,,Resnicow 2000
6472,6797,6805,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Lutein/Zeaxanthin,"",Yes,3033.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",22.4,,,ug/dL,,74,Unspecified,0.27,,,< 0.05,Yes,,,,Resnicow 2000
6521,6797,6805,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Lutein/Zeaxanthin,"",Yes,3033.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",22.4,,,ug/dL,,68,Unspecified,0.25,,,< 0.05,Yes,,,,Resnicow 2000
6473,6798,6806,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),beta-Cryptoxanthin,"",Yes,93.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",9.4,,,ug/dL,,74,Unspecified,0.48,,,< 0.01,Yes,,,,Resnicow 2000
6529,6798,6806,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),beta-Cryptoxanthin,"",Yes,93.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",9.4,,,ug/dL,,68,Unspecified,0.63,,,< 0.01,Yes,,,,Resnicow 2000
6474,6799,6807,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),alpha-Carotene,"",Yes,303.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,alpha-Carotene,"",4.1,,,ug/dL,,74,Unspecified,0.31,,,< 0.01,Yes,,,,Resnicow 2000
6537,6799,6807,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),alpha-Carotene,"",Yes,303.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,alpha-Carotene,"",4.1,,,ug/dL,,68,Unspecified,0.32,,,< 0.05,Yes,,,,Resnicow 2000
6475,6800,6808,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),beta-Carotene,"",Yes,2578.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Carotene,"",23.6,,,ug/dL,,74,Unspecified,0.18,,,>= 0.05,No,,,,Resnicow 2000
6545,6800,6808,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),beta-Carotene,"",Yes,2578.0,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Carotene,"",23.6,,,ug/dL,,68,Unspecified,0.19,,,>= 0.05,No,,,,Resnicow 2000
6476,6801,6809,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,74,Unspecified,0.24,,,< 0.05,Yes,,,,Resnicow 2000
6553,6801,6809,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,68,Unspecified,0.27,,,< 0.05,Yes,,,,Resnicow 2000
6477,6802,6810,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,74,Unspecified,0.4,,,< 0.01,Yes,,,,Resnicow 2000
6561,6802,6810,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,68,Unspecified,0.41,,,< 0.01,Yes,,,,Resnicow 2000
6370,6803,6804,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,2.7,,,servings/day,,baseline,"Serum, unspecified",HPLC,Lycopene,"",18.0,,,ug/dL,,74,Unspecified,-0.15,,,>= 0.05,No,,,,Resnicow 2000
6375,6803,6805,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,2.7,,,servings/day,,baseline,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",22.4,,,ug/dL,,74,Unspecified,0.41,,,< 0.01,Yes,,,,Resnicow 2000
6380,6803,6806,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,2.7,,,servings/day,,baseline,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",9.4,,,ug/dL,,74,Unspecified,0.33,,,< 0.01,Yes,,,,Resnicow 2000
6385,6803,6807,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,2.7,,,servings/day,,baseline,"Serum, unspecified",HPLC,alpha-Carotene,"",4.1,,,ug/dL,,74,Unspecified,0.38,,,< 0.01,Yes,,,,Resnicow 2000
6390,6803,6808,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,2.7,,,servings/day,,baseline,"Serum, unspecified",HPLC,beta-Carotene,"",23.6,,,ug/dL,,74,Unspecified,0.31,,,< 0.01,Yes,,,,Resnicow 2000
6395,6803,6809,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,2.7,,,servings/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,74,Unspecified,0.35,,,< 0.01,Yes,,,,Resnicow 2000
6400,6803,6810,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,2.7,,,servings/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,74,Unspecified,0.42,,,< 0.01,Yes,,,,Resnicow 2000
6512,6803,6804,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,2.7,,,servings/day,,baseline,"Serum, unspecified",HPLC,Lycopene,"",18.0,,,ug/dL,,68,Unspecified,-0.14,,,>= 0.05,No,,,,Resnicow 2000
6520,6803,6805,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,2.7,,,servings/day,,baseline,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",22.4,,,ug/dL,,68,Unspecified,0.42,,,< 0.01,Yes,,,,Resnicow 2000
6528,6803,6806,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,2.7,,,servings/day,,baseline,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",9.4,,,ug/dL,,68,Unspecified,0.27,,,< 0.01,Yes,,,,Resnicow 2000
6536,6803,6807,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,2.7,,,servings/day,,baseline,"Serum, unspecified",HPLC,alpha-Carotene,"",4.1,,,ug/dL,,68,Unspecified,0.39,,,< 0.01,Yes,,,,Resnicow 2000
6544,6803,6808,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,2.7,,,servings/day,,baseline,"Serum, unspecified",HPLC,beta-Carotene,"",23.6,,,ug/dL,,68,Unspecified,0.35,,,< 0.01,Yes,,,,Resnicow 2000
6552,6803,6809,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,2.7,,,servings/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,68,Unspecified,0.36,,,< 0.01,Yes,,,,Resnicow 2000
6560,6803,6810,All,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,2.7,,,servings/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,68,Unspecified,0.43,,,< 0.01,Yes,,,,Resnicow 2000
6408,6811,6895,Males,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Lycopene,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lycopene,"",,,,ug/dL,,223,Unspecified,0.04,,,>= 0.05,No,,,,Resnicow 2000
6409,6812,6896,Males,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",,,,ug/dL,,223,Unspecified,0.35,,,< 0.01,Yes,,,,Resnicow 2000
6410,6813,6897,Males,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",,,,ug/dL,,223,Unspecified,0.33,,,< 0.01,Yes,,,,Resnicow 2000
6411,6814,6898,Males,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,alpha-Carotene,"",,,,ug/dL,,223,Unspecified,0.44,,,< 0.01,Yes,,,,Resnicow 2000
6412,6815,6899,Males,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),beta-Carotene,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Carotene,"",,,,ug/dL,,223,Unspecified,0.39,,,< 0.01,Yes,,,,Resnicow 2000
6413,6816,6900,Males,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,223,Unspecified,0.36,,,< 0.01,Yes,,,,Resnicow 2000
6414,6817,6901,Males,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,223,Unspecified,0.41,,,< 0.01,Yes,,,,Resnicow 2000
6443,6839,6895,Males,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Lycopene,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lycopene,"",,,,ug/dL,,64,Unspecified,0.08,,,>= 0.05,No,,,,Resnicow 2000
6444,6840,6896,Males,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Lutein/Zeaxanthin,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",,,,ug/dL,,64,Unspecified,0.17,,,>= 0.05,No,,,,Resnicow 2000
6445,6841,6897,Males,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),beta-Cryptoxanthin,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",,,,ug/dL,,64,Unspecified,0.5,,,< 0.01,Yes,,,,Resnicow 2000
6446,6842,6898,Males,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),alpha-Carotene,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,alpha-Carotene,"",,,,ug/dL,,64,Unspecified,0.2,,,>= 0.05,No,,,,Resnicow 2000
6447,6843,6899,Males,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),beta-Carotene,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Carotene,"",,,,ug/dL,,64,Unspecified,0.35,,,< 0.01,Yes,,,,Resnicow 2000
6448,6844,6900,Males,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,64,Unspecified,0.28,,,< 0.05,Yes,,,,Resnicow 2000
6449,6845,6901,Males,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,64,Unspecified,0.42,,,< 0.01,Yes,,,,Resnicow 2000
6478,6867,6895,Males,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Lycopene,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lycopene,"",,,,ug/dL,,10,Unspecified,0.59,,,>= 0.05,No,,,,Resnicow 2000
6479,6868,6896,Males,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Lutein/Zeaxanthin,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",,,,ug/dL,,10,Unspecified,0.32,,,>= 0.05,No,,,,Resnicow 2000
6480,6869,6897,Males,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),beta-Cryptoxanthin,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",,,,ug/dL,,10,Unspecified,0.78,,,< 0.01,Yes,,,,Resnicow 2000
6481,6870,6898,Males,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),alpha-Carotene,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,alpha-Carotene,"",,,,ug/dL,,10,Unspecified,0.03,,,>= 0.05,No,,,,Resnicow 2000
6482,6871,6899,Males,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),beta-Carotene,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Carotene,"",,,,ug/dL,,10,Unspecified,0.16,,,>= 0.05,No,,,,Resnicow 2000
6483,6872,6900,Males,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,10,Unspecified,-0.03,,,>= 0.05,No,,,,Resnicow 2000
6484,6873,6901,Males,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,10,Unspecified,0.38,,,>= 0.05,No,,,,Resnicow 2000
6415,6818,6902,Females,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Lycopene,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lycopene,"",,,,ug/dL,,577,Unspecified,0.06,,,>= 0.05,No,,,,Resnicow 2000
6416,6819,6903,Females,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",,,,ug/dL,,577,Unspecified,0.16,,,< 0.01,Yes,,,,Resnicow 2000
6417,6820,6904,Females,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",,,,ug/dL,,577,Unspecified,0.35,,,< 0.01,Yes,,,,Resnicow 2000
6418,6821,6905,Females,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,alpha-Carotene,"",,,,ug/dL,,577,Unspecified,0.38,,,< 0.01,Yes,,,,Resnicow 2000
6419,6822,6906,Females,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),beta-Carotene,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Carotene,"",,,,ug/dL,,577,Unspecified,0.39,,,< 0.01,Yes,,,,Resnicow 2000
6420,6823,6907,Females,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,577,Unspecified,0.32,,,< 0.01,Yes,,,,Resnicow 2000
6421,6824,6908,Females,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,577,Unspecified,0.36,,,< 0.01,Yes,,,,Resnicow 2000
6450,6846,6902,Females,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Lycopene,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lycopene,"",,,,ug/dL,,214,Unspecified,0.14,,,>= 0.05,No,,,,Resnicow 2000
6451,6847,6903,Females,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Lutein/Zeaxanthin,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",,,,ug/dL,,214,Unspecified,0.19,,,< 0.01,Yes,,,,Resnicow 2000
6452,6848,6904,Females,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),beta-Cryptoxanthin,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",,,,ug/dL,,214,Unspecified,0.3,,,< 0.01,Yes,,,,Resnicow 2000
6453,6849,6905,Females,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),alpha-Carotene,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,alpha-Carotene,"",,,,ug/dL,,214,Unspecified,0.32,,,< 0.01,Yes,,,,Resnicow 2000
6454,6850,6906,Females,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),beta-Carotene,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Carotene,"",,,,ug/dL,,214,Unspecified,0.23,,,< 0.01,Yes,,,,Resnicow 2000
6455,6851,6907,Females,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,214,Unspecified,0.32,,,< 0.01,Yes,,,,Resnicow 2000
6456,6852,6908,Females,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,214,Unspecified,0.39,,,< 0.01,Yes,,,,Resnicow 2000
6485,6874,6902,Females,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Lycopene,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lycopene,"",,,,ug/dL,,60,Unspecified,0.01,,,>= 0.05,No,,,,Resnicow 2000
6486,6875,6903,Females,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Lutein/Zeaxanthin,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",,,,ug/dL,,60,Unspecified,0.23,,,>= 0.05,No,,,,Resnicow 2000
6487,6876,6904,Females,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),beta-Cryptoxanthin,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",,,,ug/dL,,60,Unspecified,0.42,,,< 0.01,Yes,,,,Resnicow 2000
6488,6877,6905,Females,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),alpha-Carotene,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,alpha-Carotene,"",,,,ug/dL,,60,Unspecified,0.32,,,< 0.05,Yes,,,,Resnicow 2000
6489,6878,6906,Females,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),beta-Carotene,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Carotene,"",,,,ug/dL,,60,Unspecified,0.18,,,>= 0.05,No,,,,Resnicow 2000
6490,6879,6907,Females,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,60,Unspecified,0.27,,,< 0.05,Yes,,,,Resnicow 2000
6491,6880,6908,Females,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,60,Unspecified,0.38,,,< 0.01,Yes,,,,Resnicow 2000
6429,6832,6916,Supplement users,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Lycopene,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lycopene,"",,,,ug/dL,,535,Unspecified,0.08,,,>= 0.05,No,,,,Resnicow 2000
6430,6833,6917,Supplement users,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",,,,ug/dL,,535,Unspecified,0.19,,,< 0.01,Yes,,,,Resnicow 2000
6431,6834,6918,Supplement users,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",,,,ug/dL,,535,Unspecified,0.34,,,< 0.01,Yes,,,,Resnicow 2000
6432,6835,6919,Supplement users,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,alpha-Carotene,"",,,,ug/dL,,535,Unspecified,0.39,,,< 0.01,Yes,,,,Resnicow 2000
6433,6836,6920,Supplement users,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),beta-Carotene,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Carotene,"",,,,ug/dL,,535,Unspecified,0.37,,,< 0.01,Yes,,,,Resnicow 2000
6434,6837,6921,Supplement users,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,535,Unspecified,0.33,,,< 0.01,Yes,,,,Resnicow 2000
6435,6838,6922,Supplement users,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,535,Unspecified,0.35,,,< 0.01,Yes,,,,Resnicow 2000
6464,6860,6916,Supplement users,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Lycopene,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lycopene,"",,,,ug/dL,,174,Unspecified,0.12,,,>= 0.05,No,,,,Resnicow 2000
6465,6861,6917,Supplement users,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Lutein/Zeaxanthin,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",,,,ug/dL,,174,Unspecified,0.13,,,>= 0.05,No,,,,Resnicow 2000
6466,6862,6918,Supplement users,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),beta-Cryptoxanthin,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",,,,ug/dL,,174,Unspecified,0.28,,,< 0.01,Yes,,,,Resnicow 2000
6467,6863,6919,Supplement users,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),alpha-Carotene,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,alpha-Carotene,"",,,,ug/dL,,174,Unspecified,0.33,,,< 0.01,Yes,,,,Resnicow 2000
6468,6864,6920,Supplement users,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),beta-Carotene,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Carotene,"",,,,ug/dL,,174,Unspecified,0.25,,,< 0.01,Yes,,,,Resnicow 2000
6469,6865,6921,Supplement users,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,174,Unspecified,0.31,,,< 0.01,Yes,,,,Resnicow 2000
6470,6866,6922,Supplement users,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,174,Unspecified,0.39,,,< 0.01,Yes,,,,Resnicow 2000
6499,6888,6916,Supplement users,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Lycopene,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lycopene,"",,,,ug/dL,,41,Unspecified,-0.02,,,>= 0.05,No,,,,Resnicow 2000
6500,6889,6917,Supplement users,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Lutein/Zeaxanthin,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",,,,ug/dL,,41,Unspecified,0.33,,,< 0.05,Yes,,,,Resnicow 2000
6501,6890,6918,Supplement users,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),beta-Cryptoxanthin,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",,,,ug/dL,,41,Unspecified,0.34,,,< 0.05,Yes,,,,Resnicow 2000
6502,6891,6919,Supplement users,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),alpha-Carotene,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,alpha-Carotene,"",,,,ug/dL,,41,Unspecified,0.3,,,< 0.05,Yes,,,,Resnicow 2000
6503,6892,6920,Supplement users,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),beta-Carotene,"",Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Carotene,"",,,,ug/dL,,41,Unspecified,0.27,,,>= 0.05,No,,,,Resnicow 2000
6504,6893,6921,Supplement users,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,41,Unspecified,0.24,,,>= 0.05,No,,,,Resnicow 2000
6505,6894,6922,Supplement users,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,Yes,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,41,Unspecified,0.43,,,< 0.01,Yes,,,,Resnicow 2000
6422,6825,6909,Supplement nonusers,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Lycopene,"",No,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lycopene,"",,,,ug/dL,,262,Unspecified,0.03,,,>= 0.05,No,,,,Resnicow 2000
6423,6826,6910,Supplement nonusers,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",,,,ug/dL,,262,Unspecified,0.2,,,< 0.01,Yes,,,,Resnicow 2000
6424,6827,6911,Supplement nonusers,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",No,,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",,,,ug/dL,,262,Unspecified,0.34,,,< 0.01,Yes,,,,Resnicow 2000
6425,6828,6912,Supplement nonusers,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,,,,ug/day,,baseline,"Serum, unspecified",HPLC,alpha-Carotene,"",,,,ug/dL,,262,Unspecified,0.32,,,< 0.01,Yes,,,,Resnicow 2000
6426,6829,6913,Supplement nonusers,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Carotene,"",,,,ug/dL,,262,Unspecified,0.34,,,< 0.01,Yes,,,,Resnicow 2000
6427,6830,6914,Supplement nonusers,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,No,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,262,Unspecified,0.26,,,< 0.01,Yes,,,,Resnicow 2000
6428,6831,6915,Supplement nonusers,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,-12 days,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,No,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,262,Unspecified,0.32,,,< 0.01,Yes,,,,Resnicow 2000
6457,6853,6909,Supplement nonusers,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Lycopene,"",No,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lycopene,"",,,,ug/dL,,102,Unspecified,0.16,,,>= 0.05,No,,,,Resnicow 2000
6458,6854,6910,Supplement nonusers,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Lutein/Zeaxanthin,"",No,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",,,,ug/dL,,102,Unspecified,0.24,,,< 0.05,Yes,,,,Resnicow 2000
6459,6855,6911,Supplement nonusers,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),beta-Cryptoxanthin,"",No,,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",,,,ug/dL,,102,Unspecified,0.46,,,< 0.01,Yes,,,,Resnicow 2000
6460,6856,6912,Supplement nonusers,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),alpha-Carotene,"",No,,,,ug/day,,baseline,"Serum, unspecified",HPLC,alpha-Carotene,"",,,,ug/dL,,102,Unspecified,0.2,,,< 0.05,Yes,,,,Resnicow 2000
6461,6857,6913,Supplement nonusers,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),beta-Carotene,"",No,,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Carotene,"",,,,ug/dL,,102,Unspecified,0.23,,,< 0.05,Yes,,,,Resnicow 2000
6462,6858,6914,Supplement nonusers,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,No,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,102,Unspecified,0.3,,,< 0.01,Yes,,,,Resnicow 2000
6463,6859,6915,Supplement nonusers,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,No,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,102,Unspecified,0.36,,,< 0.01,Yes,,,,Resnicow 2000
6492,6881,6909,Supplement nonusers,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Lycopene,"",No,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lycopene,"",,,,ug/dL,,29,Unspecified,0.26,,,>= 0.05,No,,,,Resnicow 2000
6493,6882,6910,Supplement nonusers,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Lutein/Zeaxanthin,"",No,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",,,,ug/dL,,29,Unspecified,0.17,,,>= 0.05,No,,,,Resnicow 2000
6494,6883,6911,Supplement nonusers,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),beta-Cryptoxanthin,"",No,,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",,,,ug/dL,,29,Unspecified,0.71,,,< 0.01,Yes,,,,Resnicow 2000
6495,6884,6912,Supplement nonusers,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),alpha-Carotene,"",No,,,,ug/day,,baseline,"Serum, unspecified",HPLC,alpha-Carotene,"",,,,ug/dL,,29,Unspecified,0.22,,,>= 0.05,No,,,,Resnicow 2000
6496,6885,6913,Supplement nonusers,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),beta-Carotene,"",No,,,,ug/day,,baseline,"Serum, unspecified",HPLC,beta-Carotene,"",,,,ug/dL,,29,Unspecified,0.09,,,>= 0.05,No,,,,Resnicow 2000
6497,6886,6914,Supplement nonusers,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,No,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,29,Unspecified,0.3,,,>= 0.05,No,,,,Resnicow 2000
6498,6887,6915,Supplement nonusers,African American adults from Black churches in Atlanta area,United States,Eat for Life Trial,,24-h Dietary recall (1-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,No,,,,ug/day,,baseline,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,29,Unspecified,0.33,,,>= 0.05,No,,,,Resnicow 2000
6562,6977,6937,All [by intake],Members of the University of Minnesota community,United States,,,Dietary record (5-day),Fruits + Vegetables,Fruits + Vegetables,,,,,servings/day,,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Enterolactone,"",3.64,2.12,,umol/day,,98,Pearson,0.19,,,< 0.01,Yes,,,,Lampe 1999
6569,6977,6938,All [by intake],Members of the University of Minnesota community,United States,,,Dietary record (5-day),Fruits + Vegetables,Fruits + Vegetables,,,,,servings/day,,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Enterodiol,"",1.25,0.45,,umol/day,,98,Pearson,0.23,,,< 0.05,Yes,,,,Lampe 1999
6576,6977,6940,All [by intake],Members of the University of Minnesota community,United States,,,Dietary record (5-day),Fruits + Vegetables,Fruits + Vegetables,,,,,servings/day,,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Lignans,Enterodiol + Enterolactone + Matairesinol,4.96,2.99,,umol/day,,98,Pearson,0.25,,,= 0.01,Yes,,,,Lampe 1999
6563,6978,6937,All [by intake],Members of the University of Minnesota community,United States,,,Dietary record (5-day),Vegetables,"",,,,,servings/day,,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Enterolactone,"",3.64,2.12,,umol/day,,98,Pearson,0.06,,,>= 0.05,No,,,,Lampe 1999
6570,6978,6938,All [by intake],Members of the University of Minnesota community,United States,,,Dietary record (5-day),Vegetables,"",,,,,servings/day,,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Enterodiol,"",1.25,0.45,,umol/day,,98,Pearson,-0.03,,,>= 0.05,No,,,,Lampe 1999
6577,6978,6940,All [by intake],Members of the University of Minnesota community,United States,,,Dietary record (5-day),Vegetables,"",,,,,servings/day,,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Lignans,Enterodiol + Enterolactone + Matairesinol,4.96,2.99,,umol/day,,98,Pearson,0.07,,,>= 0.05,No,,,,Lampe 1999
6564,6979,6937,All [by intake],Members of the University of Minnesota community,United States,,,Dietary record (5-day),Fruits,"",,,,,servings/day,,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Enterolactone,"",3.64,2.12,,umol/day,,98,Pearson,0.2,,,< 0.05,Yes,,,,Lampe 1999
6571,6979,6938,All [by intake],Members of the University of Minnesota community,United States,,,Dietary record (5-day),Fruits,"",,,,,servings/day,,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Enterodiol,"",1.25,0.45,,umol/day,,98,Pearson,0.29,,,< 0.01,Yes,,,,Lampe 1999
6578,6979,6940,All [by intake],Members of the University of Minnesota community,United States,,,Dietary record (5-day),Fruits,"",,,,,servings/day,,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Lignans,Enterodiol + Enterolactone + Matairesinol,4.96,2.99,,umol/day,,98,Pearson,0.27,,,= 0.008,Yes,,,,Lampe 1999
6565,6980,6937,All [by intake],Members of the University of Minnesota community,United States,,,Dietary record (5-day),Dietary fibre,Fibre from Cereals + Fibre from Vegetables + Fibre from Fruits,,,,,g/1000 kcal,Energy,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Enterolactone,"",3.64,2.12,,umol/day,,98,Pearson,0.24,,,< 0.05,Yes,Energy by density method ?,,,Lampe 1999
6572,6980,6938,All [by intake],Members of the University of Minnesota community,United States,,,Dietary record (5-day),Dietary fibre,Fibre from Cereals + Fibre from Vegetables + Fibre from Fruits,,,,,g/1000 kcal,Energy,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Enterodiol,"",1.25,0.45,,umol/day,,98,Pearson,0.36,,,< 0.01,Yes,Energy by density method ?,,,Lampe 1999
6579,6980,6940,All [by intake],Members of the University of Minnesota community,United States,,,Dietary record (5-day),Dietary fibre,Fibre from Cereals + Fibre from Vegetables + Fibre from Fruits,,,,,g/1000 kcal,Energy,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Lignans,Enterodiol + Enterolactone + Matairesinol,4.96,2.99,,umol/day,,98,Pearson,0.36,,,= 0.0003,Yes,Energy by density method ?,,,Lampe 1999
6566,6981,6937,All [by intake],Members of the University of Minnesota community,United States,,,Dietary record (5-day),Fibre from Vegetables,"",,,,,g/1000 kcal,Energy,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Enterolactone,"",3.64,2.12,,umol/day,,98,Pearson,0.03,,,>= 0.05,No,Energy by density method ?,,,Lampe 1999
6573,6981,6938,All [by intake],Members of the University of Minnesota community,United States,,,Dietary record (5-day),Fibre from Vegetables,"",,,,,g/1000 kcal,Energy,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Enterodiol,"",1.25,0.45,,umol/day,,98,Pearson,0.01,,,>= 0.05,No,Energy by density method ?,,,Lampe 1999
6580,6981,6940,All [by intake],Members of the University of Minnesota community,United States,,,Dietary record (5-day),Fibre from Vegetables,"",,,,,g/1000 kcal,Energy,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Lignans,Enterodiol + Enterolactone + Matairesinol,4.96,2.99,,umol/day,,98,Pearson,0.06,,,>= 0.05,No,Energy by density method ?,,,Lampe 1999
6567,6982,6937,All [by intake],Members of the University of Minnesota community,United States,,,Dietary record (5-day),Fibre from Fruits,"",,,,,g/1000 kcal,Energy,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Enterolactone,"",3.64,2.12,,umol/day,,98,Pearson,0.18,,,>= 0.05,No,Energy by density method ?,,,Lampe 1999
6574,6982,6938,All [by intake],Members of the University of Minnesota community,United States,,,Dietary record (5-day),Fibre from Fruits,"",,,,,g/1000 kcal,Energy,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Enterodiol,"",1.25,0.45,,umol/day,,98,Pearson,0.28,,,< 0.01,Yes,Energy by density method ?,,,Lampe 1999
6581,6982,6940,All [by intake],Members of the University of Minnesota community,United States,,,Dietary record (5-day),Fibre from Fruits,"",,,,,g/1000 kcal,Energy,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Lignans,Enterodiol + Enterolactone + Matairesinol,4.96,2.99,,umol/day,,98,Pearson,0.24,,,< 0.05,Yes,Energy by density method ?,,,Lampe 1999
6568,6983,6937,All [by intake],Members of the University of Minnesota community,United States,,,Dietary record (5-day),Fibre from Cereals,"",,,,,g/1000 kcal,Energy,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Enterolactone,"",3.64,2.12,,umol/day,,98,Pearson,0.22,,,< 0.05,Yes,Energy by density method ?,,,Lampe 1999
6575,6983,6938,All [by intake],Members of the University of Minnesota community,United States,,,Dietary record (5-day),Fibre from Cereals,"",,,,,g/1000 kcal,Energy,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Enterodiol,"",1.25,0.45,,umol/day,,98,Pearson,0.34,,,< 0.01,Yes,Energy by density method ?,,,Lampe 1999
6582,6983,6940,All [by intake],Members of the University of Minnesota community,United States,,,Dietary record (5-day),Fibre from Cereals,"",,,,,g/1000 kcal,Energy,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Lignans,Enterodiol + Enterolactone + Matairesinol,4.96,2.99,,umol/day,,98,Pearson,0.34,,,< 0.01,Yes,Energy by density method ?,,,Lampe 1999
6583,6984,6941,All [by intake],Members of the University of Minnesota community,United States,,,Dietary record (5-day),Soy foods,"",,,,,servings/day,,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Genistein,"",0.55,0.22,,umol/day,,98,Pearson,0.4,,,= 0.0001,Yes,,,,Lampe 1999
6584,6984,6943,All [by intake],Members of the University of Minnesota community,United States,,,Dietary record (5-day),Soy foods,"",,,,,servings/day,,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,O-Desmethylangolensin,"",0.57,0.13,,umol/day,,98,Pearson,0.37,,,= 0.0002,Yes,,,,Lampe 1999
6585,6984,6942,All [by intake],Members of the University of Minnesota community,United States,,,Dietary record (5-day),Soy foods,"",,,,,servings/day,,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Daidzein,"",1.68,0.56,,umol/day,,98,Pearson,0.34,,,= 0.0007,Yes,,,,Lampe 1999
6586,6984,6945,All [by intake],Members of the University of Minnesota community,United States,,,Dietary record (5-day),Soy foods,"",,,,,servings/day,,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + O-Desmethylangolensin,3.05,1.13,,umol/day,,98,Pearson,0.39,,,= 0.0001,Yes,,,,Lampe 1999
6587,6984,6940,All [by intake],Members of the University of Minnesota community,United States,,,Dietary record (5-day),Soy foods,"",,,,,servings/day,,,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Lignans,Enterodiol + Enterolactone + Matairesinol,4.96,2.99,,umol/day,,98,Pearson,0.28,,,= 0.006,Yes,,,,Lampe 1999
6604,7085,7097,All,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Red meat,"",,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,123,Spearman,0.47,,,< 0.001,Yes,,,"Age, Sex, Race",Myint 2000
6628,7085,7098,All,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Red meat,"",,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,123,Spearman,0.24,,,< 0.01,Yes,,,"Age, Sex, Race",Myint 2000
6605,7086,7097,All,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Poultry,"",,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,123,Spearman,0.53,,,< 0.001,Yes,,,"Age, Sex, Race",Myint 2000
6629,7086,7098,All,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Poultry,"",,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,123,Spearman,0.21,,,= 0.02,Yes,,,"Age, Sex, Race",Myint 2000
6606,7087,7097,All,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Fish,"",,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,123,Spearman,0.38,,,< 0.001,Yes,,,"Age, Sex, Race",Myint 2000
6630,7087,7098,All,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Fish,"",,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,123,Spearman,0.19,,,= 0.03,Yes,,,"Age, Sex, Race",Myint 2000
6607,7088,7097,All,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Fish + Meat,Fish + Red meat + Poultry,,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,123,Spearman,0.54,,,< 0.001,Yes,,,"Age, Sex, Race",Myint 2000
6631,7088,7098,All,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Fish + Meat,Fish + Red meat + Poultry,,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,123,Spearman,0.24,,,< 0.01,Yes,,,"Age, Sex, Race",Myint 2000
6608,7089,7097,All,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Red meat,"",,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,123,Spearman,0.48,,,< 0.001,Yes,,,"Age, Sex, Race",Myint 2000
6632,7089,7098,All,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Red meat,"",,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,123,Spearman,0.21,,,= 0.02,Yes,,,"Age, Sex, Race",Myint 2000
6609,7090,7097,All,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Poultry,"",,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,123,Spearman,0.49,,,< 0.001,Yes,,,"Age, Sex, Race",Myint 2000
6633,7090,7098,All,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Poultry,"",,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,123,Spearman,0.2,,,= 0.03,Yes,,,"Age, Sex, Race",Myint 2000
6610,7091,7097,All,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Fish,"",,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,123,Spearman,0.26,,,= 0.005,Yes,,,"Age, Sex, Race",Myint 2000
6634,7091,7098,All,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Fish,"",,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,123,Spearman,0.1,,,= 0.26,No,,,"Age, Sex, Race",Myint 2000
6611,7092,7097,All,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Fish + Meat,Fish + Red meat + Poultry,,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,123,Spearman,0.56,,,< 0.001,Yes,,,"Age, Sex, Race",Myint 2000
6635,7092,7098,All,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Fish + Meat,Fish + Red meat + Poultry,,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,123,Spearman,0.27,,,= 0.003,Yes,,,"Age, Sex, Race",Myint 2000
6588,7065,7093,Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Red meat,"",,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,54,Spearman,0.43,,,= 0.002,Yes,,,"Age, Sex",Myint 2000
6612,7065,7094,Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Red meat,"",,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,54,Spearman,0.29,,,= 0.04,Yes,,,"Age, Sex",Myint 2000
6589,7066,7093,Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Poultry,"",,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,54,Spearman,0.48,,,< 0.001,Yes,,,"Age, Sex",Myint 2000
6613,7066,7094,Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Poultry,"",,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,54,Spearman,0.2,,,= 0.17,No,,,"Age, Sex",Myint 2000
6590,7067,7093,Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Fish,"",,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,54,Spearman,0.32,,,= 0.02,Yes,,,"Age, Sex",Myint 2000
6614,7067,7094,Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Fish,"",,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,54,Spearman,0.2,,,= 0.15,No,,,"Age, Sex",Myint 2000
6591,7068,7093,Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Fish + Meat,Fish + Red meat + Poultry,,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,54,Spearman,0.5,,,< 0.001,Yes,,,"Age, Sex",Myint 2000
6615,7068,7094,Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Fish + Meat,Fish + Red meat + Poultry,,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,54,Spearman,0.28,,,= 0.04,Yes,,,"Age, Sex",Myint 2000
6592,7073,7093,Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Red meat,"",,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,54,Spearman,0.37,,,= 0.07,No,,,"Age, Sex",Myint 2000
6616,7073,7094,Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Red meat,"",,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,54,Spearman,0.2,,,= 0.16,No,,,"Age, Sex",Myint 2000
6593,7074,7093,Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Poultry,"",,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,54,Spearman,0.48,,,< 0.001,Yes,,,"Age, Sex",Myint 2000
6617,7074,7094,Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Poultry,"",,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,54,Spearman,0.19,,,= 0.19,No,,,"Age, Sex",Myint 2000
6594,7075,7093,Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Fish,"",,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,54,Spearman,0.07,,,= 0.6,No,,,"Age, Sex",Myint 2000
6618,7075,7094,Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Fish,"",,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,54,Spearman,0.17,,,= 0.23,No,,,"Age, Sex",Myint 2000
6595,7076,7093,Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Fish + Meat,Fish + Red meat + Poultry,,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,54,Spearman,0.51,,,< 0.001,Yes,,,"Age, Sex",Myint 2000
6619,7076,7094,Blacks,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Fish + Meat,Fish + Red meat + Poultry,,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,54,Spearman,0.26,,,= 0.06,No,,,"Age, Sex",Myint 2000
6596,7077,7095,Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Red meat,"",,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,69,Spearman,0.51,,,< 0.001,Yes,,,"Age, Sex",Myint 2000
6620,7077,7096,Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Red meat,"",,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,69,Spearman,0.14,,,= 0.27,No,,,"Age, Sex",Myint 2000
6597,7078,7095,Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Poultry,"",,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,69,Spearman,0.61,,,< 0.001,Yes,,,"Age, Sex",Myint 2000
6621,7078,7096,Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Poultry,"",,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,69,Spearman,0.21,,,= 0.09,No,,,"Age, Sex",Myint 2000
6598,7079,7095,Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Fish,"",,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,69,Spearman,0.48,,,< 0.001,Yes,,,"Age, Sex",Myint 2000
6622,7079,7096,Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Fish,"",,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,69,Spearman,0.15,,,= 0.22,No,,,"Age, Sex",Myint 2000
6599,7080,7095,Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Fish + Meat,Fish + Red meat + Poultry,,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,69,Spearman,0.61,,,< 0.001,Yes,,,"Age, Sex",Myint 2000
6623,7080,7096,Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Fish + Meat,Fish + Red meat + Poultry,,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,69,Spearman,0.15,,,= 0.22,No,,,"Age, Sex",Myint 2000
6600,7081,7095,Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Red meat,"",,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,69,Spearman,0.55,,,< 0.001,Yes,,,"Age, Sex",Myint 2000
6624,7081,7096,Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Red meat,"",,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,69,Spearman,0.19,,,= 0.13,No,,,"Age, Sex",Myint 2000
6601,7082,7095,Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Poultry,"",,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,69,Spearman,0.54,,,< 0.001,Yes,,,"Age, Sex",Myint 2000
6625,7082,7096,Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Poultry,"",,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,69,Spearman,0.19,,,= 0.13,No,,,"Age, Sex",Myint 2000
6602,7083,7095,Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Fish,"",,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,69,Spearman,0.43,,,< 0.001,Yes,,,"Age, Sex",Myint 2000
6626,7083,7096,Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Fish,"",,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,69,Spearman,0.02,,,= 0.85,No,,,"Age, Sex",Myint 2000
6603,7084,7095,Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Fish + Meat,Fish + Red meat + Poultry,,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,69,Spearman,0.65,,,< 0.001,Yes,,,"Age, Sex",Myint 2000
6627,7084,7096,Whites,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Fish + Meat,Fish + Red meat + Poultry,,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,69,Spearman,0.21,,,= 0.1,No,,,"Age, Sex",Myint 2000
6636,7099,7105,Blacks - Omnivores,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Fish + Meat,Fish + Red meat + Poultry,,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,44,Spearman,0.27,,,= 0.08,No,,,"Age, Sex",Myint 2000
6642,7099,7106,Blacks - Omnivores,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Fish + Meat,Fish + Red meat + Poultry,,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,44,Spearman,0.17,,,= 0.27,No,,,"Age, Sex",Myint 2000
6637,7100,7105,Blacks - Omnivores,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Fish + Meat,Fish + Red meat + Poultry,,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,44,Spearman,0.28,,,= 0.07,No,,,"Age, Sex",Myint 2000
6643,7100,7106,Blacks - Omnivores,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Fish + Meat,Fish + Red meat + Poultry,,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,44,Spearman,0.1,,,= 0.53,No,,,"Age, Sex",Myint 2000
6638,7101,7107,Whites - Omnivores,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Fish + Meat,Fish + Red meat + Poultry,,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,43,Spearman,0.22,,,= 0.17,No,,,"Age, Sex",Myint 2000
6644,7101,7108,Whites - Omnivores,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Fish + Meat,Fish + Red meat + Poultry,,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,43,Spearman,0.33,,,= 0.03,Yes,,,"Age, Sex",Myint 2000
6639,7102,7107,Whites - Omnivores,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Fish + Meat,Fish + Red meat + Poultry,,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,43,Spearman,0.34,,,= 0.03,Yes,,,"Age, Sex",Myint 2000
6645,7102,7108,Whites - Omnivores,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Fish + Meat,Fish + Red meat + Poultry,,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,43,Spearman,0.42,,,= 0.006,Yes,,,"Age, Sex",Myint 2000
6640,7103,7109,Omnivores,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Fish + Meat,Fish + Red meat + Poultry,,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,87,Spearman,0.22,,,= 0.05,No,,,"Age, Sex, Race",Myint 2000
6646,7103,7110,Omnivores,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,Food Frequency Questionnaire (FFQ),Fish + Meat,Fish + Red meat + Poultry,,,,,servings/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,87,Spearman,0.26,,,= 0.02,Yes,,,"Age, Sex, Race",Myint 2000
6641,7104,7109,Omnivores,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Fish + Meat,Fish + Red meat + Poultry,,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),1-Methylhistidine,"",,,,umol/g,Creatinine,87,Spearman,0.31,,,= 0.004,Yes,,,"Age, Sex, Race",Myint 2000
6647,7104,7110,Omnivores,Black and white Seventh-day Adventists participant in a dietary validation study,United States,AHS (Adventist Health Studies),,24-h Dietary recall (1-day),Fish + Meat,Fish + Red meat + Poultry,,,,,g/day,,,"Urine, overnight",Ion exchange chromatography (IEC),3-Methylhistidine,"",,,,umol/g,Creatinine,87,Spearman,0.31,,,= 0.005,Yes,,,"Age, Sex, Race",Myint 2000
6648,7113,7115,All,Female students in Buenos Aires University,Argentina,,,Dietary record (7-day),Zinc,"",No,9.12,,,mg/day,,,"Urine, spot",Atomic absorption spectrometry (AAS),Zinc,"",0.41,,,mg/g,Creatinine,36,Unspecified,0.481,,,= 0.0339,Yes,,,,de Portela 2000
6649,7130,7132,All,Middle-aged women from Tohoku region,Japan,,,Dietary record (3-day),Daidzein,"",,64.6,,57.9,umol/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Daidzein,"",111.7,,72.5,nmol/L,,106,Pearson,0.335,,,< 0.001,Yes,Energy by residual method,,,Arai 2000
6650,7130,7133,All,Middle-aged women from Tohoku region,Japan,,,Dietary record (3-day),Daidzein,"",,64.6,,57.9,umol/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Genistein,"",307.5,,206.1,nmol/L,,106,Pearson,0.418,,,< 0.001,Yes,Energy by residual method,,,Arai 2000
6651,7130,7134,All,Middle-aged women from Tohoku region,Japan,,,Dietary record (3-day),Daidzein,"",,64.6,,57.9,umol/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Daidzein,"",23.3,,20.5,umol/day,,106,Pearson,0.365,,,< 0.001,Yes,Energy by residual method,,,Arai 2000
6652,7130,7135,All,Middle-aged women from Tohoku region,Japan,,,Dietary record (3-day),Daidzein,"",,64.6,,57.9,umol/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Genistein,"",13.2,,10.8,umol/day,,105,Pearson,0.34,,,< 0.001,Yes,Energy by residual method,,,Arai 2000
6655,7131,7132,All,Middle-aged women from Tohoku region,Japan,,,Dietary record (3-day),Genistein,"",,111.6,,103.2,umol/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Daidzein,"",111.7,,72.5,nmol/L,,106,Pearson,0.334,,,< 0.001,Yes,Energy by residual method,,,Arai 2000
6656,7131,7133,All,Middle-aged women from Tohoku region,Japan,,,Dietary record (3-day),Genistein,"",,111.6,,103.2,umol/day,,,"Plasma, fasting",Time-resolved fluoroimmunoassay (TR-FIA) after enzymatic hydrolysis,Genistein,"",307.5,,206.1,nmol/L,,106,Pearson,0.429,,,< 0.001,Yes,Energy by residual method,,,Arai 2000
6657,7131,7134,All,Middle-aged women from Tohoku region,Japan,,,Dietary record (3-day),Genistein,"",,111.6,,103.2,umol/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Daidzein,"",23.3,,20.5,umol/day,,106,Pearson,0.377,,,< 0.001,Yes,Energy by residual method,,,Arai 2000
6658,7131,7135,All,Middle-aged women from Tohoku region,Japan,,,Dietary record (3-day),Genistein,"",,111.6,,103.2,umol/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Genistein,"",13.2,,10.8,umol/day,,105,Pearson,0.346,,,< 0.001,Yes,Energy by residual method,,,Arai 2000
6653,7147,7137,Equol metabolizers,Middle-aged women from Tohoku region,Japan,,,Dietary record (3-day),Daidzein,"",,56.7,,,umol/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Equol,"",23.4,,15.7,umol/day,,53,Pearson,0.395,,,< 0.001,Yes,Energy by residual method,,,Arai 2000
6659,7148,7137,Equol metabolizers,Middle-aged women from Tohoku region,Japan,,,Dietary record (3-day),Genistein,"",,93.0,,,umol/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,Equol,"",23.4,,15.7,umol/day,,53,Pearson,0.396,,,< 0.001,Yes,Energy by residual method,,,Arai 2000
6654,7765,7139,O-DMA metabolizers,Middle-aged women from Tohoku region,Japan,,,Dietary record (3-day),Daidzein,"",,,,,umol/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,O-Desmethylangolensin,"",3.3,,1.6,umol/day,,89,Pearson,0.272,,,< 0.05,Yes,Energy by residual method,,,Arai 2000
6660,7766,7139,O-DMA metabolizers,Middle-aged women from Tohoku region,Japan,,,Dietary record (3-day),Genistein,"",,,,,umol/day,,,"Urine, 24-h",HPLC after enzymatic hydrolysis,O-Desmethylangolensin,"",3.3,,1.6,umol/day,,89,Pearson,0.25,,,< 0.05,Yes,Energy by residual method,,,Arai 2000
6661,7232,8169,All,Women with past breast cancer with or without a high vegetable diet intervention,United States,,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,,,,servings/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,umol/L,,56,Pearson,0.3,,,< 0.05,Yes,"Energy by density method, Cholesterol",,,McEligot 1999
6662,7232,8168,All,Women with past breast cancer with or without a high vegetable diet intervention,United States,,,24-h Dietary recall (1-day),Fruits + Vegetables,"",,,,,servings/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,umol/L,,56,Pearson,0.33,,,< 0.05,Yes,"Energy by density method, Cholesterol",,,McEligot 1999
6663,7238,7233,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,656.0,,443.0,ug/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",0.082,,0.071,umol/L,,201,Pearson,0.18,,,< 0.01,Yes,,,,Tucker 1999
6669,7238,7233,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,656.0,,443.0,ug/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",0.082,,0.071,umol/L,,201,Pearson,0.2,,,< 0.01,Yes,,,"Age, Energy",Tucker 1999
6675,7238,7233,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,656.0,,443.0,ug/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",0.082,,0.071,umol/L,,201,Pearson,0.28,,,< 0.01,Yes,,,"Age, Energy, BMI, Cholesterol, Smoking status",Tucker 1999
6664,7239,7234,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",Yes,3793.0,,3206.0,ug/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",0.33,,0.27,umol/L,,201,Pearson,0.25,,,< 0.01,Yes,,,,Tucker 1999
6670,7239,7234,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",Yes,3793.0,,3206.0,ug/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",0.33,,0.27,umol/L,,201,Pearson,0.28,,,< 0.01,Yes,,,"Age, Energy",Tucker 1999
6676,7239,7234,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",Yes,3793.0,,3206.0,ug/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",0.33,,0.27,umol/L,,201,Pearson,0.31,,,< 0.01,Yes,,,"Age, Energy, BMI, Cholesterol, Smoking status",Tucker 1999
6666,7241,7235,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,63.0,,45.0,ug/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",0.2,,0.17,umol/L,,201,Pearson,0.32,,,< 0.01,Yes,,,,Tucker 1999
6672,7241,7235,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,63.0,,45.0,ug/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",0.2,,0.17,umol/L,,201,Pearson,0.35,,,< 0.01,Yes,,,"Age, Energy",Tucker 1999
6678,7241,7235,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,63.0,,45.0,ug/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",0.2,,0.17,umol/L,,201,Pearson,0.36,,,< 0.01,Yes,,,"Age, Energy, BMI, Cholesterol, Smoking status",Tucker 1999
6667,7242,7236,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Lycopene,"",,7636.0,,6404.0,ug/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",0.64,,0.55,umol/L,,201,Pearson,0.21,,,< 0.01,Yes,,,,Tucker 1999
6673,7242,7236,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Lycopene,"",,7636.0,,6404.0,ug/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",0.64,,0.55,umol/L,,201,Pearson,0.25,,,< 0.01,Yes,,,"Age, Energy",Tucker 1999
6679,7242,7236,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Lycopene,"",,7636.0,,6404.0,ug/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",0.64,,0.55,umol/L,,201,Pearson,0.31,,,< 0.01,Yes,,,"Age, Energy, BMI, Cholesterol, Smoking status",Tucker 1999
6668,7243,7237,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,2678.0,,2298.0,ug/day,,,"Plasma, non-fasting",HPLC,Lutein/Zeaxanthin,"",0.52,,0.48,umol/L,,201,Pearson,0.1,,,>= 0.05,No,,,,Tucker 1999
6674,7243,7237,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,2678.0,,2298.0,ug/day,,,"Plasma, non-fasting",HPLC,Lutein/Zeaxanthin,"",0.52,,0.48,umol/L,,201,Pearson,0.13,,,>= 0.05,No,,,"Age, Energy",Tucker 1999
6680,7243,7237,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,2678.0,,2298.0,ug/day,,,"Plasma, non-fasting",HPLC,Lutein/Zeaxanthin,"",0.52,,0.48,umol/L,,201,Pearson,0.14,,,>= 0.05,No,,,"Age, Energy, BMI, Cholesterol, Smoking status",Tucker 1999
6699,7244,7233,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,4.4,,4.0,servings/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",0.082,,0.071,umol/L,,201,Pearson,0.17,,,< 0.05,No,,,,Tucker 1999
6700,7244,7234,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,4.4,,4.0,servings/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",0.33,,0.27,umol/L,,201,Pearson,0.17,,,< 0.05,No,,,,Tucker 1999
6701,7244,7235,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,4.4,,4.0,servings/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",0.2,,0.17,umol/L,,201,Pearson,0.1,,,>= 0.05,No,,,,Tucker 1999
6702,7244,7236,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,4.4,,4.0,servings/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",0.64,,0.55,umol/L,,201,Pearson,0.0,,,>= 0.05,No,,,,Tucker 1999
6703,7244,7237,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,4.4,,4.0,servings/day,,,"Plasma, non-fasting",HPLC,Lutein/Zeaxanthin,"",0.52,,0.48,umol/L,,201,Pearson,0.02,,,>= 0.05,No,,,,Tucker 1999
6704,7244,7233,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,4.4,,4.0,servings/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",0.082,,0.071,umol/L,,201,Pearson,0.23,,,< 0.01,Yes,,,"Age, Energy",Tucker 1999
6705,7244,7234,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,4.4,,4.0,servings/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",0.33,,0.27,umol/L,,201,Pearson,0.22,,,< 0.01,Yes,,,"Age, Energy",Tucker 1999
6706,7244,7235,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,4.4,,4.0,servings/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",0.2,,0.17,umol/L,,201,Pearson,0.17,,,< 0.05,No,,,"Age, Energy",Tucker 1999
6707,7244,7236,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,4.4,,4.0,servings/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",0.64,,0.55,umol/L,,201,Pearson,0.06,,,>= 0.05,No,,,"Age, Energy",Tucker 1999
6708,7244,7237,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,4.4,,4.0,servings/day,,,"Plasma, non-fasting",HPLC,Lutein/Zeaxanthin,"",0.52,,0.48,umol/L,,201,Pearson,0.05,,,>= 0.05,No,,,"Age, Energy",Tucker 1999
6709,7244,7233,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,4.4,,4.0,servings/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",0.082,,0.071,umol/L,,201,Pearson,0.25,,,< 0.01,Yes,,,"Age, Energy, BMI, Cholesterol, Smoking status",Tucker 1999
6710,7244,7234,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,4.4,,4.0,servings/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",0.33,,0.27,umol/L,,201,Pearson,0.25,,,< 0.01,Yes,,,"Age, Energy, BMI, Cholesterol, Smoking status",Tucker 1999
6711,7244,7235,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,4.4,,4.0,servings/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",0.2,,0.17,umol/L,,201,Pearson,0.16,,,< 0.05,No,,,"Age, Energy, BMI, Cholesterol, Smoking status",Tucker 1999
6712,7244,7236,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,4.4,,4.0,servings/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",0.64,,0.55,umol/L,,201,Pearson,0.17,,,< 0.05,No,,,"Age, Energy, BMI, Cholesterol, Smoking status",Tucker 1999
6713,7244,7237,Males,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,4.4,,4.0,servings/day,,,"Plasma, non-fasting",HPLC,Lutein/Zeaxanthin,"",0.52,,0.48,umol/L,,201,Pearson,0.14,,,>= 0.05,No,,,"Age, Energy, BMI, Cholesterol, Smoking status",Tucker 1999
6681,7250,7245,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,862.0,,562.0,ug/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",0.117,,0.092,umol/L,,346,Pearson,0.33,,,< 0.0001,Yes,,,,Tucker 1999
6687,7250,7245,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,862.0,,562.0,ug/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",0.117,,0.092,umol/L,,346,Pearson,0.32,,,< 0.0001,Yes,,,"Age, Energy",Tucker 1999
6693,7250,7245,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,862.0,,562.0,ug/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",0.117,,0.092,umol/L,,346,Pearson,0.3,,,< 0.0001,Yes,,,"Age, Energy, BMI, Cholesterol, Smoking status",Tucker 1999
6682,7251,7246,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",Yes,4508.0,,3911.0,ug/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",0.51,,0.42,umol/L,,346,Pearson,0.36,,,< 0.0001,Yes,,,,Tucker 1999
6688,7251,7246,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",Yes,4508.0,,3911.0,ug/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",0.51,,0.42,umol/L,,346,Pearson,0.36,,,< 0.0001,Yes,,,"Age, Energy",Tucker 1999
6694,7251,7246,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",Yes,4508.0,,3911.0,ug/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",0.51,,0.42,umol/L,,346,Pearson,0.34,,,< 0.0001,Yes,,,"Age, Energy, BMI, Cholesterol, Smoking status",Tucker 1999
6684,7253,7247,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,75.1,,52.0,ug/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",0.27,,0.24,umol/L,,346,Pearson,0.44,,,< 0.0001,Yes,,,,Tucker 1999
6690,7253,7247,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,75.1,,52.0,ug/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",0.27,,0.24,umol/L,,346,Pearson,0.44,,,< 0.0001,Yes,,,"Age, Energy",Tucker 1999
6696,7253,7247,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,75.1,,52.0,ug/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",0.27,,0.24,umol/L,,346,Pearson,0.45,,,< 0.0001,Yes,,,"Age, Energy, BMI, Cholesterol, Smoking status",Tucker 1999
6685,7254,7248,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Lycopene,"",,7002.0,,5645.0,ug/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",0.61,,0.55,umol/L,,346,Pearson,0.35,,,< 0.0001,Yes,,,,Tucker 1999
6691,7254,7248,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Lycopene,"",,7002.0,,5645.0,ug/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",0.61,,0.55,umol/L,,346,Pearson,0.37,,,< 0.0001,Yes,,,"Age, Energy",Tucker 1999
6697,7254,7248,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Lycopene,"",,7002.0,,5645.0,ug/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",0.61,,0.55,umol/L,,346,Pearson,0.36,,,< 0.0001,Yes,,,"Age, Energy, BMI, Cholesterol, Smoking status",Tucker 1999
6686,7255,7249,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,3087.0,,2522.0,ug/day,,,"Plasma, non-fasting",HPLC,Lutein/Zeaxanthin,"",0.56,,0.5,umol/L,,346,Pearson,0.27,,,< 0.0001,Yes,,,,Tucker 1999
6692,7255,7249,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,3087.0,,2522.0,ug/day,,,"Plasma, non-fasting",HPLC,Lutein/Zeaxanthin,"",0.56,,0.5,umol/L,,346,Pearson,0.27,,,< 0.0001,Yes,,,"Age, Energy",Tucker 1999
6698,7255,7249,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,3087.0,,2522.0,ug/day,,,"Plasma, non-fasting",HPLC,Lutein/Zeaxanthin,"",0.56,,0.5,umol/L,,346,Pearson,0.24,,,< 0.0001,Yes,,,"Age, Energy, BMI, Cholesterol, Smoking status",Tucker 1999
6714,7256,7245,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,5.1,,4.8,servings/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",0.117,,0.092,umol/L,,346,Pearson,0.25,,,< 0.01,Yes,,,,Tucker 1999
6715,7256,7246,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,5.1,,4.8,servings/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",0.51,,0.42,umol/L,,346,Pearson,0.27,,,< 0.01,Yes,,,,Tucker 1999
6716,7256,7247,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,5.1,,4.8,servings/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",0.27,,0.24,umol/L,,346,Pearson,0.33,,,< 0.01,Yes,,,,Tucker 1999
6717,7256,7248,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,5.1,,4.8,servings/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",0.61,,0.55,umol/L,,346,Pearson,0.14,,,< 0.01,Yes,,,,Tucker 1999
6718,7256,7249,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,5.1,,4.8,servings/day,,,"Plasma, non-fasting",HPLC,Lutein/Zeaxanthin,"",0.56,,0.5,umol/L,,346,Pearson,0.17,,,< 0.01,Yes,,,,Tucker 1999
6719,7256,7245,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,5.1,,4.8,servings/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",0.117,,0.092,umol/L,,346,Pearson,0.25,,,< 0.01,Yes,,,"Age, Energy",Tucker 1999
6720,7256,7246,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,5.1,,4.8,servings/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",0.51,,0.42,umol/L,,346,Pearson,0.29,,,< 0.01,Yes,,,"Age, Energy",Tucker 1999
6721,7256,7247,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,5.1,,4.8,servings/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",0.27,,0.24,umol/L,,346,Pearson,0.35,,,< 0.01,Yes,,,"Age, Energy",Tucker 1999
6722,7256,7248,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,5.1,,4.8,servings/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",0.61,,0.55,umol/L,,346,Pearson,0.21,,,< 0.01,Yes,,,"Age, Energy",Tucker 1999
6723,7256,7249,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,5.1,,4.8,servings/day,,,"Plasma, non-fasting",HPLC,Lutein/Zeaxanthin,"",0.56,,0.5,umol/L,,346,Pearson,0.18,,,< 0.01,Yes,,,"Age, Energy",Tucker 1999
6724,7256,7245,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,5.1,,4.8,servings/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",0.117,,0.092,umol/L,,346,Pearson,0.23,,,< 0.01,Yes,,,"Age, Energy, BMI, Cholesterol, Smoking status",Tucker 1999
6725,7256,7246,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,5.1,,4.8,servings/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",0.51,,0.42,umol/L,,346,Pearson,0.27,,,< 0.01,Yes,,,"Age, Energy, BMI, Cholesterol, Smoking status",Tucker 1999
6726,7256,7247,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,5.1,,4.8,servings/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",0.27,,0.24,umol/L,,346,Pearson,0.34,,,< 0.01,Yes,,,"Age, Energy, BMI, Cholesterol, Smoking status",Tucker 1999
6727,7256,7248,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,5.1,,4.8,servings/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",0.61,,0.55,umol/L,,346,Pearson,0.19,,,< 0.01,Yes,,,"Age, Energy, BMI, Cholesterol, Smoking status",Tucker 1999
6728,7256,7249,Females,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,5.1,,4.8,servings/day,,,"Plasma, non-fasting",HPLC,Lutein/Zeaxanthin,"",0.56,,0.5,umol/L,,346,Pearson,0.16,,,< 0.01,Yes,,,"Age, Energy, BMI, Cholesterol, Smoking status",Tucker 1999
6665,7240,7762,Males - Supplement nonusers,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,3520.0,,2904.0,ug/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,umol/L,,177,Pearson,0.16,,,< 0.05,No,,,,Tucker 1999
6671,7240,7762,Males - Supplement nonusers,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,3520.0,,2904.0,ug/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,umol/L,,177,Pearson,0.18,,,< 0.05,No,,,"Age, Energy",Tucker 1999
6677,7240,7762,Males - Supplement nonusers,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,3520.0,,2904.0,ug/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,umol/L,,177,Pearson,0.24,,,< 0.01,Yes,,,"Age, Energy, BMI, Cholesterol, Smoking status",Tucker 1999
6683,7252,7763,Females - Supplement nonusers,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,4216.0,,3741.0,ug/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,umol/L,,314,Pearson,0.3,,,< 0.0001,Yes,,,,Tucker 1999
6689,7252,7763,Females - Supplement nonusers,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,4216.0,,3741.0,ug/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,umol/L,,314,Pearson,0.31,,,< 0.0001,Yes,,,"Age, Energy",Tucker 1999
6695,7252,7763,Females - Supplement nonusers,Elderly subjects,United States,Framingham Heart Study,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,4216.0,,3741.0,ug/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,umol/L,,314,Pearson,0.29,,,< 0.0001,Yes,,,"Age, Energy, BMI, Cholesterol, Smoking status",Tucker 1999
6729,7277,7259,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,144.0,,,ug/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",39.5,,,ug/L,,110,Pearson,0.37,,,= 0.001,Yes,,,,Romieu 1999
6737,7277,7259,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,144.0,,,ug/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",39.5,,,ug/L,,110,Pearson,0.32,,,= 0.001,Yes,"Cholesterol ?, Triglycerides ?, Energy by residual method ?, Age ?, BMI ?",,"Age, BMI, Smoking status, Energy, Cholesterol, Triglycerides",Romieu 1999
6730,7278,7260,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,1257.0,,,ug/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",253.0,,,ug/L,,110,Pearson,0.33,,,= 0.015,Yes,,,,Romieu 1999
6738,7278,7260,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,1257.0,,,ug/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",253.0,,,ug/L,,110,Pearson,0.34,,,= 0.015,Yes,"Cholesterol ?, Triglycerides ?, Energy by residual method ?, Age ?, BMI ?",,"Age, BMI, Smoking status, Energy, Cholesterol, Triglycerides",Romieu 1999
6731,7279,7261,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),Lycopene,"",,1212.0,,,ug/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",283.0,,,ug/L,,110,Pearson,0.1,,,> 0.05,No,,,,Romieu 1999
6739,7279,7261,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),Lycopene,"",,1212.0,,,ug/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",283.0,,,ug/L,,110,Pearson,0.26,,,> 0.05,No,"Cholesterol ?, Triglycerides ?, Energy by residual method ?, Age ?, BMI ?",,"Age, BMI, Smoking status, Energy, Cholesterol, Triglycerides",Romieu 1999
6732,7280,7297,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,998.0,,,ug/day,,,"Plasma, non-fasting",HPLC,Carotenoids,Zeaxanthin + Lutein,,,,ug/L,,110,Pearson,0.14,,,> 0.05,No,,,,Romieu 1999
6740,7280,7297,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,998.0,,,ug/day,,,"Plasma, non-fasting",HPLC,Carotenoids,Zeaxanthin + Lutein,,,,ug/L,,110,Pearson,0.13,,,> 0.05,No,"Cholesterol ?, Triglycerides ?, Energy by residual method ?, Age ?, BMI ?",,"Age, BMI, Smoking status, Energy, Cholesterol, Triglycerides",Romieu 1999
6733,7281,7298,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,3626.0,,,ug/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,ug/L,,110,Pearson,0.38,,,= 0.001,Yes,,,,Romieu 1999
6741,7281,7298,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,3626.0,,,ug/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,ug/L,,110,Pearson,0.4,,,> 0.05,No,"Cholesterol ?, Triglycerides ?, Energy by residual method ?, Age ?, BMI ?",,"Age, BMI, Smoking status, Energy, Cholesterol, Triglycerides",Romieu 1999
6734,7282,7264,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),Retinol,"",,809.0,,,iuretinol/day,,,"Plasma, non-fasting",HPLC,Retinol,"",414.0,,,ug/L,,110,Pearson,-0.1,,,> 0.05,No,,,,Romieu 1999
6742,7282,7264,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),Retinol,"",,809.0,,,iuretinol/day,,,"Plasma, non-fasting",HPLC,Retinol,"",414.0,,,ug/L,,110,Pearson,-0.09,,,> 0.05,No,"Cholesterol ?, Triglycerides ?, Energy by residual method ?, Age ?, BMI ?",,"Age, BMI, Smoking status, Energy, Cholesterol, Triglycerides",Romieu 1999
6735,7283,7265,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",,5.26,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",10.2,,,mg/L,,110,Pearson,-0.08,,,> 0.05,No,,,,Romieu 1999
6743,7283,7265,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",,5.26,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",10.2,,,mg/L,,110,Pearson,0.07,,,> 0.05,No,"Cholesterol ?, Triglycerides ?, Energy by residual method ?, Age ?, BMI ?",,"Age, BMI, Smoking status, Energy, Cholesterol, Triglycerides",Romieu 1999
6736,7284,7266,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",,6.26,,,mg/day,,,"Plasma, non-fasting",HPLC,gamma-Tocopherol,"",0.84,,,mg/L,,110,Pearson,0.16,,,> 0.05,No,,,,Romieu 1999
6744,7284,7266,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",,6.26,,,mg/day,,,"Plasma, non-fasting",HPLC,gamma-Tocopherol,"",0.84,,,mg/L,,110,Pearson,0.13,,,> 0.05,No,"Cholesterol ?, Triglycerides ?, Energy by residual method ?, Age ?, BMI ?",,"Age, BMI, Smoking status, Energy, Cholesterol, Triglycerides",Romieu 1999
6745,7287,7259,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,156.0,,,ug/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",39.5,,,ug/L,,110,Pearson,0.33,,,= 0.001,Yes,,,,Romieu 1999
6753,7287,7259,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,156.0,,,ug/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",39.5,,,ug/L,,110,Pearson,0.29,,,= 0.015,Yes,"Cholesterol ?, Triglycerides ?, Energy by residual method ?, Age ?, BMI ?",,"Age, BMI, Smoking status, Energy, Cholesterol, Triglycerides",Romieu 1999
6746,7288,7260,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,1165.0,,,ug/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",253.0,,,ug/L,,110,Pearson,0.17,,,> 0.05,No,,,,Romieu 1999
6754,7288,7260,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,1165.0,,,ug/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",253.0,,,ug/L,,110,Pearson,0.17,,,> 0.05,No,"Cholesterol ?, Triglycerides ?, Energy by residual method ?, Age ?, BMI ?",,"Age, BMI, Smoking status, Energy, Cholesterol, Triglycerides",Romieu 1999
6747,7289,7261,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),Lycopene,"",,1020.0,,,ug/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",283.0,,,ug/L,,110,Pearson,0.18,,,> 0.05,No,,,,Romieu 1999
6755,7289,7261,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),Lycopene,"",,1020.0,,,ug/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",283.0,,,ug/L,,110,Pearson,0.14,,,> 0.05,No,"Cholesterol ?, Triglycerides ?, Energy by residual method ?, Age ?, BMI ?",,"Age, BMI, Smoking status, Energy, Cholesterol, Triglycerides",Romieu 1999
6748,7290,7297,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,875.0,,,ug/day,,,"Plasma, non-fasting",HPLC,Carotenoids,Zeaxanthin + Lutein,,,,ug/L,,110,Pearson,0.03,,,> 0.05,No,,,,Romieu 1999
6756,7290,7297,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,875.0,,,ug/day,,,"Plasma, non-fasting",HPLC,Carotenoids,Zeaxanthin + Lutein,,,,ug/L,,110,Pearson,0.03,,,> 0.05,No,"Cholesterol ?, Triglycerides ?, Energy by residual method ?, Age ?, BMI ?",,"Age, BMI, Smoking status, Energy, Cholesterol, Triglycerides",Romieu 1999
6749,7291,7298,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,3260.0,,,ug/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,ug/L,,110,Pearson,0.27,,,= 0.015,Yes,,,,Romieu 1999
6757,7291,7298,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,3260.0,,,ug/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,ug/L,,110,Pearson,0.25,,,= 0.05,Yes,"Cholesterol ?, Triglycerides ?, Energy by residual method ?, Age ?, BMI ?",,"Age, BMI, Smoking status, Energy, Cholesterol, Triglycerides",Romieu 1999
6750,7292,7264,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),Retinol,"",,990.0,,,iuretinol/day,,,"Plasma, non-fasting",HPLC,Retinol,"",414.0,,,ug/L,,110,Pearson,-0.07,,,> 0.05,No,,,,Romieu 1999
6758,7292,7264,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),Retinol,"",,990.0,,,iuretinol/day,,,"Plasma, non-fasting",HPLC,Retinol,"",414.0,,,ug/L,,110,Pearson,0.01,,,> 0.05,No,"Cholesterol ?, Triglycerides ?, Energy by residual method ?, Age ?, BMI ?",,"Age, BMI, Smoking status, Energy, Cholesterol, Triglycerides",Romieu 1999
6751,7293,7265,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",,4.22,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",10.2,,,mg/L,,110,Pearson,-0.18,,,> 0.05,No,,,,Romieu 1999
6759,7293,7265,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",,4.22,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",10.2,,,mg/L,,110,Pearson,-0.01,,,> 0.05,No,"Cholesterol ?, Triglycerides ?, Energy by residual method ?, Age ?, BMI ?",,"Age, BMI, Smoking status, Energy, Cholesterol, Triglycerides",Romieu 1999
6752,7294,7266,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",,5.7,,,mg/day,,,"Plasma, non-fasting",HPLC,gamma-Tocopherol,"",0.84,,,mg/L,,110,Pearson,0.03,,,> 0.05,No,,,,Romieu 1999
6760,7294,7266,All,Women in the southern part of Mexico City,Mexico,,,Food Frequency Questionnaire (FFQ),gamma-Tocopherol,"",,5.7,,,mg/day,,,"Plasma, non-fasting",HPLC,gamma-Tocopherol,"",0.84,,,mg/L,,110,Pearson,0.0,,,> 0.05,No,"Cholesterol ?, Triglycerides ?, Energy by residual method ?, Age ?, BMI ?",,"Age, BMI, Smoking status, Energy, Cholesterol, Triglycerides",Romieu 1999
6761,7267,7259,All,Women in the southern part of Mexico City,Mexico,,,24-h Dietary recall (4-day),alpha-Carotene,"",,185.0,,,ug/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",39.5,,,ug/L,,110,Pearson,0.21,,,= 0.05,Yes,,,,Romieu 1999
6769,7267,7259,All,Women in the southern part of Mexico City,Mexico,,,24-h Dietary recall (4-day),alpha-Carotene,"",,185.0,,,ug/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",39.5,,,ug/L,,110,Pearson,0.23,,,= 0.05,Yes,"Cholesterol ?, Triglycerides ?, Energy by residual method ?, Age ?, BMI ?",,"Age, BMI, Smoking status, Energy, Cholesterol, Triglycerides",Romieu 1999
6762,7268,7260,All,Women in the southern part of Mexico City,Mexico,,,24-h Dietary recall (4-day),beta-Carotene,"",,1079.0,,,ug/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",253.0,,,ug/L,,110,Pearson,0.14,,,> 0.05,No,,,,Romieu 1999
6770,7268,7260,All,Women in the southern part of Mexico City,Mexico,,,24-h Dietary recall (4-day),beta-Carotene,"",,1079.0,,,ug/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",253.0,,,ug/L,,110,Pearson,0.18,,,> 0.05,No,"Cholesterol ?, Triglycerides ?, Energy by residual method ?, Age ?, BMI ?",,"Age, BMI, Smoking status, Energy, Cholesterol, Triglycerides",Romieu 1999
6763,7269,7261,All,Women in the southern part of Mexico City,Mexico,,,24-h Dietary recall (4-day),Lycopene,"",,1190.0,,,ug/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",283.0,,,ug/L,,110,Pearson,0.1,,,> 0.05,No,,,,Romieu 1999
6771,7269,7261,All,Women in the southern part of Mexico City,Mexico,,,24-h Dietary recall (4-day),Lycopene,"",,1190.0,,,ug/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",283.0,,,ug/L,,110,Pearson,0.18,,,> 0.05,No,"Cholesterol ?, Triglycerides ?, Energy by residual method ?, Age ?, BMI ?",,"Age, BMI, Smoking status, Energy, Cholesterol, Triglycerides",Romieu 1999
6764,7270,7297,All,Women in the southern part of Mexico City,Mexico,,,24-h Dietary recall (4-day),Lutein/Zeaxanthin,"",,496.0,,,ug/day,,,"Plasma, non-fasting",HPLC,Carotenoids,Zeaxanthin + Lutein,,,,ug/L,,110,Pearson,0.14,,,> 0.05,No,,,,Romieu 1999
6772,7270,7297,All,Women in the southern part of Mexico City,Mexico,,,24-h Dietary recall (4-day),Lutein/Zeaxanthin,"",,496.0,,,ug/day,,,"Plasma, non-fasting",HPLC,Carotenoids,Zeaxanthin + Lutein,,,,ug/L,,110,Pearson,0.2,,,= 0.05,Yes,"Cholesterol ?, Triglycerides ?, Energy by residual method ?, Age ?, BMI ?",,"Age, BMI, Smoking status, Energy, Cholesterol, Triglycerides",Romieu 1999
6765,7271,7298,All,Women in the southern part of Mexico City,Mexico,,,24-h Dietary recall (4-day),Carotenoids,alpha-Carotene + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,3122.0,,,ug/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,ug/L,,110,Pearson,0.1,,,> 0.05,No,,,,Romieu 1999
6773,7271,7298,All,Women in the southern part of Mexico City,Mexico,,,24-h Dietary recall (4-day),Carotenoids,alpha-Carotene + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,3122.0,,,ug/day,,,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + Zeaxanthin + Lycopene + Lutein + beta-Carotene,,,,ug/L,,110,Pearson,0.18,,,> 0.05,No,"Cholesterol ?, Triglycerides ?, Energy by residual method ?, Age ?, BMI ?",,"Age, BMI, Smoking status, Energy, Cholesterol, Triglycerides",Romieu 1999
6766,7272,7264,All,Women in the southern part of Mexico City,Mexico,,,24-h Dietary recall (4-day),Retinol,"",,664.0,,,iuretinol/day,,,"Plasma, non-fasting",HPLC,Retinol,"",414.0,,,ug/L,,110,Pearson,-0.05,,,> 0.05,No,,,,Romieu 1999
6774,7272,7264,All,Women in the southern part of Mexico City,Mexico,,,24-h Dietary recall (4-day),Retinol,"",,664.0,,,iuretinol/day,,,"Plasma, non-fasting",HPLC,Retinol,"",414.0,,,ug/L,,110,Pearson,-0.06,,,> 0.05,No,"Cholesterol ?, Triglycerides ?, Energy by residual method ?, Age ?, BMI ?",,"Age, BMI, Smoking status, Energy, Cholesterol, Triglycerides",Romieu 1999
6767,7273,7265,All,Women in the southern part of Mexico City,Mexico,,,24-h Dietary recall (4-day),alpha-Tocopherol,"",,3.19,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",10.2,,,mg/L,,110,Pearson,-0.16,,,> 0.05,No,,,,Romieu 1999
6775,7273,7265,All,Women in the southern part of Mexico City,Mexico,,,24-h Dietary recall (4-day),alpha-Tocopherol,"",,3.19,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",10.2,,,mg/L,,110,Pearson,-0.06,,,> 0.05,No,"Cholesterol ?, Triglycerides ?, Energy by residual method ?, Age ?, BMI ?",,"Age, BMI, Smoking status, Energy, Cholesterol, Triglycerides",Romieu 1999
6768,7274,7266,All,Women in the southern part of Mexico City,Mexico,,,24-h Dietary recall (4-day),gamma-Tocopherol,"",,5.54,,,mg/day,,,"Plasma, non-fasting",HPLC,gamma-Tocopherol,"",0.84,,,mg/L,,110,Pearson,-0.15,,,> 0.05,No,,,,Romieu 1999
6776,7274,7266,All,Women in the southern part of Mexico City,Mexico,,,24-h Dietary recall (4-day),gamma-Tocopherol,"",,5.54,,,mg/day,,,"Plasma, non-fasting",HPLC,gamma-Tocopherol,"",0.84,,,mg/L,,110,Pearson,-0.09,,,> 0.05,No,"Cholesterol ?, Triglycerides ?, Energy by residual method ?, Age ?, BMI ?",,"Age, BMI, Smoking status, Energy, Cholesterol, Triglycerides",Romieu 1999
6777,7302,7303,All,Volunteers from the Institute of Food Research and Nutrition,Denmark,,,Dietary record (1-day),Iodine,"",No,89.0,,82.0,ug/day,,,"Urine, 24-h",HPLC,Iodine,"",95.0,,91.0,ug/day,,10,Spearman,0.46,,,= 0.01,Yes,,,,Rasmussen 1999
6778,7314,7315,All [by gender],Participants in a dietary validation study,Germany,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Proteins,"",,75.3,,,g/day,,,"Urine, 24-h",Spectrophotometry,Nitrogen,"",97.4,,,g/day,,134,Pearson,0.41,,, ,Unspecified,,No,,Kroke 1999
6779,7314,7315,All [by gender],Participants in a dietary validation study,Germany,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Proteins,"",,75.3,,,g/day,,,"Urine, 24-h",Spectrophotometry,Nitrogen,"",97.4,,,g/day,,134,Pearson,0.46,,, ,Unspecified,,Yes,,Kroke 1999
6796,7320,7328,Males,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + 10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6) + 6-8E-Octadecenoic acids (trans-18:1n-10-12) + 7E-Hexadecenoic acid (trans-16:1n-9),,,2.57,,g/day,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + 10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6) + 6-8E-Octadecenoic acids (trans-18:1n-10-12) + 7E-Hexadecenoic acid (trans-16:1n-9),,4.93,,percentRoot,,24,Spearman,0.67,,,< 0.001,Yes,,,,Lemaitre 1998
6800,7320,7328,Males,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + 10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6) + 6-8E-Octadecenoic acids (trans-18:1n-10-12) + 7E-Hexadecenoic acid (trans-16:1n-9),,,2.57,,g/day,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + 10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6) + 6-8E-Octadecenoic acids (trans-18:1n-10-12) + 7E-Hexadecenoic acid (trans-16:1n-9),,4.93,,percentRoot,,24,Pearson,0.67,0.36,0.84,>= 0.05,No,,,,Lemaitre 1998
6804,7320,7328,Males,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + 10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6) + 6-8E-Octadecenoic acids (trans-18:1n-10-12) + 7E-Hexadecenoic acid (trans-16:1n-9),,,2.57,,g/day,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + 10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6) + 6-8E-Octadecenoic acids (trans-18:1n-10-12) + 7E-Hexadecenoic acid (trans-16:1n-9),,4.93,,percentRoot,,24,Pearson,0.71,0.43,0.86,>= 0.05,No,,,Energy,Lemaitre 1998
6808,7320,7328,Males,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + 10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6) + 6-8E-Octadecenoic acids (trans-18:1n-10-12) + 7E-Hexadecenoic acid (trans-16:1n-9),,,2.57,,g/day,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + 10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6) + 6-8E-Octadecenoic acids (trans-18:1n-10-12) + 7E-Hexadecenoic acid (trans-16:1n-9),,4.93,,percentRoot,,24,Pearson,0.76,0.51,0.89,>= 0.05,No,,,"Energy, Age, BMI",Lemaitre 1998
6797,7321,7329,Males,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),trans-Octadecenoic acids (trans-18:1),10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + 6-8E-Octadecenoic acids (trans-18:1n-10-12),,,2.24,,g/day,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecenoic acids (trans-18:1),10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + 6-8E-Octadecenoic acids (trans-18:1n-10-12),,3.5,,percentRoot,,24,Spearman,0.68,,,< 0.001,Yes,,,,Lemaitre 1998
6801,7321,7329,Males,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),trans-Octadecenoic acids (trans-18:1),10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + 6-8E-Octadecenoic acids (trans-18:1n-10-12),,,2.24,,g/day,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecenoic acids (trans-18:1),10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + 6-8E-Octadecenoic acids (trans-18:1n-10-12),,3.5,,percentRoot,,24,Pearson,0.67,0.36,0.84,>= 0.05,No,,,,Lemaitre 1998
6805,7321,7329,Males,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),trans-Octadecenoic acids (trans-18:1),10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + 6-8E-Octadecenoic acids (trans-18:1n-10-12),,,2.24,,g/day,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecenoic acids (trans-18:1),10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + 6-8E-Octadecenoic acids (trans-18:1n-10-12),,3.5,,percentRoot,,24,Pearson,0.69,0.4,0.85,>= 0.05,No,,,Energy,Lemaitre 1998
6809,7321,7329,Males,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),trans-Octadecenoic acids (trans-18:1),10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + 6-8E-Octadecenoic acids (trans-18:1n-10-12),,,2.24,,g/day,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecenoic acids (trans-18:1),10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + 6-8E-Octadecenoic acids (trans-18:1n-10-12),,3.5,,percentRoot,,24,Pearson,0.75,0.5,0.88,>= 0.05,No,,,"Energy, Age, BMI",Lemaitre 1998
6798,7322,7330,Males,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6),,,0.29,,g/day,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6),,1.17,,percentRoot,,24,Spearman,0.5,,,< 0.05,Yes,,,,Lemaitre 1998
6802,7322,7330,Males,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6),,,0.29,,g/day,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6),,1.17,,percentRoot,,24,Pearson,0.51,0.13,0.76,>= 0.05,No,,,,Lemaitre 1998
6806,7322,7330,Males,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6),,,0.29,,g/day,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6),,1.17,,percentRoot,,24,Pearson,0.56,0.2,0.79,>= 0.05,No,,,Energy,Lemaitre 1998
6810,7322,7330,Males,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6),,,0.29,,g/day,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6),,1.17,,percentRoot,,24,Pearson,0.58,0.23,0.8,>= 0.05,No,,,"Energy, Age, BMI",Lemaitre 1998
6799,7323,7331,Males,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),trans-Hexadecenoic acids (trans-16:1),Palmitelaidic acid (trans-16:1n-7) + 7E-Hexadecenoic acid (trans-16:1n-9),,,0.016,,g/day,,,"Adipose tissue, buttocks",GC-FID,trans-Hexadecenoic acids (trans-16:1),Palmitelaidic acid (trans-16:1n-7) + 7E-Hexadecenoic acid (trans-16:1n-9),,0.26,,percentRoot,,24,Spearman,0.54,,,< 0.01,Yes,,,,Lemaitre 1998
6803,7323,7331,Males,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),trans-Hexadecenoic acids (trans-16:1),Palmitelaidic acid (trans-16:1n-7) + 7E-Hexadecenoic acid (trans-16:1n-9),,,0.016,,g/day,,,"Adipose tissue, buttocks",GC-FID,trans-Hexadecenoic acids (trans-16:1),Palmitelaidic acid (trans-16:1n-7) + 7E-Hexadecenoic acid (trans-16:1n-9),,0.26,,percentRoot,,24,Pearson,0.49,0.11,0.75,>= 0.05,No,,,,Lemaitre 1998
6807,7323,7331,Males,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),trans-Hexadecenoic acids (trans-16:1),Palmitelaidic acid (trans-16:1n-7) + 7E-Hexadecenoic acid (trans-16:1n-9),,,0.016,,g/day,,,"Adipose tissue, buttocks",GC-FID,trans-Hexadecenoic acids (trans-16:1),Palmitelaidic acid (trans-16:1n-7) + 7E-Hexadecenoic acid (trans-16:1n-9),,0.26,,percentRoot,,24,Pearson,0.42,0.02,0.7,>= 0.05,No,,,Energy,Lemaitre 1998
6811,7323,7331,Males,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),trans-Hexadecenoic acids (trans-16:1),Palmitelaidic acid (trans-16:1n-7) + 7E-Hexadecenoic acid (trans-16:1n-9),,,0.016,,g/day,,,"Adipose tissue, buttocks",GC-FID,trans-Hexadecenoic acids (trans-16:1),Palmitelaidic acid (trans-16:1n-7) + 7E-Hexadecenoic acid (trans-16:1n-9),,0.26,,percentRoot,,24,Pearson,0.42,0.02,0.7,>= 0.05,No,,,"Energy, Age, BMI",Lemaitre 1998
6780,7324,7332,Females,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + 10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6) + 6-8E-Octadecenoic acids (trans-18:1n-10-12) + 7E-Hexadecenoic acid (trans-16:1n-9),,,1.99,,g/day,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + 10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6) + 6-8E-Octadecenoic acids (trans-18:1n-10-12) + 7E-Hexadecenoic acid (trans-16:1n-9),,4.4,,percentRoot,,27,Spearman,0.55,,,< 0.01,Yes,,,,Lemaitre 1998
6784,7324,7332,Females,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + 10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6) + 6-8E-Octadecenoic acids (trans-18:1n-10-12) + 7E-Hexadecenoic acid (trans-16:1n-9),,,1.99,,g/day,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + 10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6) + 6-8E-Octadecenoic acids (trans-18:1n-10-12) + 7E-Hexadecenoic acid (trans-16:1n-9),,4.4,,percentRoot,,27,Pearson,0.58,0.26,0.79,>= 0.05,No,,,,Lemaitre 1998
6788,7324,7332,Females,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + 10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6) + 6-8E-Octadecenoic acids (trans-18:1n-10-12) + 7E-Hexadecenoic acid (trans-16:1n-9),,,1.99,,g/day,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + 10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6) + 6-8E-Octadecenoic acids (trans-18:1n-10-12) + 7E-Hexadecenoic acid (trans-16:1n-9),,4.4,,percentRoot,,27,Pearson,0.51,0.16,0.74,>= 0.05,No,,,Energy,Lemaitre 1998
6792,7324,7332,Females,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + 10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6) + 6-8E-Octadecenoic acids (trans-18:1n-10-12) + 7E-Hexadecenoic acid (trans-16:1n-9),,,1.99,,g/day,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, trans",Palmitelaidic acid (trans-16:1n-7) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + 10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + cis-12-Linoelaidic acid (12cis-18:2n-6) + 6-8E-Octadecenoic acids (trans-18:1n-10-12) + 7E-Hexadecenoic acid (trans-16:1n-9),,4.4,,percentRoot,,27,Pearson,0.52,0.17,0.75,>= 0.05,No,,,"Energy, Age, BMI",Lemaitre 1998
6781,7325,7333,Females,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),trans-Octadecenoic acids (trans-18:1),10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + 6-8E-Octadecenoic acids (trans-18:1n-10-12),,,1.78,,g/day,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecenoic acids (trans-18:1),10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + 6-8E-Octadecenoic acids (trans-18:1n-10-12),,3.09,,percentRoot,,27,Spearman,0.58,,,< 0.01,Yes,,,,Lemaitre 1998
6785,7325,7333,Females,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),trans-Octadecenoic acids (trans-18:1),10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + 6-8E-Octadecenoic acids (trans-18:1n-10-12),,,1.78,,g/day,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecenoic acids (trans-18:1),10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + 6-8E-Octadecenoic acids (trans-18:1n-10-12),,3.09,,percentRoot,,27,Pearson,0.56,0.23,0.78,>= 0.05,No,,,,Lemaitre 1998
6789,7325,7333,Females,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),trans-Octadecenoic acids (trans-18:1),10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + 6-8E-Octadecenoic acids (trans-18:1n-10-12),,,1.78,,g/day,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecenoic acids (trans-18:1),10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + 6-8E-Octadecenoic acids (trans-18:1n-10-12),,3.09,,percentRoot,,27,Pearson,0.46,0.1,0.71,>= 0.05,No,,,Energy,Lemaitre 1998
6793,7325,7333,Females,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),trans-Octadecenoic acids (trans-18:1),10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + 6-8E-Octadecenoic acids (trans-18:1n-10-12),,,1.78,,g/day,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecenoic acids (trans-18:1),10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + 12E-Octadecenoic acid (trans-18:1n-6) + Elaidic acid (trans-18:1n-9) + 6-8E-Octadecenoic acids (trans-18:1n-10-12),,3.09,,percentRoot,,27,Pearson,0.48,0.12,0.73,>= 0.05,No,,,"Energy, Age, BMI",Lemaitre 1998
6782,7326,7334,Females,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6),,,0.24,,g/day,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6),,1.08,,percentRoot,,27,Spearman,0.38,,,>= 0.05,No,,,,Lemaitre 1998
6786,7326,7334,Females,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6),,,0.24,,g/day,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6),,1.08,,percentRoot,,27,Pearson,0.45,0.08,0.71,>= 0.05,No,,,,Lemaitre 1998
6790,7326,7334,Females,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6),,,0.24,,g/day,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6),,1.08,,percentRoot,,27,Pearson,0.45,0.08,0.71,>= 0.05,No,,,Energy,Lemaitre 1998
6794,7326,7334,Females,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6),,,0.24,,g/day,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecadienoic acids (trans-18:2),Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6),,1.08,,percentRoot,,27,Pearson,0.47,0.11,0.72,>= 0.05,No,,,"Energy, Age, BMI",Lemaitre 1998
6783,7327,7335,Females,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),trans-Hexadecenoic acids (trans-16:1),Palmitelaidic acid (trans-16:1n-7) + 7E-Hexadecenoic acid (trans-16:1n-9),,,0.014,,g/day,,,"Adipose tissue, buttocks",GC-FID,trans-Hexadecenoic acids (trans-16:1),Palmitelaidic acid (trans-16:1n-7) + 7E-Hexadecenoic acid (trans-16:1n-9),,0.24,,percentRoot,,27,Spearman,0.48,,,< 0.05,Yes,,,,Lemaitre 1998
6787,7327,7335,Females,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),trans-Hexadecenoic acids (trans-16:1),Palmitelaidic acid (trans-16:1n-7) + 7E-Hexadecenoic acid (trans-16:1n-9),,,0.014,,g/day,,,"Adipose tissue, buttocks",GC-FID,trans-Hexadecenoic acids (trans-16:1),Palmitelaidic acid (trans-16:1n-7) + 7E-Hexadecenoic acid (trans-16:1n-9),,0.24,,percentRoot,,27,Pearson,0.51,0.16,0.74,>= 0.05,No,,,,Lemaitre 1998
6791,7327,7335,Females,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),trans-Hexadecenoic acids (trans-16:1),Palmitelaidic acid (trans-16:1n-7) + 7E-Hexadecenoic acid (trans-16:1n-9),,,0.014,,g/day,,,"Adipose tissue, buttocks",GC-FID,trans-Hexadecenoic acids (trans-16:1),Palmitelaidic acid (trans-16:1n-7) + 7E-Hexadecenoic acid (trans-16:1n-9),,0.24,,percentRoot,,27,Pearson,0.42,0.05,0.69,>= 0.05,No,,,Energy,Lemaitre 1998
6795,7327,7335,Females,Adults in Seattle,United States,,,Food Frequency Questionnaire (FFQ),trans-Hexadecenoic acids (trans-16:1),Palmitelaidic acid (trans-16:1n-7) + 7E-Hexadecenoic acid (trans-16:1n-9),,,0.014,,g/day,,,"Adipose tissue, buttocks",GC-FID,trans-Hexadecenoic acids (trans-16:1),Palmitelaidic acid (trans-16:1n-7) + 7E-Hexadecenoic acid (trans-16:1n-9),,0.24,,percentRoot,,27,Pearson,0.3,-0.09,0.61,>= 0.05,No,,,"Energy, Age, BMI",Lemaitre 1998
6814,7341,7368,All [by supplement],Young women from Southern Ontario,Canada,,,Food Frequency Questionnaire (FFQ),Folates,"",Yes,,,346.0,ug/day,,,"Serum, fasting",Competitive protein-binding assay (CPBA),Folates,"",,,,nmol/L,,102,Pearson,0.48,,,< 0.01,Yes,,,,Green 1998
6818,7341,7369,All [by supplement],Young women from Southern Ontario,Canada,,,Food Frequency Questionnaire (FFQ),Folates,"",Yes,,,346.0,ug/day,,,"Red blood cell, fasting",Microbioassay (Lactobacillus casei),Folates,"",,,,nmol/L,,104,Pearson,0.42,,,< 0.01,Yes,,,,Green 1998
6822,7342,7370,All [by supplement],Young women from Southern Ontario,Canada,,,Food Frequency Questionnaire (FFQ),Vitamin B12,"",Yes,,,4.9,ug/day,,,"Serum, fasting",Competitive protein-binding assay (CPBA),Vitamin B12,"",,,,pmol/L,,103,Pearson,0.25,,,< 0.01,Yes,,,,Green 1998
6815,7348,7368,All [by supplement],Young women from Southern Ontario,Canada,,,Weighed Dietary record (3-day),Folates,"",Yes,,,212.0,ug/day,,,"Serum, fasting",Competitive protein-binding assay (CPBA),Folates,"",,,,nmol/L,,102,Pearson,0.65,,,< 0.01,Yes,,,,Green 1998
6819,7348,7369,All [by supplement],Young women from Southern Ontario,Canada,,,Weighed Dietary record (3-day),Folates,"",Yes,,,212.0,ug/day,,,"Red blood cell, fasting",Microbioassay (Lactobacillus casei),Folates,"",,,,nmol/L,,104,Pearson,0.5,,,< 0.01,Yes,,,,Green 1998
6823,7349,7370,All [by supplement],Young women from Southern Ontario,Canada,,,Weighed Dietary record (3-day),Vitamin B12,"",Yes,,,1.9,ug/day,,,"Serum, fasting",Competitive protein-binding assay (CPBA),Vitamin B12,"",,,,pmol/L,,103,Pearson,0.32,,,< 0.01,Yes,,,,Green 1998
6812,7337,7362,Supplement nonusers,Young women from Southern Ontario,Canada,,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,289.0,ug/day,,,"Serum, fasting",Competitive protein-binding assay (CPBA),Folates,"",,,9.1,nmol/L,,81,Pearson,0.38,,,< 0.01,Yes,,,,Green 1998
6816,7337,7363,Supplement nonusers,Young women from Southern Ontario,Canada,,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,289.0,ug/day,,,"Red blood cell, fasting",Microbioassay (Lactobacillus casei),Folates,"",,,626.0,nmol/L,,82,Pearson,0.25,,,< 0.05,Yes,,,,Green 1998
6820,7338,7364,Supplement nonusers,Young women from Southern Ontario,Canada,,,Food Frequency Questionnaire (FFQ),Vitamin B12,"",No,,,4.4,ug/day,,,"Serum, fasting",Competitive protein-binding assay (CPBA),Vitamin B12,"",,,281.0,pmol/L,,81,Pearson,0.19,,,= 0.09,No,,,,Green 1998
6813,7344,7362,Supplement nonusers,Young women from Southern Ontario,Canada,,,Weighed Dietary record (3-day),Folates,"",No,,,187.0,ug/day,,,"Serum, fasting",Competitive protein-binding assay (CPBA),Folates,"",,,9.1,nmol/L,,81,Pearson,0.46,,,< 0.01,Yes,,,,Green 1998
6817,7344,7363,Supplement nonusers,Young women from Southern Ontario,Canada,,,Weighed Dietary record (3-day),Folates,"",No,,,187.0,ug/day,,,"Red blood cell, fasting",Microbioassay (Lactobacillus casei),Folates,"",,,626.0,nmol/L,,82,Pearson,0.23,,,< 0.05,Yes,,,,Green 1998
6821,7345,7364,Supplement nonusers,Young women from Southern Ontario,Canada,,,Weighed Dietary record (3-day),Vitamin B12,"",No,,,1.7,ug/day,,,"Serum, fasting",Competitive protein-binding assay (CPBA),Vitamin B12,"",,,281.0,pmol/L,,81,Pearson,0.38,,,< 0.01,Yes,,,,Green 1998
6824,7407,7411,All,Participants in an investigation of antioxidant intake and adult onset asthma in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Vitamin A,"",Yes,,,,ug/day,,,"Plasma, unspecified",HPLC,Retinol,"",,,,umol/L,,273,Pearson,0.14,,,< 0.05,Yes,,,,Bodner 1998
6828,7407,7411,All,Participants in an investigation of antioxidant intake and adult onset asthma in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Vitamin A,"",Yes,,,,ug/day,,,"Plasma, unspecified",HPLC,Retinol,"",,,,umol/L,,273,Pearson,0.1,,,>= 0.05,No,,,"Sex, BMI, Smoking status, Cholesterol, Triglycerides, Energy",Bodner 1998
6825,7408,7412,All,Participants in an investigation of antioxidant intake and adult onset asthma in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Vitamin C,"",Yes,,,,mg/day,,,"Plasma, unspecified",Colorimetry,Ascorbic acid,"",,,,umol/L,,273,Pearson,0.42,,,< 0.001,Yes,,,,Bodner 1998
6829,7408,7412,All,Participants in an investigation of antioxidant intake and adult onset asthma in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Vitamin C,"",Yes,,,,mg/day,,,"Plasma, unspecified",Colorimetry,Ascorbic acid,"",,,,umol/L,,273,Pearson,0.41,,,< 0.001,Yes,,,"Sex, BMI, Smoking status, Energy",Bodner 1998
6826,7409,7413,All,Participants in an investigation of antioxidant intake and adult onset asthma in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Vitamin E,"",Yes,,,,mg/day,,,"Plasma, unspecified",HPLC,alpha-Tocopherol,"",,,,umol/L,,273,Pearson,0.27,,,< 0.001,Yes,,,,Bodner 1998
6830,7409,7413,All,Participants in an investigation of antioxidant intake and adult onset asthma in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Vitamin E,"",Yes,,,,mg/day,,,"Plasma, unspecified",HPLC,alpha-Tocopherol,"",,,,umol/L,,273,Pearson,0.34,,,< 0.001,Yes,,,"Sex, BMI, Smoking status, Cholesterol, Triglycerides, Energy",Bodner 1998
6827,7410,7414,All,Participants in an investigation of antioxidant intake and adult onset asthma in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",Yes,,,,ug/day,,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,273,Pearson,0.24,,,< 0.001,Yes,,,,Bodner 1998
6831,7410,7414,All,Participants in an investigation of antioxidant intake and adult onset asthma in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",Yes,,,,ug/day,,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,273,Pearson,0.26,,,< 0.001,Yes,,,"Sex, BMI, Smoking status, Cholesterol, Triglycerides, Energy",Bodner 1998
6832,7415,7419,Supplement nonusers,Participants in an investigation of antioxidant intake and adult onset asthma in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Vitamin A,"",No,,,,ug/day,,,"Plasma, unspecified",HPLC,Retinol,"",,,,umol/L,,237,Pearson,0.13,,,>= 0.05,No,,,,Bodner 1998
6836,7415,7419,Supplement nonusers,Participants in an investigation of antioxidant intake and adult onset asthma in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Vitamin A,"",No,,,,ug/day,,,"Plasma, unspecified",HPLC,Retinol,"",,,,umol/L,,237,Pearson,0.06,,,>= 0.05,No,,,"Sex, BMI, Smoking status, Cholesterol, Triglycerides, Energy",Bodner 1998
6833,7416,7420,Supplement nonusers,Participants in an investigation of antioxidant intake and adult onset asthma in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Vitamin C,"",No,,,,mg/day,,,"Plasma, unspecified",Colorimetry,Ascorbic acid,"",,,,umol/L,,237,Pearson,0.41,,,< 0.001,Yes,,,,Bodner 1998
6837,7416,7420,Supplement nonusers,Participants in an investigation of antioxidant intake and adult onset asthma in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Vitamin C,"",No,,,,mg/day,,,"Plasma, unspecified",Colorimetry,Ascorbic acid,"",,,,umol/L,,237,Pearson,0.42,,,< 0.001,Yes,,,"Sex, BMI, Smoking status, Energy",Bodner 1998
6834,7417,7421,Supplement nonusers,Participants in an investigation of antioxidant intake and adult onset asthma in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,,,,mg/day,,,"Plasma, unspecified",HPLC,alpha-Tocopherol,"",,,,umol/L,,237,Pearson,0.12,,,>= 0.05,No,,,,Bodner 1998
6838,7417,7421,Supplement nonusers,Participants in an investigation of antioxidant intake and adult onset asthma in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,,,,mg/day,,,"Plasma, unspecified",HPLC,alpha-Tocopherol,"",,,,umol/L,,237,Pearson,0.14,,,< 0.05,Yes,,,"Sex, BMI, Smoking status, Cholesterol, Triglycerides, Energy",Bodner 1998
6835,7418,7422,Supplement nonusers,Participants in an investigation of antioxidant intake and adult onset asthma in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,,,,ug/day,,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,237,Pearson,0.22,,,< 0.001,Yes,,,,Bodner 1998
6839,7418,7422,Supplement nonusers,Participants in an investigation of antioxidant intake and adult onset asthma in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,,,,ug/day,,,"Plasma, unspecified",HPLC,beta-Carotene,"",,,,umol/L,,237,Pearson,0.25,,,< 0.001,Yes,,,"Sex, BMI, Smoking status, Cholesterol, Triglycerides, Energy",Bodner 1998
6858,7438,7443,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,Fats from Dairy foods,,29.5,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.35,,,percentRoot,,81,Pearson,0.4,,,< 0.0001,Yes,,,,Wolk 1998
6859,7438,7444,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,Fats from Dairy foods,,29.5,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.24,,,percentRoot,,81,Pearson,0.23,,,< 0.05,Yes,,,,Wolk 1998
6860,7438,7445,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,Fats from Dairy foods,,29.5,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),0.58,,,percentRoot,,81,Pearson,0.38,,,< 0.0001,Yes,,,,Wolk 1998
6882,7438,7443,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,Fats from Dairy foods,,29.5,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.35,,,percentRoot,,81,Spearman,0.36,,,< 0.001,Yes,,,,Wolk 1998
6883,7438,7444,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,Fats from Dairy foods,,29.5,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.24,,,percentRoot,,81,Spearman,0.26,,,< 0.05,Yes,,,,Wolk 1998
6884,7438,7445,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,Fats from Dairy foods,,29.5,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),0.58,,,percentRoot,,81,Spearman,0.38,,,< 0.001,Yes,,,,Wolk 1998
6852,7449,7443,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.35,,,percentRoot,,81,Pearson,0.34,,,< 0.05,Yes,,,,Wolk 1998
6853,7449,7444,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.24,,,percentRoot,,81,Pearson,0.2,,,>= 0.05,No,,,,Wolk 1998
6854,7449,7445,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),0.58,,,percentRoot,,81,Pearson,0.32,,,< 0.05,Yes,,,,Wolk 1998
6876,7449,7443,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.35,,,percentRoot,,81,Spearman,0.29,,,< 0.05,Yes,,,,Wolk 1998
6877,7449,7444,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.24,,,percentRoot,,81,Spearman,0.2,,,>= 0.05,No,,,,Wolk 1998
6878,7449,7445,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),0.58,,,percentRoot,,81,Spearman,0.31,,,< 0.05,Yes,,,,Wolk 1998
6855,7450,7443,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.35,,,percentRoot,,81,Pearson,0.34,,,< 0.05,Yes,,,,Wolk 1998
6856,7450,7444,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.24,,,percentRoot,,81,Pearson,0.27,,,< 0.05,Yes,,,,Wolk 1998
6857,7450,7445,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),0.58,,,percentRoot,,81,Pearson,0.35,,,< 0.05,Yes,,,,Wolk 1998
6879,7450,7443,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.35,,,percentRoot,,81,Spearman,0.25,,,< 0.05,Yes,,,,Wolk 1998
6880,7450,7444,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.24,,,percentRoot,,81,Spearman,0.28,,,< 0.05,Yes,,,,Wolk 1998
6881,7450,7445,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),0.58,,,percentRoot,,81,Spearman,0.28,,,< 0.05,Yes,,,,Wolk 1998
6861,7451,7443,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.35,,,percentRoot,,81,Pearson,0.41,,,< 0.0001,Yes,,,,Wolk 1998
6862,7451,7444,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.24,,,percentRoot,,81,Pearson,0.25,,,< 0.05,Yes,,,,Wolk 1998
6863,7451,7445,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),0.58,,,percentRoot,,81,Pearson,0.39,,,< 0.001,Yes,,,,Wolk 1998
6885,7451,7443,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.35,,,percentRoot,,81,Spearman,0.36,,,< 0.001,Yes,,,,Wolk 1998
6886,7451,7444,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.24,,,percentRoot,,81,Spearman,0.26,,,< 0.05,Yes,,,,Wolk 1998
6887,7451,7445,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Food Frequency Questionnaire (FFQ),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),0.58,,,percentRoot,,81,Spearman,0.38,,,< 0.001,Yes,,,,Wolk 1998
6846,7428,7443,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,Fats from Dairy foods,,29.4,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.35,,,percentRoot,,81,Pearson,0.63,,,< 0.0001,Yes,,,,Wolk 1998
6847,7428,7444,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,Fats from Dairy foods,,29.4,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.24,,,percentRoot,,81,Pearson,0.42,,,< 0.0001,Yes,,,,Wolk 1998
6848,7428,7445,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,Fats from Dairy foods,,29.4,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),0.58,,,percentRoot,,81,Pearson,0.62,,,< 0.0001,Yes,,,,Wolk 1998
6870,7428,7443,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,Fats from Dairy foods,,29.4,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.35,,,percentRoot,,81,Spearman,0.59,,,< 0.0001,Yes,,,,Wolk 1998
6871,7428,7444,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,Fats from Dairy foods,,29.4,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.24,,,percentRoot,,81,Spearman,0.45,,,< 0.0001,Yes,,,,Wolk 1998
6872,7428,7445,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,Fats from Dairy foods,,29.4,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),0.58,,,percentRoot,,81,Spearman,0.6,,,< 0.0001,Yes,,,,Wolk 1998
6840,7446,7443,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.35,,,percentRoot,,81,Pearson,0.61,,,< 0.0001,Yes,,,,Wolk 1998
6841,7446,7444,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.24,,,percentRoot,,81,Pearson,0.35,,,< 0.001,Yes,,,,Wolk 1998
6842,7446,7445,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),0.58,,,percentRoot,,81,Pearson,0.58,,,< 0.0001,Yes,,,,Wolk 1998
6864,7446,7443,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.35,,,percentRoot,,81,Spearman,0.55,,,< 0.0001,Yes,,,,Wolk 1998
6865,7446,7444,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.24,,,percentRoot,,81,Spearman,0.42,,,< 0.0001,Yes,,,,Wolk 1998
6866,7446,7445,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),0.58,,,percentRoot,,81,Spearman,0.56,,,< 0.0001,Yes,,,,Wolk 1998
6843,7447,7443,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.35,,,percentRoot,,81,Pearson,0.16,,,>= 0.05,No,,,,Wolk 1998
6844,7447,7444,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.24,,,percentRoot,,81,Pearson,0.2,,,>= 0.05,No,,,,Wolk 1998
6845,7447,7445,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),0.58,,,percentRoot,,81,Pearson,0.19,,,>= 0.05,No,,,,Wolk 1998
6867,7447,7443,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.35,,,percentRoot,,81,Spearman,0.19,,,>= 0.05,No,,,,Wolk 1998
6868,7447,7444,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.24,,,percentRoot,,81,Spearman,0.2,,,>= 0.05,No,,,,Wolk 1998
6869,7447,7445,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),0.58,,,percentRoot,,81,Spearman,0.22,,,< 0.05,Yes,,,,Wolk 1998
6849,7448,7443,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.35,,,percentRoot,,81,Pearson,0.61,,,< 0.0001,Yes,,,,Wolk 1998
6850,7448,7444,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.24,,,percentRoot,,81,Pearson,0.4,,,< 0.001,Yes,,,,Wolk 1998
6851,7448,7445,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),0.58,,,percentRoot,,81,Pearson,0.6,,,< 0.0001,Yes,,,,Wolk 1998
6873,7448,7443,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Pentadecylic acid (15:0),"",0.35,,,percentRoot,,81,Spearman,0.57,,,< 0.0001,Yes,,,,Wolk 1998
6874,7448,7444,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Margaric acid (17:0),"",0.24,,,percentRoot,,81,Spearman,0.41,,,< 0.0001,Yes,,,,Wolk 1998
6875,7448,7445,All,Women in Uppsala county participant in a dietary validation study,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods + Ruminant meat,Fats from Ruminant meat + Fats from Dairy foods,,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Pentadecylic acid (15:0) + Margaric acid (17:0),0.58,,,percentRoot,,81,Spearman,0.57,,,< 0.0001,Yes,,,,Wolk 1998
6942,7459,7472,All,Men in Uppsala county participant in a prospective survey on risk factors for ischemic heart disease,Sweden,,,Dietary record (7-day),"Fatty acids, saturated (SFA)","",,14.9,,,percentEnergy,Energy,,"Serum (cholesterol esters), unspecified",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,62,Pearson,0.23,,,= 0.073,No,Energy by ?,,,Smedman 1999
6943,7461,7472,All,Men in Uppsala county participant in a prospective survey on risk factors for ischemic heart disease,Sweden,,,Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)","",,4.9,,,percentEnergy,Energy,,"Serum (cholesterol esters), unspecified",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,62,Pearson,-0.33,,,= 0.009,Yes,Energy by ?,,,Smedman 1999
6930,7464,7472,All,Men in Uppsala county participant in a prospective survey on risk factors for ischemic heart disease,Sweden,,,Dietary record (7-day),Fats from Milk,"",,5.2,,4.1,g/day,,,"Serum (cholesterol esters), unspecified",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,62,Spearman,0.26,,,= 0.039,Yes,Energy by ?,,,Smedman 1999
6936,7464,7485,All,Men in Uppsala county participant in a prospective survey on risk factors for ischemic heart disease,Sweden,,,Dietary record (7-day),Fats from Milk,"",,5.2,,4.1,g/day,,,"Serum (phospholipids), unspecified",GC-FID,Pentadecylic acid (15:0),"",0.25,,,percentRoot,,62,Spearman,0.34,,,= 0.008,Yes,Energy by ?,,,Smedman 1999
6931,7467,7472,All,Men in Uppsala county participant in a prospective survey on risk factors for ischemic heart disease,Sweden,,,Dietary record (7-day),Ice cream,"",,10.4,,0.0,g/day,,,"Serum (cholesterol esters), unspecified",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,62,Spearman,0.27,,,= 0.036,Yes,Energy by ?,,,Smedman 1999
6937,7467,7485,All,Men in Uppsala county participant in a prospective survey on risk factors for ischemic heart disease,Sweden,,,Dietary record (7-day),Ice cream,"",,10.4,,0.0,g/day,,,"Serum (phospholipids), unspecified",GC-FID,Pentadecylic acid (15:0),"",0.25,,,percentRoot,,62,Spearman,0.25,,,= 0.051,No,Energy by ?,,,Smedman 1999
6932,7468,7472,All,Men in Uppsala county participant in a prospective survey on risk factors for ischemic heart disease,Sweden,,,Dietary record (7-day),Fats from Ice cream,"",,1.2,,0.0,g/day,,,"Serum (cholesterol esters), unspecified",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,62,Spearman,0.27,,,= 0.036,Yes,Energy by ?,,,Smedman 1999
6938,7468,7485,All,Men in Uppsala county participant in a prospective survey on risk factors for ischemic heart disease,Sweden,,,Dietary record (7-day),Fats from Ice cream,"",,1.2,,0.0,g/day,,,"Serum (phospholipids), unspecified",GC-FID,Pentadecylic acid (15:0),"",0.25,,,percentRoot,,62,Spearman,0.26,,,= 0.041,Yes,Energy by ?,,,Smedman 1999
6933,7469,7472,All,Men in Uppsala county participant in a prospective survey on risk factors for ischemic heart disease,Sweden,,,Dietary record (7-day),Butter,"",,7.6,,0.0,g/day,,,"Serum (cholesterol esters), unspecified",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,62,Spearman,0.36,,,= 0.004,Yes,Energy by ?,,,Smedman 1999
6939,7469,7485,All,Men in Uppsala county participant in a prospective survey on risk factors for ischemic heart disease,Sweden,,,Dietary record (7-day),Butter,"",,7.6,,0.0,g/day,,,"Serum (phospholipids), unspecified",GC-FID,Pentadecylic acid (15:0),"",0.25,,,percentRoot,,62,Spearman,0.25,,,= 0.051,No,Energy by ?,,,Smedman 1999
6934,7470,7472,All,Men in Uppsala county participant in a prospective survey on risk factors for ischemic heart disease,Sweden,,,Dietary record (7-day),Fats from Butter,"",,6.1,,0.0,g/day,,,"Serum (cholesterol esters), unspecified",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,62,Spearman,0.36,,,= 0.004,Yes,Energy by ?,,,Smedman 1999
6940,7470,7485,All,Men in Uppsala county participant in a prospective survey on risk factors for ischemic heart disease,Sweden,,,Dietary record (7-day),Fats from Butter,"",,6.1,,0.0,g/day,,,"Serum (phospholipids), unspecified",GC-FID,Pentadecylic acid (15:0),"",0.25,,,percentRoot,,62,Spearman,0.25,,,= 0.051,No,Energy by ?,,,Smedman 1999
6935,7471,7472,All,Men in Uppsala county participant in a prospective survey on risk factors for ischemic heart disease,Sweden,,,Dietary record (7-day),Fats from Dairy foods,Fats from Cheese + Fats from Milk + Fats from Ice cream + Fats from Butter,,20.3,,16.7,g/day,,,"Serum (cholesterol esters), unspecified",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,62,Spearman,0.46,,,< 0.0001,Yes,Energy by ?,,,Smedman 1999
6941,7471,7485,All,Men in Uppsala county participant in a prospective survey on risk factors for ischemic heart disease,Sweden,,,Dietary record (7-day),Fats from Dairy foods,Fats from Cheese + Fats from Milk + Fats from Ice cream + Fats from Butter,,20.3,,16.7,g/day,,,"Serum (phospholipids), unspecified",GC-FID,Pentadecylic acid (15:0),"",0.25,,,percentRoot,,62,Spearman,0.34,,,= 0.008,Yes,Energy by ?,,,Smedman 1999
6944,7498,7472,All,Men in Uppsala county participant in a prospective survey on risk factors for ischemic heart disease,Sweden,,,Dietary record (7-day),"Fatty acids, short-chain",Butyric acid (4:0) + Caproic acid (6:0) + Caprylic acid (8:0) + Capric acid (10:0),,,,,g/day,,,"Serum (cholesterol esters), unspecified",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,62,Pearson,0.38,,,= 0.002,Yes,Energy by ?,,,Smedman 1999
6947,7498,7485,All,Men in Uppsala county participant in a prospective survey on risk factors for ischemic heart disease,Sweden,,,Dietary record (7-day),"Fatty acids, short-chain",Butyric acid (4:0) + Caproic acid (6:0) + Caprylic acid (8:0) + Capric acid (10:0),,,,,g/day,,,"Serum (phospholipids), unspecified",GC-FID,Pentadecylic acid (15:0),"",0.25,,,percentRoot,,62,Pearson,0.29,,,= 0.026,Yes,Energy by ?,,,Smedman 1999
6945,7499,7472,All,Men in Uppsala county participant in a prospective survey on risk factors for ischemic heart disease,Sweden,,,Dietary record (7-day),Myristic acid (14:0),"",,,,,g/day,,,"Serum (cholesterol esters), unspecified",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,62,Pearson,0.35,,,= 0.006,Yes,Energy by ?,,,Smedman 1999
6948,7499,7485,All,Men in Uppsala county participant in a prospective survey on risk factors for ischemic heart disease,Sweden,,,Dietary record (7-day),Myristic acid (14:0),"",,,,,g/day,,,"Serum (phospholipids), unspecified",GC-FID,Pentadecylic acid (15:0),"",0.25,,,percentRoot,,62,Pearson,0.26,,,= 0.045,Yes,Energy by ?,,,Smedman 1999
6946,7500,7472,All,Men in Uppsala county participant in a prospective survey on risk factors for ischemic heart disease,Sweden,,,Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,,,,g/day,,,"Serum (cholesterol esters), unspecified",GC-FID,Pentadecylic acid (15:0),"",0.22,,,percentRoot,,62,Pearson,-0.24,,,= 0.056,No,Energy by ?,,,Smedman 1999
6949,7549,7539,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,110,Pearson,0.36,,,< 0.05,Yes,,,,Michaud 1998
6954,7549,7539,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,110,Pearson,0.37,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
6959,7549,7539,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,110,Pearson,0.36,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
6964,7549,7539,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,110,Pearson,0.36,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
6950,7550,7540,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,110,Pearson,0.21,,,< 0.05,Yes,,,,Michaud 1998
6955,7550,7540,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,110,Pearson,0.28,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
6960,7550,7540,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,110,Pearson,0.25,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
6965,7550,7540,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,110,Pearson,0.3,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
6951,7551,7541,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,110,Pearson,0.27,,,< 0.05,Yes,,,,Michaud 1998
6956,7551,7541,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,110,Pearson,0.35,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
6961,7551,7541,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,110,Pearson,0.31,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
6966,7551,7541,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,110,Pearson,0.39,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
6952,7552,7542,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Lutein,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,110,Pearson,0.29,,,< 0.05,Yes,,,,Michaud 1998
6957,7552,7542,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Lutein,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,110,Pearson,0.33,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
6962,7552,7542,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Lutein,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,110,Pearson,0.31,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
6967,7552,7542,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Lutein,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,110,Pearson,0.35,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
6953,7553,7543,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,110,Pearson,0.28,,,< 0.05,Yes,,,,Michaud 1998
6958,7553,7543,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,110,Pearson,0.3,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
6963,7553,7543,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,110,Pearson,0.28,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
6968,7553,7543,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,110,Pearson,0.3,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
6989,7554,7539,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,110,Pearson,0.5,,,< 0.05,Yes,,,,Michaud 1998
6994,7554,7539,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,110,Pearson,0.47,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
6999,7554,7539,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,110,Pearson,0.5,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
7004,7554,7539,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,110,Pearson,0.48,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
6990,7555,7540,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,110,Pearson,0.21,,,< 0.05,Yes,,,,Michaud 1998
6995,7555,7540,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,110,Pearson,0.29,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7000,7555,7540,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,110,Pearson,0.25,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
7005,7555,7540,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,110,Pearson,0.31,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
6991,7556,7541,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,110,Pearson,0.3,,,< 0.05,Yes,,,,Michaud 1998
6996,7556,7541,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,110,Pearson,0.35,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7001,7556,7541,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,110,Pearson,0.35,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
7006,7556,7541,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,110,Pearson,0.4,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
6992,7557,7542,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Lutein,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,110,Pearson,0.39,,,< 0.05,Yes,,,,Michaud 1998
6997,7557,7542,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Lutein,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,110,Pearson,0.46,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7002,7557,7542,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Lutein,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,110,Pearson,0.39,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
7007,7557,7542,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Lutein,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,110,Pearson,0.46,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
6993,7558,7543,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,110,Pearson,0.31,,,< 0.05,Yes,,,,Michaud 1998
6998,7558,7543,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,110,Pearson,0.36,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7003,7558,7543,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,110,Pearson,0.33,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
7008,7558,7543,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,110,Pearson,0.38,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7029,7559,7539,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,110,Pearson,0.5,,,< 0.05,Yes,,,,Michaud 1998
7034,7559,7539,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,110,Pearson,0.47,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7039,7559,7539,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,110,Pearson,0.48,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
7044,7559,7539,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,110,Pearson,0.47,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7030,7560,7540,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,110,Pearson,0.24,,,< 0.05,Yes,,,,Michaud 1998
7035,7560,7540,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,110,Pearson,0.32,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7040,7560,7540,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,110,Pearson,0.28,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
7045,7560,7540,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,110,Pearson,0.35,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7031,7561,7541,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,110,Pearson,0.31,,,< 0.05,Yes,,,,Michaud 1998
7036,7561,7541,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,110,Pearson,0.39,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7041,7561,7541,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,110,Pearson,0.37,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
7046,7561,7541,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,110,Pearson,0.43,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7032,7562,7542,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Lutein,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,110,Pearson,0.38,,,< 0.05,Yes,,,,Michaud 1998
7037,7562,7542,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Lutein,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,110,Pearson,0.45,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7042,7562,7542,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Lutein,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,110,Pearson,0.4,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
7047,7562,7542,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Lutein,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,110,Pearson,0.47,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7033,7563,7543,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,110,Pearson,0.34,,,< 0.05,Yes,,,,Michaud 1998
7038,7563,7543,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,110,Pearson,0.38,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7043,7563,7543,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,110,Pearson,0.36,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
7048,7563,7543,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,110,Pearson,0.4,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7069,7579,7539,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Fruits,"",,2.91,,,servings/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,110,Pearson,0.26,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7070,7579,7540,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Fruits,"",,2.91,,,servings/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,110,Pearson,0.26,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7071,7579,7541,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Fruits,"",,2.91,,,servings/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,110,Pearson,0.43,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7072,7579,7542,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Fruits,"",,2.91,,,servings/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,110,Pearson,-0.02,,,>= 0.05,No,"Lipids, Age, BMI",,,Michaud 1998
7073,7579,7543,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Fruits,"",,2.91,,,servings/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,110,Pearson,0.21,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7074,7580,7539,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Vegetables,"",,3.51,,,servings/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,110,Pearson,0.35,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7075,7580,7540,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Vegetables,"",,3.51,,,servings/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,110,Pearson,0.29,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7076,7580,7541,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Vegetables,"",,3.51,,,servings/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,110,Pearson,0.12,,,>= 0.05,No,"Lipids, Age, BMI",,,Michaud 1998
7077,7580,7542,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Vegetables,"",,3.51,,,servings/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,110,Pearson,0.26,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7078,7580,7543,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Vegetables,"",,3.51,,,servings/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,110,Pearson,0.3,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7079,7581,7539,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,6.43,,,servings/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,110,Pearson,0.4,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7080,7581,7540,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,6.43,,,servings/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,110,Pearson,0.35,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7081,7581,7541,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,6.43,,,servings/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,110,Pearson,0.36,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7082,7581,7542,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,6.43,,,servings/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,110,Pearson,0.16,,,>= 0.05,No,"Lipids, Age, BMI",,,Michaud 1998
7083,7581,7543,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,6.43,,,servings/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,110,Pearson,0.33,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7099,7585,7539,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Dietary record (7-day),Fruits,"",,2.33,,,servings/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,110,Pearson,0.35,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7100,7585,7540,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Dietary record (7-day),Fruits,"",,2.33,,,servings/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,110,Pearson,0.37,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7101,7585,7541,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Dietary record (7-day),Fruits,"",,2.33,,,servings/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,110,Pearson,0.47,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7102,7585,7542,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Dietary record (7-day),Fruits,"",,2.33,,,servings/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,110,Pearson,0.18,,,>= 0.05,No,"Lipids, Age, BMI",,,Michaud 1998
7103,7585,7543,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Dietary record (7-day),Fruits,"",,2.33,,,servings/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,110,Pearson,0.26,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7104,7586,7539,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Dietary record (7-day),Vegetables,"",,2.34,,,servings/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,110,Pearson,0.36,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7105,7586,7540,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Dietary record (7-day),Vegetables,"",,2.34,,,servings/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,110,Pearson,0.42,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7106,7586,7541,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Dietary record (7-day),Vegetables,"",,2.34,,,servings/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,110,Pearson,0.17,,,>= 0.05,No,"Lipids, Age, BMI",,,Michaud 1998
7107,7586,7542,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Dietary record (7-day),Vegetables,"",,2.34,,,servings/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,110,Pearson,0.2,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7108,7586,7543,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Dietary record (7-day),Vegetables,"",,2.34,,,servings/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,110,Pearson,0.33,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7109,7587,7539,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Dietary record (7-day),Fruits + Vegetables,Fruits + Vegetables,,4.67,,,servings/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,110,Pearson,0.42,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7110,7587,7540,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Dietary record (7-day),Fruits + Vegetables,Fruits + Vegetables,,4.67,,,servings/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,110,Pearson,0.46,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7111,7587,7541,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Dietary record (7-day),Fruits + Vegetables,Fruits + Vegetables,,4.67,,,servings/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,110,Pearson,0.39,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7112,7587,7542,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Dietary record (7-day),Fruits + Vegetables,Fruits + Vegetables,,4.67,,,servings/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,110,Pearson,0.22,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7113,7587,7543,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Dietary record (7-day),Fruits + Vegetables,Fruits + Vegetables,,4.67,,,servings/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,110,Pearson,0.35,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
6969,7564,7544,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,162,Pearson,0.35,,,< 0.05,Yes,,,,Michaud 1998
6974,7564,7544,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,162,Pearson,0.38,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
6979,7564,7544,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,162,Pearson,0.38,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
6984,7564,7544,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,162,Pearson,0.4,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
6970,7565,7545,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,162,Pearson,0.18,,,< 0.05,Yes,,,,Michaud 1998
6975,7565,7545,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,162,Pearson,0.2,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
6980,7565,7545,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,162,Pearson,0.2,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
6985,7565,7545,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,162,Pearson,0.21,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
6971,7566,7546,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,162,Pearson,0.37,,,< 0.05,Yes,,,,Michaud 1998
6976,7566,7546,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,162,Pearson,0.32,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
6981,7566,7546,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,162,Pearson,0.36,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
6986,7566,7546,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,162,Pearson,0.29,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
6972,7567,7547,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Lutein,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,162,Pearson,0.19,,,< 0.05,Yes,,,,Michaud 1998
6977,7567,7547,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Lutein,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,162,Pearson,0.16,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
6982,7567,7547,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Lutein,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,162,Pearson,0.19,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
6987,7567,7547,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Lutein,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,162,Pearson,0.18,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
6973,7568,7548,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,162,Pearson,0.29,,,< 0.05,Yes,,,,Michaud 1998
6978,7568,7548,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,162,Pearson,0.29,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
6983,7568,7548,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,162,Pearson,0.25,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
6988,7568,7548,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,162,Pearson,0.27,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7009,7569,7544,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,162,Pearson,0.45,,,< 0.05,Yes,,,,Michaud 1998
7014,7569,7544,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,162,Pearson,0.44,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7019,7569,7544,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,162,Pearson,0.48,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
7024,7569,7544,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,162,Pearson,0.47,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7010,7570,7545,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,162,Pearson,0.28,,,< 0.05,Yes,,,,Michaud 1998
7015,7570,7545,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,162,Pearson,0.28,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7020,7570,7545,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,162,Pearson,0.31,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
7025,7570,7545,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,162,Pearson,0.3,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7011,7571,7546,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,162,Pearson,0.41,,,< 0.05,Yes,,,,Michaud 1998
7016,7571,7546,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,162,Pearson,0.34,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7021,7571,7546,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,162,Pearson,0.39,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
7026,7571,7546,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,162,Pearson,0.31,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7012,7572,7547,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Lutein,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,162,Pearson,0.19,,,< 0.05,Yes,,,,Michaud 1998
7017,7572,7547,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Lutein,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,162,Pearson,0.17,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7022,7572,7547,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Lutein,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,162,Pearson,0.19,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
7027,7572,7547,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Lutein,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,162,Pearson,0.18,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7013,7573,7548,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,162,Pearson,0.23,,,< 0.05,Yes,,,,Michaud 1998
7018,7573,7548,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,162,Pearson,0.22,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7023,7573,7548,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,162,Pearson,0.22,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
7028,7573,7548,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,162,Pearson,0.23,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7049,7574,7544,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,162,Pearson,0.44,,,< 0.05,Yes,,,,Michaud 1998
7054,7574,7544,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,162,Pearson,0.45,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7059,7574,7544,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,162,Pearson,0.47,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
7064,7574,7544,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,162,Pearson,0.48,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7050,7575,7545,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,162,Pearson,0.24,,,< 0.05,Yes,,,,Michaud 1998
7055,7575,7545,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,162,Pearson,0.3,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7060,7575,7545,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,162,Pearson,0.27,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
7065,7575,7545,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,162,Pearson,0.27,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7051,7576,7546,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,162,Pearson,0.43,,,< 0.05,Yes,,,,Michaud 1998
7056,7576,7546,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,162,Pearson,0.35,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7061,7576,7546,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,162,Pearson,0.41,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
7066,7576,7546,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,162,Pearson,0.32,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7052,7577,7547,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Lutein,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,162,Pearson,0.22,,,< 0.05,Yes,,,,Michaud 1998
7057,7577,7547,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Lutein,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,162,Pearson,0.19,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7062,7577,7547,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Lutein,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,162,Pearson,0.22,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
7067,7577,7547,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Lutein,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,162,Pearson,0.21,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7053,7578,7548,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,162,Pearson,0.28,,,< 0.05,Yes,,,,Michaud 1998
7058,7578,7548,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,162,Pearson,0.27,,,< 0.05,Yes,"Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7063,7578,7548,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,162,Pearson,0.26,,,< 0.05,Yes,Energy by residual method,,,Michaud 1998
7068,7578,7548,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Lycopene,"",,,,,mg/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,162,Pearson,0.27,,,< 0.05,Yes,"Energy by residual method, Cholesterol, Triglycerides, Age, BMI",,,Michaud 1998
7084,7582,7544,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Fruits,"",,2.55,,,servings/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,162,Pearson,0.13,,,>= 0.05,No,"Lipids, Age, BMI",,,Michaud 1998
7085,7582,7545,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Fruits,"",,2.55,,,servings/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,162,Pearson,0.2,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7086,7582,7546,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Fruits,"",,2.55,,,servings/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,162,Pearson,0.11,,,>= 0.05,No,"Lipids, Age, BMI",,,Michaud 1998
7087,7582,7547,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Fruits,"",,2.55,,,servings/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,162,Pearson,-0.02,,,>= 0.05,No,"Lipids, Age, BMI",,,Michaud 1998
7088,7582,7548,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Fruits,"",,2.55,,,servings/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,162,Pearson,0.05,,,>= 0.05,No,"Lipids, Age, BMI",,,Michaud 1998
7089,7583,7544,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Vegetables,"",,3.42,,,servings/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,162,Pearson,0.23,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7090,7583,7545,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Vegetables,"",,3.42,,,servings/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,162,Pearson,0.16,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7091,7583,7546,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Vegetables,"",,3.42,,,servings/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,162,Pearson,-0.02,,,>= 0.05,No,"Lipids, Age, BMI",,,Michaud 1998
7092,7583,7547,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Vegetables,"",,3.42,,,servings/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,162,Pearson,0.17,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7093,7583,7548,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Vegetables,"",,3.42,,,servings/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,162,Pearson,0.16,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7094,7584,7544,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,5.98,,,servings/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,mg/dL,,162,Pearson,0.22,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7095,7584,7545,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,5.98,,,servings/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,mg/dL,,162,Pearson,0.18,,,< 0.05,Yes,"Lipids, Age, BMI",,,Michaud 1998
7096,7584,7546,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,5.98,,,servings/day,,,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",,,,mg/dL,,162,Pearson,0.05,,,>= 0.05,No,"Lipids, Age, BMI",,,Michaud 1998
7097,7584,7547,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,5.98,,,servings/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,mg/dL,,162,Pearson,0.11,,,>= 0.05,No,"Lipids, Age, BMI",,,Michaud 1998
7098,7584,7548,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,5.98,,,servings/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,mg/dL,,162,Pearson,0.13,,,>= 0.05,No,"Lipids, Age, BMI",,,Michaud 1998
7117,7628,7649,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",Yes,,,16.8,g/day,,,"Adipose tissue, buttocks",GC-FID,Palmitic acid (16:0),"",,,21.4,percentRoot,,119,Spearman,0.1,-0.08,0.28,>= 0.05,No,,,,Andersen 1999
7138,7628,7660,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",Yes,,,16.8,g/day,,,"Serum, fasting",GC-FID,Palmitic acid (16:0),"",,,21.6,percentRoot,,135,Spearman,-0.08,-0.25,0.09,>= 0.05,No,,,,Andersen 1999
7118,7629,7650,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",Yes,,,26.2,g/day,,,"Adipose tissue, buttocks",GC-FID,Oleic acid (cis-18:1n-9),"",,,41.5,percentRoot,,119,Spearman,-0.15,-0.32,0.03,>= 0.05,No,,,,Andersen 1999
7139,7629,7661,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",Yes,,,26.2,g/day,,,"Serum, fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,19.7,percentRoot,,135,Spearman,-0.13,-0.29,0.04,>= 0.05,No,,,,Andersen 1999
7119,7630,7651,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",Yes,,,12.8,g/day,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,13.4,percentRoot,,119,Spearman,0.31,0.14,0.46,< 0.001,Yes,,,,Andersen 1999
7140,7630,7662,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",Yes,,,12.8,g/day,,,"Serum, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,30.2,percentRoot,,135,Spearman,0.18,0.01,0.34,>= 0.05,No,,,,Andersen 1999
7120,7631,7652,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",Yes,,,1.57,g/day,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,0.82,percentRoot,,119,Spearman,0.36,0.19,0.51,< 0.001,Yes,,,,Andersen 1999
7141,7631,7663,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",Yes,,,1.57,g/day,,,"Serum, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,0.62,percentRoot,,135,Spearman,0.31,0.15,0.46,< 0.001,Yes,,,,Andersen 1999
7121,7632,7653,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",Yes,,,0.28,g/day,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",,,0.09,percentRoot,,119,Spearman,0.45,0.29,0.58,< 0.001,Yes,,,,Andersen 1999
7142,7632,7664,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",Yes,,,0.28,g/day,,,"Serum, fasting",GC-FID,EPA (cis-20:5n-3),"",,,1.17,percentRoot,,135,Spearman,0.5,0.36,0.62,< 0.001,Yes,,,,Andersen 1999
7122,7633,7654,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),DPA (cis-22:5n-3),"",Yes,,,0.07,g/day,,,"Adipose tissue, buttocks",GC-FID,DPA (cis-22:5n-3),"",,,0.24,percentRoot,,119,Spearman,0.26,0.08,0.42,< 0.001,Yes,,,,Andersen 1999
7143,7633,7665,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),DPA (cis-22:5n-3),"",Yes,,,0.07,g/day,,,"Serum, fasting",GC-FID,DPA (cis-22:5n-3),"",,,0.62,percentRoot,,135,Spearman,0.35,0.19,0.49,< 0.001,Yes,,,,Andersen 1999
7123,7634,7655,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",Yes,,,0.46,g/day,,,"Adipose tissue, buttocks",GC-FID,DHA (cis-22:6n-3),"",,,0.24,percentRoot,,119,Spearman,0.43,0.27,0.57,< 0.001,Yes,,,,Andersen 1999
7144,7634,7666,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",Yes,,,0.46,g/day,,,"Serum, fasting",GC-FID,DHA (cis-22:6n-3),"",,,2.91,percentRoot,,135,Spearman,0.49,0.35,0.61,< 0.001,Yes,,,,Andersen 1999
7124,7635,7656,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",Yes,,,11.3,mg/day,,,"Adipose tissue, buttocks",HPLC,alpha-Tocopherol,"",,,420.6,ug/g,Fatty acids,119,Spearman,-0.05,-0.23,0.13,>= 0.05,No,,,,Andersen 1999
7145,7635,7667,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",Yes,,,11.3,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",,,24.5,umol/L,,135,Spearman,-0.1,-0.26,0.07,>= 0.05,No,,,,Andersen 1999
7114,7636,7646,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0),Yes,,,38.3,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0),,,29.9,percentRoot,,119,Spearman,0.21,0.04,0.38,< 0.05,Yes,,,,Andersen 1999
7125,7636,7646,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0),Yes,,,38.3,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0),,,29.9,percentRoot,,119,Spearman,0.18,0.0,0.35,>= 0.05,No,,,,Andersen 1999
7135,7636,7657,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0),Yes,,,38.3,percentRoot,,,"Serum, fasting",GC-FID,"Fatty acids, saturated (SFA)",Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Arachidic acid (20:0) + Behenic acid (22:0),,,30.8,percentRoot,,135,Spearman,-0.05,-0.22,0.12,>= 0.05,No,,,,Andersen 1999
7146,7636,7657,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0),Yes,,,38.3,percentRoot,,,"Serum, fasting",GC-FID,"Fatty acids, saturated (SFA)",Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Arachidic acid (20:0) + Behenic acid (22:0),,,30.8,percentRoot,,135,Spearman,0.23,0.06,0.38,< 0.01,Yes,,,,Andersen 1999
7115,7637,7647,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),Yes,,,35.5,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + trans-Octadecenoic acids (trans-18:1) + Oleic acid (cis-18:1n-9) + cis-Tetradecenoic acids (cis-14:1) + cis-Heptadecenoic acids (cis-17:1) + Asclepic acid (cis-18:1n-7) + cis-Eicosenoic acids (cis-20:1) + trans-Hexadecenoic acids (trans-16:1) + trans-Eicosenoic acids (trans-20:1) + trans-Docosenoic acids (trans-22:1) + 7Z-Hexadecenoic acid (cis-16:1n-9),,,51.4,percentRoot,,119,Spearman,-0.21,-0.38,-0.03,< 0.05,Yes,,,,Andersen 1999
7126,7637,7647,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),Yes,,,35.5,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + trans-Octadecenoic acids (trans-18:1) + Oleic acid (cis-18:1n-9) + cis-Tetradecenoic acids (cis-14:1) + cis-Heptadecenoic acids (cis-17:1) + Asclepic acid (cis-18:1n-7) + cis-Eicosenoic acids (cis-20:1) + trans-Hexadecenoic acids (trans-16:1) + trans-Eicosenoic acids (trans-20:1) + trans-Docosenoic acids (trans-22:1) + 7Z-Hexadecenoic acid (cis-16:1n-9),,,51.4,percentRoot,,119,Spearman,0.11,-0.07,0.28,>= 0.05,No,,,,Andersen 1999
7136,7637,7658,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),Yes,,,35.5,percentRoot,,,"Serum, fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + trans-Octadecenoic acids (trans-18:1) + Oleic acid (cis-18:1n-9) + cis-Heptadecenoic acids (cis-17:1) + Asclepic acid (cis-18:1n-7) + cis-Eicosenoic acids (cis-20:1) + trans-Hexadecenoic acids (trans-16:1) + 7Z-Hexadecenoic acid (cis-16:1n-9),,,24.7,percentRoot,,135,Spearman,-0.1,-0.26,0.07,>= 0.05,No,,,,Andersen 1999
7147,7637,7658,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),Yes,,,35.5,percentRoot,,,"Serum, fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + trans-Octadecenoic acids (trans-18:1) + Oleic acid (cis-18:1n-9) + cis-Heptadecenoic acids (cis-17:1) + Asclepic acid (cis-18:1n-7) + cis-Eicosenoic acids (cis-20:1) + trans-Hexadecenoic acids (trans-16:1) + 7Z-Hexadecenoic acid (cis-16:1n-9),,,24.7,percentRoot,,135,Spearman,0.08,-0.09,0.25,>= 0.05,No,,,,Andersen 1999
7116,7638,7648,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6),Yes,,,18.4,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6),,,15.4,percentRoot,,119,Spearman,0.26,0.08,0.42,< 0.01,Yes,,,,Andersen 1999
7127,7638,7648,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6),Yes,,,18.4,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6),,,15.4,percentRoot,,119,Spearman,0.34,0.17,0.49,< 0.001,Yes,,,,Andersen 1999
7137,7638,7659,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6),Yes,,,18.4,percentRoot,,,"Serum, fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,,44.6,percentRoot,,135,Spearman,0.15,-0.02,0.31,>= 0.05,No,,,,Andersen 1999
7148,7638,7659,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6),Yes,,,18.4,percentRoot,,,"Serum, fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),,,44.6,percentRoot,,135,Spearman,0.2,0.03,0.36,< 0.05,Yes,,,,Andersen 1999
7128,7639,7649,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",Yes,,,18.7,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitic acid (16:0),"",,,21.4,percentRoot,,119,Spearman,0.12,-0.06,0.3,>= 0.05,No,,,,Andersen 1999
7149,7639,7660,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",Yes,,,18.7,percentRoot,,,"Serum, fasting",GC-FID,Palmitic acid (16:0),"",,,21.6,percentRoot,,135,Spearman,0.11,-0.06,0.27,>= 0.05,No,,,,Andersen 1999
7129,7640,7650,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",Yes,,,29.5,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Oleic acid (cis-18:1n-9),"",,,41.5,percentRoot,,119,Spearman,0.18,0.0,0.35,>= 0.05,No,,,,Andersen 1999
7150,7640,7661,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",Yes,,,29.5,percentRoot,,,"Serum, fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,19.7,percentRoot,,135,Spearman,0.09,-0.08,0.26,>= 0.05,No,,,,Andersen 1999
7130,7641,7651,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",Yes,,,14.2,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,13.4,percentRoot,,119,Spearman,0.38,0.22,0.52,< 0.001,Yes,,,,Andersen 1999
7151,7641,7662,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",Yes,,,14.2,percentRoot,,,"Serum, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,30.2,percentRoot,,135,Spearman,0.16,-0.01,0.32,>= 0.05,No,,,,Andersen 1999
7131,7642,7652,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",Yes,,,1.81,percentRoot,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,0.82,percentRoot,,119,Spearman,0.42,0.26,0.56,< 0.001,Yes,,,,Andersen 1999
7152,7642,7663,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",Yes,,,1.81,percentRoot,,,"Serum, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,0.62,percentRoot,,135,Spearman,0.28,0.12,0.43,< 0.001,Yes,,,,Andersen 1999
7132,7643,7653,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",Yes,,,0.27,percentRoot,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",,,0.09,percentRoot,,119,Spearman,0.52,0.38,0.64,< 0.001,Yes,,,,Andersen 1999
7153,7643,7664,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",Yes,,,0.27,percentRoot,,,"Serum, fasting",GC-FID,EPA (cis-20:5n-3),"",,,1.17,percentRoot,,135,Spearman,0.51,0.37,0.63,< 0.001,Yes,,,,Andersen 1999
7133,7644,7654,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),DPA (cis-22:5n-3),"",Yes,,,0.07,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DPA (cis-22:5n-3),"",,,0.24,percentRoot,,119,Spearman,0.39,0.23,0.53,< 0.001,Yes,,,,Andersen 1999
7154,7644,7665,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),DPA (cis-22:5n-3),"",Yes,,,0.07,percentRoot,,,"Serum, fasting",GC-FID,DPA (cis-22:5n-3),"",,,0.62,percentRoot,,135,Spearman,0.38,0.23,0.52,< 0.001,Yes,,,,Andersen 1999
7134,7645,7655,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",Yes,,,0.43,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DHA (cis-22:6n-3),"",,,0.24,percentRoot,,119,Spearman,0.49,0.34,0.62,< 0.001,Yes,,,,Andersen 1999
7155,7645,7666,All,Men from Oerland military flight station,Norway,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",Yes,,,0.43,percentRoot,,,"Serum, fasting",GC-FID,DHA (cis-22:6n-3),"",,,2.91,percentRoot,,135,Spearman,0.52,0.39,0.63,< 0.001,Yes,,,,Andersen 1999
7157,7672,7711,All,Men in Uppsala county,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,25.2,,,g/day,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Stearic acid (18:0),"",3.9,,,percentRoot,,103,Spearman,0.11,,,>= 0.05,No,,,,Jiang 1999
7158,7672,7712,All,Men in Uppsala county,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,25.2,,,g/day,,,"Adipose tissue (triglycerides), buttocks",GC-FID,trans-Octadecenoic acids (trans-18:1),"",2.2,,,percentRoot,,103,Spearman,-0.02,,,>= 0.05,No,,,,Jiang 1999
7159,7672,7713,All,Men in Uppsala county,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,25.2,,,g/day,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Oleic acid (cis-18:1n-9),"",46.5,,,percentRoot,,103,Spearman,-0.19,,,>= 0.05,No,,,,Jiang 1999
7160,7672,7714,All,Men in Uppsala county,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,25.2,,,g/day,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",10.8,,,percentRoot,,103,Spearman,-0.46,,,< 0.001,Yes,,,,Jiang 1999
7161,7672,7715,All,Men in Uppsala county,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,25.2,,,g/day,,,"Adipose tissue (triglycerides), buttocks",GC-FID,cis-Linolenic acids (cis-18:3),"",1.7,,,percentRoot,,103,Spearman,-0.22,,,< 0.05,Yes,,,,Jiang 1999
7162,7672,7716,All,Men in Uppsala county,Sweden,,,Weighed Dietary record (7-day),Fats from Dairy foods,"",,25.2,,,g/day,,,"Adipose tissue (triglycerides), buttocks",GC-FID,"Rumenic acid (9cis,11trans-18:2n-7)","",0.5,,,percentRoot,,103,Spearman,0.42,,,< 0.001,Yes,,,,Jiang 1999
7163,7689,7711,All,Men in Uppsala county,Sweden,,,24-h Dietary recall (7-day),Fats from Dairy foods,"",,24.4,,,g/day,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Stearic acid (18:0),"",3.9,,,percentRoot,,123,Spearman,0.17,,,>= 0.05,No,,,,Jiang 1999
7164,7689,7712,All,Men in Uppsala county,Sweden,,,24-h Dietary recall (7-day),Fats from Dairy foods,"",,24.4,,,g/day,,,"Adipose tissue (triglycerides), buttocks",GC-FID,trans-Octadecenoic acids (trans-18:1),"",2.2,,,percentRoot,,123,Spearman,-0.08,,,>= 0.05,No,,,,Jiang 1999
7165,7689,7713,All,Men in Uppsala county,Sweden,,,24-h Dietary recall (7-day),Fats from Dairy foods,"",,24.4,,,g/day,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Oleic acid (cis-18:1n-9),"",46.5,,,percentRoot,,123,Spearman,-0.23,,,< 0.05,Yes,,,,Jiang 1999
7166,7689,7714,All,Men in Uppsala county,Sweden,,,24-h Dietary recall (7-day),Fats from Dairy foods,"",,24.4,,,g/day,,,"Adipose tissue (triglycerides), buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",10.8,,,percentRoot,,123,Spearman,-0.45,,,< 0.001,Yes,,,,Jiang 1999
7167,7689,7715,All,Men in Uppsala county,Sweden,,,24-h Dietary recall (7-day),Fats from Dairy foods,"",,24.4,,,g/day,,,"Adipose tissue (triglycerides), buttocks",GC-FID,cis-Linolenic acids (cis-18:3),"",1.7,,,percentRoot,,123,Spearman,-0.15,,,>= 0.05,No,,,,Jiang 1999
7168,7689,7716,All,Men in Uppsala county,Sweden,,,24-h Dietary recall (7-day),Fats from Dairy foods,"",,24.4,,,g/day,,,"Adipose tissue (triglycerides), buttocks",GC-FID,"Rumenic acid (9cis,11trans-18:2n-7)","",0.5,,,percentRoot,,123,Spearman,0.35,,,< 0.001,Yes,,,,Jiang 1999
7169,7718,7721,All [by gender],Adults,"Korea, Republic of",,,Food Frequency Questionnaire (FFQ),Iodine,"",,478.6,,,ug/day,,,"Urine, 24-h",Ion selective electrode (ISE),Iodine,"",673.6,,,ug/g,Creatinine,278,Pearson,0.6,,,< 0.01,Yes,,,,Kim 1998
7170,7853,7856,All [by ethnicity],Women from two large mammography clinics in Honolulu,United States,,baseline,Diet History Questionnaire (DHQ),Proteins from Soy foods,"",,,,,g/day,,1 day,"Urine, overnight",HPLC after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin,,,,nmol/h,,102,Spearman,0.32,,,= 0.0012,Yes,,,,Maskarinec 1998
7172,7855,7856,All [by ethnicity],Women from two large mammography clinics in Honolulu,United States,,baseline,Diet History Questionnaire (DHQ),Isoflavones,"",,,,,mg/day,,1 day,"Urine, overnight",HPLC after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin,,,,nmol/h,,102,Spearman,0.31,,,= 0.0016,Yes,,,,Maskarinec 1998
7171,7852,7856,All [by ethnicity],Women from two large mammography clinics in Honolulu,United States,,baseline,Diet History Questionnaire (DHQ),Proteins from Soy foods,"",,,,,g/day,,1 day,"Urine, overnight",HPLC after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin,,,,nmol/h,,102,Spearman,0.61,,,= 0.0001,Yes,,,,Maskarinec 1998
7173,7854,7856,All [by ethnicity],Women from two large mammography clinics in Honolulu,United States,,baseline,Diet History Questionnaire (DHQ),Isoflavones,"",,,,,mg/day,,1 day,"Urine, overnight",HPLC after enzymatic hydrolysis,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin,,,,nmol/h,,102,Spearman,0.62,,,= 0.0001,Yes,,,,Maskarinec 1998
7174,7863,7878,Males,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Sodium,Sodium from Foods,,196.0,,,mmol/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",165.0,,,mmol/day,,154,Pearson,0.09,,,> 0.05,No,,,,Sasaki 1998
7175,7863,7878,Males,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Sodium,Sodium from Foods,,196.0,,,mmol/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",165.0,,,mmol/day,,154,Pearson,0.14,,,> 0.05,No,"Creatinine, Energy by residual method",,,Sasaki 1998
7176,7864,7878,Males,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Sodium from Foods,"",,36.0,,,percentRoot,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",165.0,,,mmol/day,,154,Pearson,0.05,,,> 0.05,No,"Creatinine, Energy by residual method",,,Sasaki 1998
7177,7865,7878,Males,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Sodium from Foods,"",,11.0,,,percentRoot,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",165.0,,,mmol/day,,154,Pearson,0.18,,,< 0.05,Yes,"Creatinine, Energy by residual method",,,Sasaki 1998
7178,7866,7878,Males,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Sodium from Foods,"",,19.0,,,percentRoot,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",165.0,,,mmol/day,,154,Pearson,-0.01,,,> 0.05,No,"Creatinine, Energy by residual method",,,Sasaki 1998
7179,7867,7878,Males,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Sodium from Foods,"",,6.0,,,percentRoot,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",165.0,,,mmol/day,,154,Pearson,0.14,,,> 0.05,No,"Creatinine, Energy by residual method",,,Sasaki 1998
7180,7868,7878,Males,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Sodium from Foods,"",,17.0,,,percentRoot,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",165.0,,,mmol/day,,154,Pearson,0.05,,,> 0.05,No,"Creatinine, Energy by residual method",,,Sasaki 1998
7181,7869,7878,Males,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Sodium from Foods,"",,12.0,,,percentRoot,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",165.0,,,mmol/day,,154,Pearson,0.09,,,> 0.05,No,"Creatinine, Energy by residual method",,,Sasaki 1998
7190,7870,7879,Males,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Potassium,Potassium from Foods,,61.5,,,mmol/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",43.9,,,mmol/day,,154,Pearson,0.35,,,< 0.001,Yes,,,,Sasaki 1998
7191,7870,7879,Males,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Potassium,Potassium from Foods,,61.5,,,mmol/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",43.9,,,mmol/day,,154,Pearson,0.34,,,< 0.001,Yes,"Creatinine, Energy by residual method",,,Sasaki 1998
7192,7871,7879,Males,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Potassium from Foods,"",,2.0,,,percentRoot,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",43.9,,,mmol/day,,154,Pearson,0.03,,,> 0.05,No,"Creatinine, Energy by residual method",,,Sasaki 1998
7193,7872,7879,Males,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Potassium from Foods,"",,5.0,,,percentRoot,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",43.9,,,mmol/day,,154,Pearson,0.26,,,< 0.001,Yes,"Creatinine, Energy by residual method",,,Sasaki 1998
7194,7873,7879,Males,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Potassium from Foods,"",,23.0,,,percentRoot,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",43.9,,,mmol/day,,154,Pearson,-0.07,,,> 0.05,No,"Creatinine, Energy by residual method",,,Sasaki 1998
7195,7874,7879,Males,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Potassium from Foods,"",,28.0,,,percentRoot,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",43.9,,,mmol/day,,154,Pearson,0.19,,,> 0.05,No,"Creatinine, Energy by residual method",,,Sasaki 1998
7196,7875,7879,Males,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Potassium from Foods,"",,34.0,,,percentRoot,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",43.9,,,mmol/day,,154,Pearson,0.28,,,< 0.001,Yes,"Creatinine, Energy by residual method",,,Sasaki 1998
7197,7876,7879,Males,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Potassium from Foods,"",,8.0,,,percentRoot,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",43.9,,,mmol/day,,154,Pearson,0.09,,,> 0.05,No,"Creatinine, Energy by residual method",,,Sasaki 1998
7182,7881,7896,Females,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Sodium,Sodium from Foods,,179.0,,,mmol/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",136.0,,,mmol/day,,69,Pearson,0.16,,,> 0.05,No,,,,Sasaki 1998
7183,7881,7896,Females,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Sodium,Sodium from Foods,,179.0,,,mmol/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",136.0,,,mmol/day,,69,Pearson,0.23,,,= 0.05,Yes,"Creatinine, Energy by residual method",,,Sasaki 1998
7184,7882,7896,Females,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Sodium from Foods,"",,42.0,,,percentRoot,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",136.0,,,mmol/day,,69,Pearson,0.13,,,> 0.05,No,"Creatinine, Energy by residual method",,,Sasaki 1998
7185,7883,7896,Females,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Sodium from Foods,"",,12.0,,,percentRoot,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",136.0,,,mmol/day,,69,Pearson,0.24,,,< 0.05,Yes,"Creatinine, Energy by residual method",,,Sasaki 1998
7186,7884,7896,Females,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Sodium from Foods,"",,17.0,,,percentRoot,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",136.0,,,mmol/day,,69,Pearson,-0.1,,,> 0.05,No,"Creatinine, Energy by residual method",,,Sasaki 1998
7187,7885,7896,Females,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Sodium from Foods,"",,6.0,,,percentRoot,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",136.0,,,mmol/day,,69,Pearson,0.17,,,> 0.05,No,"Creatinine, Energy by residual method",,,Sasaki 1998
7188,7886,7896,Females,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Sodium from Foods,"",,18.0,,,percentRoot,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",136.0,,,mmol/day,,69,Pearson,0.13,,,> 0.05,No,"Creatinine, Energy by residual method",,,Sasaki 1998
7189,7887,7896,Females,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Sodium from Foods,"",,6.0,,,percentRoot,,,"Urine, 24-h",Atomic emission spectrometry (AES),Sodium,"",136.0,,,mmol/day,,69,Pearson,-0.12,,,> 0.05,No,"Creatinine, Energy by residual method",,,Sasaki 1998
7198,7888,7897,Females,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Potassium,Potassium from Foods,,56.8,,,mmol/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",41.6,,,mmol/day,,69,Pearson,0.28,,,< 0.01,Yes,,,,Sasaki 1998
7199,7888,7897,Females,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Potassium,Potassium from Foods,,56.8,,,mmol/day,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",41.6,,,mmol/day,,69,Pearson,0.4,,,< 0.001,Yes,"Creatinine, Energy by residual method",,,Sasaki 1998
7200,7889,7897,Females,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Potassium from Foods,"",,1.0,,,percentRoot,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",41.6,,,mmol/day,,69,Pearson,-0.21,,,> 0.05,No,"Creatinine, Energy by residual method",,,Sasaki 1998
7201,7890,7897,Females,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Potassium from Foods,"",,6.0,,,percentRoot,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",41.6,,,mmol/day,,69,Pearson,0.15,,,> 0.05,No,"Creatinine, Energy by residual method",,,Sasaki 1998
7202,7891,7897,Females,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Potassium from Foods,"",,20.0,,,percentRoot,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",41.6,,,mmol/day,,69,Pearson,-0.03,,,> 0.05,No,"Creatinine, Energy by residual method",,,Sasaki 1998
7203,7892,7897,Females,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Potassium from Foods,"",,34.0,,,percentRoot,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",41.6,,,mmol/day,,69,Pearson,0.42,,,< 0.001,Yes,"Creatinine, Energy by residual method",,,Sasaki 1998
7204,7893,7897,Females,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Potassium from Foods,"",,33.0,,,percentRoot,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",41.6,,,mmol/day,,69,Pearson,0.11,,,> 0.05,No,"Creatinine, Energy by residual method",,,Sasaki 1998
7205,7894,7897,Females,Freshmen students at Tokyo University of Fisheries,Japan,,,Diet History Questionnaire (DHQ),Potassium from Foods,"",,6.0,,,percentRoot,,,"Urine, 24-h",Atomic emission spectrometry (AES),Potassium,"",41.6,,,mmol/day,,69,Pearson,0.04,,,> 0.05,No,"Creatinine, Energy by residual method",,,Sasaki 1998
7208,7899,7901,Smokers,Pregnant women in Birmingham,United States,SGA (Scandinavian Successive Small-for-Gestational Age),,24-h Dietary recall (1-day),Caffeine,"",,,,,mg/day/kg,Body weight,,"Serum, fasting",HPLC,Caffeine,"",,,,ng/mL,,135,Pearson,0.37,,, ,Unspecified,,,,Klebanoff 1998
7209,7899,7902,Smokers,Pregnant women in Birmingham,United States,SGA (Scandinavian Successive Small-for-Gestational Age),,24-h Dietary recall (1-day),Caffeine,"",,,,,mg/day/kg,Body weight,,"Serum, fasting",HPLC,Paraxanthine,"",,,,ng/mL,,135,Pearson,0.5,,, ,Unspecified,,,,Klebanoff 1998
7206,7900,7903,Non-smokers,Pregnant women in Birmingham,United States,SGA (Scandinavian Successive Small-for-Gestational Age),,24-h Dietary recall (1-day),Caffeine,"",,,,,mg/day/kg,Body weight,,"Serum, fasting",HPLC,Caffeine,"",,,,ng/mL,,101,Pearson,0.51,,, ,Unspecified,,,,Klebanoff 1998
7207,7900,7904,Non-smokers,Pregnant women in Birmingham,United States,SGA (Scandinavian Successive Small-for-Gestational Age),,24-h Dietary recall (1-day),Caffeine,"",,,,,mg/day/kg,Body weight,,"Serum, fasting",HPLC,Paraxanthine,"",,,,ng/mL,,101,Pearson,0.53,,, ,Unspecified,,,,Klebanoff 1998
7210,7917,7956,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0),,39.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0),21.6,,,percentRoot,,140,Spearman,0.09,,,>= 0.01,No,,,,Garland 1998
7211,7918,7957,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6) + cis-Linolenic acids (cis-18:3),,21.1,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6) + cis-Linolenic acids (cis-18:3),21.7,,,percentRoot,,140,Spearman,0.39,,,< 0.001,Yes,,,,Garland 1998
7212,7919,7958,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,39.7,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),56.0,,,percentRoot,,140,Spearman,-0.04,,,>= 0.01,No,,,,Garland 1998
7213,7920,7959,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,20.7,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitic acid (16:0),"",15.3,,,percentRoot,,140,Spearman,0.12,,,>= 0.01,No,,,,Garland 1998
7214,7921,7960,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,18.1,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",18.5,,,percentRoot,,140,Spearman,0.35,,,< 0.001,Yes,,,,Garland 1998
7215,7922,7961,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),cis-Linolenic acids (cis-18:3),"",,2.0,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,cis-Linolenic acids (cis-18:3),"",0.9,,,percentRoot,,140,Spearman,0.25,,,< 0.01,Yes,,,,Garland 1998
7216,7923,7962,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,0.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",0.7,,,percentRoot,,140,Spearman,-0.03,,,>= 0.01,No,,,,Garland 1998
7217,7924,7963,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,36.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Oleic acid (cis-18:1n-9),"",40.5,,,percentRoot,,140,Spearman,0.08,,,>= 0.01,No,,,,Garland 1998
7218,7925,7964,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",trans-Octadecenoic acids (trans-18:1) + trans-Octadecadienoic acids (trans-18:2),,4.7,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, trans",trans-Octadecenoic acids (trans-18:1) + trans-Octadecadienoic acids (trans-18:2),6.1,,,percentRoot,,140,Spearman,0.23,,,< 0.01,Yes,,,,Garland 1998
7219,7926,7965,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),trans-Octadecenoic acids (trans-18:1),"",,3.7,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecenoic acids (trans-18:1),"",3.9,,,percentRoot,,140,Spearman,0.3,,,< 0.001,Yes,,,,Garland 1998
7220,7927,7966,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),trans-Octadecadienoic acids (trans-18:2),"",,0.7,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecadienoic acids (trans-18:2),"",0.9,,,percentRoot,,140,Spearman,0.27,,,< 0.01,Yes,,,,Garland 1998
7221,7939,7956,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0),,38.7,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0),21.6,,,percentRoot,,140,Spearman,0.16,,,>= 0.01,No,,,,Garland 1998
7222,7940,7957,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6) + cis-Linolenic acids (cis-18:3),,21.4,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6) + cis-Linolenic acids (cis-18:3),21.7,,,percentRoot,,140,Spearman,0.26,,,< 0.01,Yes,,,,Garland 1998
7223,7941,7958,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,39.9,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),56.0,,,percentRoot,,140,Spearman,0.09,,,>= 0.01,No,,,,Garland 1998
7224,7942,7959,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,20.4,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitic acid (16:0),"",15.3,,,percentRoot,,140,Spearman,0.1,,,>= 0.01,No,,,,Garland 1998
7225,7943,7960,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,18.5,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",18.5,,,percentRoot,,140,Spearman,0.23,,,< 0.01,Yes,,,,Garland 1998
7226,7944,7961,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),cis-Linolenic acids (cis-18:3),"",,1.9,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,cis-Linolenic acids (cis-18:3),"",0.9,,,percentRoot,,140,Spearman,0.33,,,< 0.001,Yes,,,,Garland 1998
7227,7945,7962,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,0.2,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",0.7,,,percentRoot,,140,Spearman,-0.07,,,>= 0.01,No,,,,Garland 1998
7228,7946,7963,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,36.7,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Oleic acid (cis-18:1n-9),"",40.5,,,percentRoot,,140,Spearman,0.16,,,>= 0.01,No,,,,Garland 1998
7229,7947,7964,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",trans-Octadecenoic acids (trans-18:1) + trans-Octadecadienoic acids (trans-18:2),,4.8,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, trans",trans-Octadecenoic acids (trans-18:1) + trans-Octadecadienoic acids (trans-18:2),6.1,,,percentRoot,,140,Spearman,0.48,,,< 0.001,Yes,,,,Garland 1998
7230,7948,7965,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),trans-Octadecenoic acids (trans-18:1),"",,3.8,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecenoic acids (trans-18:1),"",3.9,,,percentRoot,,140,Spearman,0.49,,,< 0.001,Yes,,,,Garland 1998
7231,7949,7966,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),trans-Octadecadienoic acids (trans-18:2),"",,0.7,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecadienoic acids (trans-18:2),"",0.9,,,percentRoot,,140,Spearman,0.14,,,>= 0.01,No,,,,Garland 1998
7232,7967,7956,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0),,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0),21.6,,,percentRoot,,140,Spearman,0.16,,,>= 0.01,No,,,,Garland 1998
7233,7968,7957,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6) + cis-Linolenic acids (cis-18:3),,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6) + cis-Linolenic acids (cis-18:3),21.7,,,percentRoot,,140,Spearman,0.4,,,< 0.001,Yes,,,,Garland 1998
7234,7969,7958,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),56.0,,,percentRoot,,140,Spearman,-0.04,,,>= 0.01,No,,,,Garland 1998
7235,7970,7959,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Palmitic acid (16:0),"",15.3,,,percentRoot,,140,Spearman,0.14,,,>= 0.01,No,,,,Garland 1998
7236,7971,7960,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",18.5,,,percentRoot,,140,Spearman,0.37,,,< 0.001,Yes,,,,Garland 1998
7237,7972,7961,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),cis-Linolenic acids (cis-18:3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,cis-Linolenic acids (cis-18:3),"",0.9,,,percentRoot,,140,Spearman,0.34,,,< 0.001,Yes,,,,Garland 1998
7238,7973,7962,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Arachidonic acid (AA; cis-20:4n-6),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",0.7,,,percentRoot,,140,Spearman,-0.07,,,>= 0.01,No,,,,Garland 1998
7239,7974,7963,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Oleic acid (cis-18:1n-9),"",40.5,,,percentRoot,,140,Spearman,0.12,,,>= 0.01,No,,,,Garland 1998
7240,7975,7964,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),"Fatty acids, trans",trans-Octadecenoic acids (trans-18:1) + trans-Octadecadienoic acids (trans-18:2),,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, trans",trans-Octadecenoic acids (trans-18:1) + trans-Octadecadienoic acids (trans-18:2),6.1,,,percentRoot,,140,Spearman,0.4,,,< 0.001,Yes,,,,Garland 1998
7241,7976,7965,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),trans-Octadecenoic acids (trans-18:1),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecenoic acids (trans-18:1),"",3.9,,,percentRoot,,140,Spearman,0.43,,,< 0.001,Yes,,,,Garland 1998
7242,7977,7966,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),trans-Octadecadienoic acids (trans-18:2),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,trans-Octadecadienoic acids (trans-18:2),"",0.9,,,percentRoot,,140,Spearman,0.22,,,>= 0.01,No,,,,Garland 1998
7243,7978,7956,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Dietary record (7-day),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0),21.6,,,percentRoot,,140,Spearman,0.14,,,>= 0.01,No,,Yes,,Garland 1998
7244,7979,7957,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6) + cis-Linolenic acids (cis-18:3),21.7,,,percentRoot,,140,Spearman,0.37,,,< 0.001,Yes,,Yes,,Garland 1998
7245,7980,7958,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Dietary record (7-day),"Fatty acids, monounsaturated (MUFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),56.0,,,percentRoot,,140,Spearman,0.08,,,>= 0.01,No,,Yes,,Garland 1998
7246,7989,7956,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Dietary record (7-day),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0),21.6,,,percentRoot,,140,Spearman,0.12,,,>= 0.01,No,,Yes,,Garland 1998
7247,7990,7957,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6) + cis-Linolenic acids (cis-18:3),21.7,,,percentRoot,,140,Spearman,0.37,,,< 0.001,Yes,,Yes,,Garland 1998
7248,7991,7958,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Dietary record (7-day),"Fatty acids, monounsaturated (MUFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),56.0,,,percentRoot,,140,Spearman,0.07,,,>= 0.01,No,,Yes,,Garland 1998
7249,7953,7956,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Dietary record (7-day),"Fatty acids, saturated (SFA)","",,38.8,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0),21.6,,,percentRoot,,140,Spearman,0.14,,,>= 0.01,No,,Yes,,Garland 1998
7250,7954,7957,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)","",,22.1,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6) + cis-Linolenic acids (cis-18:3),21.7,,,percentRoot,,140,Spearman,0.42,,,< 0.001,Yes,,Yes,,Garland 1998
7251,7955,7958,All,Participants in a dietary validation study,United States,NHS (Nurses' Health Study),,Dietary record (7-day),"Fatty acids, monounsaturated (MUFA)","",,39.1,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),56.0,,,percentRoot,,140,Spearman,0.08,,,>= 0.01,No,,Yes,,Garland 1998
7254,8054,8027,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,Fatty fish,,14.3,,,times/month,,,"Serum, non-fasting",GC-FID,Fatty acids,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Osbond acid (cis-22:5n-6) + Palmitic acid (16:0) + Stearic acid (18:0) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + Myristic acid (14:0) + Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Mead acid (cis-20:3n-9) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0) + Nervonic acid (cis-24:1n-9) + cis-Eicosenoic acids (cis-20:1) + cis-Cetoleic acid (cis-22:1n-11),1215.7,,,mg/L,,234,Pearson,0.01,,,>= 0.01,No,,,,Hjartaker 1997
7255,8054,8013,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,Fatty fish,,14.3,,,times/month,,,"Serum, non-fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",24.67,,,percentRoot,,234,Pearson,-0.09,,,>= 0.01,No,,,,Hjartaker 1997
7256,8054,8015,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,Fatty fish,,14.3,,,times/month,,,"Serum, non-fasting",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",2.96,,,percentRoot,,234,Pearson,-0.02,,,>= 0.01,No,,,,Hjartaker 1997
7257,8054,8016,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,Fatty fish,,14.3,,,times/month,,,"Serum, non-fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",8.75,,,percentRoot,,234,Pearson,0.07,,,>= 0.01,No,,,,Hjartaker 1997
7258,8054,8017,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,Fatty fish,,14.3,,,times/month,,,"Serum, non-fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.23,,,percentRoot,,234,Pearson,-0.1,,,>= 0.01,No,,,,Hjartaker 1997
7259,8054,8018,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,Fatty fish,,14.3,,,times/month,,,"Serum, non-fasting",GC-FID,Osbond acid (cis-22:5n-6),"",0.09,,,percentRoot,,234,Pearson,-0.1,,,>= 0.01,No,,,,Hjartaker 1997
7260,8054,8019,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,Fatty fish,,14.3,,,times/month,,,"Serum, non-fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.19,,,percentRoot,,234,Pearson,-0.08,,,>= 0.01,No,,,,Hjartaker 1997
7261,8054,8020,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,Fatty fish,,14.3,,,times/month,,,"Serum, non-fasting",GC-FID,EPA (cis-20:5n-3),"",1.98,,,percentRoot,,234,Pearson,0.09,,,>= 0.01,No,,,,Hjartaker 1997
7262,8054,8021,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,Fatty fish,,14.3,,,times/month,,,"Serum, non-fasting",GC-FID,DPA (cis-22:5n-3),"",1.33,,,percentRoot,,234,Pearson,0.12,,,>= 0.01,No,,,,Hjartaker 1997
7263,8054,8022,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,Fatty fish,,14.3,,,times/month,,,"Serum, non-fasting",GC-FID,DHA (cis-22:6n-3),"",6.92,,,percentRoot,,234,Pearson,0.15,,,>= 0.01,No,,,,Hjartaker 1997
7264,8054,8023,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,Fatty fish,,14.3,,,times/month,,,"Serum, non-fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),41.36,,,percentRoot,,234,Pearson,-0.02,,,>= 0.01,No,,,,Hjartaker 1997
7265,8054,8024,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,Fatty fish,,14.3,,,times/month,,,"Serum, non-fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Nervonic acid (cis-24:1n-9) + cis-Eicosenoic acids (cis-20:1) + cis-Cetoleic acid (cis-22:1n-11),11.02,,,percentRoot,,234,Pearson,-0.12,,,>= 0.01,No,,,,Hjartaker 1997
7266,8054,8025,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,Fatty fish,,14.3,,,times/month,,,"Serum, non-fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Osbond acid (cis-22:5n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6),37.08,,,percentRoot,,234,Pearson,-0.07,,,>= 0.01,No,,,,Hjartaker 1997
7267,8054,8026,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,Fatty fish,,14.3,,,times/month,,,"Serum, non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),10.43,,,percentRoot,,234,Pearson,0.13,,,>= 0.01,No,,,,Hjartaker 1997
7268,8055,8027,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fatty fish,"",,2.0,,,times/month,,,"Serum, non-fasting",GC-FID,Fatty acids,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Osbond acid (cis-22:5n-6) + Palmitic acid (16:0) + Stearic acid (18:0) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + Myristic acid (14:0) + Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Mead acid (cis-20:3n-9) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0) + Nervonic acid (cis-24:1n-9) + cis-Eicosenoic acids (cis-20:1) + cis-Cetoleic acid (cis-22:1n-11),1215.7,,,mg/L,,234,Pearson,0.09,,,>= 0.01,No,,,,Hjartaker 1997
7269,8055,8013,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fatty fish,"",,2.0,,,times/month,,,"Serum, non-fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",24.67,,,percentRoot,,234,Pearson,-0.23,,,< 0.001,Yes,,,,Hjartaker 1997
7270,8055,8015,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fatty fish,"",,2.0,,,times/month,,,"Serum, non-fasting",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",2.96,,,percentRoot,,234,Pearson,-0.13,,,>= 0.01,No,,,,Hjartaker 1997
7271,8055,8016,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fatty fish,"",,2.0,,,times/month,,,"Serum, non-fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",8.75,,,percentRoot,,234,Pearson,0.04,,,>= 0.01,No,,,,Hjartaker 1997
7272,8055,8017,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fatty fish,"",,2.0,,,times/month,,,"Serum, non-fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.23,,,percentRoot,,234,Pearson,-0.2,,,< 0.01,Yes,,,,Hjartaker 1997
7273,8055,8018,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fatty fish,"",,2.0,,,times/month,,,"Serum, non-fasting",GC-FID,Osbond acid (cis-22:5n-6),"",0.09,,,percentRoot,,234,Pearson,-0.13,,,>= 0.01,No,,,,Hjartaker 1997
7274,8055,8019,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fatty fish,"",,2.0,,,times/month,,,"Serum, non-fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.19,,,percentRoot,,234,Pearson,-0.07,,,>= 0.01,No,,,,Hjartaker 1997
7275,8055,8020,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fatty fish,"",,2.0,,,times/month,,,"Serum, non-fasting",GC-FID,EPA (cis-20:5n-3),"",1.98,,,percentRoot,,234,Pearson,0.24,,,< 0.001,Yes,,,,Hjartaker 1997
7276,8055,8021,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fatty fish,"",,2.0,,,times/month,,,"Serum, non-fasting",GC-FID,DPA (cis-22:5n-3),"",1.33,,,percentRoot,,234,Pearson,0.21,,,< 0.01,Yes,,,,Hjartaker 1997
7277,8055,8022,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fatty fish,"",,2.0,,,times/month,,,"Serum, non-fasting",GC-FID,DHA (cis-22:6n-3),"",6.92,,,percentRoot,,234,Pearson,0.24,,,< 0.001,Yes,,,,Hjartaker 1997
7278,8055,8023,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fatty fish,"",,2.0,,,times/month,,,"Serum, non-fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),41.36,,,percentRoot,,234,Pearson,0.09,,,>= 0.01,No,,,,Hjartaker 1997
7279,8055,8024,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fatty fish,"",,2.0,,,times/month,,,"Serum, non-fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Nervonic acid (cis-24:1n-9) + cis-Eicosenoic acids (cis-20:1) + cis-Cetoleic acid (cis-22:1n-11),11.02,,,percentRoot,,234,Pearson,-0.01,,,>= 0.01,No,,,,Hjartaker 1997
7280,8055,8025,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fatty fish,"",,2.0,,,times/month,,,"Serum, non-fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Osbond acid (cis-22:5n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6),37.08,,,percentRoot,,234,Pearson,-0.26,,,< 0.001,Yes,,,,Hjartaker 1997
7281,8055,8026,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fatty fish,"",,2.0,,,times/month,,,"Serum, non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),10.43,,,percentRoot,,234,Pearson,0.26,,,< 0.001,Yes,,,,Hjartaker 1997
7282,8056,8027,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,3.5,,,slices/week,,,"Serum, non-fasting",GC-FID,Fatty acids,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Osbond acid (cis-22:5n-6) + Palmitic acid (16:0) + Stearic acid (18:0) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + Myristic acid (14:0) + Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Mead acid (cis-20:3n-9) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0) + Nervonic acid (cis-24:1n-9) + cis-Eicosenoic acids (cis-20:1) + cis-Cetoleic acid (cis-22:1n-11),1215.7,,,mg/L,,234,Pearson,0.0,,,>= 0.01,No,,,,Hjartaker 1997
7283,8056,8013,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,3.5,,,slices/week,,,"Serum, non-fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",24.67,,,percentRoot,,234,Pearson,-0.01,,,>= 0.01,No,,,,Hjartaker 1997
7284,8056,8015,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,3.5,,,slices/week,,,"Serum, non-fasting",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",2.96,,,percentRoot,,234,Pearson,-0.18,,,< 0.01,Yes,,,,Hjartaker 1997
7285,8056,8016,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,3.5,,,slices/week,,,"Serum, non-fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",8.75,,,percentRoot,,234,Pearson,-0.13,,,>= 0.01,No,,,,Hjartaker 1997
7286,8056,8017,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,3.5,,,slices/week,,,"Serum, non-fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.23,,,percentRoot,,234,Pearson,-0.27,,,< 0.001,Yes,,,,Hjartaker 1997
7287,8056,8018,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,3.5,,,slices/week,,,"Serum, non-fasting",GC-FID,Osbond acid (cis-22:5n-6),"",0.09,,,percentRoot,,234,Pearson,-0.2,,,< 0.01,Yes,,,,Hjartaker 1997
7288,8056,8019,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,3.5,,,slices/week,,,"Serum, non-fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.19,,,percentRoot,,234,Pearson,-0.02,,,>= 0.01,No,,,,Hjartaker 1997
7289,8056,8020,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,3.5,,,slices/week,,,"Serum, non-fasting",GC-FID,EPA (cis-20:5n-3),"",1.98,,,percentRoot,,234,Pearson,0.16,,,>= 0.01,No,,,,Hjartaker 1997
7290,8056,8021,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,3.5,,,slices/week,,,"Serum, non-fasting",GC-FID,DPA (cis-22:5n-3),"",1.33,,,percentRoot,,234,Pearson,0.09,,,>= 0.01,No,,,,Hjartaker 1997
7291,8056,8022,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,3.5,,,slices/week,,,"Serum, non-fasting",GC-FID,DHA (cis-22:6n-3),"",6.92,,,percentRoot,,234,Pearson,0.18,,,< 0.01,Yes,,,,Hjartaker 1997
7292,8056,8023,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,3.5,,,slices/week,,,"Serum, non-fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),41.36,,,percentRoot,,234,Pearson,0.02,,,>= 0.01,No,,,,Hjartaker 1997
7293,8056,8024,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,3.5,,,slices/week,,,"Serum, non-fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Nervonic acid (cis-24:1n-9) + cis-Eicosenoic acids (cis-20:1) + cis-Cetoleic acid (cis-22:1n-11),11.02,,,percentRoot,,234,Pearson,-0.09,,,>= 0.01,No,,,,Hjartaker 1997
7294,8056,8025,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,3.5,,,slices/week,,,"Serum, non-fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Osbond acid (cis-22:5n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6),37.08,,,percentRoot,,234,Pearson,-0.13,,,>= 0.01,No,,,,Hjartaker 1997
7295,8056,8026,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,3.5,,,slices/week,,,"Serum, non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),10.43,,,percentRoot,,234,Pearson,0.18,,,< 0.01,Yes,,,,Hjartaker 1997
7296,8057,8027,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,3.5,,,times/year,,,"Serum, non-fasting",GC-FID,Fatty acids,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Osbond acid (cis-22:5n-6) + Palmitic acid (16:0) + Stearic acid (18:0) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + Myristic acid (14:0) + Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Mead acid (cis-20:3n-9) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0) + Nervonic acid (cis-24:1n-9) + cis-Eicosenoic acids (cis-20:1) + cis-Cetoleic acid (cis-22:1n-11),1215.7,,,mg/L,,234,Pearson,0.01,,,>= 0.01,No,,,,Hjartaker 1997
7297,8057,8013,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,3.5,,,times/year,,,"Serum, non-fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",24.67,,,percentRoot,,234,Pearson,-0.1,,,>= 0.01,No,,,,Hjartaker 1997
7298,8057,8015,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,3.5,,,times/year,,,"Serum, non-fasting",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",2.96,,,percentRoot,,234,Pearson,-0.04,,,>= 0.01,No,,,,Hjartaker 1997
7299,8057,8016,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,3.5,,,times/year,,,"Serum, non-fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",8.75,,,percentRoot,,234,Pearson,-0.08,,,>= 0.01,No,,,,Hjartaker 1997
7300,8057,8017,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,3.5,,,times/year,,,"Serum, non-fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.23,,,percentRoot,,234,Pearson,-0.21,,,< 0.01,Yes,,,,Hjartaker 1997
7301,8057,8018,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,3.5,,,times/year,,,"Serum, non-fasting",GC-FID,Osbond acid (cis-22:5n-6),"",0.09,,,percentRoot,,234,Pearson,-0.12,,,>= 0.01,No,,,,Hjartaker 1997
7302,8057,8019,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,3.5,,,times/year,,,"Serum, non-fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.19,,,percentRoot,,234,Pearson,0.09,,,>= 0.01,No,,,,Hjartaker 1997
7303,8057,8020,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,3.5,,,times/year,,,"Serum, non-fasting",GC-FID,EPA (cis-20:5n-3),"",1.98,,,percentRoot,,234,Pearson,0.15,,,>= 0.01,No,,,,Hjartaker 1997
7304,8057,8021,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,3.5,,,times/year,,,"Serum, non-fasting",GC-FID,DPA (cis-22:5n-3),"",1.33,,,percentRoot,,234,Pearson,0.13,,,>= 0.01,No,,,,Hjartaker 1997
7305,8057,8022,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,3.5,,,times/year,,,"Serum, non-fasting",GC-FID,DHA (cis-22:6n-3),"",6.92,,,percentRoot,,234,Pearson,0.21,,,< 0.01,Yes,,,,Hjartaker 1997
7306,8057,8023,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,3.5,,,times/year,,,"Serum, non-fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),41.36,,,percentRoot,,234,Pearson,0.02,,,>= 0.01,No,,,,Hjartaker 1997
7307,8057,8024,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,3.5,,,times/year,,,"Serum, non-fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Nervonic acid (cis-24:1n-9) + cis-Eicosenoic acids (cis-20:1) + cis-Cetoleic acid (cis-22:1n-11),11.02,,,percentRoot,,234,Pearson,-0.06,,,>= 0.01,No,,,,Hjartaker 1997
7308,8057,8025,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,3.5,,,times/year,,,"Serum, non-fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Osbond acid (cis-22:5n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6),37.08,,,percentRoot,,234,Pearson,-0.16,,,>= 0.01,No,,,,Hjartaker 1997
7309,8057,8026,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,3.5,,,times/year,,,"Serum, non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),10.43,,,percentRoot,,234,Pearson,0.2,,,< 0.01,Yes,,,,Hjartaker 1997
7310,8058,8027,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Shellfish,"",,9.0,,,times/year,,,"Serum, non-fasting",GC-FID,Fatty acids,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Osbond acid (cis-22:5n-6) + Palmitic acid (16:0) + Stearic acid (18:0) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + Myristic acid (14:0) + Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Mead acid (cis-20:3n-9) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0) + Nervonic acid (cis-24:1n-9) + cis-Eicosenoic acids (cis-20:1) + cis-Cetoleic acid (cis-22:1n-11),1215.7,,,mg/L,,228,Pearson,0.12,,,>= 0.01,No,,,,Hjartaker 1997
7311,8058,8013,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Shellfish,"",,9.0,,,times/year,,,"Serum, non-fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",24.67,,,percentRoot,,228,Pearson,-0.15,,,>= 0.01,No,,,,Hjartaker 1997
7312,8058,8015,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Shellfish,"",,9.0,,,times/year,,,"Serum, non-fasting",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",2.96,,,percentRoot,,228,Pearson,-0.11,,,>= 0.01,No,,,,Hjartaker 1997
7313,8058,8016,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Shellfish,"",,9.0,,,times/year,,,"Serum, non-fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",8.75,,,percentRoot,,228,Pearson,0.0,,,>= 0.01,No,,,,Hjartaker 1997
7314,8058,8017,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Shellfish,"",,9.0,,,times/year,,,"Serum, non-fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.23,,,percentRoot,,228,Pearson,-0.13,,,>= 0.01,No,,,,Hjartaker 1997
7315,8058,8018,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Shellfish,"",,9.0,,,times/year,,,"Serum, non-fasting",GC-FID,Osbond acid (cis-22:5n-6),"",0.09,,,percentRoot,,228,Pearson,-0.04,,,>= 0.01,No,,,,Hjartaker 1997
7316,8058,8019,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Shellfish,"",,9.0,,,times/year,,,"Serum, non-fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.19,,,percentRoot,,228,Pearson,-0.02,,,>= 0.01,No,,,,Hjartaker 1997
7317,8058,8020,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Shellfish,"",,9.0,,,times/year,,,"Serum, non-fasting",GC-FID,EPA (cis-20:5n-3),"",1.98,,,percentRoot,,228,Pearson,0.18,,,< 0.01,Yes,,,,Hjartaker 1997
7318,8058,8021,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Shellfish,"",,9.0,,,times/year,,,"Serum, non-fasting",GC-FID,DPA (cis-22:5n-3),"",1.33,,,percentRoot,,228,Pearson,0.11,,,>= 0.01,No,,,,Hjartaker 1997
7319,8058,8022,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Shellfish,"",,9.0,,,times/year,,,"Serum, non-fasting",GC-FID,DHA (cis-22:6n-3),"",6.92,,,percentRoot,,228,Pearson,0.14,,,>= 0.01,No,,,,Hjartaker 1997
7320,8058,8023,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Shellfish,"",,9.0,,,times/year,,,"Serum, non-fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),41.36,,,percentRoot,,228,Pearson,0.06,,,>= 0.01,No,,,,Hjartaker 1997
7321,8058,8024,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Shellfish,"",,9.0,,,times/year,,,"Serum, non-fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Nervonic acid (cis-24:1n-9) + cis-Eicosenoic acids (cis-20:1) + cis-Cetoleic acid (cis-22:1n-11),11.02,,,percentRoot,,228,Pearson,0.01,,,>= 0.01,No,,,,Hjartaker 1997
7322,8058,8025,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Shellfish,"",,9.0,,,times/year,,,"Serum, non-fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Osbond acid (cis-22:5n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6),37.08,,,percentRoot,,228,Pearson,-0.18,,,< 0.01,Yes,,,,Hjartaker 1997
7323,8058,8026,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Shellfish,"",,9.0,,,times/year,,,"Serum, non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),10.43,,,percentRoot,,228,Pearson,0.17,,,< 0.01,Yes,,,,Hjartaker 1997
7324,8059,8027,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish oil capsules,"",,,,,missing unit,,,"Serum, non-fasting",GC-FID,Fatty acids,alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Osbond acid (cis-22:5n-6) + Palmitic acid (16:0) + Stearic acid (18:0) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + Myristic acid (14:0) + Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Mead acid (cis-20:3n-9) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0) + Nervonic acid (cis-24:1n-9) + cis-Eicosenoic acids (cis-20:1) + cis-Cetoleic acid (cis-22:1n-11),1215.7,,,mg/L,,88,Pearson,0.08,,,>= 0.01,No,,,,Hjartaker 1997
7325,8059,8013,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish oil capsules,"",,,,,missing unit,,,"Serum, non-fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",24.67,,,percentRoot,,88,Pearson,-0.23,,,< 0.001,Yes,,,,Hjartaker 1997
7326,8059,8015,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish oil capsules,"",,,,,missing unit,,,"Serum, non-fasting",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",2.96,,,percentRoot,,88,Pearson,-0.23,,,< 0.001,Yes,,,,Hjartaker 1997
7327,8059,8016,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish oil capsules,"",,,,,missing unit,,,"Serum, non-fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",8.75,,,percentRoot,,88,Pearson,-0.22,,,< 0.001,Yes,,,,Hjartaker 1997
7328,8059,8017,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish oil capsules,"",,,,,missing unit,,,"Serum, non-fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",0.23,,,percentRoot,,88,Pearson,-0.29,,,< 0.001,Yes,,,,Hjartaker 1997
7329,8059,8018,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish oil capsules,"",,,,,missing unit,,,"Serum, non-fasting",GC-FID,Osbond acid (cis-22:5n-6),"",0.09,,,percentRoot,,88,Pearson,-0.2,,,< 0.01,Yes,,,,Hjartaker 1997
7330,8059,8019,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish oil capsules,"",,,,,missing unit,,,"Serum, non-fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.19,,,percentRoot,,88,Pearson,-0.12,,,>= 0.01,No,,,,Hjartaker 1997
7331,8059,8020,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish oil capsules,"",,,,,missing unit,,,"Serum, non-fasting",GC-FID,EPA (cis-20:5n-3),"",1.98,,,percentRoot,,88,Pearson,0.48,,,< 0.001,Yes,,,,Hjartaker 1997
7332,8059,8021,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish oil capsules,"",,,,,missing unit,,,"Serum, non-fasting",GC-FID,DPA (cis-22:5n-3),"",1.33,,,percentRoot,,88,Pearson,0.33,,,< 0.001,Yes,,,,Hjartaker 1997
7333,8059,8022,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish oil capsules,"",,,,,missing unit,,,"Serum, non-fasting",GC-FID,DHA (cis-22:6n-3),"",6.92,,,percentRoot,,88,Pearson,0.38,,,< 0.001,Yes,,,,Hjartaker 1997
7334,8059,8023,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish oil capsules,"",,,,,missing unit,,,"Serum, non-fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),41.36,,,percentRoot,,88,Pearson,0.02,,,>= 0.01,No,,,,Hjartaker 1997
7335,8059,8024,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish oil capsules,"",,,,,missing unit,,,"Serum, non-fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Nervonic acid (cis-24:1n-9) + cis-Eicosenoic acids (cis-20:1) + cis-Cetoleic acid (cis-22:1n-11),11.02,,,percentRoot,,88,Pearson,-0.04,,,>= 0.01,No,,,,Hjartaker 1997
7336,8059,8025,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish oil capsules,"",,,,,missing unit,,,"Serum, non-fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Osbond acid (cis-22:5n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6),37.08,,,percentRoot,,88,Pearson,-0.41,,,< 0.001,Yes,,,,Hjartaker 1997
7337,8059,8026,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish oil capsules,"",,,,,missing unit,,,"Serum, non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),10.43,,,percentRoot,,88,Pearson,0.46,,,< 0.001,Yes,,,,Hjartaker 1997
7338,8060,8047,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Seafood,Fish + Fatty fish + Shellfish,,,,81.3,g/day,,,"Serum, non-fasting",GC-FID,EPA (cis-20:5n-3),"",24.09,,,mg/L,,234,Spearman,0.2,,,< 0.01,Yes,,,,Hjartaker 1997
7339,8060,8049,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Seafood,Fish + Fatty fish + Shellfish,,,,81.3,g/day,,,"Serum, non-fasting",GC-FID,DHA (cis-22:6n-3),"",83.85,,,mg/L,,234,Spearman,0.19,,,< 0.01,Yes,,,,Hjartaker 1997
7340,8060,8053,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Seafood,Fish + Fatty fish + Shellfish,,,,81.3,g/day,,,"Serum, non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),126.48,,,mg/L,,234,Spearman,0.2,,,< 0.01,Yes,,,,Hjartaker 1997
7341,8061,8047,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,Fish + Fatty fish,,,,,g/day,,,"Serum, non-fasting",GC-FID,EPA (cis-20:5n-3),"",24.09,,,mg/L,,234,Spearman,0.15,,,>= 0.01,No,,,,Hjartaker 1997
7342,8061,8049,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,Fish + Fatty fish,,,,,g/day,,,"Serum, non-fasting",GC-FID,DHA (cis-22:6n-3),"",83.85,,,mg/L,,234,Spearman,0.15,,,>= 0.01,No,,,,Hjartaker 1997
7343,8061,8053,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,Fish + Fatty fish,,,,,g/day,,,"Serum, non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),126.48,,,mg/L,,234,Spearman,0.16,,,>= 0.01,No,,,,Hjartaker 1997
7344,8062,8047,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fatty fish,"",,,,,g/day,,,"Serum, non-fasting",GC-FID,EPA (cis-20:5n-3),"",24.09,,,mg/L,,234,Spearman,0.28,,,< 0.001,Yes,,,,Hjartaker 1997
7345,8062,8049,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fatty fish,"",,,,,g/day,,,"Serum, non-fasting",GC-FID,DHA (cis-22:6n-3),"",83.85,,,mg/L,,234,Spearman,0.29,,,< 0.001,Yes,,,,Hjartaker 1997
7346,8062,8053,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fatty fish,"",,,,,g/day,,,"Serum, non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),126.48,,,mg/L,,234,Spearman,0.3,,,< 0.001,Yes,,,,Hjartaker 1997
7347,8063,8047,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,,,,g/day,,,"Serum, non-fasting",GC-FID,EPA (cis-20:5n-3),"",24.09,,,mg/L,,234,Spearman,0.27,,,< 0.001,Yes,,,,Hjartaker 1997
7348,8063,8049,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,,,,g/day,,,"Serum, non-fasting",GC-FID,DHA (cis-22:6n-3),"",83.85,,,mg/L,,234,Spearman,0.25,,,< 0.001,Yes,,,,Hjartaker 1997
7349,8063,8053,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,,,,g/day,,,"Serum, non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),126.48,,,mg/L,,234,Spearman,0.25,,,< 0.001,Yes,,,,Hjartaker 1997
7350,8064,8047,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,,,,g/day,,,"Serum, non-fasting",GC-FID,EPA (cis-20:5n-3),"",24.09,,,mg/L,,234,Spearman,0.2,,,< 0.01,Yes,,,,Hjartaker 1997
7351,8064,8049,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,,,,g/day,,,"Serum, non-fasting",GC-FID,DHA (cis-22:6n-3),"",83.85,,,mg/L,,234,Spearman,0.25,,,< 0.001,Yes,,,,Hjartaker 1997
7352,8064,8053,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish,"",,,,,g/day,,,"Serum, non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),126.48,,,mg/L,,234,Spearman,0.24,,,< 0.001,Yes,,,,Hjartaker 1997
7353,8065,8047,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Shellfish,"",,,,,g/day,,,"Serum, non-fasting",GC-FID,EPA (cis-20:5n-3),"",24.09,,,mg/L,,228,Spearman,0.22,,,< 0.001,Yes,,,,Hjartaker 1997
7354,8065,8049,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Shellfish,"",,,,,g/day,,,"Serum, non-fasting",GC-FID,DHA (cis-22:6n-3),"",83.85,,,mg/L,,228,Spearman,0.21,,,< 0.01,Yes,,,,Hjartaker 1997
7355,8065,8053,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Shellfish,"",,,,,g/day,,,"Serum, non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),126.48,,,mg/L,,228,Spearman,0.23,,,< 0.001,Yes,,,,Hjartaker 1997
7356,8066,8047,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish oil capsules,"",,,,,g/day,,,"Serum, non-fasting",GC-FID,EPA (cis-20:5n-3),"",24.09,,,mg/L,,88,Spearman,0.45,,,< 0.001,Yes,,,,Hjartaker 1997
7357,8066,8049,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish oil capsules,"",,,,,g/day,,,"Serum, non-fasting",GC-FID,DHA (cis-22:6n-3),"",83.85,,,mg/L,,88,Spearman,0.38,,,< 0.001,Yes,,,,Hjartaker 1997
7358,8066,8053,All,Middle-aged women in the Trondheim area,Norway,,,Food Frequency Questionnaire (FFQ),Fish oil capsules,"",,,,,g/day,,,"Serum, non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),126.48,,,mg/L,,88,Spearman,0.43,,,< 0.001,Yes,,,,Hjartaker 1997
7360,8100,8103,All,Prepubertal children participant in a longitudinal study on sudden infant death syndrome in Tasmania,Australia,,,Food Frequency Questionnaire (FFQ),Potassium,"",,3484.0,,,mg/day,,,"Urine, overnight",Ion selective electrode (ISE),Potassium,"",32.0,,,mmol/day,,262,Pearson,0.14,,,= 0.016,Yes,,,,Jones 2001
7361,8104,8103,All,Prepubertal children participant in a longitudinal study on sudden infant death syndrome in Tasmania,Australia,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,,,,servings/week,,,"Urine, overnight",Ion selective electrode (ISE),Potassium,"",32.0,,,mmol/day,,262,Pearson,0.12,,,= 0.033,Yes,,,,Jones 2001
7362,8140,8144,All [by intake],Adults in Val-de-Marne area participant in a cross-sectional nutrional survey,France,,,Diet History Questionnaire (DHQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,837,Pearson,0.36,,,< 0.05,Yes,"Cholesterol, Energy by density method",,,Drewnowski 1997
7366,8140,8145,All [by intake],Adults in Val-de-Marne area participant in a cross-sectional nutrional survey,France,,,Diet History Questionnaire (DHQ),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,,"Serum, fasting",Fluorometry,Vitamin C,"",,,,umol/L,,837,Pearson,0.29,,,< 0.05,Yes,Energy by density method,,,Drewnowski 1997
7363,8141,8144,All [by intake],Adults in Val-de-Marne area participant in a cross-sectional nutrional survey,France,,,Diet History Questionnaire (DHQ),Vegetables,"",,,,,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,837,Pearson,0.3,,,< 0.05,Yes,"Cholesterol, Energy by density method",,,Drewnowski 1997
7367,8141,8145,All [by intake],Adults in Val-de-Marne area participant in a cross-sectional nutrional survey,France,,,Diet History Questionnaire (DHQ),Vegetables,"",,,,,g/day,,,"Serum, fasting",Fluorometry,Vitamin C,"",,,,umol/L,,837,Pearson,0.15,,,< 0.05,Yes,Energy by density method,,,Drewnowski 1997
7364,8142,8144,All [by intake],Adults in Val-de-Marne area participant in a cross-sectional nutrional survey,France,,,Diet History Questionnaire (DHQ),Fruits,"",,,,,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,837,Pearson,0.29,,,< 0.05,Yes,"Cholesterol, Energy by density method",,,Drewnowski 1997
7368,8142,8145,All [by intake],Adults in Val-de-Marne area participant in a cross-sectional nutrional survey,France,,,Diet History Questionnaire (DHQ),Fruits,"",,,,,g/day,,,"Serum, fasting",Fluorometry,Vitamin C,"",,,,umol/L,,837,Pearson,0.36,,,< 0.05,Yes,Energy by density method,,,Drewnowski 1997
7365,8143,8144,All [by intake],Adults in Val-de-Marne area participant in a cross-sectional nutrional survey,France,,,Diet History Questionnaire (DHQ),Fats,"",,,,,g/day,,,"Serum, fasting",HPLC,beta-Carotene,"",,,,umol/L,,837,Pearson,-0.17,,,>= 0.05,No,"Cholesterol, Energy by density method",,,Drewnowski 1997
7369,8143,8145,All [by intake],Adults in Val-de-Marne area participant in a cross-sectional nutrional survey,France,,,Diet History Questionnaire (DHQ),Fats,"",,,,,g/day,,,"Serum, fasting",Fluorometry,Vitamin C,"",,,,umol/L,,837,Pearson,-0.14,,,>= 0.05,No,Energy by density method,,,Drewnowski 1997
7370,8157,8165,All,Men from a large clinical trial,United States,PPT (Polyp Prevention Trial),,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,8.4,,,mg/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",27.1,,,umol/L,,162,Pearson,0.1,,, ,Unspecified,,,,Marshall 1997
7377,8157,8166,All,Men from a large clinical trial,United States,PPT (Polyp Prevention Trial),,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,8.4,,,mg/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",91.1,,,nmol/L,,162,Pearson,0.154,,, ,Unspecified,,,,Marshall 1997
7384,8157,8167,All,Men from a large clinical trial,United States,PPT (Polyp Prevention Trial),,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,8.4,,,mg/day,,,"Serum, fasting",HPLC,beta-Carotene,"",357.1,,,nmol/L,,162,Pearson,0.115,,, ,Unspecified,,,,Marshall 1997
7371,8158,8165,All,Men from a large clinical trial,United States,PPT (Polyp Prevention Trial),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,477.2,,,ug/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",27.1,,,umol/L,,162,Pearson,0.121,,, ,Unspecified,,,,Marshall 1997
7378,8158,8166,All,Men from a large clinical trial,United States,PPT (Polyp Prevention Trial),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,477.2,,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",91.1,,,nmol/L,,162,Pearson,0.43,,, ,Unspecified,,,,Marshall 1997
7385,8158,8167,All,Men from a large clinical trial,United States,PPT (Polyp Prevention Trial),,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,477.2,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",357.1,,,nmol/L,,162,Pearson,0.187,,, ,Unspecified,,,,Marshall 1997
7372,8159,8165,All,Men from a large clinical trial,United States,PPT (Polyp Prevention Trial),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,7984.0,,,ug/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",27.1,,,umol/L,,162,Pearson,0.131,,, ,Unspecified,,,,Marshall 1997
7379,8159,8166,All,Men from a large clinical trial,United States,PPT (Polyp Prevention Trial),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,7984.0,,,ug/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",91.1,,,nmol/L,,162,Pearson,0.359,,, ,Unspecified,,,,Marshall 1997
7386,8159,8167,All,Men from a large clinical trial,United States,PPT (Polyp Prevention Trial),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,7984.0,,,ug/day,,,"Serum, fasting",HPLC,beta-Carotene,"",357.1,,,nmol/L,,162,Pearson,0.289,,, ,Unspecified,,,,Marshall 1997
7374,8161,8165,All,Men from a large clinical trial,United States,PPT (Polyp Prevention Trial),,Food Frequency Questionnaire (FFQ),Fruits,"",,1.3,,,servings/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",27.1,,,umol/L,,162,Pearson,0.054,,, ,Unspecified,,,,Marshall 1997
7381,8161,8166,All,Men from a large clinical trial,United States,PPT (Polyp Prevention Trial),,Food Frequency Questionnaire (FFQ),Fruits,"",,1.3,,,servings/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",91.1,,,nmol/L,,162,Pearson,0.29,,, ,Unspecified,,,,Marshall 1997
7388,8161,8167,All,Men from a large clinical trial,United States,PPT (Polyp Prevention Trial),,Food Frequency Questionnaire (FFQ),Fruits,"",,1.3,,,servings/day,,,"Serum, fasting",HPLC,beta-Carotene,"",357.1,,,nmol/L,,162,Pearson,0.193,,, ,Unspecified,,,,Marshall 1997
7375,8162,8165,All,Men from a large clinical trial,United States,PPT (Polyp Prevention Trial),,Food Frequency Questionnaire (FFQ),Fruit juices + Vegetable juices,"",,0.6,,,servings/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",27.1,,,umol/L,,162,Pearson,-0.151,,, ,Unspecified,,,,Marshall 1997
7382,8162,8166,All,Men from a large clinical trial,United States,PPT (Polyp Prevention Trial),,Food Frequency Questionnaire (FFQ),Fruit juices + Vegetable juices,"",,0.6,,,servings/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",91.1,,,nmol/L,,162,Pearson,0.046,,, ,Unspecified,,,,Marshall 1997
7389,8162,8167,All,Men from a large clinical trial,United States,PPT (Polyp Prevention Trial),,Food Frequency Questionnaire (FFQ),Fruit juices + Vegetable juices,"",,0.6,,,servings/day,,,"Serum, fasting",HPLC,beta-Carotene,"",357.1,,,nmol/L,,162,Pearson,0.063,,, ,Unspecified,,,,Marshall 1997
7373,8163,8165,All,Men from a large clinical trial,United States,PPT (Polyp Prevention Trial),,Food Frequency Questionnaire (FFQ),Vegetables,"",,2.4,,,servings/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",27.1,,,umol/L,,162,Pearson,0.122,,, ,Unspecified,,,,Marshall 1997
7380,8163,8166,All,Men from a large clinical trial,United States,PPT (Polyp Prevention Trial),,Food Frequency Questionnaire (FFQ),Vegetables,"",,2.4,,,servings/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",91.1,,,nmol/L,,162,Pearson,0.313,,, ,Unspecified,,,,Marshall 1997
7387,8163,8167,All,Men from a large clinical trial,United States,PPT (Polyp Prevention Trial),,Food Frequency Questionnaire (FFQ),Vegetables,"",,2.4,,,servings/day,,,"Serum, fasting",HPLC,beta-Carotene,"",357.1,,,nmol/L,,162,Pearson,0.23,,, ,Unspecified,,,,Marshall 1997
7376,8164,8165,All,Men from a large clinical trial,United States,PPT (Polyp Prevention Trial),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,3.7,,,servings/day,,,"Serum, fasting",HPLC,alpha-Tocopherol,"",27.1,,,umol/L,,162,Pearson,0.095,,, ,Unspecified,,,,Marshall 1997
7383,8164,8166,All,Men from a large clinical trial,United States,PPT (Polyp Prevention Trial),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,3.7,,,servings/day,,,"Serum, fasting",HPLC,alpha-Carotene,"",91.1,,,nmol/L,,162,Pearson,0.342,,, ,Unspecified,,,,Marshall 1997
7390,8164,8167,All,Men from a large clinical trial,United States,PPT (Polyp Prevention Trial),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,3.7,,,servings/day,,,"Serum, fasting",HPLC,beta-Carotene,"",357.1,,,nmol/L,,162,Pearson,0.232,,, ,Unspecified,,,,Marshall 1997
7391,8206,8202,All,Participants in a vitamin K metabolic study in New England region,United States,,,Weighed Dietary record (4-day),Vitamin E (alpha-Tocopherol Equivalents),"",No,,,,mg/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,34,Pearson,0.21,,,= 0.08,No,,,,Booth 1997
7392,8207,8203,All,Participants in a vitamin K metabolic study in New England region,United States,,,Weighed Dietary record (4-day),Vitamin A (Retinol Equivalents),"",No,,,,ug/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,umol/L,,34,Pearson,-0.1,,,= 0.4,No,,,,Booth 1997
7393,8208,8204,All,Participants in a vitamin K metabolic study in New England region,United States,,,Weighed Dietary record (4-day),Vitamin D,"",No,,,,ug/day,,,"Plasma, fasting",HPLC,25-Hydroxycholecalciferol,"",,,,nmol/L,,34,Pearson,0.0,,,= 1.00,No,,,,Booth 1997
7394,8209,8205,All,Participants in a vitamin K metabolic study in New England region,United States,,,Weighed Dietary record (4-day),Phylloquinone,"",No,,,,ug/day,,,"Plasma, fasting",HPLC,Phylloquinone,"",,,,nmol/L,,34,Pearson,0.13,,,= 0.3,No,,,,Booth 1997
7395,8214,8210,All,Participants in a vitamin K metabolic study in New England region,United States,,,Weighed Dietary record (4-day),Vitamin E (alpha-Tocopherol Equivalents),"",No,,,,mg/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,34,Pearson,0.08,,,= 0.68,No,,,,Booth 1997
7396,8215,8211,All,Participants in a vitamin K metabolic study in New England region,United States,,,Weighed Dietary record (4-day),Vitamin A (Retinol Equivalents),"",No,,,,ug/day,,,"Plasma, fasting",HPLC,Retinol,"",,,,umol/L,,34,Pearson,0.17,,,= 0.17,No,,,,Booth 1997
7397,8216,8212,All,Participants in a vitamin K metabolic study in New England region,United States,,,Weighed Dietary record (4-day),Vitamin D,"",No,,,,ug/day,,,"Plasma, fasting",HPLC,25-Hydroxycholecalciferol,"",,,,nmol/L,,34,Pearson,0.32,,,= 0.08,No,,,,Booth 1997
7398,8217,8213,All,Participants in a vitamin K metabolic study in New England region,United States,,,Weighed Dietary record (4-day),Phylloquinone,"",No,,,,ug/day,,,"Plasma, fasting",HPLC,Phylloquinone,"",,,,nmol/L,,34,Pearson,0.51,,,= 0.004,Yes,,,,Booth 1997
7399,8222,8297,All,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),Nitrogen,"",,12.23,,,g/day,,,"Urine, 24-h",Method missing,Nitrogen,"",,,,g/day,,41,Pearson,0.58,,, ,Unspecified,,,,Gonzalez 1997
7405,8222,8219,All,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),Nitrogen,"",,12.23,,,g/day,,,"Urine, 24-h",Method missing,Nitrogen,"",12.96,,,g/day,,64,Pearson,0.42,,, ,Unspecified,,,,Gonzalez 1997
7412,8273,8232,All,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),beta-Carotene,"",,4418.2,,,ug/dL,,,"Plasma, fasting",HPLC,beta-Carotene,"",24.2,,,ug/dL,,72,Pearson,0.33,,, ,Unspecified,,,,Gonzalez 1997
7413,8273,8233,All,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),beta-Carotene,"",,4418.2,,,ug/dL,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,95.1,,,ug/dL,,72,Pearson,0.27,,, ,Unspecified,,,,Gonzalez 1997
7416,8273,8232,All,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),beta-Carotene,"",,4418.2,,,ug/dL,,,"Plasma, fasting",HPLC,beta-Carotene,"",24.2,,,ug/dL,,72,Pearson,0.33,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7417,8273,8233,All,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),beta-Carotene,"",,4418.2,,,ug/dL,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,95.1,,,ug/dL,,72,Pearson,0.27,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7414,8274,8234,All,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",,10.3,,,ug/dL,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",960.3,,,ug/dL,,72,Pearson,0.01,,, ,Unspecified,,,,Gonzalez 1997
7418,8274,8234,All,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",,10.3,,,ug/dL,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",960.3,,,ug/dL,,72,Pearson,0.33,,, ,Unspecified,"Energy by residual method, Cholesterol",,,Gonzalez 1997
7411,8275,8235,All,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),Vitamin C,"",,119.4,,,ug/dL,,,"Plasma, fasting",Fluorometry,Vitamin C,"",429.4,,,ug/dL,,72,Pearson,0.46,,, ,Unspecified,,,,Gonzalez 1997
7415,8275,8235,All,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),Vitamin C,"",,119.4,,,ug/dL,,,"Plasma, fasting",Fluorometry,Vitamin C,"",429.4,,,ug/dL,,72,Pearson,0.45,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7400,8225,8297,All,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Nitrogen,"",,11.55,,,g/day,,,"Urine, 24-h",Method missing,Nitrogen,"",,,,g/day,,41,Pearson,0.52,,, ,Unspecified,,,,Gonzalez 1997
7406,8225,8219,All,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Nitrogen,"",,11.55,,,g/day,,,"Urine, 24-h",Method missing,Nitrogen,"",12.96,,,g/day,,64,Pearson,0.46,,, ,Unspecified,,,,Gonzalez 1997
7424,8277,8232,All,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),beta-Carotene,"",,2976.2,,,ug/dL,,,"Plasma, fasting",HPLC,beta-Carotene,"",24.2,,,ug/dL,,72,Pearson,0.42,,, ,Unspecified,,,,Gonzalez 1997
7425,8277,8233,All,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),beta-Carotene,"",,2976.2,,,ug/dL,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,95.1,,,ug/dL,,72,Pearson,0.28,,, ,Unspecified,,,,Gonzalez 1997
7428,8277,8232,All,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),beta-Carotene,"",,2976.2,,,ug/dL,,,"Plasma, fasting",HPLC,beta-Carotene,"",24.2,,,ug/dL,,72,Pearson,0.39,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7429,8277,8233,All,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),beta-Carotene,"",,2976.2,,,ug/dL,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,95.1,,,ug/dL,,72,Pearson,0.27,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7426,8278,8234,All,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),alpha-Tocopherol,"",,9.4,,,ug/dL,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",960.3,,,ug/dL,,72,Pearson,0.01,,, ,Unspecified,,,,Gonzalez 1997
7430,8278,8234,All,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),alpha-Tocopherol,"",,9.4,,,ug/dL,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",960.3,,,ug/dL,,72,Pearson,0.36,,, ,Unspecified,"Energy by residual method, Cholesterol",,,Gonzalez 1997
7423,8279,8235,All,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Vitamin C,"",,106.4,,,ug/dL,,,"Plasma, fasting",Fluorometry,Vitamin C,"",429.4,,,ug/dL,,72,Pearson,0.49,,, ,Unspecified,,,,Gonzalez 1997
7427,8279,8235,All,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Vitamin C,"",,106.4,,,ug/dL,,,"Plasma, fasting",Fluorometry,Vitamin C,"",429.4,,,ug/dL,,72,Pearson,0.5,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7401,8223,8298,Males,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),Nitrogen,"",,13.81,,,g/day,,,"Urine, 24-h",Method missing,Nitrogen,"",,,,g/day,,21,Pearson,0.47,,, ,Unspecified,,,,Gonzalez 1997
7407,8223,8220,Males,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),Nitrogen,"",,13.81,,,g/day,,,"Urine, 24-h",Method missing,Nitrogen,"",14.72,,,g/day,,30,Pearson,0.32,,, ,Unspecified,,,,Gonzalez 1997
7432,8281,8241,Males,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),beta-Carotene,"",,4210.2,,,ug/dL,,,"Plasma, fasting",HPLC,beta-Carotene,"",15.2,,,ug/dL,,32,Pearson,0.27,,, ,Unspecified,,,,Gonzalez 1997
7433,8281,8242,Males,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),beta-Carotene,"",,4210.2,,,ug/dL,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,75.6,,,ug/dL,,32,Pearson,0.15,,, ,Unspecified,,,,Gonzalez 1997
7436,8281,8241,Males,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),beta-Carotene,"",,4210.2,,,ug/dL,,,"Plasma, fasting",HPLC,beta-Carotene,"",15.2,,,ug/dL,,32,Pearson,0.21,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7437,8281,8242,Males,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),beta-Carotene,"",,4210.2,,,ug/dL,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,75.6,,,ug/dL,,32,Pearson,0.09,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7434,8282,8243,Males,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",,11.4,,,ug/dL,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",950.5,,,ug/dL,,32,Pearson,-0.1,,, ,Unspecified,,,,Gonzalez 1997
7438,8282,8243,Males,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",,11.4,,,ug/dL,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",950.5,,,ug/dL,,32,Pearson,0.42,,, ,Unspecified,"Energy by residual method, Cholesterol",,,Gonzalez 1997
7431,8283,8244,Males,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),Vitamin C,"",,116.4,,,ug/dL,,,"Plasma, fasting",Fluorometry,Vitamin C,"",333.6,,,ug/dL,,32,Pearson,0.42,,, ,Unspecified,,,,Gonzalez 1997
7435,8283,8244,Males,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),Vitamin C,"",,116.4,,,ug/dL,,,"Plasma, fasting",Fluorometry,Vitamin C,"",333.6,,,ug/dL,,32,Pearson,0.41,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7402,8226,8298,Males,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Nitrogen,"",,13.22,,,g/day,,,"Urine, 24-h",Method missing,Nitrogen,"",,,,g/day,,21,Pearson,0.54,,, ,Unspecified,,,,Gonzalez 1997
7408,8226,8220,Males,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Nitrogen,"",,13.22,,,g/day,,,"Urine, 24-h",Method missing,Nitrogen,"",14.72,,,g/day,,30,Pearson,0.38,,, ,Unspecified,,,,Gonzalez 1997
7440,8285,8241,Males,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),beta-Carotene,"",,2796.4,,,ug/dL,,,"Plasma, fasting",HPLC,beta-Carotene,"",15.2,,,ug/dL,,32,Pearson,0.42,,, ,Unspecified,,,,Gonzalez 1997
7441,8285,8242,Males,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),beta-Carotene,"",,2796.4,,,ug/dL,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,75.6,,,ug/dL,,32,Pearson,0.19,,, ,Unspecified,,,,Gonzalez 1997
7444,8285,8241,Males,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),beta-Carotene,"",,2796.4,,,ug/dL,,,"Plasma, fasting",HPLC,beta-Carotene,"",15.2,,,ug/dL,,32,Pearson,0.37,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7445,8285,8242,Males,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),beta-Carotene,"",,2796.4,,,ug/dL,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,75.6,,,ug/dL,,32,Pearson,0.14,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7442,8286,8243,Males,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),alpha-Tocopherol,"",,10.0,,,ug/dL,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",950.5,,,ug/dL,,32,Pearson,-0.22,,, ,Unspecified,,,,Gonzalez 1997
7446,8286,8243,Males,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),alpha-Tocopherol,"",,10.0,,,ug/dL,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",950.5,,,ug/dL,,32,Pearson,0.26,,, ,Unspecified,"Energy by residual method, Cholesterol",,,Gonzalez 1997
7439,8287,8244,Males,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Vitamin C,"",,100.9,,,ug/dL,,,"Plasma, fasting",Fluorometry,Vitamin C,"",333.6,,,ug/dL,,32,Pearson,0.45,,, ,Unspecified,,,,Gonzalez 1997
7443,8287,8244,Males,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Vitamin C,"",,100.9,,,ug/dL,,,"Plasma, fasting",Fluorometry,Vitamin C,"",333.6,,,ug/dL,,32,Pearson,0.44,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7403,8224,8299,Females,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),Nitrogen,"",,10.83,,,g/day,,,"Urine, 24-h",Method missing,Nitrogen,"",,,,g/day,,20,Pearson,0.49,,, ,Unspecified,,,,Gonzalez 1997
7409,8224,8221,Females,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),Nitrogen,"",,10.83,,,g/day,,,"Urine, 24-h",Method missing,Nitrogen,"",11.39,,,g/day,,34,Pearson,0.26,,, ,Unspecified,,,,Gonzalez 1997
7448,8289,8250,Females,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),beta-Carotene,"",,4584.5,,,ug/dL,,,"Plasma, fasting",HPLC,beta-Carotene,"",31.2,,,ug/dL,,40,Pearson,0.4,,, ,Unspecified,,,,Gonzalez 1997
7449,8289,8251,Females,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),beta-Carotene,"",,4584.5,,,ug/dL,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,110.1,,,ug/dL,,40,Pearson,0.35,,, ,Unspecified,,,,Gonzalez 1997
7452,8289,8250,Females,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),beta-Carotene,"",,4584.5,,,ug/dL,,,"Plasma, fasting",HPLC,beta-Carotene,"",31.2,,,ug/dL,,40,Pearson,0.42,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7453,8289,8251,Females,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),beta-Carotene,"",,4584.5,,,ug/dL,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,110.1,,,ug/dL,,40,Pearson,0.35,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7450,8290,8252,Females,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",,9.5,,,ug/dL,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",967.9,,,ug/dL,,40,Pearson,0.06,,, ,Unspecified,,,,Gonzalez 1997
7454,8290,8252,Females,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",,9.5,,,ug/dL,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",967.9,,,ug/dL,,40,Pearson,0.31,,, ,Unspecified,"Energy by residual method, Cholesterol",,,Gonzalez 1997
7447,8291,8253,Females,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),Vitamin C,"",,121.9,,,ug/dL,,,"Plasma, fasting",Fluorometry,Vitamin C,"",508.0,,,ug/dL,,40,Pearson,0.61,,, ,Unspecified,,,,Gonzalez 1997
7451,8291,8253,Females,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),Vitamin C,"",,121.9,,,ug/dL,,,"Plasma, fasting",Fluorometry,Vitamin C,"",508.0,,,ug/dL,,40,Pearson,0.6,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7404,8227,8299,Females,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Nitrogen,"",,10.1,,,g/day,,,"Urine, 24-h",Method missing,Nitrogen,"",,,,g/day,,20,Pearson,0.22,,, ,Unspecified,,,,Gonzalez 1997
7410,8227,8221,Females,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Nitrogen,"",,10.1,,,g/day,,,"Urine, 24-h",Method missing,Nitrogen,"",11.39,,,g/day,,34,Pearson,0.15,,, ,Unspecified,,,,Gonzalez 1997
7456,8293,8250,Females,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),beta-Carotene,"",,3120.0,,,ug/dL,,,"Plasma, fasting",HPLC,beta-Carotene,"",31.2,,,ug/dL,,40,Pearson,0.44,,, ,Unspecified,,,,Gonzalez 1997
7457,8293,8251,Females,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),beta-Carotene,"",,3120.0,,,ug/dL,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,110.1,,,ug/dL,,40,Pearson,0.32,,, ,Unspecified,,,,Gonzalez 1997
7460,8293,8250,Females,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),beta-Carotene,"",,3120.0,,,ug/dL,,,"Plasma, fasting",HPLC,beta-Carotene,"",31.2,,,ug/dL,,40,Pearson,0.42,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7461,8293,8251,Females,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),beta-Carotene,"",,3120.0,,,ug/dL,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,110.1,,,ug/dL,,40,Pearson,0.31,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7458,8294,8252,Females,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),alpha-Tocopherol,"",,8.9,,,ug/dL,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",967.9,,,ug/dL,,40,Pearson,0.12,,, ,Unspecified,,,,Gonzalez 1997
7462,8294,8252,Females,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),alpha-Tocopherol,"",,8.9,,,ug/dL,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",967.9,,,ug/dL,,40,Pearson,0.42,,, ,Unspecified,"Energy by residual method, Cholesterol",,,Gonzalez 1997
7455,8295,8253,Females,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Vitamin C,"",,110.8,,,ug/dL,,,"Plasma, fasting",Fluorometry,Vitamin C,"",508.0,,,ug/dL,,40,Pearson,0.64,,, ,Unspecified,,,,Gonzalez 1997
7459,8295,8253,Females,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Vitamin C,"",,110.8,,,ug/dL,,,"Plasma, fasting",Fluorometry,Vitamin C,"",508.0,,,ug/dL,,40,Pearson,0.61,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7464,8300,8259,Smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),beta-Carotene,"",,,,,ug/dL,,,"Plasma, fasting",HPLC,beta-Carotene,"",22.6,,,ug/dL,,16,Pearson,0.04,,, ,Unspecified,,,,Gonzalez 1997
7465,8300,8260,Smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),beta-Carotene,"",,,,,ug/dL,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,94.3,,,ug/dL,,16,Pearson,0.03,,, ,Unspecified,,,,Gonzalez 1997
7468,8300,8259,Smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),beta-Carotene,"",,,,,ug/dL,,,"Plasma, fasting",HPLC,beta-Carotene,"",22.6,,,ug/dL,,16,Pearson,0.07,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7469,8300,8260,Smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),beta-Carotene,"",,,,,ug/dL,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,94.3,,,ug/dL,,16,Pearson,-0.01,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7466,8301,8261,Smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",,,,,ug/dL,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",1025.6,,,ug/dL,,16,Pearson,-0.27,,, ,Unspecified,,,,Gonzalez 1997
7470,8301,8261,Smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",,,,,ug/dL,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",1025.6,,,ug/dL,,16,Pearson,0.27,,, ,Unspecified,"Energy by residual method, Cholesterol",,,Gonzalez 1997
7463,8302,8262,Smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),Vitamin C,"",,,,,ug/dL,,,"Plasma, fasting",Fluorometry,Vitamin C,"",315.9,,,ug/dL,,16,Pearson,0.56,,, ,Unspecified,,,,Gonzalez 1997
7467,8302,8262,Smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),Vitamin C,"",,,,,ug/dL,,,"Plasma, fasting",Fluorometry,Vitamin C,"",315.9,,,ug/dL,,16,Pearson,0.64,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7472,8303,8259,Smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),beta-Carotene,"",,,,,ug/dL,,,"Plasma, fasting",HPLC,beta-Carotene,"",22.6,,,ug/dL,,16,Pearson,0.37,,, ,Unspecified,,,,Gonzalez 1997
7473,8303,8260,Smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),beta-Carotene,"",,,,,ug/dL,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,94.3,,,ug/dL,,16,Pearson,0.22,,, ,Unspecified,,,,Gonzalez 1997
7476,8303,8259,Smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),beta-Carotene,"",,,,,ug/dL,,,"Plasma, fasting",HPLC,beta-Carotene,"",22.6,,,ug/dL,,16,Pearson,0.35,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7477,8303,8260,Smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),beta-Carotene,"",,,,,ug/dL,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,94.3,,,ug/dL,,16,Pearson,0.21,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7474,8304,8261,Smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),alpha-Tocopherol,"",,,,,ug/dL,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",1025.6,,,ug/dL,,16,Pearson,-0.41,,, ,Unspecified,,,,Gonzalez 1997
7478,8304,8261,Smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),alpha-Tocopherol,"",,,,,ug/dL,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",1025.6,,,ug/dL,,16,Pearson,-0.11,,, ,Unspecified,"Energy by residual method, Cholesterol",,,Gonzalez 1997
7471,8305,8262,Smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Vitamin C,"",,,,,ug/dL,,,"Plasma, fasting",Fluorometry,Vitamin C,"",315.9,,,ug/dL,,16,Pearson,0.75,,, ,Unspecified,,,,Gonzalez 1997
7475,8305,8262,Smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Vitamin C,"",,,,,ug/dL,,,"Plasma, fasting",Fluorometry,Vitamin C,"",315.9,,,ug/dL,,16,Pearson,0.77,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7480,8306,8268,Non-smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),beta-Carotene,"",,,,,ug/dL,,,"Plasma, fasting",HPLC,beta-Carotene,"",24.7,,,ug/dL,,56,Pearson,0.39,,, ,Unspecified,,,,Gonzalez 1997
7481,8306,8269,Non-smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),beta-Carotene,"",,,,,ug/dL,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,95.3,,,ug/dL,,56,Pearson,0.32,,, ,Unspecified,,,,Gonzalez 1997
7484,8306,8268,Non-smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),beta-Carotene,"",,,,,ug/dL,,,"Plasma, fasting",HPLC,beta-Carotene,"",24.7,,,ug/dL,,56,Pearson,0.39,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7485,8306,8269,Non-smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),beta-Carotene,"",,,,,ug/dL,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,95.3,,,ug/dL,,56,Pearson,0.33,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7482,8307,8270,Non-smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",,,,,ug/dL,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",941.3,,,ug/dL,,56,Pearson,0.07,,, ,Unspecified,,,,Gonzalez 1997
7486,8307,8270,Non-smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),alpha-Tocopherol,"",,,,,ug/dL,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",941.3,,,ug/dL,,56,Pearson,0.41,,, ,Unspecified,"Energy by residual method, Cholesterol",,,Gonzalez 1997
7479,8308,8271,Non-smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),Vitamin C,"",,,,,ug/dL,,,"Plasma, fasting",Fluorometry,Vitamin C,"",462.4,,,ug/dL,,56,Pearson,0.44,,, ,Unspecified,,,,Gonzalez 1997
7483,8308,8271,Non-smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,Diet History Questionnaire (DHQ),Vitamin C,"",,,,,ug/dL,,,"Plasma, fasting",Fluorometry,Vitamin C,"",462.4,,,ug/dL,,56,Pearson,0.43,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7488,8309,8268,Non-smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),beta-Carotene,"",,,,,ug/dL,,,"Plasma, fasting",HPLC,beta-Carotene,"",24.7,,,ug/dL,,56,Pearson,0.44,,, ,Unspecified,,,,Gonzalez 1997
7489,8309,8269,Non-smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),beta-Carotene,"",,,,,ug/dL,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,95.3,,,ug/dL,,56,Pearson,0.31,,, ,Unspecified,,,,Gonzalez 1997
7492,8309,8268,Non-smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),beta-Carotene,"",,,,,ug/dL,,,"Plasma, fasting",HPLC,beta-Carotene,"",24.7,,,ug/dL,,56,Pearson,0.42,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7493,8309,8269,Non-smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),beta-Carotene,"",,,,,ug/dL,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,95.3,,,ug/dL,,56,Pearson,0.3,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7490,8310,8270,Non-smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),alpha-Tocopherol,"",,,,,ug/dL,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",941.3,,,ug/dL,,56,Pearson,0.06,,, ,Unspecified,,,,Gonzalez 1997
7494,8310,8270,Non-smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),alpha-Tocopherol,"",,,,,ug/dL,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",941.3,,,ug/dL,,56,Pearson,0.46,,, ,Unspecified,"Energy by residual method, Cholesterol",,,Gonzalez 1997
7487,8311,8271,Non-smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Vitamin C,"",,,,,ug/dL,,,"Plasma, fasting",Fluorometry,Vitamin C,"",462.4,,,ug/dL,,56,Pearson,0.36,,, ,Unspecified,,,,Gonzalez 1997
7491,8311,8271,Non-smokers,Adults in Mataró,Spain,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Vitamin C,"",,,,,ug/dL,,,"Plasma, fasting",Fluorometry,Vitamin C,"",462.4,,,ug/dL,,56,Pearson,0.36,,, ,Unspecified,Energy by residual method,,,Gonzalez 1997
7499,8331,8358,Males,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Proteins,"",,99.0,,,g/day,,,"Urine, 24-h",Chemiluminescence nitrogen analyzer,Nitrogen,"",,,,g/day,,46,Pearson,0.47,,, ,Unspecified,,No,,Ocke 1997
7504,8331,8358,Males,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Proteins,"",,99.0,,,g/day,,,"Urine, 24-h",Chemiluminescence nitrogen analyzer,Nitrogen,"",,,,g/day,,46,Pearson,0.47,,, ,Unspecified,Energy by residual method,No,,Ocke 1997
7509,8331,8358,Males,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Proteins,"",,99.0,,,g/day,,,"Urine, 24-h",Chemiluminescence nitrogen analyzer,Nitrogen,"",,,,g/day,,46,Pearson,0.56,,, ,Unspecified,,Yes,,Ocke 1997
7514,8331,8358,Males,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Proteins,"",,99.0,,,g/day,,,"Urine, 24-h",Chemiluminescence nitrogen analyzer,Nitrogen,"",,,,g/day,,46,Pearson,0.56,,, ,Unspecified,Energy by residual method,Yes,,Ocke 1997
7497,8333,8355,Males,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,1.88,,,mg/day,,,"Serum, non-fasting",HPLC,beta-Carotene,"",,,,missing unit,,63,Pearson,-0.16,,, ,Unspecified,,No,,Ocke 1997
7502,8333,8355,Males,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,1.88,,,mg/day,,,"Serum, non-fasting",HPLC,beta-Carotene,"",,,,missing unit,,63,Pearson,-0.14,,, ,Unspecified,Energy by residual method,No,,Ocke 1997
7507,8333,8355,Males,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,1.88,,,mg/day,,,"Serum, non-fasting",HPLC,beta-Carotene,"",,,,missing unit,,63,Pearson,-0.17,,, ,Unspecified,,Yes,,Ocke 1997
7512,8333,8355,Males,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,1.88,,,mg/day,,,"Serum, non-fasting",HPLC,beta-Carotene,"",,,,missing unit,,63,Pearson,-0.15,,, ,Unspecified,Energy by residual method,Yes,,Ocke 1997
7495,8335,8354,Males,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin E,"",,19.0,,,mg/day,,,"Serum, non-fasting",Fluorometry,alpha-Tocopherol,"",,,,missing unit,,63,Pearson,0.2,,, ,Unspecified,Cholesterol,No,,Ocke 1997
7500,8335,8354,Males,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin E,"",,19.0,,,mg/day,,,"Serum, non-fasting",Fluorometry,alpha-Tocopherol,"",,,,missing unit,,63,Pearson,0.29,,, ,Unspecified,"Cholesterol, Energy by residual method",No,,Ocke 1997
7505,8335,8354,Males,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin E,"",,19.0,,,mg/day,,,"Serum, non-fasting",Fluorometry,alpha-Tocopherol,"",,,,missing unit,,63,Pearson,0.21,,, ,Unspecified,Cholesterol,Yes,,Ocke 1997
7510,8335,8354,Males,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin E,"",,19.0,,,mg/day,,,"Serum, non-fasting",Fluorometry,alpha-Tocopherol,"",,,,missing unit,,63,Pearson,0.3,,, ,Unspecified,"Cholesterol, Energy by residual method",Yes,,Ocke 1997
7519,8345,8363,Females,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Proteins,"",,72.0,,,g/day,,,"Urine, 24-h",Chemiluminescence nitrogen analyzer,Nitrogen,"",,,,g/day,,43,Pearson,0.53,,, ,Unspecified,,No,,Ocke 1997
7524,8345,8363,Females,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Proteins,"",,72.0,,,g/day,,,"Urine, 24-h",Chemiluminescence nitrogen analyzer,Nitrogen,"",,,,g/day,,43,Pearson,0.63,,, ,Unspecified,Energy by residual method,No,,Ocke 1997
7529,8345,8363,Females,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Proteins,"",,72.0,,,g/day,,,"Urine, 24-h",Chemiluminescence nitrogen analyzer,Nitrogen,"",,,,g/day,,43,Pearson,0.58,,, ,Unspecified,,Yes,,Ocke 1997
7534,8345,8363,Females,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Proteins,"",,72.0,,,g/day,,,"Urine, 24-h",Chemiluminescence nitrogen analyzer,Nitrogen,"",,,,g/day,,43,Pearson,0.69,,, ,Unspecified,Energy by residual method,Yes,,Ocke 1997
7517,8347,8360,Females,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,1.51,,,mg/day,,,"Serum, non-fasting",HPLC,beta-Carotene,"",,,,missing unit,,58,Pearson,0.13,,, ,Unspecified,,No,,Ocke 1997
7522,8347,8360,Females,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,1.51,,,mg/day,,,"Serum, non-fasting",HPLC,beta-Carotene,"",,,,missing unit,,58,Pearson,0.17,,, ,Unspecified,Energy by residual method,No,,Ocke 1997
7527,8347,8360,Females,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,1.51,,,mg/day,,,"Serum, non-fasting",HPLC,beta-Carotene,"",,,,missing unit,,58,Pearson,0.14,,, ,Unspecified,,Yes,,Ocke 1997
7532,8347,8360,Females,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,1.51,,,mg/day,,,"Serum, non-fasting",HPLC,beta-Carotene,"",,,,missing unit,,58,Pearson,0.18,,, ,Unspecified,Energy by residual method,Yes,,Ocke 1997
7515,8349,8359,Females,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin E,"",,14.0,,,mg/day,,,"Serum, non-fasting",Fluorometry,alpha-Tocopherol,"",,,,missing unit,,58,Pearson,0.07,,, ,Unspecified,Cholesterol,No,,Ocke 1997
7520,8349,8359,Females,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin E,"",,14.0,,,mg/day,,,"Serum, non-fasting",Fluorometry,alpha-Tocopherol,"",,,,missing unit,,58,Pearson,0.14,,, ,Unspecified,"Cholesterol, Energy by residual method",No,,Ocke 1997
7525,8349,8359,Females,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin E,"",,14.0,,,mg/day,,,"Serum, non-fasting",Fluorometry,alpha-Tocopherol,"",,,,missing unit,,58,Pearson,0.07,,, ,Unspecified,Cholesterol,Yes,,Ocke 1997
7530,8349,8359,Females,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin E,"",,14.0,,,mg/day,,,"Serum, non-fasting",Fluorometry,alpha-Tocopherol,"",,,,missing unit,,58,Pearson,0.14,,, ,Unspecified,"Cholesterol, Energy by residual method",Yes,,Ocke 1997
7496,8350,8356,Males - Supplement nonusers,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,,,,mg/day,,,"Serum, non-fasting",Fluorometry,alpha-Tocopherol,"",,,,missing unit,,56,Pearson,0.23,,, ,Unspecified,Cholesterol,No,,Ocke 1997
7501,8350,8356,Males - Supplement nonusers,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,,,,mg/day,,,"Serum, non-fasting",Fluorometry,alpha-Tocopherol,"",,,,missing unit,,56,Pearson,0.32,,, ,Unspecified,"Cholesterol, Energy by residual method",No,,Ocke 1997
7506,8350,8356,Males - Supplement nonusers,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,,,,mg/day,,,"Serum, non-fasting",Fluorometry,alpha-Tocopherol,"",,,,missing unit,,56,Pearson,0.24,,, ,Unspecified,Cholesterol,Yes,,Ocke 1997
7511,8350,8356,Males - Supplement nonusers,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,,,,mg/day,,,"Serum, non-fasting",Fluorometry,alpha-Tocopherol,"",,,,missing unit,,56,Pearson,0.33,,, ,Unspecified,"Cholesterol, Energy by residual method",Yes,,Ocke 1997
7498,8351,8357,Males - Non-smokers,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Serum, non-fasting",HPLC,beta-Carotene,"",,,,missing unit,,41,Pearson,-0.16,,, ,Unspecified,,No,,Ocke 1997
7503,8351,8357,Males - Non-smokers,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Serum, non-fasting",HPLC,beta-Carotene,"",,,,missing unit,,41,Pearson,-0.08,,, ,Unspecified,Energy by residual method,No,,Ocke 1997
7508,8351,8357,Males - Non-smokers,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Serum, non-fasting",HPLC,beta-Carotene,"",,,,missing unit,,41,Pearson,-0.17,,, ,Unspecified,,Yes,,Ocke 1997
7513,8351,8357,Males - Non-smokers,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Serum, non-fasting",HPLC,beta-Carotene,"",,,,missing unit,,41,Pearson,-0.08,,, ,Unspecified,Energy by residual method,Yes,,Ocke 1997
7516,8352,8361,Females - Supplement nonusers,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,,,,mg/day,,,"Serum, non-fasting",Fluorometry,alpha-Tocopherol,"",,,,missing unit,,50,Pearson,0.15,,, ,Unspecified,Cholesterol,No,,Ocke 1997
7521,8352,8361,Females - Supplement nonusers,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,,,,mg/day,,,"Serum, non-fasting",Fluorometry,alpha-Tocopherol,"",,,,missing unit,,50,Pearson,0.13,,, ,Unspecified,"Cholesterol, Energy by residual method",No,,Ocke 1997
7526,8352,8361,Females - Supplement nonusers,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,,,,mg/day,,,"Serum, non-fasting",Fluorometry,alpha-Tocopherol,"",,,,missing unit,,50,Pearson,0.15,,, ,Unspecified,Cholesterol,Yes,,Ocke 1997
7531,8352,8361,Females - Supplement nonusers,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,,,,mg/day,,,"Serum, non-fasting",Fluorometry,alpha-Tocopherol,"",,,,missing unit,,50,Pearson,0.13,,, ,Unspecified,"Cholesterol, Energy by residual method",Yes,,Ocke 1997
7518,8353,8362,Females - Non-smokers,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Serum, non-fasting",HPLC,beta-Carotene,"",,,,missing unit,,39,Pearson,0.11,,, ,Unspecified,,No,,Ocke 1997
7523,8353,8362,Females - Non-smokers,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Serum, non-fasting",HPLC,beta-Carotene,"",,,,missing unit,,39,Pearson,0.17,,, ,Unspecified,Energy by residual method,No,,Ocke 1997
7528,8353,8362,Females - Non-smokers,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Serum, non-fasting",HPLC,beta-Carotene,"",,,,missing unit,,39,Pearson,0.12,,, ,Unspecified,,Yes,,Ocke 1997
7533,8353,8362,Females - Non-smokers,Participants in a dietary validation study,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Serum, non-fasting",HPLC,beta-Carotene,"",,,,missing unit,,39,Pearson,0.18,,, ,Unspecified,Energy by residual method,Yes,,Ocke 1997
7538,8412,8420,All [by gender],Schoolteachers participant in a dietary validation study,Greece,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Proteins,"",,,,,g/day,,,"Urine, 24-h",Kjeldahl method,Nitrogen,"",,,,missing unit,,79,Pearson,0.36,,, ,Unspecified,,No,"Age, BMI, Sex, Cholesterol",Katsouyanni 1997
7547,8412,8420,All [by gender],Schoolteachers participant in a dietary validation study,Greece,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Proteins,"",,,,,g/day,,,"Urine, 24-h",Kjeldahl method,Nitrogen,"",,,,missing unit,,79,Pearson,0.42,,, ,Unspecified,,Yes,"Age, BMI, Sex, Cholesterol",Katsouyanni 1997
7536,8414,8422,All [by gender],Schoolteachers participant in a dietary validation study,Greece,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,59,Pearson,0.03,,, ,Unspecified,,No,"Age, BMI, Sex, Cholesterol",Katsouyanni 1997
7537,8415,8423,All [by gender],Schoolteachers participant in a dietary validation study,Greece,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin C,"",,,,,mg/day,,,"Plasma, fasting",HPLC,Ascorbic acid,"",,,,missing unit,,54,Pearson,0.3,,, ,Unspecified,,No,"Age, BMI, Sex, Cholesterol",Katsouyanni 1997
7542,8416,8420,All [by gender],Schoolteachers participant in a dietary validation study,Greece,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Proteins,"",,,,,g/day,,,"Urine, 24-h",Kjeldahl method,Nitrogen,"",,,,missing unit,,79,Pearson,0.3,,, ,Unspecified,,No,"Age, BMI, Sex, Cholesterol",Katsouyanni 1997
7548,8416,8420,All [by gender],Schoolteachers participant in a dietary validation study,Greece,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Proteins,"",,,,,g/day,,,"Urine, 24-h",Kjeldahl method,Nitrogen,"",,,,missing unit,,79,Pearson,0.34,,, ,Unspecified,,Yes,"Age, BMI, Sex, Cholesterol",Katsouyanni 1997
7540,8418,8422,All [by gender],Schoolteachers participant in a dietary validation study,Greece,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,,,,mg/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,58,Pearson,-0.11,,, ,Unspecified,,No,"Age, BMI, Sex, Cholesterol",Katsouyanni 1997
7541,8419,8423,All [by gender],Schoolteachers participant in a dietary validation study,Greece,EPIC (European Prospective Investigation into Cancer and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin C,"",,,,,mg/day,,,"Plasma, fasting",HPLC,Ascorbic acid,"",,,,missing unit,,54,Pearson,0.14,,, ,Unspecified,,No,"Age, BMI, Sex, Cholesterol",Katsouyanni 1997
7546,8408,8420,All [by gender],Schoolteachers participant in a dietary validation study,Greece,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Proteins,"",,,,,g/day,,,"Urine, 24-h",Kjeldahl method,Nitrogen,"",,,,missing unit,,79,Pearson,0.47,,, ,Unspecified,,No,"Age, BMI, Sex, Cholesterol",Katsouyanni 1997
7544,8410,8422,All [by gender],Schoolteachers participant in a dietary validation study,Greece,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),beta-Carotene,"",,,,,mg/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,missing unit,,61,Pearson,0.22,,, ,Unspecified,,No,"Age, BMI, Sex, Cholesterol",Katsouyanni 1997
7545,8411,8423,All [by gender],Schoolteachers participant in a dietary validation study,Greece,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Vitamin C,"",,,,,mg/day,,,"Plasma, fasting",HPLC,Ascorbic acid,"",,,,missing unit,,54,Pearson,0.33,,, ,Unspecified,,No,"Age, BMI, Sex, Cholesterol",Katsouyanni 1997
7585,8460,8480,All,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,2.87,,,mg/day,,baseline,"Plasma, unspecified",HPLC,beta-Carotene,"",0.43,,,umol/L,,157,Unspecified,0.317,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7586,8461,8481,All,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,0.6,,,mg/day,,baseline,"Plasma, unspecified",HPLC,alpha-Carotene,"",0.12,,,umol/L,,144,Unspecified,0.432,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7587,8462,8482,All,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),Lycopene,"",No,0.4,,,mg/day,,baseline,"Plasma, unspecified",HPLC,Lycopene,"",0.63,,,umol/L,,144,Unspecified,0.295,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7588,8463,8483,All,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,2.13,,,mg/day,,baseline,"Plasma, unspecified",HPLC,Lutein,"",0.18,,,umol/L,,92,Unspecified,0.255,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7581,8456,8480,All,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,3.45,,,mg/day,,baseline,"Plasma, unspecified",HPLC,beta-Carotene,"",0.43,,,umol/L,,157,Unspecified,0.441,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7582,8457,8481,All,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,0.55,,,mg/day,,baseline,"Plasma, unspecified",HPLC,alpha-Carotene,"",0.12,,,umol/L,,144,Unspecified,0.431,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7583,8458,8482,All,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),Lycopene,"",No,0.43,,,mg/day,,baseline,"Plasma, unspecified",HPLC,Lycopene,"",0.63,,,umol/L,,144,Unspecified,0.265,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7584,8459,8483,All,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,1.89,,,mg/day,,baseline,"Plasma, unspecified",HPLC,Lutein,"",0.18,,,umol/L,,92,Unspecified,0.301,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7577,8452,8476,Smokers males,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,2.7,,,mg/day,,baseline,"Plasma, unspecified",HPLC,beta-Carotene,"",0.23,,,umol/L,,25,Unspecified,0.397,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7578,8453,8477,Smokers males,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,0.43,,,mg/day,,baseline,"Plasma, unspecified",HPLC,alpha-Carotene,"",0.08,,,umol/L,,21,Unspecified,0.595,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7579,8454,8478,Smokers males,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),Lycopene,"",No,0.4,,,mg/day,,baseline,"Plasma, unspecified",HPLC,Lycopene,"",0.58,,,umol/L,,21,Unspecified,0.301,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7580,8455,8479,Smokers males,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,2.31,,,mg/day,,baseline,"Plasma, unspecified",HPLC,Lutein,"",0.14,,,umol/L,,21,Unspecified,0.364,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7573,8448,8476,Smokers males,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,3.27,,,mg/day,,baseline,"Plasma, unspecified",HPLC,beta-Carotene,"",0.23,,,umol/L,,25,Unspecified,0.556,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7574,8449,8477,Smokers males,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,0.46,,,mg/day,,baseline,"Plasma, unspecified",HPLC,alpha-Carotene,"",0.08,,,umol/L,,21,Unspecified,0.671,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7575,8450,8478,Smokers males,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),Lycopene,"",No,0.46,,,mg/day,,baseline,"Plasma, unspecified",HPLC,Lycopene,"",0.58,,,umol/L,,21,Unspecified,0.15,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7576,8451,8479,Smokers males,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,2.12,,,mg/day,,baseline,"Plasma, unspecified",HPLC,Lutein,"",0.14,,,umol/L,,21,Unspecified,0.405,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7569,8444,8472,Non-smokers males,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,3.26,,,mg/day,,baseline,"Plasma, unspecified",HPLC,beta-Carotene,"",0.41,,,umol/L,,63,Unspecified,0.254,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7570,8445,8473,Non-smokers males,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,0.77,,,mg/day,,baseline,"Plasma, unspecified",HPLC,alpha-Carotene,"",0.11,,,umol/L,,55,Unspecified,0.49,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7571,8446,8474,Non-smokers males,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),Lycopene,"",No,0.39,,,mg/day,,baseline,"Plasma, unspecified",HPLC,Lycopene,"",0.66,,,umol/L,,55,Unspecified,0.226,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7572,8447,8475,Non-smokers males,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,2.11,,,mg/day,,baseline,"Plasma, unspecified",HPLC,Lutein,"",0.2,,,umol/L,,28,Unspecified,0.325,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7565,8440,8472,Non-smokers males,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,3.64,,,mg/day,,baseline,"Plasma, unspecified",HPLC,beta-Carotene,"",0.41,,,umol/L,,63,Unspecified,0.319,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7566,8441,8473,Non-smokers males,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,0.61,,,mg/day,,baseline,"Plasma, unspecified",HPLC,alpha-Carotene,"",0.11,,,umol/L,,55,Unspecified,0.507,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7567,8442,8474,Non-smokers males,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),Lycopene,"",No,0.45,,,mg/day,,baseline,"Plasma, unspecified",HPLC,Lycopene,"",0.66,,,umol/L,,55,Unspecified,0.208,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7568,8443,8475,Non-smokers males,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,1.97,,,mg/day,,baseline,"Plasma, unspecified",HPLC,Lutein,"",0.2,,,umol/L,,28,Unspecified,0.358,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7561,8436,8468,Smokers females,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,2.3,,,mg/day,,baseline,"Plasma, unspecified",HPLC,beta-Carotene,"",0.26,,,umol/L,,12,Unspecified,-0.037,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7562,8437,8469,Smokers females,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,0.42,,,mg/day,,baseline,"Plasma, unspecified",HPLC,alpha-Carotene,"",0.09,,,umol/L,,12,Unspecified,0.089,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7563,8438,8470,Smokers females,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),Lycopene,"",No,0.38,,,mg/day,,baseline,"Plasma, unspecified",HPLC,Lycopene,"",0.6,,,umol/L,,12,Unspecified,0.349,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7564,8439,8471,Smokers females,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,2.39,,,mg/day,,baseline,"Plasma, unspecified",HPLC,Lutein,"",0.18,,,umol/L,,12,Unspecified,-0.012,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7557,8432,8468,Smokers females,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,2.9,,,mg/day,,baseline,"Plasma, unspecified",HPLC,beta-Carotene,"",0.26,,,umol/L,,12,Unspecified,0.506,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7558,8433,8469,Smokers females,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,0.51,,,mg/day,,baseline,"Plasma, unspecified",HPLC,alpha-Carotene,"",0.09,,,umol/L,,12,Unspecified,0.171,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7559,8434,8470,Smokers females,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),Lycopene,"",No,0.38,,,mg/day,,baseline,"Plasma, unspecified",HPLC,Lycopene,"",0.6,,,umol/L,,12,Unspecified,0.319,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7560,8435,8471,Smokers females,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,1.93,,,mg/day,,baseline,"Plasma, unspecified",HPLC,Lutein,"",0.18,,,umol/L,,12,Unspecified,-0.014,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7553,8428,8464,Non-smokers females,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,2.61,,,mg/day,,baseline,"Plasma, unspecified",HPLC,beta-Carotene,"",0.56,,,umol/L,,56,Unspecified,0.507,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7554,8429,8465,Non-smokers females,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,0.52,,,mg/day,,baseline,"Plasma, unspecified",HPLC,alpha-Carotene,"",0.15,,,umol/L,,56,Unspecified,0.405,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7555,8430,8466,Non-smokers females,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),Lycopene,"",No,0.4,,,mg/day,,baseline,"Plasma, unspecified",HPLC,Lycopene,"",0.64,,,umol/L,,56,Unspecified,0.374,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7556,8431,8467,Non-smokers females,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,1.93,,,mg/day,,baseline,"Plasma, unspecified",HPLC,Lutein,"",0.18,,,umol/L,,31,Unspecified,0.39,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7549,8424,8464,Non-smokers females,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,3.42,,,mg/day,,baseline,"Plasma, unspecified",HPLC,beta-Carotene,"",0.56,,,umol/L,,56,Unspecified,0.577,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7550,8425,8465,Non-smokers females,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",No,0.53,,,mg/day,,baseline,"Plasma, unspecified",HPLC,alpha-Carotene,"",0.15,,,umol/L,,56,Unspecified,0.369,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7551,8426,8466,Non-smokers females,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),Lycopene,"",No,0.39,,,mg/day,,baseline,"Plasma, unspecified",HPLC,Lycopene,"",0.64,,,umol/L,,56,Unspecified,0.374,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7552,8427,8467,Non-smokers females,Adults at the Arizona Cancer Center,United States,,baseline,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",No,1.63,,,mg/day,,baseline,"Plasma, unspecified",HPLC,Lutein,"",0.18,,,umol/L,,31,Unspecified,0.449,,, ,Unspecified,,,"BMI, Energy",Ritenbaugh 1996
7596,8485,8494,All,Controls from a dietary intervention trial,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.56,,,g/day,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",0.06,,,percentRoot,,24,Pearson,0.43,,,>= 0.05,No,,,,Marckmann 1995
7601,8485,8495,All,Controls from a dietary intervention trial,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.56,,,g/day,,,"Adipose tissue, buttocks",GC-FID,DPA (cis-22:5n-3),"",0.2,,,percentRoot,,24,Pearson,0.36,,,>= 0.05,No,,,,Marckmann 1995
7606,8485,8496,All,Controls from a dietary intervention trial,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.56,,,g/day,,,"Adipose tissue, buttocks",GC-FID,DHA (cis-22:6n-3),"",0.21,,,percentRoot,,24,Pearson,0.58,,,< 0.01,Yes,,,,Marckmann 1995
7597,8489,8494,All,Controls from a dietary intervention trial,Denmark,,,Weighed Dietary record (7-day),Fish,"",,24.0,,,g/day,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",0.06,,,percentRoot,,24,Pearson,0.4,,,>= 0.05,No,,,,Marckmann 1995
7602,8489,8495,All,Controls from a dietary intervention trial,Denmark,,,Weighed Dietary record (7-day),Fish,"",,24.0,,,g/day,,,"Adipose tissue, buttocks",GC-FID,DPA (cis-22:5n-3),"",0.2,,,percentRoot,,24,Pearson,0.28,,,>= 0.05,No,,,,Marckmann 1995
7607,8489,8496,All,Controls from a dietary intervention trial,Denmark,,,Weighed Dietary record (7-day),Fish,"",,24.0,,,g/day,,,"Adipose tissue, buttocks",GC-FID,DHA (cis-22:6n-3),"",0.21,,,percentRoot,,24,Pearson,0.55,,,< 0.01,Yes,,,,Marckmann 1995
7589,8497,8490,All,Controls from a dietary intervention trial,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)","",28.6,,,percentRoot,,24,Pearson,0.34,,,>= 0.05,No,,,,Marckmann 1995
7591,8497,8492,All,Controls from a dietary intervention trial,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),12.8,,,percentRoot,,24,Pearson,-0.24,,,>= 0.05,No,,,,Marckmann 1995
7590,8498,8490,All,Controls from a dietary intervention trial,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)","",28.6,,,percentRoot,,24,Pearson,-0.23,,,>= 0.05,No,,,,Marckmann 1995
7592,8498,8492,All,Controls from a dietary intervention trial,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),12.8,,,percentRoot,,24,Pearson,0.38,,,>= 0.05,No,,,,Marckmann 1995
7593,8499,8494,All,Controls from a dietary intervention trial,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",0.06,,,percentRoot,,24,Pearson,0.45,,,< 0.05,Yes,,,,Marckmann 1995
7598,8499,8495,All,Controls from a dietary intervention trial,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DPA (cis-22:5n-3),"",0.2,,,percentRoot,,24,Pearson,0.35,,,>= 0.05,No,,,,Marckmann 1995
7603,8499,8496,All,Controls from a dietary intervention trial,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DHA (cis-22:6n-3),"",0.21,,,percentRoot,,24,Pearson,0.58,,,< 0.001,Yes,,,,Marckmann 1995
7594,8500,8494,All,Controls from a dietary intervention trial,Denmark,,,Weighed Dietary record (7-day),EPA (cis-20:5n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",0.06,,,percentRoot,,24,Pearson,0.4,,,>= 0.05,No,,,,Marckmann 1995
7599,8500,8495,All,Controls from a dietary intervention trial,Denmark,,,Weighed Dietary record (7-day),EPA (cis-20:5n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DPA (cis-22:5n-3),"",0.2,,,percentRoot,,24,Pearson,0.3,,,>= 0.05,No,,,,Marckmann 1995
7604,8500,8496,All,Controls from a dietary intervention trial,Denmark,,,Weighed Dietary record (7-day),EPA (cis-20:5n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DHA (cis-22:6n-3),"",0.21,,,percentRoot,,24,Pearson,0.52,,,< 0.01,Yes,,,,Marckmann 1995
7595,8501,8494,All,Controls from a dietary intervention trial,Denmark,,,Weighed Dietary record (7-day),DHA (cis-22:6n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",0.06,,,percentRoot,,24,Pearson,0.46,,,< 0.05,Yes,,,,Marckmann 1995
7600,8501,8495,All,Controls from a dietary intervention trial,Denmark,,,Weighed Dietary record (7-day),DHA (cis-22:6n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DPA (cis-22:5n-3),"",0.2,,,percentRoot,,24,Pearson,0.44,,,>= 0.05,No,,,,Marckmann 1995
7605,8501,8496,All,Controls from a dietary intervention trial,Denmark,,,Weighed Dietary record (7-day),DHA (cis-22:6n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DHA (cis-22:6n-3),"",0.21,,,percentRoot,,24,Pearson,0.66,,,< 0.001,Yes,,,,Marckmann 1995
7608,8505,8502,All,Students and technicians attending the Agriculture Faculty and the Nursing School of San Carlo Hospital of Milan,Italy,,,Food Frequency Questionnaire (FFQ),Proteins,"",,68.0,,,g/day,,,"Urine, 24-h",Spectrophotometry,Nitrogen,"",68.0,,,g/day,,44,Spearman,0.453,,,= 0.003,Yes,,,,Porrini 1995
7609,8506,8503,All,Students and technicians attending the Agriculture Faculty and the Nursing School of San Carlo Hospital of Milan,Italy,,,Food Frequency Questionnaire (FFQ),Phosphorus,"",,41.6,,,mmol/day,,,"Urine, 24-h",Spectrophotometry,Phosphorus,"",28.4,,,mmol/day,,44,Spearman,0.389,,,= 0.011,Yes,,,,Porrini 1995
7610,8507,8504,All,Students and technicians attending the Agriculture Faculty and the Nursing School of San Carlo Hospital of Milan,Italy,,,Food Frequency Questionnaire (FFQ),Potassium,"",,63.7,,,mmol/day,,,"Urine, 24-h",Potentiometric method,Potassium,"",53.8,,,mmol/day,,44,Spearman,0.176,,,= 0.249,No,,,,Porrini 1995
7614,8514,8511,All,Students and technicians attending the Agriculture Faculty and the Nursing School of San Carlo Hospital of Milan,Italy,,,Food Frequency Questionnaire (FFQ),Vitamin C,"",No,108.7,,,mg/day,,,"Whole blood, fasting",HPLC,Vitamin C,"",9.9,,,mg/L,,38,Spearman,0.069,,,= 0.676,No,,,,Porrini 1995
7615,8515,8512,All,Students and technicians attending the Agriculture Faculty and the Nursing School of San Carlo Hospital of Milan,Italy,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,3569.5,,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",391.0,,,ug/L,,38,Spearman,-0.068,,,= 0.679,No,,,,Porrini 1995
7616,8516,8513,All,Students and technicians attending the Agriculture Faculty and the Nursing School of San Carlo Hospital of Milan,Italy,,,Food Frequency Questionnaire (FFQ),alpha-Tocopherol,"",No,4.4,,,mg/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",11.5,,,ug/mL,,38,Spearman,-0.22,,,= 0.18,No,,,,Porrini 1995
7611,8508,8502,All,Students and technicians attending the Agriculture Faculty and the Nursing School of San Carlo Hospital of Milan,Italy,,,Weighed Dietary record (7-day),Proteins,"",,69.0,,,g/day,,,"Urine, 24-h",Spectrophotometry,Nitrogen,"",68.0,,,g/day,,44,Spearman,0.769,,,= 0.000,Yes,,,,Porrini 1995
7612,8509,8503,All,Students and technicians attending the Agriculture Faculty and the Nursing School of San Carlo Hospital of Milan,Italy,,,Weighed Dietary record (7-day),Phosphorus,"",,35.3,,,mmol/day,,,"Urine, 24-h",Spectrophotometry,Phosphorus,"",28.4,,,mmol/day,,44,Spearman,0.566,,,= 0.000,Yes,,,,Porrini 1995
7613,8510,8504,All,Students and technicians attending the Agriculture Faculty and the Nursing School of San Carlo Hospital of Milan,Italy,,,Weighed Dietary record (7-day),Potassium,"",,61.1,,,mmol/day,,,"Urine, 24-h",Potentiometric method,Potassium,"",53.8,,,mmol/day,,44,Spearman,0.417,,,= 0.006,Yes,,,,Porrini 1995
7617,8517,8511,All,Students and technicians attending the Agriculture Faculty and the Nursing School of San Carlo Hospital of Milan,Italy,,,Weighed Dietary record (7-day),Vitamin C,"",No,86.4,,,mg/day,,,"Whole blood, fasting",HPLC,Vitamin C,"",9.9,,,mg/L,,38,Spearman,0.437,,,= 0.008,Yes,,,,Porrini 1995
7618,8518,8512,All,Students and technicians attending the Agriculture Faculty and the Nursing School of San Carlo Hospital of Milan,Italy,,,Weighed Dietary record (7-day),beta-Carotene,"",No,2653.2,,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",391.0,,,ug/L,,38,Spearman,0.439,,,= 0.008,Yes,,,,Porrini 1995
7619,8519,8513,All,Students and technicians attending the Agriculture Faculty and the Nursing School of San Carlo Hospital of Milan,Italy,,,Weighed Dietary record (7-day),alpha-Tocopherol,"",No,3.7,,,mg/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",11.5,,,ug/mL,,38,Spearman,0.098,,,= 0.551,No,,,,Porrini 1995
7620,8593,8614,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0),,,,,g/day,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,percentRoot,,3570,Pearson,0.1,,,<= 0.01,Yes,,No,,Ma 1995
7761,8593,8625,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0),,,,,g/day,,,"Plasma (phospholipids), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0),,,,percentRoot,,3570,Pearson,0.06,,,<= 0.01,Yes,,No,,Ma 1995
7621,8594,8615,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,,g/day,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,percentRoot,,3570,Pearson,0.05,,,<= 0.01,Yes,,No,,Ma 1995
7762,8594,8626,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,,g/day,,,"Plasma (phospholipids), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,percentRoot,,3570,Pearson,0.06,,,<= 0.01,Yes,,No,,Ma 1995
7622,8595,8616,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,g/day,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,3570,Pearson,0.09,,,<= 0.01,Yes,,No,,Ma 1995
7763,8595,8627,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,g/day,,,"Plasma (phospholipids), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,3570,Pearson,0.05,,,<= 0.01,Yes,,No,,Ma 1995
7623,8596,8617,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),PUFA / SFA,"",,,,,without unit,,,"Plasma (cholesterol esters), fasting",GC-FID,PUFA / SFA,"",,,,without unit,,3570,Pearson,0.3,,,<= 0.01,Yes,,No,,Ma 1995
7764,8596,8628,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),PUFA / SFA,"",,,,,without unit,,,"Plasma (phospholipids), fasting",GC-FID,PUFA / SFA,"",,,,without unit,,3570,Pearson,0.24,,,<= 0.01,Yes,,No,,Ma 1995
7624,8597,8618,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,,,,g/day,,,"Plasma (cholesterol esters), fasting",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,3570,Pearson,0.04,,, ,Unspecified,,No,,Ma 1995
7765,8597,8629,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,,,,g/day,,,"Plasma (phospholipids), fasting",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,3570,Pearson,-0.01,,, ,Unspecified,,No,,Ma 1995
7625,8598,8620,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,,,,g/day,,,"Plasma (cholesterol esters), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,3570,Pearson,0.1,,,<= 0.01,Yes,,No,,Ma 1995
7766,8598,8630,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,,,,g/day,,,"Plasma (phospholipids), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,3570,Pearson,0.08,,,<= 0.01,Yes,,No,,Ma 1995
7626,8599,8621,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,g/day,,,"Plasma (cholesterol esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,3570,Pearson,0.13,,,<= 0.01,Yes,,No,,Ma 1995
7767,8599,8631,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,g/day,,,"Plasma (phospholipids), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,3570,Pearson,0.11,,,<= 0.01,Yes,,No,,Ma 1995
7627,8600,8622,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,,,,g/day,,,"Plasma (cholesterol esters), fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,percentRoot,,3570,Pearson,-0.02,,, ,Unspecified,,No,,Ma 1995
7768,8600,8632,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,,,,g/day,,,"Plasma (phospholipids), fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,percentRoot,,3570,Pearson,-0.02,,, ,Unspecified,,No,,Ma 1995
7628,8601,8623,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,,,,g/day,,,"Plasma (cholesterol esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,3570,Pearson,0.21,,,<= 0.01,Yes,,No,,Ma 1995
7769,8601,8633,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,,,,g/day,,,"Plasma (phospholipids), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,3570,Pearson,0.19,,,<= 0.01,Yes,,No,,Ma 1995
7629,8602,8624,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,,,,g/day,,,"Plasma (cholesterol esters), fasting",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,3570,Pearson,0.38,,,<= 0.01,Yes,,No,,Ma 1995
7770,8602,8634,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,,,,g/day,,,"Plasma (phospholipids), fasting",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,3570,Pearson,0.38,,,<= 0.01,Yes,,No,,Ma 1995
7630,8603,8614,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,percentRoot,,3570,Pearson,0.23,,,<= 0.01,Yes,,No,,Ma 1995
7641,8603,8615,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,percentRoot,,3570,Pearson,0.26,,,<= 0.01,Yes,,No,,Ma 1995
7652,8603,8616,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,3570,Pearson,-0.28,,,<= 0.01,Yes,,No,,Ma 1995
7663,8603,8617,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,PUFA / SFA,"",,,,without unit,,3570,Pearson,-0.28,,,<= 0.01,Yes,,No,,Ma 1995
7674,8603,8618,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,3570,Pearson,0.18,,,<= 0.01,Yes,,No,,Ma 1995
7685,8603,8619,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Stearic acid (18:0),"",,,,percentRoot,,3570,Pearson,0.1,,,<= 0.01,Yes,,No,,Ma 1995
7696,8603,8620,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,3570,Pearson,0.26,,,<= 0.01,Yes,,No,,Ma 1995
7707,8603,8621,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,3570,Pearson,-0.25,,,<= 0.01,Yes,,No,,Ma 1995
7718,8603,8622,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,percentRoot,,3570,Pearson,0.1,,,<= 0.01,Yes,,No,,Ma 1995
7729,8603,8623,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,3570,Pearson,0.11,,,<= 0.01,Yes,,No,,Ma 1995
7740,8603,8624,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,3570,Pearson,-0.1,,,<= 0.01,Yes,,No,,Ma 1995
7751,8603,8614,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,percentRoot,,3570,Pearson,0.27,,,<= 0.01,Yes,,Yes,,Ma 1995
7771,8603,8625,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0),,,,percentRoot,,3570,Pearson,0.15,,,<= 0.01,Yes,,No,,Ma 1995
7781,8603,8625,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0),,,,percentRoot,,3570,Pearson,0.2,,,<= 0.01,Yes,,Yes,,Ma 1995
7631,8604,8614,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,percentRoot,,3570,Pearson,-0.09,,,<= 0.01,Yes,,No,,Ma 1995
7642,8604,8615,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,percentRoot,,3570,Pearson,0.01,,, ,Unspecified,,No,,Ma 1995
7653,8604,8616,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,3570,Pearson,0.01,,, ,Unspecified,,No,,Ma 1995
7664,8604,8617,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,PUFA / SFA,"",,,,without unit,,3570,Pearson,0.05,,,<= 0.01,Yes,,No,,Ma 1995
7675,8604,8618,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,3570,Pearson,-0.09,,,<= 0.01,Yes,,No,,Ma 1995
7686,8604,8619,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Stearic acid (18:0),"",,,,percentRoot,,3570,Pearson,0.1,,,<= 0.01,Yes,,No,,Ma 1995
7697,8604,8620,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,3570,Pearson,0.06,,,<= 0.01,Yes,,No,,Ma 1995
7708,8604,8621,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,3570,Pearson,0.04,,, ,Unspecified,,No,,Ma 1995
7719,8604,8622,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,percentRoot,,3570,Pearson,-0.11,,,<= 0.01,Yes,,No,,Ma 1995
7730,8604,8623,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,3570,Pearson,-0.11,,,<= 0.01,Yes,,No,,Ma 1995
7741,8604,8624,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,3570,Pearson,-0.15,,,<= 0.01,Yes,,No,,Ma 1995
7752,8604,8615,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,percentRoot,,3570,Pearson,0.01,,, ,Unspecified,,Yes,,Ma 1995
7772,8604,8626,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,percentRoot,,3570,Pearson,0.05,,,<= 0.01,Yes,,No,,Ma 1995
7782,8604,8626,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,percentRoot,,3570,Pearson,0.07,,,<= 0.01,Yes,,Yes,,Ma 1995
7632,8605,8614,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,percentRoot,,3570,Pearson,-0.24,,,<= 0.01,Yes,,No,,Ma 1995
7643,8605,8615,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,percentRoot,,3570,Pearson,-0.28,,,<= 0.01,Yes,,No,,Ma 1995
7654,8605,8616,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,3570,Pearson,0.31,,,<= 0.01,Yes,,No,,Ma 1995
7665,8605,8617,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,PUFA / SFA,"",,,,without unit,,3570,Pearson,0.3,,,<= 0.01,Yes,,No,,Ma 1995
7676,8605,8618,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,3570,Pearson,-0.19,,,<= 0.01,Yes,,No,,Ma 1995
7687,8605,8619,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Stearic acid (18:0),"",,,,percentRoot,,3570,Pearson,-0.14,,,<= 0.01,Yes,,No,,Ma 1995
7698,8605,8620,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,3570,Pearson,-0.3,,,<= 0.01,Yes,,No,,Ma 1995
7709,8605,8621,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,3570,Pearson,0.28,,,<= 0.01,Yes,,No,,Ma 1995
7720,8605,8622,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,percentRoot,,3570,Pearson,-0.07,,,<= 0.01,Yes,,No,,Ma 1995
7731,8605,8623,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,3570,Pearson,-0.1,,,<= 0.01,Yes,,No,,Ma 1995
7742,8605,8624,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,3570,Pearson,0.11,,,<= 0.01,Yes,,No,,Ma 1995
7753,8605,8616,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,3570,Pearson,0.37,,,<= 0.01,Yes,,Yes,,Ma 1995
7773,8605,8627,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,3570,Pearson,0.25,,,<= 0.01,Yes,,No,,Ma 1995
7783,8605,8627,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,3570,Pearson,0.44,,,<= 0.01,Yes,,Yes,,Ma 1995
7633,8606,8614,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),PUFA / SFA,"",,,,,without unit,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,percentRoot,,3570,Pearson,-0.24,,,<= 0.01,Yes,,No,,Ma 1995
7644,8606,8615,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),PUFA / SFA,"",,,,,without unit,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,percentRoot,,3570,Pearson,-0.28,,,<= 0.01,Yes,,No,,Ma 1995
7655,8606,8616,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),PUFA / SFA,"",,,,,without unit,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,3570,Pearson,0.31,,,<= 0.01,Yes,,No,,Ma 1995
7677,8606,8618,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),PUFA / SFA,"",,,,,without unit,,,"Plasma (cholesterol esters), fasting",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,3570,Pearson,-0.19,,,<= 0.01,Yes,,No,,Ma 1995
7688,8606,8619,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),PUFA / SFA,"",,,,,without unit,,,"Plasma (cholesterol esters), fasting",GC-FID,Stearic acid (18:0),"",,,,percentRoot,,3570,Pearson,-0.14,,,<= 0.01,Yes,,No,,Ma 1995
7699,8606,8620,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),PUFA / SFA,"",,,,,without unit,,,"Plasma (cholesterol esters), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,3570,Pearson,-0.29,,,<= 0.01,Yes,,No,,Ma 1995
7710,8606,8621,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),PUFA / SFA,"",,,,,without unit,,,"Plasma (cholesterol esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,3570,Pearson,0.28,,,<= 0.01,Yes,,No,,Ma 1995
7721,8606,8622,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),PUFA / SFA,"",,,,,without unit,,,"Plasma (cholesterol esters), fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,percentRoot,,3570,Pearson,-0.08,,,<= 0.01,Yes,,No,,Ma 1995
7732,8606,8623,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),PUFA / SFA,"",,,,,without unit,,,"Plasma (cholesterol esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,3570,Pearson,-0.11,,,<= 0.01,Yes,,No,,Ma 1995
7743,8606,8624,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),PUFA / SFA,"",,,,,without unit,,,"Plasma (cholesterol esters), fasting",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,3570,Pearson,0.11,,,<= 0.01,Yes,,No,,Ma 1995
7754,8606,8617,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),PUFA / SFA,"",,,,,without unit,,,"Plasma (cholesterol esters), fasting",GC-FID,PUFA / SFA,"",,,,without unit,,3570,Pearson,0.35,,,<= 0.01,Yes,,Yes,,Ma 1995
7784,8606,8628,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),PUFA / SFA,"",,,,,without unit,,,"Plasma (phospholipids), fasting",GC-FID,PUFA / SFA,"",,,,without unit,,3570,Pearson,0.37,,,<= 0.01,Yes,,Yes,,Ma 1995
7634,8607,8614,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,percentRoot,,3570,Pearson,0.23,,,<= 0.01,Yes,,No,,Ma 1995
7645,8607,8615,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,percentRoot,,3570,Pearson,0.27,,,<= 0.01,Yes,,No,,Ma 1995
7656,8607,8616,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,3570,Pearson,-0.29,,,<= 0.01,Yes,,No,,Ma 1995
7667,8607,8617,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,PUFA / SFA,"",,,,without unit,,3570,Pearson,-0.28,,,<= 0.01,Yes,,No,,Ma 1995
7678,8607,8618,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,3570,Pearson,0.19,,,<= 0.01,Yes,,No,,Ma 1995
7689,8607,8619,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Stearic acid (18:0),"",,,,percentRoot,,3570,Pearson,0.11,,,<= 0.01,Yes,,No,,Ma 1995
7700,8607,8620,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,3570,Pearson,0.27,,,<= 0.01,Yes,,No,,Ma 1995
7711,8607,8621,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,3570,Pearson,-0.27,,,<= 0.01,Yes,,No,,Ma 1995
7722,8607,8622,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,percentRoot,,3570,Pearson,0.06,,,<= 0.01,Yes,,No,,Ma 1995
7733,8607,8623,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,3570,Pearson,0.07,,,<= 0.01,Yes,,No,,Ma 1995
7744,8607,8624,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,3570,Pearson,-0.14,,,<= 0.01,Yes,,No,,Ma 1995
7755,8607,8618,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,3570,Pearson,0.22,,,<= 0.01,Yes,,Yes,,Ma 1995
7775,8607,8629,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,3570,Pearson,0.16,,,<= 0.01,Yes,,No,,Ma 1995
7785,8607,8629,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Palmitic acid (16:0),"",,,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,3570,Pearson,0.19,,,<= 0.01,Yes,,Yes,,Ma 1995
7635,8608,8614,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Stearic acid (18:0),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,percentRoot,,3570,Pearson,0.09,,,<= 0.01,Yes,,No,,Ma 1995
7646,8608,8615,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Stearic acid (18:0),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,percentRoot,,3570,Pearson,0.2,,,<= 0.01,Yes,,No,,Ma 1995
7657,8608,8616,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Stearic acid (18:0),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,3570,Pearson,-0.2,,,<= 0.01,Yes,,No,,Ma 1995
7668,8608,8617,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Stearic acid (18:0),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,PUFA / SFA,"",,,,without unit,,3570,Pearson,-0.15,,,<= 0.01,Yes,,No,,Ma 1995
7679,8608,8618,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Stearic acid (18:0),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,3570,Pearson,0.03,,, ,Unspecified,,No,,Ma 1995
7690,8608,8619,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Stearic acid (18:0),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Stearic acid (18:0),"",,,,percentRoot,,3570,Pearson,0.17,,,<= 0.01,Yes,,No,,Ma 1995
7701,8608,8620,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Stearic acid (18:0),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,3570,Pearson,0.23,,,<= 0.01,Yes,,No,,Ma 1995
7712,8608,8621,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Stearic acid (18:0),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,3570,Pearson,-0.16,,,<= 0.01,Yes,,No,,Ma 1995
7723,8608,8622,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Stearic acid (18:0),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,percentRoot,,3570,Pearson,0.01,,, ,Unspecified,,No,,Ma 1995
7734,8608,8623,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Stearic acid (18:0),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,3570,Pearson,-0.03,,, ,Unspecified,,No,,Ma 1995
7745,8608,8624,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Stearic acid (18:0),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,3570,Pearson,-0.2,,,<= 0.01,Yes,,No,,Ma 1995
7636,8609,8614,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,percentRoot,,3570,Pearson,-0.13,,,<= 0.01,Yes,,No,,Ma 1995
7647,8609,8615,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,percentRoot,,3570,Pearson,-0.02,,, ,Unspecified,,No,,Ma 1995
7658,8609,8616,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,3570,Pearson,0.04,,, ,Unspecified,,No,,Ma 1995
7669,8609,8617,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,PUFA / SFA,"",,,,without unit,,3570,Pearson,0.1,,,<= 0.01,Yes,,No,,Ma 1995
7680,8609,8618,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,3570,Pearson,-0.14,,,<= 0.01,Yes,,No,,Ma 1995
7691,8609,8619,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Stearic acid (18:0),"",,,,percentRoot,,3570,Pearson,0.1,,,<= 0.01,Yes,,No,,Ma 1995
7702,8609,8620,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,3570,Pearson,0.03,,, ,Unspecified,,No,,Ma 1995
7713,8609,8621,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,3570,Pearson,0.08,,,<= 0.01,Yes,,No,,Ma 1995
7724,8609,8622,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,percentRoot,,3570,Pearson,-0.13,,,<= 0.01,Yes,,No,,Ma 1995
7735,8609,8623,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,3570,Pearson,-0.18,,,<= 0.01,Yes,,No,,Ma 1995
7746,8609,8624,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,3570,Pearson,-0.23,,,<= 0.01,Yes,,No,,Ma 1995
7756,8609,8620,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,3570,Pearson,0.04,,, ,Unspecified,,Yes,,Ma 1995
7776,8609,8630,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,3570,Pearson,0.08,,,<= 0.01,Yes,,No,,Ma 1995
7786,8609,8630,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,3570,Pearson,0.13,,,<= 0.01,Yes,,Yes,,Ma 1995
7637,8610,8614,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,percentRoot,,3570,Pearson,-0.25,,,<= 0.01,Yes,,No,,Ma 1995
7648,8610,8615,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,percentRoot,,3570,Pearson,-0.27,,,<= 0.01,Yes,,No,,Ma 1995
7659,8610,8616,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,3570,Pearson,0.3,,,<= 0.01,Yes,,No,,Ma 1995
7670,8610,8617,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,PUFA / SFA,"",,,,without unit,,3570,Pearson,0.3,,,<= 0.01,Yes,,No,,Ma 1995
7681,8610,8618,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,3570,Pearson,-0.21,,,<= 0.01,Yes,,No,,Ma 1995
7692,8610,8619,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Stearic acid (18:0),"",,,,percentRoot,,3570,Pearson,-0.12,,,<= 0.01,Yes,,No,,Ma 1995
7703,8610,8620,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,3570,Pearson,-0.28,,,<= 0.01,Yes,,No,,Ma 1995
7714,8610,8621,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,3570,Pearson,0.28,,,<= 0.01,Yes,,No,,Ma 1995
7725,8610,8622,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,percentRoot,,3570,Pearson,-0.11,,,<= 0.01,Yes,,No,,Ma 1995
7736,8610,8623,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,3570,Pearson,-0.16,,,<= 0.01,Yes,,No,,Ma 1995
7747,8610,8624,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,3570,Pearson,0.02,,, ,Unspecified,,No,,Ma 1995
7757,8610,8621,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,3570,Pearson,0.32,,,<= 0.01,Yes,,Yes,,Ma 1995
7777,8610,8631,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,3570,Pearson,0.22,,,<= 0.01,Yes,,No,,Ma 1995
7787,8610,8631,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,3570,Pearson,0.26,,,<= 0.01,Yes,,Yes,,Ma 1995
7638,8611,8614,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,percentRoot,,3570,Pearson,0.1,,,<= 0.01,Yes,,No,,Ma 1995
7649,8611,8615,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,percentRoot,,3570,Pearson,0.05,,,<= 0.01,Yes,,No,,Ma 1995
7660,8611,8616,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,3570,Pearson,-0.07,,,<= 0.01,Yes,,No,,Ma 1995
7671,8611,8617,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,PUFA / SFA,"",,,,without unit,,3570,Pearson,-0.09,,,<= 0.01,Yes,,No,,Ma 1995
7682,8611,8618,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,3570,Pearson,0.11,,,<= 0.01,Yes,,No,,Ma 1995
7693,8611,8619,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Stearic acid (18:0),"",,,,percentRoot,,3570,Pearson,-0.07,,,<= 0.01,Yes,,No,,Ma 1995
7704,8611,8620,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,3570,Pearson,0.01,,, ,Unspecified,,No,,Ma 1995
7715,8611,8621,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,3570,Pearson,-0.09,,,<= 0.01,Yes,,No,,Ma 1995
7726,8611,8622,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,percentRoot,,3570,Pearson,0.21,,,<= 0.01,Yes,,No,,Ma 1995
7737,8611,8623,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,3570,Pearson,0.15,,,<= 0.01,Yes,,No,,Ma 1995
7748,8611,8624,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,3570,Pearson,0.15,,,<= 0.01,Yes,,No,,Ma 1995
7758,8611,8622,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,percentRoot,,3570,Pearson,0.3,,,<= 0.01,Yes,,Yes,,Ma 1995
7778,8611,8632,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,percentRoot,,3570,Pearson,0.15,,,<= 0.01,Yes,,No,,Ma 1995
7788,8611,8632,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",No,,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,percentRoot,,3570,Pearson,0.26,,,<= 0.01,Yes,,Yes,,Ma 1995
7639,8612,8614,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,percentRoot,,3570,Pearson,-0.01,,, ,Unspecified,,No,,Ma 1995
7650,8612,8615,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,percentRoot,,3570,Pearson,-0.12,,,<= 0.01,Yes,,No,,Ma 1995
7661,8612,8616,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,3570,Pearson,0.11,,,<= 0.01,Yes,,No,,Ma 1995
7672,8612,8617,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,PUFA / SFA,"",,,,without unit,,3570,Pearson,0.06,,,<= 0.01,Yes,,No,,Ma 1995
7683,8612,8618,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,3570,Pearson,0.02,,, ,Unspecified,,No,,Ma 1995
7694,8612,8619,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Stearic acid (18:0),"",,,,percentRoot,,3570,Pearson,-0.12,,,<= 0.01,Yes,,No,,Ma 1995
7705,8612,8620,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,3570,Pearson,-0.15,,,<= 0.01,Yes,,No,,Ma 1995
7716,8612,8621,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,3570,Pearson,0.07,,,<= 0.01,Yes,,No,,Ma 1995
7727,8612,8622,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,percentRoot,,3570,Pearson,0.13,,,<= 0.01,Yes,,No,,Ma 1995
7738,8612,8623,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,3570,Pearson,0.23,,,<= 0.01,Yes,,No,,Ma 1995
7749,8612,8624,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,3570,Pearson,0.44,,,<= 0.01,Yes,,No,,Ma 1995
7759,8612,8623,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,3570,Pearson,0.32,,,<= 0.01,Yes,,Yes,,Ma 1995
7779,8612,8633,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,3570,Pearson,0.2,,,<= 0.01,Yes,,No,,Ma 1995
7789,8612,8633,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",No,,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,3570,Pearson,0.36,,,<= 0.01,Yes,,Yes,,Ma 1995
7640,8613,8614,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,percentRoot,,3570,Pearson,-0.03,,, ,Unspecified,,No,,Ma 1995
7651,8613,8615,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,,,percentRoot,,3570,Pearson,-0.13,,,<= 0.01,Yes,,No,,Ma 1995
7662,8613,8616,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,3570,Pearson,0.13,,,<= 0.01,Yes,,No,,Ma 1995
7673,8613,8617,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,PUFA / SFA,"",,,,without unit,,3570,Pearson,0.08,,,<= 0.01,Yes,,No,,Ma 1995
7684,8613,8618,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,3570,Pearson,0.0,,, ,Unspecified,,No,,Ma 1995
7695,8613,8619,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Stearic acid (18:0),"",,,,percentRoot,,3570,Pearson,-0.12,,,<= 0.01,Yes,,No,,Ma 1995
7706,8613,8620,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,3570,Pearson,-0.17,,,<= 0.01,Yes,,No,,Ma 1995
7717,8613,8621,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,3570,Pearson,0.09,,,<= 0.01,Yes,,No,,Ma 1995
7728,8613,8622,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,percentRoot,,3570,Pearson,0.14,,,<= 0.01,Yes,,No,,Ma 1995
7739,8613,8623,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,3570,Pearson,0.2,,,<= 0.01,Yes,,No,,Ma 1995
7750,8613,8624,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,3570,Pearson,0.42,,,<= 0.01,Yes,,No,,Ma 1995
7760,8613,8624,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,3570,Pearson,0.58,,,<= 0.01,Yes,,Yes,,Ma 1995
7780,8613,8634,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,3570,Pearson,0.42,,,<= 0.01,Yes,,No,,Ma 1995
7790,8613,8634,All [by gender],Middle-aged subjects,United States,ARIC (Atherosclerosis Risk in Communities),,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",No,,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,3570,Pearson,0.55,,,<= 0.01,Yes,,Yes,,Ma 1995
7791,8637,8639,All,Pregnant women in Arhus,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.23,,,g/day,,,"Red blood cell (phospholipids), unspecified",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,135,Pearson,-0.15,,, ,Unspecified,,,,Olsen 1995
7792,8637,8640,All,Pregnant women in Arhus,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.23,,,g/day,,,"Red blood cell (phospholipids), unspecified",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,135,Pearson,0.01,,, ,Unspecified,,,,Olsen 1995
7793,8637,8641,All,Pregnant women in Arhus,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.23,,,g/day,,,"Red blood cell (phospholipids), unspecified",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,percentRoot,,135,Pearson,0.02,,, ,Unspecified,,,,Olsen 1995
7794,8637,8642,All,Pregnant women in Arhus,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.23,,,g/day,,,"Red blood cell (phospholipids), unspecified",GC-FID,Arachidonic/Behenic acid,"",,,,percentRoot,,135,Pearson,-0.22,,, ,Unspecified,,,,Olsen 1995
7795,8637,8643,All,Pregnant women in Arhus,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.23,,,g/day,,,"Red blood cell (phospholipids), unspecified",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,135,Pearson,0.55,,, ,Unspecified,,,,Olsen 1995
7796,8637,8644,All,Pregnant women in Arhus,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.23,,,g/day,,,"Red blood cell (phospholipids), unspecified",GC-FID,DPA (cis-22:5n-3),"",,,,percentRoot,,135,Pearson,0.28,,, ,Unspecified,,,,Olsen 1995
7797,8637,8645,All,Pregnant women in Arhus,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.23,,,g/day,,,"Red blood cell (phospholipids), unspecified",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,135,Pearson,0.37,,, ,Unspecified,,,,Olsen 1995
7798,8637,8646,All,Pregnant women in Arhus,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.23,,,g/day,,,"Red blood cell (phospholipids), unspecified",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,135,Pearson,0.45,,, ,Unspecified,,,,Olsen 1995
7799,8637,8647,All,Pregnant women in Arhus,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.23,,,g/day,,,"Red blood cell (phospholipids), unspecified",GC-FID,(DHA + DPA + EPA) / (Arachidonic/Behenic acid),"",,,,without unit,,135,Pearson,0.51,,, ,Unspecified,,,,Olsen 1995
7800,8637,8639,All,Pregnant women in Arhus,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.23,,,g/day,,,"Red blood cell (phospholipids), unspecified",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,135,Pearson,-0.17,,, ,Unspecified,Energy by density method,,,Olsen 1995
7801,8637,8640,All,Pregnant women in Arhus,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.23,,,g/day,,,"Red blood cell (phospholipids), unspecified",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,135,Pearson,0.01,,, ,Unspecified,Energy by density method,,,Olsen 1995
7802,8637,8641,All,Pregnant women in Arhus,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.23,,,g/day,,,"Red blood cell (phospholipids), unspecified",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,percentRoot,,135,Pearson,-0.01,,, ,Unspecified,Energy by density method,,,Olsen 1995
7803,8637,8642,All,Pregnant women in Arhus,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.23,,,g/day,,,"Red blood cell (phospholipids), unspecified",GC-FID,Arachidonic/Behenic acid,"",,,,percentRoot,,135,Pearson,-0.21,,, ,Unspecified,Energy by density method,,,Olsen 1995
7804,8637,8643,All,Pregnant women in Arhus,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.23,,,g/day,,,"Red blood cell (phospholipids), unspecified",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,135,Pearson,0.58,,, ,Unspecified,Energy by density method,,,Olsen 1995
7805,8637,8644,All,Pregnant women in Arhus,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.23,,,g/day,,,"Red blood cell (phospholipids), unspecified",GC-FID,DPA (cis-22:5n-3),"",,,,percentRoot,,135,Pearson,0.3,,, ,Unspecified,Energy by density method,,,Olsen 1995
7806,8637,8645,All,Pregnant women in Arhus,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.23,,,g/day,,,"Red blood cell (phospholipids), unspecified",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,135,Pearson,0.4,,, ,Unspecified,Energy by density method,,,Olsen 1995
7807,8637,8646,All,Pregnant women in Arhus,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.23,,,g/day,,,"Red blood cell (phospholipids), unspecified",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,percentRoot,,135,Pearson,0.48,,, ,Unspecified,Energy by density method,,,Olsen 1995
7808,8637,8647,All,Pregnant women in Arhus,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,0.23,,,g/day,,,"Red blood cell (phospholipids), unspecified",GC-FID,(DHA + DPA + EPA) / (Arachidonic/Behenic acid),"",,,,without unit,,135,Pearson,0.54,,, ,Unspecified,Energy by density method,,,Olsen 1995
7809,8718,8674,All [by gender],Obese subjects with non-insulin-dependent diabetes mellitus participant in a study on weight loss,Netherlands,,,Dietary record (3-day),EPA (cis-20:5n-3),"",,,,,percentRoot,,baseline; 1 year; 2 years,"Adipose tissue (triglycerides), abdomen",GC-FID,EPA (cis-20:5n-3),"",0.09,,,percentRoot,,53,Spearman,0.66,,,< 0.05,Yes,,,,Popp-Snijders 1995
7810,8719,8677,All [by gender],Obese subjects with non-insulin-dependent diabetes mellitus participant in a study on weight loss,Netherlands,,,Dietary record (3-day),DHA (cis-22:6n-3),"",,,,,percentRoot,,baseline; 1 year; 2 years,"Adipose tissue (triglycerides), abdomen",GC-FID,DHA (cis-22:6n-3),"",0.3,,,percentRoot,,53,Spearman,0.55,,,< 0.05,Yes,,,,Popp-Snijders 1995
7811,8720,8669,All [by gender],Obese subjects with non-insulin-dependent diabetes mellitus participant in a study on weight loss,Netherlands,,,Dietary record (3-day),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,baseline; 1 year; 2 years,"Adipose tissue (triglycerides), abdomen",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",14.37,,,percentRoot,,53,Pearson,0.53,,,< 0.05,Yes,,,,Popp-Snijders 1995
7812,8721,8678,All [by gender],Obese subjects with non-insulin-dependent diabetes mellitus participant in a study on weight loss,Netherlands,,,Dietary record (3-day),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,baseline; 1 year; 2 years,"Adipose tissue (triglycerides), abdomen",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0),33.67,,,percentRoot,,53,Pearson,0.3,,,< 0.05,Yes,,,,Popp-Snijders 1995
7813,8722,8679,All [by gender],Obese subjects with non-insulin-dependent diabetes mellitus participant in a study on weight loss,Netherlands,,,Dietary record (3-day),"Fatty acids, monounsaturated (MUFA)","",,,,,percentRoot,,baseline; 1 year; 2 years,"Adipose tissue (triglycerides), abdomen",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + 11-Eicosenoic acid (cis-20:1n-9),49.44,,,percentRoot,,53,Pearson,0.22,,,>= 0.05,No,,,,Popp-Snijders 1995
7814,8723,8680,All [by gender],Obese subjects with non-insulin-dependent diabetes mellitus participant in a study on weight loss,Netherlands,,,Dietary record (3-day),"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,baseline; 1 year; 2 years,"Adipose tissue (triglycerides), abdomen",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6),16.88,,,percentRoot,,53,Pearson,0.5,,,< 0.05,Yes,,,,Popp-Snijders 1995
7815,8724,8681,All [by gender],Obese subjects with non-insulin-dependent diabetes mellitus participant in a study on weight loss,Netherlands,,,Dietary record (3-day),PUFA / SFA,"",,,,,without unit,,baseline; 1 year; 2 years,"Adipose tissue (triglycerides), abdomen",GC-FID,PUFA / SFA,"",0.5,,,without unit,,53,Pearson,0.51,,,< 0.05,Yes,,,,Popp-Snijders 1995
7819,8650,8696,Males,Obese subjects with non-insulin-dependent diabetes mellitus participant in a study on weight loss,Netherlands,,,Dietary record (3-day),"Fatty acids, saturated (SFA)","",,41.3,,,percentRoot,,baseline; 1 year; 2 years,"Adipose tissue (triglycerides), abdomen",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0),33.88,,,percentRoot,,19,Pearson,0.42,,,< 0.05,Yes,,,,Popp-Snijders 1995
7820,8651,8697,Males,Obese subjects with non-insulin-dependent diabetes mellitus participant in a study on weight loss,Netherlands,,,Dietary record (3-day),"Fatty acids, monounsaturated (MUFA)","",,35.8,,,percentRoot,,baseline; 1 year; 2 years,"Adipose tissue (triglycerides), abdomen",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + 11-Eicosenoic acid (cis-20:1n-9),49.21,,,percentRoot,,19,Pearson,0.2,,,>= 0.05,No,,,,Popp-Snijders 1995
7821,8652,8698,Males,Obese subjects with non-insulin-dependent diabetes mellitus participant in a study on weight loss,Netherlands,,,Dietary record (3-day),"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,23.1,,,percentRoot,,baseline; 1 year; 2 years,"Adipose tissue (triglycerides), abdomen",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6),16.9,,,percentRoot,,19,Pearson,0.58,,,< 0.05,Yes,,,,Popp-Snijders 1995
7822,8653,8699,Males,Obese subjects with non-insulin-dependent diabetes mellitus participant in a study on weight loss,Netherlands,,,Dietary record (3-day),PUFA / SFA,"",,0.6,,,without unit,,baseline; 1 year; 2 years,"Adipose tissue (triglycerides), abdomen",GC-FID,PUFA / SFA,"",0.5,,,without unit,,19,Pearson,0.61,,,< 0.05,Yes,,,,Popp-Snijders 1995
7818,8654,8687,Males,Obese subjects with non-insulin-dependent diabetes mellitus participant in a study on weight loss,Netherlands,,,Dietary record (3-day),Linoleic acid (LA; cis-18:2n-6),"",,20.6,,,percentRoot,,baseline; 1 year; 2 years,"Adipose tissue (triglycerides), abdomen",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",14.62,,,percentRoot,,19,Pearson,0.61,,,< 0.05,Yes,,,,Popp-Snijders 1995
7816,8655,8692,Males,Obese subjects with non-insulin-dependent diabetes mellitus participant in a study on weight loss,Netherlands,,,Dietary record (3-day),EPA (cis-20:5n-3),"",,0.2,,,percentRoot,,baseline; 1 year; 2 years,"Adipose tissue (triglycerides), abdomen",GC-FID,EPA (cis-20:5n-3),"",0.09,,,percentRoot,,19,Spearman,0.76,,,< 0.05,Yes,,,,Popp-Snijders 1995
7817,8656,8695,Males,Obese subjects with non-insulin-dependent diabetes mellitus participant in a study on weight loss,Netherlands,,,Dietary record (3-day),DHA (cis-22:6n-3),"",,0.25,,,percentRoot,,baseline; 1 year; 2 years,"Adipose tissue (triglycerides), abdomen",GC-FID,DHA (cis-22:6n-3),"",0.25,,,percentRoot,,19,Spearman,0.75,,,< 0.05,Yes,,,,Popp-Snijders 1995
7826,8657,8714,Females,Obese subjects with non-insulin-dependent diabetes mellitus participant in a study on weight loss,Netherlands,,,Dietary record (3-day),"Fatty acids, saturated (SFA)","",,42.5,,,percentRoot,,baseline; 1 year; 2 years,"Adipose tissue (triglycerides), abdomen",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0),33.56,,,percentRoot,,34,Pearson,0.25,,,>= 0.05,No,,,,Popp-Snijders 1995
7827,8658,8715,Females,Obese subjects with non-insulin-dependent diabetes mellitus participant in a study on weight loss,Netherlands,,,Dietary record (3-day),"Fatty acids, monounsaturated (MUFA)","",,36.0,,,percentRoot,,baseline; 1 year; 2 years,"Adipose tissue (triglycerides), abdomen",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + 11-Eicosenoic acid (cis-20:1n-9),49.57,,,percentRoot,,34,Pearson,0.23,,,>= 0.05,No,,,,Popp-Snijders 1995
7828,8659,8716,Females,Obese subjects with non-insulin-dependent diabetes mellitus participant in a study on weight loss,Netherlands,,,Dietary record (3-day),"Fatty acids, polyunsaturated (PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,21.5,,,percentRoot,,baseline; 1 year; 2 years,"Adipose tissue (triglycerides), abdomen",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6),16.86,,,percentRoot,,34,Pearson,0.44,,,< 0.05,Yes,,,,Popp-Snijders 1995
7829,8660,8717,Females,Obese subjects with non-insulin-dependent diabetes mellitus participant in a study on weight loss,Netherlands,,,Dietary record (3-day),PUFA / SFA,"",,0.52,,,without unit,,baseline; 1 year; 2 years,"Adipose tissue (triglycerides), abdomen",GC-FID,PUFA / SFA,"",0.5,,,without unit,,34,Pearson,0.44,,,< 0.05,Yes,,,,Popp-Snijders 1995
7825,8661,8705,Females,Obese subjects with non-insulin-dependent diabetes mellitus participant in a study on weight loss,Netherlands,,,Dietary record (3-day),Linoleic acid (LA; cis-18:2n-6),"",,19.3,,,percentRoot,,baseline; 1 year; 2 years,"Adipose tissue (triglycerides), abdomen",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",14.23,,,percentRoot,,34,Pearson,0.45,,,< 0.05,Yes,,,,Popp-Snijders 1995
7823,8662,8710,Females,Obese subjects with non-insulin-dependent diabetes mellitus participant in a study on weight loss,Netherlands,,,Dietary record (3-day),EPA (cis-20:5n-3),"",,0.16,,,percentRoot,,baseline; 1 year; 2 years,"Adipose tissue (triglycerides), abdomen",GC-FID,EPA (cis-20:5n-3),"",0.09,,,percentRoot,,34,Spearman,0.57,,,< 0.05,Yes,,,,Popp-Snijders 1995
7824,8663,8713,Females,Obese subjects with non-insulin-dependent diabetes mellitus participant in a study on weight loss,Netherlands,,,Dietary record (3-day),DHA (cis-22:6n-3),"",,0.18,,,percentRoot,,baseline; 1 year; 2 years,"Adipose tissue (triglycerides), abdomen",GC-FID,DHA (cis-22:6n-3),"",0.31,,,percentRoot,,34,Spearman,0.48,,,< 0.05,Yes,,,,Popp-Snijders 1995
7830,8725,8732,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,52.9,,47.0,servings/week,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",18.0,,,ug/dL,,99,Pearson,0.39,,, ,Yes,,,,Campbell 1994
7836,8725,8732,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,52.9,,47.0,servings/week,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",18.0,,,ug/dL,,99,Pearson,0.44,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7842,8725,8733,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,52.9,,47.0,servings/week,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",8.3,,,ug/dL,,99,Pearson,0.44,,, ,Yes,,,,Campbell 1994
7848,8725,8733,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,52.9,,47.0,servings/week,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",8.3,,,ug/dL,,99,Pearson,0.47,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7854,8725,8734,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,52.9,,47.0,servings/week,,,"Plasma, fasting",HPLC,Lycopene,"",37.3,,,ug/dL,,99,Pearson,-0.04,,, ,No,,,,Campbell 1994
7860,8725,8734,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,52.9,,47.0,servings/week,,,"Plasma, fasting",HPLC,Lycopene,"",37.3,,,ug/dL,,99,Pearson,-0.14,,, ,No,"Cholesterol, Energy by residual method",,,Campbell 1994
7866,8725,8735,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,52.9,,47.0,servings/week,,,"Plasma, fasting",HPLC,alpha-Carotene,"",5.6,,,ug/dL,,99,Pearson,0.54,,, ,Yes,,,,Campbell 1994
7872,8725,8735,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,52.9,,47.0,servings/week,,,"Plasma, fasting",HPLC,alpha-Carotene,"",5.6,,,ug/dL,,99,Pearson,0.61,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7878,8725,8736,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,52.9,,47.0,servings/week,,,"Plasma, fasting",HPLC,beta-Carotene,"",15.7,,,ug/dL,,99,Pearson,0.43,,, ,Yes,,,,Campbell 1994
7884,8725,8736,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,52.9,,47.0,servings/week,,,"Plasma, fasting",HPLC,beta-Carotene,"",15.7,,,ug/dL,,99,Pearson,0.45,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7890,8725,8738,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,52.9,,47.0,servings/week,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,99,Pearson,0.54,,, ,Yes,,,,Campbell 1994
7896,8725,8738,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,Fruits + Vegetables,,52.9,,47.0,servings/week,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,99,Pearson,0.59,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7831,8726,8732,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,30.7,,25.5,servings/week,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",18.0,,,ug/dL,,99,Pearson,0.43,,, ,Yes,,,,Campbell 1994
7837,8726,8732,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,30.7,,25.5,servings/week,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",18.0,,,ug/dL,,99,Pearson,0.48,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7843,8726,8733,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,30.7,,25.5,servings/week,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",8.3,,,ug/dL,,99,Pearson,0.3,,, ,Yes,,,,Campbell 1994
7849,8726,8733,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,30.7,,25.5,servings/week,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",8.3,,,ug/dL,,99,Pearson,0.32,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7855,8726,8734,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,30.7,,25.5,servings/week,,,"Plasma, fasting",HPLC,Lycopene,"",37.3,,,ug/dL,,99,Pearson,0.0,,, ,No,,,,Campbell 1994
7861,8726,8734,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,30.7,,25.5,servings/week,,,"Plasma, fasting",HPLC,Lycopene,"",37.3,,,ug/dL,,99,Pearson,-0.08,,, ,No,"Cholesterol, Energy by residual method",,,Campbell 1994
7867,8726,8735,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,30.7,,25.5,servings/week,,,"Plasma, fasting",HPLC,alpha-Carotene,"",5.6,,,ug/dL,,99,Pearson,0.45,,, ,Yes,,,,Campbell 1994
7873,8726,8735,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,30.7,,25.5,servings/week,,,"Plasma, fasting",HPLC,alpha-Carotene,"",5.6,,,ug/dL,,99,Pearson,0.5,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7879,8726,8736,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,30.7,,25.5,servings/week,,,"Plasma, fasting",HPLC,beta-Carotene,"",15.7,,,ug/dL,,99,Pearson,0.34,,, ,Yes,,,,Campbell 1994
7885,8726,8736,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,30.7,,25.5,servings/week,,,"Plasma, fasting",HPLC,beta-Carotene,"",15.7,,,ug/dL,,99,Pearson,0.35,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7891,8726,8738,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,30.7,,25.5,servings/week,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,99,Pearson,0.45,,, ,Yes,,,,Campbell 1994
7897,8726,8738,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Vegetables,"",,30.7,,25.5,servings/week,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,99,Pearson,0.49,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7832,8727,8732,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits,"",,22.2,,19.0,servings/week,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",18.0,,,ug/dL,,99,Pearson,0.21,,, ,Yes,,,,Campbell 1994
7838,8727,8732,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits,"",,22.2,,19.0,servings/week,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",18.0,,,ug/dL,,99,Pearson,0.24,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7844,8727,8733,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits,"",,22.2,,19.0,servings/week,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",8.3,,,ug/dL,,99,Pearson,0.54,,, ,Yes,,,,Campbell 1994
7850,8727,8733,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits,"",,22.2,,19.0,servings/week,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",8.3,,,ug/dL,,99,Pearson,0.56,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7856,8727,8734,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits,"",,22.2,,19.0,servings/week,,,"Plasma, fasting",HPLC,Lycopene,"",37.3,,,ug/dL,,99,Pearson,-0.07,,, ,No,,,,Campbell 1994
7862,8727,8734,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits,"",,22.2,,19.0,servings/week,,,"Plasma, fasting",HPLC,Lycopene,"",37.3,,,ug/dL,,99,Pearson,-0.14,,, ,No,"Cholesterol, Energy by residual method",,,Campbell 1994
7868,8727,8735,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits,"",,22.2,,19.0,servings/week,,,"Plasma, fasting",HPLC,alpha-Carotene,"",5.6,,,ug/dL,,99,Pearson,0.53,,, ,Yes,,,,Campbell 1994
7874,8727,8735,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits,"",,22.2,,19.0,servings/week,,,"Plasma, fasting",HPLC,alpha-Carotene,"",5.6,,,ug/dL,,99,Pearson,0.58,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7880,8727,8736,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits,"",,22.2,,19.0,servings/week,,,"Plasma, fasting",HPLC,beta-Carotene,"",15.7,,,ug/dL,,99,Pearson,0.45,,, ,Yes,,,,Campbell 1994
7886,8727,8736,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits,"",,22.2,,19.0,servings/week,,,"Plasma, fasting",HPLC,beta-Carotene,"",15.7,,,ug/dL,,99,Pearson,0.46,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7892,8727,8738,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits,"",,22.2,,19.0,servings/week,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,99,Pearson,0.51,,, ,Yes,,,,Campbell 1994
7898,8727,8738,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits,"",,22.2,,19.0,servings/week,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,99,Pearson,0.54,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7833,8728,8732,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,5.5,,3.5,servings/week,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",18.0,,,ug/dL,,99,Pearson,0.44,,, ,Yes,,,,Campbell 1994
7839,8728,8732,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,5.5,,3.5,servings/week,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",18.0,,,ug/dL,,99,Pearson,0.46,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7845,8728,8733,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,5.5,,3.5,servings/week,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",8.3,,,ug/dL,,99,Pearson,0.31,,, ,Yes,,,,Campbell 1994
7851,8728,8733,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,5.5,,3.5,servings/week,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",8.3,,,ug/dL,,99,Pearson,0.32,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7857,8728,8734,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,5.5,,3.5,servings/week,,,"Plasma, fasting",HPLC,Lycopene,"",37.3,,,ug/dL,,99,Pearson,-0.07,,, ,No,,,,Campbell 1994
7863,8728,8734,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,5.5,,3.5,servings/week,,,"Plasma, fasting",HPLC,Lycopene,"",37.3,,,ug/dL,,99,Pearson,-0.11,,, ,No,"Cholesterol, Energy by residual method",,,Campbell 1994
7869,8728,8735,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,5.5,,3.5,servings/week,,,"Plasma, fasting",HPLC,alpha-Carotene,"",5.6,,,ug/dL,,99,Pearson,0.46,,, ,Yes,,,,Campbell 1994
7875,8728,8735,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,5.5,,3.5,servings/week,,,"Plasma, fasting",HPLC,alpha-Carotene,"",5.6,,,ug/dL,,99,Pearson,0.47,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7881,8728,8736,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,5.5,,3.5,servings/week,,,"Plasma, fasting",HPLC,beta-Carotene,"",15.7,,,ug/dL,,99,Pearson,0.35,,, ,Yes,,,,Campbell 1994
7887,8728,8736,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,5.5,,3.5,servings/week,,,"Plasma, fasting",HPLC,beta-Carotene,"",15.7,,,ug/dL,,99,Pearson,0.35,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7893,8728,8738,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,5.5,,3.5,servings/week,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,99,Pearson,0.46,,, ,Yes,,,,Campbell 1994
7899,8728,8738,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,5.5,,3.5,servings/week,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,99,Pearson,0.47,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7834,8729,8732,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,7.0,,6.5,servings/week,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",18.0,,,ug/dL,,99,Pearson,0.17,,, ,Yes,,,,Campbell 1994
7840,8729,8732,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,7.0,,6.5,servings/week,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",18.0,,,ug/dL,,99,Pearson,0.19,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7846,8729,8733,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,7.0,,6.5,servings/week,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",8.3,,,ug/dL,,99,Pearson,0.27,,, ,Yes,,,,Campbell 1994
7852,8729,8733,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,7.0,,6.5,servings/week,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",8.3,,,ug/dL,,99,Pearson,0.28,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7858,8729,8734,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,7.0,,6.5,servings/week,,,"Plasma, fasting",HPLC,Lycopene,"",37.3,,,ug/dL,,99,Pearson,0.2,,, ,No,,,,Campbell 1994
7864,8729,8734,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,7.0,,6.5,servings/week,,,"Plasma, fasting",HPLC,Lycopene,"",37.3,,,ug/dL,,99,Pearson,0.11,,, ,No,"Cholesterol, Energy by residual method",,,Campbell 1994
7870,8729,8735,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,7.0,,6.5,servings/week,,,"Plasma, fasting",HPLC,alpha-Carotene,"",5.6,,,ug/dL,,99,Pearson,0.11,,, ,Yes,,,,Campbell 1994
7876,8729,8735,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,7.0,,6.5,servings/week,,,"Plasma, fasting",HPLC,alpha-Carotene,"",5.6,,,ug/dL,,99,Pearson,0.14,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7882,8729,8736,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,7.0,,6.5,servings/week,,,"Plasma, fasting",HPLC,beta-Carotene,"",15.7,,,ug/dL,,99,Pearson,0.19,,, ,Yes,,,,Campbell 1994
7888,8729,8736,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,7.0,,6.5,servings/week,,,"Plasma, fasting",HPLC,beta-Carotene,"",15.7,,,ug/dL,,99,Pearson,0.19,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7894,8729,8738,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,7.0,,6.5,servings/week,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,99,Pearson,0.21,,, ,Yes,,,,Campbell 1994
7900,8729,8738,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,7.0,,6.5,servings/week,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,99,Pearson,0.23,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7835,8730,8732,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,6.0,,4.0,servings/week,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",18.0,,,ug/dL,,99,Pearson,0.3,,, ,Yes,,,,Campbell 1994
7841,8730,8732,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,6.0,,4.0,servings/week,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",18.0,,,ug/dL,,99,Pearson,0.33,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7847,8730,8733,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,6.0,,4.0,servings/week,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",8.3,,,ug/dL,,99,Pearson,0.26,,, ,Yes,,,,Campbell 1994
7853,8730,8733,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,6.0,,4.0,servings/week,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",8.3,,,ug/dL,,99,Pearson,0.27,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7859,8730,8734,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,6.0,,4.0,servings/week,,,"Plasma, fasting",HPLC,Lycopene,"",37.3,,,ug/dL,,99,Pearson,-0.12,,, ,No,,,,Campbell 1994
7865,8730,8734,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,6.0,,4.0,servings/week,,,"Plasma, fasting",HPLC,Lycopene,"",37.3,,,ug/dL,,99,Pearson,-0.15,,, ,No,"Cholesterol, Energy by residual method",,,Campbell 1994
7871,8730,8735,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,6.0,,4.0,servings/week,,,"Plasma, fasting",HPLC,alpha-Carotene,"",5.6,,,ug/dL,,99,Pearson,0.67,,, ,Yes,,,,Campbell 1994
7877,8730,8735,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,6.0,,4.0,servings/week,,,"Plasma, fasting",HPLC,alpha-Carotene,"",5.6,,,ug/dL,,99,Pearson,0.69,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7883,8730,8736,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,6.0,,4.0,servings/week,,,"Plasma, fasting",HPLC,beta-Carotene,"",15.7,,,ug/dL,,99,Pearson,0.4,,, ,Yes,,,,Campbell 1994
7889,8730,8736,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,6.0,,4.0,servings/week,,,"Plasma, fasting",HPLC,beta-Carotene,"",15.7,,,ug/dL,,99,Pearson,0.41,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7895,8730,8738,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,6.0,,4.0,servings/week,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,99,Pearson,0.5,,, ,Yes,,,,Campbell 1994
7901,8730,8738,All,Volunteers from the University of Minnesota community,United States,,,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,6.0,,4.0,servings/week,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene + Lutein/Zeaxanthin,,,,ug/dL,,99,Pearson,0.53,,, ,Yes,"Cholesterol, Energy by residual method",,,Campbell 1994
7902,8747,8762,All,Women living in the Cambridge area,United Kingdom,,,Weighed Dietary record (4-day),Lutein/Zeaxanthin,"",,3.45,,,mg/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",0.399,,,umol/L,,42,Unspecified,0.24,,,= 0.068,No,,,,Scott 1996
7912,8752,8772,All,Women living in the Cambridge area,United Kingdom,,,Weighed Dietary record (4-day),beta-Carotene,"",,8.09,,,mg/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",0.44,,,umol/L,,42,Unspecified,0.045,,,= 0.303,No,,,,Scott 1996
7907,8757,8767,All,Women living in the Cambridge area,United Kingdom,,,Weighed Dietary record (4-day),Lycopene,"",,,,,mg/day,,,"Plasma, fasting",HPLC,Lycopene,"",0.266,,,umol/L,,42,Unspecified,0.416,,,= 0.004,Yes,,,,Scott 1996
7903,8748,8763,All,Women living in the Cambridge area,United Kingdom,,,Weighed Dietary record (4-day),Lutein/Zeaxanthin,"",,4.71,,,mg/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",0.374,,,umol/L,,42,Unspecified,0.549,,,< 0.001,Yes,,,,Scott 1996
7913,8753,8773,All,Women living in the Cambridge area,United Kingdom,,,Weighed Dietary record (4-day),beta-Carotene,"",,10.16,,,mg/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",0.391,,,umol/L,,42,Unspecified,0.422,,,= 0.003,Yes,,,,Scott 1996
7908,8758,8768,All,Women living in the Cambridge area,United Kingdom,,,Weighed Dietary record (4-day),Lycopene,"",,,,,mg/day,,,"Plasma, fasting",HPLC,Lycopene,"",0.248,,,umol/L,,42,Unspecified,0.297,,,= 0.032,Yes,,,,Scott 1996
7904,8749,8764,All,Women living in the Cambridge area,United Kingdom,,,Weighed Dietary record (4-day),Lutein/Zeaxanthin,"",,3.01,,,mg/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",0.493,,,umol/L,,42,Unspecified,0.298,,,= 0.031,Yes,,,,Scott 1996
7914,8754,8774,All,Women living in the Cambridge area,United Kingdom,,,Weighed Dietary record (4-day),beta-Carotene,"",,10.46,,,mg/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",0.685,,,umol/L,,42,Unspecified,0.276,,,= 0.043,Yes,,,,Scott 1996
7909,8759,8769,All,Women living in the Cambridge area,United Kingdom,,,Weighed Dietary record (4-day),Lycopene,"",,,,,mg/day,,,"Plasma, fasting",HPLC,Lycopene,"",0.394,,,umol/L,,42,Unspecified,0.0,,,= 0.37,No,,,,Scott 1996
7905,8750,8765,All,Women living in the Cambridge area,United Kingdom,,,Weighed Dietary record (4-day),Lutein/Zeaxanthin,"",,3.19,,,mg/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",0.438,,,umol/L,,42,Unspecified,0.455,,,< 0.001,Yes,,,,Scott 1996
7915,8755,8775,All,Women living in the Cambridge area,United Kingdom,,,Weighed Dietary record (4-day),beta-Carotene,"",,8.32,,,mg/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",0.653,,,umol/L,,42,Unspecified,0.11,,,= 0.299,No,,,,Scott 1996
7910,8760,8770,All,Women living in the Cambridge area,United Kingdom,,,Weighed Dietary record (4-day),Lycopene,"",,,,,mg/day,,,"Plasma, fasting",HPLC,Lycopene,"",0.374,,,umol/L,,42,Unspecified,0.539,,,< 0.001,Yes,,,,Scott 1996
7906,8751,8766,All,Women living in the Cambridge area,United Kingdom,,,Weighed Dietary record (4-day),Lutein/Zeaxanthin,"",,3.59,,,mg/day,,baseline; 1 week; 2 weeks; 3 weeks,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",0.411,,,umol/L,,42,Unspecified,0.639,,,< 0.001,Yes,,,,Scott 1996
7916,8756,8776,All,Women living in the Cambridge area,United Kingdom,,,Weighed Dietary record (4-day),beta-Carotene,"",,9.26,,,mg/day,,baseline; 1 week; 2 weeks; 3 weeks,"Plasma, fasting",HPLC,beta-Carotene,"",0.542,,,umol/L,,42,Unspecified,0.447,,,= 0.002,Yes,,,,Scott 1996
7911,8761,8771,All,Women living in the Cambridge area,United Kingdom,,,Weighed Dietary record (4-day),Lycopene,"",,,,,mg/day,,baseline; 1 week; 2 weeks; 3 weeks,"Plasma, fasting",HPLC,Lycopene,"",0.32,,,umol/L,,42,Unspecified,0.471,,,< 0.001,Yes,,,,Scott 1996
7917,8777,8787,All,Cases and controls in a case-control study on prostate cancer risk in African Americans and Caucasians,United States,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,missing unit,,,"Red blood cell membrane, unspecified",GC-FID,EPA (cis-20:5n-3),"",,,,missing unit,,124,Spearman,0.44,,, ,Unspecified,,,,Godley 1996
7927,8777,8797,All,Cases and controls in a case-control study on prostate cancer risk in African Americans and Caucasians,United States,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,missing unit,,,"Adipose tissue, upper arm, buttock or abdomen",GC-FID,EPA (cis-20:5n-3),"",,,,missing unit,,109,Spearman,0.38,,, ,Unspecified,,,,Godley 1996
7922,8782,8792,All,Cases and controls in a case-control study on prostate cancer risk in African Americans and Caucasians,United States,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,missing unit,,,"Red blood cell membrane, unspecified",GC-FID,DHA (cis-22:6n-3),"",,,,missing unit,,124,Spearman,0.41,,, ,Unspecified,,,,Godley 1996
7932,8782,8802,All,Cases and controls in a case-control study on prostate cancer risk in African Americans and Caucasians,United States,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,missing unit,,,"Adipose tissue, upper arm, buttock or abdomen",GC-FID,DHA (cis-22:6n-3),"",,,,missing unit,,109,Spearman,0.32,,, ,Unspecified,,,,Godley 1996
7918,8778,8788,Cases,Cases and controls in a case-control study on prostate cancer risk in African Americans and Caucasians,United States,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,missing unit,,,"Red blood cell membrane, unspecified",GC-FID,EPA (cis-20:5n-3),"",,,,missing unit,,88,Spearman,0.49,,, ,Unspecified,,,,Godley 1996
7928,8778,8798,Cases,Cases and controls in a case-control study on prostate cancer risk in African Americans and Caucasians,United States,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,missing unit,,,"Adipose tissue, upper arm, buttock or abdomen",GC-FID,EPA (cis-20:5n-3),"",,,,missing unit,,76,Spearman,0.43,,, ,Unspecified,,,,Godley 1996
7923,8783,8793,Cases,Cases and controls in a case-control study on prostate cancer risk in African Americans and Caucasians,United States,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,missing unit,,,"Red blood cell membrane, unspecified",GC-FID,DHA (cis-22:6n-3),"",,,,missing unit,,88,Spearman,0.47,,, ,Unspecified,,,,Godley 1996
7933,8783,8803,Cases,Cases and controls in a case-control study on prostate cancer risk in African Americans and Caucasians,United States,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,missing unit,,,"Adipose tissue, upper arm, buttock or abdomen",GC-FID,DHA (cis-22:6n-3),"",,,,missing unit,,76,Spearman,0.34,,, ,Unspecified,,,,Godley 1996
7919,8779,8789,Controls,Cases and controls in a case-control study on prostate cancer risk in African Americans and Caucasians,United States,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,missing unit,,,"Red blood cell membrane, unspecified",GC-FID,EPA (cis-20:5n-3),"",,,,missing unit,,36,Spearman,0.36,,, ,Unspecified,,,,Godley 1996
7929,8779,8799,Controls,Cases and controls in a case-control study on prostate cancer risk in African Americans and Caucasians,United States,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,missing unit,,,"Adipose tissue, upper arm, buttock or abdomen",GC-FID,EPA (cis-20:5n-3),"",,,,missing unit,,33,Spearman,0.33,,, ,Unspecified,,,,Godley 1996
7924,8784,8794,Controls,Cases and controls in a case-control study on prostate cancer risk in African Americans and Caucasians,United States,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,missing unit,,,"Red blood cell membrane, unspecified",GC-FID,DHA (cis-22:6n-3),"",,,,missing unit,,36,Spearman,0.19,,, ,Unspecified,,,,Godley 1996
7934,8784,8804,Controls,Cases and controls in a case-control study on prostate cancer risk in African Americans and Caucasians,United States,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,missing unit,,,"Adipose tissue, upper arm, buttock or abdomen",GC-FID,DHA (cis-22:6n-3),"",,,,missing unit,,33,Spearman,0.42,,, ,Unspecified,,,,Godley 1996
7920,8780,8790,African Americans,Cases and controls in a case-control study on prostate cancer risk in African Americans and Caucasians,United States,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,missing unit,,,"Red blood cell membrane, unspecified",GC-FID,EPA (cis-20:5n-3),"",,,,missing unit,,29,Spearman,0.28,,, ,Unspecified,,,,Godley 1996
7930,8780,8800,African Americans,Cases and controls in a case-control study on prostate cancer risk in African Americans and Caucasians,United States,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,missing unit,,,"Adipose tissue, upper arm, buttock or abdomen",GC-FID,EPA (cis-20:5n-3),"",,,,missing unit,,25,Spearman,0.15,,, ,Unspecified,,,,Godley 1996
7925,8785,8795,African Americans,Cases and controls in a case-control study on prostate cancer risk in African Americans and Caucasians,United States,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,missing unit,,,"Red blood cell membrane, unspecified",GC-FID,DHA (cis-22:6n-3),"",,,,missing unit,,29,Spearman,0.39,,, ,Unspecified,,,,Godley 1996
7935,8785,8805,African Americans,Cases and controls in a case-control study on prostate cancer risk in African Americans and Caucasians,United States,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,missing unit,,,"Adipose tissue, upper arm, buttock or abdomen",GC-FID,DHA (cis-22:6n-3),"",,,,missing unit,,25,Spearman,0.06,,, ,Unspecified,,,,Godley 1996
7921,8781,8791,Caucasians,Cases and controls in a case-control study on prostate cancer risk in African Americans and Caucasians,United States,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,missing unit,,,"Red blood cell membrane, unspecified",GC-FID,EPA (cis-20:5n-3),"",,,,missing unit,,95,Spearman,0.5,,, ,Unspecified,,,,Godley 1996
7931,8781,8801,Caucasians,Cases and controls in a case-control study on prostate cancer risk in African Americans and Caucasians,United States,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,missing unit,,,"Adipose tissue, upper arm, buttock or abdomen",GC-FID,EPA (cis-20:5n-3),"",,,,missing unit,,84,Spearman,0.49,,, ,Unspecified,,,,Godley 1996
7926,8786,8796,Caucasians,Cases and controls in a case-control study on prostate cancer risk in African Americans and Caucasians,United States,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,missing unit,,,"Red blood cell membrane, unspecified",GC-FID,DHA (cis-22:6n-3),"",,,,missing unit,,95,Spearman,0.41,,, ,Unspecified,,,,Godley 1996
7936,8786,8806,Caucasians,Cases and controls in a case-control study on prostate cancer risk in African Americans and Caucasians,United States,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,missing unit,,,"Adipose tissue, upper arm, buttock or abdomen",GC-FID,DHA (cis-22:6n-3),"",,,,missing unit,,84,Spearman,0.41,,, ,Unspecified,,,,Godley 1996
7949,8820,8832,All,Premenopausal women participant in a diet study on alcohol-hormone metabolism,United States,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,746.0,545.0,553.0,ug/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",0.11,0.08,0.08,mmol/L,,98,Pearson,0.52,,,< 0.05,Yes,,,,Yong 1994
7955,8820,8832,All,Premenopausal women participant in a diet study on alcohol-hormone metabolism,United States,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,746.0,545.0,553.0,ug/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",0.11,0.08,0.08,mmol/L,,98,Pearson,0.49,,,< 0.05,Yes,,,"Alcohol, BMI, Cholesterol, Energy",Yong 1994
7950,8821,8833,All,Premenopausal women participant in a diet study on alcohol-hormone metabolism,United States,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,3335.0,2697.0,2704.0,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",0.34,0.3,0.29,mmol/L,,98,Pearson,0.44,,,< 0.05,Yes,,,,Yong 1994
7956,8821,8833,All,Premenopausal women participant in a diet study on alcohol-hormone metabolism,United States,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,3335.0,2697.0,2704.0,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",0.34,0.3,0.29,mmol/L,,98,Pearson,0.49,,,< 0.05,Yes,,,"Alcohol, BMI, Cholesterol, Energy",Yong 1994
7951,8822,8834,All,Premenopausal women participant in a diet study on alcohol-hormone metabolism,United States,,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,38.0,22.0,29.0,ug/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",0.17,0.17,0.17,mmol/L,,98,Pearson,0.3,,,< 0.05,Yes,,,,Yong 1994
7957,8822,8834,All,Premenopausal women participant in a diet study on alcohol-hormone metabolism,United States,,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,38.0,22.0,29.0,ug/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",0.17,0.17,0.17,mmol/L,,98,Pearson,0.36,,,< 0.05,Yes,,,"Alcohol, BMI, Cholesterol, Energy",Yong 1994
7952,8823,8835,All,Premenopausal women participant in a diet study on alcohol-hormone metabolism,United States,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,2390.0,1808.0,1870.0,ug/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",0.46,0.43,0.43,mmol/L,,98,Pearson,0.29,,,< 0.05,Yes,,,,Yong 1994
7958,8823,8835,All,Premenopausal women participant in a diet study on alcohol-hormone metabolism,United States,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,2390.0,1808.0,1870.0,ug/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",0.46,0.43,0.43,mmol/L,,98,Pearson,0.37,,,< 0.05,Yes,,,"Alcohol, BMI, Cholesterol, Energy",Yong 1994
7953,8824,8836,All,Premenopausal women participant in a diet study on alcohol-hormone metabolism,United States,,,Food Frequency Questionnaire (FFQ),Lycopene,"",,3353.0,2981.0,3008.0,ug/day,,,"Plasma, fasting",HPLC,Lycopene,"",0.58,0.54,0.54,mmol/L,,98,Pearson,0.28,,,< 0.05,Yes,,,,Yong 1994
7959,8824,8836,All,Premenopausal women participant in a diet study on alcohol-hormone metabolism,United States,,,Food Frequency Questionnaire (FFQ),Lycopene,"",,3353.0,2981.0,3008.0,ug/day,,,"Plasma, fasting",HPLC,Lycopene,"",0.58,0.54,0.54,mmol/L,,98,Pearson,0.26,,,< 0.05,Yes,,,"Alcohol, BMI, Cholesterol, Energy",Yong 1994
7954,8825,8837,All,Premenopausal women participant in a diet study on alcohol-hormone metabolism,United States,,,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,9862.0,8103.0,8535.0,ug/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,1.66,1.57,1.57,mmol/L,,98,Pearson,0.43,,,< 0.05,Yes,,,,Yong 1994
7960,8825,8837,All,Premenopausal women participant in a diet study on alcohol-hormone metabolism,United States,,,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,9862.0,8103.0,8535.0,ug/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,1.66,1.57,1.57,mmol/L,,98,Pearson,0.49,,,< 0.05,Yes,,,"Alcohol, BMI, Cholesterol, Energy",Yong 1994
7937,8808,8832,All,Premenopausal women participant in a diet study on alcohol-hormone metabolism,United States,,,Dietary record (7-day),alpha-Carotene,"",,573.0,365.0,397.0,ug/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",0.11,0.08,0.08,mmol/L,,98,Pearson,0.59,,,< 0.05,Yes,,,,Yong 1994
7943,8808,8832,All,Premenopausal women participant in a diet study on alcohol-hormone metabolism,United States,,,Dietary record (7-day),alpha-Carotene,"",,573.0,365.0,397.0,ug/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",0.11,0.08,0.08,mmol/L,,98,Pearson,0.58,,,< 0.05,Yes,,,"Alcohol, BMI, Cholesterol, Energy",Yong 1994
7938,8809,8833,All,Premenopausal women participant in a diet study on alcohol-hormone metabolism,United States,,,Dietary record (7-day),beta-Carotene,"",,2652.0,1998.0,2098.0,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",0.34,0.3,0.29,mmol/L,,98,Pearson,0.52,,,< 0.05,Yes,,,,Yong 1994
7944,8809,8833,All,Premenopausal women participant in a diet study on alcohol-hormone metabolism,United States,,,Dietary record (7-day),beta-Carotene,"",,2652.0,1998.0,2098.0,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",0.34,0.3,0.29,mmol/L,,98,Pearson,0.51,,,< 0.05,Yes,,,"Alcohol, BMI, Cholesterol, Energy",Yong 1994
7939,8810,8834,All,Premenopausal women participant in a diet study on alcohol-hormone metabolism,United States,,,Dietary record (7-day),beta-Cryptoxanthin,"",,30.0,16.0,21.0,ug/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",0.17,0.17,0.17,mmol/L,,98,Pearson,0.49,,,< 0.05,Yes,,,,Yong 1994
7945,8810,8834,All,Premenopausal women participant in a diet study on alcohol-hormone metabolism,United States,,,Dietary record (7-day),beta-Cryptoxanthin,"",,30.0,16.0,21.0,ug/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",0.17,0.17,0.17,mmol/L,,98,Pearson,0.49,,,< 0.05,Yes,,,"Alcohol, BMI, Cholesterol, Energy",Yong 1994
7940,8811,8835,All,Premenopausal women participant in a diet study on alcohol-hormone metabolism,United States,,,Dietary record (7-day),Lutein/Zeaxanthin,"",,1860.0,1339.0,1217.0,ug/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",0.46,0.43,0.43,mmol/L,,98,Pearson,0.29,,,< 0.05,Yes,,,,Yong 1994
7946,8811,8835,All,Premenopausal women participant in a diet study on alcohol-hormone metabolism,United States,,,Dietary record (7-day),Lutein/Zeaxanthin,"",,1860.0,1339.0,1217.0,ug/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",0.46,0.43,0.43,mmol/L,,98,Pearson,0.31,,,< 0.05,Yes,,,"Alcohol, BMI, Cholesterol, Energy",Yong 1994
7941,8812,8836,All,Premenopausal women participant in a diet study on alcohol-hormone metabolism,United States,,,Dietary record (7-day),Lycopene,"",,3056.0,2208.0,2392.0,ug/day,,,"Plasma, fasting",HPLC,Lycopene,"",0.58,0.54,0.54,mmol/L,,98,Pearson,0.41,,,< 0.05,Yes,,,,Yong 1994
7947,8812,8836,All,Premenopausal women participant in a diet study on alcohol-hormone metabolism,United States,,,Dietary record (7-day),Lycopene,"",,3056.0,2208.0,2392.0,ug/day,,,"Plasma, fasting",HPLC,Lycopene,"",0.58,0.54,0.54,mmol/L,,98,Pearson,0.5,,,< 0.05,Yes,,,"Alcohol, BMI, Cholesterol, Energy",Yong 1994
7942,8813,8837,All,Premenopausal women participant in a diet study on alcohol-hormone metabolism,United States,,,Dietary record (7-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,8171.0,6634.0,6883.0,ug/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,1.66,1.57,1.57,mmol/L,,98,Pearson,0.51,,,< 0.05,Yes,,,,Yong 1994
7948,8813,8837,All,Premenopausal women participant in a diet study on alcohol-hormone metabolism,United States,,,Dietary record (7-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,8171.0,6634.0,6883.0,ug/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,1.66,1.57,1.57,mmol/L,,98,Pearson,0.57,,,< 0.05,Yes,,,"Alcohol, BMI, Cholesterol, Energy",Yong 1994
7961,8844,8846,All,Elderly women of high socioeconomic status residant in a housing complex,United States,,,Food Frequency Questionnaire (FFQ),Vitamin D,"",Yes,8.58,,,ug/day,,,"Plasma, fasting",Competitive protein-binding assay (CPBA),25-Hydroxycholecalciferol,"",63.4,,,nmol/L,,59,Pearson,0.52,,,< 0.01,Yes,,,,Salamone 1994
7962,8845,8847,All,Elderly women of high socioeconomic status residant in a housing complex,United States,,,Food Frequency Questionnaire (FFQ),Vitamin D,"",Yes,9.2,,,ug/day,,,"Plasma, fasting",Competitive protein-binding assay (CPBA),25-Hydroxycholecalciferol,"",54.7,,,nmol/L,,59,Pearson,0.63,,,< 0.01,Yes,,,,Salamone 1994
7963,8864,8866,Low sunlight exposure,Elderly women of high socioeconomic status residant in a housing complex,United States,,,Food Frequency Questionnaire (FFQ),Vitamin D,"",Yes,,,,ug/day,,,"Plasma, fasting",Competitive protein-binding assay (CPBA),25-Hydroxycholecalciferol,"",,,,nmol/L,,26,Pearson,0.71,,,< 0.01,Yes,,,,Salamone 1994
7964,8865,8867,Low sunlight exposure,Elderly women of high socioeconomic status residant in a housing complex,United States,,,Food Frequency Questionnaire (FFQ),Vitamin D,"",Yes,,,,ug/day,,,"Plasma, fasting",Competitive protein-binding assay (CPBA),25-Hydroxycholecalciferol,"",,,,nmol/L,,26,Pearson,0.8,,,< 0.01,Yes,,,,Salamone 1994
7965,8868,8870,High sunlight exposure,Elderly women of high socioeconomic status residant in a housing complex,United States,,,Food Frequency Questionnaire (FFQ),Vitamin D,"",Yes,,,,ug/day,,,"Plasma, fasting",Competitive protein-binding assay (CPBA),25-Hydroxycholecalciferol,"",,,,nmol/L,,24,Pearson,0.32,,,>= 0.05,No,,,,Salamone 1994
7966,8869,8871,High sunlight exposure,Elderly women of high socioeconomic status residant in a housing complex,United States,,,Food Frequency Questionnaire (FFQ),Vitamin D,"",Yes,,,,ug/day,,,"Plasma, fasting",Competitive protein-binding assay (CPBA),25-Hydroxycholecalciferol,"",,,,nmol/L,,24,Pearson,0.5,,,< 0.05,Yes,,,,Salamone 1994
7967,8872,8884,All,Men,United States,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,840.0,,,ug/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",0.09,,,mmol/L,,57,Spearman,0.25,,,>= 0.05,No,,,,Forman 1993
7973,8872,8884,All,Men,United States,,,Food Frequency Questionnaire (FFQ),alpha-Carotene,"",,840.0,,,ug/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",0.09,,,mmol/L,,57,Spearman,0.29,,,< 0.05,Yes,,,"Energy, % of energy from alcohol, LDL-cholesterol",Forman 1993
7968,8873,8885,All,Men,United States,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,3882.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",0.58,,,mmol/L,,57,Spearman,0.36,,,< 0.01,Yes,,,,Forman 1993
7974,8873,8885,All,Men,United States,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",,3882.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",0.58,,,mmol/L,,57,Spearman,0.36,,,< 0.01,Yes,,,"Energy, % of energy from alcohol, LDL-cholesterol",Forman 1993
7969,8874,8886,All,Men,United States,,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,62.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",0.24,,,mmol/L,,57,Spearman,0.33,,,< 0.01,Yes,,,,Forman 1993
7975,8874,8886,All,Men,United States,,,Food Frequency Questionnaire (FFQ),beta-Cryptoxanthin,"",,62.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",0.24,,,mmol/L,,57,Spearman,0.46,,,< 0.01,Yes,,,"Energy, % of energy from alcohol, LDL-cholesterol",Forman 1993
7971,8875,8887,All,Men,United States,,,Food Frequency Questionnaire (FFQ),Lycopene,"",,3879.0,,,ug/day,,,"Plasma, fasting",HPLC,Lycopene,"",1.06,,,mmol/L,,57,Spearman,0.24,,,>= 0.05,No,,,,Forman 1993
7977,8875,8887,All,Men,United States,,,Food Frequency Questionnaire (FFQ),Lycopene,"",,3879.0,,,ug/day,,,"Plasma, fasting",HPLC,Lycopene,"",1.06,,,mmol/L,,57,Spearman,0.26,,,>= 0.05,No,,,"Energy, % of energy from alcohol, LDL-cholesterol",Forman 1993
7970,8876,8888,All,Men,United States,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,2516.0,,,ug/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",0.49,,,mmol/L,,57,Spearman,0.11,,,>= 0.05,No,,,,Forman 1993
7976,8876,8888,All,Men,United States,,,Food Frequency Questionnaire (FFQ),Lutein/Zeaxanthin,"",,2516.0,,,ug/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",0.49,,,mmol/L,,57,Spearman,0.2,,,>= 0.05,No,,,"Energy, % of energy from alcohol, LDL-cholesterol, HDL cholesterol",Forman 1993
7972,8877,8889,All,Men,United States,,,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,11179.0,,,ug/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,2.46,,,mmol/L,,57,Spearman,0.24,,,>= 0.05,No,,,,Forman 1993
7978,8877,8889,All,Men,United States,,,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,11179.0,,,ug/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,2.46,,,mmol/L,,57,Spearman,0.41,,,< 0.01,Yes,,,"Energy, % of energy from alcohol, LDL-cholesterol",Forman 1993
7979,8878,8896,All,Men,United States,,,Dietary record (7-day),alpha-Carotene,"",,650.0,,,ug/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,mmol/L,,57,Spearman,0.42,,,< 0.01,Yes,,,,Forman 1993
7985,8878,8896,All,Men,United States,,,Dietary record (7-day),alpha-Carotene,"",,650.0,,,ug/day,,,"Plasma, fasting",HPLC,alpha-Carotene,"",,,,mmol/L,,57,Spearman,0.43,,,< 0.01,Yes,,,"Energy, % of energy from alcohol, LDL-cholesterol",Forman 1993
7980,8879,8897,All,Men,United States,,,Dietary record (7-day),beta-Carotene,"",,3150.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,mmol/L,,57,Spearman,0.27,,,< 0.05,Yes,,,,Forman 1993
7986,8879,8897,All,Men,United States,,,Dietary record (7-day),beta-Carotene,"",,3150.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Carotene,"",,,,mmol/L,,57,Spearman,0.26,,,>= 0.05,No,,,"Energy, % of energy from alcohol, LDL-cholesterol",Forman 1993
7981,8880,8898,All,Men,United States,,,Dietary record (7-day),beta-Cryptoxanthin,"",,38.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,mmol/L,,57,Spearman,0.48,,,< 0.01,Yes,,,,Forman 1993
7987,8880,8898,All,Men,United States,,,Dietary record (7-day),beta-Cryptoxanthin,"",,38.0,,,ug/day,,,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",,,,mmol/L,,57,Spearman,0.44,,,< 0.01,Yes,,,"Energy, % of energy from alcohol, LDL-cholesterol",Forman 1993
7983,8881,8899,All,Men,United States,,,Dietary record (7-day),Lycopene,"",,3652.0,,,ug/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,mmol/L,,57,Spearman,0.45,,,< 0.01,Yes,,,,Forman 1993
7989,8881,8899,All,Men,United States,,,Dietary record (7-day),Lycopene,"",,3652.0,,,ug/day,,,"Plasma, fasting",HPLC,Lycopene,"",,,,mmol/L,,57,Spearman,0.53,,,< 0.01,Yes,,,"Energy, % of energy from alcohol, LDL-cholesterol",Forman 1993
7982,8882,8900,All,Men,United States,,,Dietary record (7-day),Lutein/Zeaxanthin,"",,2056.0,,,ug/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,mmol/L,,57,Spearman,0.4,,,< 0.01,Yes,,,,Forman 1993
7988,8882,8900,All,Men,United States,,,Dietary record (7-day),Lutein/Zeaxanthin,"",,2056.0,,,ug/day,,,"Plasma, fasting",HPLC,Lutein/Zeaxanthin,"",,,,mmol/L,,57,Spearman,0.44,,,< 0.01,Yes,,,"Energy, % of energy from alcohol, LDL-cholesterol, HDL-cholesterol",Forman 1993
7984,8883,8901,All,Men,United States,,,Dietary record (7-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,9546.0,,,ug/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,mmol/L,,57,Spearman,0.27,,,< 0.05,Yes,,,,Forman 1993
7990,8883,8901,All,Men,United States,,,Dietary record (7-day),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,9546.0,,,ug/day,,,"Plasma, fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,,,,mmol/L,,57,Spearman,0.35,,,< 0.01,Yes,,,"Energy, % of energy from alcohol, LDL-cholesterol",Forman 1993
7991,8930,8926,All [by gender],Children in Georgia,United States,SCAN (Studies of Children's Activity and Nutrition),,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,,kiloiuretinol/day,,,"Serum, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,mg/dL,,97,Spearman,0.16,,, ,Unspecified,,,,Byers 1993
7992,8930,8927,All [by gender],Children in Georgia,United States,SCAN (Studies of Children's Activity and Nutrition),,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,,kiloiuretinol/day,,,"Serum, non-fasting",Colorimetry,Vitamin C,"",,,,mg/dL,,97,Spearman,0.14,,, ,Unspecified,,,,Byers 1993
7993,8930,8928,All [by gender],Children in Georgia,United States,SCAN (Studies of Children's Activity and Nutrition),,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,,kiloiuretinol/day,,,"Serum, non-fasting",HPLC,Retinol,"",,,,iuretinol/dL,,97,Spearman,0.13,,, ,Unspecified,,,,Byers 1993
7994,8930,8929,All [by gender],Children in Georgia,United States,SCAN (Studies of Children's Activity and Nutrition),,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,,kiloiuretinol/day,,,"Serum, non-fasting",HPLC,alpha-Tocopherol,"",,,,iualphatocopherol/dL,,97,Spearman,0.09,,, ,Unspecified,,,,Byers 1993
8011,8930,8926,All [by gender],Children in Georgia,United States,SCAN (Studies of Children's Activity and Nutrition),,Food Frequency Questionnaire (FFQ),Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,,kiloiuretinol/day,,,"Serum, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,mg/dL,,97,Spearman,0.2,0.0,0.39, ,Unspecified,,,"Age, BMI, Energy, Race, Sex, Family history of coronary disease, Triglycerides, Cholesterol",Byers 1993
7995,8931,8926,All [by gender],Children in Georgia,United States,SCAN (Studies of Children's Activity and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin C,"",,,,,mg/day,,,"Serum, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,mg/dL,,97,Spearman,0.31,,, ,Unspecified,,,,Byers 1993
7996,8931,8927,All [by gender],Children in Georgia,United States,SCAN (Studies of Children's Activity and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin C,"",,,,,mg/day,,,"Serum, non-fasting",Colorimetry,Vitamin C,"",,,,mg/dL,,97,Spearman,0.39,,, ,Unspecified,,,,Byers 1993
7997,8931,8928,All [by gender],Children in Georgia,United States,SCAN (Studies of Children's Activity and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin C,"",,,,,mg/day,,,"Serum, non-fasting",HPLC,Retinol,"",,,,iuretinol/dL,,97,Spearman,0.08,,, ,Unspecified,,,,Byers 1993
7998,8931,8929,All [by gender],Children in Georgia,United States,SCAN (Studies of Children's Activity and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin C,"",,,,,mg/day,,,"Serum, non-fasting",HPLC,alpha-Tocopherol,"",,,,iualphatocopherol/dL,,97,Spearman,0.28,,, ,Unspecified,,,,Byers 1993
8012,8931,8927,All [by gender],Children in Georgia,United States,SCAN (Studies of Children's Activity and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin C,"",,,,,mg/day,,,"Serum, non-fasting",Colorimetry,Vitamin C,"",,,,mg/dL,,97,Spearman,0.37,0.19,0.53, ,Unspecified,,,"Age, BMI, Energy, Race, Sex, Family history of coronary disease, Triglycerides, Cholesterol",Byers 1993
7999,8932,8926,All [by gender],Children in Georgia,United States,SCAN (Studies of Children's Activity and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin A,"",,,,,iuretinol/day,,,"Serum, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,mg/dL,,97,Spearman,0.09,,, ,Unspecified,,,,Byers 1993
8000,8932,8927,All [by gender],Children in Georgia,United States,SCAN (Studies of Children's Activity and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin A,"",,,,,iuretinol/day,,,"Serum, non-fasting",Colorimetry,Vitamin C,"",,,,mg/dL,,97,Spearman,0.13,,, ,Unspecified,,,,Byers 1993
8001,8932,8928,All [by gender],Children in Georgia,United States,SCAN (Studies of Children's Activity and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin A,"",,,,,iuretinol/day,,,"Serum, non-fasting",HPLC,Retinol,"",,,,iuretinol/dL,,97,Spearman,0.14,,, ,Unspecified,,,,Byers 1993
8002,8932,8929,All [by gender],Children in Georgia,United States,SCAN (Studies of Children's Activity and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin A,"",,,,,iuretinol/day,,,"Serum, non-fasting",HPLC,alpha-Tocopherol,"",,,,iualphatocopherol/dL,,97,Spearman,0.15,,, ,Unspecified,,,,Byers 1993
8013,8932,8928,All [by gender],Children in Georgia,United States,SCAN (Studies of Children's Activity and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin A,"",,,,,iuretinol/day,,,"Serum, non-fasting",HPLC,Retinol,"",,,,iuretinol/dL,,97,Spearman,0.17,-0.03,0.36, ,Unspecified,,,"Age, BMI, Energy, Race, Sex, Family history of coronary disease, Triglycerides, Cholesterol",Byers 1993
8003,8933,8926,All [by gender],Children in Georgia,United States,SCAN (Studies of Children's Activity and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin E,"",,,,,iualphatocopherol/day,,,"Serum, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,mg/dL,,97,Spearman,0.08,,, ,Unspecified,,,,Byers 1993
8004,8933,8927,All [by gender],Children in Georgia,United States,SCAN (Studies of Children's Activity and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin E,"",,,,,iualphatocopherol/day,,,"Serum, non-fasting",Colorimetry,Vitamin C,"",,,,mg/dL,,97,Spearman,0.24,,, ,Unspecified,,,,Byers 1993
8005,8933,8928,All [by gender],Children in Georgia,United States,SCAN (Studies of Children's Activity and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin E,"",,,,,iualphatocopherol/day,,,"Serum, non-fasting",HPLC,Retinol,"",,,,iuretinol/dL,,97,Spearman,0.11,,, ,Unspecified,,,,Byers 1993
8006,8933,8929,All [by gender],Children in Georgia,United States,SCAN (Studies of Children's Activity and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin E,"",,,,,iualphatocopherol/day,,,"Serum, non-fasting",HPLC,alpha-Tocopherol,"",,,,iualphatocopherol/dL,,97,Spearman,0.32,,, ,Unspecified,,,,Byers 1993
8014,8933,8929,All [by gender],Children in Georgia,United States,SCAN (Studies of Children's Activity and Nutrition),,Food Frequency Questionnaire (FFQ),Vitamin E,"",,,,,iualphatocopherol/day,,,"Serum, non-fasting",HPLC,alpha-Tocopherol,"",,,,iualphatocopherol/dL,,97,Spearman,0.32,0.13,0.49, ,Unspecified,,,"Age, BMI, Energy, Race, Sex, Family history of coronary disease, Triglycerides, Cholesterol",Byers 1993
8007,8934,8926,All [by gender],Children in Georgia,United States,SCAN (Studies of Children's Activity and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,,,,servings/day,,,"Serum, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,mg/dL,,97,Spearman,0.24,,, ,Unspecified,,,,Byers 1993
8008,8934,8927,All [by gender],Children in Georgia,United States,SCAN (Studies of Children's Activity and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,,,,servings/day,,,"Serum, non-fasting",Colorimetry,Vitamin C,"",,,,mg/dL,,97,Spearman,0.29,,, ,Unspecified,,,,Byers 1993
8009,8934,8928,All [by gender],Children in Georgia,United States,SCAN (Studies of Children's Activity and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,,,,servings/day,,,"Serum, non-fasting",HPLC,Retinol,"",,,,iuretinol/dL,,97,Spearman,0.14,,, ,Unspecified,,,,Byers 1993
8010,8934,8929,All [by gender],Children in Georgia,United States,SCAN (Studies of Children's Activity and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,,,,servings/day,,,"Serum, non-fasting",HPLC,alpha-Tocopherol,"",,,,iualphatocopherol/dL,,97,Spearman,0.17,,, ,Unspecified,,,,Byers 1993
8015,8934,8926,All [by gender],Children in Georgia,United States,SCAN (Studies of Children's Activity and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,,,,servings/day,,,"Serum, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + beta-Carotene,,,,mg/dL,,97,Spearman,0.3,0.11,0.47, ,Unspecified,,,"Age, BMI, Energy, Race, Sex, Family history of coronary disease, Triglycerides, Cholesterol",Byers 1993
8016,8934,8927,All [by gender],Children in Georgia,United States,SCAN (Studies of Children's Activity and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,,,,servings/day,,,"Serum, non-fasting",Colorimetry,Vitamin C,"",,,,mg/dL,,97,Spearman,0.34,0.15,0.51, ,Unspecified,,,"Age, BMI, Energy, Race, Sex, Family history of coronary disease, Triglycerides, Cholesterol",Byers 1993
8017,8934,8928,All [by gender],Children in Georgia,United States,SCAN (Studies of Children's Activity and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,,,,servings/day,,,"Serum, non-fasting",HPLC,Retinol,"",,,,iuretinol/dL,,97,Spearman,0.25,0.06,0.43, ,Unspecified,,,"Age, BMI, Energy, Race, Sex, Family history of coronary disease, Triglycerides, Cholesterol",Byers 1993
8018,8934,8929,All [by gender],Children in Georgia,United States,SCAN (Studies of Children's Activity and Nutrition),,Food Frequency Questionnaire (FFQ),Fruits + Vegetables,"",,,,,servings/day,,,"Serum, non-fasting",HPLC,alpha-Tocopherol,"",,,,iualphatocopherol/dL,,97,Spearman,0.24,0.05,0.47, ,Unspecified,,,"Age, BMI, Energy, Race, Sex, Family history of coronary disease, Triglycerides, Cholesterol",Byers 1993
8019,9034,9041,All [by gender],Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Capric acid (10:0),,,,percentRoot,,86,Pearson,0.24,,,< 0.05,Yes,,,,Tjonneland 1993
8026,9034,9041,All [by gender],Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Capric acid (10:0),,,,percentRoot,,86,Spearman,0.28,,,< 0.05,Yes,,,,Tjonneland 1993
8020,9035,9042,All [by gender],Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",cis-Octadecenoic acids (cis-18:1) + cis-Tetradecenoic acids (cis-14:1) + cis-Heptadecenoic acids (cis-17:1) + cis-Hexadecenoic acids (cis-16:1) + cis-Eicosenoic acids (cis-20:1) + cis-Docosenoic acids (cis-22:1) + cis-Pentadecenoic acids (cis-15:1),,,,percentRoot,,86,Pearson,0.05,,,>= 0.05,No,,,,Tjonneland 1993
8027,9035,9042,All [by gender],Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",cis-Octadecenoic acids (cis-18:1) + cis-Tetradecenoic acids (cis-14:1) + cis-Heptadecenoic acids (cis-17:1) + cis-Hexadecenoic acids (cis-16:1) + cis-Eicosenoic acids (cis-20:1) + cis-Docosenoic acids (cis-22:1) + cis-Pentadecenoic acids (cis-15:1),,,,percentRoot,,86,Spearman,0.07,,,>= 0.05,No,,,,Tjonneland 1993
8021,9036,9043,All [by gender],Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + Eicosatrienoic acid (ETE; cis-20:3n-3) + gamma-Linolenic acid (GLA; cis-18:3n-6) + cis-Docosapentaenoic acids (cis-22:5) + Stearidonic acid (cis-18:4n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3),,,,percentRoot,,86,Pearson,0.44,,,< 0.05,Yes,,,,Tjonneland 1993
8028,9036,9043,All [by gender],Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + Eicosatrienoic acid (ETE; cis-20:3n-3) + gamma-Linolenic acid (GLA; cis-18:3n-6) + cis-Docosapentaenoic acids (cis-22:5) + Stearidonic acid (cis-18:4n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3),,,,percentRoot,,86,Spearman,0.4,,,< 0.05,Yes,,,,Tjonneland 1993
8022,9037,9044,All [by gender],Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,86,Pearson,0.44,,,< 0.05,Yes,,,,Tjonneland 1993
8029,9037,9044,All [by gender],Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,86,Spearman,0.39,,,< 0.05,Yes,,,,Tjonneland 1993
8023,9038,9045,All [by gender],Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,percentRoot,,86,Pearson,0.12,,,>= 0.05,No,,,,Tjonneland 1993
8030,9038,9045,All [by gender],Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,percentRoot,,86,Spearman,0.14,,,>= 0.05,No,,,,Tjonneland 1993
8024,9039,9046,All [by gender],Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,86,Pearson,0.47,,,< 0.05,Yes,,,,Tjonneland 1993
8031,9039,9046,All [by gender],Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,86,Spearman,0.55,,,< 0.05,Yes,,,,Tjonneland 1993
8025,9040,9047,All [by gender],Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,86,Pearson,0.41,,,< 0.05,Yes,,,,Tjonneland 1993
8032,9040,9047,All [by gender],Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,86,Spearman,0.42,,,< 0.05,Yes,,,,Tjonneland 1993
8061,9013,9041,All [by gender],Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Capric acid (10:0),,,,percentRoot,,86,Pearson,0.46,,,< 0.05,Yes,,No,,Tjonneland 1993
8068,9013,9041,All [by gender],Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Capric acid (10:0),,,,percentRoot,,86,Pearson,0.49,,,< 0.05,Yes,,Yes,,Tjonneland 1993
8075,9013,9041,All [by gender],Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Capric acid (10:0),,,,percentRoot,,86,Spearman,0.52,,,< 0.05,Yes,,,,Tjonneland 1993
8062,9014,9042,All [by gender],Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, monounsaturated (MUFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",cis-Octadecenoic acids (cis-18:1) + cis-Tetradecenoic acids (cis-14:1) + cis-Heptadecenoic acids (cis-17:1) + cis-Hexadecenoic acids (cis-16:1) + cis-Eicosenoic acids (cis-20:1) + cis-Docosenoic acids (cis-22:1) + cis-Pentadecenoic acids (cis-15:1),,,,percentRoot,,86,Pearson,0.19,,,< 0.05,Yes,,No,,Tjonneland 1993
8069,9014,9042,All [by gender],Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, monounsaturated (MUFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",cis-Octadecenoic acids (cis-18:1) + cis-Tetradecenoic acids (cis-14:1) + cis-Heptadecenoic acids (cis-17:1) + cis-Hexadecenoic acids (cis-16:1) + cis-Eicosenoic acids (cis-20:1) + cis-Docosenoic acids (cis-22:1) + cis-Pentadecenoic acids (cis-15:1),,,,percentRoot,,86,Pearson,0.26,,,< 0.05,Yes,,Yes,,Tjonneland 1993
8076,9014,9042,All [by gender],Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, monounsaturated (MUFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",cis-Octadecenoic acids (cis-18:1) + cis-Tetradecenoic acids (cis-14:1) + cis-Heptadecenoic acids (cis-17:1) + cis-Hexadecenoic acids (cis-16:1) + cis-Eicosenoic acids (cis-20:1) + cis-Docosenoic acids (cis-22:1) + cis-Pentadecenoic acids (cis-15:1),,,,percentRoot,,86,Spearman,0.21,,,< 0.05,Yes,,,,Tjonneland 1993
8063,9015,9043,All [by gender],Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + Eicosatrienoic acid (ETE; cis-20:3n-3) + gamma-Linolenic acid (GLA; cis-18:3n-6) + cis-Docosapentaenoic acids (cis-22:5) + Stearidonic acid (cis-18:4n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3),,,,percentRoot,,86,Pearson,0.57,,,< 0.05,Yes,,No,,Tjonneland 1993
8070,9015,9043,All [by gender],Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + Eicosatrienoic acid (ETE; cis-20:3n-3) + gamma-Linolenic acid (GLA; cis-18:3n-6) + cis-Docosapentaenoic acids (cis-22:5) + Stearidonic acid (cis-18:4n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3),,,,percentRoot,,86,Pearson,0.63,,,< 0.05,Yes,,Yes,,Tjonneland 1993
8077,9015,9043,All [by gender],Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + Eicosatrienoic acid (ETE; cis-20:3n-3) + gamma-Linolenic acid (GLA; cis-18:3n-6) + cis-Docosapentaenoic acids (cis-22:5) + Stearidonic acid (cis-18:4n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3),,,,percentRoot,,86,Spearman,0.54,,,< 0.05,Yes,,,,Tjonneland 1993
8064,9016,9044,All [by gender],Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,86,Pearson,0.51,,,< 0.05,Yes,,No,,Tjonneland 1993
8071,9016,9044,All [by gender],Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,86,Pearson,0.57,,,< 0.05,Yes,,Yes,,Tjonneland 1993
8078,9016,9044,All [by gender],Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,86,Spearman,0.45,,,< 0.05,Yes,,,,Tjonneland 1993
8065,9017,9045,All [by gender],Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,percentRoot,,86,Pearson,0.36,,,< 0.05,Yes,,No,,Tjonneland 1993
8072,9017,9045,All [by gender],Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,percentRoot,,86,Pearson,0.4,,,< 0.05,Yes,,Yes,,Tjonneland 1993
8079,9017,9045,All [by gender],Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,percentRoot,,86,Spearman,0.36,,,< 0.05,Yes,,,,Tjonneland 1993
8066,9018,9046,All [by gender],Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),EPA (cis-20:5n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,86,Pearson,0.44,,,< 0.05,Yes,,No,,Tjonneland 1993
8073,9018,9046,All [by gender],Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),EPA (cis-20:5n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,86,Pearson,0.63,,,< 0.05,Yes,,Yes,,Tjonneland 1993
8080,9018,9046,All [by gender],Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),EPA (cis-20:5n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,86,Spearman,0.57,,,< 0.05,Yes,,,,Tjonneland 1993
8067,9019,9047,All [by gender],Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),DHA (cis-22:6n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,86,Pearson,0.55,,,< 0.05,Yes,,No,,Tjonneland 1993
8074,9019,9047,All [by gender],Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),DHA (cis-22:6n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,86,Pearson,0.8,,,< 0.05,Yes,,Yes,,Tjonneland 1993
8081,9019,9047,All [by gender],Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),DHA (cis-22:6n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,86,Spearman,0.56,,,< 0.05,Yes,,,,Tjonneland 1993
8033,9020,9048,Males,Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Capric acid (10:0),,,,percentRoot,,23,Pearson,0.27,,,>= 0.05,No,,,,Tjonneland 1993
8040,9020,9048,Males,Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Capric acid (10:0),,,,percentRoot,,23,Spearman,0.3,,,>= 0.05,No,,,,Tjonneland 1993
8034,9021,9049,Males,Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",cis-Octadecenoic acids (cis-18:1) + cis-Tetradecenoic acids (cis-14:1) + cis-Heptadecenoic acids (cis-17:1) + cis-Hexadecenoic acids (cis-16:1) + cis-Eicosenoic acids (cis-20:1) + cis-Docosenoic acids (cis-22:1) + cis-Pentadecenoic acids (cis-15:1),,,,percentRoot,,23,Pearson,0.01,,,>= 0.05,No,,,,Tjonneland 1993
8041,9021,9049,Males,Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",cis-Octadecenoic acids (cis-18:1) + cis-Tetradecenoic acids (cis-14:1) + cis-Heptadecenoic acids (cis-17:1) + cis-Hexadecenoic acids (cis-16:1) + cis-Eicosenoic acids (cis-20:1) + cis-Docosenoic acids (cis-22:1) + cis-Pentadecenoic acids (cis-15:1),,,,percentRoot,,23,Spearman,0.04,,,>= 0.05,No,,,,Tjonneland 1993
8035,9022,9050,Males,Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + Eicosatrienoic acid (ETE; cis-20:3n-3) + gamma-Linolenic acid (GLA; cis-18:3n-6) + cis-Docosapentaenoic acids (cis-22:5) + Stearidonic acid (cis-18:4n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3),,,,percentRoot,,23,Pearson,0.5,,,< 0.05,Yes,,,,Tjonneland 1993
8042,9022,9050,Males,Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + Eicosatrienoic acid (ETE; cis-20:3n-3) + gamma-Linolenic acid (GLA; cis-18:3n-6) + cis-Docosapentaenoic acids (cis-22:5) + Stearidonic acid (cis-18:4n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3),,,,percentRoot,,23,Spearman,0.55,,,< 0.05,Yes,,,,Tjonneland 1993
8036,9023,8947,Males,Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",10.08,,,percentRoot,,23,Pearson,0.52,,,< 0.05,Yes,,,,Tjonneland 1993
8043,9023,8947,Males,Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",10.08,,,percentRoot,,23,Spearman,0.53,,,< 0.05,Yes,,,,Tjonneland 1993
8037,9024,8948,Males,Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.77,,,percentRoot,,23,Pearson,0.51,,,< 0.05,Yes,,,,Tjonneland 1993
8044,9024,8948,Males,Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.77,,,percentRoot,,23,Spearman,0.53,,,< 0.05,Yes,,,,Tjonneland 1993
8038,9025,8958,Males,Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",0.07,,,percentRoot,,23,Pearson,0.53,,,< 0.05,Yes,,,,Tjonneland 1993
8045,9025,8958,Males,Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",0.07,,,percentRoot,,23,Spearman,0.6,,,< 0.05,Yes,,,,Tjonneland 1993
8039,9026,8964,Males,Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DHA (cis-22:6n-3),"",0.25,,,percentRoot,,23,Pearson,0.21,,,>= 0.05,No,,,,Tjonneland 1993
8046,9026,8964,Males,Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DHA (cis-22:6n-3),"",0.25,,,percentRoot,,23,Spearman,0.2,,,>= 0.05,No,,,,Tjonneland 1993
8082,8997,9048,Males,Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, saturated (SFA)","",,40.51,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Capric acid (10:0),,,,percentRoot,,23,Pearson,0.42,,,< 0.05,Yes,,,,Tjonneland 1993
8089,8997,9048,Males,Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, saturated (SFA)","",,40.51,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Capric acid (10:0),,,,percentRoot,,23,Spearman,0.28,,,>= 0.05,No,,,,Tjonneland 1993
8083,8998,9049,Males,Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, monounsaturated (MUFA)","",,31.94,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",cis-Octadecenoic acids (cis-18:1) + cis-Tetradecenoic acids (cis-14:1) + cis-Heptadecenoic acids (cis-17:1) + cis-Hexadecenoic acids (cis-16:1) + cis-Eicosenoic acids (cis-20:1) + cis-Docosenoic acids (cis-22:1) + cis-Pentadecenoic acids (cis-15:1),,,,percentRoot,,23,Pearson,0.04,,,>= 0.05,No,,,,Tjonneland 1993
8090,8998,9049,Males,Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, monounsaturated (MUFA)","",,31.94,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",cis-Octadecenoic acids (cis-18:1) + cis-Tetradecenoic acids (cis-14:1) + cis-Heptadecenoic acids (cis-17:1) + cis-Hexadecenoic acids (cis-16:1) + cis-Eicosenoic acids (cis-20:1) + cis-Docosenoic acids (cis-22:1) + cis-Pentadecenoic acids (cis-15:1),,,,percentRoot,,23,Spearman,0.04,,,>= 0.05,No,,,,Tjonneland 1993
8084,8999,9050,Males,Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,16.12,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + Eicosatrienoic acid (ETE; cis-20:3n-3) + gamma-Linolenic acid (GLA; cis-18:3n-6) + cis-Docosapentaenoic acids (cis-22:5) + Stearidonic acid (cis-18:4n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3),,,,percentRoot,,23,Pearson,0.74,,,< 0.05,Yes,,,,Tjonneland 1993
8091,8999,9050,Males,Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,16.12,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + Eicosatrienoic acid (ETE; cis-20:3n-3) + gamma-Linolenic acid (GLA; cis-18:3n-6) + cis-Docosapentaenoic acids (cis-22:5) + Stearidonic acid (cis-18:4n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3),,,,percentRoot,,23,Spearman,0.75,,,< 0.05,Yes,,,,Tjonneland 1993
8085,9000,8947,Males,Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,14.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",10.08,,,percentRoot,,23,Pearson,0.76,,,< 0.05,Yes,,,,Tjonneland 1993
8092,9000,8947,Males,Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,14.44,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",10.08,,,percentRoot,,23,Spearman,0.79,,,< 0.05,Yes,,,,Tjonneland 1993
8086,9001,8948,Males,Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,2.12,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.77,,,percentRoot,,23,Pearson,0.57,,,< 0.05,Yes,,,,Tjonneland 1993
8093,9001,8948,Males,Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,2.12,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.77,,,percentRoot,,23,Spearman,0.58,,,< 0.05,Yes,,,,Tjonneland 1993
8087,9002,8958,Males,Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),EPA (cis-20:5n-3),"",,0.29,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",0.07,,,percentRoot,,23,Pearson,0.15,,,>= 0.05,No,,,,Tjonneland 1993
8094,9002,8958,Males,Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),EPA (cis-20:5n-3),"",,0.29,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",0.07,,,percentRoot,,23,Spearman,0.28,,,>= 0.05,No,,,,Tjonneland 1993
8088,9003,8964,Males,Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),DHA (cis-22:6n-3),"",,0.29,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DHA (cis-22:6n-3),"",0.25,,,percentRoot,,23,Pearson,0.47,,,< 0.05,Yes,,,,Tjonneland 1993
8095,9003,8964,Males,Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),DHA (cis-22:6n-3),"",,0.29,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DHA (cis-22:6n-3),"",0.25,,,percentRoot,,23,Spearman,0.36,,,>= 0.05,No,,,,Tjonneland 1993
8047,9027,9051,Females,Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Capric acid (10:0),,,,percentRoot,,63,Pearson,0.23,,,>= 0.05,No,,,,Tjonneland 1993
8054,9027,9051,Females,Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Capric acid (10:0),,,,percentRoot,,63,Spearman,0.27,,,< 0.05,Yes,,,,Tjonneland 1993
8048,9028,9052,Females,Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",cis-Octadecenoic acids (cis-18:1) + cis-Tetradecenoic acids (cis-14:1) + cis-Heptadecenoic acids (cis-17:1) + cis-Hexadecenoic acids (cis-16:1) + cis-Eicosenoic acids (cis-20:1) + cis-Docosenoic acids (cis-22:1) + cis-Pentadecenoic acids (cis-15:1),,,,percentRoot,,63,Pearson,0.03,,,>= 0.05,No,,,,Tjonneland 1993
8055,9028,9052,Females,Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",cis-Octadecenoic acids (cis-18:1) + cis-Tetradecenoic acids (cis-14:1) + cis-Heptadecenoic acids (cis-17:1) + cis-Hexadecenoic acids (cis-16:1) + cis-Eicosenoic acids (cis-20:1) + cis-Docosenoic acids (cis-22:1) + cis-Pentadecenoic acids (cis-15:1),,,,percentRoot,,63,Spearman,0.08,,,>= 0.05,No,,,,Tjonneland 1993
8049,9029,9053,Females,Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + Eicosatrienoic acid (ETE; cis-20:3n-3) + gamma-Linolenic acid (GLA; cis-18:3n-6) + cis-Docosapentaenoic acids (cis-22:5) + Stearidonic acid (cis-18:4n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3),,,,percentRoot,,63,Pearson,0.37,,,< 0.05,Yes,,,,Tjonneland 1993
8056,9029,9053,Females,Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + Eicosatrienoic acid (ETE; cis-20:3n-3) + gamma-Linolenic acid (GLA; cis-18:3n-6) + cis-Docosapentaenoic acids (cis-22:5) + Stearidonic acid (cis-18:4n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3),,,,percentRoot,,63,Spearman,0.35,,,< 0.05,Yes,,,,Tjonneland 1993
8050,9030,8977,Females,Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",10.86,,,percentRoot,,63,Pearson,0.36,,,< 0.05,Yes,,,,Tjonneland 1993
8057,9030,8977,Females,Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",10.86,,,percentRoot,,63,Spearman,0.33,,,< 0.05,Yes,,,,Tjonneland 1993
8051,9031,8978,Females,Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.77,,,percentRoot,,63,Pearson,-0.05,,,>= 0.05,No,,,,Tjonneland 1993
8058,9031,8978,Females,Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.77,,,percentRoot,,63,Spearman,-0.02,,,>= 0.05,No,,,,Tjonneland 1993
8052,9032,8988,Females,Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",0.06,,,percentRoot,,63,Pearson,0.53,,,< 0.05,Yes,,,,Tjonneland 1993
8059,9032,8988,Females,Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",0.06,,,percentRoot,,63,Spearman,0.58,,,< 0.05,Yes,,,,Tjonneland 1993
8053,9033,8994,Females,Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DHA (cis-22:6n-3),"",0.31,,,percentRoot,,63,Pearson,0.47,,,< 0.05,Yes,,,,Tjonneland 1993
8060,9033,8994,Females,Adults living in Copenhagen,Denmark,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DHA (cis-22:6n-3),"",0.31,,,percentRoot,,63,Spearman,0.49,,,< 0.05,Yes,,,,Tjonneland 1993
8096,9006,9051,Females,Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, saturated (SFA)","",,42.41,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Capric acid (10:0),,,,percentRoot,,63,Pearson,0.56,,,< 0.05,Yes,,,,Tjonneland 1993
8103,9006,9051,Females,Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, saturated (SFA)","",,42.41,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Capric acid (10:0),,,,percentRoot,,63,Spearman,0.58,,,< 0.05,Yes,,,,Tjonneland 1993
8097,9007,9052,Females,Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, monounsaturated (MUFA)","",,31.55,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",cis-Octadecenoic acids (cis-18:1) + cis-Tetradecenoic acids (cis-14:1) + cis-Heptadecenoic acids (cis-17:1) + cis-Hexadecenoic acids (cis-16:1) + cis-Eicosenoic acids (cis-20:1) + cis-Docosenoic acids (cis-22:1) + cis-Pentadecenoic acids (cis-15:1),,,,percentRoot,,63,Pearson,0.26,,,< 0.05,Yes,,,,Tjonneland 1993
8104,9007,9052,Females,Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, monounsaturated (MUFA)","",,31.55,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",cis-Octadecenoic acids (cis-18:1) + cis-Tetradecenoic acids (cis-14:1) + cis-Heptadecenoic acids (cis-17:1) + cis-Hexadecenoic acids (cis-16:1) + cis-Eicosenoic acids (cis-20:1) + cis-Docosenoic acids (cis-22:1) + cis-Pentadecenoic acids (cis-15:1),,,,percentRoot,,63,Spearman,0.25,,,>= 0.05,No,,,,Tjonneland 1993
8098,9008,9053,Females,Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,15.42,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + Eicosatrienoic acid (ETE; cis-20:3n-3) + gamma-Linolenic acid (GLA; cis-18:3n-6) + cis-Docosapentaenoic acids (cis-22:5) + Stearidonic acid (cis-18:4n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3),,,,percentRoot,,63,Pearson,0.46,,,< 0.05,Yes,,,,Tjonneland 1993
8105,9008,9053,Females,Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6),,15.42,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + Eicosatrienoic acid (ETE; cis-20:3n-3) + gamma-Linolenic acid (GLA; cis-18:3n-6) + cis-Docosapentaenoic acids (cis-22:5) + Stearidonic acid (cis-18:4n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Docosatetraenoic acid (cis-22:4n-3),,,,percentRoot,,63,Spearman,0.4,,,< 0.05,Yes,,,,Tjonneland 1993
8099,9009,8977,Females,Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,14.56,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",10.86,,,percentRoot,,63,Pearson,0.36,,,< 0.05,Yes,,,,Tjonneland 1993
8106,9009,8977,Females,Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),Linoleic acid (LA; cis-18:2n-6),"",,14.56,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",10.86,,,percentRoot,,63,Spearman,0.28,,,< 0.05,Yes,,,,Tjonneland 1993
8100,9010,8978,Females,Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,2.21,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.77,,,percentRoot,,63,Pearson,0.26,,,< 0.05,Yes,,,,Tjonneland 1993
8107,9010,8978,Females,Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,2.21,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.77,,,percentRoot,,63,Spearman,0.29,,,< 0.05,Yes,,,,Tjonneland 1993
8101,9011,8988,Females,Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),EPA (cis-20:5n-3),"",,0.36,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",0.06,,,percentRoot,,63,Pearson,0.61,,,< 0.05,Yes,,,,Tjonneland 1993
8108,9011,8988,Females,Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),EPA (cis-20:5n-3),"",,0.36,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,EPA (cis-20:5n-3),"",0.06,,,percentRoot,,63,Spearman,0.71,,,< 0.05,Yes,,,,Tjonneland 1993
8102,9012,8994,Females,Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),DHA (cis-22:6n-3),"",,0.37,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DHA (cis-22:6n-3),"",0.31,,,percentRoot,,63,Pearson,0.57,,,< 0.05,Yes,,,,Tjonneland 1993
8109,9012,8994,Females,Adults living in Copenhagen,Denmark,,,Weighed Dietary record (7-day),DHA (cis-22:6n-3),"",,0.37,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,DHA (cis-22:6n-3),"",0.31,,,percentRoot,,63,Spearman,0.64,,,< 0.05,Yes,,,,Tjonneland 1993
8112,9056,9062,All [by supplement],Urban middle-aged men from Helsinki participant in a dietary validation study,Finland,,,Dietary record (1-day),Selenium,"",No,42.5,,,ug/day,,,Toenail,Fluorometry,Selenium,"",0.47,,,mg/kg,,166,Pearson,0.18,,, ,Unspecified,,,,Ovaskainen 1993
8110,9054,9060,Selenium supplement users,Urban middle-aged men from Helsinki participant in a dietary validation study,Finland,,,Dietary record (1-day),Selenium,"",No,42.3,,,ug/day,,,Toenail,Fluorometry,Selenium,"",0.53,,,mg/kg,,30,Pearson,0.35,,, ,Unspecified,,,,Ovaskainen 1993
8111,9055,9061,Selenium supplement nonusers,Urban middle-aged men from Helsinki participant in a dietary validation study,Finland,,,Dietary record (1-day),Selenium,"",No,42.6,,,ug/day,,,Toenail,Fluorometry,Selenium,"",0.45,,,mg/kg,,136,Pearson,0.17,,, ,Unspecified,,,,Ovaskainen 1993
8114,9183,9203,All,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin A (Carotenoids),"",Yes,,,,iubetacarotene/day,,,"Plasma, unspecified",Spectrophotometry,Vitamin A (Carotenoids),"",,,,umol/L,,137,Unspecified,0.35,,,< 0.01,Yes,Cholesterol,,,Jacques 1993
8124,9183,9203,All,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin A (Carotenoids),"",Yes,,,,iubetacarotene/day,,,"Plasma, unspecified",Spectrophotometry,Vitamin A (Carotenoids),"",,,,umol/L,,137,Unspecified,0.37,,,= 0.01,Yes,Cholesterol,,Energy,Jacques 1993
8134,9183,9203,All,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin A (Carotenoids),"",Yes,,,,iubetacarotene/day,,,"Plasma, unspecified",Spectrophotometry,Vitamin A (Carotenoids),"",,,,umol/L,,137,Unspecified,0.37,,,< 0.01,Yes,Cholesterol,,"Age, Sex, Energy",Jacques 1993
8115,9184,9204,All,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin A,"",Yes,,,,iuretinol/day,,,"Plasma, unspecified",HPLC,Retinol,"",,,,umol/L,,137,Unspecified,0.06,,,>= 0.05,No,,,,Jacques 1993
8125,9184,9204,All,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin A,"",Yes,,,,iuretinol/day,,,"Plasma, unspecified",HPLC,Retinol,"",,,,umol/L,,137,Unspecified,0.06,,,>= 0.05,No,,,Energy,Jacques 1993
8135,9184,9204,All,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin A,"",Yes,,,,iuretinol/day,,,"Plasma, unspecified",HPLC,Retinol,"",,,,umol/L,,137,Unspecified,0.07,,,>= 0.05,No,,,"Age, Sex, Energy",Jacques 1993
8116,9185,9205,All,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",Yes,,,,mg/day,,,"Plasma, unspecified",HPLC,alpha-Tocopherol,"",,,,umol/L,,137,Unspecified,0.51,,,< 0.01,Yes,Cholesterol,,,Jacques 1993
8126,9185,9205,All,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",Yes,,,,mg/day,,,"Plasma, unspecified",HPLC,alpha-Tocopherol,"",,,,umol/L,,137,Unspecified,0.52,,,= 0.01,Yes,Cholesterol,,Energy,Jacques 1993
8136,9185,9205,All,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",Yes,,,,mg/day,,,"Plasma, unspecified",HPLC,alpha-Tocopherol,"",,,,umol/L,,137,Unspecified,0.53,,,< 0.01,Yes,Cholesterol,,"Age, Sex, Energy",Jacques 1993
8117,9186,9206,All,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin D,"",Yes,,,,iuvitamind/day,,,"Plasma, unspecified",HPLC,25-Hydroxycholecalciferol,"",,,,nmol/L,,135,Unspecified,0.34,,,< 0.01,Yes,Cholesterol,,,Jacques 1993
8127,9186,9206,All,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin D,"",Yes,,,,iuvitamind/day,,,"Plasma, unspecified",HPLC,25-Hydroxycholecalciferol,"",,,,nmol/L,,135,Unspecified,0.33,,,= 0.01,Yes,Cholesterol,,Energy,Jacques 1993
8137,9186,9206,All,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin D,"",Yes,,,,iuvitamind/day,,,"Plasma, unspecified",HPLC,25-Hydroxycholecalciferol,"",,,,nmol/L,,135,Unspecified,0.35,,,< 0.01,Yes,Cholesterol,,"Age, Sex, Energy",Jacques 1993
8121,9190,9210,All,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin B12,"",Yes,,,,ug/day,,,"Plasma, unspecified",Enzyme immunoassay (EIA),Vitamin B12,"",,,,pmol/L,,132,Unspecified,0.3,,,< 0.01,Yes,,,,Jacques 1993
8131,9190,9210,All,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin B12,"",Yes,,,,ug/day,,,"Plasma, unspecified",Enzyme immunoassay (EIA),Vitamin B12,"",,,,pmol/L,,132,Unspecified,0.34,,,= 0.01,Yes,,,Energy,Jacques 1993
8141,9190,9210,All,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin B12,"",Yes,,,,ug/day,,,"Plasma, unspecified",Enzyme immunoassay (EIA),Vitamin B12,"",,,,pmol/L,,132,Unspecified,0.35,,,< 0.01,Yes,,,"Age, Sex, Energy",Jacques 1993
8122,9191,9211,All,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Folates,"",Yes,,,,ug/day,,,"Plasma, unspecified",Enzyme immunoassay (EIA),Folates,"",,,,nmol/L,,132,Unspecified,0.49,,,< 0.01,Yes,,,,Jacques 1993
8132,9191,9211,All,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Folates,"",Yes,,,,ug/day,,,"Plasma, unspecified",Enzyme immunoassay (EIA),Folates,"",,,,nmol/L,,132,Unspecified,0.62,,,= 0.01,Yes,,,Energy,Jacques 1993
8142,9191,9211,All,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Folates,"",Yes,,,,ug/day,,,"Plasma, unspecified",Enzyme immunoassay (EIA),Folates,"",,,,nmol/L,,132,Unspecified,0.63,,,< 0.01,Yes,,,"Age, Sex, Energy",Jacques 1993
8123,9192,9212,All,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin C,"",Yes,,,,mg/day,,,"Plasma, unspecified",Colorimetry,Vitamin C,"",,,,umol/L,,135,Unspecified,0.39,,,< 0.01,Yes,,,,Jacques 1993
8133,9192,9212,All,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin C,"",Yes,,,,mg/day,,,"Plasma, unspecified",Colorimetry,Vitamin C,"",,,,umol/L,,135,Unspecified,0.44,,,= 0.01,Yes,,,Energy,Jacques 1993
8143,9192,9212,All,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin C,"",Yes,,,,mg/day,,,"Plasma, unspecified",Colorimetry,Vitamin C,"",,,,umol/L,,135,Unspecified,0.43,,,< 0.01,Yes,,,"Age, Sex, Energy",Jacques 1993
8144,9193,9213,Supplement nonusers,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin A (Carotenoids),"",No,,,,iubetacarotene/day,,,"Plasma, unspecified",Spectrophotometry,Vitamin A (Carotenoids),"",,,,umol/L,,134,Unspecified,0.27,,,< 0.01,Yes,Cholesterol,,,Jacques 1993
8154,9193,9213,Supplement nonusers,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin A (Carotenoids),"",No,,,,iubetacarotene/day,,,"Plasma, unspecified",Spectrophotometry,Vitamin A (Carotenoids),"",,,,umol/L,,134,Unspecified,0.29,,,< 0.01,Yes,Cholesterol,,Energy,Jacques 1993
8164,9193,9213,Supplement nonusers,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin A (Carotenoids),"",No,,,,iubetacarotene/day,,,"Plasma, unspecified",Spectrophotometry,Vitamin A (Carotenoids),"",,,,umol/L,,134,Unspecified,0.29,,,< 0.01,Yes,Cholesterol,,"Age, Sex, Energy",Jacques 1993
8145,9194,9214,Supplement nonusers,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin A,"",No,,,,iuretinol/day,,,"Plasma, unspecified",HPLC,Retinol,"",,,,umol/L,,113,Unspecified,0.0,,,>= 0.05,No,,,,Jacques 1993
8155,9194,9214,Supplement nonusers,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin A,"",No,,,,iuretinol/day,,,"Plasma, unspecified",HPLC,Retinol,"",,,,umol/L,,113,Unspecified,0.01,,,>= 0.05,No,,,Energy,Jacques 1993
8165,9194,9214,Supplement nonusers,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin A,"",No,,,,iuretinol/day,,,"Plasma, unspecified",HPLC,Retinol,"",,,,umol/L,,113,Unspecified,0.02,,,>= 0.05,No,,,"Age, Sex, Energy",Jacques 1993
8146,9195,9215,Supplement nonusers,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",No,,,,mg/day,,,"Plasma, unspecified",HPLC,alpha-Tocopherol,"",,,,umol/L,,111,Unspecified,0.28,,,< 0.01,Yes,Cholesterol,,,Jacques 1993
8156,9195,9215,Supplement nonusers,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",No,,,,mg/day,,,"Plasma, unspecified",HPLC,alpha-Tocopherol,"",,,,umol/L,,111,Unspecified,0.32,,,< 0.01,Yes,Cholesterol,,Energy,Jacques 1993
8166,9195,9215,Supplement nonusers,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",No,,,,mg/day,,,"Plasma, unspecified",HPLC,alpha-Tocopherol,"",,,,umol/L,,111,Unspecified,0.35,,,< 0.01,Yes,Cholesterol,,"Age, Sex, Energy",Jacques 1993
8147,9196,9216,Supplement nonusers,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin D,"",No,,,,iuvitamind/day,,,"Plasma, unspecified",HPLC,25-Hydroxycholecalciferol,"",,,,nmol/L,,108,Unspecified,0.21,,,< 0.05,Yes,Cholesterol,,,Jacques 1993
8157,9196,9216,Supplement nonusers,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin D,"",No,,,,iuvitamind/day,,,"Plasma, unspecified",HPLC,25-Hydroxycholecalciferol,"",,,,nmol/L,,108,Unspecified,0.22,,,< 0.01,Yes,Cholesterol,,Energy,Jacques 1993
8167,9196,9216,Supplement nonusers,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin D,"",No,,,,iuvitamind/day,,,"Plasma, unspecified",HPLC,25-Hydroxycholecalciferol,"",,,,nmol/L,,108,Unspecified,0.25,,,< 0.01,Yes,Cholesterol,,"Age, Sex, Energy",Jacques 1993
8151,9200,9220,Supplement nonusers,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin B12,"",No,,,,ug/day,,,"Plasma, unspecified",Enzyme immunoassay (EIA),Vitamin B12,"",,,,pmol/L,,105,Unspecified,0.16,,,>= 0.05,No,,,,Jacques 1993
8161,9200,9220,Supplement nonusers,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin B12,"",No,,,,ug/day,,,"Plasma, unspecified",Enzyme immunoassay (EIA),Vitamin B12,"",,,,pmol/L,,105,Unspecified,0.2,,,< 0.05,Yes,,,Energy,Jacques 1993
8171,9200,9220,Supplement nonusers,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin B12,"",No,,,,ug/day,,,"Plasma, unspecified",Enzyme immunoassay (EIA),Vitamin B12,"",,,,pmol/L,,105,Unspecified,0.19,,,>= 0.05,No,,,"Age, Sex, Energy",Jacques 1993
8152,9201,9221,Supplement nonusers,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Plasma, unspecified",Enzyme immunoassay (EIA),Folates,"",,,,nmol/L,,110,Unspecified,0.34,,,< 0.01,Yes,,,,Jacques 1993
8162,9201,9221,Supplement nonusers,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Plasma, unspecified",Enzyme immunoassay (EIA),Folates,"",,,,nmol/L,,110,Unspecified,0.51,,,< 0.01,Yes,,,Energy,Jacques 1993
8172,9201,9221,Supplement nonusers,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Folates,"",No,,,,ug/day,,,"Plasma, unspecified",Enzyme immunoassay (EIA),Folates,"",,,,nmol/L,,110,Unspecified,0.61,,,< 0.01,Yes,,,"Age, Sex, Energy",Jacques 1993
8153,9202,9222,Supplement nonusers,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin C,"",No,,,,mg/day,,,"Plasma, unspecified",Colorimetry,Vitamin C,"",,,,umol/L,,99,Unspecified,0.34,,,< 0.01,Yes,,,,Jacques 1993
8163,9202,9222,Supplement nonusers,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin C,"",No,,,,mg/day,,,"Plasma, unspecified",Colorimetry,Vitamin C,"",,,,umol/L,,99,Unspecified,0.4,,,< 0.01,Yes,,,Energy,Jacques 1993
8173,9202,9222,Supplement nonusers,Participants in a case-control study of nutritional status and age-related cataracts,United States,,,Food Frequency Questionnaire (FFQ),Vitamin C,"",No,,,,mg/day,,,"Plasma, unspecified",Colorimetry,Vitamin C,"",,,,umol/L,,99,Unspecified,0.38,,,< 0.01,Yes,,,"Age, Sex, Energy",Jacques 1993
8174,9226,9223,All [by supplement],Men in Maryland,United States,,,Food Frequency Questionnaire (FFQ),Vitamin C,"",Yes,233.0,,,mg/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",1.03,,,mg/dL,,68,Pearson,0.43,,,= 0.0003,Yes,,,,Sinha 1992
8177,9226,9229,All [by supplement],Men in Maryland,United States,,,Food Frequency Questionnaire (FFQ),Vitamin C,"",Yes,233.0,,,mg/day,,,"Plasma, fasting",Colorimetry,L-Dehydroascorbic acid,"",,,,mg/dL,,68,Pearson,0.22,,,= 0.077,No,,,,Sinha 1992
8176,9227,9224,Supplement users,Men in Maryland,United States,,,Food Frequency Questionnaire (FFQ),Vitamin C,"",Yes,,,,mg/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",0.98,,,mg/dL,,22,Pearson,0.2,,,= 0.376,No,,,,Sinha 1992
8175,9228,9225,Supplement nonusers,Men in Maryland,United States,,,Food Frequency Questionnaire (FFQ),Vitamin C,"",No,,,,mg/day,,,"Plasma, fasting",Colorimetry,Vitamin C,"",1.12,,,mg/dL,,46,Pearson,0.48,,,= 0.0006,Yes,,,,Sinha 1992
8248,9268,9324,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Retinol,"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,Retinol,"",,,,umol/L,,110,Pearson,0.19,,,>= 0.05,No,,,,Ascherio 1992
8251,9268,9324,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Retinol,"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,Retinol,"",,,,umol/L,,110,Pearson,0.25,,,< 0.05,Yes,"Age, BMI, Cholesterol, Triglycerides",,,Ascherio 1992
8249,9332,9337,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,110,Pearson,0.3,,,< 0.05,Yes,,,,Ascherio 1992
8250,9332,9338,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,gamma-Tocopherol,"",,,,umol/L,,110,Pearson,-0.53,,,>= 0.05,No,,,,Ascherio 1992
8252,9332,9337,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,110,Pearson,0.51,,,< 0.05,Yes,"Age, BMI, Cholesterol, Triglycerides",,,Ascherio 1992
8253,9332,9338,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,gamma-Tocopherol,"",,,,umol/L,,110,Pearson,-0.51,,,>= 0.05,No,"Age, BMI, Cholesterol, Triglycerides",,,Ascherio 1992
8178,10561,9318,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Vitamin A (beta-Carotene Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,umol/L,,110,Pearson,0.53,,,< 0.05,Yes,,,,Ascherio 1992
8179,10561,9319,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Vitamin A (beta-Carotene Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,umol/L,,110,Pearson,0.29,,,< 0.05,Yes,,,,Ascherio 1992
8180,10561,9320,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Vitamin A (beta-Carotene Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,Carotenes,alpha-Carotene + beta-Carotene,,,,umol/L,,110,Pearson,0.36,,,< 0.05,Yes,,,,Ascherio 1992
8181,10561,9321,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Vitamin A (beta-Carotene Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,umol/L,,110,Pearson,0.02,,,>= 0.05,No,,,,Ascherio 1992
8182,10561,9322,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Vitamin A (beta-Carotene Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,umol/L,,110,Pearson,0.32,,,< 0.05,Yes,,,,Ascherio 1992
8183,10561,9323,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Vitamin A (beta-Carotene Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,Zeaxanthin,"",,,,umol/L,,110,Pearson,0.06,,,>= 0.05,No,,,,Ascherio 1992
8184,10561,9324,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Vitamin A (beta-Carotene Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,Retinol,"",,,,umol/L,,110,Pearson,0.07,,,>= 0.05,No,,,,Ascherio 1992
8185,10561,9318,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Vitamin A (beta-Carotene Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,umol/L,,110,Pearson,0.52,,,< 0.05,Yes,"Age, BMI, Cholesterol, Energy by residual method, Triglycerides",,,Ascherio 1992
8186,10561,9319,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Vitamin A (beta-Carotene Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,umol/L,,110,Pearson,0.34,,,< 0.05,Yes,"Age, BMI, Cholesterol, Energy by residual method, Triglycerides",,,Ascherio 1992
8187,10561,9320,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Vitamin A (beta-Carotene Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,Carotenes,alpha-Carotene + beta-Carotene,,,,umol/L,,110,Pearson,0.39,,,< 0.05,Yes,"Age, BMI, Cholesterol, Energy by residual method, Triglycerides",,,Ascherio 1992
8188,10561,9321,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Vitamin A (beta-Carotene Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,umol/L,,110,Pearson,0.13,,,>= 0.05,No,"Age, BMI, Cholesterol, Energy by residual method, Triglycerides",,,Ascherio 1992
8189,10561,9322,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Vitamin A (beta-Carotene Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,umol/L,,110,Pearson,0.36,,,< 0.05,Yes,"Age, BMI, Cholesterol, Energy by residual method, Triglycerides",,,Ascherio 1992
8190,10561,9323,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Vitamin A (beta-Carotene Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,Zeaxanthin,"",,,,umol/L,,110,Pearson,0.11,,,>= 0.05,No,"Age, BMI, Cholesterol, Energy by residual method, Triglycerides",,,Ascherio 1992
8191,10561,9324,HPFS - Non-smokers,Men living in the Boston area,United States,HPFS (Health Professionals Follow-Up Study),,Food Frequency Questionnaire (FFQ),Vitamin A (beta-Carotene Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,Retinol,"",,,,umol/L,,110,Pearson,0.11,,,>= 0.05,No,"Age, BMI, Cholesterol, Energy by residual method, Triglycerides",,,Ascherio 1992
8272,9296,9331,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Retinol,"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,Retinol,"",,,,umol/L,,162,Pearson,0.07,,,>= 0.05,No,,,,Ascherio 1992
8275,9296,9331,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Retinol,"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,Retinol,"",,,,umol/L,,162,Pearson,0.08,,,>= 0.05,No,"Age, BMI, Cholesterol, Triglycerides",,,Ascherio 1992
8273,9336,9339,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,162,Pearson,0.39,,,< 0.05,Yes,,,,Ascherio 1992
8274,9336,9340,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,gamma-Tocopherol,"",,,,umol/L,,162,Pearson,-0.41,,,>= 0.05,No,,,,Ascherio 1992
8276,9336,9339,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",,,,umol/L,,162,Pearson,0.41,,,< 0.05,Yes,"Age, BMI, Cholesterol, Triglycerides",,,Ascherio 1992
8277,9336,9340,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,gamma-Tocopherol,"",,,,umol/L,,162,Pearson,-0.42,,,>= 0.05,No,"Age, BMI, Cholesterol, Triglycerides",,,Ascherio 1992
8234,10562,9325,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Vitamin A (beta-Carotene Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,umol/L,,162,Pearson,0.4,,,< 0.05,Yes,,,,Ascherio 1992
8235,10562,9326,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Vitamin A (beta-Carotene Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,umol/L,,162,Pearson,0.29,,,< 0.05,Yes,,,,Ascherio 1992
8236,10562,9327,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Vitamin A (beta-Carotene Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,Carotenes,alpha-Carotene + beta-Carotene,,,,umol/L,,162,Pearson,0.3,,,< 0.05,Yes,,,,Ascherio 1992
8237,10562,9328,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Vitamin A (beta-Carotene Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,umol/L,,162,Pearson,0.0,,,>= 0.05,No,,,,Ascherio 1992
8238,10562,9329,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Vitamin A (beta-Carotene Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,umol/L,,162,Pearson,0.22,,,< 0.05,Yes,,,,Ascherio 1992
8239,10562,9330,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Vitamin A (beta-Carotene Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,Zeaxanthin,"",,,,umol/L,,162,Pearson,0.04,,,>= 0.05,No,,,,Ascherio 1992
8240,10562,9331,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Vitamin A (beta-Carotene Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,Retinol,"",,,,umol/L,,162,Pearson,0.21,,,< 0.05,Yes,,,,Ascherio 1992
8241,10562,9325,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Vitamin A (beta-Carotene Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,alpha-Carotene,"",,,,umol/L,,162,Pearson,0.37,,,< 0.05,Yes,"Age, BMI, Cholesterol, Energy by residual method, Triglycerides",,,Ascherio 1992
8242,10562,9326,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Vitamin A (beta-Carotene Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,beta-Carotene,"",,,,umol/L,,162,Pearson,0.3,,,< 0.05,Yes,"Age, BMI, Cholesterol, Energy by residual method, Triglycerides",,,Ascherio 1992
8243,10562,9327,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Vitamin A (beta-Carotene Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,Carotenes,alpha-Carotene + beta-Carotene,,,,umol/L,,162,Pearson,0.3,,,< 0.05,Yes,"Age, BMI, Cholesterol, Energy by residual method, Triglycerides",,,Ascherio 1992
8244,10562,9328,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Vitamin A (beta-Carotene Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,Lycopene,"",,,,umol/L,,162,Pearson,0.01,,,>= 0.05,No,"Age, BMI, Cholesterol, Energy by residual method, Triglycerides",,,Ascherio 1992
8245,10562,9329,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Vitamin A (beta-Carotene Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,Lutein,"",,,,umol/L,,162,Pearson,0.19,,,< 0.05,Yes,"Age, BMI, Cholesterol, Energy by residual method, Triglycerides",,,Ascherio 1992
8246,10562,9330,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Vitamin A (beta-Carotene Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,Zeaxanthin,"",,,,umol/L,,162,Pearson,0.02,,,>= 0.05,No,"Age, BMI, Cholesterol, Energy by residual method, Triglycerides",,,Ascherio 1992
8247,10562,9331,NHS - Non-smokers,Women living in the Boston area,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Vitamin A (beta-Carotene Equivalents),"",,,,,umol/day,,,"Plasma, non-fasting",HPLC,Retinol,"",,,,umol/L,,162,Pearson,0.13,,,>= 0.05,No,"Age, BMI, Cholesterol, Energy by residual method, Triglycerides",,,Ascherio 1992
8278,9356,9343,All,Controls in a study on diet and breast cancer in Boston area,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Lauric acid (12:0),,23.21,,,g/day,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Heneicosanoic acid (21:0) + Tricosanoic acid (23:0),24.43,,,percentRoot,,115,Spearman,0.02,,,>= 0.05,No,,,,London 1991
8287,9356,9343,All,Controls in a study on diet and breast cancer in Boston area,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Lauric acid (12:0),,23.21,,,g/day,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Heneicosanoic acid (21:0) + Tricosanoic acid (23:0),24.43,,,percentRoot,,115,Spearman,0.05,,,>= 0.05,No,,,Energy,London 1991
8279,9361,9348,All,Controls in a study on diet and breast cancer in Boston area,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,22.8,,,g/day,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Palmitelaidic acid (trans-16:1n-7) + trans-Octadecenoic acids (trans-18:1) + Oleic acid (cis-18:1n-9) + cis-Tetradecenoic acids (cis-14:1) + Asclepic acid (cis-18:1n-7) + 11-Eicosenoic acid (cis-20:1n-9) + 13-Docosenoic acid (cis-22:1n-9) + trans-Tetradecenoic acids (trans-14:1) + 13-Eicosenoic acid (cis-20:1n-7),54.49,,,percentRoot,,115,Spearman,0.08,,,>= 0.05,No,,,,London 1991
8288,9361,9348,All,Controls in a study on diet and breast cancer in Boston area,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,22.8,,,g/day,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Palmitelaidic acid (trans-16:1n-7) + trans-Octadecenoic acids (trans-18:1) + Oleic acid (cis-18:1n-9) + cis-Tetradecenoic acids (cis-14:1) + Asclepic acid (cis-18:1n-7) + 11-Eicosenoic acid (cis-20:1n-9) + 13-Docosenoic acid (cis-22:1n-9) + trans-Tetradecenoic acids (trans-14:1) + 13-Eicosenoic acid (cis-20:1n-7),54.49,,,percentRoot,,115,Spearman,0.09,,,>= 0.05,No,,,Energy,London 1991
8280,9362,9349,All,Controls in a study on diet and breast cancer in Boston area,United States,,,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,2.83,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Oleic acid (cis-18:1n-9),"",41.52,,,percentRoot,,115,Spearman,0.06,,,>= 0.05,No,,,,London 1991
8289,9362,9349,All,Controls in a study on diet and breast cancer in Boston area,United States,,,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,2.83,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Oleic acid (cis-18:1n-9),"",41.52,,,percentRoot,,115,Spearman,0.08,,,>= 0.05,No,,,Energy,London 1991
8281,9363,9350,All,Controls in a study on diet and breast cancer in Boston area,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans","",,3.44,,,g/day,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, trans-monounsaturated (trans-MUFA)",Palmitelaidic acid (trans-16:1n-7) + trans-Octadecenoic acids (trans-18:1) + trans-Tetradecenoic acids (trans-14:1),4.35,,,percentRoot,,115,Spearman,0.41,,,< 0.0001,Yes,,,,London 1991
8290,9363,9350,All,Controls in a study on diet and breast cancer in Boston area,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans","",,3.44,,,g/day,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, trans-monounsaturated (trans-MUFA)",Palmitelaidic acid (trans-16:1n-7) + trans-Octadecenoic acids (trans-18:1) + trans-Tetradecenoic acids (trans-14:1),4.35,,,percentRoot,,115,Spearman,0.46,,,< 0.0001,Yes,,,Energy,London 1991
8282,9364,9351,All,Controls in a study on diet and breast cancer in Boston area,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)","Linoleic acid (LA; cis-18:2n-6) + Fatty acids, n3-polyunsaturated (n3-PUFA) + cis-Linolenic acids (cis-18:3)",,12.47,,,g/day,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)","alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Mead acid (cis-20:3n-9) + gamma-Linolenic acid (GLA; cis-18:3n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6) + 13,16-Docosadienoic acid (cis-22:2n-6)",21.08,,,percentRoot,,115,Spearman,0.15,,,>= 0.05,No,,,,London 1991
8291,9364,9351,All,Controls in a study on diet and breast cancer in Boston area,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)","Linoleic acid (LA; cis-18:2n-6) + Fatty acids, n3-polyunsaturated (n3-PUFA) + cis-Linolenic acids (cis-18:3)",,12.47,,,g/day,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)","alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Mead acid (cis-20:3n-9) + gamma-Linolenic acid (GLA; cis-18:3n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6) + 13,16-Docosadienoic acid (cis-22:2n-6)",21.08,,,percentRoot,,115,Spearman,0.25,,,< 0.05,Yes,,,Energy,London 1991
8283,9365,9352,All,Controls in a study on diet and breast cancer in Boston area,United States,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,10.6,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",17.23,,,percentRoot,,115,Spearman,0.13,,,>= 0.05,No,,,,London 1991
8292,9365,9352,All,Controls in a study on diet and breast cancer in Boston area,United States,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,10.6,,,g/day,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",17.23,,,percentRoot,,115,Spearman,0.23,,,< 0.05,Yes,,,Energy,London 1991
8284,9366,9353,All,Controls in a study on diet and breast cancer in Boston area,United States,,,Food Frequency Questionnaire (FFQ),cis-Linolenic acids (cis-18:3),"",,1.12,,,g/day,,,"Adipose tissue, buttocks",GC-FID,cis-Linolenic acids (cis-18:3),alpha-Linolenic acid (ALA; cis-18:3n-3) + gamma-Linolenic acid (GLA; cis-18:3n-6),0.88,,,percentRoot,,115,Spearman,0.07,,,>= 0.05,No,,,,London 1991
8293,9366,9353,All,Controls in a study on diet and breast cancer in Boston area,United States,,,Food Frequency Questionnaire (FFQ),cis-Linolenic acids (cis-18:3),"",,1.12,,,g/day,,,"Adipose tissue, buttocks",GC-FID,cis-Linolenic acids (cis-18:3),alpha-Linolenic acid (ALA; cis-18:3n-3) + gamma-Linolenic acid (GLA; cis-18:3n-6),0.88,,,percentRoot,,115,Spearman,0.01,,,>= 0.05,No,,,Energy,London 1991
8285,9367,9354,All,Controls in a study on diet and breast cancer in Boston area,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)","",,0.25,,,g/day,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),0.25,,,percentRoot,,115,Spearman,0.43,,,< 0.0001,Yes,,,,London 1991
8294,9367,9354,All,Controls in a study on diet and breast cancer in Boston area,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)","",,0.25,,,g/day,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),0.25,,,percentRoot,,115,Spearman,0.43,,,< 0.0001,Yes,,,Energy,London 1991
8286,9368,9355,All,Controls in a study on diet and breast cancer in Boston area,United States,,,Food Frequency Questionnaire (FFQ),PUFA / SFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,PUFA / SFA,"",,,,without unit,,115,Spearman,0.28,,,< 0.05,Yes,,,,London 1991
8296,9369,9343,All,Controls in a study on diet and breast cancer in Boston area,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Lauric acid (12:0),,39.57,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Heneicosanoic acid (21:0) + Tricosanoic acid (23:0),24.43,,,percentRoot,,115,Spearman,0.16,,,>= 0.05,No,,,,London 1991
8297,9374,9348,All,Controls in a study on diet and breast cancer in Boston area,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,38.79,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Palmitelaidic acid (trans-16:1n-7) + trans-Octadecenoic acids (trans-18:1) + Oleic acid (cis-18:1n-9) + cis-Tetradecenoic acids (cis-14:1) + Asclepic acid (cis-18:1n-7) + 11-Eicosenoic acid (cis-20:1n-9) + 13-Docosenoic acid (cis-22:1n-9) + trans-Tetradecenoic acids (trans-14:1) + 13-Eicosenoic acid (cis-20:1n-7),54.49,,,percentRoot,,115,Spearman,0.07,,,>= 0.05,No,,,,London 1991
8298,9375,9349,All,Controls in a study on diet and breast cancer in Boston area,United States,,,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,4.77,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Oleic acid (cis-18:1n-9),"",41.52,,,percentRoot,,115,Spearman,0.03,,,>= 0.05,No,,,,London 1991
8299,9376,9350,All,Controls in a study on diet and breast cancer in Boston area,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, trans","",,5.83,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, trans-monounsaturated (trans-MUFA)",Palmitelaidic acid (trans-16:1n-7) + trans-Octadecenoic acids (trans-18:1) + trans-Tetradecenoic acids (trans-14:1),4.35,,,percentRoot,,115,Spearman,0.51,,,< 0.0001,Yes,,,,London 1991
8300,9377,9351,All,Controls in a study on diet and breast cancer in Boston area,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)","Linoleic acid (LA; cis-18:2n-6) + Fatty acids, n3-polyunsaturated (n3-PUFA) + cis-Linolenic acids (cis-18:3)",,21.64,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)","alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + Linoelaidic acid (trans-18:2n-6) + cis-9-Linoelaidic acid (9cis-18:2n-6) + Mead acid (cis-20:3n-9) + gamma-Linolenic acid (GLA; cis-18:3n-6) + cis-12-Linoelaidic acid (12cis-18:2n-6) + 13,16-Docosadienoic acid (cis-22:2n-6)",21.08,,,percentRoot,,115,Spearman,0.37,,,< 0.0001,Yes,,,,London 1991
8301,9378,9352,All,Controls in a study on diet and breast cancer in Boston area,United States,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,18.32,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",17.23,,,percentRoot,,115,Spearman,0.35,,,< 0.0001,Yes,,,,London 1991
8302,9379,9353,All,Controls in a study on diet and breast cancer in Boston area,United States,,,Food Frequency Questionnaire (FFQ),cis-Linolenic acids (cis-18:3),"",,1.96,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,cis-Linolenic acids (cis-18:3),alpha-Linolenic acid (ALA; cis-18:3n-3) + gamma-Linolenic acid (GLA; cis-18:3n-6),0.88,,,percentRoot,,115,Spearman,0.12,,,>= 0.05,No,,,,London 1991
8303,9380,9354,All,Controls in a study on diet and breast cancer in Boston area,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)","",,0.46,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),0.25,,,percentRoot,,115,Spearman,0.48,,,< 0.0001,Yes,,,,London 1991
8304,9383,9394,Smokers,Men smokers and non-smokers in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Vitamin C,"",No,49.4,,,mg/day,,,"Serum, non-fasting",Method missing,Vitamin C,"",18.4,,,umol/L,,79,Pearson,0.45,,,< 0.001,Yes,,,,Bolton-Smith 1991
8310,9383,9394,Smokers,Men smokers and non-smokers in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Vitamin C,"",No,49.4,,,mg/day,,,"Serum, non-fasting",Method missing,Vitamin C,"",18.4,,,umol/L,,79,Pearson,0.55,,,< 0.001,Yes,,,"BMI, Energy, Cholesterol, Triglycerides",Bolton-Smith 1991
8305,9384,9395,Smokers,Men smokers and non-smokers in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Retinol,"",No,768.0,,,ug/day,,,"Serum, non-fasting",Method missing,Retinol,"",597.0,,,ug/L,,79,Pearson,0.03,,,>= 0.05,No,,,,Bolton-Smith 1991
8311,9384,9395,Smokers,Men smokers and non-smokers in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Retinol,"",No,768.0,,,ug/day,,,"Serum, non-fasting",Method missing,Retinol,"",597.0,,,ug/L,,79,Pearson,-0.03,,,>= 0.05,No,,,"BMI, Energy, Cholesterol, Triglycerides",Bolton-Smith 1991
8306,9385,9396,Smokers,Men smokers and non-smokers in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,2924.0,,,ug/day,,,"Serum, non-fasting",Method missing,Vitamin A (Carotenoids),"",166.0,,,ug/L,,79,Pearson,0.03,,,>= 0.05,No,,,,Bolton-Smith 1991
8312,9385,9396,Smokers,Men smokers and non-smokers in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,2924.0,,,ug/day,,,"Serum, non-fasting",Method missing,Vitamin A (Carotenoids),"",166.0,,,ug/L,,79,Pearson,0.09,,,>= 0.05,No,,,"BMI, Energy, Cholesterol, Triglycerides",Bolton-Smith 1991
8307,9386,9397,Smokers,Men smokers and non-smokers in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Vitamin A (Retinol Equivalents),"",No,1255.0,,,ug/day,,,"Serum, non-fasting",Method missing,Vitamin A (Retinol Equivalents),"",625.0,,,ug/L,,79,Pearson,0.03,,,>= 0.05,No,,,,Bolton-Smith 1991
8313,9386,9397,Smokers,Men smokers and non-smokers in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Vitamin A (Retinol Equivalents),"",No,1255.0,,,ug/day,,,"Serum, non-fasting",Method missing,Vitamin A (Retinol Equivalents),"",625.0,,,ug/L,,79,Pearson,0.02,,,>= 0.05,No,,,"BMI, Energy, Cholesterol, Triglycerides",Bolton-Smith 1991
8308,9387,9398,Smokers,Men smokers and non-smokers in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",No,7.6,,,mg/day,,,"Serum, non-fasting",Method missing,alpha-Tocopherol,"",9.9,,,mg/L,,79,Pearson,0.2,,,>= 0.05,No,,,,Bolton-Smith 1991
8309,9387,9399,Smokers,Men smokers and non-smokers in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",No,7.6,,,mg/day,,,"Serum, non-fasting",Method missing,alpha-Tocopherol,"",1.58,,,mg/mmol,Cholesterol,79,Pearson,0.17,,,>= 0.05,No,Cholesterol,,,Bolton-Smith 1991
8314,9387,9398,Smokers,Men smokers and non-smokers in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",No,7.6,,,mg/day,,,"Serum, non-fasting",Method missing,alpha-Tocopherol,"",9.9,,,mg/L,,79,Pearson,0.27,,,< 0.05,Yes,,,"BMI, Energy, Cholesterol, Triglycerides",Bolton-Smith 1991
8315,9389,9402,Non-smokers,Men smokers and non-smokers in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Vitamin C,"",No,61.1,,,mg/day,,,"Serum, non-fasting",Method missing,Vitamin C,"",37.0,,,umol/L,,117,Pearson,0.56,,,< 0.001,Yes,,,,Bolton-Smith 1991
8321,9389,9402,Non-smokers,Men smokers and non-smokers in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Vitamin C,"",No,61.1,,,mg/day,,,"Serum, non-fasting",Method missing,Vitamin C,"",37.0,,,umol/L,,117,Pearson,0.58,,,< 0.001,Yes,,,"BMI, Energy, Cholesterol, Triglycerides",Bolton-Smith 1991
8316,9390,9403,Non-smokers,Men smokers and non-smokers in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Retinol,"",No,681.0,,,ug/day,,,"Serum, non-fasting",Method missing,Retinol,"",594.0,,,ug/L,,117,Pearson,0.15,,,< 0.05,Yes,,,,Bolton-Smith 1991
8322,9390,9403,Non-smokers,Men smokers and non-smokers in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Retinol,"",No,681.0,,,ug/day,,,"Serum, non-fasting",Method missing,Retinol,"",594.0,,,ug/L,,117,Pearson,0.05,,,>= 0.05,No,,,"BMI, Energy, Cholesterol, Triglycerides",Bolton-Smith 1991
8317,9391,9404,Non-smokers,Men smokers and non-smokers in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,3526.0,,,ug/day,,,"Serum, non-fasting",Method missing,Vitamin A (Carotenoids),"",238.0,,,ug/L,,117,Pearson,0.26,,,< 0.01,Yes,,,,Bolton-Smith 1991
8323,9391,9404,Non-smokers,Men smokers and non-smokers in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),beta-Carotene,"",No,3526.0,,,ug/day,,,"Serum, non-fasting",Method missing,Vitamin A (Carotenoids),"",238.0,,,ug/L,,117,Pearson,0.28,,,< 0.001,Yes,,,"BMI, Energy, Cholesterol, Triglycerides",Bolton-Smith 1991
8318,9392,9405,Non-smokers,Men smokers and non-smokers in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Vitamin A (Retinol Equivalents),"",No,1268.0,,,ug/day,,,"Serum, non-fasting",Method missing,Vitamin A (Retinol Equivalents),"",636.0,,,ug/L,,117,Pearson,0.18,,,< 0.05,Yes,,,,Bolton-Smith 1991
8324,9392,9405,Non-smokers,Men smokers and non-smokers in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Vitamin A (Retinol Equivalents),"",No,1268.0,,,ug/day,,,"Serum, non-fasting",Method missing,Vitamin A (Retinol Equivalents),"",636.0,,,ug/L,,117,Pearson,0.17,,,< 0.05,Yes,,,"BMI, Energy, Cholesterol, Triglycerides",Bolton-Smith 1991
8319,9393,9406,Non-smokers,Men smokers and non-smokers in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",No,7.6,,,mg/day,,,"Serum, non-fasting",Method missing,alpha-Tocopherol,"",10.9,,,mg/L,,117,Pearson,0.09,,,>= 0.05,No,,,,Bolton-Smith 1991
8320,9393,9407,Non-smokers,Men smokers and non-smokers in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",No,7.6,,,mg/day,,,"Serum, non-fasting",Method missing,alpha-Tocopherol,"",1.77,,,mg/mmol,Cholesterol,117,Pearson,0.2,,,< 0.05,Yes,Cholesterol,,,Bolton-Smith 1991
8325,9393,9406,Non-smokers,Men smokers and non-smokers in Scotland,United Kingdom,,,Food Frequency Questionnaire (FFQ),Vitamin E (alpha-Tocopherol Equivalents),"",No,7.6,,,mg/day,,,"Serum, non-fasting",Method missing,alpha-Tocopherol,"",10.9,,,mg/L,,117,Pearson,0.32,,,< 0.001,Yes,,,"BMI, Energy, Cholesterol, Triglycerides",Bolton-Smith 1991
8327,9410,9422,All [by diagnosis],Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,16.4,,,percentRoot,,,"Red blood cell membrane, unspecified",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",9.27,,,percentRoot,,99,Pearson,0.44,0.26,0.59,< 0.05,Yes,,,,Feunekes 1993
8351,9410,9428,All [by diagnosis],Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,16.4,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",14.2,,,percentRoot,,55,Pearson,0.28,0.02,0.51,< 0.05,Yes,,,,Feunekes 1993
8328,9411,9423,All [by diagnosis],Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),MUFA / Linoleic acid,"",,2.47,,,without unit,,,"Red blood cell membrane, unspecified",GC-FID,MUFA / Linoleic acid,"",1.87,,,without unit,,99,Pearson,0.41,0.23,0.56,< 0.05,Yes,,,,Feunekes 1993
8352,9411,9429,All [by diagnosis],Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),MUFA / Linoleic acid,"",,2.47,,,without unit,,,"Adipose tissue, buttocks",GC-FID,MUFA / Linoleic acid,"",3.93,,,without unit,,55,Pearson,0.25,-0.02,0.48,< 0.05,Yes,,,,Feunekes 1993
8329,9412,9424,All [by diagnosis],Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),Linoleic acid / SFA,"",,0.44,,,without unit,,,"Red blood cell membrane, unspecified",GC-FID,Linoleic acid / SFA,"",0.21,,,without unit,,99,Pearson,0.4,0.22,0.55,< 0.05,Yes,,,,Feunekes 1993
8353,9412,9430,All [by diagnosis],Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),Linoleic acid / SFA,"",,0.44,,,without unit,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid / SFA,"",0.56,,,without unit,,55,Pearson,0.33,0.07,0.55,< 0.05,Yes,,,,Feunekes 1993
8330,9413,9425,All [by diagnosis],Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6),,18.81,,,percentRoot,,,"Red blood cell membrane, unspecified",GC-FID,"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6),32.21,,,percentRoot,,99,Pearson,0.33,0.14,0.49,< 0.05,Yes,,,,Feunekes 1993
8354,9413,9431,All [by diagnosis],Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6),,18.81,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6),15.5,,,percentRoot,,55,Pearson,0.24,-0.03,0.48,< 0.05,Yes,,,,Feunekes 1993
8331,9414,9426,All [by diagnosis],Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),MUFA / PUFA,"",,2.08,,,without unit,,,"Red blood cell membrane, unspecified",GC-FID,MUFA / PUFA,"",0.53,,,without unit,,99,Pearson,0.37,0.19,0.53,< 0.05,Yes,,,,Feunekes 1993
8355,9414,9432,All [by diagnosis],Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),MUFA / PUFA,"",,2.08,,,without unit,,,"Adipose tissue, buttocks",GC-FID,MUFA / PUFA,"",3.58,,,without unit,,55,Pearson,0.24,-0.03,0.48,< 0.05,Yes,,,,Feunekes 1993
8332,9415,9427,All [by diagnosis],Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),PUFA / SFA,"",,0.5,,,without unit,,,"Red blood cell membrane, unspecified",GC-FID,PUFA / SFA,"",0.72,,,without unit,,99,Pearson,0.22,0.02,0.4,< 0.05,Yes,,,,Feunekes 1993
8356,9415,9433,All [by diagnosis],Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),PUFA / SFA,"",,0.5,,,without unit,,,"Adipose tissue, buttocks",GC-FID,PUFA / SFA,"",0.61,,,without unit,,55,Pearson,0.32,0.06,0.54,< 0.05,Yes,,,,Feunekes 1993
8345,9416,9422,All [by diagnosis],Adults living in Veenendaal,Netherlands,,2 months,Diet History Questionnaire (DHQ),Linoleic acid (LA; cis-18:2n-6),"",,15.17,,,percentRoot,,,"Red blood cell membrane, unspecified",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",9.27,,,percentRoot,,99,Pearson,0.41,0.23,0.56,< 0.05,Yes,,,,Feunekes 1993
8369,9416,9428,All [by diagnosis],Adults living in Veenendaal,Netherlands,,2 months,Diet History Questionnaire (DHQ),Linoleic acid (LA; cis-18:2n-6),"",,15.17,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",14.2,,,percentRoot,,55,Pearson,0.34,0.08,0.56,< 0.05,Yes,,,,Feunekes 1993
8346,9417,9423,All [by diagnosis],Adults living in Veenendaal,Netherlands,,2 months,Diet History Questionnaire (DHQ),MUFA / Linoleic acid,"",,2.89,,,without unit,,,"Red blood cell membrane, unspecified",GC-FID,MUFA / Linoleic acid,"",1.87,,,without unit,,99,Pearson,0.44,0.26,0.59,< 0.05,Yes,,,,Feunekes 1993
8370,9417,9429,All [by diagnosis],Adults living in Veenendaal,Netherlands,,2 months,Diet History Questionnaire (DHQ),MUFA / Linoleic acid,"",,2.89,,,without unit,,,"Adipose tissue, buttocks",GC-FID,MUFA / Linoleic acid,"",3.93,,,without unit,,55,Pearson,0.44,0.2,0.63,< 0.05,Yes,,,,Feunekes 1993
8347,9418,9424,All [by diagnosis],Adults living in Veenendaal,Netherlands,,2 months,Diet History Questionnaire (DHQ),Linoleic acid / SFA,"",,0.4,,,without unit,,,"Red blood cell membrane, unspecified",GC-FID,Linoleic acid / SFA,"",0.21,,,without unit,,99,Pearson,0.37,0.19,0.53,< 0.05,Yes,,,,Feunekes 1993
8371,9418,9430,All [by diagnosis],Adults living in Veenendaal,Netherlands,,2 months,Diet History Questionnaire (DHQ),Linoleic acid / SFA,"",,0.4,,,without unit,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid / SFA,"",0.56,,,without unit,,55,Pearson,0.3,0.04,0.52,< 0.05,Yes,,,,Feunekes 1993
8348,9419,9425,All [by diagnosis],Adults living in Veenendaal,Netherlands,,2 months,Diet History Questionnaire (DHQ),"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6),,17.94,,,percentRoot,,,"Red blood cell membrane, unspecified",GC-FID,"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6),32.21,,,percentRoot,,99,Pearson,0.38,0.2,0.54,< 0.05,Yes,,,,Feunekes 1993
8372,9419,9431,All [by diagnosis],Adults living in Veenendaal,Netherlands,,2 months,Diet History Questionnaire (DHQ),"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6),,17.94,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6),15.5,,,percentRoot,,55,Pearson,0.29,0.02,0.51,< 0.05,Yes,,,,Feunekes 1993
8349,9420,9426,All [by diagnosis],Adults living in Veenendaal,Netherlands,,2 months,Diet History Questionnaire (DHQ),MUFA / PUFA,"",,2.23,,,without unit,,,"Red blood cell membrane, unspecified",GC-FID,MUFA / PUFA,"",0.53,,,without unit,,99,Pearson,0.38,0.2,0.54,< 0.05,Yes,,,,Feunekes 1993
8373,9420,9432,All [by diagnosis],Adults living in Veenendaal,Netherlands,,2 months,Diet History Questionnaire (DHQ),MUFA / PUFA,"",,2.23,,,without unit,,,"Adipose tissue, buttocks",GC-FID,MUFA / PUFA,"",3.58,,,without unit,,55,Pearson,0.34,0.08,0.56,< 0.05,Yes,,,,Feunekes 1993
8350,9421,9427,All [by diagnosis],Adults living in Veenendaal,Netherlands,,2 months,Diet History Questionnaire (DHQ),PUFA / SFA,"",,0.47,,,without unit,,,"Red blood cell membrane, unspecified",GC-FID,PUFA / SFA,"",0.72,,,without unit,,99,Pearson,0.23,0.03,0.41,< 0.05,Yes,,,,Feunekes 1993
8374,9421,9433,All [by diagnosis],Adults living in Veenendaal,Netherlands,,2 months,Diet History Questionnaire (DHQ),PUFA / SFA,"",,0.47,,,without unit,,,"Adipose tissue, buttocks",GC-FID,PUFA / SFA,"",0.61,,,without unit,,55,Pearson,0.28,0.02,0.51,< 0.05,Yes,,,,Feunekes 1993
8333,9434,9446,Stable body mass,Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Red blood cell membrane, unspecified",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,56,Pearson,0.45,,,< 0.05,Yes,,,,Feunekes 1993
8357,9434,9458,Stable body mass,Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,29,Pearson,0.57,,,< 0.05,Yes,,,,Feunekes 1993
8334,9435,9447,Stable body mass,Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),MUFA / Linoleic acid,"",,,,,without unit,,,"Red blood cell membrane, unspecified",GC-FID,MUFA / Linoleic acid,"",,,,without unit,,56,Pearson,0.42,,,< 0.05,Yes,,,,Feunekes 1993
8358,9435,9459,Stable body mass,Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),MUFA / Linoleic acid,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,MUFA / Linoleic acid,"",,,,without unit,,29,Pearson,0.52,,,< 0.05,Yes,,,,Feunekes 1993
8335,9436,9448,Stable body mass,Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),Linoleic acid / SFA,"",,,,,without unit,,,"Red blood cell membrane, unspecified",GC-FID,Linoleic acid / SFA,"",,,,without unit,,56,Pearson,0.45,,,< 0.05,Yes,,,,Feunekes 1993
8359,9436,9460,Stable body mass,Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),Linoleic acid / SFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid / SFA,"",,,,without unit,,29,Pearson,0.53,,,< 0.05,Yes,,,,Feunekes 1993
8336,9437,9449,Stable body mass,Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Red blood cell membrane, unspecified",GC-FID,"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,56,Pearson,0.43,,,< 0.05,Yes,,,,Feunekes 1993
8360,9437,9461,Stable body mass,Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,29,Pearson,0.52,,,< 0.05,Yes,,,,Feunekes 1993
8337,9438,9450,Stable body mass,Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),MUFA / PUFA,"",,,,,without unit,,,"Red blood cell membrane, unspecified",GC-FID,MUFA / PUFA,"",,,,without unit,,56,Pearson,0.38,,,< 0.05,Yes,,,,Feunekes 1993
8361,9438,9462,Stable body mass,Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),MUFA / PUFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,MUFA / PUFA,"",,,,without unit,,29,Pearson,0.46,,,< 0.05,Yes,,,,Feunekes 1993
8338,9439,9451,Stable body mass,Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),PUFA / SFA,"",,,,,without unit,,,"Red blood cell membrane, unspecified",GC-FID,PUFA / SFA,"",,,,without unit,,56,Pearson,0.4,,,< 0.05,Yes,,,,Feunekes 1993
8362,9439,9463,Stable body mass,Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),PUFA / SFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,PUFA / SFA,"",,,,without unit,,29,Pearson,0.51,,,< 0.05,Yes,,,,Feunekes 1993
8339,9440,9452,Unstable body mass,Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Red blood cell membrane, unspecified",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,43,Pearson,0.43,,,< 0.05,Yes,,,,Feunekes 1993
8363,9440,9464,Unstable body mass,Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,26,Pearson,0.04,,,>= 0.05,No,,,,Feunekes 1993
8340,9441,9453,Unstable body mass,Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),MUFA / Linoleic acid,"",,,,,without unit,,,"Red blood cell membrane, unspecified",GC-FID,MUFA / Linoleic acid,"",,,,without unit,,43,Pearson,0.42,,,< 0.05,Yes,,,,Feunekes 1993
8364,9441,9465,Unstable body mass,Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),MUFA / Linoleic acid,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,MUFA / Linoleic acid,"",,,,without unit,,26,Pearson,-0.08,,,>= 0.05,No,,,,Feunekes 1993
8341,9442,9454,Unstable body mass,Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),Linoleic acid / SFA,"",,,,,without unit,,,"Red blood cell membrane, unspecified",GC-FID,Linoleic acid / SFA,"",,,,without unit,,43,Pearson,0.35,,,< 0.05,Yes,,,,Feunekes 1993
8365,9442,9466,Unstable body mass,Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),Linoleic acid / SFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,Linoleic acid / SFA,"",,,,without unit,,26,Pearson,0.19,,,>= 0.05,No,,,,Feunekes 1993
8342,9443,9455,Unstable body mass,Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Red blood cell membrane, unspecified",GC-FID,"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,43,Pearson,0.22,,,>= 0.05,No,,,,Feunekes 1993
8366,9443,9467,Unstable body mass,Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6),,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6),,,,percentRoot,,26,Pearson,0.09,,,>= 0.05,No,,,,Feunekes 1993
8343,9444,9456,Unstable body mass,Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),MUFA / PUFA,"",,,,,without unit,,,"Red blood cell membrane, unspecified",GC-FID,MUFA / PUFA,"",,,,without unit,,43,Pearson,0.4,,,< 0.05,Yes,,,,Feunekes 1993
8367,9444,9468,Unstable body mass,Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),MUFA / PUFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,MUFA / PUFA,"",,,,without unit,,26,Pearson,0.02,,,>= 0.05,No,,,,Feunekes 1993
8344,9445,9457,Unstable body mass,Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),PUFA / SFA,"",,,,,without unit,,,"Red blood cell membrane, unspecified",GC-FID,PUFA / SFA,"",,,,without unit,,43,Pearson,-0.03,,,>= 0.05,No,,,,Feunekes 1993
8368,9445,9469,Unstable body mass,Adults living in Veenendaal,Netherlands,,baseline,Food Frequency Questionnaire (FFQ),PUFA / SFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,PUFA / SFA,"",,,,without unit,,26,Pearson,0.22,,,>= 0.05,No,,,,Feunekes 1993
8375,9470,9471,All,Chronic HBsAg carriers or non-carniers from the village of Keneba,Gambia,,,Food analysis (HPLC),Aflatoxins,"",,1.4,,,ug/day,,,Albumin,Enzyme-linked immunosorbent assay (ELISA),Aflatoxin-albumin adducts,"",,,,pg/mg,,20,Unspecified,0.55,,,< 0.05,Yes,,,,Wild 1992
8386,9491,9748,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Carbohydrates,"",,235.0,,,g/day,,,"Plasma (triglycerides), fasting",GC-FID,Palmitic acid (16:0),"",,,,umol/L,,6,Pearson,-0.66,,,= 0.0095,Yes,,,,Lopes 1991
8387,9491,9751,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Carbohydrates,"",,235.0,,,g/day,,,"Plasma (triglycerides), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,umol/L,,6,Pearson,-0.65,,,= 0.0093,Yes,,,,Lopes 1991
8388,9491,9753,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Carbohydrates,"",,235.0,,,g/day,,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,umol/L,,6,Pearson,-0.66,,,= 0.0095,Yes,,,,Lopes 1991
8389,9491,9754,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Carbohydrates,"",,235.0,,,g/day,,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + 11-Eicosenoic acid (cis-20:1n-9),,,,umol/L,,6,Pearson,-0.67,,,= 0.0067,Yes,,,,Lopes 1991
8390,9491,9758,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Carbohydrates,"",,235.0,,,g/day,,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,percentRoot,,6,Pearson,-0.69,,,= 0.0059,Yes,,,,Lopes 1991
8376,9492,9743,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Fats,"Fatty acids, saturated (SFA) + Linoleic acid (LA; cis-18:2n-6) + Oleic acid (cis-18:1n-9)",,71.0,,,g/day,,,"Plasma (phospholipids), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,6,Pearson,0.64,,,= 0.0042,Yes,,,,Lopes 1991
8391,9499,9753,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Carbohydrates,"",,49.0,,,percentEnergy,Energy,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,umol/L,,6,Pearson,-0.62,,,= 0.0173,Yes,,,,Lopes 1991
8392,9499,9748,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Carbohydrates,"",,49.0,,,percentEnergy,Energy,,"Plasma (triglycerides), fasting",GC-FID,Palmitic acid (16:0),"",,,,umol/L,,6,Pearson,-0.62,,,= 0.0173,Yes,,,,Lopes 1991
8393,9499,9750,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Carbohydrates,"",,49.0,,,percentEnergy,Energy,,"Plasma (triglycerides), fasting",GC-FID,Stearic acid (18:0),"",,,,umol/L,,6,Pearson,-0.26,,,= 0.3251,No,,,,Lopes 1991
8394,9499,9751,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Carbohydrates,"",,49.0,,,percentEnergy,Energy,,"Plasma (triglycerides), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,umol/L,,6,Pearson,-0.56,,,= 0.0313,Yes,,,,Lopes 1991
8395,9499,9754,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Carbohydrates,"",,49.0,,,percentEnergy,Energy,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + 11-Eicosenoic acid (cis-20:1n-9),,,,umol/L,,6,Pearson,-0.54,,,= 0.0395,Yes,,,,Lopes 1991
8396,9499,9755,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Carbohydrates,"",,49.0,,,percentEnergy,Energy,,"Plasma (triglycerides), fasting",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,6,Pearson,-0.71,,,= 0.0041,Yes,,,,Lopes 1991
8397,9499,9758,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Carbohydrates,"",,49.0,,,percentEnergy,Energy,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,percentRoot,,6,Pearson,-0.71,,,= 0.0042,Yes,,,,Lopes 1991
8377,9500,9746,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Fats,Linoleic acid (LA; cis-18:2n-6) + Oleic acid (cis-18:1n-9),,33.0,,,percentEnergy,Energy,,"Plasma (free fatty acids), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,6,Pearson,-0.72,,,= 0.0008,Yes,,,,Lopes 1991
8378,9500,9745,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Fats,Linoleic acid (LA; cis-18:2n-6) + Oleic acid (cis-18:1n-9),,33.0,,,percentEnergy,Energy,,"Plasma (free fatty acids), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,6,Pearson,0.61,,,= 0.0074,Yes,,,,Lopes 1991
8379,9500,9747,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Fats,Linoleic acid (LA; cis-18:2n-6) + Oleic acid (cis-18:1n-9),,33.0,,,percentEnergy,Energy,,"Plasma (free fatty acids), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,percentRoot,,6,Pearson,-0.67,,,= 0.0022,Yes,,,,Lopes 1991
8382,9500,9757,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Fats,Linoleic acid (LA; cis-18:2n-6) + Oleic acid (cis-18:1n-9),,33.0,,,percentEnergy,Energy,,"Plasma (triglycerides), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,6,Pearson,0.7,,,= 0.0038,Yes,,,,Lopes 1991
8383,9500,9759,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Fats,Linoleic acid (LA; cis-18:2n-6) + Oleic acid (cis-18:1n-9),,33.0,,,percentEnergy,Energy,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + 11-Eicosenoic acid (cis-20:1n-9),,,,percentRoot,,6,Pearson,0.66,,,= 0.0069,Yes,,,,Lopes 1991
8380,9501,9746,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,10.0,,,percentEnergy,Energy,,"Plasma (free fatty acids), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,6,Pearson,-0.75,,,= 0.0003,Yes,,,,Lopes 1991
8381,9501,9747,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,10.0,,,percentEnergy,Energy,,"Plasma (free fatty acids), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,percentRoot,,6,Pearson,-0.66,,,= 0.003,Yes,,,,Lopes 1991
8384,9501,9757,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,10.0,,,percentEnergy,Energy,,"Plasma (triglycerides), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,6,Pearson,0.67,,,= 0.0061,Yes,,,,Lopes 1991
8385,9501,9759,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,10.0,,,percentEnergy,Energy,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + 11-Eicosenoic acid (cis-20:1n-9),,,,percentRoot,,6,Pearson,0.64,,,= 0.0109,Yes,,,,Lopes 1991
8398,9501,9761,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,10.0,,,percentEnergy,Energy,,"Plasma (cholesterol esters), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,6,Pearson,0.64,,,= 0.0053,Yes,,,,Lopes 1991
8399,9501,9762,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,10.0,,,percentEnergy,Energy,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9),,,,percentRoot,,6,Pearson,0.66,,,= 0.005,Yes,,,,Lopes 1991
8435,9501,9746,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,10.0,,,percentEnergy,Energy,,"Plasma (free fatty acids), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,6,Pearson,-0.6,,,= 0.0089,Yes,,,,Lopes 1991
8430,9502,9743,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,6.0,,,percentEnergy,Energy,,"Plasma (phospholipids), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,6,Pearson,-0.5,,,= 0.0351,Yes,,,,Lopes 1991
8431,9502,9744,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,6.0,,,percentEnergy,Energy,,"Plasma (phospholipids), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6),,,,percentRoot,,6,Pearson,0.65,,,= 0.0086,Yes,,,,Lopes 1991
8458,9502,9760,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,6.0,,,percentEnergy,Energy,,"Plasma (cholesterol esters), fasting",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,6,Pearson,-0.6,,,= 0.0092,Yes,,,,Lopes 1991
8459,9502,9761,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,6.0,,,percentEnergy,Energy,,"Plasma (cholesterol esters), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,6,Pearson,-0.61,,,= 0.0095,Yes,,,,Lopes 1991
8446,9504,9748,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,17.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,Palmitic acid (16:0),"",,,,umol/L,,6,Pearson,-0.68,,,= 0.0077,Yes,,,,Lopes 1991
8447,9504,9749,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,17.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,Palmitoleic acid (cis-16:1n-7),"",,,,umol/L,,6,Pearson,-0.62,,,= 0.0081,Yes,,,,Lopes 1991
8448,9504,9751,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,17.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,umol/L,,6,Pearson,-0.64,,,= 0.0097,Yes,,,,Lopes 1991
8449,9504,9755,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,17.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,6,Pearson,-0.73,,,= 0.0028,Yes,,,,Lopes 1991
8450,9504,9753,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,17.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,umol/L,,6,Pearson,-0.68,,,= 0.0076,Yes,,,,Lopes 1991
8451,9504,9754,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,17.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + 11-Eicosenoic acid (cis-20:1n-9),,,,umol/L,,6,Pearson,-0.67,,,= 0.0064,Yes,,,,Lopes 1991
8452,9504,9758,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,17.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,percentRoot,,6,Pearson,-0.7,,,= 0.0054,Yes,,,,Lopes 1991
8460,9504,9762,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,17.0,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9),,,,percentRoot,,6,Pearson,-0.68,,,= 0.0038,Yes,,,,Lopes 1991
8424,9505,9743,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,36.0,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,6,Pearson,0.48,,,= 0.0436,Yes,,,,Lopes 1991
8425,9505,9744,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,36.0,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6),,,,percentRoot,,6,Pearson,-0.52,,,= 0.0485,Yes,,,,Lopes 1991
8432,9505,9746,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,36.0,,,percentRoot,,,"Plasma (free fatty acids), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,6,Pearson,-0.64,,,= 0.0039,Yes,,,,Lopes 1991
8436,9505,9748,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,36.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,Palmitic acid (16:0),"",,,,umol/L,,6,Pearson,0.65,,,= 0.0121,Yes,,,,Lopes 1991
8437,9505,9749,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,36.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,Palmitoleic acid (cis-16:1n-7),"",,,,umol/L,,6,Pearson,0.6,,,= 0.0111,Yes,,,,Lopes 1991
8438,9505,9752,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,36.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,umol/L,,6,Pearson,0.67,,,= 0.0061,Yes,,,,Lopes 1991
8439,9505,9755,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,36.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,6,Pearson,0.74,,,= 0.0023,Yes,,,,Lopes 1991
8440,9505,9756,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,36.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,Palmitoleic acid (cis-16:1n-7),"",,,,percentRoot,,6,Pearson,0.6,,,= 0.0107,Yes,,,,Lopes 1991
8441,9505,9757,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,36.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,6,Pearson,0.72,,,= 0.0026,Yes,,,,Lopes 1991
8442,9505,9753,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,36.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,umol/L,,6,Pearson,0.65,,,= 0.0118,Yes,,,,Lopes 1991
8443,9505,9754,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,36.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + 11-Eicosenoic acid (cis-20:1n-9),,,,umol/L,,6,Pearson,0.68,,,= 0.0053,Yes,,,,Lopes 1991
8444,9505,9758,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,36.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,percentRoot,,6,Pearson,0.72,,,= 0.0034,Yes,,,,Lopes 1991
8445,9505,9759,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,36.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + 11-Eicosenoic acid (cis-20:1n-9),,,,percentRoot,,6,Pearson,0.73,,,= 0.0019,Yes,,,,Lopes 1991
8426,9506,9742,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,35.0,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,Stearic acid (18:0),"",,,,percentRoot,,6,Pearson,-0.64,,,= 0.004,Yes,,,,Lopes 1991
8427,9506,9743,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,35.0,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,6,Pearson,0.66,,,= 0.0025,Yes,,,,Lopes 1991
8433,9506,9746,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,35.0,,,percentRoot,,,"Plasma (free fatty acids), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,6,Pearson,-0.69,,,= 0.0016,Yes,,,,Lopes 1991
8454,9506,9761,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,35.0,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,6,Pearson,0.61,,,= 0.0094,Yes,,,,Lopes 1991
8455,9506,9762,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,35.0,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9),,,,percentRoot,,6,Pearson,0.67,,,= 0.0042,Yes,,,,Lopes 1991
8428,9507,9743,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6),,21.0,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,6,Pearson,-0.67,,,= 0.0025,Yes,,,,Lopes 1991
8429,9507,9744,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6),,21.0,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6),,,,percentRoot,,6,Pearson,0.71,,,= 0.0029,Yes,,,,Lopes 1991
8434,9507,9746,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6),,21.0,,,percentRoot,,,"Plasma (free fatty acids), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,6,Pearson,0.62,,,= 0.0066,Yes,,,,Lopes 1991
8453,9507,9759,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6),,21.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + 11-Eicosenoic acid (cis-20:1n-9),,,,percentRoot,,6,Pearson,-0.6,,,= 0.0177,Yes,,,,Lopes 1991
8456,9507,9761,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6),,21.0,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,6,Pearson,-0.69,,,= 0.0021,Yes,,,,Lopes 1991
8457,9507,9762,Males,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6),,21.0,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9),,,,percentRoot,,6,Pearson,-0.77,,,= 0.0005,Yes,,,,Lopes 1991
8410,9509,9769,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Carbohydrates,"",,184.0,,,g/day,,,"Plasma (triglycerides), fasting",GC-FID,Palmitic acid (16:0),"",,,,umol/L,,6,Pearson,-0.09,,,= 0.7205,No,,,,Lopes 1991
8411,9509,9772,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Carbohydrates,"",,184.0,,,g/day,,,"Plasma (triglycerides), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,umol/L,,6,Pearson,-0.09,,,= 0.744,No,,,,Lopes 1991
8412,9509,9774,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Carbohydrates,"",,184.0,,,g/day,,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,umol/L,,6,Pearson,-0.1,,,= 0.7165,No,,,,Lopes 1991
8413,9509,9775,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Carbohydrates,"",,184.0,,,g/day,,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + 11-Eicosenoic acid (cis-20:1n-9),,,,umol/L,,6,Pearson,-0.08,,,= 0.7557,No,,,,Lopes 1991
8414,9509,9779,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Carbohydrates,"",,184.0,,,g/day,,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,percentRoot,,6,Pearson,-0.33,,,= 0.1914,No,,,,Lopes 1991
8400,9510,9764,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Fats,"Fatty acids, saturated (SFA) + Linoleic acid (LA; cis-18:2n-6) + Oleic acid (cis-18:1n-9)",,74.0,,,g/day,,,"Plasma (phospholipids), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,6,Pearson,0.1,,,= 0.7038,No,,,,Lopes 1991
8415,9517,9774,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Carbohydrates,"",,46.0,,,percentEnergy,Energy,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,umol/L,,6,Pearson,0.59,,,= 0.0155,Yes,,,,Lopes 1991
8416,9517,9769,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Carbohydrates,"",,46.0,,,percentEnergy,Energy,,"Plasma (triglycerides), fasting",GC-FID,Palmitic acid (16:0),"",,,,umol/L,,6,Pearson,0.59,,,= 0.0153,Yes,,,,Lopes 1991
8417,9517,9771,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Carbohydrates,"",,46.0,,,percentEnergy,Energy,,"Plasma (triglycerides), fasting",GC-FID,Stearic acid (18:0),"",,,,umol/L,,6,Pearson,0.7,,,= 0.0028,Yes,,,,Lopes 1991
8418,9517,9772,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Carbohydrates,"",,46.0,,,percentEnergy,Energy,,"Plasma (triglycerides), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,umol/L,,6,Pearson,0.65,,,= 0.007,Yes,,,,Lopes 1991
8419,9517,9775,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Carbohydrates,"",,46.0,,,percentEnergy,Energy,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + 11-Eicosenoic acid (cis-20:1n-9),,,,umol/L,,6,Pearson,0.64,,,= 0.0082,Yes,,,,Lopes 1991
8420,9517,9776,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Carbohydrates,"",,46.0,,,percentEnergy,Energy,,"Plasma (triglycerides), fasting",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,6,Pearson,0.45,,,= 0.0769,No,,,,Lopes 1991
8421,9517,9779,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Carbohydrates,"",,46.0,,,percentEnergy,Energy,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,percentRoot,,6,Pearson,0.27,,,= 0.2969,No,,,,Lopes 1991
8401,9518,9767,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Fats,Linoleic acid (LA; cis-18:2n-6) + Oleic acid (cis-18:1n-9),,35.0,,,percentEnergy,Energy,,"Plasma (free fatty acids), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,6,Pearson,-0.1,,,= 0.7038,No,,,,Lopes 1991
8402,9518,9766,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Fats,Linoleic acid (LA; cis-18:2n-6) + Oleic acid (cis-18:1n-9),,35.0,,,percentEnergy,Energy,,"Plasma (free fatty acids), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,6,Pearson,0.54,,,= 0.0239,Yes,,,,Lopes 1991
8403,9518,9768,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Fats,Linoleic acid (LA; cis-18:2n-6) + Oleic acid (cis-18:1n-9),,35.0,,,percentEnergy,Energy,,"Plasma (free fatty acids), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,percentRoot,,6,Pearson,-0.28,,,= 0.2782,No,,,,Lopes 1991
8406,9518,9778,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Fats,Linoleic acid (LA; cis-18:2n-6) + Oleic acid (cis-18:1n-9),,35.0,,,percentEnergy,Energy,,"Plasma (triglycerides), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,6,Pearson,0.12,,,= 0.653,No,,,,Lopes 1991
8407,9518,9780,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Fats,Linoleic acid (LA; cis-18:2n-6) + Oleic acid (cis-18:1n-9),,35.0,,,percentEnergy,Energy,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + 11-Eicosenoic acid (cis-20:1n-9),,,,percentRoot,,6,Pearson,0.15,,,= 0.5686,No,,,,Lopes 1991
8404,9519,9767,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,11.0,,,percentEnergy,Energy,,"Plasma (free fatty acids), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,6,Pearson,-0.17,,,= 0.5276,No,,,,Lopes 1991
8405,9519,9768,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,11.0,,,percentEnergy,Energy,,"Plasma (free fatty acids), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,percentRoot,,6,Pearson,-0.1,,,= 0.7068,No,,,,Lopes 1991
8408,9519,9778,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,11.0,,,percentEnergy,Energy,,"Plasma (triglycerides), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,6,Pearson,-0.04,,,= 0.8802,No,,,,Lopes 1991
8409,9519,9780,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,11.0,,,percentEnergy,Energy,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + 11-Eicosenoic acid (cis-20:1n-9),,,,percentRoot,,6,Pearson,-0.02,,,= 0.9278,No,,,,Lopes 1991
8422,9519,9782,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,11.0,,,percentEnergy,Energy,,"Plasma (cholesterol esters), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,6,Pearson,0.13,,,= 0.6309,No,,,,Lopes 1991
8423,9519,9783,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,11.0,,,percentEnergy,Energy,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9),,,,percentRoot,,6,Pearson,-0.02,,,= 0.9323,No,,,,Lopes 1991
8472,9521,9767,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Oleic acid (cis-18:1n-9),"",,31.0,,,percentRoot,,,"Plasma (free fatty acids), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,6,Pearson,-0.18,,,= 0.4995,No,,,,Lopes 1991
8467,9522,9764,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,17.0,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,6,Pearson,0.62,,,= 0.0099,Yes,,,,Lopes 1991
8468,9522,9765,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,17.0,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6),,,,percentRoot,,6,Pearson,-0.57,,,= 0.0271,Yes,,,,Lopes 1991
8483,9522,9769,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,17.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,Palmitic acid (16:0),"",,,,umol/L,,6,Pearson,0.48,,,= 0.0577,No,,,,Lopes 1991
8484,9522,9770,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,17.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,Palmitoleic acid (cis-16:1n-7),"",,,,umol/L,,6,Pearson,0.52,,,= 0.0411,Yes,,,,Lopes 1991
8485,9522,9772,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,17.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,umol/L,,6,Pearson,0.42,,,= 0.1026,No,,,,Lopes 1991
8486,9522,9776,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,17.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,6,Pearson,0.54,,,= 0.0291,Yes,,,,Lopes 1991
8487,9522,9774,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,17.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,umol/L,,6,Pearson,0.48,,,= 0.057,No,,,,Lopes 1991
8488,9522,9775,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,17.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + 11-Eicosenoic acid (cis-20:1n-9),,,,umol/L,,6,Pearson,0.55,,,= 0.0281,Yes,,,,Lopes 1991
8489,9522,9779,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,17.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,percentRoot,,6,Pearson,0.47,,,= 0.0681,No,,,,Lopes 1991
8495,9522,9781,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,17.0,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,6,Pearson,-0.33,,,= 0.2186,No,,,,Lopes 1991
8496,9522,9782,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,17.0,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,6,Pearson,0.5,,,= 0.0468,Yes,,,,Lopes 1991
8497,9522,9783,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),Linoleic acid (LA; cis-18:2n-6),"",,17.0,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9),,,,percentRoot,,6,Pearson,0.51,,,= 0.0428,Yes,,,,Lopes 1991
8461,9523,9764,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,37.0,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,6,Pearson,-0.68,,,= 0.004,Yes,,,,Lopes 1991
8462,9523,9765,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,37.0,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6),,,,percentRoot,,6,Pearson,0.73,,,= 0.0022,Yes,,,,Lopes 1991
8469,9523,9767,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,37.0,,,percentRoot,,,"Plasma (free fatty acids), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,6,Pearson,0.67,,,= 0.0047,Yes,,,,Lopes 1991
8473,9523,9769,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,37.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,Palmitic acid (16:0),"",,,,umol/L,,6,Pearson,-0.36,,,= 0.1717,No,,,,Lopes 1991
8474,9523,9770,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,37.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,Palmitoleic acid (cis-16:1n-7),"",,,,umol/L,,6,Pearson,-0.43,,,= 0.0927,No,,,,Lopes 1991
8475,9523,9773,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,37.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,umol/L,,6,Pearson,-0.1,,,= 0.7142,No,,,,Lopes 1991
8476,9523,9776,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,37.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,Palmitic acid (16:0),"",,,,percentRoot,,6,Pearson,-0.47,,,= 0.0637,No,,,,Lopes 1991
8477,9523,9777,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,37.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,Palmitoleic acid (cis-16:1n-7),"",,,,percentRoot,,6,Pearson,-0.59,,,= 0.017,Yes,,,,Lopes 1991
8478,9523,9778,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,37.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,6,Pearson,-0.28,,,= 0.2914,No,,,,Lopes 1991
8479,9523,9774,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,37.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,umol/L,,6,Pearson,-0.36,,,= 0.1695,No,,,,Lopes 1991
8480,9523,9775,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,37.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + 11-Eicosenoic acid (cis-20:1n-9),,,,umol/L,,6,Pearson,-0.43,,,= 0.0926,No,,,,Lopes 1991
8481,9523,9779,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,37.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0),,,,percentRoot,,6,Pearson,-0.43,,,= 0.0968,No,,,,Lopes 1991
8482,9523,9780,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, saturated (SFA)","",,37.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + 11-Eicosenoic acid (cis-20:1n-9),,,,percentRoot,,6,Pearson,-0.58,,,= 0.0196,Yes,,,,Lopes 1991
8463,9524,9763,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,35.0,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,Stearic acid (18:0),"",,,,percentRoot,,6,Pearson,0.01,,,= 0.9942,No,,,,Lopes 1991
8464,9524,9764,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,35.0,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,6,Pearson,-0.15,,,= 0.5878,No,,,,Lopes 1991
8470,9524,9767,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,35.0,,,percentRoot,,,"Plasma (free fatty acids), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,6,Pearson,-0.02,,,= 0.9381,No,,,,Lopes 1991
8491,9524,9782,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,35.0,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,6,Pearson,-0.01,,,= 0.9663,No,,,,Lopes 1991
8492,9524,9783,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, monounsaturated (MUFA)",Oleic acid (cis-18:1n-9),,35.0,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9),,,,percentRoot,,6,Pearson,-0.15,,,= 0.5887,No,,,,Lopes 1991
8465,9525,9764,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6),,20.0,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,6,Pearson,0.61,,,= 0.0118,Yes,,,,Lopes 1991
8466,9525,9765,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6),,20.0,,,percentRoot,,,"Plasma (phospholipids), fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6),,,,percentRoot,,6,Pearson,-0.55,,,= 0.0326,Yes,,,,Lopes 1991
8471,9525,9767,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6),,20.0,,,percentRoot,,,"Plasma (free fatty acids), fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",,,,percentRoot,,6,Pearson,-0.48,,,= 0.0587,No,,,,Lopes 1991
8490,9525,9780,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6),,20.0,,,percentRoot,,,"Plasma (triglycerides), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + 11-Eicosenoic acid (cis-20:1n-9),,,,percentRoot,,6,Pearson,0.5,,,= 0.0467,Yes,,,,Lopes 1991
8493,9525,9782,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6),,20.0,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,Oleic acid (cis-18:1n-9),"",,,,percentRoot,,6,Pearson,0.47,,,= 0.0678,No,,,,Lopes 1991
8494,9525,9783,Females,Subjects working in a nutrition metabolism laboratory,United States,,,Food Frequency Questionnaire (FFQ),"Fatty acids, polyunsaturated (PUFA)",Linoleic acid (LA; cis-18:2n-6),,20.0,,,percentRoot,,,"Plasma (cholesterol esters), fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9),,,,percentRoot,,6,Pearson,0.48,,,= 0.0582,No,,,,Lopes 1991
8498,9784,9794,All,Mild hypertensive subjects,United States,TAIM (Trial of Antihypertensive Therapy and management),,Dietary record (3-day),Proteins,Proteins from Animal products,,83.5,,,g/day,,,"Urine, 24-h",Ion exchange chromatography (IEC),Taurine,"",844.0,,,unspecified/day,,96,Pearson,0.34,,,< 0.001,Yes,,,,Wassertheil-Smoller 1990
8500,9784,9796,All,Mild hypertensive subjects,United States,TAIM (Trial of Antihypertensive Therapy and management),,Dietary record (3-day),Proteins,Proteins from Animal products,,83.5,,,g/day,,,"Urine, 24-h",Ion exchange chromatography (IEC),1-Methylhistidine,"",640.0,,,unspecified/day,,96,Pearson,0.29,,,< 0.01,Yes,,,,Wassertheil-Smoller 1990
8501,9784,9797,All,Mild hypertensive subjects,United States,TAIM (Trial of Antihypertensive Therapy and management),,Dietary record (3-day),Proteins,Proteins from Animal products,,83.5,,,g/day,,,"Urine, 24-h",Ion exchange chromatography (IEC),3-Methylhistidine,"",231.0,,,unspecified/day,,96,Pearson,0.42,,,< 0.001,Yes,,,,Wassertheil-Smoller 1990
8502,9785,9794,All,Mild hypertensive subjects,United States,TAIM (Trial of Antihypertensive Therapy and management),,Dietary record (3-day),Proteins from Animal products,"",,49.5,,,g/day,,,"Urine, 24-h",Ion exchange chromatography (IEC),Taurine,"",844.0,,,unspecified/day,,96,Pearson,0.33,,,< 0.001,Yes,,,,Wassertheil-Smoller 1990
8504,9785,9796,All,Mild hypertensive subjects,United States,TAIM (Trial of Antihypertensive Therapy and management),,Dietary record (3-day),Proteins from Animal products,"",,49.5,,,g/day,,,"Urine, 24-h",Ion exchange chromatography (IEC),1-Methylhistidine,"",640.0,,,unspecified/day,,96,Pearson,0.28,,,< 0.01,Yes,,,,Wassertheil-Smoller 1990
8505,9785,9797,All,Mild hypertensive subjects,United States,TAIM (Trial of Antihypertensive Therapy and management),,Dietary record (3-day),Proteins from Animal products,"",,49.5,,,g/day,,,"Urine, 24-h",Ion exchange chromatography (IEC),3-Methylhistidine,"",231.0,,,unspecified/day,,96,Pearson,0.4,,,< 0.001,Yes,,,,Wassertheil-Smoller 1990
8506,9786,9798,Males,Mild hypertensive subjects,United States,TAIM (Trial of Antihypertensive Therapy and management),,Dietary record (3-day),Proteins,Proteins from Animal products,,94.8,,,g/day,,,"Urine, 24-h",Ion exchange chromatography (IEC),Taurine,"",1001.0,,,unspecified/day,,45,Pearson,0.36,,,< 0.05,Yes,,,,Wassertheil-Smoller 1990
8508,9786,9800,Males,Mild hypertensive subjects,United States,TAIM (Trial of Antihypertensive Therapy and management),,Dietary record (3-day),Proteins,Proteins from Animal products,,94.8,,,g/day,,,"Urine, 24-h",Ion exchange chromatography (IEC),1-Methylhistidine,"",688.0,,,unspecified/day,,45,Pearson,0.38,,,< 0.01,Yes,,,,Wassertheil-Smoller 1990
8509,9786,9801,Males,Mild hypertensive subjects,United States,TAIM (Trial of Antihypertensive Therapy and management),,Dietary record (3-day),Proteins,Proteins from Animal products,,94.8,,,g/day,,,"Urine, 24-h",Ion exchange chromatography (IEC),3-Methylhistidine,"",309.0,,,unspecified/day,,45,Pearson,0.12,,,> 0.1,No,,,,Wassertheil-Smoller 1990
8510,9788,9802,Females,Mild hypertensive subjects,United States,TAIM (Trial of Antihypertensive Therapy and management),,Dietary record (3-day),Proteins,Proteins from Animal products,,70.3,,,g/day,,,"Urine, 24-h",Ion exchange chromatography (IEC),Taurine,"",731.0,,,unspecified/day,,51,Pearson,0.17,,,> 0.1,No,,,,Wassertheil-Smoller 1990
8512,9788,9804,Females,Mild hypertensive subjects,United States,TAIM (Trial of Antihypertensive Therapy and management),,Dietary record (3-day),Proteins,Proteins from Animal products,,70.3,,,g/day,,,"Urine, 24-h",Ion exchange chromatography (IEC),1-Methylhistidine,"",619.0,,,unspecified/day,,51,Pearson,0.16,,,> 0.1,No,,,,Wassertheil-Smoller 1990
8513,9788,9805,Females,Mild hypertensive subjects,United States,TAIM (Trial of Antihypertensive Therapy and management),,Dietary record (3-day),Proteins,Proteins from Animal products,,70.3,,,g/day,,,"Urine, 24-h",Ion exchange chromatography (IEC),3-Methylhistidine,"",168.0,,,unspecified/day,,51,Pearson,0.2,,,> 0.1,No,,,,Wassertheil-Smoller 1990
8514,9790,9806,Whites,Mild hypertensive subjects,United States,TAIM (Trial of Antihypertensive Therapy and management),,Dietary record (3-day),Proteins,Proteins from Animal products,,85.6,,,g/day,,,"Urine, 24-h",Ion exchange chromatography (IEC),Taurine,"",704.0,,,unspecified/day,,62,Pearson,0.44,,,< 0.001,Yes,,,,Wassertheil-Smoller 1990
8516,9790,9808,Whites,Mild hypertensive subjects,United States,TAIM (Trial of Antihypertensive Therapy and management),,Dietary record (3-day),Proteins,Proteins from Animal products,,85.6,,,g/day,,,"Urine, 24-h",Ion exchange chromatography (IEC),1-Methylhistidine,"",583.0,,,unspecified/day,,62,Pearson,0.21,,,< 0.1,Yes,,,,Wassertheil-Smoller 1990
8517,9790,9809,Whites,Mild hypertensive subjects,United States,TAIM (Trial of Antihypertensive Therapy and management),,Dietary record (3-day),Proteins,Proteins from Animal products,,85.6,,,g/day,,,"Urine, 24-h",Ion exchange chromatography (IEC),3-Methylhistidine,"",288.0,,,unspecified/day,,62,Pearson,0.39,,,< 0.01,Yes,,,,Wassertheil-Smoller 1990
8518,9792,9810,Blacks,Mild hypertensive subjects,United States,TAIM (Trial of Antihypertensive Therapy and management),,Dietary record (3-day),Proteins,Proteins from Animal products,,74.9,,,g/day,,,"Urine, 24-h",Ion exchange chromatography (IEC),Taurine,"",1038.0,,,unspecified/day,,27,Pearson,0.39,,,< 0.05,Yes,,,,Wassertheil-Smoller 1990
8520,9792,9812,Blacks,Mild hypertensive subjects,United States,TAIM (Trial of Antihypertensive Therapy and management),,Dietary record (3-day),Proteins,Proteins from Animal products,,74.9,,,g/day,,,"Urine, 24-h",Ion exchange chromatography (IEC),1-Methylhistidine,"",699.0,,,unspecified/day,,27,Pearson,0.37,,,< 0.1,Yes,,,,Wassertheil-Smoller 1990
8521,9792,9813,Blacks,Mild hypertensive subjects,United States,TAIM (Trial of Antihypertensive Therapy and management),,Dietary record (3-day),Proteins,Proteins from Animal products,,74.9,,,g/day,,,"Urine, 24-h",Ion exchange chromatography (IEC),3-Methylhistidine,"",206.0,,,unspecified/day,,27,Pearson,0.49,,,< 0.01,Yes,,,,Wassertheil-Smoller 1990
8522,9862,9874,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),"Fatty acids, polyunsaturated (PUFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)","",,,,percentRoot,,321,Unspecified,0.54,,,< 0.05,Yes,,,,Plakke 1983
8523,9862,9875,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),"Fatty acids, polyunsaturated (PUFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)","",,,,percentRoot,,321,Unspecified,-0.39,,,< 0.05,Yes,,,,Plakke 1983
8524,9862,9876,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),"Fatty acids, polyunsaturated (PUFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,321,Unspecified,-0.24,,,< 0.05,Yes,,,,Plakke 1983
8525,9862,9877,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),"Fatty acids, polyunsaturated (PUFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,PUFA / SFA,"",,,,without unit,,321,Unspecified,0.51,,,< 0.05,Yes,,,,Plakke 1983
8526,9862,9878,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),"Fatty acids, polyunsaturated (PUFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,MUFA / PUFA,"",,,,without unit,,321,Unspecified,-0.48,,,< 0.05,Yes,,,,Plakke 1983
8527,9862,9879,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),"Fatty acids, polyunsaturated (PUFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,SFA / MUFA,"",,,,without unit,,321,Unspecified,0.05,,,>= 0.05,No,,,,Plakke 1983
8528,9863,9874,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),"Fatty acids, monounsaturated (MUFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)","",,,,percentRoot,,321,Unspecified,-0.22,,,< 0.05,Yes,,,,Plakke 1983
8529,9863,9875,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),"Fatty acids, monounsaturated (MUFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)","",,,,percentRoot,,321,Unspecified,0.22,,,< 0.05,Yes,,,,Plakke 1983
8530,9863,9876,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),"Fatty acids, monounsaturated (MUFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,321,Unspecified,0.03,,,>= 0.05,No,,,,Plakke 1983
8531,9863,9877,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),"Fatty acids, monounsaturated (MUFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,PUFA / SFA,"",,,,without unit,,321,Unspecified,-0.19,,,< 0.05,Yes,,,,Plakke 1983
8532,9863,9878,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),"Fatty acids, monounsaturated (MUFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,MUFA / PUFA,"",,,,without unit,,321,Unspecified,0.16,,,< 0.05,Yes,,,,Plakke 1983
8533,9863,9879,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),"Fatty acids, monounsaturated (MUFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,SFA / MUFA,"",,,,without unit,,321,Unspecified,-0.1,,,>= 0.05,No,,,,Plakke 1983
8534,9864,9874,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)","",,,,percentRoot,,321,Unspecified,-0.47,,,< 0.05,Yes,,,,Plakke 1983
8535,9864,9875,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)","",,,,percentRoot,,321,Unspecified,0.3,,,< 0.05,Yes,,,,Plakke 1983
8536,9864,9876,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,321,Unspecified,0.24,,,< 0.05,Yes,,,,Plakke 1983
8537,9864,9877,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,PUFA / SFA,"",,,,without unit,,321,Unspecified,-0.46,,,< 0.05,Yes,,,,Plakke 1983
8538,9864,9878,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,MUFA / PUFA,"",,,,without unit,,321,Unspecified,0.43,,,< 0.05,Yes,,,,Plakke 1983
8539,9864,9879,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),"Fatty acids, saturated (SFA)","",,,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,SFA / MUFA,"",,,,without unit,,321,Unspecified,0.0,,,>= 0.05,No,,,,Plakke 1983
8540,9865,9874,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),PUFA / SFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)","",,,,percentRoot,,321,Unspecified,0.51,,,< 0.05,Yes,,,,Plakke 1983
8541,9865,9875,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),PUFA / SFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)","",,,,percentRoot,,321,Unspecified,-0.36,,,< 0.05,Yes,,,,Plakke 1983
8542,9865,9876,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),PUFA / SFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,321,Unspecified,-0.22,,,< 0.05,Yes,,,,Plakke 1983
8543,9865,9877,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),PUFA / SFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,PUFA / SFA,"",,,,without unit,,321,Unspecified,0.49,,,< 0.05,Yes,,,,Plakke 1983
8544,9865,9878,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),PUFA / SFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,MUFA / PUFA,"",,,,without unit,,321,Unspecified,-0.43,,,< 0.05,Yes,,,,Plakke 1983
8545,9865,9879,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),PUFA / SFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,SFA / MUFA,"",,,,without unit,,321,Unspecified,0.04,,,>= 0.05,No,,,,Plakke 1983
8546,9866,9874,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),MUFA / PUFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)","",,,,percentRoot,,321,Unspecified,-0.52,,,< 0.05,Yes,,,,Plakke 1983
8547,9866,9875,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),MUFA / PUFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)","",,,,percentRoot,,321,Unspecified,0.34,,,< 0.05,Yes,,,,Plakke 1983
8548,9866,9876,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),MUFA / PUFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,321,Unspecified,0.27,,,< 0.05,Yes,,,,Plakke 1983
8549,9866,9877,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),MUFA / PUFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,PUFA / SFA,"",,,,without unit,,321,Unspecified,-0.49,,,< 0.05,Yes,,,,Plakke 1983
8550,9866,9878,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),MUFA / PUFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,MUFA / PUFA,"",,,,without unit,,321,Unspecified,0.5,,,< 0.05,Yes,,,,Plakke 1983
8551,9866,9879,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),MUFA / PUFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,SFA / MUFA,"",,,,without unit,,321,Unspecified,0.0,,,>= 0.05,No,,,,Plakke 1983
8552,9867,9874,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),SFA / MUFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)","",,,,percentRoot,,321,Unspecified,-0.26,,,< 0.05,Yes,,,,Plakke 1983
8553,9867,9875,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),SFA / MUFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, monounsaturated (MUFA)","",,,,percentRoot,,321,Unspecified,0.13,,,< 0.05,Yes,,,,Plakke 1983
8554,9867,9876,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),SFA / MUFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, saturated (SFA)","",,,,percentRoot,,321,Unspecified,0.17,,,< 0.05,Yes,,,,Plakke 1983
8555,9867,9877,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),SFA / MUFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,PUFA / SFA,"",,,,without unit,,321,Unspecified,-0.27,,,< 0.05,Yes,,,,Plakke 1983
8556,9867,9878,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),SFA / MUFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,MUFA / PUFA,"",,,,without unit,,321,Unspecified,0.27,,,< 0.05,Yes,,,,Plakke 1983
8557,9867,9879,All [by study],Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),SFA / MUFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,SFA / MUFA,"",,,,without unit,,321,Unspecified,0.05,,,>= 0.05,No,,,,Plakke 1983
8576,9858,9861,Controls,Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),"Fatty acids, polyunsaturated (PUFA)","",,17.4,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)","",15.3,,,percentRoot,,162,Unspecified,0.4,,,< 0.01,Yes,,,,Plakke 1983
8577,9858,9884,Controls,Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),"Fatty acids, polyunsaturated (PUFA)","",,17.4,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,PUFA / SFA,"",,,,without unit,,162,Unspecified,0.4,,,< 0.01,Yes,,,,Plakke 1983
8578,9858,9885,Controls,Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),"Fatty acids, polyunsaturated (PUFA)","",,17.4,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,MUFA / PUFA,"",,,,without unit,,162,Unspecified,-0.39,,,< 0.01,Yes,,,,Plakke 1983
8579,9872,9861,Controls,Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),PUFA / SFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)","",15.3,,,percentRoot,,162,Unspecified,0.39,,,< 0.01,Yes,,,,Plakke 1983
8580,9872,9884,Controls,Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),PUFA / SFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,PUFA / SFA,"",,,,without unit,,162,Unspecified,0.38,,,< 0.01,Yes,,,,Plakke 1983
8581,9872,9885,Controls,Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),PUFA / SFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,MUFA / PUFA,"",,,,without unit,,162,Unspecified,-0.38,,,< 0.01,Yes,,,,Plakke 1983
8582,9873,9861,Controls,Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),MUFA / PUFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)","",15.3,,,percentRoot,,162,Unspecified,-0.38,,,< 0.01,Yes,,,,Plakke 1983
8583,9873,9884,Controls,Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),MUFA / PUFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,PUFA / SFA,"",,,,without unit,,162,Unspecified,-0.39,,,< 0.01,Yes,,,,Plakke 1983
8584,9873,9885,Controls,Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),MUFA / PUFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,MUFA / PUFA,"",,,,without unit,,162,Unspecified,0.38,,,< 0.01,Yes,,,,Plakke 1983
8558,9856,9859,Adventists vegetarians,Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),"Fatty acids, polyunsaturated (PUFA)","",,23.0,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)","",18.6,,,percentRoot,,43,Unspecified,0.6,,,< 0.01,Yes,,,,Plakke 1983
8559,9856,9880,Adventists vegetarians,Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),"Fatty acids, polyunsaturated (PUFA)","",,23.0,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,PUFA / SFA,"",,,,without unit,,43,Unspecified,0.61,,,< 0.01,Yes,,,,Plakke 1983
8560,9856,9881,Adventists vegetarians,Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),"Fatty acids, polyunsaturated (PUFA)","",,23.0,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,MUFA / PUFA,"",,,,without unit,,43,Unspecified,-0.45,,,< 0.01,Yes,,,,Plakke 1983
8561,9868,9859,Adventists vegetarians,Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),PUFA / SFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)","",18.6,,,percentRoot,,43,Unspecified,0.59,,,< 0.01,Yes,,,,Plakke 1983
8562,9868,9880,Adventists vegetarians,Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),PUFA / SFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,PUFA / SFA,"",,,,without unit,,43,Unspecified,0.63,,,< 0.01,Yes,,,,Plakke 1983
8563,9868,9881,Adventists vegetarians,Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),PUFA / SFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,MUFA / PUFA,"",,,,without unit,,43,Unspecified,-0.4,,,< 0.01,Yes,,,,Plakke 1983
8564,9869,9859,Adventists vegetarians,Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),MUFA / PUFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)","",18.6,,,percentRoot,,43,Unspecified,-0.5,,,< 0.01,Yes,,,,Plakke 1983
8565,9869,9880,Adventists vegetarians,Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),MUFA / PUFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,PUFA / SFA,"",,,,without unit,,43,Unspecified,-0.5,,,< 0.01,Yes,,,,Plakke 1983
8566,9869,9881,Adventists vegetarians,Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),MUFA / PUFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,MUFA / PUFA,"",,,,without unit,,43,Unspecified,0.44,,,< 0.01,Yes,,,,Plakke 1983
8567,9857,9860,Adventists omnivores,Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),"Fatty acids, polyunsaturated (PUFA)","",,19.7,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)","",17.8,,,percentRoot,,116,Unspecified,0.57,,,< 0.01,Yes,,,,Plakke 1983
8568,9857,9882,Adventists omnivores,Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),"Fatty acids, polyunsaturated (PUFA)","",,19.7,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,PUFA / SFA,"",,,,without unit,,116,Unspecified,0.51,,,< 0.01,Yes,,,,Plakke 1983
8569,9857,9883,Adventists omnivores,Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),"Fatty acids, polyunsaturated (PUFA)","",,19.7,,,percentRoot,,,"Adipose tissue, buttocks",GC-FID,MUFA / PUFA,"",,,,without unit,,116,Unspecified,-0.52,,,< 0.01,Yes,,,,Plakke 1983
8570,9870,9860,Adventists omnivores,Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),PUFA / SFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)","",17.8,,,percentRoot,,116,Unspecified,0.49,,,< 0.01,Yes,,,,Plakke 1983
8571,9870,9882,Adventists omnivores,Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),PUFA / SFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,PUFA / SFA,"",,,,without unit,,116,Unspecified,0.46,,,< 0.01,Yes,,,,Plakke 1983
8572,9870,9883,Adventists omnivores,Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),PUFA / SFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,MUFA / PUFA,"",,,,without unit,,116,Unspecified,-0.44,,,< 0.01,Yes,,,,Plakke 1983
8573,9871,9860,Adventists omnivores,Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),MUFA / PUFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,"Fatty acids, polyunsaturated (PUFA)","",17.8,,,percentRoot,,116,Unspecified,-0.6,,,< 0.01,Yes,,,,Plakke 1983
8574,9871,9882,Adventists omnivores,Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),MUFA / PUFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,PUFA / SFA,"",,,,without unit,,116,Unspecified,-0.52,,,< 0.01,Yes,,,,Plakke 1983
8575,9871,9883,Adventists omnivores,Seventh-day Adventists and non-Adventists in Netherland,Netherlands,,,Dietary record (2-day),MUFA / PUFA,"",,,,,without unit,,,"Adipose tissue, buttocks",GC-FID,MUFA / PUFA,"",,,,without unit,,116,Unspecified,0.62,,,< 0.01,Yes,,,,Plakke 1983
8585,9889,9886,All,Staff members of laboratory and health centers in Boston area participant in a randomized trial on vitamin supplements,United States,,,Food Frequency Questionnaire (FFQ),Vitamin A (Carotenoids),"",No,5650.0,,,iubetacarotene/day,,,"Plasma, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",179.0,,,ug/dL,,58,Pearson,0.29,,,= 0.02,Yes,,,,Willett 1983
8586,9889,9886,All,Staff members of laboratory and health centers in Boston area participant in a randomized trial on vitamin supplements,United States,,,Food Frequency Questionnaire (FFQ),Vitamin A (Carotenoids),"",No,5650.0,,,iubetacarotene/day,,,"Plasma, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",179.0,,,ug/dL,,58,Pearson,0.26,,,= 0.03,Yes,,,Age,Willett 1983
8587,9889,9886,All,Staff members of laboratory and health centers in Boston area participant in a randomized trial on vitamin supplements,United States,,,Food Frequency Questionnaire (FFQ),Vitamin A (Carotenoids),"",No,5650.0,,,iubetacarotene/day,,,"Plasma, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",179.0,,,ug/dL,,58,Pearson,0.29,,,= 0.01,Yes,,,Sex,Willett 1983
8588,9889,9886,All,Staff members of laboratory and health centers in Boston area participant in a randomized trial on vitamin supplements,United States,,,Food Frequency Questionnaire (FFQ),Vitamin A (Carotenoids),"",No,5650.0,,,iubetacarotene/day,,,"Plasma, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",179.0,,,ug/dL,,58,Pearson,0.34,,,= 0.005,Yes,,,Energy,Willett 1983
8589,9889,9886,All,Staff members of laboratory and health centers in Boston area participant in a randomized trial on vitamin supplements,United States,,,Food Frequency Questionnaire (FFQ),Vitamin A (Carotenoids),"",No,5650.0,,,iubetacarotene/day,,,"Plasma, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",179.0,,,ug/dL,,58,Pearson,0.28,,,= 0.02,Yes,,,Cholesterol,Willett 1983
8590,9889,9886,All,Staff members of laboratory and health centers in Boston area participant in a randomized trial on vitamin supplements,United States,,,Food Frequency Questionnaire (FFQ),Vitamin A (Carotenoids),"",No,5650.0,,,iubetacarotene/day,,,"Plasma, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",179.0,,,ug/dL,,58,Pearson,0.3,,,= 0.01,Yes,,,Triglycerides,Willett 1983
8591,9889,9886,All,Staff members of laboratory and health centers in Boston area participant in a randomized trial on vitamin supplements,United States,,,Food Frequency Questionnaire (FFQ),Vitamin A (Carotenoids),"",No,5650.0,,,iubetacarotene/day,,,"Plasma, fasting",Spectrophotometry,Vitamin A (Carotenoids),"",179.0,,,ug/dL,,58,Pearson,0.35,,,= 0.005,Yes,,,"Age, Energy, Sex, Cholesterol, Triglycerides",Willett 1983
8592,9890,9887,All,Staff members of laboratory and health centers in Boston area participant in a randomized trial on vitamin supplements,United States,,,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,6.0,,,iualphatocopherol/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",1.03,,,mg/dL,,58,Pearson,0.12,,,= 0.19,No,,,,Willett 1983
8593,9890,9887,All,Staff members of laboratory and health centers in Boston area participant in a randomized trial on vitamin supplements,United States,,,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,6.0,,,iualphatocopherol/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",1.03,,,mg/dL,,58,Pearson,0.09,,,= 0.24,No,,,Age,Willett 1983
8594,9890,9887,All,Staff members of laboratory and health centers in Boston area participant in a randomized trial on vitamin supplements,United States,,,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,6.0,,,iualphatocopherol/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",1.03,,,mg/dL,,58,Pearson,0.11,,,= 0.21,No,,,Sex,Willett 1983
8595,9890,9887,All,Staff members of laboratory and health centers in Boston area participant in a randomized trial on vitamin supplements,United States,,,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,6.0,,,iualphatocopherol/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",1.03,,,mg/dL,,58,Pearson,0.31,,,= 0.01,Yes,,,Energy,Willett 1983
8596,9890,9887,All,Staff members of laboratory and health centers in Boston area participant in a randomized trial on vitamin supplements,United States,,,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,6.0,,,iualphatocopherol/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",1.03,,,mg/dL,,58,Pearson,0.28,,,= 0.02,Yes,,,Cholesterol,Willett 1983
8597,9890,9887,All,Staff members of laboratory and health centers in Boston area participant in a randomized trial on vitamin supplements,United States,,,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,6.0,,,iualphatocopherol/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",1.03,,,mg/dL,,58,Pearson,0.14,,,= 0.13,No,,,Triglycerides,Willett 1983
8598,9890,9887,All,Staff members of laboratory and health centers in Boston area participant in a randomized trial on vitamin supplements,United States,,,Food Frequency Questionnaire (FFQ),Vitamin E,"",No,6.0,,,iualphatocopherol/day,,,"Plasma, fasting",HPLC,alpha-Tocopherol,"",1.03,,,mg/dL,,58,Pearson,0.34,,,= 0.006,Yes,,,"Age, Energy, Sex, Cholesterol, Triglycerides",Willett 1983
8599,9891,9888,All,Staff members of laboratory and health centers in Boston area participant in a randomized trial on vitamin supplements,United States,,,Food Frequency Questionnaire (FFQ),Retinol,"",No,2340.0,,,iuretinol/day,,,"Plasma, fasting",HPLC,Retinol,"",55.9,,,ug/dL,,58,Pearson,0.09,,,= 0.25,No,,,,Willett 1983
8600,9891,9888,All,Staff members of laboratory and health centers in Boston area participant in a randomized trial on vitamin supplements,United States,,,Food Frequency Questionnaire (FFQ),Retinol,"",No,2340.0,,,iuretinol/day,,,"Plasma, fasting",HPLC,Retinol,"",55.9,,,ug/dL,,58,Pearson,0.07,,,= 0.3,No,,,Age,Willett 1983
8601,9891,9888,All,Staff members of laboratory and health centers in Boston area participant in a randomized trial on vitamin supplements,United States,,,Food Frequency Questionnaire (FFQ),Retinol,"",No,2340.0,,,iuretinol/day,,,"Plasma, fasting",HPLC,Retinol,"",55.9,,,ug/dL,,58,Pearson,0.05,,,= 0.36,No,,,Sex,Willett 1983
8602,9891,9888,All,Staff members of laboratory and health centers in Boston area participant in a randomized trial on vitamin supplements,United States,,,Food Frequency Questionnaire (FFQ),Retinol,"",No,2340.0,,,iuretinol/day,,,"Plasma, fasting",HPLC,Retinol,"",55.9,,,ug/dL,,58,Pearson,0.22,,,= 0.05,Yes,,,Energy,Willett 1983
8603,9891,9888,All,Staff members of laboratory and health centers in Boston area participant in a randomized trial on vitamin supplements,United States,,,Food Frequency Questionnaire (FFQ),Retinol,"",No,2340.0,,,iuretinol/day,,,"Plasma, fasting",HPLC,Retinol,"",55.9,,,ug/dL,,58,Pearson,0.09,,,= 0.24,No,,,Cholesterol,Willett 1983
8604,9891,9888,All,Staff members of laboratory and health centers in Boston area participant in a randomized trial on vitamin supplements,United States,,,Food Frequency Questionnaire (FFQ),Retinol,"",No,2340.0,,,iuretinol/day,,,"Plasma, fasting",HPLC,Retinol,"",55.9,,,ug/dL,,58,Pearson,0.06,,,= 0.32,No,,,Triglycerides,Willett 1983
8605,9891,9888,All,Staff members of laboratory and health centers in Boston area participant in a randomized trial on vitamin supplements,United States,,,Food Frequency Questionnaire (FFQ),Retinol,"",No,2340.0,,,iuretinol/day,,,"Plasma, fasting",HPLC,Retinol,"",55.9,,,ug/dL,,58,Pearson,0.17,,,= 0.12,No,,,"Age, Energy, Sex, Cholesterol, Triglycerides",Willett 1983
8606,9893,9896,All,Middle-aged women in Quebec particpant in a randomized clinical trial on ethyl-EPA supplementation,Canada,,,Food Frequency Questionnaire (FFQ),EPA (cis-20:5n-3),"",,85.4,,72.1,mg/day,,,"Red blood cell membrane, unspecified",GC-FID,EPA (cis-20:5n-3),"",,,,percentRoot,,65,Spearman,0.46,,,< 0.05,Yes,,,,Lucas 2009
8607,9894,9897,All,Middle-aged women in Quebec particpant in a randomized clinical trial on ethyl-EPA supplementation,Canada,,,Food Frequency Questionnaire (FFQ),DHA (cis-22:6n-3),"",,128.0,,105.0,mg/day,,,"Red blood cell membrane, unspecified",GC-FID,DHA (cis-22:6n-3),"",,,,percentRoot,,65,Spearman,0.4,,,< 0.05,Yes,,,,Lucas 2009
8608,9895,9898,All,Middle-aged women in Quebec particpant in a randomized clinical trial on ethyl-EPA supplementation,Canada,,,Food Frequency Questionnaire (FFQ),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,212.0,,184.0,mg/day,,,"Red blood cell membrane, unspecified",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,percentRoot,,65,Spearman,0.42,,,< 0.05,Yes,,,,Lucas 2009
8626,20608,20609,All,Free-living volunteers from the university campus area in Uppsala,Sweden,,,Weighed Dietary record (3-day),Whole grain rye,"",,,,,not annotated,,baseline; 3 months,"Urine, 24-h",LC-MS,HHPAA sulfate,"",,,,not annotated,,59,Pearson,0.62,,,< 0.001,Yes,,,,Hanhineva 2015
8627,20608,20610,All,Free-living volunteers from the university campus area in Uppsala,Sweden,,,Weighed Dietary record (3-day),Whole grain rye,"",,,,,not annotated,,baseline; 3 months,"Urine, 24-h",LC-MS,"3,5-DHPPA sulfate","",,,,not annotated,,59,Pearson,0.61,,,< 0.001,Yes,,,,Hanhineva 2015
8628,20608,20611,All,Free-living volunteers from the university campus area in Uppsala,Sweden,,,Weighed Dietary record (3-day),Whole grain rye,"",,,,,not annotated,,baseline; 3 months,"Urine, 24-h",LC-MS,Caffeic acid sulfate,"",,,,not annotated,,59,Pearson,0.58,,,< 0.001,Yes,,,,Hanhineva 2015
8629,20608,20612,All,Free-living volunteers from the university campus area in Uppsala,Sweden,,,Weighed Dietary record (3-day),Whole grain rye,"",,,,,not annotated,,baseline; 3 months,"Urine, 24-h",LC-MS,HPAA sulfate,"",,,,not annotated,,59,Pearson,0.54,,,< 0.001,Yes,,,,Hanhineva 2015
8630,20608,20613,All,Free-living volunteers from the university campus area in Uppsala,Sweden,,,Weighed Dietary record (3-day),Whole grain rye,"",,,,,not annotated,,baseline; 3 months,"Urine, 24-h",LC-MS,Pimelic acid,"",,,,not annotated,,59,Pearson,0.58,,,< 0.001,Yes,,,,Hanhineva 2015
8631,20608,20614,All,Free-living volunteers from the university campus area in Uppsala,Sweden,,,Weighed Dietary record (3-day),Whole grain rye,"",,,,,not annotated,,baseline; 3 months,"Urine, 24-h",LC-MS,HHPAA,"",,,,not annotated,,59,Pearson,0.54,,,< 0.001,Yes,,,,Hanhineva 2015
8632,20608,20609,All,Free-living volunteers from the university campus area in Uppsala,Sweden,,,Weighed Dietary record (3-day),Whole grain rye,"",,,,,not annotated,,baseline; 3 months,"Urine, 24-h",LC-MS,HHPAA sulfate,"",,,,not annotated,,59,Spearman,0.61,,,< 0.001,Yes,,,,Hanhineva 2015
8633,20608,20610,All,Free-living volunteers from the university campus area in Uppsala,Sweden,,,Weighed Dietary record (3-day),Whole grain rye,"",,,,,not annotated,,baseline; 3 months,"Urine, 24-h",LC-MS,"3,5-DHPPA sulfate","",,,,not annotated,,59,Spearman,0.65,,,< 0.001,Yes,,,,Hanhineva 2015
8634,20608,20611,All,Free-living volunteers from the university campus area in Uppsala,Sweden,,,Weighed Dietary record (3-day),Whole grain rye,"",,,,,not annotated,,baseline; 3 months,"Urine, 24-h",LC-MS,Caffeic acid sulfate,"",,,,not annotated,,59,Spearman,0.58,,,< 0.001,Yes,,,,Hanhineva 2015
8635,20608,20612,All,Free-living volunteers from the university campus area in Uppsala,Sweden,,,Weighed Dietary record (3-day),Whole grain rye,"",,,,,not annotated,,baseline; 3 months,"Urine, 24-h",LC-MS,HPAA sulfate,"",,,,not annotated,,59,Spearman,0.5,,,< 0.001,Yes,,,,Hanhineva 2015
8636,20608,20613,All,Free-living volunteers from the university campus area in Uppsala,Sweden,,,Weighed Dietary record (3-day),Whole grain rye,"",,,,,not annotated,,baseline; 3 months,"Urine, 24-h",LC-MS,Pimelic acid,"",,,,not annotated,,59,Spearman,0.44,,,< 0.001,Yes,,,,Hanhineva 2015
8637,20608,20614,All,Free-living volunteers from the university campus area in Uppsala,Sweden,,,Weighed Dietary record (3-day),Whole grain rye,"",,,,,not annotated,,baseline; 3 months,"Urine, 24-h",LC-MS,HHPAA,"",,,,not annotated,,59,Spearman,0.36,,,< 0.001,Yes,,,,Hanhineva 2015
8781,20627,20637,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Coffee,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Dihydroferulic acid sulfate,"",,,,not annotated,,476,Pearson,0.62,,,= 7.43e-5,Unspecified,,,,Edmands 2015
8782,20627,20638,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Coffee,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Guaiacol glucuronide,"",,,,not annotated,,476,Pearson,0.55,,,= 5.48e-4,Unspecified,,,,Edmands 2015
8783,20627,20639,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Coffee,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Feruloylquinic acid,"",,,,not annotated,,476,Pearson,0.52,,,= 1.22e-3,Unspecified,,,,Edmands 2015
8784,20627,20640,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Coffee,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Ferulic acid sulfate,"",,,,not annotated,,476,Pearson,0.49,,,= 2.75e-3,Unspecified,,,,Edmands 2015
8785,20627,20641,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Coffee,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Feruloylquinic acid glucuronide,"",,,,not annotated,,476,Pearson,0.47,,,= 4.5e-3,Unspecified,,,,Edmands 2015
8786,20627,20642,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Coffee,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,5-Caffeoylquinic acid,"",,,,not annotated,,476,Pearson,0.49,,,= 2.98e-3,Unspecified,,,,Edmands 2015
8787,20627,20643,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Coffee,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,p-Coumaric acid sulfate,"",,,,not annotated,,476,Pearson,0.43,,,= 1.02e-2,Unspecified,,,,Edmands 2015
8788,20627,20644,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Coffee,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Caffeic acid sulfate,"",,,,not annotated,,476,Pearson,0.42,,,= 1.11e-2,Unspecified,,,,Edmands 2015
8789,20627,20645,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Coffee,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Ferulic acid glucuronide,"",,,,not annotated,,476,Pearson,0.38,,,= 2.35e-2,Unspecified,,,,Edmands 2015
8790,20627,20646,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Coffee,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Hydroxyhippuric acid,"",,,,not annotated,,476,Pearson,0.37,,,= 3.08e-2,Unspecified,,,,Edmands 2015
8791,20627,20647,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Coffee,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Dihydrocaffeic acid sulfate,"",,,,not annotated,,476,Pearson,0.34,,,= 4.38e-2,Unspecified,,,,Edmands 2015
8792,20627,20648,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Coffee,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,m-Coumaric acid sulfate,"",,,,not annotated,,476,Pearson,0.38,,,= 2.35e-2,Unspecified,,,,Edmands 2015
8793,20627,20669,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Coffee,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Dihydroferulic acid glucuronide,"",,,,not annotated,,476,Pearson,0.3,,,= 7.49e-2,Unspecified,,,,Edmands 2015
8794,20627,20649,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Coffee,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,p-Hydroxyphenyllactic acid,"",,,,not annotated,,476,Pearson,0.32,,,= 6.25e-2,Unspecified,,,,Edmands 2015
8795,20627,20650,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Coffee,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Guaiacol sulfate,"",,,,not annotated,,476,Pearson,0.28,,,= 1.04e-1,Unspecified,,,,Edmands 2015
8796,20627,20651,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Coffee,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Ethylcatechol glucuronide,"",,,,not annotated,,476,Pearson,0.17,,,= 3.20e-1,Unspecified,,,,Edmands 2015
8797,20628,20652,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Wine,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Gallic acid ethyl ester sulfate,"",,,,not annotated,,476,Pearson,0.45,,,= 7.28e-2,Unspecified,,,,Edmands 2015
8798,20628,20653,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Wine,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Hydroxytyrosol sulfate,"",,,,not annotated,,476,Pearson,0.52,,,= 3.14e-2,Unspecified,,,,Edmands 2015
8799,20628,20654,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Wine,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Dihydroresveratrol glucuronide,"",,,,not annotated,,476,Pearson,0.39,,,= 1.21e-1,Unspecified,,,,Edmands 2015
8800,20628,20655,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Wine,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Syringic acid sulfate,"",,,,not annotated,,476,Pearson,0.5,,,= 4.32e-2,Unspecified,,,,Edmands 2015
8805,20628,20659,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Wine,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Methylgallic acid sulfate,"",,,,not annotated,,476,Pearson,0.44,,,= 7.67e-2,Unspecified,,,,Edmands 2015
8807,20628,20660,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Wine,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,4-O-Methylgallic acid,"",,,,not annotated,,476,Pearson,0.48,,,= 5.00e-2,Unspecified,,,,Edmands 2015
8801,20629,20656,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Citrus fruits,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Naringenin glucuronide,"",,,,not annotated,,476,Pearson,0.4,,,= 4.28e-1,Unspecified,,,,Edmands 2015
8802,20629,20657,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Citrus fruits,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Hesperetin glucuronide sulfate,"",,,,not annotated,,476,Pearson,0.36,,,= 4.80e-1,Unspecified,,,,Edmands 2015
8803,20629,20658,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Citrus fruits,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Hesperetin glucuronide,"",,,,not annotated,,476,Pearson,0.32,,,= 5.41e-1,Unspecified,,,,Edmands 2015
8804,20630,20659,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Tea,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Methylgallic acid sulfate,"",,,,not annotated,,476,Pearson,0.6,,,= 1.50e-2,Unspecified,,,,Edmands 2015
8806,20630,20660,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Tea,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,4-O-Methylgallic acid,"",,,,not annotated,,476,Pearson,0.55,,,= 2.86e-2,Unspecified,,,,Edmands 2015
8808,20630,20661,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Tea,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Dihydroxyphenyl-gamma-valerolactone sulfate,"",,,,not annotated,,476,Pearson,0.48,,,= 5.80e-2,Unspecified,,,,Edmands 2015
8809,20630,20662,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Tea,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Pyrogallol sulfate,"",,,,not annotated,,476,Pearson,0.4,,,= 1.27e-1,Unspecified,,,,Edmands 2015
8810,20630,20663,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Tea,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Hydroxyphenylvaleric acid glucuronide,"",,,,not annotated,,476,Pearson,0.39,,,= 1.36e-1,Unspecified,,,,Edmands 2015
8811,20630,20664,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Tea,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Methyl(epi)catechin sulfate,"",,,,not annotated,,476,Pearson,0.29,,,= 2.74e-1,Unspecified,,,,Edmands 2015
8819,20630,20667,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Tea,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Dihydroxyphenyl-gamma-valerolactone glucuronide,"",,,,not annotated,,476,Pearson,0.41,,,= 1.19e-1,Unspecified,,,,Edmands 2015
8812,20631,20664,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Pome fruits,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Methyl(epi)catechin sulfate,"",,,,not annotated,,476,Pearson,0.24,,,= 7.64e-1,Unspecified,,,,Edmands 2015
8814,20631,20665,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Pome fruits,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Phloretin glucuronide,"",,,,not annotated,,476,Pearson,0.3,,,= 7.04e-1,Unspecified,,,,Edmands 2015
8815,20631,20661,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Pome fruits,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Dihydroxyphenyl-gamma-valerolactone sulfate,"",,,,not annotated,,476,Pearson,0.29,,,= 7.08e-1,Unspecified,,,,Edmands 2015
8813,20632,20664,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Chocolate,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Methyl(epi)catechin sulfate,"",,,,not annotated,,476,Pearson,0.21,,,= 4.85e-1,Unspecified,,,,Edmands 2015
8816,20632,20666,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Chocolate,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,"4-Hydroxy-(3',4'-dihydroxyphenyl)valeric acid sulfate","",,,,not annotated,,476,Pearson,0.13,,,= 6.69e-1,Unspecified,,,,Edmands 2015
8817,20632,20667,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Chocolate,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Dihydroxyphenyl-gamma-valerolactone glucuronide,"",,,,not annotated,,476,Pearson,0.06,,,= 8.55e-1,Unspecified,,,,Edmands 2015
8818,20632,20668,All,"Free-living subjects from France, Germany, Greece, and Italy",France,EPIC (European Prospective Investigation into Cancer and Nutrition),,24-h Dietary recall (1-day),Chocolate,"",,,,,not annotated,,,"Urine, 24-h",LC-MS,Vanillic acid sulfate,"",,,,not annotated,,476,Pearson,-0.01,,,= 9.73e-1,Unspecified,,,,Edmands 2015
8638,20670,20672,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Serum, non-fasting",Chromatography,Trigonelline,"",,,,not annotated,,498,Pearson,0.608,,,= 4.26e-51,Yes,,,"Age, Sex, BMI, Smoking status",Guertin 2015
8639,20670,20673,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Serum, non-fasting",Chromatography,Quinic acid,"",,,,not annotated,,498,Pearson,0.585,,,= 1.62e-46,Yes,,,"Age, Sex, BMI, Smoking status",Guertin 2015
8641,20670,20675,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Serum, non-fasting",Chromatography,N-(2-Furoyl)glycine,"",,,,not annotated,,498,Pearson,0.355,,,= 4.22e-16,Yes,,,"Age, Sex, BMI, Smoking status",Guertin 2015
8642,20670,20676,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Serum, non-fasting",Chromatography,Catechol sulfate,"",,,,not annotated,,498,Pearson,0.352,,,= 7.51e-16,Yes,,,"Age, Sex, BMI, Smoking status",Guertin 2015
8640,20671,20674,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Serum, non-fasting",Chromatography,Paraxanthine,"",,,,not annotated,,498,Pearson,0.383,,,= 1.12e-18,Yes,,,"Age, Sex, BMI, Smoking status",Guertin 2015
8643,20671,20677,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Serum, non-fasting",Chromatography,Caffeine,"",,,,not annotated,,498,Pearson,0.327,,,= 1.02e-13,Yes,,,"Age, Sex, BMI, Smoking status",Guertin 2015
8644,20671,20678,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Serum, non-fasting",Chromatography,1-Methylxanthine,"",,,,not annotated,,498,Pearson,0.315,,,= 7.7e-13,Yes,,,"Age, Sex, BMI, Smoking status",Guertin 2015
8645,20671,20679,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Serum, non-fasting",Chromatography,Theophylline,"",,,,not annotated,,498,Pearson,0.306,,,= 4.06e-12,Yes,,,"Age, Sex, BMI, Smoking status",Guertin 2015
8646,20671,20680,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Serum, non-fasting",Chromatography,"1,3,7-Trimethyluric acid","",,,,not annotated,,498,Pearson,0.266,,,= 2.03e-9,Yes,,,"Age, Sex, BMI, Smoking status",Guertin 2015
8647,20671,20681,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Serum, non-fasting",Chromatography,3-Hydroxyhippuric acid,"",,,,not annotated,,498,Pearson,0.221,,,= 7.04e-7,Yes,,,"Age, Sex, BMI, Smoking status",Guertin 2015
8648,20671,20682,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Serum, non-fasting",Chromatography,Theobromine,"",,,,not annotated,,498,Pearson,0.182,,,= 4.61e-5,Yes,,,"Age, Sex, BMI, Smoking status",Guertin 2015
8649,20671,20683,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Serum, non-fasting",Chromatography,"1,7-Dimethyluric acid","",,,,not annotated,,498,Pearson,0.219,,,= 9.52e-7,Yes,,,"Age, Sex, BMI, Smoking status",Guertin 2015
8650,20671,20684,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Serum, non-fasting",Chromatography,1-Methyluric acid,"",,,,not annotated,,498,Pearson,0.21,,,= 2.7e-6,Yes,,,"Age, Sex, BMI, Smoking status",Guertin 2015
8651,20671,20685,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Serum, non-fasting",Chromatography,cyclo(Leucyl-prolyl),"",,,,not annotated,,498,Pearson,0.199,,,= 8.14e-6,Yes,,,"Age, Sex, BMI, Smoking status",Guertin 2015
8652,20671,20686,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Serum, non-fasting",Chromatography,4-Vinylphenol sulfate,"",,,,not annotated,,498,Pearson,0.188,,,= 2.65e-5,Yes,,,"Age, Sex, BMI, Smoking status",Guertin 2015
8653,20671,20687,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Serum, non-fasting",Chromatography,3-Hydroxyphenylpropionic acid,"",,,,not annotated,,498,Pearson,0.183,,,= 4.27e-5,Yes,,,"Age, Sex, BMI, Smoking status",Guertin 2015
8654,20671,20688,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Serum, non-fasting",Chromatography,Cinnamoylglycine,"",,,,not annotated,,498,Pearson,0.178,,,= 7.37e-5,Yes,,,"Age, Sex, BMI, Smoking status",Guertin 2015
8655,20689,20725,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,Proline betaine,"",,,,not annotated,,502,Pearson,0.398,,,= 2.23e-2,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8656,20689,20728,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,scyllo-Inositol,"",,,,not annotated,,502,Pearson,0.298,,,= 1.13e-11,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8657,20689,20712,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,chiro-Inositol,"",,,,not annotated,,502,Pearson,0.301,,,= 7.28e-12,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8658,20689,20720,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,N-Methylproline,"",,,,not annotated,,502,Pearson,0.298,,,= 1.15e-11,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8659,20690,20705,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Green-yellow vegetables,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,CMPF,"",,,,not annotated,,502,Pearson,0.222,,,= 5.52e-7,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8660,20691,20705,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Fish,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,CMPF,"",,,,not annotated,,502,Pearson,0.322,,,= 1.80e-13,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8661,20691,20714,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Fish,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,DHA (cis-22:6n-3),"",,,,not annotated,,502,Pearson,0.26,,,= 3.87e-9,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8662,20691,20716,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Fish,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,EPA (cis-20:5n-3),"",,,,not annotated,,502,Pearson,0.244,,,= 3.44e-8,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8663,20691,20701,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Fish,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,1-Docosahexaenoyl-sn-glycero-3-phosphocholine (PC(22:6/0:0)),"",,,,not annotated,,502,Pearson,0.237,,,= 8.27e-8,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8664,20692,20705,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Shellfish,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,CMPF,"",,,,not annotated,,502,Pearson,0.238,,,= 7.69e-8,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8665,20693,20718,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Butter,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,Methyl palmitic acid,"",,,,not annotated,,502,Pearson,0.262,,,= 2.97e-9,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8666,20693,20724,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Butter,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,Pentadecylic acid (15:0),"",,,,not annotated,,502,Pearson,0.248,,,= 2.06e-8,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8667,20693,20703,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Butter,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,10-Undecenoic acid (11:1n1),"",,,,not annotated,,502,Pearson,0.23,,,= 2.05e-7,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8668,20694,20731,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Nuts,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,Tryptophan betaine,"",,,,not annotated,,502,Pearson,0.352,,,= 6.21e-16,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8669,20694,20707,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Nuts,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,4-Vinylphenol sulfate,"",,,,not annotated,,502,Pearson,0.279,,,= 2.39e-1,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8670,20695,20730,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,Trigonelline,"",,,,not annotated,,502,Pearson,0.424,,,= 3.36e-23,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8671,20695,20727,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,Quinic acid,"",,,,not annotated,,502,Pearson,0.372,,,= 8.00e-18,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8672,20695,20702,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,1-Methylxanthine,"",,,,not annotated,,502,Pearson,0.299,,,= 9.04e-12,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8673,20695,20723,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,Paraxanthine,"",,,,not annotated,,502,Pearson,0.27,,,= 8.87e-1,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8674,20695,20719,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,N-(2-Furoyl)glycine,"",,,,not annotated,,502,Pearson,0.264,,,= 2.30e-9,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8675,20695,20711,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,Catechol sulfate,"",,,,not annotated,,502,Pearson,0.232,,,= 1.58e-7,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8676,20696,20717,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Liquor,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,Ethyl glucuronide,"",,,,not annotated,,502,Pearson,0.295,,,= 1.85e-11,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8677,20697,20717,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Alcoholic beverages,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,Ethyl glucuronide,"",,,,not annotated,,502,Pearson,0.36,,,= 1.04e-16,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8684,20697,20704,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Alcoholic beverages,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,16-Hydroxypalmitic acid,"",,,,not annotated,,502,Pearson,0.239,,,= 6.57e-8,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8685,20697,20715,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Alcoholic beverages,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,Eicosadienoic acid (cis-20:2n-6),"",,,,not annotated,,502,Pearson,0.23,,,= 2.12e-7,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8686,20697,20721,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Alcoholic beverages,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,Palmitoleic acid (cis-16:1n-7),"",,,,not annotated,,502,Pearson,0.23,,,= 2.15e-7,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8687,20697,20706,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Alcoholic beverages,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,"4-Androsten-3beta,17beta-diol disulfate 1","",,,,not annotated,,502,Pearson,0.289,,,= 5.31e-11,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8688,20697,20708,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Alcoholic beverages,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,"5-alpha-Androstan-3beta,17beta-diol disulfate","",,,,not annotated,,502,Pearson,0.254,,,= 9.21e-9,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8689,20697,20713,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Alcoholic beverages,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,cyclo(Leucyl-prolyl),"",,,,not annotated,,502,Pearson,0.249,,,= 1.84e-8,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8690,20697,20710,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Alcoholic beverages,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,Bilirubin isomer,"",,,,not annotated,,502,Pearson,0.243,,,= 3.75e-8,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8678,20698,20722,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Vitamin supplements,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,Pantothenic acid,"",,,,not annotated,,502,Pearson,0.541,,,= 3.36e-39,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8679,20698,20726,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Vitamin supplements,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,4-Pyridoxic acid,"",,,,not annotated,,502,Pearson,0.433,,,= 3.67e-24,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8680,20698,20709,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Vitamin supplements,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,alpha-Tocopherol,"",,,,not annotated,,502,Pearson,0.368,,,= 2.04e-17,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8681,20698,20729,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Vitamin supplements,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,Threonic acid,"",,,,not annotated,,502,Pearson,0.268,,,= 1.16e-9,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8682,20699,20714,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),White rice,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,DHA (cis-22:6n-3),"",,,,not annotated,,502,Pearson,0.27,,,= 9.51e-1,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8683,20700,20704,All,Cases and controls in a case-control study on colorectal cancer,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",baseline,Food Frequency Questionnaire (FFQ),Beer,"",,,,,not annotated,,baseline; 1 year,"Serum, non-fasting",Chromatography,16-Hydroxypalmitic acid,"",,,,not annotated,,502,Pearson,0.221,,,= 6.30e-7,Yes,,,"Age, Sex, Energy, Smoking status",Guertin 2014
8696,20733,20748,All,Subjects from the PhenoMeNEp substudy classified as coffee consumers and coffee non-consumers,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Coffee,"",,,,,not annotated,,,"Urine, spot",LC-MS,Atractyligenin glucuronide,"",,,,not annotated,,260,Pearson,0.534,,,< 0.0001,Yes,,,,Rothwell 2014
8697,20733,20749,All,Subjects from the PhenoMeNEp substudy classified as coffee consumers and coffee non-consumers,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Coffee,"",,,,,not annotated,,,"Urine, spot",LC-MS,cyclo(Isoleucyl-prolyl),"",,,,not annotated,,260,Pearson,0.543,,,< 0.0001,Yes,,,,Rothwell 2014
8698,20733,20750,All,Subjects from the PhenoMeNEp substudy classified as coffee consumers and coffee non-consumers,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Coffee,"",,,,,not annotated,,,"Urine, spot",LC-MS,1-Methylxanthine,"",,,,not annotated,,260,Pearson,0.508,,, ,Unspecified,,,,Rothwell 2014
8699,20733,20751,All,Subjects from the PhenoMeNEp substudy classified as coffee consumers and coffee non-consumers,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Coffee,"",,,,,not annotated,,,"Urine, spot",LC-MS,Kahweol oxide glucuronide,"",,,,not annotated,,260,Pearson,0.561,,,< 0.0001,Yes,,,,Rothwell 2014
8700,20733,20752,All,Subjects from the PhenoMeNEp substudy classified as coffee consumers and coffee non-consumers,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),,Dietary record (1-day),Coffee,"",,,,,not annotated,,,"Urine, spot",LC-MS,Trigonelline,"",,,,not annotated,,260,Pearson,0.467,,, ,Unspecified,,,,Rothwell 2014
8701,20753,20807,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,not annotated,,,"Urine, overnight",LC-MS,Proline betaine,"",,,,not annotated,,253,Pearson,0.5,,,= 4.17e-2,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8702,20753,20806,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,not annotated,,,"Urine, overnight",GC-MS,scyllo-Inositol,"",,,,not annotated,,253,Pearson,0.37,,,= 2.00e-9,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8703,20753,20798,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,not annotated,,,"Urine, overnight",LC-MS,N-Methylproline,"",,,,not annotated,,253,Pearson,0.36,,,= 8.32e-9,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8704,20753,20797,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,not annotated,,,"Urine, overnight",GC-MS,N-Methylglutamic acid,"",,,,not annotated,,253,Pearson,0.32,,,= 2.92e-7,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8705,20753,20788,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,not annotated,,,"Urine, overnight",GC-MS,chiro-Inositol,"",,,,not annotated,,253,Pearson,0.31,,,= 6.17e-7,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8706,20753,20786,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,not annotated,,,"Urine, overnight",LC-MS,4-Hydroxyproline betaine,"",,,,not annotated,,253,Pearson,0.28,,,= 7.72e-6,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8707,20753,20832,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,not annotated,,,"Serum, fasting and non-fasting",LC-MS,Proline betaine,"",,,,not annotated,,253,Pearson,0.55,,,= 4.17e-2,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8708,20753,20831,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,not annotated,,,"Serum, fasting and non-fasting",GC-MS,scyllo-Inositol,"",,,,not annotated,,253,Pearson,0.33,,,= 1.42e-7,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8709,20753,20826,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,not annotated,,,"Serum, fasting and non-fasting",LC-MS,N-Methylproline,"",,,,not annotated,,253,Pearson,0.4,,,= 1.72e-1,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8710,20753,20821,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Citrus fruits,"",,,,,not annotated,,,"Serum, fasting and non-fasting",GC-MS,chiro-Inositol,"",,,,not annotated,,253,Pearson,0.35,,,= 3.10e-8,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8711,20754,20807,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Fruit juices,"",,,,,not annotated,,,"Urine, overnight",LC-MS,Proline betaine,"",,,,not annotated,,253,Pearson,0.43,,,= 1.59e-12,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8712,20754,20806,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Fruit juices,"",,,,,not annotated,,,"Urine, overnight",GC-MS,scyllo-Inositol,"",,,,not annotated,,253,Pearson,0.29,,,= 3.58e-6,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8713,20754,20798,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Fruit juices,"",,,,,not annotated,,,"Urine, overnight",LC-MS,N-Methylproline,"",,,,not annotated,,253,Pearson,0.3,,,= 1.31e-6,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8714,20754,20797,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Fruit juices,"",,,,,not annotated,,,"Urine, overnight",GC-MS,N-Methylglutamic acid,"",,,,not annotated,,253,Pearson,0.31,,,= 7.84e-7,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8715,20754,20786,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Fruit juices,"",,,,,not annotated,,,"Urine, overnight",LC-MS,4-Hydroxyproline betaine,"",,,,not annotated,,253,Pearson,0.25,,,= 1.00e-4,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8716,20754,20832,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Fruit juices,"",,,,,not annotated,,,"Serum, fasting and non-fasting",LC-MS,Proline betaine,"",,,,not annotated,,253,Pearson,0.42,,,= 1.30e-11,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8717,20754,20831,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Fruit juices,"",,,,,not annotated,,,"Serum, fasting and non-fasting",GC-MS,scyllo-Inositol,"",,,,not annotated,,253,Pearson,0.25,,,= 7.71e-5,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8718,20754,20826,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Fruit juices,"",,,,,not annotated,,,"Serum, fasting and non-fasting",LC-MS,N-Methylproline,"",,,,not annotated,,253,Pearson,0.3,,,= 2.40e-6,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8719,20754,20821,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Fruit juices,"",,,,,not annotated,,,"Serum, fasting and non-fasting",GC-MS,chiro-Inositol,"",,,,not annotated,,253,Pearson,0.26,,,= 4.90e-5,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8720,20756,20778,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Fish,"",,,,,not annotated,,,"Urine, overnight",LC-MS,CMPF,"",,,,not annotated,,253,Pearson,0.27,,,= 2.00e-5,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8721,20756,20816,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Fish,"",,,,,not annotated,,,"Serum, fasting and non-fasting",LC-MS,CMPF,"",,,,not annotated,,253,Pearson,0.37,,,= 4.00e-9,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8722,20756,20822,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Fish,"",,,,,not annotated,,,"Serum, fasting and non-fasting",LC-MS,DHA (cis-22:6n-3),"",,,,not annotated,,253,Pearson,0.36,,,= 5.00e-9,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8723,20757,20810,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Nuts,"",,,,,not annotated,,,"Urine, overnight",LC-MS,Tryptophan betaine,"",,,,not annotated,,253,Pearson,0.41,,,= 1.44e-11,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8724,20757,20835,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Nuts,"",,,,,not annotated,,,"Serum, fasting and non-fasting",LC-MS,Tryptophan betaine,"",,,,not annotated,,253,Pearson,0.36,,,= 1.20e-8,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8725,20757,20780,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Nuts,"",,,,,not annotated,,,"Urine, overnight",LC-MS,4-Vinylphenol sulfate,"",,,,not annotated,,253,Pearson,0.31,,,= 8.97e-7,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8726,20758,20783,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Processed meat,"",,,,,not annotated,,,"Urine, overnight",LC-MS,Acetylcarnitine,"",,,,not annotated,,253,Pearson,0.26,,,= 4.42e-5,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8727,20759,20783,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Red meat,"",,,,,not annotated,,,"Urine, overnight",LC-MS,Acetylcarnitine,"",,,,not annotated,,253,Pearson,0.32,,,= 3.05e-7,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8728,20759,20811,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Red meat,"",,,,,not annotated,,,"Urine, overnight",GC-MS,Xylitol,"",,,,not annotated,,253,Pearson,0.28,,,= 8.24e-6,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8729,20759,20779,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Red meat,"",,,,,not annotated,,,"Urine, overnight",LC-MS,3-Dehydrocarnitine,"",,,,not annotated,,253,Pearson,0.26,,,= 5.00e-5,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8730,20759,20791,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Red meat,"",,,,,not annotated,,,"Urine, overnight",LC-MS,Ethyl glucuronide,"",,,,not annotated,,253,Pearson,0.25,,,= 6.20e-5,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8731,20761,20778,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Shellfish,"",,,,,not annotated,,,"Urine, overnight",LC-MS,CMPF,"",,,,not annotated,,253,Pearson,0.26,,,= 2.83e-5,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8732,20761,20816,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Shellfish,"",,,,,not annotated,,,"Serum, fasting and non-fasting",LC-MS,CMPF,"",,,,not annotated,,253,Pearson,0.38,,,= 1.00e-9,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8733,20761,20793,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Shellfish,"",,,,,not annotated,,,"Urine, overnight",GC-MS,Lysine,"",,,,not annotated,,253,Pearson,0.25,,,= 5.6e-5,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8734,20761,20789,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Shellfish,"",,,,,not annotated,,,"Urine, overnight",GC-MS,Ciliatine,"",,,,not annotated,,253,Pearson,0.25,,,= 8.2e-5,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8735,20761,20776,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Shellfish,"",,,,,not annotated,,,"Urine, overnight",GC-MS,2-Hydroxybutyric acid,"",,,,not annotated,,253,Pearson,0.25,,,= 9.46e-5,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8736,20763,20790,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Fats and oils,"",,,,,not annotated,,,"Urine, overnight",LC-MS,Creatine,"",,,,not annotated,,253,Pearson,0.3,,,= 1.76e-6,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8737,20763,20796,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Fats and oils,"",,,,,not annotated,,,"Urine, overnight",LC-MS,N-Acetyltyrosine,"",,,,not annotated,,253,Pearson,0.26,,,= 4.28e-5,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8738,20763,20795,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Fats and oils,"",,,,,not annotated,,,"Urine, overnight",LC-MS,N-Acetylglutamine,"",,,,not annotated,,253,Pearson,0.25,,,= 7.24e-5,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8739,20764,20801,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Vitamin supplements,"",,,,,not annotated,,,"Urine, overnight",LC-MS,Pantothenic acid,"",,,,not annotated,,253,Pearson,0.36,,,= 1.00e-8,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8740,20764,20827,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Vitamin supplements,"",,,,,not annotated,,,"Serum, fasting and non-fasting",LC-MS,Pantothenic acid,"",,,,not annotated,,253,Pearson,0.31,,,= 6.37e-7,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8741,20764,20777,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Vitamin supplements,"",,,,,not annotated,,,"Serum, fasting and non-fasting",GC-MS,alpha-Tocopherol,"",,,,not annotated,,253,Pearson,0.31,,,= 1.06e-6,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8742,20764,20803,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Vitamin supplements,"",,,,,not annotated,,,"Urine, overnight",LC-MS,4-Pyridoxic acid,"",,,,not annotated,,253,Pearson,0.3,,,= 1.56e-6,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8743,20764,20829,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Vitamin supplements,"",,,,,not annotated,,,"Serum, fasting and non-fasting",LC-MS,4-Pyridoxic acid,"",,,,not annotated,,253,Pearson,0.38,,,= 1.00e-9,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8744,20764,20805,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Vitamin supplements,"",,,,,not annotated,,,"Urine, overnight",LC-MS,Riboflavin,"",,,,not annotated,,253,Pearson,0.27,,,= 2.43e-5,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8745,20765,20777,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Vitamin supplements,"",,,,,not annotated,,,"Serum, fasting and non-fasting",GC-MS,alpha-Tocopherol,"",,,,not annotated,,253,Pearson,0.37,,,= 3.00e-9,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8746,20765,20817,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Vitamin supplements,"",,,,,not annotated,,,"Serum, fasting and non-fasting",LC-MS,alpha-CEHC glucuronide,"",,,,not annotated,,253,Pearson,0.27,,,= 2.31e-5,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8747,20765,20784,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Vitamin supplements,"",,,,,not annotated,,,"Urine, overnight",LC-MS,alpha-CEHC glucuronide,"",,,,not annotated,,253,Pearson,0.4,,,= 1.98e-1,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8748,20765,20785,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Vitamin supplements,"",,,,,not annotated,,,"Urine, overnight",LC-MS,alpha-CEHC sulfate,"",,,,not annotated,,253,Pearson,0.33,,,= 1.9e-7,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8749,20766,20804,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Urine, overnight",GC-MS,Quinic acid,"",,,,not annotated,,253,Pearson,0.43,,,= 1.41e-12,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8750,20766,20802,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Urine, overnight",LC-MS,Paraxanthine,"",,,,not annotated,,253,Pearson,0.42,,,= 7.35e-12,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8751,20766,20808,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Urine, overnight",LC-MS,Theophylline,"",,,,not annotated,,253,Pearson,0.41,,,= 2.91e-11,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8752,20766,20774,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Urine, overnight",LC-MS,1-Methylxanthine,"",,,,not annotated,,253,Pearson,0.39,,,= 3.21e-1,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8753,20766,20809,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Urine, overnight",LC-MS,Trigonelline,"",,,,not annotated,,253,Pearson,0.38,,,= 7.04e-1,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8754,20766,20773,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Urine, overnight",LC-MS,1-Methyluric acid,"",,,,not annotated,,253,Pearson,0.36,,,= 9.00e-9,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8755,20766,20787,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Urine, overnight",LC-MS,Caffeine,"",,,,not annotated,,253,Pearson,0.36,,,= 1.10e-8,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8756,20766,20771,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Urine, overnight",LC-MS,"1,3-Dimethyluric acid","",,,,not annotated,,253,Pearson,0.35,,,= 1.40e-8,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8757,20766,20772,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Urine, overnight",LC-MS,"1,7-Dimethyluric acid","",,,,not annotated,,253,Pearson,0.32,,,= 5.01e-7,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8758,20766,20782,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Urine, overnight",LC-MS,AFMU,"",,,,not annotated,,253,Pearson,0.33,,,= 1.33e-7,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8759,20766,20799,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Urine, overnight",GC-MS,Nicotinic acid,"",,,,not annotated,,253,Pearson,0.31,,,= 7.73e-7,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8760,20766,20794,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Urine, overnight",LC-MS,N-(2-Furoyl)glycine,"",,,,not annotated,,253,Pearson,0.28,,,= 9.59e-6,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8761,20766,20792,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Urine, overnight",LC-MS,Hippuric acid,"",,,,not annotated,,253,Pearson,0.28,,,= 1.22e-5,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8762,20766,20781,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Urine, overnight",LC-MS,AAMU,"",,,,not annotated,,253,Pearson,0.27,,,= 1.32e-5,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8763,20766,20770,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Urine, overnight",LC-MS,"1,3,7-Trimethyluric acid","",,,,not annotated,,253,Pearson,0.25,,,= 6.84e-5,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8764,20766,20828,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Serum, fasting and non-fasting",LC-MS,Paraxanthine,"",,,,not annotated,,253,Pearson,0.3,,,= 2.08e-6,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8765,20766,20830,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Serum, fasting and non-fasting",GC-MS,Quinic acid,"",,,,not annotated,,253,Pearson,0.47,,,= 2.33e-14,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8766,20766,20833,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Serum, fasting and non-fasting",LC-MS,Theophylline,"",,,,not annotated,,253,Pearson,0.34,,,= 5.80e-8,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8767,20766,20815,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Serum, fasting and non-fasting",LC-MS,1-Methylxanthine,"",,,,not annotated,,253,Pearson,0.33,,,= 1.12e-7,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8768,20766,20834,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Serum, fasting and non-fasting",LC-MS,Trigonelline,"",,,,not annotated,,253,Pearson,0.34,,,= 9.50e-8,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8769,20766,20819,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Serum, fasting and non-fasting",LC-MS,Caffeine,"",,,,not annotated,,253,Pearson,0.34,,,= 8.50e-8,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8770,20766,20813,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Serum, fasting and non-fasting",LC-MS,"1,3-Dimethyluric acid","",,,,not annotated,,253,Pearson,0.26,,,= 5.25e-5,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8771,20766,20814,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Serum, fasting and non-fasting",LC-MS,"1,7-Dimethyluric acid","",,,,not annotated,,253,Pearson,0.3,,,= 2.77e-6,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8772,20766,20820,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Serum, fasting and non-fasting",LC-MS,Catechol sulfate,"",,,,not annotated,,253,Pearson,0.29,,,= 5.55e-6,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8773,20766,20825,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Serum, fasting and non-fasting",LC-MS,N-(2-Furoyl)glycine,"",,,,not annotated,,253,Pearson,0.26,,,= 4.75e-5,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8774,20766,20812,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Coffee,"",,,,,not annotated,,,"Serum, fasting and non-fasting",LC-MS,"1,3,7-Trimethyluric acid","",,,,not annotated,,253,Pearson,0.3,,,= 2.36e-6,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8775,20767,20824,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Sugar-sweetened beverages,"",,,,,not annotated,,,"Serum, fasting and non-fasting",LC-MS,3-Methylglutarylcarnitine,"",,,,not annotated,,253,Pearson,0.25,,,= 6.91e-5,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8776,20768,20823,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Liquor,"",,,,,not annotated,,,"Serum, fasting and non-fasting",LC-MS,Ethyl glucuronide,"",,,,not annotated,,253,Pearson,0.26,,,= 3.69e-5,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8777,20768,20791,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Liquor,"",,,,,not annotated,,,"Urine, overnight",LC-MS,Ethyl glucuronide,"",,,,not annotated,,253,Pearson,0.29,,,= 2.75e-6,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8778,20769,20775,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Wine,"",,,,,not annotated,,,"Urine, overnight",GC-MS,"2,3-Dihydroxyisovaleric acid","",,,,not annotated,,253,Pearson,0.31,,,= 1.16e-6,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8779,20769,20840,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Wine,"",,,,,not annotated,,,"Urine, overnight",LC-MS,2-Isopropylmalic acid,"",,,,not annotated,,253,Pearson,0.26,,,= 3.98e-5,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8780,20769,20800,All,Cases and controls in a case-control study on colorectal adenoma,United States,Navy Colon Adenoma Study,,Food Frequency Questionnaire (FFQ),Wine,"",,,,,not annotated,,,"Urine, overnight",LC-MS,Nicotine,"",,,,not annotated,,253,Pearson,0.26,,,= 4.26e-5,Yes,,,"Age, Sex, BMI, Energy, Physical activity, Smoking status, Fasting, Case-control status, Education",Playdon 2016
8691,20841,20844,All,"Participants randomly assigned to 3 parallel interventions (healthy diet (HD), whole-grain-enriched diet (WGED), control diet) during 12 weeks",Finland,Sysdimet-HealthGrain intervention,,Dietary record (4-day),Fatty fish,"",,,,,not annotated,,,"Plasma, fasting",LC-MS,CMPF,"",,,,not annotated,,106,Spearman,0.23,,,= 0.19,Yes,,,,Hanhineva 2015
8692,20842,20845,All,"Participants randomly assigned to 3 parallel interventions (healthy diet (HD), whole-grain-enriched diet (WGED), control diet) during 12 weeks",Finland,Sysdimet-HealthGrain intervention,,Dietary record (4-day),Berries,"",,,,,not annotated,,,"Plasma, fasting",LC-MS,Hippuric acid,"",,,,not annotated,,106,Spearman,0.38,,,= 7e-5,Yes,,,,Hanhineva 2015
8693,20843,20846,All,"Participants randomly assigned to 3 parallel interventions (healthy diet (HD), whole-grain-enriched diet (WGED), control diet) during 12 weeks",Finland,Sysdimet-HealthGrain intervention,,Dietary record (4-day),Whole grain cereals,"",,,,,not annotated,,,"Plasma, fasting",LC-MS,5-n-Nonadecylresorcinol (C19:0) glucuronide,"",,,,not annotated,,106,Spearman,0.47,,,= 4e-7,Yes,,,,Hanhineva 2015
8694,20843,20847,All,"Participants randomly assigned to 3 parallel interventions (healthy diet (HD), whole-grain-enriched diet (WGED), control diet) during 12 weeks",Finland,Sysdimet-HealthGrain intervention,,Dietary record (4-day),Whole grain cereals,"",,,,,not annotated,,,"Plasma, fasting",LC-MS,5-n-(16-Heneicosenyl)-resorcinol (C21:1) glucuronide,"",,,,not annotated,,106,Spearman,0.63,,,= 1e-12,Yes,,,,Hanhineva 2015
8695,20843,20991,All,"Participants randomly assigned to 3 parallel interventions (healthy diet (HD), whole-grain-enriched diet (WGED), control diet) during 12 weeks",Finland,Sysdimet-HealthGrain intervention,,Dietary record (4-day),Whole grain cereals,"",,,,,not annotated,,,"Plasma, fasting",LC-MS,Pipecolic acid betaine,"",,,,not annotated,,106,Spearman,0.34,,,= 4e-4,Yes,,,,Hanhineva 2015
9149,22802,22061,All,Colorectal cancer cases and their controls,Denmark,HELGA,baseline,Food Frequency Questionnaire (FFQ),Cereals,"",,,,,g/day,,baseline,"Plasma, fasting and non-fasting",GC-MS,Alkylresorcinols,"",,,,nmol/L,,900,Spearman,-0.05,,,= 0.11,,,,,Knudsen 2014
9150,22803,22061,All,Colorectal cancer cases and their controls,Denmark,HELGA,baseline,Food Frequency Questionnaire (FFQ),Whole-grain bread,"",,,,,g/day,,baseline,"Plasma, fasting and non-fasting",GC-MS,Alkylresorcinols,"",,,,nmol/L,,900,Spearman,0.3,,,< 0.0001,,,,,Knudsen 2014
9151,22804,22061,All,Colorectal cancer cases and their controls,Denmark,HELGA,baseline,Food Frequency Questionnaire (FFQ),Crisp bread,"",,,,,g/day,,baseline,"Plasma, fasting and non-fasting",GC-MS,Alkylresorcinols,"",,,,nmol/L,,900,Spearman,-0.08,,,= 0.02,,,,,Knudsen 2014
9152,22805,22061,All,Colorectal cancer cases and their controls,Denmark,HELGA,baseline,Food Frequency Questionnaire (FFQ),Whole grain cereals,Cereals + Crisp bread + Whole-grain bread,,,,,g/day,,baseline,"Plasma, fasting and non-fasting",GC-MS,Alkylresorcinols,"",,,,nmol/L,,900,Spearman,0.21,,,< 0.0001,,,,,Knudsen 2014
9153,22806,22061,All,Colorectal cancer cases and their controls,Denmark,HELGA,baseline,Food Frequency Questionnaire (FFQ),Whole grain wheat,"",,,,,g/day,,baseline,"Plasma, fasting and non-fasting",GC-MS,Alkylresorcinols,"",,,,nmol/L,,900,Spearman,-0.02,,,= 0.51,,,,,Knudsen 2014
9154,22807,22061,All,Colorectal cancer cases and their controls,Denmark,HELGA,baseline,Food Frequency Questionnaire (FFQ),Whole grain rye,"",,,,,g/day,,baseline,"Plasma, fasting and non-fasting",GC-MS,Alkylresorcinols,"",,,,nmol/L,,900,Spearman,0.22,,,< 0.0001,,,,,Knudsen 2014
9155,22808,22061,All,Colorectal cancer cases and their controls,Denmark,HELGA,baseline,Food Frequency Questionnaire (FFQ),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline,"Plasma, fasting and non-fasting",GC-MS,Alkylresorcinols,"",,,,nmol/L,,900,Spearman,0.15,,,< 0.0001,,,,,Knudsen 2014
8828,22682,22693,All,Healthy volunteers residents of Tokyo or the neighboring cities in Japan,Japan,,,Weighed Dietary record (1-day),Fish + Meat,Fish + Processed meat + Beef + Pork + Chicken,,,,,g/day,,,Hair,LC-MS,PhIP,"",1376.0,,,pg/g,,20,Spearman,0.66,,,= 0.001,Yes,,,,Kobayashi 2005
8837,22682,22694,All,Healthy volunteers residents of Tokyo or the neighboring cities in Japan,Japan,,,Weighed Dietary record (1-day),Fish + Meat,Fish + Processed meat + Beef + Pork + Chicken,,,,,g/day,,,Hair,LC-MS,PhIP,"",16.6,,,ng/g,Melanin,20,Spearman,0.65,,,= 0.002,Yes,,,,Kobayashi 2005
8824,22683,22693,All,Healthy volunteers residents of Tokyo or the neighboring cities in Japan,Japan,,,Weighed Dietary record (1-day),Meat,Processed meat + Beef + Pork + Chicken,,47.7,,46.0,g/day,,,Hair,LC-MS,PhIP,"",1376.0,,,pg/g,,20,Spearman,0.68,,,= 0.001,Yes,,,,Kobayashi 2005
8833,22683,22694,All,Healthy volunteers residents of Tokyo or the neighboring cities in Japan,Japan,,,Weighed Dietary record (1-day),Meat,Processed meat + Beef + Pork + Chicken,,47.7,,46.0,g/day,,,Hair,LC-MS,PhIP,"",16.6,,,ng/g,Melanin,20,Spearman,0.69,,,= 0.001,Yes,,,,Kobayashi 2005
8827,22684,22693,All,Healthy volunteers residents of Tokyo or the neighboring cities in Japan,Japan,,,Weighed Dietary record (1-day),Fish,Fish,,21.8,,20.1,g/day,,,Hair,LC-MS,PhIP,"",1376.0,,,pg/g,,20,Spearman,0.28,,,= 0.230,No,,,,Kobayashi 2005
8836,22684,22694,All,Healthy volunteers residents of Tokyo or the neighboring cities in Japan,Japan,,,Weighed Dietary record (1-day),Fish,Fish,,21.8,,20.1,g/day,,,Hair,LC-MS,PhIP,"",16.6,,,ng/g,Melanin,20,Spearman,0.23,,,= 0.330,No,,,,Kobayashi 2005
8820,22685,22693,All,Healthy volunteers residents of Tokyo or the neighboring cities in Japan,Japan,,,Weighed Dietary record (1-day),Beef,"",,16.9,,15.2,g/day,,,Hair,LC-MS,PhIP,"",1376.0,,,pg/g,,20,Spearman,0.34,,,= 0.137,No,,,,Kobayashi 2005
8829,22685,22694,All,Healthy volunteers residents of Tokyo or the neighboring cities in Japan,Japan,,,Weighed Dietary record (1-day),Beef,"",,16.9,,15.2,g/day,,,Hair,LC-MS,PhIP,"",16.6,,,ng/g,Melanin,20,Spearman,0.48,,,= 0.031,Yes,,,,Kobayashi 2005
8821,22686,22693,All,Healthy volunteers residents of Tokyo or the neighboring cities in Japan,Japan,,,Weighed Dietary record (1-day),Pork,"",,17.7,,17.9,g/day,,,Hair,LC-MS,PhIP,"",1376.0,,,pg/g,,20,Spearman,0.46,,,= 0.039,Yes,,,,Kobayashi 2005
8830,22686,22694,All,Healthy volunteers residents of Tokyo or the neighboring cities in Japan,Japan,,,Weighed Dietary record (1-day),Pork,"",,17.7,,17.9,g/day,,,Hair,LC-MS,PhIP,"",16.6,,,ng/g,Melanin,20,Spearman,0.39,,,= 0.091,No,,,,Kobayashi 2005
8822,22687,22693,All,Healthy volunteers residents of Tokyo or the neighboring cities in Japan,Japan,,,Weighed Dietary record (1-day),Chicken,"",,9.7,,7.0,g/day,,,Hair,LC-MS,PhIP,"",1376.0,,,pg/g,,20,Spearman,0.53,,,= 0.017,Yes,,,,Kobayashi 2005
8831,22687,22694,All,Healthy volunteers residents of Tokyo or the neighboring cities in Japan,Japan,,,Weighed Dietary record (1-day),Chicken,"",,9.7,,7.0,g/day,,,Hair,LC-MS,PhIP,"",16.6,,,ng/g,Melanin,20,Spearman,0.52,,,= 0.019,Yes,,,,Kobayashi 2005
8823,22688,22693,All,Healthy volunteers residents of Tokyo or the neighboring cities in Japan,Japan,,,Weighed Dietary record (1-day),Processed meat,"",,3.4,,2.5,g/day,,,Hair,LC-MS,PhIP,"",1376.0,,,pg/g,,20,Spearman,0.15,,,= 0.536,No,,,,Kobayashi 2005
8832,22688,22694,All,Healthy volunteers residents of Tokyo or the neighboring cities in Japan,Japan,,,Weighed Dietary record (1-day),Processed meat,"",,3.4,,2.5,g/day,,,Hair,LC-MS,PhIP,"",16.6,,,ng/g,Melanin,20,Spearman,0.13,,,= 0.580,No,,,,Kobayashi 2005
8825,22689,22693,All,Healthy volunteers residents of Tokyo or the neighboring cities in Japan,Japan,,,Weighed Dietary record (1-day),Fish,"",,20.1,,17.5,g/day,,,Hair,LC-MS,PhIP,"",1376.0,,,pg/g,,20,Spearman,0.2,,,= 0.391,No,,,,Kobayashi 2005
8834,22689,22694,All,Healthy volunteers residents of Tokyo or the neighboring cities in Japan,Japan,,,Weighed Dietary record (1-day),Fish,"",,20.1,,17.5,g/day,,,Hair,LC-MS,PhIP,"",16.6,,,ng/g,Melanin,20,Spearman,0.18,,,= 0.448,No,,,,Kobayashi 2005
8826,22690,22693,All,Healthy volunteers residents of Tokyo or the neighboring cities in Japan,Japan,,,Weighed Dietary record (1-day),Fish,"",,1.7,,0.0,g/day,,,Hair,LC-MS,PhIP,"",1376.0,,,pg/g,,20,Spearman,0.09,,,= 0.709,No,,,,Kobayashi 2005
8835,22690,22694,All,Healthy volunteers residents of Tokyo or the neighboring cities in Japan,Japan,,,Weighed Dietary record (1-day),Fish,"",,1.7,,0.0,g/day,,,Hair,LC-MS,PhIP,"",16.6,,,ng/g,Melanin,20,Spearman,-0.03,,,= 0.893,No,,,,Kobayashi 2005
8838,22713,22695,All,Controls in a case-control study on ischemic heart disease,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,19.6,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Myristic acid (14:0),"",0.58,,,percentRoot,,313,Spearman,0.19,,,< 0.01,Yes,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
8839,22713,22696,All,Controls in a case-control study on ischemic heart disease,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,19.6,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Pentadecylic acid (15:0),"",0.16,,,percentRoot,,313,Spearman,0.33,,,< 0.01,Yes,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
8840,22713,22697,All,Controls in a case-control study on ischemic heart disease,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,19.6,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Palmitic acid (16:0),"",19.31,,,percentRoot,,313,Spearman,0.1,,,< 0.01,Yes,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
8841,22713,22698,All,Controls in a case-control study on ischemic heart disease,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,19.6,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,5-n-Heptadecylresorcinol (C17:0),"",0.3,,,percentRoot,,313,Spearman,0.17,,,< 0.01,Yes,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
8842,22713,22699,All,Controls in a case-control study on ischemic heart disease,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,19.6,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Stearic acid (18:0),"",7.29,,,percentRoot,,313,Spearman,0.09,,,< 0.05,Yes,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
8843,22713,22700,All,Controls in a case-control study on ischemic heart disease,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,19.6,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Palmitelaidic acid (trans-16:1n-7),"",0.15,,,percentRoot,,313,Spearman,0.27,,,< 0.01,Yes,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
8844,22713,22701,All,Controls in a case-control study on ischemic heart disease,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,19.6,,,percentRoot,,,"Plasma, fasting and non-fasting",GC-FID,Vaccenic acid (trans-18:1n-7),"",0.23,,,percentRoot,,313,Spearman,0.07,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
8845,22713,22703,All,Controls in a case-control study on ischemic heart disease,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,19.6,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,Myristic acid (14:0),"",0.19,,,percentRoot,,313,Spearman,0.14,,,< 0.01,Yes,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
8846,22713,22704,All,Controls in a case-control study on ischemic heart disease,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,19.6,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,Pentadecylic acid (15:0),"",0.1,,,percentRoot,,313,Spearman,0.28,,,< 0.01,Yes,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
8847,22713,22705,All,Controls in a case-control study on ischemic heart disease,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,19.6,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,Palmitic acid (16:0),"",18.66,,,percentRoot,,313,Spearman,0.06,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
8848,22713,22706,All,Controls in a case-control study on ischemic heart disease,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,19.6,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,5-n-Heptadecylresorcinol (C17:0),"",0.34,,,percentRoot,,313,Spearman,0.12,,,< 0.01,Yes,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
8849,22713,22707,All,Controls in a case-control study on ischemic heart disease,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,19.6,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,Stearic acid (18:0),"",13.13,,,percentRoot,,313,Spearman,0.02,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
8850,22713,22708,All,Controls in a case-control study on ischemic heart disease,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,19.6,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,Palmitelaidic acid (trans-16:1n-7),"",0.14,,,percentRoot,,313,Spearman,0.28,,,< 0.01,Yes,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
8851,22713,22709,All,Controls in a case-control study on ischemic heart disease,United States,NHS (Nurses' Health Study),,Food Frequency Questionnaire (FFQ),Fats from Dairy foods,"",,19.6,,,percentRoot,,,"Red blood cell, fasting and non-fasting",GC-FID,Vaccenic acid (trans-18:1n-7),"",0.38,,,percentRoot,,313,Spearman,-0.01,,,>= 0.05,No,,,"Age, BMI, Weight, Smoking status, Postmenopausal status, Postmenopausal hormone use, Period of blood assay, Fasting status",Sun 2007
8858,22714,22716,All,Women living in the Helsinki area,Finland,,baseline; 6 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 6 months,"Plasma, fasting",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,nmol/L,,60,Pearson,0.321,,,< 0.05,Yes,,,,Aubertin-Leheudre 2010
8859,22714,22717,All,Women living in the Helsinki area,Finland,,baseline; 6 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 6 months,"Plasma, fasting",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,nmol/L,,60,Pearson,0.385,,,< 0.01,Yes,,,,Aubertin-Leheudre 2010
8860,22714,22718,All,Women living in the Helsinki area,Finland,,baseline; 6 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 6 months,"Plasma, fasting",HPLC after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,nmol/L,,60,Pearson,0.334,,,< 0.05,Yes,,,,Aubertin-Leheudre 2010
8861,22714,22719,All,Women living in the Helsinki area,Finland,,baseline; 6 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 6 months,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/day,,60,Pearson,0.516,,,< 0.001,Yes,,,,Aubertin-Leheudre 2010
8862,22714,22720,All,Women living in the Helsinki area,Finland,,baseline; 6 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 6 months,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/day,,60,Pearson,0.444,,,< 0.001,Yes,,,,Aubertin-Leheudre 2010
8863,22714,22721,All,Women living in the Helsinki area,Finland,,baseline; 6 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 6 months,"Urine, 24-h",HPLC after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/day,,60,Pearson,0.476,,,< 0.001,Yes,,,,Aubertin-Leheudre 2010
8852,22715,22716,All,Women living in the Helsinki area,Finland,,baseline; 6 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 6 months,"Plasma, fasting",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,nmol/L,,60,Pearson,0.299,,,< 0.05,Yes,,,,Aubertin-Leheudre 2010
8853,22715,22717,All,Women living in the Helsinki area,Finland,,baseline; 6 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 6 months,"Plasma, fasting",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,nmol/L,,60,Pearson,0.397,,,< 0.01,Yes,,,,Aubertin-Leheudre 2010
8854,22715,22718,All,Women living in the Helsinki area,Finland,,baseline; 6 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 6 months,"Plasma, fasting",HPLC after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,nmol/L,,60,Pearson,0.215,,,>= 0.05,No,,,,Aubertin-Leheudre 2010
8855,22715,22719,All,Women living in the Helsinki area,Finland,,baseline; 6 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 6 months,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/day,,60,Pearson,0.524,,,< 0.001,Yes,,,,Aubertin-Leheudre 2010
8856,22715,22720,All,Women living in the Helsinki area,Finland,,baseline; 6 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 6 months,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/day,,60,Pearson,0.438,,,< 0.001,Yes,,,,Aubertin-Leheudre 2010
8857,22715,22721,All,Women living in the Helsinki area,Finland,,baseline; 6 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 6 months,"Urine, 24-h",HPLC after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/day,,60,Pearson,0.365,,,< 0.01,Yes,,,,Aubertin-Leheudre 2010
8882,22726,22754,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,17.0,,umol/day,,66,Spearman,0.52,,,< 0.001,Yes,,,,Marklund 2013
8883,22726,22754,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,17.0,,umol/day,,66,Spearman,0.63,0.39,0.79, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8902,22726,22776,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/day,,66,Spearman,0.6,,,< 0.001,Yes,,,,Marklund 2013
8903,22726,22776,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/day,,66,Spearman,0.8,0.62,0.9, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8922,22726,22766,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,28.0,,umol/day,,66,Spearman,0.51,,,< 0.001,Yes,,,,Marklund 2013
8923,22726,22766,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,28.0,,umol/day,,66,Spearman,0.65,0.42,0.8, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8942,22726,22778,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/day,,66,Spearman,0.56,,,< 0.001,Yes,,,,Marklund 2013
8943,22726,22778,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/day,,66,Spearman,0.77,0.58,0.89, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8962,22726,22768,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,45.0,,umol/day,,66,Spearman,0.51,,,< 0.001,Yes,,,,Marklund 2013
8963,22726,22768,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,45.0,,umol/day,,66,Spearman,0.65,0.42,0.81, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8982,22726,22780,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/day,,66,Spearman,0.57,,,< 0.001,Yes,,,,Marklund 2013
8983,22726,22780,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/day,,66,Spearman,0.79,0.6,0.9, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
9002,22726,22765,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,1.3,,mmol/mol,Creatinine,66,Spearman,0.46,,,< 0.001,Yes,,,,Marklund 2013
9003,22726,22765,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,1.3,,mmol/mol,Creatinine,66,Spearman,0.57,0.32,0.75, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
9022,22726,22777,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,mmol/mol,Creatinine,66,Spearman,0.39,,,< 0.01,Yes,,,,Marklund 2013
9023,22726,22777,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,mmol/mol,Creatinine,66,Spearman,0.56,0.31,0.74, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
9042,22726,22767,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,2.4,,mmol/mol,Creatinine,66,Spearman,0.48,,,< 0.001,Yes,,,,Marklund 2013
9043,22726,22767,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,2.4,,mmol/mol,Creatinine,66,Spearman,0.63,0.39,0.79, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
9062,22726,22779,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,mmol/mol,Creatinine,66,Spearman,0.41,,,< 0.001,Yes,,,,Marklund 2013
9063,22726,22779,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,mmol/mol,Creatinine,66,Spearman,0.6,0.36,0.77, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
9082,22726,22769,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,3.7,,mmol/mol,Creatinine,66,Spearman,0.47,,,< 0.001,Yes,,,,Marklund 2013
9083,22726,22769,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,3.7,,mmol/mol,Creatinine,66,Spearman,0.61,0.37,0.78, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
9102,22726,22781,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,mmol/mol,Creatinine,66,Spearman,0.44,,,< 0.001,Yes,,,,Marklund 2013
9103,22726,22781,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Fibre from Cereals,"",,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,mmol/mol,Creatinine,66,Spearman,0.62,0.39,0.78, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8866,22745,22754,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,17.0,,umol/day,,66,Spearman,0.46,,,< 0.001,Yes,,,,Marklund 2013
8867,22745,22754,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,17.0,,umol/day,,66,Spearman,0.54,0.29,0.72, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8886,22745,22776,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/day,,66,Spearman,0.54,,,< 0.001,Yes,,,,Marklund 2013
8887,22745,22776,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/day,,66,Spearman,0.69,0.47,0.83, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8906,22745,22766,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,28.0,,umol/day,,66,Spearman,0.4,,,< 0.001,Yes,,,,Marklund 2013
8907,22745,22766,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,28.0,,umol/day,,66,Spearman,0.48,0.22,0.68, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8926,22745,22778,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/day,,66,Spearman,0.44,,,< 0.001,Yes,,,,Marklund 2013
8927,22745,22778,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/day,,66,Spearman,0.6,0.36,0.77, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8946,22745,22768,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,45.0,,umol/day,,66,Spearman,0.41,,,< 0.001,Yes,,,,Marklund 2013
8947,22745,22768,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,45.0,,umol/day,,66,Spearman,0.48,0.25,0.7, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8966,22745,22780,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/day,,66,Spearman,0.47,,,< 0.001,Yes,,,,Marklund 2013
8967,22745,22780,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/day,,66,Spearman,0.63,0.4,0.79, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8986,22745,22765,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,1.3,,mmol/mol,Creatinine,66,Spearman,0.38,,,< 0.01,Yes,,,,Marklund 2013
8987,22745,22765,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,1.3,,mmol/mol,Creatinine,66,Spearman,0.49,0.23,0.69, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
9006,22745,22777,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,mmol/mol,Creatinine,66,Spearman,0.37,,,< 0.01,Yes,,,,Marklund 2013
9007,22745,22777,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,mmol/mol,Creatinine,66,Spearman,0.5,0.25,0.59, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
9026,22745,22767,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,2.4,,mmol/mol,Creatinine,66,Spearman,0.37,,,< 0.01,Yes,,,,Marklund 2013
9027,22745,22767,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,2.4,,mmol/mol,Creatinine,66,Spearman,0.5,0.24,0.69, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
9046,22745,22779,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,mmol/mol,Creatinine,66,Spearman,0.35,,,< 0.01,Yes,,,,Marklund 2013
9047,22745,22779,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,mmol/mol,Creatinine,66,Spearman,0.5,0.24,0.69, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
9066,22745,22769,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,3.7,,mmol/mol,Creatinine,66,Spearman,0.37,,,< 0.01,Yes,,,,Marklund 2013
9067,22745,22769,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,3.7,,mmol/mol,Creatinine,66,Spearman,0.49,0.59,0.69, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
9086,22745,22781,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,mmol/mol,Creatinine,66,Spearman,0.39,,,< 0.01,Yes,,,,Marklund 2013
9087,22745,22781,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,mmol/mol,Creatinine,66,Spearman,0.53,0.27,0.71, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8870,22746,22754,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,17.0,,umol/day,,66,Spearman,0.54,,,< 0.001,Yes,,,,Marklund 2013
8871,22746,22754,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,17.0,,umol/day,,66,Spearman,0.64,0.4,0.8, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8890,22746,22776,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/day,,66,Spearman,0.67,,,< 0.001,Yes,,,,Marklund 2013
8891,22746,22776,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/day,,66,Spearman,0.83,0.66,0.92, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8910,22746,22766,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,28.0,,umol/day,,66,Spearman,0.49,,,< 0.001,Yes,,,,Marklund 2013
8911,22746,22766,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,28.0,,umol/day,,66,Spearman,0.61,0.36,0.78, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8930,22746,22778,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/day,,66,Spearman,0.57,,,< 0.001,Yes,,,,Marklund 2013
8931,22746,22778,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/day,,66,Spearman,0.75,0.54,0.87, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8950,22746,22768,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,45.0,,umol/day,,66,Spearman,0.51,,,< 0.001,Yes,,,,Marklund 2013
8951,22746,22768,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,45.0,,umol/day,,66,Spearman,0.64,0.4,0.8, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8970,22746,22780,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/day,,66,Spearman,0.61,,,< 0.001,Yes,,,,Marklund 2013
8971,22746,22780,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/day,,66,Spearman,0.79,0.59,0.89, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8990,22746,22765,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,1.3,,mmol/mol,Creatinine,66,Spearman,0.49,,,< 0.001,Yes,,,,Marklund 2013
8991,22746,22765,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,1.3,,mmol/mol,Creatinine,66,Spearman,0.61,0.37,0.78, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
9010,22746,22777,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,mmol/mol,Creatinine,66,Spearman,0.53,,,< 0.001,Yes,,,,Marklund 2013
9011,22746,22777,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,mmol/mol,Creatinine,66,Spearman,0.65,0.42,0.81, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
9030,22746,22767,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,2.4,,mmol/mol,Creatinine,66,Spearman,0.45,,,< 0.001,Yes,,,,Marklund 2013
9031,22746,22767,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,2.4,,mmol/mol,Creatinine,66,Spearman,0.58,0.33,0.76, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
9050,22746,22779,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,mmol/mol,Creatinine,66,Spearman,0.47,,,< 0.001,Yes,,,,Marklund 2013
9051,22746,22779,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,mmol/mol,Creatinine,66,Spearman,0.62,0.38,0.78, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
9070,22746,22769,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,3.7,,mmol/mol,Creatinine,66,Spearman,0.47,,,< 0.001,Yes,,,,Marklund 2013
9071,22746,22769,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,3.7,,mmol/mol,Creatinine,66,Spearman,0.59,0.35,0.77, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
9090,22746,22781,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,mmol/mol,Creatinine,66,Spearman,0.52,,,< 0.001,Yes,,,,Marklund 2013
9091,22746,22781,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,mmol/mol,Creatinine,66,Spearman,0.66,0.43,0.81, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8874,22747,22754,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,17.0,,umol/day,,66,Spearman,0.5,,,< 0.001,Yes,,,,Marklund 2013
8875,22747,22754,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,17.0,,umol/day,,66,Spearman,0.56,0.32,0.73, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8894,22747,22776,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/day,,66,Spearman,0.7,,,< 0.001,Yes,,,,Marklund 2013
8895,22747,22776,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/day,,66,Spearman,0.83,0.67,0.92, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8914,22747,22766,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,28.0,,umol/day,,66,Spearman,0.54,,,< 0.001,Yes,,,,Marklund 2013
8915,22747,22766,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,28.0,,umol/day,,66,Spearman,0.65,0.43,0.8, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8934,22747,22778,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/day,,66,Spearman,0.68,,,< 0.001,Yes,,,,Marklund 2013
8935,22747,22778,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/day,,66,Spearman,0.84,0.68,0.92, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8954,22747,22768,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,45.0,,umol/day,,66,Spearman,0.54,,,< 0.001,Yes,,,,Marklund 2013
8955,22747,22768,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,45.0,,umol/day,,66,Spearman,0.65,0.44,0.8, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8974,22747,22780,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/day,,66,Spearman,0.7,,,< 0.001,Yes,,,,Marklund 2013
8975,22747,22780,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/day,,66,Spearman,0.86,0.72,0.94, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8994,22747,22765,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,1.3,,mmol/mol,Creatinine,66,Spearman,0.47,,,< 0.001,Yes,,,,Marklund 2013
8995,22747,22765,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,1.3,,mmol/mol,Creatinine,66,Spearman,0.56,0.33,0.74, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
9014,22747,22777,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,mmol/mol,Creatinine,66,Spearman,0.59,,,< 0.001,Yes,,,,Marklund 2013
9015,22747,22777,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,mmol/mol,Creatinine,66,Spearman,0.69,0.49,0.83, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
9034,22747,22767,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,2.4,,mmol/mol,Creatinine,66,Spearman,0.52,,,< 0.001,Yes,,,,Marklund 2013
9035,22747,22767,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,2.4,,mmol/mol,Creatinine,66,Spearman,0.66,0.44,0.8, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
9054,22747,22779,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,mmol/mol,Creatinine,66,Spearman,0.6,,,< 0.001,Yes,,,,Marklund 2013
9055,22747,22779,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,mmol/mol,Creatinine,66,Spearman,0.75,0.56,0.86, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
9074,22747,22769,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,3.7,,mmol/mol,Creatinine,66,Spearman,0.51,,,< 0.001,Yes,,,,Marklund 2013
9075,22747,22769,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,3.7,,mmol/mol,Creatinine,66,Spearman,0.64,0.42,0.79, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
9094,22747,22781,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,mmol/mol,Creatinine,66,Spearman,0.63,,,< 0.001,Yes,,,,Marklund 2013
9095,22747,22781,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain rye,"",,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,mmol/mol,Creatinine,66,Spearman,0.75,0.56,0.87, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8878,22748,22754,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,17.0,,umol/day,,66,Spearman,0.28,,,< 0.05,Yes,,,,Marklund 2013
8879,22748,22754,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,17.0,,umol/day,,66,Spearman,0.33,0.04,0.57, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8898,22748,22776,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/day,,66,Spearman,0.19,,,>= 0.05,No,,,,Marklund 2013
8899,22748,22776,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/day,,66,Spearman,0.22,-0.07,0.48, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8918,22748,22766,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,28.0,,umol/day,,66,Spearman,0.14,,,>= 0.05,No,,,,Marklund 2013
8919,22748,22766,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,28.0,,umol/day,,66,Spearman,0.15,-0.14,0.41, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8938,22748,22778,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/day,,66,Spearman,0.08,,,>= 0.05,No,,,,Marklund 2013
8939,22748,22778,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/day,,66,Spearman,0.1,-0.19,0.37, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8958,22748,22768,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,45.0,,umol/day,,66,Spearman,0.17,,,>= 0.05,No,,,,Marklund 2013
8959,22748,22768,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,45.0,,umol/day,,66,Spearman,0.18,-0.11,0.45, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8978,22748,22780,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/day,,66,Spearman,0.09,,,>= 0.05,No,,,,Marklund 2013
8979,22748,22780,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/day,,66,Spearman,0.12,-0.17,0.39, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8998,22748,22765,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,1.3,,mmol/mol,Creatinine,66,Spearman,0.13,,,>= 0.05,No,,,,Marklund 2013
8999,22748,22765,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,1.3,,mmol/mol,Creatinine,66,Spearman,0.15,-0.14,0.42, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
9018,22748,22777,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,mmol/mol,Creatinine,66,Spearman,0.01,,,>= 0.05,No,,,,Marklund 2013
9019,22748,22777,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,mmol/mol,Creatinine,66,Spearman,0.03,-0.25,0.31, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
9038,22748,22767,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,2.4,,mmol/mol,Creatinine,66,Spearman,0.03,,,>= 0.05,No,,,,Marklund 2013
9039,22748,22767,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,2.4,,mmol/mol,Creatinine,66,Spearman,-0.01,-0.29,0.27, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
9058,22748,22779,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,mmol/mol,Creatinine,66,Spearman,-0.05,,,>= 0.05,No,,,,Marklund 2013
9059,22748,22779,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,mmol/mol,Creatinine,66,Spearman,-0.06,-0.34,0.23, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
9078,22748,22769,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,3.7,,mmol/mol,Creatinine,66,Spearman,0.05,,,>= 0.05,No,,,,Marklund 2013
9079,22748,22769,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,3.7,,mmol/mol,Creatinine,66,Spearman,0.02,-0.26,0.3, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
9098,22748,22781,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,mmol/mol,Creatinine,66,Spearman,-0.02,,,>= 0.05,No,,,,Marklund 2013
9099,22748,22781,All,Free-living Swedish women and men,Sweden,,baseline; 2.5 months,Dietary record (3-day),Whole grain wheat,"",,,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,mmol/mol,Creatinine,66,Spearman,-0.01,-0.29,0.27, ,Unspecified,,,Within-person variation in intake variables,Marklund 2013
8880,22724,22754,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Fibre from Cereals,"",,13.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,17.0,,umol/day,,66,Spearman,0.6,,,< 0.001,Yes,,,,Marklund 2013
8900,22724,22776,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Fibre from Cereals,"",,13.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/day,,66,Spearman,0.58,,,< 0.001,Yes,,,,Marklund 2013
8920,22724,22766,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Fibre from Cereals,"",,13.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,28.0,,umol/day,,66,Spearman,0.56,,,< 0.001,Yes,,,,Marklund 2013
8940,22724,22778,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Fibre from Cereals,"",,13.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/day,,66,Spearman,0.56,,,< 0.001,Yes,,,,Marklund 2013
8960,22724,22768,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Fibre from Cereals,"",,13.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,45.0,,umol/day,,66,Spearman,0.57,,,< 0.001,Yes,,,,Marklund 2013
8980,22724,22780,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Fibre from Cereals,"",,13.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/day,,66,Spearman,0.57,,,< 0.001,Yes,,,,Marklund 2013
9000,22724,22765,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Fibre from Cereals,"",,13.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,1.3,,mmol/mol,Creatinine,66,Spearman,0.53,,,< 0.001,Yes,,,,Marklund 2013
9020,22724,22777,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Fibre from Cereals,"",,13.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,mmol/mol,Creatinine,66,Spearman,0.38,,,< 0.01,Yes,,,,Marklund 2013
9040,22724,22767,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Fibre from Cereals,"",,13.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,2.4,,mmol/mol,Creatinine,66,Spearman,0.55,,,< 0.001,Yes,,,,Marklund 2013
9060,22724,22779,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Fibre from Cereals,"",,13.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,mmol/mol,Creatinine,66,Spearman,0.41,,,< 0.001,Yes,,,,Marklund 2013
9080,22724,22769,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Fibre from Cereals,"",,13.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,3.7,,mmol/mol,Creatinine,66,Spearman,0.54,,,< 0.001,Yes,,,,Marklund 2013
9100,22724,22781,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Fibre from Cereals,"",,13.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,mmol/mol,Creatinine,66,Spearman,0.42,,,< 0.001,Yes,,,,Marklund 2013
8864,22727,22754,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,70.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,17.0,,umol/day,,66,Spearman,0.55,,,< 0.001,Yes,,,,Marklund 2013
8884,22727,22776,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,70.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/day,,66,Spearman,0.52,,,< 0.001,Yes,,,,Marklund 2013
8904,22727,22766,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,70.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,28.0,,umol/day,,66,Spearman,0.49,,,< 0.001,Yes,,,,Marklund 2013
8924,22727,22778,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,70.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/day,,66,Spearman,0.48,,,< 0.001,Yes,,,,Marklund 2013
8944,22727,22768,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,70.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,45.0,,umol/day,,66,Spearman,0.5,,,< 0.001,Yes,,,,Marklund 2013
8964,22727,22780,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,70.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/day,,66,Spearman,0.49,,,< 0.001,Yes,,,,Marklund 2013
8984,22727,22765,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,70.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,1.3,,mmol/mol,Creatinine,66,Spearman,0.46,,,< 0.001,Yes,,,,Marklund 2013
9004,22727,22777,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,70.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,mmol/mol,Creatinine,66,Spearman,0.34,,,< 0.01,Yes,,,,Marklund 2013
9024,22727,22767,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,70.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,2.4,,mmol/mol,Creatinine,66,Spearman,0.47,,,< 0.001,Yes,,,,Marklund 2013
9044,22727,22779,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,70.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,mmol/mol,Creatinine,66,Spearman,0.36,,,< 0.01,Yes,,,,Marklund 2013
9064,22727,22769,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,70.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,3.7,,mmol/mol,Creatinine,66,Spearman,0.46,,,< 0.001,Yes,,,,Marklund 2013
9084,22727,22781,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,70.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,mmol/mol,Creatinine,66,Spearman,0.38,,,< 0.01,Yes,,,,Marklund 2013
8868,22728,22754,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,47.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,17.0,,umol/day,,66,Spearman,0.61,,,< 0.001,Yes,,,,Marklund 2013
8888,22728,22776,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,47.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/day,,66,Spearman,0.6,,,< 0.001,Yes,,,,Marklund 2013
8908,22728,22766,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,47.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,28.0,,umol/day,,66,Spearman,0.57,,,< 0.001,Yes,,,,Marklund 2013
8928,22728,22778,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,47.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/day,,66,Spearman,0.58,,,< 0.001,Yes,,,,Marklund 2013
8948,22728,22768,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,47.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,45.0,,umol/day,,66,Spearman,0.59,,,< 0.001,Yes,,,,Marklund 2013
8968,22728,22780,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,47.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/day,,66,Spearman,0.59,,,< 0.001,Yes,,,,Marklund 2013
8988,22728,22765,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,47.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,1.3,,mmol/mol,Creatinine,66,Spearman,0.53,,,< 0.001,Yes,,,,Marklund 2013
9008,22728,22777,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,47.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,mmol/mol,Creatinine,66,Spearman,0.41,,,< 0.001,Yes,,,,Marklund 2013
9028,22728,22767,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,47.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,2.4,,mmol/mol,Creatinine,66,Spearman,0.53,,,< 0.001,Yes,,,,Marklund 2013
9048,22728,22779,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,47.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,mmol/mol,Creatinine,66,Spearman,0.42,,,< 0.001,Yes,,,,Marklund 2013
9068,22728,22769,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,47.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,3.7,,mmol/mol,Creatinine,66,Spearman,0.53,,,< 0.001,Yes,,,,Marklund 2013
9088,22728,22781,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,47.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,mmol/mol,Creatinine,66,Spearman,0.44,,,< 0.001,Yes,,,,Marklund 2013
8872,22729,22754,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain rye,"",,29.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,17.0,,umol/day,,66,Spearman,0.56,,,< 0.001,Yes,,,,Marklund 2013
8892,22729,22776,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain rye,"",,29.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/day,,66,Spearman,0.67,,,< 0.001,Yes,,,,Marklund 2013
8912,22729,22766,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain rye,"",,29.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,28.0,,umol/day,,66,Spearman,0.61,,,< 0.001,Yes,,,,Marklund 2013
8932,22729,22778,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain rye,"",,29.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/day,,66,Spearman,0.67,,,< 0.001,Yes,,,,Marklund 2013
8952,22729,22768,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain rye,"",,29.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,45.0,,umol/day,,66,Spearman,0.62,,,< 0.001,Yes,,,,Marklund 2013
8972,22729,22780,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain rye,"",,29.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/day,,66,Spearman,0.7,,,< 0.001,Yes,,,,Marklund 2013
8992,22729,22765,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain rye,"",,29.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,1.3,,mmol/mol,Creatinine,66,Spearman,0.53,,,< 0.001,Yes,,,,Marklund 2013
9012,22729,22777,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain rye,"",,29.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,mmol/mol,Creatinine,66,Spearman,0.58,,,< 0.001,Yes,,,,Marklund 2013
9032,22729,22767,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain rye,"",,29.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,2.4,,mmol/mol,Creatinine,66,Spearman,0.59,,,< 0.001,Yes,,,,Marklund 2013
9052,22729,22779,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain rye,"",,29.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,mmol/mol,Creatinine,66,Spearman,0.6,,,< 0.001,Yes,,,,Marklund 2013
9072,22729,22769,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain rye,"",,29.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,3.7,,mmol/mol,Creatinine,66,Spearman,0.58,,,< 0.001,Yes,,,,Marklund 2013
9092,22729,22781,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain rye,"",,29.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,mmol/mol,Creatinine,66,Spearman,0.62,,,< 0.001,Yes,,,,Marklund 2013
8876,22730,22754,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain wheat,"",,19.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,17.0,,umol/day,,66,Spearman,0.36,,,< 0.01,Yes,,,,Marklund 2013
8896,22730,22776,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain wheat,"",,19.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/day,,66,Spearman,0.23,,,>= 0.05,No,,,,Marklund 2013
8916,22730,22766,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain wheat,"",,19.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,28.0,,umol/day,,66,Spearman,0.24,,,>= 0.05,No,,,,Marklund 2013
8936,22730,22778,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain wheat,"",,19.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/day,,66,Spearman,0.15,,,>= 0.05,No,,,,Marklund 2013
8956,22730,22768,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain wheat,"",,19.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,45.0,,umol/day,,66,Spearman,0.27,,,< 0.05,Yes,,,,Marklund 2013
8976,22730,22780,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain wheat,"",,19.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/day,,66,Spearman,0.16,,,>= 0.05,No,,,,Marklund 2013
8996,22730,22765,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain wheat,"",,19.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,1.3,,mmol/mol,Creatinine,66,Spearman,0.19,,,>= 0.05,No,,,,Marklund 2013
9016,22730,22777,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain wheat,"",,19.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,mmol/mol,Creatinine,66,Spearman,-0.01,,,>= 0.05,No,,,,Marklund 2013
9036,22730,22767,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain wheat,"",,19.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,2.4,,mmol/mol,Creatinine,66,Spearman,0.12,,,>= 0.05,No,,,,Marklund 2013
9056,22730,22779,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain wheat,"",,19.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,mmol/mol,Creatinine,66,Spearman,-0.06,,,>= 0.05,No,,,,Marklund 2013
9076,22730,22769,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain wheat,"",,19.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,3.7,,mmol/mol,Creatinine,66,Spearman,0.13,,,>= 0.05,No,,,,Marklund 2013
9096,22730,22781,All,Free-living Swedish women and men,Sweden,,baseline,Dietary record (3-day),Whole grain wheat,"",,19.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,mmol/mol,Creatinine,66,Spearman,-0.03,,,>= 0.05,No,,,,Marklund 2013
8881,22725,22754,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Fibre from Cereals,"",,11.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,17.0,,umol/day,,66,Spearman,0.33,,,< 0.01,Yes,,,,Marklund 2013
8901,22725,22776,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Fibre from Cereals,"",,11.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/day,,66,Spearman,0.5,,,< 0.001,Yes,,,,Marklund 2013
8921,22725,22766,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Fibre from Cereals,"",,11.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,28.0,,umol/day,,66,Spearman,0.36,,,< 0.01,Yes,,,,Marklund 2013
8941,22725,22778,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Fibre from Cereals,"",,11.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/day,,66,Spearman,0.46,,,< 0.001,Yes,,,,Marklund 2013
8961,22725,22768,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Fibre from Cereals,"",,11.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,45.0,,umol/day,,66,Spearman,0.34,,,< 0.01,Yes,,,,Marklund 2013
8981,22725,22780,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Fibre from Cereals,"",,11.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/day,,66,Spearman,0.47,,,< 0.001,Yes,,,,Marklund 2013
9001,22725,22765,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Fibre from Cereals,"",,11.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,1.3,,mmol/mol,Creatinine,66,Spearman,0.27,,,< 0.05,Yes,,,,Marklund 2013
9021,22725,22777,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Fibre from Cereals,"",,11.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,mmol/mol,Creatinine,66,Spearman,0.35,,,< 0.01,Yes,,,,Marklund 2013
9041,22725,22767,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Fibre from Cereals,"",,11.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,2.4,,mmol/mol,Creatinine,66,Spearman,0.3,,,< 0.05,Yes,,,,Marklund 2013
9061,22725,22779,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Fibre from Cereals,"",,11.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,mmol/mol,Creatinine,66,Spearman,0.35,,,< 0.01,Yes,,,,Marklund 2013
9081,22725,22769,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Fibre from Cereals,"",,11.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,3.7,,mmol/mol,Creatinine,66,Spearman,0.29,,,< 0.05,Yes,,,,Marklund 2013
9101,22725,22781,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Fibre from Cereals,"",,11.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,mmol/mol,Creatinine,66,Spearman,0.38,,,< 0.01,Yes,,,,Marklund 2013
8865,22736,22754,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,69.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,17.0,,umol/day,,66,Spearman,0.26,,,< 0.05,Yes,,,,Marklund 2013
8885,22736,22776,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,69.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/day,,66,Spearman,0.43,,,< 0.001,Yes,,,,Marklund 2013
8905,22736,22766,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,69.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,28.0,,umol/day,,66,Spearman,0.21,,,>= 0.05,No,,,,Marklund 2013
8925,22736,22778,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,69.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/day,,66,Spearman,0.31,,,< 0.05,Yes,,,,Marklund 2013
8945,22736,22768,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,69.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,45.0,,umol/day,,66,Spearman,0.22,,,>= 0.05,No,,,,Marklund 2013
8965,22736,22780,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,69.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/day,,66,Spearman,0.35,,,< 0.01,Yes,,,,Marklund 2013
8985,22736,22765,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,69.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,1.3,,mmol/mol,Creatinine,66,Spearman,0.23,,,>= 0.05,No,,,,Marklund 2013
9005,22736,22777,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,69.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,mmol/mol,Creatinine,66,Spearman,0.34,,,< 0.01,Yes,,,,Marklund 2013
9025,22736,22767,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,69.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,2.4,,mmol/mol,Creatinine,66,Spearman,0.21,,,>= 0.05,No,,,,Marklund 2013
9045,22736,22779,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,69.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,mmol/mol,Creatinine,66,Spearman,0.28,,,< 0.05,Yes,,,,Marklund 2013
9065,22736,22769,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,69.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,3.7,,mmol/mol,Creatinine,66,Spearman,0.21,,,>= 0.05,No,,,,Marklund 2013
9085,22736,22781,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat + Whole grain oats + Whole grain rice + Whole grain barley + Whole grain corn,,69.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,mmol/mol,Creatinine,66,Spearman,0.32,,,< 0.01,Yes,,,,Marklund 2013
8869,22737,22754,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,43.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,17.0,,umol/day,,66,Spearman,0.33,,,< 0.01,Yes,,,,Marklund 2013
8889,22737,22776,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,43.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/day,,66,Spearman,0.55,,,< 0.001,Yes,,,,Marklund 2013
8909,22737,22766,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,43.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,28.0,,umol/day,,66,Spearman,0.28,,,< 0.05,Yes,,,,Marklund 2013
8929,22737,22778,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,43.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/day,,66,Spearman,0.41,,,< 0.001,Yes,,,,Marklund 2013
8949,22737,22768,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,43.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,45.0,,umol/day,,66,Spearman,0.29,,,< 0.01,Yes,,,,Marklund 2013
8969,22737,22780,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,43.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/day,,66,Spearman,0.46,,,< 0.001,Yes,,,,Marklund 2013
8989,22737,22765,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,43.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,1.3,,mmol/mol,Creatinine,66,Spearman,0.32,,,< 0.01,Yes,,,,Marklund 2013
9009,22737,22777,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,43.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,mmol/mol,Creatinine,66,Spearman,0.49,,,< 0.001,Yes,,,,Marklund 2013
9029,22737,22767,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,43.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,2.4,,mmol/mol,Creatinine,66,Spearman,0.25,,,< 0.05,Yes,,,,Marklund 2013
9049,22737,22779,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,43.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,mmol/mol,Creatinine,66,Spearman,0.4,,,< 0.001,Yes,,,,Marklund 2013
9069,22737,22769,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,43.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,3.7,,mmol/mol,Creatinine,66,Spearman,0.28,,,< 0.05,Yes,,,,Marklund 2013
9089,22737,22781,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain cereals,Whole grain rye + Whole grain wheat,,43.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,mmol/mol,Creatinine,66,Spearman,0.45,,,< 0.001,Yes,,,,Marklund 2013
8873,22738,22754,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain rye,"",,28.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,17.0,,umol/day,,66,Spearman,0.33,,,< 0.01,Yes,,,,Marklund 2013
8893,22738,22776,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain rye,"",,28.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/day,,66,Spearman,0.56,,,< 0.001,Yes,,,,Marklund 2013
8913,22738,22766,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain rye,"",,28.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,28.0,,umol/day,,66,Spearman,0.36,,,< 0.01,Yes,,,,Marklund 2013
8933,22738,22778,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain rye,"",,28.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/day,,66,Spearman,0.55,,,< 0.001,Yes,,,,Marklund 2013
8953,22738,22768,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain rye,"",,28.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,45.0,,umol/day,,66,Spearman,0.35,,,< 0.01,Yes,,,,Marklund 2013
8973,22738,22780,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain rye,"",,28.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/day,,66,Spearman,0.56,,,< 0.001,Yes,,,,Marklund 2013
8993,22738,22765,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain rye,"",,28.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,1.3,,mmol/mol,Creatinine,66,Spearman,0.32,,,< 0.01,Yes,,,,Marklund 2013
9013,22738,22777,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain rye,"",,28.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,mmol/mol,Creatinine,66,Spearman,0.48,,,< 0.001,Yes,,,,Marklund 2013
9033,22738,22767,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain rye,"",,28.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,2.4,,mmol/mol,Creatinine,66,Spearman,0.35,,,< 0.01,Yes,,,,Marklund 2013
9053,22738,22779,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain rye,"",,28.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,mmol/mol,Creatinine,66,Spearman,0.49,,,< 0.001,Yes,,,,Marklund 2013
9073,22738,22769,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain rye,"",,28.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,3.7,,mmol/mol,Creatinine,66,Spearman,0.34,,,< 0.01,Yes,,,,Marklund 2013
9093,22738,22781,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain rye,"",,28.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,mmol/mol,Creatinine,66,Spearman,0.51,,,< 0.001,Yes,,,,Marklund 2013
8877,22739,22754,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain wheat,"",,15.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,17.0,,umol/day,,66,Spearman,0.11,,,>= 0.05,No,,,,Marklund 2013
8897,22739,22776,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain wheat,"",,15.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/day,,66,Spearman,0.11,,,>= 0.05,No,,,,Marklund 2013
8917,22739,22766,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain wheat,"",,15.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,28.0,,umol/day,,66,Spearman,-0.04,,,>= 0.05,No,,,,Marklund 2013
8937,22739,22778,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain wheat,"",,15.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/day,,66,Spearman,-0.03,,,>= 0.05,No,,,,Marklund 2013
8957,22739,22768,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain wheat,"",,15.0,,,g/day,,baseline,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,45.0,,umol/day,,66,Spearman,-0.02,,,>= 0.05,No,,,,Marklund 2013
8977,22739,22780,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain wheat,"",,15.0,,,g/day,,baseline; 2.5 months,"Urine, 24-h",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,umol/day,,66,Spearman,-0.01,,,>= 0.05,No,,,,Marklund 2013
8997,22739,22765,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain wheat,"",,15.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,1.3,,mmol/mol,Creatinine,66,Spearman,0.03,,,>= 0.05,No,,,,Marklund 2013
9017,22739,22777,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain wheat,"",,15.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,mmol/mol,Creatinine,66,Spearman,0.03,,,>= 0.05,No,,,,Marklund 2013
9037,22739,22767,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain wheat,"",,15.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,2.4,,mmol/mol,Creatinine,66,Spearman,-0.12,,,>= 0.05,No,,,,Marklund 2013
9057,22739,22779,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain wheat,"",,15.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,"3,5-DHPPA","",,,,mmol/mol,Creatinine,66,Spearman,-0.03,,,>= 0.05,No,,,,Marklund 2013
9077,22739,22769,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain wheat,"",,15.0,,,g/day,,baseline,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,3.7,,mmol/mol,Creatinine,66,Spearman,-0.1,,,>= 0.05,No,,,,Marklund 2013
9097,22739,22781,All,Free-living Swedish women and men,Sweden,,2.5 months,Dietary record (3-day),Whole grain wheat,"",,15.0,,,g/day,,baseline; 2.5 months,"Urine, first morning spot",GC-MS after enzymatic hydrolysis,Alkylresorcinol metabolites,"3,5-Dihydroxybenzoic acid + 3,5-DHPPA",,,,mmol/mol,Creatinine,66,Spearman,0.0,,,>= 0.05,No,,,,Marklund 2013
9104,22787,22782,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),Dairy foods,Cheese + Yoghurt + Milk + Ice cream,,5.5,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Palmitelaidic acid (trans-16:1n-7),"",0.06,,,percentRoot,,2617,Spearman,0.15,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9105,22787,22783,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),Dairy foods,Cheese + Yoghurt + Milk + Ice cream,,5.5,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Myristic acid (14:0),"",0.26,,,percentRoot,,2617,Spearman,0.1,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9106,22787,22784,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),Dairy foods,Cheese + Yoghurt + Milk + Ice cream,,5.5,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Pentadecylic acid (15:0),"",0.17,,,percentRoot,,2617,Spearman,0.15,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9123,22788,22783,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),Dairy foods,Yoghurt + Milk,,5.9,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Myristic acid (14:0),"",0.26,,,percentRoot,,2617,Spearman,0.09,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9124,22788,22784,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),Dairy foods,Yoghurt + Milk,,5.9,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Pentadecylic acid (15:0),"",0.17,,,percentRoot,,2617,Spearman,0.14,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9107,22789,22782,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),Cheese,"",,,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Palmitelaidic acid (trans-16:1n-7),"",0.06,,,percentRoot,,2617,Spearman,0.11,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9108,22789,22783,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),Cheese,"",,,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Myristic acid (14:0),"",0.26,,,percentRoot,,2617,Spearman,0.12,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9109,22789,22784,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),Cheese,"",,,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Pentadecylic acid (15:0),"",0.17,,,percentRoot,,2617,Spearman,0.15,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9110,22790,22782,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),Cheese,"",,,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Palmitelaidic acid (trans-16:1n-7),"",0.06,,,percentRoot,,2617,Spearman,0.17,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9111,22790,22783,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),Cheese,"",,,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Myristic acid (14:0),"",0.26,,,percentRoot,,2617,Spearman,0.13,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9112,22790,22784,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),Cheese,"",,,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Pentadecylic acid (15:0),"",0.17,,,percentRoot,,2617,Spearman,0.21,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9115,22791,22784,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),Milk,"",,,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Pentadecylic acid (15:0),"",0.17,,,percentRoot,,2617,Spearman,0.07,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9119,22793,22782,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),Ice cream,"",,,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Palmitelaidic acid (trans-16:1n-7),"",0.06,,,percentRoot,,2617,Spearman,0.12,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9120,22793,22783,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),Ice cream,"",,,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Myristic acid (14:0),"",0.26,,,percentRoot,,2617,Spearman,0.06,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9121,22793,22784,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),Ice cream,"",,,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Pentadecylic acid (15:0),"",0.17,,,percentRoot,,2617,Spearman,0.1,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9129,22795,22783,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),Milk,"",,,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Myristic acid (14:0),"",0.26,,,percentRoot,,2617,Spearman,0.07,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9130,22795,22784,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),Milk,"",,,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Pentadecylic acid (15:0),"",0.17,,,percentRoot,,2617,Spearman,0.07,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9131,22796,22782,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),Yoghurt,"",,,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Palmitelaidic acid (trans-16:1n-7),"",0.06,,,percentRoot,,2617,Spearman,0.07,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9132,22796,22783,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),Yoghurt,"",,,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Myristic acid (14:0),"",0.26,,,percentRoot,,2617,Spearman,0.05,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9133,22796,22784,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),Yoghurt,"",,,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Pentadecylic acid (15:0),"",0.17,,,percentRoot,,2617,Spearman,0.06,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9134,22797,22782,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),Butter,"",,,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Palmitelaidic acid (trans-16:1n-7),"",0.06,,,percentRoot,,2617,Spearman,0.14,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9135,22797,22783,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),Butter,"",,,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Myristic acid (14:0),"",0.26,,,percentRoot,,2617,Spearman,0.07,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9136,22797,22784,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),Butter,"",,,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Pentadecylic acid (15:0),"",0.17,,,percentRoot,,2617,Spearman,0.13,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9137,22798,22782,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),Cakes,"",,,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Palmitelaidic acid (trans-16:1n-7),"",0.06,,,percentRoot,,2617,Spearman,0.18,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9138,22798,22783,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),Cakes,"",,,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Myristic acid (14:0),"",0.26,,,percentRoot,,2617,Spearman,0.06,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9139,22798,22784,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),Cakes,"",,,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Pentadecylic acid (15:0),"",0.17,,,percentRoot,,2617,Spearman,0.09,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9140,22799,22782,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),Margarine,"",,,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Palmitelaidic acid (trans-16:1n-7),"",0.06,,,percentRoot,,2617,Spearman,0.22,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9143,22800,22782,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),French fries,"",,,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Palmitelaidic acid (trans-16:1n-7),"",0.06,,,percentRoot,,2617,Spearman,0.2,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9146,22801,22782,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),Crackers,"",,,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Palmitelaidic acid (trans-16:1n-7),"",0.06,,,percentRoot,,2617,Spearman,0.07,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9148,22801,22784,All,Adults from 6 US communities,United States,MESA (Multi-Ethnic Study of Atherosclerosis),baseline,Food Frequency Questionnaire (FFQ),Crackers,"",,,,,servings/week,,baseline,"Plasma (phospholipids), fasting",GC,Pentadecylic acid (15:0),"",0.17,,,percentRoot,,2617,Spearman,-0.04,,,< 0.05,Yes,,,"Age, Sex, Race-ethnicity, Field center, Energy intake",Mozaffarian 2013
9156,22812,22818,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Bread,"",,168.7,,,g/day,,day 4,"Plasma, fasting",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,82.54,nmol/L,,31,Spearman,0.656,,,< 0.01,Yes,,,,Meija 2015
9164,22812,22823,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Bread,"",,168.7,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,31,Spearman,0.426,,,< 0.05,Yes,,,,Meija 2015
9172,22812,22824,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Bread,"",,168.7,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,31,Spearman,0.297,,,>= 0.05,No,,,,Meija 2015
9180,22812,22822,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Bread,"",,168.7,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,31,Spearman,0.35,,,>= 0.05,No,,,,Meija 2015
9188,22812,22820,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Bread,"",,168.7,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,31,Spearman,0.292,,,>= 0.05,No,,,,Meija 2015
9196,22812,22821,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Bread,"",,168.7,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,31,Spearman,0.356,,,< 0.05,Yes,,,,Meija 2015
9204,22812,22819,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Bread,"",,168.7,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,31,Spearman,0.317,,,>= 0.05,No,,,,Meija 2015
9158,22813,22818,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Rye bread,"",,125.6,,,g/day,,day 4,"Plasma, fasting",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,82.54,nmol/L,,31,Spearman,0.528,,,< 0.01,Yes,,,,Meija 2015
9166,22813,22823,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Rye bread,"",,125.6,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,31,Spearman,0.417,,,< 0.05,Yes,,,,Meija 2015
9174,22813,22824,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Rye bread,"",,125.6,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,31,Spearman,0.463,,,< 0.05,Yes,,,,Meija 2015
9182,22813,22822,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Rye bread,"",,125.6,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,31,Spearman,0.474,,,< 0.05,Yes,,,,Meija 2015
9190,22813,22820,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Rye bread,"",,125.6,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,31,Spearman,0.375,,,>= 0.05,No,,,,Meija 2015
9198,22813,22821,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Rye bread,"",,125.6,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,31,Spearman,0.556,,,< 0.01,Yes,,,,Meija 2015
9206,22813,22819,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Rye bread,"",,125.6,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,31,Spearman,0.476,,,< 0.05,Yes,,,,Meija 2015
9157,22832,22818,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Fibre from Bread,"",,,,,g/day,,day 4,"Plasma, fasting",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,82.54,nmol/L,,31,Spearman,0.607,,,< 0.01,Yes,,,,Meija 2015
9165,22832,22823,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,31,Spearman,0.466,,,< 0.01,Yes,,,,Meija 2015
9173,22832,22824,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,31,Spearman,0.403,,,< 0.05,Yes,,,,Meija 2015
9181,22832,22822,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,31,Spearman,0.443,,,< 0.05,Yes,,,,Meija 2015
9189,22832,22820,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,31,Spearman,0.336,,,>= 0.05,No,,,,Meija 2015
9197,22832,22821,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,31,Spearman,0.49,,,< 0.01,Yes,,,,Meija 2015
9205,22832,22819,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,31,Spearman,0.411,,,< 0.05,Yes,,,,Meija 2015
9159,22834,22818,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Fibre from Bread,"",,,,,g/day,,day 4,"Plasma, fasting",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,82.54,nmol/L,,31,Spearman,0.528,,,< 0.01,Yes,,,,Meija 2015
9167,22834,22823,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,31,Spearman,0.417,,,< 0.05,Yes,,,,Meija 2015
9175,22834,22824,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,31,Spearman,0.463,,,< 0.05,Yes,,,,Meija 2015
9183,22834,22822,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,31,Spearman,0.474,,,< 0.05,Yes,,,,Meija 2015
9191,22834,22820,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,31,Spearman,0.375,,,>= 0.05,No,,,,Meija 2015
9199,22834,22821,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,31,Spearman,0.556,,,< 0.01,Yes,,,,Meija 2015
9207,22834,22819,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,31,Spearman,0.476,,,< 0.05,Yes,,,,Meija 2015
9212,22838,22818,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Bread,"",,,,,g/day,,day 4,"Plasma, fasting",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,82.54,nmol/L,,31,Spearman,0.468,,,< 0.05,Yes,,,,Meija 2015
9220,22838,22823,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Bread,"",,,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,31,Spearman,0.313,,,>= 0.05,No,,,,Meija 2015
9228,22838,22824,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Bread,"",,,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,31,Spearman,0.122,,,>= 0.05,No,,,,Meija 2015
9236,22838,22822,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Bread,"",,,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,31,Spearman,0.206,,,>= 0.05,No,,,,Meija 2015
9244,22838,22820,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Bread,"",,,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,31,Spearman,0.253,,,>= 0.05,No,,,,Meija 2015
9252,22838,22821,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Bread,"",,,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,31,Spearman,0.317,,,>= 0.05,No,,,,Meija 2015
9260,22838,22819,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Bread,"",,,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,31,Spearman,0.276,,,>= 0.05,No,,,,Meija 2015
9214,22839,22818,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Rye bread,"",,,,,g/day,,day 4,"Plasma, fasting",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,82.54,nmol/L,,31,Spearman,0.334,,,>= 0.05,No,,,,Meija 2015
9222,22839,22823,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Rye bread,"",,,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,31,Spearman,0.221,,,>= 0.05,No,,,,Meija 2015
9230,22839,22824,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Rye bread,"",,,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,31,Spearman,0.152,,,>= 0.05,No,,,,Meija 2015
9238,22839,22822,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Rye bread,"",,,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,31,Spearman,0.135,,,>= 0.05,No,,,,Meija 2015
9246,22839,22820,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Rye bread,"",,,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,31,Spearman,0.335,,,>= 0.05,No,,,,Meija 2015
9254,22839,22821,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Rye bread,"",,,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,31,Spearman,0.293,,,>= 0.05,No,,,,Meija 2015
9262,22839,22819,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Rye bread,"",,,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,31,Spearman,0.26,,,>= 0.05,No,,,,Meija 2015
9213,22840,22818,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Fibre from Bread,"",,,,,g/day,,day 4,"Plasma, fasting",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,82.54,nmol/L,,31,Spearman,0.361,,,>= 0.05,No,,,,Meija 2015
9221,22840,22823,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,31,Spearman,0.305,,,>= 0.05,No,,,,Meija 2015
9229,22840,22824,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,31,Spearman,0.135,,,>= 0.05,No,,,,Meija 2015
9237,22840,22822,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,31,Spearman,0.212,,,>= 0.05,No,,,,Meija 2015
9245,22840,22820,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,31,Spearman,0.267,,,>= 0.05,No,,,,Meija 2015
9253,22840,22821,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,31,Spearman,0.333,,,>= 0.05,No,,,,Meija 2015
9261,22840,22819,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,31,Spearman,0.29,,,>= 0.05,No,,,,Meija 2015
9215,22841,22818,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Fibre from Bread,"",,,,,g/day,,day 4,"Plasma, fasting",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,82.54,nmol/L,,31,Spearman,0.382,,,>= 0.05,No,,,,Meija 2015
9223,22841,22823,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,31,Spearman,0.101,,,>= 0.05,No,,,,Meija 2015
9231,22841,22824,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,31,Spearman,0.099,,,>= 0.05,No,,,,Meija 2015
9239,22841,22822,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,31,Spearman,0.062,,,>= 0.05,No,,,,Meija 2015
9247,22841,22820,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,31,Spearman,0.238,,,>= 0.05,No,,,,Meija 2015
9255,22841,22821,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,31,Spearman,0.268,,,>= 0.05,No,,,,Meija 2015
9263,22841,22819,Prostate cancer cases,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,31,Spearman,0.203,,,>= 0.05,No,,,,Meija 2015
9160,22816,22825,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Bread,"",,153.9,,,g/day,,day 4,"Plasma, fasting",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,62.93,nmol/L,,91,Spearman,0.115,,,>= 0.05,No,,,,Meija 2015
9168,22816,22830,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Bread,"",,153.9,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,91,Spearman,0.283,,,< 0.01,Yes,,,,Meija 2015
9176,22816,22831,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Bread,"",,153.9,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,91,Spearman,0.253,,,< 0.05,Yes,,,,Meija 2015
9184,22816,22829,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Bread,"",,153.9,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,91,Spearman,0.287,,,< 0.01,Yes,,,,Meija 2015
9192,22816,22827,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Bread,"",,153.9,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,91,Spearman,0.278,,,< 0.01,Yes,,,,Meija 2015
9200,22816,22828,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Bread,"",,153.9,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,91,Spearman,0.323,,,< 0.01,Yes,,,,Meija 2015
9208,22816,22826,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Bread,"",,153.9,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,91,Spearman,0.336,,,< 0.01,Yes,,,,Meija 2015
9162,22817,22825,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Rye bread,"",,104.6,,,g/day,,day 4,"Plasma, fasting",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,62.93,nmol/L,,91,Spearman,0.151,,,>= 0.05,No,,,,Meija 2015
9170,22817,22830,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Rye bread,"",,104.6,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,91,Spearman,0.231,,,>= 0.05,No,,,,Meija 2015
9178,22817,22831,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Rye bread,"",,104.6,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,91,Spearman,0.224,,,>= 0.05,No,,,,Meija 2015
9186,22817,22829,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Rye bread,"",,104.6,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,91,Spearman,0.282,,,< 0.05,Yes,,,,Meija 2015
9194,22817,22827,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Rye bread,"",,104.6,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,91,Spearman,0.247,,,< 0.05,Yes,,,,Meija 2015
9202,22817,22828,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Rye bread,"",,104.6,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,91,Spearman,0.27,,,< 0.05,Yes,,,,Meija 2015
9210,22817,22826,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Rye bread,"",,104.6,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,91,Spearman,0.285,,,< 0.05,Yes,,,,Meija 2015
9163,22833,22825,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Fibre from Bread,"",,,,,g/day,,day 4,"Plasma, fasting",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,62.93,nmol/L,,91,Spearman,0.153,,,>= 0.05,No,,,,Meija 2015
9171,22833,22830,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,91,Spearman,0.23,,,>= 0.05,No,,,,Meija 2015
9179,22833,22831,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,91,Spearman,0.225,,,>= 0.05,No,,,,Meija 2015
9187,22833,22829,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,91,Spearman,0.282,,,< 0.05,Yes,,,,Meija 2015
9195,22833,22827,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,91,Spearman,0.247,,,< 0.05,Yes,,,,Meija 2015
9203,22833,22828,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,91,Spearman,0.271,,,< 0.05,Yes,,,,Meija 2015
9211,22833,22826,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,91,Spearman,0.285,,,< 0.05,Yes,,,,Meija 2015
9161,22835,22825,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Fibre from Bread,"",,,,,g/day,,day 4,"Plasma, fasting",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,62.93,nmol/L,,91,Spearman,0.199,,,>= 0.05,No,,,,Meija 2015
9169,22835,22830,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,91,Spearman,0.35,,,< 0.01,Yes,,,,Meija 2015
9177,22835,22831,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,91,Spearman,0.336,,,< 0.01,Yes,,,,Meija 2015
9185,22835,22829,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,91,Spearman,0.374,,,< 0.01,Yes,,,,Meija 2015
9193,22835,22827,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,91,Spearman,0.302,,,< 0.01,Yes,,,,Meija 2015
9201,22835,22828,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,91,Spearman,0.35,,,< 0.01,Yes,,,,Meija 2015
9209,22835,22826,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (3-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,91,Spearman,0.36,,,< 0.01,Yes,,,,Meija 2015
9216,22844,22825,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Bread,"",,,,,g/day,,day 4,"Plasma, fasting",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,62.93,nmol/L,,91,Spearman,0.087,,,>= 0.05,No,,,,Meija 2015
9224,22844,22830,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Bread,"",,,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,91,Spearman,0.187,,,>= 0.05,No,,,,Meija 2015
9232,22844,22831,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Bread,"",,,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,91,Spearman,0.246,,,< 0.05,Yes,,,,Meija 2015
9240,22844,22829,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Bread,"",,,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,91,Spearman,0.209,,,>= 0.05,No,,,,Meija 2015
9248,22844,22827,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Bread,"",,,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,91,Spearman,0.18,,,>= 0.05,No,,,,Meija 2015
9256,22844,22828,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Bread,"",,,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,91,Spearman,0.266,,,< 0.05,Yes,,,,Meija 2015
9264,22844,22826,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Bread,"",,,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,91,Spearman,0.253,,,< 0.05,Yes,,,,Meija 2015
9218,22845,22825,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Rye bread,"",,,,,g/day,,day 4,"Plasma, fasting",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,62.93,nmol/L,,91,Spearman,0.0,,,>= 0.05,No,,,,Meija 2015
9226,22845,22830,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Rye bread,"",,,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,91,Spearman,0.26,,,>= 0.05,No,,,,Meija 2015
9234,22845,22831,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Rye bread,"",,,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,91,Spearman,0.187,,,>= 0.05,No,,,,Meija 2015
9242,22845,22829,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Rye bread,"",,,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,91,Spearman,0.236,,,>= 0.05,No,,,,Meija 2015
9250,22845,22827,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Rye bread,"",,,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,91,Spearman,0.213,,,>= 0.05,No,,,,Meija 2015
9258,22845,22828,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Rye bread,"",,,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,91,Spearman,0.203,,,>= 0.05,No,,,,Meija 2015
9266,22845,22826,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Rye bread,"",,,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,91,Spearman,0.241,,,>= 0.05,No,,,,Meija 2015
9217,22846,22825,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Fibre from Bread,"",,,,,g/day,,day 4,"Plasma, fasting",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,62.93,nmol/L,,91,Spearman,0.17,,,>= 0.05,No,,,,Meija 2015
9225,22846,22830,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,91,Spearman,0.33,,,< 0.01,Yes,,,,Meija 2015
9233,22846,22831,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,91,Spearman,0.43,,,< 0.01,Yes,,,,Meija 2015
9241,22846,22829,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,91,Spearman,0.385,,,< 0.01,Yes,,,,Meija 2015
9249,22846,22827,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,91,Spearman,0.207,,,>= 0.05,No,,,,Meija 2015
9257,22846,22828,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,91,Spearman,0.343,,,< 0.01,Yes,,,,Meija 2015
9265,22846,22826,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,91,Spearman,0.312,,,< 0.01,Yes,,,,Meija 2015
9219,22847,22825,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Fibre from Bread,"",,,,,g/day,,day 4,"Plasma, fasting",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,62.93,nmol/L,,91,Spearman,-0.031,,,>= 0.05,No,,,,Meija 2015
9227,22847,22830,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,91,Spearman,0.246,,,>= 0.05,No,,,,Meija 2015
9235,22847,22831,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,91,Spearman,0.199,,,>= 0.05,No,,,,Meija 2015
9243,22847,22829,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-Dihydroxybenzoic acid","",,,,umol/L,,91,Spearman,0.234,,,>= 0.05,No,,,,Meija 2015
9251,22847,22827,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 12-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,91,Spearman,0.158,,,>= 0.05,No,,,,Meija 2015
9259,22847,22828,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, overnight",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,91,Spearman,0.183,,,>= 0.05,No,,,,Meija 2015
9267,22847,22826,Controls,Cases and controls in a case-control study on prostate cancer,Latvia,,baseline: day 1,Dietary record (1-day),Fibre from Bread,"",,,,,g/day,,day 3,"Urine, 24-h",HPLC after enzymatic hydrolysis,"3,5-DHPPA","",,,,umol/L,,91,Spearman,0.199,,,>= 0.05,No,,,,Meija 2015
9268,22869,22913,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,Ascorbic acid,"",,0.968,,mg/dL,,103,Spearman,0.4,0.22,0.55, ,,,No,,Lassale 2016
9269,22869,22914,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,beta-Carotene,"",,40.01,,ug/dL,,103,Spearman,0.46,0.29,0.6, ,,,No,,Lassale 2016
9270,22870,22913,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fruits,"",,,207.6,,g/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,Ascorbic acid,"",,0.968,,mg/dL,,103,Spearman,0.48,0.32,0.62, ,,,No,,Lassale 2016
9271,22870,22914,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fruits,"",,,207.6,,g/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,beta-Carotene,"",,40.01,,ug/dL,,103,Spearman,0.35,0.17,0.51, ,,,No,,Lassale 2016
9272,22871,22913,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Vegetables,"",,,244.9,,g/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,Ascorbic acid,"",,0.968,,mg/dL,,103,Spearman,0.14,-0.05,0.33, ,,,No,,Lassale 2016
9273,22871,22914,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Vegetables,"",,,244.9,,g/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,beta-Carotene,"",,40.01,,ug/dL,,103,Spearman,0.38,0.21,0.54, ,,,No,,Lassale 2016
9274,22872,22937,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fish,Fatty fish,,,34.5,,g/day,,baseline; 3 weeks,"Plasma, fasting",GC,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,mg/dL,,103,Spearman,0.4,0.22,0.55, ,,,No,,Lassale 2016
9275,22872,22916,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fish,Fatty fish,,,34.5,,g/day,,baseline; 3 weeks,"Plasma, fasting",GC,EPA (cis-20:5n-3),"",,5.02,,mg/dL,,103,Spearman,0.34,0.16,0.5, ,,,No,,Lassale 2016
9276,22872,22918,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fish,Fatty fish,,,34.5,,g/day,,baseline; 3 weeks,"Plasma, fasting",GC,DHA (cis-22:6n-3),"",,8.52,,mg/dL,,103,Spearman,0.44,0.27,0.58, ,,,No,,Lassale 2016
9277,22873,22937,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fatty fish,"",,,19.9,,g/day,,baseline; 3 weeks,"Plasma, fasting",GC,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,mg/dL,,103,Spearman,0.35,0.17,0.51, ,,,No,,Lassale 2016
9278,22873,22916,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fatty fish,"",,,19.9,,g/day,,baseline; 3 weeks,"Plasma, fasting",GC,EPA (cis-20:5n-3),"",,5.02,,mg/dL,,103,Spearman,0.34,0.15,0.5, ,,,No,,Lassale 2016
9279,22873,22918,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fatty fish,"",,,19.9,,g/day,,baseline; 3 weeks,"Plasma, fasting",GC,DHA (cis-22:6n-3),"",,8.52,,mg/dL,,103,Spearman,0.35,0.17,0.51, ,,,No,,Lassale 2016
9319,22874,22913,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Vitamin C,"",,,127.2,,mg/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,Ascorbic acid,"",,0.968,,mg/dL,,103,Spearman,0.56,0.41,0.68, ,,,No,,Lassale 2016
9320,22875,22914,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),beta-Carotene,"",,,4175.6,,ug/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,beta-Carotene,"",,40.01,,ug/dL,,103,Spearman,0.47,0.31,0.61, ,,,No,,Lassale 2016
9321,22876,22915,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,1880.6,,mg/day,,baseline; 3 weeks,"Plasma, fasting",GC,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,18.13,,mg/dL,,103,Spearman,0.29,0.1,0.45, ,,,No,,Lassale 2016
9322,22877,22916,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),EPA (cis-20:5n-3),"",,,213.6,,mg/day,,baseline; 3 weeks,"Plasma, fasting",GC,EPA (cis-20:5n-3),"",,5.02,,mg/dL,,103,Spearman,0.4,0.22,0.55, ,,,No,,Lassale 2016
9323,22878,22918,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),DPA (cis-22:5n-3),"",,,124.5,,mg/day,,baseline; 3 weeks,"Plasma, fasting",GC,DHA (cis-22:6n-3),"",,8.52,,mg/dL,,103,Spearman,0.43,0.26,0.58, ,,,No,,Lassale 2016
9295,22891,22925,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,Ascorbic acid,"",,0.943,,mg/dL,,103,Spearman,0.41,0.23,0.56, ,,Energy by residual method,Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9296,22891,22926,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,beta-Carotene,"",,40.92,,ug/dL,,103,Spearman,0.35,0.16,0.52, ,,"Energy by residual method, Cholesterol",Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9297,22892,22925,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fruits,"",,,205.1,,g/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,Ascorbic acid,"",,0.943,,mg/dL,,103,Spearman,0.49,0.32,0.63, ,,Energy by residual method,Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9298,22892,22926,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fruits,"",,,205.1,,g/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,beta-Carotene,"",,40.92,,ug/dL,,103,Spearman,0.29,0.1,0.47, ,,"Energy by residual method, Cholesterol",Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9299,22893,22925,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Vegetables,"",,,247.0,,g/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,Ascorbic acid,"",,0.943,,mg/dL,,103,Spearman,0.2,0.0,0.39, ,,Energy by residual method,Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9300,22893,22926,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Vegetables,"",,,247.0,,g/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,beta-Carotene,"",,40.92,,ug/dL,,103,Spearman,0.29,0.1,0.47, ,,"Energy by residual method, Cholesterol",Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9301,22894,22939,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fish,Fatty fish,,,32.7,,g/day,,baseline; 3 weeks,"Plasma, fasting",GC,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,mg/dL,,103,Spearman,0.51,0.35,0.64, ,,Energy by residual method,Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9302,22894,22928,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fish,Fatty fish,,,32.7,,g/day,,baseline; 3 weeks,"Plasma, fasting",GC,EPA (cis-20:5n-3),"",,4.9,,mg/dL,,103,Spearman,0.4,0.22,0.56, ,,Energy by residual method,Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9303,22894,22930,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fish,Fatty fish,,,32.7,,g/day,,baseline; 3 weeks,"Plasma, fasting",GC,DHA (cis-22:6n-3),"",,8.17,,mg/dL,,103,Spearman,0.55,0.39,0.67, ,,Energy by residual method,Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9304,22895,22939,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fatty fish,"",,,20.1,,g/day,,baseline; 3 weeks,"Plasma, fasting",GC,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,mg/dL,,103,Spearman,0.39,0.2,0.54, ,,Energy by residual method,Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9305,22895,22928,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fatty fish,"",,,20.1,,g/day,,baseline; 3 weeks,"Plasma, fasting",GC,EPA (cis-20:5n-3),"",,4.9,,mg/dL,,103,Spearman,0.43,0.25,0.58, ,,Energy by residual method,Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9306,22895,22930,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fatty fish,"",,,20.1,,g/day,,baseline; 3 weeks,"Plasma, fasting",GC,DHA (cis-22:6n-3),"",,8.17,,mg/dL,,103,Spearman,0.47,0.29,0.61, ,,Energy by residual method,Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9329,22896,22925,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Vitamin C,"",,,123.1,,mg/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,Ascorbic acid,"",,0.943,,mg/dL,,103,Spearman,0.58,0.43,0.7, ,,Energy by residual method,Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9330,22897,22926,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),beta-Carotene,"",,,4133.5,,ug/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,beta-Carotene,"",,40.92,,ug/dL,,103,Spearman,0.38,0.2,0.54, ,,"Energy by residual method, Cholesterol",Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9331,22898,22927,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,1883.0,,mg/day,,baseline; 3 weeks,"Plasma, fasting",GC,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,17.87,,mg/dL,,103,Spearman,0.23,0.04,0.41, ,,Energy by residual method,Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9332,22899,22928,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),EPA (cis-20:5n-3),"",,,129.4,,mg/day,,baseline; 3 weeks,"Plasma, fasting",GC,EPA (cis-20:5n-3),"",,4.9,,mg/dL,,103,Spearman,0.36,0.18,0.52, ,,Energy by residual method,Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9333,22900,22930,Males,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),DPA (cis-22:5n-3),"",,,68.8,,mg/day,,baseline; 3 weeks,"Plasma, fasting",GC,DHA (cis-22:6n-3),"",,8.17,,mg/dL,,103,Spearman,0.45,0.27,0.59, ,,Energy by residual method,Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9283,22880,22919,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,Ascorbic acid,"",,1.107,,mg/dL,,95,Spearman,0.27,0.07,0.44, ,,,No,,Lassale 2016
9284,22880,22920,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,beta-Carotene,"",,45.16,,ug/dL,,95,Spearman,0.37,0.19,0.54, ,,,No,,Lassale 2016
9285,22881,22919,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fruits,"",,,185.8,,g/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,Ascorbic acid,"",,1.107,,mg/dL,,95,Spearman,0.32,0.12,0.49, ,,,No,,Lassale 2016
9286,22881,22920,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fruits,"",,,185.8,,g/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,beta-Carotene,"",,45.16,,ug/dL,,95,Spearman,0.41,0.22,0.56, ,,,No,,Lassale 2016
9287,22882,22919,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Vegetables,"",,,228.8,,g/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,Ascorbic acid,"",,1.107,,mg/dL,,95,Spearman,0.09,-0.11,0.29, ,,,No,,Lassale 2016
9288,22882,22920,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Vegetables,"",,,228.8,,g/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,beta-Carotene,"",,45.16,,ug/dL,,95,Spearman,0.24,0.04,0.42, ,,,No,,Lassale 2016
9289,22883,22938,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fish,Fatty fish,,,38.9,,g/day,,baseline; 3 weeks,"Plasma, fasting",GC,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,mg/dL,,95,Spearman,0.38,0.2,0.54, ,,,No,,Lassale 2016
9290,22883,22922,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fish,Fatty fish,,,38.9,,g/day,,baseline; 3 weeks,"Plasma, fasting",GC,EPA (cis-20:5n-3),"",,5.54,,mg/dL,,95,Spearman,0.33,0.14,0.5, ,,,No,,Lassale 2016
9291,22883,22924,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fish,Fatty fish,,,38.9,,g/day,,baseline; 3 weeks,"Plasma, fasting",GC,DHA (cis-22:6n-3),"",,10.23,,mg/dL,,95,Spearman,0.4,0.22,0.56, ,,,No,,Lassale 2016
9292,22884,22938,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fatty fish,"",,,17.1,,g/day,,baseline; 3 weeks,"Plasma, fasting",GC,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,mg/dL,,95,Spearman,0.17,-0.03,0.36, ,,,No,,Lassale 2016
9293,22884,22922,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fatty fish,"",,,17.1,,g/day,,baseline; 3 weeks,"Plasma, fasting",GC,EPA (cis-20:5n-3),"",,5.54,,mg/dL,,95,Spearman,0.11,-0.09,0.31, ,,,No,,Lassale 2016
9294,22884,22924,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fatty fish,"",,,17.1,,g/day,,baseline; 3 weeks,"Plasma, fasting",GC,DHA (cis-22:6n-3),"",,10.23,,mg/dL,,95,Spearman,0.22,0.02,0.41, ,,,No,,Lassale 2016
9324,22885,22919,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Vitamin C,"",,,111.8,,mg/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,Ascorbic acid,"",,1.107,,mg/dL,,95,Spearman,0.32,0.12,0.49, ,,,No,,Lassale 2016
9325,22886,22920,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),beta-Carotene,"",,,3562.5,,ug/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,beta-Carotene,"",,45.16,,ug/dL,,95,Spearman,0.37,0.18,0.53, ,,,No,,Lassale 2016
9326,22887,22921,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,1514.9,,mg/day,,baseline; 3 weeks,"Plasma, fasting",GC,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,20.17,,mg/dL,,95,Spearman,0.35,0.15,0.51, ,,,No,,Lassale 2016
9327,22888,22922,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),EPA (cis-20:5n-3),"",,,176.5,,mg/day,,baseline; 3 weeks,"Plasma, fasting",GC,EPA (cis-20:5n-3),"",,5.54,,mg/dL,,95,Spearman,0.41,0.23,0.56, ,,,No,,Lassale 2016
9328,22890,22924,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),DHA (cis-22:6n-3),"",,,242.9,,mg/day,,baseline; 3 weeks,"Plasma, fasting",GC,DHA (cis-22:6n-3),"",,10.23,,mg/dL,,95,Spearman,0.42,0.24,0.57, ,,,No,,Lassale 2016
9307,22902,22931,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,Ascorbic acid,"",,1.088,,mg/dL,,95,Spearman,0.25,0.05,0.44, ,,Energy by residual method,Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9308,22902,22932,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fruits + Vegetables,Fruits + Vegetables,,,,,g/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,beta-Carotene,"",,46.02,,ug/dL,,95,Spearman,0.41,0.22,0.57, ,,"Energy by residual method, Cholesterol",Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9309,22903,22931,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fruits,"",,,192.5,,g/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,Ascorbic acid,"",,1.088,,mg/dL,,95,Spearman,0.28,0.07,0.46, ,,Energy by residual method,Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9310,22903,22932,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fruits,"",,,192.5,,g/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,beta-Carotene,"",,46.02,,ug/dL,,95,Spearman,0.36,0.17,0.53, ,,Energy by residual method,Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9311,22904,22931,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Vegetables,"",,,235.1,,g/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,Ascorbic acid,"",,1.088,,mg/dL,,95,Spearman,0.13,-0.08,0.33, ,,Energy by residual method,Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9312,22904,22932,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Vegetables,"",,,235.1,,g/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,beta-Carotene,"",,46.02,,ug/dL,,95,Spearman,0.37,0.17,0.53, ,,"Energy by residual method, Cholesterol",Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9313,22905,22940,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fish,Fatty fish,,,36.0,,g/day,,baseline; 3 weeks,"Plasma, fasting",GC,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,mg/dL,,95,Spearman,0.54,0.37,0.67, ,,Energy by residual method,Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9314,22905,22934,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fish,Fatty fish,,,36.0,,g/day,,baseline; 3 weeks,"Plasma, fasting",GC,EPA (cis-20:5n-3),"",,5.44,,mg/dL,,95,Spearman,0.49,0.31,0.63, ,,Energy by residual method,Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9315,22905,22936,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fish,Fatty fish,,,36.0,,g/day,,baseline; 3 weeks,"Plasma, fasting",GC,DHA (cis-22:6n-3),"",,10.0,,mg/dL,,95,Spearman,0.52,0.35,0.65, ,,Energy by residual method,Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9316,22906,22940,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fatty fish,"",,,15.7,,g/day,,baseline; 3 weeks,"Plasma, fasting",GC,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3),,,,mg/dL,,95,Spearman,0.31,0.11,0.49, ,,Energy by residual method,Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9317,22906,22934,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fatty fish,"",,,15.7,,g/day,,baseline; 3 weeks,"Plasma, fasting",GC,EPA (cis-20:5n-3),"",,5.44,,mg/dL,,95,Spearman,0.27,0.07,0.45, ,,Energy by residual method,Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9318,22906,22936,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Fatty fish,"",,,15.7,,g/day,,baseline; 3 weeks,"Plasma, fasting",GC,DHA (cis-22:6n-3),"",,10.0,,mg/dL,,95,Spearman,0.33,0.13,0.51, ,,Energy by residual method,Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9334,22907,22931,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),Vitamin C,"",,,111.6,,mg/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,Ascorbic acid,"",,1.088,,mg/dL,,95,Spearman,0.32,0.12,0.5, ,,Energy by residual method,Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9335,22908,22932,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),beta-Carotene,"",,,3523.2,,ug/day,,baseline; 3 weeks,"Plasma, fasting",HPLC,beta-Carotene,"",,46.02,,ug/dL,,95,Spearman,0.37,0.17,0.53, ,,"Energy by residual method, Cholesterol",Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9336,22909,22933,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,1449.0,,mg/day,,baseline; 3 weeks,"Plasma, fasting",GC,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,20.06,,mg/dL,,95,Spearman,0.36,0.17,0.53, ,,Energy by residual method,Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9337,22910,22934,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),EPA (cis-20:5n-3),"",,,136.9,,mg/day,,baseline; 3 weeks,"Plasma, fasting",GC,EPA (cis-20:5n-3),"",,5.44,,mg/dL,,95,Spearman,0.38,0.18,0.54, ,,Energy by residual method,Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9338,22912,22936,Females,Participants in a web-based cohort study,France,NutriNet-Santé,,Dietary record (1-day),DHA (cis-22:6n-3),"",,,213.7,,mg/day,,baseline; 3 weeks,"Plasma, fasting",GC,DHA (cis-22:6n-3),"",,10.0,,mg/dL,,95,Spearman,0.35,0.16,0.52, ,,Energy by residual method,Yes,"Age, BMI, Education, Tobbaco, Alcohol, Supplements",Lassale 2016
9339,22947,22977,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0),,,,35.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0),47.2,,,percentRoot,,279,Spearman,-0.07,,,> 0.05,No,,,,Warensjo Lemming 2015
9343,22948,22983,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9),,,,34.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9),13.5,,,percentRoot,,279,Spearman,-0.11,,,> 0.05,No,,,,Warensjo Lemming 2015
9346,22949,22986,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,14.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),39.3,,,percentRoot,,279,Spearman,0.12,,,<= 0.05,Yes,,,,Warensjo Lemming 2015
9405,22950,22978,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,Fats from Dairy foods,,,,6.7,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Myristic acid (14:0),"",0.41,,,percentRoot,,279,Spearman,0.07,,,> 0.05,No,Energy by residual method,,,Warensjo Lemming 2015
9406,22950,22978,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,Fats from Dairy foods,,,,6.7,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Myristic acid (14:0),"",0.41,,,percentRoot,,279,Spearman,0.02,,,> 0.05,No,Energy by residual method,,"Age, BMI, Smoking habits, Physical activity, Alcohol intake",Warensjo Lemming 2015
9407,22950,22979,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,Fats from Dairy foods,,,,6.7,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Pentadecylic acid (15:0),"",0.26,,,percentRoot,,279,Spearman,0.32,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9408,22950,22979,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,Fats from Dairy foods,,,,6.7,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Pentadecylic acid (15:0),"",0.26,,,percentRoot,,279,Spearman,0.09,,,> 0.05,No,Energy by residual method,,"Age, BMI, Smoking habits, Physical activity, Alcohol intake",Warensjo Lemming 2015
9409,22950,22981,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,Fats from Dairy foods,,,,6.7,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Margaric acid (17:0),"",0.43,,,percentRoot,,279,Spearman,0.16,,,<= 0.01,Yes,Energy by residual method,,,Warensjo Lemming 2015
9410,22950,22981,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,Fats from Dairy foods,,,,6.7,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Margaric acid (17:0),"",0.43,,,percentRoot,,279,Spearman,0.1,,,> 0.05,No,Energy by residual method,,"Age, BMI, Smoking habits, Physical activity, Alcohol intake",Warensjo Lemming 2015
9450,22951,22992,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Fish,Fats from Fish,,,,4.3,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),6.8,,,percentRoot,,279,Spearman,0.34,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9451,22951,22994,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Fish,Fats from Fish,,,,4.3,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,EPA (cis-20:5n-3),"",1.7,,,percentRoot,,279,Spearman,0.26,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9452,22951,22996,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Fish,Fats from Fish,,,,4.3,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,DHA (cis-22:6n-3),"",3.9,,,percentRoot,,279,Spearman,0.38,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9441,22952,22992,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fish and shellfish,"",,,,44.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),6.8,,,percentRoot,,279,Spearman,0.35,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9442,22952,22994,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fish and shellfish,"",,,,44.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,EPA (cis-20:5n-3),"",1.7,,,percentRoot,,279,Spearman,0.31,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9443,22952,22996,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fish and shellfish,"",,,,44.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,DHA (cis-22:6n-3),"",3.9,,,percentRoot,,279,Spearman,0.36,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9387,22953,22978,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Dairy foods,"",,,,319.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Myristic acid (14:0),"",0.41,,,percentRoot,,279,Spearman,0.15,,,<= 0.01,Yes,Energy by residual method,,,Warensjo Lemming 2015
9388,22953,22978,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Dairy foods,"",,,,319.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Myristic acid (14:0),"",0.41,,,percentRoot,,279,Spearman,0.12,,,> 0.05,No,Energy by residual method,,"Age, BMI, Smoking habits, Physical activity, Alcohol intake",Warensjo Lemming 2015
9389,22953,22979,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Dairy foods,"",,,,319.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Pentadecylic acid (15:0),"",0.26,,,percentRoot,,279,Spearman,0.25,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9390,22953,22979,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Dairy foods,"",,,,319.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Pentadecylic acid (15:0),"",0.26,,,percentRoot,,279,Spearman,0.22,,,<= 0.001,Yes,Energy by residual method,,"Age, BMI, Smoking habits, Physical activity, Alcohol intake",Warensjo Lemming 2015
9391,22953,22981,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Dairy foods,"",,,,319.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Margaric acid (17:0),"",0.43,,,percentRoot,,279,Spearman,0.08,,,> 0.05,No,Energy by residual method,,,Warensjo Lemming 2015
9392,22953,22981,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Dairy foods,"",,,,319.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Margaric acid (17:0),"",0.43,,,percentRoot,,279,Spearman,0.11,,,> 0.05,No,Energy by residual method,,"Age, BMI, Smoking habits, Physical activity, Alcohol intake",Warensjo Lemming 2015
9340,23040,22978,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Myristic acid (14:0),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Myristic acid (14:0),"",0.41,,,percentRoot,,279,Spearman,0.16,,,<= 0.01,Yes,,,,Warensjo Lemming 2015
9341,23041,22980,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Palmitic acid (16:0),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Palmitic acid (16:0),"",31.3,,,percentRoot,,279,Spearman,-0.02,,,> 0.05,No,,,,Warensjo Lemming 2015
9342,23042,22982,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Stearic acid (18:0),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Stearic acid (18:0),"",14.8,,,percentRoot,,279,Spearman,-0.03,,,> 0.05,No,,,,Warensjo Lemming 2015
9344,23043,22984,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Palmitoleic acid (cis-16:1n-7),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Palmitoleic acid (cis-16:1n-7),"",0.5,,,percentRoot,,279,Spearman,-0.03,,,> 0.05,No,,,,Warensjo Lemming 2015
9345,23044,22985,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Oleic acid (cis-18:1n-9),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Oleic acid (cis-18:1n-9),"",13.0,,,percentRoot,,279,Spearman,-0.1,,,> 0.05,No,,,,Warensjo Lemming 2015
9347,23045,22987,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),32.5,,,percentRoot,,279,Spearman,0.1,,,> 0.05,No,,,,Warensjo Lemming 2015
9348,23046,22988,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Linoleic acid (LA; cis-18:2n-6),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",21.3,,,percentRoot,,279,Spearman,0.07,,,> 0.05,No,,,,Warensjo Lemming 2015
9349,23047,22991,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Arachidonic acid (AA; cis-20:4n-6),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",8.3,,,percentRoot,,279,Spearman,0.07,,,> 0.05,No,,,,Warensjo Lemming 2015
9350,23048,22992,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),6.8,,,percentRoot,,279,Spearman,0.31,,,<= 0.001,Yes,,,,Warensjo Lemming 2015
9351,23049,22993,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.28,,,percentRoot,,279,Spearman,0.07,,,> 0.05,No,,,,Warensjo Lemming 2015
9352,23050,22994,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),EPA (cis-20:5n-3),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,EPA (cis-20:5n-3),"",1.7,,,percentRoot,,279,Spearman,0.34,,,<= 0.001,Yes,,,,Warensjo Lemming 2015
9353,23051,22995,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),DPA (cis-22:5n-3),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,DPA (cis-22:5n-3),"",0.93,,,percentRoot,,279,Spearman,0.05,,,> 0.05,No,,,,Warensjo Lemming 2015
9354,23052,22996,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),DHA (cis-22:6n-3),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,DHA (cis-22:6n-3),"",3.9,,,percentRoot,,279,Spearman,0.42,,,<= 0.001,Yes,,,,Warensjo Lemming 2015
9423,23079,22978,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Myristic acid (14:0),"",0.41,,,percentRoot,,279,Spearman,0.008,,,> 0.05,No,Energy by residual method,,,Warensjo Lemming 2015
9424,23079,22978,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Myristic acid (14:0),"",0.41,,,percentRoot,,279,Spearman,0.02,,,> 0.05,No,Energy by residual method,,"Age, BMI, Smoking habits, Physical activity, Alcohol intake",Warensjo Lemming 2015
9425,23079,22979,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Pentadecylic acid (15:0),"",0.26,,,percentRoot,,279,Spearman,0.31,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9426,23079,22979,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Pentadecylic acid (15:0),"",0.26,,,percentRoot,,279,Spearman,0.1,,,> 0.05,No,Energy by residual method,,"Age, BMI, Smoking habits, Physical activity, Alcohol intake",Warensjo Lemming 2015
9427,23079,22981,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Margaric acid (17:0),"",0.43,,,percentRoot,,279,Spearman,0.16,,,<= 0.01,Yes,Energy by residual method,,,Warensjo Lemming 2015
9428,23079,22981,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Margaric acid (17:0),"",0.43,,,percentRoot,,279,Spearman,0.11,,,> 0.05,No,Energy by residual method,,"Age, BMI, Smoking habits, Physical activity, Alcohol intake",Warensjo Lemming 2015
9459,23082,22992,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Fish,"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),6.8,,,percentRoot,,279,Spearman,0.33,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9460,23082,22994,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Fish,"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,EPA (cis-20:5n-3),"",1.7,,,percentRoot,,279,Spearman,0.25,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9461,23082,22996,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Fish,"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,DHA (cis-22:6n-3),"",3.9,,,percentRoot,,279,Spearman,0.37,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9468,23085,22992,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Food Frequency Questionnaire (FFQ),Fish,"",,,,,g/week,,,"Plasma (phospholipids), non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),6.8,,,percentRoot,,279,Spearman,0.45,,,<= 0.001,Yes,,,,Warensjo Lemming 2015
9469,23085,22994,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Food Frequency Questionnaire (FFQ),Fish,"",,,,,g/week,,,"Plasma (phospholipids), non-fasting",GC-FID,EPA (cis-20:5n-3),"",1.7,,,percentRoot,,279,Spearman,0.41,,,<= 0.001,Yes,,,,Warensjo Lemming 2015
9470,23085,22996,All [by gender],Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Food Frequency Questionnaire (FFQ),Fish,"",,,,,g/week,,,"Plasma (phospholipids), non-fasting",GC-FID,DHA (cis-22:6n-3),"",3.9,,,percentRoot,,279,Spearman,0.44,,,<= 0.001,Yes,,,,Warensjo Lemming 2015
9355,22957,22998,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0),,,,35.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0),47.1,,,percentRoot,,150,Spearman,-0.08,,,> 0.05,No,,,,Warensjo Lemming 2015
9359,22958,23004,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9),,,,34.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9),13.5,,,percentRoot,,150,Spearman,-0.04,,,> 0.05,No,,,,Warensjo Lemming 2015
9362,22959,23007,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,14.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),39.4,,,percentRoot,,150,Spearman,0.17,,,<= 0.05,Yes,,,,Warensjo Lemming 2015
9411,22960,22999,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,Fats from Dairy foods,,,,6.9,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Myristic acid (14:0),"",0.43,,,percentRoot,,150,Spearman,-0.006,,,> 0.05,No,Energy by residual method,,,Warensjo Lemming 2015
9412,22960,22999,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,Fats from Dairy foods,,,,6.9,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Myristic acid (14:0),"",0.43,,,percentRoot,,150,Spearman,0.03,,,> 0.05,No,Energy by residual method,,"Age, BMI, Smoking habits, Physical activity, Alcohol intake",Warensjo Lemming 2015
9413,22960,23000,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,Fats from Dairy foods,,,,6.9,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Pentadecylic acid (15:0),"",0.27,,,percentRoot,,150,Spearman,0.2,,,<= 0.01,Yes,Energy by residual method,,,Warensjo Lemming 2015
9414,22960,23000,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,Fats from Dairy foods,,,,6.9,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Pentadecylic acid (15:0),"",0.27,,,percentRoot,,150,Spearman,0.07,,,> 0.05,No,Energy by residual method,,"Age, BMI, Smoking habits, Physical activity, Alcohol intake",Warensjo Lemming 2015
9415,22960,23002,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,Fats from Dairy foods,,,,6.9,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Margaric acid (17:0),"",0.43,,,percentRoot,,150,Spearman,0.17,,,<= 0.05,Yes,Energy by residual method,,,Warensjo Lemming 2015
9416,22960,23002,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,Fats from Dairy foods,,,,6.9,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Margaric acid (17:0),"",0.43,,,percentRoot,,150,Spearman,0.2,,,<= 0.05,Yes,Energy by residual method,,"Age, BMI, Smoking habits, Physical activity, Alcohol intake",Warensjo Lemming 2015
9453,22961,23013,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Fish,Fats from Fish,,,,4.3,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),6.7,,,percentRoot,,150,Spearman,0.39,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9454,22961,23015,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Fish,Fats from Fish,,,,4.3,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,EPA (cis-20:5n-3),"",1.7,,,percentRoot,,150,Spearman,0.34,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9455,22961,23017,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Fish,Fats from Fish,,,,4.3,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,DHA (cis-22:6n-3),"",3.9,,,percentRoot,,150,Spearman,0.42,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9444,22962,23013,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fish and shellfish,"",,,,43.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),6.7,,,percentRoot,,150,Spearman,0.36,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9445,22962,23015,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fish and shellfish,"",,,,43.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,EPA (cis-20:5n-3),"",1.7,,,percentRoot,,150,Spearman,0.33,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9446,22962,23017,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fish and shellfish,"",,,,43.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,DHA (cis-22:6n-3),"",3.9,,,percentRoot,,150,Spearman,0.36,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9393,22963,22999,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Dairy foods,"",,,,346.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Myristic acid (14:0),"",0.43,,,percentRoot,,150,Spearman,0.08,,,> 0.05,No,Energy by residual method,,,Warensjo Lemming 2015
9394,22963,22999,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Dairy foods,"",,,,346.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Myristic acid (14:0),"",0.43,,,percentRoot,,150,Spearman,0.1,,,> 0.05,No,Energy by residual method,,"Age, BMI, Smoking habits, Physical activity, Alcohol intake",Warensjo Lemming 2015
9395,22963,23000,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Dairy foods,"",,,,346.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Pentadecylic acid (15:0),"",0.27,,,percentRoot,,150,Spearman,0.1,,,> 0.05,No,Energy by residual method,,,Warensjo Lemming 2015
9396,22963,23000,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Dairy foods,"",,,,346.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Pentadecylic acid (15:0),"",0.27,,,percentRoot,,150,Spearman,0.24,,,<= 0.05,Yes,Energy by residual method,,"Age, BMI, Smoking habits, Physical activity, Alcohol intake",Warensjo Lemming 2015
9397,22963,23002,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Dairy foods,"",,,,346.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Margaric acid (17:0),"",0.43,,,percentRoot,,150,Spearman,0.1,,,> 0.05,No,Energy by residual method,,,Warensjo Lemming 2015
9398,22963,23002,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Dairy foods,"",,,,346.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Margaric acid (17:0),"",0.43,,,percentRoot,,150,Spearman,0.21,,,<= 0.01,Yes,Energy by residual method,,"Age, BMI, Smoking habits, Physical activity, Alcohol intake",Warensjo Lemming 2015
9356,23053,22999,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Myristic acid (14:0),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Myristic acid (14:0),"",0.43,,,percentRoot,,150,Spearman,0.1,,,> 0.05,No,,,,Warensjo Lemming 2015
9357,23054,23001,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Palmitic acid (16:0),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Palmitic acid (16:0),"",31.2,,,percentRoot,,150,Spearman,-0.07,,,> 0.05,No,,,,Warensjo Lemming 2015
9358,23055,23003,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Stearic acid (18:0),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Stearic acid (18:0),"",14.8,,,percentRoot,,150,Spearman,0.04,,,> 0.05,No,,,,Warensjo Lemming 2015
9360,23056,23005,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Palmitoleic acid (cis-16:1n-7),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Palmitoleic acid (cis-16:1n-7),"",0.53,,,percentRoot,,150,Spearman,0.1,,,> 0.05,No,,,,Warensjo Lemming 2015
9361,23057,23006,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Oleic acid (cis-18:1n-9),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Oleic acid (cis-18:1n-9),"",12.9,,,percentRoot,,150,Spearman,-0.04,,,> 0.05,No,,,,Warensjo Lemming 2015
9363,23058,23008,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),32.6,,,percentRoot,,150,Spearman,0.08,,,> 0.05,No,,,,Warensjo Lemming 2015
9364,23059,23009,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Linoleic acid (LA; cis-18:2n-6),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",21.6,,,percentRoot,,150,Spearman,0.15,,,> 0.05,No,,,,Warensjo Lemming 2015
9365,23060,23012,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Arachidonic acid (AA; cis-20:4n-6),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",8.2,,,percentRoot,,150,Spearman,0.1,,,> 0.05,No,,,,Warensjo Lemming 2015
9366,23061,23013,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),6.7,,,percentRoot,,150,Spearman,0.33,,,<= 0.001,Yes,,,,Warensjo Lemming 2015
9367,23062,23014,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.29,,,percentRoot,,150,Spearman,0.09,,,> 0.05,No,,,,Warensjo Lemming 2015
9368,23063,23015,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),EPA (cis-20:5n-3),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,EPA (cis-20:5n-3),"",1.7,,,percentRoot,,150,Spearman,0.36,,,<= 0.001,Yes,,,,Warensjo Lemming 2015
9369,23064,23016,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),DPA (cis-22:5n-3),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,DPA (cis-22:5n-3),"",0.91,,,percentRoot,,150,Spearman,0.06,,,> 0.05,No,,,,Warensjo Lemming 2015
9370,23065,23017,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),DHA (cis-22:6n-3),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,DHA (cis-22:6n-3),"",3.9,,,percentRoot,,150,Spearman,0.44,,,<= 0.001,Yes,,,,Warensjo Lemming 2015
9429,23080,22999,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Myristic acid (14:0),"",0.43,,,percentRoot,,150,Spearman,-0.007,,,> 0.05,No,Energy by residual method,,,Warensjo Lemming 2015
9430,23080,22999,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Myristic acid (14:0),"",0.43,,,percentRoot,,150,Spearman,0.03,,,> 0.05,No,Energy by residual method,,"Age, BMI, Smoking habits, Physical activity, Alcohol intake",Warensjo Lemming 2015
9431,23080,23000,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Pentadecylic acid (15:0),"",0.27,,,percentRoot,,150,Spearman,0.18,,,<= 0.05,Yes,Energy by residual method,,,Warensjo Lemming 2015
9432,23080,23000,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Pentadecylic acid (15:0),"",0.27,,,percentRoot,,150,Spearman,0.06,,,> 0.05,No,Energy by residual method,,"Age, BMI, Smoking habits, Physical activity, Alcohol intake",Warensjo Lemming 2015
9433,23080,23002,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Margaric acid (17:0),"",0.43,,,percentRoot,,150,Spearman,0.16,,,<= 0.05,Yes,Energy by residual method,,,Warensjo Lemming 2015
9434,23080,23002,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Margaric acid (17:0),"",0.43,,,percentRoot,,150,Spearman,0.19,,,<= 0.05,Yes,Energy by residual method,,"Age, BMI, Smoking habits, Physical activity, Alcohol intake",Warensjo Lemming 2015
9462,23083,23013,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Fish,"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),6.7,,,percentRoot,,150,Spearman,0.38,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9463,23083,23015,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Fish,"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,EPA (cis-20:5n-3),"",1.7,,,percentRoot,,150,Spearman,0.32,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9464,23083,23017,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Fish,"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,DHA (cis-22:6n-3),"",3.9,,,percentRoot,,150,Spearman,0.42,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9471,23086,23013,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Food Frequency Questionnaire (FFQ),Fish,"",,,,,g/week,,,"Plasma (phospholipids), non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),6.7,,,percentRoot,,150,Spearman,0.5,,,<= 0.001,Yes,,,,Warensjo Lemming 2015
9472,23086,23015,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Food Frequency Questionnaire (FFQ),Fish,"",,,,,g/week,,,"Plasma (phospholipids), non-fasting",GC-FID,EPA (cis-20:5n-3),"",1.7,,,percentRoot,,150,Spearman,0.47,,,<= 0.001,Yes,,,,Warensjo Lemming 2015
9473,23086,23017,Females,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Food Frequency Questionnaire (FFQ),Fish,"",,,,,g/week,,,"Plasma (phospholipids), non-fasting",GC-FID,DHA (cis-22:6n-3),"",3.9,,,percentRoot,,150,Spearman,0.47,,,<= 0.001,Yes,,,,Warensjo Lemming 2015
9371,22967,23019,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0),,,,35.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0),47.3,,,percentRoot,,129,Spearman,-0.07,,,> 0.05,No,,,,Warensjo Lemming 2015
9375,22968,23025,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9),,,,34.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9),13.5,,,percentRoot,,129,Spearman,-0.21,,,<= 0.05,Yes,,,,Warensjo Lemming 2015
9378,22969,23028,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,14.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),39.2,,,percentRoot,,129,Spearman,0.07,,,> 0.05,No,,,,Warensjo Lemming 2015
9417,22970,23020,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,Fats from Dairy foods,,,,6.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Myristic acid (14:0),"",0.4,,,percentRoot,,129,Spearman,0.12,,,> 0.05,No,Energy by residual method,,,Warensjo Lemming 2015
9418,22970,23020,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,Fats from Dairy foods,,,,6.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Myristic acid (14:0),"",0.4,,,percentRoot,,129,Spearman,0.03,,,> 0.05,No,Energy by residual method,,"Age, BMI, Smoking habits, Physical activity, Alcohol intake",Warensjo Lemming 2015
9419,22970,23021,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,Fats from Dairy foods,,,,6.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Pentadecylic acid (15:0),"",0.26,,,percentRoot,,129,Spearman,0.43,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9420,22970,23021,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,Fats from Dairy foods,,,,6.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Pentadecylic acid (15:0),"",0.26,,,percentRoot,,129,Spearman,0.16,,,> 0.05,No,Energy by residual method,,"Age, BMI, Smoking habits, Physical activity, Alcohol intake",Warensjo Lemming 2015
9421,22970,23023,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,Fats from Dairy foods,,,,6.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Margaric acid (17:0),"",0.42,,,percentRoot,,129,Spearman,0.15,,,> 0.05,No,Energy by residual method,,,Warensjo Lemming 2015
9422,22970,23023,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,Fats from Dairy foods,,,,6.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Margaric acid (17:0),"",0.42,,,percentRoot,,129,Spearman,-0.04,,,> 0.05,,Energy by residual method,,"Age, BMI, Smoking habits, Physical activity, Alcohol intake",Warensjo Lemming 2015
9456,22971,23034,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Fish,Fats from Fish,,,,4.3,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),6.9,,,percentRoot,,129,Spearman,0.29,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9457,22971,23036,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Fish,Fats from Fish,,,,4.3,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,EPA (cis-20:5n-3),"",1.7,,,percentRoot,,129,Spearman,0.17,,,<= 0.05,Yes,Energy by residual method,,,Warensjo Lemming 2015
9458,22971,23038,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Fish,Fats from Fish,,,,4.3,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,DHA (cis-22:6n-3),"",3.9,,,percentRoot,,129,Spearman,0.34,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9447,22972,23034,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fish and shellfish,"",,,,47.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),6.9,,,percentRoot,,129,Spearman,0.35,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9448,22972,23036,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fish and shellfish,"",,,,47.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,EPA (cis-20:5n-3),"",1.7,,,percentRoot,,129,Spearman,0.29,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9449,22972,23038,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fish and shellfish,"",,,,47.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,DHA (cis-22:6n-3),"",3.9,,,percentRoot,,129,Spearman,0.34,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9399,22973,23020,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Dairy foods,"",,,,279.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Myristic acid (14:0),"",0.4,,,percentRoot,,129,Spearman,0.19,,,<= 0.05,Yes,Energy by residual method,,,Warensjo Lemming 2015
9400,22973,23020,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Dairy foods,"",,,,279.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Myristic acid (14:0),"",0.4,,,percentRoot,,129,Spearman,0.15,,,> 0.05,,Energy by residual method,,"Age, BMI, Smoking habits, Physical activity, Alcohol intake",Warensjo Lemming 2015
9401,22973,23021,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Dairy foods,"",,,,279.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Pentadecylic acid (15:0),"",0.26,,,percentRoot,,129,Spearman,0.36,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9402,22973,23021,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Dairy foods,"",,,,279.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Pentadecylic acid (15:0),"",0.26,,,percentRoot,,129,Spearman,0.19,,,<= 0.05,Yes,Energy by residual method,,"Age, BMI, Smoking habits, Physical activity, Alcohol intake",Warensjo Lemming 2015
9403,22973,23023,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Dairy foods,"",,,,279.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Margaric acid (17:0),"",0.42,,,percentRoot,,129,Spearman,0.05,,,> 0.05,,Energy by residual method,,,Warensjo Lemming 2015
9404,22973,23023,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Dairy foods,"",,,,279.0,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Margaric acid (17:0),"",0.42,,,percentRoot,,129,Spearman,-0.06,,,> 0.05,,Energy by residual method,,"Age, BMI, Smoking habits, Physical activity, Alcohol intake",Warensjo Lemming 2015
9372,23066,23020,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Myristic acid (14:0),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Myristic acid (14:0),"",0.4,,,percentRoot,,129,Spearman,0.21,,,<= 0.05,Yes,,,,Warensjo Lemming 2015
9373,23067,23022,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Palmitic acid (16:0),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Palmitic acid (16:0),"",31.4,,,percentRoot,,129,Spearman,0.05,,,> 0.05,,,,,Warensjo Lemming 2015
9374,23068,23024,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Stearic acid (18:0),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Stearic acid (18:0),"",14.8,,,percentRoot,,129,Spearman,-0.13,,,> 0.05,,,,,Warensjo Lemming 2015
9376,23069,23026,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Palmitoleic acid (cis-16:1n-7),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Palmitoleic acid (cis-16:1n-7),"",0.49,,,percentRoot,,129,Spearman,-0.1,,,> 0.05,,,,,Warensjo Lemming 2015
9377,23070,23027,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Oleic acid (cis-18:1n-9),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Oleic acid (cis-18:1n-9),"",13.2,,,percentRoot,,129,Spearman,-0.16,,,> 0.05,,,,,Warensjo Lemming 2015
9379,23071,23029,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),32.3,,,percentRoot,,129,Spearman,0.13,,,> 0.05,,,,,Warensjo Lemming 2015
9380,23072,23030,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Linoleic acid (LA; cis-18:2n-6),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",20.9,,,percentRoot,,129,Spearman,-0.03,,,> 0.05,,,,,Warensjo Lemming 2015
9381,23073,23033,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Arachidonic acid (AA; cis-20:4n-6),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",8.5,,,percentRoot,,129,Spearman,0.02,,,> 0.05,,,,,Warensjo Lemming 2015
9382,23074,23034,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),6.9,,,percentRoot,,129,Spearman,0.28,,,<= 0.001,Yes,,,,Warensjo Lemming 2015
9383,23075,23035,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),alpha-Linolenic acid (ALA; cis-18:3n-3),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",0.27,,,percentRoot,,129,Spearman,0.05,,,> 0.05,,,,,Warensjo Lemming 2015
9384,23076,23036,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),EPA (cis-20:5n-3),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,EPA (cis-20:5n-3),"",1.7,,,percentRoot,,129,Spearman,0.28,,,<= 0.001,Yes,,,,Warensjo Lemming 2015
9385,23077,23037,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),DPA (cis-22:5n-3),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,DPA (cis-22:5n-3),"",0.96,,,percentRoot,,129,Spearman,0.009,,,> 0.05,,,,,Warensjo Lemming 2015
9386,23078,23038,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),DHA (cis-22:6n-3),"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,DHA (cis-22:6n-3),"",3.9,,,percentRoot,,129,Spearman,0.39,,,<= 0.001,Yes,,,,Warensjo Lemming 2015
9435,23081,23020,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Myristic acid (14:0),"",0.4,,,percentRoot,,129,Spearman,0.13,,,> 0.05,,Energy by residual method,,,Warensjo Lemming 2015
9436,23081,23020,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Myristic acid (14:0),"",0.4,,,percentRoot,,129,Spearman,0.04,,,> 0.05,,Energy by residual method,,"Age, BMI, Smoking habits, Physical activity, Alcohol intake",Warensjo Lemming 2015
9437,23081,23021,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Pentadecylic acid (15:0),"",0.26,,,percentRoot,,129,Spearman,0.44,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9438,23081,23021,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Pentadecylic acid (15:0),"",0.26,,,percentRoot,,129,Spearman,0.18,,,<= 0.05,Yes,Energy by residual method,,"Age, BMI, Smoking habits, Physical activity, Alcohol intake",Warensjo Lemming 2015
9439,23081,23023,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Margaric acid (17:0),"",0.42,,,percentRoot,,129,Spearman,0.15,,,> 0.05,,Energy by residual method,,,Warensjo Lemming 2015
9440,23081,23023,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Dairy foods,"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,Margaric acid (17:0),"",0.42,,,percentRoot,,129,Spearman,-0.02,,,> 0.05,,Energy by residual method,,"Age, BMI, Smoking habits, Physical activity, Alcohol intake",Warensjo Lemming 2015
9465,23084,23034,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Fish,"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),6.9,,,percentRoot,,129,Spearman,0.29,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9466,23084,23036,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Fish,"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,EPA (cis-20:5n-3),"",1.7,,,percentRoot,,129,Spearman,0.17,,,<= 0.05,Yes,Energy by residual method,,,Warensjo Lemming 2015
9467,23084,23038,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Dietary record (4-day),Fats from Fish,"",,,,,g/10 MJ,Energy,,"Plasma (phospholipids), non-fasting",GC-FID,DHA (cis-22:6n-3),"",3.9,,,percentRoot,,129,Spearman,0.33,,,<= 0.001,Yes,Energy by residual method,,,Warensjo Lemming 2015
9474,23087,23034,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Food Frequency Questionnaire (FFQ),Fish,"",,,,,g/week,,,"Plasma (phospholipids), non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),6.9,,,percentRoot,,129,Spearman,0.38,,,<= 0.001,Yes,,,,Warensjo Lemming 2015
9475,23087,23036,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Food Frequency Questionnaire (FFQ),Fish,"",,,,,g/week,,,"Plasma (phospholipids), non-fasting",GC-FID,EPA (cis-20:5n-3),"",1.7,,,percentRoot,,129,Spearman,0.3,,,<= 0.001,Yes,,,,Warensjo Lemming 2015
9476,23087,23038,Males,Adults participant in a web-based national dietary survey,Sweden,Swedish National Dietary Survey,,Food Frequency Questionnaire (FFQ),Fish,"",,,,,g/week,,,"Plasma (phospholipids), non-fasting",GC-FID,DHA (cis-22:6n-3),"",3.9,,,percentRoot,,129,Spearman,0.4,,,<= 0.001,Yes,,,,Warensjo Lemming 2015
9479,23092,23089,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Dairy foods,Cheese + Milk,,1.5,,,servings/day,,,"Plasma (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",,,,percentRoot,,2837,Spearman,0.14,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
9480,23092,23090,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Dairy foods,Cheese + Milk,,1.5,,,servings/day,,,"Plasma (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",,,,percentRoot,,2837,Spearman,0.22,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
9481,23092,23091,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Dairy foods,Cheese + Milk,,1.5,,,servings/day,,,"Plasma (phospholipids), fasting",GC-FID,Palmitelaidic acid (trans-16:1n-7),"",,,,percentRoot,,2837,Spearman,0.07,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
9482,23093,23089,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Dairy foods,Cheese + Milk,,0.7,,,servings/day,,,"Plasma (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",,,,percentRoot,,2837,Spearman,0.09,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
9483,23093,23090,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Dairy foods,Cheese + Milk,,0.7,,,servings/day,,,"Plasma (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",,,,percentRoot,,2837,Spearman,0.16,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
9484,23093,23091,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Dairy foods,Cheese + Milk,,0.7,,,servings/day,,,"Plasma (phospholipids), fasting",GC-FID,Palmitelaidic acid (trans-16:1n-7),"",,,,percentRoot,,2837,Spearman,0.13,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
9485,23094,23089,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Dairy foods,Cheese + Milk,,0.8,,,servings/day,,,"Plasma (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",,,,percentRoot,,2837,Spearman,0.12,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
9486,23094,23090,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Dairy foods,Cheese + Milk,,0.8,,,servings/day,,,"Plasma (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",,,,percentRoot,,2837,Spearman,0.17,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
9487,23095,23089,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Cheese,"",,,,,servings/day,,,"Plasma (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",,,,percentRoot,,2837,Spearman,0.11,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
9488,23095,23090,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Cheese,"",,,,,servings/day,,,"Plasma (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",,,,percentRoot,,2837,Spearman,0.2,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
9489,23095,23091,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Cheese,"",,,,,servings/day,,,"Plasma (phospholipids), fasting",GC-FID,Palmitelaidic acid (trans-16:1n-7),"",,,,percentRoot,,2837,Spearman,0.15,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
9493,23096,23090,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Milk,"",,,,,servings/day,,,"Plasma (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",,,,percentRoot,,2837,Spearman,0.1,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
9490,23097,23089,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Cheese,"",,,,,servings/day,,,"Plasma (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",,,,percentRoot,,2837,Spearman,0.1,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
9491,23097,23090,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Cheese,"",,,,,servings/day,,,"Plasma (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",,,,percentRoot,,2837,Spearman,0.14,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
9492,23097,23091,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Cheese,"",,,,,servings/day,,,"Plasma (phospholipids), fasting",GC-FID,Palmitelaidic acid (trans-16:1n-7),"",,,,percentRoot,,2837,Spearman,0.09,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
9494,23098,23090,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Milk,"",,,,,servings/day,,,"Plasma (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",,,,percentRoot,,2837,Spearman,0.05,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
9495,23099,23089,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Milk,"",,,,,servings/day,,,"Plasma (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",,,,percentRoot,,2837,Spearman,0.07,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
9496,23099,23090,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Milk,"",,,,,servings/day,,,"Plasma (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",,,,percentRoot,,2837,Spearman,0.08,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
9497,23100,23089,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Butter,"",,0.1,,,servings/day,,,"Plasma (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",,,,percentRoot,,2837,Spearman,0.06,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
9498,23100,23090,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Butter,"",,0.1,,,servings/day,,,"Plasma (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",,,,percentRoot,,2837,Spearman,0.13,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
9499,23100,23091,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Butter,"",,0.1,,,servings/day,,,"Plasma (phospholipids), fasting",GC-FID,Palmitelaidic acid (trans-16:1n-7),"",,,,percentRoot,,2837,Spearman,0.13,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
9500,23101,23091,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Margarine,"",,0.2,,,servings/day,,,"Plasma (phospholipids), fasting",GC-FID,Palmitelaidic acid (trans-16:1n-7),"",,,,percentRoot,,2837,Spearman,0.19,,,< 0.05,Yes,,,,de Oliveira Otto 2013
9501,23102,23089,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Processed meat,"",,0.2,,,servings/day,,,"Plasma (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",,,,percentRoot,,2837,Spearman,-0.06,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
9502,23103,23089,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Meat,"",,0.4,,,servings/day,,,"Plasma (phospholipids), fasting",GC-FID,Myristic acid (14:0),"",,,,percentRoot,,2837,Spearman,-0.06,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
9503,23103,23090,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Meat,"",,0.4,,,servings/day,,,"Plasma (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",,,,percentRoot,,2837,Spearman,-0.05,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
9504,23104,23091,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),French fries,"",,,,,servings/day,,,"Plasma (phospholipids), fasting",GC-FID,Palmitelaidic acid (trans-16:1n-7),"",,,,percentRoot,,2837,Spearman,0.16,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
9505,23105,23091,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Crackers,"",,0.2,,,servings/day,,,"Plasma (phospholipids), fasting",GC-FID,Palmitelaidic acid (trans-16:1n-7),"",,,,percentRoot,,2837,Spearman,0.08,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
9506,23106,23090,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Cakes,"",,0.2,,,servings/day,,,"Plasma (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",,,,percentRoot,,2837,Spearman,0.09,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
9507,23106,23091,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Cakes,"",,0.2,,,servings/day,,,"Plasma (phospholipids), fasting",GC-FID,Palmitelaidic acid (trans-16:1n-7),"",,,,percentRoot,,2837,Spearman,0.17,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
9477,23115,23090,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Myristic acid (14:0),"",,,,,missing unit,,,"Plasma (phospholipids), fasting",GC-FID,Pentadecylic acid (15:0),"",,,,percentRoot,,2837,Spearman,0.51,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
9478,23116,23091,All,Participants in a cohort study to identify risk factors associated with CVD development and progression,United States,MESA (Multi-Ethnic Study of Atherosclerosis),,Food Frequency Questionnaire (FFQ),Pentadecylic acid (15:0),"",,,,,missing unit,,,"Plasma (phospholipids), fasting",GC-FID,Palmitelaidic acid (trans-16:1n-7),"",,,,percentRoot,,2837,Spearman,0.3,,,< 0.05,Yes,,,"Field center, Age, Sex, Ethnicity, Education, Cigarette smoking, Alcohol intake, Physical activity, BMI, Diabetes at baseline, Dietary supplements, Energy intake, Fiber intake",de Oliveira Otto 2013
